Stichwörtern/Keywords

Please select a value to browse from the list below.

; (525)
0.03 MG ESTRIOL; BACTERIAL VAGINOSIS; ATROPHY; DIAGNOSIS; FLORA; MANAGEMENT; PESSARIES; EFFICACY; THERAPY; TRACT; (1)
0er 10er 20er WWK VGR Investitionen (1)
0er 10er Steuern VGR (1)
100-PERCENT AQUEOUS-SOLUTION; CONJUGATED POLYMERS; ORDERED STRUCTURES; FLUORESCENT; ATP; DERIVATIVES; PROBE; WATER; POLYACETYLENE; PYROPHOSPHATE; ATP; Phosphate; Polythiophene; Fluorescence; UV/vis spectroscopy; Circular dichroism (1)
100-PERCENT AQUEOUS-SOLUTION; MONOSACCHARIDE DETECTION; MOLECULAR RECOGNITION; BIPYRIDINIUM SALTS; ATP; VIOLOGEN; SENSORS; PHOSPHATES; ANIONS; ASSAY; ATP; Phosphate; Charge transfer complex; Fluorescence; Pyranine; Viologen (1)
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; NECROSIS-FACTOR-ALPHA; IN-VIVO; BETA(2)-ADRENERGIC RECEPTORS; CHROMOSOMAL LOCALIZATION; ADRENERGIC-RECEPTORS; CYCLIC-NUCLEOTIDES; EPITHELIAL-CELLS; TISSUE; MODULATION; (1)
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; PITUITARY-ADRENAL AXIS; MAJOR DEPRESSION; RECEPTORS; BEHAVIOR; OBESITY; STRESS; MODEL; corticosterone; knockout; mouse; 11 beta-dehydroxysteroid dehydrogenase (1)
11-CIS-RETINOL DEHYDROGENASE GENE; RECESSIVE RETINITIS-PIGMENTOSA; NIGHT BLINDNESS; RETINYL ESTERS; DYSTROPHY; ACCUMULATION; CONE; EPITHELIUM; DISEASES; THERAPY; fundus albipunctatus; full-field ERG; dark adaptation; optical coherence tomography; fundus autofluorescence photography; multifocal ERG; lipofuscin (1)
11TH EUROPEAN WORKSHOP; PERI-IMPLANT DISEASES; ORAL-HEALTH; SECONDARY PREVENTION; MANAGING GINGIVITIS; SOCIAL INEQUALITIES; PLAQUE REMOVAL; CLINICAL-TRIAL; GLOBAL BURDEN; RISK-FACTOR; chemical plaque control; clinical recommendations; consensus conference; dental caries; evidence-based medicine; fluoride; gingivitis; interdental cleaning; mechanical plaque control; oral hygiene; periodontitis; prevention; systematic review (1)
1,25-DIHYDROXYVITAMIN D-3; INFLAMMATORY CYTOKINES; IN-VITRO; DIFFERENTIATION; MATURATION; MACROPHAGES; INTERFERON; EXPRESSION; INVITRO; (1)
1,25-DIHYDROXYVITAMIN-D3 PRODUCTION; BLOOD MONOCYTES; DENDRITIC CELLS; D-RECEPTOR; IN-VITRO; MACROPHAGES; D-3; DIFFERENTIATION; 27-HYDROXYLASE; ACTIVATION; monocyte; macrophage; dendritic cell; active vitamin D3; CYP27A1; CYP27B1; CYP24A1 (1)
1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes; biological response modifiers; synthesis; estrogen receptor affinity; estrogenic/antiestrogenic activity (1)
<1,2-BIS(2,6-DIHALO-3-HYDROXYPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; MAMMARY; platinum complexes; mammary carcinoma; mode of action; antitumor activity (1)
12-YEAR FOLLOW-UP; ANTI-HBS; ANAMNESTIC RESPONSE; SURFACE ANTIBODY; IMMUNE MEMORY; CHILDREN; BOOSTER; EFFICACY; PERSISTENCE; IMMUNIZATION; hepatitis B; infant vaccination; booster; long-term protection; determinants of protection (1)
13/15-Chemie, Phosphanylboran, Koordinationsverhalten (1)
13/15 compounds · ligand properties · pnictogen · tolman electronic parameter · triels (1)
1,3-Diphosphete, Cobalt, Reaction conditions, Gold, Silver, Weakly coordinating anion (1)
1,3-diphosphete · coordination polymer · copper · cobalt · phosphaalkynes (1)
1,3-DIPOLAR CYCLOADDITION REACTIONS; AZOMETHINE YLIDES; THIOCARBONYL YLIDES; SUBSTITUTED ETHYLENES; ELECTRON-TRANSFER; THIOKETONES; AZIRIDINES; CHEMISTRY; CRYSTAL; ALKENES; (1)
1,3-DIPOLAR CYCLOADDITIONS; TERMINAL ALKYNES; LIVING SYSTEMS; CHEMISTRY; LIGATION; AZIDES; PROTEINS; GLYCANS; CELLS; (1)
1,3-DIPOLAR CYCLOADDITIONS; TERMINAL ALKYNES; LIVING SYSTEMS; COPPER-FREE; AZIDES; LIGATION; GLYCANS; SINGLE; DNA; click chemistry; copper; FRET; peptides (1)
1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; FLUORESCENT PYROPHOSPHATE SENSOR; HISTIDINE-TAGGED PROTEINS; MOLECULAR RECOGNITION; ZINC(II) COMPLEX; LIVE CELLS; PHYSIOLOGICAL CONDITIONS; PHOSPHORYLATED PEPTIDES; CARBOXYESTER HYDROLYSIS; COORDINATION-COMPLEXES; Cross-coupling; Click chemistry; Palladium; Macrocycles; Luminescence; Molecular recognition (1)
1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; POTENT PROMOTERS; PHYSIOLOGICAL CONDITIONS; ACID ESTERS; ACCELERATION; VESICLES; METALLOMICELLES; METALLOENZYMES; SURFACTANTS; CATALYSIS; (1)
1,4,7,10-Tetraazacyclododecane; Molecular recognition; Peptide synthesis; Transition metal binding (1)
1,4-cycloaddition, anthracene, diamino alcohols (1)
; 14F42 (primary); 19E08; 19E15 (secondary) (1)
1542, Hochstift Regensburg, Konfessionswechsel, Martin Luther, Stadt der Ökumene, Stadtgeschichte, evangelisches Bayern, Ökumenisches Prinzip Regensburg, Reformation, Historische Stätte (1)
15-M, Documentary, Film, Social Movement Documentary, Basilio Martin Patino, Sylvain George, Alfonso Amador, Twiggy Hirota (1)
15-YEAR FOLLOW-UP; PROSPECTIVE RANDOMIZED-TRIAL; PLASMA-DERIVED VACCINE; INDUCED ESCAPE MUTANT; DNA YEAST VACCINE; ANTI-HBS; SURFACE-ANTIGEN; EXPANDED PROGRAM; HEPATOCELLULAR-CARCINOMA; MASS VACCINATION; hepatitis B; vaccine; long-term efficacy; booster policy; HBV mutants; vaccination programmes (1)
15 ZINTL IONS; 1,2,3-TRIPNICTOLIDE ANIONS; CLUSTERS; HEPTAPHOSPHIDE; CARBODIIMIDES; REACTIVITY; Polyarsenide; Acetylene; Liquid ammonia; Crystal structure; Zintl anions; X-ray diffraction (1)
15 ZINTL IONS; REACTIVITY; CLUSTERS; ANIONS; Polyarsenide; Polyantimonide; Liquid ammonia; Crystal structure; X-ray diffraction; Electron localization function (ELF) (1)
16S RIBOSOMAL-RNA; DENITRIFYING BACTERIA; GEN-NOV; DIAMINOPIMELIC ACID; CELL-WALL; DIVERSITY; NIRK; PCR; NITRIFICATION; REDUCTASE; Paenibacillus uliginis sp nov.; Paenibacillus purispatii sp nov.; Heterotrophic nitrification; Denitrification; Dissimilatory nitrate/nitrite reduction to ammonium; Space craft associated clean rooms; Planetary protection (1)
16S RIBOSOMAL-RNA; FLUORESCENTLY LABELED OLIGONUCLEOTIDE; YELLOWSTONE-NATIONAL-PARK; PEARLS-LIKE MORPHOLOGY; IN-SITU DETECTION; PHYLOGENETIC CHARACTERIZATION; CENARCHAEUM-SYMBIOSUM; NATURAL COMMUNITIES; ARCHAEA; BACTERIA; Archaea; Crenarchaeota; Thiothrix; sulphidic springs; string-of-pearls; psychrophilic; microbial community (1)
16S RIBOSOMAL-RNA; GENE; IDENTIFICATION; HSP65; RPOB (1)
16S RIBOSOMAL-RNA; GNOTOBIOTICALLY-REARED LAMBS; SULFATE-REDUCING BACTERIA; REDUCTIVE ACETOGENESIS; BOVINE RUMEN; ACETITOMACULUM-RUMINIS; CELLULOLYTIC BACTERIA; ESTABLISHMENT; POPULATIONS; GENE; (1)
16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; SP NOV.; RAPID IDENTIFICATION; GROWING MYCOBACTERIA; SEQUENCE-ANALYSIS; INFECTIONS; AMPLIFICATION; DISEASE; HSP65; (1)
16S RIBOSOMAL-RNA; SEA HYDROTHERMAL VENT; SITU GROWTH CHAMBER; MID-ATLANTIC RIDGE; B-DNA-POLYMERASES; IZU-BONIN ARC; SP-NOV; F420H2-QUINONE OXIDOREDUCTASE; SULFOLOBUS-SOLFATARICUS; HALORHABDUS-UTAHENSIS; hyperthermophilic; marine; strictly anaerobic; sulfate respiration; hydrogen utilization; hydrothermal systems; Archaeoglobaceae; GEBA (1)
16S RIBOSOMAL-RNA; SP NOV.; MASTOTERMES-DARWINIENSIS; RETICULITERMES-SPERATUS; ATMOSPHERIC METHANE; TARGETED PROBES; IDENTIFICATION; SOIL; GROUNDWATER; ARCHAEA; Methane oxidizing bacteria; Microflora of termites; Isolation of MOB; Methylocystis; pmoA (1)
16S RIBOSOMAL-RNA; YELLOWSTONE-NATIONAL-PARK; AMMONIA OXIDIZING ARCHAEON; SULFOLOBUS-ACIDOCALDARIUS; BACTERIAL DIVERSITY; GEOTHERMAL AREAS; ELEMENTAL SULFUR; SP-NOV; TEMPERATURE; LIFE; (1)
17‐DMAG; cardiocondyla; decanalization; HSP90; morphological divergence (1)
17β-Estradiol, Chondrogenese, MSCs, MAPK (1)
18F-fluorodeoxyglucose, PET/CT, periprosthetic joint infection, sepsis, mechanical ventilation, synchronous infection focus (1)
18F radiopharmaceuticals, Aluminum[18F]fluoride, Ubiquicidin, Antimicrobial peptides, Infection imaging (1)
18 KDA TSPO; ADULT SEPARATION ANXIETY; TERM BENZODIAZEPINE USE; RECEPTOR MESSENGER-RNA; NEUROACTIVE STEROIDS; MAJOR DEPRESSION; MOUSE MODEL; MITOCHONDRIAL; LIGAND; EXPRESSION; (1)
18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTOR; NEUROPATHIC PAIN; ETIFOXINE; THERAPY; BRAIN; CHANNELS; LIGANDS; ALLOPREGNANOLONE; RECONSTRUCTION; Dual mode-of-action; Kv7 potassium channels; Mitochondrial translocator protein 18 kDa; (TSPO); Chronic neuropathic pain; Neuroregeneration (1)
1,8-naphthalimide dyes articular-cartilage tensile-strength photolysis protein family solder skin (1)
18 RANDOMIZED-TRIALS; CLINICAL-TRIALS; COLON-CANCER; Bladder cancer; Disease-free survival; Primary endpoint; Prognosis; Radical cystectomy; Urothelial carcinoma (1)
19D25; 14G22 (1)
19.Jh 0er 10er 20er 30er 40er 50er 60er 70er Gewinne (1)
19. Jh; 0er; 10er; 20er; 30er; Industrie; Gewinne (1)
19.Jh 0er 10er D Finanzen Steuern (1)
19.Jh 0er 10er Steuern Preußen Württemberg (1)
19.Jh 0er Steuern (1)
19.Jh 1848 A B CH D ES F H I NL R SE SF UK Agrar Industrie Preise (2)
19.Jh 20.Jh Arbeitsmarkt (1)
19.Jh; 20.Jh; CH; D; Preußen; Finanzen; Steuern; Steuerwettbewerb (1)
19.Jh 20.Jh Innovation (1)
19.Jh Preußen Steuern indSt M&SSt Inzidenz (1)
1. Akute Pfortaderthrombose, 2. Chirurgische Therapie, 3. Hybridverfahren (1)
1-Benzyl-1,2,3,4-tetrahydroisoquinolines, Ethyl chloroformate, Mosher-Esters (1)
1) Cholangiozelluläres Karzinom (CCA): aggressiver Tumor mit limitierten Therapieoptionen unter anderem durch oftmals späten Diagnosezeitpunkt bedingt 2) Untersuchung des Transkriptionsfaktor E2F1 und einiger regulatorischer Gene in humanen Tuomrproben, sowie CCA-Zelllinien 3) HLM006474 als E2F1-Inhibitor beeinflusst das Wachstumsverhalten von CCA-Zellen in der Zellkultur (1)
1/D CORRECTIONS; PARTICLE PROPERTIES; SPINLESS FERMIONS; HIGH DIMENSIONS; HUBBARD-MODEL; SYSTEMS; LATTICE; APPROXIMATION; LIMIT; (1)
1H NMR; 13C NMR; 15N NMR; 29Si NMR; 31P NMR; mesoporous silica; organometallic complexes; surface; hydrogen bonding; DFT (1)
1-Motives, independence of l, Motives, Good Reduction, Néron-Ogg-Shafarevich, local systems (1)
1-N-BUTYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; ELECTROLYTIC CONDUCTIVITY; ELECTRICAL-CONDUCTIVITY; PHYSICAL-PROPERTIES; AQUEOUS-SOLUTIONS; TEMPERATURE; WATER; VISCOSITY; DENSITY; (1)
1-nitronaphthalene, arachidonic acid, cyclooxygenase, inflammatory mediators, linoleic acid, lipoxygenase, ozone (2)
1ST 6 YEARS; LUNG-FUNCTION; PRESCHOOL-CHILDREN; RISK-FACTORS; LIFE; WHEEZE; ATOPY; SENSITIZATION; ASSOCIATION; EXPOSURE; childhood asthma; phenotypes; latent class analysis; epidemiology (1)
1ST CHARACTERIZATION; 18-CROWN-6; RECOGNITION; COMPLEXES; SPECTRA; RADII; ION; VAN; supramolecular chemistry; hydrogen bond; low temperature crystal structure analysis; ammonia; crown ether; cryptand; X-ray diffraction; single crystal structure analysis (1)
1ST CHARACTERIZATION; MONOSODIUM CYANAMIDE; NEUTRON-DIFFRACTION; HYDROGEN CYANAMIDE; X-RAY; DICYANAMIDE; COMPLEX; liquid ammonia; hydrogen bonding; low-temperature crystal structure analysis; ammonium ion; cyanamide; cyanimide; dicyandiamide (1)
1ST CHARACTERIZATION; ORIENTATIONAL ORDER; ROTATIONAL-DYNAMICS; CRYSTAL-STRUCTURE; AMIDE IONS; DIFFRACTION; NH3; potassium amide diammoniate; ammoniates; crystal structure; liquid ammonia; hydrogen bonds (1)
1ST; COVID-19; Death; Mortality; Case fatality ratio; Hospitalization (1)
1ST EIGENVALUE; MANIFOLDS; GEOMETRY; SPINORS; METRICS; BOUNDS; Foliations; Sasakian manifolds; Spin geometry; Spectral geometry; Estimation of eigenvalues - upper and lower bounds (1)
1ST IMPRESSION; VISUAL COMPLEXITY; WEBSITES; USERS; PREFERENCES; INFORMATION; PERFORMANCE; EXPERIENCE; USABILITY; JUDGMENTS; aesthetics; websites; affect; user experience (1)
1ST-IN-HUMAN CLINICAL-TRIALS; STATISTICAL ISSUES; ADAPTIVE DESIGNS; TASK-FORCE; ESCALATION; QUALITY; RECOMMENDATIONS; GUIDELINES; ONCOLOGY; THERAPIES; early phase; clinical trials; SPIRIT guideline; CONSORT guideline; dose finding (1)
1ST-LINE TREATMENT; NON-INFERIORITY; SORAFENIB; Lenvatinib; Hepatocellular carcinoma; REFLECT study; Real-world cohort; Liver function; Albumin-bilirubin grade (1)
1ST-LINE TREATMENT; OPEN-LABEL; PITUITARY; OSIMERTINIB; fluorescein sodium; fluorescence-guided surgery; brain metastases; neuro-oncologic surgery; extent of resection; malignant brain tumors; neuro-oncology (1)
1ST METATARSAL; CHEVRON OSTEOTOMY; AVASCULAR NECROSIS; HEAD; SURGERY; Metatarsal; Intraosseous; Arterial supply; Plastination; Osteotomy (1)
1ST METATARSOPHALANGEAL JOINT; KELLERS OPERATION; PLATE FIXATION; ARTHRODESIS; ARTHROPLASTY; REPLACEMENT; CHEILECTOMY; ARTHROSCOPY; MANAGEMENT; ETIOLOGY; Hallux rigidus; Metatarsophalangeal joint; Arthrodesis; Cheilectomy; Arthroplasty (1)
1ST ZOEAL STAGES; DECAPODA; CRAB; SALINITY; COAST; SAUSSURE; extended larval development; Geograpsus lividus; larval stages; megalopa; zoea (1)
1ST ZOEAL STAGES; GRAPSIDAE; MORPHOLOGY; DECAPODA; GRAPSOIDEA; ECOLOGY; MESSA; DANA; (1)
1ST ZOEAL STAGES; LARVAL DEVELOPMENT; FRESH-WATER; CRUSTACEA DECAPODA; PINNOTHEROID CRABS; THERMAL TOLERANCE; IQ-TREE; MORPHOLOGY; FAMILY; GENUS; Grapsoidea; Ocypodoidea; Pinnotheroidea; Symbiosis; Terrestrialization (1)
1.WK 2.WK D JPN Zwangsarbeit (1)
1.WK 2.WK F Kgf Zwangsarbeit (1)
1.WK Zw (1)
2005 INTERNATIONAL-SOCIETY; PATHOLOGY ISUP CONSENSUS; RADICAL PROSTATECTOMY; PREOPERATIVE NOMOGRAM; DISEASE RECURRENCE; NEEDLE BIOPSIES; SPECIMENS; CARCINOMA; IMPACT; INTERMEDIATE; Gleason score 2-4; Concordance; Prognosis; Prostate cancer; Prostatectomy (1)
2005 INTERNATIONAL-SOCIETY; RADICAL PROSTATECTOMY; NEEDLE-BIOPSY; INTEROBSERVER REPRODUCIBILITY; PREOPERATIVE NOMOGRAM; DISEASE RECURRENCE; GRADING SYSTEM; CANCER; SPECIMENS; CARCINOMA; prostate cancer; radical prostatectomy; Gleason score; WHO grade; time trends; prognosis (1)
2009 INFLUENZA A(H1N1); ACUTE LUNG INJURY; RANDOMIZED CONTROLLED-TRIAL; END-EXPIRATORY PRESSURE; DISTRESS-SYNDROME; LIFE-SUPPORT; SUFFICIENT EVIDENCE; GAS-EXCHANGE; CO2 REMOVAL; VENTILATION; acute respiratory distress syndrome; extracorporeal membrane oxygenation; mechanical ventilation; review article (1)
2009 INFLUENZA A(H1N1); DISTRESS-SYNDROME; COMPLICATIONS; MORTALITY; ECMO; intracranial hemorrhage; neurologic complications; respiratory failure; stroke; veno-venous extracorporeal membrane oxygenation (1)
2009 INFLUENZA A(H1N1); MEMBRANE-OXYGENATION; DISTRESS-SYNDROME; CO2 REMOVAL; UNITED-STATES; VENTILATION; MORTALITY; VIRUS; (1)
2009 INFLUENZA A(H1N1); POSTCARDIOTOMY CARDIOGENIC-SHOCK; DISTRESS-SYNDROME; LIFE-SUPPORT; MECHANICAL VENTILATION; CIRCULATORY SUPPORT; CARDIAC-RESCUE; HIGH SURVIVAL; 6 ML/KG; VOLUME; extracorporeal membrane oxygenation; acute respiratory distress syndrome; hospital organization; critical care networks; position article (1)
2016 ESC GUIDELINES; EXCESS MORTALITY; PEOPLE; SURVEILLANCE; MANAGEMENT; BURDEN; RISK; Pharmacoepidemiology; Psychiatry; Antihypertensive agents; Drug interactions; Hypertension; drug therapy (1)
2016 ESC GUIDELINES; ISCHEMIC-STROKE; HEART-FAILURE; RISK; PREDICTOR; atrial fibrillation; brain natriuretic peptide; plasma; randomized controlled trial; risk (1)
20er 30er 40er Industrie Gewinne (1)
20er 30er 40er Maschinenbau Kfz DAIMBENZ Opel VW (1)
20er 30er 40er Steuerbilanz Bilanz Eisen Stahl MITDEUSA KRUPP VSt (1)
20er D Reparationen (1)
20er Investitionen Löhne Borchardt (1)
20er WWK 30er 40er Bilanz Steuerbilanz (1)
20er WWK 30er 40er Bilanz Steuerbilanz Gewinne (1)
20er WWK Glas Konzentration Kartelle (1)
20.Jh D F WiPol SozMaWi (1)
20.Jh EU Agrar (1)
20.Jh EU Agrar CAP (1)
20.Jh VGR (1)
20-LIKE KINASE-3 MST3; CARDIOVASCULAR-SYSTEM; CELL-MIGRATION; CCM3 MUTATIONS; PATHOGENESIS; PATHWAY; KRIT1; ACTIVATION; APOPTOSIS; GOLGI; cerebral cavernous malformation; CCM3; PDCD10; CCM2; STK25; MST4 (1)
20-YEAR FOLLOW-UP; CONSERVING SURGERY; RE-EXCISION; GUIDED LUMPECTOMY; MARGIN STATUS; RADIATION-THERAPY; LOCAL RECURRENCE; LOCALIZATION; MULTICENTER; MASTECTOMY; breast cancer; ultrasound; gynaecology (1)
21ST AMINO-ACID; DROSOPHILA-MELANOGASTER; ANTIOXIDANT ACTIVITY; CELL-PROLIFERATION; OXIDATIVE STRESS; GENETIC-CODE; ANT QUEENS; LIFE-SPAN; SELENOCYSTEINE; BIOSYNTHESIS; Selenoprotein; Selenophosphate synthetase 1; Male accessory gland proteins; Hymenoptera (1)
2+2+2 CYCLOADDITION; INTRAMOLECULAR CYCLOTRIMERIZATION; HETEROGENEOUS CATALYSIS; ORGANIC-SYNTHESIS; COMPLEXES; DIYNES; METAL; HYDROGENATIONS; TRIYNES; alkynes; arene synthesis; cyclotrimerization; iron; nanoparticles (1)
2,2'/6',2''-TERPYRIDINE; DERIVATIVES; PROBE; europium complexes; luminescent probes; citrate sensing (2)
; 2,2 '-Biphenyldiamine; Cyclometalated complexes; Cytotoxic activity; Iridium; Rhodium (1)
[2.2]Paracyclophanes; 1,2-Dibromoarenes; anti-[2.2]Paracyclophanes; Aryne generation; Diels-Alder reactions (1)
[2.2]Paracyclophanes, new derivatives of; Isobenzofuranophanes, preparation and cycloadditions (1)
2+2 PHOTOCYCLOADDITION; INTRAMOLECULAR PHOTOCYCLOADDITION; ACID CATALYSIS; FRAGMENTATION; PHOTOADDITION; IRRADIATION; REDUCTION; SCAFFOLDS; PRODUCTS; ACCESS; cycloaddition; heterocycles; photochemistry; radicals; reaction mechanisms (1)
2+2 PHOTOCYCLOADDITION REACTIONS; BRONSTED ACID; ASYMMETRIC INDUCTION; CARBOXYLIC-ACIDS; CYCLIC ENONES; PHOSPHORESCENCE; CATALYSIS; DERIVATIVES; ACTIVATION; ALPHA,BETA-ENONES; enantioselectivity; hydrogen bonds; organocatalysis; photochemistry; sensitizers (1)
2+2 PHOTOCYCLOADDITION REACTIONS; BRONSTED ACID; THIOXANTHONE; ALKYLATION; POTENTIALS; SENSITIZER; ALDEHYDES; RADICALS; IMINIUM; SINGLET; (1)
2,3-BUTANEDIONE MONOXIME; GENETIC-CONTROL; LIFE-CYCLE; GREEN; FOYN; MYOSIN; MORPHOGENESIS; ALGAE; DIFFERENTIATION; ENTEROMORPHA; Chlorophyta; gamete release; gametogenesis; sporulation inhibitors; swarming inhibitor; Ulva lactuca; Ulva mutabilis (1)
2,3-DISUBSTITUTED INDOLES; ALPHA; LIGANDS; SYSTEMS; 2-ARYL; indoles; cyclizations; heterocycles; radical reactions; dehydrogenations; microwave irradiation (1)
23S RIBOSOMAL-RNA; GASTRIC BIOPSY SPECIMENS; HELICOBACTER-PYLORI; CLARITHROMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; TRIPLE THERAPY; STRAINS; MUTATIONS; INFECTION; PCR; Helicobacter pylori; macrolide resistance; resistance testing; FISH; formalin-fixed tissue (1)
24-hour; sitting; exercise; guidelines; public health (1)
25.0 DEGREES-C; ELECTROLYTE MIXTURES; CONDUCTANCE MEASUREMENTS; IONIZATION-CONSTANTS; CONDUCTIVITY; SODIUM; WATER; TEMPERATURES; CALIBRATION; ACESULFAME; Cyclamic acid; Conductivity; Thermodynamics; Electrolyte dissociation; Dimerization; Limiting electrolyte conductivities; Ionic conductivities; Dissociation constants; Dimerization constants (1)
25 DEGREES C; VISCOSITY B-COEFFICIENTS; ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; SOLVENT STRUCTURE; HALIDE SOLUTIONS; SODIUM-BROMIDE; IONIC-RADII; RELAXATION; HYDRATION; (1)
25-GAUGE SUTURELESS VITRECTOMY; POSTERIOR VITREOUS DETACHMENT; PARS-PLANA VITRECTOMY; CATARACT-EXTRACTION; OBLIQUE SCLEROTOMIES; 20-GAUGE VITRECTOMY; REPAIR; SURGERY; PHACOEMULSIFICATION; EYES; cataract; retina; vitreous (1)
26S proteasome, gating, cryo-electron microscopy, AAA+ ATPase, integrative modeling, proteolysis, ubiquitin, ATP hydrolysis (1)
2 ADJACENT N6,N6-DIMETHYLADENOSINES; SP-NOV REPRESENTS; ESCHERICHIA-COLI; HALOFERAX-VOLCANII; KASUGAMYCIN RESISTANCE; COMPUTATIONAL PLATFORM; DIMETHYLASE DIM1P; ORTHOLOGOUS GENES; DECODING DOMAIN; METHYL-GROUPS; (1)
2-AMINOETHYL PENDANT ARMS; SCHIFF-BASE COMPLEXES; X-RAY STRUCTURE; CRYSTAL-STRUCTURE; CADMIUM(II) COMPLEX; MAGNETIC-PROPERTIES; LIGAND; COORDINATION; ZINC(II); 2,6-DIACETYLPYRIDINE; (1)
2-BODY WEAR; HUMAN-ENAMEL; SUBSTRUCTURE CERAMICS; RESTORATIVE MATERIALS; OPPOSING ZIRCONIA; GLAZED ZIRCONIA; PORCELAIN; BEHAVIOR; CROWNS; ANTAGONISTS; Two-body wear; Wear simulation; Dental ceramics; Zirconia; Surface treatment; Roughness (1)
2-c-methyl-d-erythritol 4-phosphate pathway escherichia-coli isoprenoid biosynthesis nonmevalonate pathway 4-(cytidine 5'-diphospho)-2-c-methyl-d-erythritol isopentenyl diphosphate gene 5-phosphate protein lytb (1)
2D COSY SPECTRA; ACCURATE MEASUREMENT; PROTEIN-STRUCTURE; NMR; CONSTANTS; MACROMOLECULES; SPECTROSCOPY; FOLDS; ALIGNMENT; SEQUENCES; MOCCA mixing sequence; NMR; protein structure; residual dipolar couplings; SIAM experiment (1)
2DEG, spin injection, spin transport, spintronics (1)
2D ELECTRON-GAS; INAS NANOWIRES; QUANTUM-WELLS; MAGNETORESISTANCE; ANTILOCALIZATION; HETEROSTRUCTURES; GROWTH; RINGS; FIELD; GAAS; (1)
2D Gravity, Matrix Models, AdS-CFT Correspondence (2)
2D-Gravity, Matrix Models, AdS-CFT Correspondence (1)
2-DIMENSIONAL BUBBLE DYNAMICS; DIFFUSE-INTERFACE MODEL; FRONT-TRACKING METHOD; MULTI-FLUID FLOWS; SURFACE-TENSION; BENCHMARK COMPUTATIONS; INCOMPRESSIBLE-FLOW; SPURIOUS VELOCITIES; APPROXIMATION; VOLUME; Finite elements; XFEM; Two-phase flow; Navier-Stokes; Free boundary problem; Surface tension; Interface tracking (1)
2-DIMENSIONAL ELECTRON; DIELECTRIC FUNCTION; SPIN; TEMPERATURE; CYCLOTRON; RESONANCE; (2)
2-DIMENSIONAL ELECTRON-GAS; BRANCHED FLOW; SCATTERING; SEMICONDUCTORS; INTERFERENCE; CONDUCTANCE; GAAS; Ballistic optoelcaronic quantum transport; nanoscale electronics (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; MAGNETORESISTANCE OSCILLATIONS; TRANSPORT; ARRAYS; (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; TRANSPORT; HETEROSTRUCTURES; SEMICONDUCTORS; TEMPERATURE; GRAPHENE; ARRAYS; (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; TRANSPORT; WELLS; HETEROSTRUCTURES; RADIATION; ARRAYS; FIELD; (1)
2-DIMENSIONAL ELECTRON-GAS; COULOMB DRAG; SCATTERING; HETEROSTRUCTURES; TRANSPORT; EMISSION; (1)
2-DIMENSIONAL ELECTRON-GAS; CYCLOTRON-RESONANCE; DEEP IMPURITIES; TUNNEL IONIZATION; PHOTOCONDUCTIVITY; HETEROSTRUCTURES; SEMICONDUCTORS; RELAXATION; RESISTANCE; SYSTEMS; (1)
2-DIMENSIONAL ELECTRON GASES; QUANTUM RATCHETS; TRANSPORT; INJECTION; BARRIERS; SEMICONDUCTORS; SCATTERING; (1)
2-DIMENSIONAL ELECTRON GASES; QUANTUM-WELLS; FERROMAGNETIC SEMICONDUCTORS; ORBIT INTERACTION; BAND; HETEROSTRUCTURES; ORIENTATION; SPINTRONICS; SCATTERING; LAYERS; spin Hall effect; spin-orbit coupling; III-V semiconductors (1)
2-DIMENSIONAL ELECTRON-GAS; FAR-INFRARED RADIATION; MICROWAVE-RADIATION; DEEP IMPURITIES; FIELDS; WELLS; IONIZATION; ABSORPTION; TRANSPORT; TIME; (1)
2-DIMENSIONAL ELECTRON-GAS; FIELDS; MAGNETOMETER; ENERGY; SYSTEM; WELLS; (1)
2-DIMENSIONAL ELECTRON-GAS; FORCE MICROSCOPE; COULOMB-BLOCKADE; NANOSTRUCTURES; DENSITY; PROBE; (1)
2-DIMENSIONAL ELECTRON-GAS; GAAS/ALGAAS QUANTUM-WELLS; STRONG MAGNETIC-FIELD; INVERSION-LAYERS; DYNAMIC-RESPONSE; RESONANCE; EXCITATIONS; DOTS; RADIATION; (1)
2-DIMENSIONAL ELECTRON-GAS; GAAS; SEMICONDUCTORS; (1)
2-DIMENSIONAL ELECTRON-GAS; HETEROSTRUCTURES; OXIDATION; SPECTROSCOPY; (1)
2-DIMENSIONAL ELECTRON-GAS; HGTE/CDTE-BASED HETEROSTRUCTURES; CYCLOTRON-RESONANCE; MAGNETIC-FIELDS; TOPOLOGICAL INSULATORS; LANDAU-LEVELS; TRANSPORT; GRAPHENE; SYSTEMS; SEMICONDUCTOR; (1)
2-DIMENSIONAL ELECTRON-GAS; HIGH MAGNETIC-FIELDS; SPIN-FLIP EXCITATIONS; DONOR IMPURITIES; LANDAU-LEVEL; 2 DIMENSIONS; STATES; HETEROJUNCTIONS; RESONANCE; SKYRMIONS; (1)
2-DIMENSIONAL ELECTRON-GAS; LANDAU-LEVEL; OSCILLATIONS; SPIN; cyclotron; composite fermions; surface acoustic waves (1)
2-DIMENSIONAL ELECTRON-GAS; LANDAU-LEVELS; HETEROSTRUCTURES; RESONANCE; REGIME; SYSTEM; LEVEL; (1)
2-DIMENSIONAL ELECTRON-GAS; LASERS; GAAS; (2)
2-DIMENSIONAL ELECTRON-GAS; MAGNETIC-FIELD; COMPOSITE FERMIONS; GROUND-STATES; QUANTUM FLUID; EXCITATIONS; EXCITONS; SPECTROSCOPY; TRANSITION; EMISSION; (2)
2-DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; SCATTERING; (1)
2-DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; TUNNELING IONIZATION; CYCLOTRON-RESONANCE; DEEP IMPURITIES; FIELDS; PHOTOCONDUCTIVITY; SEMICONDUCTORS; (1)
2-DIMENSIONAL ELECTRON-GAS; MULTILAYERS; INSULATOR; (1)
2-DIMENSIONAL ELECTRON-GAS; NEGATIVELY CHARGED EXCITONS; HIGH MAGNETIC-FIELDS; LUMINESCENCE SPECTRA; COMPOSITE FERMIONS; FINITE-SIZE; WELLS; GAAS; EXCITATIONS; STATES; (1)
2-DIMENSIONAL ELECTRON-GAS; NORMAL-METAL RINGS; EDGE STATES; GAAS; MAGNETORESISTANCE; FLUCTUATIONS; WAVES; (1)
2-DIMENSIONAL ELECTRON-GAS; O LANDAU-LEVEL; MAGNETIC-FIELD; COMPOSITE FERMIONS; CHARGED EXCITONS; REVERSED SPINS; GROUND-STATES; EXCITATIONS; PROBE; (1)
2-DIMENSIONAL ELECTRON-GAS; PHOTON-DRAG; OPTICAL ORIENTATION; SEMICONDUCTOR HETEROSTRUCTURES; INTERBAND-TRANSITIONS; INVERSION ASYMMETRY; ORBIT INTERACTION; POLARIZED CURRENT; CONDUCTION-BAND; SPLIT SUBBANDS; (1)
2-DIMENSIONAL ELECTRON-GAS; POINT CONTACTS; SPIN HALL; REGIME; CHANNELS; CONDUCTANCE; MICROSCOPY; CURRENTS; DENSITY; WELLS; quantum hall edge states; quantum points contacts; optolectronics (1)
2-DIMENSIONAL ELECTRON-GAS; QUANTUM POINT-CONTACT; CYCLOTRON-RESONANCE; INVERSION LAYERS; BRANCHED FLOW; SCATTERING; MOBILITY; TRANSPORT; HETEROSTRUCTURES; INTERFERENCE; (1)
2-DIMENSIONAL ELECTRON-GAS; QUANTUM-WELLS; SPINTRONICS; (1)
2-DIMENSIONAL ELECTRON-GAS; QUASI-CLASSICAL CALCULATION; MAGNETORESISTANCE OSCILLATIONS; magnetotransport; two-dimensional electron systems; lateral superlattice; Weiss oscillations (1)
2-DIMENSIONAL ELECTRON-GAS; SEMICONDUCTORS; POLARIZATION; ORIENTATION; spintronics; spin caloritronics; spin-orbit interaction; spin Hall magnetoresistance; spin Nernst magnetothermopower (1)
2-DIMENSIONAL ELECTRON-GAS; SUSPENDED GRAPHENE; DIRAC FERMIONS; MAGNETORESISTANCE OSCILLATIONS; BALLISTIC TRANSPORT; BILAYER GRAPHENE; SCATTERING; STATES; (1)
2-DIMENSIONAL ELECTRON-GAS; SYSTEM; HETEROSTRUCTURES; PHYSICS; MBE; (1)
2-DIMENSIONAL ELECTRON-GAS; TERAHERTZ DETECTION; BROWNIAN MOTORS; PLASMONICS; TRANSPORT; GRAPHENE (1)
2-DIMENSIONAL ELECTRON-GAS; ZERO-RESISTANCE STATES; CYCLOTRON-RESONANCE; OSCILLATIONS; PHOTOCONDUCTIVITY; PLASMONS; graphene; terahertz radiation; microwave-induced resistance oscillations; photodetection; nonequilibrium transport; cyclotron resonance (1)
2-DIMENSIONAL ELECTRONS; LANDAU-LEVEL; GAS; EXCITATIONS; SKYRMIONS; SYSTEM; HETEROJUNCTIONS; OSCILLATIONS; ENHANCEMENT; RESONANCE; (1)
2-DIMENSIONAL ELECTRONS; ORBIT INTERACTION; PRECESSION; RELAXATION; TRANSPORT; spin-field-effect transistor (sFET); spin-orbitcoupling; spin injection; spin diffusion; spin manipulation (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; BLOCH ELECTRONS; MAGNETOTRANSPORT; SUPERLATTICE; CONDUCTIVITY; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; COULOMB DRAG; DOUBLE-LAYER; PHASE-TRANSITIONS; COLLAPSE; EXCITATIONS; INTEGER; NU=2; (1)
2-DIMENSIONAL ELECTRON-SYSTEM; SEMICONDUCTORS; ORIENTATION; CARRIERS; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; GRAPHENE; GAS; TRANSPORT; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; MAGNETORESISTANCE OSCILLATIONS; CYCLOTRON-RESONANCE; HETEROSTRUCTURES; STATES; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; QUANTUM HALL SYSTEMS; MAGNETIC-FIELD; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; QUANTUM-WELLS; ORBIT INTERACTIONS; TOPOLOGICAL INSULATORS; WEAK ANTILOCALIZATION; EFFECT TRANSISTOR; MAGNETIC-FIELD; FINITE-WIDTH; RELAXATION; RASHBA; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; RELAXATION; SCATTERING; ORIENTATION; (1)
2-DIMENSIONAL ELECTRON; SYSTEMS; WELLS; (1)
2-DIMENSIONAL ELECTROPHORESIS; FAILING HEART; ANIMAL-MODELS; DISEASE; EXPRESSION; MYOSIN; BNP; CARDIOMYOPATHY; PROGRESSION; EVOLUTION; Heart failure; energetics; proteomics (1)
2-DIMENSIONAL EXCITONS; TRAPS; CONFINEMENT; (1)
2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEOME ANALYSIS; VIRULENCE FACTORS; DUODENAL-ULCER; CANCER; PROTEINS; DISEASE; RISK; OMEPRAZOLE; SEQUENCE; immunoproteomics; bacterial virulence factors; duodenal ulcer; immunogenicity (1)
2-DIMENSIONAL HOLES; QUANTUM TRANSPORT; MAGNETORESISTANCE; SUPERLATTICES; LATTICES; (2)
2-DIMENSIONAL HUBBARD-MODEL; QUASI-PARTICLE; OPTICAL-PROPERTIES; FERMION SYSTEMS; MOTT TRANSITION; GREENS-FUNCTION; 2 DIMENSIONS; GROUP FLOWS; MOLECULES; GW; (1)
2-DIMENSIONAL LIQUID-CHROMATOGRAPHY; CAPILLARY-ZONE-ELECTROPHORESIS; ION-EXCHANGE CHROMATOGRAPHY; FLOW GATING INTERFACE; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; BATCH INJECTION; HIGH-EFFICIENCY; MICROCOLUMN-LC; PROTEIN DIGEST; Two-dimensional separation; Capillary electrophoresis; Ion chromatography; Electrospray ionization; Mass spectrometry; Arsenic speciation (1)
2-DIMENSIONAL MATERIALS; PHOTOCONDUCTIVITY; PLASMONICS; PHOTONICS; TRANSPORT (1)
2-DIMENSIONAL MATERIALS; SINGLE-LAYER; STRUCTURAL-PROPERTIES; RAMAN-SPECTROSCOPY; OPTICAL-PROPERTIES; PBI2; GRAPHENE; PHOTOLUMINESCENCE; MOS2; SEMICONDUCTORS; two-dimensional materials; PbI2; lead iodide; transition metal halides; optoelectronics; ab initio calculations; direct bandgap (1)
2-DIMENSIONAL MATERIALS; VALLEY POLARIZATION; GENERATION; MOS2; PHOTOLUMINESCENCE; (1)
2-DIMENSIONAL POLYMERS; IN-VITRO; TRIAZINE FRAMEWORKS; CRYSTALLINE; NANOPARTICLES; DELAMINATION; EVOLUTION; CATALYSIS; PLATFORM; CARRIERS; (1)
2-DIMENSIONAL SEMIMETAL; TEMPERATURE; quantum wells; universal conductance fluctuations; two-dimensional semimetal (1)
2-DIMENSIONAL SUPERCONDUCTORS; CONVENTIONAL SUPERCONDUCTOR; KNIGHT SHIFT; TRANSITION; LOCALIZATION; PHASE; FILMS; DISORDER; LIMIT; (1)
2 DIMENSIONS; SCATTERING; PARTICLE; (1)
2D MATERIALS; REALIZATION; (1)
2D semiconductors; quantum wells; intersubband transitions; IR spectroscopy; electronic Raman scattering; Stark spectroscopy (1)
2D TMDCs, non-classical exciton diffusion, trion propagation, excited state trions, exciton-carrier scattering, electron recoil effect (1)
2-ELECTRON REDUCTION; FLAVOENZYME ACTIVITY; MODEL SYSTEMS; CYTOCHROME-C; REDOX; FLAVODOXIN; MONOLAYERS; KINETICS; RECONSTITUTION; FAMILY; (1)
2 FACES; INTERFERENCE; MECHANISMS; CONTEXT; RECALL; MODEL; Episodic memory; Retrieval; Social recall; Forgetting; Context reactivation (1)
2 FACES; INTERFERENCE; REPRESENTATION; REPETITION; RECALL; MODEL; episodic memory; retrieval; context (1)
2 FLAVOR QCD; TRANSITION-TEMPERATURE; LATTICE QCD; FREEZE-OUT; FLOW; Lattice QCD; Lattice Quantum Field Theory (1)
2-Hydroxyglutarat, 2-HG, dendritische Zellen, DC, Isozitratdehydrogenase, IDH (1)
2-Hydroxyglutarate, Dendritic Cells, Metabolism (1)
2 INTERACTING ELECTRONS; MAGNETIC-FIELD; ANALYTIC BOUNDARIES; CLASSICAL DYNAMICS; AVOIDED CROSSINGS; SYSTEMS; CHAOS; OSCILLATIONS; STATISTICS; DIFFUSION; (1)
2 INTERACTING PARTICLES; RANDOM-MATRIX THEORY; COHERENT PROPAGATION; QUANTUM DIFFUSION; SCALING THEORY; WIRE; disordered systems; localization (1)
2-LEVEL SYSTEM; DOT; DYNAMICS; SPECTROSCOPY; INTERFERENCE; COHERENCE; (1)
2-MERCAPTOETHANE SULFONATE MESNA; CELL LUNG-CANCER; CLINICAL-PHARMACOLOGY; PROTECTING AGENTS; REACTION-KINETICS; PLATINUM AGENTS; OVARIAN-CANCER; IN-VITRO; CYCLOPHOSPHAMIDE; IFOSFAMIDE; drug interactions; platinum drugs; chemoprotectants; combination chemotherapy (1)
2ND BOUNDED COHOMOLOGY; UNIFORM HYPERBOLICITY; QUASIMORPHISMS; GEOMETRY; COMPLEX; COMMUTATORS; SUBGROUPS; GRAPHS; MAPS (1)
2ND CANCER-RISK; BREAST-CANCER; INTERIM-PET; DISEASE; RADIOTHERAPY; CHEMOTHERAPY; VINBLASTINE; RADIATION; BLEOMYCIN; SURVIVORS; (1)
2ND EXTRACELLULAR LOOP; PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; IN-VITRO EVALUATION; H-1 RECEPTOR; ANTAGONIST-BINDING; INTERNATIONAL UNION; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; AGONISTS; (1)
2ND-HARMONIC GENERATION; CARBON NANOTUBES; PYTHON FRAMEWORK; OPTICAL-RESPONSE; VALLEY COHERENCE; DYNAMICS; SEMICONDUCTORS; QUTIP (1)
2ND MALIGNANCY RISK; RADIATION-THERAPY; COMBINED-MODALITY; FIELD RADIOTHERAPY; CLINICAL-TRIALS; 2 CYCLES; DISEASE; CHEMOTHERAPY; VINBLASTINE; METAANALYSIS; (1)
2ND OPINION; CANCER; HEAD; decision analysis; cost-effectiveness; health policy and practice (1)
2ND YEAR; DIFFERENTIAL SOCIALIZATION; STRANGE SITUATION; META-ANALYSIS; MOTHER; PRESCHOOL; BEHAVIOR; PATTERNS; INFANCY; 6-YEAR-OLDS; attachment theory; gender; sensitivity; exploration; socio-emotional development (1)
2-PHOTON ABSORPTION; CLEARANCE; ASSOCIATION; SPONSORSHIP; MOTIVATION; INDUSTRY; PIGMENT; DESIGN; (1)
2-PHOTON ABSORPTION; LASER-PULSES; ULTRASHORT PULSES; GAASP PHOTODIODE; RHODAMINE 6G; THIN-FILMS; 347.15 NM; AUTOCORRELATION; PHASE; INTENSITY; autocorrelator; femtosecond pulses; pulse duration measurement; rhodamine 6G; Ti : sapphire laser; two-photon absorption; two-photon fluorescence (1)
2-PHOTON INDUCED POLYMERIZATION; ARTIFICIAL PHOTOSYNTHESIS; CHARGE-TRANSFER; DYNAMICS; DONOR; CONVERSION; MIMICKING; EMISSION; COMPLEX; FILMS; chromophoric dendrimers; FRET; holistic molecular systems (1)
2-PHOTON LUMINESCENCE; PHOTOLUMINESCENCE; DYNAMICS; NANOSTRUCTURES; NANORODS; METALS; NANOANTENNAS; RELAXATION; GENERATION; ELECTRONS; Silver nanoparticles; hot carriers; photoluminescence; inelastic light scattering; multiphoton luminescence (1)
2 QUANTITATIVE INDICATORS; DETECTING TAXONICITY; CLASSIFICATION; AROUSAL; pedophilia; self-report; viewing time; Implicit Association Test; taxometrics (1)
2 sample MR; Physical activity; Myocardial infarction; Coronary Artery Disease (1)
2-STAGE REVISION; ARTICULATING SPACERS; INFECTION; MOBILE; REIMPLANTATION; COMPLICATIONS; inverse spacer; intraoperatively molded; cost-effective; (sub-) luxation; dislocation; revision knee arthroplasty (1)
2 VISUAL PATHWAYS; HEMISPHERIC-SPECIALIZATION; BEHAVIORAL LATERALIZATION; OBJECT; MODEL; RECOGNITION; PREFERENCES; ORIENTATION; ATTENTION; LANGUAGE; hemispheric dominance; brain lateralization; conditional-spatial memory; declarative-like memory; long-term memory system; domestic chick; Gallus gallus (1)
2-WELL PROBLEM; MICROSTRUCTURE; SEMICONTINUITY; ELASTOMERS; THEOREMS; ENERGY; differential inclusions; nonlinear elasticity; convex integration; solid-solid phase transitions (1)
2.WK Zwangsarbeit (1)
2-YEAR FOLLOW-UP; ACETABULAR LABRAL TEARS; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; CHONDRAL DEFECTS; ARTICULAR-CARTILAGE; DEBRIDEMENT; REPAIR; OSTEOARTHRITIS; TRANSPLANTATION; ACI; autologous chondrocyte implantation; cartilage defect; hip arthroscopy (1)
30er 40er D WiPol (1)
30er 40er Zwangsarbeit (3)
30er Profitabilität (1)
30er Wachstum VGR (1)
30er WiPol (1)
3-1 MEIOTIC DISJUNCTION; OF-THE-LITERATURE; EPISPADIAS COMPLEX; TBX1; DELETION; TRANSLOCATION; MECHANISMS; DISORDERS; MUTATIONS; PHENOTYPE; Bladder exstrophy; 22q11.21; EEC; Microduplication; MLPA; Molecular karyotyping; SNP array (1)
3,4-DIAZANORCARADIENES; PRECURSORS; azomethine ylides; 1,3-dipolar cycloadditions; alkynes; alkenes; regiochemistry (1)
3,4-DIAZANORCARADIENES; PRECURSORS; azomethine ylides; 1,3-dipolar cycloadditions; kinetics; solvent effects; linear free energy relations (1)
3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; WITHDRAWAL SYNDROME; SODIUM OXYBATE; ACID GHB; PROGESTERONE; STRESS; NEUROSTEROIDS; ECSTASY; BRAIN; INCREASES; Sodium oxybate; Gamma-hydroxybutyric acid; Club drug; Altruism; Fairness; Rape drug (1)
3',5'-CYCLIC DIGUANYLIC ACID; POLYMERASE CHAIN-REACTION; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; CYCLIC DIGUANYLATE; PSEUDOMONAS-AERUGINOSA; SIGNALING MOLECULE; ALLOSTERIC CONTROL; BIOFILM FORMATION; VACCINE ADJUVANT; C-di-GMP; Diguanylate cyclase; Enzymatic cascade; Immunomodulation; Biotechnological production (1)
-[³⁵S]GTPγS binding assay for the Y₂R and Y₄R - Luciferase gene reporter assay for the Y₂R and Y₄R - Radio- and fluorescent-labeled peptides for the Y₄R (1)
§ 36a AufenthG; Kontingentlösung; Wartezeit; Härtefallregelung; Integration; innere Sicherheit; Syrien (1)
3 ABUNDANCE CLASSES; GENE-EXPRESSION; MESSENGER-RNA; ENDOGENOUS SIRNAS; LET-7 REPRESSES; MOUSE OOCYTES; BINDING; DICER; CELL; TRANSCRIPTOME; (1)
3-BODY ATOMIC WAVEFUNCTIONS; GAUSSIAN-TYPE FUNCTIONS; INTERELECTRONIC DISTANCE FUNCTION; HYLLERAAS-TYPE CALCULATIONS; REDUCED BESSEL FUNCTIONS; SLATER-TYPE ORBITALS; MOLECULAR INTEGRALS; 3-ELECTRON INTEGRALS; ANALYTIC EXPANSIONS; SPHERICAL-HARMONICS; (1)
3-CENTER NUCLEAR ATTRACTION; GAUSSIAN-TYPE ORBITALS; EXPONENTIAL-TYPE ORBITALS; REDUCED BESSEL-FUNCTIONS; 3-DIMENSIONAL TAYLOR EXPANSIONS; INFINITE-SERIES REPRESENTATIONS; 2-ELECTRON COULOMB INTEGRALS; REPULSION MATRIX-ELEMENTS; FOURIER-TRANSFORM METHOD; MULTI-CENTRE INTEGRALS; Cartesian components; spherical tensor; Hobson's theorem; Bossel functions; spherical delta functions; quantum chemistry (1)
3D-CT, Calcaneusfraktur, volume rendering (1)
3D GRAPHENE FOAM; ANODIC-STRIPPING VOLTAMMETRY; DOPAMINE; ELECTRODES; COMPOSITE; SILVER(I); Carbon nanofibers; Miniaturized electrochemical systems; Anodic stripping voltammetry; Point-of-need devices (1)
3-DIMENSIONAL CELL-CULTURE; GROWTH-FACTOR BETA(1); IN-VIVO; OSTEOBLASTIC DIFFERENTIATION; TITANIUM SURFACES; TISSUE FORMATION; IMPLANTS; BISPHOSPHONATES; BMP-2; RATS; surface modification; hydroxyapatite; BMP-2; biomimetic material; ceramics (1)
3-DIMENSIONAL CELL-CULTURES; HUMAN GLIOMA SPHEROIDS; HUMAN-TUMOR SPHEROIDS; EARLY CLINICAL-TRIALS; IN-VITRO; PHOTODYNAMIC THERAPY; MONOCLONAL-ANTIBODY; MATHEMATICAL-MODEL; DIFFERENT REGIONS; EXTRAVASCULAR TRANSPORT; cell-based assay; 3-D culture; spheroid; co-culture; anti-tumor drug testing (1)
3-DIMENSIONAL COMPUTED-TOMOGRAPHY; INTRAARTICULAR FRACTURES; CLASSIFICATION SYSTEMS; RELIABILITY; FOOT; INTEROBSERVER; TENDONS; DISEASE; ANKLE; calcaneal fracture; CT scan; volume rendering technique; 3D reconstruction; reliability; validity (1)
3-DIMENSIONAL COMPUTED-TOMOGRAPHY; STEREOLITHOGRAPHIC MODELS; COMPLETE CADAVERS; AIDED-DESIGN; RECONSTRUCTION; SURGERY; PRESERVATION; ERROR; 3D printing; Additive manufacturing; Mandible; Quality; Accuracy (1)
3-DIMENSIONAL CONFORMAL RADIOTHERAPY; SIMULTANEOUS INTEGRATED BOOST; INTRAFRACTION MOTION; TREATMENT PLANS; IMRT; VMAT; OPTIMIZATION; flattening filter free; IMRT; prostate cancer; VMAT (1)
3-DIMENSIONAL ELASTICITY; JUSTIFICATION; MODEL; CONVERGENCE; SHELLS; RODS; (1)
3-DIMENSIONAL OBJECTS; GENDER-DIFFERENCES; STEREOTYPE THREAT; PHYSICAL-ACTIVITY; ADOLESCENTS; OBESITY; WEIGHT; ABILITY; ESTEEM; Overweight; Children; Cognitive development; Motor development; Mental rotation (1)
3-DIMENSIONAL OBJECTS; SPATIAL TRANSFORMATIONS; FAMILIAL SINISTRALITY; RIGHT-HANDERS; METAANALYSIS; REPRESENTATIONS; ABILITIES; VARIABLES; TASKS; SEX; Mental rotation; handedness; object-based transformations; egocentric transformations (1)
3-DIMENSIONAL PHOTOGRAMMETRY; VAULT ASYMMETRY; ACCURACY; RELIABILITY; DIAGNOSIS; PRECISION; DEFORMITY; SYMMETRY; INFANTS; INDEX; positional head deformation; deformational plagiocephaly; deformational brachycephaly; three-dimensional photography; orthotic helmet therapy (1)
3-DIMENSIONAL STRUCTURE; ALLOSTERIC REGULATION; CLOSED CONFORMATIONS; ALPHA-SUBUNIT; BETA-SUBUNIT; L-SERINE; PROTEIN; COMMUNICATION; BIOSYNTHESIS; INSERTIONS; substrate channeling; enzyme; X-ray crystallography; enzyme evolution; enzyme chimera (1)
3-DIMENSIONAL STRUCTURE; OPTICAL CONTROL; AMINO-ACID; WILD-TYPE; ACTIVATION; INDOLE; COMMUNICATION; MECHANISM; COMPLEX; BIOCATALYSIS; allostery; biocatalysis; enzymology; photo-control; protein design; unnatural amino acids (1)
3 DIMENSIONAL SYSTEM; DECISION-MAKING; FORAGING STRATEGY; MYRMICA-SABULETI; FOOD RECRUITMENT; COLOR-VISION; INFORMATION; ORIENTATION; HYMENOPTERA; PRIVATE; ants; information conflict; information use strategies; light levels; pheromone depositing; route learning (1)
3-DIMENSIONAL TOPOLOGICAL INSULATOR; ANALYTICAL-MODEL; DIRAC PLASMONS; FLOQUET-BLOCH; SCATTERING; BI2TE3; SB2TE3; BI2SE3; PHOTOCURRENTS; SPECTROSCOPY; Near-field microscopy; SNOM; tomography; topological insulator; surface state; band bending (2)
3 DIMENSIONS; SYSTEM; (1)
3D model; CSC; RIST; cancer stem cells; neuroblastoma; high-risk; spheroids; three-dimensional. (1)
3D model · Unicompartmental Knee Prosthesis · Tibial Component · Positioning · Arthroplasty (1)
3D MR DSA; CONVENTIONAL ANGIOGRAPHY; STENOSIS; ENDARTERECTOMY; BIFURCATION; carotid arteries; MR, carotid arteries; stenosis or obstruction, Magnetic Resonance (MR); vascular studies (1)
3D MR DSA; INTEROBSERVER VARIABILITY; DIAGNOSTIC-ACCURACY; OPTIMIZATION; ULTRASOUND; VESSELS; AORTA; carotid arteries; magnetic resonance; magnetic resonance angiography (1)
3d nucleon structure, perturbative QCD, higher order corrections (1)
3D-Perinealsonographie, Beckenbodeninsuffizienz, Harninkontinenz (1)
3D printing (1)
3D printing; additive manufacturing; DLP; oral splint; TMD; water sorption; wear behavior (1)
3D printing; oral splint; biaxial flexural strength; TMD; PMMA; DLP (1)
3D print, TBI, blocks (1)
3D-QSAR; CoMFA; Histamine H2 receptor agonists; Cardiotonics (1)
3D-REMPI SPECTROSCOPY; ALGORITHM; PHOTODISSOCIATION; TRANSFORM; DYNAMICS; TOMOGRAPHY; EXCITATION; EXPANSION; S-1; (1)
3D stimuli, automatic fixation mapping, eye movement, eye tracking, photogrammetry, virtual 3D model (1)
3-HYDROXY FATTY-ACIDS; MS DETERMINATION; SCROPHULARIACEAE; OROBANCHACEAE; GLYCOSIDES; DIACYLGLYCEROLS; IDENTIFICATION; OFFICINALIS; FLOWERS; LEAVES; Eyebright; Orobanchaceae; Acetyl monoacylglycerols; Hydroxyfatty acids; Euphrasianins (1)
3-LOOP SPLITTING FUNCTIONS; EVOLUTION-EQUATIONS; 1/N EXPANSION; EXPONENT-ETA; QCD; COMPUTATION; MODEL; CONE; (1)
3-LOOP SPLITTING FUNCTIONS; MASS ANOMALOUS DIMENSION; CONFORMAL SYMMETRY; QCD; O(1/N-F(2)); CONSTRAINTS; (1)
3-MANIFOLDS; (1)
3-MANIFOLDS; INVARIANT; KNOTS; VOLUME; Seifert fiber space; L-2-Alexander torsion; Thurston norm (1)
3-PHOSPHOGLYCERATE KINASE; TRANSCRIPTIONAL SLIPPAGE; POLYACRYLAMIDE GELS; MASS-SPECTROMETRY; GENE; DISSECTION; STABILITY; GENOME; ENZYME; TIM; DE-MALDI-TOF; frameshift; mass spectrometry; PGK-TIM fusion protein; Thermotoga maritima (1)
3 PROTEIN EXPRESSION; BLADDER-CANCER; CELL CARCINOMA; IN-VITRO; CARCINOGENESIS; PROGRESSION; MIGRATION; SURVIVAL; GROWTH; Aquaporins; Carcinogenesis; Urothelial carcinoma; Bladder cancer; Cell lines; Biomarker (1)
3-QUBIT ENTANGLEMENT; QUANTUM; WITNESSES; STATES; (1)
3RD GENERATION CEPHALOSPORINS; DRUG-DELIVERY DEVICE; 3RD-GENERATION CEPHALOSPORINS; BACTERIAL-INFECTIONS; CEFTRIAXONE; PHARMACOKINETICS; SELECTION; THERAPY; PENETRATION; MULTICENTER; (1)
3RD MOLAR AGENESIS; ACTIVATOR FUNCTION; DENTAL ANOMALIES; INDIAN HEDGEHOG; SONIC HEDGEHOG; ASSOCIATION; HYPODONTIA; POLYMORPHISMS; CHINESE; PREVALENCE; Tooth agenesis; Single nucleotide polymorphisms; Genetic variants; Skeletal class; Craniofacial morphology (1)
3RD NATIONAL-HEALTH; LOUD MUSIC; CHILDREN 6; PART II; EXPOSURE; PREVALENCE; RISK; TINNITUS; ADULTS; AGE; (1)
3RD-ORDER CONVERGENCE; VARIANT; rootfinding; Newton method; Newton-type method; Newton theorem; inverse function; iterative methods; nonlinear equations (1)
3RD STAGE; Colour Doppler; third stage of labour; placental separation; placenta accreta (1)
3' SPLICE-SITE; MESSENGER-RNA; MUTATIONS; RECOGNITION; LOCALIZATION; BINDING; EXPRESSION; STABILITY; MACHINERY; REVEALS; U2AF; zinc finger; protein stability; translation; splicing; T cell activation (1)
3T3-L1 ADIPOCYTES; INOSITOL 5'-PHOSPHATASE-2; RESISTANCE; LIVER; GLUCOSE; DEFECT; OBESITY; IMPACT; MICE; insulin resistance; obesity; high-fat diet; antisense oligonucleotide therapy; SH2 domain-containing lipid phosphatase (1)
3 TESLA; 3.0 T; WATER; SATURATION; MRI; ANGIOGRAPHY; IMAGES; (1)
3-WEEKLY CHOP CHEMOTHERAPY; NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; AGGRESSIVE LYMPHOMAS; FOLLICULAR LYMPHOMA; TRIAL; RITUXIMAB; DSHNHL; CLASSIFICATION; TRANSFORMATION; Adult patients; diffuse large B-cell lymphoma; molecular features (1)
3xHMG-box, Mitose, Chromatin (1)
40er 50er 60er 70er 80er 90er Zwangsarbeit Entschädigung (1)
40er 50er 60er SozMaWi (1)
40er 90er Zwangsarbeit Entschädigung (2)
40er A Zwangsarbeit Demographie (2)
40er; A; Zwangsarbeit; Demographie (1)
40er Holocaust Zwangsarbeit (1)
40er KZ Zwangsarbeit (2)
40er SU Zwangsarbeit (1)
40er Zwangsarbeit (6)
40er Zwangsarbeit Demographie (1)
40er Zwangsarbeit Entschädigung Demographie (2)
4,5-UNSUBSTITUTED ALKYL 3-HYDROXYPYRROLE-2-CARBOXYLATES; CONDUCTING POLYMERS; ELECTROPOLYMERIZATION; 3,4-DIALKOXYPYRROLES; OLIGOTHIOPHENES; cyclic voltammetry; oxidation; polypyrrole formation; pyrrole dimerization; reductive N-benzyl cleavage; Ullmann coupling (1)
4-FERMION INTERACTION; EVANESCENT OPERATORS; CRITICAL-BEHAVIOR; PHI(4) MODEL; REGULARIZATION; QCD; (2)
4-hydroxy-2-cyclopentenone, 2-pyrone, γ-alkylidenebutenolide, 1,3-cyclopentanedione (1)
4-MANIFOLDS; HOMOLOGY; Thompson's groups; symplectic 4-manifolds (1)
4-PART FRACTURES; ARTHROPLASTY; HEAD; proximal humerus fractures; arthroplasty; shoulder; prosthetic design; surgical technique (1)
4-PART FRACTURES; INTERNAL-FIXATION; ELDERLY-PATIENTS; OSTEOSYNTHESIS; 3-PART; CLASSIFICATION; SYSTEM; proximal humerus fracture; osteosynthesis; helix wire (1)
50er 60er 70er 80er 90er Zwangsarbeit Entschädigung (1)
51 V-NMR | aniline synthesis | kinetic analysis | photocatalysis | vanadium catalysis (1)
5.5 ANGSTROM RESOLUTION; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; MESSENGER-RNA; RAT-LIVER; SECONDARY STRUCTURE; EXPANSION SEGMENTS; CROSS-LINKING; 70S RIBOSOME; EXIT TUNNEL; modeling; molecular dynamics; flexible fitting (1)
55N10; 12J25; 46S10; 57M20 (1)
55N10; 57N65; 57K31 (primary) (1)
; 5‑ aminolevulinic acid; Methyl-5-amino-4-oxopentanoate; Photorejuvenation; Skin cancer; Actinic keratosis (1)
5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; PHASE-III; UPDATE; CANCER; photodynamic therapy; non-melanoma skin cancer; 5-aminolevulinic acid; non-oncological indications (1)
5-AMINOLEVULINIC ACID PATCH; PHOTODYNAMIC THERAPY; ACTINIC KERATOSES; DERMATOLOGY; IPL; PHOTOREJUVENATION; LASER; FACE; flash lamps; intense pulsed light; light intensities; photodynamic therapy; wavelength (1)
5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; SURVEILLANCE; CANCER; PHOTOSENSITIZATION; CARCINOMA; LESIONS; MODEL; RISK; RAT; (1)
5-AMINOLEVULINIC ACID; TOPICAL APPLICATION; PAPILLOMAVIRUS; FLUORESCENCE; WARTS; (1)
5-aryldeazaﬂavin, organophosphorus compounds, photocatalysis, tetraarylphosphonium salts, triarylphosphines, white phosphorus (1)
5’-Deoxy-5’-methylthioadenosine (MTA), methythioadenosine phosphorylase (MTAP), metabolomics, liquid chromatography-tandem mass spectrometry, methionine and polyamine pathways, Metabolomics, Flüssigchromatographie-Tandemmassenspektrometrie, Methionin- und Polyaminstoffwechselwege (1)
5-FLUOROURACIL CARDIOTOXICITY; FLUOROURACIL; CAPECITABINE; DYSFUNCTION; INFUSION; (1)
5-FLUOROURACIL PLUS LEUCOVORIN; PHASE-III TRIAL; COST-EFFECTIVENESS; COLORECTAL-CANCER; BREAST-CANCER; FLUOROURACIL; CHEMOTHERAPY; EFFICACY; CARCINOMA; RECOMMENDATIONS; capecitabine; 5-fluorouracil/leucovorin; adjuvant; colon cancer; pharmacoeconomics; cost-effectiveness (1)
5-HT2A PROMOTER POLYMORPHISM; SEROTONIN TRANSPORTER; TRANSMISSION DISEQUILIBRIUM; PSYCHIATRIC-DISORDERS; PEDIATRIC PROBANDS; FAMILY; ASSOCIATION; ADOLESCENTS; CHILDREN; LINKAGE; Obsessive-compulsive disorder; Serotonin; Glutamate transporter gene; Early onset; Brain-derived neurotrophic factor (1)
5-HT3 RECEPTOR ANTAGONISTS; ADMINISTERED SEROTONIN; DOUBLE-BLIND; FIBROMYALGIA; INJECTION; PAIN; SHOULDER; RAT; tendinopathy; therapy; 5-HT3 receptor antagonists; corticosteroids; local anesthetic (1)
5-HYDROXYINDOLEACETIC ACID CONCENTRATIONS; DIMINISHED SOCIAL COMPETENCE; PROMOTER REGION POLYMORPHISM; GENE REGULATORY REGION; NONHUMAN PRIMATE MODEL; UTAH RATING-SCALE; DSM-III-R; DEFICIT/HYPERACTIVITY DISORDER; 5-HT2C RECEPTOR; PSYCHIATRIC COMORBIDITY; serotonin transporter polymorphism; 5-HT2c Cys23Ser polymorphism; alcohol dependence; attention-deficit hyperactivity disorder; Cloninger type 1 and 2 (1)
5-LIPOXYGENASE; ALKALOIDS; antiinflammatory activity; leukotrienes; 5-lipoxygenase; Nepalese plants; traditional medicine (1)
5-Methoxytryptamine/analogs & derivatives/*chemical synthesis/pharmacology Animals Bicyclo Compounds/*chemical synthesis/pharmacology Female Guinea Pigs Indoles/*chemical synthesis/pharmacology Rats *Serotonin Antagonists Structure-Activity Relationship Tryptamines/*chemical synthesis/pharmacology (1)
5P medicine; transformed health ecosystems; system integration and interoperability; knowledge representation and management; privacy and trust (1)
5-YEAR FOLLOW-UP; ARTICULAR-CARTILAGE; DEFECTS; knee; cartilage defect; ostochondritis dissecans; autologous chondrocyte implantation (ACI); scaffold; MACI (R) (1)
60.00; 70.00; 80.00 (1)
60S RIBOSOMAL-SUBUNIT; AAA-ATPASE DRG1; SACCHAROMYCES-CEREVISIAE; PRE-RIBOSOME; NUCLEAR EXPORT; YEAST; BIOGENESIS; PROTEIN; RNA; ASSOCIATION; (1)
6 BETA 4; ADHESION MOLECULES; ALPHA-6-BETA-4 INTEGRIN; STEM-CELLS; INVASIVE GROWTH; TUMOR INVASION; E-CADHERIN; CANCER; MIGRATION; HEMIDESMOSOMES; (1)
6-MINUTE WALK; DEPRESSION; PHQ-9; COMORBIDITIES; SEVERITY; Post-Acute COVID Syndrome; Lung function; Symptoms; Depression; Somatization; HrQoL (1)
6-MINUTE WALK DISTANCE; DISEASE MANAGEMENT REVEAL; IMPORTANT DIFFERENCE; PREDICTIVE-VALUE; HEART-FAILURE; THERAPY; TRIALS; GUIDELINES; DIAGNOSIS; SURVIVAL; Pulmonary arterial hypertension; PAH; 6-Minute walk test; Risk stratification; Cut-off value (1)
6-MINUTE WALK TEST; CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; VENTILATORY RESPONSE; ERGOMETRY EXERCISE; VASCULAR-DISEASE; NITRIC-OXIDE; CAPACITY; BOSENTAN; pulmonary hypertension; cardiopulmonary exercise testing; pulmonary function; pulmonary hemodynamics (1)
6-MINUTE WALK TEST; DIFFUSION CAPACITY; CARDIAC-OUTPUT; MORTALITY; SURVIVAL; RESERVE; IMPACT; DLCO; inert-gas rebreathing; prognosis; pulmonary blood flow; pulmonary hypertension (1)
6-MINUTE WALK TEST; HEART-FAILURE; VALVE ANNULOPLASTY; GENDER-DIFFERENCES; EUROPEAN-SOCIETY; SEX-DIFFERENCES; RISK PATIENTS; OUTCOMES; VALIDITY; RELIABILITY; (1)
6-SUBSTITUTED 2-PYRONES; CYCLOPENTADIENONE; BIOSYNTHESIS; PHOSPHINE; pyrone; furfural; furfuryl alcohol; renewable resources; Piancatelli- rearrangement; flash vacuum pyrolysis (1)
6-YEAR-OLD CHILDREN; GENDER-DIFFERENCES; COORDINATION; PERFORMANCE; ATTENTION; CULTURE; FITNESS; EXPERT; (1)
70-GENE PROGNOSIS-SIGNATURE; VALIDATION; THERAPY; IMMUNOHISTOCHEMISTRY; ADJUVANT; SURVIVAL; WOMEN; breast cancer; MammaPrint; 70-gene expression profile; TargetPrint; microarray; adjuvant therapy (1)
75.50.Pp, 75.70.Cn, 75.75.+a, 78.20.Ls, 78.66.Hf, 85.75.-d (1)
8-aza- and 8-oxabicyclo[3.2.1]octanes • cyclopropanated furans and pyrroles • cocaine analogues • microwave-assisted [3+2] cycloaddition • tropanes • isoquinuclidines (1)
8-VERTEX LATTICE MODEL; YANG-MILLS THEORY; SCATTERING-AMPLITUDES; EXCLUSIVE PROCESSES; PARTITION-FUNCTION; Q-OPERATOR; QCD; INTEGRABILITY; (1)
90er Zwangsarbeit Entschädigung (2)
90 Sr, Elfenbein, Datierung (1)
9, 10-Phenanthrenequinones; Acyloin condensation; Enantiomers, liquid chromatography of; Barriers to racemization (1)
949 GERMAN TEACHERS; HEALTH; SAMPLE; Breathing therapy; Teacher; Burnout syndrome (1)
9-AMINO(9-DEOXY)CINCHONA ALKALOIDS; CINCHONA ALKALOIDS; COMBINED NMR; DECARBOXYLATION; DERIVATIVES; COPPER(I); ACID; (1)
9-ATOM GERMANIUM CLUSTERS; GE-9(4-) ZINTL ANIONS; INTERMETALLOID CLUSTERS; CRYSTAL-STRUCTURE; SPHERICAL AROMATICITY; WAVE-FUNCTIONS; LINEAR TRIMER; HARTREE-FOCK; TERNARY; BINARY; antimony; cluster compounds; copper; DFT calculations; tin (1)
A167V; channelopathy; EAST-Syndrome; KCNJ10; patch clamp; tubulopathy, SeSAME-Symdrome (1)
A(1)A(0) ATP SYNTHASE; NANOARCHAEUM-EQUITANS; PYROCOCCUS-FURIOSUS; SP-NOV; TRANSPORT; INSIGHTS; ULTRASTRUCTURE; COMPLEXES; PROTEINS; ORIGIN; Archaea; ATP synthase; ATPase; immunolabeling; sulfur reductase (1)
A1. Computer simulation, A1. Crystal morphology, A1. Dendrites, A1. Growth models, A1. Morphological stability, A1. Solidification, A2. Growth from vapour (1)
A(1)-HOMOTOPY; A(1)-connectedness; Moduli of vector bundles; A(1)-concordance (1)
A(1)-HOMOTOPY THEORY; (1)
A1. Low-dimensional structures; A3. Molecular beam epitaxy; B2. Semiconducting galliumarsenide; B3. Heterojunction semiconductor devices (1)
a(2a) adenosine receptor crystal-structure amino-acid beta(2)-adrenergic receptor structural instability adrenergic-receptor guinea-pig activation rhodopsin state (1)
A(2A) ADENOSINE RECEPTOR; CRYSTAL-STRUCTURE; AMINO-ACID; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSTABILITY; ADRENERGIC-RECEPTOR; GUINEA-PIG; ACTIVATION; RHODOPSIN; STATE; (1)
A3. Metalorganic vapor phase epitaxy; B1. Nitrides; B2. Semiconducting III–V materials (1)
A3. Molecular beam epitaxy; B1. GaMnAs; B2. Magnetic materials; B2. Semiconducting materials (1)
A3. Molecular beam epitaxy; B1. GaMnAs; B2. Semiconducting III–IV materials; B3. Spintronic devices (1)
A64FX; ECM model; Lattice quantum chromodynamics; sparse matrix-vector multiplication (1)
AAV, IL-10, Herztransplantation bei Ratten (1)
ABBREVIATED DEVELOPMENT DECAPODA; GRAPSIDAE CRUSTACEA; CRABS; SALINITY; STARVATION; EVOLUTION; SESARMINAE; (1)
ABCA1-DEPENDENT CHOLESTEROL EFFLUX; PHOSPHOLIPID TRANSFER PROTEIN; AORTIC ENDOTHELIAL-CELLS; I MIMETIC PEPTIDE; INDUCED INSULIN-RESISTANCE; DEATH DOMAIN PROTEIN; E-KNOCKOUT MICE; TANGIER-DISEASE; APOA-I; APOLIPOPROTEIN-E; ATP binding cassette transporter; chronic overnutrition; apolipoprotein (1)
ABCA4; ABCR; carrier frequency; founder mutation; STGD; retinal dystrophies (1)
ABCA4, Morbus Stargardt, molekulare Diagnostik (1)
ABCA4, Morbus Stargardt, VMD2, Morbus Best, ADVIRC, Exon Trapping-Analyse, Stargardt disease, Best disease, exon trapping analysis (1)
ABCA4, M. Stargardt, Mutationsanalyse, direkte Sequenzierung (1)
ABCA4 splicing, retinal degeneration (1)
ABCG2 modulators, ATPase, ABCG2 inhibition (1)
ABCG2 transporter, inhibitors, water solubility, stability (1)
ABC-Transporter , Apolipoproteine , Kernrezeptor , High-density-Lipoproteine , Very-low-density-Lipoproteine , Triglyceride , Cholesterinstoffwechsel , ZNF202 , transkriptioneller Repressor , PPARdelta , ZNF202 , transcriptional repressor , PPAR delta (1)
ABC-Transporter , Lipidstoffwechsel , ABCA1 , AOX1 , ABCA7 , ABCA1 , AOX1 , ABCA7 (1)
ABC transporter, P-glycoprotein, tariquidar, brain tumors, glioblastoma, blood-brain barrier, paclitaxel, MDR, Paclitaxel, optical imaging (1)
ABDOMINAL ADIPOSITY; COMPUTED-TOMOGRAPHY; INTRAABDOMINAL FAT; ANTHROPOMETRIC MEASUREMENTS; RISK-FACTORS; WEIGHT-LOSS; ULTRASONOGRAPHY; OBESITY; RELIABILITY; THICKNESS; Reproducibility; Validity; Ultrasound; Magnetic resonance imaging; Abdominal fat compartments (1)
ABDOMINAL-AORTA; INFECTED ANEURYSM; REPLACEMENT; MANAGEMENT; spondylitis; mycotic aneurysm; pneumoniae (1)
ABDOMINAL AORTIC-ANEURYSM; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCUS; SEQUENCE VARIANT; COMMON VARIANTS; HEART-DISEASE; DOUBLE-BLIND; (1)
ABDOMINAL AORTIC-ANEURYSM; INFERIOR MESENTERIC-ARTERY; STENT-GRAFT TREATMENT; ENDOVASCULAR REPAIR; FOLLOW-UP; PERIGRAFT LEAKS; HELICAL CT; EMBOLIZATION; CLASSIFICATION; ENDOGRAFT; aortic aneurysm; endovascular therapy; stent graft; endoleak (1)
ABDOMINAL AORTIC-ANEURYSM; REPAIR; OUTCOMES; ANATOMY; abdominal aortic aneurysm; endovascular aneurysm repair; stent-graft; aortic neck; mural thrombus; calcification; conical neck; hostile neck; short neck; angulated neck; type I endoleak; migration; EndoAnchor (1)
ABDOMINAL AORTIC-ANEURYSMS; ENDOVASCULAR REPAIR; RUPTURE; FAILURE; Endoleak; Endovascular aortic aneurysm repair (EVAR); Onyx (1)
ABDOMINAL AORTIC-ANEURYSMS; ENDOVASCULAR TREATMENT; SINGLE-CENTER; REPAIR; DEVICE; DESIGN; EXPERIENCE; Endovascular; Anaconda; Abdominal aorta aneurysm; Stent (1)
ABDOMINAL AORTIC-ANEURYSMS; INFERIOR MESENTERIC-ARTERY; ENDOVASCULAR REPAIR; RISK-FACTORS; PREDICTIVE FACTORS; INTRASAC THROMBUS; VOLUME; IMPACT; LOAD; ANTICOAGULATION; Cardiovascular diseases; Vascular diseases; Aneurysm; Endoleak; Blood vessel prosthesis (1)
ABDOMINAL COMPARTMENT SYNDROME; INTRAABDOMINAL HYPERTENSION; INCREASES; severe acute pancreatitis; intra-abdominal compartment syndrome; decompression laparotomy; intensive care unit; respiratory failure (1)
ABDOMINAL COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; RADIATION-DOSE REDUCTION; IMAGE QUALITY; MULTIDETECTOR CT; PHANTOM; ALGORITHM; SAFIRE; NOISE; ANGIOGRAPHY; (1)
abdominal pain; appendicitis; simple; conservative treatment; appendectomy; pediatrics (1)
Abdominal trauma · Bowel injury · Damage control surgery · Decision making · Severely injured patients (1)
ABDOMINAL-WALL DEFECTS; PRENATAL-DIAGNOSIS; DELIVERY; REPAIR; MALFORMATIONS; MANAGEMENT; REDUCTION; omphalocele; gastroschisis; long-term outcome; quality of life; prenatal counselling (1)
ABDOMINAL-WALL; PEG; DECOMPRESSION; PLACEMENT; GUIDANCE; CHILDREN; (1)
ABDOMINIS MYOCUTANEOUS FLAP; LEVATOR ABDOMINOPERINEAL EXCISION; LOW RECTAL-CANCER; PERINEAL RECONSTRUCTION; CLINICAL-APPLICATION; RESECTION; OUTCOMES; CLOSURE; METAANALYSIS; EXPERIENCE; Rectum resection; rectum extirpation; pelvic defect; perineal defect; posterior thigh flap; VRAM flap (1)
ABDOMINO-PERINEAL RESECTION; COLO-ANAL ANASTOMOSIS; SAVING RESECTION; ANTERIOR RESECTION; SURGICAL TREATMENT; INTRAMURAL SPREAD; CARCINOMA; SURVIVAL; EXCISION; EXTIRPATION; rectal cancer; intersphincteric resection; complication; recurrence; continence (1)
ABDUCTOR MUSCLE STRENGTH; FEMORAL OFFSET; PELVIC TILT; DISCREPANCY; JOINT; INEQUALITY; COMPONENT; MOTION; minimally invasive; hip arthroplasty; total joint replacement; computer-assisted surgery; total hip replacement (1)
ABDUCTOR MUSCLE STRENGTH; QUALITY-OF-LIFE; FEMORAL OFFSET; GREATER TROCHANTER; ARTHRITIS; OUTCOMES; EUROQOL; (1)
ABELIAN COVERINGS; COBORDISM INVARIANTS; SIGNATURE INVARIANTS; HOMOLOGY; KNOTS; TORSION; (1)
; abelian polylogarithm; arithmetic Chow groups; Arakelov geometry; Deligne cohomology (1)
; Abelian polylogarithm; Deligne; Beilinson cohomology; Arakelov theory (1)
ABELIAN P-SUBGROUPS; CLASSIFYING-SPACES; HOMOTOPY-THEORY; FUSION SYSTEMS; LIE-GROUPS; T-FUNCTOR; COHOMOLOGY; UNIQUENESS; MODULES; (1)
Abelsche Mannigfaltigkeit , Geradenbündel , K-Theorie, Chow-Gruppe , algebraische Zykel , Höhenpaarungen , algebraic cycles , heightpairing (1)
Abernethy malformation; patent ductus venosus Arantii; hereditary hemorrhagic telangiectasia; ultrasonography; contrast-enhanced ultrasound (1)
A. Bilayer system; D. Quantum Hall; D. Quantum phase transition; D. Metastable phase (1)
AB-INITIO; (1)
ABINITIO; (1)
AB-INITIO CALCULATION; III-V(110) SURFACES; PHONONS; SCATTERING; MONOLAYERS; INP(110); (110)SURFACES; GAAS; (1)
AB-INITIO CALCULATION; III-V SEMICONDUCTORS; RAY STANDING-WAVE; VIBRATIONAL PROPERTIES; GAAS(110) SURFACE; SI(111); MONOLAYERS; SCATTERING; RECONSTRUCTION; DISPERSION; (1)
ab initio calculations; energy gap; excitons; HF calculations; optical constants; orbital calculations; periodic structures; polymers; tight-binding calculations (1)
AB-INITIO; CHEMISTRY; DENSITY; BORON; (1)
AB-INITIO; DENSITY; ENVIRONMENTS; ATTRACTION; DFT; sp(2)-hybridized centers; gain of energy; ipso-carbon atom; phenyl compounds; pyramidalization (1)
AB-INITIO; ELEMENTAL BORON; BARE BORON; CLUSTERS; PLANAR; TRANSITION; SHEETS; nanotubes; boron; structural stability; electronic properties; work function; ballistic transport; ab initio calculations (1)
ab initio, first principles, density functional theory, DFT, magneto-optics, magneto-optical Kerr effect, MOKE, anisotropic MOKE, hydrogenated graphene, WIEN2k, Fe/GaAs(001), spintronics, spin injection (1)
AB-INITIO; NH3; (1)
AB-INITIO; OPTICAL-SPECTRA; FERROMAGNETISM; MONOLAYER; STACKING; MN; FE (1)
Ab-initio-Rechnung , Hochdruck , Phasendiagramm , Pseudopotenzialmethode , Strukturelle Phasenumwandlung , Thermodynamische Stabilität , Gitterdynamik , , ab-initio calculation , high-pressure phase transition , Imma phase , semiconductor , lattice dynamics (1)
Ab-initio-Rechnung , Inelastische Neutronenstreuung , Neutronenstreuung , Gitterdynamik , Dichtefunktionalformalismus , Temperaturabhängigkeit , Fluoride , Druckabhängigkeit , Grüneisen-Parameter , volumenabhängige Gitterdynamik , temperaturabhängige Gitterdynamik , ab-initio calculation , neutron scattering , temperature dependent lattice dynamics , fluorides , volume dependence (1)
Ab-initio-Rechnung , Störungstheorie , Debye-Waller-Faktor , Dichtefunktionalformalismus , Strukturanalyse , EXAFS , , Ab initio calculaton , perturbation theory , Debye-Waller factor , density functional theory , structural analysis (1)
ABIOTIC GUANIDINIUM; PHASE-TRANSFER; BINDING; REAGENTS; DESIGN; COMPLEXATION; CHEMISTRY; METHANOL; ANIONS; HOST; (1)
ablation, adenosine, atrial fibrillation, endoscopic visualization, laser, reconnection (1)
ABLATION; LIVER; SAFETY; bile ducts; hepatic tumors; electroporation (1)
ABLATION; LIVER; TUMORS; (1)
ABLATION MECHANISM; PULSE DURATION; ENAMEL; CO2 laser; hydroxyapatite; infrared absorption; laser ablation; plasma threshold; PO4 mode; upconversion (1)
ABLATION STANDARDIZATION; THERMAL ABLATION; SAFETY; DIAGNOSIS; TERMINOLOGY; RECURRENCE; EFFICACY; RISK; CT; irreversible electroporation; hepatocellular carcinoma; early detection; magnetic resonance imaging; Gd-EOB-DTPA (1)
Ablationstherapie, Lebertumore. Komplikationen, Gerinnungsparameter, Blutung (1)
Ablation techniques, Carcinoma (hepatocellular), Colorectal neoplasms, Electroporation, Irreversible, electroporation (1)
Ablenkung , Maßeinheit , Strecke , visuelle Sekundäraufgabe , Streckenabschnitte , Autofahren , distraction , visual secondary task , driving , measurement , measures (1)
abnormal aggression; vasopressin; serotonin; HPA axis; trait anxiety; HAB rats; LAB rats; violence (1)
ABNORMAL NEURONAL MIGRATION; TUBA1A MUTATION; CORTICAL DEVELOPMENT; CORPUS-CALLOSUM; WIDE SPECTRUM; ALPHA; BRAIN; MALFORMATIONS; MECHANISMS; DATABASE; TUBA1A; Tubulin; Tubulinopathy; Lissencephaly; Brain malformation; Microcephaly; Developmental delay; Human phenotype ontology (1)
ABOUTNESS; GRAMMAR; Coastal Marind; information structure; noun phrases; Papuan languages; syntax (1)
; Abruzzo; endemism; molecular phylogeny; National Park; nomenclature; taxonomy (1)
ABSA, aspect based sentiment analysis, sentiment analysisa, annotation, human annotation (1)
Abschiebung, Kollektivausweisung, non-refoulement (1)
ABSENT CORPUS-CALLOSUM; AMBIGUOUS GENITALIA; MENTAL-RETARDATION; ARX; MUTATIONS; EPILEPSY; X-linked lissencephaly; abnormal genitalia; renal phosphate wasting; intractable epilepsy; chronic diarrhoea (1)
ABSENT CORPUS-CALLOSUM; MENTAL-RETARDATION; AMBIGUOUS GENITALIA; HOMEOBOX GENE; (1)
ABSOLUTE-CONFIGURATION; COURTSHIP BEHAVIOR; MATE RECOGNITION; DAIRY FARMS; FATTY-ACID; HYMENOPTERA; COMPONENTS; PTEROMALIDAE; BEETLE; ALKADIENES; cuticular hydrocarbons; mate finding; parasitoid wasp; contact sex pheromone; Urolepis rufipes (1)
ABSOLUTE-CONFIGURATION; CRYSTALLOGRAPHY; DAMAGE; crystalline sponge; copper K beta radiation; metal-organic frameworks; X-ray analysis (1)
ABSOLUTE ERROR MAE; INTERMITTENT DEMAND; TIME-SERIES; NEURAL-NETWORK; MODELS; PREDICTION; COMBINATION; ACCURACY; IMPACT; RMSE; Security vulnerability; Prediction; Forecasting; Competition setup; Time series (1)
absolute Galois group, extension without simple ramification, local fields of residue characteristic 2 (1)
ABSOLUTE HARDNESS; CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; HIGH PRESSURES; ANTIMONY; PHASES; TRANSITION; TELLURIUM; STABILITY; PARAMETER; gold; antimony; Au-Sb phases; high-pressure synthesis; chemical hardness; charge transfer; density-functional calculations (1)
ABSOLUTE RATE CONSTANTS; PHOTO-OXIDATION; COMPLEXES; PHOTOREDUCTION; KINETICS; PHOTOCHEMISTRY; PLATINUM; PALLADIUM; RADICALS; METAL; photooxidation; tetrachloroplatinate(II); chloroform (1)
ABSOLUTE SETS; CONJECTURE; (1)
Absorption; Cations; Colloids; Crystallography; Uranium (1)
ABSORPTION FINE-STRUCTURE; COMPOSITE THIN-FILMS; CIRCULAR-DICHROISM; ELECTRON-YIELD; CARBON-FILMS; XPS SPECTRA; NICKEL; METAL; CARBIDE; COBALT; (1)
ABSORPTION INHIBITOR EZETIMIBE; HIGH-THROUGHPUT QUANTIFICATION; SPHINGOMYELIN DEGRADATION; DENSITY-LIPOPROTEINS; DIFFERENT MECHANISMS; CA++ ANTAGONISTS; HIGH-AFFINITY; OXIDIZED LDL; RECEPTOR; EFFLUX; ezetimibe; aminopeptidase-N; raft; SOAT1; cholesterol processing (1)
ABSORPTION; INK; (1)
ABSORPTION SPECTRA; MERCURY; PHOTOLUMINESCENCE; CYCLOHEXANE; GENERATION; COMPLEXES; BIPHENYL; electronic spectra; photoluminescence; photochemistry; charge transfer; mercury (1)
Absorptionsspektroskopie , Hochdruckapparatebau , Kohlendioxid , Mikroemulsion , Reaktionskinetik , Bandenanalyse , Carotin <beta-> , di-HCF4 , micellare Lösung , Perfluoropolyetherammoniumcarboxylat , analysis of bands , carotene <beta-> , di-HCF4 , micellar solution , perfluoropolyether ammonium carboxylate (1)
Absorptionsspektroskopie , Photorezeptor , Grünalgen , Phototropismus , Triplettzustand , Reaktionsmechanismus , Flavoenzym , Reaktive Zwischenstufe , Chlamidomonas reinhardii , Phototropin , LOV , zeitaufgelöste Spektroskopie , Flavin , Phototropin , LOV , photoreceptor , flavoprotein , flavin mononucleotide (1)
Absorptionsspektroskopie , Photorezeptor , Riboflavinphosphat <Riboflavin-5'-phosphat> , Grünalgen , Reaktive Zwischenstufe , Flavoenzym , Chlamydomonas reinhardii , Reaktionsmechanismus , Gametogenese , Phototropismus , Triplettzustand , Phototropin , LOV , zeitaufgelöste Spektroskopie , Flavin , Radikal , Phototropin , LOV , photoreceptor , flavoprotein , flavin mononucleotide (1)
Abstammung, Verwandtschaft, Familienrecht, Mutterschaft, Vaterschaft (1)
ABSTRACTS; FATE; PRESENTATIONS; abstracts; meetings; publication rates; pancreas research; American Pancreatic Association; European Pancreatic Club (1)
ABSTRACTS; SOCIETY; PRESENTATIONS; PUBLICATION; FATE; MEETINGS; REVIEWER; PROGRAM; RATES; congress; poster exhibition; abstract; redundance; quality management (1)
Abtreibung, Schwangerschaftsabbruch, Stillgeburt (1)
ABUSE CECA; MALTREATMENT; INTERVIEW; CARE; NEUROPEPTIDES; TRANSMISSION; ASSOCIATION; VASOPRESSIN; VALIDATION; MODERATION; Childhood adversity; Parenting; Mother-child interaction; Gene-environment interaction; Oxytocin receptor gene (1)
ABUSE; erythropoiesis; high altitude; erythropoietin misuse (1)
ABUSE; SCALE; DISSOCIATION; DISORDERS; TRAUMA; ADULTS; PTSD; Childhood sexual trauma; Personal identity; Body image; Somatization disorder (1)
abutment, core build-up, mechanical loading, resin, thermal cycling, water sorption, zirconia (1)
Acacia, AFLP, Directed Dispersal, Frugivore, Kalahari, Nurse Tree (1)
Academic Achievement (1)
ACADEMIC-ACHIEVEMENT; DELIBERATE PRACTICE; SOCIOECONOMIC-STATUS; COGNITIVE-ABILITY; PERFORMANCE; ADOLESCENTS; EXCELLENCE; GENDER; SCHOOL; STEREOTYPES; expert interview; qualitative research; STEMM education; talent development (1)
ACADEMIC-ACHIEVEMENT; JUDGMENT ACCURACY; FLUENCY; STUDENTS; ACQUISITION; ENGLISH; MODEL; METAANALYSIS; PREDICTORS; AWARENESS; reading skills; reading comprehension; teacher assessments; passage comprehension; word recognition (1)
ACADEMIC-ACHIEVEMENT; LITERACY DEVELOPMENT; ELEMENTARY-SCHOOL; MIDDLE-SCHOOL; ENTRANCE AGE; CHILDREN; LANGUAGE; PRESCHOOL; ACQUISITION; PRECURSORS; narrative quality; phonological awareness; reading; story memory; vocabulary (1)
academic elective intentions, school career choices, school subjects, STEM, value beliefs (1)
ACADEMIC EMOTIONS; ACHIEVEMENT SETTINGS; ANTECEDENTS; MATHEMATICS; INTERVENTIONS; PERFORMANCE; MOTIVATION; OUTCOMES; MODELS; GROWTH; Enjoyment; Boredom; Cognitive learning strategies; Intraindividual and interindividual differences (1)
; academic freedom; android; dream; Internet; material culture; media science studies; posthumanism; robot; technology; wishful thinking (1)
ACADEMIC LIBRARIANSHIP – KNOWLEDGE MANAGEMENT – PROFESSIONAL IMAGE (1)
ACADEMIC OUTCOMES; CHILDREN; PERFORMANCE; SURVIVORS; GROWTH; UPDATE; children; cognitive function; cognitive impairment; complications; pediatric liver transplantation; WISC IV (1)
ACADEMIC-PERFORMANCE; INTELLIGENCE; CONFLICT; TRUST; ANTECEDENTS; TASK; ORGANIZATIONS; COLLABORATION; ENVIRONMENTS; METAANALYSIS; Emotional competence; Team learning behaviours; Systematic review; Emotional intelligence; Work teams (1)
ACADEMIC-PERFORMANCE; MOTIVATE ADOLESCENTS; GENDER STEREOTYPES; SELF-EFFICACY; ROLE-MODELS; MATHEMATICS; PARENTS; WOMEN; BELIEFS; CAREER; Female students; Selective science high schools; Social agents; STEM majors (1)
ACADEMIC-PERFORMANCE; SELF-CONTROL; INSOMNIA; INDEX; CONSUMPTION; VALIDATION; COLLEGE; SMOKING; (1)
; Academic plastic surgery; research funding; DFG; BMBF; DGUV; BMWi; peer review; research funding report (1)
ACADEMIC PROCRASTINATION; TRAIT PROCRASTINATION; PERSONAL PROJECTS; INTENTIONS; HEALTH; PERSPECTIVE; BEHAVIOR; FUTURE; MODEL; (1)
ACADEMIC RADIOLOGY; WORK; economics, medical; costs, cost analysis; interventional procedures (1)
ACADEMIC SELF-CONCEPT; COGNITIVE STRATEGIES; STUDENTS; EFFICACY; PERFORMANCE; MOTIVATION; BOREDOM; GOALS; METAANALYSIS; MATHEMATICS; achievement emotions; learning preferences; self-regulated learning; learning strategies (1)
Academic self-concept ● STEM ● Competence beliefs ● Value beliefs ● Career aspirations (1)
ACCELERATED BLOOD CLEARANCE; PROTEIN ADSORPTION PATTERNS; LIPOSOMAL DOXORUBICIN DOXIL; TUMOR-BEARING MICE; ACTIVATION-RELATED PSEUDOALLERGY; MOLECULAR-WEIGHT KININOGEN; SOLID-LIPID-NANOPARTICLES; ALBUMIN-BOUND PACLITAXEL; COMPLEMENT ACTIVATION; SERUM-PROTEINS; (1)
accelerated intermittent theta burst stimulation (aiTBS), feasibility, home-based treatment, major depressive disorder (MDD), transcranial magnetic stimulation (TMS) (1)
ACCELERATED MOLECULAR-DYNAMICS; FREE-ENERGY CALCULATIONS; MONTE-CARLO METHOD; TRP-CAGE; INFREQUENT EVENTS; ALANINE DIPEPTIDE; EXPLICIT SOLVENT; LAMBDA-DYNAMICS; LOCAL ELEVATION; ALGORITHM; (1)
ACCELERATES ODOR DISCRIMINATION; ADULT-BORN NEURONS; THETA-OSCILLATIONS; GAMMA-OSCILLATIONS; DENDRODENDRITIC SYNAPSES; LATERAL INHIBITION; PYRAMIDAL NEURONS; AWAKE MICE; DISTINCT; SPIKE; (1)
ACCELERATOR MASS-SPECTROMETRY; IN-VITRO; LUNG-CANCER; TOBACCO-SMOKE; COMET ASSAY; DNA-DAMAGE; CELLS; METABOLISM; CONSTITUENTS; LYMPHOCYTES; genotoxicity; nicotine; Comet assay; mini-organ cultures; human epithelia (1)
ACCEPTANCE-INDUCING-CELLS; RENAL-TRANSPLANTATION; T-CELLS; BLOOD MONOCYTES; TOLERANCE; THERAPY; PREVENTION; RECIPIENTS; INDUCTION; REJECTION; cell therapy; immunosuppression; regulatory macrophage (1)
ACCEPTANCE-INDUCING-CELLS; TACROLIMUS MONOTHERAPY; IMMUNOSUPPRESSION; PRETREATMENT; ACTIVATION; REJECTION; TOLERANCE; DRIVEN; STATE; (1)
ACCEPTOR CENTER; GERMANIUM; LOCALIZATION; TRANSPORT; PHYSICS; GAP; (1)
ACCEPTOR DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; PHOTOVOLTAIC CELLS; CONJUGATED POLYMERS; CHARGE GENERATION; THIN-FILMS; MORPHOLOGY; DONOR; ENERGY; BLENDS; (1)
ACCEPTOR-SUBSTITUTED CYCLOPROPANES; TAMING HAZARDOUS CHEMISTRY; DIAZO-COMPOUNDS; LIGHT; OPTIMIZATION; FURANS (1)
access control - anonymity - application security - computer networks - data anonymization and sanitization - data mining - database and storage security - information accountability and usage control - malware - management and querying of encryped data - mobile security - outsourcing - privacy preservation - pseudonymity - security services - social network security and privacy - systems security - traffic monitoring - untraceability (1)
Access Control, Digital Nudges, Choice Defaults, Expert Interviews, User Study, Formalization (1)
Access control, Identity management, Model-driven security, Requirements, Business process modelling, Security (1)
Access Control Model, Identity Management (IdM), Web Service-Oriented Architecture (WSOA), Metamodel, Policy Decision Point (PDP), Business Process Execution Language (BPEL) (1)
Access Control, Service-Oriented Architecture, Model-Driven Development (1)
ACCESS-CONTROL; SYSTEMS; MODELS; RBAC; Role-based access control; RBAC; Role theory; Information Security; Survey (1)
ACCESSORY MEDULLA; OPTIC LOBE; IMMUNOREACTIVE NEURONS; DROSOPHILA-MELANOGASTER; LOCOMOTOR RHYTHMS; SYSTEM; CLOCK; BRAIN; ORGANIZATION; CRICKETS; neuroanatomy; circadian rhythms; pigment-dispersing factor; accessory medulla; neuronal tracing; immunocytochemistry; cockroach, Leucophaea maderae (Insecta) (1)
ACCESSORY RENAL-ARTERIES; LOWER-EXTREMITY ARTERIES; BREATH-HOLD; GADOPENTETATE DIMEGLUMINE; CONVENTIONAL ANGIOGRAPHY; CAROTID-ENDARTERECTOMY; PRELIMINARY EXPERIENCE; OCCLUSIVE DISEASE; STENOSIS; OPTIMIZATION; contrast media; magnetic resonance angiography; multicenter study (1)
Access Reviews; Decision Quality; Crowd Sourcing; Identity and Access Management; Compliance (1)
Access to healthcare · Migration of medical professionals · Refugees from Ukraine · Temporary protection (1)
; access to information; Europe; central; health science; librarianship; libraries; health care; library services (1)
ACCIDENTS INVOLVING PATIENTS; MOTOR-VEHICLE ACCIDENTS; AUTOMOBILE ACCIDENTS; APNEA PATIENTS; RISK; ROAD; SIMULATION; EXPOSURE; FATIGUE; Fitness to drive; polysomnography; sleepiness; sleep quality; vigilance (1)
acclimation | climate change | climatic gradient | gametophytes | heat waves | local adaptation | seed | Silene vulgaris (1)
ACC, motor cortex, theta, beta, conflict, response priming (1)
Accounting regime adoption; Cost of equity capital; Multi-factor model; IFRS; U.S. GAAP; Germany (1)
ACCURACY; JUDGMENTS; COMPETENCE; Diagnostic skills; diagnostic competence; teacher judgment accuracy; instructional quality; teacher competence (1)
ACCURACY; REPRODUCIBILITY; ERROR; Orthodontic model analysis; Measuring agreement; Digitized plaster models; 3D printing; CAD-CAM workflow (1)
ACCURATE PLACEMENT; INTRAATRIAL ECG; DIAGNOSIS; PRESSURE; central venous catheterization, adverse effects, methods; dysrhythmia, prevention; electrocardiogram (ECG), intravascular (1)
ACE2; EXPRESSION; (1)
ACE2; EXPRESSION; COVID-19 pandemic; SARS-CoV-2; ACE2; ACE inhibitor; Heart failure; Left ventricular assist device (1)
ACETABULAR COMPONENT; COMPUTER NAVIGATION; CUP PLACEMENT; REPLACEMENT; ACCURACY; MOTION; RANGE; POSITION; VERSION; Hip arthroplasty; Stem version; Combined anteversion; Imageless navigation (1)
ACETABULAR COMPONENT; IMPINGEMENT-FREE; REPLACEMENT; ANTEVERSION; PROSTHESIS; NAVIGATION; ZONE; THA; total hip arthroplasty; cup position; parallax effect (1)
ACETABULAR COMPONENT; IMPINGEMENT; RANGE; ORIENTATION; ACCURACY; Femur First; Combined anteversion; Impingement; THR; THA (1)
ACETABULAR COMPONENT; IMPINGEMENT; REPLACEMENT; ANTEVERSION; ORIENTATION; RANGE; NAVIGATION; MOTION; WEAR; (1)
ACETABULAR COMPONENT ORIENTATION; ASSISTED ORTHOPEDIC-SURGERY; CT-BASED MEASUREMENT; COMPUTER NAVIGATION; PLAIN RADIOGRAPHS; SPINE SURGERY; FREE-HAND; DISLOCATION; PLACEMENT; REPLACEMENT; (1)
ACETABULAR CUP NAVIGATION; TOTAL KNEE ARTHROPLASTY; IMAGELESS NAVIGATION; POLYETHYLENE WEAR; COMPONENT; REPLACEMENT; OFFSET; SYSTEM; IMPINGEMENT; ORIENTATION; Computer assisted orthopaedic surgery; Femur first concept; Total hip replacement; Combined anteversion; Noninvasive reference system (1)
ACETABULAR DYSPLASIA; CONGENITAL DISLOCATION; FOLLOW-UP; ARTHROPLASTY; RECONSTRUCTION; COMPONENTS; POSITION; SYSTEM; (1)
ACETABULAR IMPINGEMENT; Acetabulum; Conservative treatment; Femur; Hip joint; Radiology (1)
Acetabulumchirurgie · Infraazetabuläre Schraube · Navigationssystem · Acetabulumfraktur · Vorderer und hinterer Pfeiler · Beckenchirurgie (1)
Acetaldehyde, Disodium-pentakis-(cyano-C)-nitrosyl-ferrate(2), Simon-Awe Reaction, Enamine Intermediate (1)
ACETATE KINASE; ESCHERICHIA-COLI; INORGANIC-PHOSPHATE; RESPONSE-REGULATOR; ACYL-PHOSPHATES; PATHWAY; ASSAY; PHOSPHORYLATION; HYDROLYSIS; SYSTEMS; (1)
ACETOXY-SUBSTITUTED 1,1,2-TRIPHENYLBUT-1-ENES; DEPENDENT MAMMARY-CARCINOMA; TUMOR INHIBITING ACTIVITY; CRYSTAL-STRUCTURE; VARIABLE SUBSTITUENTS; 2-PHENYL RING; COMPLEXES; (CH3O)(C6H3CL)(CH2)(2)(C6H2CL2)(OCH3); 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes; biological responses modifiers; synthesis; estrogen receptor affinity; estrogenic/antiestrogenic activity (1)
ACETYLATED ALPHA-TUBULIN; INTRAFLAGELLAR TRANSPORT; MESSENGER-RNA; BASAL BODIES; NUCLEAR TRANSFORMATION; REINHARDTII; GENE; FLAGELLAR; LOCALIZATION; RESISTANCE; basal body; centriole; flagella; microtubule associated proteins; antisense RNA (1)
ACETYLCHOLINE-INDUCED HYPOTENSION; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; 15-LIPOXYGENASE; GENE; ATHEROSCLEROSIS; MACROPHAGES; INVOLVEMENT; RABBITS; 15-Lipoxygenase; 12-Lipoxygenase; 15-LOX; 12-LOX; ALOX15; ALOX12; Inflammation; Atherosclerosis; Myocardial infarction; Genetics; Haplotype; Polymorphism (1)
ACETYLCHOLINE-RECEPTOR ANTIBODIES; NEUROMUSCULAR-JUNCTION; MOUSE MODEL; PROTEIN 4; MUSK; MUSCLE; LRP4; MICE; (1)
ACETYLCHOLINE-RECEPTOR; LINEAGE COMMITMENT; THYMIC EMIGRANTS; SELECTION; IDENTIFICATION; THYMECTOMY; THYMOCYTES; PHENOTYPE; INFECTION; APOPTOSIS; (1)
ACETYLCHOLINE-RECEPTOR; T-CELLS; B-CELLS; CLINICOIMMUNOLOGICAL CHARACTERISTICS; GRAVIS THYMUS; MYOID CELLS; THYMECTOMY; THYMOMA; IMMUNOSENESCENCE; ANTIBODIES; Thymus; Myasthenia gravis; Autoimmunity; Thymectomy Atrophy; Ageing (1)
Acetylcholinesterase; Histamine H-3 receptor; Dual-acting ligand; Learning; Memory; Passive avoidance paradigm; Dizocilpine; Scopolamine; Pyrilamine; Zolantidine (1)
ACETYLCHOLINESTERASE INHIBITORS; DONEPEZIL HYDROCHLORIDE; DESIGN; CONSTRUCTION; RING; DRUG; PDE4; Alkyne; indanone; Pd/C; iodine; hydration (1)
ACETYLCHOLINESTERASE INHIBITORS; HETERO-BIVALENT; RATIONAL DESIGN; ACTIVE-SITE; BINDING; LIGANDS; FLUCTUATIONS; RECEPTORS; SALTS; Alzheimer's disease; Cholinesterase; Molecular docking; Bivalent inhibitors; Quinazolinimines (1)
ACETYL-COA-CARBOXYLASE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SATURATION MUTAGENESIS; YEAST; BIOSYNTHESIS; BINDING; CELLS; (1)
ACETYL-COA-CARBOXYLASE; FATTY-ACID SYNTHESIS; BIOTIN HOLOENZYME SYNTHETASE; ESCHERICHIA-COLI; RECOMBINANT PROTEINS; POSTTRANSLATIONAL MODIFICATION; ENZYMATIC BIOTINYLATION; YEAST; GENE; COENZYME; (1)
ACETYL-COA CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; GENE; YEAST; CLONING; IDENTIFICATION; TRANSCRIPTION; BIOSYNTHESIS; PERMEASES; SYMPORTER; biotin transport; vht1(+); Schizosaccharomyces pombe; allantoate transporter; vitamin H (1)
Acetyl phosphate, biogenic amines, ruthenium complex, RGB readout, test strips, chameleon dye, acetate, enzymatic assay, fluorescence, anion probes, fisch, AcP (1)
ACETYLSALICYLIC-ACID; ANALGESIC EFFICACY; CLUSTER HEADACHE; CLINICAL-TRIALS; PARACETAMOL; SAFETY; SUMATRIPTAN; MANAGEMENT; MEDICATION; IBUPROFEN; migraine; acetaminophen; parenteral; acute treatment (1)
acetylsalicylic acid; anticoagulation; dipyrone; multiple electrode aggregometry (Multiplate); platelet function; thromboelastography (TEG) (1)
ACETYLTRANSFERASE GCN5; ADA2; SAGA complex; Histone acetyltransferase; GCN5; Deubiquitination module; Plant (1)
ACHIEVEMENT ATTRIBUTIONS; EARLY ADOLESCENCE; GOAL ORIENTATION; HIGH-SCHOOL; EFFICACY; STUDENTS; PERFORMANCE; MOTIVATION; PERCEPTIONS; KNOWLEDGE; Self-regulated learning; Training program; Elementary school; Mathematics; Growth curves; Time management; Homework activities (1)
ACHIEVEMENT EMOTIONS; ACADEMIC-PERFORMANCE; SELF-REGULATION; STUDENTS; CONFLICTS; LEISURE; ALTERNATIVES; PERSISTENCE; TEMPTATION; VALUES; Academic functioning; Motivational conflict; Motivational interference; Positive affect; Self-regulated learning (1)
ACHIEVEMENT GOALS; INTELLIGENCE INFLUENCE; INTRINSIC MOTIVATION; MAIN IDEAS; MIND-SETS; BELIEFS; ORIENTATIONS; PERFORMANCE; COMPETENCE; INTERVENTIONS; implicit theories about ability; mindsets; incremental theory; entity theory; growth mindset; fixed mindset; cognitive learning strategies; metacognitive learning strategies (1)
ACHIEVEMENT; IMPLICIT; QUESTIONNAIRE; VALIDITY; NEED; Thematic Apperception Test; evaluation; validity (1)
ACHIEVEMENT STATUS; MYELOMENINGOCELE; PROFILE; MEMORY; (1)
Achillessehnenruptur, Freizeitsport, Lebensqualität, Outcome (1)
Achillessehne, Sonoelastographie, adipose-derived stem cells (1)
Achilles tendon healing; Achilles tendon biomechanical properties; shear wave elastography (1)
Achilles tendon, longterme, elastography (1)
Achilles tendon rupture, Achillessehnenverletzung, early functional rehabilitation, frühe funktionelle Nachbehandlung, ankle fractures, Sprunggelenksfrakturen, calcaneal fractures, Calcaneusfrakturen, orthosis, Orthese, immobilization, Immobilisierung (1)
ACID 2-THIOPHENE-3-YL-ETHYL ESTER; CONDUCTING POLYMERS; DUAL DESCRIPTOR; NANOPARTICLES; CELLULOSE; FIBERS; BOX; Alginate films; Conducting polymer; Poly(octanoic acid 2-thiophen-3-yl-ethyl ester) (1)
ACID 2-THIOPHENE-3-YL-ETHYL ESTER; CONDUCTING POLYMERS; SURFACE-TENSION; GREEN SYNTHESIS; SOL-GEL; BLENDS; COMPOSITES; POLYETHYLENE; SCAFFOLD; CHITIN; (1)
ACID; ACIDIFICATION; MEMBRANE; GROWTH; (1)
acid, AD-HoC, bromoaniline, C(sp²)–S coupling, cross-coupling, photoredox (1)
ACID AMIDE HYDROLASE; COLLAGEN-INDUCED ARTHRITIS; CB1 RECEPTORS; ANANDAMIDE; FIBROBLASTS; ACTIVATION; EXPRESSION; SYSTEM; TISSUE; OSTEOARTHRITIS; Synoviocytes; Tumor necrosis factor; Interleukin 6; Interleukin 8; Synovial fibroblasts; TRPV1; TRPA1; Cannabinoids; Anandamide; Matrix metalloproteinase 3; Collagen-induced arthritis (1)
ACID-BINDING PROTEIN; CELL LINE HL-60; X-RECEPTOR; DENDRITIC CELLS; NUCLEAR RECEPTOR; THYROID-HORMONE; BLOOD MONOCYTES; MESSENGER-RNA; ALL-TRANS; RXR-ALPHA; (1)
ACID-DERIVATIVES; ANTAGONISTS; LIGANDS; FAMILY; METATHESIS; POTENT; HYDROGENATION; LUMINESCENCE; EXPRESSION; PEPTIDES; (1)
ACID-INDUCED APOPTOSIS; ABERRANT CRYPT FOCI; PERMEABILITY TRANSITION; URSODEOXYCHOLIC ACID; CYTOCHROME-C; FAS LIGAND; HEPATOCYTE APOPTOSIS; RAT HEPATOCYTES; INJURY; LIVER; bile acid; apoptosis; CD95; colon cancer; mitochondrial transmembrane potential (1)
Acidithiobacillus, Metallosphaera, S-Layer, acidophil, Pyrit-Oxidation, Oberflächenadhäsion (1)
ACIDITY CONSTANTS; THERMAL-BEHAVIOR; AQUEOUS-SOLUTION; PK(A) VALUES; COSMO-RS; STABILITY; CURCUMIN; ABSORPTION; FLAVONOIDS; MECHANISM; Quercetin; Meglumine; Hydrotrope; Water-solubilization; Oxidation; pH (1)
ACID MALTASE DEFICIENCY; ALGLUCOSIDASE ALPHA; MRI; ULTRASONOGRAPHY; CHILDHOOD; DIAGNOSIS; GLYCOGEN; CHILDREN; Infantile Pompe disease; Adult Pompe disease; Acid maltase deficiency; GAA-deficiency; Muscle ultrasound; Quantitative grey scale analysis (1)
ACID) MICROSPHERES; RELEASE CHARACTERISTICS; INVIVO DEGRADATION; PLGA MICROSPHERES; MONOMER RELEASE; AQUEOUS-MEDIA; EROSION; MATRICES; DEVICES; POLY(ORTHO-ESTER)S; bioerosion; modeling; controlled drug delivery; release mechanism; biodegradation; Monte Carlo simulation (1)
ACID PHARMACOKINETICS; ACUTE REJECTION; EC-MPS; CYCLOSPORINE; MMF; IMMUNOSUPPRESSION; MULTICENTER; COMBINATION; PREVENTION; EFFICACY; mycophenolate sodium; enteric-coated mycophenolic acid; mycophenolate mofetil; inosine monophosphate dehydrogenase; pharmacokinetics; pharmacodynamics (1)
ACID POLYMERIZATION; DIATOM BIOSILICA; PEPTIDES; (1)
ACID; SECRETION; (1)
ACID-SECRETION; K+ CHANNELS; CARDIAC-ARRHYTHMIAS; APICAL MEMBRANE; CL CONDUCTANCES; KNOCKOUT MOUSE; OXYNTIC CELLS; KCNQ1; GENE; K(V)LQT1; (1)
ACID-SENSITIVE PROTEIN; MALIGNANT-MELANOMA; SERUM MARKER; CARTILAGE; EXPRESSION; COLLAGEN; CLONING; GENE; MIA; CD-RAP; chondrocyte; differentiation; tissue engineering (1)
ACID SPHINGOMYELINASE; ANTIDEPRESSANT; ACTIVATION; BEHAVIOR; STRESS; CERAMIDASE; ALCOHOL; MODEL; anxiety; depression; sphingolipids; sphingomyelinase; ceramidase (1)
ACID SPHINGOMYELINASE GENE; TANDEM MASS-SPECTROMETRY; SECRETORY SPHINGOMYELINASE; ENDOTHELIAL-CELLS; ATHEROGENIC LIPOPROTEINS; CULTURED HUMAN; RECEPTOR G2A; EXPRESSION; LIGAND; INFLAMMATION; outcome; lipoproteins; sphingomyelinase; phospholipase; SAPS score; prognostic marker (1)
ACID; STABILITY; PREHARVEST; CHEMISTRY; SOLVENT; LIFE; Solubilization; Extraction; Stabilization; Curcumin; Precipitation; Antioxidant (1)
ACID-TRIETHYLAMINE MIXTURE; AROMATIC KETONES; IONIC LIQUID; PALLADIUM CATALYST; HIGHLY EFFICIENT; IRON CATALYSTS; RU CATALYST; NANOPARTICLES; SUPPORTS; POLYMERIZATION; Asymmetric catalysis; Magnetic nanoparticle; Organic-inorganic hybrid material; Asymmetric transfer hydrogenation; Immobilized catalyst; Ruthenium; Recycling (1)
ACID; TUMORS; (1)
ACI- Stenose, Arteria carotis interna Stenose, Eversionsendarteriektomie, EEA, carotid artery stenting, CAS stent, Restenose, Kinking, Intimahyperplasie, carotid artery stenosis , carotid endarterectomy, stroke prevention, restenosis (1)
AC joint dislocation; acromioclavicular joint; Rockwood classification; vertical instability; shoulder girdle (1)
ACL, complex knee injury, knee dislocation, PCL, Schenck classification (1)
ACL RECONSTRUCTION; INTRAFLAGELLAR TRANSPORT; GROWTH-PLATE; ANATOMY; PROPRIOCEPTION; Primary cilia; Anterior cruciate ligament; Ultrastructure; Ligament damage; Mechanotransduction (1)
ACL RECONSTRUCTION; OSTEOCHONDRAL LESIONS; CHONDRAL LESIONS; SOCCER PLAYERS; NORMAL KNEE; SURGERY; TEARS; TIME; OSTEOARTHRITIS; MENISCECTOMY; ACL rupture; ACL repair; Cartilage lesion; Meniscus repair; Osteoarthritis (1)
ACL RECONSTRUCTION; STRENGTH; WEIGHTBEARING; PRINCIPLES; anterior cruciate ligament reconstruction; early rehabilitation; hamstring tendon graft; bone tendon-bone graft; patella tendon graft (1)
ACL rehabilitation, ACL surgery, amateur, knee injury, prevention programme, professional, soccer (1)
acne, acneiform eruption, adverse drug reactions, rosacea, skin-directed therapy, targeted therapies (1)
acne vulgaris, acneiform eruption, adverse reaction, cystic fibrosis, isotretinoin (1)
ACOD1; IRG1; citraconate; infection; itaconate; mesaconate; transport; uptake (1)
ACOD1, IRG1, itaconate, mesaconate, citraconate, uptake, transport, infection (1)
ACOUSTIC ANALYSIS; SLEEP-APNEA; INTENSITY; SNORES; NOISE; HOME; Snoring; Breathing; Acoustic; Definition; Psychoacoustic (1)
ACOUSTIC ANALYSIS; SLEEP-APNEA; SNORES; NOISE; SITE; Snoring; OSAS; Frequency analysis; Microphone; Recording (1)
Acoustic communication; reproduction; spectral analysis; electric fish; vocalisation; aggression (1)
ACOUSTIC RHINOMETRY; PARANASAL SINUSES; NOSE; PHYSIOLOGY; ANATOMY; Nasal cycle; wakefulness; sleep; body position; head position (1)
ACOUSTIC STRAIN WAVES; SKELETAL-MUSCLE; CEREBRAL-PALSY; IMMOBILIZATION; STIFFNESS; ADAPTABILITY; magnetic resonance imaging; muscles; rehabilitation; stress (1)
ACOUSTIC-WAVES; ELASTIC MEDIA; SOLITONS; CRYSTALS; PULSES; (1)
ACQUIRED FLATFOOT DEFORMITY; POSTERIOR TIBIAL TENDON; DYSFUNCTION; Adult flatfoot; Hindfoot deformity; Coalitio; Ankle arthritis; Charcot foot (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; B-CELL DEPLETION; CARINII-PNEUMONIA; LYMPHOMA PATIENTS; LUPUS NEPHRITIS; INFECTIONS; THERAPY (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ENTEROCYTOZOON-BIENEUSI; BRONCHOALVEOLAR LAVAGE; SURFACE-WATER; INFECTION; HELLEM; CUNICULI; PATIENT; AIDS; IDENTIFICATION; (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; SKIN; THERAPY; HIV; photochemotherapy; photosensitizer; diode laser (1)
ACQUIRED MRSA; COMMUNITY; PNEUMONIA; EPIDEMIOLOGY; PREVALENCE; HOUSEHOLD; AUSTRALIA; STRAINS; GENES; TEAM (1)
ACQUIRED-RESISTANCE; KINASE INHIBITOR; C-KIT; WILD-TYPE; CANCER; ACTIVATION; MECHANISMS; GROWTH; IMATINIB; MUTATION; (1)
ACQUISITION; Domain-specific practice activities; Expertise; Professional development; Social interactions; Visual arts (1)
ACRIDINE-ORANGE; SPECIMENS; biobanking; prostate cancer (PCa); fluorescence confocal microscopy (FCM); digital medicine; cryoasservation; targeted sampling (1)
Acromioclavicular; Joint instability; Coracoclavicular; Allograft; Autograft (1)
; acromioclavicular joint; sonography; diagnostics; shoulder; injuries of the acromioclavicular joint (1)
ACROMYRMEX-OCTOSPINOSUS; ATTA-CEPHALOTES; MYRMECIA-GULOSA; GROWING ANTS; ATTINE ANTS; HYMENOPTERA; FORMICIDAE; SECRETIONS; GARDENS; SEXDENS; Acromyrmex; metapleural gland; antibiotics; pathogens (1)
ACROMYRMEX-STRIATUS ROGER; CYTOGENETIC CHARACTERIZATION; CENTROMERIC HETEROCHROMATIN; HYMENOPTERA-FORMICIDAE; SPECIATION; ATTINI; REARRANGEMENTS; POLYMORPHISM; INVERSIONS; NUMBERS; Centromere; Karyotype length; Gene flow; Trachymyrmex holmgreni; Formicidae (1)
ACRYLIC RESIN COMPOSITE; FIXED PARTIAL DENTURES; FLEXURAL PROPERTIES; WATER STORAGE; FATIGUE RESISTANCE; E-GLASS; FRACTURE-TOUGHNESS; STRENGTH; ADAPTATION; PLACEMENT; (1)
ACRYLIC RESIN COMPOSITE; POLY(METHYL METHACRYLATE); GLASS-FIBER; DENTISTRY; STRENGTH; INTERFACE; POLYMERS; fiber reinforced composite packing; flexure strength (1)
AC surface impedance; Flux lines; Levitation; Pinning; YBaCuO ceramics (1)
Actin-bindende Proteine , Actin-Filament , Pollenschlauch , Gametophyt , Spitzenwachstum , Genexpression , Molekularbiologie , Ackerschmalwand , Aktin-Dynamik , doppelte Befruchtung , Armadillo Protein , ARM repeat , actin dynamics , polarity , pollen tube tip growth , egg cell (1)
Actin dynamics, Spir, post-translational modification, Mass spectrometry (1)
Actin-Filament , Proteine , Wechselwirkung , Inositphosphatide , Ezrin , PIP2 , ezrin , PIP2 , F-actin (1)
ACTIN-FRAGMIN KINASE; DNA-POLYMERASE-ALPHA; CELL-CYCLE; SLIME-MOLD; BETA-POLY(L-MALATE); PLASMODIUM; PROTEIN; POLYMALATASE; POLY(BETA-L-MALATE); CRYSTALLIN; Physarum polycephalum; plasmodium; polymalatase; polymalic acid; spherulin 3b (1)
actinic elastosis; melanoma; nevogenesis; carcinogenesis; histopathology (1)
ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; PAIN; TEMPERATURE; MULTICENTER; EXPOSURE; SKIN; (1)
Actinic keratosis, Nonmelanoma skin cancer, Photolyase, Medical device, Photoprotection, Photorepair (1)
ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AUTOANTIBODIES; ENDOCARDITIS; LEUKOTOXIN; PERIODONTITIS; HLA-DRB1; BACTERIA; SEROTYPE; STRAINS; rheumatoid arthritis; ACPA; anti-CCP; Aggregatibacter actinomycetemcomitans; autoantibodies (1)
ACTINOMYCES-NAESLUNDII; ORAL ACTINOMYCES; IMMUNOGLOBULIN-A; MUCINS MG1; CHILDREN; COLONIZATION; STREPTOCOCCI; RECEPTORS; ADHESINS; BACTERIA; saliva; proteins; mucins; infants; development (1)
ACTINOMYCES-NAESLUNDII; STREPTOCOCCUS-MUTANS; SINGLET OXYGEN; RESISTANCE; INACTIVATION; EFFICACY; VALIDATION; DENTISTRY; BACTERIA; IMPACT; Caries; Chlorhexidine; Phenalen-1-one; Photodynamic therapy; Polymicrobial biofilm; Streptococcus mutans (1)
; actinomycetes; treatment of actinomycosis; cervicofacial infection; diagnosis of actinomycosis; head and neck infection; bacterial infection (1)
action categories, action features, neural representations, fMRI, brain decoding (1)
action categorization; action observation; action recognition; fMRI; EEG (1)
ACTION-EFFECT BINDING; ACTION CO-REPRESENTATION; WOODEN HAND; COMPATIBILITY; PERCEPTION; INTEGRATION; ACTIVATE; OBJECT; TEC; stimulus-response compatibility; go-nogo Simon task; modality; event representations; referential coding; Theory of Event Coding (1)
Action execution; Action observation; fNIRS; Neuroimaging; Complex everyday task; Egocentric/allocentric viewpoint (1)
ACTION PREDICTION; SOCIAL COGNITION; FALSE BELIEF; RATIONAL ACTION; ACTION GOALS; T TESTS; INFANTS; INFORMATION; ACCOUNT; OTHERS; Statistical learning; Visual attention; Anticipatory looking; Action perception (1)
Action recognition · Action understanding · Free recall · Natural scene · Object recognition · Perception · Scene recognition (1)
action recognition, LOTC, EEG, representational similarity analysis, fMRI-EEG fusion (1)
Action representations; Action categories; Action features; Behavioral similarity (1)
ACTION VIDEO GAMES; VISUAL-CORTEX; TEXTURE-DISCRIMINATION; MOTION DISCRIMINATION; VERNIER ACUITY; POP-OUT; ORIENTATION; IMPROVEMENT; ATTENTION; TASK; Perceptual learning; Functional MRI; Feedback; Coherent motion detection (1)
ACTIOTOPE MODEL; GIFTEDNESS; RESOURCES; FRAMEWORK; music; talent development; educational capital; learning capital; domain specificity (1)
ACTIVATED CARBON FILTERS; PSEUDOMONAS-AERUGINOSA; TAP-WATER; MINERAL-WATER; CONTAMINATION; SURVIVAL; HEMODIALYSIS; INFECTIONS; OUTBREAK; soda fountain; microbiological follow-up; drinking water; soda water; mineral water (1)
Activated charcoal, Inorganic phosphate, Interfering substances, Leaf phosphate extract, Malachite green, Phosphate determination (1)
ACTIVATED CHLORIDE CHANNEL; AIRWAY SMOOTH-MUSCLE; CA2+-ACTIVATED CL-CHANNEL; REVERSE TRANSFECTION; CYSTIC-FIBROSIS; TMEM16A; PROTEINS; EXPRESSION; PERMEABILITY; SCRAMBLASE; Intracellular traffic; Endoplasmic reticulum; Calcium-activated chloride channels; Cystic fibrosis; Automated fluorescence microscopy (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; CYSTIC-FIBROSIS; SMOOTH-MUSCLE; MUCOCILIARY CLEARANCE; SECRETION; MUCIN; ASTHMA; HYPERRESPONSIVENESS; OVEREXPRESSION; TMEM16A; ETX001; Eact; brevenal; asthma; cystic fibrosis; airways (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; GLAND ACINAR-CELLS; CALCIUM; TMEM16A; SECRETION; CURRENTS; VOLTAGE; AIRWAYS; FLUID; (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; SMOOTH-MUSCLE-CELLS; ANOCTAMIN 1; ASTHMA PHENOTYPES; MUCIN SECRETION; ANIMAL-MODELS; EXPRESSION; CANCER; CURRENTS; TMEM16A antagonist; niclosamide; nitazoxanide; bronchodilator; desensitization; airway smooth muscle (ASM); calcium-activated chloride channel; drug repositioning (1)
ACTIVATED CHLORIDE CHANNEL; CYSTIC-FIBROSIS; TMEM16A; EXPRESSION; SECRETION; ASTHMA; OVEREXPRESSION; BICARBONATE; THERAPY; DRUG; (1)
ACTIVATED CHLORIDE CHANNEL; FLUID SECRETION; CFTR; EXPRESSION; TRANSPORT; PROTEINS; DIFFERENTIATION; OVEREXPRESSION; ASSOCIATION; MODULATION; CLCA1; TMEM16A; anoctamin 1; airway epithelium; mucus; MUC5AC; KCNN4 (1)
ACTIVATED CHLORIDE CHANNEL; GASTROINTESTINAL STROMAL TUMORS; TISSUE MICROARRAY ANALYSIS; ION CHANNELS; BREAST-CANCER; TRANSCRIPTOME ANALYSIS; AMPLIFICATION; GENE; PROLIFERATION; TMEM16A; (1)
ACTIVATED CHLORIDE CHANNEL; GOBLET CELL HYPERPLASIA; BICARBONATE; MODULATION; MECHANISM; TRANSPORT; OVEREXPRESSION; ANOCTAMINS; REGULATOR; PROTEIN; anoctamin 1; cystic fibrosis; asthma; Ca2+ signaling (1)
ACTIVATED CHLORIDE CHANNEL; ION CHANNELS; AMINO-ACID; CALCIUM; CURRENTS; MOUSE; CONDUCTANCE; MEMBRANE; PROTEIN; FAMILY; Ano6; ORCC; TMEM16F; Migration; CCR7 (1)
ACTIVATED CHLORIDE CHANNELS; CA2+-ACTIVATED CL-CHANNELS; AGE-DEPENDENT DIARRHEA; ION CHANNELS; TRANSMEMBRANE PROTEIN; TRANSCRIPTOME ANALYSIS; INTERSTITIAL-CELLS; SENSORY NEURONS; MOLECULAR-BASIS; LUNG LIQUID; Ca2+-activated Cl- currents; CaCC; TMEM16A; Ano 1; Anoctamin; TMEM16B; TMEM16E; TMEM16F; TMEM16G; TMEM16H; TMEM16J; TMEM16K; Cystic fibrosis; Proliferation; Cancer; Development, SHH (1)
ACTIVATED CHLORIDE CHANNELS; CYSTIC-FIBROSIS; MACULAR DYSTROPHY; PRIMARY CULTURES; PROTEIN-KINASE; HT(29) CELLS; CALCIUM; MOUSE; TRANSPORT; CURRENTS; (1)
ACTIVATED CHLORIDE CHANNELS; ION-TRANSPORT; PROTEIN; CELLS; TMEM16A; BESTROPHIN; COMPLEX; CANCER; (1)
ACTIVATED CHLORIDE CHANNEL; TMEM16A; TARGET; OVEREXPRESSION; CFTR; TMEM16A; TMEM16F; asthma; inflammatory airway disease; COVID-19; hydrospheres; nanospheres; niclosamide (1)
ACTIVATED CHLORIDE CONDUCTANCE; DEPENDENT PROTEIN-KINASE; PHOSPHATE SIGNALING PATHWAYS; COLONIC EPITHELIAL-CELLS; CYSTIC-FIBROSIS; MYOINOSITOL 3,4,5,6-TETRAKISPHOSPHATE; INOSITOL 3,4,5,6-TETRAKISPHOSPHATE; HUMAN ITPK1; ANNEXIN-IV; LINE T-84; INO-4995; INO4913; anoctamin 1; TMEM16A; inositol phosphates; Ins(3; 4; 5; 6)P4; inositol 3; 4; 5; 6-tetrakisphosphate; Ins(1; 3; 4; 5)P4; inositol 1; 3; 4; 5-tetrakisphosphate; Ca2+-activated Cl- channels; CaCC (1)
ACTIVATED CHLORIDE CURRENTS; MEMBRANE-PROTEIN; SENSORY NEURONS; WEB TOOL; TMEM16A; EXPRESSION; BESTROPHIN; ARTERIAL; CELLS; CaCC; TMEM16A; TMEM16D; TMEM16E; TMEM16F; TMEM16G; TMEM16H; TMEM16J; TMEM16K; Ca2+-activated Cl- channels; CaCC; Calmodulin; Anoctamin (1)
ACTIVATED CHLORIDE SECRETION; CA2+-ACTIVATED CL-CHANNEL; CALCIUM; HYPOXIA; PROLIFERATION; MORPHOGENESIS; COMPONENT; PATHWAYS; TMEM16F; BNIP3; (1)
ACTIVATED C-KINASE; MOLECULAR-WEIGHT ADIPONECTIN; HUMAN CEREBROSPINAL-FLUID; PRIMARY HUMAN HEPATOCYTES; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; APOLIPOPROTEIN-B; MUSCLE-CELLS; T-CADHERIN; Adiponectin receptor; APPL; Endocytosis (1)
ACTIVATED DELAYED FLUORESCENCE; 3-COORDINATE COPPER(I) COMPLEXES; METAL-COMPLEXES; PHOTOPHYSICAL PROPERTIES; THEORETICAL CALCULATIONS; COORDINATION-COMPOUNDS; LUMINESCENT COMPLEXES; PHOSPHORESCENT DYES; SUBSTITUTED LIGANDS; IRIDIUM COMPLEXES; (1)
ACTIVATED DELAYED FLUORESCENCE; AGGREGATION-INDUCED EMISSION; COPPER(I) COMPLEXES; MECHANOCHROMIC LUMINESCENCE; CUPROPHILIC INTERACTIONS; PHOTOPHYSICAL PROPERTIES; ROOM-TEMPERATURE; CU(I) COMPLEXES; SOLID-STATE; PHOSPHORESCENCE; (1)
ACTIVATED DELAYED FLUORESCENCE; COPPER(I) COMPLEXES; IRIDIUM COMPLEXES; TRIPLET EMITTERS; BASIS-SETS; EMISSION; STATE; SINGLET; DIODES; EFFICIENCY; (1)
ACTIVATED DELAYED FLUORESCENCE; CU(I) COMPLEXES; TRIPLET EMITTERS; CU-I; EMISSION; DESIGN; BLUE; EFFICIENCY; ELECTROLUMINESCENCE; LIGANDS; dimeric copper(I) complexes; P boolean AND N phosphine ligands; combined thermally activated delayed fluorescence and phosphorescence; thermally activated delayed fluorescence (TADF); combined singlet and triplet harvesting; organic light emitting diodes (OLEDs); white emission; white light emitting OLED (WOLED) (1)
ACTIVATED DELAYED FLUORESCENCE; EXCITED-STATE; PHOTOPHYSICAL PROPERTIES; CUPROUS COMPLEXES; TRIPHENYLPHOSPHINE COMPLEXES; MONOVALENT COPPER; CU(I) COMPLEXES; LUMINESCENCE; BLUE; ELECTROLUMINESCENCE (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; DINUCLEAR COPPER(I) COMPLEXES; BASIS-SETS; PHOTOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURES; EMITTERS; DESIGN; BLUE; EMISSION; dimeric copper(I) complexes; P boolean AND N phosphine ligands; X-ray structures; combined thermally activated delayed fluorescence (TADF) and phosphorescence; combined singlet and triplet harvesting; high emission quantum yields; tunability of photophysical properties; zero-field splitting (ZFS); spin-lattice relaxation (SLR); triplet substate decay components (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; IRIDIUM(III) COMPLEXES; TRIPLET EMITTERS; CYCLOMETALATED PLATINUM(II); NONRADIATIVE DECAY; OLED APPLICATIONS; PHOSPHORESCENCE; LUMINESCENCE; LIGAND (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; PHOTOINDUCED STRUCTURAL-CHANGE; CHARGE-TRANSFER STATES; COPPER(I) COMPLEXES; EXCITED-STATE; TRIPLET EMITTERS; PHOTOPHYSICAL PROPERTIES; OSMIUM(II) COMPLEXES; TRANSIENT ABSORPTION; Thermally activated delayed fluorescence; (TADF); Intersystem crossing; Fluorescence; Phosphorescence; Copper(I) dimers; Spin-orbit coupling; Femtosecond spectroscopy; Organic light emitting diodes (OLEDs) (1)
ACTIVATED DELAYED FLUORESCENCE; LOWEST TRIPLET-STATE; CARBON-DIOXIDE; CHEMICAL SENSORS; DISSOLVED-OXYGEN; LIQUID SOLUTION; C-70; PRESSURE; PHOSPHORESCENCE; PROBES; (1)
ACTIVATED DELAYED FLUORESCENCE; PHOTOPHYSICAL PROPERTIES; ELECTRONIC STATES; PT(II) COMPOUNDS; DESIGN STRATEGY; HIGH-RESOLUTION; CHARGE-TRANSFER; SINGLET; CU(I); BENZOPHENONE; OLEDs; state tuning; ultra-fast reverse intersystem crossing; ultra-small singlet-triplet gap; thermally activated delayed fluorescence (1)
ACTIVATED DELAYED FLUORESCENCE; TRIPLET-SINGLET EMISSION; LIGHT-EMITTING-DIODES; MOLECULAR DESIGN; PHOSPHORESCENCE (1)
ACTIVATED K+ CHANNELS; NMR STRUCTURE; COUPLING-CONSTANTS; BACKBONE DYNAMICS; BETA-SUBUNIT; MECHANISMS; PROTEIN; GATE; HIPPOCAMPUS; PORE; (1)
ACTIVATED POTASSIUM CHANNEL; CYSTIC-FIBROSIS AIRWAYS; K+ CHANNELS; ION-TRANSPORT; CHLORIDE SECRETION; OPIATE RECEPTORS; AFFERENT-FIBERS; CL-SECRETION; FROG-SKIN; RAT; asimadoline; kappa-opiate receptor agonist; epithelial transport; EMD 61753 (1)
ACTIVATED POTASSIUM CHANNELS; FOCAL ADHESION KINASE; CALCIUM-CHANNELS; CA2+ CHANNELS; CULTURED RAT; ALPHA-V-BETA-5 INTEGRIN; BEST-DISEASE; LIGHT PEAK; ROD; PROTEIN; L-type Ca2+-channel; BK K+-channel; Bestrophin-1; Phagocytosis; Retinal pigment epithelium (1)
ACTIVATED POTASSIUM CHANNELS; MYOENDOTHELIAL GAP-JUNCTIONS; CA2+-ACTIVATED K+ CHANNELS; EDHF-TYPE RELAXATION; WORKING GROUP-REPORT; HYPERPOLARIZING FACTOR; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; EPOXYEICOSATRIENOIC ACIDS; HEME OXYGENASE; diabetes; calcium-activated potassium channel; vasodilation; endothelium; nitric oxide; endothelium-derived hyperpolarization; mesenteric artery (1)
ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; AMINO-ACID-METABOLISM; AFRICAN LUNGFISH; UREA TRANSPORTER; IN-VIVO; PROTOPTERUS-AETHIOPICUS; PROLONGED STARVATION; RAT MUSCLE; ESTIVATION; (1)
ACTIVATED PROTEIN-KINASE; AMYLOID PRECURSOR PROTEIN; COENZYME-A REDUCTASE; HUMAN APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; DROSOPHILA-MELANOGASTER; BETA-PEPTIDE; CELL; GENE; IDENTIFICATION; amyloid precursor protein-like; cholesterol; Drosophila; neurodegeneration (1)
ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; DE-NOVO; ADENINE-NUCLEOTIDES; ATP-SYNTHASE; DNA-CONTENT; IN-VIVO; MYOCYTES; METABOLISM; (1)
ACTIVATED PROTEIN-KINASE; CELL-CYCLE; NF-Y; NEUTROPHIL GELATINASE; HEMATOPOIETIC-CELLS; GRANULE PROTEIN; EARLY EVENTS; M-CSF; EXPRESSION; PROLIFERATION; Macrophage colony-stimulating factor; Gene regulation; Transcription factors (1)
ACTIVATED PROTEIN-KINASE; CHOLESTEROL TRANSPORT; LIPID-ACCUMULATION; METABOLIC-CONTROL; BINDING; MACROPHAGES; EXPRESSION; RECEPTOR; ATHEROSCLEROSIS; TRAFFICKING; adiponectin; annexin A6; diabetes mellitus, Type 2; monocytes; obesity (1)
ACTIVATED PROTEIN-KINASE; CLASS-II TRANSACTIVATOR; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; IMMUNE-RESPONSES; CUTTING EDGE; IFN-GAMMA; SIGNAL-TRANSDUCTION; LARGE NUMBERS; HUMAN BLOOD; dendritic cell; glioma; maturation; IL-12; TGF-beta 2; Toll-like receptor (1)
ACTIVATED PROTEIN-KINASE; CYSTEINE-RICH DOMAIN; PLASMA-MEMBRANE; PHOSPHATIDIC-ACID; REGULATORY DOMAIN; BINDING DOMAINS; IN-VITRO; C-GAMMA; RAS; ZINC; biosensors; quartz crystal microbalance; Raf kinase; scanning probe microscopy; solid-supported bilayers (1)
ACTIVATED PROTEIN-KINASE; CYSTIC-FIBROSIS GENE; TRANSMEMBRANE CONDUCTANCE REGULATOR; HCO3-SECRETION; RENAL-FAILURE; BICARBONATE; CELLS; INHIBITION; TRANSPORT; Cystic fibrosis transmembrane conductance regulator; CFTR AMP; PKA AMP-activated protein kinase; S573C; Pancreatitis; Metformin; Pancreas; Chloride secretion (1)
ACTIVATED PROTEIN-KINASE; DENDRITIC CELL VACCINATION; TUMOR-NECROSIS-FACTOR; CD4 T-CELLS; PHASE-I/II TRIAL; MALIGNANT GLIOMA; 4-1BB LIGAND; COSTIMULATORY MOLECULE; PROSTAGLANDIN E-2; SIGNALING PATHWAY; Glioblastoma; Dendritic cells; CD137; P38MAPK inhibitors; CD25 (1)
ACTIVATED PROTEIN-KINASE; FACTOR SCATTER FACTOR; FACTOR-I; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; RECEPTOR; MITOGEN; ISLET; HORMONE; DIFFERENTIATION; (1)
ACTIVATED PROTEIN-KINASE; FIBROBLAST-GROWTH-FACTOR; SIMULATED MICROGRAVITY; CANCER-CELLS; CYCLIN-A; MAMMALIAN-CELLS; DNA-REPLICATION; EXTRACELLULAR-MATRIX; MODELED MICROGRAVITY; REGULATED EXPRESSION; Endothelial cells; Parabolic flight; Microgravity; Hypergravity; Vibration; Cytoskeleton; Angiogenesis; Extracellular matrix; Apoptosis; Cell cycle (1)
ACTIVATED PROTEIN-KINASE; LYSOSOMAL ACID LIPASE; HUMAN BLOOD MONOCYTES; FACTOR-KAPPA-B; HUMAN MACROPHAGES; ADIPOSE-TISSUE; DEFICIENT MICE; TNF-ALPHA; ATHEROSCLEROSIS; EXPRESSION; endotoxin; inflammation; adipokine; diabetes (1)
ACTIVATED PROTEIN-KINASE; MAMMALIAN PROKINETICINS; AMPHIBIAN HOMOLOG; NERVOUS-SYSTEM; BV8; CELLS; IDENTIFICATION; INVOLVEMENT; SUPPRESSION; CONVERSION; (1)
ACTIVATED PROTEIN-KINASE; MESSENGER-RNA STABILITY; RICH ELEMENT; TRANSLATIONAL CONTROL; POSTTRANSCRIPTIONAL REGULATION; POSTTRANSLATIONAL REGULATION; TRISTETRAPROLIN EXPRESSION; MACROPHAGE DIFFERENTIATION; GENE-EXPRESSION; HYPOXIA; (1)
ACTIVATED PROTEIN-KINASE; MESSENGER-RNA STABILIZATION; TRANSCRIPTION FACTOR SOX9; CYCLIN-DEPENDENT KINASES; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; P38 MAP KINASE; CHONDROCYTE DIFFERENTIATION; BONE-MARROW; INDUCED PHOSPHORYLATION; Sox9; Adipogenic differentiation; Adult MSC; Cell cycle; Proliferation; Signalling (1)
ACTIVATED PROTEIN-KINASE; NA/K-ATPASE; GENE; RS1; EXPRESSION; RHODOPSIN; PHOTORECEPTOR; MUTATIONS; ADHESION; MUTANTS; (1)
ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; PLASMA-PROTEIN; MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; GENE-EXPRESSION; (1)
ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; ADHESION KINASE; ERK5; MICE; P130(CAS); BMK1/ERK5; ACTIN; TRANSCRIPTION; (1)
ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; FUNGAL CELL; NIDULANS; GENE; PKCA; STRESS; MODEL; MPKA; Cell wall integrity; CWI; Mkk2; Mkk1; MpkA (1)
ACTIVATED PROTEIN-KINASE; SODIUM-CHANNEL; TRANSPORT; CELLS; INHIBITION; AMPK; AMPK alpha 1; ENaC; Epithelial Na+ channel; Knockout (1)
ACTIVATED PROTEIN-KINASE; SPLICE VARIANTS; MESSENGER-RNA; IN-VITRO; PANCREATIC-CANCER; GHRH RECEPTORS; IGF-I; EXPRESSION; PROLIFERATION; MECHANISMS; breast cancer; GHRH; estrogen receptor (1)
ACTIVATED PROTEIN-KINASE; SYNOVIAL-FLUID; EXPRESSION; PROLIFERATION; MODEL; PAIN; TRANSCRIPTION; INTEGRINS; CARTILAGE; JOINT; osteoarthritis; SP; alpha CGRP; sensory nervous system; chondrocyte metabolism; ERK; cAMP; AKT (1)
ACTIVATED PROTEIN-KINASE; TANDEM MASS-SPECTROMETRY; FATTY LIVER-DISEASE; HIGH-THROUGHPUT QUANTIFICATION; TYPE-2 DIABETES-MELLITUS; PHOSPHATIDYLCHOLINE SYNTHESIS; NONALCOHOLIC STEATOHEPATITIS; RAT HEPATOCYTES; HEPG2 CELLS; METABOLISM; dyslipidemia; apolipoprotein B; metformin; phosphatidylcholine; ABCB4 (1)
ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR MEF2; TEMPORAL REGULATION; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; STRESS RESPONSES; PERIOD PROTEIN; PHOSPHORYLATION; PATHWAY; NEURONS; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE-CONDUCTANCE-REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; APICAL MEMBRANE; R-DOMAIN; CHANNEL; CAMP; PHOSPHORYLATION; TRANSPORT; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; CANINE TRACHEAL EPITHELIUM; INHIBITS NA+ ABSORPTION; STABLE ENTERO-TOXIN; PSEUDOMONAS-AERUGINOSA; ION-TRANSPORT; SACCHAROMYCES-BOULARDII; KLEBSIELLA-PNEUMONIAE; AIRWAY EPITHELIUM; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; MOUSE SKELETAL-MUSCLE; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; ION-TRANSPORT; GLUCOSE-UPTAKE; CHANNEL; KNOCKOUT; LUNG; Cystic fibrosis transmembrane conductance regulator; CFTR; AMPK (1)
ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; LOBULAR BREAST CANCERS; CELL-CELL-ADHESION; BETA-CATENIN; EXPRESSION; P38; PATHWAY; GROWTH; GENE; melanoma; E-cadherin; p-p38; NF kappa B (1)
ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR LKB1; GLYCINE N-METHYLTRANSFERASE; HYPOXIA-INDUCIBLE FACTOR; HEPATOCELLULAR-CARCINOMA; MOLECULAR-DYNAMICS; SUMO CONJUGATION; C-ZETA; AMPK; PHOSPHORYLATION; LKB1; SUMO; HCC; SIRT1; STRAD alpha (1)
ACTIVATED PROTEIN-KINASE; VIVO PERFUSION TECHNIQUE; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; POTASSIUM CHANNELS; EPITHELIAL-CELLS; SODIUM-CHLORIDE; BK CHANNELS; CALCIUM; CONDUCTANCE; prolactin; BK channels; CFTR; EnaC; Ca2+-activated Cl channels; epithelial transport; secretion; colon; ion channels (1)
ACTIVATED RECEPTOR-GAMMA; ADIPOSE CELL LINE; COA OXIDASE GENE; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; 3T3-L1 ADIPOCYTES; RESPONSE ELEMENT; LEPTIN PROMOTER; collagenous repeat containing sequence of 26-kDa protein; adipocyte; peroxisome proliferator-activated; receptor gamma; adiponectin; resistin (1)
ACTIVATED-RECEPTOR-GAMMA; AMP RESPONSE ELEMENT; BLOOD-PRESSURE; CALU-6 CELLS; JUXTAGLOMERULAR CELLS; REGULATORY ELEMENTS; PROXIMAL PROMOTER; BINDING PROTEIN; LXR-ALPHA; TRANSCRIPTION; cAMP; Cell culture; Gene expression; Renin; Transgenic mouse (1)
ACTIVATED RECEPTOR-GAMMA; C/EBP-BETA; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; FAT DIFFERENTIATION; MITOCHONDRIAL BIOGENESIS; LENTIVIRAL VECTORS; GENE-EXPRESSION; STEM-CELLS; MICRORNA-155; (1)
ACTIVATED RECEPTOR-GAMMA; C-REACTIVE PROTEIN; THERAPEUTIC TARGET; SIGNALING PATHWAY; CLINICAL-TRIALS; CELL-GROWTH; IN-VITRO; EXPRESSION; CANCER; HEPATOCARCINOGENESIS; Hepatocellular carcinoma; Biomodulatory therapy; COX-2 inhibitor; Pioglitazone; Metronomic low-dose chemotherapy; Anakoinosis (1)
ACTIVATED-RECEPTOR-GAMMA; ENDOTHELIAL GROWTH-FACTOR; SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; CELL-CYCLE ARREST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN PROSTATE-CANCER; HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN PANCREATIC-CANCER; METASTATIC BREAST-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; tumor-stroma interaction; stroma-targeted therapy; PPAR gamma; COX-2; mTOR; rapamycin; metronomic chemotherapy; tumor angiogenesis; antiangiogenic (1)
ACTIVATED-RECEPTOR-GAMMA; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; MALIGNANT GLIOMA; CLINICAL-TRIALS; CYCLOOXYGENASE-2; EXPRESSION; APOPTOSIS; CANCER; GROWTH; glioblastoma; anaplastic glioma; low-dose chemotherapy; drug resistance; capecitabine; temozolomide; pioglitazone; rofecoxib (1)
ACTIVATED-RECEPTOR-GAMMA; HUMAN PROSTATE-CANCER; PPAR-GAMMA; IN-VITRO; CARCINOMA CELLS; APOPTOSIS; THIAZOLIDINEDIONES; AGONISTS; ROSIGLITAZONE; EXPRESSION; Pioglitazone; Glitazones; Lactate; pH; Tumor cell proliferation; 2-Deoxyglucose (1)
ACTIVATED-RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; ACID DEHYDROGENASE-ACTIVITY; MACROPHAGE GENE-EXPRESSION; NF-KAPPA-B; 13-HODE DEHYDROGENASE; LINOLEIC-ACID; ULCERATIVE-COLITIS; DIFFERENTIATION; PIOGLITAZONE; 13-oxo-ODE; endogenous ligand; 13-HODE dehydrogenase; Ulcerative colitis; PPAR gamma; colonic epithelial cells (1)
ACTIVATED RECEPTOR-GAMMA; INTRAVENOUS CHALLENGE MODEL; INNATE IMMUNE-RESPONSE; BONE-MARROW; DENDRITIC CELLS; BACTERIAL-INFECTION; HOST-DEFENSE; CRYPTOCOCCUS-NEOFORMANS; ALBICANS INFECTIONS; PROGENITOR CELLS; (1)
ACTIVATED-RECEPTOR-GAMMA; JUXTAGLOMERULAR CELLS; RESPONSIVE ELEMENT; CALU-6 CELLS; BINDING; PROMOTER; KIDNEY; TRANSCRIPTION; MECHANISMS; OBESITY; (1)
ACTIVATED RECEPTOR-GAMMA; PHASE-II TRIALS; PPAR-GAMMA; COLORECTAL-CANCER; INHIBITION; EXPRESSION; LIGANDS; CYCLOOXYGENASE-2; PROGRESSION; TUMORS; angiostatic chemotherapy; drug resistance; pioglitazone; antiinflammatory therapy; rofecoxib (1)
ACTIVATED-RECEPTOR-GAMMA; POLYMERASE-CHAIN-REACTION; TYPE-2 DIABETES-MELLITUS; BETA-CELL; GENE-EXPRESSION; PPAR-GAMMA; PROINSULIN BIOSYNTHESIS; CHRONIC EXPOSURE; MESSENGER-RNA; FATTY-ACIDS; (1)
ACTIVATED-RECEPTOR-GAMMA; VISCERAL ADIPOSE-TISSUE; LIVER ALDEHYDE OXIDASE; OXIDATIVE STRESS; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; POTENTIAL ROLE; MESSENGER-RNA; FATTY-ACIDS; PROTEIN; adipocytes; adipose tissue; peroxisome proliferator-activated receptor agonist (1)
ACTIVATED RECEPTOR GPR4; ARTERIAL CHEMORECEPTORS; RETROTRAPEZOID NUCLEUS; POTASSIUM CHANNELS; MOLECULAR AUTOPSY; UNEXPECTED DEATH; PHOX2B; CO2; MUTATIONS; EPILEPSY; (1)
ACTIVATED T-CELLS; RENIN-ANGIOTENSIN SYSTEM; NUCLEAR FACTOR; MACULA DENSA; INDUCED NEPHROTOXICITY; TRANSCRIPTION FACTOR; MOLECULAR-BIOLOGY; STIMULATED RENIN; RESPONSE ELEMENT; MATRIX PROTEINS; (1)
ACTIVATES PPAR-ALPHA; CELL-CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; CANCER; LIVER; TRANSCRIPTION; APOPTOSIS; REDUCTASE; STATINS; GLUCOSE; (1)
ACTIVATING-POLYPEPTIDE-II; ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; MULTISYNTHETASE COMPLEX; HUMAN-MELANOMA; CELL PICKING; CYTOKINE; APOPTOSIS; EXPRESSION; ANGIOGENESIS; (1)
ACTIVATING PROTEIN GAP; H-RAS; CRYSTAL-STRUCTURE; DIFFRACTION DATA; P21 RAS; KINASE; DOMAIN; TRANSFORMATION; DISTINCT; COMPLEX; (1)
ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; NEGATIVE REGULATOR; GENETIC-CONTROL; PROTECTS MICE; SEPTIC SHOCK; DOUBLE-BLIND; GLUTATHIONE; INFLAMMATION; (1)
ACTIVATING TRANSCRIPTION FACTOR-3; REGULATES AKT KINASE; CARCINOMA CELLS; C-MET; HEAT-SHOCK-PROTEIN-90 FUNCTION; PHASE-I; EXPRESSION; RECEPTOR; METASTASIS; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; (1)
ACTIVATION; ALCOHOL; (1)
ACTIVATION; DEGENERATION; ARPE-19; C5A; RPE; EXPRESSION; SECRETION; MODELS; DAMAGE; VEGF; oxidative stress; retinal pigment epithelial cells; complement system; inflammasome; foxp3; olaparib (1)
ACTIVATION; ELEMENTS; BOND (1)
ACTIVATION; IMINES; DIENE; aldol reaction; Bronsted acids; enantioselectivity; organocatalysis; oxocarbenium ions (1)
ACTIVATION; KIDNEY; Circadian rhythm; Nuclear factor E2 related factor 2; Renal ischemia-reperfusion injury; Renal denervation; Tert-butylhydroquinone (1)
ACTIVATION; REGIONS; EXONS; DNA; Alu exonization; gene evolution; primates; tumor necrosis factor receptor gene; differentially spliced transcripts (1)
ACTIVATOR INHIBITOR-1 GENE; UNCOUPLING PROTEIN UCP; PROMOTER POLYMORPHISM; PRO12ALA POLYMORPHISM; INSULIN-RESISTANCE; LDL-CHOLESTEROL; OBESITY; ASSOCIATION; DISEASE; VARIANT; diabetes mellitus type 2; polymorphism; candidate gene; dyslipidemia (1)
ACTIVE ANTIRETROVIRAL THERAPY; MONOCYTE CHEMOTACTIC PROTEIN-1; HIV-1-INFECTED ADULTS; RECEPTOR EXPRESSION; BETA; QUANTIFICATION; MIP-1-ALPHA; INDINAVIR; VIREMIA; RANTES; chemokine mRNA levels; mononucleated cells; antiretrovirals; NNRTIs; PIs; HIV (1)
ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; ILEAL RELEASE CAPSULES; BECLOMETHASONE DIPROPIONATE; ORAL BUDESONIDE; 5-AMINOSALICYLIC ACID; MAINTENANCE TREATMENT; RETENTION ENEMAS; CONTROLLED-TRIAL; DOUBLE-BLIND; Steroids; inflammatory bowel disease (1)
ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; MODIFIED RELEASE BUDESONIDE; DOUBLE-BLIND; MULTICENTER TRIAL; 5-AMINOSALICYLIC ACID; ESCHERICHIA-COLI; DRUG-TREATMENT; AZATHIOPRINE; METAANALYSIS; (1)
ACTIVE CROHNS-DISEASE; FISTULA-IN-ANO; WIRELESS CAPSULE ENDOSCOPY; HELICAL CT-ENTEROCLYSIS; ORAL CONTRAST AGENTS; SURGICAL FINDINGS; MR ENTEROCLYSIS; SMALL-INTESTINE; FOLLOW-THROUGH; GRANULOCYTE SCINTIGRAPHY; abdominal CT; endoscopy; enteroclysis; MRI; virtual colonography (1)
ACTIVE CROHNS-DISEASE; GERMINATED BARLEY FOODSTUFF; RANDOMIZED CONTROLLED-TRIAL; HLA-B27 TRANSGENIC RATS; LACTIC-ACID BACTERIA; NONPATHOGENIC ESCHERICHIA-COLI; CLOSTRIDIUM-DIFFICILE COLITIS; LACTOBACILLUS-RHAMNOSUS GG; RESIDENT INTESTINAL FLORA; PLACEBO-CONTROLLED TRIAL; inflammatory bowel disease; antibiotics; probiotics (1)
ACTIVE CROHNS-DISEASE; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; RECOMBINANT HUMAN INTERLEUKIN-10; RANDOMIZED CONTROLLED-TRIAL; ESTABLISHED EXPERIMENTAL COLITIS; ENGINEERED HUMAN-ANTIBODY; SIDED ULCERATIVE-COLITIS; PROPRIA T-LYMPHOCYTES; COTTON-TOP TAMARIN; Crohn's disease; ulcerative colitis; tumor necrosis factor-alpha; T lymphocytes; anti-sense; cytokines; growth factors (1)
ACTIVE CROHNS-DISEASE; LYMPHOCYTIC COLITIS; GENE-EXPRESSION; ORAL BUDESONIDE; PREDNISOLONE; (1)
ACTIVE CROHNS-DISEASE; MODIFIED-RELEASE BUDESONIDE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ENTERAL NUTRITION; MULTICENTER TRIAL; DRUG-TREATMENT; 5-AMINOSALICYLIC ACID; ORAL BUDESONIDE; CLINICAL-TRIAL; (1)
ACTIVE CROHNS-DISEASE; PLACEBO-CONTROLLED TRIAL; RECOMBINANT HUMAN INTERLEUKIN-10; ESTABLISHED EXPERIMENTAL COLITIS; REFRACTORY ULCERATIVE-COLITIS; RANDOMIZED CONTROLLED TRIAL; ENGINEERED HUMAN-ANTIBODY; NECROSIS-FACTOR-ALPHA; COTTON-TOP TAMARIN; DOUBLE-BLIND; (1)
ACTIVE CROHNS-DISEASE; TREATMENT RESPONSE; MR ENTEROCLYSIS; CONTRAST AGENT; HYDRO-MRI; ABDOMEN; SCINTIGRAPHY; TOMOGRAPHY; SEQUENCES; REALITY; Crohn's disease; inflammatory bowel disease; capsule endoscopy; magnetic resonance imaging; virtual endoscopy; enteroscopy (1)
ACTIVE DNA DEMETHYLATION; CPG ISLANDS; METHYLATION; TRANSCRIPTION; PHAGOCYTOSIS; EPIGENOMICS; EXPRESSION; SIGNATURES; MICRORNAS; ENHANCERS; Monocyte; Macrophage; Epigenetics; Methylation; Enhancer; Next-generation sequencing; Ten eleven translocation methylcytosine dioxygenase; TET; DEEP; IHEC (1)
ACTIVE GALACTIC NUCLEI; HIGH-ENERGY EMISSION; GAMMA-RAY EMISSION; INVERSE-COMPTON; TEV VARIABILITY; JETS; DISTRIBUTIONS; PHOTONS; FLOWS; galaxies: active; galaxies: jets; BL Lacertae objects: general; radiation mechanisms: non-thermal; methods: analytical (1)
ACTIVE INFECTIVE ENDOCARDITIS; POLYTETRAFLUOROETHYLENE LEAFLET EXTENSIONS; INTERVALVULAR FIBROUS BODY; RING ABSCESS; REPLACEMENT; SURGERY; COMPLICATIONS; DETERMINANTS; FREQUENCY; DIAGNOSIS; endocarditis; patch repair; survival; recurrence (1)
ACTIVE NITROGEN LIGANDS; ASYMMETRIC CATALYSIS; ALLYLIC SUBSTITUTION; 2,2'-BIPYRIDINE; KETONES; OLEFINS; (1)
ACTIVE PERSONAL DOSIMETERS; INTERVENTIONAL RADIOLOGY; OPERATOR; arteries; angiography; angioplasty; radiation safety (1)
ACTIVE-SET METHOD; MONOTONE MULTIGRID METHODS; SADDLE-POINT PROBLEMS; INDEFINITE SYSTEMS; LINEAR-SYSTEMS; OPTIMIZATION; EQUATIONS; SEGMENTATION; SIMULATIONS; ALGORITHM; PDE-constrained optimization; Allen-Cahn model; Newton method; Saddle point systems; Preconditioning; Krylov subspace solver (1)
ACTIVE-SITE; FORCE-FIELD; LABORATORY EVOLUTION; GENETIC SELECTION; BINDING-SITE; ENZYMES; BIOCATALYSTS; CREATION; SPACE; PARAMETERIZATION; directed evolution; enantioselectivity; enzymes; molecular dynamics; mutagenesis (1)
ACTIVE SUBUNIT; EXOSOME; PROTEIN; MECHANISM; RELAXATION; INSIGHTS; enzyme regulation; mRNA decay; NMR spectroscopy; conformational changes; scavenger decapping enzyme (1)
ACTIVE SURVEILLANCE; CONSENSUS; ABLATION; RISK; Biopsy; Consensus; Eligibility criteria; Focal therapy; Focal therapy modalities; Hemiablation; Multiparametric magnetic resonance imaging; Patient selection; Partial ablation; Prostate neoplasms (1)
ACTIVE SURVEILLANCE; MRI; focal therapy; prostate cancer; survey; indications; acceptance; real world (1)
ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; PATIENT SELECTION; FOLLOW-UP; BIOPSY; HETEROGENEITY; CRYOABLATION; CRYOSURGERY; PROGRESSION; PROMISE; Review; Prostate cancer; Focal therapy; Active surveillance; Ablation therapies (1)
ACTIVE WARM-UP; LOW-BACK-PAIN; PHYSICAL-ACTIVITY; HEADACHE EPIDEMIOLOGY; EXERTIONAL HEADACHE; AEROBIC EXERCISE; HEAT ILLNESS; NECK PAIN; PROPHYLAXIS; FITNESS; migraine; headache; sports; physical exercise; review (1)
activities of daily living; ADL; human activity recognition; HAR; batch learning; stream learning; algorithm comparison (1)
ACTIVITY-COEFFICIENTS; FLAMMABLE SOLVENTS; LIQUID-MIXTURES; MODEL; (1)
ACTIVITY-COEFFICIENTS; OSMOTIC COEFFICIENTS; AQUEOUS-SOLUTIONS; SALT-SOLUTIONS; ION-BINDING; SODIUM; WATER; THIOCYANATE; 25-DEGREES; INTERFACE; Vapor pressure osmometry; Osmotic coefficients; Sodium L-glutamate; Sodium thiocyanate; Electrolyte; Ternary solution (1)
activity of daily living; human activity recognition; data preparation; dataset integration; machine learning (1)
activity recognition; smartphone; pedestrian navigation; naturalistic data; machine learning (1)
ACTIVITY-REGULATED GENES; MALIGNANT-MELANOMA; METASTATIC MELANOMA; INHIBITORY-ACTIVITY; S100 PROTEIN; CELLS; EXPRESSION; CANCER; APOPTOSIS; THERAPY; NRN1; melanoma; migration; biomarker; serum (1)
; actor network theory; biblical exegesis; history of sociology; Bruno Latour; Charles Peguy; materialism; tradition (1)
ACUTE ABDOMINAL-PAIN; COMPUTED-TOMOGRAPHY; MANAGEMENT; IMPACT; CT; Case reports; Radiological imaging; Impact; Diagnosis; Radiology (1)
ACUTE BIPOLAR MANIA; PERSONALITY-DISORDER; DOUBLE-BLIND; PLACEBO; SCHIZOPHRENIA; EFFICACY; SAFETY; borderline personality disorder; aripiprazole (1)
ACUTE BIPOLAR MANIA; SCHIZOAFFECTIVE-DISORDER; CLINICAL-EFFICACY; SCHIZOPHRENIA; OLANZAPINE; PSYCHOPATHOLOGY; ANTIPSYCHOTICS; HALOPERIDOL; ZIPRASIDONE; DYSFUNCTION; (1)
ACUTE CHOLANGITIS; BILIARY DRAINAGE; DUCT STONES; ANTIBIOTICS; THERAPY; (1)
ACUTE COLONIC DIVERTICULITIS; ACUTE SIGMOID DIVERTICULITIS; COMPUTED-TOMOGRAPHY; NATURAL-HISTORY; GUIDED DRAINAGE; CT; ACCURACY; DIFFERENTIATION; COLONOGRAPHY; GUIDELINES; abdomen; CT; MR imaging; inflammation (1)
ACUTE COLONIC DIVERTICULITIS; MR-COLONOGRAPHY; CONVENTIONAL COLONOSCOPY; BOWEL-DISEASE; CT; magnetic resonance imaging; computed tomography; diverticulosis; diverticulitis; virtual colonography (1)
ACUTE COLONIC PSEUDOOBSTRUCTION; SMALL-BOWEL OBSTRUCTION; POSTOPERATIVE ILEUS; INTESTINAL-OBSTRUCTION; ACUTE ABDOMEN; PERFORATION; ADHESIONS; DISEASE; THERAPY; PATIENT; (1)
Acute compartment syndrome, Total knee arthroplasty, Complications, Case report (1)
acute coronary syndrome; adherence; dual anti-platelet therapy (DAPT); smartphone-based support; study design; ticagrelor (1)
ACUTE-CORONARY-SYNDROME; RETICULUM CA2+ LEAK; LATE SODIUM CURRENT; PROTEIN-KINASE-II; RANDOMIZED CONTROLLED-TRIAL; SUDDEN CARDIAC DEATH; RYANODINE RECEPTOR; ANTIANGINAL AGENT; HEART-FAILURE; NA+ CURRENTS; Atrial fibrillation; Heart failure; Anti-arrhythmic therapy; Ranolazine; Dronedarone; Electrophysiology (1)
ACUTE CORONARY SYNDROMES; CARDIAC ALLOGRAFTS; GRAFT DYSFUNCTION; ORGAN DONORS; SHORT-TERM; SURVIVAL; SOCIETY; VALUES; heart transplantation; organ donor selection; transplant outcome; troponin I (1)
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; POPULATION; ASSAY; MARKER; MORTALITY; APOPTOSIS; DIAGNOSIS; RISK; cardiac markers; chronic heart failure; high-sensitive troponin T; natriuretic peptides (1)
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; INTERVENTION; CARE; REVASCULARIZATION; CARDIOLOGY; MORTALITY; STRATEGY; OUTCOMES; SOCIETY; Unstable angina; Chest pain unit; Guideline; Timing; Cardiovascular events (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; ACUTE HEART-FAILURE; GRACE RISK SCORES; EMERGENCY-DEPARTMENT; MYOCARDIAL-INFARCTION; GUIDELINES; DISEASE; ACS; MANAGEMENT; Dyspnea; Chest pain; Acute coronary syndrome; Heart failure; Prognosis; Outcome (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; CRITICAL PATHWAYS; MANAGEMENT; SOCIETY; CARDIOLOGY; OUTCOMES; ESC; Acute coronary syndrome; Chest Pain Unit; guideline-adherence; time intervals (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; STRATEGY; INTERVENTION; METAANALYSIS; IMMEDIATE; WOMEN; Chest pain unit; NSTEMI; Coronary intervention; Prognosis (1)
ACUTE CORONARY SYNDROMES; SYSTOLIC DYSFUNCTION BEAUTIFUL; ARTERY-DISEASE; ATRIAL-FIBRILLATION; CONTROLLED-TRIAL; CPU-REGISTRY; RISK-FACTOR; MORTALITY; ASSOCIATION; IVABRADINE; Acute myocardial infarction; Heart rate; Mortality; Chest Pain Unit; Outcome (1)
Acute faecal incontinence, ICU, prevalence, skin breakdown, faecal management system (1)
Acute graft-versus-host disease · aGvHD · Allogeneic hematopoietic stem cell transplantation · Ruxolitinib · Steroidrefractory acute graft-versus-host disease · JAK1/2 kinase inhibitor (1)
ACUTE GVHD; END-POINT; THERAPY; RISK; SURVIVAL; SCORE; (1)
acute GVHD; hematopoietic cell transplantation; pediatrics; prophylaxis; treatment (1)
ACUTE GVHD; TRANSPLANTATION; DIAGNOSIS; CRITERIA; MARROW; GvHD; CEUS; parametric imaging; allogeneic stem cell transplantation; dynamic vascularization (1)
acute heart failure; advanced heart failure; hemodynamics; inodilator; inotrope; neurohormone; regulatory clinical trial (1)
ACUTE HEART-FAILURE; BRAIN NATRIURETIC PEPTIDE; CARBOHYDRATE ANTIGEN-125; PREDICTIVE-VALUE; SERUM-LEVELS; REPLACEMENT; MORTALITY; STENOSIS; OUTCOMES; DISEASE; Transcatheter aortic valve implantation; Tumor marker carbohydrate antigen 125; Logistic EuroSCORE; Risk prediction (1)
ACUTE HEART-FAILURE; BRAIN NATRIURETIC PEPTIDE; HIGH-RISK PATIENTS; SERUM-LEVELS; STENOSIS; REPLACEMENT; SOCIETY; SURGERY; CA125; (1)
ACUTE HYDROCEPHALUS; CEREBRAL ANEURYSMS; COILING; Subarachnoid hemorrhage; Third ventricular diameter; Shunt dependency (1)
ACUTE HYPERGLYCEMIA; REGULATES MONOCYTE; HUMAN MACROPHAGES; INTERLEUKIN-8; EXPRESSION; INHIBITOR; GLUCOSE; ALPHA; NEUTROPHILS; ADHESION; Chemokine; Blood monocyte; Insulin; Oral glucose uptake (1)
acute injuries, overuse injuries, risk factors, youth, amateur, team handball (1)
ACUTE INTERMITTENT PORPHYRIA; COGNITIVE DEFICITS; ASSOCIATION; MOUSE; TRANSCRIPTOME; CHILDHOOD; TRAITS; PSYCHOSIS; DISORDER; VARIANTS; (1)
Acute intermittent porphyria; Porphyria; Cerebral vasospasm; Givosiran; Acute axonal neuropathy (1)
ACUTE INTERSTITIAL NEPHRITIS; KAWASAKI DISEASE; PATHOGENESIS; exanthema; acute anuric renal failure; drug-induced acute interstitial nephritis (1)
ACUTE ISCHEMIC-STROKE; COOPERATIVE ACUTE STROKE; THROMBOLYTIC THERAPY; T-PA; INTRAVENOUS THROMBOLYSIS; CLINICAL-PRACTICE; EXPERIENCE; ECASS; MORTALITY; ALTEPLASE; stroke; telemedicine; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; HEMIPLEGIC MIGRAINE; UNILATERAL HYPERPERFUSION; DIFFERENTIAL-DIAGNOSIS; DIFFUSION; HEADACHE; SPECT; (1)
ACUTE ISCHEMIC-STROKE; INTRAARTERIAL THROMBOLYSIS; ENDOVASCULAR THERAPY; OCCLUSION; BASICS; HYPOATTENUATION; RECANALIZATION; THROMBOSIS; TRIAL; SCORE; Basilar artery occlusion; CTA source images; coma; ischemic stroke; imaging scores; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; COST-EFFECTIVENESS; CARE; EMERGENCY; SAFETY; OUTCOMES; ATTACK; area under curve; cerebrovascular disorders; cohort studies; humans; risk (1)
ACUTE ISCHEMIC-STROKE; OFF-LABEL THROMBOLYSIS; INTRAVENOUS THROMBOLYSIS; CARE; IMPLEMENTATION; DEFINITIONS; ALTEPLASE; CRITERIA; PROJECT; general surgery; hemorrhage; safety; stroke; tissue-type plasminogen activator (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; PLASMINOGEN-ACTIVATOR; REMOTE EVALUATION; POOLED ANALYSIS; RURAL-AREAS; TELESTROKE; SYSTEM; RELIABILITY; THROMBOLYSIS; stroke; telemedicine; stroke unit; quality; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; REMOTE EVALUATION; RURAL-AREAS; RELIABILITY; TELESTROKE; BAVARIA; NETWORK; SYSTEM; TEMPIS; (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; REMOTE EVALUATION; RURAL-AREAS; TELESTROKE; BAVARIA; RELIABILITY; HOSPITALS; NETWORK; SCALE; Telemedicine; Stroke; Acceptance; Quality of care (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; TIME; TELESTROKE; MINUTES; BAVARIA; TEMPIS; TRIAL; LEVEL; MODEL; delivery of health care; stroke; telemedicine; telestroke; thrombolysis; time delays (1)
ACUTE ISCHEMIC-STROKE; POSTSTROKE DEPRESSION; LESION LOCATION; FOLLOW-UP; MORTALITY; INFARCTION; FREQUENCY; RISK; CARE; Stroke; Thrombolysis; Outcome; Depression; Quality of life (1)
ACUTE ISCHEMIC-STROKE; QUALITY-OF-LIFE; RECURRENT STROKE; MECHANICAL THROMBECTOMY; PLASMINOGEN-ACTIVATOR; HOSPITAL COSTS; UNITED-STATES; RISK-FACTORS; CARE COSTS; POPULATION; Pediatrics; Stroke; Thrombectomy; Cost-benefit analysis (1)
ACUTE ISCHEMIC-STROKE; SCREENING SWALLOWING FUNCTION; ASPIRATION PNEUMONIA; PERIODONTITIS; INTUBATION; INFARCTION; DYSPHAGIA; DISCHARGE; DISEASES; OUTCOMES; oral health; oral microbiota; stroke; stroke care; pneumonia; stroke-associated pneumonia (1)
ACUTE ISCHEMIC-STROKE; TELEMEDICAL PROJECT; CARE; THROMBOLYSIS; GUIDELINES; TELESTROKE; OUTCOMES; UNITS; (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; ECASS II; EXPERIENCE; THERAPY; MORTALITY; ALTEPLASE; SUBTYPES; cerebral ischemia; elderly; stroke; thrombolytic therapy (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; HELICOPTER TRANSPORT; COST-EFFECTIVENESS; EXPERIENCE; THERAPY; RELIABILITY; ROUTINE; ECASS; SCALE; acute care; cerebral infarct; complications; economics; intracerebral hemorrhage; stroke management; thrombolysis; remote evaluation; telemedicine; telestroke (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; PILOT PROJECT; TELESTROKE; FEASIBILITY; RELIABILITY; HOSPITALS; THERAPY; BAVARIA; TEMPIS; (1)
ACUTE ISCHEMIC-STROKE; TRIAL (1)
acute kidney failure; AKI; risk factors; survival (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; GRAFT-SURGERY; RISK-FACTOR; LOW HEMATOCRIT; TRANSFUSION; MULTICENTER; MORTALITY; SURVIVAL; anemia; minimized extracorporeal circulation; coronary artery bypass grafting; cardiopulmonary bypass (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; MYOCARDIAL REVASCULARIZATION; ON-PUMP; HEART; MECC; Coronary revascularization (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; TERM SURVIVAL; RISK-FACTORS; SURGERY; PUMP; REVASCULARIZATION; MORTALITY; INFECTION; (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; OFF-PUMP; ON-PUMP; ELDERLY-PATIENTS; FOLLOW-UP; REVASCULARIZATION; MORTALITY; SURVIVAL; Coronary artery bypass grafting; Minimized extracorporeal circulation; Mortality; Outcome (1)
ACUTE KIDNEY INJURY; DATA NORMALIZATION; CARDIAC-SURGERY; DATA SETS; NMR; METABOLOMICS; REGRESSION; SELECTION; DISEASE; MODEL; metabolomics; NMR; LASSO; zero-sum; normalization; scaling (1)
ACUTE KIDNEY INJURY; FACTOR-I; SEPSIS; DIAGNOSIS; ADENOCARCINOMA; BIOMARKER; SYSTEM; AXIS; sepsis; SIRS; COVID-19; dialysis; procalcitonin; survival (1)
ACUTE KIDNEY INJURY; FAILURE; DISEASE; INCREASES; DIALYSIS; RIFLE; RISK; Branched endovascular aortic repair (BEVAR); Staged procedure; Temporary aneurysm sack perfusion (TASP); Acute kidney injury (AKI); Chronic kidney disease (CKD) (1)
ACUTE KIDNEY INJURY; HUMAN ERYTHROCYTES; MICROCIRCULATION; MORPHOLOGY; DISEASE; OSMOLAR; ULTRASONOGRAPHY; DIFFERENTIATION; INTRAARTERIAL; MORTALITY; (1)
Acute kidney injury, Intraoperative fluid management, Fluid therapy, Breast neoplasms/surgery, Breast reconstruction, Urinary biomarkers (1)
ACUTE KIDNEY INJURY; METABOLITES; DISEASE; ROBUST; URINE; NMR metabolomics; data preprocessing; feature extraction (1)
ACUTE KIDNEY INJURY; MINIATURIZED EXTRACORPOREAL-CIRCULATION; INFLAMMATORY RESPONSE; CARDIAC-SURGERY; CRYSTALLOID CARDIOPLEGIA; MYOCARDIAL PROTECTION; BLOOD-TRANSFUSION; METAANALYSIS; REDUCTION; OUTCOMES; body-mass-index; coronary artery bypass grafting; extracorporeal circuit (1)
ACUTE KIDNEY INJURY; SEPTIC SHOCK; SEVERE INFLAMMATION; NITRIC-OXIDE; TNF-ALPHA; ACTIVATION; ENDOTOXEMIA; RATS; MICE; TRANSPORTERS; cecal ligation and puncture; kidney; inflammation; vasopressin; cytokines (1)
ACUTE KIDNEY INJURY; STEM-CELLS; ARTIFICIAL INTERSTITIUM; PROGENITOR CELLS; REPAIR; DIFFERENTIATION; TRANSPLANTATION; ORGANOGENESIS; TUBULOGENESIS; GENERATION; Tissue engineering; Perfusion culture; Kidney; Tubule; Polyester fleece; Artificial interstitium (1)
ACUTE KIDNEY INJURY; STEM-CELLS; INTERSTITIAL INTERFACE; REGENERATIVE MEDICINE; RABBIT KIDNEY; MICRO-FIBERS; NEPHROGENESIS; MESENCHYME; MATRIX; TRANSPLANTATION; Kidney; Organ capsule; Stem/progenitor cell niche; Extracellular matrix; Electron microscopy; Tannic acid; Microfibers (1)
ACUTE KIDNEY INJURY; STEM-CELLS; OBSTRUCTIVE NEPHROPATHY; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; TUBULOGENESIS; FIBROSIS; THERAPY; ALPHA; regeneration; extracellular matrix; interstitium; artificial interstitium; kidney; ruthenium red; tannic acid; electron microscopy (1)
ACUTE KIDNEY INJURY; STEM-CELLS; REPAIR; THERAPY; DISEASE; kidney; stem/progenitor cells; abnormal development; extracellular matrix; glutaraldehyde; cupromeronic blue; ruthenium red; tannic acid; transmission electron microscopy (1)
ACUTE LUNG FAILURE; ADULT PATIENTS; PREDICTING SURVIVAL; LIFE-SUPPORT; OUTCOMES; ECMO; cardiogenic shock; cause of death; critical care; extracorporeal membrane oxygenation; risk factors (1)
ACUTE LUNG INJURY; CRITICAL ILLNESS; HEALTH SURVEY; SURVIVORS; CARE; Tracheostomy; ARDS; Intensive care; Health-related quality of life; Return-to-work (1)
ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; EXTRACORPOREAL MEMBRANE-OXYGENATION; RECEIVING MECHANICAL VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; TIDAL VOLUMES; MORTALITY; EPIDEMIOLOGY; Acute respiratory distress syndrome; Care setting; Mechanical ventilation; Driving pressure; Biphasic positive airway pressure (1)
ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; MEMBRANE-OXYGENATION; ADULT PATIENTS; PROTECTIVE VENTILATION; DRIVING PRESSURE; TIDAL VOLUMES; CO-2 REMOVAL; CO2 REMOVAL; 6 ML/KG; acute respiratory distress syndrome; extracorporeal life support; extracorporeal membrane oxygenation; extracorporeal carbon dioxide removal; ventilator-induced lung injury (1)
ACUTE LUNG INJURY; HEROIN OVERDOSE; INTRAVENOUS NALOXONE; YOUNG MALE; PATIENT; ANTAGONISM; ANESTHESIA; NALMEFENE; PROPOFOL; PATTERNS; Airway obstruction; Apnea; Opioids; Overdose; Respiration, artificial (1)
ACUTE LUNG INJURY; INTENSIVE-CARE UNITS; DISTRESS-SYNDROME; CLINICAL-TRIAL; LIFE-SUPPORT; TRANSFUSION REQUIREMENTS; BLOOD-TRANSFUSION; CRITICALLY-ILL; HIGH SURVIVAL; CO2 REMOVAL; (1)
ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; INDUCIBLE FACTOR-I; ECTO-5'-NUCLEOTIDASE CD73; EXTRACELLULAR ADENOSINE; KIDNEY-DISEASE; GROWTH-FACTOR; NUCLEOTIDE PHOSPHOHYDROLYSIS; (1)
ACUTE LUNG INJURY; MECHANICAL VENTILATION; FAILURE; INFLAMMATION; ASSIST; TRIAL; MODEL; CO2; (1)
ACUTE LUNG INJURY; OXYGENATION; VENTILATION; SURVIVAL; TRAUMA; acute respiratory distress syndrome; prone position; oxygenation; incomplete prone position (1)
ACUTE LUNG INJURY; STEM-CELLS; SECRETION; ARDS; ARDS; ECMO; MSC; models; animal (1)
ACUTE LUNG INJURY; UMBILICAL-CORD BLOOD; MULTIDETECTOR COMPUTED-TOMOGRAPHY; MESENCHYMAL STEM-CELLS; COLONY-FORMING CELLS; IN-VITRO; THROMBOTIC DEPOSITS; CARDIOVASCULAR RISK; ENDOTHELIAL-CELLS; BONE-MARROW; ECMO; Adherence; Endothelial-like cells; Mesenchymal stem cells (1)
acute lymphoblastic leukaemia | chemotherapy | children | defibrotide | pEBMT diagnostic criteria for VOD/SOS | veno-occlusive disease/sinusoidal obstruction syndrome (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; ANTIBODY BLINATUMOMAB; ENGAGING ANTIBODY; ADULT PATIENTS; RELAPSE; CHEMOTHERAPY; THERAPY; SALVAGE; CANCER; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA MICROARRAYS; CANCER OUTCOMES; BREAST-CANCER; PREDICTION; CLASSIFICATION; ADENOCARCINOMA; NORMALIZATION; VALIDATION; LYMPHOMA; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; GENETIC ALTERATIONS; IDH2 MUTATIONS; CELL CARCINOMA; TET2; PSF; MYELODYSPLASIA; TRANSCRIPTION; EXPRESSION; LYMPHOMA; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-DOSE CHEMOTHERAPY; MINIMAL RESIDUAL DISEASE; SEVERE APLASTIC-ANEMIA; UNRELATED DONOR TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; LYMPHOMA WORKING PARTY; ACUTE MYELOID-LEUKEMIA; CORD BLOOD TRANSPLANTATION; LONG-TERM OUTCOMES; (1)
ACUTE-LYMPHOBLASTIC-LEUKEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONSTRUCTURAL PROTEIN; APLASTIC CRISIS; ARTHRITIS; CHILDREN; ANTIBODIES; DISEASE; PATHOGENESIS; ASSOCIATION; Haematological disease; leukaemia; oncological disease; parvovirus B19; persistence (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED CYTIDINE DEAMINASE; C-MYB PROTOONCOGENE; BETA-CATENIN; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; MESSENGER-RNA; ACTIVATION; MIR-155; GENE; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HIGH-DOSE METHOTREXATE; NON-HODGKINS-LYMPHOMA; CODOX-M/IVAC; CELL LYMPHOMA; GROUP-B; CHILDREN; SURVIVAL; THERAPY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IL2R-GAMMA(NULL) MICE; INITIATING CELLS; SCID MOUSE; AML CELLS; T-CELLS; ENGRAFTMENT; CANCER; HETEROGENEITY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IN-VITRO; PRECURSOR CELLS; EXPRESSION; TEETH; BONE; OSTEONECROSIS; OSTERIX; PCS; Dental sac; microarray analysis; osteogenesis; teleocalcin; ZBTB16 protein; human (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; LONG-TERM; 2ND REMISSION; INTRAVENOUS BUSULFAN; PEDIATRIC-PATIENTS; CHILDREN; BLOOD; OUTCOMES; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; SOLID CANCERS; AIEOP-BFM; LYMPHOID IRRADIATION; CUMULATIVE INCIDENCE; THYROID-CARCINOMA; CHILDHOOD; THERAPY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; BUSULFAN-CYCLOPHOSPHAMIDE; CYTOTOXIC THERAPY; CHILDREN; BLOOD; ETOPOSIDE; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; ANTIBODY BLINATUMOMAB; INOTUZUMAB OZOGAMICIN; FREE SURVIVAL; LINEAGE; TRANSPLANTATION; CHEMOTHERAPY; PROGNOSIS; FAILURE; SALVAGE; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; STANDARD-RISK; PHASE-II; NELARABINE; THERAPY; DISEASE; TRIALS; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; RESIDUAL DISEASE PRIOR; RANDOMIZED PHASE-III; INDUCTION CHEMOTHERAPY; ANTILEUKEMIC AGENTS; COMPLETE REMISSION; (1)
ACUTE MESENTERIC ISCHEMIA; SPLANCHNIC ARTERY-STENOSIS; VENOUS THROMBOSIS; DIAGNOSIS; INFARCTION; MANAGEMENT; OCCLUSION; DISEASE; CT; SONOGRAPHY; intestinal ischaemia; mesenteric ischaemia; non-occlusive ischaemia; diagnosis; treatment; angiography; mesenteric venous thrombosis (1)
ACUTE MIDDLE MACULOPATHY; AUTOFLUORESCENCE; LOCALIZATION; REFLECTANCE; AMN; Classification; Characterization; SD-OCT; Follow-up (1)
acute myelocytic leukemia, all-trans retinoic acid, anakoinosis, angiosarcoma, azacitidine, cancer hallmarks, dexamethasone, Hodgkin’s lymphoma (1)
ACUTE MYELOGENOUS LEUKEMIA; HLA-IDENTICAL SIBLINGS; VERSUS-HOST-DISEASE; MYELODYSPLASTIC SYNDROME; MAINTENANCE THERAPY; REDUCED-INTENSITY; MARROW-TRANSPLANTATION; GEMTUZUMAB OZOGAMICIN; PERFORMANCE STATUS; COMORBIDITY INDEX; Acute myeloid leukemia; Refractory; Allogeneic stem cell transplantation; HLA-matched related donor; Unrelated donor; Graft-versus-host disease (1)
ACUTE MYELOGENOUS LEUKEMIA; HUMAN BONE-MARROW; ADHESION MOLECULES; CELLS; CD34(+); AML; acute myeloid leukemia; adhesion molecules; L-selectin; immunophenotyping; prognosis (1)
ACUTE MYELOGENOUS LEUKEMIA; INDEPENDENT PROGNOSTIC RELEVANCE; COLONY-STIMULATING FACTOR; SOUTHWEST-ONCOLOGY-GROUP; COUNCIL AML11 TRIAL; RANDOMIZED-TRIAL; GENE-MUTATIONS; ADULT PATIENTS; MYELODYSPLASTIC SYNDROME; PROLONGED MAINTENANCE; (1)
ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; CYTOSINE-ARABINOSIDE; FLAG-IDA; G-CSF; PHASE-III; ARA-C; IDARUBICIN; CHEMOTHERAPY; THERAPY; acute myeloid leukemia; relapse; chemotherapy; cytarabine; fludarabine (1)
ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; FLT3 MUTATIONS; BONE-MARROW; COMBINATION; CHEMOTHERAPY; CYTARABINE; AML; CLASSIFICATION; (1)
; acute myeloid leukaemia; relapse; second allogeneic haematopoietic cell transplant (1)
ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ALLOGENEIC BONE-MARROW; STEM-CELLS; IN-VIVO; LYMPHOCYTIC-LEUKEMIA; ANTITUMOR IMMUNITY; RELAPSED LEUKEMIA; NAIVE PRECURSORS; TUMOR-REGRESSION; Allogeneic hematopoietic stem cell transplantation; adoptive T-cell therapy; acute myeloid leukemia; CD45RA-derived cytolytic T lymphocytes; patient-individualized immunotherapy; donor-patient specific humanized mouse model (1)
ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CALM-AF10 FUSION GENE; BONE-MARROW; INCREASED ANGIOGENESIS; EXPRESSION PROFILES; TRANSGENIC MICE; HISTONE H3K4ME3; T-ALL; CALM/AF10; microarray; GSEA; myeloid and lymphoid neoplasia; genomic instability and DNA repair (1)
ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; REGIMEN-RELATED TOXICITY; MYELODYSPLASTIC SYNDROME; UNRELATED DONORS; OLDER PATIENTS; INTENSITY; THERAPY; GRAFT; (1)
ACUTE MYELOID-LEUKEMIA; CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; DIAGNOSTIC PURPOSES; FOLLOW-UP; PROTEIN; SERUM; BIOMARKERS; SEQUENCE; PATHOPHYSIOLOGY; (1)
ACUTE MYELOID-LEUKEMIA; CHIMERIC ANTIGEN RECEPTORS; TYROSINE KINASE; B-CELL; EXPRESSION; INHIBITOR; MUTATIONS; RESISTANCE; ANTIBODY; DOMAIN; (1)
acute myeloid leukemia, cohesin mutations, spatial chromatin structure, epigenetics, gene regulation, STAG2, hematology, hematopoietic stem cells (1)
ACUTE MYELOID-LEUKEMIA; COMMON STANDARD ARM; AML; TRANSPLANTATION; CHEMOTHERAPY; INDUCTION (1)
ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; GENETIC ENTITY; C/EBP-ALPHA; MUTATIONS; TRANSCRIPTION; DEFICIENCY; PROGNOSIS; REVEAL; DEFINE; (1)
ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASE; ESCHERICHIA-COLI; VALPROIC ACID; GAMMA; 5-AZACYTIDINE; INHIBITION; MUTATIONS; APOPTOSIS; CHEMOTHERAPY; azacitidine; all-trans retinoic acid; pioglitazone; acute myeloid leukemia; differentiation (1)
ACUTE MYELOID-LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; INTERNAL TANDEM DUPLICATION; LINKED GLYCOSYLATION; ITD MUTATIONS; FLT3 ITD; CANCER; TUNICAMYCIN; TRANSFORMATION; INACTIVATION; acute myeloid leukemia; FLT3ITD; tunicamycin; selective cytotoxicity (1)
ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; RIBONUCLEOPROTEIN COMPLEXES; WIDE IDENTIFICATION; C/EBP-ALPHA; RIP-CHIP; PROTEIN; DIFFERENTIATION; PATTERNS; ASSOCIATION; (1)
ACUTE MYELOID-LEUKEMIA; GENE; IDENTIFICATION; NEUROBLASTOMA; TRANSLOCATION; TRIAL (1)
ACUTE MYELOID-LEUKEMIA; GROUP-B; PROGNOSTIC-SIGNIFICANCE; CHILDREN; CANCER; MUTATIONS; THERAPY; TRIAL; KIT; INTENSIFICATION; (1)
ACUTE MYELOID-LEUKEMIA; HEAT-SHOCK-PROTEIN-70 MEMBRANE EXPRESSION; ACUTE LYMPHOBLASTIC-LEUKEMIA; RELATIVE GENE-EXPRESSION; NATURAL-KILLER-CELLS; HUMAN TUMOR-CELLS; CYTOCHROME-C; BOUND HEAT-SHOCK-PROTEIN-70; CYTOLYTIC ACTIVITY; INDUCTION THERAPY; Hsp; Leukemia; mRNA expression; Real-time RT-PCR; Cell surface expression (1)
ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH; (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; ACTIVATING MUTATION; MYELODYSPLASTIC SYNDROME; JUXTAMEMBRANE DOMAIN; OLDER PATIENTS; CELL-LINES; AML; CHEMOTHERAPY; acute myeloid leukaemia; tyrosine kinase inhibitor; resistance; small molecule; fms-like tyrosine kinase 3 (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; C-KIT LIGAND; CONSTITUTIVE ACTIVATION; PROGENITOR CELLS; RECEPTOR GENE; STEM-CELLS; 32D CELLS; IN-VITRO; GROWTH; bis(1H-2-indolyl)-1-methanones; Flt3; tyrosine kinase; signal transduction (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; HOST-DISEASE; REGULATORY FACTOR; ACUTE GVHD; ALLO-SCT; TRANSPLANTATION; INTERLEUKIN-15; ACTIVATION; MAINTENANCE; (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATIONS; FLT3 INHIBITOR; C-KIT; RESISTANCE MUTATIONS; CLINICAL RESISTANCE; CONFER RESISTANCE; DRUG-RESISTANCE; F691L MUTATION; IN-VITRO (1)
ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE 1; IDH2 MUTATIONS; CHROMATOGRAPHY/MASS SPECTROMETRY; MAGNETIC-RESONANCE; 2-HYDROXYGLUTARATE; CANCER; GLIOMAS; L-2-HYDROXYGLUTARATE; METABOLITES; D-2 hydroxyglutarate; IDH mutations; bioluminescence imaging; oncometabolite; glioblastoma (1)
ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE MUTATIONS; MITOCHONDRIAL OXYGEN-CONSUMPTION; HYPOXIA-INDUCIBLE FACTOR; MAMMALIAN TARGET; IDH2 MUTATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; AEROBIC GLYCOLYSIS; RAPAMYCIN MTOR; DIFFERENTIATION; immunometabolism; oncometabolite; acute myeloid leukemia; IDH mutation; Th17; Tregs; 2HG; Immunosurveillance; Inflammation and cancer (1)
ACUTE MYELOID-LEUKEMIA; LACTIC-ACID; PROGNOSTIC-SIGNIFICANCE; IDH MUTATION; MACROPHAGES; MITOCHONDRIAL; METABOLISM; SURVIVAL; KINASE; INFILTRATION; isocitrate dehydrogenase; hydroxyglutarate; dendritic cells; tumor environment; activation (1)
ACUTE MYELOID-LEUKEMIA; NORMAL HEMATOPOIESIS; ANTIVIRAL ACTIVITY; POTENT; DERIVATIVES; ANGIOGENESIS; DISEASE; TARGETS; DOMAIN; ACIDS; bisbenzofuranylmethanone; receptor tyrosine kinase; FLT3; PDGFR; bisindolymethanone; benzofuranylindolylmethanone (1)
ACUTE MYELOID-LEUKEMIA; OLDER PATIENTS; DOSE CYTARABINE; GENE-MUTATIONS; RETINOIC ACID; AML; CHEMOTHERAPY; DECITABINE; DIAGNOSIS; RECOMMENDATIONS; (1)
ACUTE MYELOID-LEUKEMIA; PROGNOSTIC VALUE; MUTATIONS; FLT3; IDENTIFICATION; CHEMOTHERAPY; DIAGNOSIS; RESPONSES; ADULTS; D835; acute myeloid leukemia; relapse; allogeneic stem cell transplantation; biomodulatory treatment; anakoinosis (1)
ACUTE MYELOID-LEUKEMIA; PTP-OC PROMOTER; CELL FATES; EXPRESSION; DIFFERENTIATION; MICROGLIA; PROGENITORS; PHOSPHATASE; PU.1; Macrophage differentiation; Exon arrays; ChIP-Chip; PUER cells; Ptpro; Regulatory network (1)
ACUTE MYELOID-LEUKEMIA; SMALL-MOLECULE INHIBITORS; HISTONE DEACETYLASE; STEM-CELLS; ANTIINFLAMMATORY DRUGS; C-MYC; TARGETING HDAC3; DNA-DAMAGE; GENE; CYCLOOXYGENASE; AML; beta-catenin; HDAC; HDACi; indomethacin; molecular marker; MYC; WT1 (1)
ACUTE MYELOID-LEUKEMIA; SYSTEMS; leukemic skin infiltration; myelodysplastic syndrome; acute myeloid leukemia; biomodulatory treatment; anakoinosis (1)
ACUTE MYELOID-LEUKEMIA; UNDERSTANDING DISTRESS; LYMPHOMA SURVIVORS; MULTIPLE-MYELOMA; PATIENT; PREVALENCE; COMMUNICATION; PERSPECTIVES; EXPERIENCES; MANAGEMENT; Haematological cancer; Survivorship; Unmet needs; Content analysis; Patient-centred care (1)
Acute myleoid leukemia, FLT3 mutations, Tyrosine kinase inhibitor, Type I/II inhibitor In vivo mouse model (1)
ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; MONOCYTOSIS; ANGIOPLASTY; PERFUSION; RECOVERY; COUNT; HEART; myocardial infarction; inflammation; cardiovascular magnetic resonance; prognosis; white blood cells (1)
ACUTE MYOCARDIAL-INFARCTION; A-TYPE; B-TYPE; ECHOCARDIOGRAPHIC MEASUREMENTS; CARDIAC HORMONE; HEART-DISEASE; HYPERTENSION; EXPRESSION; SECRETION; FAILURE; natriuretic peptides; LV dysfunction; LV hypertrophy; heart failure; hypertension (1)
ACUTE MYOCARDIAL-INFARCTION; BETA-D-GLUCOSAMINIDASE; ACUTE-RENAL-FAILURE; URINARY BIOMARKERS; HEART-FAILURE; PREDICTION; DIAGNOSIS; SURGERY; DAMAGE; PATHOGENESIS; ACS; cardiorenal syndrome; KIM-1; NAG; NGAL; renal biomarkers (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; CORONARY-PATIENTS; COUNTERPULSATION; SUPPORT; METAANALYSIS; PERFORMANCE; EXPERIENCE; EUROSCORE; Intraaortic balloon pumping; Cardiac surgery; EuroSCORE; Mortality; Prophylaxis (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; LIFE-SUPPORT; EARLY REVASCULARIZATION; CARDIAC-ARREST; INTERVENTION; OUTCOMES; ECMO; Coronary angiography; Cardiopulmonary resuscitation (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOPULMONARY BYPASS; SURGERY; REVASCULARIZATION; SYSTEM; INTERVENTION; EUROSCORE; PUMP; Coronary artery bypass surgery; Minimized extracorporeal circulation; Emergency revascularization; Mortality; Propensity score analysis (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; MICROVASCULAR OBSTRUCTION; PROGNOSTIC VALUE; HYPERTROPHY; REPERFUSION; DYSFUNCTION; RECOVERY; FAILURE; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Prognosis; Late gadolinium enhancement imaging (1)
ACUTE MYOCARDIAL-INFARCTION; CHEST-PAIN; DEFINITION; DIAGNOSIS; COLLEGE; MARKERS; SYSTEM; STAY; TIME; UNIT; acute myocardial infarction; analytical performance; troponin T; multicentre evaluation; point-of-care testing (1)
ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ST-SEGMENT ELEVATION; ATOMIC-BOMB SURVIVORS; DIFFERENTIAL LEUKOCYTE COUNT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTIMA-MEDIA THICKNESS; BLOOD-CELL SUBTYPES; LONG-TERM MORTALITY; C-REACTIVE PROTEIN; Low Lymphocyte Count; Inflammation; Immunodeficiency; Cardiovascular disease; Risk Stratification; Acute Coronary Syndromes; Acute Myocardial Infarction; Lymphocyte Apoptosis (1)
ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; NONPARAMETRIC APPROACH; NATRIURETIC PEPTIDE; CARDIAC-HYPERTROPHY; SENSITIVE ASSAY; BIOMARKERS; PREDICTION; MORTALITY; (1)
ACUTE MYOCARDIAL-INFARCTION; ELECTRICAL ALTERNANS; VENTRICULAR TACHYARRHYTHMIAS; PROGNOSTIC-SIGNIFICANCE; EXERCISE; INSTABILITY; ARRHYTHMIAS; PREDICTOR; HUMANS; MTWA; T-wave alternans; ventricular tachycardia; noninvasive risk stratification (1)
ACUTE MYOCARDIAL-INFARCTION; GROWTH-FACTOR ANTAGONIST; GP IIB/IIIA INHIBITORS; TRAPIDIL TRIAZOLOPYRIMIDINE; CORONARY ANGIOPLASTY; TICLOPIDINE; PREVENTION; ASPIRIN; STROKE; DIPYRIDAMOLE; (1)
ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS-MAGNESIUM; TRIALS; (1)
ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; PROGNOSTIC-SIGNIFICANCE; PRIMARY ANGIOPLASTY; EPICARDIAL FLOW; PERFUSION GRADE; BLUSH GRADE; NO-REFLOW; REPERFUSION; RESOLUTION; Cardiovascular magnetic resonance; Microvascular obstruction; ST-segment resolution; Sum of ST-segment elevation; ST-segment elevation myocardial infarction (1)
ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; ST-SEGMENT ELEVATION; CARDIAC TROPONIN-T; RISK STRATIFICATION; ARTERY-DISEASE; PLASMA-LEVELS; BNP; SIZE; PROGNOSIS; acute coronary syndromes; natriuretic peptide; N-terminal pro-brain natriuretic peptide; prognosis; serial changes (1)
ACUTE MYOCARDIAL-INFARCTION; LOCKDOWN; (1)
ACUTE MYOCARDIAL-INFARCTION; LONG-TERM OUTCOMES; ARTERY; PREDICTORS; PCI; MANAGEMENT; MORTALITY; (1)
ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; CORONARY-OCCLUSION; REPERFUSION; HEART; DISEASE; DETERMINANTS; RECOVERY; Cardiovascular magnetic resonance; Reperfusion injury; Prognosis; Adverse remodeling (1)
ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ONE-YEAR SURVIVAL; CULPRIT LESION; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; OPEN-LABEL; (1)
ACUTE MYOCARDIAL-INFARCTION; PROGRAMMED VENTRICULAR STIMULATION; HOSPITAL CARDIAC-ARREST; T-WAVE ALTERNANS; RATE-VARIABILITY; EJECTION FRACTION; BAROREFLEX SENSITIVITY; ARRHYTHMIC EVENTS; SUDDEN-DEATH; SHORT-TERM; heart rate turbulence; risk stratification; myocardial infarction; diabetes mellitus (1)
ACUTE MYOCARDIAL-INFARCTION; SOLUBLE RECEPTOR SFLT-1; DISEASE RISK-FACTORS; ADIPOSE-TISSUE; GENE-EXPRESSION; BREAST-CANCER; PLASMA-LEVELS; OBESITY; ASSOCIATION; ADIPOCYTES; (1)
ACUTE MYOCARDIAL-INFARCTION; STRESS CARDIOMYOPATHY; MOUSE MODEL; TAKO-TSUBO; CARDIOMYOCYTES; ISOPROTERENOL; PATHOGENESIS; DEFICIENCY; PATHWAY; broken heart syndrome; catecholamine; electrical activity; iPSC cardiomyocytes; lipotoxicity; TTS pathogenesis (1)
ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; PROGNOSTIC-SIGNIFICANCE; NO-REFLOW; REPERFUSION; RECOVERY; SIZE; ECHOCARDIOGRAPHY; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Microvascular obstruction (1)
ACUTE MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; HEART-RATE; VENTRICULAR-ARRHYTHMIAS; RISK STRATIFICATION; NATRIURETIC PEPTIDE; CLINICAL-USE; MADIT-II; MORTALITY; TRIAL; (1)
ACUTE MYOCARDIAL-INFARCTION; SYNDROME TAKO-TSUBO; ST-SEGMENT ELEVATION; CARDIOMYOPATHY; PREVALENCE; TRIGGER; SCORE; 1ST; Takotsubo syndrome; Myocardial infarction; Acute coronary syndrome; Coronary artery disease; Cardiac catheterization; Outcome (1)
ACUTE MYOCARDIAL-ISCHEMIA; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; REPERFUSION INJURY; SURVIVAL; MONOCROTALINE; BIOMARKERS; REGISTRY; INFLAMMATION; EXPRESSION; Heart failure [C14.280.434]; Hypertension pulmonary [C08.381.423]; Matrix metalloproteinases [D08.811.277.656.675.374.525]; Prognosis [E01.789]; Survival analysis [E05.318.740.998] (1)
ACUTE NECROTIZING ENCEPHALOPATHY; REVERSIBLE SPLENIAL LESION; CORPUS-CALLOSUM; CHILDREN; ENCEPHALITIS/ENCEPHALOPATHY; COMPLICATIONS; INFECTION; JAPAN; Acute necrotizing encephalitis of childhood; Mild encephalopathy with a reversible splenial lesion; Atypical hemorrhage (1)
ACUTE NECROTIZING PANCREATITIS; PERCUTANEOUS DRAINAGE; ORGAN FAILURE; DOUBLE-BLIND; ENDOSCOPIC SPHINCTEROTOMY; RETROPERITONEAL APPROACH; GALLSTONE PANCREATITIS; SURGICAL-TREATMENT; CATHETER DRAINAGE; INFECTED NECROSIS; (1)
ACUTE PATELLAR DISLOCATION; LATERAL FEMORAL CONDYLE; CARTILAGE REPAIR; PIN FIXATION; JOINT; FRAGMENTS; RECONSTRUCTION; MULTICENTER; INJURIES; DEFECTS; Osteochondral fractures of the knee; Meta-analysis; No valid conclusions; High failure rate (1)
acute phase proteins | chemotaxis | NETosis | neutrophil function | ROS (1)
ACUTE-PHASE RESPONSE; BACTERIAL TRANSLOCATION; FACTOR-I; INTESTINAL ADAPTATION; ENHANCED GROWTH; SMALL-BOWEL; APOPTOSIS; RATS; BURN; INJURY; burns; growth factors; gut; apoptosis; proliferation; rats (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; CRITICAL ILLNESS; LIPOPOLYSACCHARIDE; CYTOKINES; DISEASE; HORMONE; ILL; (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; SEPTIC SHOCK; GENE-TRANSCRIPTION; IMPROVES SURVIVAL; CRITICAL ILLNESS; HORMONE; INTERLEUKIN-1; SUPPRESSORS; CACHECTIN; sepsis; inflammation; trauma; burn; insulin; immunity; liver; signaling (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; TRANSCRIPTIONAL REGULATION; CYTOKINE SYNTHESIS; CRITICAL ILLNESS; HUMAN MONOCYTES; INJURY; HORMONE; SUPPRESSORS; CACHECTIN; (1)
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; CCAAT/ENHANCER-BINDING-PROTEINS; DNA-DAMAGE RESPONSE; PML-RAR-ALPHA; CLASS-I HDAC; VALPROIC ACID; MULTIPLE-MYELOMA; C/EBP-BETA; APL; ATRA; DNA damage; HDAC; HDACi; Histone acetylation (1)
acute promyelocytic leukemia, chloroma, myeloid sarcoma, PML-RARA rearrangement, normal blood counts (1)
ACUTE PROMYELOCYTIC LEUKEMIA; COLONY-STIMULATING FACTOR; CYTOSINE-ARABINOSIDE; MYELODYSPLASTIC SYNDROME; ARSENIC TRIOXIDE; MUTATIONS; CHEMOTHERAPY; EXPRESSION; PROGNOSIS; BLASTS; Acute myeloid leukemia; All-trans retinoic acid; Nucleophosmin-1 (1)
acute promyelocytic leukemia; high dose cytosine arabinoside; relapse rate; white blood cell count (1)
ACUTE PROMYELOCYTIC LEUKEMIA; RECURRENT MALIGNANT GLIOMAS; 13-CIS-RETINOIC ACID; GROWTH-FACTOR; CELL-LINES; CANCER CHEMOPREVENTION; ASTROCYTOMA-CELLS; CLINICAL-TRIAL; BREAST-CANCER; IN-VITRO; anaplastic glioma; 13-cis retinoic acid; glioblastoma; high-grade glioma; maintenance therapy; retinoids (1)
ACUTE PSYCHOSOCIAL STRESS; EFFORT-REWARD-IMBALANCE; CORTISOL AWAKENING RESPONSE; JOB-STRESS; CLINICAL BURNOUT; DEPRESSION SCALE; HOSPITAL ANXIETY; WHITEHALL II; DISORDERS; EMPLOYMENT; ACTH(1-24) (Synacthen) test; chronic work stress; dexamethasone-CRH test; emotional exhaustion; HPA axis regulation; overcommitment (1)
ACUTE PSYCHOSOCIAL STRESS; HPA AXIS RESPONSES; GENDER-DIFFERENCES; HEART-RATE; CARDIOVASCULAR INDEXES; CHALLENGE HYPOTHESIS; ENDOCRINE RESPONSES; TESTOSTERONE CHANGE; HUMAN-AGGRESSION; YOUNG MEN; Competition; Decision making; Stress; Cortisol; Heart rate; Testosterone (1)
ACUTE PSYCHOSOCIAL STRESS; PHOBIA INVENTORY SPIN; SALIVARY CORTISOL; HEART-RATE; CARDIOVASCULAR REACTIVITY; PSYCHOMETRIC PROPERTIES; CONCEPTUAL INFORMATION; GENDER-DIFFERENCES; EVALUATIVE THREAT; HABITUAL SMOKERS; Virtual reality; Skin conductance level; Salivary cortisol; Heart rate; Social stress; Trier Social Stress Test (TSST) (1)
ACUTE PULMONARY-EMBOLISM; MYOCARDIAL-INFARCTION; GUIDELINES; PREVALENCE; ADMISSIONS; MANAGEMENT; MORBIDITY; OUTCOMES; SOCIETY; ESC; COVID-19; peripheral artery disease; time-trends; amputation; intervention (1)
ACUTE QUADRIPLEGIC MYOPATHY; INFLAMMATORY RESPONSE SYNDROME; RESPIRATORY-DISTRESS-SYNDROME; ITALIAN MULTICENTER CRIMYNE; DIRECT MUSCLE STIMULATION; MULTIPLE ORGAN FAILURE; SKELETAL-MUSCLE; MECHANICAL VENTILATION; NEUROMUSCULAR WEAKNESS; RISK-FACTORS; ICU-acquired weakness; Critical illness polyneuropathy; Critical illness myopathy; Pathomechanisms; Prevention (1)
ACUTE-RADIATION-SYNDROME; WHOLE-BLOOD SAMPLES; PERIPHERAL-BLOOD; DIAGNOSIS; POLONIUM; (1)
ACUTE REJECTION; T-CELLS; CXCR3-BINDING CHEMOKINES; INTERNATIONAL UNION; IP-10; INFILTRATION; VASCULOPATHY; NOMENCLATURE; PHARMACOLOGY; NEPHROPATHY; chemokine receptors; CXCR3; human renal allograft rejection; immunohistochemistry (1)
ACUTE-RENAL-FAILURE; ADENOSINE ANTAGONIST THEOPHYLLINE; RISK-FACTORS; CARDIAC-SURGERY; CONTRAST-MEDIA; INSUFFICIENCY; DYSFUNCTION; PREVENTS; OUTCOMES; RATS; acute renal failure; adenosine A1 antagonist; cardiac surgery; glomerular filtration rate; renal function (1)
ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; PREDICTION; THERAPY; SCORE; (1)
Acute renal failure – dopamine; prophylaxis; treatment; Akutes Nierenversagen; Dopamin; Prophylaxe; Therapie (1)
ACUTE-RENAL-FAILURE; FLUID RESUSCITATION; SEVERE SEPSIS; SEVERITY SCORE; ILL PATIENTS; HETASTARCH; THERAPY; MULTICENTER; VALIDATION; STRATEGIES; Hydroxyethyl starch; High volume; Acute kidney injury; Renal replacement therapy; Elderly trauma patient; Intensive care unit (1)
ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; DOWN-REGULATION; NITRIC-OXIDE; DOUBLE-BLIND; EXPERIMENTAL PYELONEPHRITIS; CONCENTRATING ABILITY; MOLECULAR-MECHANISMS; GENE-EXPRESSION; lipopolysaccharide; glucocorticoids (1)
ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; SEVERE SEPSIS; SEVERE INFLAMMATION; GLOMERULAR BARRIER; SIZE-SELECTIVITY; PROXIMAL TUBULE; SEPTIC SHOCK; NITRIC-OXIDE; KAPPA-B; acute renal failure; albumin; inflammation; ischemia; lipopolysaccharide (1)
ACUTE-RENAL-FAILURE; LIPOPOLYSACCHARIDE-INDUCED THROMBOCYTOPENIA; ACUTE KIDNEY INJURY; PLATELET-AGGREGATION; IN-VIVO; CYCLOOXYGENASE-2 INHIBITION; CARDIOVASCULAR FAILURE; CONSCIOUS MICE; SEVERE SEPSIS; SEPTIC SHOCK; lipopolysaccharide; cyclooxygenase; acute kidney injury; thromboxane; inflammation (1)
ACUTE-RENAL-FAILURE; OFF-PUMP; ON-PUMP; SERUM CREATININE; MYOCARDIAL REVASCULARIZATION; EXTRACORPOREAL-CIRCULATION; CARDIAC-SURGERY; DYSFUNCTION; MORTALITY; PROGNOSIS; Cardiopulmonary bypass; Coronary artery bypass grafting; Acute kidney injury (1)
ACUTE-RENAL-FAILURE; ORGANIC CATION/CARNITINE TRANSPORTER; NUCLEAR-MAGNETIC-RESONANCE; INTENSIVE-CARE-UNIT; L-CARNITINE; ISCHEMIA/REPERFUSION INJURY; NORMALIZATION METHODS; MASS-SPECTROMETRY; CROSS-VALIDATION; LEUKOTRIENE B-4; Acute kidney injury (AKI); Metabolomics; NMR spectroscopy; Classification (1)
ACUTE-RENAL-FAILURE; POPULATION; PROGNOSIS; MORTALITY; DYSFUNCTION; SURVIVAL; DIALYSIS; CRITERIA; IMPACT; VALVE; Acute kidney injury; cardiac surgery; extracorporeal circulation; mortality; septuagenarians; octogenarians (1)
ACUTE-RENAL-FAILURE; POSTEXERCISE PROTEINURIA; ATHLETIC PSEUDONEPHRITIS; EXERCISE; HYDRATION; RESPONSES; HEAT; MICROALBUMINURIA; HEMATURIA; ALBUMIN; albuminuria; exercise; fluid intake; haematuria; hydration; march; proteinuria (1)
ACUTE-RENAL-FAILURE; SIROLIMUS-BASED IMMUNOSUPPRESSION; ANTI-THYMOCYTE GLOBULIN; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE NEPHROTOXICITY; INDUCTION THERAPY; RISK-FACTORS; ALEMTUZUMAB CAMPATH-1H; KIDNEY-TRANSPLANTATION; SERUM CREATININE; calcineurin inhibitors; cyclosporin; kidney function; liver transplantation; sirolimus; tacrolimus (1)
ACUTE-RENAL-FAILURE; TUBULAR EPITHELIAL-CELLS; LINDAU TUMOR-SUPPRESSOR; GENE-EXPRESSION; INTRARENAL OXYGENATION; PROLYL HYDROXYLATION; REPERFUSION INJURY; RAT KIDNEYS; HIF-ALPHA; IN-VIVO; (1)
ACUTE RESPIRATORY-FAILURE; ACUTE LUNG FAILURE; LIFE-SUPPORT; PREDICTING SURVIVAL; ADULT PATIENTS; ECMO; MORTALITY; SHOCK; extracorporeal membrane oxygenation; long-term outcome; respiratory failure; survival (1)
ACUTE RESPIRATORY SYNDROME; CRITICAL-CARE; TRANSMISSION; COVID-19; Aerosol; Droplets; Staff safety; Endoscopy (1)
ACUTE RESPIRATORY SYNDROME; HEALTH-CARE WORKERS; PHYSICIANS; (1)
ACUTE RESPIRATORY SYNDROME; HONG-KONG; CORONAVIRUS; IDENTIFICATION; infectious diseases; emerging infections; epidemiology; SARS; HIV-1 infection (1)
ACUTE-RESPIRATORY-SYNDROME; LINKED-IMMUNOSORBENT-ASSAY; SARS-ASSOCIATED CORONAVIRUS; TRACT DISEASE; CROSS-REACTIVITY; KAWASAKI-DISEASE; NL63 INFECTION; HONG-KONG; HKU1; CHILDREN; human coronavirus; nucleocapsid; line immunoassay; SARS; seroprevalence; cross-reaction (1)
ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION; T-CELL RESPONSES; PERSISTENT LCMV INFECTION; DENDRITIC CELLS; VIRUS-INFECTION; INFLUENZA INFECTION; IMMUNE-RESPONSES; LUNG PATHOLOGY; PATHOGENESIS; (1)
acute stress | amygdala | fMRI | ScanSTRESS | striatum (1)
acute stress, chronic stress, microglia, microglial morphology, partner loss, prefrontal cortex, sex differences (1)
acute stress exposure; Trier Social Stress Test (TSST); everyday moral decision-making; altruistic decisions; stress hormones; cortisol; social closeness; timing; gender differences; personality (1)
acute stress, muscular imbalances, motor control, sEMG (1)
ACUTE STROKE; CRANIECTOMY; BRAIN; GROWTH; ischemia; magnetic resonance imaging; middle cerebral artery occlusion; outcome; rats (1)
Acute stroke; Emergency medicine; Prehospital diagnostics; Transcranial neurosonography; Mobile health unit (1)
acute stroke, emergency medicine, prehospital diagnostics, transcranial neurosonography, mobile health unit, akuter Schlaganfall, Notfallmedizin, prähospitale Diagnostik, transkranielle Neurosonographie, Schlaganfallmobil, TCCS (1)
ACUTE STROKE; ENDOVASCULAR THROMBECTOMY; TRANSCRANIAL ULTRASOUND; ACCESS; prehospital stroke diagnosis; large vessel occlusion; ultrasound; thrombectomy; brain perfusion; SONAS (R); prehospital stroke scales; point-of-care diagnostics (1)
ACUTE VESTIBULAR SYNDROME; VIDEO-OCULOGRAPHY; PROJECT; DIFFERENTIATION; SYMPTOMS; NEURITIS; HINTS; dizziness; vertigo; telemedicine; emergency medicine; stroke; diagnostic method; acute vestibular syndrome (1)
ACUTE VESTIBULAR SYNDROME; VIDEO-OCULOGRAPHY; STROKE; DIFFERENTIATION; STRATEGIES; ALGORITHM; NEURITIS; ACCURACY; COVID-19; dizziness; vertigo; telemedicine; emergency department; stroke; HINTS; video head impulse test (1)
; Acute visual loss; Central retinal artery occlusion; Choroidal infarction; Microcatheter embolization; Ethmoidal metastasis (1)
ACYL-COA SYNTHETASE; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE; MASS-SPECTROMETRY; LIVER-DISEASE; CELL-DEATH; CHAIN; MICE; METABOLISM; FATP4; Fatty acid transport protein 4; Lipoapoptosis; Steatosis; Lipidomics; Fatty acyl-CoA; Saturated fatty acid (1)
ACYL-COA SYNTHETASE; ICHTHYOSIS PREMATURITY SYNDROME; INDUCED INSULIN-RESISTANCE; BAICALEIN 5,6,7-TRIMETHYL ETHER; ADIPOSE-TISSUE; PLASMA-MEMBRANE; NONALCOHOLIC STEATOHEPATITIS; GENOMIC REORGANIZATION; GENETIC POLYMORPHISMS; CHOLESTEROL UPTAKE (1)
ACYL-COA SYNTHETASE; TANDEM MASS-SPECTROMETRY; BARRIER FUNCTION; PERMEABILITY BARRIER; TIGHT JUNCTIONS; STRATUM-CORNEUM; SKIN; EXPRESSION; CLONING; COMPONENTS; ceramides; epidermis; Fatp4; fatty acid metabolism; fatty acid transport (1)
Acyl groups (migration of, in alpha -(dimethylamino)-N-(beta -hydroxy-alpha -methylphenethyl)-N-methylhydrocinnamamide) EPHEDRINE STEREOISOMERISM STEREOISOMERISM EPHEDRINE PSEUDOEPHEDRINE STEREOISOMERISM (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; G-PROTEIN; Y-4 RECEPTOR; SELECTIVE AGONISTS; PICOMOLAR AFFINITY; PHOSPHOLIPASE-C; AT(1) RECEPTORS; RGD PEPTIDES; SIDE-CHAIN; ANTAGONISTS; (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; HIGHLY POTENT; SUBTYPE SELECTIVITY; NPY Y-2; AFFINITY; LIGANDS; RADIOLIGAND; Neuropeptide Y; NPY Y-1 receptor antagonist; Y-4 receptor antagonist; Bivalent ligand; Dimeric argininamide derivatives (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; NEUROPEPTIDE-Y; CANCER; POTENT; RADIOLIGAND; INHIBITION; LIGANDS; DESIGN; CELLS; (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; RAT-BRAIN; BINDING-SITES; AUTORADIOGRAPHIC DISTRIBUTION; RECEPTOR ANTAGONISTS; YY2 RECEPTOR; Y-2; LIGANDS; AFFINITY; PEPTIDE; acylguanidines; bioisosterism; neuropeptideY; radiochemistry; radioligands (1)
Acylguanidines; Lactam formation; Degradation rate; UV spectroscopy (1)
Acylguanidine, trans-H-bond scalar couplings, w couplings, conformation analysis, NMR, Acylguanidin, trans-Wasserstoffbrücken-Kopplungen, W-Kopplungen, Konformationsanalyse (1)
ACYLPHLOROGLUCINOL DERIVATIVES; HYPERFORIN; ANTIBACTERIAL; INHIBITOR; PAPUANUM; ERECTUM; Hypericum empetrifolium; Hypericaceae; Acylphloroglucinols; Anti-angiogenic activity; NMR guided fractionation (1)
ADAM15, Death receptor signaling, Cell death, Necroptosis, Apoptosis, Proteomics (1)
ADAMANTANE DERIVATIVES; SUBSTITUTED ADAMANTANES; ALIPHATIC-HYDROCARBONS; TRIFLUOROACETIC-ACID; 1-ADAMANTYL CHLORIDE; BETA-PEPTIDE; AMINO-ACIDS; IN-VITRO; OXIDATION; OLIGOMERS; amino acids; C-H activation; hydrocarbons; peptides; phase-transfer catalysis (1)
ADAM Proteins; Animals; *Brain Ischemia: DT, drug therapy; *Brain Ischemia: EN, enzymology; *Enzyme Inhibitors: PD, pharmacology; Matrix Metalloproteinase 2: AI, antagonists & inhibitors; Matrix Metalloproteinase 9: AI, antagonists & inhibitors; *Matrix Metalloproteinases: AI, antagonists & inhibitors; Metalloendopeptidases: ME, metabolism; Models, Animal; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha: ME, metabolism; 0 (Enzyme Inhibitors); 0 (Tumor Necrosis Factor-alpha); EC 3.4.24.- (ADAM Proteins); EC 3.4.24.- (Matrix Metalloproteinases); EC 3.4.24.- (Metalloendopeptidases); EC 3.4.24.- (tumor necrosis factor-alpha convertase); EC 3.4.24.24 (Matrix Metalloproteinase 2); EC 3.4.24.35 (Matrix Metalloproteinase 9) (1)
Adams operations, algebraic K-theory, differential algebraic K-theory, higher algebra (1)
adaptation, channel,s motion-onset VEP, N200 wave, perceived velocity, speed dependence (1)
adaptation, contrast dependence, motion VEP, N200 wave, pattern VEP, P100 wave (1)
Adaptation; Motion perception; Direction discrimination; Speed discrimination (1)
ADAPTED PERTURBATION-THEORY; DENSITY-FUNCTIONAL THEORY; CONSISTENT BASIS-SETS; KOHN-SHAM ORBITALS; ELECTRON CORRELATION; PSEUDOPOTENTIALS; PROGRAM; CRYSCOR; DNA; (1)
ADAPTER PROTEIN CRK; CANCER; EXPRESSION; IMMUNOTHERAPY; ANTIGENS; CLASSIFICATION; ACTIVATION; STANDARD; VACCINES; THERAPY; (1)
adaption, age, habituation, olfaction, smell (1)
adaptive design; Bayesian inference; incoherence; maximum tolerable dose (1)
adaptive design bias-correction conditional bias flexible design point estimation (1)
adaptive design bootstrap conditional inference coverage estimation group sequential interim analyses (1)
Adaptive design, covariate adjustment, multi-arm, treatment selection, UMVCUE (1)
Adaptive designs Adaptive clinical trials Clinical trials Efficiency Resource requirements Trial coordination (1)
adaptive designs, conditional error, design modification, multi-arm multi-stage (1)
adaptive designs infectious diseases multi-arm multi-stage order restriction (1)
Adaptive Erklärkompetenz · Refined Consensus Model of PCK · Reflexionskompetenz · Videografie (1)
Adaptive Kompetenzen, Sonderpädagogik, Pädagogik bei geistiger Behinderung, Definitionskriterium für geistige Behinderung, AKo (1)
adaptive mutation, chlorhexidine digluconate, resistance, Streptococcus, oral, genome, transcriptome (1)
Adaptive platform trial, dose-escalation, COVID-19, randomized, seamless, time-to-improvement (1)
ADAPTIVE PROTEIN EVOLUTION; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; SULFOLOBUS-SOLFATARICUS; EXTREME THERMOPHILE; DIRECTED EVOLUTION; 3-ISOPROPYLMALATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STABILITY; MUTAGENESIS; ADAPTATION; biosynthesis; enzymes; phosphoribosyl-transferase; protein stability; Sulfolobus solfataricus (1)
ADAPTIVE RADIATION; MALILI LAKES; HYBRIDIZATION; DECAPODA; INDONESIA; BRACHYURA; BARCODES; TAXONOMY; MATANO; FISH; species flock; adaptive radiation; ecotypes; morphotypes; genetic barcoding; Cox1 mtDNA (1)
ADAPTIVE RADIATION; WESTERN JAMAICA; BIODIVERSITY; BRACHYURA; GRAPSIDAE; endemism; biodiversity; troglophile; conservation; karst (1)
adaptive servo-ventilation; acute myocardial infarction; sleep-disordered breathing; cardiac arrhythmias (1)
ADAPTIVE SERVO-VENTILATION; APNEA; THERAPY; HF; MECHANISM; CPAP (1)
ADAPTIVE SERVO-VENTILATION; CAPILLARY WEDGE PRESSURE; VENTRICULAR DYSFUNCTION; SYSTOLIC DYSFUNCTION; EJECTION FRACTION; APNEA; POPULATION; EPIDEMIOLOGY; RATIONALE; MORTALITY; Cheyne-Stokes respiration; heart failure; sleep apnea; sleep-disordered breathing (1)
ADAPTIVE SERVO-VENTILATION; CHEYNE-STOKES RESPIRATION; NOCTURNAL ARRHYTHMIAS; MORTALITY; ECTOPY; DEATH; RISK; HF; DYSFUNCTION; PREVALENCE; (1)
ADAPTIVE SERVO-VENTILATION; EUROPEAN-SOCIETY; APNEA; DIAGNOSIS; CLASSIFICATION; ASSOCIATION; GUIDELINES; PROGNOSIS; IMPACT; ESC; Heart failure with preserved ejection fraction; Heart failure; Obstructive sleep apnoea; Central sleep apnoea; Prevalence; Predictors (1)
ADAPTIVE SERVO-VENTILATION; HEART-FAILURE; OUTCOMES; STIMULATION; ASSOCIATION; THERAPY; IMPACT; COPD; Schlafapnoe; Herzinsuffizienz; Komorbiditaten; CPAP; Therapiemoglichkeiten; sleep apnea; heart failure; comorbidities; CPAP; therapeuticaloptions (1)
ADAPTIVE SIGNIFICANCE; DISPERSAL STRATEGIES; ERGATOID QUEENS; HYMENOPTERA; FORMICIDAE; INTERCASTES; DIMORPHISM; BEHAVIOR; ECOLOGY; FEMALES; queen polymorphism; wing reduction; dispersal; Monomorium (1)
ADAPTIVE TRANSPORT NETWORK; SLIME-MOLD; SHORTEST; ALGORITHM; ROBUST; MODEL; Physarum Learner; Structure learning; Bayesian Network (1)
adatom diffusion; graphene nanoribbons; scanning tunneling microscopy; electromigration (1)
ADDITIONAL BOUNDARY-CONDITIONS; OF-MASS QUANTIZATION; QUANTUM-WELLS; PHONON SCATTERING; VALENCE-BAND; POLARITON; INTERFERENCE; CRYSTALS; LUMINESCENCE; PROPAGATION; (1)
ADDITION ENERGIES; CONDUCTANCE; (1)
ADDITIONS; (1)
ADDITION SPECTRUM; ANDERSON MODEL; DOT; TRANSISTOR; COULOMB; SPECTROSCOPY; OSCILLATIONS; TRANSPORT; REGIME; STATES; (1)
additive arithmetical semigroups; asymptotics (1)
Additive manufacturing Direct ink writing Sustainable biomaterials Iron-eggshell composite Biodegradable implant Bone substitution (1)
ADD-ON THERAPY; INHIBITION; ASK1; SIMVASTATIN; APOPTOSIS; IMATINIB; KINASE; DRUGS (1)
Address-obfuscating techniques, email, empirical analysis, honeypot, security by design, security by obscurity, spam (1)
ADDUCTOR POLLICIS MUSCLE; DOUBLE-BURST STIMULATION; GENERAL-ANESTHESIA; TRAIN-OF-4 RATIO; CARE-UNIT; SPONTANEOUS-RECOVERY; RESPIRATORY EVENTS; PERIOPERATIVE MANAGEMENT; NEOSTIGMINE REVERSAL; INCOMPLETE REVERSAL; Muscle relaxants; Neuromuscular monitoring; Sugammadex; Neostigmine; Acceleromyography (1)
ADDUCTOR POLLICIS MUSCLES; NEUROMUSCULAR BLOCKADE; ANESTHETIZED PATIENTS; ORBICULARIS OCULI; HUMANS; VECURONIUM; ANESTHESIA; LARYNX; TIME; neuromuscular non-de polarizing agents, mivacurium; diaphragm, monitoring; adductor pollicis, monitoring, acceleromyography; stimulation, nerve, electric, magnetic; airway pressure monitoring, airway occlusion pressure (1)
Adducts, Amines, Elements, Nuclear magnetic resonance spectroscopy, Reactivity (1)
Addukte, Kupferhalogenide, Goldhalogenide, Phosphorchalkogenide, Phosphorpolysulfide, Arsenchalkogenide, Realgar, lichtinduzierte Effekte, Einkristallstrukturanaylse, Raman-Spektroskopie (1)
Addukt , Titantetrachlorid , Phosphorchalkogenide , Molekülverbindungen , Phosphorsulfid , Phosphorselenid , Tantalpentachlorid , Niobpentachlorid , Co-Kristallisat , phosphorus sulphide , phosphorus selenide , tantalum pentachloride , niobium pentachloride , co-crystal (1)
Adduktverbindungen, Pnicogenchalcogenide, Methallhalogenide (1)
Adelic divisors · Volumes and restricted volumes · Augmented base locus · Okounkov bodies (1)
ADENINE-NUCLEOTIDES; ATPASE ACTIVITY; PLASMA FACTOR; RELEASE; ERYTHROCYTE; RECEPTOR; CD39; RAT; DIPHOSPHOHYDROLASE; IDENTIFICATION; corlicosteroid; ecto-apyrase; endothelium; Mesangium; heinopexin; nephrotic syndrome (1)
ADENOASSOCIATED VIRUS TYPE-2; LEBERS CONGENITAL AMAUROSIS; GROWTH-FACTOR RECEPTOR; AIRWAY EPITHELIA; INTRACELLULAR TRAFFICKING; TRANSDUCTION EFFICIENCY; PIGMENTED EPITHELIUM; SUBRETINAL INJECTION; NUCLEAR TRAFFICKING; ENDOTHELIAL-CELLS; (1)
ADENOASSOCIATED VIRUS VECTOR; HIGH-LEVEL EXPRESSION; TAIL VEIN INJECTION; SKELETAL-MUSCLE; HUMAN ALPHA-1-ANTITRYPSIN; VIRAL INTERLEUKIN-10; CARDIAC ALLOGRAFTS; THERAPY PROGRESS; RAPID INJECTION; DNA TRANSFER; gene therapy; transplantation; DNA; AAV; plasmid (1)
ADENOASSOCIATED VIRUS VECTORS; HEPARAN-SULFATE PROTEOGLYCAN; PRIMARY BILIARY-CIRRHOSIS; CARBON-MONOXIDE; GENE-TRANSFER; ALCOHOLIC CIRRHOSIS; DOUBLE-BLIND; IN-VIVO; THERAPY; TRANSDUCTION; (1)
ADENOCARCINOMA; ABLATION; SAFETY; Interventional radiology; Robotic assistance; Irreversible electroporation; Liver tumor; CT-guided; Stereotactic navigation (1)
ADENOID CYSTIC CARCINOMA; EPIDERMAL-GROWTH-FACTOR; EX PLEOMORPHIC ADENOMA; ACINIC CELL CARCINOMAS; FACTOR RECEPTOR; PAROTID-GLAND; MUCOEPIDERMOID CARCINOMA; IMATINIB MESYLATE; PARAFFIN SECTIONS; MIB-1 ANTIBODY; C-KIT; EGFR; Ki67; prognostic factors; salivary gland cancer (1)
ADENOID CYSTIC CARCINOMA; FIBROBLAST-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; ENDOTHELIAL-CELLS; P53 ACTIVITY; LUNG-CANCER; COPY NUMBER; EXPRESSION; PATHWAY; FGFR1; FGFR3; MDM2; MDM4; prognosis; salivary gland cancer (1)
ADENOID CYSTIC CARCINOMA; PLEOMORPHIC ADENOMA; CELL-CARCINOMA; DNA ANALYSIS; ANEUPLOIDY; PLOIDY; salivary gland tumours; DNA flow cytometry; aneuploidy; S-phase fraction (1)
ADENOID CYSTIC CARCINOMA; SALIVARY-GLAND CARCINOMA; Adenoid-cystic carcinoma (ACC); head and neck cancer; FLAVINO assay; chemoresponse test; pembrolizumab; cetuximab (1)
ADENOMA-CARCINOMA SEQUENCE; COLORECTAL-CANCER; SMALL-INTESTINE; AMPULLARY CARCINOMA; HISTOLOGIC TYPES; PROGNOSIS; ADENOCARCINOMA; EXPRESSION; SURVIVAL; PATHOGENESIS; Ampullary carcinoma; Papilla of Vater; FISH; TMA; Amplification; CCND1 (1)
ADENOMA-CARCINOMA SEQUENCE; K-RAS MUTATION; TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR RECEPTORS; DNA-REPLICATION ERRORS; LONG-TERM SURVIVAL; COLORECTAL-CANCER; GENE-MUTATIONS; BILIARY-TRACT; COLON-CANCER; ampullary neoplasm; histomorphology; molecular characteristics; prognostic factor; microsatellite instability; MSI; long-term survival (1)
ADENOMA-CARCINOMA SEQUENCE; MICROSATELLITE INSTABILITY; VATER; PAPILLA; ADENOCARCINOMA; NEOPLASMS; SURVIVAL; PANCREATICOBILIARY; DIFFERENTIATION; TUMORS; (1)
adenosine signalling, biomarker, cytoplasmatic PD-L1, exosome, head and neck squamous cell carcinoma, immune checkpoint resistance, tumour-associated neutrophils (TAN) (1)
ADENOSINE-TRIPHOSPHATE SULFURYLASE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; CHROMATIUM-VINOSUM; RIFTIA-PACHYPTILA; AQUIFEX-AEOLICUS; MUTAGENESIS; (1)
Adenoviren , Transformation , E4orf3 , PML , p300 , 'Hit and Run'-Transformation , E4orf3 , PML , p300 , 'hit and run'-transformation (1)
Adenoviren , Transformation <Genetik> , Tumor , Gentherapie , E4ORF3 , PML , p300 , Azetylierung , E4ORF3 , PML , p300 , acetylation , transformation (1)
Adenovirus 5 , Apoptosis , Lebertransplantation , Postischämiesyndrom , Adenoviren , bcl-2 , bcl-2, liver transplantation , adenovirus , apoptosis , ischemia-/ reperfusion-injury (1)
Adenovirus 5 , Gentherapie , Fluorouracil , Dickdarmentzündung , Colonkrebs , Tumor , Adenoviren , Coxsackie-Adenovirusrezeptor , CAR , 5-FU , Dextrane Sodium Sulphate , DSS (1)
Adenovirus 5 , Maligne Transformation , Protein p53 , Genregulation , E1B-55K , NES , PML-NBs , Mre11 , E1B-55K , NES , PML-NBs , Mre11 (1)
Adenovirus 5 , Replikation , Protein p53 , SUMO , Regulation , Messenger-RNS , Membrantransport , Ubiquitin-ähnliche Proteine , NES , RNA-Export , E1B-55K , E4orf6 , Mre11 , E1B-55K , E4orf6 , NES , SUMO , RNA-export (1)
Adenovirus 5 , Transformation <Genetik> , Replikation , Virusvektor , Protein p53 , Virusmutanten , Klonierungssystem , Adenoviruspunktmutanten , adenovirus 5 , transformation , replikation , virusvektor , cloningsystem (1)
Adenovirus 5 , Virales Onkogen , RNS-Spleißen , Transformation <Genetik> , E1B-55K , E1B-156R , E1B-93R , E1B-84R , Adenovirus 5 , E1B-55K , E1B-156R , E1B-93R , E1B-84R , transformation (1)
Adenovirus; DMS-Seq; Bioinformatics; Virus Maturation Subject Categories Chromatin, Transcription & Genomics; Microbiology, Virology & Host Pathogen Interaction (1)
Adenoviruses, HumanApoptosisApoptosis Regulatory ProteinsCarcinoma, HepatocellularCaspasesDrug Resistance, NeoplasmEnzyme ActivationGene TherapyGene Transfer TechniquesHepatocytesHumansLiver NeoplasmsMembrane GlycoproteinsTNF-Related Apoptosis-Inducing LigandTransduction, GeneticTumor Cells, CulturedTumor Necrosis Factor-alpha apoptosisarticlecancer cell culturecancer inhibitioncell deathcontrolled studygene transferhumanhuman cellliver cell carcinomaliver cell culturepriority journalpromoter region adenovirus vectorFAS ligandtumor necrosis factor related apoptosis inducing ligand (1)
ADENOVIRUS FIBER; PROTEIN; bacteriophage T4; short tail fiber; stability; T-even bacteriophages (1)
ADENOVIRUS FIBER; TAILSPIKE PROTEIN; BETA-HELIX; DOMAIN; REFINEMENT; STABILITY; MODEL; SHAFT; MOTIF; MAPS; bacteriophage T4; gene product 12; short fibre; triple beta-helix; heat-stability (1)
ADENOVIRUS INFECTION; VIRAL-INFECTIONS; DISEASE; RECIPIENTS; IMMUNOTHERAPY; EXPANSION; EFFECTOR; THERAPY; CD4(+); RISK; (1)
ADENYLATE-CYCLASE; IN-VIVO; RECEPTOR; FEAR; NEURONS; ANXIETY; MEMORY; PROJECTIONS; EXTINCTION; AGONIST; (1)
ADENYLATE-CYCLASE TOXIN; NUCLEOTIDE-GATED CHANNELS; BOMBARDMENT MASS-SPECTROMETRY; DEPENDENT PROTEIN-KINASE; LETHAL FACTOR CLEAVES; CYTIDINE 3'-5'-CYCLIC MONOPHOSPHATE; CYCLIC CMP PHOSPHODIESTERASE; HUMAN MONOCLONAL-ANTIBODY; SOLUBLE GUANYLYL CYCLASE; PROTECTIVE ANTIGEN; adenylyl cyclase toxin; anthrax; Bacillus anthracis; edema factor; edema toxin (1)
Adenylatzyklase-Inhibitoren, MANT-Nukleotide, Röntgenkristallstruktur mit MANT-ITP, Kardiomyozyten, L-typ Calciumkanal, Elektrophysiologie; Adenylyl cyclase inhibitors, MANT nucleotides, crystal structure with MANT-ITP, cardiomyocytes, basal L-type calcium current, whole cell patch clamp technique (1)
adenylyl cyclase; B103 neuroblastoma cells; constitutive G-protein-coupled receptor activity; Gs-protein; Lesch–Nyhan disease; nucleotides (1)
Adenylyl cyclase; Calmodulin; Edema factor; Fluorescence spectroscopy; (M)ANT-nucleotides; Molecular modeling (1)
ADENYLYL-CYCLASE ISOFORMS; CYCLIC-GMP; PYRIMIDINE NUCLEOTIDES; GUANINE-NUCLEOTIDES; FORSKOLIN ANALOGS; HEART-FAILURE; INHIBITION; DISRUPTION; PURINE; 2'(3')-O-(N-METHYLANTHRANILOYL)-GUANOSINE; MANT-nucleotides; AC inhibition; Cardiomyocytes; Whole-cell patch clamp; L-type calcium current; Isoproterenol (1)
ADENYLYL-CYCLASE ISOFORMS; INHIBITION; DERIVATIVES; DIMETHOXYCARBENE; ACTIVATION; 1,2-DIOLS; Medicinal chemistry; Biological activity; Fused-ring systems; Carbenes; Rearrangement (1)
ADENYLYL-CYCLASE; NITRIC-OXIDE; NUCLEOSIDE 5'-TRIPHOSPHATES; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; PULMONARY-HYPERTENSION; BORDETELLA-PERTUSSIS; SELECTIVE INHIBITORS; ORGANIC-MOLECULES; CATALYTIC DOMAINS; (1)
ADENYLYL-CYCLASE; PHARMACOLOGICAL CHARACTERIZATION; ANTIINFLAMMATORY PROPERTIES; H-4-RECEPTOR AGONIST; ADRENERGIC-RECEPTOR; T-CELLS; INFLAMMATION; ACTIVATION; POTENT; INHIBITION; (1)
adenylyl cyclase, polycystic kidney disease, forskolin, MANT-nucleotides (1)
adenylyl cyclases, toxins, edema factor, Bacillus anthracis, Bordetella pertussis, cyclic nucleotides (1)
Adhäsion , Integrine , Heterotransplantation , Stammzelle , Blutstammzelle , Transplantation , Zelladhäsion , SCID-Maus , VLA-4 , VLA-5 , SCF , NOD/SCID , VLA-4 , VLA-5 , SCF , NOD/SCID (1)
adhäsive Befestigung; selektive Kariesexkavation; Karies; Kavitätenpräparation; Kompositrestaurationen (1)
Adhäsivsysteme, Dentinpermeabilität, hydraulische Leitfähigkeit , Adper Prompt L- Pop, Gluma Desensitizer, EXL 683, EXM678 & EXM671C, Flodec Adhesives, dentin permeability, hydraulic conductance, Adper Prompt L- Pop, Gluma Desensitizer, EXL 683, EXM678 & EXM671C, Flodec (1)
ADHERENCE; Penile neoplasm; Academic centers; Nonacademic centers; Caseload; Second-opinion portal (1)
ADHERENT ADJUVANT TREATMENT; PHASE-II TRIAL; MULTICENTER COHORT; CLINICAL-ONCOLOGY/COLLEGE; MONOCLONAL-ANTIBODY; AMERICAN-SOCIETY; FOLLOW-UP; TRASTUZUMAB; CHEMOTHERAPY; RECOMMENDATIONS; (1)
adherent adult stem cells, mesenchymal stem cells, multipotent adult progenitor cells, solid organ transplantation, immunotherapy, scoring adverse events, phase I trial (1)
Adhesion, antimicrobial agents/inhibitors, antimicrobials, bacterial and biofilm (1)
ADHESION MOLECULE; COLORECTAL-CANCER; CEA FAMILY; ANTIGEN; EXPRESSION; CEACAM6; MEMBERS; PROGRESSION; MECHANISMS; PROTEINS; CEACAM6; immune checkpoint inhibitor; humanized antibody; T cell; immune response; elimination of cancer cells (1)
ADHESION MOLECULE JAM; DROSOPHILA EPITHELIAL-CELLS; TIGHT JUNCTION PROTEIN; PDZ DOMAIN SPECIFICITY; KINASE-C; COMPLEX; BINDING; APKC; SEQUENCE; BAZOOKA; (1)
ADHESION MOLECULE; PROGNOSTIC-SIGNIFICANCE; FASCICLIN-I; INVASION; GROWTH; PROTEIN; IDENTIFICATION; ANGIOGENESIS; MARKER; (1)
ADHESION MOLECULES; BACTERIAL LIPOPOLYSACCHARIDE; HUMAN BLOOD; DIFFERENTIATION; MATURATION; RECEPTOR; CD14; MODULATION; LAMININ; BINDING; (1)
adhesion promoter, electrochemical deposition, electronic devices (1)
ADHESION; STOMATITIS; ETIOLOGY; Candida albicans; denture; biofilm; stomatitis (1)
Adhesiveness Animal Antibodies, Fungal/*isolation & purification Antibodies, Monoclonal/*isolation & purification Antibody Affinity Binding Sites, Antibody Carbohydrates/isolation & purification Chemistry Fungal Proteins/*immunology Glycoproteins/*immunology Immunoglobulins, Fab Myxomycetes/*immunology Rabbits (1)
ADHESIVE STRENGTH; FIBRIN GLUE; IN-VITRO; REPAIR; INTEGRATION; INHIBITION; articular cartilage; cartilage repair; minimally invasive surgical procedure (1)
ADHESIVE SYSTEMS; BRACKETS; LONG; (1)
ADHESIVE SYSTEMS; PULP RESPONSE; CYTO-TOXICITY; DENTIN; INVITRO; PERMEABILITY; PRETREATMENT; STRENGTH; BOVINE; (1)
Ad-hoc networks, privacy, security, mix-zone, tracking, VANET (1)
AD-HoC, photoredox catalysis, visible light, nickel, cross-coupling, difunctionalization (1)
ADHS, exekutive Funktionen, motorische Fähigkeiten, körperliche Aktivität (1)
ADHS, subkortikale Strukturen, Nucleus Caudatus, Globus Pallidum (1)
ADIABATIC PASSAGE; DEVICES; DYNAMICS; STATES; BITS; PAIR; (1)
ADIC L-FUNCTIONS; ELLIPTIC-CURVES; COMPLEX MULTIPLICATION; 11R23 (primary) (1)
ADIC L-FUNCTIONS; ELLIPTIC-CURVES; INVARIANT; Iwasawa theory; weak Leopoldt conjecture; Iwasawa mu-invariant; elliptic curves; complex multiplication (1)
adipocyte, adipokines, ascites, liver cirrhosis, peritonitis, Adipokine, Aszites, Adipozyten, Leberzirrhose, Peritonitis (1)
adipocytokines, umbilical cord blood, birth weight, birth mode, lifestyle factors, bmi, weight gain, maternal risk factors, smoking, alcohol consumption (1)
Adipogene Stammzellen,Differenzierung,alveoläre Osteoblasten,Zementoblasten (1)
adipokine; chemerin; leukocyte; cancer (1)
adiponectin bacterial infection inflammation SARS-CoV-2 obesity sepsis (1)
adiponectin; chemerin; leptin; SARS-CoV-2; COVID-19; pneumonia; intensive care (1)
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19 (1)
ADIPONECTIN GENE-EXPRESSION; ADIPOSE CELL LINE; 3T3-L1 ADIPOCYTES; METABOLIC SYNDROME; RESISTIN; DIFFERENTIATION; TISSUE; CULTURE; PROTEIN; FETUIN; adipocyte; insulin; growth hormone; glucose; adiponectin; resistin (1)
adiponectin; leptin; MELD; ascites; portal vein (1)
adiponectin, lipocalin-2, leptin, galectin-3,chemerin, interleukin-6, kidney, liver, inflammatory bowel disease, biomarker (1)
Adiponectin, myocardial infarction (1)
Adiponektin, IL-6, Aktivin, Resistin, Typ 2 Diabetes Mellitus (1)
Adiponektin, Monozyten, Annexin A6, Typ 2 Diabetes, Übergewicht, Reinheit, Adiponectin, Monocytes, Type 2 Diabetes, Obesity (1)
Adiponektin, NASH, Leberfibrose, TGF, Chemerin, BAMBI, Activin A (1)
ADIPOSE CELL LINE; BINDING SITES; DIFFERENTIATION; CLONING; ADIPSIN; FAMILY; MOUSE; TRANSCRIPTION; COMPLEMENT; CONVERSION; adipocyte; mesenchyme; CORS-26; promoter; cartilage (1)
ADIPOSE CELL LINE; INSULIN-RESISTANCE; CROHNS-DISEASE; CREEPING FAT; DIFFERENTIATION; TISSUE; EXPRESSION; PREADIPOCYTES; CULTURE; OBESITY; (1)
ADIPOSE CELL LINE; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOCYTOKINE VISFATIN; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; FAT; EXPRESSION; DIFFERENTIATION; INFLAMMATION; (1)
ADIPOSE CELL-LINE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; LIVER-INJURY; ADIPONECTIN; OBESITY; ADIPOCYTOKINES; GLUCOSE; TISSUE; EXPRESSION; adipocytokines; dietary lipids; inflammation (1)
ADIPOSE CELL LINE; SERUM VISFATIN; METABOLIC SYNDROME; ADIPOCYTOKINE VISFATIN; GLUCOSE-METABOLISM; INSULIN-SECRETION; DIABETES-MELLITUS; GENE-EXPRESSION; INNATE IMMUNITY; MISSING LINK; visfatin; oral lipid load test; adipose tissue; adipokine; fatty acid (1)
ADIPOSE CONVERSION; CELL-LINE; DIFFERENTIATION; ADIPOGENESIS; ADIPOCYTE; EXPRESSION; SCAFFOLDS; adipocyte; adipogenesis; adipose tissue engineering; extracellular matrix; fat; leptin; scaffold; unilocular; 3-D cell culture; 3T3-L1 (1)
; adipose-derived stem cells; facial rejuvenation; patient’ s satisfaction; fat grafting; stromal vascular fraction (1)
ADIPOSE; PROTEIN; OBESITY; diabetes; adiponectin; adipocyte; high-density lipoprotein-cholesterol; lipid metabolism (1)
ADIPOSE-SPECIFIC PROTEIN; 3T3-L1 ADIPOCYTES; GLYCEROPHOSPHATE DEHYDROGENASE; INSULIN-RESISTANCE; GENE-EXPRESSION; OBESE GENE; ADIPONECTIN; CLONING; TISSUE; BINDING; ionomycin; dibutyryl-cycloAMP; Tumour Necrosis Factor alpha (TNFalpha) apM1-antibody; Acrp30/AdipoQ; GBP28; adiponectin (1)
ADIPOSE STROMAL CELLS; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; AROMATASE EXPRESSION; GENE-EXPRESSION; SYNOVIAL-FLUID; IN-VITRO; INTERLEUKIN-6; ESTROGEN; DEHYDROEPIANDROSTERONE; (1)
Adipose tissue, adipogenesis, spheroids, 3-D culture, coculture, adipose-derived stem cells, endothelial cells, vascularization, tissue engineering (1)
ADIPOSE-TISSUE; CANCER; VOLUME; CELLS; SURGERY; Congenital breast asymmetry; PROM; Autologous fat injections; Fat grafting; Lipograft; Implant augmentation; Breast augmentation; 3D volumetry; Three-dimensional imaging; Breast-QTM (1)
ADIPOSE-TISSUE; CARDIAC ABNORMALITIES; HEART-DISEASE; INTERLEUKIN-18; EXPRESSION; OBESITY; ADIPOCYTES; CYTOKINES; STENOSIS; CELLS; adiposity; cardiovascular diseases; coronary artery bypass grafting surgery; epicardial fat depot; interleukin-18; valve replacement (1)
ADIPOSE-TISSUE; CELLS; SAFETY; RISK; Autologous fat grafting; Transplantation; Breast Cancer; Reconstruction; Safety (1)
ADIPOSE-TISSUE; CYCLOOXYGENASE-2; INFLAMMATION; EXPRESSION; OBESITY; (1)
ADIPOSE-TISSUE; DECONGESTIVE PHYSIOTHERAPY; SURGICAL-TREATMENT; LIPOEDEMA; LIPOSUCTION; LYMPHEDEMA; LEGS; THERAPY; CELLS; WOMEN; (1)
ADIPOSE-TISSUE DEPOTS; CHOLESTEROL TRANSPORT; ADIPOKINE SECRETION; 3T3-L1 CELLS; VISCERAL FAT; IN-VITRO; OBESITY; INSULIN; MICE; ADIPOGENESIS; Intra-abdominal fat; Obesity; Lipid droplet; Lipolysis; Adipokine (1)
ADIPOSE-TISSUE DYSFUNCTION; NITRIC-OXIDE SYNTHASE; FREE FATTY-ACIDS; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; LIPIDOMIC ANALYSIS; ATHEROGENIC DIET; OXIDATIVE STRESS; 3T3-L1 CELLS; NULL MICE; Insulin signaling; White adipose tissue; Fatty liver (1)
adipose tissue, dyslipidemia, adipokine, inflammation (1)
ADIPOSE-TISSUE; GRAFT RETENTION; FAT GRAFTS; ANGIOGENESIS; SURVIVAL; VOLUME; INJECTION; VIABILITY; (1)
adipose tissue; histology; immunohistochemistry; fat grafting; stromal vascular fraction; extracellular matrix; mechanical processing (1)
ADIPOSE-TISSUE; IMMUNE-RESPONSE; REPRODUCTIVE FUNCTION; HUMORAL IMMUNITY; INNATE IMMUNITY; OBESE-PATIENTS; PROLACTIN; MACROPHAGES; MICE; AGE; B cell function; High-fat diet; Ageing; Immunoglobulin isotypes (1)
ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; TNF-ALPHA; FATTY-ACIDS; OBESITY; ADIPOKINE; ADIPOGENESIS; (1)
ADIPOSE-TISSUE; IN-VIVO; OBESITY; INFLAMMATION; ADIPOKINE; VISFATIN; FAT; progranulin; glucose tolerance test; lipid tolerance test (1)
adipose tissue; lipedema; single-cell RNA sequencing; adipocyte (1)
ADIPOSE-TISSUE; MACROPHAGE ACTIVATION; ATHEROSCLEROSIS; OBESITY; FAT; ACCUMULATION; INFLAMMATION; PERILIPIN; DEPOT; MICE; Epicardial adipose tissue (EAT); Coronary artery disease (CAD); Macrophages infiltration; Toll-like receptors (TLRs) (1)
adipose tissue; osteoarthritis; clinical therapy (1)
ADIPOSE-TISSUE; PROTEIN COMPLEX; FATTY-ACIDS; GROWTH; DIFFERENTIATION; EXPRESSION; PROLIFERATION; LOCALIZATION; CYTOSKELETAL; INTERACTS; Adipogenesis; Lipolysis; Triglycerides; Insulin (1)
ADIPOSE-TISSUE; RAGE; OBESITY; INFLAMMATION; DEFICIENCY; (1)
adipose tissue; stromal vascular fraction; extracellular matrix; cryopreservation; DMSO; CELT; CELTPLUS (1)
Adipositas, Fettgewebe, Lipidtropfen, Syntrophin, Stoffwechsel, Caveolin-1, obesity, adipose tissue, lipid droplets, metabolism (1)
Adipositas; Körperzusammensetzung; Epidemiologische Studien; Krebs; Mortalität / obesity; body composition; epidemiologic studies; cancer; mortality (1)
Adipositas, (Non-)Healthy Obese, Geschlechterspezifität Adiposity, (Non-)Healthy Obese, gender-specific differences (1)
Adiposity, Heart failure, Echocardiography (1)
ADJUSTED LIFE-YEARS; QUALITY-OF-LIFE; VALUATION METHODS; HEALTH STATES; UTILITIES; EQ-5D; AUSTRALIA; COUNTRIES; FRAMEWORK; EUROQOL; DALYs; valuation; pairwise comparison; ranking; disability weights (1)
ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT; COLORECTAL-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; RISK; 5-FU; oxaliplatin; Adjuvant chemotherapy; Cancer registry; Adverse event (1)
ADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; POSTMENOPAUSAL WOMEN; OLDER; COMORBIDITY; PREVALENCE; YOUNGER; SCORE; RISK; Breast cancer; Hormone and node positive; Chemotherapy; Elderly patients; Overall survival; Distant metastases-free survival (1)
ADJUVANT CHEMOTHERAPY; OUTCOMES; IMPACT; TIME; INITIATION; SURVIVAL; SURGERY; THERAPY; Time to systemic therapy; Triple negative breast cancer; Neoadjuvant chemotherapy; Clinical cancer registry data (1)
ADJUVANT ENDOCRINE THERAPY; SHORT VERSION; FOLLOW-UP; CARE; COHORT; RECURRENCE; OUTCOMES; CENTERS; breast cancer; cancer registry; quality assurance (1)
ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; IMMUNE-SYSTEM; SEMAPHORINS; GUIDANCE; RATS; NEUROTRANSMITTERS; INFLAMMATION; PEPTIDE; TISSUE; (1)
ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; BETA(2)-ADRENERGIC AGONIST SALBUTAMOL; BETA-ADRENERGIC RECEPTORS; BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; GLUCOCORTICOID-RECEPTOR; SYNOVIAL TISSUE; HUMAN-MONOCYTES; (1)
ADJUVANT PEMBROLIZUMAB; SURGICAL-MANAGEMENT; INVASION; SUNITINIB; PROLIFERATION; NEPHRECTOMY; ASSOCIATION; METASTASIS; EXTENSION; MIR-221; kidney cancer; RCC; venous infiltration; biomarker; miR; risk stratification (1)
ADJUVANT RADIOTHERAPY (1)
ADJUVANT RADIOTHERAPY; METASTATIC MELANOMA; CEREBRAL METASTASES; STEREOTACTIC RADIOSURGERY; PROGNOSTIC-FACTORS; BRAIN METASTASES; NECK DISSECTION; IRRADIATION; TOXICITY; VEMURAFENIB; Radiotherapy; Radiosurgery; Lentigomaligna; Brainmetastases; Radioimmunotherapy (1)
ADMA, CKD, homoarginine, risk marker, SDMA (1)
Administracji, polnisch, Manssen (1)
administration, employment, tenure (1)
Administration, Oral Anilides: CH, chemistry Anilides: PK, pharmacokinetics Biological Availability *Echinacea Fatty Acids, Unsaturated: CH, chemistry *Fatty Acids, Unsaturated: PK, pharmacokinetics Humans Plant Extracts: CH, chemistry Plant Extracts: PK, pharmacokinetics Plant Roots: CH, chemistry Plant Stems: CH, chemistry Polyunsaturated Alkamides 0 (2,4,8,10-dodecatetraenoic acid isobutylamide) 0 (Anilides) 0 (Fatty Acids, Unsaturated) 0 (Plant Extracts) 0 (Polyunsaturated Alkamides) (1)
Administration, Oral Animals Anthelmintics: AD, administration & dosage *Anthelmintics: TU, therapeutic use Feces: PS, parasitology Haemonchiasis: DT, drug therapy *Haemonchiasis: VE, veterinary Haemonchus: DE, drug effects Haemonchus: GD, growth & development Intestinal Diseases, Parasitic: DT, drug therapy Intestinal Diseases, Parasitic: VE, veterinary Parasite Egg Count: VE, veterinary *Phytotherapy Phytotherapy: VE, veterinary Plant Extracts: AD, administration & dosage *Plant Extracts: TU, therapeutic use Random Allocation Sheep *Sheep Diseases: DT, drug therapy Trichostrongylosis: DT, drug therapy *Trichostrongylosis: VE, veterinary Trichostrongylus: DE, drug effects Trichostrongylus: GD, growth & development 0 (Anthelmintics) 0 (Plant Extracts) (1)
; Admission control; Informational uncertainty; Revenue management; Cloud computing (1)
Adolescence, Major depressive disorder, Anxiety disorders, Functional connectivity, Oxytocin, Cortisol, Alpha-amylase, Montreal imaging stress task, Psychosocial stress (1)
Adolescent Adult Aged Dose-Response Relationship, Drug English Abstract Female Human Male Middle Age Streptokinase/*administration & dosage/adverse effects Thrombophlebitis/*drug therapy (1)
Adolescent brain development; Puberty; Age; Magnetic resonance imaging (MRI); Gray matter volume; White matter tracts (1)
adolescent fracture; pediatric traumatology; trauma surgery; standardized treatment (1)
Adolescent idiopathic scoliosis (AIS) · Large language models (LLMs) · Patient education · Spine surgery · Artificial intelligence (AI) (1)
ADOLESCENTS; (1)
adolescents | alexithymia | anorexia nervosa | cortical surface area | cortical thickness | cortical volume | precuneus | psychopathology (1)
ADOLESCENTS; CHALLENGES; Emergency Remote Teaching; students; peers; Covid-19; disability (1)
ADOLESCENTS SEXUAL-BEHAVIOR; VIOLENT VIDEO GAMES; ROCK-MUSIC VIDEOS; HEAVY-METAL MUSIC; ALCOHOL-USE; MASS-MEDIA; AGGRESSIVE THOUGHTS; SMOKING INITIATION; PROSOCIAL BEHAVIOR; CIGARETTE-SMOKING; risk taking; risk-glorifying media; media effects; general learning model; meta-analysis (1)
adolescents, stress, personality, temperament, cortisol, alpha-amylase, subjective stress (1)
Adoleszenz; Jugendliteratur; Jugendroman; Schuljahr 09; Schuljahr 10; Schuljahr 11; Spielfilm; Deutschunterricht; Reiseroman; Textanalyse; Deutschland (1)
ADOLF MEYER-ABICH; history of biology; history and philosophy of biology; Lebensphilosophie; phenomenology; neo-Kantianism; organismic biology; Hans-Jorg Rheinberger; biophilosophy; theoretical biology (1)
adoptive cell therapy, CAR, chimeric antigen receptor, T cell (1)
ADOPTIVE TRANSFER; CYTOMEGALOVIRUS DISEASE; TRANSPLANTATION; RECONSTITUTION; IMMUNITY; RECIPIENTS; THERAPY; IMMUNOTHERAPY; MULTICENTER; LYMPHOCYTES; (1)
ADOPTIVE TRANSFER; LYMPHOCYTES; CD8(+); COSTIMULATION; GENERATION; ACTIVATION; RESPONSES; IMMUNITY; AVIDITY; CD4(+); (1)
ADOPTIVE TRANSFER; RESISTANCE; EXPRESSION; A20; IDENTIFICATION; INHIBITION; LKB1; AKT; INFLAMMATION; PROGRESSION; tumor escape; immunotherapy; cytokines; immunomodulation; CD8-positive T-lymphocytes (1)
ADPKD · Cyst fluid · Metabolomics · NMR spectroscopy · Mass spectrometry · Patient clustering (1)
ADPKD Polycystin-1 Polycystin-2 PKD1 PKD2 (1)
ADPKD, Polycystin-2, Primäres Zilium, primary cilium (1)
Adptive Kompetenzen, Adaptives verhalten, Förderschwerpunkt geistige Entwicklung (1)
ADRENAL AXIS ACTIVITY; HIPPOCAMPAL VOLUME; CHILDHOOD TRAUMA; HPA AXIS; STRESS; BRAIN; CORTISOL; DISEASE; MEMORY; MRI; (1)
ADRENAL AXIS ACTIVITY; LONG-TERM CORTISOL; DEPRESSIVE SYMPTOMS; PERCEIVED STRESS; INTRAINDIVIDUAL STABILITY; PSYCHIATRIC-DISORDERS; SOCIOECONOMIC-STATUS; FUTURE-DIRECTIONS; MORNING CORTISOL; MAJOR DEPRESSION; (1)
ADRENAL AXIS; STRESS; RISK; ASSOCIATION; PREVALENCE; INTERVIEW; DISORDER; BEHAVIOR; GROWTH; SAMPLE; Non-suicidal self-injury; Adolescents; Pituitary gland volume; Magnetic Resonance Imaging (MRI); Manual tracing (1)
Adrenal cortex · Mouse models · Aldosteronism · Secretion · Pathophysiology (1)
ADRENAL-CORTICAL CARCINOMA; LONG-TERM SURVIVAL; ADJUVANT MITOTANE; CLINICAL MANAGEMENT; PROGNOSTIC-FACTORS; CANCER-PATIENTS; PLUS MITOTANE; RESECTION; FEATURES; SERIES; (1)
Adrenalectomy; Adrenal carcinoma; Adrenal cyst; Adrenal endocrine dysfunction; Adrenal gland; Pheochromocytoma (1)
adrenal gland, aldosterone, hyperaldosteronism, potassium channels, Task1, Task3, Trek1, Kcnq1, Kcne3, Kcne4, Kcnma1, Nebenniere, Aldosteron, Hyperaldosteronismus, Kalium Kanäle (1)
ADRENAL GLOMERULOSA CELLS; BACKGROUND K+ CHANNEL; ANGIOTENSIN-II; PRIMARY HYPERALDOSTERONISM; MEMBRANE DEPOLARIZATION; SUBUNIT COMPOSITION; SIGNALING PATHWAYS; IONIC CURRENTS; ATP HYDROLYSIS; MESSENGER-RNA; K2P; KCNK2; KCNK3; KCNK9; adrenocortical zonation; aldosterone; angiotensin II; adrenal cortex (1)
ADRENERGIC-RECEPTOR SUBTYPES; PYRIMIDINE NUCLEOTIDES; DISEASE DEVELOPMENT; CELL-PROLIFERATION; MOLECULAR ANALYSIS; COLLECTING DUCT; MESSENGER-RNAS; RENIN RELEASE; RAT-KIDNEY; SF9 CELLS; Adenylyl cyclase; Kidney cortex; Kidney medulla; MANT nucleotides; Polycystic kidney disease; Glucagon (1)
ADRENERGIC-STIMULATED LIPOLYSIS; MESSENGER-RNA EXPRESSION; UNCOUPLING PROTEIN; BROWN FAT; METABOLISM; DISEASE; OBESE; INTERLEUKIN-6; ACCUMULATION; LIPOSUCTION; (1)
ADRENOCORTICAL CARCINOMA; CORTICAL CARCINOMA; CAUTIONARY NOTE; RESECTION; CONVERSION; Adrenocortical carcinoma; laparoscopic adrenalectomy; postoperative complications (1)
ADRENOCORTICAL CARCINOMA; TUMORS; INCIDENTALOMAS; MANAGEMENT; MASSES; benign; giant; adrenal adenoma; spontaneous rupture. (1)
ADRENOCORTICAL CELL-LINE; ZONA GLOMERULOSA CELLS; ANGIOTENSIN-II; POTASSIUM CHANNEL; SOMATIC MUTATIONS; NA/K-ATPASE; KCNJ5 MUTATIONS; K+ CHANNEL; SEVERE HYPERALDOSTERONISM; NCI-H295 CELLS; (1)
ADRENOCORTICAL RESPONSES; STRESS REACTIVITY; STRANGE SITUATION; HEART-RATE; SECURITY; TEMPERAMENT; ADAPTATION; QUALITY; attachment; Strange Situation; biobehavioral organization; adrenocortical activity; cardiac activity (1)
Adrenomedullin, Infection, Sepsis, Emergency department, Point-of-care (1)
AdS-CFT Correspondence, Boundary Quantum Field Theory, Holography and Condensed Matter Physics (AdS/CMT), Non-Equilibrium Field Theory (1)
AdS-CFT Correspondence, Conformal Field Models in String Theory, Holography and Condensed Matter Physics (AdS/CMT) (1)
AdS-CFT Correspondence, Holography and Condensed Matter Physics (AdS/CMT), Matrix Models, Random Systems (1)
AdS/CFT, Gauge/Gravity Duality, Higher Derivative Corrections, Gravitational Shockwave Collisions, Heavy Ion Physics, Quark Gluon Plasma, Holography, Numerical Relativity, Super Yang Mills Theory (1)
Adsorbed substances (dyes, double-resonant second harmonic generation by); Dyes (laser double-resonant second harmonic generation from adsorbed films of); Laser radiation (second harmonic generation of, double-resonant, from adsorbed dyes); laser second harmonic dye film; Nile Blue A second harmonic Rhodamine 6G second harmonic (1)
Adsorption Dopants Topological insulators Atomic force microscopy Noncontact atomic force microscopy (1)
ADSORPTION; PARTICLES; ANTIGENS; CULTURE; CELLS; HIV/AIDS; vaccine delivery; silica; protein delivery; nanoparticle(s); envelope (1)
Adsorption , polymere Einzelkette , Kettendynamik , Trans-Gauche Flip , Konformationsumlagerung , polymeric single chain , chain dynamics , trans-gauche flip , change in conformation (1)
Adsorptive enrichment Thermal desorption Adsorbents Air analysis (1)
Adult; Aged; analysis; Dupuytren's Contracture; Fascia; Female; Humans; innervation; Male; Mast Cells; Middle Aged; Nerve Fibers; pathology; Research Support,Non-U.S.Gov't; Substance P (2)
"Adult", "Aged", "Chromosome Aberrations", "Chromosome Inversion", "Cluster Analysis", "Core Binding Factors", "Female", "Gene Expression Profiling", "Gene Expression Regulation, Neoplastic", "Humans", "Karyotyping", "Leukemia, Myeloid, Acute", "Male", "Middle Aged", "Mutation", "Oligonucleotide Array Sequence Analysis", "Prognosis", "Proto-Oncogene Proteins c-kit", "Survival Rate", "Tumor Markers, Biological", "fms-Like Tyrosine Kinase 3" (1)
ADULT AGE-DIFFERENCES; IMAGINED SPATIAL TRANSFORMATIONS; WORKING-MEMORY; PERSPECTIVE-TAKING; TASK-PERFORMANCE; OLDER-ADULTS; SPEED; CHILDREN; ABILITIES; COGNITION; mental rotation; developmental changes; object-based and egocentric transformations (1)
ADULT ATTACHMENT; DISCRIMINANT VALIDITY; INTERVIEW; ANXIETY; ATTENTION; PATTERNS; THREAT; STRATEGIES; MOTHER; INFANT; attachment state of mind; perception; perceptual vigilance; perceptual defense (1)
ADULT ATTACHMENT; STARTLE REFLEX; ATTENTION; PROBE; ADOLESCENCE; INFORMATION; EXPRESSION; STIMULI; STATE; MIND; attachment; parental care; electrophysiology; emotion perception (1)
adult; BRAF mutation; Langerhans cell histiocytosis; multisystemic; pathogenesis; peroxisome proliferatoreactivated receptor (1)
Adulte Neurogenese, Parkinson, α-Synuclein, mThy1, Hippocampus, Bulbus olfactorius, Dendriten, Synaptische Spines, retrovirales Tracing adult neurogenesis, parkinson, α-synuclein, mThy1, hippocampus, olfactory bulb, dendrites, synaptic spines, retroviral tracing (1)
Adulte Stammzellen , Fibroblastenwachstumsfaktor , Tissue Engineering , Fettgewebe , Biomimetische Polymere , mesenchymal stem cells , basic fibroblast growth factor , tissue engineering , adipose tissue , biomimetic polymers (1)
ADULT HIPPOCAMPAL NEUROGENESIS; ANTAGONIST MIFEPRISTONE NORMALIZES; GENERATED GRANULE CELLS; DENTATE GYRUS; TRAIT ANXIETY; PSYCHOSOCIAL STRESS; MATERNAL-BEHAVIOR; NEUROENDOCRINE RESPONSES; ANIMAL-MODEL; FEMALE RATS; depression; doublecortin; early life; hippocampus; HPA axis (1)
ADULT HIPPOCAMPAL NEUROGENESIS; ELEMENT-BINDING PROTEIN; RAT DENTATE GYRUS; CELL-PROLIFERATION; NEUROTROPHIC FACTOR; INCREASES NEUROGENESIS; PSYCHOSOCIAL STRESS; PROGENITOR CELLS; BALB/CJ MICE; VOLUME LOSS; antidepressant; neuronal survival; hippocampus; doublecortin; mouse model (1)
ADULT HIPPOCAMPAL NEUROGENESIS; RAT DENTATE GYRUS; STEM-CELLS; CORTICOSTEROID RECEPTORS; PSYCHOSOCIAL STRESS; NEURONAL FATE; GROWTH-FACTOR; DEXAMETHASONE; PROLIFERATION; EXPRESSION; Neural stem cells; Neural progenitors; Neuropeptides; Stress; Cell proliferation; Astroglia (1)
ADULT HUMAN FIBROBLASTS; LONGITUDINAL-FOLLOW-UP; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; PRECURSOR CELLS; NEURONAL DIFFERENTIATION; INTELLECTUAL-DEVELOPMENT; ANOPHTHALMIA SYNDROME; MOUSE FIBROBLASTS; AUTISTIC DISORDER; HCMV; IE1; neural progenitor cells; SOX2; STAT3 (1)
ADULT HUMAN HEPATOCYTES; LARGE ENVELOPE PROTEIN; LARGE SURFACE PROTEIN; HEPATOMA-CELL LINE; IN-VITRO; TUPAIA HEPATOCYTES; PRE-S1 DOMAIN; INFECTION; ENTRY; REPLICATION; (1)
ADULT HYPOTHALAMUS; NEURITE OUTGROWTH; PC12 CELLS; RECEPTOR; MEF2; VASOPRESSIN; RAT; ACTIVATION; EXPRESSION; ANXIETY; Oxytocin; Neurite retraction; Myocyte enhancer factor 2 (MEF-2); MAP kinase pathway (1)
ADULT MAMMALIAN BRAIN; NEWLY GENERATED NEURONS; DENTATE GYRUS; OLFACTORY-BULB; GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; STEM-CELLS; DOUBLECORTIN; PROLIFERATION; adult neurogenesis; doublecortin; fluorescent reporter protein; neural stem cell; neuronal migration; transgenic mouse (1)
ADULT MAMMALIAN CARDIOMYOCYTES; CARDIAC STEM-CELLS; MYOCARDIAL REGENERATION; MECHANICAL SUPPORT; HYPERTROPHY; INFARCTION; MYOCYTES; FAILURE; REGRESSION; APOPTOSIS; heart-assist devices; heart failure; hypertrophy; pathology; remodeling (1)
ADULT-MOUSE LUNG; GENE-EXPRESSION; QUANTIFICATION; ADENOCARCINOMA; IDENTIFICATION; GELSOLIN; PROTEIN; AIRWAY; NOISE; (1)
ADULT NEOVASCULARIZATION; TUMOR REFRACTORINESS; ENDOTHELIAL-CELLS; BLOOD MONOCYTES; GENE-EXPRESSION; MACROPHAGES; SUBSETS; GROWTH; MICE; PROGRESSION; (1)
ADULT NEPHROTIC SYNDROME; MEMBRANOUS NEPHROPATHY; AUTOIMMUNE-DISEASES; RANDOMIZED-TRIAL; FOLLOW-UP; THERAPY; CHILDREN; GLOMERULONEPHRITIS; METHYLPREDNISOLONE; MULTICENTER; cyclosporine A (CsA); nephrotic syndrome; focal segmental glomerulosclerosis (FSGS) (1)
ADULT OLFACTORY-BULB; EPIDERMAL-GROWTH-FACTOR; LEWY-BODY-DISEASE; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CELL-DEATH; SUBVENTRICULAR ZONE; GAMMA-SYNUCLEIN; RAT HIPPOCAMPUS; cell death; neural stem/progenitor cells; neurogenesis; olfactory bulb; Parkinson's disease; synucleinopathy (1)
ADULT-ONSET ASTHMA; PREVALENCE; GENDER; RISK; Asthma; Chronic diseases; Respiratory diseases; General population; Cohort study (1)
ADULT PATIENTS; INTERHOSPITAL TRANSPORTS; EXPERIENCE; SUPPORT; FAILURE; VOLUME; ORGANIZATION; RETRIEVAL; SURVIVAL; TEAM; extracorporeal membrane oxygenation; ECMO; interhospital; international; transport; organization; equipment (1)
ADULT PATIENTS; MECHANICAL VENTILATION; INJURY; DETERMINANTS; EXPERIENCE; MORTALITY; FAILURE; ARDS; Carbon dioxide removal; HFOV; High-frequency oscillatory ventilation; iLA; Interventional lung assist (1)
ADULT-RAT BRAIN; ALZHEIMERS-DISEASE; STEM-CELLS; BETA DEPOSITION; SECRETED FORMS; GROWTH-FACTOR; MOUSE MODELS; MUTANT; AGE; NEUROGENESIS; Alzheimer's disease; amyloid; APP; A beta; CNS; brain; transgenic mouse; stereology; neurodegeneration; stem cells; neurogenesis; gliogenesis; microglia; aging (1)
ADULT-RAT BRAIN; CELL-PROLIFERATION; DENTATE GYRUS; GROWTH-FACTOR; NEURONS; MECHANISM; EXPOSURE; DEATH; MOUSE; DEPRIVATION; environmental stimulation; exercise; mouse; proliferation (1)
ADULT RHESUS-MONKEYS; MACACA-MULATTA; ENDOCHONDRAL OSSIFICATION; VERTICAL DIMENSION; GENE-EXPRESSION; X COLLAGEN; CHONDROCYTES; ADAPTATION; RAT; MATRIX; Collagen; Matrix metalloproteinase; Quantitative RT-PCR; Temporomandibular joint; Vascular endothelial growth factor (1)
ADULT SEPARATION ANXIETY; PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; MAJOR DEPRESSION; EFFICACY; DENSITY; DISORDERS; MICROGLIA; DISEASE; BURDEN; TSPO; platelets; depression; antidepressant; therapy response (1)
ADULTS PRACTICE PARAMETERS; QUALITY-OF-LIFE; HEART-FAILURE; APNEA SYNDROMES; PREVALENCE; ASSOCIATION; POPULATION; GUIDELINE; SERVOVENTILATION; INSTRUMENT; (1)
ADULTS; tinnitus; education; medical; hearing; PhD studentship; heterogeneity of tinnitus (1)
ADULT SURVIVORS; FOLLOW-UP; HEALTH OUTCOMES; EXPERIENCES; GUIDELINES; ATTENDANCE; SUPPORT; COHORT; Cancer survivorship; Follow-up studies; Cancer; Late effect; Follow-up guidelines; Insurance claims processing; Transition to adult care; Informal caregivers (1)
ADVANCED BREAST-CANCER; CELL LUNG-CANCER; PHASE-III TRIAL; EUROPEAN-ORGANIZATION; COLORECTAL-CANCER; EORTC QLQ-C30; CLINICAL-TRIALS; QUESTIONNAIRE; CHEMOTHERAPY; RESPONSIVENESS; cancer clinical trial; completion-time window; health-related quality of life; quality of life (1)
ADVANCED BREAST-CANCER; NONSTEROIDAL AROMATASE INHIBITORS; PHASE-II TRIAL; POSTMENOPAUSAL WOMEN; ESTROGEN-RECEPTOR; ACTIVATION; EXPRESSION; FAILURE; aromatase; cell growth; exemestane; paclitaxel; tumor cell line (1)
ADVANCED CANCER; CONSULTATION; DISCUSSIONS; INDICATORS; INPATIENTS; ATTITUDES; SURVIVAL; SURGERY; MODEL; Palliative care; Anesthesiology; Operating rooms; Perioperative period (1)
ADVANCED COLORECTAL-CANCER; DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY; RANDOMIZED PHASE-III; EVERY 3 WEEKS; IRINOTECAN (CPT-11)-INDUCED DIARRHEA; CAMPTOTHECIN DERIVATIVE IRINOTECAN; PATIENTS RECEIVING 5-FLUOROURACIL; FLUOROURACIL PLUS LEUCOVORIN; ANTICANCER DRUG IRINOTECAN; IRRITABLE-BOWEL-SYNDROME; diarrhea; chemotherapy; irinotecan; CPT-11; 5-fluorouracil; octreotide; loperamide; glutamine (1)
ADVANCED GASTRIC-CANCER; OPEN-LABEL; KINASE INHIBITOR; SUPPORTIVE CARE; BREAST-CANCER; CHEMOTHERAPY; TRASTUZUMAB; PACLITAXEL; PLACEBO; SURVIVAL; Gastric cancer; HER2; EGFR; Lapatinib (1)
; advanced glycation endproducts; bile duct cancers; EPIC study; gallbladder cancer; hepatocellular carcinoma (1)
ADVANCED HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET; KINASE-ACTIVITY; DOUBLE-BLIND; PHASE-III; SORAFENIB; MET; RECEPTOR; hepatocellular carcinoma; multikinase inhibitor; cabozantinib; combination therapy; clinically; preclinical; c-MET (1)
ADVANCED HIP OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; MRI; HISTOPATHOLOGY; ABNORMALITIES; HISTOLOGY; PATTERN; LESIONS; KNEES; Bone marrow; Bone marrow edema; Osteitis; Magnetic resonance imaging; Histology (1)
Advance directives, palliative care, paramedics, prehospital emergency care (1)
ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; SKILLS; KNOWLEDGE; SURVIVAL; DOCTORS; CHAIN; resuscitation; emergency medical care; cardiac arrest; training model; hospital doctor (1)
ADVANCED LIFE-SUPPORT; NONTECHNICAL SKILLS; CARDIOPULMONARY-RESUSCITATION; PERFORMANCE; DEATH; RETENTION; PATIENT; STRESS; Simulation; Cardiopulmonary resuscitation; Mountain rescue; Non-technical skills; Personnel evaluation (1)
ADVANCED MAILLARD REACTION; EXTRACELLULAR-MATRIX; NUCLEAR-PROTEIN; HEPG2 CELLS; DEHYDROGENASES/REDUCTASES; IDENTIFICATION; LOCALIZATION; METABOLISM; GENOMES; DAMAGE; Hep27; carbonyl reductase; short-chain dehydrogenase/reductase; dicarbonyl compounds (1)
ADVANCED MELANOMA; BLOOD-COUNT; IPILIMUMAB; TOXICITY; REGULARIZATION; AUTOIMMUNITY; THERAPY; biomarker; checkpoint inhibition; irAEs; immune-related adverse events; validation; prediction (1)
; advanced melanoma; BRAF; predictive models; binary logistic regression; classification and regression trees (1)
ADVANCED THYMOMA; GERM-CELL; RESECTION; CLASSIFICATION; THYMUS; HEART; Mediastinum; Mediastinal tumors; differential diagnosis; Thymoma; Thymic carcinoma; Radical resection (1)
Advanced training content; Medical specialist for internal medicine and rheumatology; E‑ logbook; Advanced training periods; Advanced training authorization (1)
ADVANCED UROTHELIAL CANCER; MESSENGER-RNA; AMPLIFICATION TARGET; P53-DEFICIENT CELLS; URINARY-BLADDER; TUMOR-FORMATION; CARCINOMA; THERAPY; SNP309; TP53; bladder cancer; MDM2; HDMX; marker; prognosis (1)
ADVANTAGES; SYSTEM; laterality; horse; rider; sensory laterality; motor laterality; novel object; side preference (1)
ADVERSE CHILDHOOD EXPERIENCES; VICTIMIZATION; METAANALYSIS; PEDOPHILIA; DEVIANCE; BEHAVIOR; HISTORY; SWEDISH; Child sexual abuse; sexual abuse experiences; sexual interest in children (1)
ADVERSE DRUG EVENTS; CARE; PREVENTABILITY; POLYPHARMACY; PERFORMANCE; ADMISSION; RISK; Drug-drug interaction; Clinical decision support systems (CDSS); Adverse drug reaction; Expenditure of time; Chronic pain; Polypharmacy (1)
ADVERSE DRUG-REACTIONS; SCHIZOPHRENIC-PATIENTS; CYTOCHROME-P450 2D6; PLASMA-LEVELS; POLYMORPHISM; CYP2D6; PSYCHIATRY; 9-HYDROXYRISPERIDONE; RECEPTOR; SAFETY; Risperidone; Therapeutic drug monitoring; Plasma concentration; CGI; Treatment response (1)
ADVERSE EVENTS; ANTI-PD-1; BLOCKADE; CANCER; TOXICITIES; (1)
adverse events; chronic kidney disease; epidemiology; interactive visualization; multimorbidity; kidney failure, chronic cardiovascular system infections kidney mortality adverse event multimorbidity (1)
ADVERSE OUTCOMES; METABOLOMICS; SULFAMETHOXAZOLE; TRIMETHOPRIM; NONADHERENCE; PEOPLE; BURDEN; RATES; (1)
ADVERSE SELECTION; IMPERFECT INFORMATION; ASYMMETRIC INFORMATION; INSURANCE MARKETS; CHOICE; MODEL; MAINTENANCE; COMPETITION; DEFAULT; RISK; Housing; Tenure choice; Asymmetric information; Screening (1)
ADVERTISED PRICES; BAYESIAN-ANALYSIS; 99-ENDING PRICES; 9-ENDING PRICES; SCANNER DATA; ENDINGS; MODELS; SIGNAL; KNOWLEDGE; PRODUCTS; odd price; even price; heterogeneity; hierarchical Bayes (1)
AEDES-AEGYPTI; CARBON-DIOXIDE; ODOR; PERU; (1)
; Aedes aegypti; Dengue; Virus; Molecular tests (1)
AEDES-AEGYPTI DIPTERA; MALARIA MOSQUITOS; ATTRACTION; CULICIDAE; ODORS; RESPONSES; HUMANS; IDENTIFICATION; OLFACTOMETER; SIMULIIDAE; (1)
AEDES-AEGYPTI; MOSQUITO REPELLENT; LACTIC-ACID; DEET; WATER; PENETRATION; EMULSIONS; CUMULANTS; EFFICACY; (1)
AEGYPTI DIPTERA-CULICIDAE; MOSQUITO MANAGEMENT; POPULATION-SIZE; VECTOR CONTROL; UNITED-STATES; PUBLIC-HEALTH; TSETSE-FLY; DISPERSAL; FLORIDA; SURVEILLANCE; Culicidae; Aedes albopictus; BG-Sentinel mosquito trap; mosquito control; nuisance reduction (1)
Aerobic exercise, Agency, Heart rate, Virtual reality, Visual flow (1)
AEROPYRUM-PERNIX K1; ARCHAEON THERMOCOCCUS-KODAKARAENSIS; HYPERTHERMOPHILIC ARCHAEON; ESCHERICHIA-COLI; BIENZYME COMPLEX; BETA-SUBUNIT; ACETYLSERINE SULFHYDRYLASE; 3-DIMENSIONAL STRUCTURE; SALMONELLA-TYPHIMURIUM; MOLECULAR-GRAPHICS; (1)
Aerosol delivery, Nanoparticles, Gene therapy, Vaccines, Anti-microbial, Aerosol devices (1)
AEROSOL; FENOTEROL; TOCOLYSIS; (1)
Aerosols; Carbohydrates; Electrodes; Nanofibers; Sensors (1)
AERUGINOSA-INDUCED PNEUMONIA; A VIRUS; POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHIL TRANSMIGRATION; SURFACE EXPRESSION; GENE-EXPRESSION; PRIMARY CULTURE; INTACT MICE; PULMONARY; MACROPHAGES; (1)
AESTHETIC RESTORATIVE MATERIALS; IN-VITRO; HYDROGEN-PEROXIDE; PHYSICAL-PROPERTIES; RESIN COMPOSITE; AGENTS; CYTOTOXICITY; MONOMERS; SURFACE; MICROHARDNESS; Bleaching; Peroxide; Dental composite; Elution; Comonomer; Polymer network (1)
aesthetics, Albert the Great, figural knowledge, Gospel of John, manuduction, medieval biblical exegesis, medieval metaphysics (1)
Aesthetics, user interface design, website design, symmetry, visual complexity, colorfulness (1)
Afamin; chronic kidney disease; high risk population; kidney failure; prospective study (1)
AF-DX 384; AUTORADIOGRAPHIC DISTRIBUTION; ANTAGONIST TRIPITRAMINE; ALZHEIMERS-DISEASE; COMMON SITE; RAT-BRAIN; MODULATORS; AGONISTS; M2; ACETYLCHOLINE; Muscarinic acetylcholine receptors; Dibenzodiazepinones; Antagonists; Dimeric ligands; Allosteric binding; AF-DX 384 (1)
AFFECTED COASTAL MOUNTAINS; MORPHOLOGICAL CHARACTERS; CHLOROPLAST DNA; RAPD VARIATION; PLASTID GENES; INDIAN-OCEAN; SPECIES DELIMITATION; NATURAL-POPULATIONS; NONCODING REGIONS; UNIVERSAL PRIMERS; AFLP; cpDNA PCR-RFLP; Fragmentation; Monsoon forest; Phylogeography; South Arabia (1)
affective computing, augmented reality, emotion, facial, recognition, hololens (1)
affective computing, emotion detection, space invaders, gaming, dynamic game balancing, game engineering (1)
affective computing, smart light bulbs, lighting, emotion detection, sentiment analysis (1)
Affective computing; usability engineering; usability; sentiment analysis; emotion analysis; usability test; system usability scale (1)
affective disorder antidepressant cytokines inflammation (1)
Affective disorders; Epidemiology; Incidence; Nationwide analysis (1)
AFFECT REDUCES BREADTH; COGNITIVE CONTROL; REWARD; STABILITY; EMOTION; FLEXIBILITY; MODULATION; DOPAMINE; PROSPECT; ANGER (1)
AFFERENT ARTERIOLES; NITRIC-OXIDE; JUXTAGLOMERULAR CELLS; ANGIOTENSIN-II; T-TYPE; EXPRESSION; SECRETION; INHIBITION; RELEASE; EXOCYTOSIS; exocytosis; norepinephrine; secretion; nitric oxide; blood pressure (1)
AFFERENT ARTERIOLES; OXIDATIVE STRESS; TUBULOGLOMERULAR FEEDBACK; ENDOTHELIAL DYSFUNCTION; HYPERTENSIVE-RATS; DEFICIENT MICE; KNOCKOUT MICE; INHIBITION; RECEPTORS; KIDNEY; afferent arterioles; CuZnSOD; hypertension; ICSOD; oxidative stress; superoxide; SOD1; kidney (1)
AFFERENT DENERVATION PREVENTS; LEFT-VENTRICULAR HYPERTROPHY; UREMIC RATS; PROTEIN EXPRESSION; ISCHEMIA TOLERANCE; HYPERTENSIVE RATS; DIALYSIS PATIENTS; KIDNEY-DISEASE; ABLATION MODEL; NERVE ACTIVITY; uremic cardiomyopathy; capillary supply; vascular endothelial growth factor; capillary/myocyte mismatch; sympathetic nervous system; renal denervation; chronic renal failure (1)
Affiliation , zwischenmenschliche Beziehung , Anschlussmotivation , soziale Systeme , affiliation motive , social systems , interpersonal balance (1)
AFFINITY-CHROMATOGRAPHY; SOLUTION CHEMISTRY; CRYSTAL-STRUCTURES; BINDING-SITE; ION; CYCLEN; SYSTEM; potentiometric titration; coordinative binding; IDA; NTA; cyclen; binding constant (1)
Affinity-purification coupled to mass spectrometry; Chromatin; Epigenetic; Gene transcription; Histones; histone ubiquitination; mRNA export; mRNA processing; RNA polymerase II; SPT16; SSRP1; transcript elongation factor; transcript elongation complex (1)
Affinity sensor; Self-assembly; Capacitive sensor; Signal amplification; Immunosensor; Biosensor (1)
AFFINITY UP-REGULATION; RHEUMATOID-ARTHRITIS; INTEGRIN ACTIVATION; ENDOGENOUS CANNABINOIDS; CELL-MIGRATION; CANCER CELLS; RELEASE; TRPV1; OSTEOARTHRITIS; EXPRESSION; (1)
Affordance judgments, Aging, Judgment tendency, Overestimation, Underestimation (1)
AFLP; genotyping; Leucanthemum; Nanopore; Senecio (1)
AFLP, phylogeography, temperate grasslands, Central Europe, postglacial immigration, population genetics (1)
AFM air ambient environment mechanical exfoliation TMDCs atomic resolution particles ice-like water (1)
AFM, CO tip, subatomic resolution, adatoms, CO bending, absolute distance, force deconvolution, ill-posed inversion problem, inflection point test (1)
AFM, Graphene, Calcite, qPlus Sensor, ambient conditions, air, liquid (1)
AFM, Rasterkraftmikroskopie, qPlus Sensor, atomare Auflösung, molekulare Auflösung, DNA, Lipide, Doppellipidschicht, biological samples, atomic resolution, FM-AFM, Muskovit, Mica, TMDC, Umbebungsbedingungen, ambient, Reaktivität, Lichtfeld (1)
AFM, Rasterkraftmikroskopie, STM, Rastertunnelmikroskopie, isolierende Oberflächen, Cu2N, Magnetkraftmikroskopie, MFM, qPlus, Tieftemperatur, Ultrahochvakuum (1)
AFM, STM, light-matter interaction, photoexcitation, single molecule, atomic scale, laser, molecular motion, coherent control, ultrafast physics, lightwave, orbital imaging, photocurrent, surface science (1)
AFM, STM, STS, on-surface chemistry, atomical control, atomic scale manipulation, single molecule, ether-bond fission, tip-induced chemical reaction, triplet liefetime, triplet quenching, molecular oxygen, pentacene triplet lifetime, unpaired-electron, orbital imaging, organic spintronics, organic radicals, Blatter radical, Kondo resonance (1)
AFM, STM, UHV, Si (111)7×7, noncontact mode, attractive mode, contact mode, atomic resolution, tip-sample interaction, force measurement (1)
African American; childhood asthma; exacerbations; Latino; pharmacogenomics (1)
AFRICAN-AMERICAN SUICIDE; 1ST YEAR; CARE; STRATEGIES; LITHUANIA; DIAGNOSIS; SUPPORT; COHORT; DEATH; LIFE; (1)
AFRICAN-GREEN MONKEYS; T-CELL RESPONSES; DNA VACCINE; RHESUS MACAQUES; RSV INFECTION; F-PROTEIN; PROTECTIVE EFFICACY; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; IMMUNIZATION; (1)
AFRICAN WEAVER ANT; APIS-MELLIFERA L; HONEY-BEE; COLLECTIVE DECISIONS; SOCIAL INSECTS; ARGENTINE ANT; ARMY ANTS; BEHAVIOR; HYMENOPTERA; FORMICIDAE; self-assemblages; chains; bivouacs; swarms; aggregation (1)
AFTERCARE; forensic aftercare; forensic outpatient treatment; recidivism rates (1)
Aftereffects; Saturation; Psychophysics (1)
AG1478; epidermal growth factor receptor; gene expression analysis; glioma; siRNA (1)
Agape, Alpha and Omega, App. Sciences, Artificial Intelligence (AI), astronomy, atomic bomb, atomic core, business, capitalism, communism, Creator God, creativity, creation, Critical Realism, Democracy, development, earth, economics, Ecumenism, electrons, engineering, environment, ethics, evolution, Existentialism, finances, goals, God, history of thoughts, heroism, Humanism, Human Rights, Idealism, intention, justice, Koran, KI, Laudato Si, life, love, migration, morals, motivation, natural sciences, NS terror, obligation, philosophy, peace, physics, policy, politics, polity, probability, process, progress, providence, purpose, Quantum Theory, Qumran, religion, Second Vatican Council, sciences, Scriptures, sustainability, Sustainer God, technology, theology, values, virtues, weapons, world war (unjust), K.B.Achhammer,H.Arendt, Aristoteles, I.G.Barbour, K.Barth, K.Berger, J.M.Bergoglio, H.Blumenberg, J.B.Cobb, H.Conzelmann, M.Delgado, A.Delp, M.Drieschner, R.P.Feynman, H.G.Frankfurt, W.Glenn, Th.Görnitz, D.R.Griffin, R.Guardini, R.Habeck, J.Habermas, Ch.Hartshorne, St.Hawking, M.Heesch, M.Heidegger, W.Heisenberg, H.Himmler, O.Höffe, M.Hossenfelder, H.Jonas, A.I.Kang, I.Kant, H.Küng, D.Ch.Kwon, P.Lapide, H.Lenk, W.Lienemann, M.Luther, M.Lutz-Bachmann, M.Maring, J.Metz, K.M.Meyer-Abich, J.Moltmann, H.Mommsen, J.Nidda-Rümelin, R.Niebour, M.Niemöller, N.E.Thomas, W.Pannenberg, G.Picht, Platon, J.Polkinghorne, K.Popper, H.Poser, Ch.Rapp, J.Ratzinger, J.Rawls, N.Rescher, G.Ropohl, H.Schnädelbach, E.Schockenhoff, J.H.Strong, H.Schwarz, P.Teilhard de Chardin, H.Thielicke, P.Tillich, Th.Tracy, R.Warren, M.Weber, C.F.v.Weizsäcker, A.N.Whitehead, A.Zeilinger, Zweites Vatikanisches Konzil, Hingabeliebe, Anfang und Ende, Angewandte Wissenschaften, Künstliche Intelligenz (KI), Astronomie, Atombombe, Atomkern, Geschäfts-Betrieb, Kapitalismus, Kommunismus, Schöpfer-Gott, Kreativität, Schöpfung, Kritischer Realismus, Demokratie, Entwicklung, Erde, Ökonomie-Wirtschaft, Ökumene, Elektronen, Ingenieurs-Technik, Umwelt, Ethik, Evolution, Existentialismus, Finanzen, Ziele, Gott, Geistes-Geschichte, Heldentum, Humanismus, Menschenrechte, Idealismus, Handlungs-Absicht, Gerechtigkeit, Quran, AI, Päpstliche Enzyklika, Leben, Liebe, Migration, Moral und Sitte, Motivation, Natur-Wissenschaft, Nazi-Terror, Pflicht, Philosophie, Friede, Physik, Politik-Strategie, Politik-Prozessbereich, Politik-Ordnungsform, Wahrscheinlichkeit-Statistik, Prozess, Fortschritt, Vorsehung, Zweck, Quanten-Theorie, Qumran-Rollen, Religion, Zweites Vatikanisches Konzil, Wissenschaften, Schriftstellen, Nachhaltigkeit, Erhalter-Gott, Technologie, Theologie, Werte, Tugenden, Waffen-Rüstung, Welt-Krieg (un-gerecht). (1)
Agar Animals Cell Survival Cisplatin: PD, pharmacology *Colony-Forming Units Assay Freezing Mice Tissue Preservation *Tumor Cells, Cultured: DE, drug effects *Tumor Stem Cell Assay (1)
Agaricus; basidiolipids; glyco-inositol-phospho-ceramides; glycolipids; sphingolipids (1)
AGAT; fibrosis; mitochondriopathy; protein deposits; tubulopathy (1)
AGC1 DEFICIENCY; SLC25A13 GENE; MUTATIONS; CITRIN; MUSCLE; IDENTIFICATION; FREQUENCY; DIAGNOSIS; DISORDER; DISEASE; mitochondrial disease; epilepsy; hepatopathy; aspartate glutamate carrier 1 deficiency; AGC1; citrin deficiency; Citrullinemia; treatment; modified Atkins diet; serine (1)
aG-DRG system · Cost efficiency · Traumatology · Elective orthopaedics · Hip · Shoulder (1)
AGED 45 YEARS; KIDNEY-TRANSPLANTATION; SURVIVAL; EUROTRANSPLANT; MORTALITY; PATIENT; (1)
AGED 60 YEARS; ELDERLY-PATIENTS; COMPREHENSIVE ANALYSIS; BRENTUXIMAB VEDOTIN; RANDOMIZED-TRIAL; BLEOMYCIN; ABVD; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; COMBINATION; Hodgkin lymphoma; older; ABVD; IMID; lenalidomide (1)
AGE-DEPENDENT DIARRHEA; BRUSH-BORDER MEMBRANE; ION-TRANSPORT; NONSTRUCTURAL GLYCOPROTEIN; INTRACELLULAR CALCIUM; ELECTROLYTE TRANSPORT; ENTEROTOXIN; CHANNELS; VIRUS; EXPRESSION; Rotavirus; NSP4; Ca2+-activated Cl- channels; TMEM16A; ENaC; Epithelial Na+ channels; SGLT1; Colonic epithelium; Diarrhea (1)
AGE-DEPENDENT DIARRHEA; CYSTIC-FIBROSIS; MOUSE AIRWAYS; CHANNEL; CELLS; SECRETION; MEMBRANE; GLANDS; CA2+; HEPATOCYTES; (1)
aged; evidence map; lifestyle interventions; obesity (1)
AGED GREATER-THAN-OR-EQUAL-TO-40 YEARS; QUALITY-OF-CARE; UNITED-STATES; HEALTH INTERVIEW; POMERANIA SHIP; MACULAR EDEMA; KORA F4; RETINOPATHY; PREVALENCE; POPULATION; Diabetes; Diabetic retinopathy; Eye care; Ocular disease; Trends (1)
AGED HUMAN SKIN; HORMONE REPLACEMENT THERAPY; ULTRAVIOLET-B IRRADIATION; GREEN TEA POLYPHENOLS; IN-VIVO; INFRARED RADIATION; MITOCHONDRIAL-DNA; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; PHOTOAGED SKIN; extrinsic skin ageing; intrinsic skin ageing; matrix metalloproteinases; photoageing; retinoids; UV radiation (1)
aged; lifestyle interventions; network meta‐analysis; obesity; sarcopenic obesity (1)
AGE; Ivory; Dating; Age assessment; C-14; Sr-90; Th-228 (1)
agency costs; credit channel; hump-shaped uncertainty shocks; time-varying uncertainty. (1)
agency costs, credit channel, time-varying uncertainty (2)
agency costs; credit channel; time-varying uncertainty (1)
Agency costs, credit channel, time-varying uncertainty, residential investment, housing production, calibration (1)
AGENCY COSTS; DETERMINANTS; SPILLOVERS; GOVERNANCE; MODELS; FIRM; REITs; REOCs; conversion; agency conflicts (1)
AGENT; (1)
AGENT-BASED MODELS; LIFE TABLE MODEL; DYNAMICS; DIPTERA; FEVER; VALIDATION; CULICIDAE; PROTOCOL; INSECTS; ECOLOGY; Individual-based model; Agent-based model; Ecological model; Aedes aegypti mosquito; Multi-agent simulation; BG-Sentinel (1)
agentenbasierte Modellierung, Multiagentensystem, Einzelhandel, Simulation, Konsumentenverhalten, Prognose, Szenarien, Emergenz, strategische Standortplanung, Einzelhandel, E-Commerce, Modellierung, integrative Methode, Validierung, Verifizierung, Kalibrierung agent-based modeling, multi-agent system, retail, simulation, consumer behavior, forecasting, scenarios, emergence, strategic location planning, retail, e-commerce, modeling, integrative method, validation, verification, calibration (1)
AGENT; intraarterial MRI; MR angiography; MR-guided intervention (1)
AGE; Periodontitis; Physical activity; Etiology; Prevention (1)
AGE-RELATED-CHANGES; AUDITORY-EVOKED POTENTIALS; LATERAL SUPERIOR OLIVE; BRAIN-STEM RESPONSES; DEPENDENT CHANGES; MEDIAL NUCLEUS; TRAPEZOID BODY; GAP DETECTION; TEMPORAL ACUITY; FISCHER-344 RAT; Brain; Aging; Presbyacusis; Central hearing loss; GABA (1)
AGE-RELATED-CHANGES; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; PITUITARY-ADRENAL AXIS; BONE-MINERAL DENSITY; SULFATE DHEAS LEVELS; SEX-HORMONE STATUS; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; DEHYDROEPIANDROSTERONE-SULFATE; aging; cytokine; hormone; neurotransmitter; immune systems endocrine system; nervous system (1)
AGE-RELATED-CHANGES; DEPENDENT CALCIUM-CHANNELS; RAT-BRAIN; MERIONES-UNGUICULATUS; ANTIEPILEPTIC DRUGS; TEMPORAL ACUITY; AUDITORY-SYSTEM; ANIMAL-MODEL; HEARING-LOSS; TINNITUS; (1)
AGE-RELATED DECLINES; SPATIAL ABILITIES; SEX-DIFFERENCES; RIGHT HANDS; TRANSFORMATIONS; BODY; MEMORY; PERSPECTIVE; CHILDREN; TASK; Mental rotation; Motor; Performance; Gender difference; Balance ability; Older adults (1)
Age-related macular degeneration (AMD); Gene expression regulation, eQTL, TWAS (1)
; age-related macular degeneration; Anti-VEGF; choroidal neovascularization; intravitreal injection; Lucentis; Ranibizumab; spectral domain optical coherence tomography (1)
; age-related macular degeneration; bilateral diseases; maximum likelihood; measurement error; response misclassification (1)
age-related macular degeneration; diabetic retinopathy; choroid; neovascularization; ligand receptor interaction (1)
age-related macular degeneration, NRTN, Neurturin, AMD (1)
Age-related macular degeneration; Susceptibility; Logistic regression; Cox regression; Genetic risk score (1)
AGE-RELATED MACULOPATHY; GEOGRAPHIC ATROPHY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; CORTICAL REORGANIZATION; FIBER TRACTS; RISK-FACTORS; HUMAN BRAIN; PREVALENCE; CORTEX; Macular degeneration; Visual pathway; Visual field; Voxel-based morphometry (1)
AGE-RELATED MACULOPATHY; HORMONE REPLACEMENT THERAPY; CENTRAL SEROUS CHORIORETINOPATHY; MACULAR DEGENERATION; RISK-FACTORS; DRY EYE; AXIAL LENGTH; EARLY MENOPAUSE; SEX-HORMONES; PREVALENCE; Sex medicine; Gender difference; Sex hormones; Personalized medicine; Epidemiological differences (1)
agglomeration, displacement, thick labor markets (1)
Agglutination Cell Adhesion Dictyostelium/cytology/genetics/*physiology Fungi/cytology/genetics/*physiology Gels *Mutation Species Specificity (1)
AGG-Luxation, AC-Gelenksluxation, Acromioclaviculargelenks-Luxation, Schultereckgelenks-Sprengung, Trapezoideodeltoidalfaszie, Fasciendoppelung, Rockwood, Tossy, Kirschnerdraht, Constant-Score, Acj-luxation, Ac-joint-luxation, acromioclavicular joint luxation, acromioclavicular joint separation, acromioclavicular joint dislocation, fascia trapecoideodeltoidalis, doubling of the fascia trapecoideodeltoidalis, K-wire (1)
AGGREGATE GROWTH-MODELS; APPROXIMATION; Numerical methods; Gauss Seidel method; Projection methods; Real business cycles; Crash state (1)
AGGREGATION-INDUCED EMISSION; DOPED SOL-GEL; SURFACE-PLASMON RESONANCE; PHOTOINDUCED ELECTRON-TRANSFER; MESOPOROUS SILICA NANOPARTICLES; METAL-ORGANIC FRAMEWORKS; GRAPHENE QUANTUM DOTS; FLOW-INJECTION ANALYSIS; ISOELECTRIC POINT DETERMINATION; EVANESCENT-WAVE ABSORPTION; (1)
AGGREGATION-INDUCED EMISSION; LIGHT-EMITTING DEVICES; TRANSITION-METAL-COMPLEXES; DISCRETE ORGANOPLATINUM(II) METALLACYCLES; ORGANIC ELECTROLUMINESCENT DEVICES; IRIDIUM(III) COMPLEXES; EXCITED-STATES; DUAL EMISSION; HEAVY-ATOM; DIPLATINUM(II,II) COMPLEXES; (1)
Aggregation, Ion pair, intermolecular interactions, NMR spectroscopy, dimer, hydrogen bonds, DOSY, pyridinamide catalyst (1)
aggregation phenylphosphine chloride solubilization soly (1)
AGGREGATION SUBSTANCE; PLASMID TRANSFER; FAECALIS; HEMOLYSIN; INFECTIONS; CHEESE; ENDOCARDITIS; STRAINS; SYSTEM; MILK; (1)
Aggression , Angst , Ratte , Neuroendokrinologie , Emotionales Verhalten , Kampfverhalten , Kommunikationsverhalten , Verhaltenskontrolle , Resident-Intruder Test , abnormale Aggression , Wistar-Ratte , Vasopressin , Stress , aggression , anxiety , arginine-vasopressin , behaviour , neurobiology (1)
Aggression depressive disorders emotional reactivity self-harm trauma and stressor-related disorders (1)
aggression, electric fish, sound production, territory, vocalisation (1)
Aggression, Gewalt, Aggression und Psychiatrie, aggressive Patienten, Aggressionsprädiktoren, Epidemiologie von Aggression, aggression inpatient, epidemiology, aggressive behaviour in psychiatry, aggressive predictors (1)
AGGRESSION SCALE; VIEWING TIME; ATTRACTION; ASSOCIATION; RECIDIVISM; PREFERENCE; OFFENDERS; IMPLICIT; (1)
AGGRESSIVE-BEHAVIOR; EMOTIONAL BEHAVIOR; SOCIAL DEPRIVATION; ADULT-RATS; STRESS; MICE; RELEASE; BRAIN; COMMUNICATION; CONSEQUENCES; Corticosterone; Corticotropin-releasing hormone; Early life stress; HPA axis; Paraventricular nucleus; Social behavior; Vasopressin (1)
AGGRESSIVE-BEHAVIOR; PHYSIOLOGICAL AROUSAL; PROSOCIAL BEHAVIOR; STATE HOSTILITY; SELF-EFFICACY; PLAY; FLOW; FEELINGS; PERFORMANCE; ENJOYMENT; (1)
AGGRESSIVE-BEHAVIOR; UNIPOLAR DEPRESSION; BIPOLAR DISORDER; CARBAMAZEPINE; ATTACKS; TOLERABILITY; AGITATION; DEMENTIA; EFFICACY; QUALITY; depressive disorders; aggression; topiramate; ability testing; weight loss (1)
AGGRESSIVE MELANOMA PHENOTYPE; ANGIOGENESIS IN-VITRO; UROKINASE RECEPTOR; ENDOTHELIAL-CELLS; TUMOR-GROWTH; P-CADHERIN; EXPRESSION; PROTEIN; CANCER; PROLIFERATION; (1)
Aggressive Steuerplanung (1)
AGGRESSIVE VARIANTS; HISTOLOGIC SUBTYPES; CLASSIFICATION; PARAMETERS; PAPILLARY; FEATURES; UTILITY; KIDNEY; TUMORS; GRADE; Nephrectomy; Gender; Survival; Cox regression analysis; Tumor (1)
AGING-IN-PLACE; SOCIOECONOMIC-STATUS; ALCOHOL-CONSUMPTION; PEOPLE; SF-36; DISABILITY; LOCUS; MULTIMORBIDITY; QUESTIONNAIRE; IMPUTATION; Health-related quality of life; HRQOL; SF-36; Social factors; Older German adults; Multiple linear regression (1)
Aging, Nucleolus, Nuclear Architecutre (1)
AGING SURGEON; CARE; FEEDBACK; SEEKING; AGE; Increasing time of practice; Expertise; Life long learning; Deliberate practice; Emergency medicine (1)
Aglycons Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (anthocyanidins resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, and isoflavonoids) Drug metabolism Pharmacokinetics (resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, and isoflavonoids) Flavonoids Isoflavonoids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, an flavonoid proanthocyanidine isoflavonoid metab pharmacokinetics review (1)
AGNOGENIC MYELOID METAPLASIA; DONOR-LYMPHOCYTE INFUSION; IDIOPATHIC MYELOFIBROSIS; ESSENTIAL THROMBOCYTHEMIA; MYELOPROLIFERATIVE DISORDERS; PROGNOSTIC-FACTORS; GRUPPO-ITALIANO; MIDOLLO-OSSEO; GRAFT; MUTATION; (1)
AGNOGENIC MYELOID METAPLASIA; INTERNATIONAL-WORKING-GROUP; PROGNOSTIC SCORING SYSTEM; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC MYELOFIBROSIS; V617F MUTATION; DISEASE; (1)
AGNOGENIC MYELOID METAPLASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; EXTRAMEDULLARY HEMATOPOIESIS; MYELOPROLIFERATIVE-SYNDROME; IDIOPATHIC MYELOFIBROSIS; NATURAL HISTORY; BLOOD FLOW; PERITONEAL; MEGAKARYOCYTES; CIRCULATION; ascites; myelofibrosis; portal hypertension; portosystemic shunt (1)
AGNOGENIC MYELOID METAPLASIA; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC-FACTORS; SURVIVAL; LEUKEMIA; CRITERIA; SYSTEM; (1)
AGONIST-INDUCED DESENSITIZATION; PROTEIN-COUPLED RECEPTORS; RESTLESS LEGS SYNDROME; BETA-ARRESTIN; D-3 RECEPTORS; HIGH-AFFINITY; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MULTIPLE CLASSES; DRUG-ADDICTION; GPCR; dopamine D-2-like receptors; beta-arrestin; GRK; Emerald luciferase; functional assay (1)
AGONIST; RECEPTORS; H-1-RECEPTOR; PHARMACOLOGY; IMIDAZOLYLPROPYLGUANIDINES; ANALOGS; arpromidine; guanidines; histamine H-1 receptor; histamine H-2 receptor; impromicline (1)
AGONIST ZOLMITRIPTAN 311C90; HUMAN BLINK REFLEX; CENTRAL COMPONENT; DORSAL-HORN; BRAIN; PAIN; CAT; CONVERGENCE; MENINGEAL; HUMANS; (1)
Agrammatismus , Funktionelle NMR-Tomographie , Syntaktische Kongruenz , Motorisches Sprachzentrum , Morphometrie , Syntax , , developmental language impairment , fmri , syntax , semantics , Broca area (1)
AGRICULTURAL LANDSCAPE; POPULATION-SIZE; PLANT; FRAGMENTATION; SCROPHULARIACEAE; FITNESS; IMPACT; AFLP; FLOW; amplified fragment length polymorphism; Cape Floristic Region; Cape lowland; fynbos Biome; landscape genetics (1)
AGRI-ENVIRONMENT SCHEMES; LAND-USE CHANGE; BIODIVERSITY; GRASSLANDS; TRAITS; FLORA; CONSERVATION; STRATEGIES; VEGETATION; SERVICES; agri-environment schemes; butterflies; conservation; ecosystem processes; flowering plants; functional types (1)
AGRI-ENVIRONMENT SCHEMES; PLANT-SPECIES RICHNESS; CALCAREOUS GRASSLANDS; FIELD MARGINS; BIODIVERSITY; HABITAT; MANAGEMENT; HEDGEROWS; AGROECOSYSTEMS; HOVERFLIES; Field margins; Forest fringes; Hedges; Vineyards; Pits; Quarries; Education; Inventory; Protection; Restoration; Re-creation (1)
AGRILUS-PLANIPENNIS FAIRMAIRE; EMERALD ASH BORER; LARIOPHAGUS-DISTINGUENDUS; COURTSHIP BEHAVIOR; SOCIAL WASP; IDENTIFICATION; HYMENOPTERA; COLEOPTERA; COMPONENT; PTEROMALIDAE; courtship; parasitic wasp; arrestment; Hymenoptera; Pteromalidae; sexual communication; mate recognition cue; 3-methylalkanes (1)
Agrimonia eupatoria; Calcareous grasslands; Campanula rotundifolia; Genetic variation; Knautia arvensis; Recolonization; Restoration (1)
AG Systemlandschaft E-Ressourcen; Elektronische Zeitschriftenbibliothek (1)
A(H1N1) INFECTION; UNITED-STATES; VIRUS; CHILE; Seasonal influenza; Pandemic influenza A (H1N1); Post-pandemic season; Comorbidities; ICU admission (1)
A H1N1 VIRUS; RT-PCR; INFECTION; EMERGENCE; PANDEMICS; LNA; (1)
A H1N1 VIRUS; TIME PCR ASSAYS; RT-PCR; INFECTION; EMERGENCE; PANDEMICS; (1)
AHARONOV-BOHM CAGES; SPIN; CONDUCTION; PARTICLES; CURRENTS; LAYERS; WELLS; (1)
Aharonov-Bohm effect, Coulomb blockade, quantum dots, tunnelling (1)
Aharonov–Bohm effect; Coupled double dot; Cotunneling (1)
Aharonov-Bohm effect, Mesoscopic Physics, Spintronics (1)
AHARONOV-BOHM OSCILLATIONS; NONLINEAR CONDUCTANCE; FLUCTUATIONS; WIRES; RELAXATION; ENSEMBLE; SAMPLES; ENERGY; LOOPS (1)
AHARONOV-BOHM OSCILLATIONS; PERSISTENT CURRENTS; SINGLE; SHELL; LOOP; SPIN; DOT; (1)
AHARONOV-BOHM OSCILLATIONS; QUANTUM TRANSPORT; MESOSCOPIC RINGS; BERRYS PHASE; ORBIT INTERACTION; ELECTRONICS; SCATTERING; SPECTRUM; SYSTEMS; DEVICE; (1)
AHARONOV-BOHM OSCILLATIONS; TRANSPORT; SPIN; (1)
A. Heterojunctions; A. Nanostructures; D. Electron–electron interactions; E. Inelastic light scattering (1)
A. Heterojunctions; A. Surfaces and interfaces; D. Cyclotron resonance; D. Electron–electron interactions; E. Light absorption and reflection (1)
AIDS , Proteine , HIV , Virus , virus (1)
AIDS VIRUSES; MATRIX PROTEIN; HIV TYPE-1; IDENTIFICATION; SEQUENCES; THAILAND; VACCINES; GAG; PARTICLES; ISOLATE; (1)
AIHA, CD47, ITP (1)
AI KI generative KI Künstliche Intelligenz Große Sprachmodelle Large Language Models LLM Large Language Models ChatGPT GPT Evaluierung HELM LegalBench LexGPT Evaluation (1)
; AION; Ophthalmologic complication; Visual loss in dialysis; Visual loss in sepsis; Visual field defect (1)
AIR ABRASION; SURFACE-TREATMENT; CURED COMPOSITES; RESIN CEMENTS; ADHESIVE; EUGENOL; SYSTEMS; INLAYS; ENERGY; eugenol; temporary cement; sandblasting; shear bond strength; ceramic; dentin; excavator; resin based luting cement (1)
Airbus, Boeing, aircraft deliveries, nonmarket environment, political sale, subsidies (1)
Airbus; economic history; boeing; civil aviation; government support (1)
Air (CARS of, pure rotational); Temperature (detn. of, pure rotational CARS in); Raman spectra (CARS, of carbon monoxide); Spectrochemical analysis (Raman, coherent anti-Stokes, multiplex rotational); CARS nitrogen oxygen air; Raman nitrogen oxygen air; carbon monoxide CARS; analysis gas CARS; thermometry gas CARS (1)
AIR-CONDITIONED PHOTOTHERAPY; DOSE UVA1 PHOTOTHERAPY; HEALTH-STATE UTILITIES; WILLINGNESS-TO-PAY; OF-LIFE; DISEASE-ACTIVITY; SKIN DISEASES; PSORALEN PHOTOCHEMOTHERAPY; FLUTICASONE PROPIONATE; GREATLY IMPROVES; (1)
AIR-CONDITIONED PHOTOTHERAPY; ULTRAVIOLET-B; DEAD-SEA; SALT-SOLUTIONS; TASK-FORCE; PSORIASIS; ECZEMA; BATHS; IRRADIATION; VALIDATION; atopic dermatitis; balneophototherapy; Dead Sea salt; narrow-band UVB therapy; phototherapy; SCORAD; TOMESA (1)
Aircraft sales, civil aircraft procurement, colonial legacy, global south (1)
AIRE; Microsatellite instability; MicroRNA; SMARCA4; Myasthenia gravis; Immune checkpoint inhibitors (1)
; air medical service; night; interhospital transfer; helicopter (1)
; air medical service; night; primary mission; helicopter (1)
AIR-WATER-INTERFACE; 1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; MOLECULAR RECOGNITION; BASE-PAIRS; PHYSIOLOGICAL CONDITIONS; SUPRAMOLECULAR POLYMERS; POTENT PROMOTERS; DNA-REPLICATION; AQUEOUS-MEDIA; SDS MICELLES; hydrogen bonds; interfaces; macrocycles; nucleotides; self-assembly (1)
AIR-WATER-INTERFACE; DER-WAALS FORCES; VANDERWAALS FORCES; HYDROPHOBIC ATTRACTION; OPTICAL CAVITATION; DISPERSION FORCES; SOLVENT STRUCTURE; ION SPECIFICITY; LIFSHITZ THEORY; SALT-SOLUTIONS; Hofmeister effects; electrolytes; molecular interactions; hydrophobic interactions; dispersion forces (1)
AIR/WATER INTERFACE; LIQUID INTERFACE; BINDING; ELECTROLYTES; COALESCENCE; TENSION; BUBBLES; (1)
AIR/WATER INTERFACE; LIQUID INTERFACE; SURFACE-TENSION; ION ADSORPTION; COALESCENCE; WATER; SIMULATIONS; SOLVATION; DYNAMICS; BINDING; (1)
AIR-WATER-INTERFACE; MOLECULAR RECOGNITION; MICELLAR-SOLUTION; POTENT PROMOTERS; HYDROLYSIS; COMPLEXES; MODEL; PHOSPHATE; ARRAYS; DNA; (1)
AIR/WATER INTERFACE; ORNSTEIN-ZERNIKE; AQUEOUS-SOLUTION; SOLVATION; WATER; SIMULATIONS; IONS; ACETONITRILE; MIXTURES; ACETONE; solvation; ions; water (1)
AIR-WATER-INTERFACE; SELECTIVE RECOGNITION; MOLECULAR RECOGNITION; BASE-PAIRS; MULTISITE RECOGNITION; ZINC(II) COMPLEX; MONOLAYERS; ADENINE; MODEL; 1,4,7,10-TETRAAZACYCLODODECANE; base pairing cooperativity; macrocycles; nucleobases; self-assembly; thin films (1)
AIRWAY INFLAMMATION; EXPRESSION; ASSOCIATION; asthma; bronchitis; children; polymorphisms; wheezing (1)
AIRWAY RESPONSIVENESS; IMMUNOGLOBULIN-E; METHYLATION; PATHWAY; IL-6; SET; epigenetic; biomarker; methylation; asthma; FeNO; BDR; precision medicine (1)
AIRWAY SMOOTH-MUSCLE; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; POLYSPECIFIC CATION TRANSPORTERS; NONNEURONAL CHOLINERGIC SYSTEM; RECEPTORS MEDIATE STIMULATION; LUNG FIBROBLAST PROLIFERATION; MUCOCILIARY CLEARANCE; IPRATROPIUM BROMIDE; ANTICHOLINERGIC BRONCHODILATOR; Tiotropium; COPD; Mechanisms; Inflammation; Remodelling; Mucus; Cough (1)
AIRWAY SMOOTH-MUSCLE; SEVERE ASTHMA; TERM SAFETY; EFFICACY; COSTS; respiratory medicine (see thoracic medicine); asthma; bronchoscopy; chronic airways disease (1)
airways; TMEM16A; SLC26A9 (1)
AI transparency, Provenance, Provenance question, AI governance (1)
Ajuga salicifolia (ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (ionone ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (iridoid ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (phenylethyl ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) ionone iridoid phenylethanoid glycoside Ajuga (1)
AKI, incidence, consequences, renal recovery (1)
AKT EXPRESSION; BREAST-CANCER; TRANSCRIPTION FACTOR; PHOSPHORYLATED AKT; GASTRIC-CANCER; LUNG-CANCER; CARCINOMA; INVASION; TRANSLOCATION; TRANSLATION; Salivary gland cancer; AKT; mTOR; PI3K; S6rp; Prognosis (1)
Akupunktur, Opioide, LONTS, chronisches Schmerzsyndrom, Opioid-Langzeittherapie, RCT, Lebensqualität, Opioidreduktion, Schmerztoleranz, acupuncture, opioids, chronic pain syndrome, long-term opioid therapy, quality of life, opioid reduction, pain tolerance (1)
Akupunktur, Stress, Prüfungsangst, TSST (1)
akute körperliche Belastung, Monozytensubpopulationen, Metabolisches Syndrom (1)
Akute Lymphatische Leukämie, Glukokortikoide, 2-Desoxy-Glukose, VDAC1, Glykolyse, Tumormetabolismus, Apoptose (1)
Akute mesenteriale Ischämie, Darmnekrose, perkutane endovaskuläre Intervention, Stentrevaskularisierung (1)
Akute mesenteriale Ischämie, Darmresektion, Gefäßchirurgie, Herzinsuffizienz, Acetylsalicylsäure, acute mesenteric ischemia, intestinal resection, vascular surgery, myocardial insufficiency, acetylsalicylic acid (1)
Akute myeloische Leukämie, acute myeloid leukemia, all-trans retinoic acid, All-trans Retinsäure, ATRA, pioglitazone, Pioglitazon 5-azacitidin 5-Azacytidin (1)
Akute Myeloische Leukämie (AML), Tyrosinkinaseinhibitoren (TKIs), FLT3, FLT3-ITD, FLT3-TKD, Proteolysis targeting chimeras (PROTACs) (1)
akute Myokarditis, LGE, 18-Segmentmodell, kardiale MRT (1)
akute Nierenschädigung; Risiko; Biomarker; große chirurgische Eingriffe; Mortalität (1)
akute Pankreatitis, Low-T3-Syndrom, NTIS, Non-Thyroidal-Illness-Syndrome (1)
akute Pfortaderthrombose, PVT, TIPS, TIPSS, Thrombolyse, endovaskulär, radiologisch-interventionell (1)
Akuter Myokardinfarkt, TpTe, QT, Schlafapnoe (1)
Akute Vergiftung, Beatmungstherapie, deutsche internistische Intensivstation, Entwicklung der Intensivmedizin, internistische Intensivstation, Intoxikation, Pankreatitis, Reanimation, Scoring System, Sepsis, acute pancreatitis, antibiotic use, APACHE scoring system, catecholamine therapy, development of intensive care, intensive care unit, intoxication, kidney dialysis, length of stay, mechanical ventilation, mortality in intensive care units, outcome analysis, respiratory therapy, resuscitation, sepsis (1)
Akut nekrotisierende Pankreatitis, Adiponektin, Resistin (1)
Akypo, SAXS, SANS, Kleinwinkelstreuung, Small-angle scattering, Self-Assembly, Selbstorganisation, Alkyl Ether Carboxylate, Tenside, Surfactants, Phasendiagramm, Phase diagram, nematic phase, liquid crystals, Flüssigkristalle (1)
; alanine; chirality; conformation; diastereoselectivity; pyramidalization (1)
ALANINE RACEMASE GENE; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; ANTIMICROBIAL PEPTIDES; NUCLEOTIDE-SEQUENCE; CARRIER PROTEIN; DLT OPERON; BIOSYNTHESIS; CLONING; PEPTIDOGLYCAN; (1)
alanine scan, functional annotation of enzymes, haloacid dehalogenase superfamily, histidinol phosphate phosphatase (1)
ALASKENSIS ROHWER HYMENOPTERA; AIR OXIDATION-PRODUCT; MITE VARROA-JACOBSONI; NESTMATE DISCRIMINATION; CUTICULAR HYDROCARBONS; PHEROMONE COMPONENTS; KIN DISCRIMINATION; BEE; RECOGNITION; ONTOGENY; Apis mellifera; cuticular hydrocarbon; nestmate recognition; volatiles; Philanthus triangulum; kairomone; (Z)-11-eicosen-1-ol (1)
ALBANESE VARIETIES; ZERO-CYCLES; CHOW GROUP; 0-CYCLES; FIELD; algebraic geometry; K-theory (1)
Albert le Grand, Âme, Château, Évangile selon Saint Luc, Exégèse, Femme, Maître Eckhart, Marthe et Marie, Vie active, Vie contemplative (1)
Albert le Grand, Articulation des deux Testaments, Augustin, Baptême, Eckhart, Énonciation, Évangile de Jean, Figure, Identité, Jean Damascène, Médiation, Pierre Lombard, Prophète, Signe, Témoin, Théologie sacramentaire, Verbe/Verbe, Voix (1)
Albert le Grand, Michel Henry, vie, métaphysique, exégèse médiévale, philosophie médiévale, phénoménologie (1)
Albert the Great, Meister Eckhart, Gospel of John, Neoplatonism, Dynamic Unity (1)
Albrecht IV., Bayern, Dynastie, Politik, Heiraten, Kirchenpolitik, Hausbegriff, Wittelsbach, Habsburg, Maximilian I. (1)
Albrecht von Haller, Physikotheologie, Voltaire, Aufklärung, Atheismus, Physiologie, Embryologie, Präformationslehre, Charles Bonnet, physiology, embryology, preformation (1)
ALBUMIN-BILIRUBIN SCORE; HEPATOCELLULAR-CARCINOMA; MODEL; FAILURE; (1)
ALCALIGENES-EUTROPHUS; IMMOBILIZATION; BIOLUMINESCENCE; CONSTRUCTION; EXPRESSION; SENSOR; GENES; genetically engineered Alcaligenes eutrophus; bioluminescence; biosensor; optical fibers; heavy metal ions (1)
ALCOHOL-CONSUMPTION; CHILD PORNOGRAPHY; DECISION-MAKING; INTERNET; OFFENDERS; AROUSAL; INTENTIONS; MYOPIA; ABUSE; MODEL; (1)
ALCOHOL COPOLYMER ONYX; VASCULAR MALFORMATIONS; ENDOVASCULAR TREATMENT; ETHANOL EMBOLIZATION; VEIN; Venous intervention; Embolization/embolization/embolotherapy; Vascular malformations; Arteriovenous (1)
ALCOHOL-DEHYDROGENASE; ISOENZYME VARIATION; ALLOZYME DIVERSITY; MOLECULES; CONCERT; GENEA; Bromus; cytotaxonomy; morphological variation; isozyme diversity (1)
ALCOHOL DEPENDENCE; DRUG-ADDICTION; SOCIAL DEFEAT; PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM; RATS; RECEPTOR; ANXIETY; VASOPRESSIN; EXPRESSION; Anxiety; baclofen; CSC; ethanol; oxytocin; stress (1)
ALCOHOL DEPENDENCE; GENERAL-POPULATION; MEDIATION ANALYSIS; SOCIAL DISTANCE; ATTITUDES; DEPRESSION; BELIEFS; PEOPLE; SCHIZOPHRENIA; STEREOTYPES; Social stigma; Intervention study; Schizophrenia; Depression (1)
alcohol dependence, self-efficacy, probability of relapse (1)
Alcohol Dependence; Smoking; Recovery from Alcohol Dependence; (1)
Alcohol dependency, alcohol dependence, alcoholism, alcohol addiction, social factors, social circumstances, family factors, Alkoholabhängigkeit, soziale Einflussfaktoren, familiäre Einflussfaktoren (1)
ALCOHOL; HEALTH; INFECTION; REGRESSION; SANITIZER; PATIENT; IMPACT; RATES; POWER; RUB; behavioral change; hospital visitors; persuasion; hand hygiene; field experiment (1)
alcohol recidivism; liver transplantation (1)
Alcohols, Phase transitions, Potassium, Solution chemistry, Thermodynamic, properties (1)
ALCOHOL; TRAUMA; YOUTH; RISK; AGE; Prevention; P; A; R; T; Y program; Trauma; Youth (1)
ALDEHYDE OXIDASE ACTIVITY; ASCLEPIADACEAE PLANTS; GLYCOSIDES; CONSTITUENTS; GAGAMININE; WILFORDI (1)
ALDEHYDES; alkaloids; beta-carboline; chrysotricine; hydroborations (1)
aldehyde surfactant micellization (1)
ALDEHYDE TOSYLHYDRAZONES; GEM-DIFLUOROALKENES; C-F; BOND FORMATION; AZO ANIONS; TRIFLUOROMETHYLATION; ALKYLATION; ALKENES; DIFLUOROOLEFINATION; FUNCTIONALIZATION; (1)
ALDIMINES CYTOSTATIC ETHYLENEDIAMINES ETHYLENEDIAMINES CYTOSTATIC (1)
Aldol Reaction, Carbon Dioxide, Benzamidine, Regulated Catalysis (1)
Aldol reactions; Amino aldehydes; Donor-acceptor cyclopropanes; Felkin-Anh rule; Nucleophilic additions (1)
ALDOL REACTIONS; ETHER ENAMINES; NMR; ORGANOCATALYSIS; ACETONITRILE; CATALYSIS; ALDEHYDES; OXAZOLIDINONES; SELECTIVITY; BASICITY; aldol reaction; enamines; ion pairs; NMR spectroscopy; organocatalysis (1)
Aldosteron, Aldosteron-produzierendes Adenom, primärer Hyperaldosteronismus, Na+/K+-ATPase, Nebenniere (1)
Aldosteron , Cyclo-AMP , Genregulation , Renin-Angiotensin-System , Transforming Growth Factor , , aldosterone , cyclic- AMP , gene regulation , renin- angiotensin- system , transforming growth factor beta (1)
Aldosterone, adrenal gland, K2P, KCNK9 (1)
ALDOSTERONE-INDUCED PROTEIN; THICK ASCENDING LIMB; NA-CL COTRANSPORTER; BARTTERS-SYNDROME; MESSENGER-RNA; CHANNEL; KIDNEY; MUTATIONS; LOCALIZATION; EXPRESSION; chloride channel; gene transcription; kidney; salt diet; sodium balance (1)
ALDOSTERONE-PRODUCING ADENOMAS; ACUTE REGULATORY PROTEIN; SOMATIC MUTATIONS; GLOMERULOSA CELLS; SEVERE HYPERALDOSTERONISM; SARCOPLASMIC-RETICULUM; CHANNEL MUTATIONS; KCNJ5 MUTATIONS; ANGIOTENSIN-II; LOW-RENIN; (1)
ALDOSTERONE-PRODUCING ADENOMAS; HYPERTENSION; EXPRESSION; CELLS; (1)
ALDOSTERONE-PRODUCING ADENOMAS; KCNJ5 MUTATIONS; GENE-EXPRESSION; CHANNEL; PREVALENCE; ATP1A1; ACID; (1)
ALDOSTERONE-PRODUCING ADENOMAS; POTASSIUM CHANNEL; K+ CHANNEL; REMEDIABLE ALDOSTERONISM; ADRENAL-HYPERPLASIA; SELECTIVITY FILTER; ION SELECTIVITY; MOLECULAR-BASIS; HYPERTENSION; KCNJ5; (1)
Aldosteron, Primärer Hyperaldosteronismus, Task3, KCNJ5, adrenales Renin-Angiotensin-System, NCX-Transporter, Aldosteron-produzierendes Adenom (1)
Aldosteronrezeptorblockade, Aldosteron, Renin, Angiotensin, Eplerenon, Renin-Angiotensin-System, RAAS, ZDF-Ratte, Hyperaldosteronismus, Diabetes mellitus, diabetische Nephropathie (1)
Aldosteronsynthase-Knockout-Maus, Renin-Angiotensin-Aldosteron-System (1)
Alemtuzumab Mutliple Sklerose IFN-γ Immuntherapie Aktionsmechanismen, Autoantigen, Immunotherapy, mechanism of action, multiple sclerosis, alemtuzumab, autoantigen, T cell (1)
ALEXANDER POLYNOMIALS; L-2-ALEXANDER TORSION; REIDEMEISTER TORSION; INVARIANTS; APPROXIMATION; CONJECTURE; (1)
ALEXITHYMIA; SOMATIZATION; DEPRESSION; SCALE; (1)
Alfred Hegar, Gynäkologe, Rassenhygiene (1)
AlGaAs; Double layer 2DEG; Drag (1)
AlGaAs; Fractional quantum Hall effect; Drag; Nuclear spin (1)
AlGaAs/GaAs/AlAs; Heterostructures (1)
ALGA CHLAMYDOMONAS-REINHARDTII; BLUE-LIGHT RECEPTOR; SPECTROSCOPIC CHARACTERIZATION; FLUORESCENCE; RIBOFLAVIN; BEHAVIOR; DOMAIN; TRANSDUCTION; ABSORPTION; GROWTH; FMN; flavinmononucleotide; FAD; flavin-adeneine-dinucleotide; lumichrome; lumiflavin; formyllumiflavin; riboflavin; dihydroxymethyllumiflavin; lumiflavin-hydroxy-acetaldehyde; photo-degradation; absorption cross-section spectra; fluorescence quantum distributions; mass spectra (1)
ALGA CHLAMYDOMONAS-REINHARDTII; NONCODING RNAS; VOLVOX-CARTERI; MICRORNAS; EVOLUTION; BIOGENESIS; ELEGANS; ROLES; TOOL; Sequencing data; miRNA identification; RNA secondary structure; Chlamydomonas reinhardtii; Small RNA sequencing; Next generation sequencing (1)
ALGA HAEMATOCOCCUS-PLUVIALIS; RETINAL-BINDING POCKET; SENSORY RHODOPSIN-I; 9-METHYL GROUP; PHOTOELECTRIC RESPONSES; PHOTOPHOBIC RESPONSES; REINHARDTII MUTANT; FLAGELLATED ALGAE; ELECTRIC-CURRENTS; SIGNALING STATES; (1)
ALGAN/GAN SUPERLATTICES; GAN; HETEROSTRUCTURES; TRANSPORT; SEMICONDUCTORS; NUCLEATION; SAPPHIRE; QUALITY; LAYER; aluminium compounds; electrical conductivity; electroluminescence; electron holography; gallium compounds; Hall effect; hole density; hole mobility; III-V semiconductors; light emitting diodes; MOCVD; reflectometry; semiconductor heterojunctions; valence bands; vapour phase epitaxial growth; wide band gap semiconductors; X-ray diffraction; X-ray reflection (1)
ALGEBRA; ANTIRINGS; MATRICES; (1)
ALGEBRA; ANTIRINGS; MATRICES; Tropical algebra; Supertropical modules; Bilinear forms; Quadratic forms; Quadratic pairs; Supertropicalization; Varieties (1)
ALGEBRA; Fredholm property; non-smooth pseudodifferential operators (1)
ALGEBRAIC COBORDISM; LANDWEBER EXACTNESS; CHERN CLASSES; COHOMOLOGY; MODULES; SPECTRUM; (1)
; algebraic cycles; class field theory; arithmetic schemes (1)
ALGEBRAIC CYCLES; THEOREMS; FIELDS; higher zero-cycles; restriction map; n-torsion (1)
algebraic geometry, algebraic stacks, category theory, stable homotopy theory, comodules, local cohomology (1)
Algebraic Geometry, Arakelov Geometry, Volumes (1)
ALGEBRAIC-GEOMETRY; EQUIVARIANT; COHOMOLOGY; SPECTRUM; MODULES; SUPPORT (1)
algebraic geometry, resolution of singularities, blow-up, ridge, directrix (1)
ALGEBRAIC K-THEORY; A(1)-HOMOTOPY THEORY; WEIL TRANSFER; OPERATIONS; COBORDISM; SPECTRA; DESCENT; OBJECTS; SLICES (1)
ALGEBRAIC K-THEORY; COBORDISM CATEGORY; MODEL; (1)
ALGEBRAIC K-THEORY; COHOMOLOGY; VARIETIES; FIELDS; TORSION; (1)
ALGEBRAIC K-THEORY; ELLIPTIC-CURVES; RINGS; CONJECTURE; OPERATIONS; etale cohomology; motivic cohomology; non-commutative Iwasawa-theory (1)
ALGEBRAIC K-THEORY; INFINITY-CATEGORIES; SPACE; Beilinson regulator; K-theory; Absolute Hodge cohomology; Ring spectra; Motivic homotopy theory (1)
ALGEBRAIC K-THEORY; MAP; (1)
ALGEBRAIC K-THEORY; QUASI-CATEGORIES; THEOREM; THOMASON; Waldhausen K-theory; Additivity; Quasicategory; Joyal model structure; Natural pushout functor (1)
ALGEBRAIC K-THEORY; RING SPECTRA; COHOMOLOGY THEORIES; MODULI; (1)
ALGEBRAIC K-THEORY; SPECTRAL ASYMMETRY; HOMOLOGY; Regulators; differential cohomology; algebraic K-theory of smooth functions; Connes-Karoubi character (1)
ALGEBRAIC K-THEORY; TOPOLOGICAL CYCLIC HOMOLOGY; STABLE-HOMOTOPY GROUPS; SYMMETRIC SPECTRA; ZETA-FUNCTIONS; LOOP SPACE; REPRESENTATIONS; NILPOTENCY; OPERATIONS; F-1; K-theory; G-theory; Monoids; lambda-rings; F-1-algebras; Stable homotopy groups; Equivariant sphere spectrum; Assembly maps; Whitehead groups (1)
Algebraic quantum field theory, fermionic signature operator, quantum field theory on curved spacetimes, mathematical physics, Dirac operator (1)
algebraic topology, stable equivariant homotopy theory, homotopy limit spectral sequence, vanishing line, group cohomology (1)
algebraische Geometrie, formale Schemata, Algebraizität, formale Keime (1)
Algebraische Geometrie , Kristalline Kohomologie , , algebraic geometry , crystalline cohomology (1)
ALGEBRAS; BOUNDEDNESS; SPACES; Non-smooth pseudodifferential operators; Fredholm index; spectral invariance (1)
ALGEBRAS; MODULES; COHOMOLOGY; (1)
Alginate Antimicrobial agent Interpenetrating polymer network hydrogel pH-modifying hydrogel Stem cell Wound dressing (1)
alginate, biomaterial, bioprinting, central nervous system, neural tissue engineering,regenerative medicine, spinal cord injury (1)
alginate; cell scaffold; chitosan; chronic wound; human skin construct; hydrogel; interpenetrating polymer network; pH value; poly(ethylene glycol); wound dressing (1)
ALGINATE IMPRESSIONS; DENTAL CASTS; TOOTH-SIZE; RELIABILITY; REPRODUCIBILITY; VALIDITY; PLASTER; Orthodontics; Retrospective studies; Digital model analysis; Cone-beam computed tomography; Method reliability (1)
Alginat, Hyaluronsäure, Adhäsionsprophylaxe, alginate, hyaluronic acid, adhesion prevention (1)
ALGORITHM; (3)
ALGORITHM; combinatorial optimization; Monte Carlo; threshold accepting; global optimization; Traveling Salesman Problem; Vehicle Routing Problem; network optimization (1)
Algorithm; Conical intersection; Curve crossing model; Potential energy surface; Transition state structure (gradient projection method for constraint optimization and relaxed energy paths on conical intersection spaces and potential energy surfaces); gradient projection method constraint optimization conical intersection potential surface (1)
Algorithm; Curve crossing model; Electronic state; Electronic transition; Ground state; MCSCF; Photochemistry; Photolysis; Potential energy surface (locating conical intersections relevant to photochem. reactions); locating conical intersection photochem reaction (1)
ALGORITHM; Emergency medical services; Airway management; Hemorrhage; Education; Amberg-Schwandorf algorithm for initial triage (1)
Algorithm (for response functions and susceptibilities for multiresonant nonlinear optical spectroscopy) Spectrometry Ultraviolet and visible spectrometry (nonlinear, response functions in susceptibilities for multiresonant) Optical nonlinear property (spectroscopy, response functions and susceptibility for multiresonant) Mathematics Quantum chemistry (perturbation theory, for response functions and susceptibilities for multiresonant nonlinear optical spectroscopy) perturbation theory multiresonant nonlinear optical spectroscopy (1)
ALGORITHM; optimization; Monte Carlo; production planning; scheduling; assembly line; supply chain management; enterprise resource planning; advanced planning and scheduling (1)
Algorithms Amino Acid Sequence Carrier Proteins/*chemistry/metabolism Computers Flavodoxin/metabolism Molecular Sequence Data NAD/metabolism Protein Conformation *Protein Engineering Proteins/*chemistry/metabolism Support, Non-U.S. Gov't (1)
Algorithms and Theoretical Developments, Lattice QCD, Lattice Quantum Field Theory (1)
"Algorithms", "Artificial Intelligence", "Computer Simulation", "Gene Expression Profiling", "Models, Biological", "Multigene Family", "Oligonucleotide Array Sequence Analysis", "Pattern Recognition, Automated", "Software" (1)
Algorithms Bacillus subtilis/genetics Base Composition DNA Repair/*genetics DNA Replication/genetics DNA, Bacterial/chemistry/*genetics Escherichia coli/*genetics Genome, Bacterial Markov Chains Mutation/genetics Repetitive Sequences, Nucleic Acid/*genetics Site-Specific DNA Methyltransferase (Cytosine-Specific)/genetics Support, Non-U.S. Gov't (1)
Algorithms Codon, Initiator/genetics Databases, Genetic Escherichia coli/genetics Genes, Bacterial *Genetic Techniques Genomics/statistics & numerical data Research Support, Non-U.S. Gov't Salmonella typhimurium/genetics *Software (1)
Algorithms Design Experimentation Languages Security business activity monitoring complex event processing discriminant analysis event driven architecture fraud detection service oriented computing neural network (1)
ALGORITHMS; DIAGNOSIS; Deep learning; Melanoma; Skin cancer; Artificial intelligence (1)
ALGORITHMS; DIAGNOSIS; Melanoma; Skin cancer; Artificial intelligence (1)
ALGORITHM; SIGNAL; Empirical mode decomposition; Green's function; Discrete cosine transform; Face recognition; Face verification; k-NN; SVM; Filters (1)
ALGORITHMS; metaheuristics; scatter search; capacitated clustering problems; capacitated p-median problems (1)
ALGORITHMS; Triage; Mass casualty incidents; Emergency medical services; Simulation; Training (1)
Aligner, Finite-Elemente-Methode, Kräfte, Momente, Biokompatibilität (1)
ALIGNMENT; OUTCOMES; knee arthroplasty; unicompartmental; navigation; pinless (1)
ALIGNMENT RODS; KNEE; ROTATION; PLANE; TIBIA; AXIS; long-leg radiographs; weight-bearing; mMPTA; mLDFA; mLPFA; mLDTA; rotation; rotational error; limb alignment; deformity (1)
ALIGNMENT; SURGERY; SYSTEM; ACCURACY; Total knee arthroplasty; Alignment; Navigation; CAS; Pinless; TKA (1)
ALIPHATIC EPOXIDES; IN-VITRO; HYDROCARBONS; GENOTOXICITY; METABOLITES; DERIVATIVES; HYDROLASES; CHEMICALS; ALDEHYDES; VIVO; epoxide; silorane; mutagenicity; Ames test; Salmonella typhimurium (1)
ALKALI-HALIDES; MAIN GROUP; AG; COMPLEXES; CHEMISTRY; electronic spectra; luminescence; charge transfer; silver complexes; rhenium complexes (1)
ALKALI-HALIDE SURFACES; QUARTZ TUNING FORK; NACL(100) SURFACE; WATER-ADSORPTION; HYDRATION FORCES; CANTILEVERS; SENSOR; MODE; LIQUID; VACUUM; (1)
alkali metal | auride | DFT | thallium | X-ray (1)
Alkali metal-bis(trimethylsilyl) phosphides; iso-tetraphosphines; (PP)-bond formation (1)
Alkali metal-bis(trimethylsilyl)phosphides; iso-tetraphosphines; (PP) bond formation (1)
Alkali metal bis(trimethylsilyl)phosphides; tris(trimethylsilyl)phosphine; syntheses; NMR investigation (1)
ALKALI-METAL COMPLEXES; STABILITY-CONSTANTS; LITHIUM PERCHLORATE; NONAQUEOUS SOLVENTS; ION COMPLEXES; CROWN-ETHERS; CONDUCTANCE; ACETONITRILE; MIXTURES; BENZO-15-CROWN-5; formation constants; stilbene crown ethers; conductometric titration; alkali metal cations; silver cation; nitromethane (1)
; Alkali metal; Hydrogen bonds; Crystal structure (1)
ALKALIMETALLE ZU HALBMETALLEN; CRYSTAL-STRUCTURE; DAS VERHALTEN; TETRAHEDRO-TETRASTANNIDE; LIQUID-AMMONIA; ANIONS; REFINEMENT; TETRASILICIDE; SN-4(4-); CLUSTERS; Zintl compounds; liquid ammonia; crystal structure (1)
ALKALIMETALLE ZU HALBMETALLEN; DAS VERHALTEN; METAL; ANNOUNCEMENT; ALLOYS; PHASES; Zintl anions; Intermetallic phases; Liquid ammonia; Cage compounds; Tetrels (1)
ALKALIMETALLE ZU HALBMETALLEN; QUANTUM-MECHANICAL CALCULATIONS; LIQUID-AMMONIA; ZINTL CLUSTERS; DAS VERHALTEN; SOLUTION CHEMISTRY; ELEMENTS; ANIONS; REFINEMENT; RB; Silicon; X-ray diffration; Zintl anions; Liquid ammonia (1)
Alkalimetallthallide, Zintl, Intermetalle, Ammoniak, DFT (1)
alkali metals · carbonyl metalates · Ellis-carbonylates · liquid ammonia · transition metals (1)
Alkali metals; Cesium; Crystal structure; Energy; Potassium (1)
Alkali metals,Cluster chemistry,Crystal structure,Metal clusters,Potassium (1)
Alkali metals, Cluster chemistry, Indium, Intermetallics, Metal clusters (1)
alkali metals • DFT • DSC • NMR spectroscopy • thallium • X-ray diffraction • Zintl phases (1)
ALKALI-METALS; ZINTL PHASE; CHEMISTRY; CLUSTERS; WORK; Thallium; X-Ray structure; alkali metals; single crystals; large x-ray absorption coefficient (1)
ALKALINE-EARTH FLUORIDES; FAST-ION CONDUCTION; ELECTRONIC-STRUCTURE; MOLECULAR-DYNAMICS; CALCIUM-FLUORIDE; TEMPERATURE-DEPENDENCE; SUPERIONIC CONDUCTORS; PERTURBATION-THEORY; OPTICAL-PROPERTIES; ELASTIC-CONSTANTS; (1)
ALKALINE-EARTH FLUORIDES; PRESSURE; SILICON; SOLIDS; SRF2; (1)
ALKALINE-PHOSPHATASE ACTIVITY; MATRIX METALLOPROTEINASES; OSTEOCLAST FORMATION; TISSUE; COMPRESSION; TENSION; CELLS; PDL; INTERLEUKIN-6; RESORPTION; Osteoclasts; Interleukin 6; Vascular endothelial growth factor A; Cell culture techniques; Bone remodeling (1)
ALKALINE-PHOSPHATASE; GENE-EXPRESSION; IN-VITRO; (1)
ALKALOIDS; Corydalis platycarpa; Corydalis ochotensis var. raddeana; Fumariaceae; cell cultures; biotransformation; LC-MS; LC-NMR; secondary metabolism; protoberberine alkaloids (1)
; alkaloids; vincetene; absolute configuration; ozonolysis; 1,2-propanediyl dibenzoate; chiral resolution (1)
ALKAPTONURIA; ochronosis; alkaptonuria; secondary gonarthrosis; knee (1)
Alkene-bromoarene coupling, palladium-catalyzed, Heck-type; [2.2]Paracyclophanes, tetrastyryl-substituted; 1,4-Distyrylbenzene chromphors, double-layered (1)
Alkene Difunctionalization, Photocatalysis, Continuous Flow, Multicomponent Processes (1)
alkenes alkynylboronates cobalt cycloaddition diene ligands (1)
Alkenes · Cobalt · Homogenous Catalysis · Hydrogenation · Ion Pairing (1)
ALKENES; NITROGEN; AMINOBROMINATION; AMINES; AMINOHALOGENATION; AMINOCHLORINATION (1)
Alkoholabhängigkeit, qualifizierte Entzugsbehandlung, Langzeitstudien, Katamnese, Rück-fallprävention (1)
Alkohol, Ethanol, Lipide, Steatosis, Steatohepatitis, CYP2E1, Autophagie (1)
Alkohol, Nikotin, Illegale Drogen, Abhängigkeit, ADHS, alcohol, nicotine, illegal drugs, addiction, ADHD (1)
ALKYL AMINO CARBENES; MAIN-GROUP; HETEROCYCLIC CARBENES; WHITE PHOSPHORUS; P-4; ACTIVATION; ELEMENTS; ASP3; AS-4; COMPLEXES; CAAC; interpnictogen compound; polyarsenic compounds; yellow arsenic (1)
alkylation; boron; phosphanylboranes; phosphonium salts; phosphorus (1)
ALKYLATION; COMPLEX; (1)
ALKYLATION; FUNCTIONALIZATION; ACIDITIES; ALKENES; (1)
alkylcarboxylate sodium laurate bilayer vesicle selfassembly pH cytotoxicity topical (1)
ALKYL CHAIN-LENGTH; SURFACE-TENSION; THERMOPHYSICAL PROPERTIES; PHYSICOCHEMICAL PROPERTIES; 1-ETHYL-3-METHYLIMIDAZOLIUM ACETATE; ELECTROLYTIC CONDUCTIVITY; TEMPERATURE-DEPENDENCE; HEAT-CAPACITIES; CARBON-DIOXIDE; 1-HEXYL-3-METHYLIMIDAZOLIUM; (1)
alkyl ether carboxylic acid; bicelle; lyotropic nematic phase; nematic gel; small-angle scattering (1)
Alkylierungen; Halbleiter; Organokatalyse; Photokatalyse; Sichtbares Licht (1)
ALKYLTRIMETHYLAMMONIUM BROMIDE MICELLES; ANGLE NEUTRON-SCATTERING; ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; CHAIN-LENGTH; WATER; COUNTERION; DODECYLTRIMETHYLAMMONIUM; COMPRESSIBILITY; SPECTROSCOPY; (1)
ALKYNE COMPLEXES; PHOTOCHEMICAL PROPERTIES; MOLECULAR DESIGN; COPPER; D10; electronic spectra; luminescence; charge transfer; photochemistry; copper complexes; acetylene complexes (1)
alkynes; cycloaddition; intermediates; P ligands; tungsten (1)
alkynes; cycloadditions; heterocycles; polycycles; transition metals (1)
ALKYNYLPLATINUM(II) TERPYRIDYL COMPLEXES; INFRARED NIR EMISSION; INTRAMOLECULAR EXCIMER; CYCLOMETALATED PLATINUM(II); PHASE-TRANSITIONS; PHOSPHORESCENCE EMISSION; ELECTRONIC SPECTROSCOPY; 2ND-HARMONIC GENERATION; IRIDIUM(III) COMPLEXES; LUMINESCENT PROPERTIES; (1)
ALL-CAUSE MORTALITY; AGED 40-64 YEARS; FOLLOW-UP; MIDDLE-AGE; PROSPECTIVE COHORT; US ADULTS; OLD-AGE; INDEX; OVERWEIGHT; MEN; body mass index; body weight; mortality; obesity; weight gain; weight loss (1)
ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; UNITED-STATES; SITTING TIME; OLDER-ADULTS; US ADULTS; EXERCISE; BEHAVIORS; RISK; HEALTH; PHYSICAL ACTIVITY; SEDENTARY BEHAVIOR; ACCELEROMETRY; ISOTEMPORAL SUBSTITUTION; MORTALITY (1)
ALL-CAUSE MORTALITY; HEALTH; DISEASE; alcohol; burden of disease; beneficial effect; risk factor; global; methodology; average consumption; patterns of drinking (1)
ALL-CAUSE MORTALITY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; VENTRICULAR ASSIST DEVICES; COGNITIVE-BEHAVIORAL THERAPY; PALLIATIVE CARE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; DEPRESSIVE SYMPTOMS; DISEASE MANAGEMENT; ANTIDEPRESSANT USE; Heart failure; Psychological Factors; Depression; Anxiety; Palliative Care; Review; Risk Factors; Psychosocial (1)
ALL-CAUSE MORTALITY; OBJECTIVE SLEEP; FOLLOW-UP; WOMEN; APNEA; INSOMNIA; DISEASE; MEN; COMMUNITY; HEALTH; Heart failure; Prognosis; Sleep duration; Sleep efficiency; Sleep-disordered breathing; Mortality (1)
ALL-CAUSE MORTALITY; PERIOPERATIVE MORTALITY; COMORBIDITY INDEXES; PROGNOSTIC-FACTOR; AGE; CLASSIFICATION; DEPLETION; OUTCOMES; COHORT; Frailty; Skeletal muscle mass; Bladder cancer; Prognosis; Urinary bladder neoplasm (1)
ALL-CAUSE MORTALITY; RETIRED-PERSONS DIET; PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; 10-YEAR MORTALITY; AMERICAN-ASSOCIATION; NATIONAL-INSTITUTES; METABOLIC SYNDROME; SMOKING-CESSATION; Waist circumference; Physical activity; Smoking; Diet; Lifestyle; Mortality (1)
ALL-CERAMIC CROWNS; DENTAL RESTORATIONS; FLEXURAL STRENGTH; BITE FORCE; CEMENTS; SURFACE; PERFORMANCE; FAILURE; TEMPERATURE; RELIABILITY; Implant; Zirconia; Cement; Fracture resistance; Marginal adaptation; Chipping; e-modulus; Stiffness (1)
ALL-CERAMIC CROWNS; LITHIUM-DISILICATE CROWNS; FIXED-PARTIAL DENTURES; CLINICAL-EVALUATION; LABORATORY SIMULATION; LUTING AGENTS; SYSTEMS; MICROLEAKAGE; RESIN; FATIGUE; Cementation; Crown; Ceramics; Zirconia-reinforced lithium silicate; Marginal adaptation; Fracture resistance (1)
ALL-CERAMIC CROWNS; OF-THE-LITERATURE; FIBER-REINFORCED COMPOSITE; ROOT-CANAL TREATMENT; CORE BUILD-UPS; IN-VITRO; DENTAL PROSTHESES; LOAD CAPABILITY; COMPLICATION RATES; CHEWING SIMULATION; All ceramic; chewing simulation; dowel; post and core technique (1)
ALL-CERAMIC RESTORATIONS; CORTICAL BONE THICKNESS; FRACTURE-RESISTANCE; DENTAL IMPLANTS; ORAL IMPLANTS; LABORATORY SIMULATION; TITANIUM; ABUTMENTS; STRENGTH; CROWNS; Implant; Zirconia; One-piece; Two-piece; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; CORTICAL BONE THICKNESS; FRACTURE-RESISTANCE; SINGLE-TOOTH; DENTAL IMPLANT; ORAL IMPLANTS; LABORATORY SIMULATION; STRESS-DISTRIBUTION; TITANIUM IMPLANTS; FINITE-ELEMENT; Zirconia implant; Two-piece implant; Abutment; Ceramic; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; FRACTURE-RESISTANCE; SINGLE-TOOTH; LABORATORY SIMULATION; IMPLANT ABUTMENTS; DENTAL IMPLANTS; STRENGTH; SURFACES; VIVO; CONNECTIONS; Implant; Abutment; Zirconia; Titanium; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; PARTIAL DENTURES; VENEERING CERAMICS; MATERIALS DESIGN; PART II; CROWNS; STRENGTH; FAILURE; FRACTOGRAPHY; MASTICATION; Fixed dental prostheses; Zirconia; Fabrication; Milling (1)
Alle Module, Provenance Management (1)
Allen-Cahn system, parabolic obstacle problems, linear elas- ticity, mathematical programs with complementarity constraints, opti- mality conditions, Trust-Region-Newton method (1)
Allen-Cahn system, parabolic obstacle problems, MPECs, mathematical programs with complementarity constraints, optimality conditions. (1)
Allen-Cahn systems, non-local constraints, variational inequality, vector-valued obstacle problems, primal-dual active set method, semi-smooth Newton method (1)
ALLERGIC AIRWAY INFLAMMATION; C-KIT EXPRESSION; FC-EPSILON-RI; W-SH; MICE; DEFICIENT; RESPONSES; LOCUS; MODEL; MOUSE; (1)
ALLERGIC AIRWAY INFLAMMATION; GLYCOSAMINOGLYCAN-BINDING; CHEMOKINE RECEPTORS; HEPARAN-SULFATE; IN-VIVO; OLIGOMERIZATION; ASTHMA; RANTES; EOSINOPHILS; RECRUITMENT; allergy; chemokine; leukocytes; glycosaminoglycan (1)
ALLERGIC CONTACT-DERMATITIS; DELAYED-HYPERSENSITIVITY; COMPLICATIONS; PIGMENTS; SARCOIDOSIS; RADIATION; LASER; INKS; Adverse tattoo reactions; Hypersensitivity; Azo pigment; Analytical chemistry; Histology (1)
ALLERGIC REACTIONS; CORTICOSTEROIDS; HYDROCORTISONE; BRONCHOSPASM; THERAPY; (1)
Allergisches Asthma , SNP , Immunglobulin E , Eosinophilie , Fallstudie , Immungenetik , Assoziationsstudie , STAT6 , Chromosom 12q , IGF1 , LTA4H , allergic asthma , SNP , association study , chromosome 12q (1)
ALLERGY; immunohistochemistry; steel implant; titanium implant (1)
Allgemeine Didaktik , Computerunterstütztes Lernen , Systemadministration , Didaktik , Unix , Virtuelles Unix Labor , System administration , education , Unix , Virtual Unix Lab (1)
Allgemeine Relativitätstheorie , Schwarzschild-Metrik , Wellengleichung , , general Relativity , Schwarzschild-geometry , wave Equation (1)
Allgemeines Gleichgewichtsmodell , Außenhandel , Unvollständige Konkurrenz, , (1)
allgemeines Persönlichkeitsrecht, Fußball, Fußballspieler, Verfassungsrecht, Verfassung, Grundgesetz, Manssen (1)
allgemeines Verwaltungsrecht, Verwaltungsrecht, UTB-Basics, Manssen (1)
Allianz-Studie; DeepGreen; EZB; Finanzierungsperspektiven; Informationsversorgung; Infra Wiss Blogs; Nachhaltige Finanzierung; Open-Access-Infrastrukturen; Open-Access-Monitor; Partizipatives Format; Projekt- vs. Dauerfinanzierung; SCOSS (1)
allocation probability, inference, nonmyopic, power, testing for superiority (1)
ALLOGENEIC BLOOD-TRANSFUSION; CARDIAC-SURGERY; FAT REMOVAL; INTRAOPERATIVE AUTOTRANSFUSION; QUALITY-ASSURANCE; TOTAL HIP; METAANALYSIS; CANCER; SAVER; EFFICACY; Autologous blood transfusion; Harvesting; Production; Retransfusion; Hemotherapy guidelines (1)
ALLOGENEIC BONE-MARROW; TUMOR-IMMUNOTHERAPY; VIVO PERSISTENCE; LYMPHOCYTES; REGRESSION; CLONES; CANCER; DONOR; INTERLEUKIN-2; SURVIVAL; (1)
Allogeneic hematopoietic stem cell transplantation, Bone marrow transplantation, Chronic graft-versus-host disease, Central nervous system, Diagnosis criteria (1)
Allogeneic hematopoietic stem cell transplantation, Bone marrow transplantation, Chronic graft-versus-host disease, Immunosuppressive therapy, Steroids, Ruxolitinib, Belumosudil (1)
Allogeneic hematopoietic stem cell transplantation . Chronic graft-versus-host disease . Tocilizumab . Interleukin-6 (1)
allogeneic hematopoietic stem cell transplantation; graft-versus-host disease; CD4+CD25+FOXP3+; regulatory T-cells; FOXP3; homing receptor profile; migration; all-trans retinoic acid; polyclonal expansion; skin-homing receptor; gut-homing receptor; isolation and expansion of regulatory t-cells; allogene hämatopoetische Stammzelltransplantation; Graft-versus-Host Erkrankung; regulatorische T-Zellen; zelluläre Migration; CD45RA ;Homingrezeptorprofil; Hauthomingrezeptoren; gastrointestinale Homingrezeptoren; polyklonale Stimulation; all-trans Retinsäure; Isolation und polyklonalen Expansion; CLA; CCR4; CCR10; CD103; CCR9; CD49d; alpha4beta7 integrin; α4β7 (1)
; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Comorbidity; Nutritional treatment; Quality of life (1)
Allogeneic-hematopoietic stem cell transplantation · Secondary solid malignancies · Graft-versus-host disease · Chemotherapy-only conditioning · Acute myeloid leukemia (1)
allogeneic stem cell transplantation, Burkit leukemia, R-DHAP, relapse, salvage therapy (1)
allogeneic stem cell transplantation, Graft vs Host Disease, pathophysiology, Treatment, innate immunity and responses, Adaptive Immunity (1)
Allogeneic stem cell transplantation – GvHD – Microbiome – Receptors of innate immunity – Intestinal immune regulation – Antimicrobial peptides (1)
Allogeneic stem cell transplantation; GvHD; Microbiome; Receptors of innate immunity; Intestinal immuneregulation; Antimicrobial peptides (1)
ALLOGENEIC TRANSPLANTATION; SELECTIVE DEPLETION; MEMORY; LYMPHOCYTES; IMMUNOTHERAPY; STIMULATION; CD4(+); CTL; CD45RA; naive; memory; T cells; alloreactivity; GVHD (1)
allogene Knochenmarktransplantation, graft-versus-host disease (GvHD), xenogene GvHD, CD4+CD25+ regulatorische T-Zellen (1)
Allogene Knochenmarktransplantation, Spender-gegen-Wirt-Reaktion, B-Zell-Rekonstitution, CD4+CD25+ regulatorische T-Zellen, Immunregulation, allogeneic bone marrow transplantation, graft-versus-host-disease, B cell reconstitution, CD4+CD25+ regulatory T cells, immune regulation (1)
allogene PBSCT, ICU, GvHD, allogeneic PBSCT (1)
Allogene Stammzelltransplantation, Myelofibrose, graft failure, engraftment (1)
Allogene SZT, GVHD, B-Zell-Rekonstitution, CLP, FoxP3 DTR, Treg-Ablation, GVL-Effekt, B-Zell-Lymphom, anti-Stroma; allogenic SCT, B-cell reconstitution, GVL, B-cell lymphoma (1)
allogenic, autologous, serum eye drops, validation (1)
Allogenic stem cell transplantation, Continuous medical education, Semi-structured interviews, Qualitative research, Physician training (1)
ALLOGRAFT NEPHROPATHY; RENAL PERFUSION; BLOOD-FLOW; ULTRASONOGRAPHY; MICROCIRCULATION; QUANTIFICATION; SONOGRAPHY; SURVIVAL; IMPACT; CEUS; TIC-analysis; ROI; region of interest; CEUS; contrast-enhanced ultrasound; kidney transplantation; perfusion analysis (1)
allograft rejection, biopsies, kidney transplantation, metabolomics, urine test (1)
ALLOGRAFT-REJECTION; CELL RECEPTOR; ANTIBODY; SUPPRESSION; MOLECULES; gene transfer; immunosuppression; presensitization; soluble donor MHC class I (1)
ALLOGRAFT-REJECTION; ORGANIZING PNEUMONIA; PULMONARY ALLOGRAFT; TOLERANCE; RECIPIENTS; DAMAGE; bronchiolitis obliterans; histopathology; pulmonary allograft rejection; rat lung transplantation (1)
ALLOGRAFT-REJECTION; REDUCES ATHEROSCLEROSIS; CHEMOKINE RECEPTORS; DEFICIENT MICE; EXPRESSION; INVOLVEMENT; SURVIVAL; ABSENCE; RANTES; RATS; (1)
ALLOGRAFT-REJECTION; SDZ-RAD; CYCLOSPORINE; RECIPIENTS; MODELS; PROLIFERATION; STRATEGIES; THERAPY; INJURY; Bronchiolitis obliterans; Vasculopathy; Everolimus; Animal model; Chronic rejection (1)
Allograft survival, heart transplantation, chronic rejection, TREM-1, innate immunity (1)
Allokationssystem, Herztransplantation, Warteliste (1)
Allokation von Risikokapital; Co-Semivarianz; Semivarianz (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; ACTION-POTENTIALS; SCHIFF-BASE; ABSORPTION; PROTEIN; NEURONS; DEPROTONATION; RHODOPSIN; QuasAr1; Archaerhodopsin 3; genetically encoded fluorescent voltage sensor; absorption spectroscopic characterization; fluorescence studies; photocycle dynamics; photoisomerization; deprotonation; reprotonation (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; F-2(-) COLOR-CENTERS; AGGREGATION; LIGHT; BEHAVIOR; RED; Archon2; Archaerhodopsin 3; genetically encoded voltage sensor (GEVI); absorption spectroscopic characterization; fluorescence spectroscopic characterization; apparent protein melting temperature; thermal stability (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; GENETICALLY ENCODED SENSORS; PROBE; INDICATORS; MECHANISM; Numerical photocycle dynamics simulation; Photoisomerization; Ground-state isomerization; Ground-state deprotonation; Ground-state re-protonation; Protein recovery (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; SENSITIVE DYES; SCHIFF-BASE; RHODOPSIN; ABSORPTION; DEPROTONATION; INTERSECTION; MECHANISM; LIFETIME; PROTEIN; Archon2; Archaerhodopsin 3; Genetically encoded voltage sensor (GEVI); Absorption spectroscopic studies; Photocycle dynamics; Photoisomerization; Thermal activated isomerization; Thermal activated deprotonation; Thermal activated re-protonation (1)
ALLOSTERIC AGONIST AMN082; ANXIETY-LIKE BEHAVIORS; PSYCHOLOGICAL STRESS; MOOD DISORDERS; AMYGDALA PLASTICITY; MESSENGER-RNA; IN-VITRO; HPA AXIS; BRAIN; ANTIDEPRESSANT; Metabotropic glutamate receptor subtype 7; Knockout; Chronic psychosocial stress; Chronic subordinate colony housing; Affective and somatic pathologies (1)
ALLOSTERIC REGULATION; CROSS-LINKING; ASSEMBLIES; MECHANISM; CRYSTALS; COMPLEX; MASS; (1)
ALLOSTERIC REGULATION; MULTIENZYME COMPLEX; COMPUTATIONAL TOOLS; CRYSTAL-STRUCTURE; EVOLUTION; SUBUNIT; HYPERTHERMOPHILE; ENSEMBLES; TRPB; tryptophan synthase; distal mutations; allostery; enzyme design; shortest path map; ancestral sequence reconstruction (1)
ALLOSTERIC REGULATION; MULTIENZYME COMPLEX; MOLECULAR-GRAPHICS; SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; BIENZYME COMPLEX; RECONSTRUCTION; MECHANISM; EVOLUTION; SOFTWARE; (1)
ALLOSTERIC REGULATION; SECONDARY METABOLISM; CATALYTIC MECHANISM; GENE; enzymes; molecular evolution; primary metabolism; protein design; secondary metabolism (1)
allosterische Kontrolle, Ammoniakkanal, Histidin Biosynthese, Tryptophan Biosynthese, allosteric mechanism, ammonia chanel, histidine biosynthesis, tryptophan biosynthesis (1)
allostery, molecular dynamics simulations, multi-enzyme complexes, shortest path map, stand-alone enzyme, tryptophan synthase (1)
Allotropie; Cobalt; Käfigverbindungen; Phosphor (1)
ALLOY NANOPARTICLES; HYDROGEN-PEROXIDE; NICKEL-HYDROXIDE; NI NANOPARTICLES; GLUCOSE; ELECTRODE; EFFICIENT; FABRICATION; COMPOSITES; carbon nanofibers; electrochemical sensors; electrospinning; laser-induced carbonization; nanocatalysts (1)
ALLOYS; (1)
ALLOYS; TB; FE; CO; multilayers; rare earth metals; exchange interactions; ferrimagnetism; perpendicular magnetic anisotropy (1)
ALL-SOLID-STATE; PORE-SIZE DISTRIBUTION; SELF-POWERED SYSTEMS; 1D SILVER-NANOWIRE; HIGH-PERFORMANCE; ASYMMETRIC SUPERCAPACITORS; ELECTROCHEMICAL CAPACITORS; FLEXIBLE SUPERCAPACITORS; FIBER SUPERCAPACITORS; ELECTRONIC TEXTILES; (1)
Alltag, Gespräch, Gruppengespräch, Alltagsgespräch, Tetralog, (verbale) Dominanz, gesprochene Sprache, Soziolinguistik, Sprache und Geschlecht, Sprache und Alter, everyday life, conversation, group conversation, everyday conversation, tetralogue, (verbal) dominance, spoken language, social linguistics, language and gender, language and age (1)
ALLYLIC ALKYLATION; DESIGN; DERIVATIVES; MOPAS; pyrroles; 3-oxo-2,3-diliydropyrrole; allylations; amino acids; catalysis; palladium (1)
Allylliganden; Dichtefunktionalrechnungen; Phosphinidene; Phosphor; Radikale (1)
ALN; SAPPHIRE; SILICON; metalorganic vapor phase epitaxy; nitrides; semiconducting III-V materials (1)
Aloe - Aloin - Glucosylation (C-) - Glycosides (C-, biosynthesis) (1)
ALPHA-1-ACID GLYCOPROTEIN; (1)
Alpha-1-Antitrypsin Deficiency; Patient-Reported Outcome Measure; Supporting Data for Systematic Selection Process (1)
ALPHA-1(I) PROCOLLAGEN GENE; NF-KAPPA-B; SCLERODERMA FIBROBLASTS; DERMAL FIBROBLASTS; TRANSFORMING GROWTH-FACTOR-BETA-1; PULMONARY FIBROSIS; UNINVOLVED SKIN; EXPRESSION; MCP-1; CHEMOKINES; (1)
ALPHA(2)BETA(2) COMPLEX; 3-DIMENSIONAL STRUCTURE; ANTIBACTERIAL ACTIVITY; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; OPTICAL CONTROL; ACTIVE-SITES; IN-VIVO; COMMUNICATION; antibiotics; azo compounds; enzymes; inhibitors; photopharmacology (1)
ALPHA-2B PLUS RIBAVIRIN; INTERFERON-ALPHA; HCV INFECTION; PEGINTERFERON; DISEASE; RISK; COMBINATION; ADOLESCENTS; COINFECTION; PREVALENCE; (1)
ALPHA 7 INTEGRIN; LIGAND-BINDING SPECIFICITIES; CHAIN-G-DOMAIN; SER-ARG YIGSR; CELL-ADHESION; SKELETAL-MUSCLE; ALPHA-7-BETA-1 INTEGRIN; CRYSTAL-STRUCTURE; A-CHAIN; EXTRACELLULAR SEGMENT; alpha7 integrin; X1,X2 splice variants; laminin isoforms; homology modeling; molecular dynamics simulation (1)
ALPHA-A-CRYSTALLIN; MAMMALIAN SWI/SNF COMPLEXES; GENE-EXPRESSION; TRANSGENIC MICE; P53-INDEPENDENT APOPTOSIS; MUSCLE DIFFERENTIATION; PAX6 EXPRESSION; DNA; PROMOTER; GROWTH; (1)
ALPHA-A-CRYSTALLIN; OCULOCUTANEOUS ALBINISM OCA2; HEAT-SHOCK-PROTEIN; FOVEAL HYPOPLASIA; DOMINANT CATARACT; MISSENSE MUTATION; B-CRYSTALLIN; GENE; MOUSE; ELECTRORETINOGRAPHY; cataract; P; CRYAA; mutation; human; macular; hypoplasia (1)
ALPHA-A-CRYSTALLIN; TRANSCRIPTION FACTOR YY1; RENAL-COLOBOMA SYNDROME; PROGENITOR CELLS; LENS INDUCTION; TRANSGENIC MICE; NERVOUS-SYSTEM; C-MAF; GENE; DEFECTS; (1)
ALPHA-AMINO-ACIDS; PHOTOCATALYTIC HYDROGEN-PRODUCTION; ELECTRON-DEFICIENT ALKENES; ALIPHATIC CARBOXYLIC-ACIDS; PHOTOREDOX CATALYSIS; NICKEL CATALYSIS; EOSIN-Y; HETEROGENEOUS PHOTOCATALYSIS; MERGING PHOTOREDOX; COUPLING REACTIONS; (1)
ALPHA-AMINO-ACIDS; SOLID-PHASE SYNTHESIS; EFFICIENT ASYMMETRIC-SYNTHESIS; DIELS-ALDER REACTIONS; SUBSTITUTED 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACIDS; DIASTEREOSELECTIVE 1,3-DIPOLAR CYCLOADDITIONS; CYCLIC DEHYDROPEPTIDE LACTONE; CONJUGATE RADICAL-ADDITION; CHIRAL GLYCINE EQUIVALENT; CONTAINING MODEL PEPTIDES; amino acids; peptides; alpha.beta-dehydroamino acids; natural products; alkenes (1)
ALPHA-AMINOADIPIC ACID; AMINO-ACIDS; PENICILLIN; ESTERS; 3-carboxycyclopentylglycines; enzymatic resolution; Aspergillus melleus; absolute configuration (1)
ALPHA-AMYLASE GENE; HIGHER-PLANTS; SUGAR SENSOR; EXPRESSION; CELLS; PHOSPHORYLATION; TRANSDUCTION; REPRESSION; EMBRYOS; GROWTH; Lycopersicon peruvianum; glucosamine; hexokinase inhibitor; MAP kinase (1)
ALPHA-AMYLASE; SWISS-MODEL; PREDICTION; LOCATION; ENVIRONMENT; MECHANISM; BACTERIA; GENE; alpha-1,4-amylase; endophyte; docking; homology modelling; Bacillus amyloliquefaciens (1)
ALPHA-B-CRYSTALLIN; GROWTH-FACTOR-BETA; METALLOPROTEINASE TYPE-2 ACTIVATION; RETINAL-PIGMENT EPITHELIUM; PERFUSED AMPHIBIAN HEART; OPEN-ANGLE GLAUCOMA; TGF-BETA; TRABECULAR MESHWORK; ENDOTHELIAL-CELLS; UP-REGULATION; (1)
ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; CHAPERONE-LIKE ACTIVITY; GAMMA-S-CRYSTALLIN; BOVINE EYE LENS; X-RAY-ANALYSIS; C-TERMINAL EXTENSIONS; AGE-RELATED CATARACT; SPORE COAT PROTEIN; ACCEPTOR DONOR RELATIONSHIPS; cataract; chaperone; crystallins; development; evolution; eye lens; protein stability (1)
ALPHA-B-CRYSTALLIN; STEM-CELLS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; AQUEOUS-HUMOR; GROWTH-CHARACTERISTICS; CORNEAL ENDOTHELIUM; GENE-EXPRESSION; TISSUE-CULTURE; PRIMATE EYE; Aqueous humor dynamics; Conventional outflow; Glaucoma; Intraocular pressure; Ocular hypertension (1)
ALPHA/BETA-PEPTIDES; CIS/TRANS STEREOCHEMISTRY; AMPHIPHILES INFLUENCE; DENSITY FUNCTIONALS; CONFORMATIONAL BIAS; SYNTHETIC ENZYMES; PROLINE CATALYSIS; SEQUENCE SPACE; CYCLOBUTANE; EFFICIENT; (1)
ALPHA-BETA-TUBULIN; NEURONAL MIGRATION; POLYMICROGYRIA; BRAIN; PHENOTYPE; SPECTRUM; EXPRESSION; ISOTYPES; PAX6; lissencephaly; polymicrogyria; corpus callosum; tubulinopathy; neuronal migration (1)
alpha,beta-ungesättigte Carbonylverbindungen, Entzündung, Naturstoffsynthese, Limnophilaspiroketon/ alpha,beta-unsaturated carbonyl compounds, inflammation, natural product synthesis, Limnophilaspiroketone (1)
ALPHA,BETA-UNSATURATED ALDEHYDES; ASYMMETRIC-SYNTHESIS; TRANSITION-STATES; ENAMINE CATALYSIS; ACETALDEHYDE; STEP; STEREOSELECTIVITY; AMINOCATALYSIS; OXAZOLIDINONES; DIARYLPROLINOL; (1)
ALPHA,BETA-UNSATURATED GAMMA-BUTYROLACTAM; MBH-TYPE PRODUCTS; TERTIARY-AMINES; TETRAHYDROISOQUINOLINE DERIVATIVES; PHOTOREDOX CATALYSIS; MOLECULAR-OXYGEN; ALPHA-ARYLATION; NITROGEN ATOM; ACTIVATION; ALDEHYDES; (1)
ALPHA,BETA-UNSATURATED KETONES; 1,3-DICARBONYL COMPOUNDS; CATALYZED CARBOXYLATION; CYCLOADDITION REACTIONS; POLYSUBSTITUTED FURANS; ALCOHOLS; TRANSFORMATION; ACTIVATION; DIBENZOBARRELENES; REARRANGEMENT (1)
ALPHA-CHYMOTRYPSIN ACTIVITY; ENABLE OPTICAL CONTROL; BY-PRODUCT FORMATION; HDAC INHIBITORS; DIARYLETHENE DERIVATIVES; ENZYME-INHIBITORS; VISIBLE-LIGHT; AZOBENZENE; PHOTOSWITCH; RECEPTORS; (1)
ALPHA-CYCLODEXTRIN; WATER-STRUCTURE; NANOPARTICLES; DELIVERY; POLYPSEUDOROTAXANES; LYOPHILIZATION; STABILIZATION; PERMEABILITY; SACCHARIDES; FORMULATION; cosolvent evaporation; dexamethasone; direct dialysis; drug load; freeze-drying; HP beta CD; lyophilization; O/W emulsion; polymeric micelles; polypseudorotaxane; SBE beta CD; beta-cyclodextrins (1)
ALPHA-DEFENSINS; GVHD; MORTALITY; INTERLEUKIN-22; (1)
ALPHA-DIAZOCARBONYL COMPOUNDS; ORGANIC PHOTOREDOX CATALYSIS; 1,3-DICARBONYL COMPOUNDS; FLOW MICROREACTORS; PYRROLE SYNTHESIS; 2H-AZIRINES; COPPER; QUINOXALINES; RADICALS; ALKENES; visible-light photocatalysis; pyrazines; synthetic methods; vinyl azides; photocascade process (1)
ALPHA-DYSTROGLYCAN BINDING; LAMININ LAMININ BETA-2; BASEMENT-MEMBRANES; NEURITE OUTGROWTH; CELL-ADHESION; S-LAMININ; EXTRACELLULAR-MATRIX; HUMAN PLACENTA; LG MODULES; IN-VIVO; Extracellular matrix; Basement membrane; Laminin; Recombinant expression; Integrin; Neurite outgrowth (1)
ALPHA ER-ALPHA; MESSENGER-RNA EXPRESSION; BREAST-CANCER; OVARIAN-CANCER; ENDOMETRIAL CANCER; DIFFERENTIAL EXPRESSION; DNA METHYLATION; PROGNOSTIC-SIGNIFICANCE; CYTOPLASMIC EXPRESSION; PROGESTERONE-RECEPTORS; Ovarian cancer; Endometrial cancer; Estrogen receptor beta (1)
ALPHA ER-ALPHA; PREDICTS POOR SURVIVAL; BREAST-CANCER; PROGESTERONE-RECEPTOR; CELL-LINE; DIFFERENTIAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPT VARIANTS; GENE-EXPRESSION; MESSENGER-RNAS; estrogen related receptor; estrogen receptors; G protein-coupled estrogen receptor; ovarian cancer; endometrial cancer (1)
ALPHA-HELICAL STATES; CHEMICAL-SHIFTS; POLYPEPTIDE IAPP; ISLET; PROTEIN; FIBRILLATION; DEPENDENCE; MECHANISM; IDENTIFICATION; AGGREGATION; IAPP; Amylin; Amyloid; NMR; Fibrils (1)
ALPHA-HYDROXY-KETONES; N-HETEROCYCLIC CARBENES; CARBON BOND FORMATIONS; BENZOIN CONDENSATION; ASYMMETRIC-SYNTHESIS; ANION EQUIVALENTS; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC ACYLATION; LANTHANUM TRICYANIDE; THIAZOLIUM SALT; (1)
ALPHA-HYDROXYLATING MONOOXYGENASE; FUSARIC 5-BUTYLPICOLINIC ACID; PEPTIDE AMIDATION; COPPER; DIOXYGEN; dopamine beta-monooxygenase inhibitors; QSAR; picolinic acids; dopamine beta-monooxygenase binding site (1)
ALPHA-HYDROXYSTEROID DEHYDROGENASE; RANDOMIZED CONTROLLED-TRIAL; KETO REDUCTASE SUPERFAMILY; PROGESTERONE-RECEPTOR GENE; TISSUE DISTRIBUTION; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASES; PSYCHIATRIC-DISORDERS; NEUROACTIVE STEROIDS; EMOTIONAL MEMORY; BINDING PROTEIN; panic disorder; neurosteroids; association; SNPs; gender-specific; anxiety (1)
ALPHA-OSCILLATIONS; CONTOUR INTEGRATION; GLOBAL SHAPES; AREA V1; CORTEX; ATTENTION; FMRI; SYNCHRONIZATION; MECHANISM; FREQUENCY; (1)
ALPHA-OXOCARBOXYLIC ACIDS; DECARBOXYLATIVE ACYLARYLATION; SYNTHETIC APPLICATIONS; HETEROAROMATIC BASES; CARBOXYLIC-ACIDS; ALKYLATION; DRIVEN; REACTIVITY; AMINATION; CHEMISTRY (1)
ALPHA-PRIMASE; MITOTIC-CYCLE; BETA-POLY(L-MALATE); PLASMODIA; PROTEINS; poly(malic acid); cell cycle; S-phase; DNA synthesis; histones (1)
ALPHA-STABLE DISTRIBUTIONS; INTERSTITIAL BRACHYTHERAPY; BREAST IRRADIATION; BAYESIAN-INFERENCE; QUALITY-ASSURANCE; UNIMODALITY; PROSTATE; SURGERY; multi-dimensional scaling; electromagnetic tracking; brachytherapy; Levy distributions; hartigan-dip-test (1)
alpha-Syntrophin, SNTA, Fettgewebe, Adipozyten, Nicht-alkoholische Fettlebererkrankung, non-alcoholic fatty liver disease, adipose tissue, adipocytes, SNTA, alpha-syntrophin (1)
ALPHA-SYNUCLEIN; LIR MOTIF; RENAL-DISEASE; AUTOPHAGY; LMX1B; EXPRESSION; PROTEIN; IDENTIFICATION; MAINTENANCE; GENERATION; (1)
ALPHA-SYNUCLEIN; SELECTIVE NEURODEGENERATION; PESTICIDE EXPOSURE; INDUCED TOXICITY; NEURONAL DEATH; PC12 CELLS; ROTENONE; MELANOGASTER; MUTATION; Dopamine; Cell death; Parkinson's disease; Drosophila; alpha-Synuclein; Rotenone; Neuroprotection (1)
ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; MUTANTS; NEURODEGENERATION; NEUROTOXICITY; INACTIVATION; DEGENERATION; SUPPRESSION; PATHWAY; PINK1; animal model; drosophila; neurodegeneration; paraquat; rotenone; synuclein (1)
ALPHA-TRYPSIN INHIBITOR; BREAST-CANCER; HEAVY-CHAIN; EXTRACELLULAR-MATRIX; CELL-CARCINOMA; HYALURONAN; FAMILY; EXPRESSION; TISSUE; GENE; (1)
ALPHA-TRYPSIN INHIBITOR; FACTOR-STIMULATED GENE-6; SHAP-HYALURONAN COMPLEX; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; HEAVY-CHAIN; OVARIAN-CANCER; FAMILY; BINDING; TISSUE; inter-alpha-trypsin inhibitor heavy chain ( ITIH); breast cancer; prognostic marker; predictive marker; tumour invasion; metastasis (1)
alpine farming, palaeobotany, palynology, pedoanthracology, land use history, (1)
Alpine rivers | founder and bottleneck effects | genetic variation | hydrological alterations | Myricaria germanica | restoration measures (1)
ALR, augmenter of liver regeneration, Akut-Phase-Reaktion, Zytokine (1)
ALR, GPCR, ADAM17, EGF-R, IL-6 signaling, Regeneration, Inflammation (1)
ALS, amyotrophic lateral sclerosis, G-CSF, CCL2, MCP-1, TNF-α (1)
ALS, FTD, dipeptide-repeat proteins, UPS, cryoelectron microscopy, cryo-EM, cryo-ET, cryo-FIB (1)
ALS, G-CSF, Biomarker (1)
ALTERED FUNCTIONAL CONNECTIVITY; CENTRAL VISION LOSS; VISUAL-FIELD MAPS; MOTOR CORTEX; ACTIVATION; MRI; ADJACENT; TOOLBOX; GLIOMAS; LATERALIZATION; brain tumor; vessel malformation; functional magnetic resonance imaging; blood-oxygenation level-dependent; task-based functional connectivity; occipital lobe; retinotopic mapping; preoperative noninvasive mapping; preoperative imaging (1)
ALTERED LIPID-METABOLISM; IRON-SULFUR CLUSTERS; MOLECULAR-MECHANISMS; MOUSE MODELS; FRATAXIN; HOMEOSTASIS; UNIPORTER; MEMBRANES; HEME; LOCALIZATION; MAMs; Frataxin; Calcium; Lipid peroxidation; Vitamin E; N-acetylcysteine (1)
ALTERED SCHAEDLER FLORA; GERM-FREE MICE; BACTERIAL-CONTAMINATION; MOUSE-MICROBIOTA; COLONIZATION; RESISTANCE; STABILITY; BARRIER; Germ-free; Defined microbiota animal models; Microbiological monitoring; 16S rRNA gene sequencing; Microisolator cages; Gnotobiotic experiments (1)
ALTERED SCHAEDLER FLORA; REGULATORY T-CELLS; GUT MICROBIOME; ULCERATIVE-COLITIS; RHEUMATOID-ARTHRITIS; MURINE MICROBIOTA; HYDROGEN-SULFIDE; CROHNS-DISEASE; MOUSE MODEL; FREE MICE; Gut microbiota; Mouse husbandry; C57BL/6J; 16S rRNA gene (1)
ALTERED STATES; BRAIN; EEG; CONSCIOUSNESS; EXPERIENCE; SELF; DEVICE; ALPHA; THETA; classification; electroencephalography; meditation; states of consciousness (1)
Alterität/ fremde Welten; Dritte Welt und fremde Welten und Interkulturalität; Frauen und Mädchen; Frauen-/ Mädchen-/ Mutterbild; Identität; Preise (1)
ALTERNATING-CURRENT STIMULATION; TRANSCRANIAL DIRECT; BRAIN OSCILLATIONS; VISUAL-PERCEPTION; SPATIAL ATTENTION; ELECTRIC-FIELD; ALPHA-PHASE; ENTRAINMENT; MECHANISM; SUPPRESSION; (1)
ALTERNATIVE COMPLEMENT PATHWAY; APOPTOTIC CELLS; DENDRITIC CELLS; MEMBRANE MICROPARTICLES; CELLULAR MICROPARTICLES; PHOSPHOLIPID ASYMMETRY; PLASMA-MEMBRANE; BLOOD-CELLS; RECEPTOR; PHOSPHATIDYLSERINE; microparticles; complement; B cells; monocytes (1)
ALTERNATIVE CONFORMATIONS; STRUCTURAL ELEMENTS; BINDING MODE; V3 LOOP; ANTIBODY; COMPLEX; IDENTIFICATION; NEUTRALIZATION; INHIBITORS; PHENOTYPE; peptide; protein-protein interaction; HIV-1; gp120; coreceptor; CXCR4; V3 loop (1)
Alternative Finance, Sustainable Finance, Non-Financial Factors (1)
Alternative fuel vehicle; Facility location; Refueling station; Capacity planning; Multi-period; Network transformation; Refueling infrastructure (1)
ALTERNATIVELY ACTIVATED MACROPHAGES; TISSUE-RESIDENT MACROPHAGES; LITOMOSOIDES-SIGMODONTIS; REVEALS; IGM; INTERLEUKIN-4; POLARIZATION; PROTECTION; MONOCYTES; MICE; (1)
ALTERNATIVE MEDICINE; COMPLEMENTARY; COMPONENTS; COLITIS; RESIN; myrrh; coffee charcoal; chamomile flower; IBD; intestinal barrier; inflammation; mucosa; co-culture cell model (1)
ALTERNATIVE MEDICINE; COMPLEMENTARY; GERMANY; GPS; Non-medically trained practitioners; Cooperation; Complementary and alternative medicine (1)
ALTERNATIVE REPRODUCTIVE STRATEGIES; FLORAL INDUCTION; POLYMORPHISM; QUEENS; HYMENOPTERA; INSECTS; FORMICIDAE; EVOLUTION; TACTICS; TEMPERATURE; (1)
ALTERNATIVE REPRODUCTIVE TACTICS; DIFFERENTIAL EXPRESSION; HONEY-BEE; PHENOTYPIC PLASTICITY; GENOME-WIDE; MALE MORPH; CAMPONOTUS-FLORIDANUS; QUEEN DEVELOPMENT; JUVENILE-HORMONE; DIMORPHIC MALES; developmental plasticity; Cardiocondyla obscurior; RNAseq; caste determination; sphingolipid; transcription factor binding site (1)
ALTERNATIVE REPRODUCTIVE TACTICS; MITOCHONDRIAL-DNA; DIMORPHIC MALES; ERGATOID MALES; PONERINE ANT; HYMENOPTERA; BEHAVIOR; EVOLUTION; PARASITES; POLYGYNY; Cardiocondyla venustula; Male diphenism; Ergatoid male; Intracolony mtDNA variation (1)
ALTERNATIVE REPRODUCTIVE TACTICS; SOLENOPSIS-INVICTA; POLYGYNOUS ANT; SIZE; DNA; QUEENS; HYMENOPTERA; FORMICIDAE; RELATEDNESS; STRATEGIES; alternative tactics; colony structure; local adaptation; nestmate recognition; reproductive strategy; social insects (1)
Altersabhängige Makuladegeneration, AMD, Bevacizumab , Ranibizumab, Pegaptanib, Triamcinolon, VEGF, anti-VEGF Therapie, Choroidale Neovaskularisation, CNV, VEGF (1)
Altersabhängige Makuladegeneration, AMD, oxidativer Stress, Nicotinamid, Nikotinamid, VEGF, iPSC-RPE, retinales Pigmentepithel, RPE (1)
Altersabhängige Makuladegeneration, Genetik, Prävention/ age-related macular degeneration, genetics, prevention (1)
Altersabhängige Makuladegeneration; genetische Assoziationen; microRNA (1)
altersabhängige Makuladegeneration, Literaturanalyse, AMD, Genetik, Humangenetik, Literaturrecherche (1)
Altersbedingte Makuladegeneration (AMD); retinales Pigmentepithel (RPE); extrazelluläre Matrix (EZM); (1)
Alter, Schwerhörigkeit, Presbyacusis, Hörbahn, Wüstenrennmaus, aging, hearing loss, GABA, inferior colliculus, auditory aging, central auditory system, gerbil (1)
Alterstraumatologie; Mortalität, osteoporotische Frakturen; orthogeriatrics; mortality; osteoporotic fractures (1)
Alterstraumatologie; standardisierte Behandlungspfade; Struktur- und Prozessqualität (1)
Alterung, soziale Insekten, Verpaarung, Reproduktion (1)
altgriechische Inschrift, Paläographie, Herstellungstechnik (1)
ALTITUDINAL GRADIENT; PLANT-COMMUNITIES; DIVERSITY; PATTERNS; SIZE; POLLINATION; PHENOLOGY; RESPONSES; DURATION; ECOLOGY; community assembly; environmental filtering; environmental gradient; floral traits; flowering phenology; high-elevation communities; reproductive success (1)
altruism; ants; matricide; queen execution; Temnothorax; worker reproduction (1)
altruistic preferences; financial inclusion; financial intermediation; peer-to-peer platforms (1)
aluminium alloys; cobalt alloys; enhanced magnetoresistance; iron alloys; Kerr magneto-optical effect; magnetic structure; magnetic thin films; magnetisation; nucleation; (1)
aluminium compounds; electric current; exchange interactions (electron); III-V semiconductors; II-VI semiconductors; indium compounds; manganese compounds; molecular beam epitaxial growth; semiconductor quantum wells; semimagnetic semiconductors; wide band gap semiconductors; zinc compounds; (1)
; aluminium compounds; gallium arsenide; III-V semiconductors; impurity distribution; photoconductivity; photovoltaic effects; segregation; semiconductor doping; semiconductor growth; semiconductor quantum wells; silicon (1)
aluminium compounds, gallium arsenide, III-V semiconductors, microcavity lasers, semiconductor quantum wells, light scattering (1)
aluminium compounds, gallium arsenide, III-V semiconductors, semiconductor quantum dots, Coulomb blockade, displacement measurement, micromechanical resonators, microsensors (1)
aluminium compounds, gallium arsenide, semiconductor quantum wells, III-V semiconductors, oscillator strengths, excitons, photoluminescence, light absorption, two-dimensional electron gas, quantum Hall effect, triplet state (1)
Aluminium; Dichtefunktionalrechnungen; Gallium; Lewis-Säuren; Phosphor (1)
aluminium · gallium · main group compound · nacnacligands · yellowarsenic (1)
Aluminium; H2-Eliminierungen; Lewis-Basen; Lewis-Säuren; Phosphor (1)
Aluminium, Phosphor, Lewis Säure, Lewis Base, Oligomerisierung, Mechanismusaufklärung, 13/15-Verbindungen, Kristallographie (1)
aluminum; density functional calculations; gallium; Lewis acids; phosphorus (1)
ALUMINUM NITRIDE POWDER; SILICON-NITRIDE; DISPERSION; REACTIVITY; MEDIA; (1)
Aluminum; Phosphorus; Hydrides; Reactivity; Lewis bases (1)
ALUMINUM; PRECURSORS; AMMONIA; PHOSPHANYLALANE; CHEMISTRY; HYDROGEN; HYDRIDES; GALLIUM; BORANE; beta-diketiminate ligands; diarsanides; diphosphanide; group 13 metals; main-group elements (1)
ALVEOLAR FLUID CLEARANCE; SURFACE LIQUID VOLUME; NA+ CHANNEL; ELASTASE ACTIVATION; INHIBITORY PEPTIDE; XENOPUS-OOCYTES; T-COFFEE; CLEAVAGE; MOUSE; FURIN; (1)
ALVEOLAR MACROPHAGE APOPTOSIS; PNEUMOCOCCAL PNEUMONIA; HOST-DEFENSE; MURINE MODEL; PROTECTIVE IMMUNITY; PULMONARY INFECTION; PROLONGS SURVIVAL; CCL2-CCR2 AXIS; FLT3 LIGAND; PATHOGENESIS; (1)
ALVEOLAR MACROPHAGES; TISSUE MACROPHAGES; FETAL MONOCYTES; DENDRITIC CELLS; 1ST WEEK; INFLAMMATION; MOUSE; HOMEOSTASIS; EXPRESSION; INFECTION; Asthma; type 2 immunity; neonate; TGF-beta; lung immunity; macrophage; monocyte; chemokine (1)
Alzheimer dementia, Dignity, Ethics, Assisted suicide, Integrative dementia therapy model (1)
Alzheimer disease Anti-Alzheimer's agents Antioxidants Hypericum perforatum Phagocytosis (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) beta -Amyloid Role: ADV (Adverse effect, including toxicity), BIOL (Biological study) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Reactive oxygen species Role: BSU (Biological study, unclassified), BIOL (Biological study) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Flavanols Flavonoids Role: DMA (Drug mechanism of action), PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Cell membrane (fluidity Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Neuroglia (microglia Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Hypericum perforatum ext compd amyloid toxicity microglia Alzheimer's (1)
Alzheimer disease Cognitive disorders Enzyme inhibitors NMDA receptor antagonists Neurodegenerative disease Structure-activity relationship (bivalent beta -carbolines as potential multitarget anti-alzheimer agents) NMDA receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (bivalent beta -carbolines as potential multitarget anti-alzheimer agents) Toxins Role: BSU (Biological study, unclassified), BIOL (Biological study) (excitotoxins bivalent beta -carbolines as potential multitarget anti-alzheimer agents) acetylcholinesterase inhibitor NMDA Alzheimers disease carboline deriv SAR prepn (1)
ALZHEIMER DRUG CANDIDATES; MOLECULAR-DYNAMICS; DISEASE; DERIVATIVES; RESTRAINTS; RECEPTORS; COMPLEXES; SWITCHES; BINDING; DESIGN; (1)
ALZHEIMER DRUG CANDIDATES; OXIDATIVE STRESS; CELL-DEATH; HYBRID MOLECULES; GLUTAMATE TOXICITY; NO-DONOR; DISEASE; HEPATOTOXICITY; BUTYRYLCHOLINESTERASE; SILYBIN; (1)
Alzheimer-Krankheit , Demenz , Frontotemporale Demenz , Apolipoprotein E , Familienanamnese , Genetik , ApoE-Polymorphismus , dementia , FTD , family history , genetics , ApoE polymorphism (1)
ALZHEIMERS-DISEASE (1)
ALZHEIMERS-DISEASE; AMINO-ACIDS; CARBODIIMIDES; STABILIZATION; PROPENSITIES; DERIVATIVES; (1)
Alzheimer's disease; amyloid‐beta; aryl hydrocarbon receptor; mass cytometry; tau pathology; tryptophan (1)
ALZHEIMERS-DISEASE; CARE; Dementia; Life story; Remembering self; Experiencing self; Body memory (1)
ALZHEIMERS-DISEASE; CELL-DEATH; RAT; HEPATOTOXICITY; VIVO; TETRAHYDROAMINOACRIDINE; PHARMACOKINETICS; PATHOGENESIS; HEPATOCYTES; FLUVOXAMINE; codrug; microsomal metabolites; silibinin; stability; tacrine (1)
ALZHEIMERS-DISEASE; E GENOTYPE; PSYCHOTIC SYMPTOMS; GENE POLYMORPHISMS; LATE-ONSET; HALLUCINATIONS; DELUSIONS; DECLINE; PHENOTYPES; ANXIETY; Anxiety; apolipoprotein E epsilon 4 (ApoE epsilon 4); ApoE epsilon 4 homozygosity; delusion; depression; epsilon 4/epsilon 4 homozygosity; epsilon 4/epsilon 4 homozygous; hallucinations; psychiatric symptoms (1)
ALZHEIMERS-DISEASE; HUMAN-BRAIN; METABOLISM; BLOOD; RATS; GLYCEROPHOSPHOLIPIDS; HYPERTRIGLYCERIDEMIA; NEUROINFLAMMATION; APOPTOSIS; ETHANOL; ALDH2; lipidomics; chronic alcohol exposure; cerebral cortex; knock-in (1)
ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HYBRID MOLECULES; NEURONAL CELLS; BUTYRYLCHOLINESTERASE; DESIGN; ACETYLCHOLINESTERASE; QUINAZOLINIMINES; RIVASTIGMINE; SELECTIVITY; Alzheimer's disease; butyrylcholinesterase; carbamates; neuroprotection (1)
ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; CONTRACTILE ACTIVITY; SKELETAL-MUSCLE; COMPLEX-I; DYSFUNCTION; FISSION; COGNITION; DYNAMICS; Alzheimer's disease; amyloid-beta; A beta PP mutation; Dimebon; latrepirdine; mitochondrial dynamics; mitochondrial dysfunction; mitochondrial mass; mitochondrial morphology; mitochondrial respiratory complexes; OXPHOS (1)
ALZHEIMERS-DISEASE; PHOSPHATIDYLINOSITOL 3-KINASE; NEURODEGENERATIVE DISEASES; MACROPHAGE ACTIVATION; MONONUCLEAR PHAGOCYTE; ANTIOXIDANT RESPONSE; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; (1)
Alzheimer's disease, prevalence, gerontology (1)
ALZHEIMERS-DISEASE; PROTEIN; MUTATIONS; ABCA7; SUSCEPTIBILITY; DEFICIENCY; EXPRESSION; GENOTYPES; TRAITS; LOCI; (1)
ALZHEIMERS-DISEASE; RATS; BEHAVIOR; MAZE; SCOPOLAMINE; HIPPOCAMPUS; PERFORMANCE; RESTRICTION; METRIFONATE; INJECTION; Mouse behavior; Learning; Memory; Attention; Alzheimer's disease; ADHD; Cognitive enhancer; Animal model (1)
ALZHEIMERS-DISEASE RISK; POLYMORPHISM; ASSOCIATION; PROMOTER (1)
ALZHEIMERS-DISEASE; SCREENING-TEST; DEMENTIA; COMMUNITY; dementia; Syndrom-Kurztest; Mini-Mental-Sate-Examination; Clock drawing test; correlation; multiple regression; response surface analysis; psychopharmacological research (1)
ALZHEIMERS-DISEASE; TRANSGENIC MICE; BETA-PEPTIDE; SOLUTION NMR; AMYLOID-BETA(1-42); PROTOFIBRILS; IMPROVES; (1)
ALZHEIMERS-DISEASE; WORKING-MEMORY; BRAIN RESERVE; IMPAIRMENT; DEMENTIA; COHORT; multiple sclerosis; neuropsychology; cognition; cognitive reserve; educational status (1)
Amateurfußball, Bubble-Soccer, Verletzungen, Risikofaktoren (1)
AMATEUR SOCCER PLAYERS; PROFESSIONAL FOOTBALL; WARM-UP; MUSCULOSKELETAL COMPLAINTS; PHYSIOLOGY; EXERCISE; PROGRAMS; epidemiology; football; injury; match officials; prevention; referee (1)
; amber; photoluminescence; pyrene (1)
AMBIENT CONDITIONS; INTRALIGAND PHOSPHORESCENCE; ISOCYANIDE COMPLEXES; CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; SPECTROSCOPY; PLATINUM; RHODIUM; DISSOCIATION; LEAD(II); electronic spectra; luminescence; iridium; acetylacetonate (1)
AMBIENT CONDITIONS; OPTICAL-PROPERTIES; EXCITED-STATES; LIGANDS; SPECTRA; Iron(II) complexes; Binap complexes; Luminescence; Phosphorescence (1)
AMBIENT CONDITIONS; OPTICAL-PROPERTIES; SILVER; PHOSPHORESCENCE; GENERATION; COMPLEXES; INTRALIGAND; EXCITATION; STATE; Luminescence; Photochemistry; Silver; Quinolinolate (1)
AMBIENT ENDOTOXIN CONCENTRATIONS; ENRICHMENT SYSTEM VACES; SIMULTANEOUS IN-VIVO; OXIDATIVE STRESS; GLIOBLASTOMA-MULTIFORME; BIOLOGICAL CONSTITUENTS; RESTRICTIVE RECEPTOR; TRANSITION-METALS; VITRO EVALUATION; GENE-EXPRESSION; (1)
AMBIVALENCE; WORKERS; qualitative research; frontline workers; COVID-19; intensive care unit; acute critical care; pandemic experience; ambivalence (1)
Ambulant erworbene Pneumonie (CAP), Antibiotic Stewardship Intervention, Leitlinienadhärenz, Mortalität (1)
; Ambulatory surgery; Hip prosthesis implantation; Hospital stay; Knee arthroplasty; Prehabilitation; Micro-Hip (1)
AMD, age related macular degeneration, age-related-macular-degeneration, altersbedingte Makuladegeneration, RPE, retinal pigment epithelium, retinales Pigmentepithel, VTN, Vitronectin, rs704, subretinal (1)
AMD, age-related macular degeneration, hiPSC-RPE cells, NRF2, HMOX1, NQO1 (1)
AMD, Altersabhängige Makuladegeneration, age-related macula degeneration, genetics, Genetik, association, Assoziation, microRNA, circulating microRNA, risk prediction, Risikovorhersage, DAPL1, geographic atrophy, Geographische Atrophie, lesion growth, Wachstum der Läsionen (1)
AMD, Altersabhängige Makuladegeneration, Geographische Atrophie, Progression, Wachstum, genetische Assoziation, Genetik, Einflussfaktoren (1)
AMD, AREDS, KORA, PACKYEARS, ARMS2 (1)
AMD, HTRA1, TGF-β1, microglia (1)
AMD, neovascular, OCT, ranibizumab, retina (1)
AMD, Neurturin, NRTN (1)
AMD · Populationsbasierte Studie · Selbstangabe · Krankheitsbewusstsein · Überberichterstattung/Unterberichterstattung (1)
AMEBOCYTE LYSATE ASSAY; DIVALENT-CATIONS; LIPOPOLYSACCHARIDE; PROTEINS; REMOVAL; Endotoxin; Lipopolysaccharide; Low endotoxin recovery; LER; Limulus amebocyte lysate; LAL (1)
Ameisen , Chalepoxenus , Artbildung , Soziale Insekten , Parasitismus , Formicoxenini , Sozialparasitismus , social parasitism , ants , radiation (1)
Ameisen , Reproduktion , Plastizität , Genetische Variabilität , Phänotyp , Fortpflanzung , Heterogenität , , ants , reproduction , plasticity (1)
Ameise, Paarung, Sexuelle Selektion, Kutikuläre Kohlenwasserstoffe, Reproduktionsbiologie, akzessorische Drüsen, Spermientransfer, ant, mating, sexual selection, cuticular hydrocarbons, reproductive biology, accessory gland, sperm transfer (1)
AMENABLE-GROUPS; AMENABILITY; Uniformly finite homology; semi-norms on homology; rigidity (1)
AMERICAN-COLLEGE; SYNOVIAL-FLUID; CLASSIFICATION; HYPERURICEMIA; COMORBIDITIES; GUIDELINES; MANAGEMENT; ADHERENCE; CRYSTALS; THERAPY; (1)
American foulbrood; bacterial pathogens; Paenibacillus larvae; photon-upconversion nanoparticle; upconversion-linked immunosorbent assay (1)
AMERICAN-HEART-ASSOCIATION; ATHEROSCLEROTIC LESIONS; IMMUNOHISTOCHEMICAL LOCALIZATION; CHEMOATTRACTANT PROTEIN-1; CARDIOVASCULAR-DISEASE; COMPLEMENT ACTIVATION; NEUTROPHIL CHEMOTAXIS; VASCULAR-LESIONS; UNSTABLE ANGINA; CELLS; C-reactive proteins; C-reactive protein receptors; monocytes; chemotaxis; atherogenesis (1)
AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; HEALTH-CARE-PROFESSIONALS; FOUNDATION-OF-CANADA; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; RECOMMENDED GUIDELINES; CONDUCTING RESEARCH; SOUTHERN-AFRICA; In-hospital resuscitation; Resuscitation protocol; Improved quality of patient's care; Emergency team; IHE protocol (1)
AMERICAN-HEART-ASSOCIATION; CARDIORESPIRATORY FITNESS; SEDENTARY BEHAVIOR; NONCOMMUNICABLE DISEASES; ADULTS; ACCELEROMETER; RECOMMENDATIONS; VALIDATION; INACTIVITY; WORLDWIDE; Validation; Physical activity questionnaire; Recommendations; Population surveillance (1)
AMERICAN JOINT COMMITTEE; CANCER STAGING SYSTEM; CUTANEOUS MALIGNANT-MELANOMA; MELANOCYTIC SKIN-LESIONS; FOLLOW-UP; RISK-FACTOR; EPILUMINESCENCE MICROSCOPY; DERMATOLOGICAL-SOCIETY; I MELANOMA; ABCD RULE; A-B-C-D rule; dermoscopy; melanoma diagnosis; surveillance; tumor node metastasis classification (1)
AMERICAN JOINT COMMITTEE; MALIGNANT-MELANOMA; GERMAN GUIDELINES; METASTATIC MELANOMA; CUTANEOUS MELANOMA; RADIATION-THERAPY; MELANOCYTIC NEVI; RISK-FACTOR; RADIOTHERAPY; ADJUVANT; skin cancer; surgery; radiotherapy; adjuvant therapy; cancer treatment (1)
AMERICAN SOCIETY; CONSERVATION; LUMPECTOMY; CARCINOMA; IRRADIATION; MASTECTOMY; ACCURACY; EXCISION; IMPACT; TRIAL; Breast imaging; Margin control; Breast surgery; Specimen ultrasound (1)
AMERICAN SURGEONS; BURNOUT; quality of life; surgery; work load; risk factors (1)
AMERICAN SURGEONS; MEDICAL-SCHOOL; BURNOUT; Quality of life; Surgeons; Work overload; Risk factors (1)
American women's suffrage, American women's anti-suffrage, dialectic, enligthtenment (1)
AMES DWARF MICE; TOR PATHWAY; SIGNALING PATHWAY; EXTENSION; RESTRICTION; ELEGANS; TARGET; GROWTH; CANCER; MOUSE; rapamycin; lifespan; renal transplantation; TOR (1)
Amide , Antagonist , Argininderivate , Festphasentechnik , Peptide , Rezeptor , Argininamid , Festphasensynthese , Neuropeptid Y Y1-Rezeptorantagonist , NPY , Radioligand , Argininamide , Neuropeptide Y Y1 Receptor Antagonist , NPY , Radioligand , Solid Phase Synthesis (1)
AMIDE; POTASSIUM; rubidium amide; ammoniates; crystal structures; liquid ammonia; hydrogen bonds (1)
AMIDES; (1)
Amides Role: RCT (Reactant), RACT (Reactant or reagent) (Mannich reaction with bis(chloroethyl)amine, attempted) Neoplasm inhibitors (bis(2-chloroethyl)aminomethyl amides) benzamide bischloroethylaminomethyl carcinostatic chloroethylaminomethylbenzamide carcinostatic sarcoma chloroethylaminomethylbenzamide acetamide trichloro carcinostatic (1)
Amidohydrolase superfamily • Enantioselectivity • Enzyme catalysis • Enzyme promiscuity • Fleeting chiral intermediates (1)
Amination · Radical polar crossover · Single electron transfer · Ritter reaction · Amidation (1)
aminations; -amino alcohols; asymmetric aminohydroxylation; Chloramine-T; osmium compounds (1)
AMINE-BORANE ADDUCTS; METAL-CATALYZED FORMATION; PHOSPHORUS-BORON BONDS; AMMONIA-BORANE; TRANSITION-METAL; INORGANIC POLYMERS; B-N; DEHYDROGENATION; CHEMISTRY; NITROGEN; Arsenic; Boron; Hydroarsination; Main group; Oxidation (1)
Amine , Imine , Transferhydrierung , Katalyse , Chelatliganden , Amines , Imines , Catalysis , Transfer Hydrogenation (1)
AMINE LIGHT STABILIZERS; MOLECULAR-OXYGEN; ALIPHATIC-AMINES; CHEMICAL SENSORS; CARBON-DIOXIDE; TRACE OXYGEN; LUMINESCENCE; PHOTOOXIDATION; TEMPERATURE; COMPLEXES; (1)
Amines (N-benzylidene, redn. of) (1)
Amines Role: ANST (Analytical study) (sepn. of, Craig distribution in) sepn amines Craig distribution amines sepn Craig distribution Craig distribution sepn amines distribution Craig sepn amines (1)
Amines Role: RCT (Reactant), RACT (Reactant or reagent) (prepn. properties and reactions of) review amine heterocyclic amine review arom amine review aliph amine review (1)
Amines Role: USES (Uses) (effect on Schiff base redn. by activated aluminum) Reduction (of Schiff bases by activated aluminum, effect of aluminum and mercury salts and of amines on) Schiff bases Role: PRP (Properties) (redn. by activated aluminum, effect of aluminum and mercury salts and of amines on) MECHANISMS REDN SCHIFF BASE SCHIFF BASE REDN MECHANISMS REDNS ACTIVATED ALUMINUM ALUMINUM ACTIVATED REDNS (1)
Amines (sepn. of, quant.) (1)
AMINO-ACID AVAILABILITY; FAST DIETARY PROTEINS; INSULIN-RESISTANCE; PROSTATE-CANCER; SKELETAL-MUSCLE; L-LEUCINE; GLUTAMATE-DEHYDROGENASE; INCREASED CONSUMPTION; PREMENOPAUSAL WOMEN; SIGNALING PATHWAY; Adipogenesis; Body weight; Branched-chain amino acids; Glutaminolysis; Insulin resistance; Milk proteins; microRNA; mTORC1; Obesity; Prostate cancer (1)
AMINO-ACID-COMPOSITION; CENTRAL-NERVOUS-SYSTEM; EUROPEAN BEEWOLF; PHILANTHUS-TRIANGULUM; BAYESIAN-INFERENCE; SPORE GERMINATION; ADAPTIVE IMMUNITY; PARASITOID WASP; BURYING BEETLES; REACTIVE OXYGEN; (1)
AMINO-ACID DECARBOXYLASE; AUTOIMMUNE; HYDROXYLASE-1; CELLS; APECED; serotonin; diarrhea; constipation; entero-endrocrine cells; Paneth cells (1)
AMINO-ACID ESTERS; METALLOMICELLES; SOLVENTS; ORIGIN; (1)
AMINO-ACID; IN-VITRO; STRATEGY; TC-99M; 1-HYDROXY-7-AZABENZOTRIAZOLE; RADIOPHARMACEUTICALS; DERIVATIVES; TECHNETIUM; LIGAND; RE; solid-phase peptide synthesis; metal complex; single amino acid chelate (1)
AMINO-ACID-METABOLISM; MAMMARY-GLAND; BOVINE-MILK; SUBCLINICAL KETOSIS; NMR-SPECTROSCOPY; KETONE-BODIES; DE-NOVO; GC-MS; CHOLINE; METHIONINE; milk metabolomics; nuclear magnetic resonance; mass spectrometry (1)
AMINO-ACID MIXTURE; POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE PATIENTS; TYROSINE DEPLETION; HANDWRITING MOVEMENTS; SUBSTANTIA-NIGRA; DRAWING MOVEMENTS; BASAL GANGLIA; TRANSCRANIAL ULTRASOUND; HEALTHY-VOLUNTEERS; dopamine; Parkinson's disease; transcranial sonography; acute phenylalanine and tyrosine depletion; handwriting; kinematic analysis (1)
AMINO-ACID NEUROTRANSMITTERS; ROSTRAL MIGRATORY STREAM; OLFACTORY-BULB CULTURES; NEWLY GENERATED NEURONS; NERVE GROWTH-FACTOR; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; 192 IGG-SAPORIN; BASAL FOREBRAIN; DENTATE GYRUS; dentate gyrus; olfactory bulb; immunotoxin; cell death; progenitor cells (1)
AMINO-ACID; NUTRITIONAL EPIDEMIOLOGY; RELATIVE VALIDITY; DISEASE; POPULATION; PATTERNS; PROJECT; PROTEIN; PLASMA; ENERGY; (1)
AMINO-ACID PERMEASE; PLASMA-MEMBRANE ATPASE; LIPID-PROTEIN INTERACTIONS; DETERGENT-RESISTANT MEMBRANES; SPHINGOID BASE SYNTHESIS; CELL-SURFACE STABILITY; SACCHAROMYCES-CEREVISIAE; INTERNALIZATION STEP; BIOLOGICAL-MEMBRANES; TRYPTOPHAN PERMEASE; (1)
AMINO-ACID PERMEASES; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; LACTOSE PERMEASE; ESCHERICHIA-COLI; PROTEIN; SHR3P; GENE; VESICLES; phosphatidyl ethanolamine (PE); arginine permease; secretary pathway retention (1)
AMINO-ACID; PROTEIN; CHORISMATE; IDENTIFICATION; PHOTOCONTROL; MECHANISM; feedback inhibition; anthranilate synthase; genetic code expansion; photoresponsive noncanonical amino acid; tryptophan (1)
AMINO-ACID RECEPTORS; NMDA RECEPTOR; ASPARTATE; ACETYLCHOLINESTERASE; INHIBITORS; GLUTAMATE; ANTAGONISTS; CHANNELS; LIGANDS; DISEASE; (1)
AMINO-ACID RECOGNITION; ION-SELECTIVE LIGANDS; MOLECULAR RECOGNITION; COPPER(II) COMPLEXES; AQUEOUS SOLVENTS; ETHOXYCARBONYL ISOTHIOCYANATE; ELECTROCHEMICAL SENSORS; ADRENALINE RECEPTORS; CARBOXYLATE BINDING; CHIRAL RECOGNITION; Guanidinium; Unnatural amino acid; Recognition; Ligand; Pyrrole (1)
AMINO-ACID-RESIDUES; BRILLIANT BLUE R-250; EARLY REGION 1B; POLYACRYLAMIDE GEL-ELECTROPHORESIS; SECONDARY STRUCTURE PREDICTION; NATIVELY UNFOLDED PROTEINS; HUMAN-PAROTID SALIVA; DNA-BINDING; UNSTRUCTURED PROTEINS; PROLINE-RICH; Adenovirus; E1B-55K; Intrinsically disordered proteins (IDPs) (1)
AMINO-ACID; R-GLUTAMYLETHYLAMIDE; ANTICIPATORY ANXIETY; BEHAVIOR; LIPOCALIN-2; INGESTION; DISORDER; CAFFEINE; RELEASE; TASTE; L -theanine; Relaxation; Stress; Anxiety; Food matrix (1)
amino acids; α -phenylpropionic acid; ibuprofen; chirality; diastereoselectivity; analysis of CSD structures; X-ray structure determination (1)
AMINO-ACIDS; DESIGN; PEPTIDOMIMETICS; SCAFFOLDS; MIMETICS; PEPTIDES; peptidomimetics; heterocycles; lactams; structure elucidation; amino acids (1)
Amino Acid Sequence Chorismate Mutase/antagonists & inhibitors/chemistry/genetics/*metabolism Cloning, Molecular DNA, Bacterial/chemistry/isolation & purification Enzyme Inhibitors/pharmacology Enzyme Stability Genes, Bacterial Kinetics Models, Molecular Molecular Sequence Data Molecular Weight Phylogeny Protein Conformation Protein Subunits/physiology Recombinant Proteins/metabolism Research Support, Non-U.S. Gov't Sequence Alignment Sequence Analysis, DNA Sequence Homology, Amino Acid Thermus thermophilus/*enzymology/*genetics Tyrosine/*pharmacology (1)
amino acids, photocatalysis, NPY, NTS (1)
Amino acids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (alkyl esters, dichloroplatinum complexes, prepn. and antitumor activity of) Cytotoxic agents Neoplasm inhibitors (dichloro(amino acid)platinum complexes) Alcohols Role: RCT (Reactant), RACT (Reactant or reagent) (aliph., reaction of, with amino acid platinum complexes in hydrochloric acid presence) chloro amino acid platinum cytostatic (1)
Amino acids Role: BIOL (Biological study) (antagonists, aminoacyl tRNA synthetase inhibitory and antileukemic activities of) Neoplasm inhibitors (leukemia, amino acid antagonists as, aminoacyl tRNA synthetase inhibition in relation to) amino acid antagonist antiproliferation tRNA synthetase (1)
Amino acids Role: RCT (Reactant), RACT (Reactant or reagent) (degrdn. and hydrolysis of, at high temp. and pressure, thermophilic microorganism in relation to); Pyrodictium occultum (high temp. and pressure effect on amino acids of, viability in relation to); Heat (on biol. mols. and microorganisms); Bacteria (thermophilic, high temp. and pressure effect on amino acids of, viability in relation to); heat thermophilic bacteria degrdn amino acid degrdn heat pressure peptide degrdn heat pressure (1)
Amino acids Role: SPN (Synthetic preparation), PREP (Preparation) (arom. amide derivs., prepn. of) amino acid amide xylyl phenylalkyl aniline dimethyl aminoacyl benzylamine aminoacyl phenethylamine aminoacyl (1)
Amino acids Role: SPN (Synthetic preparation), PREP (Preparation) (N-phthalyl, prepn. of, by substitution reactions of N-carbethoxyphthalimide, racemization in) Racemization (in substitution reactions of amino acids with N-carbethoxyphthalimide) Substitution reaction (of N-carbethoxyphthalimide with amino acids, racemization in) phthalyl amino acid substitution amino acid racemization carbethoxyphthalimide substitution racemization phthalyl amino acid (1)
AMINO-ACID SUBSTITUTIONS; ARG-GLY-ASP; CELL ATTACHMENT; ALPHA-3-BETA-1 INTEGRIN; T-CELL; ALPHA(3)BETA(1) INTEGRIN; ALPHA-4-BETA-1 INTEGRIN; NEURITE OUTGROWTH; MESANGIAL CELLS; I REPEATS; (1)
aminoarylpropylene estradiol receptor inactivity propylene aminoaryl estradiol (1)
Aminocatalysis / NMR-Spectroscopy (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; AMINO-ACIDS; ROBINSON ANNULATION; LINEAR PEPTIDES; WATER; PROLINE; CONDENSATION; ORGANOCATALYSIS; CONFORMATIONS; EFFICIENT; (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; ASYMMETRIC CONJUGATE ADDITIONS; CHIRAL BICYCLIC LACTAMS; L-GLUTAMIC ACID; STEREOSELECTIVE-SYNTHESIS; STEREOCONTROLLED SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; AMINO-ACIDS; ANALOGS; AMINOTRANSFERASE; (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; ENHANCED ANTIOPIATE ACTIVITY; HETEROCYCLIC SERIES; PEPTIDE MOLECULES; TASTE PROPERTIES; NEUROPEPTIDE-Y; ANALOGS; ALPHA; THIOSEMICARBAZONES; PEPTIDOMIMETICS; amino acids; cyclopropanes; peptidomimetics; catalysis; pyridines; indoles (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; N-ACYLIMINIUM ION; ASYMMETRIC-SYNTHESIS; HETEROAROMATIC ACRYLATES; AMINO-ACIDS; (+)-LENTIGINOSINE; (-)-SWAINSONINE; INDOLIZIDINE; INHIBITORS; DERIVATIVES; (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; NMR-SPECTROSCOPY; RELATIVE CONFIGURATION; ALPHA/BETA-PEPTIDES; ALIGNMENT MEDIA; LINEAR PEPTIDES; ENHANCED NMR; RDCS; CRYSTALLOGRAPHY; PREDICTION; conformation analysis; NMR spectroscopy; peptides; peptidic foldamers; residual dipolar couplings; unnatural amino acids (2)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; PROTEIN-COUPLED RECEPTORS; FEEDING-BEHAVIOR; PEPTIDES; NARCOLEPSY; NEUROPEPTIDE; GENE; ANTAGONISTS; REGULATOR; APPETITE; orexin; hypocretin; structure-activity relationship; CD; beta-aminocyclopropane carboxylic acids (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; RESTRICTED PEPTIDE ISOSTERES; 3 MEMBERED RING; AMINO-ACIDS; ORGANIC-SYNTHESIS; BUILDING-BLOCKS; ENANTIOSELECTIVE SYNTHESIS; 1,2,3-TRISUBSTITUTED CYCLOPROPANES; FUNCTIONALIZED CHLOROENAMINES; 1,2-CYCLOPROPANEDICARBOXYLIC ACIDS; (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; RGD PEPTIDES; ADHESION; DESIGN; amino acids; conformational analysis; integrins; peptides; structure-activity relationships (1)
Aminoglykoside · ¹⁹F NMR · NMR-Spektroskopie · RNA-Dynamik (1)
aminohydroxylations; amino acids; asymmetric catalysis; taxolTM (paclitaxel); pyridines (1)
Aminolaevulinic acid (ALA); Protoporphyrin IX; Topical; Compartment model- Pharmacokinetics (1)
Aminolevulinic acid; Fluorescein; Glioma; Survey and questionnaires (1)
Aminomethylation (by cancer-inhibiting substances) Cancer (inhibitors of, aminomethylating substances as) (1)
Aminophosphine Chalcogenides, P-Stereogenic Compounds, Hydrogen Bonds, Aggregation (1)
aminophosphines · organocatalysis · P-stereogenic compounds · synthetic methods · transition metal catalysis (1)
Aminosäureanaloga , Aminosäuren <beta-> , Neuropeptid Y , Konformationsanalyse , RGD-Sequenz , Konformation , Chemische Synthese , Aminocyclopropancarbonsäure , konformativ eingeschränkte Aminosäuren , beta-amino acids , conformationally restricted amino acids , foldamers , neuropeptide Y , RGD (1)
Aminosäureester , Enantioselektivität , Katalytische Isomerisierung , Rutheniumkomplexe , Osmiumkomplexe , Übergangsmetalle , Konfigurationsstabilität , aminoacid ester , enantioselectivity , catalytic isomerisation , ruthenium complexes , osmium complexes (1)
Aminosäuren <beta->, Aminosäuren <gamma->, Stereoselektive Synthese, Nitrone, Dipolare Cycloaddition, Piperazindion <2,5->, Diketopiperazin-Aminosäuren, Cispentacin, amino acids <beta->, amino acids <gamma->, intramolecular nitrone cycloaddition, cispentacin, diketopiperazine amino acid (1)
Aminosäuren <beta-> , Elektronentransfer , Peptidsynthese , Peptidbibliothek , Kombinatorische Synthese , Konformationsänderung , Konformationsanalyse , Aminosäuren <gamma-> , konformativ eingeschränkte Aminosäuren , Scaffolds für kombinatorische Chemie , konformationally rigid amino acids , new scaffolds for kombinatorial chemistry , Libryra synthesis photo induced electron transfer (1)
Aminosäuren <beta-> , Zirkulardichroismus , Konformationsanalyse , Schleifen , Peptidsynthese , , beta-amino acids , turns , circular dichroism , conformational analysis , peptide synthesis (1)
Aminosäuretransport, Phloem, sink Gewebe, Nematoden, Ertrag, Transport, Same (1)
AMI, Occlusion, EVAR (1)
AMITERMES ISOPTERA; ORIENTATION; ARCHITECTURE; TEMPERATURE; ANT; Australia; 'magnetic' termites; meridional termites; mound architecture; thermoregulation (1)
Amitermes meridionalis, Australia, Isoptera, microsatellites, social insects, magnetic termites, meridional, mound architecture, thermoregulation, gas exchange, food availability, building, high population differentiation, northern Australia, population genetics (1)
AML, acute myeolic leukemia, relapse, survival, stem cells, complete remission, prognostic factor, LOH, MSI, akute myeloische Leukämie, Remission, Remissionshämatopoese, Prognose, genetische Instabilität (1)
AML; Immuntherapie; TZR; HLA-DPB1 (1)
AML; Infections in Immunocompromised Hosts; Immunology; Immunotherapy; Molecular Genetics; Stem Cell Transplantation (1)
AMMONIA-BORANE; ELECTRONIC-STRUCTURE; OLEFIN HYDROGENATION; COMPLEXES; IRON; METAL; CHEMISTRY; MECHANISM; RELEASE; ROUTE; amine-boranes; catalysis; cobalt; dehydrogenation; transfer hydrogenation (1)
AMMONIA-BORANE; HYDROLYTIC DEHYDROGENATION; SODIUM-ALGINATE; METAL-IONS; GENERATION; ADSORPTION; NANOCATALYSTS; EVOLUTION; ADSORBENT; PLATINUM; NiPt nanoparticles; Catalyst; Biohydrogel; Hydrogen production; ammonia borane (1)
Ammoniak , Arsen , Blei , Chalkogenometallate , , ammonia , arsenic , lead , chalcogenometalates (1)
Ammoniak , Germanium , Käfigverbindungen , Germanide , Zintl-Anion , Germanid , germanium , germanide , ammonia , cluster (1)
AMMONIA-OXIDIZING ARCHAEA; RNA SEQUENCE DATA; METHANOGENIC ARCHAEA; NATURAL COMMUNITIES; HUMAN MICROBIOME; CLEAN ROOMS; BACTERIAL; DIVERSITY; ENVIRONMENTS; ALIGNMENT; (1)
AMMONIATE; ANION; (1)
AMMONIUM ACETATE; SURFACE FORCES; CO-ION; ADSORPTION; BILAYERS; EQUATION; BINDING; Colloid; DLVO; Poisson-Boltzmann; Potential of mean force; Self-assembled monolayer (1)
AMMONIUM-CHLORIDE; IN-VITRO; TOLERABILITY; CHLORAMINES; DIAGNOSIS; EFFICACY; AGENTS; RABBIT; NCT; acanthamoeba; candida; keratitis; antiseptic; cornea infection model; chloramines; keratoconjunctivitis (1)
ammonium, receptor, amino acid, neurotransmitter, peptide, recognition, luminescent, PET, cyclopeptide, binding, ligand, phosphate, complex (1)
amniotic fluid, amino acids, folic acid, thiocyanate, cleft of lips, jaws, palate, prevention, Amnionflüssigkeit, Aminosäuren, Folsäure, Thiocyanat, LKGS, Prävention (1)
AMNIOTIC MEMBRANE TRANSPLANTATION; MITOMYCIN-C; AUTOGRAFT TRANSPLANTATION; RANDOMIZED-TRIAL; RECURRENCE; SURGERY; SIZE; Pterygium; Pterygium surgery; Conjunctival surgery; Conjunctival autograft; Amniotic membrane transplantation (1)
AMORPHOUS CALCIUM-CARBONATE; PRE-NUCLEATION CLUSTERS; NONCLASSICAL NUCLEATION; PRENUCLEATION CLUSTERS; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BIOMINERALIZATION; PRECIPITATION; BIOMORPHS; SYSTEMS; (1)
AMORPHOUS CALCIUM-CARBONATE; THIN-FILM FORMATION; EGGSHELL MATRIX; FUNCTIONAL-CHARACTERIZATION; BIOMINERALIZATION; PROTEINS; PRECURSOR; HENS; STABILIZATION; PRECIPITATION; (2)
AMORPHOUS CALCIUM-CARBONATE; X-RAY-DIFFRACTION; ENDOPLASMIC-RETICULUM; CANDIDA-ALBICANS; ORGANIC MATRIX; PHASE; GALLOPROVINCIALIS; SYNTHETASE; ARAGONITE; POLYOXIN; (1)
AMORPHOUS CALCIUM-PHOSPHATE; RESIN-BASED COMPOSITES; ANTIBACTERIAL ACTIVITY; SURFACE-PROPERTIES; RESTORATIVE MATERIALS; DENTAL MATERIALS; PLAQUE; RELEASE; HYDROXYAPATITE; NANOCOMPOSITE; (1)
Amorphous calcium phosphate; Silicon dioxide; Composite resins; Flexural strength; Tooth remineralization (1)
AMORPHOUS FERROMAGNETS; HEISENBERG FERROMAGNETS; CURIE-TEMPERATURE; WAVES; SEMICONDUCTORS; (1)
AMORPHOUS RED PHOSPHORUS; CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; ELECTRICAL-PROPERTIES; PERIODIC-SYSTEMS; MIXED CONDUCTOR; LITHIUM; CHEMISTRY; ULTRAPHOSPHATE; AG10TE4BR3; coinage metals; indium; mineralization reactions; phosphorus; polyphosphides (1)
amoxicillin/clavulanic acid; antibiotic prophylaxis; infectious complications; transrectal prostate biopsy (1)
amperometric detection, capillary electrophoresis, dual detection concept, flow splitting, massspectrometry (1)
Amperometrie, Massenspektrometrie, Dualdetektion, Kapillarelektrophorese (1)
amphetamine anesthetics, local chemistry, pharmaceutical ephedrine experimental lab study *Amphetamine *Anesthetics, Local *Chemistry, Pharmaceutical *Ephedrine *Research 0 (Anesthetics, Local) (1)
AMPHIBIA ANURA; DIET; BRAZIL; anatomy; Anura; food spectrum analysis; gut content analysis; incision; invasive method (1)
AMPHIPHILIC BLOCK-COPOLYMERS; FRACTURE ELECTRON-MICROSCOPY; ANGLE NEUTRON-SCATTERING; D-LIMONENE; BICONTINUOUS MICROEMULSIONS; PHASE-EQUILIBRIA; GRADIENT SYSTEMS; FUEL PROPERTIES; METHYL-ESTERS; BIODIESEL; (1)
amphiphilic cyclodextrins, phospholipid model membranes, membrane modification, polyrotaxanes, sliding tethered ligands, ligand-receptor interactions (1)
AMPHIPHILIC DIBLOCK COPOLYMERS; KINETICALLY FROZEN COLLOIDS; DRUG-DELIVERY; NONIONIC SURFACTANT; BLOCK-COPOLYMERS; VIVO STABILITY; NANOPARTICLES; SYSTEMS; PEG; MACROSURFACTANTS; field flow fractionation; foerster resonance energy transfer; polymeric micelles; serum stability; transmission electron microscopy (1)
Amphitheater, öffentliche Spiele, Spielegeber, Gladiatoren, Tierhetzen, öffentliche Hinrichtungen, römische Kaiserzeit, munera gladiatoria, editor muneris, naumachia, damnatio ad bestias, damnatio ad ferrum, lanista, liber spectaculorum, amphitheatre, public games, gladiators, venationes, public executions, Roman empire (1)
AMPHITRITE DARWIN CIRRIPEDIA; LARVAL DEVELOPMENT; THORACICA; REPRODUCTION; BEHAVIOUR; GULF; SEA; (1)
Amphotericin B, AML, invasive Mykosen, Nephrotoxizität, Antimykotika, Neutropenie (1)
AMPKγ, CG9413, CG16717, CG32702, Dachshund, DP Transkriptionsfaktor, PIP5K59B, mir210, Drosophila, Nephrozyt, Nierenfunktion, kortikale Randzone, glomeruläre Filtration, Filtrationsbarriere, Schlitzmembran, Nephrozytendiaphragma (1)
Amplex Red · H2 O2 · hydrogels · hydrogen peroxide · sensors (1)
AMPLIFIED LANTHANIDE LUMINESCENCE; BIOANALYTICAL ASSAYS; REACTION VESSELS; HYDROGEL MATRIX; BINDING-SITES; PROBE; SENSITIZER; NANOTUBES; COMPLEXES; MEMBRANES; (2)
AMPLIFIED LANTHANIDE LUMINESCENCE; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; OXIDATIVE ENZYMES; SUBSTRATE-BINDING; GLUCOSE-OXIDASE; EUROPIUM PROBE; FLUORESCENCE; COMPLEX; ACID; fluorescent probes; imaging agents; immunoassays; peroxidase activity; time-resolved spectrometry (1)
AMPLIFIED SPONTANEOUS EMISSION; OPTICAL-MICROCAVITY STRUCTURE; DOO-PPV FILMS; CONJUGATED-POLYMER; ELECTROLUMINESCENT DIODES; WAVE-GUIDES; NEAT FILMS; LIGHT; LASER; GAIN; leaky mode emission; asymmetric wave-guide; luminescent polymers; multiple-beam reflection; refractive index dependence (1)
AMPLIFIED SPONTANEOUS EMISSION; ORGANIC ELECTROLUMINESCENT DEVICES; OPTICAL-CONSTANTS MEASUREMENT; SPIRO-TYPE MOLECULES; CONJUGATED-POLYMER; THIN-FILMS; 8-HYDROXYQUINOLINE ALUMINUM; FLUORESCENCE BEHAVIOR; MICRORING LASER; RHODAMINE 6G; travelling-wave lasing; amplified spontaneous emission; triphenylamine dimer TPD; TPD neat films; optical constants; absorption cross-sections; fluorescence quantum yields (1)
AMPLIFIED SPONTANEOUS EMISSION; PHOTO-PHYSICAL CHARACTERIZATION; OPTICAL-CONSTANTS MEASUREMENT; LIGHT-EMITTING DEVICES; THIN-FILMS; NEAT FILMS; ENERGY-TRANSFER; MEH-PPV; FLUORESCENCE BEHAVIOR; RHODAMINE 6G; (1)
AMPLIFIED SPONTANEOUS EMISSION; POLYMER THIN-FILMS; CONJUGATED-POLYMER; STIMULATED-EMISSION; ALTERNATING COPOLYMER; FLUORESCENCE BEHAVIOR; LUMINESCENT POLYMERS; EMITTING MATERIAL; MAIN-CHAIN; DYE-LASER; polymer lasers; thin-film lasers; TPA-based polymers; triphenylamine-vinylene-phenylenevinylene copolymers; travelling-wave lasing; amplified spontaneous emission (1)
AMPLIFIED SPONTANEOUS EMISSION; SOLID-STATE LASERS; OPTICAL-CONSTANTS MEASUREMENT; CONJUGATED-POLYMER-FILMS; SPIRO-TYPE MOLECULES; STIMULATED-EMISSION; CONDUCTING POLYMER; ORGANIC MATERIALS; THIN-FILMS; DYE-LASER; luminescent polymers; wave-guided amplified spontaneous emission; wave-guided traveling wave laser action; mirror-less lasing; leaky mode emission; optical constants; absorption behaviour; fluorescence behaviour; triphenylarnine dimers; TPD; MEH-PPV (1)
AMPLIFIED SPONTANEOUS EMISSION; SOLID-STATE LASERS; OPTICAL-CONSTANTS MEASUREMENT; EXCITON-EXCITON ANNIHILATION; SPIRO-TYPE MOLECULES; CONJUGATED POLYMERS; FLUORESCENCE BEHAVIOR; STIMULATED-EMISSION; PHENYLENE-VINYLENE; RHODAMINE 6G; organic molecular thin-film laser; thianthrene-distyrylbenzene; optical constants; absorption spectroscopy; fluorescence spectroscopy; distributed-feedback laser; travelling-wave laser (1)
AMPLITUDE; QCD; DISTRIBUTIONS; MESONS; (1)
Ampullary carcinoma, p53, maspin, SMAD4, loss of heterozygosity, chromosome 17p, chromosome 18q, microsatellite instability (1)
AMPUTATION; LIMB; Hip disarticulation; Hemipelvectomy; Amputation; Infection; Tumor; Survival (1)
AMPUTEES; (1)
AMS(MOS): 65L05. CR: 5.16 (2)
Amyloid; Amyloidosis; Primary localized cutaneous nodular amyloidosis (1)
AMYLOID BETA-PEPTIDE; HIGHLY POTENT; OXIDATIVE STRESS; DISEASE; ACETYLCHOLINESTERASE; INHIBITORS; TOXICITY; SITES; LEAD; tacrine; ferulic acid; cholinesterase inhibitor; antioxidant; anti-Alzheimer drug; hybrid molecule (1)
AMYLOID-BETA-PEPTIDE; NITROGEN-BRIDGEHEAD COMPOUNDS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CHOLINESTERASE-INHIBITORS; CHOLESTEROL ESTERASE; HUMAN ACETYLCHOLINESTERASE; MOLECULAR RECOGNITION; BIOLOGICAL EVALUATION; GENETIC ALGORITHM; (1)
; Amyloidosis; Biopsy; Conjunctiva; Fornix; Chemotherapy (1)
AMYLOID PRECURSOR PROTEIN; NITRIC-OXIDE SYNTHASE; SIGNAL-TRANSDUCTION; TEMPORAL CORTEX; HUMAN BRAIN; AGONISTS; THERAPIES; BINDING; SYSTEM; ACTIVATION; muscarinic receptors; dementia; agonist; antagonist (1)
AMYLOID PRECURSOR PROTEIN; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; BETA-SECRETASE; S-ADENOSYLHOMOCYSTEINE; STEM-CELLS; INCREASES; GENE; HYPOMETHYLATION; PRESENILIN-1; Alzheimer's disease; 5 '-Untranslated region; BACE1; DNA methylation; Microglial cells (1)
AMYLOID PRECURSOR PROTEIN; POLYUNSATURATED FATTY-ACIDS; ALZHEIMERS-DISEASE; ANTIGEN PRESENTATION; INSULIN-RESISTANCE; N-3 PUFA; RAFTS; CHOLESTEROL; CELLS; DOMAINS; disease; lipid membrane microdomain; metabolic overload (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; ASSESSMENT QUESTIONNAIRE ALSAQ-40; FUNCTIONAL RATING-SCALE; NONINVASIVE VENTILATION; SURVIVAL; DEPRESSION; VERSION; RELIABILITY; VALIDATION; VALIDITY; Amyotrophic Lateral Sclerosis (ALS); Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5); ALS treatment; "bulbar-onset" ALS (bALS); "limb-onset" ALS (lALS); EuroQol Five Dimension Five Level Scale (EQ-5D-5L); health-related quality of life (HRQoL); quality of life (QoL); symptom-specific treatment; assistive devices (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; BETA; INHIBITION; NUSINERSEN; RILUZOLE; INJURY; AGENT; TGF beta-signaling; neurogenesis; neurodegeneration; amyotrophic lateral sclerosis; GLP-ToxStudy; antisense oligonucleotide therapy; LNA (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; GUT MICROBIOTA; PARKINSONS-DISEASE; NEUROINFLAMMATION; CNS; Amyotrophic lateral sclerosis; ALS; Fecal microbiota; Gut microbiota; Microbiome; 16S rRNA gene sequencing (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; DIAGNOSTIC CLASSIFICATION; SEXUAL-DIMORPHISM; MRI; DELAY; PREDICTORS; PATHOLOGY; SPECTRUM; TRIAL; WHITE; Amyotrophic lateral sclerosis; Biomarkers; Neuroimaging; Cortical thickness; Longitudinal study; MRI (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; EPIDEMIOLOGY; CRITERIA; DISEASE; Amyotrophic lateral sclerosis; Motor neuron disease; Prognostic factors; Survival; Germany; China (1)
amyotrophic lateral sclerosis, granulocyte-colony stimulating factor, cytokines, hematopoietic stem and progenitor cells, HSPC, treatment (1)
; amyotrophic lateral sclerosis; granulocyte-colony stimulating factor (G-CSF); filgrastim; biomarker; modeling; principal component analysis (PCA); cytokines; stem cell (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; SPINAL-CORD; DIAGNOSTIC CLASSIFICATION; CORTICOSPINAL TRACT; STRUCTURAL-CHANGES; KENNEDYS DISEASE; WHITE; INVOLVEMENT; Motor neuron disease; Primary lateral sclerosis; Poliomyelitis; Neuroimaging; Clinical trials (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; ALS PATIENTS; STIMULATION; ELECTROMYOGRAPHY; DISEASE; STROKE; motor unit; motor unit number; motor unit number estimation; MUNE; electroneurography; electromyography (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; DISCHARGE RATES; DISEASE; electromyography; electroneurography; motor unit number estimation; amyotrophic lateral sclerosis (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; NEURON DISEASE; HUMAN MUSCLES; ALS PATIENTS; REPRODUCIBILITY; Amyotrophic lateral sclerosis; Motor unit number index; Motor unit number estimation; Spike-triggered averaging motor unit number estimation; Incremental stimulation motor unit number estimation (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; LOBAR DEGENERATION; GENETIC-VARIATION; HEXANUCLEOTIDE REPEAT; SUSCEPTIBILITY LOCI; DIAGNOSTIC-CRITERIA; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; COMMON VARIANTS; (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; LOBAR DEGENERATION; MUTATIONS; TAU; DISEASE; TDP-43; MASP2; Frontotemporal dementia; Genetic analysis; Association study; Amytrophic lateral sclerosis (1)
Amyotrophic Lateral Sclerosis, Magnetic Resonance Imaging, Biomarker (1)
; amyotrophic lateral sclerosis; motor neuron disease; biomarker; motor unit; MUNIX (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; DIAGNOSTIC CLASSIFICATION; PSEUDOBULBAR AFFECT; ALS; PATTERNS; MRI; DEGENERATION; INVOLVEMENT; PATHOLOGY; Amyotrophic lateral sclerosis; Neuroimaging; MRI; Diagnostic classification; Biomarker; Precision medicine (1)
Amyotrophic lateral sclerosis Motor unit number index Motor unit number estimation Spike-triggered averaging motor unit number estimation Incremental stimulation motor unit number estimation (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE MOTOR NEURONOPATHY; HEAVY NEUROFILAMENT SUBUNIT; NUCLEOCYTOPLASMIC TRANSPORT; COFACTOR-B; ALPHA-TUBULIN; CELL-DEATH; PROFILIN 1; MUTATIONS; MICRORNAS; Amyotrophic lateral sclerosis; Frontotemporal dementia; MicroRNA; TBCE; Microtubules; Zebrafish (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-OF-LIFE; SPASTIC PARAPLEGIA; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; COSTS; Motor Neuron Disease (MND); Cost of illness (COI); Health-related Quality of Life (HRQoL); Quality-adjusted life years (QALYs); Socio-economic burden; Cost-utilities (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; TEMPORAL DISPERSION; F-WAVES; NEUROPATHIES; DIAGNOSIS; CRITERIA; VELOCITY; Temporal dispersion; Demyelination; High-frequency attenuation; F-wave chronodispersion; A-waves; Motor nerve conduction (1)
ANABAENA SENSORY RHODOPSIN; TIME-RESOLVED FLUORESCENCE; EXCITED-STATE DYNAMICS; PHOTOCHEMICAL-REACTION; ELECTRON-TRANSFER; FEMTOSECOND SPECTROSCOPY; PROTON-TRANSFER; BACTERIORHODOPSIN; ABSORPTION; LIGHT; (1)
Anacardiaceae Cytotoxicity Mass spectra (butein from mosquitoxylum jamaicense ext. showed strongest cytotoxic activity than dammarenediol, 2,3-trans-3-methoxyfustin, Me gallate, sulfuretin in KB cell line) Natural products Role: NPO (Natural product occurrence), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (butein from mosquitoxylum jamaicense ext. showed strongest cytot NMR (carbon-13 butein from mosquitoxylum jamaicense ext. showed strongest cytotoxic activity than dammarenediol, 2,3-trans-3-methoxyfustin, Me gallate, sulfuretin in KB cell line) mosquitoxylum jamaicense ext cytotoxicity (1)
anaemia, anesthesia, blood transfusion, surgery, transfusion trigger (1)
Anaemia; Translational research (1)
ANAEROBIC AMMONIUM OXIDATION; GRAM-POSITIVE BACTERIA; S-LAYER; OXIDIZING BACTERIA; MASS-SPECTROMETRY; BUDDING BACTERIA; WALL POLYMERS; GLYCOSYLATION; MECHANISM; SEQUENCE; (1)
anaerobic environments; Mars; analogues; biomarkers; microarray (1)
ANAEROBIC NAPHTHALENE DEGRADATION; CRUDE-OIL BIODEGRADATION; VERTICAL FRACTURE-ZONE; COASTAL-PLAIN AQUIFER; CHAIN N-ALKANES; HYDROGEN STORAGE; DEEP-SUBSURFACE; MICROBIAL COMMUNITIES; SP NOV.; METHANOGENIC BACTERIA; Biomethanation; Methanogenic archaea; Underground gas storage; Deep reservoirs; Low carbon economy (1)
anaerobic samples, analogues, extremophiles, isolation, Mars, model organisms (1)
anakoinosis, biomodulation, metronomic chemotherapy, PPAR g, mTOR, umbrella trial, pioglitazone, molecular diagnostics (1)
anakoinosis, communicative reprogramming, master modifiers, systems biology, metastatic tumors, reprogramming information flux (1)
anakoinosis; communicative reprogramming; nuclear transcription factors; metronomic low-dose chemotherapy; glitazones; all-trans retinoic acid; COX-2 inhibitor; master modulators; undruggable targets; therapy pillar; peroxisome proliferator-activated receptors (PPARs); energy homeostasis; metabolic regulations; organ cross-talk; cancer and reprogramming of energy metabolism; systems biology (1)
Anakoinosis, communicative reprogramming, transcriptional modulators, metronomic low-dose chemotherapy, glitazones, all-trans retinoic acid, COX-2 inhibitor, master modulators (1)
anal canal | bowel symptoms | prostate cancer | prostatectomy | quality of life | radiotherapy (1)
ANALGESIC-BASED SEDATION; ETHICAL CONFLICTS; ONCOLOGY PATIENTS; PHYSICIANS; LEGITIMACY; SERVICES; DISEASE; BORDER; Emergency medicine; Palliative medicine; Emergency medical algorithms; Advance directive; End-of-life decisions (1)
ANALGESIC-BASED SEDATION; OFF-LABEL USE; JUDICIAL LEGITIMACY; MORPHINE; DRUGS; SUPERVISION; COMPETENCE; OPIOIDS; TRAUMA; EMS; Emergency medical services; Emergency authority; Standard authorization; Algorithms; Professional competence (1)
Analysenmessgerät, Digitales Messgerät, Elektronisches Messgerät, Temperaturmessung, Quarzmikrowaage, Potentiostat, measurement equipment, potentiostat, QCM, thermometer (1)
ANALYSIS GENE-EXPRESSION; CAP-ANALYSIS; TRANSCRIPTIONAL LANDSCAPE; FUNCTIONAL ANNOTATION; NATIONAL CENTER; HUMAN GENOME; RNA-SEQ; DATABASE; ONTOLOGIES; MOUSE; (1)
ANALYTICAL DEVICES; BIOSENSORS; DOPAMINE; MEDIA; Electroanalytical Electrochemistry; Electrochemical Engineering; Sensors; Theory and Modelling (1)
ANALYTICAL ENERGY GRADIENTS; PHENOL-WATER CLUSTERS; UV DOUBLE-RESONANCE; INTERMOLECULAR VIBRATIONS; MODEL CC2; THEORETICAL CHARACTERIZATION; IDENTITY APPROXIMATION; PERTURBATION-THEORY; ABSORPTION-SPECTRA; SUPERSONIC JET; (1)
ANALYTICAL-MODEL; SPECTROSCOPY; ULTRAFAST; POLARITONS; ABSORPTION; NANOWIRES; PROBES; TIP; scattering-type SNOM; mid-infrared; nanoscopy; tomography; finite element method; demodulated fields (2)
analytical science, surface plasmon resonace (SPR), mass spectroscopic, electrochemistry, lateral flow assay (LFA) (1)
ANALYTIC CONTINUATION; PARTON DISTRIBUTIONS; EXCLUSIVE PROCESSES; WAVE-FUNCTIONS; FORM-FACTOR; LIGHT-CONE; QCD; EXPANSION; EVOLUTION; FACTORIZATION; perturbative corrections; deeply virtual compton scattering; conformal symmetry (1)
ANALYTIC HIERARCHY PROCESS; PORTFOLIO SELECTION; CHAIN MANAGEMENT; ORDER ALLOCATION; MUTUAL FUNDS; SUSTAINABILITY; RISK; PERFORMANCE; CRITERIA; OPTIMIZATION; Supply chain management; Supplier selection; Sustainability; Logistics; Decision support systems (1)
ANALYTIC SPACES; COHOMOLOGY; CATEGORIES; LIMITS; Stein space; Berkovich space; Bornological space; Nuclear space (1)
ANALYTIC SPACES; PIECEWISE POLYNOMIALS; INTERSECTION THEORY; VARIETIES; SUBVARIETIES; HEIGHTS; differential forms on Berkovich spaces; Chambert-Loir measures; tropical intersection theory; nonarchimedean Arakelov theory (1)
ANALYTIC SPACES; UNIFORMIZATION; REDUCTION; THEOREM; pluripotential theory; non-archimedean geometry; test ideals (1)
ANALYTIC TORSION; CHERN CHARACTER; VECTOR-BUNDLES; INDEX THEOREM; SINGULARITIES; RESOLUTION; VARIETY; FIELD; Regulators; Beilinson's regulator; Absolute Hodge cohomology; Differential cohomology; Differential algebraic K-theory; Lott's conjecture (1)
Analytic varieties, algebraic varieties, amoebas, coamoebas, logarithmic limit sets, phase limit sets, spherical polyhedrons (1)
Anämie, cGKI, cGMP, IRAG, IRAG1, PKGI, Splenomegalie (1)
ANAPHASE-PROMOTING-COMPLEX; APC-DEPENDENT PROTEOLYSIS; MITOTIC CYCLIN CLB2; KEN-BOX MOTIFS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; PHOSPHATASE CDC14; CHROMOSOME ARMS; NUCLEAR EXPORT; S-PHASE; (1)
ANAPHASE-PROMOTING-COMPLEX; MITOTIC CHECKPOINT COMPLEX; DEPENDENT NUCLEAR EXPORT; CELL-CYCLE CONTROL; SACCHAROMYCES-CEREVISIAE; MULTISITE PHOSPHORYLATION; S-PHASE; FLUORESCENT PROTEIN; DEGRON RECOGNITION; GLOBAL ANALYSIS; (1)
ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT GENES; POLO-LIKE KINASE-1; BETA-CATENIN; COLORECTAL-CANCER; FUNCTIONAL INTERACTION; APC; CELLS; MUTATIONS; SPINDLE; Axin2/conductin; colorectal cancer; Wnt signaling; spindle checkpoint; APC (1)
anaphylaxis, anti-IgA, immunetolerance, intravenousimmunoglobulins (1)
ANAPLASTIC GLIOMAS; GLIOBLASTOMA; TRIAL; TUMORS; CLASSIFICATION; ASTROCYTOMAS; TEMOZOLOMIDE; METHYLATION; PROGNOSIS; Glioblastoma; Anaplastic glioma; Precision oncology; Stratification; Biomarker (1)
ANASTATICA-HIEROCHUNTICA; NEGEV DESERT; TEMPERATURE; DISPERSAL; SALINITY; STORAGE; LIGHT; POPULATIONS; SEROTINY; ISRAEL; Arabian Gulf; desert climate; light; seed germination; temperature (1)
Anästhesie, Lunge, Blood Air Barrier Model, Diffusion (1)
Anästhesie, Neurochirurgie, Intensivmedizin, Abführverhalten, Hirndruck, anesthesia, neurosurgery, intensive care, defecation pattern, intracranial pressure (1)
Anästhesie, Prämedikation, QM, Patientenaufklärung, perioperative Betreuung, Prozessoptimierung, Universitätsklinikum (1)
anastomotic leakage, laboratory parameters, open vs. laparoscopic bowel resection (1)
ANASTOMOTIC STENOSES; PLACEMENT; THERAPY; Venous intervention; Stenting; Vena cava; Liver; Stenosis (1)
ANATOMICAL VARIATION; CADAVER SPECIMENS; SURGERY; RHINOPLASTY; CARTILAGE; EPISTAXIS; Nasal septum; Anatomy; Silastic splints; Surface pressure; NdFeB magnets (1)
; anatomy; body worlds exhibition; plastination; medical teaching; emotional reactions; health prevention (1)
ANATOMY; MODELS; credit rating; basel II; backtesting; risk management; credit risk modeling (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, ed5438, uncovers, self-learning (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, foxp, mutants, deficient, operant, self-learning (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, isoform, operant (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, morphological, alterations, brains (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, mutant, impaired, operant, self- (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, mutants, isoform (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, operant (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, sequences, phylogenetic, foxp, subfamily (1)
ANCA-ASSOCIATED VASCULITIS; LUPUS NEPHRITIS; INDUCTION TREATMENT; RANDOMIZED-TRIAL; IGA NEPHROPATHY; INTRAVENOUS CYCLOPHOSPHAMIDE; MYCOPHENOLATE-MOFETIL; THERAPY; RITUXIMAB; ANCA-assoziierte Vaskulitis; IgA-Nephropathie; Lupusnephritis; Therapie; ANCA-associated vasculitis; IgA-Nephropathy; Lupus nephritis; treatment (1)
ANCA-ASSOCIATED VASCULITIS; REMISSION-INDUCTION; IGA NEPHROPATHY; CYCLOPHOSPHAMIDE; glomerulopathy; IgA nephropathy; ANCA-associated vasculitis; hemolytic-uremic syndrome (1)
ANCA-IFT, ANCA-assoziierte-Vaskulitis, Screeening (1)
ANCESTRAL SEQUENCE RECONSTRUCTION; PROTEINS; IDENTIFICATION; MECHANISMS; COMPLEXES; REVEALS; ENZYME; ancestral sequence reconstruction; enzyme; ether lipids; oligomerization; protein evolution; protein stability; thermostability (1)
ancient DNA (aDNA), human mitochondrial DNA haplogroup, DNA profiling, polymerase chain reaction (PCR), Early Neolithic, Bandkeramik (LBK), Ukraine (1)
ANCIENT ESCAPE CIRCUIT; AVIAN PREDATOR; VARIABILITY; PERSONALITY; BEHAVIOR; EXPLOITATION; SENSITIVITY; EVOLUTION; NETWORK; BRAIN; (1)
Ancient grasslands, Biodiversity, Bohemian Karst, Central Europe, Conservation value; Dry grassland vegetation; Jurassic mountains, Land use indicators; Recent grasslands, Soil properties, Soil seed bank, Species richness. (1)
Anderson localization, quantum Hall effect, disordered systems, symmetries, many-body localization, thermalization, ergodicity, criticality, topological materials (1)
ANDERSON MODEL; MIXED-VALENCE; EQUILIBRIUM; STATES; APPROXIMATION; TRANSPORT; SYSTEMS; (1)
ANDERSON MODEL; RENORMALIZATION-GROUP; MIXED-VALENCE; EQUILIBRIUM; STATES; ALLOYS; METALS; (1)
ANDERSON MODEL; TRANSPORT; (1)
Anderson transitions, Quantum Hall effect, Dephasing, Multifractality (1)
ANDERSON TRANSITIONS; TRANSPORT; EIGENVALUES; PERCOLATION; SYMMETRIES; STATES; (1)
Andreev bound states, Andreev reflection, Josephson effect, Rashba coupling, Diodes (1)
ANDREEV BOUND-STATES; JOSEPHSON; TRANSPORT; RELAXATION; TRANSITION; IMBALANCE; NANOWIRE (1)
ANDREEV BOUND-STATES; MAJORANA FERMIONS; FERROMAGNET; SUPERCONDUCTIVITY; IMPURITY; SPECTROSCOPY; NANOWIRE; BARRIER; PHASE; (1)
ANDREEV BOUND-STATES; TRANSPORT; JOSEPHSON; (1)
ANDREEV BOUND-STATES; TRANSPORT; SUPERCONDUCTOR; REGIME; (1)
ANDREEV REFLECTION; ROOM-TEMPERATURE; MAGNETORESISTANCE; SUPERCURRENTS; (1)
ANDREEV-REFLECTION; SPIN POLARIZATION; EXCESS CURRENTS; FERROMAGNET; SUPERCURRENTS; FIELD; METAL; FILMS; CO; superconducting triplet pairing; polarized neutron reflectometry; paramagnetic Meissner response (1)
ANDROGEN-DEPRIVATION THERAPY; BICALUTAMIDE 150 MG; MEDIAN FOLLOW-UP; BILATERAL ORCHIECTOMY; RADICAL PROSTATECTOMY; RANDOMIZED-TRIALS; STANDARD CARE; CASTRATION; DIETHYLSTILBESTROL; MONOTHERAPY; prostate cancer; hormone therapy; castration; maximal androgen blockade; flare phenomenon (1)
ANDROGEN DEPRIVATION THERAPY; BREAST-CANCER; RT-QPCR; ESTROGEN; STAGE; SUBTYPES; IDENTIFICATION; PROGRESSION; VALIDATION; RECURRENCE; Androgen receptor; Bladder cancer; Estrogen receptor; ESR; Progesterone receptor; Urothelial carcinoma (1)
ANDROGEN RECEPTOR EXPRESSION; EFFERENT DUCTULE EPITHELIUM; MALE REPRODUCTIVE-ORGANS; ELECTRON-MICROSCOPY; ESTROGEN-RECEPTORS; BULL; EPIDIDYMIS; TESTIS; LIGHT; DIFFERENTIATION; rete testis; efferent ductules; urogenital junction; ultrastructure; bovine (1)
; Android; Malware; Automated analysis; Machine learning (1)
Anellation • Cu photocatalysis • Heterocycles •Radical pathway • α-nitro radicals (1)
anemia, chronic kidney disease, geography, glomerular filtration rate, hemoglobin, sex (1)
Anemia, Immune hemolysis, Hemolytic anemia, Autoimmune hemolytic anemia (1)
anesthesiology, bibliometry, children, internationalization, publications, resear (1)
Anesthetics (3-[(3-hydroxy-1-methylpropyl)amino]butyric acid derivs. as local) (1)
Anesthetics (aminoacyl 2,6-xylidides) aminoacyl aniline anesthetic aniline aminoacyl anesthetic anesthetic aminoacyl aniline (1)
Anesthetics (ar-alkoxy-N-alkyl-alpha -phenylbenzylamines as) Schiff bases Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (prepn. and reaction of, with phenyllithium) AMINES BENZHYDRYL ALKYL BENZHYDRYL ALKYL AMINES ALKYL BENZHYDRYL AMINES (1)
ANESTHETICS BENZHYDRYLAMINES BENZHYDRYLAMINES ANESTHETICS (1)
Anesthetics (cinchocaine homologs as local) cinchocaine homologs anesthetic activity anesthetic activity cinchocaine homologs dibucaine analogs anesthetics Nupercaine analogs anesthetics (1)
Anesthetics (local, dimethylaniline and ephedrine enantiomers as) local anesthetic membrane protein nerve conduction anesthetic (1)
Anesthetics (local, mechanism of action of) review local anesthetic nerve anesthetic review (1)
Anesthetics (local) Psychotherapeutic agents (parasympatholytic activity of) Parasympatholytic substances (psychotherapeutic agents as) Psychotomimetic agents (review on) (1)
Anesthetics (N-aminoacylephedrine derivs. as local) Nerves (blocking agents for, N-aminoacylephedrine derivs. as, chemoreceptors and) Hydrocinnamamide Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (anesthetic activity of, nerve receptor and) EPHEDRINES PHENYLALANINE PHENYLALANINE EPHEDRINES ANESTHETICS EPHEDRINES (1)
Anesthetics (N-aminoacyl ephedrine isomers as local) Molecular structure-biological activity relationships (androgen-inhibiting, of D-homosteroids and 1,2-methylene steroids) Molecular structure-biological activity relationships (anesthetic, of N-aminoacyl ephedrine stereoisomers) ANESTHETIC EFFECT AMINOACYL EPHEDRINES AMINOACYL EPHEDRINES ANESTHETIC EFFECT EPHEDRINES STEREOISOMERS ANESTHESIA (1)
Anesthetics (N-aminoacylephedrines as) AMINOACYLEPHEDRINES ANESTHETICS EPHEDRINES EPHEDRINES ANESTHETICS (1)
Anesthetics (pharmacology of local) anesthetics mechanism review review mechanism anesthetics (1)
Anesthetics (piperidinomethylbenzamide derivs. as local) piperidinomethylbenzamides local anesthetics local anesthetics anesthetics local benzamides local anesthetics (1)
ANESTHETIC TECHNIQUE; RETROSPECTIVE ANALYSIS; EPIDURAL-ANESTHESIA; LOCAL-ANESTHETICS; SURGERY; RECURRENCE; APOPTOSIS; ANALGESIA; ROPIVACAINE; RECOVERY; Lidocaine; local anesthetics; cell proliferation; apoptosis; cell cycle (1)
Aneurysma, CFD-Simulation, A. basilaris, Hitzdrahtanemometrie, aneurysm, basilar artery, hot-wire anemometry (1)
ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR CERVICAL DISKECTOMY; LUMBAR DISC SURGERY; SEVERE HEAD-INJURY; POSTOPERATIVE PAIN; SURGICAL RESEARCH; MILD HYPOTHERMIA; DOUBLE-BLIND; PILOT TRIAL; THERAPY; citation index; evidence-based medicine; literature review (1)
ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; NEUROPEPTIDE; ISCHEMIA; MIGRAINE; ARTERIES; DAMAGE; CGRP; Calcitonin-gene related peptide; Cerebral vasospasm; Neuropeptide Y; Neuropeptides; Subarachnoid hemorrhage (1)
; aneurysm; coil; device; drug; platelets (1)
Aneurysm; dissecting; Stents; Surgical procedures; operative (1)
; aneurysm; ductus arteriosus; congenital; infancy (1)
ANEURYSM REPAIR; CRITERIA; MIGRATION; ENDOLEAK; HOSTILE; RISK; sealing zone; EVAR; AAA; Delphi consensus (1)
ANEURYSM REPAIR; EXPERIENCE; ANATOMY; TRIAL; Abdominal aortic aneurysm; Endovascular aneurysm repair; Gore Excluder; Repositioning; Proximal deployment (1)
Anforderungen, Identitätsmanagement, Geschäftsprozess, Geschäftsprozessmodell, Modellierung, Sicherheitsanforderungen, UML, Zugriffskontrolle, Zugriffskontrollaussagen (1)
Anforderungen, Identitätsmanagement, Geschäftsprozess, Geschäftsprozessmodell, Modellierung, Sicherheitsanforderungen, Zugriffskontrolle, Zugriffskontrollaussagen (2)
Angeborene Immunität , Rekombinantes Protein , Sepsis , Toll-like-Rezeptoren , Immunreaktion , Lipopolysaccharide , Lipopolysaccharid , Fusionsprotein , innate immunity , Toll-like receptors , sepsis , recombinant protein , lipopolysaccharid , fusion protein (1)
Angelica archangelica (Iberogast contg. Angelicae radix ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Carum carvi (Iberogast contg. Carum carvi ext. carvone showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Chelidonium majus (Iberogast contg. Chelidonium majus ext. chelidonic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Glycyrrhiza glabra (Iberogast contg. Glycyrhiza glabra ext. glycyrrhizic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberis amara (Iberogast contg. Iberis amara ext. glucoberin, cucurbitamine E and I showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Bioavailability Human (Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Matricaria chamomilla (Iberogast contg. Matricaria reticulata ext. bisabololoxide A showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Melissa officinalis (Iberogast contg. Melissa officinalis ext. rosamarinic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Mentha piperita (Iberogast contg. Mentha piperita ext. menthol showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Silybum marianum (Iberogast contg. Silybum marianum ext. silibinin showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Adenocarcinoma Colon neoplasm (colon adenocarcinoma Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberogast natural pharmaceutical absorption bioavailability colon adenocarcinoma (1)
Angewandte Chemie, Chemie, Aufklärung, Institutionalisierung, Kameralistik, Ökonomie, Universitäten, Utilitarismus; Johan Gottschalk Wallerius; XVIII Jh . (1)
Angewandte Ethik, Moralische Begründung, Prinzipilismus, Verantwortung, Pflicht, Praxisnormen, Individualethik (1)
Angewandte Geomorphologie , Amberg <Oberpfalz> , Bergbau , Fließgewässer , Schmidmühlen , Landschaftsentwicklung , Mittelalter , Vils <Oberpfalz, Fluss> , Altkartenanalyse , historic maps , historic mining , fluvial geomorphology (1)
Angewandte Informatik , Informatikunterricht , Datenanalyse , UNIX , Systemadministration , Evaluierung , Unix , Virtuelles Unix Labor , System administration , evaluation , Unix , Virtual Unix Lab (1)
Angewandte Physik , Heterostruktur , Lithographie <Halbleitertechnologie> , Halbleiter , Ladungstransport , Magnetismus , Nanostrukturiertes Material , Mikro-Hall-Magnetometrie , Aharonov-Bohm-Effekt , Berry-Phase , 2DEG , Nanostrukturen , micro-Hall-magnetometry , Aharonov-Bohm-effect , Berry-phase , 2DEG , nanostructures (1)
Angiogenese , CAM , Galactane , Interaktion , Fibroblastenwachstumsfaktor , Entzündung , Gliom , Galactansulfat , VEGF , Interleukin-2 , inflammation , glioma , galactan sulfate , VEGF , interleukin-2 (1)
Angiogenese, Müllerzellen, Frühgeborenenretinopathie, OIR, beta-Catenin, Retina, Mäuse, Tamoxifen, Cre-Rekombinase, Wnt (1)
ANGIOGENESIS; CELLS; INHIBITION; GROWTH; CINCA; Skin ulcer; ProstaglandinE; Angiogenesis; Wound healing (1)
ANGIOGENESIS; GROWTH; INHIBITOR; EFFICACY; CELLS; angiogenesis; cancer; drug administration; immunosuppression; post-transplant malignancy; rapamycin (1)
ANGIOGENESIS; INHIBITION; CANCER; (1)
ANGIOGENESIS IN-VITRO; HUMAN FACTOR-VIII; GENE-THERAPY; TUBE FORMATION; VIVO; INDUCTION; EXPRESSION; MICE; DIFFERENTIATION; MICROVESSELS; (1)
ANGIOGENIC FACTORS; EXPRESSION; PREGNANCY; INHIBITION; PREDICTION; PERFUSION; PRESSURE; PLACENTA; hypertension; mice; placenta; pregnancy; trophoblast (1)
ANGIOGENIC FACTORS; TYROSINE KINASE-1; PREDICTION; DIAGNOSIS; PREECLAMPSIA; PREGNANCY; FEMUR; CLASSIFICATION; HYPERTENSION; ASSOCIATION; Fetal growth restriction; sFlt-1; PlGF; Soluble Fms-like tyrosine kinase 1; Placental growth factor; Time to delivery; Feto-maternal Doppler parameters (1)
ANGIOGRAPHY (1)
Angiography, arteries, central venous catheter, percutaneous closure device, vascular interventional radiology (1)
ANGIOGRAPHY; arteries; transluminal angioplasty; magnetic resonance (MR) guidance; stents and prostheses; passive instrument visualization (1)
ANGIOGRAPHY SOURCE IMAGES; ACUTE ISCHEMIC-STROKE; INTRAARTERIAL THROMBOLYSIS; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; INFARCT CORE; OCCLUSION; MRI; RECANALIZATION; ALTEPLASE; CT perfusion; basilar artery occlusion; pc-ASPECTS (1)
ANGIOLYMPHOID HYPERPLASIA; CLONALITY; EOSINOPHILIA; Kimura's disease; hard palate; timorous lesion; oral cancer; inflammatory disease (1)
*Angiosperms: CH, chemistry Cell Line Chemiluminescent Measurements *Furans: CH, chemistry Humans Lignans: CH, chemistry *Lignans: IP, isolation & purification Lignans: PD, pharmacology *Luminol: CH, chemistry Neutrophils: DE, drug effects 0 (Furans) 0 (Lignans) (1)
ANGIOSTATIC THERAPY; PHASE-II; KAPPA-B; PIOGLITAZONE; TROFOSFAMIDE; ROFECOXIB; DISEASE; VEMURAFENIB; ETORICOXIB; CARCINOMA; Langerhans-cell-histiocytosis; biomodulation; anakoinosis; metronomic chemotherapy; anti-inflammation (1)
Angiotensin 1-9, Cardiomyocyte hypertrophy, Calcium Handling, Mitochondrial Dynamics. (1)
ANGIOTENSIN-CONVERTING ENZYME; (1)
ANGIOTENSIN-CONVERTING ENZYME; ATRIAL-NATRIURETIC-FACTOR; NITRIC-OXIDE; ALDOSTERONE; ENDOTHELIN; LUNG; HYPERTENSION; HEMODYNAMICS; DISEASE; HUMANS; chronic hypoxia; endothelin; nitric oxide; renal renin expression (1)
ANGIOTENSIN-CONVERTING ENZYME; DOWN-REGULATION; CULTURED HUMAN; JUXTAGLOMERULAR CELLS; ENDOTHELIAL-CELLS; AS4.1 CELLS; TNF-ALPHA; ENDOTOXIN; RECEPTOR; INTERLEUKIN-1; As4.1 cells; juxtaglomerular cells; knockout mice (1)
ANGIOTENSIN CONVERTING ENZYME; II RECEPTOR SUBTYPES; RAT-BRAIN; CRE RECOMBINASE; IMMUNOCYTOCHEMICAL LOCALIZATION; GENE-TRANSCRIPTION; GS-ALPHA; SYSTEM; TISSUE; MICE; Brain renin-angiotensin system; Neurochemistry; Brain development (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE; DELETION POLYMORPHISM; MYOCARDIAL-INFARCTION; ASSOCIATION; RENIN; RISK; MEN; ACE-gene; polymorphism; heart (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR HYPERTROPHY; DELETION POLYMORPHISM; HEART-FAILURE; SYSTEMIC HYPERTENSION; INTERVAL DISPERSION; ARRHYTHMIC EVENTS; RISK FACTOR; GENE; MORTALITY; ACE polymorphism; renin angiotensin system; myocardial infarction; QT dispersion; remodelling (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR MASS; GENDER-SPECIFIC DIFFERENCES; BRAIN NATRIURETIC PEPTIDE; BLOOD-PRESSURE LEVELS; BETA-3 SUBUNIT GENE; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; ANTIHYPERTENSIVE DRUGS; ARTERIAL-HYPERTENSION; left ventricular hypertrophy; heart failure; genetics; obesity (1)
ANGIOTENSIN-CONVERTING-ENZYME; PRESSURE-OVERLOAD HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; EXPERIMENTAL HEART-FAILURE; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; AORTIC-STENOSIS; ANTIHYPERTENSIVE THERAPY; GENE-EXPRESSION; tissue ACE; angiotensin-converting enzyme inhibitors; endothelial dysfunction; cardiovascular disease (1)
ANGIOTENSIN-CONVERTING ENZYME; PRESSURE-OVERLOAD; PERIOSTIN EXPRESSION; CARDIAC-HYPERTROPHY; TRANSCRIPTIONAL REGULATION; DD-GENOTYPE; RISK-FACTOR; RECEPTOR; SYSTEM; MOUSE; Heart failure; Transverse aortic constriction; Gene expression; Genetic background; Cardiac function (1)
ANGIOTENSIN-CONVERTING ENZYME; RECEPTOR KNOCKOUT MICE; CAT ELECTRORETINOGRAM; OCULAR-TISSUES; GANGLION-CELLS; BLOOD-PRESSURE; MESSENGER-RNA; BOVINE EYE; SECRETION; KIDNEY; blood barrier; angiotensin; AT(1); water deprivation (1)
ANGIOTENSIN-CONVERTING-ENZYME; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE-SYNTHASE; ATRIAL-NATRIURETIC-PEPTIDE; MESSENGER-RNA EXPRESSION; SYMPATHETIC-NERVE ACTIVITY; BRADYKININ B-2 RECEPTOR; SPONTANEOUSLY HYPERTENSIVE-RATS; TISSUE-SPECIFIC EXPRESSION; MACULA DENSA CONTROL; (1)
Angiotensin II, Albumin, glomeruläre Filtrationsbarriere (1)
ANGIOTENSIN-II; CARDIAC MACROPHAGES; OSTEOPONTIN; FIBROSIS; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; MECHANISMS; CELLS; (1)
ANGIOTENSIN-II; GENE-TRANSFER; QUANTUM DOTS; RIBONUCLEASE; EXPRESSION; TRANSFECTION; ACTIVATION; MEMBRANE; CULTURE; (1)
ANGIOTENSIN-II; GLOMERULAR MESANGIUM; POLYETHYLENE-GLYCOL; DRUG-DELIVERY; RECEPTOR; VIRUS; BINDING; AT(1); INTERNALIZATION; TRAFFICKING; mesangial cells; multivalent nanoparticles; renal targeting; stepwise cell recognition; virus-mimetic (1)
ANGIOTENSIN-II; QUANTUM DOTS; IN-VIVO; INTRAVENOUS-INJECTION; DIABETIC-RETINOPATHY; ENDOTHELIAL-CELLS; RECEPTOR BLOCKADE; NEOVASCULARIZATION; INFLAMMATION; CANDESARTAN; Multivalency; EXP3174; Quantum dots; Age-related macular degeneration; Diabetic retinopathy; Angiotensin II (1)
ANGIOTENSIN-II RECEPTORS; SUBFORNICAL ORGAN; VASOPRESSIN RELEASE; RAT-BRAIN; CIRCUMVENTRICULAR ORGANS; PARAVENTRICULAR NUCLEUS; WATER-BALANCE; LOSARTAN; EXPRESSION; EFFERENTS; autoradiography; brain nuclei; angiotensin II; rat (1)
ANGIOTENSIN-II RECEPTOR; TRUNCATED AT(1A) RECEPTOR; MUSCLE-CELL-GROWTH; TYPE-1 RECEPTOR; GENE-EXPRESSION; INTERACTING MOLECULE; SIGNAL-TRANSDUCTION; RENIN SECRETION; AT1 RECEPTOR; RAT-KIDNEY; (1)
ANGIOTENSIN-NEPRILYSIN INHIBITION; LATE SODIUM CURRENT; PROTEIN-KINASE-II; NATRIURETIC PEPTIDE; CA2+ LEAK; SACUBITRIL/VALSARTAN; ARRHYTHMIAS; DYSFUNCTION; LCZ696; Heart failure; Entresto; Neprilysin inhibition; Ca cycling; SR Ca leak; Arrhythmia (1)
ANGLE NEUTRON-SCATTERING; ALKYL SULFATE MICELLES; CHAIN-LENGTH; DYNAMICS; DEPOLARIZATION; COUNTERION; LIFETIME; PROBES; MODEL; CORE; dyes; fluorescence spectroscopy; micelles; porphyrinoids (1)
ANGLE NEUTRON-SCATTERING; DODECYL-SULFATE MICELLES; ELECTRON-SPIN RESONANCE; AQUEOUS NABR SOLUTIONS; TO-ROD TRANSITION; IONIC SURFACTANTS; GEMINI SURFACTANTS; DODECYLTRIMETHYLAMMONIUM CHLORIDE; AIR/WATER INTERFACE; MAGNETIC-RELAXATION; (1)
ANGLE NEUTRON-SCATTERING; METHANOL PLUS 1-OCTANOL; NANO-DROPLET FORMATION; TERNARY-SYSTEMS; MICELLAR-SOLUTIONS; BINARY-MIXTURES; WATER; ETHANOL; EQUILIBRIUM; SOLVATION; (1)
ANGLE NEUTRON-SCATTERING; OIL MICROEMULSIONS; WATER; SYSTEMS; SURFACTANTLESS; SOLVENT; HEXANE; (1)
ANGLE NEUTRON-SCATTERING; WEAKLY STRUCTURED MIXTURES; CUBIC PHASE; BEHAVIOR; NANOPARTICLES; TRANSITION; SURFACTANT; WATER; MICROSTRUCTURE; SOLVENT; (1)
ANGLE NEUTRON-SCATTERING; X-RAY-SCATTERING; BICONTINUOUS MICROEMULSIONS; ELECTRICAL-CONDUCTIVITY; TERNARY MICROEMULSIONS; INTERFACIAL-TENSION; REVERSE MICELLES; PERCOLATION; MICROSTRUCTURE; VISCOSITY; (1)
ANGLE NEUTRON-SCATTERING; X-RAY-SCATTERING; INTERFACIAL CURVATURES; OIL MICROEMULSIONS; DETERGENTLESS MICROEMULSIONS; BICONTINUOUS MICROEMULSIONS; ENZYMATIC-REACTIONS; CONTRAST VARIATION; PHASE-DIAGRAM; MIXTURES; (1)
angles (1)
ANGLE-SPINNING NMR; NUCLEAR-MAGNETIC-RESONANCE; HYDROGEN-BOND GEOMETRY; SOLID-STATE; TRIPHENYLPHOSPHINE OXIDE; CRYSTAL-STRUCTURE; SPECTROSCOPIC SIGNATURES; NEUTRON-DIFFRACTION; MOLECULAR-STRUCTURE; SHIELDING TENSOR; (1)
Angstpatient, Kommunikation, Zahnmedizin, Zahnarzt, Angst, Phobie, Crossmediales Seminar, Blended Learning, Selbstgesteuertes Lernen, Problemorientiertes Lernen, Problembasiertes Lernen, E-Learning, Multimedia, Neue Medien, Interaktivität, Lernplattform, Universität, fear patients, anxious patients, dentist, dentistry, anxiety, phobia, communication, cross-media, self-directed learning, problem-oriented learning, new media, interactivity, learning plattform, university (1)
Angular distribution function; Photoionization; Photolysis; Singlet state transition; Velocity (velocity-map ion-imaging of NO fragment from UV-photodissocn. of nitrosobenzene); photodissocn UV nitrosobenzene velocity map ion imaging (1)
ANGULAR-DISTRIBUTIONS; QUARK; NUCLEON; MODEL; (1)
ANGULAR-MOMENTUM; GENERATION; EXCITATION; ELECTRON; DYNAMICS; REVERSAL; PULSES; METALS; NI; (1)
ANGULAR RECONSTITUTION; BREVIBACTERIUM LINENS; THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURES; CARBOXYSOME SHELL; PROTEIN; PEROXIDASE; RESOLUTION; FERRITIN; SEQUENCE; (1)
ANGULAR STABLE PLATE; INTERNAL-FIXATION; OPERATIVE TREATMENT; ELDERLY-PATIENTS; TRIAL; BONE; AUGMENTATION; PRESERVATION; MANAGEMENT; REDUCTION; Proximal humeral fracture; Dynamic fixation; Gliding humerus plate; PHILOS (1)
anharmonicity | dissociation energy | Morse potential | potential energy surface | protonated inert gases | scalar coupling | term approximation (1)
ANHARMONIC LATTICES; EXOTIC SOLITONS; ACOUSTIC-WAVES; EQUATION; MODES; MEDIA; (1)
Anharmonic molecular vibration; Electronic transition; Franck-Condon principle; Morse potential; Photolysis; Rotamers; UV and visible spectra; Vibronic level (measurement and assignment of vibrationally resolved UV absorption spectrum of syn-Me nitrite isolated in argon matrix at 12 K); anharmonic vibration UV absorption spectra methyl nitrite rotamer (1)
Animal *Antibodies, Monoclonal Antigens, Surface/*analysis Cell Adhesion Cell Aggregation Cell Membrane/immunology/ultrastructure Dictyostelium/*immunology/physiology Glycoproteins/*analysis Hybridomas/immunology Mice Microscopy, Electron Microscopy (1)
ANIMAL-ASSISTED THERAPY; HUMAN HEALTH; OSTRACISM; PETS; ACCEPTANCE; REJECTION; BEHAVIOR; PROGRAM; ANXIETY; BELONG; Social exclusion; Companion animal; Coping; Mental health (1)
Animal cell line (Caco-2 cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Animal cell line (KB cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Antitumor agents (carcinoma cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) New natural products (comnostins A-E (diterpenoids) Biomphalaria glabrata Molluscicides (cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Antibiotics Configuration (novel extracellular diterpenoids with biol. activity from the cyanobacterium Nostoc commune) Diterpenes Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence Crystal structure (of comnostin A) Molecular structure (of comnostins A-E (diterpenoids) cyanobacteria bioactive diterpenoid comnostin bioactive diterpenoid Nostoc antibiotic comnostin Nostoc molluscicide comnostin B Nostoc cytotoxicity comnostin B Nostoc crystal structure comnostin A (1)
Animal cell line (Caco-2 Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Cytotoxic agents Echinacea atrorubens Human Intestine Pharmacokinetics (Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Amides Role: PKT (Pharmacokinetics), BIOL (Biological study) (Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Echinacea alkamide transport Caco2 human intestinal absorption (1)
Animal cell line (JURKAT cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) Animal cell line (KB cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) New natural products (ajugasalicigenin (stigmastane sterol) New natural products (ajugasaliciosides F-H (stigmastane sterols) Cytotoxicity Human (cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) Ajuga salicifolia (new stigmastane sterols from Ajuga salicifolia) Molecular structure (of ajugasalicigenin (stigmastane sterol) Molecular structure (of ajugasaliciosides F-H (stigmastane sterols) Sterols Role: BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), PREP (Preparation) (stigmastane new stigmastane sterols from Ajuga salicifolia) stigmastane sterol Ajuga (1)
Animal communication signal; Animal orientation signal; Electric organ discharge; Microprocessor; Digital synthesis; Analogue-to-digital conversion; Digital-to-analogue conversion; Signal waveform (1)
animal model; electrophysiology; multifocal ERG; X-linked juvenile retinoschisis (1)
ANIMAL-MODEL; PH; SKIN; ALGINATE; CHITOSAN; BEHAVIOR; FILMS; CARE; cell scaffold; chronic wound; human skin construct; pH-responsive hydrogel; wound dressing (1)
ANIMAL-MODEL; RESISTANT; EFFICACY; STERILIZATION; BIOFILMS; PIG; (1)
ANIMAL-MODELS; MTOR; MICE; GROWTH; CELLS; AKT2; GLUCOKINASE; CHOLANGITIS; LIPOGENESIS; INHIBITION; (1)
ANIMAL-MODELS; TRICALCIUM PHOSPHATE; GROWTH-FACTORS; SCAFFOLDS; POLYCAPROLACTONE; DEFECTS; RHBMP-2; BIOREACTOR; CARTILAGE; IMPLANT; (1)
ANIMAL PRODUCTS; DNA GYRASE; FLUOROQUINOLONES; RESIDUES; CIPROFLOXACIN; QUINOLONES; BINDING; REACTIVITY; ANTIBODIES; SENSORS; surface plasmon resonance; nucleic acid; biosensor; enrofloxacin; fluoroquinolones; layer-by-layer deposition (1)
Animal replacement, Biomedical research, Human tissue, Pharmacotoxicological studies, Research tissue banking (1)
Animal replacement, Biotech Industry, ECVAM – European Commission for the validation of alternative methods, Human Tissue, Pharmaceutical companies, Pharmaco-Toxicological research, Refinement and reduction, Research Tissue Bank (1)
Animals *Antineoplastic Agents Binding, Competitive Estrogen Antagonists: CS, chemical synthesis *Estrogen Antagonists: PD, pharmacology Mammary Neoplasms, Experimental: ME, metabolism Mammary Neoplasms, Experimental: PA, pathology *Mammary Neoplasms, Experimental: PC, prevention & control Mice Receptors, Estradiol: DE, drug effects 0 (Antineoplastic Agents) 0 (Estrogen Antagonists) 0 (Receptors, Estradiol) (1)
Animals *Antineoplastic Agents Cell Division: DE, drug effects Cell Line Leukemia L1210: DT, drug therapy Mammary Neoplasms, Experimental: DT, drug therapy Mice *Neoplasms, Experimental: DT, drug therapy *Organometallic Compounds: TU, therapeutic use Receptors, Estrogen: ME, metabolism Structure-Activity Relationship 0 (Antineoplastic Agents) 0 (Organometallic Compounds) 0 (Receptors, Estrogen) (1)
Animals *Antineoplastic Agents: PD, pharmacology Breast Neoplasms: PA, pathology Carcinoma, Ehrlich Tumor: PA, pathology Cell Line Drug Screening Assays, Antitumor Humans Leukemia P388: PA, pathology *Organoplatinum Compounds: TU, therapeutic use Stereoisomerism Structure-Activity Relationship 0 (Antineoplastic Agents) 0 (Organoplatinum Compounds) (1)
Animals Aorta, Thoracic/drug effects Chromones/*chemical synthesis/pharmacology Male Muscle, Smooth, Vascular/drug effects Rats Rats, Wistar Vasodilator Agents/*chemical synthesis/pharmacology (1)
"Animals", "B-Lymphocytes", "Biological Evolution", "Cell Differentiation", "Child", "Child, Preschool", "Dosage Compensation, Genetic", "Female", "Gene Expression Profiling", "Humans", "Infant", "Male", "Mice", "Selection, Genetic", "Species Specificity", "T-Lymphocytes", "Up-Regulation" (1)
Animals Cells, Cultured Models, Chemical *Plant Extracts: IP, isolation & purification Plant Extracts: PD, pharmacology *Trees: CH, chemistry Triterpenes: CH, chemistry *Triterpenes: IP, isolation & purification 0 (Plant Extracts) 0 (Triterpenes) (1)
Animals Chemistry Guanidines/*pharmacology Guinea Pigs Heart/*drug effects *Histamine H2 Antagonists Imidazoles/*pharmacology Impromidine Structure-Activity Relationship (1)
"Animals", "Computational Biology", "Databases, Genetic", "Gene Expression Profiling", "Humans", "Molecular Diagnostic Techniques", "Oligonucleotide Array Sequence Analysis" (1)
Animals Dose-Response Relationship, Drug Electrodes, Implanted Histamine/administration & dosage/*analogs & derivatives/pharmacology Histamine Agonists/administration & dosage/*pharmacology Injections, Intraventricular Male Pyrilamine/pharmacology Rats Rats, Wistar Sleep/drug effects Wakefulness/*drug effects (1)
Animals Guinea Pigs Heart Atria/drug effects Histamine/*analogs & derivatives/chemical synthesis/pharmacology Histamine Agonists/*chemical synthesis/pharmacology Histamine H2 Antagonists/*chemical synthesis/pharmacology Muscle, Smooth/drug effects Structure-Activity Relationship (1)
Animals Guinea Pigs Heart Atria/drug effects Histamine/*analogs & derivatives/pharmacology Histamine Agonists/*chemical synthesis/pharmacology Ileum/drug effects Muscle Contraction/drug effects Structure-Activity Relationship (1)
Animals Lactones/*chemical synthesis/pharmacology Male Rats Rats, Wistar *Serotonin Antagonists Structure-Activity Relationship (1)
Animal tissue culture (diamine ligand release from cisplatin analog in) diamine ligand release cisplatin analog cell (1)
ANIMATED PEDAGOGICAL AGENTS; FEMALE STUDENTS ATTITUDES; ACADEMIC-PERFORMANCE; ENVIRONMENTS; MULTIMEDIA; BELIEFS; AVATARS; GENDER; MODELS; E-learning; Pedagogical agents; Intrinsic motivation; Performance (1)
ANION-BINDING CATALYSIS; REISSERT-TYPE REACTION; N-ACYLIMINIUM IONS; ENANTIOSELECTIVE ADDITION; ASYMMETRIC CATALYSIS; TERMINAL ALKYNES; CLICK CHEMISTRY; NUCLEOPHILIC DEAROMATIZATION; 1,3-DIPOLAR CYCLOADDITIONS; BIFUNCTIONAL CATALYST; Triazoles; Lewis Acid Catalysis; Anion-Binding Organocatalysis; Heterocycles; Dearomatization (1)
ANION-BINDING; EUROPIUM(III) COMPLEXES; WATER; CONSTANTS; EU3+; SELECTIVITY; EQUILIBRIA; EMISSION; LIGANDS; BIOLOGY (1)
ANION CHANNELS; ESSENTIAL COMPONENT; INDUCED ACTIVATION; VRAC; EXPRESSION; PHYSIOLOGY; RESPONSES; DEATH; CELLS; ANO1; VRAC; CaCC; TMEM16 proteins; anoctamin; ANO1 (1)
anion-exchange, nanoﬁbers, nucleic acids, pH-tunable surface charge, point-of-care, solid-phase extraction, zwitterionic (1)
Anionic complex ; Bromo complex ; Quaternary ammonium compound ; Acetonitrile ; Photochemical reaction ; Charge transfer ; Electron spectrometry ; Bismuth III Complexes ; Lead II Complexes ; Tin II Complexes ; Antimony III Complexes ; Non metal Complexes ; (1)
anionic pncitogenylborane derivative; anorganic anionic chelating ligand and linker; anionic 13/15 oligomers; (1)
ANIONIC SURFACTANTS; TETRAALKYLAMMONIUM BROMIDES; TETRABUTYLAMMONIUM BROMIDE; PHYSICOCHEMICAL PROPERTIES; OLIGOETHER CARBOXYLATES; IONIZATION DEGREE; AQUEOUS MIXTURES; SODIUM; SOLUBILITY; CHOLINE (1)
ANION-PI INTERACTIONS; CHARGE-TRANSFER; PHOTOPHYSICAL PROPERTIES; ELECTRONIC-STRUCTURE; COPPER(I) COMPLEXES; C-3 SYMMETRY; CATION-PI; LIGAND; GOLD(I); COORDINATION; coinage metal ions; ligand design; phosphane ligands; pi interactions; tridentate ligands (1)
ANION-PI INTERACTIONS; GAUSSIAN-BASIS SETS; N-LIGAND COMPLEXES; CRYSTAL-STRUCTURES; COORDINATION CHEMISTRY; TRANSITION-METALS; CYCLO-E(5) LIGAND; BUILDING-BLOCKS; ATOMS LI; CLUSTER; copper; host-guest systems; iron; P ligands; self-assembly (2)
ANION RECOGNITION; ION; PROTEINS; REAGENTS; WATERS; PROBE; (1)
Anions; Catalysts; Cobalt; Cross coupling reaction; Organic compounds (1)
Anions, Cobalt, Ligands, Nuclear magnetic resonance spectroscopy, Sandwich compounds (1)
ANIONS; FRAGMENTATION; CHEMISTRY; CLUSTERS; LIGANDS; AS2S3; SALTS; cobalt; arsenic; sulfur; selenium; mixed ligands (1)
Aniontensid , Ionische Polymere , Natriumdodecylsulfat , Adsorptionsschicht , Adsorption , Kraftmikroskopie , Dynamische Lichtstreuung , Fällung , Glimmer , Siliciumdioxid , Polymer JR 400 , Polymer-Tensid Wechselwirkungen , Wiederauflösung , Kraft-Abstands-Kurve , Hydrophobisierung , Polymer JR 400 , Polymer-Surfactant Interactions , Resolubilisation , Force vs. Distance Curves , Hydrophobisation (1)
ANISOMYCIN-INDUCED AMNESIA; CONDITIONED DEFEAT; SYNTHESIS INHIBITION; TIME WINDOWS; CONSOLIDATION; AVOIDANCE; AMYGDALA; PERIODS; KINASE; HIPPOCAMPUS; social fear; social anxiety; anisomycin; protein synthesis; social investigation; fear learning; fear acquisition; fear extinction; fear memory; memory consolidation (1)
anisotropic magnetoresistance; ground state; nanotube; permalloy; vortex; spin wave; dispersion; asymmetric; non-reciprocity (1)
anisotropic surface diffusion; mean curvature flow; crystalline surface; energy; triple junctions; parametric finite elements, Schur complement, tangential movement (1)
ANISOTROPY BARRIER; RELAXATION; MAGNETIZATION; EXCHANGE; FIELD; COMPLEXES; BLOCKING; LIGAND; (1)
Ankle, Ankle joint, Tarsal joint, Radiotherapy, Low-dose radiation (1)
; ankle injury; ligament rupture; treatment; rehabilitation; immobilization; weight bearing; orthosis (1)
Ankle · Peroneus brevis tendon reconstruction · Split lesion · Postural stability (1)
Anlageverhalten , Arbitrage, Behavioral Finance , Grenzen der Arbitrage , Existenz eines Gleichgewichts , Sonnenflecken, behavioral finance , limits of arbitrage , existence of an equilibrium , sunspots (1)
annealing, conducting polymers, electrodes, gold, optimisation, organic light emitting diodes, silver, surface enhanced Raman scattering (1)
annealing, electronic density of states, gallium arsenide, gallium compounds, III-V semiconductors, magnetoresistance, manganese compounds, paramagnetic materials, semimagnetic semiconductors, Zeeman effect (1)
Anne Hutchinson, Mary Dyer, John Winthrop, Thomas Weld, John Cotton, Thomas Shepard, Anne Bradstreet, John Tombes, Richard Baxter, Increase Mather, John Spencer, Cotton Mather; monstrosity, monstrous births, hybridity, Monstrosität; monströse Geburten; New England, Puritanism, Massachusetts Bay Colony, Congregationalism, Antinomian Controversy; intellectual history, New Science, Scientific Revolution; Wissenschaftsgeschichte (1)
Annexin I , , Annexin A1 , quartz crystal microbalance , model membranes (1)
Annexin II , Annexine , Kraftmikroskopie , Lipidmembran , , annexin , AFM (1)
annexins; adipose tissue; adiponectin; cholesterol; glucose homeostasis; inflammation; insulin; lipid metabolism; obesity; triglycerides (1)
ANNONACEAE; DERIVATIVES; RUFA; Uvaria valderramensis; Annonaceae; Chemotaxonomy; Valderepoxide; Seco-cyclohexenes; Chalcones (1)
Annotation, Annotation Tool, Sentiment Annotation, User-Centered Design (1)
Annotation; Bewertung; Elektronisches Publizieren; Kosten; Lernen; Software; Werkzeug; wissenschaftlicher Text (1)
Annotation; Corpora; Standardisierung; Stand off-Annotation; Textmarkup; Korpusarchitektur; PAULA; ANNIS; Gate; MMAX (1)
Annotation , Evaluation , Diachronie , Historische Sprachwissenschaft , Softwareergonomie , Benutzerfreundlichkeit , Korpus <Linguistik> , Annotationswerkzeug , Annotationstools , Softwareevaluation , ISO9126 , annotation tools , software evaluation , ISO9126 (1)
annotation extraction, multispectral imaging, computer vision (1)
Annotation , Korpus <Linguistik> , Regensburg / Universität / Linguistische Informationswissenschaft , Diachronie , Historische Syntax , , (1)
annotation, proof-reading, digitalization (1)
Annotation; Standards; Corpora; Qualitätsmodell; Bewertung (1)
Annotation Tool, Aspect-Based Sentiment Analysis, Retrieval-Augmented Generation, Large Language Models, AI Assistance, NLP, ABSA, LLMs (1)
annotation, usability, corpus linguistics, digital humanities (1)
Annotation, Usability, Digital Humanities, Korpuslinguistik (1)
; annoyance; road traffic noise; motorbike noise; motorcycle noise; exposure-response functions; non-acoustic factors; background noise (1)
ANNULAR BILLIARD; DYNAMICS; (1)
ANNULAR BILLIARD; MIXED SYSTEMS; GHOST ORBITS; QUANTUM; DYNAMICS; OSCILLATOR; TRANSPORT; (1)
ANNULATION; CYCLOPROPYLANILINES; CYCLOPROPANES; OXIDATION; (1)
Annulenes, Role: PRP (Properties) (methano-bridged, transannular interaction in); Magnetic circular dichroism; Oscillator strength; Ultraviolet and visible spectra (of methano-bridged annulenes); Molecular orbital (CNDO/S, of methano-bridged annulenes); Energy level excitation (electronic, of methano-bridged annulenes); Aromaticity (homo-, of methanoannulenes); Fluorescence (polarized, of methano-bridged annulenes); transannular interaction methanoannulene MO; fluorescence methanoannulene; UV methanoannulene; homoaromaticity methanoannulene MO; electronic transition methanoannulene MO; magnetic CD methanoannulene (1)
Anoctamin 1 · Anoctamin 6 · Inflammation · Asthma · Cystic fibrosis · COVID-19 (1)
anoctamin 6; ANO6; TMEM16F; phospholipid scrambling; Ca2+ signaling; ion currents (1)
Anoctamin 9 · ANO9 · TMEM16J · T cells · T lymphocytes · calcium signaling · immune response ·PMCA · Orai1 (1)
anoctamin; ANO1; ANO6; TMEM16A; TMEM16F; cancer; proliferation; apoptosis; Ca2+ signaling; inflammation (1)
Anoctamin family, Volume regulation, RVD, VRAC, Cell proliferation, Apoptosis, Cancer, Innate immunity (1)
Anoctamins, CaCC, calmodulin (1)
ANOMALIES; CLASSIFICATION; DIAGNOSIS; (1)
ANOMALIES HEMANGIOMAS; FLOW LESIONS; FOLLOW-UP; CLASSIFICATION; Magnetic resonance imaging; Magnetic resonance angiography; Vascular malformation; Arteriovenous malformation; Arteriovenous fistula (1)
ANOMALOUS DIMENSION; ANGULAR-MOMENTUM; BETA-FUNCTION; TRACE; MASS; RENORMALIZATION; INVARIANCE; SCALAR; Higher-Order Perturbative Calculations; Properties of Hadrons (1)
ANOMALOUS DIMENSION; CURRENT CORRELATORS; BETA-FUNCTION; O(ALPHA(3)(S)); VACUUM; (1)
ANOMALOUS DIMENSIONS; COMPOSITE-OPERATORS; CREWTHER RELATION; ADLER FUNCTION; SUM-RULES; ANNIHILATION; CONSTRAINTS; SPECTRUM; (1)
ANOMALOUS DIMENSIONS; QCD; RENORMALIZATION; PRODUCTS; Perturbative QCD; Renormalization Group (1)
ANOMALOUS DIMENSIONS; SPLITTING FUNCTIONS; QCD; EQUATIONS (1)
anomalous dispersion, X-ray absorption spectroscopy, crystallography (1)
anomalous Hall effect; coherent potential approximation; disordered alloys; electronic transport; Kubo formalism; relativistic Korringa–Kohn–Rostoker (1)
Anomalous Higgs Couplings, Electroweak Precision Physics, Higgs Properties (1)
ANOMALOUS HYSTERESIS LOOPS; COMPENSATION TEMPERATURE; ABSORPTION; VICINITY; (1)
ANOMALOUS MAGNETIC-MOMENT; PI(+)PI(-) CROSS-SECTION; PROCESS E(+) E(-); PION FORM-FACTOR; ENERGY-RANGE; CMD-2 DETECTOR; R-UDS; ANNIHILATION; UPDATE (1)
anomalous Nernst effect, atomic force microscopy, magnetothermal microscopy, near-field microscopy, photocurrent nanoscopy (1)
ANOMALOUS O-17 COMPOSITIONS; ISOTOPIC COMPOSITION; SULFUR-DIOXIDE; SULFATE; DESERT; WATER; DELTA-O-18; OXIDATION; ENVIRONMENTS; ATMOSPHERE; Namib Desert; desert soils; gypsum; sulfates; O-18/O-16; O-17/O-16; atmospheric precipitation; dimethyl sulfide (1)
Anomalous stochastic diffusion; Chaotic magnetic transport; Magnetic superlattices (1)
anomalous transport, chiral magnetic effect, chiral separation effect, Weyl semimetal, Overlap fermions, matrix sign function, dense QCD, numerical differentiation of matrix functions (1)
Anomaly detection · Business processes · Service-oriented systems · Deep learning · Security (1)
Anomie · Crisis of democracy · Liberalism · Hegemony · Collective identity (1)
Anonymisation, Pseudonyms, Mix zone, Mesh network, Device-to-device, Privacy (1)
Anonymität, Navigation, Graphen, l-Diversity (1)
anonymity, mix-networks, traffic analysis, disclosure attacks (1)
anonymization; anonymized; confidentiality; data science; data sharing; deidentification; identification; medical informatics; privacy; privacy-enhancing technologies; privacy-utility trade-off; security (1)
Anonymous and unobservable communication systems (8)
Anonymous and unobservable communication systems, Legal aspects of information security (4)
Anonymous and unobservable communication systems, Privacy enhancing technologies (27)
Anonymous and unobservable communication systems, Security in general (overviews/surveys), Mobile communication (1)
Anorektale Malformationen, Sakrale Nervenstimulation (1)
Anorektale Manometrie, Halbleiter, Kinder, Normwerte, Untersuchungsprotokoll, Leitlinien (1)
anorexia nervosa, body mass index, outcome, predictors, therapy, treatment, weight gain (1)
Anorexia nervosa, Bulimia nervosa, AVEM (1)
Anorexia nervosa, Bulimia nervosa, Therapieeffekt (1)
ANOREXIA-NERVOSA PATIENTS; EMOTION REGULATION; OWN BODY; FUNCTIONAL NEUROANATOMY; MIRROR EXPOSURE; OBESE-PATIENTS; OVERVALUATION; EXTRASTRIATE; DISSATISFACTION; SHAPE/WEIGHT; eating disorders; clinical neuroscience; body image; task functional imaging; human studies (1)
Anorganische Chemie, Ammoniak, Röntgenstrukturanalyse, Quantenchemie, Hauptgruppenelemente (1)
Anorganische Chemie, Carbonylate, Ammoniak (1)
Anorganische Chemie, Zintl, Ammoniak (1)
ANOVA; VARIANCE; ECOLOGY; OVERDISPERSION; FLEXIBILITY; ERROR; REML; fixed effects; generalized linear models; hierarchical models; mixed-effects models; multilevel models; random effects (1)
anpirtoline carbon 14 piperidinethiol substitution chloropyridine carbon labeled (1)
Anregungsspektroskopie , Emissionsspektroskopie , Helium-Nanotropfen-Isolationsspektroskopie , Protonentransfer , , excitation-spectroscopy , emission-spectrocsopy , helium-nanodroplet-isolation-spectroscopy , proton-transfer (1)
ANTAGONISTIC REGULATORS; CLOACAL EXSTROPHY; OEIS COMPLEX; TRANSLOCATION; EXPRESSION; ANOMALIES; FAMILIES; BEEC; bladder exstrophy; chromosome 9q34; epispadias; SET gene (1)
ANTAGONIST TROPISETRON; SEROTONIN RECEPTOR; DOUBLE-BLIND; SPINAL-CORD; FIBROMYALGIA PATIENTS; MIGRAINE HEADACHE; PARTIAL AGONIST; NERVOUS-SYSTEM; SUBSTANCE-P; ONDANSETRON; 5-HT3 receptor; 5-HT3-receptor antagonist; tropisetron; ondansetron; pain; immunomodulation (1)
ANTARCTIC COLD REVERSAL; SOUTHWESTERN KALAHARI; DESERT NAMIBIA; YOUNGER DRYAS; CLAY-MINERALS; KUISEB RIVER; HOMEB SILTS; NAMA GROUP; ICE-AGE; PAN; Slack water deposit; OSL; 14C; climate fluctuations; shifting rainfall zones (1)
ANTARCTIC SEA-ICE; BACTERIA; DEGRADATION; DIVERSITY; OXIDATION; EVOLUTION; NOV.; Marinobacter; polycyclic aromatic hydrocarbon; naphthalenr; marine bacterium; dioxygenase; horizontal gene transfer (1)
ANT ATTA-COLOMBICA; LEAF-CUTTING ANTS; APIS-MELLIFERA L; SOCIAL HYMENOPTERA; MULTIPLE PATERNITY; FORMICA ANTS; POLYANDRY; EVOLUTION; QUEENS; RELATEDNESS; Acromyrmex octospinosus; polyandry; parasitism; metapleural gland (1)
ANT CATAGLYPHIS-NIGER; DIRECT BEHAVIORAL EVIDENCE; FEMALE EUROPEAN BEEWOLVES; SOLENOPSIS-INVICTA BUREN; IMPORTED FIRE ANT; SOLITARY WASP; PHILANTHUS-TRIANGULUM; COMPARATIVE MORPHOLOGY; PERIPLANETA-AMERICANA; NESTMATE RECOGNITION; Cephalic gland; Head gland; Hydrocarbons; Alkyl benzoates; Convergent evolution (1)
ANT CATAGLYPHIS-NIGER; EUROPEAN BEEWOLF; TERRITORIAL BEHAVIOR; F HYMENOPTERA; COLONY ODOR; SPHECIDAE; COMPONENTS; SECRETIONS; RECOGNITION; SPECIATION; Philanthus triangulum; Crabronidae; Sphecidae; hymenoptera; European beewolf; chemical dimorphism (1)
ANT CATAGLYPHIS-NIGER; INSECT CUTICULAR HYDROCARBONS; DIRECT BEHAVIORAL EVIDENCE; FEMALE EUROPEAN BEEWOLVES; SOLITARY WASP; PHILANTHUS-TRIANGULUM; NESTMATE RECOGNITION; PHYSICAL-PROPERTIES; STINGLESS BEES; SEX-PHEROMONE; (1)
Ant; Competition; Pachycondyla harpax; Recruitment; Tandem running (1)
Anteile, Stochastik, Bruchrechnung, Kompetenzorientierung, natürliche Häufigkeiten (1)
ANTENNAL LOBE; SPATIAL REPRESENTATION; CAENORHABDITIS-ELEGANS; SEX-PHEROMONE; RECEPTOR; NEURONS; ODORS; BRAIN; FLIES; MICE; (1)
ANTERIOR CERVICAL DISKECTOMY; PLGA-BASED MICROPARTICLES; IN-VITRO CHARACTERIZATION; MORPHOGENETIC PROTEIN-2; ANGIOGENESIS; RELEASE; VEGF; FUSION; REPAIR; MICROSPHERES; growth factor; scaffold; bone; repair; regeneration; microparticle; segmental defect (1)
ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; CLOSURE PROCESSES; BAND RESPONSES; TIME-COURSE; HUMAN EEG; MEMORY; HUMANS; TOMOGRAPHY; POTENTIALS; source analyses; BESA; LORETA; induced; evoked; gamma; ERP; ERD/ERS (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; CONTROL ADJUSTMENTS; AVERSIVE SIGNALS; CONTEXT; ERIKSEN; DRIVEN; SIMON; TASK; INTEGRATION; Cognitive control; Congruency sequence effect; Conflict; Aversive signals (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; NEGATIVE AFFECT; NEURAL MECHANISMS; DECISION-MAKING; CONFLICT; ADJUSTMENTS; MOTIVATION; SYSTEM; PERFORMANCE; Errors; Post-error slowing; Performance monitoring; EMG; Affect; Cognitive control (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; PROPORTION CONGRUENT; AVERSIVE SIGNALS; ADAPTATION; LOCATION; ACTIVATION; AVOIDANCE; VALENCE; TASK; context specific proportion congruency; aversive signals; conflict adaptation (1)
ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; PREFRONTAL CORTEX; ELECTROPHYSIOLOGICAL EVIDENCE; AUTOMATIC ACTIVATION; DECISION-MAKING; WORKING-MEMORY; SIMON TASK; ADAPTATION; RESPONSES; cognitive control; conflict adaptation; affect; reward; conflict monitoring (1)
ANTERIOR CINGULATE CORTEX; FRONTAL-CORTEX; STIMULATION; DEPRESSION; CONNECTIVITY; RTMS; PREDICTOR; TMS; (1)
ANTERIOR CINGULATE CORTEX; HUMAN CEREBRAL-CORTEX; CORTICAL DEVELOPMENT; DIFFUSION; RELIABILITY; THICKNESS; NETWORKS; VALIDITY; OBESITY; SYSTEM; (1)
ANTERIOR CINGULATE CORTEX; IMPLICIT ASSOCIATION TEST; ERROR-RELATED NEGATIVITY; COLOR-WORD INTERFERENCE; COGNITIVE CONTROL; PROCESSING FLUENCY; AUTOMATIC ACTIVATION; STROOP TASK; SIMON TASK; RESPONSES; Cognitive control; Conflict; Priming; Anterior cingulate cortex (1)
ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; COGNITIVE CONTROL; AUTOMATIC ACTIVATION; INTERFERENCE; EXCLUSION; RESPONSES; FLUENCY; PAIN; Cognitive control; Conflict monitoring; Anterior cingulate cortex; Affective priming (1)
ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; SEQUENTIAL MODULATIONS; PREFRONTAL CORTEX; PARAMETRIC MANIPULATION; EXECUTIVE FUNCTIONS; STROOP TASK; TOP-DOWN; STIMULUS; SIMON; (1)
ANTERIOR CINGULATE CORTEX; OPTIC FLOW; VESTIBULAR CORTEX; HUMAN BRAIN; FUNCTIONAL-PROPERTIES; PARIETAL LOBE; AREAS MT; PERCEPTION; PRECUNEUS; FIELD; 3D; fMRI; linear vection; object-motion; optic-flow; self-motion (1)
ANTERIOR CINGULATE CORTEX; PERCEPTUAL FLUENCY; DESIRABLE DIFFICULTY; AVERSIVE SIGNALS; DECISION-MAKING; ICONIC GESTURES; CONFLICT; SPEECH; DISFLUENCY; MEMORY; Aversive signals; Effort mobilization; Hearing; Perceptual fluency; Sequential processing adjustments (1)
ANTERIOR CINGULATE CORTEX; PSYCHOSOCIAL STRESS; SALIVARY; BRAIN; CONNECTIVITY; DORSAL; ACTIVATION; ADAPTATION; NETWORKS; EXPOSURE; Hair cortisol concentration; Acute social stress; Immunization; Resilience; fMRI; dACC (1)
ANTERIOR CINGULATE CORTEX; WORKING-MEMORY TASK; DECISION-MAKING; ELECTROMAGNETIC TOMOGRAPHY; EXECUTIVE FUNCTIONS; PREFRONTAL CORTEX; OCCIPITAL CORTEX; BRAIN ACTIVITY; ALPHA-ACTIVITY; TIME PRESSURE; speed-accuracy tradeoff; anterior cingulate cortex; motor cortex; brain oscillations; conflict; response priming (1)
ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; DEFECTS; MENISCUS; TIME; COMPLICATIONS; INJURIES; LESIONS; TISSUE; Cartilage treatment knee; Concomitant surgery; Comorbidity; Osteotomy; Instability; Meniscus (1)
ANTERIOR CRUCIATE LIGAMENT; DEFICIENT KNEE; RISK-FACTORS; RECONSTRUCTION; INJURIES; PLATEAU; REPAIRS; JOINT; OSTEOARTHRITIS; METAANALYSIS; Posterior tibial slope; High tibial slope; Acute ACL insufficiency; Meniscal lesion (1)
ANTERIOR CRUCIATE LIGAMENT; DIRECT CONVERSION; TENOGENIC PHENOTYPE; TGF-BETA; IN-VITRO; CONSERVATIVE MANAGEMENT; STEM/PROGENITOR CELLS; NONSURGICAL TREATMENT; SURGICAL-TREATMENT; GAMMA-IRRADIATION; dermal fibroblasts; tenogenic differentiation; tendon tissue engineering; microarray data analysis; in vitro; in vivo; clinical studies (1)
anterior cruciate ligament, handball, injury prevention, knee injury (1)
ANTERIOR CRUCIATE LIGAMENT; IN-SITU FORCES; STRAIN BEHAVIOR; MOTION; RECONSTRUCTION; FLEXION; COMPLICATIONS; RELIABILITY; RANGE; VIVO; knee; extension; ROM; goniometer (1)
ANTERIOR CRUCIATE LIGAMENT; PLATELET-RICH PLASMA; NATURAL-HISTORY; TEARS; RECONSTRUCTION; REPAIR; OUTCOMES; Knee; Partial ACL rupture; Autologous conditioned plasma; ACP; Preservation technique (1)
ANTERIOR CRUCIATE LIGAMENT; SOCCER PLAYERS; ELITE FOOTBALL; UEFA INJURY; RISK-FACTOR; PREVENTION; PROGRAM; EPIDEMIOLOGY; SEASONS; AUDIT; Professional football; Soccer; PCL ruptures; ACL ruptures; Injury severity; Injury prevention (1)
ANTERIOR CRUCIATE LIGAMENT; YOUNG FEMALE PLAYERS; TRAINING-PROGRAM; RISK-FACTORS; WARM-UP; YOUTH; SOCCER; FOOTBALL; REGISTRATION; ACL; Team handball; Handball; Adolescent; Injury; Prevention; Knee; Anterior cruciate ligament (1)
ANTERIOR DISLOCATION; GLENOHUMERAL JOINT; STABILITY; arthroplasty; biomechanics; shoulder joint; glenoid; proximal humerus (1)
ANTERIOR ETHMOIDAL NERVE; KOLLIKER-FUSE NUCLEI; NASAL-MUCOSA; HORSERADISH-PEROXIDASE; ELECTRICAL-STIMULATION; CENTRAL PROJECTIONS; DIVING RESPONSE; C-FOS; RAT; REFLEX; Trigeminal; Brainstem; Behavior (1)
ANTERIOR; FEATURES; Impingement; Bony; Soft tissue; Arthroscopy; Chronic ankle pain (1)
ANTERIOR HARD PALATE; PARAMEDIAN PALATE; MINI-IMPLANTS; SUCCESS RATE; THICKNESS; ANCHORAGE; PLACEMENT; GROWTH; VOLUME; CBCT; Palatal insertion; Orthodontic implant; Bone height; Skeletal anchorage (1)
ANTERIOR INSULA; COMPUTATIONAL PSYCHIATRY; FACIAL EXPRESSIONS; FMRI NEUROFEEDBACK; BRAIN ACTIVATION; EMOTION; STIMULI; CORTEX; PAIN; SIMILARITIES; Affective neuroscience; Emotions; fMRI; Individual; Representational similarity analysis (1)
ANTERIOR INTERBODY FUSION; TERM FOLLOW-UP; BONE GRAFT; DEGENERATIVE DISEASE; ONE-LEVEL; DISCECTOMY; DISKECTOMY; FIXATION; STABILIZATION; COMPLICATIONS; anterior plating; cervical spine; anterior spondylodesis (1)
ANTERIOR-LATERAL EYES; VISUAL-PERCEPTION; PRINCIPAL EYES; DENDRYPHANTINAE; SALTICIDAE; MOVEMENTS; BEHAVIOR; TRACKING; RETINAE; CHICKS; (1)
ANTERIOR PELVIC RING; PUBIC RAMUS SCREW; INTRAOPERATIVE FLUOROSCOPY; FIXATION; FRACTURES; (1)
ANTERIOR SHOULDER DISLOCATION; GLENOID DEFECT; BANKART REPAIR; INSTABILITY; RELIABILITY; STABILITY; ACCURACY; CT; Glenoid defect; Shoulder instability; Three-dimensional measurement; Two-dimensional measurement; Scapula; Shoulder; Ratio method; Best fit circle (1)
ANTERIOR TEMPORAL-LOBE; NEURAL BASIS; SENTENCE COMPREHENSION; BROCAS REGION; ZEBRA FINCHES; INDIVIDUAL-DIFFERENCES; SYNTACTIC STRUCTURE; PREFRONTAL CORTEX; CHINESE CHARACTER; BRAIN BASIS; Broca's area; Merge; syntactic processing; natural language comprehension; fMRI (1)
ANTERIOR URETHRAL STRICTURES; SUBSTITUTION URETHROPLASTY; ORAL-MUCOSA; MANAGEMENT; RECONSTRUCTION; HARVEST; DISEASE; Urethroplasty; Penile skin flap; Buccal mucosa graft; Urethral stricture; Recurrence (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COLOR DOPPLER ULTRASOUND; PERFORATOR FLAP; CUTANEOUS PERFORATORS; PREOPERATIVE ASSESSMENT; DUPLEX ULTRASONOGRAPHY; DIAGNOSTIC EFFICACY; FEMORAL-ARTERY; RECONSTRUCTION; Plastic surgery; Reconstructive surgery; ALT flap; Perforator; Perforator mapping; Ultrasound; Sonography; Angiography; Color Duplex ultrasound; Color coded; Duplex sonography; Power Doppler; Flap design; Suprafascial harvest; Thin ALT flap (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ENHANCED ULTRASOUND CEUS; CUTANEOUS PERFORATORS; DOPPLER ULTRASOUND; ULTRASONOGRAPHY; ELEVATION; RECONSTRUCTION; ACCURACY; EFFICACY; (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; CONTRAST-ENHANCED ULTRASOUND; HAND-HELD DOPPLER; CUTANEOUS PERFORATORS; BREAST RECONSTRUCTION; PREOPERATIVE IDENTIFICATION; DUPLEX ULTRASONOGRAPHY; DIAGNOSTIC EFFICACY; (1)
ANTEROLATERAL THIGH FLAP; LATISSIMUS-DORSI MUSCLE; FREE SCAPULAR FLAP; LOWER-EXTREMITY; AMPUTATION STUMP; CANCER ABLATION; SOFT-TISSUE; OSTEOMYELITIS; FOOT; FRACTURES; Lower extremity; Tissue defects; Parascapular flap; Bone reconstruction (1)
ANTHEMIS; ARCHANTHEMIS; CHLOROPLAST DNA; COTA; ITS; MEDITERRANEAN; MICRO-MORPHOLOGY; TAXONOMY (1)
Anthemis tinctoria tinctoria Antioxidants Structure-activity relationship (phenolic compds. with antioxidant activity from Anthemis tinctoria L. (Asteraceae) phenolic antioxidant Anthemis tinctoria Asteraceae (1)
Anthocyan, Anthocyanidin, Anthocyanin, Procyanidin, CYP1A2, CYP2C19, Fluvoxamin, Proanthocyanidin, Fluvoxamine (1)
Anthocyane, CYP2C9, französisches Pradoxon, Antioxidativ, Lebensmittel-Medikamenten-Interaktionen, Flavonoide, sekundäre Pflanzeninhaltsstoffe, Inhibitionskonstante, halbmaximale Hemmkonzentration, nichtkompetitive Enzymhemmung, Cytochrom (1)
anthocyanin; anthocyanidin; flavonoid; ABC transporter; MDR1; P-glycoprotein; BCRP (1)
ANTHRACIS SPORES; EXTRACTION KITS; RIBOSOMAL-RNA; IDENTIFICATION; STRAINS; DNA; GUIDELINES; ALIGNMENT; BACTERIA; GELATIN; Bacillus spores; ces gene; gyrB gene; IAC; qPCR; 16S rRNA gene (1)
Anthracycline, Cardiomyopathy, Heart failure, CaMKIIδ, ROS, SR Ca leak (1)
Anthracyclin-induced cardiotoxicity (ACT); Induced pluripotent stem cells (iPSC); Cardiomyocytes; Cardiac fibroblasts; Heart failure; Doxorubicin (1)
Anthralin; Anthralin derivatives; Nitroxides; Nitroxide reduction; ESR; Free radicals (1)
anthralin; dithranol; psoriasis; DNA; base damage; free radicals (1)
Anthralin, in vitro studies • Antipsoriatic drugs • CAS 480-22-8 • Dithranol • Free radicals • Glucose-6-phosphate dehydrogenase, inhibition (1)
Anthralin — Stability — Phospholipids — Liposomes (1)
Anthralin; UV/Vis spectroscopy; Fluorescence spectroscopy; Alkylated derivatives (1)
ANTHRANILATE SYNTHASE; ESCHERICHIA-COLI; MOLECULAR-GRAPHICS; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURES; GLUTAMINE; MECHANISM; MUTATIONS; SOFTWARE; CONSERVATION; allostery; ancestral sequence reconstruction; bi-enzyme complex; catalytic triad; glutamine amidotransferases (1)
anthraquinone sulfonates · hydrogen atom transfer · oxidation · photochemistry · water (1)
anthraquinone, walnut, Juglans regia, polyketide, shikimic acid, sampling, QuEChERS, leaves, moss, GC-MS/MS (1)
ANTHROPOMETRIC MEASURES; FERTILITY DRUGS; HISTOLOGIC TYPE; IN-VITRO; WOMEN; INFERTILITY; BREAST; ASSOCIATION; CARCINOMA; OVULATION; reproductive factors; ovarian malignancy; parity; lactation; infertility; PCO syndrome (1)
; anti‐ vascular endothelial growth factor; long‐ term outcomes; ranibizumab; retinopathy of prematurity (1)
ANTIARRHYTHMIC-DRUG THERAPY; DEVICE FOLLOW-UP; TRIAL; COVID-19; Implantable cardioverter defibrillator; Remote patient monitoring; Arrhythmia (1)
; Anti asthmatic drugs; Antibodies; Omalizumab; Mepolizumab; Benralizumab; Dupi-lumab; Questionnaire; Asthma; Germany (1)
ANTIBACTERIAL ACTIVITIES; ETHANOL; ANTIOXIDANT; QUALITY; Mentha spicata L.; Essential oil; O/W microemulsions; Food-approved microemulsions; Sweetening and coloring additives (1)
ANTIBACTERIAL ACTIVITY; MATERNITY; Vanuatu; Traditional medicine; Ethnobotany; Oceania; Medicinal plant (1)
Antibacterial agents (antibacterial terpenoids from Crossopetalum gaumeri) Diterpenes Triterpenes Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) Steroids Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (ca cytotoxic cardenolides from Crossopetalum gaumeri) New natural products (cardenolides and terpenoids from Crossopetalum gaumeri) Crossopetalum gaumeri (cytotoxic cardenolides and antibacterial terpenoids from Crossopetalum gaumeri) Cytotoxic agents (cytotoxic cardenolides from Crossopetalum gaumeri) Molecular structure (of cardenolides and terpenoids from Crossopetalum gaumeri) cardenolide Crossopetalum cytotoxic agent terpenoid Crossopetalum antibacterial agent (1)
Antibacterial agents Bacillus cereus Bark Calophyllum brasiliense Staphylococcus epidermidis (new chromanone acids with antibacterial activity from Calophyllum brasiliense) Molecular structure (of chromanone acids from Calophyllum brasiliense) chromanone acid antibacterial Calophyllum brasiliense mol structure (1)
Anti-Bacterial Agents: CH, chemistry Anti-Bacterial Agents: IP, isolation & purification *Anti-Bacterial Agents: PD, pharmacology Gram-Positive Bacteria: DE, drug effects Magnetic Resonance Spectroscopy Microbial Sensitivity Tests Molecular Structure *Plants, Medicinal: CH, chemistry Triterpenes: CH, chemistry Triterpenes: IP, isolation & purification *Triterpenes: PD, pharmacology 0 (Anti-Bacterial Agents) 0 (Triterpenes) (1)
ANTIBACTERIAL HOST-DEFENSE; TOLL-LIKE RECEPTORS; T-REGULATORY-CELLS; DENDRITIC CELLS; POLYMICROBIAL SEPSIS; IMMUNE SUPPRESSION; INDUCED IMMUNOPARALYSIS; ENDOTOXIN TOLERANCE; INNATE IMMUNITY; B-CELLS; Antibody response; CLP; Immune suppression; MDSC; Sepsis (1)
ANTIBACTERIAL MONOMER MDPB; SELF-ETCH ADHESIVE; CLINICAL-EVALUATION; RESIN-COMPOSITES; PERFORMANCE; SHRINKAGE; SYSTEMS; (1)
ANTIBACTERIAL PEPTIDES; RESISTANCE; DISCOVERY; DERMCIDIN; DATABASE; antimicrobial peptides; artificial intelligence; bacteria; drug discovery; machine learning; antimicrobial resistance (1)
antibakteriell, antimikrobiell, MDPB, Füllungsmaterial, antibacterial, antimicrobial, filling material (1)
antibiotic-loaded bone cement (ALBC); polymethylmethacrylate (PMMA); Galleria mellonella; prosthetic joint infection (PJI); multidrug-resistant bacteria (1)
antibiotic-loaded bone cement; Galleria mellonella; prosthetic joint infection; Staphylococcus aureus; biofilm; in vivo (1)
Antibiotic prophylaxis · Empirical antibiotic therapy · Local antibiotic therapy · Fracture-related infection · Practice guideline (1)
; Antibiotic resistance; Antibiotic stewardship; Knowledge; Multidrug-resistant organisms; Questionnaire; Urology (1)
; antibiotic resistance; bacteriology; DNA microarray; PCR (1)
ANTIBIOTIC-RESISTANCE; KNOWLEDGE; PERCEPTIONS; INFECTIONS; DOCTORS; JUNIOR; antibiotic resistance; multi-resistant pathogens; antibiotic stewardship; questionnaire; knowledge; surgery (1)
ANTIBIOTIC-RESISTANCE; MULTICENTER TRIAL; ACID CONTROL; SUSCEPTIBILITY; INFECTION; PROVIDES; METAANALYSIS; OMEPRAZOLE; REGIMENS; EFFICACY; (1)
Antibiotics (amino acid antagonists, targeting for aminoacyl-tRNA synthetases) Amino acids Role: BIOL (Biological study) (antagonist of, targeting for aminoacyl-tRNA synthetases, antibacterial activity of) Escherichia coli (inhibition of, by amino acid antagonist targeting for aminoacyl-tRNA synthetases) Molecular structure-biological activity relationship (bactericidal, of amino acid antagonists targeting for aminoacyl-tRNA synthetases) aminoacyl tRNA synthetase inhibitor antibacterial (1)
Antibiotics Antitumor agents Hypericum amblycalyx (antibacterial and cytotoxic activity of prenylated bicyclic acylphloroglucinol derivs. from Hypericum amblycalyx) Toxins Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxins antibacterial and cytotoxic activity of prenylated bicyclic acylphloroglucinol derivs. from Hypericum amblycalyx) New natural products (hypercalyxone A (bicyclic acylphloroglucinol deriv.) New natural products (hypercalyxone B (bicyclic acylphloroglucinol deriv.) Molecular structure (of hypercalyxones (bicyclic acylphloroglucinol derivs.) antibacterial cytotoxin prenylated bicyclic acylphloroglucinol deriv Hypericum (1)
antibiotics echocardiography cardiovascular diseases inflammation extracellular matrix kidney failure, chronic left ventricle blood pressure fibrosis flow cytometry bone wires cardiovascular system endothelium feces genes interleukin-17 intestines ligands mesenteric arteries myography nephrectomy plasma aryl hydrocarbon receptor sequence analysis, rna tibia tryptophan uremia c-reactive protein measurement heart histology mice mortality pharmacology immune mediator intestinal bacteria correlation studies metabolites phenotype determination microbiome small molecule attenuation th17 cells metabolomics rna-seq gastrointestinal microbiome microbiota (1)
Antibiotics Fungicides Phyllanthus piscatorum Protozoacides (antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Toxins Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxins antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Molecular structure (of piscatorin (arylnaphthalide lignan) New natural products (piscatorin (arylnaphthalide lignan) Pesticides (piscicides antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Phyllanthus justicidin B piscatorin fungicide protozoacide cytotoxin piscicide (1)
antibiotics, glioblastoma, intestinal microbiome, survival, therapy-related toxicity (1)
Antibiotic stewardship · Antimicrobial resistance rates · Calculated antibiotic therapy · Community-acquired urinary tract infection · Elderly patients · Geriatric patients · Infection · Symptomatic urinary tract infection · Urinary tract infection (1)
Antibiotic stewardship, selective reporting, interpretative reporting (1)
Antibiotic Stewardship, selektives Antibiogramm, Streptococcus pneumoniae (1)
Antibiotic Stewardship, Standard operating procedure, Microbiological diagnostics, Quality of results, Neurocritical care (1)
ANTIBIOTICS; TISSUE; PHARMACOKINETICS; PLASMA; Target-site sampling; Microdialysis; Relative recovery; Calibration; Influential factors; In vitro; Drug combinations (1)
ANTIBIOTIC-TREATMENT; EXTRACELLULAR DNA; BIOFILM; PLGA; EFFICACY; MODEL; COMBINATION; THERAPY; TARGET; VIVO; Biofilm; Fracture -related infection; Bone healing; Hydrogel; Dual release; Osteoporosis (1)
ANTIBIOTIC USE; BREAST-CANCER; COLORECTAL-CANCER; MICROBIOTA; THERAPY; GLIOBLASTOMA; TEMOZOLOMIDE; INFECTION; EXPOSURE; TUMORS; antibiotics; antifungals; case-control study; glioma; infectious disease (1)
ANTIBIOTIC USE; STEWARDSHIP; RESISTANCE; IMPACT; INFECTIONS; INTERVENTION; PRESCRIPTION; CIRRHOSIS; infectious diseases; intensive care unit (ICU); interprofessional collaboration; carbapenem antibiotics; hospital pharmacists; antimicrobial resistance; antibiotic prescribing (1)
Antibiotikaprophylaxe · Empirische Antibiotikatherapie · Lokale Antibiotikatherapie · Implantatassoziierte Infektion · Fraktur (1)
Antibiotikaresistenz, Diagnose, Symptome, Harnwegsinfektionen, Urinkultur, Antibiotika-Stewardship, Uropathogene, Zystitis, Pyelonephritis, Enterobacteriaceae, gramnegative Bakterien, Einhaltung von Leitlinien, Mikrobiologische Urinuntersuchungen, multiresistente Erreger antibiotic resistance, diagnostic, symptoms, urinary tract infections, urine culture, antibiotic stewardship, uropathogenic escheria coli, recurrent cysitis, pyelonephritis, enterobacteriaceae, gram-negative bacteria, guideline adherence, urine microbiology testing, multidrug resistant pathogen (1)
Antibiotikaresistenzen; Antibiotikaprophylaxe; Urolithiasis; Ureterorenoskopie; Antibiotic Stewardship (ABS) (1)
Antibiotikaresistenz, Keimnachweis, Urologie, Pyelonephritis, Prostatitis, Epididymitis, Antibiotika, ABS (1)
Antibiotikaresistenz, multiresistente Erreger, Antibiotic Stewardship, Fragebogen, Wissen, Urologie Antibiotic Resistance; Antibiotic Stewardship; Knowledge; Multidrug-Resistant-Organisms; Questionnaire; Urology (1)
ANTIBODIES; IMMUNITY; COVID-19; SARS-CoV-2; Serological biomarkers; Antibodies; WHO International Standard; Correlates of Protection; COVID-19 immune response (1)
Antibodies, Monoclonal Biological Transport, Active Carbohydrates/analysis Concanavalin A/metabolism Dictyostelium/*analysis Fluorescent Antibody Technique Glycosylation Molecular Weight Support, Non-U.S. Gov't Surface Properties Viral Proteins/*metabolism Wheat Germ Agglutinins/metabolism (1)
ANTIBODIES; paraneoplastic syndrome; anti-Hu antibodies; antineuronal antibodies; limbic encephalomyelitis; small cell bronchial carcinoma (1)
ANTIBODIES; TARGET; Borna disease virus 1 (BoDV-1); zoonosis; encephalitis; diagnostics; immunopathology; ELISpot; T cells; IFN-gamma; peptides (1)
Antibody-Antigen-Interaction, Mutagenesis, Protein Modeling, ATR-FTIRSpectroscopy, Immuno Infrared Sensor, Molecular dynamics simulations, Solanezumab, Amyloid-Beta, Alzheimer (1)
ANTIBODY-DRUG CONJUGATE; NON-HODGKIN-LYMPHOMA; AXICABTAGENE CILOLEUCEL; OUTCOMES; SURVIVAL; (1)
antibody-mediated rejection | daratumumab | microvascular inflammation (1)
ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; HLA ANTIBODIES; SOLUBLE CD30; GRAFT LOSS; KIDNEY; BINDING; kidney transplantation; donor-specific anti HLA antibodies; sCD30; risk stratification; ABMR; antibody-mediated rejection (1)
ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; HUMAN-LEUKOCYTE ANTIGENS; DP-SPECIFIC ANTIBODIES; IMMUNOLOGICAL RISK; CLINICAL-RELEVANCE; RENAL-TRANSPLANT; BEAD ASSAYS; CROSS-MATCH; C1Q; HLA antibodies; immunological risk; kidney transplantation; unacceptable antigen mismatches; waiting time (1)
ANTIBODY-MEDIATED REJECTION; MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; MHC CLASS-II; ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; MAST-CELLS; IN-VITRO; HUMAN HAND; transplant; reconstructive surgery; vascularized composite allotransplantation; VCA; alloimmune response; acute rejection; chronic rejection (1)
ANTIBODY-MEDIATED REJECTION; ONCE-DAILY TACROLIMUS; PROLONGED-RELEASE TACROLIMUS; DELAYED GRAFT FUNCTION; TWICE-DAILY TACROLIMUS; REGENERATIVE MEDICINE APPROACH; CHRONIC ALLOGRAFT NEPHROPATHY; ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; HUMAN-LEUKOCYTE ANTIGEN; (1)
ANTIBODY-MEDIATED REJECTION; RECIPIENTS; DP; antibody-mediated rejection; HLA typing; HLA-antibody post-transplantation; rejection (1)
; antibody; neutralizing; COVID-19; SARS-CoV-2; children (1)
ANTIBODY; POPULATION; Concomitant vaccination; IC51; Japanese encephalitis; Travel; Hepatitis A; Interaction (1)
; antibody response; COVID-19 outbreak; COVID-19 outbreak; COVID-19 pandemic; healthcare workers; immunoglobulin development; infection chain; SARS-CoV-2 (1)
ANTICANCER DRUG CISPLATIN; OVERCOMING PLATINUM RESISTANCE; SUPEROXIDE-DISMUTASE; CELLULAR PHARMACOLOGY; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; OVARIAN-CARCINOMA; PROGNOSTIC VALUE; DISEASE PROTEIN; CANCER; (1)
ANTICANCER DRUG METHOTREXATE; EGG-BOX MODEL; CROSS-LINKING; MOLECULAR-DYNAMICS; CONTROLLED-RELEASE; FORCE-FIELD; MECHANICAL-PROPERTIES; HYDROGEL FORMATION; DELIVERY SYSTEMS; POLYSACCHARIDES; (1)
ANTICANCER DRUG SCREEN; GYROCARPUS-AMERICANUS; ANTIMALARIAL ACTIVITY; DYSOXYLUM-KUSKUSENSE; NATURAL-PRODUCTS; PHYTOCHEMISTRY; DITERPENES; cytotoxicity; antibacterial; antifungal; antiprotozoal; traditional medicine; Vanuatu (1)
ANTICARDIOLIPIN ANTIBODIES; ENDOTHELIAL-CELLS; BETA(2)-GLYCOPROTEIN-I; GAMMOPATHY; BINDING; M. Waldenstroem; antiphospholipid antibodies; cardiolipin; phosphatidylserine (1)
ANTI-CD3 MONOCLONAL-ANTIBODY; RECOMBINANT HUMAN INTERLEUKIN-10; VERSUS-HOST-DISEASE; T-CELLS; HUMANIZED ANTI-CD3; DOSE-ESCALATION; BONE-MARROW; PHASE-I; OKT3; VISILIZUMAB; Crohn's Disease; Ulcerative Colitis; Immune Regulation; IFN (1)
Anticipation Coefficient, Credit Rating Agencies, Rating Quality, Global Financial Crisis, Structured Finance Rating (1)
anticoagulants, anticoagulation-related haematuria, antithrombotic therapy, gross haematuria, urologic malignancy (1)
; anticoagulation; cardiopulmonary bypass; extracorporeal life support; extracorporeal membrane oxygenation; mechanical circulatory support; nitric oxide; thrombosis (1)
ANTICOAGULATION PRACTICES; ASSIST; COHORT; (1)
ANTICOAGULATION PRACTICES; MORTALITY (1)
Anti-corruption disclosure, Disclosure changes, Directive 2014/95/EU, Legitimacy theory (1)
Antidementivum, Therapeutisches Drug Monitoring, Donepezil, antidementive, Antidementiva, Wirkstoffkonzentration, Alzheimer (1)
ANTIDEPRESSANT-LIKE ACTIONS; DEPRESSIVE-LIKE BEHAVIOR; ANIMAL-MODELS; SODIUM-BUTYRATE; RAT MODEL; BRAIN; ACTIVATION; STRESS; ESCITALOPRAM; CITALOPRAM; (1)
ANTIDEPRESSANT-LIKE ACTIVITY; ANIMAL-MODEL; DEPRESSION; SEROTONIN; RATS; ELTOPRAZINE; IPSAPIRONE; STRATEGIES; BUSPIRONE; 8-OH-DPAT; behavior; forced swimming test; 8-OH-DPAT; serotonin (5-HT); stress; 5-HT1A receptor; S-15535 (1)
ANTIDEPRESSANT RESPONSE; CLINICAL PREDICTORS; SERUM-LEVELS; DRUG; RISPERIDONE; METABOLITES; PHENOTYPE; AGE; Venlafaxine; Therapeutic drug monitoring; Plasma concentration; CGI; Treatment response (1)
Antidepressants (phenylalanylphenylalkylamine derivs. as, structure in relation to) Molecular structure-biological activity relationship (antidepressant, of phenylalanylphenylalkylamines) phenylalanylphenylalkylamine deriv antidepressant structure (1)
Antidepressants (phenylalanylphenylalkylamines) Molecular structure-biological activity relationship (antidepressant, of aminoacylphenylalkylamines) phenylalanylphenylalkylamine antidepressant (1)
ANTIDEPRESSANT VENLAFAXINE; DRUG-INTERACTIONS; MAJOR DEPRESSION; P-GLYCOPROTEIN; PHARMACOKINETICS; CYP2D6; METABOLITES; DESVENLAFAXINE; NORTRIPTYLINE; POLYMORPHISM; pharmacokinetics; venlafaxine; depression treatment (1)
anti-D,foetomaternalhaemorrhage,particlegel immunoassay (1)
Antidot arrays; Commensurability effects; Broken symmetry (1)
Antidot arrays; Magnetoluminescence; Commensurability effects (1)
Antidot arrays; Negative magnetoresistance (1)
Antidot lattice; Commensurability peaks; AFM-lithography (1)
Antidots; Negative magnetoresistance; Commensurability peaks (1)
ANTIEPILEPTIC DRUGS; NEUROSURGERY; PROPHYLAXIS; TRIALS; SAFETY; Anticonvulsants; Craniotomy; Levetiracetam; Phenytoin; Seizure (1)
ANTIESTROGEN RESISTANCE; PROTEIN-KINASE; TUMOR-CELLS; RECEPTOR; EXPRESSION; FAMILY; LINES; DEATH; ACTIVATION; IDENTIFICATION; apoptosis; breast cancer cell line; drug resistance; estrogen receptor modulator; tamoxifen (1)
ANTIESTROGENS; benzoxepines; anti-implantation; anti-fertility; non-steroidal; anti-estrogens (1)
ANTI-FACTOR-VIII; ANTINUCLEAR ANTIBODIES; NATURAL ANTIBODIES; AUTOIMMUNITY; DISEASES; (1)
ANTIFERROMAGNETIC EXCHANGE; FIELD; SUSCEPTIBILITY; SEMICONDUCTORS; CD1-XMNXTE; TRANSPORT; HETEROSTRUCTURES; CONDUCTIVITY; LIMIT; IONS; (1)
ANTIFERROMAGNETIC-FERROMAGNETIC TRANSITION; SPIN DYNAMICS; REVERSAL; ALLOYS; (1)
ANTIFERROMAGNETIC INTERLAYER EXCHANGE; PERPENDICULAR GIANT MAGNETORESISTANCE; AB-INITIO CALCULATIONS; MAGNETIC MULTILAYERS; FE/CR MULTILAYERS; LAYER; SUPERLATTICES; CONDUCTANCE; ALLOYS; NI; giant magnetoresistance; non-metallic spacers; impurities; two-band model (1)
ANTIGEN CROSS-PRESENTATION; INTERFERON-PRODUCING CELLS; MOUSE LYMPH-NODES; CD8(+) T-CELLS; IN-VIVO; LANGERHANS CELLS; INFLUENZA-VIRUS; CUTTING EDGE; HUMAN BLOOD; SURFACE PHENOTYPE; dendritic cells; plasmacytoid; virus; HSV; human; murine (1)
ANTIGEN GENE PROMOTER; JAPANESE POPULATION; BREAST-CANCER; RISK; SUSCEPTIBILITY; ASSOCIATION; MUTATIONS; THERAPY; REGION; prostate cancer; polymorphisms; PSA (1)
ANTIGEN-INDUCED ARTHRITIS; INTERLEUKIN-10 PRODUCTION; CATECHOLAMINERGIC CELLS; MACROPHAGES; RECEPTOR; MODEL; DIFFERENTIATION; MODULATION; PROTOCOL; TISSUE; Antigen-induced arthritis; Catecholamines; Inflammation; Pain-related behavior; Macrophages; Arginase-1; Tyrosine hydroxylase; Dorsal root ganglia neurons; Interleukin-4 (1)
ANTIGEN-INDUCED ARTHRITIS; POLYETHYLENE WEAR DEBRIS; TOTAL HIP ARTHROPLASTIES; SYNOVIAL MICROCIRCULATION; INTRAVITAL MICROSCOPY; ADHESION MOLECULES; PARTICULATE DEBRIS; TITANIUM PARTICLES; COBALT-CHROMIUM; BONE-RESORPTION; (1)
ANTIGEN PRESENTATION; BREAST-CANCER; EXTRACELLULAR-MATRIX; COSTIMULATORY MOLECULES; INTESTINAL MACROPHAGES; BONE-RESORPTION; CELLS; EXPRESSION; PROTEASES; MUCOSA; cathepsin D; inflammatory bowel disease; macrophages (1)
ANTIGEN-PRESENTING CELLS; ADHERENT TUMOR-CELLS; SOLUBLE FAS LIGAND; DNA FRAGMENTATION; DENDRITIC CELLS; DOWN-REGULATION; T-LYMPHOCYTES; CONSTRUCTION; CYTOTOXICITY; DEGRADATION; (1)
ANTIGEN-PRESENTING CELLS; CYTOTOXIC T-LYMPHOCYTES; PERIPHERAL-BLOOD; METASTATIC MELANOMA; LOW-FREQUENCY; IMMUNIZATION; INDUCTION; ENHANCEMENT; IMMUNITY; (1)
ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; SIGNALING PATHWAY; IMMUNOTHERAPY; RECRUITMENT; LXR; MACROPHAGES; METABOLISM; ACTIVATION; MECHANISMS; (1)
ANTIGEN-PRESENTING CELLS; HEMATOPOIETIC PROGENITOR CELLS; METASTATIC MELANOMA; T-CELLS; IN-VITRO; IMMUNE-RESPONSES; BLOOD MONOCYTES; PHASE-I; LYMPHOCYTES; INDUCTION; cell fusion; cell hybrids; dendritic cells; melanoma; vaccination (1)
ANTIGEN-PRESENTING CELLS; HUMAN PERIPHERAL-BLOOD; IN-VIVO; COSTIMULATORY SIGNALS; STIMULATORY CAPACITY; MEDIATED APOPTOSIS; IMMUNE-SYSTEM; GENE-TRANSFER; MURINE MODEL; DEATH; (1)
ANTIGEN-PRESENTING CELLS; IMMATURE DENDRITIC CELLS; INTERFERON-GAMMA; FAS LIGAND; ALTERNATIVE ACTIVATION; STIMULATION; MATURATION; TOLERANCE; INHIBITION; EXPRESSION; (1)
ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNE-RESPONSE; TOLERANCE; INDUCTION; CD95; APOPTOSIS; SYSTEM; DEATH; TOOL; dendritic cells; graft-versus-host disease; T cell; tolerance (1)
ANTIGEN-PRESENTING CELLS; RECOMBINANT ADENOVIRUS VECTOR; RESPONSES IN-VIVO; CD4(+) T-CELLS; DOWN-REGULATION; FAS/CD95-MEDIATED APOPTOSIS; ALLOGRAFT SURVIVAL; GENE-TRANSFER; MURINE MODEL; EXPRESSION; (1)
Antihypertensives (norfenefrine azomethines) Ring closure and formation (oxazolidines from norfenefrine and aldehydes and ketones) antihypotensive norfenefrine azomethine hypertensive norfenefrine azomethine oxazolidine hydroxyphenyl cyclization norfenefrine aldehyde ketone condensation norfenefrine aldehyde ketone (1)
ANTIIDIOTYPE VACCINE; HODGKINS LYMPHOMA; SPACER DOMAIN; B-CELL; EXPRESSION; RECEPTOR; ACTIVATION; IL-4; PROLIFERATION; CONSTRUCTION; (1)
Anti-Infective Agents: CH, chemistry *Anti-Infective Agents: IP, isolation & purification Anti-Infective Agents: PD, pharmacology *Coumarins: CH, chemistry Coumarins: PD, pharmacology Microbial Sensitivity Tests Plant Extracts: CH, chemistry *Plant Extracts: IP, isolation & purification Plant Extracts: PD, pharmacology *Plants: CH, chemistry Spectrum Analysis 0 (Anti-Infective Agents) 0 (Coumarins) 0 (Plant Extracts) (1)
*Anti-Infective Agents: PD, pharmacology *Antineoplastic Agents, Phytogenic: PD, pharmacology *Antiprotozoal Agents: PD, pharmacology Cell Line, Tumor Humans Microbial Sensitivity Tests Parasitic Sensitivity Tests *Plant Extracts: PD, pharmacology Plant Leaves: CH, chemistry *Plants, Medicinal: CH, chemistry Vanuatu 0 (Anti-Infective Agents) 0 (Antineoplastic Agents, Phytogenic) 0 (Antiprotozoal Agents) 0 (Plant Extracts) (1)
Anti-inflammatory agents Verbesina turbacensis (bornyl cinnamate derivs. with antiinflammatory activity from Verbesina turbacensis) Natural products Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (bornyl cin bornyl cinnamate deriv antiinflammatory Verbesina (1)
ANTIINFLAMMATORY PATHWAY; SYSTEM; PHARMACOKINETICS; INFLAMMATION; ENDOTOXEMIA; EXPRESSION; SEPSIS; HUMANS; Cholinergic-anti-inflammatory-pathway; Cholinesterase inhibitors; Immunomodulation; Mac-1; Non-neuronal-cholinergic system; Oxidative burst; Reactive oxygen species (1)
ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; CROHNS-DISEASE; DENDRITIC CELL; INFLAMMATORY RESPONSES; MESSENGER-RNA; ACTIVATION; EXPRESSION; APOPTOSIS; MOLECULE; BINDING; Colitis; Crohn's disease; Inflammation; Inflammatory bowel disease; Ulcerative colitis; Galectin-3 (1)
Antike MA NZ 19.Jh 20.Jh Finanzen Steuern (1)
Antikörper, Interleukin-3, rheumatoide Arthritis (1)
ANTI-MARKOVNIKOV HYDROAMINATION; MODEL; ALKENES; PHENOXYL/PHENOL; BENZYL/TOLUENE; OXIDATION; MECHANISM; SYSTEMS; PHENOLS; ACCESS (1)
Anti-MCV, mutiertes citrulliniertes Vimentin, ACPA, Rheumafaktoren, Anti-CCP, Rheumatoide Arthritis, chronische Polyarthritis (1)
ANTIMICROBIAL ACTIVITY; BEES HYMENOPTERA; CUTICULAR LIPIDS; FUNGI; ATTACHMENT; CUTICLE; PREY; WASP; Philanthus triangulum; Hymenoptera; Crabronidae; honeybee; Apis mellifera; postpharyngeal gland; prey preservation; (Z)-9-pentacosene (1)
ANTIMICROBIAL AGENT; PLAQUE; DISCOLORATION; GINGIVITIS; EFFICACY; BRACKETS; GEL; (1)
antimicrobial; bacteria; light; oral; visible (1)
ANTIMICROBIAL CHEMOTHERAPY PACT; GRAM-NEGATIVE BACTERIA; SINGLET OXYGEN; TOLUIDINE-BLUE; PHOTODYNAMIC THERAPY; IN-VITRO; PHENOTHIAZINIUM PHOTOSENSITIZERS; PHOTOBACTERICIDAL EFFICACY; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; (1)
ANTIMICROBIAL CHEMOTHERAPY PACT; PORPHINE TETRA TOSYLATE; BIOFILM FORMATION; DRUG-RESISTANCE; ORAL CANDIDOSIS; METHYLENE-BLUE; IN-VITRO; SINGLET OXYGEN; PHOTOSENSITIZED OXIDATION; FUNGAL-INFECTIONS; APDT; Candida albicans; Photodynamic inactivation; ROS; Singlet oxygen; Topical treatment (1)
; Antimicrobial-coated nails; Infection prevention; Quality of life (1)
Antimicrobial coating, inanimate surface, pathogen transmission, test norm, wet and dry testing, resistance (1)
ANTIMICROBIAL PEPTIDE LL-37; FIBROBLAST-GROWTH-FACTOR; HUMAN DERMAL FIBROBLASTS; NF-KAPPA-B; KERATINOCYTE MIGRATION; EPIDERMAL-GROWTH; SKIN WOUNDS; IN-VITRO; SIGNALING PATHWAYS; CATHELICIDIN LL-37; cellular; molecular; novel findings; signal transduction; pH value; skin wound (1)
antimicrobial peptides (AMPs); machine learning (ML); antimicrobial resistance; biofilm eradication; wound infection; 3D human epidermal model (1)
ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; IL-1-BETA; CELLS; MACROPHAGES; CHEMOTAXIS; STATES; Beta-defensins; p2x7 receptor; Pro-inflammatory cytokines; TLR agonists (1)
antimicrobial peptides; photocrosslinkable hydrogel; polymer modification; SAAP-148; wound infection (1)
ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; PHOTODYNAMIC THERAPY; DISCHARGE PLASMA; DRUG-RESISTANCE; CHLORHEXIDINE; PERSPECTIVE; INFECTIONS; DEFENSINS; ADHERENCE; (1)
ANTIMICROBIAL PHOTODYNAMIC THERAPY; SINGLET OXYGEN; ESCHERICHIA-COLI; G-QUADRUPLEX; ACINETOBACTER-BAUMANNII; METHYLENE-BLUE; IN-VITRO; INACTIVATION; PORPHYRIN; PHOTOINACTIVATION; (1)
ANTIMICROBIAL PHOTODYNAMIC THERAPY; SYSTEMIC AMOXICILLIN; MICROBIAL PROFILES; GLOBAL BURDEN; MODEL; PATHOGENS; DISEASES; HEALTH; METRONIDAZOLE; VALIDATION; Biofilm; microcosm; subgingival; oral microbiome; 16S rDNA; periodontitis (1)
ANTIMICROBIAL RESISTANCE; BETA-LACTAMASES; SURVEILLANCE; MICROBIOLOGY; COLONIZATION; ENTEROBACTER; DERMATOLOGY; PATHOGENS; Chronic wound; Pseudomonas aeruginosa; Antibiotic; Robert Koch Institute; Prevention (1)
ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; CLARITHROMYCIN; METAANALYSIS; MULTICENTER; INFECTION; EXPOSURE; CORPUS; ANTRUM; antibiotic resistance rate; antibiotic susceptibility testing; antibiotic stewardship; updated treatment strategies; Helicobacter pylori infection; chronic atrophic gastritis; intestinal metaplasia (1)
ANTIMICROBIAL RESISTANCE; THERAPY; optimal effective concentration combination (OPECC); synergy; bacterial resistance; checkerboard assay; binary; combination therapy; antibiotics; antiseptics; Escherichia coli (1)
Antimicrobial surface, Photodynamic coating, Decontamination, Pathogen transmission, Hospital-acquired infections (1)
ANTIMICROBIAL SUSCEPTIBILITIES; INFECTIONS; chlorhexidine; antibiotic resistance; antiseptic; biofilm (1)
antimicrobials, wound healing, Staphylococcus aureus, Candidozyma auris, chronic wounds, bovine lactoferricin, Ex vivo wound model, multidrug-resistant (MDR) (1)
antimikrobielle photodynamische Therapie (aPDT), Escherichia coli, Stressantwort (1)
; anti-modernism; conspiracism; conspiracy thinking; Enlightenment; history of ideas; intellectual history (1)
Antimon · Argentophile Wechselwirkungen · Schwach Koordinierende Anionen · Selbstorganisation · Silber (1)
Antimon; Bindungsanalyse; Dichtefunktionalrechnungen; Pnicogenliganden; Wolfram (1)
antimony · arsenic · coordination-compounds · chelating complexes · copper · phosphorus (1)
antimony · arsenic · interpnictogen · molybdenum · phosphorus (1)
Antimony; Coordination compounds; Cluster compounds; Crystal structure (1)
Antimony; Cyclopentadienyl complexes; Crystal structure (1)
antimony; heterocumulenes; pnictides; tripodal ligands; tungsten (1)
Antimony; Iron; Cobalt; Cluster; Polyhedra (1)
ANTINEOPLASTIC AGENTS; COLCHICINE; CANCER; COMBRETASTATIN-A-4; BINDING; (1)
Antineoplastic Combined Chemotherapy Protocols: PD, pharmacology *Antineoplastic Combined Chemotherapy Protocols: TU, therapeutic use Breast Neoplasms: AN, analysis *Breast Neoplasms: DT, drug therapy Breast Neoplasms: PA, pathology Humans *Interferons: AD, administration & dosage Receptors, Estrogen: AN, analysis *Tamoxifen: AD, administration & dosage Tumor Cells, Cultured: DE, drug effects 0 (Receptors, Estrogen) (1)
ANTINEOPLASTIC DRUGS; SURFACE CONTAMINATION; HOSPITAL PERSONNEL; PHARMACY; AGENTS; MESOTHELIOMA; SURGERY; WORKERS; URINE; Hyperthermic intrathoracic chemotherapy; HITOC; Cisplatin; Surface contamination; Occupational exposure (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; GLOMERULAR BASEMENT-MEMBRANE; CHURG-STRAUSS-SYNDROME; ANCA-ASSOCIATED VASCULITIS; T-CELL EPITOPE; MICROSCOPIC POLYANGIITIS; RENAL INVOLVEMENT; IV COLLAGEN; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; pulmorenal syndrome; glomerulonephritis; pulmonary hemorrhagia; ovasculitis (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; PROTEOGLYCAN-INDUCED ARTHRITIS; HEAT-SHOCK PROTEIN; ANTIPERINUCLEAR FACTOR; B-CELLS; CARTILAGE PROTEOGLYCAN; BALB/C MICE; ANTIKERATIN ANTIBODIES; AUTOIMMUNE-DISEASES; PERIPHERAL-BLOOD; (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; RHEUMATOID-ARTHRITIS; IGG4-RELATED DISEASE; CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; ANTIPHOSPHOLIPID SYNDROME; INTERNATIONAL CONSENSUS; ANTIDRUG ANTIBODIES; AMERICAN-COLLEGE; AUTOANTIBODIES; antibodies; autoimmune diseases; biomarker; diagnostics (1)
Antiöstrogene , Brustkrebs , Östrogenrezeptor , Furanderivate , Pyranderivate , Heterocyclische Verbindungen , Ligand <Biochemie> , Antiestrogene , Estrogen Rezeptor , Hormon-abhängiger Brustkrebs , Endokrine Therapie , Diphenylfuran , Antiestrogens , Estrogen receptor , Hormone-dependent brest cancer , Endocrine therapy , Diphenylfuran (1)
ANTIOXIDANT ACTIVITY; INDUCED APOPTOSIS; CARCINOMA-CELLS; CHICK-EMBRYO; CANCER-CELLS; FLAVONOIDS; CYTOTOXICITY; ACTIVATION; EXTRACT; AGENTS; Kaempferol; Polyphenol; Flavonoid; Histone deacetylase; Epigenetics (1)
ANTIOXIDANT ENZYME EXPRESSION; RETICULUM CA2+ LEAK; CLINICAL PRESENTATION; RISK-FACTORS; PREVALENCE; IMPACT; ESTROGEN; ASSOCIATION; PROTEIN; CAMKII; sleep apnea; sleep-disordered breathing; gender; atrial fibrillation; heart failure; cardiovascular disease; diabetes (1)
ANTIOXIDANT RESPONSE; B-VIRUS; HUMAN HEPATOCYTES; OXIDATIVE STRESS; VIRAL-HEPATITIS; RNA REPLICATION; NS5A; ACTIVATION; PROTEASOME; EXPRESSION; (1)
ANTIOXIDANT-RESPONSE-ELEMENT; DOUBLE-STRAND BREAKS; DNA-DAMAGE; GENE-EXPRESSION; HUMAN P53; DRUG-RESISTANCE; PROTEIN-KINASE; CANDIDATE MEDIATOR; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; melanoma; PD-1; immune checkpoint inhibition; resistance; brain metastases (1)
Antioxidants Atractylodes lancea (antioxidant activity of constituents from Atractylodes lancea) Natural products Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (antioxidant activity of cons atractylodin deriv antioxidant Atractylodes (1)
Antioxidants Cholinesterase inhibitors Structure-activity relationship (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties) butyrylcholinesterase inhibitor antioxidant quinazolinimine lipoate prepn SAR (1)
Antioxidants Cytotoxicity Hypericum Radical scavengers Structure-activity relationship (antioxidant activity of phloroglucinol derivs. from hypericum species) Reactive oxygen species Role: BSU (Biological study, unclassified), BIOL (Biological study) (antioxidant activity of phloroglucinol derivs. from hypericum species) Respiration (burst antioxidant activity of phloroglucinol derivs. from hypericum species) antioxidant phloroglucinol deriv hypericum structure activity (1)
Antioxidants (phenolic prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Terpenes Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (phenolic prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Antitumor agents Neoplasm (prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Chalcones Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa Phenols Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (terpenoid prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) prenylated geranylated Humulus lupulus chalcone prepn antitumor antioxidative activity (1)
ANTIOXIDANT; STABILITY; NANOTECHNOLOGY; PROLIFERATION; BIOSYNTHESIS; LEMONGRASS; AGENTS; SAFETY; ALPHA; (1)
antiphospholipid syndrome, blood platelets, lipidomics, platelet activation, platelet function tests (1)
Antiproliferative activity, piperazine derivatives, triphenyl derivatives, erythroid differentiation, anticancer agents (1)
ANTIPSORIATIC ANTHRONES; KERATINOCYTE GROWTH; LICHEN METABOLITES; 5-LIPOXYGENASE; 1,8-DIHYDROXY-9(10H)-ANTHRACENONES; INACTIVATION; DERIVATIVES; ANTHRALIN; RADICALS; TARGET; antiproliferative activity; keratinocytes; lactate dehydrogenase release; leukotriene biosynthesis; obtusatic acid (1)
antipsychotic agents; extrapyramidal side-effects; gait; hypokinesia; movement disorder; schizophrenia; treadmill walking (1)
ANTIPSYCHOTIC POLYPHARMACY; SCHIZOAFFECTIVE DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; META-REGRESSION; CLOZAPINE; AUGMENTATION; RISPERIDONE; TOLERABILITY; METAANALYSIS; EFFICACY; Schizophrenia; Antipsychotics; Combination; Amisulpride; Olanzapine; Polypharmacy (1)
ANTIREFLECTION COATINGS; DESIGN (1)
ANTIRETROVIRAL THERAPY; CONJOINT-ANALYSIS; ADHERENCE; OUTCOMES; MEN; EDUCATION; HIV/AIDS; INTERNET; HAART; AIDS; HIV/AIDS; adherence; patients' preferences; conjoint analysis (1)
antirheumatic drugs | biologics | comorbidity | drugs | erythroderma | fumarates | Germany | outcome | psoriasis | treatmen (1)
ANTI-SARS-COV-2 ANTIBODY; SEROPREVALENCE; COVID-19; SARS-CoV-2; COVID-19; longitudinal; durability; population-based; antibody; neutralization; avidity (1)
Antisemitismus · Apartheid · BDS · Demokratie · Israel · Westjordanland (1)
antisense oligonucleotides; antibodies; tissue targeting; fluorescence imaging; tumor angiogenesis (1)
antiseptic, chlorhexidine, CHX, resistance, adaptation, tolerance, persistence, efflux pump (1)
Antiseptics · Antimicrobial photodynamic therapy · aPDT · Binary · OPECC · Synergy (1)
ANTI-SIGMA FACTOR; BACTERIAL CHEMOTAXIS; RESPONSE REGULATOR; SIGNAL-TRANSDUCTION; RHIZOBIUM-MELILOTI; ESCHERICHIA-COLI; HISTIDINE KINASE; RHODOBACTER-SPHAEROIDES; SENSORY TRANSDUCTION; HELICOBACTER-PYLORI; (1)
ANTISOCIAL PERSONALITY-DISORDER; LOBE ABNORMALITIES; STRUCTURAL MRI; VOLUME; PERSPECTIVE; EMPATHY; BRAIN; SCHIZOPHRENIA; HIPPOCAMPUS; ALCOHOLISM; psychopathy; frontotemporal network; PCL-R; volume loss; pathogenesis; superior temporal gyrus; voxel-based morphometry; brain structure (1)
ANTISOCIAL PERSONALITY-DISORDER; PREFRONTAL GRAY-MATTER; MIRROR NEURON SYSTEM; SOCIAL COGNITION; FEARFUL EXPRESSIONS; FALSE BELIEF; MIND; CORTEX; METAANALYSIS; INDIVIDUALS; Psychopathy; Intention; Theory of Mind; Social interaction; fMRI (1)
ANTISOCIAL PERSONALITY-DISORDER; STARTLE REFLEX; ORBITOFRONTAL CORTEX; LOBE ABNORMALITIES; RESPONSE REVERSAL; AVERSIVE STIMULUS; NEGATIVE AFFECT; GRAY-MATTER; MODULATION; SELF; (1)
antitermination; transcription; NusB protein; NMR spectroscopy; RNA-binding protein (1)
ANTITUMOR-ACTIVITY; CANCER-THERAPY; PHASE-I; GROWTH; PROLIFERATION; TRANSCRIPTION; SENSITIVITY; REPRESSION; KINASE; TUMORS; (1)
ANTITUMOR-ACTIVITY; COMPLEXES; LIGANDS; ALCOHOLS; THERAPY; AGENTS; (1)
ANTITUMOR-ACTIVITY; HER2 EXPRESSION; IMMUNE-RESPONSE; TRASTUZUMAB; PERTUZUMAB; COMBINATION; RESISTANCE; MECHANISM; HERCEPTIN; SK-BR-3; Anti-HER2 antibody; Breast cancer; Treatment efficiency; Humanized tumor mice; Monoclonal antibody (1)
ANTITUMOR-ACTIVITY; KINASE INHIBITOR; CANCER; AKT; PATHWAY; THERAPY; MODELS; HEPATOCARCINOGENESIS; COACTIVATION; GENERATION; Intrahepatic cholangiocarcinoma; Dual mTOR inhibitor; Targeted therapy; Gemcitabine; Translational medicine; Mouse model; MLN0128 (1)
Antitumor agent resistance Antitumor agent resistance Complexation Mammary gland Prostate gland (optimization of cisplatin for treatment of hormone dependent tumoral diseases) DNA Estrogen receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (optimization of cisplatin for treatment of hormone dependent tumoral diseases) review cisplatin carboplatin breast prostate cancer antitumor resistance (1)
Antitumor agent resistance Antitumor agent resistance Drug design Mammary gland Prostate gland (optimization of cisplatin for treatment of hormone-dependent tumoral diseases) review cisplatin complex hormone dependent tumor antitumor resistance (1)
Antitumor agents; Bladder; Human; Structure-activity relationship (carboplatin derivs. with superior antitumor activity compared to the parent compd.); Ovary, neoplasm (cisplatin-resistant, carboplatin derivs. with superior antitumor activity compared to the parent compd.); carboplatin deriv prepn (1)
Antitumor agents (brain hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Development (child, hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Brain, neoplasms (hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Brain, neoplasms (inhibitors, hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); child brain tumor chemotherapy hyaluronidase combination (1)
Antitumor agents Cytotoxicity Human Immunosuppressants Lymphocyte Marrubium cylleneum Marrubium velutinum Molecular structure Natural products (labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) Diterpenes Role: PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (labdane labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) Diterpenes Role: PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (norditerpenes labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) labdane diterpene Marrubium mol structure cytotoxicity immunomodulator antitumor (1)
Antitumor agents Human Leukemia Psoralea morisiana (cytotoxic prenylated isoflavonoids from Bituminaria morisiana) Isoflavonoids Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (cytotoxic prenylated isoflavonoids Flavonoids Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (pterocarpans cytotoxic prenylated isoflavonoids from Bituminaria morisiana) antitumor prenylated isoflavonoid Bituminaria isolation leukemia (1)
Antitumor agents (mammary gland platinum bis(fluorophenyl)ethylenediamine DMSO complexes as) Mammary gland (neoplasm, inhibitors platinum bis(fluorophenyl)ethylenediamine DMSO complexes as) platinum fluorophenylethylenediamine DMSO prepn breast antitumor agent (1)
Antitumor agents ([rac-1,2-bis(4-fluorophenyl)ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin deriv., antitumor effect); Molecular structure ([rac-1,2-bis(4-fluorophenyl)ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin deriv., mol. structure); fluorophenyl ethylendiamine cyclobutane carboxylatoplatinum synthesis anticancer; carboplatin deriv anticancer (1)
Antitumor agents Warionia saharae (cytotoxic 6,7-cis and 6,7-trans configured guaianolides from Warionia saharae) Guaianolides Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxic 6,7-ci New natural products (moroccolide A and saharanolides A-B (guaianolides) Molecular structure (of moroccolide A and saharanolides A-B (guaianolides) guaianolide Warionia antitumor agent sesquiterpene lactone Warionia antitumor agent (1)
ANTITUMOR NECROSIS FACTOR; RECEIVING CONCOMITANT METHOTREXATE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ALPHA MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INFLAMMATORY DISEASES; BLOCKING-AGENTS; THERAPY; ETANERCEPT; rheumatoid arthritis; biologics; TNF-inhibitors; effectiveness; quality-adjusted life-year (1)
ANTI-VEGF TREATMENT; HEALTH-CARE RESEARCH; VISUAL-ACUITY; RANDOMIZED-TRIAL; DEFERRED LASER; OUTCOMES; DEGENERATION; PATTERNS; PROMPT; Diabetic macular edema; Observational study; Ranibizumab; Treatment outcome; Vascular endothelial growth factor A (1)
ANTIVIRAL ACTIVITY; AVIAN BORNAVIRUS; PATHOGENESIS; REPLICATION; AMANTADINE; INHIBITION; RIBAVIRIN; SEQUENCE; (1)
Antizipation, vorausschauendes Fahren, Situationsbewusstsein, Verkehrspsychologie, Faktor Mensch, anticipation, anticipatory driving, situation awareness, traffic psychology, human factors (1)
antizipierter Vertragsbruch; vorweggenommene Nichterfüllung; Rechtsbehelf; Aufhebung des Vertrages vor Fälligkeit anticipatory breach of contract; non-performance; remedies; termination before the obligation becomes due (1)
ANT LASIUS-NIGER; INFORMATIONAL SOCIAL-INFLUENCE; COLLECTIVE DECISION-MAKING; PUBLIC INFORMATION; DEPENDENT DECISIONS; TIME PREFERENCE; ADAPTIVE USE; CHOICE; VIOLATIONS; INSECTS; social information; value perception; preference; conformity; recruitment; pheromone trails (1)
ANT LEPTOTHORAX-NYLANDERI; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; COLONY SIZE; DIACAMMA SP; INSECT SOCIETIES; SOCIAL INSECTS; MONANDROUS ANT; NEST-SITE; QUEEN; group cohesion; conflict resolution; colony size; worker policing; worker reproduction; Temnothorax unifasciatus (1)
Anton Vilsmeier (1)
ANT PLATYTHYREA-PUNCTATA; JUVENILE-HORMONE; SOCIAL-BEHAVIOR; PONERINE ANT; HONEY-BEES; BODY-SIZE; DROSOPHILA-MELANOGASTER; APIS-MELLIFERA; LIFE-SPAN; EVOLUTION; division of labour; social dominance; environmental stress; clonality; Formicidae (1)
ANTRAL ISOLATION; CONTACT FORCE; ABLATION; ADENOSINE; CATHETER; RECONNECTION; CONDUCTION; ablation; atrial fibrillation; reconnection; adenosine; high power (1)
ants | behavioral asymetry | insects | lateralization | motor bias (1)
ANTS CAMPONOTUS-FLORIDANUS; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; GENOME EVOLUTION; HARPEGNATHOS-SALTATOR; SOLENOPSIS-INVICTA; DNA METHYLATION; DRAFT GENOME; FIRE ANT; PROTEIN; (1)
ants; chemical profile; cuticular hydrocarbons; genetic variation; nestmate recognition; Temnothorax (1)
Ants · Human-mediated dispersal · Nest material · Nest-site selection · Temnothorax species · Urbanization (1)
ANTS; ISOPTERA; COMB; INCOMPATIBILITY; CONFLICT; ENZYMES; MOUNDS; ORIGIN; THERMOREGULATION; ESTABLISHMENT; evolutionary conflict; host symbiont conflict; mutualism; symbiosis; Termitomyces (1)
ants, neuroactives, invasion biology, spinosad, caffeine, pest management (1)
Ants · Pheromone · Decision-making · Information use (1)
Ants, third party reproduction, inbreeding, relatedness coefficient (1)
ANUS-SPINAL DEFECTS; CLASSIC BLADDER EXSTROPHY; IN-VITRO FERTILIZATION; OF-THE-LITERATURE; CLOACAL EXSTROPHY; IMPERFORATE ANUS; INCONTINENT EPISPADIAS; PRENATAL-DIAGNOSIS; TRIPLET PREGNANCY; SMOOTH-MUSCLE (1)
Anwaltsvergütung; Autonomie der Parteien; Vereinbarung; Anwaltsvertrag (1)
Anwendungssystemintegration, Enterprise Application Integration (EAI), Investitionsentscheidung (1)
anxiety; arti4cial intelligence; autonomous driving; autonomous vehicle acceptance; public transport; trait anxiety (1)
anxiety, attentional control, goal-directed attention, distractor, visual search (1)
anxiety disorder, agoraphobia, social anxiety, specific phobia, exposure therapy, virtual reality, meta-analysis, systematic review (1)
ANXIETY DISORDER; CENTRAL AMYGDALA; CONTEXTUAL FEAR; MEDIAL AMYGDALA; MALE RATS; VASOPRESSIN; RECEPTOR; MICE; BEHAVIOR; MEMORY; (1)
ANXIETY DISORDER; MAJOR DEPRESSION; PHARMACOTHERAPY; COMORBIDITY; MULTICENTER; FLUVOXAMINE; VENLAFAXINE; EFFICACY; (1)
ANXIETY DISORDERS; BELIEFS QUESTIONNAIRE; EXTINCTION TREATMENT; MASSIVE EXTINCTION; CONDITIONED FEAR; GERMAN VERSION; ALCOHOL CUES; THERAPY; RENEWAL; RETURN; Multiple contexts; Multiple stimuli; Return of fear; Spider phobia; Virtual reality exposure (1)
ANXIETY DISORDERS; FEAR; PHOBIA; ENVIRONMENT; RESPONSES; ETIOLOGY; THERAPY; STARTLE; HUMANS; social fear conditioning; virtual reality; operant conditioning paradigm; heart rate; fear-potentiated startle; social anxiety (1)
ANXIETY DISORDERS; SELF-EFFICACY; FLIGHT ANXIETY; FEAR REDUCTION; SPIDER PHOBIA; DISTRACTION; METAANALYSIS; INFORMATION; STIMULI; DANGER; Virtual reality; Exposure therapy; Diaphragmatic breathing; Aviophobia; Experimental study (1)
Anxiety-happiness psychosis; Erlangen School; history of psychiatry; Karl Leonhard; NS-psychiatry; schizophrenias (1)
ANXIETY-LIKE BEHAVIOR; GERM-FREE; MICE; PROBIOTICS; CULTURE; ABSENCE; STRESS; TRIAL; FLORA; DIET; Microbiota-gut-brain-axis; Translational metagenomics; Hypothalamo-hypophyseal system; Functional imaging; Psychobiotics (1)
anxiety, oxytocin, P2X4R (1)
Anxiety reduction · Allergic reaction · Corona virus · Polyethylene glycol · Vaccines (1)
Anxiety-related behavior, Corticosterone, Etifoxine, Passive stress-coping, Spine density, TSPO (1)
ANXIETY-RELATED BEHAVIOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR MESSENGER-RNA; FEMALE RATS; ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; LACTATING RATS; BINDING-SITES; MICROTUS-OCHROGASTER; GENE-EXPRESSION; antagonist; central amygdala; microdialysis; paraventricular nucleus; rat; V1a receptor (1)
ANXIETY-RELATED BEHAVIOR; MONOGAMOUS VOLE; STRESS-RESPONSE; RECOGNITION; BRAIN; CONSEQUENCES; OXYTOCIN; EXPRESSION; DISORDERS; FOREBRAIN; microdialysis; oxytocin; recognition; septum; V1a receptor; vasopressin; viral vector (1)
ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENOCORTICAL AXIS; MILK-EJECTION REFLEX; PERIPHERAL RELEASE; BRAIN OXYTOCIN; LATE PREGNANCY; RAT-BRAIN; SUPRAOPTIC NUCLEI; MESSENGER-RNA; SWIM STRESS; maternal aggression; maternal behaviour; microdialysis; stress (1)
ANXIETY-RELATED BEHAVIOR; SEXUAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; CENTRAL AMYGDALA; SOCIAL-BEHAVIOR; BRAIN OXYTOCIN; STRESS; VASOPRESSIN; SYSTEM; NEUROBIOLOGY; (1)
ANXIETY SENSITIVITY; RHESUS-MONKEYS; BEHAVIOR; HIPPOCAMPAL; PHOBIAS; MAZE; RATS; MICE; Agoraphobia; Animal models; Anxiety sensitivity; Avoidance behavior; Open field test; Thigmotaxis (1)
ANXIETY; Somatoform Disorder; Comorbidity; Prevalence; Psychosomatic Inpatients (1)
anzestrale Sequenzrekonstruktion; Phylogenie; Proteindesign; Proteinevolution (1)
Aortenaneurysma, Aortendissektion, hypothermer Kreislaufstillstand, selektive antegrade Hirnperfusion, Lebensqualität, Sickness Impact Profile (1)
AORTIC-ANEURYSM; INTENTIONAL OCCLUSION; SERUM CREATININE; EQUATION; SOCIETY; CARE; Aneurysm; EVAR; Accessory renal arteries; Acute kidney injury; Chronic kidney disease (1)
AORTIC BIOPROSTHETIC VALVES; CALCIFICATION; IMPLANTATION; SUBSTITUTES; REPLACEMENT; (1)
AORTIC ENDOTHELIAL-CELLS; PLASMA-LEVELS; MCP-1 GENE; NEPHROPATHY; EXPRESSION; DISEASE; ATHEROSCLEROSIS; SUSCEPTIBILITY; ASSOCIATION; MICE; MCP-1; polymorphism; promoter; type 2 diabetes (1)
aortic valve disease, new devices (in general), percutaneous valve therapy (1)
aortic valve endocarditis; native valve endocarditis; prosthetic valve endocarditis; health-related quality of life; Minnesota Living with HF Questionnaire (1)
AORTIC-VALVE IMPLANTATION; EXTRACORPOREAL MEMBRANE-OXYGENATION; LOW-FLOW; CARDIOPULMONARY BYPASS; CONTRACTILE RESERVE; RISK STRATIFICATION; TRANSCATHETER; GRADIENT; REPLACEMENT; STENOSIS; Depressed left ventricular function; Aortic stenosis; TAVI; ECMO; Multidisciplinary Heart Team (1)
AORTIC-VALVE IMPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; CARDIAC ARREST SYNDROME; CARDIOPULMONARY; RESUSCITATION; COMPLICATIONS; Cardiac arrest; Extracorporeal membrane oxygenation; ECLS; Cardiopulmonary resuscitation (1)
AORTIC-VALVE IMPLANTATION; RISK-FACTORS; POSTOPERATIVE DELIRIUM; GENERAL-ANESTHESIA; LOCAL-ANESTHESIA; NAUSEA; PREVENTION; MORBIDITY; MORTALITY; OUTCOMES; (1)
AORTIC-VALVE REPLACEMENT; EXPERIENCE; (1)
AORTIC-VALVE-REPLACEMENT; INTERMEDIATE-RISK PATIENTS; CONDUCTION ABNORMALITIES; TRANSCATHETER; PREDICTORS; REGURGITATION; REGISTRY; COMPLICATIONS; OUTCOMES; DEVICE; (1)
AORTIC-VALVE REPLACEMENT; PULMONARY AUTOGRAFT; MAGNETIC-RESONANCE; CHILDREN; ROOT; MASS; REGURGITATION; STENOSIS; DISEASE; heart; aortic valve disease; Ross procedure; cine MRI; left ventricular hypertrophy (1)
AORTIC-VALVE-REPLACEMENT; QUALITY-OF-LIFE; SERUM CREATININE; ELDERLY-PATIENTS; TERM SURVIVAL; MORTALITY; IMPACT; EUROSCORE; OUTCOMES; FAILURE; octogenarians; cardiac surgery; acute kidney injury; renal dysfunction; mortality (1)
; aortoenteric; aortointestinal; fistula; endovascular aneurysm repair; abdominal aortic aneurysm (1)
AORTOILIAC OCCLUSIVE DISEASE; ENDOVASCULAR TREATMENT; OUTCOMES; MANAGEMENT; Critical limb ischemia; Aorto-bi-femoral bypass graft; Intermittent claudication; Aortoiliac occlusive disease; Long-term outcome (1)
AORTOILIAC OCCLUSIVE DISEASE; ENDOVASCULAR TREATMENT; SURGICAL RECONSTRUCTION; COMMON; BYPASS; HYBRID; Remote iliac artery endarterectomy; Iliac artery occlusive disease (1)
AP-2 TRANSCRIPTION FACTOR; CARDIAC OUTFLOW TRACT; CAUSE CHAR-SYNDROME; NEURAL CREST CELLS; FACTOR AP-2-BETA; MICE; MUTATIONS; CLONING; EXPRESSION; DEFECTS; (1)
APATITE-FORMATION; LACTIC-ACID; OSTEOBLAST DIFFERENTIATION; PHOTOCATALYTIC ACTIVITY; HYDROGEN-PEROXIDE; RAMAN-SCATTERING; INFRARED-SPECTRA; SOLID-STATE; IN-VITRO; CARBONATE; Laser micro/nanostructured titanium surface; NaOH-CaCl2-Heat-water treatment; Biomimetic calcium phosphate deposition; Biocompatibility; Osteogenic differentiation (1)
APC/C; degron; Cdh1; Cdc20; cell cycle; Zellzyklus; Cdk phosphorylation; Cdk Phosphorylierung; Ubiquitin-Ligase (1)
APC; EZB; Förderbedingungen; Kostentransparenz; Open Access; Publikationskosten; Transformationsverträge; openCost APC; EZB; Open Access; cost transparency; funding conditions; openCost; publication costs; transformative agreements (1)
APCI-TOF-MS; ION-SOURCE; ADVANTAGES; GC-APCI-HRTOFMS; Ionization efficiency; Atmospheric pressure chemical ionization; GC-APCI II source; Metabolomics (1)
APC TUMOR-SUPPRESSOR; WINGLESS SIGNALING PATHWAYS; BETA-CATENIN; COLORECTAL TUMORS; COLI-PROTEIN; MICROTUBULE CYTOSKELETON; PHENOTYPIC VARIABILITY; NEGATIVE REGULATOR; SOMATIC MUTATIONS; ADHESION COMPLEX; APC gene; APC protein; apoptosis; cell cycle; chromosomal stability; familial adenomatous polyposis; germline mutatio; wnt signaling; cell adhesion and migration (1)
APERT-SYNDROME; EXPRESSION; MUTATION; LIGAND; acne pathogenesis; acneiform naevus; Apert syndrome; FGFR2 mutation; fibroblast growth factor signalling; interleukin-1 alpha (1)
Aphantasia, Mental imagery, Mental comparisons, Vividness, Sensorimotor simulation (1)
apheresis platelet concentrates, conveyor system, platelet function, pneumatic tube system (1)
APHERESIS PLATELETS; IN-VITRO; MICROPARTICLES BIND; ADAPTIVE IMMUNITY; FLOW-CYTOMETRY; P-SELECTIN; STORAGE; MODULATION; ACTIVATION; VIABILITY; (1)
APHIDOPHAGOUS-SYRPHIDAE; DECEPTIVE POLLINATION; EPISYRPHUS-BALTEATUS; OVIPOSITION SITE; DIVERSITY; DIPTERA; EVOLUTION; PLANT; VOLATILES; FLIES; deceptive pollination; chemical mimicry; pheromone (1)
APICAL-BASAL AXIS; DNA-REPLICATION; WIDE ANALYSIS; ZEA-MAYS; EARLY EMBRYOGENESIS; SPERM CELLS; ARABIDOPSIS EMBRYO; FLOWERING PLANTS; PATERNAL GENOMES; MCM PROTEINS; (1)
APICAL-BASAL AXIS; PLANT DEVELOPMENT; SEED DEVELOPMENT; BIOSYNTHESIS; TRANSPORT; EMBRYOGENESIS; HOMEOSTASIS; (1)
API for data stores, schema evolution language, schema management, eager migration, lazy migration, schema versioning (1)
APIS-MELLIFERA-CAPENSIS; CUTICULAR HYDROCARBONS; PLATYTHYREA-PUNCTATA; QUEENLESS ANT; PONERINE ANT; HONEY-BEE; RHYTIDOPONERA-CONFUSA; REPRODUCTIVE STATUS; SOCIAL INSECTS; HYMENOPTERA; (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; FUNGUS-GROWING ANTS; HONEY-BEE COLONIES; FACULTATIVELY POLYGYNOUS ANT; SEX-RATIOS VARY; KIN-SELECTION; MATING FREQUENCY; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; IMPORTED FIRE ANT; LEAF-CUTTING ANTS; HONEY-BEES; HYGIENIC BEHAVIOR; INNATE IMMUNITY; METARHIZIUM-ANISOPLIAE; METAPLEURAL GLANDS; DISEASE RESISTANCE; physiological immune systems; evolutionary immunology; hygienic behaviour; self/non-self-recognition; levels of selection; immune regulation (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; PLATYTHYREA-PUNCTATA; COLONY DEFENSE; REPRODUCTION; SOCIETIES; EVOLUTION; CONFLICT; BEHAVIOR; QUEEN; Platythyrea punctata; colony fusion; worker policing; animal personalities; behavioural syndromes (1)
APIS-MELLIFERA-CAPENSIS; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; SOCIETIES; CONFLICT; FORMICIDAE; HONEYBEE; QUEENS; WASP; ant; dominance hierarchy; Platythyrea punctata; reproductive conflict; thelytokous parthenogenesis; worker policing (1)
APIS-MELLIFERA-CAPENSIS; THELYTOCOUS-PARTHENOGENESIS; RECOMBINATION RATES; CLONAL REPRODUCTION; SEX DETERMINATION; CENTRAL FUSION; HYMENOPTERA; WORKERS; FORMICIDAE; CONSEQUENCES; Apomixis; Automixis; Diploid males; Heterozygosity; Sex determination (1)
APIS-MELLIFERA-CARNICA; KIN RECOGNITION; BEE; HYDROCARBONS; HYPOTHESIS; BEHAVIOR; STAGE; CUES; (1)
APIS-MELLIFERA COLONIES; WESTERN HARVESTER ANT; SEXUAL SELECTION; SOCIAL-BEHAVIOR; REPRODUCTION; EVOLUTION; HYMENOPTERA; COMPETITION; COST; HONEYBEE; ants; male quality; sperm quality; Temnothorax; worker reproduction (1)
APIS-MELLIFERA; SEX-RATIOS; INTRASPECIFIC PARASITISM; SOCIAL-BEHAVIOR; MONANDROUS ANT; LIFE-SPAN; REPRODUCTION; POLYDOMY; HYMENOPTERA; ALLOCATION; (1)
apixaban, rivaroxaban, dabigatran, TDM, therapeutisches drug monitoring, therapeutic drug monitoring, DOAK, NOAK, UHPLC, Arzneimittelinteraktionen, Konzentrationsbestimmung (1)
apocrypha; New Testament canon; reception history; open canon (1)
ApoE, dementia, diabetes, family history (1)
APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; POLYMORPHISMS; ECTIM; (1)
APOLIPOPROTEIN-A-I; NONVESICULAR STEROL TRANSPORT; RAB PROTEINS; CHOLESTEROL; CELLS; EFFLUX; GOLGI; ABCA1; ATHEROSCLEROSIS; METABOLISM; HDL; lipid efflux; vesicular trafficking (1)
APOLIPOPROTEIN-A-I; TRANSMEMBRANE CONDUCTANCE REGULATOR; STEROL-DEPENDENT REGULATION; FACTOR PATHWAY INHIBITOR; LIVER-X-RECEPTOR; CHOLESTEROL EFFLUX; TANGIER-DISEASE; PLASMA-MEMBRANE; SPHINGOSINE 1-PHOSPHATE; CELLULAR CHOLESTEROL; ABCA1; apolipoproteins; beta 2-syntrophin; Cdc42; cholesterol homeostasis; microdomains; vesicular transport (1)
Apolipoprotein A-IV, Kidney function, Cancer, Inflammation, Prospective study (1)
APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; ONSET; ASSOCIATION; RELATIVES; ALLELE; RISK; AGE; dementia; Alzheimer's disease; ApoE; family history (1)
APOLIPOPROTEIN-E GENE; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; RISK; TAU; PROTEIN; ALLELE; LOCUS; Dementia; FTD; Family history; Genetics; ApoE polymorphism (1)
APOLIPOPROTEIN-E GENOTYPES; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; EPSILON-4 ALLELE; SYNAPSE LOSS; ONSET; RISK; AGE; POPULATION; DEMENTIA; Parkinson; ApoE epsilon 4/epsilon 4; ApoE epsilon 4 homozygosity; Parkinsonian signs; Alzheimer; Dementia; Genetics (1)
APOLIPOPROTEIN-E; MOUSE MODEL; TSPO; GENE; DISEASE; EFFLUX; LIGAND; BRAIN; ETIFOXINE; MECHANISM; de novo neurosteroidogenesis; 18 kDa Translocator Protein; Cholesterol homeostasis; Surveillant microglia; Autocrine regulation; TSPO ligand (1)
APOLIPOPROTEIN-L GENE; AFRICAN-AMERICANS; ALLOGRAFT SURVIVAL; ENDOTHELIAL-CELLS; MESANGIAL CELLS; EXPRESSION; DISEASE; IDENTIFICATION; NEPHROPATHY; VARIANTS; (1)
APOLIPOPROTEIN N-ACYLTRANSFERASE; METHIONINE SALVAGE PATHWAY; INTACT POLAR LIPIDS; ESCHERICHIA-COLI; TRANSFER-RNA; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PYROCOCCUS-HORIKOSHII; THERMOACIDOPHILIC ARCHAEON; THERMOPLASMA-ACIDOPHILUM; (1)
apolipoprotein; triglyceride; cholesterol; septic shock; survival (1)
APOLOGY STRATEGIES; AUSTRALIAN ENGLISH; POLITENESS; SPEECH; INDIRECTNESS; GERMAN; Big Brother; British English; directives; discourse completion test; dyadic model; elicitation tools; German; group interaction; linguistic politeness; natural data; non-dyadic interaction; Polish; politeness strategies; proposal; reality TV; request; role play (1)
Apoptose, intrinsische Apoptose, Mitochondrien, BCL-2-Proteine, BH3-Mimetika, BCL-XL, mitochondriales Priming, hyperosmotischer Stress, Tumorumgebung, p53, BAX, NF-κB, hyperosmotic stress, intrinsic apoptosis, BH3 mimetics, BCL-2 protein family, tumor environment (1)
Apoptose, Mammakarzinomzellen, Estrogenrezeptor Beta/ apoptosis, breast cancer cell lines, estrogen receptor beta (1)
; apoptosis; ASTX660; SMAC mimetic; TNF; TRAIL (1)
Apoptosis , Bäckerhefe , Saccharomyces cerevisiae , N-Glykosylierung , Autophagozytose , Kex1p , apoptosis , yeast , N-glycosylation , autophagy , Kex1p (1)
apoptosis, cancer, human, tumour immunology, viral (1)
; apoptosis; ECP; extracorporeal photopheresis; validation (1)
Apoptosis , Epithelzelle , Zellkontakt , Caspasen , Colon , Signaltransduktion , Anoikis , anoikis (1)
Apoptosis , Immuntoleranz , Fas-Ligand , Dendritische Zelle , , dendritic cell , Fas ligand , tolerance , apoptosis (1)
APOPTOSIS-INDUCING LIGAND; CELL-SURFACE ANTIGEN; MITOCHONDRIAL-MEMBRANE; TUMORICIDAL ACTIVITY; ANTITUMOR-ACTIVITY; DENDRITIC CELLS; HIGH-SALT; CASPASE 8; TRAIL; BAX; (1)
; apoptosis; melanoma cells; plasma; senescence (1)
Apoptosis , Neurogenese , Caspasen , Adulte Stammzelle , , adult neurogenesis , apoptosis (1)
APOPTOSIS; PROTEIN; MECHANOSENSATION; PROLIFERATION; RELEASE; OUABAIN; CYCLE; polycystin-1; NF-kappa B; promoter activity; siRNA; apoptosis; PKC alpha (1)
Apoptosis, tissue factor, mesangial cell, IL-1, PKC (1)
APOPTOTIC CELLS; PROPERDIN BINDS; MESSENGER-RNA; HIGH-RISK; VARIANT; RARE; EXPRESSION; REGULATORS; DISEASE; CONFERS; (1)
APPARENT MOLAL VOLUMES; ELECTROLYTIC CONDUCTIVITY; HYDROPHOBIC HYDRATION; PRIMARY STANDARDS; HALIDE SOLUTIONS; DILUTE-SOLUTIONS; IONS; WATER; CONDUCTANCE; EXPANSIBILITIES; (1)
APPARENT MOLAR VOLUMES; PRESSURE 0.35 MPA; MEAN SPHERICAL APPROXIMATION; LIQUID-VAPOR-EQUILIBRIUM; THERMODYNAMIC PROPERTIES; ELECTROLYTE-SOLUTIONS; 393.15 K; SODIUM-CHLORIDE; ACTIVITY-COEFFICIENTS; TEMPERATURE-DEPENDENCE; electrolyte; nonelectrolyte; osmotic coefficient; dilution enthalpy; heat capacity (1)
App-basiertes Training, Selbststabilisierung, Jugendalter, Motivation, Stressmanagement (1)
App-basiert, Physiotherapie-Trainingsprogramm, somatischer Tinnitus, Single-case-Studie (1)
APPENDAGE DEVELOPMENT; ECTODYSPLASIN; HAIR; GENE; (1)
Appendicitis, Conservative, Children (1)
Appendizitisdiagnostik, unklarer Unterbauchschmerz (1)
appetitive olfactory learning, starvation, motivation, drosophila (1)
APPLIED 5-AMINOLEVULINIC ACID; 2.5-PERCENT HYALURONAN GEL; TOPICAL 3.0-PERCENT DICLOFENAC; EMITTING DIODE LIGHT; FOLLOW-UP; IN-VITRO; GUIDELINES; IMIQUIMOD; EFFICACY; VULVAR; actinic keratosis; aminolaevulinic acid; multicentre trial; phase III; photodynamic therapy; randomized controlled trial (1)
Appraisal-Based Indices, Smoothing, Real Estate Returns (1)
APPROPRIATE ORDER; SOCIAL RANK; INDEX; MODEL; DomiCalc; dominance ranking; I&SI method; inconsistent dyad; matrix reordering technique; nonuniqueness (1)
APPROXIMATE BAYESIAN COMPUTATION; LANDSCAPE CONNECTIVITY; POPULATION; ECOLOGY; RANGE; DISPERSAL; EVOLUTION; BEHAVIOR; Approximate Bayesian Computation; Athene noctua; choosing optimal summary statistics; IBM parametrization; landscape connectivity; movement ecology (1)
APPROXIMATE COULOMB POTENTIALS; AUXILIARY BASIS-SETS; PLATINUM(II) COMPLEXES; PHOSPHINE-LIGANDS; CRYSTAL-STRUCTURE; EXCITED-STATES; PHOTOLUMINESCENCE; ENERGY; DITHIOLATE; ATOMS; electronic spectra; luminescence; platinum complexes; phosphatic complexes; quantumchemical calculations (1)
APPROXIMATE COULOMB POTENTIALS; REGULAR TETRAHEDRAL GEOMETRY; NUCLEAR MAGNETIC-RESONANCE; ZETA VALENCE QUALITY; AUXILIARY BASIS-SETS; GAUSSIAN-BASIS SETS; P-31 MAS-NMR; CRYSTAL-STRUCTURES; MOLECULAR-STRUCTURE; STRUCTURAL-CHARACTERIZATION; cobalt; gold; phosphorus; sandwich complexes; silver; solid-state NMR spectroscopy (1)
APPROXIMATE ENTROPY; I DISORDER; COMPLEXITY; SYMPTOMS; HORMONE; CHRONORECORD; IRREGULARITY; INSIGHT; (1)
APPROXIMATE NUMBER; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL-CHANGE; SERIAL DEPENDENCE; INTUITIVE SENSE; ACUITY; DISCRIMINATION; PERCEPTION; (1)
APPROXIMATION; crystal structure; lead; optical spectroscopy; tungstates; vibrational spectroscopy (1)
APPROXIMATION; DFT; Meta-GGA; black phosphorous; stacking; transmission (1)
APPROXIMATION; POLYACENE; ACENES; GW; (1)
APRIL, Rheumatoide Arthritis, Interleukin-6 (1)
APROTIC DONOR SOLVENTS; DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; FTIR SPECTROSCOPY; PAIR FORMATION; SOLVATION; LITHIUM; SODIUM; AGGREGATION; dielectric relaxation; infrared spectroscopy; ion association; solvation number; acetonitrile; perchlorates (1)
APTERUS HETEROPTERA; MEGACOPTA-PUNCTATISSIMA; BACTERIAL SYMBIONTS; PLATASPID STINKBUG; RHODNIUS PROLIXUS; ESCHERICHIA-COLI; NOCARDIA RHODNII; CARPENTER ANTS; COPY NUMBER; GUT; (1)
A. quantum wells; A. semiconductors; D. electron-phonon interaction; D. phonons; E. light absorption and reflection (1)
AQUAPORIN WATER CHANNELS; UROTHELIAL CARCINOMA; NEOADJUVANT; BIOMARKERS; MIGRATION; GROWTH; STAGE; Aquaporin 3 (AQP3); Biomarker; Muscle-invasive bladder cancer; Prognostic value; Oncological outcome; Muscle-invasive urothelial carcinoma; Prognosis; Cancer-specific survival (1)
AQUEOUS ACETIC-ACID; HYDROGEN-PEROXIDE; SODIUM-CHLORIDE; PERACETIC-ACID; KINETICS; REBH; HALOPEROXIDASE; MECHANISMS; CHEMISTRY; PHENOLS; enzyme models; flavins; oxidative; chlorination photocatalysis (1)
AQUEOUS AMINO-ACID; NONAQUEOUS ELECTROLYTE-SOLUTIONS; THERMODYNAMIC PROPERTIES; ADIABATIC COMPRESSIBILITIES; VAPOR-PRESSURES; HEAT-CAPACITIES; IONIC-STRENGTH; VOLUMES; CONSTANTS; SODIUM; vapor pressure osmometry; emf; activity coefficients; osmotic coefficients; glycine; L-histidine; L-histidine hydrochloride; glutamic acid; sodium L-glutamate; calcium L-glutamate; amino acid (1)
Aqueous coupling reactions; photochemistry; melting point depression (1)
AQUEOUS-ELECTROLYTE-SOLUTIONS; ELECTRICAL-CONDUCTIVITY; RELAXATION SPECTROSCOPY; TEMPERATURE-DEPENDENCE; MOLECULAR-SOLVENTS; PAIR FORMATION; MIXTURES; DYNAMICS; CONDUCTANCE; COEFFICIENTS; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; FOLGE CHEMISCHER RELAXATION; MAGNESIUM-SULFATE; SOLVENT RELAXATION; RAMAN-SCATTERING; METAL IONS; WATER; SCHALLABSORPTION; PERMITTIVITY; 5-DEGREES-C; complex formation; dielectric relaxation; hydration; ion pairs; liquids (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; MOLECULAR-DYNAMICS; WATER-STRUCTURE; HOFMEISTER SERIES; TETRAALKYLAMMONIUM SALTS; NEUTRON-DIFFRACTION; ANION-BINDING; TETRAETHYLAMMONIUM; SPECTROSCOPY; SIMULATION; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; TEMPERATURE-DEPENDENCE; HEAT-CAPACITIES; SODIUM TETRAPHENYLBORATE; HYDROPHOBIC HYDRATION; SOLVENT RELAXATION; ORGANIC SOLVENTS; WATER-STRUCTURE; B-COEFFICIENTS; LIQUID WATER; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; TETRAMETHYLAMMONIUM CHLORIDE; HYDROGEN-BONDS; SIMULATION; (1)
AQUEOUS FOAMS; SURFACTANT; FILMS; PARTICLES; SYNERGISM; NEUTRON; AGGREGATION; BEHAVIOR; ORIGIN; Superchaotrope; Nano-ion; Stable foam; Foam SANS; Mixed surfactant foam (1)
AQUEOUS-HUMOR FLARE; RETINAL DETACHMENTS; RISK-FACTORS; VITRECTOMY; REPRODUCIBILITY; INFLAMMATION; MANAGEMENT; VALIDITY; METER; Complication; Proliferative vitreoretinopathy; Prophylaxis; Retinal detachment; Vitrectomy (1)
AQUEOUS-HUMOR OUTFLOW; OPEN-ANGLE GLAUCOMA; EXTRACELLULAR-MATRIX TURNOVER; OCULAR HYPERTENSION TREATMENT; NORMAL-TENSION GLAUCOMA; INTRAOCULAR-PRESSURE; STRESS FIBERS; OPTIC-NERVE; ELECTRON-MICROSCOPY; MECHANICAL-STRESS; (1)
AQUEOUS-ORGANIC SOLVENTS; ELECTROLYTE-SOLUTIONS; N-METHYLFORMAMIDE; EARTH-METAL; MOLAR VOLUMES; MIXED-SOLVENT; SPECTROSCOPY; FRICTION; N,N-DIMETHYLACETAMIDE; CONDUCTANCE; (1)
AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; PHOTOCHEMICAL REDUCTION; ELECTRON-TRANSFER; PROTECTING GROUPS; TRIPLET FLAVINS; AMINO-ACID; PROTEIN; DYNAMICS; LINKERS; cage compounds; DNA; electron transfer; flavins; photochemistry (1)
AQUEOUS-SOLUTION; COLLOIDAL GOLD; AU ATOMS; SPECTRA; PHOTOCHEMISTRY; STATE; AG; electronic spectra; photochemistry; gold complexes; gold atoms; gold colloids (1)
AQUEOUS-SOLUTION; COMPLEXES; DNA; PHOTOCHEMISTRY; PORPHYRINS; photophysics; photochemistry; charge transfer; dissociation; metalloporphyrin; mercury (1)
AQUEOUS-SOLUTION; COMPLEX; RECOGNITION; (1)
AQUEOUS-SOLUTION; FLUORESCENCE SPECTROSCOPY; MONONUCLEOTIDE MOLECULES; RESOLVED IDENTIFICATION; ROOM-TEMPERATURE; DIODE-LASER; MICROCAPILLARY; FLUCTUATIONS; (1)
AQUEOUS-SOLUTION; METHYL-ORANGE; CHITOSAN BEADS; WASTE-WATER; BINDING CHARACTERISTICS; CHARGE-DENSITY; ANIONIC DYES; ADSORPTION; SORPTION; COMPOSITE; ionene; metachromasy; methyl orange; ponceau SS; direct blue 1; sorption (1)
AQUEOUS-SOLUTION; MIXTURES; SPECTROMETRY; TEMPERATURE; RELAXATION; BEHAVIOR; PROLINE; (1)
AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; ZINC(II) COMPLEX; LIPID-BILAYER; AMINO-ACIDS; AIR-WATER; RECEPTOR; PROTEIN; MODEL; PROBES; artificial receptors; environment-sensitive dyes; fluorescence spectroscopy; molecular recognition; vesicles (1)
AQUEOUS-SOLUTION; ORGANIC SOLUTES; IONIC VOLUMES; ELECTROLYTES; 100-DEGREES-C; 0-DEGREES-C; MIXTURES; SALTS; Apparent molal volumes; Asymmetrical cations; Partial molar volumes; Aqueous solutions; Quaternary ammonium cations (1)
AQUEOUS-SOLUTIONS; ALKYLTRIMETHYLAMMONIUM BROMIDES; HEXYLTRIMETHYLAMMONIUM BROMIDE; OCTYLTRIMETHYLAMMONIUM BROMIDE; ADIABATIC COMPRESSIBILITY; PSEUDOPHASES COEXISTENCE; TEMPERATURE-DEPENDENCE; MICELLE FORMATION; WATER; Two-point scaling; Heat capacity; Micellar solution; Octyltrimethylammonium bromide; Hexyltrimethylammonium bromide (1)
AQUEOUS-SOLUTIONS; PROTEIN; SURFACTANTS; REACTIVITY; MELAFEN; MODEL; SALT; (1)
AQUEOUS-SOLUTIONS; SODIUM-ACETATE; HISTIDINE; (1)
AQUEOUS-SOLUTIONS; SODIUM; WATER; GLUTAMATE; Vapor pressure osmometry; Osmotic coefficients; Magnesium L-glutamate; Magnesium L-aspartate; Electrolyte; Activity coefficient (1)
AQUEOUS SOLVATION SHELLS; LIQUID WATER; PHYTIC ACID; VIBRATIONAL-RELAXATION; IONS; DISTILLATION; Salting-out; Salting-in; Organic compounds; Pentasodium phytate; Separation (1)
AQUEOUS UREA SOLUTIONS; AMINO-ACIDS; PROTEIN DENATURATION; GLYCINE BETAINE; TRANSFER MODEL; SOLUBILITY; STABILITY; OSMOLYTE; BACKBONE; Transfer free energy; Concentration scale; Solute-solvent interaction; Cosolvent and osmolyte effects on proteins; Preferential interaction; Thermodynamics of solvation (1)
Arabidopsis; auxin; EJC; embryogenesis; Mago nashi; signaling; splicing (1)
Arabidopsis, double fertilization, female gametophyte, membrane proteins, secreted proteins, cell-to-cell communication, DUF962 (1)
ARABIDOPSIS FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; SCUTELLAR TISSUE; SYNERGID CELLS; ZEA-MAYS; PLANT; GENES; FERTILIZATION; EXPRESSION; PROTEINS; (1)
ARABIDOPSIS FEMALE GAMETOPHYTE; MALE-GAMETE DELIVERY; SYNERGID CELL; DOUBLE FERTILIZATION; FLOWERING PLANTS; TORENIA-FOURNIERI; NITRIC-OXIDE; ZEA-MAYS; GENES; THALIANA (1)
ARABIDOPSIS; FERTILITY; PEPTIDES; NUCLEUS; GENES; RNA; (1)
; Arabidopsis thaliana; chromatin organization; chromosomes; condensin; interphase nuclei; SMC proteins (1)
Arabidopsis thaliana; database; function prediction; gene expression; microarray; unsupervised meta-analysis (1)
Arabidopsis thaliana, Doppelte Befruchtung, Eizelle, Spermazelle, Gameteninteraktion (1)
ARABIDOPSIS-THALIANA; ENDOSPERM DEVELOPMENT; PROTEOME ANALYSIS; GENETIC-ANALYSIS; H1 VARIANTS; HMG DOMAIN; CHROMATIN; EXPRESSION; PROTEINS; DNA; Chromatin; DNA interaction; H1; Linker histone; 2D-gel electrophoresis (1)
ARABIDOPSIS-THALIANA; FERTILIZATION; COMMUNICATION; EMBRYO; PLANTS; FATE; Cell-cell communication; Egg cell; Female gametophyte (1)
ARABIDOPSIS-THALIANA; FERTILIZATION; EGG; IDENTIFICATION; BLOCK; HAP2; (1)
Arabidopsis thaliana; microarrays; radio frequency electromagnetic fields; suspension cultured plant cells (1)
Arabidopsis thaliana, MOS11, mRNA export, nucleocytosolic transport, protein interactions, RNA-binding protein, TREX. (1)
ARABIDOPSIS-THALIANA; PATTERN-FORMATION; LEAF POLARITY; MICRORNAS; EXPRESSION; MIRNA; ROOT; TISSUES; PROTEIN; MIR319; Arabidopsis thaliana; microRNA; short interfering RNA; insitu hybridization; expression pattern; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride; technical advance (1)
ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; SEED DORMANCY; EXPRESSION; SUBUNIT; CYCLE; SPT4; PROCESSIVITY; GROWTH; Affinity purification; Arabidopsis; Auxin; Histone acetylation; Plant proteomics; Protein interaction (1)
ARABIDOPSIS-THALIANA; TRANSPORT; GROWTH; FAMILY; PHOSPHORYLATION; ENDOCYTOSIS; PHYLLOTAXIS; INHIBITION; EXPRESSION; CARRIERS; Arabidopsis; AGC kinases; auxin; auxin efflux; auxin transport; protein kinases; plant (1)
Arabiopsis, Transcript elongation, RNA-Polymerase II, deep sequencing (1)
Arachidonsäure, Abstoßung, Nierentransplantation, HETE, Leukotrien, Prostaglandin, Urin, EIA, arachidonic acid, rejection, kidney transplantation, leucotrien, prostaglandin, urine (1)
ARAKELOV GEOMETRY; LINE BUNDLES; SMALL HEIGHT; SMALL POINTS; Equidistribution of cycles; Arakelov geometry; Heights; Essential minimum (1)
AR, Augmentierte Realität, Augmented reality, head-up displays, field study, contact analogue, navigation, Navigation masking Maskierung (1)
ARBEITSGEMEINSCHAFT-INTERNISTISCHE-ONKOLOGIE; ADVANCED ESOPHAGOGASTRIC CANCER; PHASE-II TRIAL; GASTROESOPHAGEAL JUNCTION; 1ST-LINE THERAPY; ADENOCARCINOMA; CISPLATIN; CHEMOTHERAPY; FLUOROURACIL; SURGERY; (1)
Arbeitsgestaltung; Automation; Ergonomie; Exoskelett; Fließfertigung; Industrieroboter; Produktionssystem (1)
Arbeitslosenunterstützung , Arbeitslosigkeit , Reallohn , Offene Volkswirtschaft , Lohnbildung, , benefit system , unemployment , real wages , open economy , wage bargaining (1)
Arbeitslosigkeit , Pendler , Dauer , Deutschland , Stellensuche , Lohnstruktur , Asymmetrie , Pendeln , asymmetrische Lohnverteilung , Unemployment , Commuting , asymmetric wage distribution , median-preserving spread (1)
Arbeitsmarkt , Ereignisdatenanalyse , Cox-Regressionsmodell, , (1)
Arbeitsmedizin, Ludwig Hirt, 19. Jahrhundert, Arbeitsschutzmaßnahmen (1)
Arbeitsplatz (1)
Arbeitsteilung, Ameisen Verhalten, reproduktive Alterung, soziale Immunologie, Honigbienen, Ameisen, Patogene, Alterung, Homeostase, labour division, policing effectiveness, group size, social cession, moribund emigration (1)
Arbeitszeitbedingungen, Krankenhausfinanzierungsrecht, Manssen (1)
Arbitrage Pricing Theory - Faktorenmodelle - Portfolio Management - Querschnittsregression (1)
ARBITRARILY PRIMED PCR; ABERRANT CRYPT FOCI; RHEUMATOID-ARTHRITIS; IDENTIFICATION; RNA; DISPLAY; TISSUE; PROBES; HYBRIDIZATION; SYNOVIOCYTES; cDNA array; AtlasImage (TM) software; laser mediated microdissection; RAP-PCR; rheumatoid arthritis; colon cancer (1)
ARBITRARILY PRIMED PCR; CAPTURE MICRODISSECTION; RNA; (1)
ARBITRARILY PRIMED PCR; CAPTURE MICRODISSECTION; SUBTRACTIVE HYBRIDIZATION; MOLECULAR ANALYSIS; CARCINOMA-CELLS; SINGLE CELLS; C-JUN; RNA; TISSUE; IDENTIFICATION; (1)
ARBITRARILY PRIMED PCR; RESPIRATORY BURST ACTIVITY; URSODEOXYCHOLIC ACID; ADENOCARCINOMA CELLS; DIFFERENTIAL DISPLAY; CARCINOMA-CELLS; MESSENGER-RNA; FREE-RADICALS; F344 RATS; IN-VITRO; (1)
ARBITRARY BOND ANGLE; PAIR; DRIVEN; NANOPARTICLES; RELAXATION; MULTILAYER; DYNAMICS; EQUATION; BEHAVIOR; DOMAINS; (1)
ARBITRARY BOND-ANGLE; PAIR; NANOPARTICLES; EXCITATION; DYNAMICS; FIELD; magnetization reversal; spin-polarized current; Stoner particle (1)
ARBUSCULAR MYCORRHIZA; FUNGI; GROWTH; ROOTS; NETWORKS; COLONIZATION; DIVERSITY; BENEFITS; INVASION; IDENTITY; Mycorrhizal dependency; Biomass allocation; Soil nutrient availability; Competitive interactions; Hieracium pilosella; Plantago lanceolata (1)
Archaeabakterien , Transkription <Genetik> , RNS-Polymerase II , Untereinheit , Struktur-Aktivitäts-Beziehung , Pyrococcus furiosus , , Archaea , transcription , RNA polymerase , subunit E� , active center (1)
Archaea, CO2 fixation, immunogold localization (2)
Archaea, Crenarchaeota, Ignicoccus, chemolithoautotroph, Zellbiologie, Energiekonservierung, A1AO ATP-Synthase, H2:Schwefel-Oxidoreduktase, funktionelle Kompartimentierung, energetisierte äußere Membran, Intermembrankompartiment (1)
; Archaea; Desulfurococcales; sulfur-reducing; hyperthermophile (1)
Archaea, Fiber, Zellanhang, Verankerungsstruktur (1)
Archaea/*genetics Bacteria/classification/*genetics Gene Transfer Techniques *Genome, Archaeal Methanosarcina/classification/*genetics/metabolism Open Reading Frames Phylogeny Support, Non-U.S. Gov't (1)
Archaea, hyperthermophilic, flagella, Methanocaldococcus villosus, Pyrococcus furiosus (1)
archaeal coculture, symbiotic interaction, neutral interaction, negative interaction, adhesion (1)
ARCHAEAL EXOSOME; NMR-SPECTROSCOPY; STRUCTURAL BASIS; RNA DEGRADATION; CAP RECOGNITION; PROTEINS; BINDING; ACTIVATION; PROTEASOME; DCP1-DCP2; mRNA decapping; Dcp2; NMR spectroscopy; catalytic activity; protein dynamics (1)
ARCHAEAL HISTONE; METHANOTHERMUS-FERVIDUS; IGNICOCCUS-HOSPITALIS; CRYSTAL-STRUCTURE; FOLD; DNA; NUCLEOSOME; PROTEINS; EVOLUTION; EQUITANS; (1)
ARCHAEAL LIPOTHRIXVIRUS; GENOME ORGANIZATION; EUKARYAL VIRUSES; GENUS ACIDIANUS; SIRV1; SEQUENCES; HOST; TRANSCRIPTION; ENVIRONMENTS; SULFOLOBUS; (1)
ARCHAEAL TRANSCRIPTION; HYDROTHERMAL VENT; SP. NOV.; FLAGELLA; GENES; ACTIVATOR; PROMOTER; OPERON; MUTANT; Archaea; archaellum; transcriptomics; EarA; Thermococcales; single-molecule sequencing; transcriptional regulator (1)
ARCHAEAL TRANSCRIPTION; RNA-POLYMERASE; MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; FACTOR-B; PROTEIN; TRMB; IDENTIFICATION; THERMOCOCCUS; ARCHITECTURE; archaea; Pyrococcus; transcriptional activation; TFB-RF1; ABC transporter; ChIP-seq (1)
Archaea, Membranproteine (1)
Archaea, Transcription initiation, Pyrococcus, TFB, Bpa, DNA bending, TFB B-reader, UV Cross-linking (1)
Archaea, transcription, RNA polymerase, elongation complex (1)
archaea,transcriptomics, genomics, Nanopore, pyrococcus, bidirectional, transcription, rRNA, modifications, CopR (1)
ARCHAEBACTERIA; BACTERIA; ARCHAEA; HYBRIDIZATION; ALGORITHM; MOBILIS; SYSTEM; GRAPHS; hyperthermophile; anaerobic; organotroph; sulfur respiration; spheroid-shaped; non-motile; extracellular enzymes; Desulfurococcaceae; GEBA (1)
ARCHAEBACTERIUM SULFOLOBUS; HALOARCULA-MARISMORTUI; TOTAL RECONSTITUTION; STRUCTURAL BASIS; MODEL ORGANISMS; RNA; ARCHAEA; SUBUNITS; 16S; BACTERIA; Ribosome; ribosome biogenesis; archaea; non-model organism; RNA (1)
ARCHAEBACTERIUM SULFOLOBUS-SOLFATARICUS; MAMMALIAN MITOCHONDRIAL RIBOSOME; MASS-SPECTROMETRIC ANALYSIS; RNA-BINDING-PROTEIN; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; CRYO-EM; TOTAL RECONSTITUTION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; archaea; cryo electron microscopy; Pyrobaculum aerophilum; ribosomal protein; Sulfolobus acidocaldarius; mass spectrometry (1)
ARCHAEBACTERIUM SULFOLOBUS; TRANSLATION INITIATION; EUKARYAL VIRUSES; PARTICLE SSV1; DNA; GENOME; ACIDOCALDARIUS; SOLFATARICUS; MECHANISMS; FAMILY; (1)
ARCHAEBACTERIUM THERMOPROTEUS-NEUTROPHILUS; CO2 FIXATION PATHWAYS; CITRIC-ACID CYCLE; 3-HYDROXYPROPIONATE CYCLE; CHLOROFLEXUS-AURANTIACUS; COENZYME-A; SP-NOV; C-13-NMR; ENZYMES; 4-HYDROXYBUTYRYL-COA; 4-hydroxybutyryl-CoA dehydratase; CO2 fixation pathway; acetyl-CoA (1)
ARCHAEBACTERIUM THERMOPROTEUS-NEUTROPHILUS; RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; EUBACTERIUM CHLOROFLEXUS-AURANTIACUS; MONOXIDE DEHYDROGENASE PATHWAY; PYROCOCCUS-KODAKARAENSIS KOD1; SULFATE-REDUCING BACTERIA; TRICARBOXYLIC-ACID CYCLE; COMPLETE GENOME SEQUENCE; SP-NOV REPRESENTS; 3-HYDROXYPROPIONATE CYCLE; CO2 fixation; autotrophy; archaea; ribulose 1,5-bisphosphate carboxylase; 3-hydroxypropionate cycle; biotin (1)
Archaebakterien , Extremophiler Mikroorganismus , In-vitro-Kultur , Schwefelquelle , Fluoreszenz-in-situ-Hybridisierung , Hybride , Mikrobielle Lebensgemeinschaft , CTC , Crenarchaea , Euryarchaea , Thiothrix , SM1 euryarchaeon , string of pearls , psychrophilic , sulfidic springs , microbial community (1)
Archaebakterien , Parasit , anaerober Stoffwechsel , Ether-Lipide , Histone , Kohlendioxidfixierung , Wirt , Membranlipide , Ignicoccus hospitalis , Nanoarchaeum equitans , archaea , anaerobic metabolism , co2 fixation , lipids , histones (1)
Archaeen, KsgA, Dim1, Ribosomen (1)
ARCHAEON ACIDIANUS-AMBIVALENS; AUTOMATED SEQUENCE SELECTION; NOVO PROTEIN DESIGN; ADENYLATE KINASE; BINDING; CLUSTER; COORDINATION; SIMULATION; REDUCTION; MOLECULE; (1)
ARCHAEON DESULFUROLOBUS-AMBIVALENS; PARACOCCUS-PANTOTROPHUS GB17; ESCHERICHIA-COLI; PURIFICATION; OXIDATION; BACTERIA; ENZYMES; GENE; OXYGENASE/REDUCTASE; THIOSULFATE; electron paramagnetic resonance (EPR); hyperthermophilic archaea; quaternary structure; reversible denaturation; sulphur oxidation (1)
ARCHAEON HALOARCULA-MARISMORTUI; COA SYNTHETASE; A SYNTHETASE; NANOARCHAEUM-EQUITANS; PYROCOCCUS-FURIOSUS; ACETATE FORMATION; ESCHERICHIA-COLI; ATP SYNTHESIS; ASSOCIATION EQUILIBRIUM; METHANOTHRIX-SOEHNGENII; (1)
ARCHAEON IGNICOCCUS-HOSPITALIS; AUTOTROPHIC CARBON FIXATION; OUTER-MEMBRANE; GEN. NOV.; PROTEIN; METHYLGLYOXAL; ASSIMILATION; REDUCTASE; COENZYME; INSIGHTS; Archaea; compartmentalization; CO2 fixation; immunogold labeling (1)
ARCHAEON METHANOCOCCUS-VOLTAE; HALOBACTERIUM-SALINARUM; MOTILITY STRUCTURE; PROTEINS; MOTOR; VECTORS; GENES; IDENTIFICATION; LOCALIZATION; MARIPALUDIS; (1)
ARCHAEON METHANOCOCCUS-VOLTAE; HALOBACTERIUM-SALINARUM; SULFOLOBUS-SOLFATARICUS; PSEUDOMONAS-AERUGINOSA; EXTREME ENVIRONMENTS; BETA-GALACTOSIDASE; BACTERIAL FLAGELLA; IV PILI; MOTILITY; GENES; (1)
ARCHAEON PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; DESULFUROCOCCUS-KAMCHATKENSIS; FERREDOXIN OXIDOREDUCTASE; ELEMENTAL SULFUR; HOT-SPRINGS; SYSTEM; ARCHAEBACTERIA; INSIGHTS; SYNTHASE; hyperthermophile; strictly fermentative metabolism; sulfur reduction; obligate anaerobic; hot solfataric spring; Desulfurococcaceae; Crenarchaeota; GEBA (1)
ARCHAEON PYROCOCCUS-FURIOSUS; MEMBRANE-BOUND HYDROGENASE; ELEMENTAL SULFUR; HYPERTHERMUS-BUTYLICUS; TOOL; REDUCTION; IDENTIFICATION; ARCHAEBACTERIUM; SPECIFICITY; REPRESENTS; (1)
ARCHAEON THERMOCOCCUS-KODAKARAENSIS; HYPERTHERMOPHILIC CHITINASE; CATALYTIC DOMAIN; SP-NOV; BINDING; KOD1; CHITONOPHAGUS; SEQUENCE; FAMILY; GROWTH; (1)
ARCHAEON THERMOCOCCUS-KODAKARAENSIS; TRANSCRIPTION IN-VITRO; HYPERTHERMOPHILIC ARCHAEON; EXCISION-REPAIR; RNA-POLYMERASE; EXPRESSION; PLASMID; GENE; ARCHAEBACTERIUM; REPLICATION; (1)
ARCHAEON THERMOCOCCUS-LITORALIS; CELL-FREE TRANSCRIPTION; ABC TRANSPORTER; HYPERTHERMOPHILIC ARCHAEA; SULFOLOBUS-SOLFATARICUS; BIOCHEMICAL-ANALYSIS; SYSTEM; REGULATOR; GLUCOKINASE; BACTERIA; (1)
ARCHAEON THERMOCOCCUS-LITORALIS; CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; BIOCHEMICAL-ANALYSIS; ESCHERICHIA-COLI; IN-VIVO; INITIATION; EXPRESSION; SUBUNIT; SYSTEM; (1)
Archaeum, 3D-Struktur, Proteom (1)
Archetype, Bookish Platforms, BookTok, consent capital, memes, reading industry, romantasy (1)
ARCHIMEDEAN ANALYTIC SPACES; FAITHFUL TROPICALIZATION; VARIETIES; GEOMETRY; SUBVARIETIES; COHOMOLOGY; HEIGHTS; IMAGE; Tropicalization; Skeleton; Berkovich space; Analytic geometry; Non-Archimedean geometry (1)
architecture, framework, multitouch, widgets (1)
ARCHITECTURE; pHealth; ecosystem; architecture; modeling; interoperability; knowledge representation; knowledge management (1)
ARCHITECTURES; MANAGEMENT; DESIGN; CARE; INFRASTRUCTURE; STANDARDS; Integrated health care systems; Systems analysis; Software process engineering; Model-Driven Architecture; Semantic interoperability; Unified process; HL7 (1)
ARCHITECTURES; PARADIGM; HEALTH; Clinical models; Architectural framework; Ontologies; Knowledge representation; Data elements (1)
archive, botanical society (1)
archive ; botanical society ; digitization ; transcription (1)
archive, digitization, herbarium, long term archiving, persistent identifier, botanical society, structural metadata (1)
Archivsituation; Archive; Großforschung (1)
ARC THERAPY VMAT; CLINICAL-EVALUATION; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; FILM DOSIMETRY; RECONSTRUCTIONS; RADIOTHERAPY; OPTIMIZATION; IMAGES; WATER; Metal artifact reduction; Metal artifacts; MAR; Dental implants; Dose calculation; Gafchromic; Radiation therapy (1)
ARDS; (1)
ARDS, iLA, interventional Lung Assist, ultraprotektive Beatmung, ultraprotektive Ventilation, lungenprotektive Beatmung, lungenprotektive Ventilation, Lungenversagen, extrakorporale Lungenunterstützung (1)
ARDS; neutrophil; surface epitope; ROS; intensive care; flow cytometry (1)
area; biodiversity; biogeographical region; environmental heterogeneity; global species richness; species-area relationship (1)
AREA MARKING; HYMENOPTERA; COLONIES; RECOGNITION; WORKERS; HYDROCARBONS; RECRUITMENT; ACCEPTANCE; SELECTION; BEHAVIOR; Leptothorax gredleri; Nest selection; Colony founding; Queen adoption; Functional monogyny (1)
area PIC; area PIVC; self-motion perception; vestibular cortex; visual-vestibular network (1)
ARENE-RUTHENIUM COMPLEXES; BREAST-CANCER; METAL-COMPLEXES; CELLULAR UPTAKE; FERROCENE; CYTOTOXICITY; DERIVATIVES; SERIES; MODE; Bioorganometallic chemistry; Ferrocene; Ruthenium; Antitumor agents (1)
Arf1, ADP-Ribosylierungsfaktor 1, Hochdruck, NMR, konformationelle Gleichgewichte, Guaninnukleotid-bindende Proteine (1)
arfi, fibrosis, daa (1)
ARGENTINE ANT; ESSENTIAL COMPONENT; POPULATION BIOLOGY; GENETIC-VARIATION; DIMORPHIC MALES; HYMENOPTERA; FORMICIDAE; EVOLUTION; COLONIES; BEHAVIOR; invasive ants; unicoloniality; polygyny; intranidal mating; competition (1)
ARGENTINE ANT; IRIDOMYRMEX-HUMILIS; CARDIOCONDYLA ANTS; DIMORPHIC MALES; PARASITIC WASP; HYMENOPTERA; ALLOCATION; EVOLUTION; ELIMINATION; (1)
ARGININE METHYLTRANSFERASE 5; PHOSPHORYLASE MTAP EXPRESSION; METHYLTHIOADENOSINE PHOSPHORYLASE; MALIGNANT-MELANOMA; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; GROWTH; CARM1; PROGRESSION; PRMT; Methylthioadenosine; Melanoma; MAPK/ERK signalling; Protein arginine methylation (1)
ARGININE METHYLTRANSFERASE 5; PRE-MESSENGER-RNA; METHYLTHIOADENOSINE PHOSPHORYLASE; LUNG-CANCER; METHYLATION; PROGRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; VULNERABILITY; (1)
ARGININE-VASOPRESSIN; SEX-DIFFERENCES; MATERNAL AGGRESSION; CENTRAL AMYGDALA; INTRASPECIFIC AGGRESSION; SOCIAL AVOIDANCE; RECEPTOR-BINDING; BRAIN OXYTOCIN; BEHAVIOR; RELEASE; (1)
ARGININOSUCCINATE LYASE GENE; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; NUCLEAR TRANSFORMATION; INTRAGENIC COMPLEMENTATION; INTRAFLAGELLAR TRANSPORT; INSERTIONAL MUTAGENESIS; RESISTANCE; MUTANTS; CLONING; intragenic suppressor; nuclear transformation; marker; targeting (1)
Arglabin, asymmetrische Synthese, Franesyl-Transferase, Naturstoffe, Totalsynthese, Arglabin, asymmetric synthesis, farnesyl transferase, natural products, total synthesis (1)
Argonaute, Ago, chromatin, DAM-ID, DAMID, nucleus (1)
Argonaute; Archaea; FRET; single molecule; nuclease; (1)
Argonaute, LSm, small RNA (1)
ARGONAUTE PROTEIN COMPLEXES; CHAPERONE ACTIVITY; GENE-EXPRESSION; NONCODING RNA; RECOGNITION; BIOGENESIS; PRECURSORS; CATALYSIS; REVEALS; SNORNAS; (1)
Argonaute proteins, Ago-APP, Argonaute modification, Argonaute phosphorylation (1)
ARGONAUTE PROTEINS; CELL-PROLIFERATION; EXPRESSION; INVASION; PATHWAY; MIRNAS; Melanoma; microRNA; RNA-Seq (1)
ARGONAUTE PROTEINS; INFLAMMATION; BIOGENESIS; MIR-155; CANCER; ATHEROSCLEROSIS; INFECTION; RESPONSES; TARGET; MicroRNA; MiR-155; MiR-455; Regulation of gene expression; Dendritic cell; Macrophage (1)
Argonaute proteins, phosphorylation, disorders, disease (1)
ARGON-LASER; PHOTODYNAMIC THERAPY; PHOTOCOAGULATION; laser treatment; polypoidal choroidal vasculopathy; macula edema; indocyanine green angiography; retina; choroid (1)
ARGON PLASMA; REPAIR; CELLS; (1)
argon water microscopic mesoscopic structure review (1)
ARGUMENTATION SKILLS; MULTIPLE REPRESENTATIONS; PERSONAL EPISTEMOLOGY; INSTRUCTION; BELIEFS; KNOWLEDGE; EXAMPLES; SELF; PROMPTS; Training intervention; Argumentative thinking; Evaluativist epistemological understanding; Epistemic orientation; Intellectual values; Conceptual knowledge (1)
Argyrodite, Ionenleiter, Festelektrolyte, anharmonische Strukturverfeinerung, Impedanzspektroskopie, Mößbauer-Spektroskopie, ionic conductors, solid electrolytes, anharmonic structure refinement, impedance spectroscopy, Mössbauer spectroscopy (1)
Argyrodite , Ionenleiter , Impedanzspektroskopie , Silberverbindungen , Münzmetallverbindungen , Kupferverbindungen , Strukturchemie , Struktur-Eigenschafts-Beziehungen , Münzmetallthiophosphate , Anharmonische Strukturverfeinerung , Jana2000 , Diffusionsvolumen , ionconductors , solid state chemistry , structure property relations , anharmonic structure refinement , diffusion volume (1)
Arithmetical D-modules, isocrystals, Frobenius, dual functor (1)
Arithmetical Skills; Curriculum Based Measurement; Special Needs (1)
Arithmetic divisors, DSP, local heights, Chambert-Loir measures, Berkovich spaces, Skeleta of Berkovich spaces (1)
ARITHMETIC SCHEMES; SINGULAR HOMOLOGY; VARIETIES; class field theory; arithmetic schemes; Tame coverings (1)
ARITHMETIC SCHEMES; VARIETIES; SURFACES; (1)
ARM FLEXION; EXTENSION; PREDISPOSITIONS; METAANALYSIS; BEHAVIOR; VALENCE; TASKS; Approach-avoidance; Evaluation goal; Automatic; Ultimate; Distal (1)
ARM FLEXION; EXTENSION; RESPONSES; VALENCE; PREDISPOSITIONS; AUTOMATICITY; METAANALYSIS; BEHAVIORS; MOVEMENTS; APPRAISAL; approach; avoidance; automatic; ultimate; distal; immediate; affect (1)
Arnica montana; Plant conservation; Endangered species; Reproductive fitness; Genetic variation; Reintroduction; Restoration (1)
Aromatase , Differenzierung , Komplement <Immunologie> , Praeadipozyt , Purinozeptor , Klassischer Aktivierungsweg , Serinprotease , preadipocyte , purinoceptor , classical pathway , serine protease (1)
AROMATASE INHIBITOR; (1)
AROMATIC 1,5-HYDROGEN TRANSFER; HYDROGEN-TRANSFER-REACTIONS; ATOM TRANSFER; ENANTIOSELECTIVE SYNTHESIS; TRANSLOCATION REACTIONS; ALKYLATION SUBUNIT; ETHERS; ARYL; SUBSTITUENT; PRECURSORS; dihydrobenzofurans; radicals; hydrogen transfer; ringclosure; radical reactions (1)
AROMATIC-ALDEHYDES; AEROBIC CONDITIONS; NHC CATALYSIS; ALPHA,BETA-UNSATURATED ALDEHYDES; NUCLEOPHILIC CARBENES; MICHAEL ADDITION; ESTERIFICATION; ESTERS; ORGANOCATALYSIS; HALIDES; esterifications; N-heterocyclic carbenes; organocatalysis; oxidations; Umpolung reactions (1)
AROMATIC-COMPOUNDS; BENZOYL-COENZYME; HETERODISULFIDE REDUCTASE; ELECTRON BIFURCATION; THAUERA-AROMATICA; DEGRADATION; METABOLISM; FERREDOXIN; PROTEINS; CLUSTERS; metalloenzyme; electron bifurcation; electron transfer; aromatic compound; membrane protein complex (1)
Aromatic compounds; Enantioselective synthesis; Hydrocarbons; Ketones; Pharmaceuticals (1)
Aromatic compounds; Group 15 compounds; Hydrocarbons; Oxides; Selenides (1)
Aromatic compounds; Heterocyclic compounds, Role: PRP (Properties) (excitation energies of first excited singlet, triplet, and quintet states of, calcn. of); Molecular orbital (INDO-CI, of org. compds.); Energy level excitation (electronic, of org. compds., accessibility of lowest quintet state of, through triplet-triplet anhilation); org compd lowest quintet state (1)
AROMATIC-COMPOUNDS; OXYGEN; ENDOPEROXIDES; (1)
Aromatic compounds, Role: PRP (Properties) (Cohen bond orders of, CNDO/2 calcns. of); Bond order (Cohen, calcn. of, of mol. in ground and excited states, wave function in); Atomic orbital (in Cohen-bond-order calcn. for mol. in ground and excited states); Bond energy (of mol., Cohen bond orders in relation to); Molecular orbital (AVE, in Cohen-bond-order calcn. for mol. in ground and excited states); Molecular orbital (CNDO/2, in Cohen-bond-order calcn. for mol. in ground and excited states); Wave function (MC, in Cohen-bond-order calcn. for mol. in ground and excited states); Bond order (Wiberg index, calcn. of, of mol. in ground and excited state, wave functions in); excited mol Cohen bond order; wave function bond order mol; CNDO bond order mol; MO bond order mol; AO bond order mol; energy bond order mol; electron configuration mol wave function; Wiberg index mol wave function (1)
AROMATIC INTERACTIONS; BENZENE DIMER; SPECTROSCOPIC PROPERTIES; TEMPERATURE-DEPENDENCE; CYCLOMETALATED RH3+; MOLECULAR-CRYSTALS; IRIDIUM COMPLEXES; ELECTRONIC STATES; PT(II) COMPOUNDS; CHARGE-TRANSFER; (1)
AROMATIC IODINATION; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; IODINE; AMINATION; MOLECULES; OXYGEN; ACID; Anthraquinone; Arenes; Iodination; Oxidative Iodination; Photocatalysis (1)
aromaticity • carbene • cyclo-P5 • electrophilic activation • phosphorus (1)
AROMATIC NITRATION; ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; NITROGEN-DIOXIDE; NO3 RADICALS; FORMIC-ACID; CHEMISTRY; CATION; FLUOROALCOHOLS; ACETONITRILE; (1)
aromatic substitutions • weak bases • radical reactions • thiolations • carbonylations (1)
AROMATICUM STRAIN EBN1; BACTERIUM RHODOPSEUDOMONAS-PALUSTRIS; DENITRIFYING BACTERIUM; ANAEROBIC DEGRADATION; BETA-OXIDATION; COENZYME-A; HYDROXYCINNAMOYL-COENZYME; GEL-ELECTROPHORESIS; LIGNIN BIOSYNTHESIS; THAUERA-AROMATICA; Animal proteomics; Liver proteome; Metabolomics; Nonalcoholic steatohepatitis; Two-dimensional differential in-gel electrophoresis (1)
AROUSAL (1)
Arousal reaction , Schnarchen , Informationsgehalt , Schlafverhalten , Wecken , , arousal , information content , snoring (1)
ARRAY BIOSENSOR; MULTICHANNEL IMMUNOSENSOR; SYSTEM; IMMUNOASSAY; ANTIBODY; ASSAYS; biosensor; chemiluminescence; capillary enzyme immunoassay; multiplex detection; biological agent; microfluidics (1)
; array-CGH; bioinformatics; chip diagnostics; epigenetics; tissue arrays (1)
ARRAY RETINAL PROSTHESIS; ELECTRICAL-STIMULATION; MICROPHOTODIODE ARRAY; RABBIT RETINA; BLIND; animal model; retinal implant; visual prosthesis (1)
arrhythmia; chronic kidney disease; cardio renal; SGLT2 inhibitor; CaMKII; cardiac electrophysiology; renin–angiotensin–aldosterone; acidosis; autonomic nervous system; connexin 43 (1)
; arrhythmia; genetics; long-QT syndrome; physiology; sudden cardiac death (1)
arrhythmia‐induced cardiomyopathy | atrial fibrillation | quality of life | right ventricular function (1)
arsenic; boron; density functional calculations; phosphorus; tungsten (1)
ARSENIC-BRIDGED <1>FERROCENOPHANES; 1 FERROCENOPHANES; ROP; HOMOPOLYMERS; COPOLYMERS; POLYMERS; [1]ferrocenophane; [1.1]ferrocenophane; ring-opening polymerization (ROP); phosphorus; chirality (1)
arsenic, chromium, diarsene, iron, tungsten (1)
Arsenic · Cluster · Cobalt · Phosphorus · Redox chemistry (1)
ARSENIC CONTAMINATION; DRINKING-WATER; GROUNDWATER; ADSORPTION; CHEMISORPTION; MECHANISMS; ACIDITY; MCM-41; NORTH; L-cysteine; Amino acid; As (V); Adsorption; Silica; Sol-gel (1)
Arsenic; Crystal structure; Gallium; Molybdenum; Phosphorus (2)
Arsenic · Functionalization · Germylene · Nucleophiles · Silylene (1)
Arsenic; group 11 metals; iron; molybdenum; phosphorus; supramolecular chemistry (1)
ARSENIC(III) HALIDE-COMPLEXES; N-HETEROCYCLIC CARBENE; BASIS-SETS; PHOSPHORUS; ACTIVATION; REACTIVITY; TRANSFORMATION; P-4; arsenic; fluorine; halogenation; nucleophilic quenching; phosphorus (1)
ARSENIC REMOVAL; HEAVY-METALS; ADSORPTION; WATER; BANGLADESH; ACID; CONTAMINATION; WASTEWATERS; ENVIRONMENT; SORBENT (1)
ARSENIC SULFIDES; REALGAR; AS4S4; PARAREALGAR; Crystal structure; HgI2 center dot As4S4; Raman spectroscopy; arsenic sulfides; light-induced alteration; realgar; pararealgar (1)
ARSENIC SULFIDES; REALGAR; PARAREALGAR; AS4S4; HGI2-CENTER-DOT-AS4S4; MOLECULES; EXPOSURE; ADDUCT; CAGES; ASS; X-ray single-crystal diffraction; Raman spectroscopy; Realgar-type As4S4 molecule; Pararealgar-type As4S4 molecule; Photo-induced solid-state isomerization; Ab initio band structure calculations (1)
arsenido complexes; complexes with elements of group 15; phosphido complexes; tungsten compounds (1)
Arsenidokomplexe; Komplexe mit Pnictidliganden; Phosphidokomplexe; Wolframverbindungen (1)
Arsenium ion • Bond insertion • Quantum crystallography • Ring strain • Strain-release (1)
Arsenkomplexe, Koordinationschemie, Synthese (1)
Arsen; Kupfer; Molybdän; Selbstorganisation; Silber (1)
Arsen, metallorganische Chemie, Koordinationsverbindungen, Polymere (1)
Arsen, Schwefel, Phosphor, Realgar, Dimorphit, Pararealgar, Kupferhalogenide, Koordinationspolymere, Metallocenhydrid-Komplexe, Arsensulfid-Liganden, Schwache Wechselwirkungen, Röntgenstrukturanalyse, Raman-Spektroskopie (1)
Art. 12 GG, Berufsfreiheit, Manssen, Mangoldt, Klein, Starck, Kommentar (1)
Art. 23 BRK, Diskriminierung, angemessene Vorkehrungen, Unterstützung, Sorgerechtsentzug (2)
Art. 68 BayBO, Manssen, Greim (1)
Arteiovenöse Malformation, AVM, zyklische mechanische Dehnung, Tube-Formation-Assay, Bevacizumab, Thalidomid, VEGF (1)
ARTERIAL-BLOOD-FLOW; LIVER; ENDOTOXEMIA; PERFUSION; EXCHANGE; PROBES; color flow Doppler sonography; portal vein; splanchnic perfusion; hyperdynamic endotoxin shock; comparative study (1)
ARTERIAL-BLOOD PRESSURE; PODOCYTE NUMBER; GLOMERULAR INJURY; KNOCKOUT MICE; MOUSE MODELS; MURINE MODEL; LEPTIN; SUSCEPTIBILITY; EXPRESSION; OBESITY; (1)
ARTERIAL BUFFER RESPONSE; PORTAL-VEIN THROMBOSIS; CIRRHOSIS CORRELATION; BLOOD-FLOW; INTEREQUIPMENT VARIABILITY; ACUTE DECOMPENSATION; DOPPLER; RESISTANCE; MODEL; MELD; liver disease; liver cirrhosis; acute-on-chronic liver failure; liver perfusion; doppler ultrasound; critical care medicine (1)
ARTERIAL-HYPERTENSION; DEFICIENT RATS; UP-REGULATION; THERAPY; SURVIVAL; LUNGS; CELLS; Ambrisentan; Bosentan; monocrotaline; pulmonary hypertension; prostacyclin synthase (1)
ARTERIAL-HYPERTENSION; EISENMENGER-SYNDROME; SURVIVAL PROSPECTS; SINGLE-CENTER; LONG-TERM; DIAGNOSIS; THERAPY; ANTICOAGULATION; PREDICTORS; GUIDELINES; congenital heart disease; pulmonary hypertension; pulmonary arterial hypertension; adults; observational; survival; targeted therapy (1)
ARTERIAL-HYPERTENSION; HEART CATHETERIZATION; CT EVALUATION; DIAMETER; DISTENSIBILITY; DIAGNOSIS; EXERCISE; PRESSURE; FIBROSIS; pulmonary hypertension (PH); multidetector computed tomography (MDCT); thoracic imaging; WHO classification (1)
ARTERIAL-HYPERTENSION; SILDENAFIL; THERAPY; RATS; TADALAFIL; PDE5; Pulmonary hypertension; Vardenafil; Exercise capacity; Monocrotaline (1)
ARTERIAL-HYPERTENSION; THERAPY; OUTCOMES; REGISTRY; Exercise; Pulmonary hypertension; Right ventricle; Survival (1)
ARTERIAL-HYPERTENSION; TRICUSPID REGURGITATION; DOPPLER ULTRASOUND; SYSTEMIC-SCLEROSIS; SYSTOLIC PRESSURE; (1)
ARTERIAL ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; THERAPY; METAANALYSIS; (1)
ARTERIAL ISCHEMIC-STROKE; UNILATERAL BRAIN-LESIONS; SICKLE-CELL-DISEASE; CEREBRAL INFARCTION; HEMIPLEGIC CHILDREN; RISK-FACTORS; CEREBROVASCULAR-DISEASE; PSYCHIATRIC-PROBLEMS; TERM NEWBORN; AGE ONE; behavior; childhood; clinical outcome; ischemic stroke; quality of life (1)
ARTERIAL OCCLUSIVE DISEASE; INDEPENDENT RISK FACTOR; EARLY ATHEROSCLEROSIS; PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; LOWERING THERAPY; CORONARY; DYSFUNCTION; HUMANS; HYPERHOMOCYST(E)INEMIA; homocysteine; hypercholesterolemia; endothelium; nitric oxide; atherosclerosis; lipids; foreram blood flow (1)
ARTERIAL RECONSTRUCTION; POSTOPERATIVE LYMPHOCELES; LYMPHATIC COMPLICATIONS; PERCUTANEOUS DRAINAGE; RADIATION-THERAPY; FEMORAL-ARTERY; GROIN; SCLEROTHERAPY; DOXYCYCLINE; DISSECTION; lymphorrhea; irradiation of lymph fistula; radiotherapy of benign disease (1)
ARTERIAL STIFFNESS; AUGMENTATION INDEX; REPAIR; VALIDATION; PRESSURE; abdominal aortic aneurysm (AAA); arterial stiffness; atherosclerosis; endovascular aneurysm repair (EVAR); Mobil-O-Graph; pulse wave velocity (PWV) (1)
Arteriosklerose , Differentielle Genexpression , Phagozytose , Fluoreszenz Mikroskopie , Protein-Protein Interaktion , ABCA1 , Syntaxin 13 , beta2-syntrophin , Affymetrix gene chips (1)
Arteriosklerose, Genexpression , Bioaktive Verbindungen , Genregulation , Lipide , Makrophage , Atherosklerose , Genexpression , E-LDL , Bioaktive Lipide , atherosclerosis , gene expression , E-LDL , bioactive lipids , foam cells (1)
Arteriosklerose , Schaumzelle , Blut , Opsonisierung , Atherosklerose , Opsonine , Schaumzellen , atherosclerosis , opsonins , foam cells (1)
arterio-ureteral, ureteroarterial, ureteroiliac, fistula, endovascular (1)
; Arteriovenous fistula; Ultrasound; 3-D imaging; Power Doppler; Hemodialysis (1)
ARTERIOVENOUS-MALFORMATIONS; ETHANOL EMBOLIZATION; CLASSIFICATION; Therapeutic embolization; Materials; Microcatheter; Complications; Vascular malformations (1)
Arteriovenous malformations · Fast Flow malformations · Bevacizumab · Thalidomide · VEGF · VEGF inhibitor · Mechanical stress · Microenvironment (1)
ARTERIOVENOUS-MALFORMATIONS; TELANGIECTASIA; PROSTACYCLIN; (1)
ARTERY ANEURYSM; BRAIN EDEMA; GLIOBLASTOMA; MECHANISM; RUPTURE; GROWTH; giant intracranial aneurysm; aneurysm volume; perianeurysmal edema; partially thrombosed aneurysm; vascular disorders (1)
ARTERY ANEURYSM; ENDOVASCULAR EMBOLIZATION; EXPERIENCE; MANAGEMENT; IMMEDIATE; INJURIES; STENT; COIL; renal bleeding; aneurysm; renal fistula; liquid embolization; Onyx (1)
ARTERY ANEURYSMS; PREVALENCE; ECTASIA; DISEASE; Giant coronary aneurysm; Pathomechanism; Coronary atherosclerosis; Surgery (1)
ARTERY BALLOON COUNTERPULSATION; MECHANICAL CIRCULATORY SUPPORT; CLINICAL-EXPERIENCE; PATHOPHYSIOLOGY; MANAGEMENT; SYSTEM; Right heart failure; Temporary circulatory assistance; RVAD (1)
ARTERY-BYPASS-SURGERY; AORTIC-VALVE-REPLACEMENT; IN-HOSPITAL MORTALITY; TERM SURVIVAL; GRAFT-SURGERY; CORONARY; MORBIDITY; EUROSCORE; IMPACT; WOMEN; cardiac surgery; gender; mortality; octogenarians; risk stratification (1)
ARTERY-BYPASS SURGERY; FROZEN ELEPHANT TRUNK; CORONARY-ARTERY; REOPERATIVE SURGERY; RISK-FACTOR; MORTALITY; OUTCOMES; aortic valve or complete root; coronary artery bypass grafting; CABG; aortic valve surgery; reoperation (1)
ARTERY-BYPASS SURGERY; MINIATURIZED CARDIOPULMONARY BYPASS; ACUTE KIDNEY INJURY; MINIMIZED PERFUSION CIRCUITS; CORONARY REVASCULARIZATION; GRAFT-SURGERY; INFLAMMATORY RESPONSE; CARDIOVASCULAR ANESTHESIOLOGISTS; BLOOD CONSERVATION; HEPARIN; Extracorporeal circulation; Minimally invasive extracorporeal circulation; Cardiopulmonary bypass; Modular systems; Systemic inflammation reaction syndrome; Complications (1)
ARTERY-BYPASS-SURGERY; OPERATIVE MORTALITY; FEMALE GENDER; GRAFT-SURGERY; EUROSCORE; RISK; Gender; CABG; Coronary surgery; Minimized extracorporeal circulation; Mortality (1)
ARTERY-BYPASS SURGERY; PERICARDIAL-EFFUSION; ADVERSE OUTCOMES; TRANSFUSION; RISK; REEXPLORATION; re-exploration; bleeding; tamponade; cardiac surgery (1)
ARTERY; CELLS; DIAMETER; vascular tissue engineering; small-calibre graft; endothelium; biomechanics; human umbilical vein; bioreactor (1)
ARTERY; COMPRESSION; popliteal entrapment syndrome; deep vein thrombosis; chronic venous insufficiency (1)
ARTERY DISSECTION; CERVICAL-SPINE; CT ANGIOGRAPHY; TRAUMA; polytrauma; MRI; acute diagnostic; ISS (1)
ARTERY HARVEST; PREOPERATIVE ASSESSMENT; HAND CIRCULATION; ULTRASONOGRAPHY; RECONSTRUCTION; Allen's test; radial forearm free flap; atherosclerosis; angiography; perfusion of the hand (1)
ARTERY OCCLUSION; FOCAL ISCHEMIA; TIGHT JUNCTION; STROKE; PERMEABILITY; WATER; DISRUPTION; INFARCTION; PROTEINS; ALBUMIN; blood-brain barrier; cerebral edema; magnetic resonance imaging; stroke (1)
ART, Gestationsdiabetes mellitus, GDM, Glukosetoleranzstörung, oGTT (1)
ARTHRITIS CLINICAL-TRIALS; DISEASE-ACTIVITY; SEVERITY SCORE; DERMATITIS; OMERACT; TOOL; RHEUMATOLOGY; CHILDREN; EFFICACY; PATIENT; atopic dermatitis; consensus study; measurement; outcome domain; study endpoint (1)
ARTHRITIS; DISEASES; FOOT; rheumatoid arthritis; ankle joint; synovectomy; long-term results (1)
ARTHRITIS; ETANERCEPT; TRIAL; TOE; (1)
Arthritis, Katecholamine, Sympathikus, Rheumatologie, Innere Medizin (1)
ARTHRITIS; POPP; TOE; arthritis; periostitis; psoriasis; psoriatic arthritis; POPP (1)
ARTHRITIS; PROTEIN; TISSUE; (1)
Arthritis psoriatica , Rheumatoide Arthritis , Schuppenflechte , Screening , Fragebogen , arztunabhängig , Psoriasis , Patientenfragebogen , questionnaire , psoriasis , psoriatic , arthritis , rheumatoid (1)
ARTHRITIS; RAT; rheumatoid arthritis; cicadian rhythm; anti-inflammatory drugs; glucocorticoids; timed drug release (1)
Arthritis, Rheumatologie, Innere Medizin, Katecholamine (1)
Arthritis, Sauerstoffverbrauch, Tiermodell (1)
ARTHRODESIS; JOINT; Ankle; Arthritis; Arthroplasty; Joint replacement; Aseptic loosening (1)
ARTHROGRYPOSIS MULTIPLEX CONGENITA; NEUROMUSCULAR-JUNCTION SYNAPTOPATHY; DELTA-SUBUNIT MUTATION; MYASTHENIC SYNDROME; PTERYGIUM SYNDROME; RAPSYN MUTATIONS; BINDING; LETHAL; UNDERLIE; ORIGIN; (1)
ARTHROPLASTY; ALIGNMENT; ERROR; AXIS; LIMB; Long-leg radiograph; TKA; Osteotomy; Knee; Rotation; Lower limb alignment; Fibula (1)
ARTHROPLASTY; CUP; PLACEMENT; MOTION; DISLOCATION; ACCURACY; WEAR; (1)
arthroplasty, dislocation, epidemiology, joint, knee (1)
ARTHROPLASTY; POSITION; RESTORATION; ALIGNMENT; Bony landmarks; Knee revision surgery; MRI measurement; Joint line (1)
ARTHROPLASTY; Register data; Randomized controlled studies; Care-related data; Data linkage; Research infrastructure (1)
; Arthropods; conservation; insect decline; Lepidoptera; light pollution; phototaxis (1)
ARTHROPOD SUCCESSION; FERTILIZATION SUCCESS; DEGEER COLEOPTERA; EXPOSED CARRION; ISLAND; CURCULIONIDAE; FECUNDITY; PATTERNS; REMAINS; WEEVIL; Forensic entomology; Dermestes maculatus; (Z9)-unsaturated fatty acid isopropyl esters; Cadaver odour; Pheromone; Piglet cadaver (1)
ARTHROSCOPIC CORRELATION; JOINT FLUID; CUFF TEARS; GLENOHUMERAL JOINT; DIAGNOSIS; LESIONS; INTEROBSERVER; ENHANCEMENT; DISEASE; ABER; (1)
ARTHROSCOPIC KNEE SURGERY; ARTICULAR-CARTILAGE; CHONDROCYTE APOPTOSIS; PROGENITOR CELLS; BUPIVACAINE; ROPIVACAINE; PHOSPHATIDYLSERINE; OSTEOARTHRITIS; INJECTION; EXPOSURE; (1)
ARTHROSCOPIC KNEE SURGERY; ARTICULAR-CARTILAGE; IN-VITRO; HUMAN CHONDROCYTES; PROGENITOR CELLS; BUPIVACAINE; ROPIVACAINE; INJECTION; LIDOCAINE; APOPTOSIS; Local anesthetics; Mesenchymal stem cells; Chondrogenesis; Chondrotoxicity (1)
ARTHROSCOPIC REPAIR; FOLLOW-UP; PATTERNS; STRENGTH; OUTCOMES; SURGERY; rotatorenmanschettenlasion; arthroskopie; schulter; rotatorenmanschettenrekonstruktion; umfrage (1)
ARTHROSCOPIC SYNOVECTOMY; FOLLOW-UP; RADIOLUNATE ARTHRODESIS; ELBOW JOINT; ARTHRITIS; ARTHROPLASTY; WRIST; MULTICENTER; SYNOVITIS; HIP; orthopaedic rheumatology; synovectomy; arthroplasty; arthrodesis; joint replacement (1)
ARTHROSCOPIC SYNOVECTOMY; WRIST ARTHROPLASTY; ARTHRODESIS; ARTHRITIS; Rheumatoid arthritis; Carpal collapse; Arthroscopic synovectomy; Biomechanics; Multidisciplinarity (1)
ARTHROSCOPIC TREATMENT; CALCAREOUS TENDINITIS; FOLLOW-UP; SHOULDER; LITHOTRIPSY; CAVITATION; DEPOSITS; BLIND; ESWL; (1)
ARTHROSCOPIC TREATMENT; TREATMENT STRATEGIES; CARTILAGE REPAIR; TALAR DOME; ANKLE; DISSECANS; DEFECTS; DEBRIDEMENT; LIGAMENT; regulatory issues; general; articular cartilage; tissue; ankle; joint involved; other; non-surgical therapy; guidelines (1)
Arthroscopy; shoulder; rotator cuff; labrum; biceps; tendon; tenodesis; tenotomy (1)
Arthroscopy, Shoulder, Rotator cuff, Labrum, Biceps, Tendon, Tenodesis, Tenotomy (1)
Arthrose, Interleukin-1β, Mesenchymale Stammzellen, Physioxie (1)
Arthrose; Knieknorpel; Neuropilin-1; Semaphorin 3A; Sema3A; NRP1; chondrocyte cloning; MMP13; VEGFA; articular cartilage; osteoarthritis; NRP1-Knockdown (1)
arthrosis deformans, radiotherapie, bestrahlung, (1)
ARTICULAR-CARTILAGE; ABRASION ARTHROPLASTY; RHEUMATOID-ARTHRITIS; KNEE; REPAIR; TRANSPLANTATION; DEFECTS; PERIOSTEUM; SCAFFOLDS; UPDATE; chondrosphere; cartilage lesion; autologous chondrocyte implantation; severe combined immunodeficiency mouse model (1)
ARTICULAR-CARTILAGE; BLUNT IMPACT; SUBCHONDRAL FRACTURES; PATELLOFEMORAL JOINT; BONE; INJURIES; SURFACES; LOADS; MODEL; Dynamic impact; Knee; Osteochondral injury; Histology (1)
ARTICULAR-CARTILAGE DEFECTS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; CONTINUOUS PASSIVE MOTION; FULL-THICKNESS DEFECTS; KNEE-JOINT; MENISCAL TRANSPLANTATION; OSTEOARTHRITIC KNEE; CONTROLLED TRIAL; FOLLOW-UP; IN-VITRO; osteoarthritis; methods; tissue engineering; autologous chondrocyte transplantation (1)
ARTICULAR-CARTILAGE DEFECTS; CHONDRAL DEFECTS; KNEE; REPAIR; TRIAL; TRANSPLANTATION; MEMBRANE; OUTCOMES; LESIONS; RETURN; autologous chondrocyte implantation; cartilage defect; hydrogel; knee joint; large lesions (1)
ARTICULAR-CARTILAGE DEFECTS; CHONDROCYTE IMPLANTATION; CHONDRAL DEFECTS; FOLLOW-UP; KNEE; REPAIR; OSTEOARTHRITIS; METAANALYSIS; OUTCOMES; SURGERY; Articular cartilage; Autologous Matrix-Induced Chondrogenesis (AMIC (R)); Chondro-Gide (R); Knee surgery; Microfracture (1)
ARTICULAR-CARTILAGE DEFECTS; PARTIAL-THICKNESS DEFECTS; PLATELET LYSATE TECHNIQUE; MARROW STROMAL CELLS; AUTOLOGOUS CHONDROCYTE; KNEE OSTEOARTHRITIS; TRICALCIUM PHOSPHATE; CLINICAL-APPLICATION; FOLLOW-UP; MODEL; Osteoarthritis; Trauma; Cartilage; Focal defect; Clinical; Preclinical; Animal model; Ovine; Porcine; Equine; Chondral; Osteochondral; Hyaline; Mesenchymal stem cells; Platelet-rich plasma; Bone-marrow concentrate; Tissue engineering; Collagen; Fibrin gel (1)
ARTICULAR-CARTILAGE DEGENERATION; ARTHROSCOPIC EVIDENCE; TIBIOFEMORAL JOINT; PAIN; ARTHROPLASTY; OSTEOPHYTES; VALIDATION; SEVERITY; SYMPTOMS; UPDATE; knee osteoarthritis; pain; X-ray; chondromalacia; correlation (1)
ARTICULAR-CARTILAGE; II COLLAGEN; PROTEOGLYCAN METABOLISM; POLYMER SCAFFOLDS; MATRIX SYNTHESIS; CHONDROCYTES; CULTURES; EXPLANTS; INTERLEUKIN-4; TGF-BETA-1; (1)
ARTICULAR-CARTILAGE; II COLLAGEN; TISSUE; GLUE; MODEL; CONSTRUCTS; SURGERY; DESIGN; SYSTEM; RECONSTRUCTION; (1)
ARTICULAR-CARTILAGE LESIONS; 2-YEAR FOLLOW-UP; OSTEOCHONDRITIS-DISSECANS; GRAFT HYPERTROPHY; CHONDRAL DEFECTS; KNEE; TRANSPLANTATION; REPAIR; OSTEOARTHRITIS; SCAFFOLD; cartilage defect; MACT; cell characterization; adverse events; short-term clinical outcome (1)
ARTICULAR-CARTILAGE; METABOLIC RESPONSE; MATRIX SYNTHESIS; EXPLANTS; INVITRO; PROTEOGLYCAN; FIBRONECTIN; COMPRESSION; STIMULATION; CULTURES; chondrogenesis; stem cell; bone marrow; mechanobiology (1)
ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; BIOREACTOR; OPTODES; CELLS; cartilage; oxygen; tissue engineering; optical oxygen sensor (1)
ARTICULAR-CARTILAGE REPAIR; BONE-MARROW; MICROFRACTURE TECHNIQUE; CHONDRAL DEFECTS; PROGENITOR CELLS; FOLLOW-UP; IN-VIVO; KNEE; IMPLANTATION; MODEL; Cartilage defect; Mesenchymal stem cells; Chondrocytes; Autologous chondrocyte implantation; Chondrogenesis (1)
ARTICULAR-CARTILAGE REPAIR; FOLLOW-UP; IMPLANTATION ACI; DEFECTS; KNEE; TISSUE; REGENERATION; OUTCOMES; TRIAL; LESIONS; autologous chondrocyte transplantation; Chondrosphere; tissue engineering; ACT3D; Spherox (1)
ARTICULAR-CARTILAGE; TISSUE; OSTEOARTHRITIS; HISTOPATHOLOGY; KNEE; CLASSIFICATION; DEGENERATION; INTEGRITY; MENISCUS; SYSTEM; Endoprothesis; Meniscus; Crucial ligament; Synovial membrane; Tissue engineering; Autologous chondrocyte transplantation (1)
ARTICULAR-CARTILAGE; TRANSPLANTATION; HYDROGEL; OUTCOMES; REPAIR; knee; cartilage; regeneration; cell; transplantation; chondrocyte (1)
ARTICULAR CHONDROCYTES; IN-VITRO; APOPTOSIS; OSTEOARTHRITIS; LIDOCAINE; PHOSPHATIDYLSERINE; CHONDROLYSIS; ARTHROSCOPY; INJECTION; EXPOSURE; (1)
ARTICULAR CHONDROCYTES; QUANTITATIVE PROTEOMICS; OSTEOARTHRITIS; QUANTIFICATION; MECHANISMS; EXPRESSION; PROTEIN-1; COMPLEXES; CULTURE; TISSUE; Osteoarthritis; Secretome; Chondrogenic progenitor cells; Mass spectrometry; Tissue engineering (1)
ARTIFACTS; PLACEMENT; VISUALIZATION; INTERVENTIONS; CATHETER; ANEURYSM; arteries, grafts and prostheses; arteries, MR; magnetic resonance(MR), artifact; magnetic resonance(MR), vascular studies; stents and prostheses (1)
ARTIFICIAL ATOMS; ADDITION SPECTRUM; MAGNETIC-FIELDS; COULOMB; SPECTROSCOPY; (1)
ARTIFICIAL ATOMS; GATE; (1)
ARTIFICIAL BETA-SHEET; AMINO-ACIDS MOPAS; GROWTH-HORMONE; CONCANAVALIN-A; MODEL SYSTEMS; RECOGNITION; FOLDAMERS; LIGANDS; DESIGN; STRAND; peptide mimics; pyrimidine; hydrazine acid; luminescence; FRET (1)
ARTIFICIAL BETA-SHEET; MOLECULAR SCAFFOLDS; ASYMMETRIC-SYNTHESIS; DESIGNED MOLECULES; HAIRPIN FORMATION; STRAND; STABILIZATION; PEPTIDOMIMETICS; RECOGNITION; NUCLEATION; (1)
artificial intelligence, brain metastasis, machine learning, radiomics (1)
ARTIFICIAL-INTELLIGENCE; DATA CAPTURE; RADIOMICS; FEATURES; PET; REPRODUCIBILITY; VARIABILITY; STABILITY; Interoperability; Harmonisation; Image Data; Clinical Data; nuclear medicine (1)
Artificial Intelligence, Data Quality, Data Analysis, Automated Planning of Process Models (1)
; artificial intelligence; healthcare systems; low-and-middle income countries; scoping review; implementation challenges (1)
ARTIFICIAL-INTELLIGENCE; IMMUNE; (1)
Artificial Intelligence, Machine Learning, Optimization, Software Engineering, Statistics, ADAM Optimizer (1)
artificial intelligence, online consumer reviews, data understanding, enhanced approaches, explanations, recommender systems, aspect-based sentiment analysis (1)
Artificial intelligence, Sentiment, Deep learning, Commercial real estate, Market liquidity, News analytics (1)
Artificial intelligence, Software development, AI-assistance, Security, Coding (1)
ARTIFICIAL INTERSTITIUM; CULTURE; TUBULES; DIFFERENTIATION; RECEPTOR; TUBULOGENESIS; MORPHOGENESIS; INHIBITION; EXPRESSION; GENERATION; Kidney; Stem/progenitor cells; Tubules; Aldosterone; Perfusion culture; Artificial interstitium; Biomaterial; Drug delivery (1)
ARTIFICIAL ION-CHANNEL; AMMONIUM CATIONS; RECOGNITION; RECEPTOR; BINDING; TRANSPORT; PEPTIDES; POLYMERS; BEHAVIOR; MODELS; (1)
ARTIFICIAL IRIS; CONTRAST SENSITIVITY; NORMAL VALUES; PROSTHESIS; ANIRIDIA; APHAKIA; TRAUMA; Aniridia; Pupillary reconstruction; Ocular trauma; Eye injury; IOL (1)
ARTIFICIAL LUNG; (1)
ARTIFICIAL METEORITES; PLANETARY PROTECTION; ATMOSPHERIC ENTRY; EXPOSE-E; SURVIVAL; SPORES; MICROORGANISMS; METHANE; MARS; IDENTIFICATION; ExoMars; Planetary protection; Life-detection; Astrobiology; Cleanroom microbiota (1)
ARTIFICIAL MOUTH; ORAL BACTERIA; RESTORATIONS; CEMENT; RESIN; CULTURE; Bioreactor; Secondary caries; Caries model; Micro-CT; Streptococcus mutans (1)
Artificial Neural Networks;Pen Interface;Note Taking; Design Science; Image Processing; CNN; (2)
ARTIFICIAL ORAL ENVIRONMENT; DENTAL CERAMICS; WEAR SIMULATOR; FORCE; oral stress simulation; masticator; artificial mouth; artificial periodontium (1)
ARTIFICIAL ORAL ENVIRONMENT; MICROTENSILE BOND STRENGTH; ALL-CERAMIC RESTORATIONS; FIXED-PARTIAL DENTURES; DIFFERENT COMPONENTS; WEAR SIMULATOR; BITE FORCE; PARAMETERS; ZIRCONIA; Simulation; Survival rate; TCML; CAD/CAM (1)
ARTIFICIAL PHOTOSYNTHESIS; CONJUGATED POLYMERS; AMINATION; REDUCTION; ARENES; H2O2; Heterogeneous Catalysis; Visible Light; Semiconductor Photoredox Catalysis; C-H Functionalization; Radical (1)
ARTIFICIAL SIGNAL-TRANSDUCTION; SYNTHETIC RECEPTORS; RECOGNITION; VESICLES; SURFACE; MICELLES; LIGANDS; fluorescence; imprinting; metal complexes; molecular recognition; vesicle membranes (1)
ARTIFICIAL SKIN; BURN INJURY; SURGERY; (1)
Artilysin(R), Antimykobakterielle Proteinwirkstoffe, Mykobakteriophagen, Lysine (1)
ARTIN GROUPS; BOUNDED COHOMOLOGY; CONJUGACY; Hochschild homology; rapid decay group algebras; semi-hyperbolic groups (1)
ARTIN GROUPS; K-THEORY; NOVIKOV CONJECTURES; BOUNDED COHOMOLOGY; BOUNDARIES; DIMENSION; HOMOLOGY; COMPLEXES; ALGEBRAS; SYSTEMS; Combings; Z-boundaries; coronas; coarse assembly map; asymptotic dimension; coarse homology theories; transgression maps; non-positively curved spaces and groups (1)
; Artisanal and small-scale gold mining; ASGM; Zimbabwe; Exposure assessment; Mercury; Human biomonitoring (1)
ARVC, Natriumhomöostase, hiPSC (1)
ARVC, PKP2, hiPSC, Mitochondriale Sauerstoffradikale, Antioxidantien, ROS (1)
ARVC; voltage gated sodium current; hiPSC; plakophilin-2; intercalated disc; arrhythmogenesis (1)
ARYL (2)
ARYLAMINE N-ACETYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; METABOLIC-ACTIVATION; SMALL-INTESTINE; TYPE-1 NAT1; HUMAN LIVER; ACETYLATION; POLYMORPHISM; RELEASE; ulcerative colitis; Crohn's disease; intestinal complications (1)
arylazopyrazoles • fentanyl • μ-opioid receptor • Gprotein- coupled receptor • photopharmacology (1)
ARYLBORONIC ACIDS; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ARYL HALIDES; CHEMICAL-REACTIONS; COUPLING REACTIONS; DISCOVERY; HYDROXYLATION; ASSAY; TOOL; (1)
ARYL BROMIDES; PHOTOREDOX CATALYSIS; UNACTIVATED ALKYL; ACTIVATION; LIGHT; TRIFLUOROMETHYLATION; UNLOCKING; FLUORINE; cross coupling; halogen atom transfer; late-stage functionalization; nickel catalysis; photocatalysis (1)
ARYLCYCLOPROPANE CATION RADICALS; 3-ELECTRON S(N)2 REACTIONS; PHOTOCHEMICAL ADDITION; DERIVATIVES; BIOGENESIS; STRATEGIES; INHIBITORS; PROBES; aryl cyclopropane; late-stage modification; photochemistry; radical chain reactions; beta-chloro ketones (1)
ARYL DIAZONIUM SALTS; C-H ARYLATION; ORGANIC-SYNTHESIS; METAL-FREE; LIGHT; RADICALS; PHOTOOXIDATION; GENERATION; COMPLEXES; CHEMISTRY; amino-arylation; aryl radicals; Meerwein addition; photocatalysis; visible light (1)
ARYL DIAZONIUM SALTS; C-H ARYLATION; VISIBLE-LIGHT; EOSIN-Y; ORGANIC-SYNTHESIS; REDOX POTENTIALS; RADICALS; DYES; DERIVATIVES; COMPLEXES; carbonylation; esters; organocatalysis; photoredox catalysis; redox reaction; visible light (1)
ARYL DIAZONIUM SALTS; FLUORESCENT-PROBES; ELECTRON-TRANSFER; DYNAMIC CONTROL; CATALYSIS; ARYLATION; DYES; C-H arylation; dyes; photocatalysis; radicals; radical anions (1)
ARYL DIAZONIUM SALTS; LIGHT PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; METAL-FREE; CHEMICAL ACTINOMETRY; BOND FORMATION; C-C; ARYLATION; DERIVATIVES; BORYLATION; mechanism; organocatalysis; photocatalysis; photoredox catalysis; quantum yields; visible light (1)
ARYL DIAZONIUM SALTS; METAL-FREE; C-H; ARENEDIAZONIUM SALTS; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; LIGHT; ARYLATION; CATALYSIS; CHEMISTRY; formyloxylation-arylation; Meerwein reaction; photocatalysis; diazonium salts; N,N-dimethylformamide (1)
ARYL DIAZONIUM SALTS; PHOTOREDOX CATALYSIS; REDUCTIVE DEAMINATION; ORGANIC-SYNTHESIS; METAL-FREE; EOSIN Y; DERIVATIVES; AMINES; HYDRODEDIAZONIATION; PROTODEDIAZONIATION; defunctionalization; organocatalysis; photocatalysis; radical reactions (1)
ARYL DIAZONIUM SALTS; SOLVENT-FREE REACTION; VISIBLE-LIGHT; METAL-FREE; SUBSTITUTED PYRIDINES; EFFICIENT SYNTHESIS; 2,4,6-TRIARYLPYRIDINES; FUNCTIONALIZATION; NITROGEN; LIGANDS; (1)
ARYL FLUOROALKYL SULFIDES; MEDICINAL CHEMISTRY; OXIDATIVE TRIFLUOROMETHYLTHIOLATION; NUCLEOPHILIC TRIFLUOROMETHYLATION; TRIFLUOROMETHANESULFENYL CHLORIDE; SELECTIVE FLUORINATION; CONVENIENT SYNTHESIS; ELEMENTAL SULFUR; LIQUID-CRYSTALS; DRUG DESIGN; Aromatic substitution; Photoredox catalysis; Radical reactions; Fluorinations; Thiols; Fluorine (1)
ARYL GRIGNARD-REAGENTS; ALKYL-HALIDES; ORGANIC-SYNTHESIS; ALKENYL HALIDES; BR/MG EXCHANGE; ZINC REAGENTS; COMPLEXES; OLEFINS; ISOMERIZATIONS; ARYLMAGNESIUM; biaryls; cross-coupling; Grignard reactions; iron; sustainable chemistry (1)
ARYL GRIGNARD-REAGENTS; SECONDARY ALKYL-HALIDES; BEARING BETA-HYDROGENS; ORGANOMANGANESE REAGENTS; ALKENYL HALIDES; CHLORIDES; PHOSPHATES; REACTIVITY; ARYLATION; MAGNESIUM; catalysis; cross couplings; iron; reaction mechanisms (1)
aryl halides · C─C bond formation · cobalt · photocatalysis · visible light (1)
ARYL HALIDES; PHOTOREDOX; REDUCTION; DERIVATIVES; GENERATION; FLUORESCENCE; EFFICIENT; RADICALS; FAMILY; ANIONS; Acridinium; Acridone; Photoelectrochemistry; Photoredox Catalysis; Preassembly (1)
ARYL-HALOGEN BONDS; OXIDATIVE ADDITION; PLATINUM(II) COMPLEXES; ORGANOPLATINUM(II) COMPOUNDS; TRANSITION-METALS; CRYSTAL-STRUCTURE; OLED APPLICATIONS; TRIPLET EMITTERS; PHOSPHORESCENCE; SUBSTITUTION; (1)
ARYLHYDRAZINES; PHOTOCATALYSIS; AZIDATION; PYRROLES; COMPLEX; (1)
ARYL-HYDROCARBON RECEPTOR; 3-HYDROXYANTHRANILIC ACID; TRYPTOPHAN-METABOLITES; QUINOLINIC ACID; CANCER; RADIATION; SKIN; interferon-gamma; melanocytes; melanoma; metabolism; tryptophan (1)
ARYL-HYDROCARBON RECEPTOR; IMMUNE-RESPONSES; METABOLISM; TRYPTOPHAN; ACID; INDUCTION; SURVIVAL; COLITIS; T cell metabolism; immunosuppression; tumour microenvironment; indoleamine-2,3-dioxygenase; cancer metabolism; aryl hydrocarbon receptor (1)
ARYL-HYDROCARBON RECEPTOR; SULFATE; MICROBIOME; DIVERSITY; IL-12; Indoxyl 3-sulfate; Tolerogenic dendritic cells; IL-12; T cells; IFN gamma; TNF (1)
ARYL IODIDES; LIGANDS; PHOTOREDOX; (1)
Arzneimittelinteraktionen, CYP-P450, Cytochrom P 450, Abbauwege von Arzneimitteln (1)
Arzneimittelnebenwirkung , Neuroleptikum , Perazin , Olanzapin , Risperidon , Dosis-Wirkungs-Beziehung , Kombinationstherapie , Clozapin , typische und atypische Neuroleptika , Biperiden , extrapyramidale Nebenwirkungen , loose- binding D2- Rezeptor , Chlorpromazinäquivalente , Biperiden , extrapyramidal side-effect , Schizophrenia , atypical and typical antipsychotics , chlorpromazine equivalents (1)
Arzneimitteltherapiesicherheit, Risikopatient, Zahnarztpraxis, Multimorbidität, Polypharmazie (1)
Arzneistoffträger , Triglyceride , Kontrollierte Wirkstofffreisetzung , Proteine , Lipidmatrix , Protein , Kontrollierte Freigabe , Konfokale Mikroskopie , Freisetzungsmechanismus , Lipid matrix , protein , controlled release , confocal microscopy , release mechanism (1)
Ärzte, Psychologen,Psychotherapeuten, psychosomatische Behandlung / clinicians, doctors outside the clinic, psychologists, psychotherapists (1)
Ärztliches Berufsethos, Friedrich Joseph Haass, Medizin der Romantik, Naturphilosopie, Gefängnisschutzgesellschaft Moskau (1)
Ärztliche Sterbehilfe, Sterbebegleitung, Euthanasie (1)
Arzt-Patient-Beziehung, Patientenzufriedenheit, Qualitätsmanagement, Soziale Kompetenz, physician-patient-interaction, patients’ satisfaction, quality management, social competence (1)
ASB10, Glaukom, Expression (1)
ASCENDENS STENT PERITONITIS; IL-6 IMPROVES SURVIVAL; PROTECTS MICE; ANIMAL-MODELS; SEPSIS; INTERLEUKIN-6; PHOSPHATASE-1; MORTALITY; MACROPHAGES; INFECTION; cytokines; sepsis; signalling (1)
ASCENDING AORTIC-STENOSIS; LOCAL-ANESTHETIC AGENTS; OUTWARD K+ CURRENT; INDUCED ASYSTOLE; SODIUM-CHANNELS; CARDIAC-ARREST; SUCCESSFUL RESUSCITATION; FAT EMULSIONS; HUMAN HEART; MYOCYTES; (1)
ASCERTAINMENT SAMPLING PROBLEM; BREAST-CANCER; PROSTATE-CANCER; FAMILY-HISTORY; MUTATIONS; CARRIERS; OVARIAN; RESOLUTION; (1)
ASCITES; (1)
ASCITES TUMOR-CELLS; ANION CHANNELS; DECREASE; CALCIUM; CONDUCTANCE; CAMP; PROLIFERATION; STIMULATION; INHIBITION; ACTIVATION; (1)
ASCITES TUMOR-CELLS; MAJOR ENERGY-SOURCE; C-MYC; CANCER-CELLS; MAMMALIAN-CELLS; GENE-EXPRESSION; BUTHIONINE SULFOXIMINE; IN-VIVO; METABOLISM; GROWTH; (1)
ASCITIC FLUID; CIRRHOSIS; CEFOTAXIME; (1)
ASCITIC FLUID; CIRRHOTIC-PATIENTS; ESCHERICHIA-COLI; RISK-FACTORS; INFECTIONS; NORFLOXACIN; PROPHYLAXIS; ASSOCIATION; RECURRENCE; MORTALITY; Spontaneous bacterial peritonitis; Ascites; Cirrhosis; Infection; Resistance (1)
ASCITIC FLUID; HIP; CALPROTECTIN; ARTHROPLASTY; ASPIRATION; DEBRIDEMENT; CULTURE; BIOPSY; periprosthetic joint infection; PJI; diagnostic marker; diagnostics; synovial fluid (1)
; ascoconidia; Australia; Graphidaceae; lichenized ascomycetes; Thelotremataceae; Topeliopsis; Venezuela (1)
ASCOMYCOTA OSTROPALES GRAPHIDACEAE; NORTHERN THAILAND; THELOTREMOID GRAPHIDACEAE; SOUTHEAST-ASIA; LECANOROMYCETES OSTROPALES; MOLECULAR-DATA; GENUS; TAXA; RECORDS; FORESTS; Asia; biodiversity; lichens; new records; taxonomy (1)
ASCORBIC-ACID; IN-VITRO; CHONDROCYTE CULTURES; MECHANICAL INJURY; GENE-EXPRESSION; REPAIR; COLLAGEN; DEHYDROEPIANDROSTERONE; DEGRADATION; INHIBITION; (1)
ASCORBIC-ACID; OXIDATIVE STRESS; CONTRAST AGENT; MITOCHONDRIAL DYSFUNCTION; PHOSPHATIDYLCHOLINE; DEFICIENCY; CULTURES; GULO; CEUS; vitamin C; immune system; liposomal packing; sonography; enhanced resorption (1)
ASDEX UPGRADE; MODES; (1)
A. semiconductors; A. quantum wells; D. tunnelling (1)
A. semiconductors; B. crystal structure and symmetry; C. X-ray scattering; D. order-disorder effects; E. optical properties (1)
aseptic revision, constrained, knee arthroplasty, register study, unconstrained, unicondylar (1)
; Asia; Bank capital; Bank lending; Commercial banks; Credit portfolio risk; Systemic risk (1)
ASIAN CORN-BORER; NASONIA-VITRIPENNIS; TRICHOGRAMMA-BRASSICAE; HONEY-BEES; PHEROMONAL COMMUNICATION; INSECTICIDE CHLORPYRIFOS; SYSTEMIC INSECTICIDES; OSTRINIA-FURNACALIS; PESTICIDE EXPOSURE; NEONICOTINOIDS; (1)
Asobara japonica | community analyses | laboratory studies | longitudinal study | symbionts (1)
; Asp525His; EPAS1; erythrocytosis; erythropoietin synthesis; oxygen-sensing pathway (1)
ASPARAGINE-LINKED GLYCOSYLATION; OUTER CHAIN ELONGATION; SACCHAROMYCES-CEREVISIAE; GLYCOPROTEIN-BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; APPARATUS; MUTANTS; PATHWAY; OLIGOSACCHARIDES; (1)
ASPARAGINE-LINKED GLYCOSYLATION; YEAST MUTANTS DEFICIENT; PROTEIN GLYCOSYLATION; THERAPY; PATHWAY; CLONING; FUCOSE; (1)
ASPARAGINE-LINKED OLIGOSACCHARIDES; DEFICIENT GLYCOPROTEIN SYNDROME; UNFOLDED PROTEIN RESPONSE; YEAST MUTANTS DEFICIENT; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; CONGENITAL DISORDER; OLIGOSACCHARYLTRANSFERASE COMPLEX; ACETYLGLUCOSAMINYLTRANSFERASE-I; GLYCOSYLATION PATHWAY; (1)
ASPARAGINE-LINKED OLIGOSACCHARIDES; SACCHAROMYCES-CEREVISIAE; GENE POMT1; PROTEIN; FAMILY; MANNOSYLTRANSFERASES; IDENTIFICATION; DEGRADATION; TRANSFERASE; MUTATIONS; (1)
aspartate sodium osmotic activity coeff vapor pressure thermodn water glutamate sodium osmotic activity coeff vapor pressure vapor pressure osmometry Pitzer equation mean spherical approxn (1)
Aspect-Based Sentiment Analysis, Large Language Models, Data Annotation, NLP, ABSA, LLMs (1)
Aspect-Based Sentiment Analysis, Large Language Models, Restaurant Reviews, Annotation Quality, Dataset Annotation, NLP, ABSA, LLMs (1)
Aspecto léxico, aspecto gramatical, Progresivo, Prospectivo, Aoristo, Habitual, Continuo, perfectivo, imperfectivo, estado, evento, estatividad, perífrasis verbal, Aspekt, Progressiv, Prospektiv, Perfekt, Aorist, perfektiv, imperfektiv, Zustand, Ereignis, Stativität, Aktionsart, Verbalperiphrase, Gewohnheit, Iterativität (1)
ASPIRATION; COMPLICATIONS; GASTROSTOMY; RISK; stroke; dysphagia; neurorehabilitation; stroke outcome; feeding tubes (1)
ASPIRATION; multicolor technic; methylenblue swallow; FEES; dysphagia; food viscosities (1)
Aspirationspneumonitis, Säureaspiration, Lungenschaden, Inhalationsnarkose, intravenöse Anästhesie, Endothelin, Ratten, aspiration pneumonia, acid aspiration, lung injury, inhaled anesthesia, intravenous anesthesia, endothelin, rats (1)
ASP-LYS-PRO; AMINO-ACIDS; LUMINESCENT RECEPTOR; AQUEOUS-SOLUTION; PEPTIDES; COMPLEXATION; RECOGNITION; IMPROVEMENT; MECHANISMS; SWITCHES; (1)
ASSAY; LIPOSOMES; STRIP; Lateral flow assays; Laser-induced carbon nanofibers; Electrochemical detection; Liposomes; 3D-porouselectrodes (1)
ASSAY; MANAGEMENT; intraoperative parathyroid hormone measurement; Minimal-invasive parathyroidectomy; Multiple gland disease; Primary hyperparathyroidism (1)
Assays; Bacteria; Extraction; Genetics; Vesicles (1)
Assays, Biopolymers, Immunology, Peptides and proteins, Vesicles (1)
Assays; Biopolymers; Monomers; Peptides and proteins; Vesicles (1)
Assays, Conjugate acid-base pairs, Genetics, Peptides and proteins, Vesicles (1)
Assays; Fluorescence; Ligands; Peptides and proteins; Receptors (1)
ASSAYS; IMMUNOASSAYS; ANTIBODIES; COVID-19; SARS-CoV-2; COVID-19; serological immune response; serological tests; ELISA; ECLIA; LFA (1)
ASSAYS; VIRUS; Hepatitis A; Outbreak; Berries; Genotyping (1)
ASSAY; TECHNOLOGIES; SENSORS; BINDING; LABELS; HTS; laser-induced fluorescence; lifetime; fluorescent label; affinity binding; affinity assay; decay time (1)
ASSEMBLED GE ISLANDS; NANOSTRUCTURES; EPITAXY; SURFACE; WELLS; GAAS; GAS; (1)
ASSEMBLED GOLD ELECTRODE; GLASSY-CARBON ELECTRODE; ELECTROCHEMICAL-BEHAVIOR; ASCORBIC-ACID; COMPLEXES; SENSORS; SERUM; Uric acid; Fluorescence; Oxygen sensor; Oxygen probe; Enzymatic assay (1)
ASSEMBLY FACTORS; ENVIRONMENT; BIOGENESIS; DOMAINS; SYSTEM; MODEL; NMD3; LSG1; L25; (1)
Assembly line balancing; collaborative robots; cobots; Benders’ decomposition; collaboration (1)
Assembly line balancing; Collaborative robots; Exoskeletons; Cost-oriented; Ergonomics (1)
assembly line balancing, cost orientation, ergonomics, collaborative robots, industry 4.0 (1)
Assembly Line; Equipment Failure; Throughput Rate; Downstream Station; Assembly Line Balance Problem (1)
assembly rules, plant functional traits, calcareous grassland, grassland management, sowing experiment, seed limitation (1)
ASSERTIVE COMMUNITY TREATMENT; CRITICAL TIME INTERVENTION; HOSPITAL TREATMENT; ECONOMIC-IMPACTS; VALIDITY; RESPONSIVENESS; EQ-5D; HOMELESSNESS; EUROQOL; QUALITY; high utilizers; cost effectiveness; discharge planning; randomized controlled trial; quality-adjusted life years; needs (1)
ASSESSING ANTIDEPRESSANT ACTIVITY; SUSTAINED ATTENTION-DEFICIT; FORCED SWIMMING TEST; EMOTION PERCEPTION; DEPRESSION; STRESS; MOUSE; BEHAVIOR; RODENTS; BRAIN; endophenotype; genetically modified mice; translational medicine; TREK-1 (1)
ASSESSMENT ACCURACY; UNAWARE; PERFORMANCE; KNOWLEDGE; METAANALYSIS; REPLICATION; PERCEPTIONS; TEACHERS; FEEDBACK; Dunning-Kruger effect; students for the teaching profession; self-assessment ability; grade; school education (1)
Assessment, Business Analytics, Currency, Data Quality, Metric (1)
assessment | compulsive exercise | driven exercise | eating disorders | excessive exercise (1)
Assessment; inclusive schools; levels of school development; measurement invariance; school quality (1)
; assessment of occupational aptitude; prediction of success of occupational retraining in office management; regression model (1)
assessment, public speaking anxiety, scoping review, social anxiety, virtual reality, virtual reality exposure therapy, virtual social environments (1)
ASSESSMENT TOOL; INDEX; OUTCOMES; INTERVENTION; HFRS; Revision arthroplasty; Adverse events; Outcome; Frailty (1)
Asset-backed securities; Basel II and III; Collateralized debt obligations; Economic downturn; Mortgage-backed securities; Home equity loan securities; Ratings-based approach (1)
Asset-backed Security, Credit Rating Agency, Collateralized Debt Obligation, Economic Downturn, Fee Revenue, Forecasting, Global Financial Crisis, Home Equity Loans, Impairment, Mortgage-backed Security, Rating, Securitization, Structured Finance Transaction (1)
asset correlation, bank regulation, Basel II, credit risk, default correlation, default probability, logit model, probit model, time-discrete hazard rate (1)
Asset-liability management; Predictability; Stochastic programming; Scenario generation; VAR process (1)
asset pricing, banking, spillover, errors-in-variables bias, abnormal returns, Ukraine, Russia, ESG, Sustainability, fund flows (1)
Asset Pricing, Corporate Social Responsibility, Market Efficiency, Buy-and-Hold Abnormal Return, Earnings Surprises (1)
Asset Pricing, Empirical Asset Pricing, Mispricing, Equity Markets, Portfolio Management, Asset Management, Luxury Watches, Collectibles, Alternative Investments (1)
Asset pricing, Factor model, Fama-French, Liquidity, Real estate equities, Asset liquidity, G10, G11, G12, G15 (1)
asset value; correlation; credit portfolio; loss given default; Merton model; probability of default; recovery; volatility G20; G28; C51 (1)
Assia Djebar, Die Frauen von Algier, Algerien, Algerierin, Algier, Frankreich, Novelle, Erzählung, Kurzerzählung, Geschichte, Kabylisch, Kolonisierung, Kolonialismus, postkolonial, Dekolonisierung, Orientalismus, Kultur, Gesellschaft, Politik, Religion Sprache Frau Gender Hierarchie Patriarchat patriarchalisch Tradition Analyse Interpretation Narrativik Ästhetik Hermeneutik Didaktik Unterricht Lehrer, Lehrkraft Material Interkulturalität interkulturell Assia Djebar Women of Algiers Algeria Algerian Algiers France short novel story short story history Kabyle colonization colonialism postcolonial decolonization orientalism culture society politics religion language woman gender hierarchy patriarchy patriarchal tradition analysis interpretation narrativity esthetics hermeneutics didactics lesson teacher material interculturality intercultural Assia Djebar Femmes d’Alger dans leur appartement Algérie Algérienne Alger France nouvelle conte récit court histoire kabyle colonisation colonialisme postcolonial décolonisation orientalisme culture société politique religion langue femme genre hiérarchie patriarcat patriarcal tradition analyse interprétation narrativité esthétique herméneutique didactique cours prof matériel interculturalité interculturel (1)
assignment; homology; programs; automatic (1)
ASSIST (1)
assistance system, cooperative problem solving, human-computer interaction, mobile information needs (1)
ASSIST DEVICE SUPPORT; HEART-FAILURE; WORKING HEART; PLASMA; VASOSTATINS; MORTALITY; FRAGMENT; (1)
ASSISTED CLOSURE; TREATMENT OPTIONS; ESOPHAGEAL; STENT; Endoscopic vacuum therapy; Anastomotic leak; Esophagectomy; Gastric tube reconstruction; Endoscopic vacuum-assisted closure therapy; Negative pressure wound therapy (1)
ASSISTED EXTRACTION; HPLC METHOD; CHEMISTRY; PIGMENTS; SOLVENT; MODEL; CO2; Curcumin; Surfactant-free microemulsions; Extraction; COSMO-RS; Green chemistry; Food (1)
ASSISTED INJECTION; CAPILLARY; COMBINATION; SIMULATION; Capillary electrophoresis; Electrochemistry; Mass spectrometry; Redox studies; Screen-printed electrodes (1)
ASSISTED-LASER-DESORPTION/IONIZATION; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; ANTIBIOTICS; FUNGI; MALDI; PEPTAIBIOTICS; SPORES; AMPULLOSPORUM; PEPTIDES; (1)
ASSISTED MICRONEUROSURGERY; QEVO (R); micro-inspection tool; neuro-endoscopy; cerebral aneurysm; aneurysm clipping; vascular neurosurgery; KINEVO (1)
ASSISTED RADICAL PROSTATECTOMY; FUNCTIONAL OUTCOMES; RENAL MASSES; CANCER; SAFETY; ABLATION; EFFICACY; METAANALYSIS; THERAPY; TUMORS; (1)
Assisted Social Identity Management, Audience Segregation, Contextual Integrity, Social Web, Privacy (1)
ASSISTED SUBEPITHELIAL KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; ALCOHOL EXPOSURE; SURFACE ABLATION; CELL VIABILITY; LASIK; MORPHOLOGY; MYOPIA; FLAP; (1)
ASSISTED SUBEPITHELIAL KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; EPITHELIAL KERATOMILEUSIS; MYOPIC ASTIGMATISM; (1)
ASSISTED THORACIC-SURGERY; SECONDARY SPONTANEOUS PNEUMOTHORAX; RECURRENT SPONTANEOUS PNEUMOTHORAX; CHEST TUBE PLACEMENT; PERSISTENT AIR-LEAK; OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRANSTHORACIC NEEDLE-BIOPSY; PERCUTANEOUS LUNG-BIOPSY; MINIMAL-INVASIVE SURGERY; spontaneous pneumothorax; pneumothorax; primary spontaneous pneumothorax; secondary spontaneous pneumothorax; postinterventional pneumothorax; chest tube; VATS (1)
ASSISTED THORACIC-SURGERY; SECONDARY SPONTANEOUS PNEUMOTHORAX; RECURRENT SPONTANEOUS PNEUMOTHORAX; MINIMAL-INVASIVE SURGERY; CHEST TUBE PLACEMENT; PERSISTENT AIR-LEAK; OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRANSTHORACIC NEEDLE-BIOPSY; PERCUTANEOUS LUNG-BIOPSY; Primary spontaneous pneumothorax; Secondary spontaneous pneumothorax; Post-interventional pneumothorax (1)
ASSISTED WOUND CLOSURE; TEMPORARY ABDOMINAL CLOSURE; SEPTIC PATIENTS; CONSENSUS DEFINITIONS; DELAYED CLOSURE; DAMAGE CONTROL; VACUUM; MESH; THERAPY; TRACTION; Open abdomen; Peritonitis; Fascial closure; Hernia; Abdominal compartment syndrome; Abdominal trauma; Burst abdomen; NPWT; VAC (1)
Assistive robotics; sensor fusion; sensor modeling; exploration; robot control; information gain prediction (1)
ASSOCIATING FLUID THEORY; SODIUM-CHLORIDE SYSTEM; PERTURBED-CHAIN SAFT; EQUATION-OF-STATE; PLUS 1-BUTANOL; VARIABLE RANGE; PHASE-BEHAVIOR; SALT SOLUTIONS; NRTL MODEL; WATER; HMF; LLE; Salt; ePC-SAFT; Salting-out; Extraction; Prediction; Modeling (1)
associating liver partition and portal vein ligation for staged hepatectomy; colorectal liver metastases; portal vein embolization (1)
ASSOCIATION (1)
ASSOCIATION ANALYSES IDENTIFY; GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; SOMATIC MUTATIONS; CHANNEL MUTATIONS; KCNJ5 MUTATIONS; CA2+ CHANNELS; RENIN RATIO; HYPERTENSION; ADENOMAS; aldosterone to renin ratio; calcium signaling; genome-wide association study; knockout mice; primary hyperaldosteronism; solute carrier family 26 (sulfate transporter); member 2 protein; human (1)
ASSOCIATION; EXPRESSION; RISK; 5q31 cytokine gene cluster; linkage disequilibrium; Protocadherin-1; polymorphism (1)
ASSOCIATION; GENOME; (1)
ASSOCIATION; METAANALYSIS; RISK; LOCI; PRESSURE; DESIGN; coronary artery disease; genetics; meta-analysis; polymorphism; single nucleotide; stroke (1)
ASSOCIATION; Orthodontic tooth movement; Salt; Myeloid cells; Root resorptions; Osteoclasts; Osteoblasts (1)
ASSOCIATION; POLYMORPHISMS; PREDISPOSITION; HAPLOTYPE; VARIANT; Genetic polymorphism; Orthodontics; Root resorption; Systematic review (1)
ASSOCIATIONS; (1)
ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; PROPHYLACTIC IMPLANTATION; ANTIARRHYTHMIA DEVICES; CARDIAC-PACEMAKERS; SERVICE-LIFE; THERAPY; PREVENTION; REPLACEMENT; COMMITTEE; Implantable cardioverter-defibrillator; Battery; Longevity (1)
ASSOCIATIVE RECOGNITION; EPISODIC MEMORY; FALSE MEMORIES; FREE-RECALL; ROC CURVES; MODEL; RECOLLECTION; INHIBITION; LISTS; FAMILIARITY; episodic memory; retrieval-induced forgetting; recognition; recollection; familiarity (1)
ASTERACEAE; BIOGEOGRAPHY; DISPERSAL-VICARIANCE ANALYSIS; DIVA; MEDITERRANEAN BASIN; MOLECULAR CLOCK; NRDNA ITS (1)
Asteraceae; Cladanthus; Mecomischus; molecular phylogeny; Rhetinolepis; Santolina (1)
Asteraceae, Climate change, Hybridisation, Hybrid zone, Introgression, Phenology (1)
; Asterothryiaceae; Fissurinoideae; Gomphillaceae; Graphideae (1)
Aster tripolium; genetic diversity; molecular variance; RAPD; Salicornia ramosissima; salt tolerance (1)
Ästhesioneuroblastom, IMRT, VMAT (1)
Ästhetik, UI-Attribute, User Interface, Symmetrie, Buntheit, visuelle Komplexität, Persönlichkeit, Geschlecht, Design, UI-Design, Webseiten-Design, Webseiten (1)
Ästhetik, User Interface, Symmetrie, visuelle Komplexität, Buntheit, Webseiten (1)
Ästhetik, Web, Webseiten, Mensch-Maschine Interaktion, Emotion, affektives Priming (1)
ASTHMA (1)
ASTHMA; (1)
ASTHMA; ASSOCIATION; DISEASE; BIRTH; CHILDHOOD; CHILDREN; ECZEMA; MECHANISMS; MUTATIONS; BURDEN; Atopic dermatitis; persistent atopic dermatitis; prognosis; inflammation; soluble IL-6 receptor; single nucleotide polymorphism; longitudinal study; population-based cohort; candidate association study; genetic risk factor (1)
ASTHMA; CHILDREN; GENE; EXACERBATIONS; ASSOCIATION; EXPRESSION; ALLERGY; CELLS; FCER1A; FCER2; fine mapping; genetic variants; IgE (1)
ASTHMA; POLYMORPHISM; MECHANISMS; RECEPTOR; ADRB2; asthma; neutrophils; SNP; (2)AR agonist (1)
ASTHMA; PREGNANCY; INFANTS; RISK; CONTAMINANTS; CONSUMPTION; EXPOSURE; ECZEMA; Diet; Mediterranean; Pregnancy; Breastfeeding; Infant food; Omega 3 fatty acids (1)
ASTHMA; SYMPTOMS; bioacoustics; children; cough monitor; wheezing (1)
ASTHMA; T(H)17; DIFFERENTIATION; RESPONSES; TRENDS; (1)
asthma treatment; childhood asthma; exacerbations; genetic polymorphism; pharmacogenomics (1)
Asthma, Zirkadianer Rhythmus, Nächtliches Asthma, Genetische Interaktion (1)
Astragalus illyricus (cycloastragenol glycosides from Astragalus illyricus root ext.) astraverrucin I astragaloside III cyclounifolioside B chemotaxonomy Astragalus cycloastragenol glycoside chemotaxonomy Astragalus (1)
Astrocytes, synapses, antidepressants (1)
Asyl Flüchtlingsschutz Abschiebung Bürgerkrieg (1)
Asylsuchende, Gesundheitsspektrum, Global Health, Public Health, Impfungen (1)
Asylum seekers, Health care, Health literacy, Health promotion, Access to health care, Refugees health (1)
ASYMMETRIC ALDOL REACTION; ACYCLIC AMINO-ACIDS; ORGANIC-SYNTHESIS; HENRY REACTION; PROMISCUITY; biocatalysis; carbon-carbon bond formation; gelatin; Henry reaction; protein (1)
ASYMMETRIC ALDOL REACTION; HENRY REACTION; KNOEVENAGEL CONDENSATION; HYDROXYNITRILE LYASE; GREEN CHEMISTRY; CATALYST; WATER; CHITIN; ACETYLATION; SOLVENT; (1)
ASYMMETRIC ALDOL REACTIONS; BOND-FORMING REACTIONS; CARBONYL-COMPOUNDS; IMINIUM CATALYSIS; MICHAEL ADDITION; HYDROGEN-BONDS; DIARYLPROLINOL ETHERS; ORGANIC-CHEMISTRY; CH/PI INTERACTION; SOMO ACTIVATION; (1)
ASYMMETRIC ALLYLIC ALKYLATION; HYDROGENATION; ALLYLATION; WATER; ACID; PD; (1)
ASYMMETRIC ALLYLIC ALKYLATION; N-HETEROCYCLIC-CARBENE; CROSS-COUPLING REACTIONS; METAL-COMPLEXES; AMINOCARBENE COMPLEXES; NHC COMPLEXES; COPPER-FREE; LIGANDS; PD; ISOCYANIDES; (1)
ASYMMETRICAL POLYMICROGYRIA; MICROTUBULE DYNAMICS; CORTICAL DEVELOPMENT; BRAIN MALFORMATIONS; NEURONAL MIGRATION; WIDE SPECTRUM; AXON GUIDANCE; MUTATIONS; TUBB2B; ALPHA; Tubulin genes; Cerebellum; Dysplasia; Mutation; Neuroimaging (1)
ASYMMETRIC BENZOIN CONDENSATION; BICYCLIC THIAZOLIUM SALTS; N-HETEROCYCLIC CARBENES; CARBON BOND FORMATIONS; ALPHA-HYDROXY KETONES; ANION EQUIVALENTS; TRIAZOLIUM SALTS; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC ACYLATION; LANTHANUM TRICYANIDE; organic synthesis; carbenes; heterocycles; catalysis; umpolung reactions (1)
ASYMMETRIC CATALYSIS; allylation; catalysis; kinetic resolution; palladium; stereoselectivity (1)
ASYMMETRIC CATALYSIS; ARYLBORONIC ACIDS; BENZYLIC HALIDES; ARYL BROMIDES; COMPLEXES; CYCLOPROPANATION; bis(oxazoles); pincer ligands; Suzuki-Miyaura cross coupling; palladium; biaryls (1)
ASYMMETRIC CATALYSIS; BIS(OXAZOLINE) LIGANDS; CLICK-CHEMISTRY; CHIRAL LIGANDS; COPPER-COMPLEXES; TERMINAL ALKYNES; AZIDE-ALKYNE; CYCLOADDITION; CYCLOPROPANATIONS; SELECTIVITY; (1)
ASYMMETRIC CATALYSIS; COMPLEXES; HYDROSILYLATION; catalysis; chirality; transfer hydrogenation; tridentate ligands (1)
; asymmetric catalysis; enantioselectivity; hydrogen bonds; ligand design; silver (1)
ASYMMETRIC CATALYSIS; KINETIC RESOLUTION; BIDENTATE LIGANDS; BICYCLIC LACTAMS; HYDROGENATION; COMPLEXES; 1,2-DIOLS; NANOPARTICLES; INHIBITORS; CHEMISTRY; Supramolecular chemistry; -Self-assembly; N ligands; Asymmetric catalysis; Acylation (1)
ASYMMETRIC CATALYSIS; METAL-COMPLEXES; STEREOSELECTIVITY; CYCLOPROPANATION; HYDROSILYLATION; 1,4-ADDITION; VERSATILE; CHEMISTRY; KETONES; BINDING; chirality; circular dichroism; helical structures; structure elucidation; transition metals (1)
ASYMMETRIC CELL-DIVISION; APICAL-BASAL POLARITY; N-TERMINAL DOMAIN; EPITHELIAL POLARITY; DROSOPHILA NEUROBLASTS; PAR PROTEINS; PDZ DOMAINS; BAZOOKA; APKC; COMPLEX; Cell polarity; Par3; Adherens junctions; Drosophila; Lipid binding (1)
ASYMMETRIC CONJUGATE ADDITION; DIETHYL-ETHER; DIALKYLZINC REAGENTS; AGGREGATION; REACTIVITY; LIGANDS; NMR; asymmetric catalysis; copper; NMR spectroscopy; phosphorous; structure elucidation (1)
ASYMMETRIC DEAROMATIZATION; HETEROAROMATIC-COMPOUNDS; LEWIS-BASE; SALTS; ORGANOCATALYSTS; DERIVATIVES; HYDROGENATION; CLEVIDIPINE; INVERSION; REAGENTS; anion-binding catalysis; dearomatization; enantioselectivity; pyridine; triazoles (1)
asymmetric dimethylarginine, evaporation, high-performance liquid chromatography, solid-phase extraction (1)
asymmetric dimethylarginine, evaporation, high‐performance liquid chromatography, solid‐phase extraction (1)
ASYMMETRIC DIVISION; SUMO; SUMOYLATION; CONJUGATION; MODIFIER; TRANSFORMATION; ASSOCIATION; ARABIDOPSIS; REGULATOR; MECHANISM; (1)
ASYMMETRIC HYDROGENATION; COORDINATION CHEMISTRY; SILYLATIVE REDUCTION; HYDROBORATION; HYDROSILYLATION; COMPLEXES; 1,2-DIHYDROPYRIDINES; 1,4-HYDROBORATION; DEAROMATIZATION; REACTIVITY; Chelates; Hydroboration; Phosphites; Reaction mechanisms; Rhodium (1)
ASYMMETRIC HYDROGENATION; DIPHOSPHINE LIGANDS; CATALYSIS; EFFICIENT; COMPLEXES; BINAP; FUNCTIONALITIES; ARPROMIDINE; REDUCTION; OLEFINS; (1)
ASYMMETRIC HYDROGENATION; OXIME ETHERS; COMPLEXES; HYDROLYSIS; catalysis; hydrogenation (stereoselective); folic acid (1)
ASYMMETRIC HYDROGENATION; PHOTOREDOX CATALYSIS; ISOQUINOLINIUM SALTS; SECONDARY; EFFICIENT; ORGANOCATALYSIS; PHOTOCATALYSIS; ANTHRAQUINONES; BENZYLAMINES; DERIVATIVES; photocatalysis; aerobic oxidation; imines; heterocycles; super acids (1)
asymmetric information, credit rationing (1)
Asymmetric information, credit rationing, credit risk, portfolio risk, risk aversion, underinvestment, overinvestment, offshoring, unemployment, North-South trade, union wage setting, bargaining power (1)
Asymmetric Information, enforcement problems, equilibrium credit rationing, aggregate risk, group lending, social sanctions, social returns, portfolio choice, separation properties (1)
Asymmetric information, Financial markets, Green loans, Hidden information, Hidden action, Project risk (1)
ASYMMETRIC MICHAEL ADDITION; BIFUNCTIONAL ORGANOCATALYSTS; PYRROLIDINE-THIOUREA; NITROOLEFINS; NITROSTYRENE; NITROALKENES; ALDEHYDES; Organocatalysis; Enantioselectivity; Conjugate addition; Amines (1)
ASYMMETRIC MICHAEL ADDITION; OXAZOLINE COPPER-COMPLEXES; FRIEDEL-CRAFTS REACTION; BIS(OXAZOLINE) LIGANDS; ENANTIOSELECTIVE CATALYSIS; ELECTROSTATIC INTERACTIONS; BENZYLIDENE MALONATE; CYCLOPROPANATION; INDOLES; EFFICIENCY; (1)
ASYMMETRIC MICHAEL ADDITION; RECOVERABLE CATALYSTS; ORGANIC CATALYSTS; SUPPORTED PROLINE; WATER; ALDEHYDES; ORGANOCATALYSIS; FUNCTIONALIZATION; NUCLEOPHILES; DERIVATIVES; (1)
ASYMMETRIC ORGANOCATALYSIS; ALDEHYDES; IMIDAZOLIDINONES; 3-HYDROXYFLAVONE; AMINOCATALYSIS; OXAZOLIDINONES; AMINATION; MECHANISM; SOLVENTS; ACIDS; aldol reaction; enamines; NMR spectroscopy; organocatalysis; proline catalysis (1)
Asymmetric oxidations, chemoselective oxidation, polymer supports, asymmetric sulfoxidation, asymmetric kinetic resolution of sec alcohols (1)
ASYMMETRIC SILICON; CRYSTAL-STRUCTURE; ALKOXYSILANES; CONVERSION; ACCESS; Aminochlorosilanes; Chirality; Interaction patterns; Silanols; Silicon (1)
ASYMMETRIC-SYNTHESIS; (1)
ASYMMETRIC TOTAL-SYNTHESIS; NITROGEN-CONTAINING HETEROCYCLES; ENANTIOSELECTIVE TOTAL SYNTHESES; AZA-PIANCATELLI REARRANGEMENT; EPOXIDE-OPENING CASCADES; RING-CLOSING METATHESIS; C-H FUNCTIONALIZATION; ACHMATOWICZ REARRANGEMENT; NATURAL-PRODUCTS; BETA-LACTAMS; (1)
ASYMMETRIC TRANSFER HYDROGENATION; 1,3-DIPOLAR CYCLOADDITION; IMINES; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; ACTIVATION; REDUCTION; MECHANISM; DESIGN; MODEL; Chiral Phosphoric Acids; Enantioselectivity; Ion Pair Catalysis; NMR; Reaction Mechanism (1)
ASYMMETRIC TRANSFER HYDROGENATION; 2-COMPONENT MOLECULAR-CRYSTAL; 2-AMINO-2'-HYDROXY-1,1'-BINAPHTHYL; 2,2'-DIAMINO-1,1'-BINAPHTHYL; 2-NAPHTHYLAMINE; TRANSFORMATION; 2-NAPHTHOL; CHLORIDE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; ALPHA,BETA-UNSATURATED CARBOXYLIC-ACIDS; LIGAND BIFUNCTIONAL CATALYSIS; DYNAMIC KINETIC RESOLUTION; PONNDORF-VERLEY REDUCTION; AROMATIC KETONES; DENDRITIC CATALYSTS; CARBONYL-COMPOUNDS; PROCHIRAL KETONES; CHIRAL LIGANDS; binaphthyl ligands; ruthenium complexes; chirality; enantioselective catalysis; hydrogen transfer (1)
ASYMMETRIC TRANSFER HYDROGENATION; CHEMICAL-EXCHANGE; MECHANISTIC TOOL; SPECTROSCOPY; MODEL; INTERMEDIATE; PREFERENCES; SELECTIVITY; DIFFUSION; MOTIONS; (1)
ASYMMETRIC TRANSFER HYDROGENATION; CHLORIDE SUBSTITUTION-REACTIONS; CYCLORUTHENATED (R)(C)-(+)-N,N-DIMETHYL-ALPHA-(2-NAPHTHYL) ETHYLAMINE; SCHIFF-BASE COMPLEXES; X-RAY STRUCTURE; CRYSTAL-STRUCTURES; STEREOCHEMISTRY; ATOM; DIASTEREOSELECTIVITY; ACETOPHENONE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; ELECTRONIC-STRUCTURE; CARBONYL-COMPLEXES; OLEFINS; DEHYDROGENATION; NANOPARTICLES; CHEMISTRY; MECHANISM; RELEVANT; KINETICS; arene complexes; cobalt; homogeneous catalysis; hydrogenations; iron (1)
ASYMMETRIC TRANSFER HYDROGENATION; EXCHANGE SATURATION-TRANSFER; PROTON CHEMICAL-EXCHANGE; THERMODYNAMIC STABILITY; MECHANISTIC TOOL; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; REDUCTION; BONDS (1)
ASYMMETRIC TRANSFER HYDROGENATION; HENRY REACTION; AMINO-ALCOHOLS; CHIRAL LIGANDS; BENZOYLATION; DESYMMETRIZATION; DERIVATIVES; DESIGN (1)
ASYMMETRIC TRANSFER HYDROGENATION; IRON CATALYSTS; REDUCTIVE AMINATION; ZINC-COMPLEXES; NON-INNOCENT; REACTIVITY; METAL; COBALT; CARBAALANES; ZIRCONIUM; aluminium; hydrides; main group metal catalysis; hydrogenation; imines (1)
ASYMMETRIC TRANSFER HYDROGENATION; MANNICH-TYPE REACTION; NONCOVALENT INTERACTIONS; CONFORMATIONAL-ANALYSIS; TRANSITION-STATES; STRECKER REACTION; MODEL SYSTEMS; NMR; ACTIVATION; DISPERSION; (1)
ASYMMETRIC TRANSFER HYDROGENATION; MANNICH-TYPE REACTION; NONCOVALENT INTERACTIONS; MULTIDIMENSIONAL NMR; SPECTROSCOPY; MOLECULES; BINDING; MODE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; TRANSFER RADICAL POLYMERIZATION; ORGANIC-SYNTHESIS; ENCAPSULATED NANOPARTICLES; SUPPORTED REAGENTS; TERMINAL ALKYNES; SOLID-PHASE; CATALYSTS; LIGANDS; NANOCAPSULES; (1)
Asymmetrische Katalyse, Bis(oxazoline), enantioselektiv, chiral asymmetric catalysis, enantioselective (1)
asymmetrischen Reaktionen, Organokatalysatoren, chiraler, chiral, asymmetric reaction, organocatalysis (1)
Asymmetrisches Dimethylarginin, ADMA, HPLC, SPE, Abdampfen, Schizophrenie, Depression, Bipolare Störung, Schizoaffektive Störung, Asymmetric dimethylarginine, Evaporation, Schizophrenia, Bipolar disorder, Schizoaffektive disorder (1)
Asymmetrische Synthese , Guaianolide , Arglabin , Sesquiterpenlactone , Tricyclische Verbindungen , , asymmetric synthesis , guaianolide , Arglabin (1)
Asymmetrische Synthese , Heterogene Katalyse , Homogene Katalyse , Metallkomplexe , Kupferkomplexe , Immobilisierung , Sternpolymere , Ligand , Azabisoxazoline , Azabisoxazolines (1)
Asymmetrische Synthese / Katalyse , Aminosäurederivate , Decarboxylierung , alpha-Fluorketone , China-Alkaloidderivate , Asymmetric catalysis , alpha-amino acid derivatives , alpha-fluoroketones , decarboxylation , cinchona alkaloid derivatives (1)
Asymmetrische Synthese / Katalyse , Enantioselektivität , Organische Synthese , stickstoffhaltige Liganden , asymmetric catalysis , chiral ligands (1)
Asymmetrische Synthese / Katalyse , Katalyse , Immobilisierung , Polymergebundener Stoff , asymmetrische Aktivierung , immobilisierte Liganden , asymmetric Activation , immobilized Aza-bis(oxazolines) , asymmetric catalysis (1)
Asymmetrische Synthese / Katalyse , Rutheniumkomplexe , Imine , Binaphthyle , , enantioselective catalysis , ruthenium complex , 1,1´-binaphthyl (1)
Asymmetrische Synthese , Swainsonin , Aminosäuren <gamma-> , Polyole , Schädlingsbekämpfungsmittel , Chemische Synthese , Cytostatikum , Lentiginosin , Zwittermicin A , swainsonine , lentiginosine , zwittermicin A (1)
ASYMMETRY; AUGMENTATION; VOLUME; Three-dimensional imaging; Breast reconstruction; Breast symmetry; Digital anthropometry (1)
ASYMPTOMATIC CAROTID ATHEROSCLEROSIS; DENSITY-LIPOPROTEIN CHOLESTEROL; HUMAN-PLASMA; MEDIA THICKNESS; SERUM LYCOPENE; HEART-DISEASE; ANIMAL-MODEL; CAROTENOIDS; RISK; ANTIOXIDANTS; (1)
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; MULTINODULAR GOITER; NONTOXIC GOITER; NODULAR GOITER; SURGERY; THERAPY; DISEASE; BENIGN; HYPOCALCEMIA; RECURRENCE; thyroid surgery; parathyroid resection; goiter prophylaxis; thyroid cancer; hypoparathyroidism (1)
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; PREOPERATIVE LOCALIZATION; PARATHYROID ADENOMAS; SURGICAL-TREATMENT; SURGERY; THERAPY; ASSAY; (1)
ASYMPTOTIC-BEHAVIOR; ANOMALOUS-DIMENSIONS; EXCLUSIVE PROCESSES; WAVE-FUNCTION; OPERATORS; DECAYS; HARD; SOFT; (1)
ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; ALGORITHM; CURRENTS; ORDER (1)
ASYNCHRONY; ARDS; (1)
AT1-Rezeptoren, Angiotensin II, Niere, FoxD1-Stromazellen, Renin, RAAS (1)
AT(2) RECEPTOR PROTEIN; IN-SITU HYBRIDIZATION; RAT PROXIMAL TUBULE; II-RECEPTOR; CONVERTING-ENZYME; MESSENGER-RNA; GENE-EXPRESSION; TYPE-2 RECEPTOR; LOCALIZATION; AT(1); Angiotensinogen; angiotensin; glomerulus; microdissection; mRNA; receptor; renin; RT-PCR; tubulus (1)
AT; ATM; breast cancer; ataxia telangiectasia mutated; risk; variant (1)
Ataxia-Telangiectasia, Breast Cancer; c.7271T>G, Ionizing Radiation (1)
ATAXIA-TELANGIECTASIA; EARLY-ONSET; MISSENSE MUTATIONS; FAMILY REGISTRY; OVARIAN-CANCER; BRCA1; SUSCEPTIBILITY; EXPRESSION; PREDICTION; SEQUENCE; (1)
ATAXIA-TELANGIECTASIA GENE; RESOLUTION MELTING ANALYSIS; AFFECT PROTEIN FUNCTION; EARLY-ONSET; ALLELIC VARIANTS; FAMILIAL BREAST; TRUNCATING MUTATIONS; DNA-DAMAGE; SUSCEPTIBILITY ALLELES; GERMLINE MUTATIONS; (1)
ATAXIA-TELANGIECTASIA HETEROZYGOTES; SEQUENCE VARIANTS; PROTEIN FUNCTION; DNA-DAMAGE; RISK; MISSENSE; CARRIERS; FAMILIES; BRCA1; SUSCEPTIBILITY; (1)
Atemschutzmasken, Chirurgischer Mund-Nasenschutz, FFP2-Masken, FFP3-Masken mit Ausatemventil, Interstitielle Lungenerkrankung, Sechs Minuten-Gehtest, Belastbarkeit, Blutgasparameter, Face masks, surgical mask, FFP2-mask, valved FFP3-mask, interstitial lung disease, exercise, Bloodgas analysis parameters (1)
atezolizumab; BCLC B; bevacizumab; hepatocellular carcinoma; immunotherapy; liver cancer; PD-L1; transarterial chemoembolization; VEGF (1)
ATHEROSCLEROTIC RENOVASCULAR DISEASE; TRANS-LUMINAL ANGIOPLASTY; TERM FOLLOW-UP; FIBROMUSCULAR DYSPLASIA; PLACEMENT; HYPERTENSION; LESIONS; arteriosclerosis; renal arteries; stents (1)
ATHEROSCLEROTIC ULCERS; NATURAL-HISTORY; endovascular aortic repair; balloon-expandable stent-grafts; penetrating aortic ulcer; atherosclerosis; off-label (1)
ATHEROSCLEROTIC VASCULAR-DISEASE; PARTIAL RECORDING PROTOCOLS; PERIODONTAL-DISEASE; ASSOCIATION; Epidemiology; Cohort study; Dentistry; German National Cohort (GNC) (1)
ATHEROTHROMBOTIC STROKE; ALOX5AP; POLYMORPHISMS; ASSOCIATION; POPULATION; CHINESE; RISK; (1)
ATIYAH-SINGER INDEX; SUPERSYMMETRY; COHOMOLOGY; FORMULAS; HOMOLOGY; THEOREM; Atiyah-Singer index theorem; Localization on loop space; Chern character (1)
Atlanta-axiale Rotationssubluxation; Manuelle Therapie; AARS; AARS im Kindesalter (1)
ATLANTIC COAST; UNITED-STATES; PACIFIC CRAB; GRAPSIDAE; DECAPODA; CRUSTACEA; HABITAT; POPULATION; DISPERSAL; AMERICA; Crustacea; human-mediated introduction; invasion; Adriatic Sea; Istra (1)
ATLANTIC-MEDITERRANEAN TRANSITION; PACHYGRAPSUS-MARMORATUS DECAPODA; LOBSTER PALINURUS-ELEPHAS; BLACK-SEA; MEGANYCTIPHANES-NORVEGICA; INTEGRATED SOFTWARE; STATISTICAL TESTS; DIFFERENTIATION; NEUTRALITY; SEQUENCES; Phylogeography; Larval dispersal; Mediterranean Sea; Crustacea Brachyura; mtDNA CoxI (1)
atlantic salmon; prior residence; territoriality; aggression; life-history strategies (1)
ATLANTIC SALMON; PROTEINS; Antibodies; Challenge; Immunology; Infection; Lumpsucker; Pasteurellosis; Pathology; Vaccination (1)
ATLANTIS-II; KEBRIT DEEP; CULTIVATION; SEQUENCES; SEDIMENTS; DISCOVERY; GROWTH; brine; moderately halophilic; piezotolerant; Red Sea; Salinisphaera; Salinisphaera shabanensis; Shaban Deep (1)
ATMOSPHERIC-PRESSURE PLASMA; BARRIER DISCHARGE PLASMA; RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; CONTACT-FREE INACTIVATION; COLD-PLASMA; ESCHERICHIA-COLI; ARGON PLASMA; NONTHERMAL PLASMA; HACAT-KERATINOCYTES; Wound healing; Mechanisms of action; Medics; Physicists; Biologists (1)
ATMOSPHERIC-PRESSURE PLASMA; RESISTANT STAPHYLOCOCCUS-AUREUS; DIELECTRIC BARRIER DISCHARGE; FULL-FACIAL REJUVENATION; STERILIZATION; COAGULATION; BACTERIA; CELLS; AIR; plasma medicine; plasma; cold atmospheric plasma; microbiology; chronic wounds; sterilization; disinfection (1)
Atmung , Fluoreszenz , Sauerstoffsensor , Toxizitätstest , Wasserstoffionenkonzentration , Chemischer Sensor , Pseudomonas putida , Mikrotiter-Platte , pH-Sensor , Atmungshemmtest , Toxikologische Tests , respirometry , pH sensor , oxygen sensor , fluorescence , Pseudomonas putida (1)
atomare Auflösung an Luft, Weltneuheit, qPlus Sensor, Rasterkraftmikroskopie, AFM, atomic force microscope, Calcit, Kaliumbromid, Graphen, potassium bromid, calcite, HOPG, Moleküladsorbatfilme, Hochauflösung, atomic resolution, growth and desolution processes (1)
ATOM FORCE-FIELD; AQUEOUS-SOLUTION; BASE PROPERTY; DYNAMICS; NEUTRALIZATION; SIMULATIONS; SOLVATION; MECHANISM; BEAMLINE; BL04B2; (1)
ATOMIC-ABSORPTION; VALIDATION; SOLVATOCHROMISM; GATIFLOXACIN; ANTIBIOTICS; EFFICACY; PROBES; probes; lanthanide complexes; moxifloxacin HCl; luminescence; fluorescence; HPLC (1)
ATOMICALLY THIN SEMICONDUCTOR; MONOLAYER WSE2; INTERLAYER EXCITONS; MOS2; GENERATION; EMITTERS; FIELDS; LAYER; (1)
atomically thin solids, van der Waals magnets, anisotropic excitons, ultrafast dynamics, femtosecond near-field microscopy, terahertz (1)
atomic force microscope; atomic orbitals (1)
ATOMIC-FORCE MICROSCOPE; DNA; BIOSILICA; ACID; (1)
Atomic force microscope; Nanostructures; Lithography (1)
ATOMIC-FORCE MICROSCOPE; SCANNING-TUNNELING-MICROSCOPE; QUANTUM HALL REGIME; COULOMB-BLOCKADE OSCILLATIONS; POINT CONTACTS; CONDUCTANCE; DOT; TRANSPORT; FABRICATION; SPECTRUM; atomic force lithography; semiconductor nanostructures; 2DEG (1)
Atomic force microscope; Semiconductor nanostructures; Nanolithography (1)
ATOMIC-FORCE MICROSCOPY; ADSORPTION; RESOLUTION; SURFACE; CO; MOLECULE; ENERGY; ORDER; (1)
atomic force microscopy, AFM, cluster, Fe on Cu(111), subatomic resolution, lateral manipulation, instrumentation, COFI, tip termination, CO-terminated tip (1)
atomic force microscopy (AFM); conformational dynamics; dynamic/static heterogeneity; Förster resonance energy transfer (FRET); fluorescence spectroscopy; single molecules; super-resolution microscopy (1)
ATOMIC-FORCE MICROSCOPY; ALKALI-HALIDE SURFACES; WATER; GROWTH; ambient conditions; atomic force microscopy; material transport; relative humidity (1)
ATOMIC-FORCE MICROSCOPY; CAPSULAR CONTRACTURE; BREAST IMPLANT; AUGMENTATION RHINOPLASTY; STREPTOCOCCUS-SANGUIS; SUBCLINICAL INFECTION; SURFACE MODIFICATION; ANTIBACTERIAL; COLONIZATION; ADHESION; silicone implants; copper additives; Staphyolcoccus epidermidis; implant infection; capsular contracture; antibacterial effect (1)
ATOMIC-FORCE MICROSCOPY; CONSISTENT ELECTRONIC-STRUCTURE; TUNNELING MICROSCOPE; SURFACE-STATES; WORK FUNCTION; CO MOLECULES; IDENTIFICATION; ANISOTROPY; FILMS; (1)
atomic force microscopy; crystal faces; force sensors; image resolution; nickel compounds; specimen preparation (1)
ATOMIC-FORCE MICROSCOPY; DETERGENT-RESISTANT MEMBRANES; CONDENSED COMPLEXES; MODEL MEMBRANES; GANGLIOSIDE GM1; RAFT FORMATION; CHOLESTEROL; BILAYERS; PHOSPHATIDYLCHOLINE; CEREBROSIDES; (1)
Atomic force microscopy; Frequency modulation atomic force microscopy; Dynamic force microscopy; Atomic resolution; Tip–sample interaction; Dissipation; Thermal noise; APN (1)
ATOMIC-FORCE MICROSCOPY; FUNCTIONAL CORE/SHELL NANOPARTICLES; GLASSY-CARBON ELECTRODES; POLYELECTROLYTE MULTILAYERS; GOLD NANOPARTICLES; PROTEIN ADSORPTION; SIRNA DELIVERY; WEAK POLYELECTROLYTES; FILM ELECTRODES; CHARGE-REVERSAL; Layer-by-layer; planar surface; AFM; nanoparticle; protein adsorption; cell association (1)
ATOMIC-FORCE MICROSCOPY; GRAPHENE NANORIBBON HETEROJUNCTIONS; SCANNING PROBE MICROSCOPY; C-H ACTIVATION; CHEMICAL-STRUCTURE; COUPLING REACTIONS; CRYSTAL-STRUCTURES; REDOX PROPERTIES; SCHOLL REACTION; BAND-GAP; (1)
ATOMIC-FORCE MICROSCOPY; HIGH-RESOLUTION; RESPIRATORY ACTIVITY; ACTIVE SURFACES; MODEL NEURONS; HELA-CELLS; PROBES; FABRICATION; SECM; MICROELECTRODES; (1)
ATOMIC-FORCE MICROSCOPY; HUMAN ACHILLES-TENDON; STEM/PROGENITOR CELLS; SKELETAL-MUSCLE; CHONDROMODULIN-I; BIOMECHANICAL PROPERTIES; PERIODONTAL-LIGAMENT; ELASTIC PROPERTIES; CONNECTIVE-TISSUE; STEM-CELLS; Tendons; Tenomodulin; Knockout mouse model; Running tests; Atomic force microscopy; Collagen I crosslinking (1)
Atomic force microscopy; Intermittent contact; Tapping mode (1)
atomic force microscopy, lateral force microscopy, density functional theory, in-plane interactions (1)
atomic force microscopy; lateral force microscopy; molecular switch; copper phthalocyanine; molecular manipulation; frustrated rotation (1)
ATOMIC-FORCE MICROSCOPY; LIPID-BILAYERS; FLUID MEMBRANES; MECHANICS; TENSION; BIOMEMBRANES; SPECTROSCOPY; DEFORMATION; ALDOSTERONE; TENSEGRITY; atomic force microscopy; bending rigidity; epithelial cells; indentation; lateral tension (1)
ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; SURFACES; MORPHOLOGY; RESONATORS; TOPOGRAPHY; MEMBRANES; STIFFNESS; Porous silicon; cell adhesion; force spectroscopy; indentation (1)
atomic force microscopy | N-Heterocyclic carbenes | on-surface characterization | scanning tunneling microscopy | ultrathin insulating films (1)
atomic force microscopy, on-surface synthesis, cyclo[18]carbon, scanning tunneling microscopy-induced luminescence, Rasterkraftmikroskopie, Oberflächengestützte Synthese, Cyclo[18]carbon, Rastertunnelmikroskopie-induzierte Lumineszenz (1)
ATOMIC-FORCE MICROSCOPY; OPPOSITELY CHARGED SURFACTANTS; ANIONIC SURFACTANT; CATIONIC POLYMER; CELLULOSE; SYSTEMS; POLYELECTROLYTE; LAYERS; VISCOELASTICITY; NONEQUILIBRIUM; (1)
ATOMIC-FORCE MICROSCOPY; PI-CONJUGATED MOLECULES; SINGLE-MOLECULE; ELECTRONIC-STRUCTURE; WORK FUNCTION; CHARGE-STATE; OLIGOTHIOPHENE; INTERFERENCE; CONDUCTANCE; WIRES; (1)
ATOMIC-FORCE MICROSCOPY; QUANTUM-DOT; LOGIC GATE; CELL; LOCALIZATION; FLOW; Quantum cellular automata; single molecule; self-assembly; scanning tunneling microscopy; density-functional theory (1)
ATOMIC-FORCE MICROSCOPY; QUARTZ TUNING FORK; RESOLUTION; DISTANCE; SENSOR; (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; DISSIPATION; SURFACE; MODE (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; SURFACE; (1)
atomic force microscopy, scanning probe microscopy, lateral force microscopy, surface science (1)
ATOMIC-FORCE MICROSCOPY; SCANNING TUNNELING MICROSCOPE; BUILDING-BLOCKS; BOND FORMATION; CHARGE-STATE; SURFACE; RESOLUTION; ADATOMS; WIRES; FILMS; (1)
atomic force microscopy, scanning tunneling microscopy, single electron charging, single molecule, on-surface chemistry (1)
atomic force microscopy, scanning tunneling microsocpy, scanning probe microsocpy, qPlus sensor, needle sensor, signal-to-noise ratio, subatomic resolution, spin resolution, exchange interaction, topological insulator (1)
ATOMIC-FORCE MICROSCOPY; SENSOR; SURFACE; (1)
atomic force microscopy, single-electron charging, dissipation, self-assembly, Rasterkraftmikroskopie, Einzelelektronenladen, Dämpfung, molekulare Selbstassemblierung (1)
ATOMIC-FORCE MICROSCOPY; SINGLE; JUNCTION; Molecules; charge state; control; intramolecular; contrast; STM (1)
Atomic Force Microscopy, Single molecules, Electron Spin Resonance, Excited states, Spectroscopy (1)
Atomic force microscopy, Solid-liquid interfaces, Water (1)
atomic force microscopy; sub–Angstrom spatial resolution; higher harmonics; qPlus sensor (1)
ATOMIC-FORCE MICROSCOPY; SUPPORTED LIPID-BILAYERS; QUARTZ TUNING FORK; OPTICAL MICROSCOPY; AMBIENT CONDITIONS; CHEMICAL-ANALYSIS; MODULATION; RESOLUTION; LIQUID; SPECTROSCOPY; (1)
ATOMIC-FORCE MICROSCOPY; TUNNELING MICROSCOPE; CHARGE-STATE; VIBRATIONAL SPECTROSCOPY; CHEMICAL-STRUCTURE; FREQUENCY-SHIFTS; BOND FORMATION; RESOLUTION; SURFACE; MANIPULATION; (1)
ATOMIC-FORCE MICROSCOPY; WORK FUNCTION; TIP; SPECTROSCOPY; GAAS; METALS; STATES; (1)
ATOMIC-RESOLUTION; FORCE; FRICTION; MOLECULE; MICROSCOPY; SURFACE; (1)
ATOMIC-RESOLUTION; FRICTION; SHIFTS; TIP; atomic force microscopy; lateral force microscopy; Pt(111); frequency-modulation lateral force microscopy (FM-LFM); force deconvolution (1)
ATOMIC-RESOLUTION; MAGNETIC-MOMENTS; SURFACE; NIO(100); IMAGES; TIP; (1)
ATOMIC-RESOLUTION STRUCTURE; NMR-SPECTROSCOPY; AMINO-ACIDS; PROTEIN; ILLUMINATION; RELAXATION; DISEASE; SWITCH; photo-CIDNP; NMR spectroscopy; in situ illumination; LytA-derived peptide; tyrosine side chains; molecular motion; conformational transition (1)
Atomic spectra, Helium, Autoionization, Resonances, Two-electron atoms, Spectral methods (1)
atomic vibrations; local phonon density; root mean displacement (1)
ATOM-PROBE; LOCAL MAGNIFICATION; TIP SHAPE; RECONSTRUCTION; EVAPORATION; EVOLUTION; (1)
ATOMS; GAS; (1)
ATOPIC-DERMATITIS; (1)
ATOPIC-DERMATITIS; CHRONIC ITCH; T-CELLS; SKIN; MEDICINE; INFLAMMATION; STIMULATION; IRRADIATION; DERMATOLOGY; MECHANISMS; (1)
ATOPIC-DERMATITIS; DISEASE SEVERITY; GENERAL HEALTH; RATED HEALTH; DISCORDANCE; CARPE; GENDER; ADULTS; PAIN; SEX; concordance; self-reported health; hand eczema (1)
ATOPIC-DERMATITIS; DRUG; PATHOGENESIS; cutaneous side-effects; beta-receptor blockers; erosive lichen planus; FK506; tacrolimus (1)
atopic dermatitis, eczema, measurement properties, patient‐reported outcome measures, quality of life (1)
ATOPIC-DERMATITIS; GROWTH-FACTOR; FIBROBLAST PROLIFERATION; RHEUMATOID-ARTHRITIS; ITCH; NEUROPEPTIDES; INFLAMMATION; CELLS; MECHANISMS; EXPRESSION; Itch; NGF; Hyperinnervation; Atopic dermatitis; Nerve fibers (1)
ATOPIC-DERMATITIS; HEALTH INTERVIEW; 25-HYDROXYVITAMIN D; D DEFICIENCY; KIGGS; PREVALENCE; ALLERGY; DISEASES; atopy; eczema; epidemiology; vitamin D (1)
ATOPIC-DERMATITIS; INTERNATIONAL CONSENSUS; OUTCOME MEASURES; CLINICAL-TRIALS; ECZEMA; GUIDELINES; QUALITY; SYSTEM; COSMIN; AREA; Validity; Reliability; Sensitivity to change; Measurement instrument; Questionnaires (1)
ATOPIC-DERMATITIS; MANAGEMENT; GUIDELINES; (1)
ATOPIC-DERMATITIS; OUTCOME MEASURES; SKIN DISEASES; METHODOLOGICAL QUALITY; GERMAN INSTRUMENT; DERMATOLOGY; HEALTH; PSORIASIS; INDEX; VALIDATION; core outcome set; eczema; Harmonising Outcome Measures for Eczema initiative; measurement properties; quality of life (1)
ATOPIC-DERMATITIS SEVERITY; CONSENSUS; QUALITY; SCORAD; DELPHI; SIGNS; SETS; (1)
Atopische Dermatitis, Erkrankungsdauer, SCORAD, systemische Therapie (1)
ATOPY; RISK; DIVERSITY; BACTERIA; SUSCEPTIBILITY; POLYMORPHISMS; COLONIZATION; ENVIRONMENTS; ASSOCIATION; VARIANTS; (1)
ATP, amyloid beta aggregation, molecular dynamics simulations (1)
ATP-BINDING-CASSETTE; DENSITY-LIPOPROTEIN CHOLESTEROL; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; TANGIER-DISEASE PATIENTS; APOLIPOPROTEIN-A-I; CELLULAR CHOLESTEROL; SCAVENGER RECEPTOR; P-GLYCOPROTEIN; COMBINED HYPERLIPIDEMIA; (1)
ATP-BINDING CASSETTE; INDUCIBLE FACTOR-I; TRANSPORTER A1; KNOCKOUT MICE; TANGIER-DISEASE; FACTOR 1-ALPHA; APOA-I; PATHWAY; GENE; ATHEROSCLEROSIS; ABCA1; Hypoxia; HIF-1; Macrophages; Atherosclerosis; Cholesterol efflux (1)
ATP-BINDING-CASSETTE; LIVER-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; RETINOIC ACID RECEPTORS; FOAM-CELL-FORMATION; HYPOXIA-INDUCIBLE FACTOR-1; UNSATURATED FATTY-ACIDS; ATHEROSCLEROTIC LESION DEVELOPMENT; ABCA1; ABCG1; lipid transport; nuclear receptor; sterol regulatory element binding protein; oxysterols; retinoid; ZNF202 (1)
ATP-BINDING CASSETTE; PROSTAGLANDIN-D-SYNTHASE; DISEASE GENE ABCR; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; STEROL-DEPENDENT REGULATION; RNA TISSUE DISTRIBUTION; APOLIPOPROTEIN-D; TANGIER-DISEASE; MOLECULAR-CLONING; ABC transporter; ABCA2; macrophage; cholesterol; neural lipid transport; neuropathy; myelination (1)
ATP-BINDING CASSETTE; TANGIER-DISEASE; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; TRANSPORTER ABCA7; FACTOR-I; IDENTIFICATION; ORGANIZATION; EXPRESSION; MUTATIONS; (1)
ATP-CITRATE LYASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GROWTH; ASSOCIATION; METABOLISM; STEATOSIS; PROMOTER; GENOME; GENE; (1)
ATRA reaction · Copper(II) ·Difunctionalization · Homogenous catalysis · Photocatalysis (1)
Atrazine mercapturate; Enzyme-linked immunosorbent assay (ELISA); Solid phase extraction (SPE); Online solid phase extraction; Liquid chromatography–mass spectrometry (LC–MS); Human biomonitoring (1)
Atrial arrhythmias; TASK-1; Antiarrhythmic therapies; Human atrium; K2P3.1; Doxapram (1)
ATRIAL-FIBRILLATION; BALLOON; atrial fibrillation; pulmonary vein isolation; high-power short-duration; laser balloon; adenosine (1)
atrial fibrillation; broken heart syndrome; outcome; Takotsubo syndrome (1)
atrial fibrillation, Ca²⁺/calmodulin-dependent protein kinase II, CaMKII, SR Ca²⁺ leak, Ca²⁺ sparks, ryanodine receptor, RyR2 (1)
atrial fibrillation; calcium-calmodulin-dependent protein kinase type 2; excitation contraction coupling; heart failure; oxidative stress (1)
ATRIAL-FIBRILLATION; CARDIOVASCULAR EVENTS; CRYPTOGENIC STROKE; HEART-FAILURE; PREVALENCE; CARDIOPATHY; PREVENTION; OUTCOMES; CAMKII; IMPACT; acute myocardial infarction; p wave terminal force; central sleep apnea; sleep-disordered breathing (1)
ATRIAL-FIBRILLATION; CATHETER ABLATION; BALLOON CATHETER; FOLLOW-UP; RECURRENCE; EXPERIENCE; POINT; Atrial fibrillation; Ablation; Laser; Endoscopic visualization; Adenosine; Reconnection (1)
ATRIAL-FIBRILLATION; CATHETER ABLATION; HEART-FAILURE; Arrhythmia-induced cardiomyopathy; Tachymyopathy; Heart failure; Tachycardia (1)
Atrial fibrillation; Chronic obstructive pulmonary disease; Spirometry; Hyperinflation; Hypoxia (1)
Atrial fibrillation, epicardial ablation, HIFU (1)
ATRIAL-FIBRILLATION; PREVENTION; FIND-AF(RANDOMISED); POPULATION; Stroke; Atrial fibrillation; Electrocardiographic monitoring; Randomized controlled trial (1)
Atrial fibrillation, Pulmonary vein isolation, PVAC (1)
atrial fibrillation; tachymyopathy; heart failure; left ventricular dysfunction; rhythm control; cardiac MRI; late gadolinium enhancement (1)
ATRIAL SEPTAL OCCLUDER; PERCUTANEOUS RETRIEVAL; FOREIGN-BODIES; VENOUS CATHETERIZATION; PULMONARY-ARTERY; SURGICAL REMOVAL; ACCESS SYSTEMS; COMPLICATIONS; EXPERIENCE; PORT; angiography; interventional procedures; safety; technical aspects (1)
AT-RISK; PSYCHOLOGICAL CHARACTERISTICS; TALENT DEVELOPMENT; YOUTH; CHILDREN; BENEFITS; ADOLESCENTS; PERFORMANCE; PROGRAMS; OUTCOMES; mentoring; mentoring paradox; regulation; space of possibilities; actiotope (1)
ATROPHIC ACNE SCARS; PULSED DYE-LASER; CO2-LASER TREATMENT; CONTROLLED-TRIAL; CO2; Ablative fractional laser resurfacing; skin graft; cosmetic outcome; scar; scar reduction (1)
ATTACHMENTS; (1)
ATTENTIONAL BIAS; BEHAVIORAL-INHIBITION; P300; PREVALENCE; RESPONSES; CHILDREN; IMPULSIVITY; SENSITIVITY; ADIPOSITY; DISORDER; loss of control eating; adolescents; event-related potentials; P3; Go; NoGo task; visual food stimuli (1)
ATTENTIONAL BIAS; BRAIN; PATTERNS; EMOTION; CORTEX; FMRI; GEOMETRY; STIMULI; SPACE; TRAIT; fMRI; individual differences; multivariate pattern analysis; precision psychiatry; representational similarity analysis; task-based imaging (1)
ATTENTIONAL BLINK; STIMULI; SEARCH; RSVP; IDENTIFICATION; INFORMATION; OFFENDERS; EMOTION; PATTERN; TARGETS; Attention-based measurement; rapid serial visual presentation; sexual preference; pop out effect; attentional blink (1)
ATTENTIONAL LOAD; SELECTIVE ATTENTION; MODULATES RESPONSES; MECHANISMS; CORTEX; COMPETITION; PERCEPTION; MOTION; Attentional control; Retinotopic mapping; Target enhancement; Distractor suppression; Perceptual load (1)
ATTENTION AWARENESS SCALE; SHORT-TERM MEDITATION; COGNITIVE THERAPY; STRESS REDUCTION; KENTUCKY INVENTORY; EMOTION REGULATION; IMMUNE FUNCTION; RESPONSE THEORY; SELF-REPORT; VALIDATION; Mindfulness; Measurement; Assessment; Review; Questionnaire (1)
ATTENTION; CHILDREN; DISORDER; handwriting; ADHD; hyperactivity; kinematic aspects; qualitative aspects (1)
attention deficit/hyperactivity disorder children; brain monoamines; cortical inhibition; rapid eye movement sleep; ultradian cycling (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHRONIC PLACENTAL INSUFFICIENCY; DEFICIT HYPERACTIVITY DISORDER; EFFORTFUL CONTROL; BIRTH-WEIGHT; RESPONSE-INHIBITION; NEURAL BASIS; COGNITIVE CONTROL; DEVELOPMENTAL PSYCHOPATHOLOGY; EXTERNALIZING PROBLEMS; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DANGEROUS SPORTS; PARTICIPATION; HEALTH; BEHAVIOR; ACHIEVEMENT; PERCEPTIONS; SCALE; birth order; extreme sports; personality; risk perception; risk-taking (1)
ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; CENTRAL NICOTINIC RECEPTORS; ANIMAL-MODEL; COGNITIVE IMPAIRMENT; WORKING-MEMORY; WISTAR-KYOTO; PERFORMANCE; AMPHETAMINE; DOPAMINE; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-ENERGETIC MODEL; LARGE MULTICENTER ADHD; FAMILY RISK ANALYSIS; DELAY AVERSION; SELF-REGULATION; RESPONSE-INHIBITION; DIAGNOSTIC-APPROACH; CRITERION VALIDITY; ADHD; neuropsychological performance; emotional lability; executive functions; delay aversion (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MAGNESIUM STATUS; CHILDREN; SUPPLEMENTATION; INTERVENTION; ASSOCIATIONS; METAANALYSIS; ADOLESCENTS; BEHAVIOR; ADHD; Management; Nutrition; Micronutrients; Minerals; Magnesium; Iron; Zinc; Vitamins; Vitamin D; Probiotics; Dietary patterns; Mediterranean diet; DASH diet; Few-foods diet; Oligoantigenic diet; Elimination diet; Lifestyle (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PERFORMANCE-BASED MEASURES; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; PROSPECTIVE MEMORY; EF TESTS; CHILDREN; METHYLPHENIDATE; QUESTIONNAIRE; adult ADHD; assessment; cognition; complaints; neuropsychological testing (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; RELIABLE DIGIT SPAN; SYMPTOM EXAGGERATION; NEUROPSYCHOLOGICAL ASSESSMENT; COLLEGE-STUDENTS; DIFFICULTIES; METAANALYSIS; SAMPLE; MISUSE; adult ADHD; noncredible; performance validity; feigning; faking (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; WORKING-MEMORY; INHIBITORY CONTROL; CONTROLLED-TRIAL; ADOLESCENTS; COORDINATION; MEDICATION; ADHD; Physical activity; Beneficial effects; Executive functions (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; WORKING-MEMORY; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; CHILDREN; PERFORMANCE; INHIBITION; COGNITION; EFFICACY; Adult ADHD; cognition; memory; methylphenidate; treatment (1)
attention-deficit/hyperactivity disorder, micronutrients, diet, lifestyle, treatment (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEAR-INFRARED SPECTROSCOPY; DEFICIT-HYPERACTIVITY DISORDER; ODOR DISCRIMINATION; ADULT NEUROGENESIS; PARKINSONS-DISEASE; VERBAL FLUENCY; ACTIVATION; DOPAMINE; CORTEX; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEAR-INFRARED SPECTROSCOPY; DEFICIT HYPERACTIVITY DISORDER; STOP-SIGNAL; METAANALYSIS; PERFORMANCE; IMPULSIVITY; CHILDREN; VALIDITY; MOTOR; ADHD; n-back; stop signal; near-infrared spectroscopy; impulsivity (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEURODEGENERATIVE DISEASE; ADULT NEUROGENESIS; BULIMIA-NERVOSA; DOPAMINE; DYSFUNCTION; MECHANISMS; DEFICITS; BULB; IDENTIFICATION; Anorexia nervosa; Olfaction; Medication; Co-morbidity (1)
ATTENTION DEFICIT/HYPERACTIVITY DISORDER; POLYUNSATURATED FATTY-ACIDS; PREFRONTAL CORTEX; SPATIAL MEMORY; SUPPLEMENTATION; IMPULSIVITY; CHILDREN; DEFICITS; DIETS; Omega-3 fatty acids; Sugar; Working memory; Cognition; Rat (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REACTIVE ATTACHMENT DISORDER; DEVELOPMENTAL CONTINUITIES; CLINICAL PRESENTATION; ROMANIAN ADOPTEES; EFFORTFUL CONTROL; LATE ADOLESCENCE; EGO RESILIENCY; CHILDREN; DEPRIVATION; Reactive Attachment Disorder; ADHD; middle childhood; personality; ego-resiliency (1)
Attention deficit hyperactivity disorder; Therapy; Complementary and alternative medical therapies; Yoga (1)
attention; executive functions; humans; norepinephrine; prefrontal cortex (1)
ATTENUATES VASCULAR CONTRACTION; ESTROGEN-RECEPTOR; PLASMA-MEMBRANE; ESTRADIOL; ALPHA; GPR30; ENDOTHELIUM; ARTERIES; BETA; INHIBITION; 17 beta-Estradiol; G-protein-coupled receptor 30 (GPR30); Vasorelaxation; G1; G15 (1)
ATTITUDE; LITERACY; COMPREHENSION; POLARIZATION; INDIVIDUALS; REJECTION; SELECTION; SKILLS; COVID-19 pandemic; motivated reasoning; motivated science reception; numeracy (1)
ATTITUDES; EDUCATION; TEACHERS; Attitudes towards modelling; Engineering students; Mathematical modelling competency; Student independence; Teaching design (1)
Attitudes · Sustainability · Mindfulness · Heartfulness · Connectedness to Nature · Prosocialness (1)
attitudes towards integration, inclusive education, special educational needs, disabilities (1)
ATTOSECOND CONTROL; PHOTOEMISSION; TRANSPORT; CURRENTS; (1)
ATTOSECOND METROLOGY; TERAHERTZ PULSES; GENERATION; SPECTROSCOPY; SOLIDS; (1)
Attosekundenphysik; Festkörperphysik; Lichtwellenelektronik; Licht-Materie-Wechselwirkung; Vielteilchen-Korrelationen (1)
Attraktivität, Schönheit, Gesicht, Durchschnittlichkeit, Durchschnittsgesichter, Symmetrie, Asymmetrie, sexueller Dimorphismus, Maskulinität, Femininität, Kindchenschema, Durchschnittshypothese, Morphing, Composites, Chimärengesichter, Raffael-Effekt, Gesichtsprofil, Methodenartefakte, attractiveness, beauty, facial attractiveness, facial beauty, face, averageness, average faces, symmetry, asymmetry, sexual dimorphism, masculinity, femininity, babyface, babyfaceness, average hypothesis, morphing, composites, chimeric faces, distinctiveness, Raffael effect, facial profile, replication, scientific method (1)
ATTR, Amyloidose, Transthyretin, Kardiomyopathie, funktioneller Status, ATTR-CM, diastolische Herzinsuffizienz, NYHA (1)
ATTRIBUTING FALSE BELIEFS; TRACK OTHERS BELIEFS; ACTION ANTICIPATION; EXECUTIVE FUNCTION; SOCIAL-SKILLS; EYE TRACKING; MIND; DISORDER; INFANTS; ABSENCE; mentalizing; implicit Theory of Mind; autism spectrum condition; executive function; eye tracking (1)
A-TYPE PROANTHOCYANIDINS; CONDENSED TANNINS; POLYMERIC PROANTHOCYANIDINS; ABSOLUTE-CONFIGURATION; CIRCULAR-DICHROISM; STEREOCHEMISTRY; 4-ARYLFLAVAN-3-OLS; SPECTROSCOPY; CONSTITUENTS; EPHEDRA; Morella salicifolia; Myricaceae; Dioic acid glycosides; Proanthocyanidins; Ellagic acid derivatives; Hydrolysable tannins (1)
ATYPICAL ANTIPSYCHOTIC-DRUGS; PLACEBO-CONTROLLED TRIALS; ALZHEIMERS-DISEASE; DOUBLE-BLIND; RANDOMIZED-TRIAL; NATURAL-HISTORY; CLINICAL-TRIAL; HALOPERIDOL; RISPERIDONE; METAANALYSIS; dementia; antipsychotics; drug-drug interactions; comorbidity (1)
atypical fibroxanthoma; pleomorphic dermal sarcoma; dermatofibrosarcoma protuberans; Merkel cell carcinoma; Kaposi sarcoma; leiomyosarcoma (1)
atypical pulmonary arteriel hypertension specific therapy cardiovascular risk factors (1)
ATYPICAL TERATOID/RHABDOID TUMORS; CENTRAL-NERVOUS-SYSTEM; CLASSIFICATION; METHYLATION; EXPRESSION; GENES; SURROGATES; LOCATION; CHILDREN; AGE; Atypical teratoid; rhabdoid tumor; Sonic hedgehog; DNA methylation profiling; Gene expression; OLIG2; GFAP; ASCL1; Neuroradiology; Prognosis; Overall survival (1)
ATYPICAL TERATOID/RHABDOID TUMORS; PHASE-I; RADIATION SENSITIVITY; COMBINATION THERAPY; PEDIATRIC-PATIENTS; MYELOID-LEUKEMIA; CANCER-PATIENTS; CELL VACCINE; RISK-FACTORS; CHILDREN; ATRT; decitabine; malignant rhabdoid tumor; relapsed and refractory rhabdoid tumors (1)
Atypische Mykobakterien , Neutrophiler Granulozyt , G-CSF , Virulenz , Cytokine , Mycobacterium avium , , MOTT , NTM , MAC , mycobacteria , mycobacterium avium , neutrophil granulocytes , granulocytes , cytokines , phagosomal processing , killing (1)
Au(111) density functional theory • on-surface synthesis • scanning tunneling microscopy • surface chemistry • X-ray photoemission spectroscopy (1)
Auctions, Equity crowdfunding, Valuation of shares (1)
AUDIOVISUAL SPEECH-PERCEPTION; SUPERIOR TEMPORAL SULCUS; OROFACIAL MOTOR REPRESENTATION; AUDITORY-VISUAL INTERACTIONS; CHIMPANZEE PAN-TROGLODYTES; BIMODAL DIVIDED ATTENTION; MACAQUES MACACA-MULATTA; SACCADIC EYE-MOVEMENTS; OLD-WORLD MONKEYS; MULTISENSORY INTEGRATION; (1)
AUDIOVISUAL SYNCHRONY; THETA OSCILLATIONS; NETWORK OSCILLATIONS; AMYGDALA CIRCUITS; MEMORY; ENTRAINMENT; ACTIVATION; EMOTION; (1)
audit fees, biodiversity accounting, biodiversity finance, biodiversity risk, industrial ecology, sustainable development (1)
AUDITORY BRAIN-STEM; COCHLEAR-NUCLEUS; GLYCINE IMMUNOREACTIVITY; INFERIOR COLLICULUS; TRAPEZOID BODY; MEDIAL NUCLEUS; GABA IMMUNOREACTIVITY; MONGOLIAN GERBIL; FISCHER-344 RAT; RHESUS-MONKEY; binaural hearing; aging; GABA; glycine; olivary complex; sound localization (1)
AUDITORY BRAIN-STEM; FAST-SPIKING CELLS; INFERIOR COLLICULUS; HEARING-LOSS; NEUROTROPHIC FACTOR; CHLORIDE HOMEOSTASIS; ACOUSTIC STIMULATION; PARVALBUMIN NEURONS; STARTLE PARADIGM; TONIC INHIBITION; (1)
AUDITORY-BRAIN-STEM; GERBIL MERIONES-UNGUICULATUS; HAIR CELL REGENERATION; BUDGERIGARS MELOPSITTACUS-UNDULATUS; ANTEROVENTRAL COCHLEAR NUCLEUS; SENSORINEURAL HEARING-LOSS; AGE-RELATED-CHANGES; SERINUS-CANARIUS; EVOKED POTENTIALS; MONGOLIAN GERBIL; (1)
AUDITORY-CORTEX; (1)
AUDITORY-CORTEX; ANIMAL-MODELS; CONNECTIVITY; FMRI; PET; Functional brain imaging; Diagnostic imaging; Positron emission tomography computed tomography; Electroencephalography; Magnetic resonance imaging (1)
AUDITORY-CORTEX; AREA; TMS (1)
AUDITORY-CORTEX; ESTIMATING THRESHOLDS; RESIDUAL INHIBITION; EXCITABILITY; TRNS; TDCS; Tinnitus; Transcranial random noise stimulation; Acoustic stimulation; Hearing; Auditory perception; Psychoacoustics; Audiology (1)
AUDITORY-CORTEX; HUMAN BRAIN; RTMS; (1)
auditory cortex; plasticity; rTMS; voxel-based morphometry (1)
AUDITORY-CORTEX; REORGANIZATION; SUPPRESSION; RTMS; (1)
AUDITORY-EVOKED RESPONSE; PREPULSE INHIBITION; INDIVIDUAL-DIFFERENCES; EYEBLINK RESPONSE; EMOTION; ANXIETY; REFLEX; BLINK; MOOD; ATTENTION; Depression; Affective startle modulation; Ambiguity; Interpretation bias; Cognitive theory (1)
AUDITORY-NERVE FIBERS; COMODULATION MASKING RELEASE; SIGNAL DURATION; GUINEA-PIG; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; COCHLEAR NUCLEUS; PURE-TONES; CAT; THRESHOLDS; presbyacusis; psychoacoustic testing; psychometric function; simultaneous masking; response latency; comodulation masking release (1)
AUDITORY-NERVE FIBERS; OUTER HAIR-CELLS; MAMMALIAN COCHLEA; SPEECH SOUNDS; NOISE; REPRESENTATION; CHANNELS; BENEFIT; NUMBER; MODEL; Auditory perception; Speech perception; Conductive hearing loss; Sensorineural hearing loss; Retrocochlear diseases (1)
AUDITORY-NERVE FIBERS; TIME-VARYING SOUNDS; SHORT-TERM-MEMORY; MASKED INTENSITY DISCRIMINATION; MAXIMUM-LIKELIHOOD-ESTIMATION; REPEATED-MEASURES DESIGNS; OF-FIT TESTS; ROC CURVES; LOGISTIC-REGRESSION; PERCEPTUAL WEIGHTS; Dynamic loudness; Time-varying sounds; Intensity discrimination; Temporal perceptual weights; Perceptual weight analysis; Molecular psychophysics; Loudness model (1)
AUDITORY ODDBALL TASK; WORKING-MEMORY TASK; EEG-ALPHA; FREQUENCY-CHARACTERISTICS; ATTENTIONAL MODULATION; STIMULUS ONSET; RESPONSES; DYNAMICS; SYNCHRONIZATION; POWER; alpha; electroencephalogram; EEG; cognitive neuroscience; evoked model; phase synchronization (1)
AUDITORY VERBAL HALLUCINATIONS; NEURITE ORIENTATION DISPERSION; INNER SPEECH; PSYCHOTIC SYMPTOMS; SCHIZOPHRENIA; CONTINUUM; VOICES; CONNECTIVITY; NEUROANATOMY; METAANALYSIS; Hallucination; Superior temporal gyrus; LSHS; Schizophrenia; NODDI; Diffusion MRI (1)
AUDITORY-VISUAL INTERACTIONS; DIVIDED ATTENTION; EVOKED-POTENTIALS; INTEGRATION; ACTIVATION; CORTEX; RESPONSES; HUMANS; divided attention; reaction time; event-related potential; multisensory process (1)
audit reporting, FinBERT, goodwill impairment, key audit matters, natural language processing, prediction (1)
Aufbereitung; Schäden; mikrochirurgische Instrumente; Stapeschirurgie; reprocessing; damage; microsurgical devices; stapes surgery (1)
Aufgeklärter Absolutismus , Schulpolitik , Triaspolitik , Physiokraten , Reformpolitik , Einheitssteuer , Karl Friedrich <Baden, Großherzog> , Reform , Zensur in Baden , Reichs- und Territorialpolitik Badens , Kindermorddebtatte in Baden , Baden Geschichte 1750-1810 , Charles Frederick of Baden (1746-1811) , enlightened absolutism , physiocrats , reforms in Baden 1750-1810 , history of Baden (1750-1810) (1)
aufklärungspflicht; § 31 WpHG; Rechtsbehelfe; Wertpapierdienstleistungsunternehmen (1)
Aufsatzsammlung (1)
Augenbewegung , Bewegungswahrnehmung , Kleinhirn , Kognitive Psychologie , fMRT , auditiv-visuelle Bewegungswahrnehmung , kortikale Aktivierungsmuster , fMRI , audio-visual motion perception , cerebellum , eye movements , neural correlates (1)
Augenlinse, Aufbaueffekt, Hochvoltstrahlung (1)
AUGMENTATION; ULTRASOUND; Breast cancer; breast reconstruction; lightweight implants (1)
AUGMENTATION; VOLUME; MAMMAPLASTY; SHAPE; Breast augmentation; Breast implant; 3D volumetry; 3D measurement; 3D scan; Topographic shift (1)
Augmentative and Alternative Communication, Generative AI, Conversational Contexts, Automated Utterance Composition, Design Science Research (1)
Augmentative and Alternative Communication Systems, Artificial Intelligence, Conversation Phases, Conversational Contexts, Systematic Literature Review (1)
Augmented and alternative communication, Speech impairment, Tablet-PC, Open Source (1)
augmented reality; digital twin; cybersecurity; cyber-physical systems (1)
AUGMENTED REALITY; eHealth; Mobile applications; Virtual; Augmented reality; Digital logbook; eLearning (1)
Augmented Reality, Head-up Display (1)
Augmented reality; head-up display; field study; contact analogue; navigation; masking (1)
Augmented Reality, Mental Health, Cognitive Behavioural Therapy, Virtual Reality (1)
AUGMENTED REALITY; PERFORMANCE; AUDIO; SOUND; Immersive analytics; mixed reality; spatial sounds; visual analytics; hololens (1)
AUGMENTED-WAVE METHOD; BORON-NITRIDE; POINT-DEFECTS; ELECTRONIC-PROPERTIES; MOLECULAR-DYNAMICS; ROOM-TEMPERATURE; GRAPHENE; NANORIBBONS; STATES; LAYERS; (1)
AUGMENTED-WAVE METHOD; PSEUDOPOTENTIALS; SPINTRONICS; ATOMS; (1)
AUGMENTED-WAVE METHOD; SURFACE-DIFFUSION; LONG JUMPS; FORCE MICROSCOPY; (1)
AUGMENTED-WAVE METHOD; THIN-FILMS; SURFACE; ENERGY; GOLD; (1)
; Augmenter of liver regeneration; Bile acids; Cholestasis; Glycogen synthase kinase-3 beta; Anti-apoptotic signaling; Myeloid cell leukemia 1 (1)
Augmenter of liver regeneration; GFER; Isoforms; Function; Regulation; Location (1)
AUGSBURG CASE-COHORT; SUDDEN-DEATH; QT INTERVAL; HEART-RATE; ELECTROCARDIOGRAM; DESIGN; VARIANT; WOMEN; (1)
AUGUSTE-D; DISEASE; MUTATIONS; PRESENILIN-2; REDISCOVERY; (1)
AU-RICH RNA; ESCHERICHIA-COLI; MESSENGER-RNA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IN-VITRO; CRYSTAL-STRUCTURE; ZETA-CRYSTALLIN; POSTTRANSCRIPTIONAL REGULATION; ADENYLATE KINASE; CROSS-LINKING; metabolic enzymes; REM hypothesis; RNA-binding protein; prokaryotes; SELEX; unconventional RNA binding; MS2 phage; quinone oxidoreductase (1)
AURICULO-VERTEBRAL SPECTRUM; HEMIFACIAL MICROSOMIA; GOLDENHAR SYNDROME; FACIAL ASYMMETRY; 1ST; INVOLVEMENT; DYSPLASIA; FEATURES; Mandibulofacial dysostosis; Congenital abnormalities; Hemifacial microsomia; Maxillary sinus; Goldenhar syndrome (1)
Ausfallwahrscheinlichkeit , Kreditrisiko, Probability of Default , PD , Assetkorrelation , Ausfallkorrelation , Kreditrisikomanagement, Probability of Default , asset correlation , default correlation , credit risk , credit risk management (1)
Ausländerwahlrecht (1)
Auslandsgeltung, Europäisierung, Internationalisierung, Internetüberwachung, Telekommunikationsüberwachung, Rechtsweggarantie (1)
Auslautverhärtung, Lernverlaufsdiagnostik, Progress Monitoring, Rechtschreiben, Skilltest (1)
Aussagepsychologie , Visuelles Gedächtnis , Gedächtnisleistung , Gedächtnis , Episodisches Gedächtnis , Intelligenzstörung , Lernbehinderung , Jugend / Lernbehinderung , Lernbehinderter , Glaubwürdigkeit , Realitätsüberwachung , Quellendifferenzierung , Intelligenzminderung , Glaubhaftigkeitsdiagnostik , kriterienorientierte Aussageanalyse , reality monitoring , source monitoring , learning disablility , witness , CBCA (1)
Ausstrahlungseffekt, Spillover, Diversifikation, Diversifikationserfolg, Industriegüter, Fit, Kundenverhalten, Stammgeschäft, Synergie, Prognose, Strategisches Management, Spill-over effect, diversification, diversification success, industrial goods, fit, customer behavior, core business, synergy, forecasting, strategic management (1)
AUSTRALIAN ARID ZONE; BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; ECOSYSTEM SERVICES; FOOD WEBS; MANAGEMENT; RIVER; LANDSCAPES; CONNECTIVITY; PRINCIPLES; Keystone species; Keystone; Meso-filter; Ecosystem services; Biodiversity (1)
AUSTRALIAN TROPICAL SAVANNA; SIZE CLASS DISTRIBUTIONS; TIMBER FOREST PRODUCTS; BURKINA-FASO; POPULATION-STRUCTURE; WOODY-PLANTS; EVOLUTIONARY ECOLOGY; DETARIUM-MICROCARPUM; CAPTURE-RECAPTURE; MODEL SELECTION; Benin; Diameter growth; Land-cover type; Multistate capture-recapture models; Permanent plots; Population dynamics; Woody plants (1)
AUSTRIA; SCHIZOPHRENIA; DIAGNOSIS; STIGMA; FAMILY; UNIT; mother-child treatment unit; generalized anxiety disorder; treatment results (1)
Aus- und Fortbildung, Bibliotheken (1)
Authentication, Passkey, Password, FIDO2, Security, User Study, Field Study, Accounts (1)
Authentication , (RBAC) Authorisation , Ontology-Based Access Control , Ontology Trust and Privacy Modeling , Spring Security (1)
AUTHORITARIAN; CONFLICT; POWER; Occupation; policy; entrenchment; de facto states; demodernization; armed conflict; Ukraine; Russia (1)
AUTISM; GENES (1)
Autism spectrum disorder, Bipolar affective disorder, Co-occurrence, Prevalence (1)
AUTISM SPECTRUM DISORDERS; MOUSE MODELS; ULTRASONIC VOCALIZATIONS; SPATIAL MEMORY; SYSTEM; MICE; CHILDREN; IMPAIRMENTS; PERFORMANCE; INTEGRATION; Otolith; Early development; B6Ei.GL-Nox3het/J; Gravity; Vestibular system; Autism (1)
AUTISM SPECTRUM DISORDERS; PITUITARY-ADRENAL AXIS; FEMALE PRAIRIE VOLES; VASOPRESSIN RELEASE; BRAIN OXYTOCIN; PARAVENTRICULAR NUCLEUS; MEDIAL AMYGDALA; MICROTUS-OCHROGASTER; INTERMALE AGGRESSION; INTRANASAL OXYTOCIN; social preference; social interaction; social defeat; amygdala; vasopressin; anxiety (1)
Autismus; Autismusspektrumstörungen; ASS, Spielförderung; Sozialtraining; kollaborative Spiel-Intervention; Lego®; Gruppenintervention; Sozialkompetenz (1)
Autismus, Endophänotyp, Kandidatengen, exekutive Funktionen, Arbeitsgedächtnis, visuell-räumliche Leistungen, soziale Interaktion, Turm von London, Modified Card Sorting Test, Intra-Extradimensional-Shift, Zahlen nachsprechen, Spatial Working Memory, Mosaiktest, Children's Embedded Figures Test, SRS, HANES-KJ, KAT II, 5-HTTLPR, DAT1, OXTR, CNTNAP2 (1)
Autismus , Frühkindlicher Autismus , Autismus , frühes Erwachsenenalter , Ablösung vom Elternhaus , autism , early adulthood (1)
Autismus-Spektrum-Störung, TEACCH®, neuronale Entwicklungsstörung, sozio-emotionale Entwicklung, Förderung (1)
AUTOBIOGRAPHICAL MEMORIES; WORDS; DETAILS; RECALL; Episodic memory; Emotion; Retrieval-induced forgetting; Material; Dispositional affectivity (1)
AUTOBIOGRAPHICAL MEMORY; IDENTITY; SELF; collective memory; memory for historical events; mental time travel; aging; generational differences (1)
Autobiographie , Exilliteratur , Galizien , Alexander Granach , Henry William Katz , (1)
Autobiographisches Gedächtnis (1)
Autocatalysis · Combinatorial Library · Sulfonamides · Flow Chemistry · Photocatalysis (1)
autogenes Training, autogenic relaxation, autogenic training (1)
autoimmune disease, Multiple Sclerosis, Antigen Presentation, autoantigen, T cell, B cell, HLA (1)
autoimmune diseases, haematopoietic stem cell transplantation, paediatric (1)
Autoimmune hemolytic anemia · AIHA · Immune thrombocytopenia · ITP · Evans’ syndrome · Anti-CD20 · Rituximab (1)
AUTOIMMUNE HEMOLYTIC-ANEMIA; TRANSPLANTATION; RECURRENT; PATIENT; DOXYCYCLINE; DISEASE; giant cell hepatitis; fulminant liver failure; liver transplantation (1)
AUTOIMMUNE HEPATITIS; SCORING SYSTEM; DIAGNOSIS; MANAGEMENT; PATHOGENESIS; OVERLAP; (1)
autoimmune-induced alopecia; iron chelators; HIF-1 alpha; hair restoration (1)
Autoimmune liver disease, Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosingcholangitis, Sex, Fibrosis score (1)
AUTOIMMUNE LIVER-DISEASE; CHRONIC HEPATITIS-C; URSODEOXYCHOLIC ACID; OVERLAP SYNDROME; DESTRUCTIVE CHOLANGITIS; BIOCHEMICAL RESPONSE; MEDICAL PROGRESS; CONTROLLED-TRIAL; VIRAL-HEPATITIS; SERUM BILIRUBIN; primary biliary cirrhosis; autoimmune hepatitis; overlap syndrome; ursodeoxycholic acid; prognosis; predictive scores; Mayo Risk Score (1)
Autoimmunenzephalitis, Enzephalitis, NMDA, autoimmun, paraneoplastisch, limbische Enzephalitis, Neuropsychologie (1)
AUTOIMMUNE RHEUMATIC-DISEASES; INTERSTITIAL LUNG-DISEASE; POPULATION-BASED COHORT; PULMONARY-FIBROSIS; SURVIVAL; MORTALITY; ATHEROSCLEROSIS; MANIFESTATIONS; HYPERTENSION; ACCURACY; (1)
autoimmunity; central nervous system; multiple sclerosis; autoimmune encephalitis; biomarkers; clinical outcomes (1)
autologe Chondrozytentransplantation, ACT, 3D-Zellkulturen, automatisch Bildanalyse (1)
autologe Meniskuszellen, mesenchymale Stammzellen, Tissue-Engineering, chondrogenes Potential (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE DEFECTS; MARROW-STIMULATION TECHNIQUES; FOLLOW-UP; KNEE ARTHROSCOPIES; ALLOGRAFT TRANSPLANTATION; MICROFRACTURE TECHNIQUE; SURGICAL-TREATMENT; REPAIR; LESIONS; Early osteoarthritis; Regenerative cartilage treatment; Biomaterials; Microfracture; Autologous chondrocyte transplantation; Allografts; Osteochondral autografts (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; FOLLOW-UP; TRANSPLANTATION; DISSECANS; REPAIR; PRESERVATION; MOSAICPLASTY; MINIMUM; Osteochondral defects; Bone block augmentation; Cancellous bone grafting; Chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; BONE-MARROW EDEMA; ARTICULAR-CARTILAGE; TISSUE REGENERATION; CHONDRAL DEFECTS; ORTHOPEDIC-SURGERY; GERMAN SOCIETY; KNEE-JOINT; MICROFRACTURE; REPAIR; Cartilage; Survey; Cartilage repair; Cartilage transplantation; Microfracture (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; CONTINUOUS PASSIVE MOTION; FULL-THICKNESS DEFECTS; ARTICULAR-CARTILAGE; POSTTRAUMATIC OSTEOARTHRITIS; SURGICAL TECHNIQUE; MICROFRACTURE; SURGERY; SCIENCE; LESIONS; postoperative rehabilitation; cartilage repair; microfracturing; MACT; OATS (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; CRUCIATE LIGAMENT RECONSTRUCTION; OPEN-WEDGE OSTEOTOMY; ARTICULAR-CARTILAGE; KNEE-JOINT; ARTHROSCOPIC SURGERY; FOLLOW-UP; ALLOGRAFT TRANSPLANTATION; MENISCAL TRANSPLANTATION; PARTIAL MENISCECTOMY; Arthritis; Cartilage defect; Cartilage replacement procedure; Joint integrity; Chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; FRESH OSTEOCHONDRAL ALLOGRAFTS; DEFECTS; TRANSPLANTATION; RESTORATION; JOINT; (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; FULL-THICKNESS DEFECTS; GROWTH-FACTOR DELIVERY; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; OSTEOCHONDRAL REPAIR; MARROW STIMULATION; FEMORAL CONDYLE; CANINE MODEL; KNEE; subchondral bone; cartilage; microfracture; skeletal maturity (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; PATELLAR DISLOCATION; DEROTATION OSTEOTOMY; KNEE; CARTILAGE; OSTEOARTHRITIS; MALALIGNMENT; INJURY; Distal femoral osteotomy; Rotational osteotomy; Retropatellar pressure; Contact pressure (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; QUADRICEPS STRENGTH; KNEE; OSTEOARTHRITIS; DEFECTS; INJURY; SEX; PREDICTS; WEAKNESS; gender; sex; cartilage; surgery; repair (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; KNEE; LESIONS; PATELLAR; PAIN; TRANSPLANTATION; MORPHOLOGY; INJURY; REPAIR; Cartilage defect; Patellofemoral; Knee; Registry; Pain (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; LATERAL RETINACULAR RELEASE; THICKNESS CHONDRAL DEFECTS; MESENCHYMAL STEM-CELLS; ANTERIOR KNEE PAIN; ARTICULAR-CARTILAGE; LIGAMENT RECONSTRUCTION; FOLLOW-UP; OSTEOCHONDRAL TRANSPLANTATION; CHONDROMALACIA PATELLAE; Patellofemoral joint; Cartilage defect; Realignment; Microfracturing; Autologous chondrocyte implantation (ACI) (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MARROW STIMULATION; REPAIR; knee joint; cartilage; ACI; autologous chondrocyte implantation; registry; joint preservation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; 2-YEAR FOLLOW-UP; ACETABULAR CHONDRAL DEFECTS; FEMOROACETABULAR IMPINGEMENT; ARTICULAR-CARTILAGE; ARTHROSCOPIC TREATMENT; MICROFRACTURE TECHNIQUE; OSTEOCHONDRAL LESIONS; GERMAN SOCIETY; hip; chondral defects; microfracture; autologous matrix induced chondrogenesis; autologous chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; CLINICAL TISSUE REGENERATION; RANDOMIZED CONTROLLED-TRIAL; MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; FOLLOW-UP; CHONDRAL DEFECTS; NEXT-GENERATION; GERMAN SOCIETY; Microfracturing; Autologous matrix-induced chondrogenesis; Osteochondral transplantation; Autologous chondrocyte transplantation; Allograft (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; CLINICAL TISSUE REGENERATION; RANDOMIZED CONTROLLED-TRIAL; MESENCHYMAL STEM-CELLS; FOLLOW-UP; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; NEXT-GENERATION; GERMAN SOCIETY; Microfracturing; Autologous matrix-induced chondrogenesis; Osteochondral transplantation; Autologous chondrocyte transplantation; Allograft (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; MEDIAL MALLEOLAR OSTEOTOMY; ARTHROSCOPIC TREATMENT; TALAR DOME; AUTOGRAFT TRANSPLANTATION; TRANSCHONDRAL FRACTURES; CARTILAGE DEFECTS; TALUS; DISSECANS; cartilage lesion; ankle; treatment; recommendations (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MEDIAL COMPARTMENT; KNEE; RESTORATION; DEFECTS; OSTEOARTHRITIS; COMPLICATIONS; ALIGNMENT; PRESSURE; VARUS; High tibial osteotomy; Cartilage surgery; Cartilage repair; Factors; Concomitant surgery (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS; MATRIX-INDUCED CHONDROGENESIS; BONE-MARROW STIMULATION; ARTICULAR-CARTILAGE; FOLLOW-UP; EARLY OSTEOARTHRITIS; CHONDRAL DEFECTS; OSTEOCHONDRAL DEFECTS; CLINICAL-OUTCOMES; Autologous chondrocyte transplantation; Knee; Regeneration; Cartilage; Cell-based; Stem cells; Meniscus; Anterior cruciate ligament; Leg axis; Osteotomy (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; OSTEOARTHRITIS OUTCOME SCORE; LONG-TERM OUTCOMES; CHONDRAL DEFECTS; KNEE INJURY; FOLLOW-UP; MICROFRACTURE; 1ST-GENERATION; CLASSIFICATION; COMPLICATIONS; revision surgery; cartilage; German Cartilage Registry; knee (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; OSTEOARTHRITIS OUTCOME SCORE; MICROFRACTURE; ARTHROSCOPIES; INJURY; TRIAL; JOINT; Cartilage defect; Knee surgery; Cartilage surgery; Autologous chondrocyte; Cell therapie (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; REGISTRY KNORPELREGISTER DGOU; DISEASE PROGRESSION; SURGICAL-TREATMENT; LOWER-LIMBS; OSTEOARTHRITIS; DEFECTS; ALIGNMENT; REPAIR; SURGERY; knee; cartilage; varus; valgus; CartilageRegistry DGOU (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; SKELETALLY MATURE KNEE; CARTILAGE REPAIR; INTERNAL-FIXATION; FEMORAL CONDYLE; DISSECANS; DEFECTS; BONE; TRANSPLANTATION; ASSOCIATION; autologous chondrocyte; grafts; cartilage transplantation; grafts; knee; joint involved; MACT; bone grafting (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; TOTAL KNEE ARTHROPLASTY; HIGH TIBIAL OSTEOTOMY; CLINICAL-OUTCOMES; FOLLOW-UP; DEFECTS; LESIONS; EXPECTATIONS; TRIAL; MICROFRACTURE; Cartilage; Knee; Patient satisfaction; Outcome parameter; Regeneration; Joint preservation; ACI; Bone marrow stimulation (1)
AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; CARTILAGE REPAIR; LESIONS; IMPLANTATION; REGENERATION; STRATEGIES; GUIDELINE; OUTCOMES; SURGERY; scaffolds; cartilage; osteochondral; knee; osteoarthritis; guidelines (1)
AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; INTERMITTENT HYDROSTATIC-PRESSURE; IN-VITRO; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; ARTIFICIAL TISSUES; KNEE; OSTEOARTHRITIS; PROTEOGLYCAN; DEFECTS; biocompatability; bioreactor; in vitro test; cell culture; human articular cartilage; tissue culture; perfusion; differentiation (1)
autologous fat grafting; scar therapy; adipose-derived stem cells; tissue regeneration (1)
AUTOLOGOUS FAT INJECTION; BREAST AUGMENTATION; EMBOLISM SYNDROME; TISSUE; PATHOPHYSIOLOGY; PATHOGENESIS; SAFE; SKIN; Lipofilling; pressure monitoring; Brava; fat embolism syndrome (1)
autologous fat transfer; lipofilling; intersyringe processing; mechanical processing; fat graft; cell-enriched lipotransfer (1)
AUTOLOGOUS TRANSFUSION; CARDIAC-SURGERY; CELL SALVAGE; INTRAOPERATIVE AUTOTRANSFUSION; CHILDREN; INFANTS; CRANIOSYNOSTOSIS; MANAGEMENT; QUALITY; SAVER; (1)
AUTOLOGOUS TRANSPLANT; RELAPSED DLBCL; T-CELLS; BLOOD (1)
automated assignment; combinatorial minimization; proteins; threshold accepting (1)
Automated breast ultrasound, ABUS, HHUS, Resektionsrandkontrolle, Resection margin control, BET (1)
; Automated individual traffic; hybrid driver-machine; environment systems (1)
automated kinetic perimetry, automated static perimetry, children, visual field, strabismus (1)
Automated segmentation; Neural nets; U-Net; Medical imaging; Non-enhancing brain tumor (1)
Automated sequential assignment; Homology-based protein NMR chemical shift prediction; Protein NMR chemical shift databases; Multiple alignment (1)
Automated Testing, Personas, Domain-Specific Languages, Model-Based Software Engineering, Test Models (1)
AUTOMATED VEHICLE ACCEPTANCE; USER ACCEPTANCE; TRUST; VALIDATION; NUMBER; DETERMINANTS; PEOPLE; MODELS; CARS; Autonomous driving; Artificial intelligence; Latent profile analysis; Autonomous vehicle acceptance; User groups (1)
AUTOMATIC ACTIVATION; COUNTER-REGULATION; INTERFERENCE; VALENCE; REWARD; BIASES; TASK; affective priming; conflict aversiveness; automatic versus controlled processing; Stroop (1)
AUTOMATIC CATEGORIZATION; PROJECTS; CLASSIFICATION; BYTECODE; Software similarity; Secondary study; Machine learning (1)
automatic formant prediction; FAVE; Trinidadian English; vowels; New Englishes; formant ceiling optimization; automated acoustic analysis (1)
AUTOMATIC LIVER; HEPATOBILIARY PHASE; GADOLINIUM CHELATE; ACTIVE CONTOURS; HEPATIC-UPTAKE; SEGMENTATION; AGENT; CT; REMNANT; DTPA; liver segmentation; liver volumetry; semantic segmentation; fully automated segmentation; contrast-enhanced liver MRI (1)
automatisches informatives Summarizing; informatives Passagen-Retrieval; Within-Document-Retrieval; R-Precision; Informativität; Evaluation; Informationslinguistik (1)
AUTOMICTIC PARTHENOGENESIS; EVOLUTIONARY GENETICS; CLONAL ANT; HYMENOPTERA; VARIABILITY; POPULATIONS; FORMICIDAE; SEQUENCES; Platythyrea; thelytoky; facultative parthenogenesis; population structure; gamergate (1)
Automobillogistik; Anwendungsarchitektur; Informationssystemarchitektur; SOA (4)
Automobillogistik; Kapazitätsplanung; Anwendungsarchitektur; Informationssystemarchitektur; SOA (2)
automotive assembly; prototype; capacity scheduling; decision support system; spreadsheets (1)
Autonmous driving, autonomous vehicles, technology acceptance, autonomous vehicle acceptance (1)
Autonome Systeme, autonomes System, autonomes Fahren, autonomes Fahrzeug, autonome Fahrzeuge, selbstfahrend, künstliche Intelligenz, KI, Haftung, Deliktsrecht, außervertragliche Haftung, Rechtspolitik, artificial intelligence, AI (1)
Autonomie, Gesundheit, Gesundheitsreform, Gesundheitsstrukturgesetz, Gesundheitssystem, Gesundheitsverständnis, Krankheit, Medizin, Patientenautonomie, Patientenverfügung, Sterbehilfe (1)
Autonomie, Psychiatrie, Patientenverfügungen, Interviews (1)
autonomous driving, artificial intelligence, technology acceptance, psychological distance, autonomous vehicle acceptance, construal level theory (1)
AUTOSOMAL RECESSIVE SYNDROME; CONGENITAL DISORDERS; CHARGE-SYNDROME; MENTAL-RETARDATION; JOUBERT-SYNDROME; CDG; MUTATIONS; GENE; BIOSYNTHESIS; SPECTRUM; congenital disorders of glycosylation; SRD5A3-CDG; CDG type Iq; glycosylation; dolichol metabolism; polyprenol reductase; SRD5A3; vermis hypoplasia; coloboma; cataract; glaucoma (1)
AUTO-TRANSPLANTATION; RENAL HYPERPARATHYROIDISM; TISSUE; AUTOGRAFTS; CRYOPRESERVATION; DISEASE; GLANDS; SITE; Secondary hyperparathyroidism; Parathyroidectomy with autotransplantation; Recurrence; Autotransplant(s)-hyperparathyroidism; Re-operation; Possible metachronous autotransplantation (1)
AUTOTROPHIC CO2 FIXATION; METHANOTROPHIC BACTERIA; PHOTOSYNTHETIC BACTERIA; METHANOGENIC BACTERIA; RIBULOSE BISPHOSPHATE; GENOME SEQUENCE; REDUCTION; DIOXIDE; GROWTH; LIPIDS; (1)
Autounfall, Verkehrsunfall, Verkehrsunfallforschung, Fahrerangaben, Aussage, selbstberichtete Geschwindigkeit, selbstberichtete Reaktion, Vorunfallphase, Zuverlässigkeit, Genauigkeit, Plausibilität, Event Data Recorder, EDR, car accident, traffic accident research, driver statement, self-report, self-reported speed, pre-crash phase, reporting accuracy, plausibility, reliability (1)
AUXILIARY BASIS-SETS; COORDINATION POLYMERS; SILVER(I) COMPLEXES; LIGAND COMPLEXES; DESIGN; PENTAPHOSPHAFERROCENE; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); POLYPHOSPHORUS; SUPRAMOLECULE; arsenic; coordination polymers; N ligands; self-assembly; silver (1)
AUXILIARY BASIS-SETS; CORRELATION-ENERGY; P5X2+ X; PHOSPHORUS; BR; APPROXIMATION; ACTIVATION; EXCHANGE; SALTS; ATOMS (1)
AUXILIARY BASIS-SETS; CRYSTAL-STRUCTURE; CONFIGURATION; COMPLEXES; LIGANDS; CH/PI; ATOMS; (1)
AUXILIARY BASIS-SETS; KOHN-SHAM ORBITALS; THYMINE DIMER; SKIN-CANCER; ENERGIES; EFFICIENCY; PHOTOLYASE; SUNLIGHT; REPAIR; computational chemistry; DNA damage; hydrogen bonds; nucleobases; photochemistry (1)
AUXILIARY BASIS-SETS; RAY CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; ELECTRON CORRELATION; AB-INITIO; P4X3 X; TETRAPHOSPHORUS; MOLECULES; SULFUR; ENERGY; ab initio calculations; molecular adducts; niobium; phosphorus; sulfur; tantalum (1)
auxin, cytokinin, PIN proteins, AGCVIII kinases, plant parasitic nematodes, phloem development (1)
Auxine , Mais , Pflanzenhormon , Koleoptile , Geotropismus , Streckungswachstum , Elongation , SAUR , elongation , auxin , coleoptile , maize , SAUR (1)
Avantgarde Valle-Inclán esperpento edad de plata Theosophie Bohème Madrid modernismo Nihilismus Luces de bohemia (1)
AVASCULAR NECROSIS; ASEPTIC OSTEONECROSIS; CORE DECOMPRESSION; NEEDLE-BIOPSY; BONE; HIP; TRANSPLANTATION; GRAFT; necrosis of the femoral head; core decompression; stem cells; tissue repair cells (TRCs); beta-TCP (1)
Avastin, Glioblastom, Rezidiv (1)
avatars, Proteus effect, exergames, virtual reality, body ownership, perception of effort, sweating (1)
avatars, Proteus effect, virtual reality, cycling, physical performance, body ownership (1)
Avatars, virtual reality, Proteus effect, body ownership, rubber hand illusion, presence, cognitive performance, physical performance (1)
AVEM; Burnout; berufsbezogene Therapie; Stress; berufliches Bewältigungsverhalten; Rehabilitation (1)
Aveneae; Lophochloa; Macaronesia; taxonomy (1)
Aversive signals; Effort Mobilization; Hearing; Perceptual Fluency; Sequential Processing Adjustments (1)
AVIAN BROOD PARASITISM; SLAVE-MAKING ANT; HARPAGOXENUS SUBLAEVIS NYL; COLONY STRUCTURE; CUCULUS-CANORUS; HOST DEFENSES; ARMS-RACE; FORMICIDAE; CUCKOO; ADAPTATION; adaptation; ants; coevolution; geographical mosaic; social parasites; sympatry (1)
AVIAN BROOD PARASITISM; SLAVE-MAKING ANTS; FALSE DISCOVERY RATE; RAIDING BEHAVIOR; LEPTOTHORAX-DULOTICUS; SLAVEMAKING ANT; MODEL SYSTEM; ARMS RACES; COEVOLUTION; FORMICIDAE; ants; co-evolution; host defences; selection pressure; social parasites; specialization (1)
Avignon, Kirchengeschichte und Religionsgeschichte (1)
A VIRUS; BREFELDIN-A; SIMIAN VIRUS-40; KIDNEY-CELLS; OWL MONKEYS; LINE CACO-2; POLIOVIRUS; TRANSPORT; LIVER; REPLICATION; (1)
AVIUM-INTRACELLULARE INFECTION; COOKSON-TYPE REAGENT; 25-HYDROXYVITAMIN D-3; HUMAN PLASMA; HYPERCALCEMIA; PATIENT; 1,25-DIHYDROXYVITAMIN-D; AIDS; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; PERSPECTIVE; 1 alpha,25-dihydroxyvitamin D-3; 25-hydroxyvitamin D-3; 24R,25-dihydroxyvitamin D-3; UPLC; LC-MS; metabolic profiling; derivatization (1)
AVOIDANCE MOTOR ACTIONS; 3-DIMENSIONAL OBJECTS; SEX-DIFFERENCES; ABILITY; TRANSFORMATIONS; CHILDREN; WOMEN; (1)
avulsion; dental trauma; diagnosis; endodontic management; tooth fracture; tooth injuries (1)
AWAKE CRANIOTOMY; ANESTHETIC MANAGEMENT; SURGERY; PATIENT; NEUROSURGERY; EXPERIENCE; PRESSURE; PROPOFOL; FENTANYL; Anesthetics; Brain mapping; Neuro-oncology; Neuropsychology; Neurosurgery (1)
Awake craniotomy; brain mapping; complications; continuous awake craniotomy protocol; glioma; seizure (1)
AWAKE CRANIOTOMY; NERVE BLOCKS; ANESTHESIA; INFILTRATION; ROPIVACAINE; PLACEMENT; RELIEF; HEAD; Nerve block anesthesia; Cranial nerves; Scalp block; Awake craniotomy (1)
; Awareness of predatory journals; Orthopaedic and trauma surgeons; Online survey; Open access journals (1)
AXENIC AMASTIGOTES; GENE-EXPRESSION; MACROPHAGES; DONOVANI; PROMASTIGOTES; INFECTION; LIPOPHOSPHOGLYCAN; CHOLESTEROL; TEMPERATURE; CULTIVATION; human macrophages; neutrophils; amastigotes; promastigotes; axenic culture; endocytosis and phagocytosis (1)
AXIAL SPONDYLOARTHRITIS; GADOLINIUM; ANATOMY; LESIONS; spondyloarthritis (SpA); sacroiliac joints (SIJ); magnetic resonance imaging (MRI) (1)
AXICABTAGENE CILOLEUCEL; SALVAGE; (1)
AXILLARY BUD OUTGROWTH; FLORAL SYMMETRY; TRANSCRIPTION FACTORS; MOLECULAR EVOLUTION; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; SEQUENCE ALIGNMENT; PLANT-GROWTH; EXPRESSION; ANTIRRHINUM; TCP; tb1; CYCLOIDEA; PCF1; Zea mays; Oryza sativa; Brachypodium distachyon; Sorghum bicolor; gene family; monocot; whole genome duplication (1)
AXILLARY DISSECTION; LOCALIZATION; MAGSEED; Breast cancer; Neoadjuvant chemotherapy; Target lymph node; Targeted axillary dissection; Magnetic seed (1)
Axiom, Dying, Death (1)
Axion dark matter; QCD on the lattice; Instantons (1)
Axis fractures · Cervical spine · Geriatric population · In-hospital mortality · Risk factors (1)
AXIS PLASMA RESONANCE; VORTEX LIQUID-PHASE; LAYERED SUPERCONDUCTORS; COUPLED SUPERCONDUCTORS; SINGLE-CRYSTALS; STATE; (1)
AXL; EXPRESSION; CANCER; SURVIVAL; Prognosis; Gas 6; Papillary renal cell carcinoma; Survival (1)
AXONAL LOAD; SURGICAL ANATOMY; PAROTID-GLAND; GRAFT; PALSY; REGENERATION; PATTERNS; facial nerve; facial muscles; anatomy; nerve transfer; axons; Bell's palsy; facial paralysis; transplants; facial expression (1)
AXON INITIAL SEGMENT; LATERAL DENDRITES; HIPPOCAMPAL ASTROCYTES; PYRAMIDAL NEURONS; SODIUM LOADS; CALCIUM; SPINES; PROPAGATION; SPIKES; INHIBITION; olfactory bulb; granule cell; mitral cell axon; active dendrites; sodium transient; two-photon imaging; SBFI (1)
Azacrown ether, Macrocycle, Cyclization (1)
azaspirocycles • radicals • alkynes • decarboxylation • photoredox (1)
aza-Wacker coupling azoles alkenes selenium-π-acid catalysis photoredox catalysis (1)
AZIDE-ALKYNE CYCLOADDITION; DISTANCE MEASUREMENTS; EPR SPECTROSCOPY; 1,3-DIPOLAR CYCLOADDITIONS; ESCHERICHIA-COLI; TERMINAL ALKYNES; LIVING CELLS; GENETIC-CODE; AMINO-ACID; PROTEINS; Site-directed spin labeling; EPR spectroscopy; Orthogonal labeling; Click chemistry; DEER; In vivo EPR (1)
AZIDE-ALKYNE CYCLOADDITION; METAL-ADHESIVE POLYMERS; CLICK CHEMISTRY; CORROSION-INHIBITORS; ORGANOPHOSPHONIC ACID; MILD-STEEL; DERIVATIVES; TRIAZOLE; SURFACE; COPPER; click chemistry; copper-catalyzed azide-alkyne cycloaddition; aluminum alloy; adhesion property; corrosion protection (1)
AZIDE-ALKYNE CYCLOADDITION; MOLECULAR-MASS GELATORS; ROBUST ORGANIC GELS; HETEROGENEOUS CATALYSIS; FUNCTIONAL MATERIALS; GOLD NANOPARTICLES; IONIC LIQUID; ENANTIOSELECTIVE ACETYLATION; SILICA NANOARCHITECTURES; SILVER NANOPARTICLES; (1)
AZIDE-ALKYNE CYCLOADDITION; ONE-POT SYNTHESIS; BOND OXIDATIVE FUNCTIONALIZATION; HYPERVALENT IODINE REAGENTS; CLICK-CHEMISTRY ROUTE; COUPLING REACTIONS; 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES; BIOLOGICAL EVALUATION; RAPID SYNTHESIS; DIAZO TRANSFER; azidation; click chemistry; copper catalysis; oxidative C-H functionalization; triazoles (1)
Azide , Ammoniak , Amide , Ammoniumverbindungen , Wasserstoffbrückenbindung , Wasserstoffbrückenbindungen , Dicyanamide , hydrogen bonds , azides , ammonia , amides , ammonium compounds (1)
azide; polymer reagent; PEG (1)
azidosiloxycyclohexene, gamma-amino acid, tetrapeptide, antimycobacterial butyrolactones, Geissman-Waiss lactone (1)
AZIMUTHAL DEPENDENCE; FRAGMENTATION; ASYMMETRIES; SCATTERING; COLLINS; MODEL; NUCLEON; BOSON; Deep Inelastic Scattering; Parton Model; QCD (1)
AZIRIDINATION; AMIDATION; REAGENT; IODINE; MILD; Iminoiodinanes; Cyclic Ethers; C-H functionalization; Amino Alcohols; Visible Light; Photochemistry (1)
AZITHROMYCIN; HMR-3647; PHARMACOKINETICS; ROXITHROMYCIN; ANTIBIOTICS; DIFFUSION; LUNG; ketolides; pharmacokinetics; nasal tissue (1)
AZITHROMYCIN; RACECADOTRIL; LOPERAMIDE; RIFAXIMIN; CHILDREN; CIPROFLOXACIN; THAILAND; EFFICACY; TRIAL; travelers' diarrhea; pathogenic spectrum; rehydration; antibiotic therapy (1)
azobenzene, enzyme catalysis, photocontrol, photoswitches, unnatural amino acids (1)
azobenzene • enzyme catalysis • photocontrol • unnatural amino acids (1)
azobenzene • enzyme catalysis • protein dynamics • vibrational energy transfer • unnatural amino acids (1)
Azorín , Machado, Antonio <Schriftsteller> , Unamuno, Miguel de , Landschaft < Motiv> , Erinnerung , Identität , Generation von 98 , Kastilien , Generation von 1898 , Kastilien , Alterität , Visualität , Romantik , National identity , Modernism , Castilia , Landscape , Generation of 1898 (1)
B19-ASSOCIATED HEMOPHAGOCYTIC SYNDROME; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONSTRUCTURAL PROTEIN; NEUTROPENIA; ANTIBODIES; VIRUS; CHILDHOOD; CHILDREN; THERAPY; DISEASE; chronic autoimmune neutropenia/thrombocytopenia; parvovirus B19 infection (1)
B19 INFECTION; MATERNAL INFECTION; RISK-FACTORS; SEROPREVALENCE; TRANSMISSION; POPULATION; WORKERS; pregnancy; fifth disease; stillbirth; miscarriage; health economics (1)
B19 INFECTION; RHEUMATIC-DISEASE; PERSISTENCE; DNA; CHILDHOOD; antiphospholipid antibodies; juvenile arthritis; parvovirus B19; persistent infection (1)
B7 FAMILY-MEMBER; T-CELLS; EXPRESSION ANALYSIS; NUCLEAR FACTOR; MACROPHAGES; SELECTION; PACKAGE; B7-H4; TRANSPLANTATION; INFLAMMATION; (1)
BAA, Diametermessungen, Volumetrie, AAA, Diameter measurements, Volumetry (1)
BABOON HEART-TRANSPLANTATION; ANTI-PIG ANTIBODIES; TO-HUMAN MODEL; PULMONARY XENOTRANSPLANTATION; IN-VITRO; XENOGRAFT REJECTION; NATURAL ANTIBODIES; CYNOMOLGUS MONKEYS; ALPHA-GAL; ORGAN XENOTRANSPLANTATION; xenotransplantation; GAS914; alpha-Gal antibody; hyperacute rejection; pulmonary xenograft dysfunction (1)
Babylonian astronomy/astrology, lunarphases,Dodecatemoria (meanvalue scheme), squares of zodiacal signs (2)
Babylonian Mathematical Astronomy, Lunar and Solar Theory, Dodecatemoria, Calendar Texts (1)
BACILLUS-ANTHRACIS; EDEMA FACTOR; PYRIMIDINE NUCLEOTIDES; ORGANIC-MOLECULES; STRUCTURAL BASIS; FORCE-FIELD; ANALOGS; PURINE; SITE; GTP; (1)
BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; CEREUS; TOXIN; GENES; (1)
BACILLUS-ANTHRACIS SPORES; SAMPLE COLLECTION METHOD; NONPOROUS SURFACES; CLEAN ROOMS; SPACECRAFT SURFACES; ENVIRONMENTS; CONTAMINATION; ENDOSPORES; DIVERSITY; SURVIVAL; (1)
BACILLUS-ANTHRACIS; STRUCTURAL BASIS; TOXIN; INHIBITION; CALMODULIN; ANALOGS; INFECTION; BINDING; PURINE; (1)
BACILLUS-CALMETTE-GUERIN; ACTIVATED KILLER-CELLS; DENDRITIC CELLS; ADOPTIVE IMMUNOTHERAPY; UROTHELIAL CARCINOMA; PROPHYLAXIS; PROGRESSION; INTERFERON; RECURRENCE; (1)
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; ASSISTED RADICAL CYSTECTOMY; TRANSITIONAL-CELL CARCINOMA; RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; FLAT UROTHELIAL HYPERPLASIAS; FREQUENT FGFR3 MUTATIONS; GENOME-WIDE ASSOCIATION; (1)
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; PREDICTING RECURRENCE; PROGRESSION; TA; MULTICENTER; SURVIVAL; OUTCOMES; IMPACT; TUMORS; Grade; Guidelines; Non-muscle-invasive bladder cancer; Prognostic factors; Progression; Risk groups; WHO 1973 2004/2016 (1)
BACILLUS-CALMETTE-GUERIN; EORTC RISK TABLES; TRANSITIONAL-CELL CARCINOMA; EUROPEAN ORGANIZATION; EXTERNAL VALIDATION; IN-SITU; PROGRESSION; RECURRENCE; T1; MORTALITY; urothelial bladder carcinoma; stage pT1; transurethral resection; WHO 1973 grading; instillation therapy (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL CARCINOMA; HUMAN URINARY-BLADDER; FOLLOW-UP; CANCER; RECURRENCE; GRADE; PROGRESSION; EXPRESSION; SURVIVAL; Biomarkers; Early invasive bladder cancer; Immunohistochemistry; Prognosis; Urothelial bladder carcinoma (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; RANDOMIZED CLINICAL-TRIALS; INTRAVESICAL ADJUVANT CHEMOTHERAPY; MITOMYCIN-C INSTILLATION; LONG-TERM EFFICACY; TRANSURETHRAL RESECTION; EUROPEAN-ORGANIZATION; STAGE TA; FOLLOW-UP; Macrohematuria; Cystoscopy; Transurethral resection; Instillations; Bacillus CalmetteGuerin (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL CARCINOMA; RANDOMIZED CLINICAL-TRIALS; INTRAVESICAL MITOMYCIN-C; T1 PAPILLARY CARCINOMA; FOLLOW-UP CYSTOSCOPY; LONG-TERM EFFICACY; HIGH-RISK TA; IN-SITU; TRANSURETHRAL RESECTION; Bacillus Calmette-Guerin (BCG); Bladder cancer; Cystectomy; Diagnosis; Guidelines; Intravesical chemotherapy; Prognosis; Transurethral resection (TUR); Urothelial carcinoma; European Association of Urology (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; RESTAGING TRANSURETHRAL RESECTION; GROUP RANDOMIZED PHASE-3; URINE-BASED MARKERS; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; PHOTODYNAMIC DIAGNOSIS; PROGNOSTIC VALUE; FOLLOW-UP; Diagnostics, photodynamic; Invasion pattern; Therapy, intravesicle; Therapy, bladder preserving; Cystectomy (1)
BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; KI67 EXPRESSION; GRADE; HER2; P53; PROGRESSION; SURVIVAL; SUBTYPES; Bladder cancer; Non-muscle-invasive bladder cancer; ERBB2; Carcinoma in situ; Progression; Prognostic factors (1)
Bacillus cereus Micrococcus luteus Staphylococcus epidermidis (antibacterial activity of phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone A phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone B phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone C phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone D phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone E phloroglucinol derivs. from Hypericum papuanum) Antibacterial agents New natural products St.-John's-wort (phloroglucinol derivs. from Hypericum papuanum) phloroglucinol deriv Hypericum (1)
BACILLUS-CIRCULANS WL-12; AMORPHOUS CALCIUM-CARBONATE; YEAST-CELL WALL; BINDING DOMAIN; ORGANIC MATRIX; BETA-CHITIN; THALASSIOSIRA FLUVIATILIS; SACCHAROMYCES-CEREVISIAE; ELECTRON-DIFFRACTION; A1; biomineralization; mollusk shell; embryonic development; insoluble matrix; chitin-protem complex; confocal fluorescence microscopy; amorphous calcium carbonate; aragonite (1)
Bacillus/*genetics Bacillus subtilis/genetics Base Composition Biological Transport/genetics Chromosomes, Bacterial/*genetics DNA, Bacterial/*chemistry Endopeptidases/genetics Genes, Bacterial/genetics/physiology Genes, rRNA *Genome, Bacterial Genomics Glyoxylates/metabolism Lipase/genetics Lipoproteins/genetics Metabolism/genetics Molecular Sequence Data Open Reading Frames Peptides, Cyclic/genetics Polysaccharide-Lyases/genetics RNA, Transfer/genetics Recombination, Genetic Regulatory Sequences, Nucleic Acid Research Support, Non-U.S. Gov't Ribonucleotide Reductases/genetics *Sequence Analysis, DNA Synteny Transposases/genetics (1)
BACILLUS-SUBTILIS; BACTERIAL-SPORES; ELECTRON-MICROSCOPE; GERMINATION; CEREUS; THURINGIENSIS; ENVIRONMENTS; INHIBITION; MEGATERIUM; SPACECRAFT; Bacillus; planetary protection; PMA; spore (1)
BACILLUS-SUBTILIS; LIPID BIOSYNTHESIS; PYROPHOSPHATE SYNTHETASE; MOLECULAR-GRAPHICS; CRYSTAL-STRUCTURES; GENE-EXPRESSION; EVOLUTION; PROTEINS; BACTERIA; FOLD; (1)
BACILLUS-SUBTILIS SPORES; INTENSIVE-CARE UNITS; CLEAN ROOMS; PLANETARY PROTECTION; ANTIMICROBIAL SUSCEPTIBILITY; MICROBIAL-CONTAMINATION; SKIN MICROBIOME; SP-NOV.; BACTERIA; DIVERSITY; International Space Station; Microbiome; Confined habitat; Archaea; Extremotolerant (1)
BACILLUS-SUBTILIS; SYNTHASE; biosynthesis; enzymes; ether lipids; functional assignment; glycerol-1-phosphate (1)
BACILLUS-SUBTILIS; TRYPTOPHAN BIOSYNTHESIS; INTERACTION SPECIFICITY; ANTHRANILATE SYNTHASE; FOLIC-ACID; DOMAIN; SIGNAL; GENE; AMIDOTRANSFERASE; ARCHAEBACTERIA; protein-protein interactions; protein interfaces; interface add-on; glutamine amidotransferases; protein evolution (1)
Background assumptions, Complexity, Darwinism, Emergence, Evo-Devo, Extended Synthesis, Modern Synthesis (1)
BACKGROUND CHARACTERISTICS; LINKAGE ANALYSIS; MODUS-OPERANDI; SCENE ACTIONS; PERSONALITY; SYSTEM; (1)
BACKGROUND VARIABLES; lumbar disc surgery; conservative treatment; surgery (1)
; Back pain; Biopsycho social understanding; Multimodal therapy concept; Organization; Clinical pathway (1)
BACK-PAIN; CANAL STENOSIS; CLAUDICATION; POPULATION; GUIDELINE; OUTCOMES; SURGERY; Microdecompression; Lumbar ischialgia; Spinal claudication; Spondylodesis; Therapy (1)
BACK-PAIN; DEPRESSION; ASSOCIATION; SEVERITY; PARAMETERS; DIAGNOSIS; IMPACT; CARE; LSS; quality of life; disability; sex differences; pain (1)
BACK-PAIN; HIP OSTEOARTHRITIS; PREVALENCE; OSTEOPOROSIS; EPIDEMIOLOGY; DISEASES; BURDEN; KNEE; Musculoskeletal disorders; Back pain; Osteoarthritis; Arthritis; Osteoporosis; General population (1)
Back pain prevention, Primary-school children, Posture, Psychological well-being, Trunk muscle endurance, Functional mobility (1)
Back pain, Working conditions, Healthcare workers, Risk factors (1)
BACKPROPAGATING ACTION-POTENTIALS; DENDRITIC SPINES; CALCIUM INFLUX; SYNAPTIC SIGNALS; NMDA RECEPTORS; NEURONS; SPIKE; INHIBITION; ACTIVATION; MECHANISMS; coincidence detection; granule cell; NEURON model; olfactory bulb; spine spike; two-photon uncaging (1)
BACKWARD-MASKING DEFICITS; WORKING-MEMORY; THETA OSCILLATIONS; HUMAN BRAIN; DYSFUNCTION; ATTENTION; NETWORK; TASK; MECHANISMS; DYNAMICS; synchronization; schizophrenia; theta; oscillations; resting state; inattentional blindness (1)
baclofen combination trial dose individualisation dose-finding methadone opiate detoxification (1)
BACTEREMIA; Luer access split septum system; C-port; Central venous catheter; Contamination; Health risks (1)
bacteremia sepsis adipokines s.aureus outcome adiponektin visfatin resistin (1)
BACTERIA; ARCHAEA; ALGORITHM; DATABASE; MEMBERS; SYSTEM; GRAPHS; NOV.; TOOL; anaerobic; thermophilic; neutrophilic; obligately chemolithoautotrophic; Gram-negative; marine; sulfur-reducing; Desulfurobacteriaceae; GEBA (1)
bacteria, coculture techniques, dental pulp, dentin, glucose, lactic acid (1)
BACTERIA; COLITIS; COMMUNITIES; MICROFLORA; REVEALS; GUT; colitis; microbiota; polymerase chain reaction/denaturing gradient gel electrophoresis; 16S ribosomal RNA gene; transgenic rats (1)
BACTERIAL ADHESION; IN-VITRO; BIOMATERIAL SURFACES; BIOFILM FORMATION; IONIC-STRENGTH; MUTANS; MECHANISMS; BINDING; FORCES; RESIN; Dental materials; Protein absorption; Bacterial adhesion; Saliva (1)
BACTERIAL AEROSOL CONTAMINATION; POVIDONE-IODINE; HYDROGEN-PEROXIDE; AIR CONTAMINATION; ESSENTIAL OILS; EFFICACY; CHLORHEXIDINE; LISTERINE(R); ANTISEPTICS; MOUTHRINSE; Mouthwash; Mouth rinse; Infection control; SARS-CoV-2 (1)
BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; WATER ACTIVITY; MARTIAN SOIL; GALE CRATER; MARS; STRESS; SALTS; REDUCTION; RADIATION; perchlorates; morphology; thermophiles; desiccation; survival (1)
BACTERIAL ENDOPHTHALMITIS; POSTOPERATIVE ENDOPHTHALMITIS; PATHOGENESIS; PROPHYLAXIS; FEATURES; endogenous endophthalmitis; sepsis; ocular infection; general disease (1)
BACTERIAL ENDOSYMBIONT; STREPTOMYCES-PHILANTHI; PROKARYOTIC GENOMES; EVOLUTION; SEQUENCE; PROTECT; GROEL; RECONSTRUCTION; TRANSCRIPTOME; HYMENOPTERA; defensive symbiosis; protective mutualism; genome erosion; pseudogenization; Streptomyces (1)
BACTERIAL-ENDOTOXINS; OUTER-MEMBRANE; BIOLOGICAL-ACTIVITY; DIVALENT-CATIONS; LIPOPOLYSACCHARIDES; REMOVAL; ASSAY; PERMEABILITY; SODIUM; Endotoxin; Lipopolysaccharide; Low endotoxin recovery; LER; Masking; Limulus amebocyte lysate; LAL (1)
BACTERIAL FLAGELLAR MOTOR; RHIZOBIUM-LUPINI H13-3; ROTOR PROTEIN FLIG; ESCHERICHIA-COLI; TORQUE GENERATION; CHEMOTAXIS; ROTATION; COMPLEX; MOTILITY; VECTORS; (1)
BACTERIAL-INFECTION; ORGAN FAILURE; SEPSIS; GUIDELINES; CIRRHOSIS; INCREASE; MARKER; SHOCK; cytokines; procalcitonin; fever; infection; sepsis; prognosis (1)
BACTERIAL-INFECTION; SEPSIS; CIRRHOSIS; MARKER; SHOCK; cytokines; fever; infection; procalcitonin; prognosis; sepsis (1)
BACTERIAL LIPOPOLYSACCHARIDE; PLASMA-MEMBRANE; ENERGY-TRANSFER; PHAGOCYTOSIS; RETENTION; COMPLEXES; PATHWAY; CELLS; GENE; rafts; CD14; ceramide; lipopolysaccharide; receptor complexes (1)
BACTERIAL-MENINGITIS; bone marrow transplantation; Enterococcus faecium; gramstain; meningitis; microscopy (1)
Bacterial phosphotransferase system; Heteronuclear NMR; Secondary structure; Histidine phosphate; (Escherichia coli) (1)
BACTERIAL POLY<(R)-3-HYDROXYBUTYRATE>; POLYMERS; POLY(3-HYDROXYBUTYRATE); MISCIBILITY; COPOLYMERS; MORPHOLOGY; DYNAMICS; BLENDS; dielectric relaxation; poly[(R)-3-hydroxybutyrate]; crystallization; ageing (1)
Bacterial Proteins/genetics/metabolism Base Sequence Chromosome Mapping Codon Cosmids/genetics Cystic Fibrosis/microbiology *Genome, Bacterial Human Molecular Chaperones/genetics Molecular Sequence Data Open Reading Frames Pseudomonas aeruginosa/genetics/*pathogenicity RNA, Transfer, Amino Acyl/*genetics Sequence Analysis, DNA Species Specificity Support, Non-U.S. Gov't *Variation (Genetics) (1)
BACTERIAL-RESISTANCE; DRESSINGS; SILVER; ULCERS; CARE; Chronic wounds; Ulcer; Wound therapy; Topical therapy; Cutaneous wound healing (1)
BACTERIAL-RESISTANCE; SILVER; NANOPARTICLES; Antimicrobial surface; Photodynamic coating; Decontamination; Pathogen transmission; Hospital-acquired infections (1)
BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; GUT MICROBIOME; ENDOMETRIAL MICROBIOTA; IMPLANTATION FAILURE; UTERINE MICROBIOTA; PRETERM DELIVERY; WEIGHT-LOSS; PCR ASSAY; PROBIOTICS; Clinical assessment; Fertility; Pregnancy outcomes; Probiotics; Reproductive microbiome (1)
Bactericidal action and Bacteriostatic action (of beta -aminoketones) Ketones Role: BIOL (Biological study) (beta -amino-, antimycotic activity of, mechanism of) Fungicides and Fungistats (beta -aminoketones as) review aminoketone antimycotic mechanism fungus aminoketone review (1)
bactericidal/permeability-increasing protein; dendritic cells; T cells; Th22; interleukin-2; interleukin-22; colitis; microbiota; DAMP; alarmin (1)
BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; (LPS)-BINDING PROTEIN; CELL ACTIVATION; GENE POLYMORPHISMS; SEVERE SEPSIS; IN-VIVO; LPS; PHASE; MICE; RECOGNITION; (1)
Bactericides, Disinfectants and Antiseptics Fungicides and Fungistats Neoplasm inhibitors (dithiourethanes) dithiourethane fungistatic antibacterial dithiourethane dithiocarbamate fungistatic (1)
Bactericides, Disinfectants and Antiseptics Fungicides and Fungistats Neoplasm inhibitors (tris(hydroxymethyl) melamine derivs.) melamine deriv carcinostatic bacteriostatic fungistatic melamine deriv tumor inhibition alkylating triazine (1)
Bactericides, Disinfectants and Antiseptics (glycylglycine platinum complex) Neoplasm inhibitors (Walker 256 carcinosarcoma, glycylglycine platinum complex) Neoplasm inhibitors (sarcoma 180, glycylglycine platinum complex) Neoplasm inhibitors (yoshidasarcoma, glycylglycine platinum complex) peptide platinum chloride complex bactericide glycylglycine platinum complex carcinostat glycylglycine platinum complex (1)
Bactericides, Disinfectants and Antiseptics (hydroxybenzamide derivs. as) Staphylococcus (aureus (includes albus and citreus), hydroxybenzamide deriv. effect on) Benzoic acid Benzoic acid Salicylic acid (bactericidal action of) (1)
Bactericides, Disinfectants and Antiseptics Neoplasm inhibitors (dichlorodipeptide ester platinum complexes) Deoxyribonucleic acids Proteins Ribonucleic acids Role: FORM (Formation, nonpreparative) (formation of, by neoplasm, dichlorodipeptide ester platinum complex inhibition of) peptide platinum complex neoplasm inhibitor (1)
Bactericides, Disinfectants and Antiseptics Neoplasm inhibitors (Mannich bases of dihydroxydiethylstilbenes) Mannich bases Role: BIOL (Biological study) (of dihydroxydiethylstilbenes) Mannich base stilbene antimicrobial antitumor antitumor Mannich base stilbene cytostatic Mannich base stilbene aminomethylstilbene cytostatic (1)
Bactericides Fungicides (amino ketones) Ketones Role: BIOL (Biological study) (amino, fungicidal activity and partition coeffs. and soly. of) Partition (of amino ketones) cytostatic agent antibacteria agent antifungal compd bacteriostatic compd beta amino ketone fungistats (1)
BACTERIOPHAGE ENDOLYSINS; BACTERIOLYTIC AGENT; IMPLANT RETENTION; SOFT-TISSUE; BIOFILM; LYSOSTAPHIN; ANTIBIOTICS; MODEL; DEBRIDEMENT; PROTECTS; Staphylococcus aureus; MRSA; biofilm; orthopaedic infection; osteomyelitis; fracture-related infection; enzybiotic; endolysin (1)
bacteriophage, fracture-related infection, metagenomic, Masquelet, hydrogel (1)
BACTERIOPHAGES; INFECTION; phage therapy; antimicrobial resistance; regulatory framework; Germany (1)
Bacteriophages, Phage therapy, Randomized-controlled trials (1)
BACTERIUM RHODOTHERMUS-MARINUS; ACIDIANUS-AMBIVALENS; QUINOL OXIDASE; COVALENT FLAVINYLATION; TERMINAL OXIDASE; ENZYME; REDOX; PURIFICATION; ELECTRON; COMPLEX; thermoacidophilic archaeon; Suffiblobus metallicus; NADH dehydrogenase (1)
BACTERIUM THERMOTOGA-MARITIMA; BACILLUS-PUMILUS; EXPRESSION; ENZYMES; STEAROTHERMOPHILUS; PURIFICATION; DEGRADATION; SYSTEM; (1)
BACTERIUM THERMOTOGA-MARITIMA; HEAT-SHOCK-PROTEIN; GAMMA-B-CRYSTALLIN; BOVINE EYE LENS; C-TERMINAL EXTENSIONS; SPORE COAT PROTEIN; X-RAY STRUCTURES; CHAPERONE ALPHA-CRYSTALLIN; INTACT 2-DOMAIN PROTEIN; AGE-RELATED-CHANGES; cataract; crystallins; eye lens; domain interactions; protein stability; stress proteins (1)
BACTERIUM THERMOTOGA-MARITIMA; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; STABILITY; DENATURANT; DYNAMICS; STATES; ACID; L9; (1)
BACTERIUM THIOBACILLUS-CUPRINUS; METAL-MOBILIZING BACTERIUM; SP-NOV; PEROMETABOLIS; DELICATUS; INTERMEDIUS; OXIDATION; GENUS; (1)
BAEYER-VILLIGER MONOOXYGENASES; GLYCEROL PHOSPHATE SYNTHASE; DIRECTED EVOLUTION; ARTIFICIAL METALLOENZYMES; ENANTIOSELECTIVE CATALYSIS; HYBRID CATALYSTS; ASYMMETRIC HYDROGENATION; SATURATION MUTAGENESIS; CHEMICAL-MODIFICATION; STRUCTURAL EVIDENCE; bioconjugation; directed evolution; enzymes hybrid catalysts; transition metals (1)
BAFF, APRIL, cABMR, ABMR, dnDSA (1)
BAFF/APRIL SYSTEM; BAFF; ABMR; Immunological risk stratification; Kidney transplantation (1)
BAFF/APRIL SYSTEM; SURVIVAL; APRIL; EXPRESSION; RECIPIENTS; INFECTION; BAFF; Allograft rejection; Viral infection; Antibody mediated rejection; Steroid resistance; Allograft function (1)
BAFF, BAFF-Rezeptor, TACI, BCMA, Synoviale Fibroblasten, Rheumatoide Arthritis, RA (1)
BAFF, Nierentransplantation, Donorspezifische Antikörper, Abstossung, AMR (1)
BAG-OF-MARBLES; SELF-RENEWAL; TRANSLATIONAL CONTROL; ASYMMETRIC DIVISION; TRANSGENIC RNAI; CYST FORMATION; SEX-LETHAL; NIPPED-A; GENE; MAINTENANCE; Stem cells; RNA-seq; Drosophila; RIP-seq; Transcriptome (1)
bait evaluation; pest control; Linepithema humile; bitterness perception; bait aversion; bait attractiveness; invasive ants (1)
Bait evaluation · Pest control · Linepithema humile · Insecticide detection · Bait aversion · Bait attractiveness · Invasive ants (1)
bakterielle Adhäsion, Komposit, Füllkörper, S. mutans, S. sanguinis, surface free energy, Oberflächenrauheit (1)
bakterielle Adhäsion, Puffer, Speichelbeschichtung, Streptococcus gordonii, Netzwinkel (1)
Bakteriorhodopsin , Chlamydomonas reinhardii , Biologisches Modell , Poröse Membran , Aluminate , Adsorption , Funktionalisierung <Chemie> , Proteine , Photoresist , Nanoporöser Stoff , Modellsystem , lichtaktiviert , model system , light-activated (1)
balance; body asymmetry; equitation; horse; motor laterality; sensory laterality; stress; welfare (1)
BALANITIS-XEROTICA-OBLITERANS; BOYS; INFECTIONS; PHIMOSIS; SURGERY; PENIS; Patient information; Urinary tract infection; Cryptorchidism; Penis; Diathermy (1)
BALANITIS-XEROTICA-OBLITERANS; ET-ATROPHICUS; PHIMOSIS; CHILDHOOD; Balanitis sclerotica obliterans; BXO; Childhood; Lichen sclerosus et atrophicus; Relapse; Tacrolimus ointment; Topical therapy (1)
BALANITIS-XEROTICA-OBLITERANS; ET-ATROPHICUS; SEXUAL-ABUSE; CASE SERIES; CHILDHOOD; DIAGNOSIS; BOYS; ASSOCIATION; PHIMOSIS; PLANUS; Phimosis; Microtrauma; Meatal stenosis; Autoimmunity; Cortisone (1)
; Balassa-Samuelson; Product variety; Measurement errors; Pairwise regressions (1)
Baldrian , Sennes , Umkehrphasen-HPLC , Qualitätskontrolle , Extrakt , Lignane , Valerensäure , Sennoside , Dünnschichtchromatographie , ICH-guidelines , Stabilitätsprüfung , Stability control , ICH-guidelines (1)
Balkan history, Balkan studies, Federalism, Balkan nationalism, Bulgarian history, nationalism, social networks, intellectual history, Socialgeschichte Bulgariens, Nationalismus auf dem Balkan, soziale Netzwerken auf dem Balkan (1)
BALLISTIC MAGNETORESISTANCE; ELECTRON-MICROSCOPY; (1)
ballistic systems, nondiagonal contribution, off-diagonal contributions, quantum transport, RMT predictions, semiclassical, spin-orbit interaction (1)
BALLISTIC TRANSPORT; SUSPENDED GRAPHENE; TRANSFER TORQUE; LAYER GRAPHENE; BORON-NITRIDE; SPINTRONICS; SINGLE; FUNDAMENTALS; LIFETIMES; (1)
Ballistische-Elektronen-Emissions-Mikroskopie , Schottky-Kontakt , Halbleitergrenzfläche , Übergitter , Ferromagnetische Heterostruktur , , Ballistic-Electron-Emission-Microscopy , Schottkybarrier , heterostructure , semiconductor interface (1)
Balneophototherapie und Schmalband-UVB-Bestrahlung, Badewassertemperatur, Badedauer, Photosensibilität, Psoriasis, balneophototherapy, narrowband- ultraviolet B, temperature of Dead Sea salt solution, bathtime, photosensitivity, psoriasis (1)
Baltic Germans, ego-documents, personal accounts, forced mgration, Second World War, National Socialism (1)
Balzac, Honoré de (1)
; Banach manifold of C-k-mappings; Compact-open topology; Omega-lemma; Infinite dimensional manifolds (1)
Banach manifolds; Causal fermion systems; Infinite-dimensional analysis; Expedient differential calculus; Frechet-smooth Riemannian structures; Non-smooth analysis (1)
BAND ALIGNMENT; SUPERCONDUCTIVITY; GRAPHITE; CRYSTALS; (1)
BAND-EDGE EXCITONS; OPTICAL-RESPONSE; BROADENING PARAMETERS; ELECTRONIC-STRUCTURE; SINGLE-LAYER; SEMICONDUCTOR; MOS2; RENORMALIZATION; LINEWIDTH; EVOLUTION; 2D materials; excitons; exciton-phonon interaction; scattering lifetime (1)
Band gap; Charge; Density of states; Edge states; Electrical conductivity; Fermi surface; Photocurrent; Topological materials (1)
Band gap, Local density of states, Surface states, Topological materials, van Hove singularity, Atomic force microscopy, Density functional theory, GW method, Noncontact atomic force microscopy, Scanning tunneling microscopy, Scanning tunneling spectroscopy, Tight-binding model, Wannier function methods (1)
BAND-GAP POLYMERS; ELECTRONIC-STRUCTURE; MOLECULAR-SYSTEMS; AB-INITIO; DYES; POLYSQUARAINES; RECOGNITION; REDUCTION; SENSOR; STATE; (1)
BANDGAP RENORMALIZATION; ELECTRICAL CONTROL; MONOLAYER MOS2; SPIN; DYNAMICS; GENERATION; COHERENCE; MOMENTUM; WS2 (1)
BAND-GAP RENORMALIZATION; LUTTINGER LIQUID; WELLS; GAAS; (1)
BANDGAP TRANSITION; POLARIZATION; EXCITATIONS; LAYER; WSE2 (1)
BANDIT; Best arm identification; User studies; Racing algorithms (1)
BAND-STRUCTURE; (1)
BAND-STRUCTURE; BILAYER GRAPHENE; RHOMBOHEDRAL GRAPHITE; TRILAYER GRAPHENE; DIRAC FERMIONS; 1ST-PRINCIPLES; TRANSPORT; STATES; (1)
BAND-STRUCTURE; CYCLOTRON-RESONANCE; CONDUCTION-BAND; LIGHT-HOLE; SEMICONDUCTORS; WELLS; STATES; HELIX; (1)
BAND-STRUCTURE; JUNCTIONS; SPECTRUM; FIELD (1)
BAND-STRUCTURE; LASERS; (1)
BAND-STRUCTURE; MAJORANA FERMIONS; QUANTUM-WELLS; SEMICONDUCTORS; GROWTH; SUPERCONDUCTOR; CONDUCTANCE; GAAS; APPROXIMATION; SUPERLATTICES; (1)
; band structure; molybdenum compounds; monolayers; photoluminescence; Raman spectra; semiconductor materials (1)
BAND-STRUCTURE; MULTIFERROICS; TRANSPORT; (1)
BAND-STRUCTURE; NANOWIRE; SEMICONDUCTORS; ZINCBLENDE; POLYTYPES; (1)
BAND-STRUCTURE; SPECTRUM; GE; (2)
BAND ULTRAVIOLET-B; VERSUS-HOST-DISEASE; MEDIUM-DOSE UVA1; T-CELL LYMPHOMA; SEVERE ATOPIC-DERMATITIS; 308-NM EXCIMER-LASER; BRITISH PHOTODERMATOLOGY GROUP; PLAQUE-TYPE PSORIASIS; DISABLING PANSCLEROTIC MORPHEA; PUVA-BATH PHOTOCHEMOTHERAPY; (1)
Bank, Credit Risk; Risk Management, R (1)
Bankenarchitektur (1)
Bankenarchitekturen (1)
Bankenarchitekturen, Geschäftsmodell (1)
Bankenkrise , Moral Hazard , Asymmetrische Information, Bank-runs , Finanzintermediation, Financial Intermediation , Bank Runs , Asymmetric Information , Moral Hazard (1)
Banking, Wertschöpfungsnetze (1)
Bank insolvency, Bank bailout, monetary shocks, REITs, REITs’ risk-return profile (1)
BANK INTEREST MARGINS; EMPIRICAL-EVIDENCE; FINANCIAL CRISIS; MONETARY-POLICY; TRANSMISSION; DISEQUILIBRIUM; DETERMINANTS; LIQUIDITY; GERMANY; Bank lending; Loans; Financial vulnerability; Loan-rate spreads; Institutions; Macroeconomic shocks (1)
BANK INTEREST MARGINS; PANEL-DATA; TESTS; Interest rate spreads; Banks; Financial crisis; Czech Republic (1)
BANK RUNS; ESTATE; LIQUIDITY; INDEXES; PRICES; IMPACT; BIAS; Appraisal-based valuation; Transaction-based valuation; Hedonic pricing; Commercial real estate; Open-end real estate funds (1)
BANKRUPTCY REORGANIZATION; (1)
Bankvertrieb; Web 2.0 (1)
BAOBAB ADANSONIA-DIGITATA; TIMBER FOREST PRODUCTS; LAND-USE TYPE; WEST-AFRICA; SAVANNA VEGETATION; SEMIARID SAVANNA; PROTECTED AREAS; WOODY-PLANTS; DYNAMICS; BENIN; Harvesting; Land use; Non-timber forest products; Size class distribution; West African savanna (1)
B AORTIC DISSECTION; SPINAL-CORD ISCHEMIA; ENDOVASCULAR REPAIR; EDITORS CHOICE; OUTCOMES; MANAGEMENT; SURGERY; Fenestrated; Branched; Chronic dissection; Thoraco-abdominal aneurysm (1)
; Barcode; Cytochrome oxidase 1; CEAMARC; Taxonomy; Systematics (1)
BARDET-BIEDL-SYNDROME; SEA-URCHIN SPERM; RIGHT AXIS DETERMINATION; HUMAN OBESITY SYNDROME; LEFT-RIGHT ASYMMETRY; PRIMARY CILIA; CATION CHANNEL; PLASMA-MEMBRANE; PKD1 GENE; EPITHELIAL-CELLS (1)
Bardt-Biedl-Syndrom, BBS2, BBS4, Oligogener Vererbungsmodus, Ziliopathie (1)
Bargeldloser Zahlungsverkehr , Elektronischer Zahlungsverkehr , Electronic Government , Vorgehensmodell , Kreditkarte, Zahlungsverfahren , öffentliche Verwaltung, E-Payment , E-Government (1)
BARIUM CARBONATE; CALCIUM-CARBONATE; BIOMIMETIC CRYSTALLIZATION; MORPHOLOGICAL COMPLEXITY; RICH ENVIRONMENTS; SELF-ORGANIZATION; BLOCK-COPOLYMER; CRYSTAL; ARAGONITE; PRECIPITATION; (1)
BARIUM CARBONATE; RICH ENVIRONMENTS; CRYSTALS; PRECIPITATION; MORPHOLOGY; ARAGONITE; NACRE; CRYSTALLIZATION; MINERALIZATION; NANOCRYSTALS; barium; biomimetic synthesis; biomorphs; kinetics; self-assembly; silica (1)
BARIUM CARBONATE; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BIOMORPHS; BIOMINERALIZATION; CRYSTALLIZATION; SYSTEMS; COPRECIPITATION; ARAGONITE; COMPLEX; (1)
Barium carbonate, silica, silica-carbonate biomorphs, biomimetic crystallization, core-shell-shell nanoparticles, pH constant titration, crystallization on micropatterned substrates (1)
barium compounds, bismuth compounds, ferroelectric materials, ferroelectric thin films, optical harmonic generation, X-ray diffraction, electron microscopy (1)
baroreceptors; pain; asymptomatic myocardial ischaemia (1)
baroreceptors; PRES; blood pressure; antinociception (1)
BAROREFLEX ACTIVATION THERAPY; SINUS NERVE-STIMULATION; HIGH BLOOD-PRESSURE; RESISTANT HYPERTENSION; HEART-RATE; ARTERIAL-HYPERTENSION; SURGICAL TECHNIQUE; FEASIBILITY TRIAL; UNITED-STATES; HUMANS; Electric stimulation therapy; Carotid sinus; Anesthesia; Baroreceptor reflex; Hypertension (1)
Barrel <alpha, beta-> , molekulare Evolution , gerichtete Evolution , Rationales Design , Barrel <alpha, beta-> , molecular evolution , directed evolution , rational design (1)
Barrel <alpha, beta-> , Proteine , Molekulare Evolution , Proteinfaltung , Strukturanalyse , (beta/alpha)2-Module , HisF , Imidazolglycerinphosphat Synthase , (beta/alpha)8-barrel fold , (beta/alpha)2-unit , HisF , Imidazolglycerolphosphatsynthase , evolution (1)
Barrett, Karzinomrisiko, Verlaufskontrolle (1)
BARRIER; DIODE; (1)
Barrierefreiheit, ASP.NET, BITV, Rich Client Funktionalität, Benutzerdefinierte Steuerelemente, JavaScript-Unabhängigkeit (1)
Barrierefreiheit, Inklusion, Diskriminierung, Verbandsklage (1)
Barrierefreiheit; Word; Layout; Publikation; Anleitung (1)
Barrierefreiheit, Zugänglichkeit, Nahverkehr, Fernverkehr, UN-Behindertenrechtskonvention, BRK, CRPD, Menschen mit Behinderungen, Bundesverfassungsgericht, BVerfG, Europäischer Gerichtshof für Menschenrechte, EGMR, EMRK (1)
BARRIER FUNCTION; HEART-FAILURE; ACTIVATION; KINASE; CAMP; PERMEABILITY; ENHANCEMENT; DYSFUNCTION; PROTECTS; EFFICACY; Endothelium; Hyperpermeability; Crataegus extract; Signaling pathways (1)
BARRIER-HEIGHT; WORK FUNCTION; CHARGE-STATE; MICROSCOPY; MOLECULE; STM; RESOLUTION; SURFACES; DISTANCE; METALS; (1)
BARRIER PERMEATION; QUANTUM-CHEMISTRY; SCREENING MODEL; REAL SOLVENTS; SOLVATION; ENERGY; (1)
BART Heterogeneity in treatment effects Personalized medicine Predicted individual treatment effects (1)
BART · Heterogeneity in treatment effects · Personalized medicine · Predicted individual treatment effects (1)
Bartik labor demand shocks; time-varying uncertainty shocks; real options effects; housing market (1)
BARYON DENSITY; SYMMETRY; (1)
BASAL ANGIOSPERMS; INSECT POLLINATION; BEETLE POLLINATION; ARACEAE; EVOLUTION; THERMOGENESIS; BIOLOGY; SCENT; DIVERSIFICATION; INFLORESCENCES (1)
BASAL-CELL CARCINOMA; DELTA-AMINOLEVULINIC-ACID; TOPICAL METHYL AMINOLEVULINATE; RENAL-TRANSPLANT RECIPIENTS; BOWENS-DISEASE; ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; FOLLOW-UP; ENDOGENOUS PROTOPORPHYRIN; RANDOMIZED MULTICENTER; (1)
BASAL-CELL CARCINOMA; GENOMIC ANALYSIS; NEVUS SYNDROME; HUMAN HOMOLOG; MEDULLOBLASTOMA; SPECTRUM; RECEPTOR; ABNORMALITIES; MALFORMATIONS; OVERGROWTH; (1)
BASAL-CELL CARCINOMA; INTENSE PULSED-LIGHT; NONMELANOMA SKIN-CANCER; DELTA-AMINOLEVULINIC-ACID; ORGAN-TRANSPLANT RECIPIENTS; MULTIPLE ACTINIC KERATOSES; 5-PERCENT IMIQUIMOD CREAM; VULVAR LICHEN-SCLEROSUS; COMPARATIVE SPLIT-FACE; REAL-LIFE PRACTICE; 5-aminolaevulinic acid; dermatology; guidelines; methyl aminolaevulinate; non-melanoma skin cancer; photodynamic therapy (1)
BASAL-CELL CARCINOMA; IRRITANT CONTACT-DERMATITIS; MOHS MICROGRAPHIC SURGERY; REAL-TIME; MALIGNANT-MELANOMA; HUMAN-SKIN; REFLECTANCE MICROSCOPY; ROUTINE HISTOLOGY; LENTIGO MALIGNA; DIAGNOSIS; in vivo imaging technique; non-invasive pathology; melanoma (1)
BASAL-CELL CARCINOMA; MALIGNANT-MELANOMA; LYMPH-NODE; YAG LASER; HYPERPLASIA; LIGHT; INKS; (1)
BASAL-CELL CARCINOMA; PHOTODYNAMIC THERAPY; aminolevulinic acid; thin film; plaster; rapid release; skin permeation (1)
BASAL-CELL CARCINOMA; RENAL-TRANSPLANT RECIPIENTS; RANDOMIZED CONTROLLED-TRIAL; IMIQUIMOD 5-PERCENT CREAM; 5-YEAR FOLLOW-UP; AMINOLEVULINATE PHOTODYNAMIC THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL; SURGICAL EXCISION; SUN EXPOSURE; (1)
BASAL-CELL CARCINOMAS; FOLLICULAR DIFFERENTIATION; SOMATIC MUTATIONS; NEVUS; TRICHOEPITHELIOMAS; POLYMORPHISM; ASSOCIATION; DELETIONS; NEOPLASM; CANCER; trichoblastoma; PTCH gene; basal cell carcinoma; trichoepitbelioma; appendageal tumor; adnexal tumor; skin (1)
BASAL-CELL CARCINOMA; SQUAMOUS-CELL; ESOPHAGEAL CANCER; GENE-MUTATIONS; PENILE CANCER; KINASE-B; TUMORS; HEAD; EXPRESSION; DOMAIN; AKT1; basal cell carcinoma; non-melanoma skin cancer; PIK3CA; squamous cell carcinoma (1)
BASAL-CELL CARCINOMAS; TOPICAL METHYL AMINOLEVULINATE; 5-AMINOLEVULINIC ACID METHYLESTER; BOWENS-DISEASE; ACTINIC KERATOSES; IN-VIVO; SOLAR KERATOSES; LIGHT; TRIAL; LASER; photodynamic therapy; fluorescence detection; aminolevulinic acid; methyl aminolevulinate; skin cancer (1)
BASAL-CELL CARCINOMAS; TOPICAL METHYL AMINOLEVULINATE; NONMELANOMA SKIN-CANCER; 5-AMINOLEVULINIC ACID; BOWENS-DISEASE; ACTINIC KERATOSES; INCOHERENT-LIGHT; TRANSPLANT RECIPIENTS; CLINICAL-TRIAL; ACNE-VULGARIS; aminolevulinic acid; inflammatory dermatoses; methyl aminolevulinate; photodynamic therapy; skin cancer (1)
BASAL CEREBRAL-ARTERIES; DOPPLER SONOGRAPHY; LIMITATIONS; VELOCITY; VALUES; carotid siphon; transcranial color-coded sonography (TCCS); reference values; cerebrovascular disease; stroke (1)
BASAL GANGLIA; ACTIVATION; CORTEX; FMRI; INPATIENTS; PATTERNS; REGIONS; (1)
BASAL GANGLIA CIRCUITS; SONG CONTROL NUCLEI; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; ZEBRA FINCH; MOTOR COORDINATION; LANGUAGE DISORDERS; FLIGHT ORIENTATION; VISUAL-SYSTEM; SEVERE SPEECH; (1)
BASAL GANGLIA; ISCHEMIC STROKE; RISK-FACTORS; CHILDREN; DYSTONIA; LESIONS; TRAUMA; (1)
BASE-CATALYZED REACTIONS; SIDE-CHAIN ALKENYLATION; POTASSIUM TERT-BUTOXIDE; H BOND ADDITION; ANIONIC-POLYMERIZATION; ALPHA-METHYLSTYRENE; ENANTIOSELECTIVE CARBOLITHIATION; ISOPRENE POLYMERIZATION; EQUILIBRIUM ACIDITIES; AROMATIC-HYDROCARBONS; (1)
BASEL-II; CREDIT RISK; DETERMINANTS; CYCLICALITY; RATES; GAAP 326; IFRS 9; Lifetime expected loss; Loan loss provisioning; Regulatory capital; SICR (1)
Basel II, IT-Strategien, Bankvertrieb, Filial-Banking (1)
Basel II, Kreditrisiko, Rating, Ausfallwahrscheinlichkeiten, Backtesting, Validierung (1)
Basel II, Rating, Projektentwicklung, Finanzierung (1)
BASE-LINE DATA; PHARYNGEAL CANCER; KNOWLEDGE; ATTITUDES; ALCOHOL; PHYSICIANS; TOBACCO; dentist; early detection; opinion; oral cancer; practice (1)
BASEMENT-MEMBRANE COLLAGEN; EXTRACELLULAR-MATRIX MESOGLEA; AMINO-ACID SEQUENCE; STRUCTURAL ORGANIZATION; CAENORHABDITIS-ELEGANS; ALPHA-2(IV) COLLAGEN; CHAIN; GENE; LAMININ; IDENTIFICATION; (1)
BASEMENT-MEMBRANE; HEAD REGENERATION; LAMININ CHAIN; BASAL LAMINA; IV COLLAGEN; VULGARIS; MESOGLEA; EXPRESSION; NEMATOCYTES; FIBRONECTIN; (1)
BASEMENT-MEMBRANE; NEPHROTIC SYNDROME; SULFADIAZINE; EXPOSURE; DEPOSITS; SERUM; Argyria; soluble silver; silver salts; renal insufficiency; silver deposits (1)
BASEMENT-MEMBRANES; GOLD NANOPARTICLES; MECHANICAL-PROPERTIES; POLYETHYLENE-GLYCOL; COLLAGEN GELS; I COLLAGEN; EX-VIVO; PEG; DIFFUSION; PARTICLES; Mobility; ECM; PEGylation density; Nanoparticles; Collagen; Matrigel; Surface charge; Interaction (1)
base pairing cooperativity · macrocycles · nucleobases · self-assembly · thin films (1)
BASE-PAIR SEQUENCES; MINOR-GROOVE; DNA; RECOGNITION; IMIDAZOLE; POLYAMIDES; NETROPSIN; LIGANDS; MOTIF (1)
Base Sequence DNA Repair/genetics Deoxyribonuclease I/*genetics/metabolism Escherichia coli/enzymology/*genetics Evolution Fluorescent Dyes *Genome, Bacterial Molecular Sequence Data Mutagenesis Oligonucleotides/analysis Substrate Specificity/genetics Support, Non-U.S. Gov't (1)
Base Sequence Endonucleases/*analysis Escherichia coli/enzymology/genetics Molecular Sequence Data *Sequence Analysis, DNA Software Support, Non-U.S. Gov't (1)
Basicity; Diastereotopomerization; Imines; Steric shielding; Steric strain (1)
basicity; NMR spectroscopy; peralkylated guanidines; protonation; proton sponges (1)
basidiomycetes; fungi; glyco-inositol-phospho-ceramides; glycolipids; glycosphingolipids (1)
BASILAR PAPILLA; SERINUS-CANARIUS; GUINEA-PIG; AUDITORY-THRESHOLDS; BARN OWL; INNERVATION; COCHLEAR; CHICKEN; DEGENERATION; MORPHOLOGY; bird; cochlea; basilar papilla; hair cell; pathology; axon diameter (1)
BASILAR SYNDROME; ENCEPHALOPATHIES; SPECTRUM; TOP; Unconsciousness; Secondary headaches; Seizures; Dizziness; Paraneoplastic syndrome (1)
Basisdokument, CAG, eJustice, generative KI, Justiz, LLM, Parteivortrag, RAG, Retrieval-Augmented, Relation, Relationstabelle, Schriftsatz, Verfahrensdokument, Zivilprozess (1)
Basisdokument, Digitalisierung, eJustice, Justiz, Kommunikationsplattform, Legal Tech, Online-Verfahren, Reallabor, Verfahrensdokument, Zivilprozess (1)
Basisdokument Digitalisierung Evaluierung Parteivortrag qualitative Inhaltsanalyse Reallabor Zivilprozess (1)
Basisdokument, Evaluation, mixed methods, Reallabor, strukturierter Parteivortrag (1)
Basisdokument, Reallabor, Zivilprozess, Rechtsinformatik, Legal Tech, Qualitative Inhaltsanalyse, Interview (1)
BASIS-SETS; ACCURACY; MP2; (1)
BASIS-SETS; APPROXIMATION; ATOMS; MODEL; Solvation COSMO-RS (1)
Basis sets; Chemical calculations; Molecules (1)
BASIS-SETS; FLUORESCENCE; EFFICIENT; POLYMERS; PHOTOPHYSICS; APPROXIMATE; SIMULATIONS; DISPERSION; PATHWAYS; EXCHANGE; (1)
BASIS-SETS; INELASTIC-SCATTERING; HE ATOMS; DIFFRACTION; ADSORPTION; CRYSTALS; VALENCE; PROGRAM; QUALITY; SYSTEMS; (1)
BASIS-SETS; NEUTRON-DIFFRACTION; 1ST PRINCIPLES; WAVE-FUNCTIONS; SOLIDS; PRESSURE; (1)
BASKET; multicategory purchase models; promotion effects; multivariate probit; Markov chain Monte Carlo; stochastic model search (1)
Basket trial, adaptive design, calibration, information borrowing, Bayesian modelling, error control (1)
BASOLATERAL TAL MEMBRANES; THICK ASCENDING LIMB; CL CHANNELS; KIDNEY; CLONING; CELLS; HETEROGENEITY; EXPRESSION; MEDULLA; PROTEIN; mTAL; sodium chloride; furosemide; salt regulation; loop diuretics; Bartter's syndrome (1)
basophile Granulozyten, Gedächtnisimmunantwort, TH2-Zellen, antigen-spezifische Antikörper-Produktion (1)
Basophils, Basophile Granulozyten, GvHD, Graft-versus-host-disease, Spender-Wirt-Reaktion, MLR, CD4, T-Zellen, T cells, syngeneic T cell proliferation, Zytokine, cytokines, Interleukin 4, Interleukin 6, IL-4, IL-6, T cell proliferation, T-zellproliferation (1)
BASOPHILS; Facial transplantation; Transplant; Reconstructive surgery; Vascularized composite allotransplantation; Vascularized composite allograft (1)
Batch building, Discrete-time modeling, Queueing theory, Stochastic finite elements (1)
BATH-WATER DELIVERY; PUVA THERAPY; CALCIPOTRIOL MC-903; CARCINOGENIC RISK; PLUS UVA; PHOTOCHEMOTHERAPY; 8-METHOXYPSORALEN; PSORALENS; SKIN; COMBINATION; psoriasis; UVB; PUVA; bath-PUVA; side effects (1)
BATTEN-DISEASE; MOUSE MODEL; GENE-EXPRESSION; RETINITIS-PIGMENTOSA; ENDOCYTIC PATHWAY; MICROGLIAL CELLS; CLN3 PROTEIN; CATHEPSIN-D; ACTIVATION; KNOCK; Juvenile neuronal ceroid lipofuscinosis; CLN3; Microglia; Minocycline; Retinal degeneration (1)
Batterie , Optimierung , Phasendiagramm , Lithiumion , Elektrolyt , Zustandsdiagramm , Flüssgkeitsbereich , Leitfähigkeit , LiBOB , Thermistor , Phase diagram , liquid range , conductivity , LiBOB , Thermistor (1)
Batteriezellen, OEMS, Gasentwicklung, SEI Bildung (1)
BATTERY ELECTROLYTES; NONAQUEOUS ELECTROLYTES; ANODIC BEHAVIOR; PASSIVE FILM; SALTS; GRAPHITE; LIPF6; CONDUCTANCE; ANIONS; (1)
BATTERY ELECTROLYTES; SALTS; (1)
BATTERY ELECTROLYTES; SALTS; CONDUCTIVITY; LIBOB; (1)
Bauaufsichtliche Zustimmung (1)
BAUM-CONNES CONJECTURE; V-MANIFOLDS; THEOREMS; OPERATORS; SPACES; (1)
Baumunfälle, Baum, Mensch, Schutz, Verfassungsrecht, Amtshaftung, Manssen (1)
Baunutzungsrecht, Manssen (1)
Bauordnungsrecht, Manssen (1)
Bauplanungsrecht (1)
Bauplanungsrecht , Regionalplanung , Hochwasserschutz , Kommunale Selbstverwaltung , Wasserwirtschaftsbehörde , , Landuse- planning , regional planning , flood protection , municipal right of self- administration , water authority (1)
Baurecht; Bestandsschutz; Eigentum; Grundgesetz (1)
Baurecht; Einvernehmen; § 36 BauGB (1)
; Bavaria; Baden; Wurttemberg; judge; judicial system; Enlightenment; Napoleon; Feuerbach; judicial independence (1)
Bayerische Alpen , Dendrochronologie , Dendrogeomorphologie , Boden , Bodenkunde , Bodenkartierung , Massenbewegung <Geomorphologie> , Rutschung , Kriechbewegung , Lawine , Muren , fluviale Verschüttung , Niederschlagsschwellenwerte , Gefahrenkarte , Lahnenwiesgraben , Skeleton Plot , massmovements , dendrochronology , debris flow , slides (1)
Bayerische Bauordnung; Nachbarbeteiligung (1)
Bayerischer Bürgermeister, Doppelvertretung Bürgermeister, Grundstücksverträge, Manssen (1)
Bayerische Staatsbibliothek ; Open Access ; Portal <Internet> (1)
Bayern 1920-1924 Weimarer Republik Aufstieg der NSDAP Bayerische Ministerpräsidenten Einwohnerwehr (1)
Bayern , Ausländischer Arbeitnehmer / Beschäftigung , Arbeitslosigkeit , Migration , Selbständigkeit , Ausländerbeschäftigung , Selbständigkeit von Ausländern , Arbeitslosigkeit von Ausländern , Migration , Zweite Generation , migration , Bavaria , employment of foreigners , self-employment of foreigners , unemployment of foreigners (1)
Bayern / Forstverwaltung / Geschichte 1745-1777 , Kosteletzky von Sladowa, Johann Heinrich / Biographie , Kosteletzky von Sladowa, Johann Heinrich / Biography (1)
Bayern-Landshut , Adel , Mittelalter / Geschichte 1250-1500 , Heinrich der Reiche , Heinrich XVI. , Heinrich der Reiche , Heinrich XVI. (1)
Bayern, Regensburg, Wirtschaftsgeschichte, Gewerbe, Kleinhandel, Kramerinnung, Handelsstand,19. Jahrhundert, Gewerbegesetz (1)
Bayern-Straubing-Holland, Rechnungsbuch, Geschichte 1424/25, Johann III. Ohnegnade, Hussiten-Kriege, Quelle, Frühneuhochdeutsch, Konzeptbuch, Reinschrift, Bavaria-Straubing-Holland, account book, history 1424/25, John III. Pitiless, Hussite wars, historical source, early New High German, draft book, fair copy (1)
Bayesian decision-theoretic model Clinical trials Delayed responses Dynamic programming Response-adaptive randomisation (1)
; Bayesian estimation; generalized linear models; hidden Markov models; hidden semi‐ Markov models; Monte Carlo Newton‐ Raphson (1)
Bayesian experimental designs, historical data, rare-disease trials, robustness, sample size (1)
Bayesian hierarchical model; COVID‐ 19; epidemic surveillance; infectious disease epidemiology; nowcasting (1)
Bayesian Inference; bias correction; biased models; data imbalance; robust inference (1)
Bayesian inference | informal likelihood | inverse modelling | parameter estimation | predictive uncertainty | sensitivity analysis | simulation models | uncertainty propagation (1)
Bayesian inference; Probability judgements; Representation of information; Natural frequencies (1)
Bayesianisches Denken, Doppelbaum, Einheitsquadrat, Calculation, Covariation (1)
Bayesianisches Denken, natürliche Häufigkeiten, Baumdiagramme, medizinische Entscheidungsfindungsprozesse, Mammographie-Problem, 2-Test-Fall (1)
BAYESIAN NETWORKS; (1)
BAYESIAN NETWORKS; STEM-CELLS; REGULATORY NETWORKS; RNA INTERFERENCE; INFERENCE; PATHWAYS; perturbation data; network reconstruction (1)
BAYESIAN PHYLOGENETIC INFERENCE; L. COMPOSITAE; MRBAYES; CLASSIFICATION; POLYPLOIDS; ASTERACEAE; AMERICAN; MARKERS; EXAMPLE; NRDNA; Asteraceae; Biogeography; Miocene; Pleistocene; Polyploidy; Sicilian channel; Speciation (1)
; Bayesian reasoning; Clinical reasoning; Diagnostic efficiency; Natural frequencies; Undergraduate medical students (1)
Bayesian reasoning; natural frequencies; probabilities; einstellung; tree diagram (1)
Bayesian reasoning, natural frequencies, probabilities, Einstellung, tree diagram (1)
- Bayesian reasoning - Probabilities - Natural frequencies - Tree diagrams - 2x2 tables (1)
Bayesian reasoning, Training study, Double tree, Unit square, Natural frequencies, Probability tree (1)
Bayesian reasoning, visualization, natural frequencies (1)
Bayesian sample size determination; Borrowing strength; Master protocol; Mixture prior; Phase II (1)
Bayes, natural frequencies, tree diagrams, medicine (1)
Bazooka, PAR-3, aPKC, PAR-1, Crumbs, adherens junctions, cell polarity (1)
B-CELL ACTIVATION; NEUTRALIZING ANTIBODIES; SARS-COV-2; INFECTION; TRANSMISSION; RESPONSES; IMMUNITY; ACE2; SARS-CoV-2 S protein; seroreactivity; COVID-19 samples; cross-reactivity; Pre-COVID-19 samples; malaria endemic-area (1)
B-CELL; ANTIGEN; CD19; EXPRESSION; REMISSIONS; MATURATION; EFFICACY; (1)
B-CELL-DEPLETION; THROMBOTIC THROMBOCYTOPENIC PURPURA; RANDOMIZED CONTROLLED-TRIAL; CENTRAL-NERVOUS-SYSTEM; INTRAVENOUS IMMUNOGLOBULIN THERAPY; AUTOIMMUNE HEMOLYTIC-ANEMIA; CONNECTIVE-TISSUE-DISEASE; INTERSTITIAL LUNG-DISEASE; CONTROLLED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; adverse events; biological response modifiers; consensus; evidence; off-label treatment; systemic lupus erythematosus (1)
B-CELL DEVELOPMENT; PLASMA-CELLS; NERVE FIBERS; T-CELLS; TRANSCRIPTION; ARTHRITIS; MEMORY; NICHE; DIFFERENTIATION; PROLIFERATION; (1)
B-CELL FOLLICLES; BENIGN; DISEASE; TRACTOGRAPHY; FEATURES; ATROPHY; SYSTEM; (1)
B-CELL HOMEOSTASIS; CHRONIC GVHD; IBRUTINIB; EFFICACY; Allogeneic stem cell transplantation; Chronic graft-versus-host disease; Rituximab (1)
B-CELL LYMPHOMA; BREAST-CANCER; PANCREATIC-CANCER; EXPRESSION PROFILES; LUNG ADENOCARCINOMA; SURVIVAL; SIGNATURE; CLASSIFICATION; METASTASIS; VALIDATION; (1)
B cell Lymphoma, Causal Inference, IDA, Virtual experiments, normalization (1)
B-CELL LYMPHOMA; COMPARATIVE GENOMIC HYBRIDIZATION; TISSUE MICROARRAY; SURVIVAL; CANCER; (1)
B-CELL LYMPHOMA; DNA COPY NUMBER; CHRONIC LYMPHOCYTIC-LEUKEMIA; MOLECULAR CHARACTERIZATION; CHROMOSOMAL-ABNORMALITIES; MALIGNANT-LYMPHOMA; PROGNOSTIC FACTORS; CONSENSUS REGIONS; BURKITTS-LYMPHOMA; HYBRIDIZATION; (1)
B-CELL LYMPHOMA; FDG PET; CT; Lymphoma; Aggressive B-cell lymphoma; Bone marrow biopsy; Diagnostic performance (1)
B-CELL LYMPHOMA; GENE-EXPRESSION; MOLECULAR CHARACTERISTICS; FOLLICULAR LYMPHOMA; CLASSIFICATION; DIAGNOSIS; CHILDREN; FREQUENT; SUBTYPE; GENOME; Epstein-Barr virus status; Burkitt lymphoma; age; mutations (1)
B-CELL LYMPHOMA; GENE; EXPRESSION; PATTERNS; (1)
B-CELL LYMPHOMA; GENE-EXPRESSION; TUMOR MICROENVIRONMENT; IMAGE-ANALYSIS; SURVIVAL; Macrophage; Immunohistochemical staining; CD14; CD163; Automated cell counting; ROF filtering; Floating threshold; Rule-based detection (1)
B-CELL LYMPHOMA; MYC; INACTIVATION; DIAGNOSIS; PROTEINS; (1)
B-CELL LYMPHOMA; PANCREATIC ACINAR-CELLS; KINASE-I; MEMBRANE-PROTEIN; PLATELET-AGGREGATION; SUSCEPTIBILITY LOCUS; PROTEOMIC ANALYSIS; NUCLEAR-ENVELOPE; LRMP GENE; RECEPTOR; cGMP; cGKI; IP3R-I; IP3R-II; IP3R-III; IRAG; IRAG1; IRAG2; Jaw1; LRMP; MRVI1; PKGI (1)
B-CELL LYMPHOMA; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; VARIABLE SELECTION; MASS-SPECTROMETRY; BURKITTS-LYMPHOMA; CLASSIFICATION; REGULARIZATION; REGRESSION; PROTEOMICS; (1)
B-CELL LYMPHOMA; RITUXIMAB; MYC; CYTOGENETICS; DIAGNOSIS; SURVIVAL; NanoString; nCounter; classifier; Burkitt; diffuse large B-cell lymphoma; MYC (1)
B-CELL LYMPHOMAS; CLINICAL-FEATURES; TRANSLOCATION; CLASSIFICATION; PROLIFERATION; T(14/18); STRESS; (1)
B-CELL LYMPHOMAS; HETEROGENEITY; GENOME; (1)
B-CELL-LYMPHOMA; TUMOR-GROWTH; NODE; LYMPHOTOXIN; LYMPHANGIOGENESIS; BEVACIZUMAB; RITUXIMAB; BEHAVIOR; STROMA; NICHE; (1)
B-CELL RECEPTORS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; IN-VIVO; VECTORED IMMUNOPROPHYLAXIS; SHIV TRANSMISSION; ENVELOPE PROTEIN; RATIONAL DESIGN; HUMANIZED MICE; POTENT; (1)
B-CELLS; METABOLISM; CLL; REMISSIONS; CAPACITY; FATE; IMMUNODEFICIENCY; TRANSPLANTATION; INTERLEUKIN-10; SUPPRESSION; (1)
B-CELLS; PLACEBO; RISK; RITUXIMAB; Ocrelizumab; B-cell depletion; Monoclonal antibody; CD 20; Multiple sclerosis; Immunomodulatory treatment; Side effects (1)
BCG; intravesical chemotherapy; early cystectomy; high-risk non-muscle-invasive bladder cancer (1)
BCG VACCINATION; ISOLATED TUBERCULOSIS; MUSCLE; COMPLICATIONS; INVOLVEMENT; (1)
BCL11B; C2H2-type zinc finger protein; recognition code; genotype-phenotype correlation; type 2 innate lymphoid cells (1)
BCL-2 PROTEIN EXPRESSION; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; RAT DENTATE GYRUS; TRANSGENIC MICE; OLFACTORY-BULB; COGNITIVE DECLINE; NERVOUS-SYSTEM; FAMILY-MEMBERS; NEURONS; dentate gyrus; neuronal differentiation; neuronal progenitor; programmed cell death; proliferation (1)
BCL-6 PROTEIN EXPRESSION; CENTER B-CELLS; NASOPHARYNGEAL CARCINOMAS; MESSENGER-RNA; HUMAN TISSUES; T-CELLS; CANCER; GENE; IDENTIFICATION; ESTABLISHMENT; (1)
B-C MESON; PRODUCTION NEAR-THRESHOLD; QCD SUM-RULES; PROTON-NUCLEUS COLLISIONS; OBSERVED CROSS-SECTIONS; TO-LEADING-ORDER; VACUUM POLARIZATION FUNCTION; FIXED-TARGET EXPERIMENTS; EFFECTIVE-FIELD THEORY; PLUS AU COLLISIONS; (1)
BDL, NASH, NAFLD, liver, fibrosis, PI3K, steatosis (1)
BDNF, GDNF, tinnitus, sexual dimorphism, genetic variation (1)
BEAM-ANGLE OPTIMIZATION; DOSE CALCULATION; PHOTON BEAMS; RADIOTHERAPY; ALGORITHM; IMRT; SENSITIVITY; VMC; (1)
BEAM COMPUTED-TOMOGRAPHY; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; PROGNOSTIC VALUE; ATHEROSCLEROTIC PLAQUE; RISK-FACTORS; DISEASE; CALCIUM; ADULTS; AGE; calcification; cardiovascular risk profile; coronary artery disease; myocardial infarction; pulse pressure; systolic blood pressure (1)
BEAM COMPUTED-TOMOGRAPHY; TOOTH MOVEMENT; LOCALIZATION; DURATION; TEETH; (1)
BEAM DISPLACEMENT; TOTAL REFLECTION; DIRECTIONAL EMISSION; CRITICAL ANGLE; MICROLASERS; LASERS; (1)
BEAM DISPLACEMENT; TOTAL REFLECTION; DIRECTIONAL EMISSION; WAVE CHAOS; CAVITIES; RAY; SCATTERING; DYNAMICS; (1)
BEAM RADIATION-THERAPY; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; OUTCOMES; SURGERY; PRESERVATION; RADIOTHERAPY; CARCINOMA; TUMORS; Brachytherapy; Bladder-preserving therapy; Bladder cancer; Interstitial radiotherapy; Urinary bladder neoplasm (1)
BEAM RADIATION-THERAPY; RADICAL PROSTATECTOMY; ULTRASOUND; IMPLANTATION; RADIOTHERAPY; OUTCOMES; FAILURE; (1)
BEAN PHASEOLUS-VULGARIS; NA+ CHANNEL; KAPPA-B; PHYTOHEMAGGLUTININ; DISEASE; SODIUM; CELLS; DELTA; COLON; RAT; phytohemagglutinin; red kidney beans; jackbeans; concanavalin A; ENaC; epithelial transport; diarrhea; ion transport; airways; intestine (1)
Beatles, interdisziplinärer Unterricht, Musikunterricht, Englischunterricht, Deutschunterricht, Popmusik, Jugendkultur, kulturelle Bildung, Populärkultur (1)
BEAVER DAM EYE; DYSTROPHY BEST-DISEASE; BLUE MOUNTAINS EYE; FAMILIAL AGGREGATION; SUSCEPTIBILITY LOCI; STARGARDT-DISEASE; GENOMEWIDE-SCAN; EXTENDED FAMILIES; ALLELIC VARIATION; APOLIPOPROTEIN-E; age-related macular degeneration; complement factor H; sequence variation; association studies (1)
BEAVER DAM EYE; STARGARDT-DISEASE GENE; COMPLEX HUMAN-DISEASES; SUSCEPTIBILITY LOCI; FAMILIAL AGGREGATION; LINKAGE ANALYSIS; EXTENDED FAMILIES; BIPOLAR DISORDER; OXIDATIVE STRESS; APOLIPOPROTEIN-E; (1)
because · conditionals · conditional logic · difference-making · relevance · explanation · reason · defined conditionals (1)
BECK ANXIETY INVENTORY; PSYCHOMETRIC PROPERTIES; AWARENESS; ALLOCATION; DISORDERS; TRAIT; DONT; information processing; perception of threat; anxiety; children; conditioning (1)
BECK DEPRESSION; MENTAL-IMAGERY; PSYCHOMETRIC PROPERTIES; CLINICAL DEPRESSION; EMOTIONAL FACES; ANXIETY; INVENTORY; MEMORY; MIND; VULNERABILITY; Depression; Interpretation bias; Attention bias; Attention bias modification; Cognitive training (1)
Beckenbruch , Osteosynthese , Polytrauma , Fixateur interne , Beckenringfraktur , minimal-invasive Stabilisierung , pelvic ring injury , minimally-invasive stabilization (1)
Beckenendlage, Sectio vs. vaginal, APGAR-Score, Nabelschnurarterien-pH-Wert, Geburtsmodi (1)
Beckenringfraktur, Lebensqualität, minimal invasiv, pelvic ring fracture, quality of life, SF-36, EQ-5D, TIFI, ILA (1)
Beckenringverletzungen · Computertomografie · Polytrauma · Beckengurt · Bildartefakte · Clear-the pelvis-Algorithmus (1)
BECKWITH-WIEDEMANN-SYNDROME; MATERNAL UNIPARENTAL DISOMY; NEONATAL DIABETES-MELLITUS; IMPRINTED LOCI; METHYLATION ANALYSIS; DNA METHYLATION; CHROMOSOME-14; KCNQ1OT1; REGION; ASSAY; (1)
Bedarfsplanung; Nachbesetzung; Eigentumsschutz; Vertragsarztpraxis; MVZ (1)
bedingte Wahrscheinlichkeiten, Schnittwahrscheinlichkeiten, Stochastik, Visualisierungen, Unterrichtsvorschlag, natürliche Häufigkeiten (5)
BEDSIDE DIAGNOSIS; PLEURAL EFFUSION; DEVICE; Deep vein thrombosis; mobile ultrasound; peripheral thrombosis; VScan Air (1)
BEDSIDE DIAGNOSIS; PLEURAL EFFUSION; TRAUMA FAST; SONOGRAPHY; Point-of-care ultrasound; Vscan Air; high-end ultrasound (1)
Bedside-Methode , Spritzen , Heparin , Blutgasanalyse , , point of care testing , rotation thrombelastometry , anticoagulation , Heparin , syringe (1)
Bedside-Methode , Spritzen , Heparin , Blutgasanalyse , Point of care testing, Rotation Thrombelastometry, Anticoagulation, Heparin, Syringe (1)
BEE APIS-MELLIFERA; FOOD RECRUITMENT; CUTICULAR HYDROCARBONS; DECISION-MAKING; NECTAR FORAGERS; TASK DECISIONS; ARGENTINE ANT; HONEY-BEES; BEHAVIOR; DISCRIMINATION; signal; cue; accuracy; speed; trade-off; cuticular hydrocarbons; social regulation; trail pheromone (1)
BEECH FAGUS-SYLVATICA; CLONAL DIVERSITY; CENTRAL-EUROPE; PLANT-POPULATIONS; L. RANUNCULACEAE; SPECIES-DIVERSITY; LIFE-HISTORIES; DNA MARKERS; LAND-USE; DISPERSAL; AFLPs; Beech forest; Myrmecochory; Seed provenances; Understory herb (1)
BEE COLLETES-CUNICULARIUS; REPRODUCTIVE ISOLATION; OPHRYS ORCHIDACEAE; SEX-PHEROMONE; CUTICULAR HYDROCARBONS; SELECTION MAINTAINS; GENUS OPHRYS; ODOR SIGNALS; MIMICRY; EVOLUTION; Sexual deception; Speciation; Orchidaceae; Floral scent; Hybridization; Chemical mimicry (1)
BEER-LAMBERT LAW; ADULT HEAD; HUMAN BRAIN; SPECTROSCOPY FNIRS; PHOTON MIGRATION; PROPAGATION; SCATTERING; MODEL; TISSUES; MEDIA; (1)
bees, bumblebees, cognitive bias, decoy effect, foraging behaviour (1)
Beethoven, Christian Schreiber, Messe, Chorpartitur. Johann Nepomuk Hummel (1)
Beethoven, Messe, Benedict Scholz, Chorpartitur (1)
beetle, competition, cooperation, fitness, pest insect (1)
BEETLE NICROPHORUS-VESPILLOIDES; BURYING BEETLES; JUVENILE-HORMONE; BREEDING STATUS; ZEA-MAYS; PROLACTIN; EVOLUTION; WORKERS; INSECT; SILPHIDAE; (1)
Befindlichkeitsfragebogen; BVV-18; Evaluation psychosomatischer Behandlung (1)
Befunderhebungsfehler, Befundsicherungsfehler, grober Behandlungsfehler, Beweislastumkehr, Beweisvereitelung, omitted medical examination, losing a diagnostic finding, grave error in treatment, reversed onus of proof, missing evidence caused by the opponent (1)
Begründung des Bestandsmanagements Klassisches deterministisches Bestellmengenmodell Newsvendor-Modell Periodisches Bestandsmanagement Kontinuierliches Bestandsmanagement Unsicherer Nachschub Zentralisierung von Sicherheitsbeständen Bestands-Risiko-Management (1)
Behandlung kolorektaler Lebermetastasen (1)
Behandlung von Tinnitus, transkranielle Magnetstimulation, Elektroenzephalografie (1)
BEHAVIOR; (1)
BEHAVIORAL-ANALYSIS SYSTEM; RANDOMIZED CONTROLLED-TRIAL; STAR-ASTERISK-D; COMORBIDITY SURVEY REPLICATION; ALGORITHM-GUIDED TREATMENT; FOLLOW-UP; PLUS PHARMACOTHERAPY; DYSTHYMIC DISORDER; CHILDHOOD TRAUMA; MENTAL-HEALTH; Chronic depression; Response; Anti-depressive treatment; German algorithm project (1)
; behavioral economics; heuristics; bias; fast-and-frugal heuristics; Kahneman; Tversky; Gigerenzer (1)
Behavioral experiment · Managerial decisions · Nudging · Risk aversion · Uncertainty aversion (1)
Behavioral finance; Biases; Cognitive abilities; Cognitive reflection test (1)
Behavioral finance · Investment bias · Peer-to-business lending · Crowdlending · Risk-adjusted return on capital · Diversification (1)
BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION; TASTE-AVERSION; CYCLOSPORINE-A; ANIMAL-MODELS; EXTINCTION; MECHANISMS; MEMORY; DRUG; COLLAGEN; THERAPY; (1)
BEHAVIORAL RHYTHMS; MELANOGASTER; PHOTORECEPTOR; PROTEIN; ENTRAINMENT; OSCILLATOR; ROLES; BRAIN; BLIND; FLIES; F-box; polymorphism; photoreception (1)
BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; GENE ENCODES; CLOCK GENES; BRAIN; PERIOD; PROTEIN; NEUROPEPTIDE; EXPRESSION; CELLS; Drosophila; circadian clock; neuropeptides; PDF receptor; IPNamide; nplp1; glass (1)
Behavior; Biogeography (Population Studies); General Life Studies; Morphology; Pathology; Systematics and Taxonomy (1)
BEHAVIOR-CHANGE; PANDEMIC INFLUENZA; PLANNED BEHAVIOR; HONG-KONG; HEALTH BEHAVIOR; SARS EPIDEMIC; RISK; COMMUNITY; TRANSMISSION; OUTBREAK; Health promotion; human influenza; hand-washing; randomized controlled trial (1)
Behavior; Communication; Development; Ecology (Environmental Sciences); Endocrine System (Chemical Coordination and Homeostasis); Parasitology; Pathology; Physiology; Reproductive System (Reproduction) (1)
Behavior ; Ecology (Environmental Sciences) ; Physiology ; Reproductive System (Reproduction) (1)
BEHAVIOR; ELEMENTS; Lorentz microscopy; differential phase contrast; hysteresis loop; magnetic domains (1)
BEHAVIOR; Hand hygiene compliance; WHO Five Moments; Empathy; Motivation; Pro-social behaviour; Healthcare workers; Nurses; Physicians; Patient safety (1)
BEHAVIOR; Hymenoptera; Hypoponera; microsatellites; Ponerinae (1)
BEHAVIOR; MASS; (1)
BEHAVIORS; PERFORMANCE; MANAGEMENT; Analytical depth of cognitive processes; Conflict analysis; Content of cognitive processes; Expertise; Team leader (1)
BEHAVIORS; Street racing; Attitudes; Risk-taking driving; Video games; Internet survey (1)
BEHAVIOR; TWIN; QUESTIONNAIRE; ZYGOSITY; AROUSAL; MEN; Pedophilia; Sexual age preferences; Twins; Conditioning; Child abuse (1)
behavioural change, reflection, search expertise, user study (1)
Behinderung, Fragebogen, Behinderungsbegriff, Sonderpädagogik, Inklusion (1)
Behinderung, Fragebogen, Disabilities Studies, (1)
Beinachsen; Jugendfußball; Handball; Beinachsabweichungen (1)
Beitragssatzungen, Manssen (1)
Béla Bartók; Vokalmusik; Musikanalyse; "Herzog Blaubarts Burg"; "Cantata profana"; "Fünf Lieder" op. 15; "Fünf Lieder" op. 16; "Aus vergangenen Zeiten"; 27 zwei- und dreistimmige Chöre a cappella; Kompositionsstil (1)
Belastungen, Kontrollüberzeugungen, Bewältigungsstrategien, Befindlichkeit unter Medikation, Behandlungszufriedenheit, Lebensqualität, psychisch Kranke, Angehörige, Burden, locus of control, coping strategies, subjective well being under medication, treatment satisfaction, quality of life, mental illness, caregiver (1)
Belief revision, epistemic entrenchment, theory change (1)
Belief revision; Theory change; Severe withdrawal; Irrevocable revision; Irrefutable revision (1)
BELIEFS RATIONALIZE; AUCTIONS; INFORMATION; RELAXATION; EMOTIONS; EXPLAIN; VALUES; PRICE; Hypothetical thinking; Cursed equilibrium; Winner's curse (1)
BE-LIKE; COPULA; VARIABILITY (1)
BELIMUMAB; PATHOGENESIS; INFLAMMATION; inflammation; BLyS; BAFF receptor (BAFF-R); MXA; pDC; interferon; B cell; cutaneous lupus erythematosus (1)
BELLS-PALSY; DIAGNOSIS; MANAGEMENT; PARALYSIS; ETIOLOGY; MUSCLES; MEMBERS; facial palsy; facial paralysis; House-Brackmann scale; artificial intelligence; deep learning; bell's palsy; smile restoration; facial reanimation; application (1)
BELLS-PALSY; HEALTH COMMUNICATION; SURGERY; MANAGEMENT; TWITTER; EDUCATION; IMPACT; facial palsy; facial paralysis; Bell palsy; social media; SoMe; Facebook; Instagram; Twitter; TikTok; Facial Palsy Awareness Week (1)
Benchmark; Combination trial; Dose finding; Partial ordering; Power likelihood (1)
Bendamustine, esters of bendamustine, cytostatic, alkylating agent, anticancer agent (1)
BENDAMUSTINE; MELPHALAN; CANCER; MECHANISM; PATTERN; PLASMA; bendamustine; chlorambucil; derivatives; melphalan; nitrogen mustards (1)
Bendamustin, ester, stability, cytotoxicity, breast cancer initiating cells, Topotecan, ABCG2 (1)
BENDING-TORSION THEORY; INEXTENSIBLE RODS; CURVED RODS; LIMIT; Wave equation; von Karman equation; nonlinear elasticity; long time existence (1)
BENDING-TORSION THEORY; NONLINEAR ELASTICITY; INEXTENSIBLE RODS; CURVED RODS; LIMIT; DERIVATION; MODELS; Wave equation; Nonlinear elasticity; Thin rods; Dimension reduction (1)
BENEFITS; SEARCH; WORLD; NIGHT; Light pollution; Urban evolution; Anthropogenic selection; Urbanisation; Artificial light at night; Steatoda triangulosa (1)
BENFORDS LAW; FRAUD DETECTION; 1ST DIGIT; NUMBERS; Benford's law; Digital analysis; Forensic accounting; Military expenditure data (1)
BENFORDS LAW; FRAUD DETECTION; DIGIT PROBLEM; 1ST DIGIT; Benford's law; government statistics; fraud detection; auditing (1)
BENIGN BILIARY STRICTURES; HEPATIC RESECTION; RISK; CHOLECYSTECTOMY; COMPLICATIONS; EXPERIENCE; DUCT; bile ducts; interventional procedures; percutaneous; PTC; PTBD; biliary leakage (1)
benigne adenomatöse kolorektale Polypen, Substanz P, Noradrenalin, Semaphorin 3A, Semaphorin 3F, sympathisches Nervensystem, sensibles Nervensystem (1)
benigne spinale Tumore, spinale Neurinome, spinale Schwannome, spinale Chirurgie, funktioneller Outcome, Neurochirurgie (1)
BENIGN ESSENTIAL BLEPHAROSPASM; BOTULINUM-A TOXIN; OF-LIFE; HEMIFACIAL SPASM; QUESTIONNAIRE; RADIOTHERAPY; GLIOMAS; blepharospasm; quality of life; social well-being; emotional well-being; botulinum toxin (1)
BENIGN PROSTATIC HYPERPLASIA; BLADDER OUTLET OBSTRUCTION; QUALITY-OF-LIFE; OVERACTIVE BLADDER; IMPACT; INCONTINENCE; METAANALYSIS; FINASTERIDE; PREVALENCE; COUNTRIES; lower urinary tract symptoms (LUTS); treatment guidelines; storage symptoms; voiding symptoms; overactive bladder (1)
Benign salivary gland tumors, Warthin’s tumor, Pleomorphic adenoma, Cystadenolymphoma (1)
BENIGN SKIN TUMORS; ACTIVATING MUTATIONS; GROWTH; BLADDER; CRANIOSYNOSTOSIS; ACHONDROPLASIA; FREQUENCY; EXPOSURE; SUNLIGHT; (1)
BENIGN SKIN TUMORS; FACTOR RECEPTOR-3; SEBORRHEIC KERATOSES; THANATOPHORIC DYSPLASIA; ACTIVATING MUTATIONS; EPIDERMAL NEVI; TRANSMEMBRANE MUTATION; ACANTHOSIS NIGRICANS; MULTIPLE-MYELOMA; PIK3CA MUTATIONS; FGFR3; Keratinocyte; Skin; Cell growth; Apoptosis (1)
Benutzerfreundlichkeit , iPhone , Mensch-Maschine-Kommunikation , Mobile Telekommunikation , Mobiles Internet , Handy , Evaluation , Mobile Computing , , usabiltiy , iPhone , human computer interaction , mobile communication , mobile phone , mobile internet , mobile computing , evaluation (1)
Benutzerführung; Benutzeroberfläche: Bewertung; Bildschirmarbeitsplatz; Desktop; Funktionalität; Gestaltung; Interaktion; Suchmaschine; Desktop Search Engine; Information Retrieval (1)
BENZENE DIMER; ASYMMETRIC-SYNTHESIS; HYDROGENATION; CATALYSTS; (1)
BENZODIAZEPINE DEPENDENCE; THERAPEUTIC-EFFICACY; PHYSICAL-DEPENDENCE; POSTMARKETING SURVEILLANCE; EPILEPTIC SEIZURES; SEVERE INSOMNIA; WITHDRAWAL; TOLERANCE; SLEEP; DRUG; dependence; drug abuse; hypnotics; insomnia.review; zolpidem; zopiclone (1)
BENZODIAZEPINE-RECEPTOR-LIGAND; LONG RESIDENCE TIME; 18 KDA; ANXIOLYTIC ETIFOXINE; TSPO-LIGANDS; MITOCHONDRIAL; APOPTOSIS; CELLS; LIPOPOLYSACCHARIDE; REGENERATION; translocator protein 18 KDa; human microglial cells; neuroinflammation; interleukins; neurosteroids (1)
BENZODIAZEPINE USE; DENDRITIC SPINES; BRAIN; CELL; METABOLISM; STABILITY; LIGANDS; DISEASE; BINDING; TREM2; (1)
BENZOHETEROCYCLIC DERIVATIVES; ANTICANCER DRUGS; DEATH; 1,2,4-THIADIAZOLES; DISTAMYCIN; INHIBITION; CHEMISTRY; SPONGES; BINDING; HL-60; hybrid; apoptosis; leukaemia; antiproliferative activity (1)
BENZOPHENONE; 2,5-DIKETOPIPERAZINES; MECHANISM; Amino Acids; C-H Activation; Enantioselectivity; Nitrogen Heterocycles; Photochemistry (1)
Benzotriazol, Polyvinylimidazol, Adsorption, Quarzmikrowaage Benzotriazole, Polyvinylimidazole, adsorption, quartz crystal microbalance (QCM) (1)
BENZYL ALCOHOL DERIVATIVES; ALPHA-KETO ACIDS; FACILE OXIDATION; THIAZOLIUM ION; ELECTRON-TRANSFER; CATIONIC MICELLE; COENZYME MODELS; FLAVIN ANALOG; ESTERIFICATION; BISCOENZYME; electron transfer; flavins; homogeneous catalysis; oxidation; photocatalysis (1)
BENZYL ALCOHOL; PHOTOOXIDATION; ACTIVATION; benzylic alcohol; oxidation; photocatalysis; solvent free; visible light (1)
Bereitstellungsfunktion des Rechts, liberale Ordnung, freiheitliche Ordnung, Familieneinheit, Familienzusammenführung, Einzelfallgerechtigkeit, Verfahrensdimension, Beschleunigungsgebot (1)
Bergbaunachfolgelandschaft , Thüringen <Ost> , Boden , Schwermetall , Aue , Abraumhalde , Uranbergbau , Uran-238 , Kontamination , Sickerwasser , Wismut GmbH , Saugkerzen , sequenzielle Extraktion , suction cups , sequential extraction procedure (1)
BERGMAN CYCLIZATION; CHEMICAL-SYNTHESIS; ANTITUMOR-ACTIVITY; MOLECULAR DESIGN; DNA CLEAVAGE; DYNEMICIN-A; CYCLOAROMATIZATION; RING; FUNCTIONALITIES; REARRANGEMENT; (1)
BERGMAN CYCLIZATION; CONJUGATED ENEDIYNES; CHEMICAL SYNTHESIS; MOLECULAR DESIGN; DNA CLEAVAGE; DYNEMICIN-A; RING; CYCLOAROMATIZATION; FUNCTIONALITIES; REARRANGEMENT; (1)
BERGMAN CYCLIZATION; ENYNE-ALLENES; P-BENZYNES; AB-INITIO; DENSITY; ENERGY; CHEMISTRY; CYCLOAROMATIZATION; STABILITY; DESIGN; (1)
BERGMANNS RULE; GRADIENTS; Bergmann's rule; elevation; life-history trait; worker size (1)
BERGMANNS RULE; SOCIAL INSECTS; COLONY SIZE; HYMENOPTERA; FORMICIDAE; ECTOTHERMS; PATTERNS; (1)
Bericht , Regensburg / Universität , Jahresbericht , annual report , University of Regensburg (3)
Bericht , Regensburg / Universitätsbibliothek , , annual report , University Library of Regensburg (1)
Bericht , Regensburg / Universitätsbibliothek , Jahresbericht , annual report , University Library of Regensburg (32)
; Beris-Edwards model; liquid crystals; Navier-Stokes equations; Q-tensor; strong-in-time solutions (1)
Berkovich analytic spaces, formal geometry, abelian varieties, canonical measures (1)
Berkovich analytic spaces, non-archimedean geometry, abelian varieties, Dolbeault cohomology, weakly smooth forms, first Chern form, tropical geometry, Raynaud extension, Delta-forms (1)
Berkovich Spaces, Non-Archimedean Analytic Geometry, Vector Bundles, Chern currents, Chern forms, Segre currents, Monge-Ampère measures, Arakelov Theory, Green currents (1)
BERKOVICH SPACES; Non-archimedean geometry; Berkovich spaces; Non-archimedean curves; Mumford curves; Smooth differential forms on; Berkovich spaces; Tropicalizations; Poincare duality (1)
BERLIN DEFINITION; ARDS (1)
Bernoulli; Euler; and Genocchi polynomials; convergence analysis; interpolatory quadrature formulas; Lagrange polynomial interpolant; mean value theorems; Newton– Cotes formula; ordinary differential equations (ODEs); quadrature rules; series expansions; weighted and non‐ weighted cases; weight functions (1)
BERRY PHASE; CONDUCTANCE FLUCTUATIONS; RINGS; (1)
BERRY-PHASE; DYNAMICS; (1)
BERRY-PHASE; PARTICLES; ORIENTATION; ELECTRONS; DYNAMICS; (1)
BERRY PHASE; QUANTUM TRANSPORT; MAGNETIC-FIELD; RESISTANCE; CONDUCTANCE; INJECTION; CONDUCTIVITY; ADIABATICITY; SPINTRONICS; ELECTRONS; (1)
BERRY PHASE; SPIN; MANIPULATION; SYMMETRY; bilayer graphene; g-factor modulation; quantum dots; valleytronics (1)
BERRYS PHASE; (1)
BERRYS PHASE; CONDUCTANCE; (1)
BERRYS PHASE; QUANTUM; OSCILLATIONS; CONDUCTANCE; LOCALIZATION; ADIABATICITY; SPECTRUM; (1)
BERRYS PHASE; QUANTUM TRANSPORT; OSCILLATIONS; CONDUCTANCE; SPECTRUM; CURRENTS; WELLS; RINGS; (1)
BERTH ALLOCATION; OIL PRICE; SHIP; OPTIMIZATION; EMISSIONS; Maritime transportation; Bunker fuel consumption; Real data; Statistical analysis (1)
Bertini theorem over finite fields, smooth hypersurface section, closed point sieve (1)
BERTopic · Topic modeling · Sentiment analysis · Natural language processing (1)
Beruf, Berufsvorbereitung, Ausbildung, Inklusion, Förderschule, Lernbehinderung, Lernschwierigkeiten, Förderbedarf, Unterstützungsbedarf, Fallbeispiele, Bayern (1)
Berufliche Bildung, Sonderpädagogischer Förderbedarf, Schulentwicklung (1)
Berufsfreiheit, Berufsausübung, Manssen (1)
Berufsfreiheit, Verfassungsrecht, Manssen (1)
Berufshaftung , Ärztlicher Kunstfehler , Deutschland , Arzt , Haftung , Geschichte , Arzthaftung , Arztstrafrecht , Behandlungsfehler , Entwicklung der Arzthaftung , legal history , development of medical liability , criminal liability in medical law (1)
Berufsschule (2)
Berufswahl, Recht auf Arbeit, Deutsch, Israelisch, Manssen (1)
Beschleuniger, matched linac, flatness filter free, FFF (1)
Bessarabien, Dobrudscha, Schwarzmeerraum (1)
BEST1, Bestrophin 1, BD, ARB, ADVIRC, Pathomechanismus (1)
BEST1; Bestrophin-1; Bestrophinopathien; Patch Clamp (1)
Bestandsaufbau; Konsortienbildung; Urheberrecht (1)
Best arm identification; User studies; Racing algorithms (1)
Bestattung, Kultur, Bestattungskultur, Bestattungsgesetz (1)
Bestattungsrecht, Bestattungsgesetze, Synopse, Zusammenschau, Vergleich, Leiche, Verstorbene, Hinterbliebene (1)
BEST-DISEASE; MISSENSE MUTATIONS; GENE; CHANNELS; VMD2; BISRETINOIDS; RETINA; MICE; MONOUBIQUITINATION; LOCALIZATION; Bestrophin-1; BEST1; Vitelliform macular dystrophy; Protein stability; Sperm motility; Best1(Y227N) knock-in mouse (1)
Best-Krankheit , Chloridkanal , Calcium , Membranproteine, Genexpression , Bestrophin , Vmd2 , Cl(-)-Leitfähigkeit , bestrophin , Vmd2 , Cl- conductance (1)
Bestrahlung , Hitzeschock-Proteine , Cytostatikum , Onkologie , Hämatologie , Membranexpression , Natürliche Killerzelle , Tumortherapie , Heat Shock Protein , Irradiation , Cytostatica , Membrane-expression , Natural Killer Cell (1)
Bestrahlung, Kopf- und Hals-Tumore, Speichel, Mikrobiom, Mundgesundheit, Sialochemische Zusammensetzung (1)
Bestrophin-1, BEST1, Allele-specific targeting, CRISPR/Cas9, Dominant-negative mutation, BVMD, Best disease, Autosomal dominant retinal disorder (1)
Bestrophin-1, BEST1, Knockout, hiPSC, RPE, Curcumin, Curcumin Light, lysosomaler pH, POS, Rhodopsin, Autofluoreszenz, M. Best, ARB, Bestrophinopathien (1)
Bestrophin-1, endoplasmic reticulum, store-operated calcium entry (1)
Bestrophin-1, Morbus Best, Wirkstoffscreening (1)
Bestrophin-1, RPE, L-Typ-Kanal, CaV1.3 Untereinheit, beta-Untereinheit (1)
Bestrophin; Juvenile vitelliform macular dystrophy; Longitudinal course; Optical coherence tomography; Electrooculogram; Fundus autofluorescence (1)
BETA 1 GENE; DISEASE PROGRESSION; JAPANESE PATIENTS; NATURAL-HISTORY; VIRUS-INFECTION; UNITED-STATES; TGF-BETA; TGF-BETA-1; EXPRESSION; RECEPTOR; TGF-beta 1; Gene polymorphism; LightCycler; Viral hepatitis; Fibrosis (1)
BETA(2)-ADRENERGIC AGONIST SALBUTAMOL; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; CHEMICAL SYMPATHECTOMY; PLASMA EXTRAVASATION; SYNOVIAL TISSUE; JOINT INJURY; MECHANISMS; INDUCTION; NOREPINEPHRINE; (1)
BETA(2) ADRENERGIC-RECEPTOR; G-PROTEIN; FUNCTIONAL SELECTIVITY; FUSION PROTEINS; FIELD ANALYSIS; AGONIST; QUANTIFICATION; DERIVATIVES; MECHANISM; LIGANDS; Functional selectivity; beta(2)-Adrenergic receptor; Biased ligand; Bias quantification; Structure-bias relationships; Fenoterol (1)
BETA-3 SUBUNIT GENE; AMBULATORY BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; ASSOCIATION; HYPERTROPHY; VARIANT; MASS; GNB3; POPULATION; RENIN; genetics; myocardium; hypertrophy; G proteins; signal transduction (1)
beta-adrenergic signaling; isoprenaline; CaMKII; IL6R; cardiomyocyte; hypertrophy; hypertensive cardiomyopathy (1)
BETA-ADRENOCEPTOR ANTAGONISTS; MAJOR DEPRESSIVE DISORDER; HUMAN-LIVER; SPARTEINE OXIDATION; IN-VITRO; VENLAFAXINE; METABOLISM; 2D6; PHARMACOKINETICS; ANTIDEPRESSANTS; Therapeutic drug monitoring; Venlafaxine; CYP2D6; Metoprolol; Melperone; Bisoprolol (1)
beta-Adrenorezeptor, liganden spezifische Konformationen, Katecholamine (1)
BETA-AGONIST; INHALED CORTICOSTEROIDS; PRECISION MEDICINE; ORMDL3 EXPRESSION; AIR-POLLUTION; LUNG-FUNCTION; GALA II; POLYMORPHISMS; GENOTYPE; RISK; ADRB2; asthma exacerbations; haplotypes; inhaled corticosteroids; long-acting beta(2)-agonists (1)
BETA-AMINO ACID; AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; PROTEIN-PROTEIN INTERACTIONS; QUATERNARY STRUCTURE; HETEROGENEOUS BACKBONES; SECONDARY STRUCTURE; CYCLIC-PEPTIDES; CRYSTALLOGRAPHIC CHARACTERIZATION; STRUCTURAL-CHARACTERIZATION; ALPHA,BETA-HYBRID PEPTIDES; Foldamers; beta-Amino acids; alpha/beta-Peptides; Peptide mimicry; Protein surface recognition; Protein-protein interactions (1)
BETA-AMINOCYCLOPROPANECARBOXYLIC ACIDS; CHLORITE-HYDROGEN-PEROXIDE; ELECTRO-ORGANIC REACTIONS; ANODIC AMIDE OXIDATIONS; CARBOXYLIC-ACIDS; ACETIC-ACID; HYDROXYPIPERIDINE ALKALOIDS; BUILDING-BLOCK; FORMIC ACID; CHEMISTRY; (1)
; beta B1-CTGF; primary open-angle glaucoma; apoptosis; caspase 3; neurofilament H; Bax/Bcl2; synapse (1)
BETA-BAND OSCILLATIONS; ALPHA-OSCILLATIONS; EEG; INFANTS; MODULATION; INHIBITION; Motor system development; Action understanding; execution; and; observation; Mu suppression; Brain development; Common coding (1)
BETA-CARBOLINES; DERIVATIVES; ACID; (1)
BETA-CAROTENE; ALPHA-TOCOPHEROL; VITAMIN-A; FOLLOW-UP; ACID; MICRONUTRIENTS; ASSOCIATION; EXPRESSION; RECEPTORS; NUTRITION; (1)
BETA-CATENIN; BREAST-CARCINOMA; REPRESSOR SNAIL; CELL-LINES; INVASION; TARGET; GROWTH; CANCER; HYPERMETHYLATION; DIFFERENTIATION; Dickkopf; tumor-suppressor gene; Wnt signaling; malignant melanoma; cancer (1)
BETA-CATENIN; CELL-PROLIFERATION; WNT/BETA-CATENIN; MICROARRAY DATA; PATHWAY DATA; IDENTIFICATION; MIGRATION; MECHANISM; RESOURCE; SUBTYPES; (1)
BETA-CATENIN; COLON-CANCER; ADENOMATOUS POLYPOSIS; REGULATES EXPRESSION; STEM-CELLS; CYCLIN D1; COMPLEX; TARGET; APC; PROGRESSION; Niclosamide; Drug repositioning; CRC cell lines; Inhibition of canonical and noncanonical Wnt signaling; Selective chemotherapeutic efficacy (1)
BETA-CATENIN; COLON-CANCER; MUTATIONS; GENE; (1)
BETA-CATENIN; GENE-EXPRESSION; CHROMATIN; ISWI; COMPLEX; TRANSCRIPTION; PROTEIN; PATHWAY; CANCER; TARGETS; (1)
BETA-CATENIN; HIPPO PATHWAY; EFFECTORS YAP; LIVER-CANCER; TUMORIGENESIS; COMPLEX; HEPATOBLASTOMA; SUPPRESSES; ACTIVATION; EXPRESSION; YAP; TAZ; c-MYC; Hepatocellular carcinoma (1)
BETA-CATENIN; TAZ; YAP; INHIBITOR; DISTINCT; COMPLEX; GROWTH; ss-Catenin; Hippo/YAP; Intrahepatic Cholangiocarcinoma; TEADs (1)
BETA-CATENIN; YAP/TAZ; PATHWAY; LATS2; TAZ; YAP; (1)
BETA-CELL; ALPHA-CELLS; PROINSULIN BIOSYNTHESIS; GENE-EXPRESSION; SECRETION; GLUCOSE; METABOLISM; RELEASE; TUMORS; INS-1; insulinoma; islet; glucagon; preproglucagon-mRNA; free fatty acids (1)
beta-cell; cytokine; cytotoxicity; fyn-related kinase (FRK)/RAK; kinase inhibitor; knockout (1)
BETA-CELL FUNCTION; METABOLIC SYNDROME; GLUCOSE-UPTAKE; INFLAMMATION; RESISTANCE; OBESITY; ADIPOKINE; ATHEROSCLEROSIS; MICE; Insulin; obesity; OGTT (1)
BETA-CELL TURNOVER; LINE INS-1; SECRETION; GLUCOSE; PROINSULIN; PALMITATE; BIOSYNTHESIS; ELEVATION; EXPOSURE; PLASMA; Free fatty acids; immunoreactive insulin; c-peptide; glucagon; pancreatic islet (1)
BETA-CYCLODEXTRIN; AQUEOUS-SOLUTION; RHEOLOGICAL BEHAVIOR; POLY(ETHYLENE OXIDE); COPOLYMERS; STABILIZATION; NANOPARTICLES; DERIVATIVES; ACID); Hydrogels; Cyclodextrin; Isothermal titration calorimetry (1)
BETA-CYCLODEXTRIN; MOLECULAR RECOGNITION; PROCAINE HYDROCHLORIDE; AQUEOUS-SOLUTION; COMPLEXES; FLUORESCENCE; CHEMISTRY; ENCAPSULATION; TEMPERATURE; RECEPTORS; cyclodextrin-drug interaction; association constant; double reciprocal plot; Benesi-Hildebrand method; benzocaine; tetracaine; host-guest interaction (1)
BETA-D-GLUCAN; CARINII-PNEUMONIA; MEMBRANE FILTERS; DIAGNOSIS; ASSAY; PLASMA; MARKER; BLOOD; (1->3)-BETA-D-GLUCAN; COLONIZATION; beta-d-Glucan; Pneumocystis jirovecii pneumonia; prognosis (1)
BETA-D-GLUCOSAMINIDASE; URINARY BIOMARKERS; MOLECULE-1; PREDICTORS; CREATININE; DISEASE; SURGERY; IMPACT; (1)
BETA-D-GLUCOSAMINIDASE; WORSENING RENAL-FUNCTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; TUBULAR DAMAGE; INJURY MOLECULE-1; ESC GUIDELINES; IMPAIRMENT; ASSOCIATION; DIAGNOSIS; cardiorenal syndrome; chronic heart failure; CKD progression; NAG; tubular markers (1)
BETA-GALACTOSIDASE; INDIVIDUAL MOLECULES; LIPID VESICLES; BINDING; CHAMBERS; READOUT; RANGE; SCALE; Arrays; Enzyme kinetics; Digital concentration readout; Fluorescence microscopy; Single molecule detection (1)
BETA-GAMMA-SUBUNITS; PHOSPHOLIPASE-C; MEDIATES CHEMOTAXIS; ADENYLATE-CYCLASE; GUINEA-PIG; RECEPTOR; CELLS; TRANSDUCTION; STIMULATION; EXPRESSION; Histamine receptor; Inflammation; G protein-coupled receptor; Second messenger; Mitogen-activated protein kinase (1)
BETA-GLUCAN RECEPTOR; MURINE CUTANEOUS LEISHMANIASIS; C-TYPE LECTIN-1; CD4(+) T-CELLS; REAL-TIME PCR; BALB/C MICE; LANGERHANS CELLS; CANDIDA-ALBICANS; VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; Curdlan; beta-glucan; Dectin-1; cutaneous leishmaniasis; adaptive immunity; dendritic cells; T helper 1 and T helper 2 cells (1)
BETA-GLUCAN RECEPTOR; PEPTIDASE-LIKE 2A; B-CELL; PATTERN-RECOGNITION; PROTEASE SPPL2A; DENDRITIC CELLS; NEGATIVE REGULATION; TNF-ALPHA; ACTIVATION; INDUCTION; (1)
BETA-H ELIMINATION; ATOM TRANSFER HAT; DECATUNGSTATE ANION; HOMOGENEOUS SYSTEM; HYDROGEN EVOLUTION; N-HETEROCYCLES; DESATURATION; DERIVATIVES; ACTIVATION; CATALYSIS; Photocatalysis; Dehydrogenation; HAT Catalysis; beta-hydride elimination; Enamide (1)
BETAINE CARRIER BETP; CONFORMATIONAL DYNAMICS; CORYNEBACTERIUM-GLUTAMICUM; ALTERNATING-ACCESS; STRUCTURAL BIOLOGY; MECHANISM; SYMPORTER; SITES; PERMEATION; LIPOSOMES; (1)
BETA-LACTAM ANTIBIOTICS; CARE; HEMODIAFILTRATION; DETERMINANT; PREDICTION; SUFFICIENT; THERAPY; SEPSIS; Intensive care medicine; Model-informed precision dosing; Piperacillin; Pharmacokinetics; pharmacodynamics; Therapeutic drug monitoring (1)
BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; HUMAN SERUM-ALBUMIN; GLOMERULAR-FILTRATION; ULTRAVIOLET DETECTION; CLINICAL-RELEVANCE; UNBOUND FRACTION; SEPTIC PATIENTS; HUMAN PLASMA; KINETICS; albumin; cystatin C; dosing; HPLC; pharmacodynamics; ultrafiltration (1)
BETA-LACTAM ANTIBIOTICS; HUMAN SERUM; Cephalosporin; Nitroimidazole; Unbound fraction; Tissue; Ultrafiltration; Microdialysis (1)
BETA-LACTAM ANTIBIOTICS; MORBIDLY OBESE; POPULATION PHARMACOKINETICS; HPLC; PHARMACODYNAMICS; PIPERACILLIN; PHARMACOLOGY; antibiotic dosing; concentrations; meropenem; microdialysis; obesity; pharmacokinetics; soft tissue; pharmacodynamics (1)
BETA-LACTAM ANTIBIOTICS; TANDEM MASS-SPECTROMETRY; CRITICALLY-ILL PATIENTS; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; SEPTIC PATIENTS; HUMAN SERUM; QUANTIFICATION; PHARMACOKINETICS; ANIDULAFUNGIN; antibiotics; critically ill patients; liquid chromatography; mass spectrometry; therapeutic drug monitoring (1)
beta-lactams, PK/PD, antimicrobials, antibiotics, beta-lactamase inhibitor (1)
Betamethasone, Escherichia coli (E. coli), Humanized mice, Indomethacin, neonatal sepsis (1)
Betamethason; Indometacin; Fenoterol; Aktivierungszustand Monozyten; neonatal; maternal (1)
BETA; NEURODEGENERATION; INHIBITION; THERAPIES; antisense oligonucleotide therapy; LNA; TGFss-signaling; neurodegeneration; ALS (1)
BETA-PEPTIDE; EXPERIMENTAL CONSTRAINTS; CHEMICAL-SHIFTS; RAS PROTEIN; FIBRILS; DISEASE; N-15; A-BETA(1-40); HYPOTHESIS; COMPLEXES; Alzheimer's disease; amyloid -peptides; high-pressure chemistry; NMR spectroscopy (1)
BETA-RECEPTOR BLOCKADE; ANGIOTENSIN SYSTEM; RAT-KIDNEY; AT(1A) RECEPTOR; NITRIC-OXIDE; MACULA DENSA; DIETARY SALT; CYCLOOXYGENASE-2 EXPRESSION; ALDOSTERONE SYNTHASE; CAPILLARY-PRESSURE; AT(1a) knockout (1)
BETA-SELECTIVE HYDROCARBOXYLATION; CARBOXYLIC-ACIDS; POTENT INHIBITORS; EFFICIENT; ALKENES; DICARBOFUNCTIONALIZATION; POLYMERIZATION; SULFONYLATION; CONVERSION; COUPLINGS; alpha-substituted acrylates; carbon dioxide; carboxylic acids; photocatalysis; sustainability (1)
BETA-STRAND; ORGANOZINC CHEMISTRY; SECONDARY STRUCTURE; LIGATING RESIDUES; L-PHENYLALANINE; HELIX BUNDLES; PRION PROTEIN; SCRAPIE PRION; ALPHA-AMINO; PEPTIDES; amino acids; metal chelates; organozinc compounds; C-C bond formation; Negishi coupling (1)
beta, systematic risk, corporate social responsibility, sustainability (1)
Beta-Thalassaemie, Endokrinopathien, Knochenstatus, kurative Therapie, Stammzelltransplantation/ Endocrinopathies, Bone Status, Beta-Thalassemia, stem cell transplantation, CRISPR/Cas9 (1)
BETA-THALASSEMIA; HEART-FAILURE; EPIGENETICS; CARDIOMYOPATHY; RECRUITMENT; REPRESSION; DYNAMICS; LANGUAGE; LESSONS; SIGNALS; histone phosphorylation; gene expression; heart (1)
beta, theta, combined EEG-fMRI, brain oscillations, encoding, episodic memory (1)
BETA-TRACE PROTEIN; PROSTAGLANDIN D SYNTHASE; KIDNEY-FUNCTION; SERUM CREATININE; CYSTATIN C; GFR; beta-trace protein; chronic kidney disease; genome-wide association studies; GFR estimation equations; glomerular filtration markers (1)
BETA-TRICALCIUM PHOSPHATE; SPONTANEOUS BONE REGENERATION; TISSUE-ENGINEERED BONE; ANORGANIC BOVINE BONE; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; CRITICAL SIZE DEFECT; FREEZE-DRIED BONE; MAXILLOFACIAL SURGERY; CALCIUM-PHOSPHATE; Jaw cysts; Enucleation; Defect filling; Bone grafts; Ossification; Complications (1)
Bethe Ansatz, Lattice Integrable Models, Phase Transitions, Scale and Conformal Symmetries (1)
Bethe-Salpeter equation Excitons Magneto-optics Spin-orbit coupling Transition metal dichalcogenides Group theory (1)
Betreuungsgeld Herdprämie (1)
Betriebliche Ausbildung (1)
Betriebliche Ruhegeldverpflichtung (1)
Betriebliches Bildungsmanagement (1)
Betriebswirtschaftliche Studiengänge, Kompetenzorientierte Lernziele, Management-Forschung, Grundprobleme der Betriebswirtschaft (1)
BET V 1; AIRBORNE POLLEN; AIR-POLLUTION; ASTHMA EXACERBATIONS; CLIMATE-CHANGE; WEED POLLEN; CIUDAD REAL; HAY-FEVER; EXPOSURE; AEROALLERGENS; Aeroallergens; Allergic rhinitis; Asthma; Emergency medical services; Grass pollen (1)
Bevacizumab, diabetische Retinopathie, diabetisches Makulaödem, Visus (1)
BEVACIZUMAB PLUS IRINOTECAN; RECURRENT MALIGNANT GLIOMA; MAGNETIC-RESONANCE-SPECTROSCOPY; PHASE-II TRIAL; APPARENT DIFFUSION-COEFFICIENT; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-AGENT BEVACIZUMAB; ADC HISTOGRAM ANALYSIS; CEREBRAL BLOOD-VOLUME; F-18-FET PET; high-grade glioma; antiangiogenic treatment; MRI; PET; multimodal response assessment (1)
BEVERIDGE CURVE; UNEMPLOYMENT; DYNAMICS; TERM; matching approach; quantity-quality trade-off; labor market reforms; Germany (1)
Beveridge curve, worker flows, tightness, unobserved components, Hartz reforms (1)
Bewertung, Evaluation, Konzept, Flugzeug, hochagil, Eurofighter, Cockpit, Mensch-Maschine-System, Belastung, Beanspruchung, Informationsverarbeitung, informatorische Belastung, informatorische Beanspruchung, Workload, Aufmerksamkeit, Zusatzaufgabe, Zeigeaufgaben, Rapid Aiming Tasks, Multitasking, Schwierigkeit, Leistung, Geschwindigkeit, Fehler, Schnittstelle, Interface, Trackball, Touchscreen, panoramic, display, Großflächendisplay (1)
Bewusstsein , Phänomen , Unerklärliches Phänomen , Kognition , Qualia , Kognitive Linguistik , Kognitionswissenschaft , Erklärung , Philosophie , Erklärungslücke , Phänomenales Bewusstsein , qualia , phenomenal consciousness , explanation gap , cognitive illusion (1)
Beziehungsmarketing - Kundenorientierung - Vertriebsorganisation - Benchmarking (1)
Bezugsnormorientierung; PISA; Mehrebenenmodelle; Schulische Leistungsbeurteilung (1)
BFP, CAD, CAIBE, CBED, CCD, DPC, EBL, EDX, EELS, EFTEM, EMCD, FEG, FEM, FFP, FIB, FWHM, HWHM, LM-STEM, MC, OAM, PCB, PCM, PDE, PECVD, SEM, SNR, STEM, TEM, XMCD, Boersch Phase Plate, twin aperture (1)
BH3 MIMETIC ABT-737; BCL-B; NMR-SPECTROSCOPY; RESISTANCE; AUTOPHAGY; NUR77; BFL-1; CONFORMATION; INHIBITORS; CONVERSION; apoptosis; autophagy; B cell lymphoma 2 (Bcl-2) family; NMR; protein-protein interaction; Bcl-b; Bfl-1; NR4A1; Nur77 (1)
BH3-ONLY PROTEINS; HEPATOMA-CELLS; VENETOCLAX; CANCER; APOPTOSIS; MITOCHONDRIA; SENSITIVITY; DEPENDENCY; MECHANISMS; PATHWAYS; hepatocellular carcinoma (HCC); apoptosis; BH3-mimetics; ABT-199; venetoclax; MIK665; S64315 (1)
BI2TE3; PHOTOEMISSION; INSULATORS; BI2SE3; MICROSCOPE; GENERATION; ELECTRONS; METROLOGY; SOLIDS; DELAYS; (1)
BI2-XINXSE3 SINGLE-CRYSTALS; TUNNELING IONIZATION; OPTICAL-PROPERTIES; INSULATORS; BI2SE3; FIELDS; CENTERS; topological insulator; terahertz radiation; photoelectromagnetic effect (1)
BIAS; Certified cancer center; Pancreatic cancer; Cohort study; Survival; Cox regression (1)
BIAXIAL FLEXURAL STRENGTH; PHASE-TRANSFORMATION; Y-TZP; TETRAGONAL ZIRCONIA; GLAZED ZIRCONIA; CERAMIC WEAR; ROUGHNESS; ENAMEL; RELIABILITY; PERFORMANCE; Monolithic zirconia; Adjustment; Polishing; Wear; Roughness; Phase transformation (1)
Bibel, Exegese, Theologie, Geschichte, Rezeption (1)
Bibel; Geschichte; Hermeneutik; Philosophische Theologie; Reformation; Slowakei (1)
Bibel, Kirchengeschichte 500-1500, Mittelalter, Katholische Kirche, Gotteslehre, Philosophie (1)
Bible; suicide; suicidal ideation; theology (1)
Bibliographieren; bibliographische Instrumente; traditionelle Medien; neue Medien; bibliothekarische Werkzeuge (1)
Bibliometric Analysis (1)
bibliometrics (1)
Bibliometrie (1)
Bibliometrie; Dienstleistung; Forschungszentrum Jülich (1)
Bibliometrie , Trendanalyse , Naturwissenschaften , Trendbeobachtung , Trenderkennung , Scientometrie , bibliometrics , scientometrics , trend recognition (1)
Bibliothek; China; Shanghai-Library (1)
Bibliothek; DBIS; Datenbanken; database (1)
Bibliotheken , Bibliothekstypen , Euregio , Adressen (1)
Bibliotheken; Dienstleistung; Portfolio-Analyse; Serviceanalyse (1)
Bibliotheken; Qualitätsmanagement; Elektronische Services; E-Journals (1)
Bibliotheksservices; Community-Treffen; DBIS; Datenbank-Infosystem; EZB; Elektronische Zeitschriften; Elektronische Zeitschriftenbibliothek; Klassifikation; RVK; Regensburger Verbundklassifikation; UR Library; wissenschaftliche Datenbanken; Erschließung, Linked Open Data, RDA Classification; Community Meeting; DBIS; Database Information System; EZB; Electronic Journals; Electronic Journals Library; Library Services; RVK; Regensburger Verbundklassifikation; UR Library; scholarly databases (1)
Bibliothekssysteme; Horizon; Forschungszentrum Jülich; Dienstleistung; OPAC (1)
Bibliothekswesen ; Russland (1)
BIBP 3226, neuropeptide Y, acylguanidine, irreversible ligands (1)
BICINCTUS MICKEL HYMENOPTERA; POSTPHARYNGEAL GLAND; SOLITARY WASP; SEX-PHEROMONE; SOCIAL GLAND; SPHECIDAE; SECRETIONS; BEHAVIOR; VOLATILES; CHEMISTRY; sexual selection; pheromone; postpharyngeal gland; scent marking (1)
BICOID MESSENGER-RNA; BINDING PROTEIN RRM4; ENDOPLASMIC-RETICULUM; FLUORESCENT PROTEIN; LOCALIZATION; TRANSPORT; SEQUENCE; IDENTIFICATION; RECOGNITION; EXPRESSION; fluorescence microscopy; GATEWAY technology; RNA binding protein; RNA transport; technical advance; lambda N22 (1)
BICONDYLAR SLEDGE PROSTHESES; ANTERIOR CRUCIATE LIGAMENT; IN-VIVO KINEMATICS; QUALITY-OF-LIFE; FOLLOW-UP; POSTURAL STABILITY; REPLACEMENT; RETENTION; SURVIVORSHIP; STRENGTH; Unicompartmental knee arthroplasty (UKA); Bicruciate-retaining total knee arthroplasty (BCR-TKA); Outcome; Proprioception (1)
BICONDYLAR SLEDGE PROSTHESES; IN-VIVO KINEMATICS; QUALITY-OF-LIFE; FORGOTTEN JOINT; FOLLOW-UP; REPLACEMENT; VALIDATION; LIGAMENTS; RETENTION; BEARING; Unicompartmental knee arthroplasty (UKA); Bicruciate-retaining total knee arthroplasty (BCR-TKA); Outcome; Patient Reported Outcome Measurement (PROM); Forgotten Joint Score (FJS) (1)
BIDENTATE NITROGEN LIGANDS; CROSS-COUPLING REACTIONS; ALPHA-DIIMINE LIGANDS; PALLADIUM COMPLEXES; ALKYL-HALIDES; ETHYLENE POLYMERIZATION; OLEFIN POLYMERIZATION; ELECTRONIC-STRUCTURES; ALKENE HYDROGENATION; CRYSTAL-STRUCTURES; electrochemistry; hydrogenations; imines; iron; redox-active ligands (1)
BIDIMENSIONAL EMD; Empirical mode decomposition; Green's function; FMRI; SVM; VIMFs (1)
BIDIMENSIONAL EMD; INTERPOLATION; Alzheimer's disease; empirical mode decomosition; Green's function; SVM; RF (1)
BIDIMENSIONAL EMD; SPECT IMAGES; TIME-SERIES; CLASSIFICATION; SIGNALS; SPLINES; INTERPOLATION; RECOGNITION; CURVATURE; ALGORITHM; Empirical mode decomposition; Green's function; Surface Interpolation (1)
BIEXTENSIONS; (1)
Biextension , Zykel , Blochsche Biextension , Poincaré-Biextension , höhere Picard-Varietäten , Bloch-biextension , Poincaré-biextension , higher Picard-varieties (1)
BIFUNCTIONAL DIKETOPIPERAZINE SCAFFOLDS; BIOLOGICAL EVALUATION; ASYMMETRIC-SYNTHESIS; MOLECULAR-MECHANICS; PEPTIDOMIMETICS; PEPTIDES; ACID; ALPHA-V-BETA-3; SELECTIVITY; ANTAGONISTS; peptidomimetics; integrin ligands; beta-amino acids; NMR conformational analysis (1)
Big Data, Analytics, Business Analystics, Logistik, Supply Chain Management (1)
Big Data, Analytics, personal data, personal health infor- mation, privacy, security, policies (1)
Big Data, Big Social Data, Big Data Analytics (1)
BIG-DATA; BIOMASS; MISSPECIFICATION; PARAMETERS; TEMPERATE; INFERENCE; CARBON; Bayesian inference; inverse modelling; model calibration; model discrepancy; multiple constraints; predictive uncertainty; structural model error; systematic data bias (1)
BIG DATA; BREAST-CANCER; HYBRID MODELS; HEALTH; CAUSAL; PREDICTION; SIGNATURE; PATIENT; EVOLUTION; DISCOVERY; Personalized medicine; Precision medicine; Stratified medicine; P4 medicine; Machine learning; Artificial intelligence; Big data; Biomarkers (1)
BIG; METABOLOMICS; ALGORITHM; Clustering of 3D-structure similarity; Network of secondary metabolites; Metabolites; Biological activities; KNApSAcK family databases; Phytochemistry; Structure-property relationships; Visualization, Cheminformatics; 'Bioinformatics (1)
Bilateral retinal detachment, Fellow eye, Vitrectomy, Buckle surgery, Anatomic success rate, Retinal symmetry (1)
BILATERAL URETERAL OBSTRUCTION; ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; CYCLOOXYGENASE-2 EXPRESSION; RENIN EXPRESSION; DRUG TRANSPORT; CORTICAL OAT1; UP-REGULATION; IN-VIVO; FAILURE; sepsis; cyclooxygenase; prostaglandins; ischemia; inflammation (1)
BILAYER GRAPHENE; CARBON NANOTUBES; ELECTRON SPINS; DIAMOND; ENTANGLEMENT; QUBITS; NANOSTRUCTURES; POLARIZATION; CONFINEMENT; RESONANCE; (1)
bilayer graphene, chirality, Fabry-Perot interference (1)
BILAYER GRAPHENE; DIRAC FERMIONS; BERRYS PHASE; (1)
bilayer graphene, g-factor modulation, quantum dots, valleytronics (1)
bilayer graphene, ray-wave correspondence, anisotropic dispersion, asymmetric micro cavities, emission characteristics, controlling electron dynamics (1)
BILAYER-LIPID-MEMBRANES; ESCHERICHIA-COLI PORINS; ION-CHANNEL; MOLECULAR-DYNAMICS; BACTERIAL PORINS; PATCH-CLAMP; SILICON; MONOLAYERS; CHIP; RECONSTITUTION; (1)
BILAYER-LIPID-MEMBRANES; SOLID-SUPPORTED MEMBRANES; SCANNING FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; IMPREGNATED MILLIPORE FILTERS; POLYMER/LIPID COMPOSITE FILMS; MICHIGANENSE SSP NEBRASKENSE; SINGLE-CHANNEL RECORDINGS; TIN-OXIDE ELECTRODES; CYTOCHROME-C-OXIDASE; solid-supported membranes; BLMs; impedance spectroscopy; channel-forming peptides; channel proteins; transporters (1)
Bild , Bedeutung , Gebrauchstheorie der Bedeutung , , Picture , meaning (1)
Bilder, Bildkarten, Fördermaterial, Förderung, Leseförderung, Unterrichtsmaterial (1)
Bilder, Fotos, Grab, Gräber, Friedhof, Kriegerdenkmal, Frankreich, Krieg (1)
Bilder, Fotos, Kirchen, Santiago de Compostela, Pilgern, Pilgerweg (1)
Bildkompetenz, Visual Literacy, Augenbewegungen, Kunst, Expertise, Eye Tracking, Messung (1)
Bildungsforschung; Empirische Religionspädagogik; Erklären im Unterricht; Schöpfungsglaube (1)
Bildungsforschung; Selbstregulation; Lehrer; Leseförderung; Lesekompetenz; Lesetraining; Handreichung (1)
Bildungsniveau, Eltern-Kind Beziehung, Bildung im Wissenschaftlichen Bereich, Mann-Whitney-U-Test, Familieneinkommen, Deutschland, Bayern, Medizin Studenten, sozialer Status, Sozialer Hintergrund, Familienhintergrund, beruflicher Hintergrund der Eltern, Akademiker, Studienfach, explorative Studie, konfirmatorische Studie, Educational Status, Parent-Child Relations, Science Education, Mann Whitney U Test, family income, Germany, Bavaria, Medical Students, Social Class, Social Background, Occupation, Academics, Subject of Study, explorative study, confirmatory study (1)
Bildungssprache; Empirische Forschung; Fachdidaktik; Sprache; Umgangssprache; Mathematik; Mathematikunterricht; Fachunterricht; Forschungsstand; Analyse; Bestandsaufnahme; Diskurs; Dokument; Fachsprache; Literaturbericht; Deutschland (1)
Bildungssprache, Sprachförderung, themenzentrierte Sprachförderung, Sprachbildung, Deutschunterricht, Fachunterricht, Heterogenität (1)
Bildungsstandards; Fernsehen; Medien und Deutschunterricht; Nachrichten; Schreibkompetenz; Sekundarstufe I; Sekundarstufe II; Unterrichtsmodelle; Zeitschriften/ Zeitungen (1)
Bildungsstand; Empirische Bildungsforschung; Klassische Testtheorie; Kompetenzorientierung; Mathematik; mehrdimensionale Bildung ;nationale Begleitstudie; nationaler Vergleich; Naturwissenschaft; PISA; PISA 2022; PISA-Fragebögen; Reflexion; Schulleistungsstudie; Schulleistungsuntersuchung; standardisierte Erhebungsinstrumente (1)
Bildungstheorie, Modernismus, Katholische Religionspädagogik, Theologiestudium (1)
BILE-ACID METABOLISM; CHOLESTEROL HOMEOSTASIS; OXIDATION-PRODUCTS; OXYSTEROLS; PLASMA; SERUM; STRESS; BRAIN; 24S-HYDROXYCHOLESTEROL; SEPARATION; GC-triple quad MS; Oxysterols; Bile acids; Chemical ionization (1)
bile acid profiles pediatric hepatobiliary diseases (1)
BILE-ACIDS; BURN INJURY; BACTERIAL TRANSLOCATION; INCREASES APOPTOSIS; SMALL-BOWEL; RATS; PERMEABILITY; CELLS; DEATH; STARVATION; (1)
BILE-ACIDS; GUT MICROBIOTA; HUMAN FECES; FAT; LIPIDOMICS; STEROLS; DIET; Lipidomics; Microbiome; Feces; Triglyceride; Diglyceride; High-resolution mass spectrometry (1)
BILE-ACID SYNTHESIS; HMG-COA REDUCTASE; URSODEOXYCHOLIC ACID; LOVASTATIN THERAPY; GALLSTONE DISEASE; NUCLEATION TIME; METABOLISM; PRAVASTATIN; SECRETION; HUMANS; bile acids; cholelithiasis; hydroxymethylglutaryl CoA reductase inhibitors (1)
BILE-DUCT CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; IMMUNOHISTOCHEMICAL MARKERS; PROTEOMIC ANALYSIS; CANCER; COMMON; LIVER; MALDI-MSI; tandem mass spectrometry; pancreatic ductal adenocarcinoma; cholangiocarcinoma; machine learning; supervised classification; proteomics; peptides (1)
BILE-DUCT DILATATION; LIVER RESECTION; TRANSPLANTATION; CLASSIFICATION; COMPLICATIONS; SURGERY; (1)
BILE-DUCT; LIVER-TRANSPLANTATION; PALLIATIVE TREATMENT; STRICTURES; HEPATICOJEJUNOSTOMY; GALLBLADDER; SURGERY; BENIGN; CANCER; cholestasis; hepatojejunostomy; hepatogastrostomy (1)
BILE-DUCT OBSTRUCTION; METALLIC STENTS; RANDOMIZED TRIAL; PALLIATIVE TREATMENT; ENDOPROSTHESES; DRAINAGE; COMPLICATIONS; SURGERY; CANCER; BYPASS; cholestasis; jaundice, obstructive; stents; biliary tract (1)
BILE-DUCTS; RISK-FACTORS; DONOR; MANAGEMENT; RECONSTRUCTION; RECIPIENTS; LEAKAGE; STRICTURES; EXPERIENCE; DIAGNOSIS; early biliary complications; pediatric liver transplantation (1)
BILE-DUCT STONES; PAPILLARY DILATION; BALLOON SPHINCTEROPLASTY; RANDOMIZED TRIAL; REMOVAL; COMPLICATIONS; MANAGEMENT; PLACEMENT; STENTS; bile duct stones; papillary stenosis; balloon dilation; transhepatic sphincteroplasty; percutaneous bile stone extraction (1)
BILE-DUCT SYNDROME; TRIMETHOPRIM-SULFAMETHOXAZOLE; CARINII-PNEUMONIA; ADVERSE-REACTIONS; AIDS; TRIMETHOPRIM/SULFAMETHOXAZOLE; PANCREATITIS; LIVER; HIV; Pneumocystis pneumonia; Trimethoprim-sulfamethoxazole; Adverse effects; Intrahepatic cholestasis (1)
BILE LEAKS; MANAGEMENT; CHOLANGIOGRAPHY; LIVER; COMPLICATIONS; PREVENTION; DRAINS; DUCTS; Biliary fistula; Biliary leakage; Biliary complications; Hepatopancreaticobiliary surgery; Endoscopic retrograde cholangiopancreatography (1)
BILIARY ATRESIA; EPITHELIAL INJURY; CELLS; OBSTRUCTION; MACROPHAGES; FETAL; LYMPHOCYTES; EXPRESSION; DISEASE; MURINE; (1)
biliary atresia, PELD score, liver fibrosis (1)
BILIARY CAST SYNDROME; ORTHOTOPIC LIVER-TRANSPLANTATION; SEPTIC SHOCK; COMPLICATIONS; GUT; (1)
BILIARY COMPLICATIONS; REFERRAL PATTERN; CHOLANGIOGRAPHY; LESIONS; RECONSTRUCTION; REPAIR; bile duct injury; laparoscopic cholecystectomy; surgical management; follow-up (1)
BILIARY-TRACT; ABSCESS; PHARMACOKINETICS; CHOLANGITIS; INFECTIONS; MANAGEMENT; ETIOLOGY; SURGERY; TRENDS; Moxifloxacin; Liver penetration; Pharmacokinetics; Liver abscess (1)
BILIARY-TRACT CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; PRIMARY SCLEROSING CHOLANGITIS; MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA; HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA; ISOCITRATE DEHYDROGENASE 1; CIRCULATING TUMOR-CELLS; STEM-LIKE PLASTICITY; BILE-DUCT CANCER; PERIHILAR CHOLANGIOCARCINOMA; (1)
BILIARY-TRACT; INTRAHEPATIC CHOLANGIOCARCINOMA; CANCER; LIVER; MICE; GENERATION; DISCOVERY; (1)
BILIPSCHITZ EQUIVALENCE; MACROSCOPIC DIMENSION; ESSENTIAL MANIFOLDS; INVARIANT-MEANS; AMENABILITY; (1)
BILLIARDS; CAVITIES; STADIUM; CHAOS; SHAPE; (1)
Bimetallic and trimetallic triphosphine complexes; synthesis; NMR; IR (1)
Bimetallic complex, Redox properties, self-sensitized photocatalysis, CO2 reduction (1)
BIMODAL DIVIDED ATTENTION; INTERHEMISPHERIC NEURAL SUMMATION; AUDITORY-VISUAL INTERACTIONS; SIMPLE REACTION-TIME; INTERSENSORY FACILITATION; MOTOR COMPONENT; RESPONSE FORCE; COACTIVATION; INTEGRATION; SIGNALS; (1)
BINARY RELEVANCE; TASK COMPLEXITY; SEEKING; KNOWLEDGE; AGREEMENT; DESIGN; Conversational search; information needs; conversational agents (1)
Binaural auralizations / Virtual reality / Sound source localization / Subjective audio realism / Eye-tracking / Social presence / Head related impulse responses / Gaze / Attention (1)
BINDING CASSETTE TRANSPORTER-1; DENSITY-LIPOPROTEIN DEFICIENCY; AMERICAN-HEART-ASSOCIATION; TANGIER-DISEASE; APOLIPOPROTEIN-E; HISTOLOGICAL CLASSIFICATION; VASCULAR-LESIONS; BONE-MARROW; MICE; CHOLESTEROL; (1)
BINDING CASSETTE TRANSPORTER-1; DENSITY-LIPOPROTEIN DEFICIENCY; TANGIER-DISEASE; APOPTOTIC CELLS; CHOLESTEROL EFFLUX; PLASMA-MEMBRANE; PROTEIN; ENGULFMENT; PHOSPHATIDYLSERINE; REDISTRIBUTION; human ABCA1; membrane protein; Baculovirus-insect cell expression system; ATP binding; ATPase activity; nucleotide occlusion; cholesterol and lipid metabolism (1)
BINDING CASSETTE TRANSPORTER-1; DISEASE GENE ABCR; TRANSMEMBRANE CONDUCTANCE REGULATOR; FAMILIAL INTRAHEPATIC CHOLESTASIS; DUBIN-JOHNSON-SYNDROME; MAP KINASE CASCADE; TANGIER-DISEASE; P-GLYCOPROTEIN; STARGARDT-DISEASE; PLASMA-MEMBRANE; (1)
BINDING CASSETTE TRANSPORTER-1; MEDIATED CELLULAR CHOLESTEROL; HIGH-DENSITY-LIPOPROTEINS; TANGIER-DISEASE; PLASMA-MEMBRANE; EPITHELIAL-CELLS; RAFTS; MACROPHAGES; EXPRESSION; DEFICIENCY; ABCA1; CDC42; microvilli; monocytes; rafts (1)
BINDING CASSETTE TRANSPORTER-1; MULTIDRUG-RESISTANCE PROTEIN; DISEASE GENE ABCR; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; DUBIN-JOHNSON-SYNDROME; CONJUGATE EXPORT PUMP; MDR1 P-GLYCOPROTEIN; MAP KINASE CASCADE; RECEPTOR LXR-ALPHA; ABC transporter; ABCA1; macrophage; lipid; cholesterol; phospholipids; caveolin; NPC1; review (1)
BINDING CASSETTE TRANSPORTER-1; STEROL-DEPENDENT REGULATION; TANGIER-DISEASE; GENOMIC ORGANIZATION; DIETARY-CHOLESTEROL; PROMOTER REGION; GENE; IDENTIFICATION; MUTATIONS; CLONING; (1)
BINDING CASSETTE TRANSPORTER-1; STEROL-DEPENDENT REGULATION; TANGIER-DISEASE; GENOMIC ORGANIZATION; DIETARY-CHOLESTEROL; PROMOTER REGION; GENE; IDENTIFICATION; MUTATIONS; SITOSTEROLEMIA; (1)
BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; CHOLESTEROL; ABCA1; familial high-density lipoprotein deficiency; Tangier disease; genetic testing (1)
BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; GENE; ORGANIZATION; MUTATIONS; PROTEINS; SITOSTEROLEMIA; IDENTIFICATION; CHOLESTEROL; INVENTORY; (1)
BINDING CASSETTE TRANSPORTER-1; VERSUS-HOST DISEASE; TANGIER-DISEASE; MARROW TRANSPLANTATION; PROTEINS; PROMOTER; DONORS; IDENTIFICATION; EXPRESSION; INVENTORY; (1)
BINDING CASSETTE TRANSPORTER; APOLIPOPROTEIN-A-I; CHOLESTEROL EFFLUX; PLASMA-MEMBRANE; RHO-GTPASES; PROTEIN A1; DISEASE; MACROPHAGES; ENDOCYTOSIS; TRAFFICKING; (1)
BINDING DOMAIN; GTP ANALOG; CONFORMATIONAL STATES; EFFECTOR INTERACTION; DYNAMIC PROPERTIES; HUMAN CANCER; K-RAS; IDENTIFICATION; LIGAND; PATHWAY; conformational dynamics; drug design; Ras protein; signal transduction (1)
BINDING DOMAIN; PROTEIN-KINASE; P21(RAS); P21; Ras; conformational dynamics; effector interaction; P-31 NMR spectroscopy (1)
Binding modes, Inhibitors, Membranous adenylyl cyclase, Soluble adenylyl cyclase, Soluble guanylyl cyclase, Structure, Substrates (1)
BINDING PEPTIDES; COMPLEXES; 1,4,7,10-tetraazacyclododecane; molecular recognition; peptide synthesis; transition metal binding (1)
BINDING-PROTEIN-C; ENGINEERED HEART-TISSUE; KNOCK-IN MICE; UBIQUITIN-PROTEASOME SYSTEM; 2011 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; MUSCLE LIM PROTEIN-1; SKELETAL-MUSCLE; DEPENDENT ACTIVATION; CARDIAC-HYPERTROPHY; Hypertrophic cardiomyopathy; Hypertrophy; FHL2; Engineered heart tissue; Hypercontractility (1)
BINDING PROTEIN-C; HEAVY-CHAIN GENE; BETA-CARDIAC MYOSIN; ALPHA-TROPOMYOSIN; DISEASE GENE; IDENTIFICATION; POPULATION; SARCOMERE; SITE; genetic diagnosis; hypertrophic cardiomyopathy; mutation; sarcomeric genes; SSCP (1)
BINDING-PROTEIN-C; LATE SODIUM CURRENT; RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEART-FAILURE; SARCOMERIC CARDIOMYOPATHIES; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; TROPONIN-T; PRACTICE GUIDELINES; CURRENT INHIBITION; Hypertrophic cardiomyopathy; Ranolazine; Ca2+ sensitivity; beta-Adrenergic signalling; Cardiac myosin-binding protein C (1)
BINDING PROTEIN; CLOCK; GENE; IDENTIFICATION; ALGAE; (1)
BINDING-PROTEIN-C; STRETCH-ACTIVATED CHANNELS; KINASE-II; PERFUSION-PRESSURE; CARDIAC-MUSCLE; PHOSPHORYLATION; FORCE; RAT; CONTRACTION; FAILURE; Anrep effect; CaMKII; Ca(2+)handling proteins; cMyBP-C; elastance-time curve; end-systolic elastance (Ees); LV contractility; myofilament phosphorylation (1)
BINDING-PROTEIN-C; UBIQUITIN-PROTEASOME SYSTEM; REDUCING-BODY MYOPATHY; MUSCLE LIM PROTEIN-1; MESSENGER-RNA DECAY; SKELETAL-MUSCLE; SCAPULOPERONEAL MYOPATHY; CARDIAC DYSFUNCTION; DANON DISEASE; MUTATIONS; (1)
BINDING-PROTEIN; GENE FAMILY; VIRULENCE GENES; WIDE ANALYSIS; HETEROCHROMATIN; STEVOR; ACETYLATION; ERYTHROCYTE; PHOSPHORYLATION; INVASION; malaria; P; falciparum; chromatin; bromodomain; variant surface antigens (1)
BINDING PROTEIN; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; EXOSOME; LINKING; CLIP; IDENTIFICATION; REVEALS; SITES; DNA; (1)
BINDING PROTEIN; OBESITY; DIET; DEFINITION; PREVALENCE; EXPRESSION; STRESS; MODEL; MICE; MRI; (1)
BINDING-PROTEINS; SIGNAL PEPTIDES; II SECRETION; MEMBRANE; HOMOLOG; IDENTIFICATION; TRANSPORT; GENUS; PILT; Cell envelope; Archaea; Sulfolobus; S-layer (1)
BINDING-SITES; COLORIMETRIC DETECTION; ARTIFICIAL RECEPTORS; ENZYME-INHIBITORS; AQUEOUS-SOLUTION; CLICK CHEMISTRY; LIPID-MEMBRANES; RECOGNITION; SURFACE; CHEMOSENSORS; (1)
BINDING-SITES; DNA-BINDING; PROXIMAL PROMOTER; TRANSCRIPTION; ARTHRITIS; ELEMENTS; ENHANCER; REGION; MOUSE; C/EBP; CORS-26 gene; promoter; bone; skeletal development (1)
Bindungsaktivierung, Nickel, Phosphaalkinoligomere, Phosphatetrahedrane, Phosphor (1)
BINGE DRINKING; CLOCK; CRHR1; ADOLESCENCE; ADAPTATION; EXPRESSION; DEPENDENCE; PHYSIOLOGY; BEHAVIOR; EVENTS; (1)
binge eating | bulimia nervosa | purging | weight gain | weight suppression (1)
BINGE-EATING DISORDER; QUALITY-OF-LIFE; CASE SERIES; IMPROVEMENT; bulimia nervosa; topiramate; frequency of binging/purging; body weight; health-related quality of life (1)
BINOCULAR DISPARITY; STEREOSCOPIC DEPTH; 3D SHAPE; FUNCTIONAL-ORGANIZATION; INTRAPARIETAL SULCUS; SURFACE ORIENTATION; 3-DIMENSIONAL SHAPE; VISUAL-CORTEX; PARIETAL CORTEX; DORSAL; realness; stereopsis; fMRI; parietal cortex; intraparietal sulcus; 3D perception; depth perception (1)
BINOCULAR-RIVALRY; PERCEPTUAL BISTABILITY; COMPETITION MODELS; NETWORK MODEL; CIRCUITS; MOTION; CORTEX; NOISE; AREA; (1)
BINOCULAR-RIVALRY; VISUAL-PERCEPTION; GAMMA-ACTIVITY; EFFECT SIZE; EEG-DATA; PHASE; CONSCIOUSNESS; STIMULI; OSCILLATIONS; ALPHA; EEG; Breaking continuous flash suppression; Visual perception; Consciousness (1)
BINUCLEAR METAL CENTER; BACTERIAL PHOSPHOTRIESTERASE; UNKNOWN FUNCTION; ENZYME; PROTEIN; MEMBER; DIVERSITY; COMPLEX; SITE; KEGG; (1)
BIOANALYTICAL METHOD VALIDATION; PLASMA OXYTOCIN; INTRANASAL OXYTOCIN; PERIPHERAL OXYTOCIN; URINARY OXYTOCIN; CEREBROSPINAL-FLUID; ENDOGENOUS OXYTOCIN; PSYCHIATRIC-DISORDERS; AFFILIATIVE BEHAVIOR; PSYCHOSOCIAL STRESS (1)
BIOARTIFICIAL PANCREAS; ENGINEERED CARTILAGE; COLLAGEN SPONGES; OXYGEN-TENSION; HEART-VALVES; STEM-CELLS; CULTURE; BONE; CHONDROCYTES; SCAFFOLDS; (1)
Bioavailability, Biocompatibility, Cyclosporine A, Dry eye disease, In-situ nanosuspension, Surfactant micelles (1)
; bioavailability; low doses; tropisetron; volunteers (1)
biobank; biospecimen; biosample; quality; cryotube; liquid nitrogen (1)
biobanking; precision medicine; biobank education; training (1)
Biobank, Standardisierung, personalisierte Medizin, ISO 20387 (1)
BIO-BASED SOLVENTS; CELL-WALL; SACCHAROMYCES-CEREVISIAE; RAPID METHOD; COSMO-RS; CELLULOSIC BIOETHANOL; YEAST; MICROWAVE; PURIFICATION; ULTRASOUND; Bligh and Dyer; Folch; bio-sourced solvent; yeast; lipids (1)
(bio)catalysis, biopolymer, polysaccharide, chitosan, alginate, carrageenan, protein, gelatin, silk fibroin, hydrogel, C-C bond formation, Henry reaction, direct aldol reaction, Knoevenagel condensation, Michael addition (1)
BIOCATALYTIC METHANATION; CARBON-DIOXIDE; MASS-TRANSFER; HYDROGEN; THERMOAUTOTROPHICUS; NOV.; Optimized packing-organism combination; Liquid hold-up maximization; Methanothermobacter; Methanothermococcus; Methane production (1)
BIOCEMENT-D; RAT BONE; OSTEOPONTIN; SIALOPROTEIN; OSTEOBLASTS; bone defects; bone substitute materials; calcium-phosphate collagen cement; jaw; phosphoserine (1)
BIOCHEMICAL FAILURE; TRANSRECTAL HIFU; biochemical failure; biopsy; high-intensity focused ultrasound; PSA (1)
BIOCHEMICAL FAILURE; TRANSRECTAL HIFU; THERAPY; OUTCOMES; RADIOTHERAPY; FEASIBILITY; Biochemical failure; Follow-up; High-intensity focused ultrasound; Nadir; Prostate cancer; PSA (1)
Biochemie, Molekularbiologie, Archaebakterien, Transkription <Genetik>, Pyrococcus furiosus, Transkriptionsregulator, biochemistry, molecular biology (1)
Biochemie , Molekularbiologie , Archaebakterien , Transkription <Genetik> , Startreaktion , Pyrococcus furiosus , Transkriptionsfaktor , , biochemistry , molecular biology (1)
Biochemie , Molekularbiologie , RNS-Polymerase II , RNS-Polymerase III , Archaebakterien , Transkription <Genetik> , Pyrococcus furiosus , , biochemistry , molecular biology , RNA polymerase II , RNA polymerase III , archaea (1)
Biochemistry, Biological techniques, Cell biology, Molecular biology, Neuroscience (1)
Biochemistry Biophysics Biotechnology Microbiology Structural biology (1)
biochemistry, protein evolution, protein design, secondary metabolism, xenobiotic metabolism (1)
biocompatibility, biomaterial, fibrosis, semiautomatic scoring (1)
biocompatible solvents, ionic liquid, deep eutectic solvent, cellulose, biopolymer, solubilization, biodegradability, hydrotrope, COSMO-RS, choline, betaine, carnitine, levulinate, itaconate (1)
BIODEGRADABLE MICROSPHERES; CONTROLLED-RELEASE; DRUG-DELIVERY; PROTEIN; STABILITY; STABILIZATION; ENCAPSULATION; NANOSPHERES; ADSORPTION; poly(lactic acid); poly(ethylene glycol); block copolymer; peptide stability; acylation (1)
BIODEGRADABLE MICROSPHERES; POLY(ETHYLENE GLYCOL); PROTEIN-STRUCTURE; S/O/W EMULSION; NANOSUSPENSIONS; ENCAPSULATION; EFFICACY; PEPTIDE; WATER; CRYSTALLIZATION; bioactivity of insulin; Box-Behnken design; high pressure homogenization; insulin; micronization (1)
BIODEGRADABLE MICROSPHERES; TRIGLYCERIDE MATRICES; SUSTAINED DELIVERY; MALIGNANT GLIOMA; RADIOSENSITIZATION; 5-FLUOROURACIL; MICROPARTICLES; DEGRADATION; EXCIPIENT; INSULIN; lipid; implant; controlled release; release mechanism; mathematical modeling (1)
BIODEGRADABLE PLGA MICROSPHERES; CONTROLLED DRUG-DELIVERY; NEUROTROPHIC FACTOR; SPINAL-CORD; NEURODEGENERATIVE DISEASES; TRIGLYCERIDE MATRICES; NEURONAL SURVIVAL; SUSTAINED-RELEASE; NGF STABILITY; ADULT-RATS; manufacturing strategies; confocal microscopy; protein drugs; lipid matrices; brain biocompatibility (1)
BIODEGRADABLE POLYMERIC SCAFFOLDS; INDUCED PHASE-SEPARATION; DIBLOCK COPOLYMERS; FOAMS; FABRICATION; CARTILAGE; BONE; DESIGN; ORGANS; CELLS; scaffold; lipid; polylactic acid; polyethylene oxide; cartilage tissue engineering (1)
BIODEGRADABLE POLYMER SCAFFOLDS; PROTEIN ADSORPTION; PROPERTIES RELEVANT; MODEL SURFACES; BIOMATERIALS; ATTACHMENT; FIBRONECTIN; MIGRATION; GLYCOL); DENSITY; (1)
BIODEGRADABLE POLYMERS; CONTROLLED-RELEASE; PLGA MICROSPHERES; VITRO RELEASE; SYSTEMS; PLA; biocompatibility; biodegradable polymers; controlled release/delivery; hydrogels; injectables; poly(lactic/glycolic) acid (PLGA/PLA); polymer biodegradation; polymeric drug carrier; excipients; formulation; bioavailability; diffusion; distribution; in vitro/in vivo correlation; peptide delivery; peptides; pharmakokinetics; stability; toxicology (1)
BIODEGRADABLE POLYURETHANES; SOLVENT-FREE; POLYMERS; GLYCOL); copolymerization; critical solution temperatures; polyurethanes; tensile strength; thermoresponsive materials (1)
BIODEGRADABLE TRIBLOCK COPOLYMER; TISSUE; DELIVERY; STABILIZATION; FORMULATIONS; STABILITY; ACYLATION; ACID; protein; insulin; controlled release; lipid; bioactivity; cartilage; tissue engineering (1)
BIODIESEL FUELS; VEGETABLE-OILS; PHASE-BEHAVIOR; DENSITY; TEMPERATURE; VISCOSITY; MIXTURES; ETHANOL; BIOMASS; COMBUSTION; (1)
BIODISTRIBUTION; NANOCARRIERS; Lipid nanocapsules; SPIONs; TEM; Fluorescence microscopy; ICP-OES (1)
Biodiversität, Landwirtschaft, Kirche, Kirchengrund, Kirchenland, Artenreiche Landwirtschaft, Schöpfungsverantwortung, Handreichung (1)
Biodiversität, Populationsgenetik, Jamaika, Puerto Rico, Phylogenie, Epilobocera, Sesarma, Phylogeografie, ITS1, ND1, key innovation, Epilobocera, Sesarma, ITS1, ND1 (1)
biodiversity; biogeography; comparative sequence analysis; ribosomal; identification key; mitochondrial and ribosomal DNA; molecular systematics; morphological comparison; speciation; species delineation; taxonomy (1)
Biodiversity; Connectivity; Functional traits; Grasslands; Habitat deterioration; Land use change; Landscape matrix; Plants (1)
biodiversity conservation, genetic variation, inbreeding, outbreeding, species-rich grassland, local see mixture, local plant material, reintroduction (1)
bioelectrical impedance analysis | cancer | cancer patients | fitness | outpatient clinic | physical performance (1)
BIOELECTRICAL-IMPEDANCE ANALYSIS; LEAN BODY-MASS; BLOOD-PRESSURE; CHILDREN; SIZE; ADOLESCENTS; VALIDATION; HYPERTENSION; HYPERTROPHY; IMPACT; fat-free mass; left ventricular mass; approximation; allometric signal (1)
Biofilme, antimikrobielle photodynamische Therapie, Chlorhexdin (1)
BIOFILM FORMATION; IN-VITRO; RESIN COMPOSITES; BONDING MATERIALS; SURFACE; ADHERENCE; ASSAY; PROLIFERATION; CYTOTOXICITY; APPLIANCES; (1)
BIOFILM FORMATION; PYROCOCCUS-FURIOSUS; ADHESION; ARCHAEA; GENUS; (1)
Biofilm, Prothesenbasismaterialien, Metalloxid-Nanopartikel, PMMA, Candida albicans (1)
biofuel formulation diesel engine test (1)
biofuel, vegetable oil, FAME, antioxidant (1)
Biofunctional nanofibers; Biosensing; Electrospinning; Lab-on-a-chip (1)
BIOGENESIS; CIRCRNAS; ABUNDANT; REPEATS; EXON; (1)
BIOGENIC-AMINES; ALIPHATIC-AMINES; GAS CHROMATOGRAPHY; CHAMELEON LABELS; WATER SAMPLES; FOOD SAMPLES; PROTEINS; DERIVATIZATION; Sensor; Amines; Water; Soil; Microplate (1)
BIOGENIC-AMINES; DYES; SOLVOLYSIS; GREEN; PROBE; RED; (1)
biogenic amines, starvation, starvation resistance, insects, proboscis extension response (1)
BIOGENIC SILICA; CELL-CYCLE; MORPHOGENESIS; POLYAMINES; DEPOSITION; BIOSILICA; GROWTH; OCEAN; ACID; BIOMINERALIZATION; diatoms; biomineralization; silicification; silicon-storage pool; solid-state Si-29 NMR spectroscopy; confocal laser fluorescence microscopy (1)
Biogeographie , Dispersion , Modell , Ausdauernde Pflanzen , Diaspore , Verbreitungsökologie , Kolonisierung , Silberbaumgewächse , , seed dispersal , biogeography , model , perennial plants (1)
Biogeography (Population Studies); Ecology (Environmental Sciences); General Life Studies; Morphology; Systematics and Taxonomy (1)
Biogeography (Population Studies); Morphology; Systematics and Taxonomy (1)
Biographie , , Frauen der Romantik , DDR-Literatur , Christa Wolf , Sigrid Damm , Brigitte Struzyk , (1)
Biokompatibilität; Amalgam; Kompositkunststoffe; Allergie; Toxizität (1)
BIOLOGICAL-ACTIVITY; METAL-COMPLEXES; RHODIUM; BINDING; Bioorganometallic chemistry; Cyclometalated complexes; Iridium; Organometallic anticancer drugs (1)
BIOLOGICAL AGENTS; METHOTREXATE; (1)
biological complexity; biological diversity; endosymbiosis; evolving systems; hybridisation; hybrid speciation; organisms; phylogenetics; symbiosis; systematics; theory of evolution (1)
BIOLOGICAL EVALUATION; ANTICANCER ACTIVITY; DERIVATIVES; ANTITUMOR; AGENTS; ACID; (1)
BIOLOGICAL EVALUATION; KINASE; DESIGN; PYRIDINYLIMIDAZOLES; OXETANES; INDUCER; PROTEIN; POTENT; protein kinase; kinase inhibitor; 9H-pyrimido[4; 5-b]indole; glycogen synthase kinase-3β metabolic stability (1)
BIOLOGICALLY-ACTIVE PEPTIDES; RING-CLOSING METATHESIS; CHAIN CHIRAL CENTERS; ASYMMETRIC-SYNTHESIS; SIDE-CHAIN; ETHYLENE BIOSYNTHESIS; ORGANIC-SYNTHESIS; ALPHA,ALPHA-DIALKYL-ALPHA-AMINO ACIDS; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; C-ALPHA,ALPHA-DIALKYLATED GLYCINES; artificial amino acids; cyclic compounds; synthesis; conformation (1)
BIOLOGICALLY IMPORTANT LIGANDS; DOUBLE-BOND ISOMERIZATION; SCHIFF-BASE COMPLEXES; LEWIS-ACID CATALYSIS; ALPHA-AMINO-ACIDS; X-RAY STRUCTURE; X=Y-ZH SYSTEMS; POTENTIAL 1,3-DIPOLES; RUTHENIUM COMPLEXES; ORGANIC-SYNTHESIS; (1)
BIOLOGICALLY IMPORTANT LIGANDS; TRANSITION-METAL COMPLEXES; CHIRAL RUTHENIUM COMPLEXES; SCHIFF-BASE COMPLEX; MONOXIDE LIGANDS; DIASTEREOSELECTIVITY; CONFIGURATION; REACTIVITY; STEREOCHEMISTRY; EPIMERIZATION; enantiomers; diastereomers; half-sandwich complexes; 1 : 1 diastereomer co-crystallization; molecular recognition (1)
BIOLOGICALLY IMPORTANT LIGANDS; TRANSITION-METAL COMPLEXES; HALF-SANDWICH COMPLEXES; SCHIFF-BASE COMPLEX; RUTHENIUM(II) COMPLEXES; CONFIGURATION; REACTIVITY; DIASTEREOSELECTIVITY; SUBSTITUTION; RHODIUM(III); (1)
BIOLOGICAL-PSYCHIATRY WFSBP; HANS RATING-SCALE; DEPRESSION SCALE; WORLD-FEDERATION; CONTROLLED-TRIAL; BRAIN; GUIDELINES; SOCIETIES; TMS; Residual schizophrenia; Repetitive transcranial magnetic stimulation; Neurobiology (1)
Biological sciences, Neuroscience, Behavioral neuroscience (1)
BIOLOGICAL WARFARE AGENTS; BIOSENSOR; IDENTIFICATION; SYSTEM; ASSAY; biosensor; chemiluminescence; immunoassay; multianalyte detection (1)
BIOLOGICAL WARFARE AGENTS; MULTICHANNEL IMMUNOSENSOR; MONOCLONAL-ANTIBODY; CYANOBACTERIA; IMMUNOASSAY; HEPATOTOXINS; WATERS; BRAZIL; CYANOTOXINS; TOXINS; Microcystin; Biosensor; ELISA; FSC; Cyanobacteria (1)
Biologie Elektronenmikroskopie Konferenz Lebenswissenschaft Materialwissenschaft Physik Tagung (5)
Biologieunterricht , Art , Form , Gymnasium , Kontext , Artenkenntnis , Formenkenntnis , Biodiversität , biology , plants , animals , high school , context (1)
BIOLOGY; INJURY; CELLS; EXPRESSION; ADHESIONS; SCAFFOLDS; RUPTURE; REPAIR; Murine patellar tendon; Patellar tendon transplantation; Tendon regeneration (1)
Biolumineszenz, GPCR, Luciferase (1)
Biomarker; Biopsy; Chemoprevention; Sox9 (1)
Biomarker, Brustschmerz, Herzinsuffizienz (1)
biomarker, cancer, citrate, tumour microenvironment, plasma membrane citrate carrier (pmCiC) (1)
biomarker, cerebrovascular manipulation, clip, coil, cognition, neuropeptide Y (NPY), outcome, unruptured intracranial aneurysms (UIA) (1)
; biomarker; clinical decision-making; clinical research/practice; clinical trial; immunobiology; immunosuppression/immune modulation; immunosuppressive regimens - minimization/withdrawal; kidney transplantation/nephrology; rejection: acute (1)
Biomarker, drug development, precision oncology, sequence of trials (1)
Biomarker; head-and-neck cancer; lung cancer; metastasis; proteomics (1)
Biomarker, Nectin-1, T-VEC, onkolytic virotherapy, T-VEC, melanoma, pmCiC, Citrate, metabolism (1)
biomarker; neonatal brain injury; hypoxic-ischemic encephalopathy (HIE); diagnostic tools; prognostic indicators; neonatal encephalopathy (NE) (1)
biomarker, prognostic, diagnostic, extracellular vesicles, kidney function (1)
BIOMARKERS; BIOPSIES; CHILDREN; Kidney transplant rejection; Urinary metabolites; Biomarker; NMR-spectroscopy; Non-invasive test (1)
biomarkers | bladder cancer | GDF-15 | interleukin 6 | sarcopenia | urothelial cancer (1)
Biomarkers; cardiac death; cardiac diseases; cardiovascular disease (CVD); chronic kidney disease (CKD); heart failure; heart type fatty acid binding protein (H-FABP); high-sensitivity troponin T (hs-TNT); kidney diseases; prognosis; renal function (1)
biomarkers, cardiovascular outcomes, cohort, eGFR, suPAR, uACR (1)
; biomarkers; genomics; lipids; lipoproteins; publications (1)
BIOMARKER SIGNATURE; TOLERANCE; REJECTION; HUMANS; (1)
Biomarker, Tumor microenvironment, Urothelial cancer, Immunology, Interleukin (1)
BIOMATERIALS; DEBRIDEMENT; DRESSINGS; FOOT; biodegradable matrix; silica gel fibre matrix; venous ulcer (1)
; Biomaterials; Standard operation procedure; Pre-analytics; Artefacts; Feasibility study (1)
Biomaterials, Surface Modification, Self-Assembled Monolayers, Protein Adsorption (1)
biomechanics, growth, stress, morphoelasticity, multiplicative decomposition (1)
Biomechanics; muscle injury; attention; musculoskeletal simulation (1)
Biomechanik; Osteoporose; Prävention; Motion Capture; Belastungen; high-impact; Wearables; Muskuloskelettale Simulation (1)
Biomechanik, Skilanglauf, Sportmedizin, Biathlon, obere Extremität, Muskelaktivitäten, EMG, Motion- Capture- System, Feldstudie, Vortriebskraft (1)
BioMed Central, BMC, Springer, Open Access Lunch (1)
BIOMEDICAL APPLICATIONS; CHEMISTRY; DELIVERY; GELS; PH; (1)
BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; GENE DELIVERY; ANTISENSE OLIGONUCLEOTIDES; NONIONIC SURFACTANT; VESICLES NIOSOMES; KAPPA-CARRAGEENAN; RELEASE; METHYLCELLULOSE; RNA; (1)
biomedical ethics, Prinzipienethik, GTE (Geschichte, Theorie und Ethik), Medizinethik, Beachamp und Childress (1)
BIOMEDICAL PUBLICATIONS; BIBLIOMETRIC ANALYSIS; INTERNAL-MEDICINE; EUROPEAN-UNION; WORLD REGIONS; GLOBAL BURDEN; IMPACT; COUNTRIES; (1)
Biomembran , Elektronenmikroskopie , Molekulare Bioinformatik , Sekundärstruktur , Oligomerisation , Wirt , Parasit , Membranproteine , Archaeen , elektrophysiologische Studien , Ignicoccus hospitalis , Nanoarchaeum equitans , Membranporen , Proteinanalytik , archaea , electrophysiological studies , membrane pores , protein analytics , electron microscopy (1)
Biometric identity trust (1)
Biometric signature authentication, biometric person authentication, Handwritten PIN recognition, Dynamic Time Warping (DTW), Charaterization of parkinson’s disease, Biometrische Unterschriften-Authentifizierung, biometrische Personen-Authentifizierung, Handschriftliche PIN-Erkennung, Dynamic-Time-Warping (DTW), Beschreibung der Parkinson-Krankheit (1)
Biometrie, Tippverhalten, Replay, Profilalterung, Qualität des Merkmals, Authentisierung und Authorisierung, AAI, Referenzmodell, biometrics, typing behavior, replay, template aging, feature quality, authentication and authorisation, AAI, reference model (1)
biomimetic catalysts; photooxidations; photocycloadditions; photoisomerizations; cycloeliminations (1)
BIOMIMETIC SENSORS; GOLD ELECTRODES; BIOSENSORS; RECEPTOR; FILMS; SERUM; capacitive sensor; creatinine; molecularly imprinted polymers; chemical sensor; photografted polymerization (1)
Biomineralisation, Dictyostelium discoideum, Molluskenschale, organische Matrix, Myosin-Chitinsynthase, rekombinante Myosindomäne, biomineralization, dictyostelium discoideum, myosin-chitinsynthase, recombinant myosin domain, organic matrix, mollusc shell (1)
; biomodulation; anakoinosis; NSCLC; checkpoint inhibition; pioglitazone; nivolumab; priming; metronomic chemotherapy; clarithromycin (1)
BIOMOLECULAR HOMOCHIRALITY; WEAK-INTERACTIONS; MOLECULES; SPECTRA; ENERGIES; BOND; chirality; chirped-pulse Fourier-transform rotational spectroscopy; microwave spectroscopy; nuclear quadrupole coupling; parity violation (1)
BIOMOLECULES; LASER; RED; PH; Nanoparticles; Silica; Polystyrene; Fluorescence; Label (1)
; bioorganometallic chemistry; cellular imaging; iridium; luminescence lifetime; rhodium (1)
BIOORGANOMETALLIC CHEMISTRY; MOLECULAR RECOGNITION; METAL-COMPLEXES; ACID GUESTS; DNA; PHOTOREACTIVITY; RHODIUM(III); HOSTS; electronic spectra; photochemistry; nucleoside complexes; rhodium complexes (1)
Bioorthogonal chemistry; Unnatural amino acids; Amber suppression; eGFP; Genetic code expansion (1)
Biopolymere , Schleimpilze , Physarum polycephalum , SSH , dsRNA , L-Malat , GPoly(en-Expression , Physarum polycephalum , SSH , dsRNA , poly(L-malate) , gene expression (1)
; biopolymers; crystallization; synthesis (1)
BIOPSYCHOSOCIAL MODEL; HEALTH-PROMOTION; STRESS REDUCTION; ANTONOVSKYS SENSE; COHERENCE SCALE; SOCIAL SUPPORT; MINDFULNESS; SPIRITUALITY; LIFE; COMMUNITIES; (1)
biosensor, cryopreservation, cytotoxicity, ECIS, insect cells, pesticides, smart farming, whole‐cell biosensing (1)
Biosensor , Ionenkanal , Lipide / Doppelschicht , Biomembran , poröses Substrat , membrane , lipid bilayer , ion channel , biosensor , porous matrix (1)
BIOSENSOR; NANOFIBERS; FABRICATION; Optical and electrochemical (bio)sensors; Hydrogel; Polymer membrane; Deposition techniques (1)
Biosensors, Glucose, Lactate, Potassium, Optical Detection, Electrochemical Detection, Oxidase, Europium Tetracycline, Sweat Analysis, Wearable Sensor, Continuous Monitoring (1)
Biosensors, mycotoxins, surface plasmon resonance (1)
BIOSYNTHESIS; CELLS; Sparticola triseptata; structure elucidation; ECD-TDDFT; antiproliferative; cytotoxic; actin inhibitors (1)
Biosynthesis, Fatty acid, Fructose, Galactose, Glucose, Hymenoptera, Lipogenesis, Parasitoid, Stable isotope labeling, Sucrose, Trehalose, Triacyl glyceride (1)
biosynthesis of isoprenoids 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate isopentenyl diphosphate dimethylallyl diphosphate Isopentenyl-diphosphate isomerase escherichia-coli isoprenoid biosynthesis 2-c-methyl-d-erythritol 4-phosphate 4-(cytidine 5'-diphospho)-2-c-methyl-d-erythritol 5-phosphate precursor thiamin enzyme gene (1)
BIOSYNTHESIS; STEROLS; LATEX; CONSTITUENTS; SEEDLINGS; LATHYRIS; LEAVES; 24-methylene cycloartanol; Cycloartenol; Cycloartenol acetate; Euphorbia acanthothamnos; Euphorbiaceae; Sterols accumulation (1)
BIOSYNTHETIC POLY(GAMMA-GLUTAMIC ACID); SIDE-CHAIN CRYSTALLINITY; MELTING TRANSITIONS; HOLLOW SPHERES; ALKYL ESTERS; POLYPEPTIDES; BEHAVIOR; FUSION; HEATS; (1)
BIOTECHNOLOGICAL PRODUCTION; AU; anti-Markovnikov addition; epoxidation; photocatalysis; redox equivalents; semiconductors (1)
BIOTECHNOLOGY INDUSTRY; INNOVATION; COLLABORATION; INTEGRATION; PERFORMANCE; ALLIANCES; NETWORKS; licensing strategy; technology-based firms; technology transfer; biotech industry (1)
BIOTIC INTERACTIONS; ENVIRONMENTAL DNA; CLIMATE-CHANGE; MULTIVARIATE; BIODIVERSITY; ABUNDANCE; COOCCURRENCE; ARTHROPODS; MECHANISMS; FRAMEWORK; big data; co-occurrence; machine learning; metacommunity; regularization; statistics (1)
Biotin , Wahrnehmung , Saccharomyces cerevisiae , Membrantransport , Regulation , Genregulation , Bäckerhefe , Biotinmangel , Vitamintransport , biotin , sensing , Saccharomyces cerevisiae , biotin depletion , gene regulation (1)
BIOTRANSFORMATION; OLEORESIN; METABOLITES; DERIVATIVES; TERPENOIDS; GLYCOSIDES; OXIDE; Microbial transformation; Ent-polyalthic acid; Ent-labdane diterpenes; Aspergillus brasiliensis; Antifungal activity; Candida glabrata (1)
Biotyp, Gingivadicke, Sonographie, Ultraschallmessung, Morphologie, Zahnform, Gingiva, Gingivatransluzenz, Gingivabreite, Papillenhöhe, Therapieplanung (1)
bipartite networks, causal inference, deep learning, hummingbirds, insect pollinators, machine learning, pollination syndromes, predictive modelling (1)
BIPOLAR CELLS; CGMP-PHOSPHODIESTERASE; MUSCULAR-DYSTROPHY; PHENOTYPIC IMPACT; CHANNEL SUBUNIT; CONE DYSTROPHY; GAMMA-SUBUNIT; COMPLETE FORM; MOUSE RETINA; PROTEIN; (1)
bipolar disorder, case report, electroconvulsive therapy, hypertrophic cardiomyopathy, major depressive disorder (1)
BIPOLAR DISORDER; ECONOMIC BURDEN; MOOD DISORDERS; UNITED-STATES; DEPRESSION; THERAPY; affective disorders; bipolar disorder; major depression; anxiety; network (1)
BIPOLAR DISORDER; FAMILY-MEMBERS; SCHIZOPHRENIC-PATIENTS; SUBJECTIVE BURDEN; RELATIVES; ADULT; STRATEGIES; OUTCOMES; PARENTS; STRESS; Caregiver; caregiver burden; reward; coping; psychiatric inpatient (1)
BIPOLAR DISORDER; METAANALYSIS; SCHIZOPHRENIA; INFLAMMATION; CYTOKINES; ANTIDEPRESSANTS; BIOMARKER; KNOCKOUT; EFFICACY; DISEASE; Chemokines; Macrophage-derived chemokine; Major depression; Antidepressant; Therapy response (1)
; Bipolar disorders; Guidelines; Evidence; Self-help; Quality of health careder (1)
BIPOLAR-II-DISORDER; DIVALPROEX SODIUM; AGGRESSION; SYMPTOMS; COMORBIDITY; SAMPLE; SERIES; TRIAL; ANGER; GABA; (1)
Bipyrrole , Methoxygruppe , Synthon , Polybipyrrole , Chemische Synthese , Elektrochemie , Pyrrolderivate , Aminogruppe , , bipyrrole , electrochemistry , polypyrrole (1)
; birch; Betula pendula; Betulaceae; essential oil; GC; GC-MS; hydrodistillation; microdistillation (1)
BIRCH OUTER BARK; CORK SUBERIN; POTATO-TUBER; STRUCTURAL-CHARACTERIZATION; QUERCUS-SUBER; FERULIC ACID; CELL-WALL; CUTIN; POLYESTER; BIOSYNTHESIS; (1)
Birch-Swinnerton-Dyer conjecture, étale Kohomologie, L-Funktionen, Abelsche Schemata über höherdimensionalen Basen (1)
Bird; Basilar papilla; Morphology; Hair cell; Stereovilli (1)
Bird; Canary; Cochlea; Hair-Cell; Pathology; Deafness (1)
BIRD-DISPERSED PLANT; SEEDLING ESTABLISHMENT; SOUTH-AFRICA; FRAGMENTATION; GERMINATION; FYNBOS; CONSEQUENCES; VEGETATION; DIVERSITY; GRASSES; artificial bird perches; bush clumps; Cape Floristic Region; Fynbos biome; Otholobium hirtum; underground termitaria (1)
Bird; Hearing; Auditory nerve; Temporal resolution; Gap detection (1)
Bird; Hearing deficit; Cochlea; Middle eai; Evoked potential (1)
bird names England Bavaria Austria dialectology onomastics semantics morphology etymology (1)
Birth cohort · Haematuria · Proteinuria · Newborn · Kidney disease · Urine test (1)
BIRTH-DEFECTS; FAMILIES; TECHNOLOGIES; BORN; bladder exstrophy and epispadias complex; congenital abnormalities; pregnancy; reproductive medicine; reproductive techniques, assisted (1)
BIRTHMARKS; NEONATE; LESIONS; congenital skin lesions; nevus flammeus; melanocytic nevus (1)
BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; MOTHERS OWN MILK; SELENIUM SUPPLEMENTATION; CONTROLLED-TRIAL; PROBIOTICS; METAANALYSIS; FORMULA; RISK; PREVENTION; (1)
Bisdienes; Diels-Alder reaction with p-benzoquinone; p-Cyclophanes, bridge-anellated (1)
BISIMIDINATE GA(DDP); OLEFIN COMPLEXES; BASIS-SETS; GA BONDS; CL BOND; INSERTION; ACTIVATION; CHEMISTRY; LIGANDS; COORDINATION; (1)
Bis(isonitrile) ligand, Wacker oxidation, transfer hydrogenation, imine hydrogenation, cyclopropanation (1)
BISMUTH OXIDES, STRONTIUM OXIDES, CALCIUM OXIDES, COPPER OXIDES, OPTICAL PROPERTIES, NONLINEAR OPTICS, INFRARED RADIATION, SUPERCONDUCTIVITY, SUPERCONDUCTING FILMS, JOSEPHSON JUNCTIONS, GRAIN BOUNDARIES (1)
BISMUTH OXIDES, STRONTIUM OXIDES, CALCIUM OXIDES, CUPRATES, MULTI−ELEMENT COMPOUNDS, HIGH−TC SUPERCONDUCTORS, PHOTODETECTORS, SPECTRAL RESPONSE, GRANULAR MATERIALS, JOSEPHSON EFFECT, WEAK LINKS, INFRARED RADIATION (1)
BISMUTH OXIDE SULFATE; LA FOSSA CRATER; CRYSTAL-STRUCTURE; PYROLYSIS PRODUCTS; AEOLIAN ISLANDS; BALICZUNICITE; BI2O(SO4)(2); OXYSULFATE; BI2(SO4)3; VULCANO; Bismuth oxysulfate; Crystal structure; Electronic structure; Thermal properties (1)
bismuth phochemistry • decarboxylative C─N coupling • preassembly (1)
BISPECTRAL INDEX; ANESTHETIC DEPTH; MONITOR; PERFORMANCE; ALGORITHMS; BIS; narcotrend; children; sevoflurane (1)
Bispectral index, hypnosis, hypnotic susceptibility, mind–body intervention, trance (1)
BISPECTRAL INDEX; PEDIATRIC ANESTHESIA; PROPOFOL ANESTHESIA; GENERAL-ANESTHESIA; HYPNOTIC LEVEL; AEP-INDEX; PERFORMANCE; RECOVERY; SURGERY; REQUIREMENTS; (1)
BISPECTRAL INDEX; PHYSIOLOGICAL SLEEP; FREQUENCY-ANALYSIS; OBSTRUCTION SITE; APNEA; NASENDOSCOPY; PARAMETERS; SEDATION; DEPTH; Snoring; Drug-induced sleep endoscopy; Frequency analysis; Psychoacoustic; OSAS (1)
BISPECTRAL INDEX; STRESS INDEX; GENERAL-ANESTHESIA; PATIENT RESPONSIVENESS; RESPONSES; ENTROPY; SURGERY; SEVOFLURANE; MANAGEMENT; ANALGESIA; anaesthesia, depth; EEG; SPI/surgical pleth index; stress; surgery, day-case; sympathetic nervous system (1)
bisphenol-A, child, lactation, mercury, pregnancy (1)
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; ORTHODONTIC TOOTH MOVEMENT; ROOT RESORPTION; IMMUNE-SYSTEM; COMPLEX; Immune system; Oral diseases; Oral microbiota; Immune responses; Host microbial interactions (1)
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; SURGEONS POSITION PAPER; IMAGING FINDINGS; ZOLEDRONIC ACID; AMERICAN ASSOCIATION; CANCER-PATIENTS; DENOSUMAB; UPDATE; STAGE; panoramic radiography; MRONJ; radiographic findings; bisphosphonates; denosumab (1)
; bisphosphonate; bone targeting; functionalization of polymers; nanoparticles; poly(ethylene glycol) (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; BUCCAL FAT PAD; SURGEONS POSITION PAPER; RISK-FACTORS; AMERICAN ASSOCIATION; MANAGEMENT; FLAP; PREVENTION; MRONJ; Bisphosphonates; Mylohyoid Muscle Flap; Denosumab; Buccal Fat Flap; Surgery (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; CANCER-PATIENTS; INFECTED OSTEORADIONECROSIS; BONE METASTASES; BREAST-CANCER; MANAGEMENT; DENOSUMAB; PREVALENCE; RESECTION; Bisphosphonates; Denosumab; Osteonecrosis; Surgery; Recurrence (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; RISK-FACTORS; MANAGEMENT; CANCER; DENOSUMAB; histopathology; inflammation; regeneration; medication-related osteonecrosis of the jaw; surgery (1)
Bisphosphonates, Denosumab, Osteonecrosis, Surgery. Recurrence, Quality of life (1)
Bisphosphonates, Denosumab, Osteonecrosis, Surgery, Recurrence, Quality of life, Bisphosphonate, Kiefernekrose (1)
BITE-ANGLE DIPHOSPHINES; COMPLEXES; (1)
BITE FORCE; IN-VITRO; CLINICAL-PERFORMANCE; SINGLE-RETAINER; OCCLUSAL FORCES; STRENGTH; SURVIVAL; DESIGN; CEMENT; BRIDGES; Zirconia; Anterior FPDs; Single retainer; Fracture characteristics (1)
BITE FORCE; TRANSLUCENCY; GENERATIONS; CERAMICS; STRENGTH; DEPTH; PHASE; Zirconia; Ceramics; Dental prosthesis; Crystallography; Scanning electron microscopy (1)
BITING LEMMA; SEMICONTINUITY; THEOREM; (1)
bivalent ligands, fluorescent ligands, dopamine D1 receptor, histamine H3 receptor (1)
bivalent ligands, human histamine H1R (hH1R), human histamine H2R (hH2R), signaling pathways, HEK293T CRE Luc (1)
B KINASE-ALPHA; FACTOR-KAPPA-B; PROTEIN-KINASE; ERK; PROLIFERATION; ACTIVATION; APOPTOSIS; LUPULONE; BETA; Humulus lupulus L.; hop; bitter acids; hepatocellular carcinoma; AP-1; nuclear factor kappa B; ERK1/2 (1)
black box, hedonic modeling, interpretable machine learning, rental estimation, residential real estate (1)
BLACK-HOLE ENTROPY; QUANTUM-GRAVITY; EXTENSION; GEOMETRY; METRICS; SPACE; SPIN; Kerr isolated horizons; Ashtekar-Barbero connection variables; Horizon boundary condition (1)
BLACK-HOLE GEOMETRY; FIELD; PERTURBATIONS; PARTICLES; ELECTRON; METRICS; WAVES; Kerr geometry; Massive Dirac equation; Newman-Penrose formalism; Horizon-penetrating coordinates; Mode solutions (1)
BLACK-HOLE; GRAVITATIONAL COLLAPSE; GRAVITY; EQUATIONS; VAIDYA; black hole collapse; quantum gravity; loop quantum gravity; junction conditions (1)
Black holes · Dirac equation · Reissner-Nordström metric · horizon penetrating coordinates (1)
; Black Holes in String Theory; M(atrix) Theories; Matrix Models; Nonperturbative Effects (1)
BLACK-HOLE; SPACE-TIME; TRANSITION; MODEL; Gauge-gravity correspondence; Lattice Quantum Field Theory; M(atrix) Theories (1)
BLACK-HOLE; STABILITY; PERTURBATIONS; SCHWARZSCHILD; (1)
BLACK-HOLES; TIME EVOLUTION; THERMALIZATION; FIELDS; CHAOS; Entropy; thermalization; equilibration; Husimi distribution; eigenstate thermalization; entanglement entropy (1)
BLACK-HOLE; STRINGS; Gauge-gravity correspondence; Lattice Quantum Field Theory; M(atrix) Theories (1)
BLACK PHOSPHORUS; CONDUCTION ELECTRONS; SINGLE-CRYSTALS; SPINTRONICS; SEMICONDUCTOR; FUNDAMENTALS; EXFOLIATION; MOBILITY; (1)
BLACK PHOSPHORUS; ENERGY; EXCITONS; (1)
BLACK PHOSPHORUS; TIGHT-BINDING; CRYSTALS; (1)
BLADDER-CANCER; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; URINARY CYTOLOGY; BTA STAT; FLUORESCENCE; TUMORS; APOPTOSIS; SURVIVIN; CT; bladder carcinoma; diagnosis; urine markers; imaging; fluorescence endoscopy (1)
BLADDER-CANCER; 90-DAY MORTALITY; COMPLICATIONS; VOLUME; ASSOCIATION; MORBIDITY; SURVIVAL; Bladder; Cancer; 30-day mortality; 90-day mortality; Radical cystectomy; Urothelial carcinoma (1)
bladder cancer, carcinoma in situ, cytology, NMIBC, urine marker, Xpert (1)
BLADDER-CANCER; CELL CARCINOMA; URINARY-TRACT; OUTCOMES; THROMBOCYTOSIS; GUIDELINES; CYSTECTOMY; IMPACT; TUMORS; Outcome; Platelet; Radical nephroureterectomy; Recurrence-free survival; Thrombocytosis; Upper tract urothelial carcinoma (1)
BLADDER-CANCER CELLS; NF-KAPPA-B; MASS-SPECTROMETRY; ANTIOXIDATIVE ACTIVITY; PRENYLATED CHALCONES; HUMULUS-LUPULUS; EXTRACT; METABOLITES; XANTHOHUMOL; PATHWAY; Piper methysticum; kava; flavokawain; cardamonin metabolism; human liver microsomes; glucuronides (1)
BLADDER-CANCER; CIGARETTE-SMOKE; SUPPRESSOR GENE; BREAST-CANCER; E-CADHERIN; CARCINOMA; ADENOCARCINOMA; GROWTH; CARCINOGENESIS; DIFFERENTIATION; gene expression; cDNA array; NSCLC; benign bronchial epithelium; smoker and non-smoker (1)
BLADDER-CANCER; CIGARETTE-SMOKING; PROSTATE-CANCER; RISK-FACTOR; TOBACCO USE; AWARENESS; QUESTIONNAIRE; METAANALYSIS; ASSOCIATION; CARCINOMA; Bladder cancer; Educational work; Patient knowledge; Prostate cancer; Smoking (1)
BLADDER-CANCER; CIGARETTE-SMOKING; RISK-FACTORS; TOBACCO USE; EPIDEMIOLOGY; KNOWLEDGE; PROGNOSIS; AWARENESS; MORTALITY; Cigarette smoking; Health facility planning; Neoplasm staging; Surveys and questionnaires; Urinary bladder neoplasms (1)
bladder cancer; consensus; Delphi; diagnosis; treatment; follow-up (1)
Bladder cancer; Consensus; Delphi; Diagnosis; Treatment; Follow-up (1)
Bladder cancer; Diagnostic imaging; Lymph node metastases; Fluorodeoxyglucose F18; Positron emission tomography and computed tomography; Transitional cell carcinoma; Urinary bladder neoplasms (1)
bladder cancer, EMT, grade group, NMIBC, tumour budding (1)
BLADDER-CANCER; GROWTH; ACHONDROPLASIA; DISORDERS; SUNLIGHT; (1)
; bladder cancer; hospital volume; postoperative mortality; radical cystectomy; #blcsm; #BladderCancer; #uroonc (1)
BLADDER-CANCER; MICROSCOPIC HEMATURIA; RISK; ASSOCIATION; MANAGEMENT; ADULTS; CARE; MEN; AUA; Bladder cancer; Disease management; Guidelines; Microhematuria; Nomogram; Risk factors (1)
BLADDER-CANCER; NEOADJUVANT CHEMOTHERAPY; EXTRACAPSULAR EXTENSION; METASTASES; DISSECTION; SURVIVAL; LEVEL; Bladder cancer; Lymphatic metastasis; Cystectomy; Perinodal lymphovascular invasion; Extranodal extension (1)
BLADDER-CANCER; P53 GENE; PROTEIN EXPRESSION; MUTATOR PHENOTYPE; HMSH2 PROTEIN; INSTABILITY; HETEROZYGOSITY; MUTATIONS; REPEATS; TUMORS; (1)
BLADDER-CANCER; RADICAL CYSTECTOMY; CARCINOMA; checkpoint inhibition; chemotherapy; immune; neoadjuvant; urothelial cancer (1)
Bladder cancer, Radical cystectomy, Nomogram, Outcome (1)
BLADDER-CANCER; RADICAL NEPHROURETERECTOMY; ONCOLOGIC OUTCOMES; MORTALITY; SURVIVAL; DIAGNOSIS; DISPARITY; GENDER; EXTENT; race; prognosis; urinary tract cancer; urothelial carcinoma; nephroureterectomy; recurrence (1)
BLADDER-CANCER; RECURRENCE; RISK; SURVIVAL; CARCINOMA; PATHOLOGY; DISEASE; MODEL; bladder cancer; evaluation; nomogram; prognosis; radical cystectomy; urothelial carcinoma (1)
BLADDER-CANCER; RISK; Bladder; Bladder carcinoma; Immunohistochemistry; Transurethral resection; Etiology; Risk factor; CHEK2 (1)
BLADDER-CANCER; URINARY-TRACT; MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; CARCINOMAS; PROGRESSION; SPREAD; bladder; bladder neoplasms; urothelium; microsatellite repeats; methylation (1)
Bladder cancer; Urothelial carcinoma; Cystoscopy; Diagnosis; Transurethral resection (TUR); Prognosis; Bacillus Calmette-Guerin (BCG); Intravesical chemotherapy; BCG unresponsive; Radical cystectomy; Follow-up; Guidelines; European Association of Urology (EAU) (1)
BLADDER-CANCER; UROTHELIAL CARCINOMA; URINARY-DIVERSION; PROGNOSTIC VALUE; MORTALITY; ASSOCIATION; COMORBIDITY; VALIDATION; OUTCOMES; AGE; Cystectomy; Non-muscle-invasive bladder cancer; Complications; Morbidity; Bladder carcinoma; Urothelial neoplasm (1)
; bladder exstrophy; congenital heart defects; primary closure (1)
BLADDER EXSTROPHY; DIAGNOSIS; VARIANTS; (1)
Bladder exstrophy-epispadias complex · Immunohistochemistry · Nerve growth factor · Urothelium · Delayed procedure (1)
BLADDER EXSTROPHY; ERECTILE DYSFUNCTION; FOLLOW-UP; RECONSTRUCTION; CHILDHOOD; HEALTH; (1)
; bladder exstrophy; hyperalgesia; nerve growth factor; immunohistochemistry; pain (1)
BLADDER EXSTROPHY; INGUINAL-HERNIAS; SURGICAL ANATOMY; PRIMARY CLOSURE; REPAIR; IMPACT; MUSCLE; PENIS; exstrophy-epispadias complex (EEC); operative outcome; outcome assessment; treatment strategies; staged approach; single-stage approach; post-operative complications (1)
BLADDER EXSTROPHY; SEXUAL FUNCTION; BORN; MEN; (1)
BLADDER EXSTROPHY; SEXUAL FUNCTION; DYSFUNCTION; BOYS; BORN; psychosexual development; bladder exstrophy; epispadias; sexual dysfunctions, psychological; questionnaires (1)
bladder neck reconstruction, bladder neck stenosis, BMG, BNC, end-to-end anastomosis, reconstructive urology, robotic surgery, stricture resection, urethral strictures, YV plasty (1)
BLADDER NECK RECONSTRUCTION; TERM-FOLLOW-UP; MAINZ-POUCH-I; NEUROGENIC BLADDER; AUGMENTATION CYSTOPLASTY; FECAL INCONTINENCE; COMPLICATIONS; EXSTROPHY; STOMA; ANASTOMOSIS; neurogenic bladder dysfunction; continent urinary diversion; enterocystoplasty; long-term complications (1)
BLADDER; SYMPTOMS (1)
Blasenekstrophie, Epispadie, BEEK, Hüfte, Hüftdysplasie, Coxarthrose (1)
Blasenkarzinom, Zystektomie, Hochrisiko-NMIBC, Frühzystektomie (1)
Blasenkrebs , Photodynamische Therapie , Chemotherapie , Porphyrin-Platin(II)-Komplexe , selektive Anreicherung , Porphyrin-platinum complexes , bladder cancer , photodynamic therapy , chemotherapy , selective accumulation (1)
Blastic plasmocytoid dendritic cell neoplasm · Tagraxofusp · CD123 · IL-3 · Diphteria toxin · MDS (1)
Blaue-Augen-Stereotyp, Orientierungspunkte, Irisbedeckungsgrad (1)
BL; DLBCL; FFPE; NMR; SWATH-MS; metabolomics; proteomics; pyruvate (1)
Bleaching, shear bond strength, Ceramic Bracket, Enamel Colour, Bleichen, Keramikbracket, Schmelz, Adhäsivsystem, CIELab (1)
BLEBS (1)
; Bleeding disorders; Paraproteinaemia; Acquired von Willebrand syndrome; von Willebrand factor; Monoclonal gammopathy of undetermined significance (1)
BLEEDING RISK-FACTORS; ELECTRICAL CARDIOVERSION; ORAL ANTICOAGULANTS; OBESITY PARADOX; METAANALYSIS; PERSISTENT; SCORE; (1)
Blend, Wortkreuzung, Phrasenkreuzung, Wortverschmelzung Kontamination, Portemanteau-Wort, Kofferwort, WordNexus, Wortbildung, Korpuslinguistik (1)
BLEOMYCIN-INDUCED SCLERODERMA; HUMAN DERMAL FIBROBLASTS; SMOOTH MUSCLE ACTIN; ARGON PLASMA; CHRONIC WOUNDS; GENE-EXPRESSION; SCLEROTIC SKIN; GROWTH-FACTOR; ANIMAL-MODEL; TGF-BETA; cold atmospheric plasma; localized scleroderma; anti-fibrosis; bleomycin-induced fibrosis (1)
BLEOMYCIN-INDUCED SCLERODERMA; TGF-BETA; SCLEROTIC SKIN; ANIMAL-MODEL; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; INCREASED EXPRESSION; CELL-PROLIFERATION; DERMAL FIBROBLASTS; RENAL FIBROSIS; (1)
Bleomycin, Simvastatin, Lungenfibrose (1)
BLEPHAROPLASTY; PTOSIS; Eye axis; Jaguar's eye; Oblique eye axis (1)
BLINDED RESPONSE EVALUATION; SKIN REJUVENATION; HAIR REMOVAL; FLASHLAMP; THERAPY; TRIAL; CHILDREN; SYSTEM; IPL; ALEXANDRITE; port-wine stain; lasers; pulsed dye laser; flashlamp-pumped (1)
BLIND SEPARATION; complex ICA; multidimensional ICA; separability (1)
BLIND SEPARATION; GEOMETRIC-PROPERTIES; NONLINEAR MIXTURES; ALGORITHM; blind separation; independent component analysis; simulated annealing; competitive learning; neural networks (1)
; blind source separation (BSS); sparse component analysis (SCA); underdetermined mixtures (1)
BLIND SOURCE SEPARATION; DECOMPOSITION; MIXTURES; (1)
BLIND SOURCE SEPARATION; SOLVENT SUPPRESSION; NEURAL IMPLEMENTATION; 2ND-ORDER STATISTICS; RESIDUAL WATER; JADE-ALGORITHM; PROTON SPECTRA; SIGNALS; CONVOLUTION; FILTERS; blind source separation; independent component analysis; generalized eigenvalue decomposition; matrix pencil; 2D NOESY proton NMR spectra (1)
BLINK; IDENTIFICATION; METAANALYSIS; OFFENDERS; COGNITION; EMOTION; AROUSAL; FAKING; attention-based measurement; attentional blink; fakeability; rapid serial visual presentation; sexual preference (1)
Blink reflex, magnesium sulfate, masseter inhibitory reflex, neurophysiology, silent period, tetanus. (1)
BLINK REFLEX; TRIGEMINAL NERVE; SENSITIZATION; PAIN; NEURONS; ATTACK; POTENTIALS; corneal reflex; migraine; electrophysiological study; trigeminal facilitation; sumatriptan (1)
BLISS, GALACTICS, Gaussian sampler, Machine-Learning, postquantum cryptography, side-channel analysis (1)
Blitzlichtphotolyse, LOV Domänen, Photokatalyse, Acetabulariarhodopsin, multichromophore Sammelsysteme (1)
Blitzschlag/neurologische, neuropsychologische und psychiatrische Langzeitschäden/Behandlung und Prognose (1)
BLOCH ELECTRONS; BERRYS PHASE; GRAPHITE; DEPENDENCE; SPECTRUM; RIBBONS; (1)
BLOCH ELECTRONS; FLOQUET; STATES; (2)
BLOCH-KATO CONJECTURE; GALOIS STRUCTURE; VALUES; UNITS; RINGS; (1)
BLOCHMANNIA-FLORIDANUS; BACTERIAL SYMBIONTS; GENOME SEQUENCE; ENDOSYMBIONTS; CARDIOCONDYLA; HOST; REPLACEMENT; PERSPECTIVE; HYMENOPTERA; PHYLOGENY (1)
BLOCHMANNIA-FLORIDANUS; WOLBACHIA INFECTION; WOOD ANTS; BACTERIUM; FITNESS; CONSEQUENCES; REPRODUCTION; ELIMINATION; MICROBIOTA; OOGENESIS; Bacteria; Candidatus Westeberhardia cardiocondylae; fitness; rifampicin; social insects; symbiosis; Wolbachia sp. (1)
BLOCH OSCILLATIONS; (2)
BLOCH OSCILLATIONS; GENERATION; (1)
BLOCH OSCILLATIONS; OPTICAL LATTICES; ULTRACOLD ATOMS; BOUND-STATES; EINSTEIN; RESONANCES; TRANSITION; SYSTEMS; FIELDS; GAS; (1)
BLOCH OSCILLATIONS; RADIATION; (1)
BLOCH OSCILLATIONS; THZ RADIATION; GAAS/ALAS SUPERLATTICE; WAVES; TERAHERTZ; ELECTRONS; FIELD; semiconductor-superlattice; parametric gain; terahertz radiation source (1)
BLOCKADE; (1)
Blockchain, Bitcoin, Altcoin, Mining, Kryptowährung, Distributed Ledger Technology, Proof-of-Work, PoW, Proof-of-Stake, PoS, Smart Contracts, Ethereum, Ether (1)
blocking; deactivation; development of inhibition; forgetting; inhibition; list-strength effect; part-list cuing impairment; relearning; retrieval-induced directed forgetting; suppression; think/no-think impairment (1)
Blog, Chat, digitale Schriftlichkeit, Foren, Medienrepertoire, Multiliteralität, Schreibrepertoire, unterstützte Kommunikation (1)
BLOOD; (1)
BLOOD-BRAIN-BARRIER; BATTEN-DISEASE; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; NEURAL DAMAGE; MUTANT MICE; OPTIC-NERVE; PROTEIN; DEGENERATION; CNS; neuronal ceroid lipofuscinosis; neurodegeneration; neuroinflammation; T-lymphocytes; axonal damage (1)
Blood–brain barrier, brain abscess, fluorescein sodium, fluorescence-guided surgery, YELLOW 560 nm filter (1)
blood–brain barrier, cerebral edema, magnetic resonance imaging, stroke (1)
BLOOD-BRAIN-BARRIER; ELEVATED PLUS-MAZE; SPATIAL MEMORY; PARAVENTRICULAR NUCLEUS; OBJECT RECOGNITION; OXYTOCIN; VASOPRESSIN; RECEPTOR; SYSTEM; HUMANS; Neuropeptide S; Memory; Plus-maze; Nasal; Anxiety; Rats (1)
blood-brain barrier, EphR/ephrin, endothelial cells, astrocytes, neurovascular disorders, neuropsychiatric disorders (1)
BLOOD-BRAIN-BARRIER; EPILEPSY; CYTOKINES; SEIZURES; Seizures; Innate immune system; Preictal change (1)
BLOOD-BRAIN-BARRIER; EPITHELIUM-DERIVED FACTOR; ENDOTHELIAL GROWTH-FACTOR; REACTIVE ASTROCYTES; ARTERY OCCLUSION; NEUROLOGICAL DISORDERS; STROKE RESEARCH; INJURY; RATS; DISRUPTION; (1)
BLOOD-BRAIN-BARRIER; GLYCOL ETHERS; VAPORIZATION; ENTHALPIES; IRRITATION; MIXTURES; ASSAYS; RANGE; RATS; (1)
Blood–brain barrier; Ischemia/reperfusion injury; Hypoxia-inducible factor; Multidrug resistance; ABC transporters; Stroke (1)
BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; SIDE POPULATION; IN-VITRO; HALF-TRANSPORTER; FUMITREMORGIN-C; STEM-CELLS; BCRP/ABCG2; PENETRATION; (1)
BLOOD-BRAIN-BARRIER; PERMEABILITY; MEMBRANE; DIFFUSION; SYSTEMS; SECM; (1)
BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN INHIBITOR; MEDIATED MULTIDRUG-RESISTANCE; CENTRAL-NERVOUS-SYSTEM; IN-VIVO REVERSAL; ORAL BIOAVAILABILITY; PHARMACOKINETIC PROPERTIES; CYTOCHROME-P450 3A; GF120918; VITRO; blood brain barrier; ABCB1; P-glycoprotein 170; valspodar; elacridar; tariquidar; paclitaxel (1)
BLOOD-BRAIN-BARRIER; PROTEIN-KINASE CK2; EPIDERMAL-GROWTH-FACTOR; TRANSFERRIN RECEPTOR; IN-VIVO; N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMERS; PHYSARUM-POLYCEPHALUM; MONOCLONAL-ANTIBODY; THERAPEUTIC AGENTS; ANTITUMOR-ACTIVITY; biodegradable; brain cancer; breast cancer; imaging analysis; multiple antibodies; multiple drug delivery; multitargeting; Polycefin; poly(malic acid); tumor angiogenesis (1)
BLOOD-CELL SCINTIGRAPHY; NUCLEAR SCINTIGRAPHY; HEMORRHAGE; MANAGEMENT; EXPERIENCE; TC-99M; EPIDEMIOLOGY; ACCURACY; INVIVO; gastrointestinal bleeding; scintigraphy; localisation; angiography (1)
BLOOD CHIMERISM; TRANSFUSION SYNDROME; DISCORDANT; PREGNANCY; FERTILIZATION; ULTRASOUND; RARE; SEX; sex discordance; gemini; ART; sonography (1)
BLOOD COMPONENTS; MICROBIAL-CONTAMINATION; APHERESIS TECHNOLOGY; PERIPHERAL-BLOOD; CELL PRODUCTS; REDUCTION; PLATELETS; DIVERSION; (1)
blood differential count, COVID-19, hemato-morphology, peripheral blood smear, SARS-CoV-2 (1)
blood donation, convalescent plasma, COVID‐19, donor screening, SARS‐CoV‐2 pandemic (1)
BLOOD-DONORS; LIVER-TRANSPLANTATION; NATURAL-HISTORY; PORCINE LIVERS; RISK-FACTORS; ANTIBODIES; RIBAVIRIN; ZOONOSIS; SWINE; NETHERLANDS; hepatitis E Virus; renal transplantation; liver transplantation (1)
BLOOD-DONORS; SOUTHEASTERN GERMANY; ANTIBODY PREVALENCE; FRANCE; INFECTION; DECLINE; HUMANS; EUROPE; HEV; anti-HEV IgG; epidemiology; foodborne infections; hepatitis E; longitudinal study; viral hepatitis (1)
BLOOD-FLOW AUTOREGULATION; THICK ASCENDING LIMB; TUBULOGLOMERULAR FEEDBACK; MYOGENIC AUTOREGULATION; PROSTAGLANDIN SYSTEM; BARTTERS-SYNDROME; ARACHIDONIC-ACID; ANGIOTENSIN-II; LOOP DIURETICS; NITRIC-OXIDE; renal blood flow; superficial blood flow; candesartan; decapsulation; tubular pressure; NKCC1 knockout (1)
BLOOD-FLOW CHANGES; ASCENDING AORTA; CONTRAST; ULTRASOUND; MICROSPHERES; VALIDATION; STENOSIS; ACCESS; Colour duplex ultrasound; contrast-enhanced ultrasound; fluorescence-labelled microspheres; haemorrhagic shock; organ perfusion; pig; real time (1)
BLOOD-FLOW; COMPARATIVE PHARMACODYNAMICS; PROTEIN BINDING; BRAIN INJURY; METABOLISM; HEMODYNAMICS; QUANTITATION; CIRCULATION; MEPERIDINE; CLONIDINE; bloodbrain equilibrium; opioid serum concentration (1)
BLOOD-FLOW; HEART; aortic coarctation; magnetic resonance imaging; echocardiography (1)
BLOOD-FLOW; VASOCONSTRICTION; RECOVERY; ISCHEMIA; RELEASE; HUMANS; myocardial and cerebral blood flow; ventricular tachycardia; cardiac contractility; D-ribose; c-fos (1)
BLOOD-FLOW; VASOPRESSIN; MULTIMERS; SHOCK; aortic valve replacement; platelet consumption; TAVR; thrombocytopenia; von Willebrand factor (1)
BLOOD-GAS-ANALYSIS; ERRORS; Point-of-care testing; Tonometry; Partial pressures; Temperature (1)
BLOOD-GROUP ANTIGENS; POLYACRYLAMIDE GELS; CARBONIC-ANHYDRASE; ORAL ACTINOMYCES; BINDING; MUCIN; INFECTION; ELECTROPHORESIS; INFLAMMATION; AGGLUTININ; Adhesins; Helicobacter pylori; Proteome map; Saliva (1)
Blood irradiation;Autologous transfusion;Dosimetry;Blutbestrahlung;Autologe Transfusion;Dosimetrie (1)
Blood; Metabolites; Metabolomics; NMR; Plasma; Serum; Standardization. (1)
BLOOD MONONUCLEAR-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; CANCER-PATIENTS; TUMOR-ANTIGEN; HEALTHY-INDIVIDUALS; PROTEIN SURVIVIN; DENDRITIC CELLS; EFFECTOR-CELLS; EX-VIVO; (1)
BLOOD MONONUCLEAR-CELLS; GROWTH-FACTOR; HUMAN-MONOCYTES; SENSORY NEURONS; EXPRESSION; MACROPHAGES; INFLAMMATION; NEUROPEPTIDES; ACTIVATION; RECEPTOR; rheumatoid arthritis; calcitonin gene-related peptide; SP; sensory nerve fibre; sympathetic nerve fibre; tyrosine hydroxylase (1)
BLOOD MONONUCLEAR-CELLS; LARGE SURFACE PROTEIN; INFECTION; LINE; TRANSCRIPTION; DETERMINANTS; REPLICATION; PROGENITOR; BINDING; DOMAIN; (1)
BLOOD MONONUCLEAR-CELLS; LOW-DOSE METHOTREXATE; NECROSIS FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; FOLIC-ACID; SYNOVIAL MACROPHAGES; ANTIRHEUMATIC DRUGS; ADENOSINE RECEPTORS; PULSE METHOTREXATE; ORAL METHOTREXATE; (1)
BLOOD MONONUCLEAR-CELLS; MAJOR DEPRESSION; IMMUNE-SYSTEM; EXPRESSION; MICRORNA; DEFEAT; PREVALENCE; CYTOKINES; SUSCEPTIBILITY; DISEASE; Immune system; Leukocyte; Major depressive disorder; microRNA; Resilience; Stress (1)
BLOOD MONONUCLEAR-CELLS; SMOOTH-MUSCLE-CELLS; INFLAMMATORY MECHANISMS; OXIDATIVE STRESS; ATHEROSCLEROSIS; MONOCYTE; INTERVENTION; ATORVASTATIN; SIMVASTATIN; CYCLOPHILIN; Inflammation; PBMCs; Proteome (1)
BLOOD MONONUCLEAR-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SYMPATHETIC-NERVE FIBERS; BREAST CANCER-CELLS; IMMUNOGLOBULIN PRODUCTION; SYNOVIAL MACROPHAGES; AROMATASE-ACTIVITY; GENE-EXPRESSION; DNA ANTIBODY; IN-VITRO; (1)
BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; GENE-RELATED PEPTIDE; NF-KAPPA-B; SEX-HORMONE STATUS; SUBSTANCE-P; LUPUS-ERYTHEMATOSUS; ADRENAL AXIS; SYNOVIAL TISSUE; DEHYDROEPIANDROSTERONE-SULFATE; (1)
BLOOD-PRESSURE; ALDOSTERONE SECRETION; GLOMERULOSA CELLS; ADRENAL-CORTEX; K+ CHANNEL; METAANALYSIS; CONDUCTANCE; EXPRESSION; MUTATIONS; VARIANTS; (1)
blood pressure, blood loss, cardiac surgery, coagulation, Blutdruck, Blutverlust, Herzchirurgie, Antikoagulation. (1)
BLOOD-PRESSURE CONTROL; INTRACEREBRAL HEMORRHAGE; SUPERFICIAL SIDEROSIS; ATRIAL-FIBRILLATION; STROKE; DISEASE; MICROBLEEDS; PREVALENCE; DEMENTIA; STENOSIS; cerebral amyloid angiopathy; intracerebral hemorrhage; long term outcome; risk factors (cardiovascular) comorbidities; computer tomography; magnetic resonance imaging (1)
blood pressure; endothelin-1; mice; pericytes; vasodilation (1)
BLOOD-PRESSURE; FATTY-ACID; short chain fatty acids; coronary artery disease; propionate; atherosclerosis; microbiome (1)
BLOOD-PRESSURE; JUXTAGLOMERULAR CELLS; INTRACELLULAR CALCIUM; CONVERTING ENZYME; DEFICIENT MICE; MACULA DENSA; SALT INTAKE; EXPRESSION; ALDOSTERONE; RELEASE; aldosterone synthase knockout; isolated perfused kidney; renin cell hyperplasia; renin secretion (1)
BLOOD-PRESSURE; LEUKOCYTE RECRUITMENT; ASSOCIATION ANALYSIS; GENERAL-POPULATION; HEART-DISEASE; HAPLOGROUP-I; ATHEROSCLEROSIS; RISK; INFLAMMATION; PERSPECTIVE; (1)
BLOOD-PRESSURE; METABOLIC DISEASES; COHORT; ONSET; Heaping; Digit preference; Simulation study; Effect estimates; Epidemiologic study; Hypertension; Cardiovascular comorbidities (1)
BLOOD-PRESSURE REGULATION; RECEPTOR-DEFICIENT MICE; GENE-EXPRESSION; RAT-KIDNEY; REACTIVE HYPERRENINEMIA; TYPE-1 RECEPTOR; ACE-INHIBITION; RENAL GROWTH; ALDOSTERONE; CELLS; AT(1) receptor; kidney; mice; renin (1)
BLOOD-PRESSURE; RISK-FACTORS; OVERWEIGHT; EPIDEMIOLOGY; PROGRESSION; PREVALENCE; DISEASE; STYLE; low calorie diet; metabolic syndrome; weight loss; blood pressure; quality of life (1)
BLOOD-PRESSURE; TUBULOGLOMERULAR FEEDBACK; PLASMA-MEMBRANE; MICE LACKING; IN-VITRO; SYSTEM; KIDNEY; ATRAP; PHOSPHORYLATION; INFLAMMATION; (1)
BLOOD PROGENITOR CELLS; HIGH-DOSE CHEMOTHERAPY; SLAM FAMILY RECEPTORS; NON-HODGKINS-LYMPHOMA; FACTOR G-CSF; PERIPHERAL-BLOOD; STEM/PROGENITOR CELLS; MULTIPLE-MYELOMA; CXCR4 ANTAGONIST; TERM ENGRAFTMENT; Granulocyte colony stimulating factor; Mobilization; Hematopoietic stem cells (1)
BLOOD PUMPS; centrifugal pump; extracorporeal membrane oxygenation; hemolysis; magnetical levitation; newborn; neonate (1)
BLOOD-RETINA BARRIER; LONG-TERM CULTURE; IN-VITRO; CELL-CULTURE; TRACHEAL EPITHELIUM; CORNEAL EPITHELIUM; BRAIN-BARRIER; STEM-CELLS; MODEL; DIFFERENTIATION; (1)
BLOOD SALVAGE; CARDIAC-SURGERY; TRANSFUSION; CANCER; ANEMIA; AUTOTRANSFUSION; CONSERVATION; REPLACEMENT; EFFICACY; QUALITY; Blood loss; Blood conservation; Blood transfusion, autologous; Cancer surgery; Quality management (1)
BLOOD SALVAGE; PLASMA-LEVELS; RICH; QUALITY; ACTIVATION; STORAGE; (1)
BLOOD-STREAM INFECTIONS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; SURVEILLANCE; BACTEREMIA; FUNGEMIA; ICU; (1)
BLOOD-STREAM INFECTIONS; CARE-ASSOCIATED INFECTIONS; NATIONAL PREVALENCE; GERMANY; INTERVENTION; (1)
BLOOD-STREAM INFECTIONS; METHICILLIN-RESISTANT; ANTIBIOTIC-TREATMENT; MORTALITY; ENDOCARDITIS; CARE; IDENTIFICATION; EXPERIENCE; NATIONWIDE; HOSPITALS; staphylococcus aureus; bloodstream infection; complications; antibiotic treatment; INSTINCT (1)
BLOOD-STREAM INFECTIONS; SURVIVAL; THERAPY; PROSTACYCLIN; GUIDELINES; SYSTEM; treprostinil; survival; mortality; pump; pulmonary hypertension (1)
BLOOD-STREAM INFECTIONS; TUMOR-NECROSIS-FACTOR; PLACEBO-CONTROLLED TRIAL; INTENSIVE-CARE; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; SECULAR TRENDS; UNITED-STATES; DOUBLE-BLIND; FACTOR-ALPHA; (1)
; blood transfusion; cystectomy; propensity score; recurrence; survival (1)
BLOOD-VESSELS; FLUORESCENCE MICROSCOPY; VASOMOTOR NERVES; SIZE-SPECTRA; INNERVATION; NUMBER; MICROVASCULATURE; RECONSTRUCTION; ARCHITECTURE; FIBERS; (1)
BLOOD-VESSELS; IRRADIATION; PARAMETERS; DURATION; NM; flashlamp-pumped dye laser; fluence; long-pulsed tunable dye laser; port-wine stains; pulse duration; wavelength (1)
BLOWOUT FRACTURES; RECONSTRUCTION; ENOPHTHALMOS; orbital floor fracture; orbital volume analysis; three-dimensional measurement; PDS foil; titanium mesh (1)
BLOW-UP PHENOMENA; YAMABE EQUATION; Scalar curvature; Tensor symmetrizations; Tensor contractions (1)
Blue and green light, TiO2, PbBiO2X, reductions, C-C bond formations (1)
BLUE-DYE; NEOADJUVANT CHEMOTHERAPY; SURGERY; BENEFIT; TRIAL; RADIOISOTOPE; METAANALYSIS; CARCINOMA; UPDATE; LIFE; (1)
BLUE-DYE; SENTINEL; BIOPSY; FLUORESCENCE; WOMEN; IDENTIFICATION; RADIOTRACER; Cervical cancer; Lymph node mapping; Indocyanine green (1)
Blue-enriched light-emitting glasses · Shift work · Sleepiness · Alertness · Occupational safety (1)
BLUE-GREEN-ALGAE; EXPERIMENTAL SILICIFICATION; EXPERIMENTAL FOSSILIZATION; EXPERIMENTAL DIAGENESIS; MOLECULAR PRESERVATION; EXTREMOPHILIC ARCHAEA; RAMAN-SPECTROSCOPY; MERIDIANI-PLANUM; ARCHEAN CHERTS; ATACAMA DESERT; (1)
BLUE-GREEN-ALGAE; MARINE CYANOBACTERIUM TRICHODESMIUM; DEPENDENT OXYGEN-CONSUMPTION; NITROGENASE ACTIVITY; ELECTRON-TRANSPORT; FILAMENTOUS CYANOBACTERIA; FIXATION; CYLINDRICA; PCC-7120; STRESS; Acclimation to abiotic stress; Heterocyst differentiation; Nitrogen fixation; Two-dimensional (imaging) measurements of chlorophyll fluorescence kinetics of individual (1)
BLUE-GREEN ALGAE; NITROGEN-FIXATION; NUCLEOTIDE-SEQUENCE; CELL-ENVELOPE; GENE; EXPRESSION; GROWTH; OXYGEN; DIFFERENTIATION; PHOTOSYNTHESIS; (1)
BLUE-GREEN-ALGA; NITROGENASE ACTIVITY; MULTIDRUG EFFLUX; OUTER-MEMBRANE; PCC 7120; DIAZOTROPHIC GROWTH; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; CELL-ENVELOPE; CYANOBACTERIUM; (1)
BLUE LASER-DIODE; SEMICONDUCTOR-LASER; NITROGEN-DIOXIDE; SPECTROSCOPY; SPECTROMETER; EXCITATION; REGION; CELL; NM; Photoacoustic spectroscopy; Nitrogen dioxide (NO2); Low-cost (blue diode laser, MEMS microphone) 3D printed cell; pptV-level (1)
BLUE-LIGHT PHOTORECEPTOR; COLI DNA PHOTOLYASE; FLASH-PHOTOLYSIS; CHLAMYDOMONAS-REINHARDTII; PHOTOCHEMICAL PROPERTIES; CHLOROPLAST RELOCATION; PHOTOTROPIN FAMILY; ARABIDOPSIS NPH1; PHOT-LOV1 DOMAIN; SPECTROSCOPY; (1)
BLUE-LIGHT PHOTORECEPTOR; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; INFRARED-SPECTROSCOPY; AQUEOUS-SOLUTION; AMINO-ACIDS; PROTEIN; FLAVIN; DOMAIN; TYROSINE; Lyophilized photo-activated cyclase NgPAC2; BLUF domain; Amoeboflagellate Naegleria gruberi; Flavin; Tyr-Tyr cross-linking; o,o '-Dityrosine; Fluorescence quenching; Flavin reduction (1)
BLUE-LIGHT PHOTORECEPTORS; COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; SPECTROSCOPIC CHARACTERIZATION; FOLIC-ACID; ARABIDOPSIS-THALIANA; PTERIN DERIVATIVES; ABSORPTION; TETRAHYDROFOLATE; IDENTIFICATION; (6R,S)-5,10-Methenyltetrahydrofolate chloride (MTHF-Cl); (6R,S)-10-Formyltetrahydrofolate (10-HCO-H4folate); 10-Formyldihydrofolate (10-HCO-H2folate); 10-Formylfolate (10-HCO-folate); Fluorescence quantum yield; Fluorescence quantum distribution; Fluorescence lifetime; Photo-induced charge transfer; Dyadic behaviour (1)
BLUE-LIGHT PHOTORECEPTORS; DOMAIN; PHOTOTROPIN-1; PHOTOCYCLE; PHOT-LOV1; RECEPTOR; FLAVIN; biological photoreceptor; electron transfer; flavin mononucleotide; LOV domain; photochemistry (1)
BLUE-LIGHT PHOTORECEPTORS; FLUORESCENCE BEHAVIOR; SILICATE XEROGEL; AQUEOUS-SOLUTION; MODEL SYSTEM; SOLVENT; PHOTOPHYSICS; SINGLET; EXCIMER; SPECTRA; isoalloxazine; flavoquinone; pyrene; 1-methylpyrene; dipeptide bridge; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; Forster-type energy transfer; electron transfer (1)
BLUE-LIGHT PHOTORECEPTORS; RHODAMINE 6G SOLUTIONS; QUANTUM YIELD; FLUORESCENCE; FLAVIN; BEHAVIOR; SINGLET; SYSTEM; LASER; MOLECULES; isoalloxazine dyes; flavoquinone dyes; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; mass-spectroscopic analysis (1)
BLUE-LIGHT PHOTORECEPTORS; SINGLET OXYGEN YIELDS; AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; EXCITED-STATES; QUANTUM YIELD; PHOTOPHYSICAL PROPERTIES; FLAVIN DERIVATIVES; EMISSION BEHAVIOR; PH-DEPENDENCE; Riboflavin; Lumiflavin; Starch films; Polystyrene films; Fluorescence; Phosphorescence; Delayed fluorescence; Luminescence quantum yields; Luminescence lifetimes; Quantum yield of intersystem-crossing (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; AVENA-SATIVA; ELECTRON-TRANSFER; PHOT-LOV1 DOMAIN; FLAVIN; PHOTOTROPIN; MECHANISM; PROTEIN; FLAVOPROTEINS; flavins; photochemistry; photocycles; photoreceptors; redox chemistry (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; PHOTORECEPTOR PHOTOTROPIN; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; C450A MUTANT; AVENA-SATIVA; ABSORPTION; PROTEIN; (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; PLANT PHOTORECEPTOR DOMAIN; ARABIDOPSIS NPH1; LOV2 DOMAIN; CHLOROPLAST RELOCATION; ELECTRONIC-STRUCTURE; PHOTOTROPIN; PHOTOCYCLE; RESONANCE; (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; PLANT PHOTORECEPTOR DOMAIN; S-H BAND; ADIANTUM PHYTOCHROME3; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; BINDING DOMAINS; PHOTOTROPIN; PHOTOCYCLE; (1)
BLUE-LIGHT RECEPTOR; EMISSION SPECTROSCOPIC CHARACTERIZATION; ALGA CHLAMYDOMONAS-REINHARDTII; MUTATED PHOT-LOV1 DOMAIN; BINDING DOMAINS; HIGHER-PLANTS; AVENA-SATIVA; PHOTOTROPIN; FLAVIN; PHOTOCYCLE; (1)
BLUE-LIGHT RECEPTOR; EMISSION SPECTROSCOPIC CHARACTERIZATION; INTRAMOLECULAR CHARGE-TRANSFER; SEXUAL LIFE-CYCLE; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSFER; LOV2 DOMAIN; SIGNAL-TRANSDUCTION; RIBOFLAVIN ANALOGS; ABSORPTION-SPECTRA; Roseoflavin monophosphate; Phototropin; Cofactor-exchanged LOV1 domain; RoLOV photo-cycle; LOV photo-cycle; Photo-induced protein re-conformation (1)
BLUE-LIGHT RECEPTOR; INDUCED STRUCTURAL-CHANGES; ARABIDOPSIS PHOTOTROPIN-1; PHOT-LOV1 DOMAIN; ADIANTUM PHYTOCHROME3; MOLECULAR-DYNAMICS; AVENA-SATIVA; MECHANISM; PROTEIN; KINASE; LOV1-domain of Chlamydomonas reinhardtii; Signal transduction mechanism; Blue-light photoreceptor protein; Phototropin; Molecular dynamics simulation (1)
BLUE-LIGHT RECEPTOR; MUTATED PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; LOV1 DOMAIN; PHOTOCHEMICAL PROPERTIES; FLUORESCENCE BEHAVIOR; BINDING DOMAIN; HIGHER-PLANTS; FLAVIN; PHOTOTROPIN; LOV domain; phototropin; blue-light photoreceptor; Chlamydomonas reinhardtii; absorption spectroscopy; fluorescence spectroscopy; photo-cycle; flavoprotein; FMN; flavin-C(4a)-cysteinyl adduct (1)
BLUE-LIGHT RECEPTOR; PHOT-LOV1 DOMAIN; SPECTROSCOPIC CHARACTERIZATION; FLAVIN MONONUCLEOTIDE; PHOTOADDUCT FORMATION; STRUCTURAL-CHANGES; PULSE-RADIOLYSIS; ARABIDOPSIS NPH1; BINDING DOMAIN; EXCITED-STATE; (1)
BLUE-LIGHT RECEPTOR; PLANT PHOTORECEPTOR DOMAIN; LOV2 DOMAIN; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; SIGNAL-TRANSDUCTION; FLAVIN CHROMOPHORES; INDOCYANINE GREEN; TRIPLET FORMATION; ELECTRON-TRANSFER; LOV2 domain; flavin mononucleotide; phototropin; Chlamydomonas reinhardtii; photo-bleaching; reductive electron transfer; flavin-C(4a)-cysteinyl adduct (1)
BLUE-LIGHT RECEPTOR; PLANT PHOTORECEPTOR DOMAIN; PARTICLE MESH EWALD; CHLAMYDOMONAS-REINHARDTII; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; PHOTOTROPIN; PHOTOCYCLE; SWITCH; FAMILY; (1)
BLUE-LIGHT RECEPTORS; EXCITED-STATE ABSORPTION; ARABIDOPSIS NPH1; PHOTOCHEMICAL PROPERTIES; CHLOROPLAST RELOCATION; BINDING DOMAINS; EOSIN-Y; PHOTOTROPIN; LASER; PHOTORECEPTOR; triplet quantum yield; intersystem-crossing; riboflavin; flavin mononucleotide; LOV1 domain; alga Chlamydomonas reinhardtii (1)
BLUE-LIGHT RECEPTOR; STRUCTURAL-CHANGES; INDOCYANINE GREEN; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; BINDING DOMAINS; HIGHER-PLANTS; AVENA-SATIVA; LOV1 DOMAIN; PHOTOTROPIN; LOV2 domain; flavin mononucleotide; phototropin; phot; Chlamydomonas reinhardtii; absorption cross-section spectra; fluorescence spectroscopy; photo-bleaching; flavin-C(4a)-cysteinyl adduct; quantum yield of adduct formation (1)
BLUE-LIGHT; STRUCTURAL BASIS; DNA-BINDING; AUREOCHROME-LOV; PROTEIN; OXYGEN; PHOTORECEPTOR; PHOTOTROPIN; PHOTOCYCLE; REVEALS; (1)
BLUE MOUNTAINS EYE; CARDIOVASCULAR RISK-FACTORS; LONG-TERM INCIDENCE; SEVERITY SCALE; REGRESSION SPLINES; 10-YEAR INCIDENCE; CATARACT-SURGERY; POOLED FINDINGS; GRADING SYSTEM; 3 CONTINENTS; (1)
BLUE-MOUNTAINS-EYE; VISUAL IMPAIRMENT PROJECT; 5-YEAR INCIDENCE; RISK-FACTORS; 10-YEAR INCIDENCE; SEVERITY SCALE; MACULOPATHY; PROGRESSION; PREVALENCE; ASSOCIATION; Prevalence; Incidence; Progression; Risk factors; Diagnostic imaging (1)
BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; ACTIVITY IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; STT3 PROTEIN; INTEGRITY; PATHWAY; GENE; GLYCOSYLATION; oligosaccharyltransferase; protein glycosylation; endoplasmic reticulum; dolichol; Saccharomyces cerevisiae (1)
BLUE NATIVE ELECTROPHORESIS; PATHOGEN CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYL-TRANSFERASE; ENDOPLASMIC-RETICULUM; SHUTTLE VECTORS; GENE FAMILY; YEAST; GLYCOSYLATION; PURIFICATION; (1)
BLUNT ABDOMINAL-TRAUMA; PREHOSPITAL ULTRASOUND; COMPUTED-TOMOGRAPHY; PERITONEAL-LAVAGE; HELD ULTRASOUND; INJURY; SONOGRAPHY; MANAGEMENT; BOWEL; (1)
BLUNT CEREBROVASCULAR INJURIES; MASK BONE ELIMINATION; CT ANGIOGRAPHY; ARTERY INJURIES; DISSECTION; DIAGNOSIS; NECK; RECONSTRUCTION; ACCURACY; OUTCOMES; artifacts; carotid artery; dissection; multidetector computed tomography; trauma (1)
BLUNT CEREBROVASCULAR INJURY; CAROTID-ARTERY; SCREENING CRITERIA; cervical artery dissection; vertebral artery; carotid artery; polytrauma; severely injured; computed tomography (1)
BLUNT CEREBROVASCULAR INJURY; SCREENING CRITERIA; polytrauma; carotid artery; vertebral artery; dissection; blunt trauma; computed tomography angiogram (1)
BLUNT CHEST TRAUMA; COMPUTED-TOMOGRAPHY; CT; FRACTURES; RADIOGRAPHY; ribs; thorax; conventional radiography; CT; trauma (1)
BLUNT CHEST TRAUMA; PERICARDIAL-EFFUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; COMPRESSION; DRAINAGE; Cardiac tamponade; Computer tomography; Transthoracic echocardiography (1)
BLUNT CHEST TRAUMA; SOFT-TISSUE TRAUMA; INJURY; BRAIN; SCORE; NONUNIONS; RUST; fracture healing; chest trauma; thoracic trauma; bone consolidation; nonunion; RUST (1)
BLUNT LIVER TRAUMA; NONOPERATIVE MANAGEMENT; COMPUTED-TOMOGRAPHY; BILE LEAKS; BILIARY-TRACT; INJURY; CT; COMPLICATIONS; DIAGNOSIS; SPHINCTEROTOMY; Liver trauma; Classification; Non-operative therapy; Interventional therapy (1)
Blutbestrahlung, Dosimetrie, Blutbestrahlungsgerät (1)
Blutbestrahlung, Strahlenwirkung, Dosimetrie (1)
Blutgasanalysatoren, Base Excess, Doppelmessungen (1)
Blut-Hirn-Schranke , ABC-Transporter , PGP , Taxol , Transferrinrezeptor , Targeted drug delivery , Hirntumor , Hirnmetastase , Multidrug-Resistenz , Calcein-AM, ABCG2 , Lungentumore , Elacridar , Tariquidar , calcein-AM , ABCG2 , lung cancer , elacridar , tariquidar (1)
Bluthochdruck, Primärer Hyperaldosteronismus, Calcium-Kanal, CACNA1H (1)
Blutstammzelltransplantation, Graft-versus-Host Disease (GvHD), Ambulanz, Nachsorge, EBM/ Hematopoietic stem cell transplantation, Graft-versus-Host Disease (GvHD), outpatient department, follow up, EBM (1)
B-LYMPHOCYTE STIMULATOR; T-CELL; DISEASE PROGRESSION; PD-L1 EXPRESSION; HODGKIN-LYMPHOMA; RECEPTOR; CANCER; EFFICACY; BLYS; ACTIVATION; (1)
B-MESON; DISTRIBUTION AMPLITUDE; FACTORIZATION; GAMMA; (1)
BMP-7 (Bone morphogenetic protein-7), avascular meniscal lesions, Tissue Engineering, gelatine-hyaluronan-composite matrice, avaskuläre Meniskusläsionen, Gelatine-Hyaluronsäure-Kompositmatrix (1)
BNST;EPM;maternal aggression;maternal behaviour;maternal care;maternal motivation;MPOA;pup retrieval;PVN;vasopressin;V1a receptors;V1b receptors (1)
BOARD APPROVAL; MULTICENTER; PROTOCOL; IRB; CHALLENGES; MULTISITE; RESPONSES; STANDARD; Versorgungsforschung; Ethikvotum; Ethikkommission; Vorgehen; Aufwand; health services research; institutional review board; ethical vote; procedure; workload (1)
Board size, management board, operating performance, German dual board system (1)
BOAR SUS-SCROFA; TUBERCULOSIS COMPLEX; STRAIN DIFFERENTIATION; CATTLE; EPIDEMIOLOGY; IDENTIFICATION; INFECTIONS; OUTBREAK; NOV; (1)
BOCHNER-WEITZENBOCK FORMULAS; RIEMANNIAN-MANIFOLDS; KAHLERIAN GRADIENTS; REPRESENTATIONS; OPERATORS; SPINORS; Generalized gradient; G-structure; conformal invariance; conformal weight (1)
Bodenbakterien , Motilität , Molekularer Motor , Elektrostatische Wechselwirkung , , soil bacteria , motility , molecular motor , electrostatic interaction (1)
Bodenerosion , Kolluvium , Landnutzung , Absolute Datierung , Datierung , Latène-Zeit , Viereckschanze , Vegetationsgeschichte <Fach> , Bodenkartierung , Landschaftsgeschichte , Landnutzungsmodell , Geoarchiv , Physiotope , soil erosion , colluvium , land use model , geoarchive , geoarchaeology (2)
Bodenerosion , Kolluvium , Paläobotanik , Terra fusca , Sediment , Boden , Karst , Fränkische Alb , , soil erosion , colluvium , prehistoric settlement , landscape change , human impact , karst , pedological analysis , sediments , Terra Fusca (1)
Bodenkunde , Bodengeographie , Arbeitsgemeinschaft , Erosion , Exkursion , Kolluvium , Auenlehm , Landschaftsgeschichte , Bodenerosion , Vegetationsgeschichte , Colluvium , flood loam , landscape history , soil erosion , vegetation history (1)
Bodenlehrpfad , Bodenkunde , Bodenentwicklung , Bodenprofil , Erläuterungsband , Bodenhorizonte , geologische Schichten , Substrate , Sedimente , soil learning path , pedogenesis , soil developement , soil science , soil profile (1)
Bodenreform, Eigentumsordnung, Mittel- und Osteuropa, Manssen, Banaszak, Pielemeier (1)
BODIES; Convex geometry; intersection theory; toric varieties; b-Chow groups; Riemann-Zariski spaces (1)
BODIES; FANS; b-divisors; Convex analysis; Polyhedral spaces; Tropical geometry; Monge-Ampere measures (1)
BODIPY DYES; SPECTROSCOPIC PROPERTIES; REVERSIBLE TERMINATOR; HIGHLY FLUORESCENT; PROBES; BASE; DERIVATIVES; NUCLEOTIDE; DESIGN; PROTEINS; (1)
Bodipy-Farbstoffe, Pyrromethen-Farbstoffe, bodipy dyes, pyrromethene dyes, angeregter Zustand, excited state, Grundzustand, groundstate, Düsenstrahlexpansion, supersonic jet expansion, Laserspektroskopie, laser spectroscopy, Anregungsspektroskopie, excitation spectroscopy, Emissionsspektroskopie, emission spectroscopy, optische Doppelresonanzspektroskopie, optical double resonance spectroscopy, Helium-Nanotropfen-Isolationsspektroskopie, helium-nanodroplet-isolation-spectroscopy, Torsionsschwingungen, torsional vibrations, niederfrequente Schwingungsmoden, low-frequency vibrational modes (1)
BoDV-1, zoonosis, complement system, immunopathogenesis, biomarkers (1)
BODY APPROXIMATION METHODS; MESHKOV-GLICK MODEL; SOLVABLE MODEL; STATES; VALIDITY; GRAVITY; LIMIT; (1)
BODY-COVER MODEL; 2-MASS MODEL; AIR-FLOW; FUNDAMENTAL-FREQUENCY; SUBGLOTTAL PRESSURE; GLOBAL OPTIMIZATION; PHONATION; VIBRATION; CLASSIFICATION; OSCILLATION; Inverse problem; High-speed videoendoscopy; Vocal fold oscillation; Two-mass model (1)
BODY DYSMORPHIC DISORDER; MAJOR DEPRESSION; WIDESPREAD PAIN; RISK-FACTOR; HEALTH; TMD; FIBROMYALGIA; SYMPTOMS; SCALE; PSYCHOPATHOLOGY; facial emotion recognition; emotional processing; temporomandibular disorder; somatoform disorders; Facially Expressed Emotion Labelling test; alexithymia; somatisation (1)
BODY-FAT DISTRIBUTION; PHYSICAL ATTRACTIVENESS; BREAST SIZE; EVOLUTIONARY PSYCHOLOGY; MASS INDEX; INSULIN-RESISTANCE; RATIO HYPOTHESIS; SECULAR CHANGES; SEX-DIFFERENCES; THIN STANDARD; Attractiveness; Bodily attractiveness; Sex differences; Figure; Waist-to-hip ratio; Bust size; Breast size (1)
BODY-FAT DISTRIBUTION; VENTRICULAR DIASTOLIC FUNCTION; METABOLIC SYNDROME; SEX-DIFFERENCES; ADIPOSE-TISSUE; INSULIN-RESISTANCE; RISK-FACTORS; CARDIOVASCULAR RISK; UNITED-STATES; US ADULTS; Sex differences; Cardiometabolic health; Metabolic syndrome; Body fat distribution; Adiponectin (1)
BODY-FAT; PROTEIN-1 GENE; SULFATE; OBESITY; POLYMORPHISM; UCP; uncoupling protein-1; DHEAS; diabetes mellitus (1)
BODY-FAT; SUBCUTANEOUS FAT; ADIPOSE-TISSUE; RISK; ASSOCIATION; DISEASE; HYPERTENSION; INSIGHTS; LINK; Obesity genetics; GWAS; Obesity subtypes; Metabolic disease; Mendelian randomization (1)
Body image, Female athletes, Lean and non-lean sports, Explicit and implicit attitudes (1)
BODY-MASS INDEX; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; LIFE-STYLE INTERVENTION; CARDIORESPIRATORY FITNESS; WAIST CIRCUMFERENCE; OLDER-ADULTS; RISK-FACTORS; WEIGHT-LOSS; WOMEN; abdominal fat; adiposity; body fat distribution; body mass index; exercise; mortality; motor activity (1)
BODY-MASS INDEX; ASSOCIATION ANALYSIS; NATIONAL-HEALTH; DURATION; METAANALYSIS; VARIANTS; COMMON; TRAITS; RISK; IDENTIFICATION; (1)
BODY-MASS INDEX; BIOELECTRICAL-IMPEDANCE ANALYSIS; ALL-CAUSE MORTALITY; OBESITY PARADOX; CANCER; FAT; REPRODUCIBILITY; QUANTIFICATION; ASSOCIATION; VALIDATION; Anthropometry; Sonography of abdominal fat compartments; 3D body scanning; Magnetic resonance imaging; Population-based cohort (1)
BODY-MASS INDEX; BIOLOGICAL PATHWAYS; ANALYSES IDENTIFY; GLYCEMIC TRAITS; LOCI; VARIANTS; DISEASE; (1)
BODY-MASS INDEX; BREAST-CANCER; ANOIKIS RESISTANCE; FATTY-ACIDS; OBESITY; METASTASIS; ANGPTL4; PROLIFERATION; BETA/DELTA; LIPOLYSIS; (1)
BODY-MASS INDEX; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; PUBLIC-HEALTH; BIOBANK; coronary artery disease; genetics; myocardial infarction; prognosis; secondary prevention (1)
BODY-MASS INDEX; CARE; DEFINITIONS; PREDICTORS; INFECTION; MORTALITY; OUTCOMES; COHORT; IMPACT; Staphylococcus aureus; Bacteremia; Outcome; Mortality (1)
BODY-MASS INDEX; DIFFICULTIES QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; CHILDHOOD PSORIASIS; CHILDREN; BURDEN; ADOLESCENTS; DISEASE; PREVALENCE; DISABILITY; Quality of Life; Psoriasis; Pediatrics; Adolescent; Child, mental health; Socioeconomic status (1)
BODY-MASS INDEX; DOSE-RESPONSE METAANALYSIS; NON-HODGKINS-LYMPHOMA; COLORECTAL-CANCER; GASTRIC-CANCER; BREAST-CANCER; LIFE-STYLE; PROSTATE-CANCER; PROCESSED MEAT; EUROPEAN CODE; (1)
BODY-MASS INDEX; EARLY RHEUMATOID-ARTHRITIS; PITUITARY-ADRENAL AXIS; TUMOR-NECROSIS-FACTOR; SYMPATHETIC-NERVE FIBERS; GLUCOCORTICOID-RECEPTOR; ENERGY-EXPENDITURE; IN-VITRO; ADRENOCORTICAL AXIS; PSYCHOSOCIAL STRESS; chronic inflammatory disease; rheumatoid arthritis; psychological stress; systemic disease sequelae (1)
BODY-MASS INDEX; ENDOPLASMIC-RETICULUM STRESS; GASTRIC BYPASS-SURGERY; CELL IMMUNE-RESPONSE; STAGE RENAL-DISEASE; KIDNEY-TRANSPLANT; INSULIN-RESISTANCE; LIVER-TRANSPLANTATION; ADIPOSE-TISSUE; RISK-FACTOR; Obesity; Transplantation outcome; Alloimmunity (1)
BODY-MASS INDEX; ENVIRONMENT INTERACTION; QUANTITATIVE TRAITS; FAT DISTRIBUTION; ASSOCIATION; LOCI; SUSCEPTIBILITY; EPIDEMIOLOGY; EFFICIENT; VARIANTS; (1)
BODY-MASS INDEX; EXTREME OBESITY; MISSING HERITABILITY; COMMON VARIANTS; CONFER RISK; EARLY-ONSET; ASSOCIATION; POPULATION; EXPRESSION; SORTILIN; (1)
BODY-MASS INDEX; FOLLOW-UP; ASSOCIATION; RS9939609; GERMAN; LOCI; GENE; DIET; FTO; (1)
BODY-MASS INDEX; GENE-EXPRESSION; SERUM LEPTIN; MESSENGER-RNA; PLASMA LEPTIN; NITRIC-OXIDE; FOOD-INTAKE; INSULIN; ADIPOCYTES; TISSUE; (1)
BODY-MASS INDEX; GENOME-WIDE METAANALYSIS; PHENOTYPIC VARIABILITY; VARIANTS; OBESITY; INSIGHTS; SNPS; (1)
BODY-MASS INDEX; INCREASED DAYTIME SLEEPINESS; QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; SURGICAL-TREATMENT; OBESITY; CHILDREN; HYPERPHAGIA; DIAGNOSIS; Craniopharyngioma; Hypothalamus; Obesity; Quality of life; Irradiation (1)
BODY-MASS INDEX; INSULIN-RESISTANCE; NMR-SPECTROSCOPY; SYSTEMS EPIDEMIOLOGY; HEALTHY-ADULTS; RISK-FACTORS; OBESITY; PROFILES; CHOLINE; MICE; (1)
BODY-MASS INDEX; INTERLEUKIN-6 GENE; TNF-ALPHA; -174 G/C; METAANALYSIS; MELLITUS; IL-6; ASSOCIATION; C-174G; PLASMA; (1)
BODY-MASS INDEX; INVASIVE BLADDER-CANCER; UROTHELIAL CARCINOMA; IMPACT; OUTCOMES; DISEASE; (1)
BODY-MASS INDEX; INVOLVEMENT; DIAGNOSIS; THERAPY; CHILDREN; SURGERY; (1)
BODY-MASS INDEX; LARGE US COHORT; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; UNITED-STATES; GLYCEMIC INDEX; OBESITY; WEIGHT; HEIGHT; WOMEN; pancreatic cancer; anthropometry; pooled analysis; deceased (1)
BODY-MASS INDEX; LIFE-STYLE FACTORS; CAUSE-SPECIFIC MORTALITY; POPULATION-BASED COHORT; OCCUPATIONAL EXPOSURES; ANTHROPOMETRIC FACTORS; CIGARETTE-SMOKING; POOLED ANALYSIS; AARP DIET; OBESITY; Physical activity; Pancreatic cancer; Meta-analysis (1)
BODY-MASS INDEX; MAJOR PSYCHIATRIC-DISORDERS; APOLIPOPROTEIN-E; LATE-LIFE; METABOLIC SYNDROME; LIPID-LEVELS; RISK LOCI; COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; OLDER-ADULTS; dementia; obesity; loci; cross-disorder; shared (1)
BODY-MASS INDEX; MARIJUANA USERS; NATIONAL-HEALTH; INSULIN; TOBACCO; WEIGHT; RISK; CONSUMPTION; DRONABINOL; THOUGHTS; Cannabis use; Obesity (1)
BODY-MASS INDEX; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; RISK-FACTORS; MEN; COMPLICATIONS; EVENTS; ADULTS; (1)
BODY-MASS INDEX; NIH-AARP DIET; BREAST-CANCER; OVARIAN-CANCER; SEDENTARY BEHAVIOR; ENDOMETRIAL CANCER; COLORECTAL-CANCER; PROSPECTIVE COHORT; PANCREATIC-CANCER; SECULAR TRENDS; Exercise; Motor activity; Sedentary lifestyle; Neoplasms; Carcinogenesis; Disease; Primary prevention; Europe (1)
BODY-MASS INDEX; NIH-AARP DIET; COLORECTAL-CANCER; BREAST-CANCER; NATIONAL INSTITUTES; PROSTATE-CANCER; TIME; METAANALYSIS; ASSOCIATION; HEALTH; (1)
BODY-MASS INDEX; NORWEGIAN MEN; UNITED-STATES; FOLLOW-UP; PHYSICAL-ACTIVITY; SIZE; ANTHROPOMETRY; NUTRITION; COHORTS; WEIGHT; height; prostate cancer; aggressiveness (1)
body mass index | obesity | overweight | plate cleaning | plate clearing (1)
BODY-MASS INDEX; OLDER-ADULTS; LEISURE-TIME; LIFE-STYLE; CARDIORESPIRATORY FITNESS; ABDOMINAL FATNESS; DISEASE; ASSOCIATION; INTENSITY; HEALTH; Physical activity; Walking; Cardiorespiratory fitness; Heart failure; Meta-analysis (1)
BODY-MASS INDEX; PHYSICAL-ACTIVITY; RISK-FACTORS; SIGMOID COLON; LARGE-BOWEL; LIFE-STYLE; ASYMPTOMATIC INDIVIDUALS; CARCINOMA SEQUENCE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; Adiposity; Obesity; Colorectal adenoma; Hyperplastic polyps; Women (1)
BODY-MASS INDEX; PHYSICAL FUNCTION; JOINT ALIGNMENT; LOWER-EXTREMITY; OSTEOARTHRITIS; PROGRESSION; CHILDREN; LENGTH; ANGLE; knee alignment; clinical measurement; hip-knee-ankle angle; full-leg radiograph (1)
BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; HORMONE-REPLACEMENT THERAPY; ENDOMETRIAL CANCER; PROSTATE-CANCER; UNITED-STATES; ANTHROPOMETRIC FACTORS; BIOLOGICAL MECHANISMS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; Body mass index; Cancer risk; Population-attributable risk; Cancer prevention (1)
BODY-MASS INDEX; PREOPERATIVE PLASMA-LEVELS; BLADDER-CANCER; CELL CARCINOMA; RISK; SURVIVAL; IMPACT; MORTALITY; COHORT; ADULTS; bladder cancer; BMI; obesity; prognosis; radical cystectomy; survival; urothelial carcinoma (1)
BODY-MASS INDEX; PROPORTIONAL-HAZARDS; OBESITY; METAANALYSIS; ASSOCIATION; ADIPOSITY; SUBTYPE; COHORT; Adiposity; Body fat; Obesity; Ovarian cancer risk (1)
BODY-MASS INDEX; QUALITY-OF-LIFE; CLEFT CYSTS; FOLLOW-UP; SURGICAL-TREATMENT; LESIONS; REGION; MANAGEMENT; FEATURES; TUMORS; (1)
BODY-MASS INDEX; RAMAN-SPECTROSCOPY; ADIPOCYTES; OBESITY; MECHANISMS; NANOPARTICLES; PROGRESSION; METASTASIS; LIPOLYSIS; CULTURES; (1)
BODY-MASS INDEX; REACTIVE PROTEIN-LEVELS; GENE-EXPRESSION; IDENTICAL-TWINS; ADIPOCYTE DIFFERENTIATION; ASSOCIATION METAANALYSIS; ACTIVITY QUESTIONNAIRES; FAT DISTRIBUTION; BINDING PROTEIN; FOOD-INTAKE; (1)
BODY-MASS INDEX; RISK-FACTORS; MEN; STATISTICS; SMOKING; OBESITY; WOMEN; physical activity; bladder cancer; meta-analysis (1)
BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; RANDOMIZED CONTROLLED-TRIAL; ULTRA-PROCESSED FOODS; WEIGHT-GAIN; PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; CHILDHOOD OBESITY; LIKELY IMPACT; VISCERAL FAT; Energy intake; Energy expenditure; Energy balance; Obesity; Satiety; Diet (1)
BODY-MASS INDEX; SURVIVAL; TEMOZOLOMIDE; ASSOCIATION; PARADOX; HYPERGLYCEMIA; MORTALITY; BENEFIT; DAMAGE; Glioblastoma; Temozolomide; Obesity; MGMT (1)
BODY-MASS INDEX; WAIST-HIP RATIO; FAT DISTRIBUTION; ENZYME-ACTIVITIES; ADULT HEIGHT; PPAR-GAMMA; RISK; VARIANTS; METAANALYSIS; OBESITY; (1)
BODY-MASS INDEX; WEIGHT-REDUCTION; INSIGHTS; LOCI; genetic risk score; obesity; single nucleotide polymorphism; weight (1)
BODY-MASS INDEX; WILLIAMS-BEUREN-SYNDROME; GENOME-WIDE ASSOCIATION; DELETION SYNDROME; DEVELOPMENTAL DELAY; HUMAN HEIGHT; VARIANTS; OBESITY; SNP; MICRODUPLICATION; (1)
Body-Mass-Index , Zunge , NMR-Tomographie , Zungenvolumen , Magnetresonanztomographie , tongue volume , magnetic resonance imaging (1)
BODY-SIZE; LIFE-SPAN; SOCIAL INSECTS; EVOLUTION; FECUNDITY; QUEENS; LONGEVITY; SENESCENCE; AGE; PRODUCTIVITY; (1)
BODY-SORTING MACHINERY; INTRACELLULAR TRAFFICKING; AUTOPHAGIC DEGRADATION; MULTIVESICULAR BODIES; VACUOLE BIOGENESIS; CLATHRIN COATS; CELL-MIGRATION; COMPONENT; RECEPTOR; THALIANA; ubiquitin; ESCRT; DUB; clathrin; Arabidopsis (1)
BODY-TEMPERATURE; THERMOMETRY; ACCURACY (1)
BODY TOPICAL APPLICATION; HUMAN SKIN; VISIBLE-LIGHT; FREE-RADICALS; SUNSCREENS; ULTRAVIOLET; PHOTOPROTECTION; NANOPARTICLES; IRRADIATION; ABSORPTION; (1)
Body weight , Food intake , Menstrual cycle , Stochastic processes , Spectral analysis , Korpergewicht , Nahrungsaufnahme , Menstruationszyklus , Stochastische Prozesse , Spektralanalyse (1)
Bohigas, Giannoni and Schmit, Ehrenfest-time effects, Mesoscopic physics, Quantum Chaos, Quantum effects, Random Matrix Theory, Semiclassical methods (1)
Böhmen; Deutschland; Europagedanke; Evangelischer Theologe; Geschichte; Theologe (1)
Böhmen; Stadtgeschichte; Litoměřice; Bibliographie (1)
Böhmische Länder, Evangelische Kirche, Geschichte, Kučera, Zdeněk, Theologie, Tschechien, Tschechoslowakei (1)
BOHRING-OPITZ SYNDROME; NOVO FRAMESHIFT MUTATION; INTELLECTUAL DISABILITY; GENE; DISORDERS; PHENOTYPE; FAMILY; (1)
; Boletales; chemosystematics; Coniophoraceae; 28S gene; Hydnomerulius gen. nov.; Leucogyrophana; Alpova; nuclear encoded ribosomal DNA (1)
Bombus terrestris · Foraging efficiency · Flower selectivity · Interindividual variation · Behavioral flexibility (1)
BOMBUS-TERRESTRIS; LANDSCAPE-SCALE; NEST CLIMATE; HONEY-BEE; PARASITES; TRANSMISSION; CONSERVATION; DIVERSITY; STRESS; GROWTH; bee; cities; colony growth; energetic stress; fitness; foraging; Neogregarines; reproductive success; temperature; Trypanosomes (1)
bond activation · cobalt · nickel · nitrogen heterocycles · phosphorus heterocycles (1)
bond activation, nickel, phosphaalkyne oligomers, phosphatetrahedranes, phosphorus (1)
BOND ACTIVATION; REDOX CHEMISTRY; C-H; PORPHYRINOGEN; COMPLEXES; OXIDATION; HYDRIDES; AMMONIA; FORMS; (1)
BOND COVALENT RADII; ARSINIDENE COMPLEXES; PHOSPHINIDENE; SUBSTITUTION; EXPANSION; SULFUR; SINGLE; RING (1)
BOND COVALENT RADII; BASIS-SETS; COMPLEXES; PHOSPHORUS; SINGLE; arsenic; iron cluster; redox chemistry (1)
BOND COVALENT RADII; C-H ACTIVATION; MOLECULAR-STRUCTURES; STRUCTURAL-CHARACTERIZATION; 1,3-DIPHOSPHOLYL ANIONS; TRIPHOSPHA-FERROCENES; IRON COMPLEXES; CRYSTAL; PHOSPHORUS; LIGANDS; Supramolecular chemistry; Self-assembly; Polymers; Phosphaferrocenes; Copper (1)
BOND COVALENT RADII; COMPLEXES; PENTAPHOSPHAFERROCENE; REACTIVITY; Arsenic; Functionalization; Iron; Nucleophiles; Polyarsenide Units (1)
BOND COVALENT RADII; LIGANDS; CHEMISTRY; ROUTE (1)
BOND COVALENT RADII; MOLECULAR-STRUCTURE; WHITE PHOSPHORUS; COMPLEXES; LIGAND; P-4; FUNCTIONALIZATION; REACTIVITY; ACTIVATION; CRYSTAL; (1)
BOND COVALENT RADII; NICKEL-COMPLEXES; PENTAPHOSPHAFERROCENE; PHOSPHORUS; ELEMENTS; REACTIVITY; REDUCTION; FERROCENE; MECHANISM; DESIGN; arsenic; heterometallic complexes• phosphorus; redox chemistry; transfer reactions (1)
BOND COVALENT RADII; PHOSPHORUS; ACTIVATION; ALKYL; RINGS; electrophile; heterocycle; polypnictogen; rearrangement; ring expansion (1)
BOND COVALENT RADII; SANDWICH COMPLEXES; LIGAND; P-4; HEXAPHOSPHABENZENE; COORDINATION; cobalt; cyclo-P-n ligands; iron; nickel; triple-decker complexes (1)
BOND-DISSOCIATION ENERGIES; S-NITROSOTHIOLS; METHYL NITRITE; MOLECULAR-BEAM; NO FRAGMENT; AB-INITIO; PHOTODISSOCIATION DYNAMICS; VELOCITY DISTRIBUTION; UV-PHOTODISSOCIATION; ABSORPTION-SPECTRUM; (1)
BOND DONOR CATALYSTS; ASYMMETRIC CATALYSIS; HYDROGEN-BOND; SOLID-PHASE; CONTAINING HETEROCYCLES; BIFUNCTIONAL CATALYST; TERMINAL ALKYNES; LEWIS-BASE; ORGANOCATALYSIS; DERIVATIVES; anion-binding; enantioselective reactions; isoquinolines; organocatalysis; triazoles (1)
BOND DONORS; ENOL ETHERS; ORGANOCATALYSIS; ACTIVATION; LIGANDS; INVERSION; FOLDAMER; ACIDS; IONS; (1)
BONDED CARBONYL DIMERS; DIAQUODIMERCURY(I) CATION; CHARGE-TRANSFER; PHOTOCHEMISTRY; COMPLEXES; OXYGEN; (1)
BONDED CARBONYL DIMERS; PHOTOCHEMISTRY; COMPLEXES; HYDROGEN; PEROXIDE; OXYGEN; SOLAR; EXCITATION; ENERGY; STATE; coordination chemistry; osmium; photocatalysis; photochemistry; water splitting (1)
BOND-FORMING REACTIONS; ASYMMETRIC MICHAEL ADDITION; ALDOL REACTIONS; ALPHA-ALKYLATION; C-C; DIARYLPROLINOL ETHERS; ALDEHYDES; CATALYSIS; CASCADE; ORGANOCATALYSIS; (1)
BOND-FORMING REACTIONS; DEHYDROGENATIVE COUPLING REACTIONS; PHOTOREDOX CATALYSIS; C-C; TERTIARY-AMINES; DUAL CATALYSIS; OXIDATIVE HYDROXYLATION; MERGING PHOTOREDOX; ARYLBORONIC ACIDS; HIGHLY EFFICIENT; (1)
BONDING AGENTS; IN-VITRO; TRICLOSAN; GLUTARALDEHYDE; CHLORHEXIDINE; RESIN; GLUTARDIALDEHYDE; RESTORATIONS; REPLACEMENT; PLACEMENT; (1)
BONDING ANALYSIS; CUBIC CLUSTERS; ORGANOMETALLIC COMPOUNDS; MOLECULAR-STRUCTURES; TRANSITION; COMPLEXES; APPROXIMATION; COORDINATION; LIGANDS; CS3TE22; carbonyl complexes; cluster compounds; cobalt; niobium; tellurium (1)
BOND-ORIENTATIONAL ANISOTROPY; X-RAY-DIFFRACTION; METAL THIN-FILMS; STRUCTURAL ANISOTROPY; ELECTRON-SCATTERING; MULTILAYERS; ORIGIN; amorphous; anisotropy; pair distribution function; magnetic; perpendicular (1)
BOND PORTFOLIO MANAGEMENT; LIABILITY MANAGEMENT; MARKET PRICE; CREDIT RISK; MODEL; SIMULATION; SECURITIES; ASSET; Dynamic stochastic programming; Stochastic linear programming; Cash management; Market price of risk; Change of measure; Scenario generation (1)
BOND STRENGTH; COMPOSITE RESTORATIONS; CLINICAL-PERFORMANCE; INTERNAL ADAPTATION; CAST GOLD; RESIN; SYSTEMS; MICROLEAKAGE; CEMENT; ENAMEL; (1)
BOND STRENGTH; MECHANICAL-PROPERTIES; FRACTURE-RESISTANCE; SURFACE-TREATMENT; LIGHT; EXPANSION; POLYMERIZATION; TRANSMISSION; SHRINKAGE; TOUGHNESS; CAD/CAM; Composite; Ceramic; Fitting; TCML (1)
BOND STRENGTH; RESINS; fibre-reinforced composite; crowns; cementation; marginal adaptation; fracture load (1)
BOND-VALENCE PARAMETERS; ELECTRON LOCALIZATION; CRYSTAL-STRUCTURE; GENERATION; (1)
BONE AUGMENTATION; ARTHRODESIS; REVISION; REPLACEMENT; DEFECTS; IMPLANT; INFECTION; Ankle joint; Reoperation; Arthrodesis; Allogeneic transplantation; Intramedullary nailing (1)
BONE-CEMENT; FLUCONAZOLE; ETEST; ARTHROPLASTY; Candida; arthritis; osteomyelitis; endoprosthesis; fluconazole (1)
bone composition; function; jaw bone; metabolism; remodeling (1)
BONE-FORMATION; COLLAGEN; SIZE; Atelopeptidization; demineralization; dentin-pulp complex; regeneration; treated dentin matrix; xenograft (1)
BONE-FORMATION; ECTOPIC OSSIFICATION; JOINT REPLACEMENT; INDOMETHACIN; PREVENTION; PROPHYLAXIS; DICLOFENAC; heterotopic ossifications; total hip arthroplasty; predisposing factors; prophylaxis (1)
BONE-FORMATION; ILIAC CREST; SURFACE-ROUGHNESS; CELL RESPONSE; CALCIUM; IMPLANTS; OSSEOINTEGRATION; COMPLICATIONS; SUBSTITUTES; SUBSTRATE; bone; implant; Ti-6Al-7Nb; rat; sheep; cell culture; biocompatibility (1)
BONE-FORMATION; MURINE MODEL; MUSCLE; ARTHROPLASTY; CHONDROCYTES; INJURY; TRAUMA; Hypoxia; Mesenchymal progenitor cell; Heterotopic ossification; Pathogenesis (1)
BONE GLA PROTEIN; SIALOPHOSPHOPROTEIN DSPP; HUMAN FIBROBLASTS; PULP CELLS; LINE; RAT; ESTABLISHMENT; SIALOPROTEIN; OSTEOCALCIN; GENE; dental papilla cells; Simian virus 40 large t antigen (SV40 ltAg); immortalization; gene expression; mineralized tissue specific proteins (1)
Bone heating, Dental implant, Drill cooling, Printed template, Guided template (1)
BONE LOSS; SUBSTANCE-P; INBRED STRAINS; DIFFERENTIATION; MODEL; ACTIVATION; DEPRESSION; CALLUS; REPAIR; fracture; substance P; alpha-CGRP; sympathectomy; sympathetic nerve fibers; ovariectomy; sensory nervous system; bone repair; bone remodeling (2)
BONE-MARROW; BETA-CHAINS; T-CELLS; LIGANDS; IL-7; PROLIFERATION; INHIBITION; CONTRIBUTE; DIVERSITY; MECHANISM; (1)
BONE-MARROW-CELLS; BLOOD STEM-CELLS; PERIPHERAL-BLOOD; IN-VIVO; PROGENITOR CELLS; CD34(+) CELLS; EXPRESSION; ADHESION; HEPATOCYTES; RECOVERY; cord blood; stem cell factor; stem cell transplantation; tissue distribution (1)
BONE-MARROW-CELLS; THERAPY POSITION STATEMENT; STEM-CELLS; HEPATOCYTE TRANSPLANTATION; INTERNATIONAL-SOCIETY; FUSION; DIFFERENTIATION; RETRORSINE; MICE; REPLACEMENT; multipotent mesenchymal stromal cells; liver regeneration; hepatocyte transplantation dipeptidyl peptidase IV rat model; transdifferentiation in vivo (1)
BONE-MARROW; CLINICAL MANIFESTATIONS; NONSTRUCTURAL PROTEIN; BLOOD-DONORS; P6 PROMOTER; DNA; ANTIBODIES; PERSISTENCE; ARTHRITIS; IGG; parvovirus 1319; NS1-protein; juvenile arthritis; viral persistence (1)
BONE-MARROW EDEMA; CORE DECOMPRESSION; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; TRANSIENT OSTEOPOROSIS; INTERTROCHANTERIC OSTEOTOMY; ELECTROMAGNETIC-FIELDS; CONSERVATIVE TREATMENT; SURVIVORSHIP ANALYSIS; HIP; osteonecrosis of the femoral head; conservative treatment; core decompression; total hip arthroplasty (1)
BONE-MARROW EDEMA; PROSTACYCLIN ANALOG ILOPROST; CORE DECOMPRESSION; NONTRAUMATIC OSTEONECROSIS; TRANSIENT OSTEOPOROSIS; ELECTROMAGNETIC-FIELDS; AVASCULAR NECROSIS; HIP; COLLAPSE; ALENDRONATE; femoral head necrosis; conservative treatment; medical evidence (1)
BONE-MARROW EDEMA; SHOCK-WAVE THERAPY; OSTEITIS PUBIS; CONSERVATIVE TREATMENT; IMAGING FINDINGS; SOCCER PLAYERS; INJURIES; DIAGNOSIS; SYMPHYSIS; HIP; Football; Soccer; Pubic overload; Groin pain; Shock wave therapy; Osteitis pubis (1)
BONE-MARROW FAILURE; ACUTE MYELOID-LEUKEMIA; FANCONI-ANEMIA; CONDITIONING REGIMEN; CHILDREN; VARIANTS; BLOOD; CLASSIFICATION; COMPLICATIONS; GUIDELINES (1)
BONE-MARROW FAILURE; DNA-DAMAGE; EVOLUTION; DISEASES; MICE; (1)
BONE-MARROW FAILURE; PULMONARY-FIBROSIS; GENETIC FEATURES; APLASTIC-ANEMIA; MUTATIONS; DIAGNOSIS; COHORT; (1)
BONE-MARROW; IMMUNE-RESPONSE; EMPTY CAPSIDS; INFECTION; PROTEINS; IDENTIFICATION; B19-PARVOVIRUS; ANTIBODIES; SEQUENCE; ARTHRITIS; (1)
BONE-MARROW RESCUE; CENTRAL-NERVOUS-SYSTEM; STEM-CELL RESCUE; HIGH-GRADE GLIOMAS; CHILDRENS CANCER GROUP; HIGH-RISK; MYELOABLATIVE CHEMOTHERAPY; YOUNG-CHILDREN; METASTATIC MEDULLOBLASTOMA; GLIOBLASTOMA-MULTIFORME; brain tumors; bone marrow transplantation; stem cell transplantation; high-dose chemotherapy; children; glioma; medulloblastoma; ependymoma (1)
bone marrow stimulation, chondroplasty, hip arthroscopy, hip preserving surgery, microfracture (1)
BONE-MARROW TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; TERM-FOLLOW-UP; RELAPSE; BLOOD; DONOR; RISK; Hematological malignancies, advanced; Allogeneic stem cell transplantation; Graft versus host disease, chronic; Myeloablative conditioning; Reduced intensity conditioning (1)
BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE-CENTER EXPERIENCE; ALLOGENEIC TRANSPLANTATION; FOLLOW-UP; MALIGNANCIES; SURVIVAL; OUTCOMES; RISK; Second HSCT; Relapse pediatric acute leukemia; cGVHD (1)
BONE-MARROW-TRANSPLANTATION; ACUTE VIRAL-HEPATITIS; REVERSE SEROCONVERSION; CHRONIC GVHD; LAMIVUDINE TREATMENT; ANTI-HBS; PATIENT; PREVALENCE; MANAGEMENT; RECOVERY; haematopoietic stem cell transplantation; hepatitis B virus; reactivation; reverse seroconversion (1)
BONE-MARROW-TRANSPLANTATION; AML-COOPERATIVE-GROUP; WORLD-HEALTH-ORGANIZATION; COLONY-STIMULATING FACTOR; INTENSIVE CHEMOTHERAPY; COMPLETE REMISSION; CYTOSINE-ARABINOSIDE; RANDOMIZED-TRIAL; 1ST REMISSION; CLASSIFICATION; (1)
BONE-MARROW-TRANSPLANTATION; ANTI-THYMOCYTE GLOBULIN; MONOCLONAL-ANTIBODIES; ACUTE GVHD; LYMPHOPROLIFERATIVE DISORDER; ANTITHYMOCYTE GLOBULIN; THERAPY; LYMPHOCYTES; DONORS; stem cell transplantation; graft-versus-host disease; monoclonal antibody; OKT3 (1)
BONE-MARROW-TRANSPLANTATION; APOPTOSIS; RADIATION; DISEASE; SERUM; DEATH (1)
BONE-MARROW-TRANSPLANTATION; CAR-T-CELLS; FRANCOPHONE SOCIETY; FRENCH SOCIETY; MANAGEMENT; RECOMMENDATIONS; DISEASE; RECIPIENTS; ADULT; LIFE; (1)
BONE-MARROW-TRANSPLANTATION; CENTRAL-NERVOUS-SYSTEM; ICAM-1; ACCUMULATION; INVOLVEMENT; ACTIVATION; LESIONS; VCAM-1; CELLS; BRAIN; immunohistochemistry; cerebrovascular disorders; endothelium, vascular; graft-versus-host disease; cell adhesion molecules (1)
BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD; RISK; ASSOCIATION; DEFICIENCY; DIAGNOSIS; RESPONSES; CORRELATE; RECOVERY; SURVIVAL; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Bone marrow transplantation; BAFF; Immature B cells (1)
BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; LONG-TERM SURVIVAL; UNRELATED DONORS; CHRONIC GVHD; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PREDICTIVE FACTORS; Risk factor; Outcome; Chronic graft-versus-host disease; Allogeneic stem cell transplantation (1)
BONE-MARROW TRANSPLANTATION; COLONY-STIMULATING FACTOR; HIGH-DOSE CHEMOTHERAPY; CD8(+) T-CELLS; INTENSIVE CHEMOTHERAPY; LYMPHOCYTE SUBSETS; CANCER-PATIENTS; BREAST-CANCER; MONOCYTES; RELEASE; hematopoietic stem cell transplantation; antineoplastic drug therapy; leukocyte subsets; cytokines; hematopoietic recovery (1)
BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; MATCHED UNRELATED DONORS; WORKING GROUP-REPORT; FOLLOW-UP; ANTITHYMOCYTE GLOBULIN; CLINICAL-TRIALS; COMPETING RISKS; DEPLETION; SURVIVAL; (1)
BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; TOTAL-BODY IRRADIATION; QUALITY-OF-LIFE; DRY EYE; CORNEAL PERFORATION; CLINICAL-TRIALS; PHACOEMULSIFICATION; DIAGNOSIS; SEVERITY; Graft-versus-host-disease; Cataract; Phacoemulsification; Complication (1)
BONE-MARROW-TRANSPLANTATION; CONSORTIUM INTERNATIONAL-CONFERENCE; BLOOD INSTITUTE/PEDIATRIC BLOOD; SYNDROMES CONSENSUS STATEMENT; NATIONAL-CANCER-INSTITUTE; FAILURE SYNDROMES; GROWTH-HORMONE; FERTILITY PRESERVATION; SHORT STATURE; CHILDREN; (1)
BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; RELAPSE-FREE SURVIVAL; QUALITY-OF-LIFE; CHILDREN; CHIMERISM; PATIENT; GRAFTS; CURE; (1)
BONE-MARROW-TRANSPLANTATION; DEVELOPMENT PROJECT; CLINICAL-TRIALS; DIAGNOSIS; RECIPIENTS; CRITERIA; (1)
BONE-MARROW-TRANSPLANTATION; EXPRESSING FAS LIGAND; DENDRITIC CELLS; IN-VIVO; CD95 LIGAND; MULTIPLE-SCLEROSIS; GRAFT-REJECTION; MURINE MODEL; INDUCTION; TOLERANCE; (1)
Bone marrow transplantation, Graft versus host disease, Tissue, Treg cells, Tissue repair program, Knochenmarkstransplantation, Transplantat-gegen-Wirt-Krankheit, Gewebe-Treg-Zellen, Gewebereparaturprogramm (1)
bone marrow transplantation; Gram stain; meningitis; microscopy (1)
BONE-MARROW-TRANSPLANTATION; GUILLAIN-BARRE-SYNDROME; CENTRAL-NERVOUS-SYSTEM; DONOR LYMPHOCYTE INFUSION; INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC MYELOID-LEUKEMIA; SOLID-ORGAN TRANSPLANTATION; IMMUNE-MEDIATED MYELOPATHY; WORKING GROUP-REPORT; MYASTHENIA-GRAVIS; chronic graft-versus-host disease; allogeneic haematopoietic stem cell transplantation; neurologic manifestations; supportive care (1)
BONE-MARROW-TRANSPLANTATION; GUILLAIN-BARRE-SYNDROME; INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; POLYNEUROPATHY; CRITERIA; COMPLICATIONS; MANIFESTATION; (1)
BONE-MARROW-TRANSPLANTATION; GUT MICROBIOTA; T-CELLS; ENTEROCOCCUS; MICROFLORA; DEFENSE; HEALTH; GVHD; Microbiome; Metagenomics; Clinical allogeneic transplantation (1)
BONE-MARROW TRANSPLANTATION; HEMORRHAGIC CYSTITIS; RECIPIENTS; DISEASE; RISK; HOST; DNA; adenoviral infection; allogeneic stem cell transplantation; prospective surveillance study (1)
BONE-MARROW-TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; TUMOR-NECROSIS-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; 4G/5G POLYMORPHISM; VEIN-THROMBOSIS; REDUCTASE GENE; RISK; METHOTREXATE; hematopoietic stem-cell transplantation; thrombophilic gene mutation; hemostatic complication (1)
BONE-MARROW-TRANSPLANTATION; HIGH-DOSE BUSULFAN; OVARIAN-FUNCTION; CONDITIONING REGIMEN; LATE COMPLICATIONS; ENDOCRINE FUNCTION; CHILDHOOD-CANCER; SURVIVORS; GROWTH; CYCLOPHOSPHAMIDE; Gonadal damage; Busulfan; Treosulfan; Pubertal stage (1)
BONE-MARROW TRANSPLANTATION; HOST DISEASE; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; PROCALCITONIN; SERUM; INFECTION; SEPSIS; GRAFT; COAGULATION; antithymocyte globulin; side-effects; treatment; transplantation (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; CARDIAC ALLOGRAFT-REJECTION; CHEMOKINE RECEPTORS; LUNG INJURY; MET-RANTES; LEUKOCYTE RECRUITMENT; INDUCED ARTHRITIS; CCR1 ANTAGONISTS; BETA CHEMOKINES; (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; STEM-CELL TRANSPLANTATION; SURFACTANT PROTEIN-A; EARLY PROINFLAMMATORY EVENTS; SIGNIFICANTLY CONTRIBUTES; BRONCHIOLITIS-OBLITERANS; INTERSTITIAL PNEUMONITIS; INJURY; RECEPTOR; allogeneic stem cell transplantation; lung; graft-versus-host disease; pulmonary function; restrictive; obstructive (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; TERM FOLLOW-UP; TOTAL-BODY IRRADIATION; TNF-ALPHA; FACTOR RECEPTORS; CONTROLLED TRIAL; LIPOPOLYSACCHARIDE STIMULATION; COMPARING METHOTREXATE; CYTOKINE DYSREGULATION; (1)
BONE-MARROW-TRANSPLANTATION; INFECTION; RECIPIENT; VIREMIA; DISEASE (1)
BONE-MARROW-TRANSPLANTATION; INFLAMMATORY-BOWEL-DISEASE; GVHD; HISTOPATHOLOGY; MICROBIOTA; INTESTINE; LECTIN; TRIALS; (1)
BONE-MARROW TRANSPLANTATION; INTENSIFIED CHEMOTHERAPY; POMB/ACE CHEMOTHERAPY; RANDOMIZED TRIAL; TUMORS; CARBOPLATIN; THERAPY; CLASSIFICATION; TOXICITY; REGIMEN; (1)
BONE-MARROW-TRANSPLANTATION; INTRAVENOUS IMMUNE GLOBULIN; IMMUNOGLOBULIN THERAPY; VIRAL-DNA; INFECTION; TRANSMISSION; RECIPIENTS; APLASIA; VIRUS; PLASMA; (1)
BONE-MARROW-TRANSPLANTATION; INTRAVENOUS TREOSULFAN; CONDITIONING REGIMEN; SKIN-GRAFTS; TOXICITY; DISEASE; BLOOD; PHARMACOKINETICS; IRRADIATION; RECIPIENTS; treosulphan; transplantation; pharmacokinetic; allogeneic; conditioning (1)
BONE-MARROW-TRANSPLANTATION; LONG-TERM SURVIVORS; QUALITY-OF-LIFE; BREAST-CANCER; NEUROPSYCHOLOGIC IMPACT; ADJUVANT CHEMOTHERAPY; IMPAIRMENT; LEUKEMIA; DEFICITS; MEMORY; cancer; psycho-oncology; neurotoxicity; oncological rehabilitation; neuropsychological diagnostics; quality of life (1)
BONE-MARROW-TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGENS; IMMUNE RECONSTITUTION; FUNCTIONAL ASPLENIA; IGA DEFICIENCY; CHRONIC GVHD; RISK-FACTORS; ANTIBODY; RECIPIENTS; RITUXIMAB; chronic graft-versus host disease; immunoglobulin; infection; lymphocyte; stem cell transplantation (1)
BONE-MARROW TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; HEMATOPOIETIC STEM-CELLS; MATCHED SIBLING DONORS; APLASTIC-ANEMIA; HUMAN RECIPIENTS; ACUTE GVHD; LEUKEMIA; COMPLICATIONS; THERAPY; allogeneic stem cell transplantation; bone marrow transplantation; graft-versus-host disease; acute GvHD; chronic GvHD; sclerodermiform GvHD; lichenoid GvHD; therapy (1)
BONE-MARROW TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; STEM-CELL TRANSPLANTATION; MATCHED SIBLING DONORS; HUMAN RECIPIENTS; ACUTE GVHD; COMPLICATIONS; MANIFESTATIONS; SEVERITY; TARGET; allogeneic stem cell transplantation; bone marrow transplantation; Graft-versus-Host-Disease; sclerodermiform GvHD; lichenoid GvHD (1)
BONE-MARROW-TRANSPLANTATION; NITRIC-OXIDE; ADHESION MOLECULES; AORTIC STIFFNESS; VASCULAR ENDOTHELIUM; INDEPENDENT PREDICTOR; INTERFERON-GAMMA; GROWTH-FACTOR; CELL-DEATH; IFN-GAMMA; Endothelial dysfunction; Compliance of resistance arteries; Graft-versus-host disease; Endothelial nitric oxide synthase (eNOS); Inducible nitric oxide synthase (iNOS) (1)
BONE-MARROW-TRANSPLANTATION; PATIENT-CENTERED CARE; LONG-TERM SURVIVORS; CANCER SURVIVORS; DECISION-MAKING; INFECTIOUS COMPLICATIONS; UNMET NEEDS; OF-LIFE; HEALTH; CAREGIVERS; allogeneic hematopoietic stem cells transplantation; survivorship; patients view; framework analysis; qualitative research; GvHD (1)
BONE-MARROW-TRANSPLANTATION; PHOTORECEPTOR CELL-DEATH; GENE-EXPRESSION; RAT RETINA; NERVOUS-SYSTEM; IN-VIVO; MEMBRANE GLYCOPROTEIN; MICROARRAY ANALYSIS; INNATE IMMUNITY; DYING NEURONS; neoronal homeostasis; toll-like receptors; early growth response factor 1 (1)
BONE-MARROW-TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD LEUKOCYTES; NON-HODGKINS-LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; INFECTIOUS-MONONUCLEOSIS; BURKITTS LYMPHOMA; DISORDER; RISK; LOAD; Epstein-Barr virus diagnosis; semiquantitative PCR; posttransplant; lymphoproliferative disease; antiviral therapy (1)
BONE-MARROW-TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; GENE-EXPRESSION; ENVELOPE GLYCOPROTEINS; PERIPHERAL-BLOOD; CARRIER STATE; RISK-FACTORS; RECIPIENTS; DNA; DISEASE; lytic cycle; viral reactivation; TaqMan-PCR; lymphoproliferation (1)
BONE-MARROW-TRANSPLANTATION; RADIATION CHIMERAS; SECONDARY DISEASE; MICROFLORA; CYTOKINES; ENDOTOXIN; BACTERIA; LESIONS; (1)
BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; EPIDERMAL LANGERHANS CELLS; CONTACT HYPERSENSITIVITY; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; PREVENTS; SKIN; CD4(+)CD25(+); INDUCTION; (1)
BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; STEM-CELL; CMV INFECTION; PNEUMONIA; MODEL; DISSEMINATION; MORTALITY; THERAPY; LATENCY; (1)
BONE-MARROW-TRANSPLANTATION; REVERSE SEROCONVERSION; VIRUS INFECTION; ADOPTIVE TRANSFER; SURFACE-ANTIGEN; CHRONIC GRAFT; HOST-DISEASE; RECOVERY; MAINTENANCE; POLYMERASE; allogeneic haematopoietic stem cell transplantation; hepatitis B virus; mutation; reverse seroconversion; vaccination (1)
BONE-MARROW-TRANSPLANTATION; SINUSOIDAL OBSTRUCTION SYNDROME; TISSUE-PLASMINOGEN ACTIVATOR; REGIMEN-RELATED TOXICITY; HIGH-RISK POPULATION; IN-VITRO; GEMTUZUMAB OZOGAMICIN; URSODEOXYCHOLIC ACID; INTRAVENOUS BUSULFAN; VENOCCLUSIVE DISEASE; defibrotide; sinusoidal obstruction syndrome; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; SKIN EXPLANT MODEL; DISEASE; DONOR; RISK; GVHD; ACTIVATION; RECIPIENTS; FREQUENCY; REJECTION; Natural regulatory T cells; Graft-versus-host disease; Hematopoietic stem-cell transplantation (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ACUTE ALLOGRAFT-REJECTION; CD4(+) T-CELLS; INTERFERON-GAMMA; CLINICAL-TRIALS; CHRONIC GVHD; RISK-FACTORS; BAFF; CHEMOKINES; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; HIGH-DOSE CYTARABINE; 1ST REMISSION; POSTREMISSION THERAPY; CHEMOTHERAPY; TRIAL; RECOMMENDATIONS; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INTERSTITIAL PNEUMONITIS; DOSE-RATE; VERIFICATION; TOXICITY; LEUKEMIA; THERAPY; ADULTS; TBI; Total body irradiation; Sweeping beam technique; Lung shielding; Dosimetry; 3D treatment planning (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MATCHED SIBLING DONORS; FREQUENCY-ANALYSIS; HUMAN RECIPIENTS; PROPHYLAXIS; OLDER; AGE; ALLOREACTIVITY; MALIGNANCIES; skin explant model; graft-versus-host disease; hematopoietic stem cell transplant (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; GENE POLYMORPHISMS; FEMALE DONORS; LABIAL SALIVA; BLOOD; graft-versus-host disease; biomarkers (1)
BONE-MARROW TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MIXED HEMATOPOIETIC CHIMERISM; POLYMERASE CHAIN-REACTION; GRAFT-VERSUS-LEUKEMIA; IDENTICAL LITTERMATE DOGS; COLONY-STIMULATING FACTOR; CHRONIC MYELOID-LEUKEMIA; 2 IRRADIATION REGIMENS; BLOOD PROGENITOR CELLS; reduced conditioning; allogeneic transplantation; mixed chimerism; regimen-related toxicity (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; NITRIC-OXIDE; INTERFERON-GAMMA; ENDOTHELIAL DYSFUNCTION; IFN-GAMMA; RESISTANCE ARTERIES; MOUSE LUNG; INTERLEUKIN-10; MICE; Vascular graft-versus-host disease (GVHD); Indoleamine 2,3-dioxygenase (IDO); Adiponectin (APN); Cytokines (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SEVERE DRY EYE; RISK-FACTORS; DIAGNOSIS; CRITERIA; CORNEAL; Verification; Ocular chronic graft-versus-host disease; Grading scale (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; TOLL-LIKE RECEPTORS; INFLAMMATORY BOWEL DISEASES; MOUSE RADIATION CHIMERAS; NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; T-CELLS; NOD2/CARD15 VARIANTS; INTESTINAL MICROFLORA; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; INTERFERON-GAMMA; FUNGAL-INFECTIONS; THERAPY (1)
BONE-MARROW-TRANSPLANTATION; SYNDROME/VENO-OCCLUSIVE DISEASE; HIGH-RISK POPULATION; ENDOTHELIAL-CELLS; OBSTRUCTION SYNDROME; COMPASSIONATE-USE; URSODEOXYCHOLIC ACID; SIGNIFICANT TOXICITY; MULTIORGAN FAILURE; EUROPEAN-SOCIETY; Defibrotide; endothelial cell activation; fibrinolysis; hematopoietic stem cell transplantation; hepatic veno-occlusive disease; multi-organ dysfunction; multi-organ failure; sinusoidal obstruction syndrome; thrombosis (1)
BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; COMPETING RISKS; ANTITHYMOCYTE GLOBULIN; LYMPHOCYTE GLOBULIN; CLINICAL-TRIALS; STEM-CELLS; DEPLETION; LEUKEMIA; SURVIVAL; (1)
BONE-MARROW-TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VERSUS-HOST-DISEASE; HEMOLYTIC-UREMIC SYNDROME; PROPHYLAXIS; BLOOD; bone marrow transplantation; hematopoietic stem cell transplantation; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; transplant-associated microangiopathy (1)
BONE-MARROW-TRANSPLANTATION; TOTAL-BODY IRRADIATION; VERSUS-HOST DISEASE; THERAPY; IMMUNOSUPPRESSION; MALIGNANCIES; CHIMERISM; ANCHOR; ANEMIA; paroxysmal nocturnal hemoglobinuria; allogeneic HCT (1)
BONE-MARROW-TRANSPLANTATION; TRANSCRIPTION FACTOR FOXP3; IMMUNOLOGICAL SELF-TOLERANCE; ANTIGEN-PRESENTING CELLS; EX-VIVO; EXPANDED CD4(+)CD25(+); GENE-EXPRESSION; DENDRITIC CELLS; L-SELECTIN; TGF-BETA; (1)
BONE-MARROW-TRANSPLANTATION; TUMOR-NECROSIS-FACTOR; VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; LIPOPOLYSACCHARIDE STIMULATION; INTERSTITIAL PNEUMONITIS; PULMONARY INFLAMMATION; MONOCLONAL-ANTIBODIES; MUTANT MICE; DONOR CELLS; bone marrow transplantation; endothelium; graft-versus-host disease; cytokines (1)
BONE-MARROW-TRANSPLANTATION; UNRELATED DONOR; COMPARABLE SURVIVAL; IDENTICAL SIBLINGS; GRAFT; RISK; MISMATCH; BLOOD; ALLOREACTIVITY; RECIPIENTS; HLA disparity; Non-HLA donor characteristics (1)
BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE; HOST DISEASE; LIVER; MARKER; GRAFT; MICROANGIOPATHY; PARAMETERS; RECIPIENTS; TOXICITY; hematopoietic stem cell transplantation; protein C; procollagen III peptide; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST DISEASE; CELLS; endothelium; LDL; cell sorting; lung; mouse; isolation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; HIGH-DOSE CHEMOTHERAPY; ANTITHYMOCYTE GLOBULIN; HIGH-RISK; PROGNOSTIC-FACTORS; CHIMERISM; BLOOD; REGIMEN; PRETRANSPLANTATION; SCT; reduced-toxicity conditioning; fludarabine; treosulfan; multiple myeloma (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; IN-VITRO EXPANSION; EX-VIVO; TRANSCRIPTION FACTORS; FATE DETERMINATION; DNA METHYLATION; GENE-EXPRESSION; CUTTING EDGE; TH17 CELLS; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; IN-VITRO EXPANSION; FOXP3 EXPRESSION; SUPPRESSIVE FUNCTION; GENE-EXPRESSION; EX-VIVO; TRANSCRIPTION; RESPONSES; DIFFERENTIATION; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LIVER-DISEASE; ORGAN FAILURE; DEFIBROTIDE; GRAFT; COMPLICATIONS; MICROANGIOPATHY; DISPOSITION; ACTIVATION; hematopoietic stem cell transplantation; plasminogen activator inhibitor-1; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LUNG ALLOGRAFT-REJECTION; TOTAL-BODY IRRADIATION; SEVERE APLASTIC-ANEMIA; CHEMOKINE EXPRESSION; TNF-ALPHA; INTERSTITIAL PNEUMONITIS; EPITHELIAL-CELLS; IFN-GAMMA; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LUNG INJURY; CELL APOPTOSIS; IN-VIVO; MICE; EXPRESSION; MICROANGIOPATHY; KERATINOCYTES; LYMPHOCYTES; bone marrow transplantation; endothelium; lung; graft-versus-host disease; cytokines (1)
BONE-MARROW TRANSPLANTATION; VERSUS-HOST DISEASE; LYMPHOCYTE-T ADHESION; INTERLEUKIN-10 PROTECTS; BACTERIAL-ENDOTOXIN; IN-VITRO; INTERFERON; MECHANISMS; CYTOKINES; BINDING; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; NONINFECTIOUS PULMONARY COMPLICATIONS; INTESTINAL EPITHELIAL-CELLS; AIR-FLOW OBSTRUCTION; CROHNS-DISEASE; ANTIMICROBIAL PEPTIDES; LUNG TRANSPLANTATION; CARD15 MUTATIONS; AIRWAYS DISEASE; bronchiolitis obliterans; chronic GVHD; NOD2; stem cell transplantation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; TCR-ALPHA/BETA; CD19 DEPLETION; B-CELLS; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; EUROPEAN-SOCIETY; FREE SURVIVAL; acute leukaemia; paediatric [MeSH]; stem cell transplantation (HSCT); haploidentical allogeneic stem cell transplantation; T-cell depletion; post-transplant cyclophosphamide; Beijing (1)
BONE-MARROW TRANSPLANTATION; VERSUS-HOST DISEASE; RADIATION-INDUCED ACTIVATION; NECROSIS-FACTOR-ALPHA; BACTERIAL-ENDOTOXIN; IN-VITRO; VENOOCCLUSIVE DISEASE; T-LYMPHOCYTES; DEATH; VIVO; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; REGULATORY CELLS; CUTTING EDGE; SUPPRESSION; REJECTION; RESPONSES; IDENTIFICATION; ALLOGENICITY; ACTIVATION; cytotoxicity; endothelial cells; immune effector cells; transplantation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST DISEASE; REGULATORY T-CELLS (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; RISK-FACTORS; COMPETING RISKS; CHILDREN; LIVER; RECIPIENTS; DIAGNOSIS; COHORT; BLOOD; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; SERUM LEVELS; VENOOCCLUSIVE DISEASE; CYTOKINE LEVELS; MAJOR COMPLICATIONS; IL-6 LEVELS; CHILDREN; SEPSIS; GRAFT; hematopoietic stem cell transplantation; C-reactive protein; interleukin-6; procalcitonin (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; TNF-ALPHA; TRANSMEMBRANE FORM; CD40 LIGAND; COSTIMULATORY SIGNAL; BACTERIAL-ENDOTOXIN; CROHNS-DISEASE; CD30 LIGAND; FAS LIGAND; anti-endothelial response; mTNF; reverse signalling; T cells (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; VENOOCCLUSIVE DISEASE; GRAFT; LIVER; TRIAL; HEMORRHAGE; DIAGNOSIS; SURVIVAL; IMPACT; bleeding; bone marrow and stem cell transplantation; recombinant activated factor VII (1)
BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; BISPHOSPHONATE-RELATED OSTEONECROSIS; HEMATOPOIETIC-CELL TRANSPLANTATION; SURGEONS POSITION PAPER; TOPICAL TACROLIMUS; DEVELOPMENT PROJECT; MULTIPLE-MYELOMA; RISK-FACTORS; PILOCARPINE HYDROCHLORIDE; Oral cGVHD; Topical Treatment; Diagnosis (1)
BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; DEVELOPMENT PROJECT; CLINICAL-TRIALS; APOPTOSIS; BIOPSIES; KAPPA; Intestinal GvHD; Diagnosis; Histology; Consensus criteria (1)
BONE-MARROW; TUMOR-ANTIGEN; OVERLAPPING EPITOPES; COLORECTAL-CANCER; IMMUNE-RESPONSE; HLA-DP; RAS; VACCINES; LYMPHOCYTES; CD4(+); Long-peptide vaccination; tumor-specific mutated antigens; tumor mutation specific T cell responses; regulatory T cells; T-reg; common driver mutations; p53; Kras (1)
BONE METASTASES; ADHESION; ORGANIZATION; FIBRONECTIN; OSTEOBLASTS; PREVALENCE; ELASTICITY; INTEGRINS; RICKETS; DISEASE; (1)
BONE METASTASES; CARCINOMA; TL-201; TUMORS; SCANS; SPECT; CT; thyroid cancer; radionuclide bone scanning; whole-body I-131 scintigraphy; dual-isotope scintigraphy (1)
BONE-MINERAL DENSITY; ARTHROPLASTY; MUSCLE; GAIT; MULTIBODY; PATTERNS; HEIGHT; MODELS; MASS; THR; THA; hip; surgical approaches; conventional surgery; minimally invasive surgery; early recovery; force angles; biomechanics (1)
BONE-MINERAL DENSITY; CROHNS-DISEASE; I COLLAGEN; ULCERATIVE-COLITIS; CONTROLLED TRIAL; RESORPTION; FRACTURES; SUPPLEMENTATION; EXCRETION; bone mineral density; inflammatory bowel disease; osteoporosis; urinary N-telopeptides (1)
BONE-MINERAL DENSITY; D-RECEPTOR; 25-HYDROXYVITAMIN D; CALCIUM-ABSORPTION; FOK1 POLYMORPHISM; D METABOLISM; SUSCEPTIBILITY; EXPRESSION; INCISOR; BIOLOGY; 25-hydroxyvitamin D3 1-alpha-hydroxylase; receptors; calcitriol; polymorphism; single nucleotide; vitamin D3 24-hydroxylase; vitamin D-binding protein (1)
BONE-MINERAL DENSITY; GENE POLYMORPHISMS; PREMENOPAUSAL WOMEN; CALCIUM-ABSORPTION; ALLELIC VARIATION; OSTEOPOROSIS; SUSCEPTIBILITY; TURNOVER; DISEASE; LOCUS; vitamin D receptor; genotypes; bone mineral density; primary biliary cirrhosis; autoimmunity (1)
BONE-MINERAL DENSITY; HIP FRACTURE; OSTEOPOROTIC FRACTURES; FAILURE LOAD; WOMEN; RISK; STRENGTH; FALLS; FUTURE; COSTS; hip fracture; osteoporosis; cement; augmentation; femoroplasty (1)
BONE-MINERAL DENSITY; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; MULTIPLE-MYELOMA; NECROSIS-FACTOR; EXPRESSION; CELLS; RESORPTION; CYTOKINE; HORMONE; (1)
BONE-MINERAL DENSITY; LOWER-EXTREMITY FUNCTION; QUALITY-OF-LIFE; SARCOPENIC-OBESITY; WEIGHT-LOSS; PHYSICAL FUNCTION; ELDERLY-WOMEN; RISK-FACTORS; ADULTS; HEALTH; geriatric medicine; nutrition & dietetics; sports medicine (1)
BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; QUANTITATIVE COMPUTED-TOMOGRAPHY; GENOME-WIDE ASSOCIATION; DISEASE; ULTRASOUND; INSTRUMENTS; FRACTURE; RISK; MASS; Mendelian randomization; ankylosing spondylitis; osteoporosis; bone mineral density; single nucleotide polymorphisms; GWAS (1)
BONE MORPHOGENETIC PROTEIN-2; GENE-EXPRESSION; FLUID SHEAR; SIGNALING PATHWAYS; UP-REGULATION; CELLS; BETA; PHOSPHORYLATION; DIFFERENTIATION; OSTEOPROTEGERIN; Scaffold; mechanical signals; BMP; SMAD signaling; dorsomorphin (1)
BONE MORPHOGENETIC PROTEIN-2; HUMAN OSTEOGENIC PROTEIN-1; OSTEOCHONDRAL DEFECTS; ALIPHATIC POLYESTERS; SEGMENTAL DEFECTS; IN-VIVO; MODEL; REPAIR; DEGRADATION; FRACTURE; Polycaprolactone; BMP (bone morphogenetic protein); Ovine animal model; Bone tissue engineering (1)
BONE MORPHOGENETIC PROTEIN-2; KAPPA-B PATHWAY; CELLS IN-VITRO; LIGAMENT CELLS; GENE-EXPRESSION; GROWTH-FACTOR; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; CLINICAL-PARAMETERS; Biomechanics; dental occlusion; enamel matrix proteins; periodontal ligament (1)
BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; OLIGOMERIC MATRIX PROTEIN; IN-VITRO; PROGENITOR CELLS; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; CARTILAGE; INSULIN; (1)
BONE MORPHOGENETIC PROTEIN-2; VASCULOGENIC MIMICRY; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; GENE-THERAPY; ID PROTEINS; IN-VITRO; GROWTH; CANCER; malignant melanoma; endothelium; migration; invasion; angiogenesis (1)
BONE MORPHOGENETIC PROTEIN-4; CARBONIC-ANHYDRASE ACTIVITY; SURFACE HISTIDYL RESIDUES; HEMATOPOIETIC STEM-CELLS; NORMAL ADULT HEMOGLOBIN; YOLK-SAC; OXYGEN-TRANSPORT; CHICK-EMBRYO; BLOOD-ISLAND; PRIMITIVE ERYTHROPOIESIS; BMP; VEGF; GATA; erythropoietin; oxygen affinity (1)
BONE MORPHOGENETIC PROTEIN-9; TGF-BETA SUPERFAMILY; HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; SIGNALING PATHWAYS; PROLIFERATION; EXPRESSION; ANGIOGENESIS; FIBROGENESIS; (1)
bone morphogenetic protein (BMP) iron liver SMAD transcription factor transforming growth factor beta (TGF-β) ALK5 HJV hepcidin (1)
Bone Morphogenetic Proteins, BMP, microRNA, miRNA, miR-196a, bFGF, HOX-B7, Dido, Malignes Melanom, melanoma (1)
BONE MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; CYCLIC TENSILE STRAIN; HYDROSTATIC-PRESSURE; IN-VITRO; CHONDROCYTES; PROLIFERATION; OSTEOBLASTS; DIFFERENTIATION; FIBROCHONDROCYTES; Biomechanical loading; Fibrochondrocyte; Articular chondrocyte; Osteoblast; Gene expression (1)
BONE MORPHOGENETIC PROTEINS; FIBROBLAST-GROWTH-FACTOR; MESSENGER-RNA; TUMOR-GROWTH; IN-VITRO; PROMOTES PROGRESSION; CELL-PROLIFERATION; OVARIAN-CANCER; BREAST-CANCER; INVASION; Malignant melanoma; Bone morphogenetic proteins; MicroRNA; HOX genes; Fibroblast growth factor; Migration (1)
Bone Morphogenetic Proteins, Hypoxie, HIF-1alpha, Ets-1, Eisenstoffwechsel, Hämojuvelin, Hepcidin, hepatozelluläres Karzinom, hypoxia, iron metabolism, hepatocellular carcinoma (1)
BONE MORPHOGENETIC PROTEINS; MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; CELL INVASION; IN-VITRO; EXPRESSION; APOPTOSIS; INTEGRINS; MIGRATION; malignant melanoma; bone morphogenic protein; Dido1; integrin alpha V; migration; invasion (1)
BONE MORPHOGENETIC PROTEINS; NECROSIS-FACTOR-ALPHA; MAST-CELLS; MELANOMA-CELLS; METABOTROPIC GLUTAMATE-RECEPTOR-1; HEPCIDIN EXPRESSION; MALIGNANT-MELANOMA; BMP6; REGULATOR; HISTAMINE; (1)
BONE; OSTEOMYELITIS; Osteomyelitis; Debridement; Operative surgical procedures; Antibiotics; Biofilm (1)
BONE; PROPHYLAXIS; GENTAMICIN; FLUCLOXACILLIN; CEMENT; HIP; fracture-related infection; antimicrobial resistance; empiric antibiotic treatment (1)
Bone substitute material, Bortezomib, Multiple myeloma, Osteolytic bone lesions, Local treatment, Minimal residual disease (1)
BONY LANDMARKS; ARTHROPLASTY; RESTORATION; REPLACEMENT; NAVIGATION; ALIGNMENT; Joint line; Knee revision surgery; Contralateral knee; Fibular head (1)
book mol liq water (1)
book phys chem liq mol macromol biomol (1)
BOOK-TO-MARKET; CROSS-SECTIONAL RETURNS; STOCK RETURNS; INTERNATIONAL EVIDENCE; CONTRARIAN INVESTMENT; SHARE ISSUANCE; VALUE PREMIUM; RISK-FACTORS; SIZE; MOMENTUM; Value; Growth; Stock issues; Stock repurchases; International markets (1)
BOOLEAN-AND-N; BIMETALLIC REACTIVITY; CARBOXYLATE COORDINATION; LIGANDS; CHEMISTRY; SYSTEMS; DIOXYGEN; bridging ligands; N-functionalized cyclopentadienyl ligands; manganese; cobalt; bimetallic complexes (1)
BOOLEAN-AND-N; HETEROBIMETALLIC SYSTEMS; CARBOXYLATE COORDINATION; NICKEL(II) COMPLEXES; LIGANDS; CHEMISTRY; REACTIVITY; bridging ligands; cyclopentadienyl ligands; manganese; nickel; heterometallic complexes (1)
BOOMERANG DYSPLASIA; FILAMIN-A; MUTATIONS; FLNB; GENE; DISEASE; BINDING; DISLOCATIONS; ABNORMALITY; DEFICIENCY; Larsen syndrome; FLNB; Mutation; Gain-of-function; Autosomal-dominant; Pre-mRNA splicing (1)
Boost Effect, Nudge Effect, Browsing Privacy (1)
boosts, nudges, web browsing, human information behavior, privacy (1)
BORDERLINE PERSONALITY-DISORDER; MAJOR DEPRESSION; SELF-REPORT; CHILDHOOD TRAUMA; LIFE EVENTS; METAANALYSIS; SECURITY; STYLE; SENSITIVITY; INTERVIEWS; Adult attachment; Depression; Psychotherapy; Coherence; AAI; In-patients (1)
BORDERLINE PERSONALITY-DISORDER; MAJOR DEPRESSIVE DISORDER; SUICIDAL-BEHAVIOR; FUNCTIONAL CONNECTIVITY; STRUCTURAL-CHANGES; MORPHOMETRIC MRI; FEMALE-PATIENTS; YOUNG-ADULTS; AMYGDALA; BRAIN; Insula; Anterior cingulate cortex; Structural MRI; Grey matter volume (1)
BORDERLINE PERSONALITY-DISORDER; MODEL SELECTION; RISK-TAKING; DEPRESSION; HARM; INTERVENTION; RELIABILITY; PREVALENCE; BIOMARKERS; INTERVIEW; Non-suicidal self-injury; Psychological intervention; Therapy; Outcome; Resting-state connectivity; Adolescents (1)
BORDERLINE PERSONALITY-DISORDER; SUICIDAL-BEHAVIOR; HELP-SEEKING; ASSOCIATION; PREVALENCE; THOUGHTS; HARM; TRAJECTORIES; Nonsuicidal self-injury; Randomized controlled trial; Adolescents; Psychotherapy; Longitudinal outcome (1)
BORDERLINE PERSONALITY-DISORDER; SUICIDAL-BEHAVIOR; THOUGHTS; PREVALENCE; RISK; VALIDATION; INTERVIEW; HARM; MUTILATION; SCALE; emotional reactivity; suicidal behavior; self-injurious behavior; non-suicidal self-injury; emergency; adolescents; family related factors (1)
; borderline pulmonary hypertension; computed tomography; early diagnosis; pulmonary artery dilatation; screening (1)
BORDETELLA-PERTUSSIS; STRUCTURAL BASIS; PYRIMIDINE NUCLEOTIDES; CALMODULIN-BINDING; ORGANIC-MOLECULES; FORCE-FIELD; PROTEINS; PURINE; 5'-TRIPHOSPHATES; ANALOGS; Adenylyl cyclase; Bacillus anthracis; Edema factor; MANT nucleotide; Molecular modelling; Fluorescence spectroscopy (1)
bordism; characteristic numbers; defects in ordered media (1)
bordism, geometrizations, eta-invariant (1)
BORIC-ACID GLASS; XANTHENE DYES; DELAYED FLUORESCENCE; ORGANIC-MOLECULES; AQUEOUS-SOLUTION; QUANTUM YIELD; THIN-FILMS; PHOSPHORESCENCE; ABSORPTION; POLYMER; Fluorone dyes; Fluorescein; Dibromofluorescein; Eosin Y; Erythrosine B; Rose bengal; Biofilms; Gelatin; Starch; Chitosan; Absorption cross-sections; Luminescence quantum distributions; Fluorescence lifetimes; Phosphorescence (1)
BORING GIANT CLAM; WEST PACIFIC; POPULATION-STRUCTURE; GENETIC-STRUCTURE; GENUS OCYPODE; REEF FISHES; BRACHYURA; PHYLOGEOGRAPHY; HISTORY; GROWTH; Centre of Accumulation; Centre of Origin; Centre of Overlap; Coral Triangle; Decapoda; Indo-Pacific; phylogeography (1)
Borna disease virus 1 (BoDV-1) · Encephalitis · Zoonosis · ELISpot · Indirect immune fluorescence assay (iIFA) (1)
Borna disease virus 1 (BoDV-1), Epidemiology, Austria, RT-qPCR, Serology (1)
Borna disease virus (BoDV-1) · Encephalitis · Multiple sclerosis (MS) · ELISA · iIFA · Serology (1)
boron, cations, carbenes, germanium, hydrides, main group elements, phosphorus (1)
BORON-DIPYRROMETHENE DYES; PHOTONIC LOGIC GATES; X-RAY-STRUCTURE; CATION COMPLEXATION; CHARGE-TRANSFER; SPECTROSCOPIC PROPERTIES; PHOTOPHYSICAL PROPERTIES; METAL-ION; INHIBIT; FLUOROIONOPHORES; charge transfer; dyes/pigments; fluorescence; logic gates; molecular devices (1)
boron doped p-Ge - shallow acceptors - Zeeman-splitting (1)
BORON-TRIFLUORIDE; SYSTEMS; WATER; borosulfates; Brø nsted acid; Lewis acid; Lewis acid base adduct; silicate analogue (1)
Bor , Phosphor , Chalkogene , Aluminium , Lewis-Base , Lewis-Säure , Halogenierung , Oxidation , Pyrolyse , Phosphanylborane , Reaktivität , Phosphanylborane , Wolframpentacarbonyl , phosphanylborane , tungstenpentacarbonyl (1)
Bor-Phosphor-Verbindungen , Phosphor , Arsen , Lewis-Säure , Lewis-Base , Monomere , Stickstoffgruppe , Borgruppe , 13/15-Verbindungen , Bor-Arsen-Verbindungen , 13/15-compounds , Boron-Arsenic-Compounds (1)
; Borrelia burgdorferi; CSF cytology; lymphoid cells; non-Hodgkin lymphoma (1)
BORRELIA-BURGDORFERI; PERIPLASMIC FLAGELLA; TREPONEMA-DENTICOLA; ELECTRON-MICROSCOPY; TEMPERATURE; CHEMOTAXIS; MORPHOLOGY; ARCHAEA; BIOLOGY; PHYLUM; Spirochaeta thermophila; cell body plan; changing cell morphology; motility; high temperature light microscopy; electron microscopy (1)
Borylation; Photochemistry; Inert carbon−heteroatom bonds; DMSO anion; Transition-metal-free (1)
BOSE-EINSTEIN CONDENSATE; ALIGNING MOLECULES; DISSIPATIVE DYNAMICS; PULSES; SPECTROSCOPY; SUPERFLUID; FIELD; (1)
Bose-Einstein condensates, Bose-Einstein Kondensate, matter waves, Materiewellen, weak localization, schwache Lokalisierung, Gross-Pitaevskii equation, Gross-Pitaevskii Gleichung, quantum billiard, Quantenbilliard, quantum transport, Quantentransport (1)
BOSE-EINSTEIN CONDENSATE; WAVE-FRONT DISLOCATIONS; OPTICAL VORTEX SOLITONS; VORTICES; SINGULARITIES; MOTION; (1)
BOSE-EINSTEIN CONDENSATION; COUPLED QUANTUM-WELLS; DYNAMICS; STORAGE; TRAPS; Dipolar exciton; exciton trap; exciton antitrap; electro-optical modulator (1)
BOSE-EINSTEIN CONDENSATION; DIMENSIONAL ELECTRON-GAS; SPIN POLARIZATION; CONDUCTANCE; (1)
BOSE-EINSTEIN CONDENSATION; FERROMAGNETISM; DYNAMICS; STATES; exciton; skyrmion; magnetic monolayer; CrI3 monolayer; asymmetric scattering; exciton localization; topological defect (1)
BOSE-EINSTEIN CONDENSATION; MATTER; LIGHT (1)
BOSE-EINSTEIN CONDENSATION; MULTIPLE-QUANTUM-WELLS; PHOTOCURRENT SPECTROSCOPY; COULOMB DRAG; GAS; GAAS; HETEROSTRUCTURES; SYSTEMS; LIQUID; SUPERFLUIDITY; (1)
BOSE-EINSTEIN CONDENSATION; QUANTUM; POLARITONS; BAND; strong light-matter coupling; dynamic Stark effect; exciton-polaritons; ultrafast control (1)
BOSE-EINSTEIN CONDENSATION; TERAHERTZ; (1)
BOSE-EINSTEIN CONDENSATION; TRAPS; CONFINEMENT; TRANSISTOR; RELAXATION; POLARITONS; (1)
Bose-Einstein-Kondensation , Schwache Lokalisation , Transportprozess , Nichtlineares Phänomen , Unordnung , Mesoskopisches System , Quantentransport , kohärente Rückstreuung , quantum transport , coherent backscattering (1)
Bose-Einstein-Kondensation , Transportprozess , Mesoskopisches System , Nichtlineares Phänomen , Unordnung , Resonanter Transport , Bose-Einstein condensation , transport , mesoscopic systems , nonlinear phenomena , disorder (1)
BOSE-GAS; ULTRACOLD GASES; WAVE-EQUATION; FINITE DOMAIN; EIGENFREQUENCIES; PARTICLE; ATOMS; BOX; (1)
Bosentan, Bleomycin, Endothelin, Pulmonale Hypertonie, Lungenfibrose, Leistungsfähigkeit (1)
Bosentan, Endothelin, Endothelin-1, Endothelinrezeptorantagonist, pulmonale Fibrose, pulmonale Hypertonie, Bleomycin, Ratte, ANP, BNP, ET, ETA, ETB, Rezeptorgenexpression, Genexpression, Natriuretische Peptide, endothelins, endothelin receptor antagonist, pulmonary fibrosis, pulmonary hypertension, rat, receptor gene expression, gene expression, natriuretic peptides (1)
BOSENTAN; SILDENAFIL; AMBRISENTAN; TADALAFIL; Pulmonary arterial hypertension; Macitentan; Vardenafil; Combination therapy; Endothelin receptor antagonist; Phosphodiesterase-5 inhibitor (1)
BOSNIAK CLASSIFICATION; COMPUTED-TOMOGRAPHY; MASSES; PREVALENCE; UPDATE; SYSTEM; US; Contrast-enhanced ultrasound; CEUS; Bosniak; renal cyst (1)
BOSONIZATION; (1)
BOSON PRODUCTION; QUARK; ANNIHILATION; NLO Computations; QCD Phenomenology (1)
botanical society, field maple, "Gart der Gesundheit", herbals, Hieronymus Bock, historical books, horse chestnut tree, "Kreutterbuch", Leonhart Fuchs, l’Obel, maize, Mattioli, Otto Kandler, plant history, tobacco, Wonnecke von Kaub, woodcut (1)
BOTULINUM-TOXIN-A; CERVICOGENIC HEADACHE; MIGRAINE PATIENTS; DURA-MATER; STIMULATION; NEURONS; INPUT; MECHANISMS; RESPONSES; RAT; chronic tension type headache; greater occipital nerve; nerve block; trigeminal nerve; pathophysiology (1)
botulinum toxin; headache; migraine; tensiontype headache; therapy (1)
BOTULINUM TOXIN; MASSETER; (1)
BOUNDARY-CONDITIONS; MOTION; EVOLUTION; STABILITY; SURFACES; EQUATION; GRAPHS; (1)
BOUNDARY CROSSING PROBABILITIES; BROWNIAN-MOTION; CAPITAL STRUCTURE; RATE DEBT; APPROXIMATIONS; OPTIONS; RATES; TIME; RISK; Credit default swap; Structural model; Default boundary; Green's function; Calibration (1)
boundary eigenvalue problems; lambda-dependent boundary conditions; completeness; minimality; Fourier series expansions; Riesz basis (1)
boundary problem, surface tension, anisotropy, kinetic undercooling, Gibbs–Thomson law, dendritic growth, snow crystal growth, facet breaking. (1)
BOUNDARY-VALUE-PROBLEMS; PSEUDODIFFERENTIAL-OPERATORS; DIRICHLET PROBLEM; MU-TRANSMISSION; REGULARITY; EQUATIONS; HEAT (1)
BOUNDARY-VALUE-PROBLEMS; WAVE-EQUATION; SCHWARZSCHILD GEOMETRY; DECAY; (1)
bounded cohomology, amenable groups, groupoids, mapping theorem, uniformly finite homology (1)
bounded cohomology, boundedly acyclic groups, binate groups, pseudo-mitotic groups, Thompson groups (1)
bounded cohomology, cup product, quasimorphisms, median graphs (1)
; Bounded cohomology; homotopy fibers; acyclic modules; amenable groups; boundedly acyclic groups (1)
BOUNDED COHOMOLOGY; MINIMAL ENTROPY; Simplicial volume; Bounded cohomology; Rationality in (co)homology (1)
BOUNDED COHOMOLOGY; NOVIKOV-CONJECTURE; Group homology; Novikov conjecture (1)
BOUND INHIBITOR BAMBI; TGF-BETA; INSULIN-RESISTANCE; LEPTIN; CELLS; WHITE; LIPOPOLYSACCHARIDE; ADIPOGENESIS; INFLAMMATION; ACTIVATION; Bambi; Actin alpha 2 smooth muscle; Collagen; White fat; Brown fat; Lipopolysaccharide (1)
BOUNDS; Dirac operator; eigenvalue estimates (1)
BOUND-STATES; SPIN; (1)
BOUND-STATES; SUPERCURRENT; IMPURITIES; TRANSPORT; DEVICES; (1)
BOVINE ALPHA-CRYSTALLIN; H-1-NMR SPECTROSCOPY; DISULFIDE BOND; AMINO-ACIDS; DOMAIN; LACTALBUMIN; BINDING; SURFACE; flexibility; Hsp25; molecular chaperone; small heat shock protein; spectroscopy (1)
BOVINE ARTICULAR CHONDROCYTES; MESENCHYMAL PROGENITOR CELLS; POLYMERASE CHAIN-REACTION; TGF-BETA; DIFFERENTIATION; CARTILAGE; GENES; OSTEOARTHRITIS; COMBINATION; DISPLAY; RNA arbitrarily primed PCR; TGF beta 1; bone marrow-derived stem cells; chondrocytes (1)
BOVINE COLLAGEN MATRIX; MYCOPHENOLATE-MOFETIL; CROHN-DISEASE; TOPICAL TREATMENT; CYCLOSPORINE-A; CLOFAZIMINE; THALIDOMIDE; TACROLIMUS; SKIN; COMBINATION; (1)
BOVINE DENTIN; RESTORATIVE MATERIALS; ETCHING PRIMERS; AGENTS; POLYMERIZATION; COMPOSITE; RelyX Unicem; shear bond strength; enamel; dentin; thermocycling (1)
BOVINE ENAMEL; FLUORIDE; CARIES; DECLINE; GELS; Cerium chloride; Enamel; Fluoride (1)
BOVINE; gonadogenesis; nephrostome; mesonephros; opisthonephros; Acipenser ruthenus (1)
BOVINE SERUM-ALBUMIN; IN-VIVO DEPLETION; DENDRITIC CELLS; MOUSE MODEL; MEMBRANOUS NEPHROPATHY; NEPHROTIC-SYNDROME; TRANSGENIC MOUSE; T-CELLS; RECEPTOR; KIDNEY; diphtheria toxin; mouse model; podocytes; proteinuria; slit membrane (1)
BOVINE SERUM-ALBUMIN; IONIC-STRENGTH; SEDIMENTATION; PROTEINS; polyion diffusion coefficient; concentration dependence of the diffusion coefficient; BSA; effective net charge; fluorescence label; Boltzmann gradient method; diffusion cell (1)
BOVINE SERUM-ALBUMIN; METHYLMALONIC ACID; INTRINSIC-FACTOR; HYPERVITAMINEMIA B12; LIPID-METABOLISM; COBALAMIN; DEFICIENCY; FOLATE; AGE; HOMOCYSTEINE; glycogen storage disease; glycogen; vitamin B-12; cobalamin; liver transaminases; vitamin B(12)intake (1)
BOVINE TESTICULAR HYALURONIDASE; CAPILLARY-ELECTROPHORESIS; SERUM HYALURONIDASE; COLORIMETRIC METHOD; PURIFICATION; EXPRESSION; ENZYME; TRANSGLYCOSYLATION; INHIBITORS; PLASMA; bovine testicular hyaluronidase; human Hyal-1; human PH-20; bee venom hyaluronidase; capillary zone electrophoresis (1)
BOVINE TESTICULAR HYALURONIDASE; POLYACRYLAMIDE-GEL ELECTROPHORESIS; IONIZATION MASS-SPECTROMETRY; BETA-GALACTOSIDASE; CANCER BIOLOGY; ACID; MECHANISM; PRODUCTS; GLYCOSAMINOGLYCANS; QUANTITATION; Bovine testicular hyaluronidase; Capillary electrophoresis; High performance anion exchange chromatography; Hyaluronan oligosaccharides; Pulsed amperometric detection; Turbidimetric hyaluronidase assay (1)
BOVINE THROMBIN; FIBRIN-GLUE; FACTOR-V; IMMUNIZATION; fibrin glue; thrombocytes; wound healing; matrix; growth factors (1)
BOWEL-DISEASE; CHRONIC ENTEROCOLITIS; ADAM17 DELETION; COLITIS; IDENTIFICATION; MOUSE; CELLS; STAT3; LINKS; ER; (1)
BOWEL-DISEASE; MICRORNA EXPRESSION; ULCERATIVE-COLITIS; IN-VIVO; MICE; IL-1-BETA; CELLS; ACTIVATION; COLON; IL-1; (1)
BOWEL-DISEASE; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; ULCERATIVE-COLITIS; ADHESION MOLECULES; CROHNS-DISEASE; EXPRESSION; METABOLITE; MUCOSA; EPIPOLYTHIODIOXOPIPERAZINES; DSS-colitis; NF-kappa B; gliotoxin (1)
BOWEL-DISEASE; ULCERATIVE-COLITIS; T-CELLS; IN-VIVO; INDUCED ARTHRITIS; ST2 RECEPTOR; MAST-CELLS; CYTOKINE; MICE; PATHOGENESIS; IL-33; intestinal immune system; chronic DSS-colitis; chronic experimental colitis (1)
BOWEL ISCHEMIA; MANAGEMENT; DISORDERS; DIAGNOSIS; mesenteric ischemia; intestinal resection; vascular surgery; myocardial insufficiency; acetylsalicylic acid (1)
Bowel movement; Defecation; Constipation; Intracranial pressure; Neurosurgical intensive care (1)
BOWEL PREPARATION; COMPLETION RATES; IMPACT; PERFORMANCE; DIFFICULTY; PAIN; colonoscopy; insertion time; withdrawal time (1)
BOX-BINDING PROTEIN-1; BREAST-CANCER CELLS; NUCLEAR-LOCALIZATION; MESSENGER-RNA; SIGNALING PATHWAYS; DRUG-RESISTANCE; TRANSLATION; INHIBITION; EXPRESSION; GROWTH; MAPK signalling; melanoma; NF?B signalling; PI3K signalling; YB-1 (1)
BOX-BINDING PROTEIN-1; P53 TUMOR-SUPPRESSOR; LATE GENE-EXPRESSION; EARLY REGION 4; TRANSCRIPTION FACTOR; NUCLEAR EXPRESSION; DNA-REPLICATION; P53-INDEPENDENT APOPTOSIS; P-GLYCOPROTEIN; INFECTED-CELLS; (1)
BOYDII SPECIES COMPLEX; PSEUDALLESCHERIA-BOYDII; INFECTION; TRANSPLANTATION; EPIDEMIOLOGY; COMBINATIONS; PROLIFICANS; THERAPY; CANCER; Pseudallescheria boydii; Scedosporium apiospermum; soft tissue abscess; voriconazole; caspofungin; allogeneic stem cell transplantation; combination therapy (1)
BPI, Business Process Improvement, knowledge elicitation, Business Process Improvement, Meta Modeling, Formalization (1)
BPI, infection, inflammation, pneumonia, colitis, mouse genetic background (1)
BPM, Ethical Values, Sociotechnical System, Benevolent BPM, Ethics-aware BPM (1)
BPM, Ethics, Moral, Socio-technical systems, Ethical value, Literature review (1)
BPML, BPMN, information losses (1)
BPS MONOPOLES; INSTANTONS; CONFINEMENT; TOPOLOGY; (1)
; Braces; Hip; Sitting; Spine; Thorax (1)
BRACHIAL-PLEXUS BLOCK; POSTOPERATIVE PAIN; AMBULATORY ANESTHESIA; REGIONAL ANESTHESIA; SURGERY; ANALGESIA; PROPOFOL; Peripheral nerve block; Outpatient; Day surgery; Regional anesthesia; Femoral and sciatic nerve block; ASA III (1)
Brachytherapie, Ru 106, Augenapplikatoren, Qualitätssicherung (1)
BRACHYTHERAPY (2)
BRACHYTHERAPY; brachytherapy; electromagnetic tracking; multi-dimensional scaling; point set registration (1)
BRACHYURA PORTUNIDAE; CRYPTIC INVASIONS; 1896 EXPANDS; RATHBUN; RECORDS; COAST; DECAPODA; DNA; Atlantic blue crab; invasive species; founder effect; gene flow; COI; haplotype (1)
BRAF MUTATION; INSTABILITY; CIMP; colorectal cancer; DNA methylation; epigenetics; gene regulation; neoplasia (1)
BRAIN-ABSCESS; animal provoked injury; C. perfringens; encephalitis; therapy scheme (1)
BRAIN; ACCUMULATION; DISABILITY; DIAGNOSIS; sodium; multiple sclerosis; therapy; MRI; white matter; inversion recovery (1)
BRAIN ACTIVATION; TASK; NIRS; MECHANISMS; EXPRESSION; ATTENTION; VERSION; SYSTEM; AUTISM; CORTEX; NIRS; joint-action; 5-HTTLPR (1)
BRAIN; APPEARANCE; VARIANTS; LESION; CCM; susceptibility-weighted imaging; SWI; high-field MRI; magnetic resonance imaging; cerebral cavernous malformations; familial disease; familial cavernomatosis; CCM1-3; vascular disorders (1)
Brain atrophy; cerebral atrophy; acute ischemic stroke; cerebrovascular disease; reperfusion (1)
brain cancer, glioblastoma, temozolomide, HDAC inhibitors, SLC transporters (1)
BRAIN CANCER-PATIENTS; MINI-MENTAL-STATE; TERM-FOLLOW-UP; EUROPEAN-ORGANIZATION; RADIATION-THERAPY; ANAPLASTIC OLIGODENDROGLIOMA; TEMOZOLOMIDE CHEMOTHERAPY; CLINICAL-TRIALS; ADULT PATIENTS; DOSE-RESPONSE; (1)
BRAIN; CRITICALITY; SCALE; EEG; sensory-processing sensitivity; EEG; self-organized criticality; nonlinear dynamics; entropy (1)
BRAIN-DEATH; TRANSPLANTATION; REJECTION; PRESERVATION; DYSFUNCTION; TRIAL; IL-6; heart transplantation; hypothermic machine perfusion; organ preservation; static cold storage (1)
Brain fog · Chronic fatigue syndrome · COVID-19 · SARS-CoV-2 · Hypoxia-inducible-factor-1 · Hyperbaric oxygen therapy (HBOT) · Long COVID · Post COVID condition (1)
BRAIN GENE-EXPRESSION; INSECT FAT-BODY; SOCIAL-DOMINANCE; PONERINE ANT; LIFE-SPAN; TASK-PERFORMANCE; PHARAOHS ANT; NUTRITION; WORKERS; REPRODUCTION; Eusociality; Reproduction; Nutrition; Fat content; Clonality; Formicidae (1)
; brain imaging; contrast imaging; transcranial ultrasound (1)
BRAIN-INJURY; BIOMARKERS; PROTEIN; SEIZURES; MARKERS; Neurofilament; NfL; Febrile seizures; Epilepsy; Tumor; Children (1)
BRAIN-INJURY; POLYMORPHONUCLEAR LEUKOCYTES; RELEASE; PLASMA; polymorphonuclear neutrophil; subarachnoidal hemorrhage; cerebrospinal fluid; respiratory burst; N-formyl-l-methionyl-l-leucyl-l-phenylalanine; phorbol 12-myristate 13-acetate (1)
BRAIN-INJURY; RISK-FACTORS; EXCISION; ARTHROPLASTY; Heterotopic ossification; Trauma; Therapy; Fracture; Prophylaxis (1)
BRAIN LATERALIZATION; MOTOR LATERALITY; TELEOST FISH; DISADVANTAGES; PREFERENCES; ADVANTAGES; ASYMMETRY; EVOLUTION; RESPONSES; OBJECTS; Horse; Laterality; Eye preference; Emotion; Vision (1)
BRAIN METASTASES; BRANCHED EVOLUTION; COLORECTAL-CANCER; PRIMARY TUMORS; CELL-LINES; COLONIZATION; PROGRESSION; GROWTH; HETEROGENEITY; DISSEMINATION; Breast cancer; Metastasis; WNT signaling; Prognostic score (1)
brain metastases | competing risks | cumulative incidence function | fractionated stereotactic radiotherapy | Kaplan‐Meier | local failure | premature deaths (1)
; Brain metastases; elderly patients; targeted therapy; survival (1)
brain metastases | neurological symptoms | patient selection | whole-brain radiotherapy (1)
BRAIN METASTASIS; BREAST-CANCER; BETA-CATENIN; CELLS; MELANOMA; CHEMOTHERAPY; INVASION; TISSUE; astrocytes; brain metastasis; glial-pseudo capsule; metastatic infiltration; organ-specific defense (1)
Brain metastasis, Cause of death, Histological growth pattern, Infiltration, Local metastatic expansion, Meningeal metastasis, MMPI, Neurological decline, Recolonization, Secondary dissemination (1)
Brain metastasis, CONVIVO, HGP, meningeal metastasis, MetInfilt, MMPI, MRI (1)
; brain metastasis; extent of resection; comprehensive oncological treatment; systemic treatment (1)
brainmetastasis; functionalmagnetic resonance imaging; blood oxygenation level-dependent imaging; functional connectivity; percent signal change (1)
Brain metastasis / glutathione / LEF1 / metastatic colonization / ROS (1)
Brain metastasis, macrophages, microglia, interleukin-4 (IL-4) (1)
BRAIN; MRI; HEMATOMAS; SIGNAL; IMAGES; brain; intracranial hemorrhage; magnetic resonance imaging (MRI); diffision-weighted imaging (DWI); apparent diffusion coefficient (ADC) (1)
BRAIN NATRIURETIC PEPTIDE; AMINO-TERMINAL PROBNP; HEART-FAILURE; DIAGNOSTIC-ACCURACY; GENOTYPE-IMPUTATION; CARDIAC DEVELOPMENT; CHLORIDE CHANNELS; BLOOD-PRESSURE; BNP; DISEASE; (1)
BRAIN NATRIURETIC PEPTIDE; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; FULLY-AUTOMATED IMMUNOASSAY; EMERGENCY DIAGNOSIS; MYOCARDIAL-INFARCTION; ACUTE DYSPNEA; MARKERS; ASSAY; BIOCHEMISTRY; BNP; heart failure; natriuretic peptides; NT-proBNP; POCT (1)
BRAIN NATRIURETIC PEPTIDE; CONVERTING ENZYME-INHIBITOR; HEART-FAILURE; SYSTOLIC DYSFUNCTION; PLASMA BRAIN; ESSENTIAL-HYPERTENSION; EMERGENCY DIAGNOSIS; BODY-COMPOSITION; COMMUNITY; PREVALENCE; heart failure; diastolic dysfunction; BNP; LV hypertrophy; echocardiography (1)
BRAIN NATRIURETIC PEPTIDE; CORONARY-ARTERY-DISEASE; VASCULAR-SURGERY; MYOCARDIAL-INFARCTION; MORTALITY; HEART; VALIDATION; GUIDELINES; ASSAY; CARE; High-sensitive Troponin T; Cardiac risk; Non-cardiac surgery; NT-proBNP (1)
BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; SENSITIVE TROPONIN-T; DIFFERENTIATION FACTOR-15; GALECTIN-3; MARKER; HYPERTROPHY; ASSOCIATION; chronic heart failure; emerging biomarkers; GDF-15; highly sensitive troponin; natriuretic peptides (1)
BRAIN NATRIURETIC PEPTIDE; INDUCED HEART-FAILURE; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; CHAMBER QUANTIFICATION; OLDER-ADULTS; DYSFUNCTION; MORTALITY; EVENTS; RISK; (1)
BRAIN NATRIURETIC PEPTIDE; NEUROENDOCRINE DYSFUNCTION; STIMULATION TEST; SEPTIC SHOCK; HYPONATREMIA; INJURY; HYPOPITUITARISM; CORTICOTROPIN; PREVALENCE; DEFICIENCY; aneurysmal SAH; pituitary dysfunction; hypopituitarism; hyponatremia (1)
BRAIN NATRIURETIC PEPTIDE; NONINVASIVE MECHANICAL VENTILATION; PULMONARY ARTERIAL-HYPERTENSION; HEART-FAILURE; LUNG-DISEASE; SYSTEMIC-SCLEROSIS; COR-PULMONALE; DYSPNEA; BNP; DYSFUNCTION; brain natriuretic peptide; chronic respiratory failure; congestive heart failure; non-invasive ventilation; right ventricular overload; survival (1)
BRAIN OSCILLATIONS; SUBSEQUENT MEMORY; IN-VITRO; GAMMA OSCILLATIONS; NEURAL ACTIVITY; WORKING-MEMORY; EEG; THETA; FMRI; SYNCHRONIZATION; (1)
BRAIN OXYTOCIN; NEURONAL-ACTIVITY; PLASMA OXYTOCIN; TRPC6 CHANNELS; AUTISM; RECEPTOR; ANXIETY; RELEASE; VASOPRESSIN; PLASTICITY; oxytocin; salience; MEF2; anxiety; stress; cellular morphology (1)
BRAIN; PATHOPHYSIOLOGY; MIGRAINE; (1)
BRAIN PATHWAY DIFFERENCES; SCREENING QUESTIONNAIRE; PROGRESSION; MARKER; Parkinson's disease; REM sleep behavior disorder; Depression; Connectometry; Diffusion MRI (1)
BRAIN PERFUSION; IMAGING MODES; COLOR DOPPLER; TUMOR PERFUSION; GROWTH-FACTOR; ANGIOGENESIS; RADIATION; TISSUE; QUANTIFICATION; PERMEABILITY; neurosonology ultrasound contrast agent; neurooncology; Transcranial perfusion sonography (1)
BRAIN POTENTIALS; RELATIVE CLAUSES; LANGUAGE; COMPREHENSION; DYNAMICS; MERGE; CATEGORIZATION; CONSTRAINTS; INTEGRATION; COMPONENT; Chinese complex sentence; syntactic information; semantic information; ELAN; block effect; ERP (1)
BRAIN POTENTIALS; SEX-DIFFERENCES; TRANSFORMATION; COMPLEXITY; ASYMMETRY; LATENCY; OBJECTS; GENDER; SPEED; cognition; event-related potentials; lateralization; mental rotation (1)
BRAIN RENIN-ANGIOTENSIN; INSERTION/DELETION POLYMORPHISM; PSYCHIATRIC-DISORDERS; EPIGENETIC REGULATION; MATERNAL-CARE; COMT PROMOTER; SYSTEM; EXPRESSION; RECEPTOR; DISEASE; (1)
brain slices; glycine receptors; hypoglossal motoneurons; molecular modelling; patch-clamp; photopharmacology (1)
BRAIN-STEM; ADULT; MIGLUSTAT; CHILDREN; SCALE; GENE; Niemann-Pick disease, type C; Lysosomal storage diseases; Substrate reduction therapy; Miglustat; Glycosphingolipids (1)
BRAIN-STEM GLIOMAS; CHILDRENS-CANCER-GROUP; HYPERFRACTIONATED RADIATION-THERAPY; SIMULTANEOUS RADIOCHEMOTHERAPY; PEDIATRIC-PATIENTS; MIDBRAIN TUMORS; TECTAL TUMORS; PHASE-I/II; RADIOTHERAPY; ETOPOSIDE; chemotherapy; children; irradiation; pontine glioma; survival (1)
BRAIN-STEM GLIOMAS; LEPTOMENINGEAL DISSEMINATION; PEDIATRIC-PATIENTS; PHASE I/II; HYPERFRACTIONATED RADIOTHERAPY; SIMULTANEOUS RADIOCHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; CHILDHOOD; HEMATOLOGY; ETOPOSIDE; secondary dissemination; leptomeningeal dissemination; high-grade gliomas; children (1)
BRAIN-STEM RESPONSE; OLDER-ADULTS; PRIMARY-CARE; HEARING-LOSS; SOUND; HYPERSENSITIVITY; QUESTIONNAIRE; SYMPTOMS; OUTCOMES; PHQ-9; tinnitus; auditory evoked potential; auditory brainstem response; auditory middle latency response; tinnitus-related distress; tinnitus handicap inventory; machine learning; classification modelling; wavelet scattering transform (1)
BRAIN-STEM-RESPONSES; AUDITORY-NERVE; INNER-EAR; TYTO-ALBA; NUCLEUS MAGNOCELLULARIS; KANAMYCIN OTOTOXICITY; DISCHARGE PATTERNS; BASILAR PAPILLA; PHASE-LOCKING; ROUND WINDOW; hearing; auditory; bird; avian; basilar papilla (1)
BRAIN-STEM; VASCULAR MALFORMATIONS; Neuroradiology; MRI; Head; Vascular malformation (1)
BRAIN-STIMULATION; DESIRE INVENTORY; NEURAL BASIS; DISORDER; DEPRESSION; PREFERENCE; DIAGNOSIS; BEHAVIOR; Dorsolateral Prefrontal Cortex; Hypersexual; Neuromodulation; Sexual Arousal; Repetitive Transcranial Magnetic Stimulation (1)
BRAIN-STIMULATION; QUESTIONNAIRE; POWER; CONNECTIVITY; NETWORK; TRAUMA; SCALE; (1)
BRAIN; STIMULATION; RATS; acute ischemic stroke; C-reactive protein levels; immunoregulatory response; stroke laterality; white blood cell count (1)
BRAIN STRUCTURES; DYSFUNCTION; DISABILITY; IMPACT; autonomic dysfunction; central bladder control; neuroimaging; neuroinflammatory disease (1)
BRAIN-TISSUE OXYGEN; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; OPTICAL SENSORS; TENSION; PH; MICROCIRCULATION; PRESSURE; DELIVERY; PO(2); Oxygen gradients; Cortex; PO(2) maps; Visualisation of radial oxygen gradients; Rat cortices (1)
brain tumor, emergency, glioblastoma, psycho-oncology, spatial distance (1)
Brain tumor, Glioblastoma, Palliative care, Primary palliative care, Specialized palliative care, Neuropalliative, care, Overall survival (1)
BRAIN-TUMOR GROUP; LOW-GRADE GLIOMA; EUROPEAN ORGANIZATION; OLIGODENDROGLIAL TUMORS; IDH2 MUTATIONS; III TRIAL; PROCARBAZINE; VINCRISTINE; GLIOBLASTOMA; CHEMOTHERAPY; (1)
Brain tumor, Patient, Family caregiver, Psychooncologic need, Need for referral to psychooncology care, Information need, Depression (1)
BRAIN-TUMORS; CANCER STATISTICS; GROWTH-FACTORS; INSULIN; COHORT; ADULTS; VALIDITY; WEIGHT; SYSTEM; HEALTH; (1)
BRAIN-TUMORS; FMRI ACTIVATION; MOTOR CORTEX; CONNECTIVITY; MRI; GRADE; PROGRESSION; PROGNOSIS; ADJACENT; SURVIVAL; glioblastoma; heterogeneity; brain tumor; functional magnetic resonance imaging; blood oxygenation level dependent imaging; task-based functional connectivity; preoperative mapping; preoperative noninvasive imaging (1)
BRAIN-TUMORS; IDENTIFICATION; (2)
BRAIN-TUMORS; POSTOPERATIVE SEIZURES; ANTICONVULSANT PROPHYLAXIS; CLINICAL ARTICLE; LEVETIRACETAM; PHENYTOIN; EPILEPSY; METAANALYSIS; PREVENTION; SURGERY; Anticonvulsants; Phenytoin; Craniotomy; Hypotension; Perioperative care (1)
BRAIN WHITE-MATTER; POSTERIOR CINGULATE CORTEX; MACULAR DEGENERATION; COGNITIVE IMPAIRMENT; VISUAL-CORTEX; RELAXATION RATES; WATER DIFFUSION; CEREBRAL-CORTEX; ESTIMATED IRON; 3.0 T; Aging; Cortical surface; DTI; Macular degeneration; Neurodegeneration; Superficial white matter (1)
BRANCHED STENT-GRAFTS; MODERN SURGICAL ERA; REPAIR; DISSECTION; EXPERIENCE; MORTALITY; Fenestrated; Branched; Aortic dissection; Type B; Post-dissection aneurysm (1)
BRANCHIAL CLEFT ANOMALIES; Branchiogenic cyst; Lateral neck cyst; Lymphoepithelial cyst; Tonsillectomy (1)
BRANCHING FRACTION; HEAVY QUARKONIA; CROSS-SECTIONS; OZI RULE; TRANSITIONS; (1)
branching, single-slip, plasticity (1)
Brand choice - duration analysis - hazard models - purchase incidence - stochastic models of buyer behavior (1)
BRAND CHOICE; FEEDFORWARD NETWORKS; SALES PROMOTIONS; PROBIT MODEL; PRICE; HETEROGENEITY; IMPACT; BEHAVIOR; PRODUCTS; choice model; multilayer perceptron; marketing; neural networks; brand choice (1)
Brand Choice; Latent Class Models; Nonlinear Effects. (1)
Brand Choice Model; Generalized Additive Model; Multinomial Logit (1)
BRAND CHOICE MODELS; GENERALIZED-METHOD; MOMENTS; INSTRUMENTS; VARIABLES; (D) Marketing; Direct marketing; Endogeneity; Hierarchical Bayesian modeling (1)
Brandwunden, Elektrochirurgie, Wundheilung / burns, electrosurgery, wound healing (1)
Brasilicardin A; Natural products; Immunosuppressant; Molecular sieves; Carbohydrates; Deacetylation (1)
BRASSINOSTEROID SIGNAL-TRANSDUCTION; MOLECULAR INTERACTION DATABASE; LATERAL ROOT DEVELOPMENT; WATER-LIMITED CONDITIONS; LENGTH CDNA MICROARRAY; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; GENE-EXPRESSION; BRASSICA-NAPUS; IMPROVES DROUGHT; (1)
BRAZILIAN ATLANTIC FOREST; SPECIES GEOGRAPHIC DISTRIBUTIONS; GENETIC-STRUCTURE; PHYLOGENETIC ANALYSIS; DNA POLYMORPHISM; LATE QUATERNARY; RAIN-FOREST; DIVERSITY; EVOLUTION; PATTERNS; (1)
BRAZILIAN BUTT LIFT; CLASSIFICATION-SYSTEM; RECOMMENDATIONS; SURGERY; SAFETY; ASERF; Gluteal augmentation; Brazilian butt lifting; Autologous fat grafting; Artificial intelligence (1)
BRCA1-ASSOCIATED PROTEIN-1; UBIQUITIN HYDROLASE; ASSOCIATION; (1)
BRCA1; BRCA2; lifestyle factors; ovarian cancer; preneoplastic changes; prophylactic salpingo-oophorectomy (1)
BRCA1 MUTATION CARRIERS; HEREDITARY BREAST; OVARIAN-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; FAMILY-HISTORY; MRE11; ASSOCIATION; MODIFIERS; AGE; Breast cancer; Age at onset; DNA-repair genes; Next-generation-sequencing; Panel sequencing; Extreme phenotypes; Hereditary breast and ovarian cancer; BRCA1; DNA-repair (1)
BRCA, Adhärenz, Brustkrebs, Eierstockrebs, FBREK, Regensburg, Teilnahmerate, Screening, adherence, breast cancer, ovarian cancer, participation rate, germany, Doktorarbeit (1)
BREAK-JUNCTION; CONDUCTANCE; TRANSPORT; COPPER; (1)
BREAKTHROUGH CANCER PAIN; DOUBLE-BLIND; OPEN-LABEL; MU-G; PREVALENCE; SPRAY; CROSSOVER; CITRATE; DEFINITION; MANAGEMENT; Breakthrough pain; Pain management; Opioid dependence; Fentanyl; Analgesics, short-acting (1)
BREAST AUGMENTATION; CONTRACTURE; IMPLANTS; breast augmentation; connective tissue; extracorporeal shock wave therapy; mammary implants (1)
BREAST AUGMENTATION; MATRIX METALLOPROTEINASES; BACTERIAL BIOFILMS; LIVER FIBROSIS; CONTRACTURE; EXPRESSION; SMOOTH; CLASSIFICATION; COMPLICATIONS; MACROPHAGES; (1)
BREAST-CANCER; 3-KINASE; PIK3CA; Breast cancer; Liquid biopsy; Proficiency testing; Alpelisib (1)
BREAST-CANCER; AKT ACTIVITY; SDZ RAD; TARGET; ovarian cancer; endometrial adenocarcinoma; mTOR; RAD001 (1)
Breast cancer, Anthropometry, Body shape, Biomarker, Mediation, Interaction (1)
BREAST-CANCER; BCL-2; AMPLIFICATION; NAVITOCLAX; EXPRESSION; PHASE-2; (1)
BREAST-CANCER; BLUE-DYE; ISOSULFAN BLUE; SURGERY; BENEFIT; IDENTIFICATION; NANOPARTICLES; RADIOISOTOPE; DISSECTION; Sentinel biopsy; Breast cancer; Neoadjuvant therapy; Indocyanine green (1)
BREAST-CANCER; BRAIN METASTASIS; GROWTH-FACTOR; MACROPHAGES; PROGRESSION; PROMOTE; TISSUE; TUMORS; MICE; INHIBITION; anti-CSF-1; colonization; monocyte-derived cells; microglia; metastasis (1)
BREAST-CANCER CELLS; ANESTHETIC TECHNIQUE; GROWTH; ACID; PROLIFERATION; PARACETAMOL; RECURRENCE; EXPRESSION; INCREASES; DIPYRONE; Cancer; acetaminophen; metamizole; cell proliferation; apoptosis (1)
BREAST-CANCER-CELLS; ARYL-HYDROCARBON RECEPTOR; CYCLIN-DEPENDENT KINASE; LIGAND-INDEPENDENT ACTIVATION; STEROID-HORMONE RECEPTORS; BETA MESSENGER-RNA; ACTIVITY IN-VITRO; ALPHA ER-ALPHA; HISTONE DEACETYLASE INHIBITORS; DNA-BINDING DOMAIN; Estrogene receptors; estrogen co-activators; estrogen co-repressors; MAPK; histone acetyltransferase; histone deacetylase; aromatic hydrocarbon receptor; estrogen receptor related proteins; protein kinases; cyclase kinases; kinase inhibitors (1)
BREAST-CANCER CELLS; BETA-CATENIN; LUNG-CANCER; ADHESION; GUIDANCE; ACTIVATION; RECEPTOR; MIDLINE; GROWTH; BRAIN; (1)
BREAST-CANCER CELLS; DOMAIN ANTIBODIES; FLUORESCENT NANOCRYSTALS; GROWTH; MICE; AUTOFLUORESCENCE; XENOGRAFTS; MODEL; (1)
BREAST-CANCER CELLS; DRUG LEADS; INDOLE; REGIOSELECTIVITY; BENGACARBOLINE; CYTOTOXICITY; Anticancer activity; HEPG-2; MCF-7; 1,2,4-Triazolethiones; Selectivity; Alkylation (1)
BREAST-CANCER CELLS; GENE-EXPRESSION; PROSTATE-CANCER; DIETARY INDOLE-3-CARBINOL; LYMPHOCYTE DEVELOPMENT; ENDOMETRIAL CANCER; ESTROGEN-RECEPTORS; ANTICANCER AGENT; DOWN-REGULATION; HEPG2 CELLS; 3,3-diindolylmethane; ER-AP-1 signal transduction; Phytoestrogens; Safety of phytochemicals; Telomerase (1)
BREAST-CANCER CELLS; HISTONE-DEACETYLASE INHIBITOR; CYCLE ARREST; ANTITUMOR-ACTIVITY; STEROID SULFATASE; TRICHOSTATIN-A; APOPTOSIS; PROLIFERATION; 2-PHENYLINDOLES; ELLIPTICINE; phenylindoles; aroyl hydrazones; breast cancer cells; glioblastoma cells; cell cycle arrest; apoptosis (1)
BREAST-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; ENDOPLASMIC-RETICULUM BIK; POTENT ANTITUMOR-ACTIVITY; BCL-2 FAMILY-MEMBERS; PHASE-II TRIAL; BH3-ONLY PROTEIN; METASTATIC MELANOMA; MULTIPLE-MYELOMA; MEK INHIBITION; Melanoma; Vemurafenib; Trametinib; BIK/NBK; Apoptosis (1)
BREAST-CANCER; CELLS; MACROPHAGE; BUPARLISIB; TISSUE; INTERFACE; RECEPTOR; PATHWAY; MICROENVIRONMENT; IDENTIFICATION; Astrocytes; BKM120; brain metastasis; macrophages; microglia; PI3K; RPPA (1)
BREAST-CANCER CELLS; OVARIAN-CANCER; GPR30; 17-BETA-ESTRADIOL; PROLIFERATION; GENE; ACTIVATION; RELEASE; EGF; Endometrial adenocarcinoma; G protein-coupled estrogen receptor; GPER; G-1 (1)
BREAST-CANCER CELLS; TUMOR-INITIATING CELLS; RESISTANCE PROTEIN; SIDE POPULATION; STEM-CELL; CD44; THERAPY; PROLIFERATION; MOLECULE; ADHESION; breast cancer; topotecan; ABCG2; CD24; EpCAM; flow cytometry; mammosphere formation; tumorigenicity (1)
BREAST-CANCER CELLS; ZD1839 IRESSA; GLIOBLASTOMA-MULTIFORME; ONCOGENE ADDICTION; MALIGNANT GLIOMAS; GENETIC PATHWAYS; LUNG-CANCER; TUMOR-CELLS; PHASE-I/II; IN-VITRO; glioblastoma; targeted therapy; epidermal growth factor receptor; HER2/neu (1)
Breast cancer, Cellular immunity, Immune escape, Immunoediting, Immunosurveillance, Immunotherapy (2)
; breast cancer; cen17; FISH; Her2; polysomy (1)
BREAST-CANCER; CHEMOTHERAPY; GROWTH; CELLS; (1)
; breast cancer; circulating tumor microemboli; metastatic dissemination; tumor fraction; copy number alteration; low-pass whole genome sequencing (1)
BREAST-CANCER; COMBINATION CHEMOTHERAPY; RADICAL RESECTION; THERAPY; 5-FLUOROURACIL; MULTICENTER; CARCINOMA; ADENOCARCINOMA; STATISTICS; RECURRENCE; (1)
BREAST-CANCER; DIFFERENTIATION ANTIGEN; IDENTIFICATION; MACROPHAGES; EXPRESSION; IMMUNOTHERAPY; LYMPHOCYTES; REGRESSION; DEFICIENT; SECRETION; NY-BR-1; Differentiation antigen; CTL epitope; HLA transgenic mice (1)
Breast cancer, early dissemination, Metastasis, Her2, PGR, miRNA (1)
BREAST-CANCER; ESR2 POLYMORPHISMS; RISK; VARIANTS; EXPRESSION; WOMEN; ASSOCIATION; ALPHA; Endometrial cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case-control study (1)
BREAST-CANCER; ESTROGEN; EXPRESSION; BETA; PROGRESSION; PATHWAY; GROWTH; GENE; P21; 17 beta-estradiol; dihydrotestosterone; tamoxifen; bicalutamide; telomerase LNCaP (1)
breast cancer; ethnicity; geography; mutation; ovarian cancer (1)
breast cancer; follow-up; health services research; guideline adherence; daily clinical practice (1)
BREAST-CANCER; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; OLIGONUCLEOTIDE ARRAYS; MALIGNANT-MELANOMAS; CUTANEOUS MELANOMA; BINDING-PROTEINS; FAMILY; APOPTOSIS; PLU-1; melanoma; transcription; gene expression; retinoblastoma protein binding protein; apoptosis (1)
BREAST-CANCER; GENE-PRODUCT; OF-VIEW; EXPRESSION; PLU-1; TRANSCRIPTION; TISSUES; EPHB6; RBP1; cell cycle; PLU-1; malignant melanoma; tumor progression (1)
BREAST-CANCER; GENETIC-ANALYSIS; PROGRESSION; RATES (1)
breast cancer, GHRH, rapamycin, antagonist, inhibition, hormone, Brustkrebs, Mammakarzinom, Inhibition (1)
breast cancer, Her2, ErbB2, targeted therapy, trastuzumab, anthracyclines, epirubicin, taxanes, paclitaxel, NK cell, antibody-dependent cellular cytotoxicity, ADCC (1)
breast cancer, HER4, humanized tumor mouse, biomarker (1)
Breast cancer, Hormone and node positive, Chemotherapy, Elderly patients, Overall survival, Distant metastases-free survival (1)
BREAST-CANCER; LOCAL-CONTROL; LUNG-CANCER; RADIOTHERAPY; TIMES; INCREASE; (1)
breast cancer; locoregional recurrence; cumulative recurrence rate; overall survival; recurrence-free survival; autologous reconstruction; allogeneic reconstruction; primary reconstruction; dormant cancer cells (1)
breast cancer, Luminal, (humanized) tumor mouse (1)
BREAST-CANCER; MACROPHAGE INFILTRATION; LACTIC-ACID; METABOLIC CLASSIFICATION; MALIGNANT-TUMORS; BLOOD MONOCYTES; CARCINOMA-CELLS; INVASION; PROGRESSION; METASTASIS; cell migration; cytokines; lactate; microenvironment; monocytes; tumor (1)
breast cancer; mammary carcinoma; lipofilling; autologous fat grafting; adipose-tissue-derived stem cells; exosomes; extracellular vesicles (1)
Breast cancer, menopausal status, adipositas, estrogen receptor, CYP19 aromatase, steroid sulfatase, adiponectin, AdipoR1/R2, insulin resistance, insulin receptor (1)
BREAST-CANCER; MESENCHYMAL TRANSITION; TUMOR-CELLS; BONE-MARROW; EXPRESSION; DIAGNOSIS; EMT; (1)
Breast Cancer, Metastasis, Disseminated Cancer Cell (1)
BREAST-CANCER METASTASIS; TUMOR-METASTASIS; BONE-MARROW; CELLS; PROGRESSION; CYTOKERATIN; MECHANISMS; Metastasis; Breast cancer; Transgenic models; DTC; Her2 (1)
; Breast cancer; Micrometastases; Lymph node; Adjuvant chemotherapy; Survival (1)
BREAST-CANCER; NITRIC-OXIDE; PROMOTES; RECEPTOR; METASTASIS; MICROENVIRONMENT; INTERFACE; TISSUE; GENE; (1)
breast cancer, ovarian cancer, endometrial cancer, estrogen, estrogen related receptor alpha, single nucleotide polymorphism, ESRRA, SNP (1)
BREAST-CANCER PATIENTS; LIVER METASTASES; GROWTH-PATTERNS; SUPRAMARGINAL RESECTION; COLORECTAL-CANCER; BRAIN METASTASES; SURVIVAL; INVASION; LUNG; CARCINOMAS; Dissemination; Displacing; Infiltration; Interface; Macro-metastasis (1)
BREAST-CANCER PATIENTS; LOCAL-CONTROL; RADIATION-THERAPY; PATIENT INFORMATION; LUNG-CANCER; TIME FACTOR; CARCINOMA; DELAYS; HEAD; GERMANY; allocation; ethics; radiotherapy; treatment time; waiting list; waiting time; resource distribution; justice (1)
BREAST-CANCER PATIENTS; OVARIAN TISSUE CRYOPRESERVATION; VITRIFICATION; CHEMOTHERAPY; STIMULATION; MUTATIONS; SURVIVORS; OUTCOMES; RISK; AGE; fertility preservation; oncologic diseases; guideline (1)
BREAST-CANCER PATIENTS; TUMOR-INFILTRATING LYMPHOCYTES; BONE-MARROW; ANTIBODY-RESPONSES; COLORECTAL-CANCER; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; METASTATIC MELANOMA; PANCREATIC-CANCER; PEPTIDE VACCINES; Malignant melanoma; Memory T cells; Autoantibodies; Regulatory T cells (1)
BREAST-CANCER PATIENTS; TUMOR-STROMA RATIO; PROGNOSTIC VALUE; MRI; COEFFICIENT; CARCINOMA; CELLULARITY; DIAGNOSIS; PERFUSION; GLIOMAS; (1)
BREAST-CANCER; PHOSPHOLIPID-METABOLISM; LUNG-CANCER; PKC-ALPHA; KAPPA-B; EXPRESSION; KINASE; D1; PHOSPHODIESTERASE; OVEREXPRESSION; glycerophosphodiesterase 5; phosphatidic acid; lysophosphatidic acid; glycerophosphocholine phosphodiesterase GDE1 homolog (Saccharomyces cerevisiae); glycerophosphodiester phosphodiesterase domain containing 6 (1)
BREAST-CANCER; PSYCHOLOGICAL ADJUSTMENT; CHRONIC ILLNESS; COUPLES; CAREGIVERS; VALIDATION; SURVIVORS; LIFE; Cancer; Oncology; Dyadic coping; Supportive care needs; Couples (1)
BREAST-CANCER; RADICAL CYSTECTOMY; HEPATOCELLULAR-CARCINOMA; REGULATES EXPRESSION; MEDIATES RESISTANCE; MOLECULAR SUBTYPES; LUMINAL SUBTYPES; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; FOXM1; muscle invasive bladder cancer; KI67; subclassification; survival prediction (1)
BREAST-CANCER; RADICAL PROSTATECTOMY; PREDICTS; RECURRENCE; SELECTION; SURVIVAL; SURGERY; (1)
BREAST-CANCER; RECEPTOR; 2-PHENYLINDOLES; ANTIESTROGENS; FULVESTRANT; TAMOXIFEN; (1)
BREAST-CANCER; REPORTED OUTCOMES; SURVIVORSHIP; INTIMACY; ONCOLOGY; WOMEN; Cancer; patient-reported outcomes; quality of life; sexual health; survivor (1)
BREAST-CANCER; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; GROWTH-FACTOR; CELL; PROLIFERATION; MEDICINE; THERAPY; DISEASE; TARGETS; Adverse events; Antidepressant; Multitarget; Salicylates (Salicin); Imipramine; Gene microarray (1)
breast cancer, sarcoma, head and neck cancer, skin cancer, malignant melanoma, monoclonal antibody, immunotherapy, immune checkpoint inhibitors (1)
BREAST-CANCER; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; PARABOLIC FLIGHT; KINASE INHIBITOR; BCL-2 FAMILY; SURVIVIN; CARCINOMA; DEATH; GENE; Thyroid cancer; Sunitinib; Irradiation; Apoptosis; Survivin; Caspases (1)
BREAST-CANCER THERAPY; PROOF-OF-CONCEPT; GERMANY; CARE; CENTERS; CERTIFICATION; Data quality; Cohort studies; Guidelines; Source data verification; Data quality indicators (DQI) (1)
BREAST-CANCER; TUMOR CHARACTERISTICS; UROTHELIAL CARCINOMA; GERMLINE MUTATIONS; GASTRIC-CANCER; RISK; RECURRENCE; EXPRESSION; CYSTECTOMY; GENE; Non-muscle-invasive bladder cancer; NMIBC; CHEK2; Smoking status; Progression (1)
BREAST-CANCER; TUMOR MICROENVIRONMENT; ABERRANT METHYLATION; MICROARRAY ANALYSIS; CELL-LINES; PROGRESSION; SFRP1; FIBROBLASTS; CARCINOMA; TARGETS; pancreatic ductal adenocarcinoma; chronic pancreatitis; expression profiling; microarray; stroma; microdissection; WNT5a (1)
BREAST-CANCER; WOMEN; MAMMOGRAPHY; HISTORY; RISK; reduction mammaplasty; occult breast cancer findings; international multicenter study; breast cancer screening (1)
BREAST-CONSERVING SURGERY; CONSERVATION SURGERY; CANCER; TIME; REEXCISION; CARCINOMA; NEED; Cavity shaving; Margin shaving; Cavity margin shaving; Lumpectomy; Breast-conserving surgery; therapy; Breast cancer (1)
breastfeeding; DNA methyltransferase; epigenetic regulation; exosome; FTO; infant formula; lactation; miRNA-148a; milk; non-communicalbe diseases of civilization (1)
; breast imaging; e-learning; medical education; curriculum radiology; blended learning; training in breast radiology (1)
BREAST IMPLANTS; HYALURONIC-ACID; SKIN FIBROSIS; DISEASE; MYOFIBROBLASTS; MARKERS; MATRIX; SAFETY; PIIINP; (1)
Breast reconstruction, Breast augmentation, Breast lipofilling, Lipofilling, Bra pressure, ADSC, Processed fat cells, CELT (1)
BREAST RECONSTRUCTION; COMPUTED-TOMOGRAPHY; QUANTITATIVE-ANALYSIS; VASCULAR ANATOMY; PERFUSION ZONES; OPERATIVE TIME; CT ANGIOGRAPHY; ABDOMINAL-WALL; NECROSIS; NUMBER; Autologous breast reconstruction; free flap surgery; DIEP flap; flap perfusion; medial row perforator; lateral row perforator; perforator number; Indocyanine Green fluorescence angiography (1)
; breast reconstruction; deep inferior epigastric perforator (DIEP) flap; breast cancer; microsurgery; plastic surgery; reconstructive surgery (1)
BREAST RECONSTRUCTION; RISK-FACTORS; ELDERLY-PATIENTS; TOBACCO SMOKING; NECK-DEFECTS; BLOOD-FLOW; COMPLICATIONS; HEAD; REPLACEMENT; ANASTOMOSIS; cigarette smoking; nicotine; free flap reconstruction (1)
BREAST-REDUCTION; MACROMASTIA; SYMPTOMS; SURGERY; OUTCOMES; HYPERTROPHY; IMPROVEMENT; QUALITY; SUCCESS; HEALTH; breast hypertrophy; reduction mammaplasty; macromastia; breast; QoL (1)
Breast surgery · Breast reconstruction · Breast implants · Lightweight breast implants (1)
BREATH ACETONE; GAS SENSOR; SPECTROSCOPY; NO2; DIODE; FORMALDEHYDE; DIOXIDE; QEPAS; BAND; NM; Acetone detection; Photoacoustic spectroscopy; High power UV LED; UV LED collimation system; Acetone breath analysis (1)
Bremse , Radschlupfregelung , wheel slip control (1)
BRENTUXIMAB VEDOTIN SGN-35; NON-HODGKIN-LYMPHOMA; METRONOMIC CHEMOTHERAPY; PHASE-II; THERAPY; CYCLOPHOSPHAMIDE; TROFOSFAMIDE; LEUKEMIA; ANTIBODY; TEPIP; relapsed; refractory PTCL; PTCL; metronomic chemotherapy; all-oral treatment; relapsed lymphoma; palliative treatment (1)
Breslow Intermediate, Photochemie, Cyclopropane (1)
Brexit, event study, perception, Google Trends, GJR-GARCH, United King- dom (1)
BRIDGED BIS(GUANIDINATE) LIGAND; ANSA BIS(AMIDINATE) LIGAND; MAIN-GROUP ELEMENTS; STRUCTURAL-CHARACTERIZATION; LINKED BIS(AMIDINATE); HETEROMETALLIC COMPLEXES; LACTIDE POLYMERIZATION; BINUCLEATING LIGANDS; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURES; (1)
BRIDGED DIRUTHENIUM COMPLEXES; AB-INITIO PSEUDOPOTENTIALS; IRON SIGMA-ACETYLIDES; X-RAY-STRUCTURE; VINYL-RUTHENIUM; ELECTRON DELOCALIZATION; TRIRUTHENIUM COMPLEXES; INSERTION REACTIONS; OSMIUM COMPLEXES; RADICAL CATIONS; (1)
BRIDGE KELVIN RESISTOR; LOW-CONTACT-RESISTANCE; DEVICES; Graphene; electrical contacts; TLM (1)
BRIDGING PHOSPHANES; CONJUGATED SYSTEMS; METALLACYCLES; COMPLEXES; POLYMERS; CHEMISTRY; LIGANDS; BINDING; aliphatic linkers; copper; London dispersion interactions; metallacycles; supramolecular chemistry (1)
BRIDGING PHOSPHANES; RHODIUM COMPLEXES; LIGANDS; POLYMERS; MODE; IONS; (1)
BRILLOUIN LIGHT-SCATTERING; MAGNETIC VORTEX CORES; FERROMAGNET; MOTION; (1)
BRILLOUIN LIGHT-SCATTERING; REFRACTION; (1)
BRILLOUIN-ZONE INTEGRATIONS; BAND-GAP; MOLECULES; SPINTRONICS; (1)
BRINE-SEAWATER INTERFACE; SHABAN DEEP; KEBRIT DEEP; DIVERSITY; HYBRIDIZATION; SEQUENCES; COMMUNITY; DNA; (1)
BRITAIN; CHINA; WEST (1)
BROADLY NEUTRALIZING ANTIBODIES; ANTI-HIV-1 ANTIBODIES; BISPECIFIC ANTIBODIES; INHIBITION; ENDOCYTOSIS; THERAPY; VIREMIA; TRAFFICKING; COMBINATION; INFECTION; (1)
BROADLY NEUTRALIZING ANTIBODIES; ANTI-HIV-1 ANTIBODIES; RESPONSES; VACCINE; RECEPTORS; PROTEIN; DESIGN; STABILIZATION; IMMUNIZATION; DOMAIN; Nanotechnology; Silica nanoparticles; HIV-1; Vaccine; Immunogen design; Germline-targeting; Env; B cells; Multivalent interaction; Affinity; Avidity (1)
BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN COMPLEX; VESICULAR STOMATITIS-VIRUS; DNA PRIME; DEPENDENT EPITOPE; RHESUS MACAQUES; TFH CELLS; IMMUNOGENICITY; ACTIVATION; PROTECTION; trimeric ConCv5 KIKO protein; HIV-1 vaccine; DNA; VSV-GP and NYVAC vectors; membrane display; mice immunization; T and B cells; antibodies (1)
BROADLY NEUTRALIZING ANTIBODIES; MEMORY B-CELLS; REPEAT PROTEINS; RIBOSOME DISPLAY; RAPID SELECTION; AFFINITY; RESPONSES; BINDERS; COEVOLUTION; MATURATION; (1)
BROADLY NEUTRALIZING ANTIBODIES; VESICULAR STOMATITIS-VIRUS; IMMUNODEFICIENCY-VIRUS; RHESUS MACAQUES; TFH CELLS; DNA PRIME; IN-VIVO; STRAIN; IMMUNOGENICITY; ACTIVATION; HIV-1 Env; vaccine; VSV-GP; NYVAC; mice immunization; T and B cells; antibodies; immune correlates (1)
BROADLY NEUTRALIZING ANTIBODIES; VIRUS-LIKE PARTICLES; ENVELOPE GLYCOPROTEIN COMPLEX; CYTOTOXIC T-CELLS; DENDRITIC CELLS; CROSS-LINKING; B-CELLS; HUMORAL IMMUNITY; LYMPHATIC-SYSTEM; GP120 PROTEINS; Nanoparticles; Vaccine delivery; HIV-1/AIDS; Lymph node distribution; Multivalence, Envelope glycoprotein (Env) (1)
bromodeoxyuridine, cellular plasticity, doublecortin, dystonia, DYT1, hippocampus, olfactory bulb, subventricular zone, torsinA (1)
bronchial asthma; beta-2-adrenoceptors; camp; theophylline; circadian variation (1)
BRONCHIAL EPITHELIAL-CELLS; AIRWAY EPITHELIUM; GENE-EXPRESSION; IN-VITRO; RELEASE; CYTOKINES; ICAM-1; RANTES; ROLES; IL-6; bronchial epithelial cell; complementary deoxyribonucleic array (1)
BRONCHIAL EPITHELIAL-CELLS; CYSTIC-FIBROSIS MOUSE; GUINEA-PIG; CL-SECRETION; INFLAMMATION; EXPRESSION; MICE; INHIBITION; MODULATION; CHANNELS; airway epithelium; trypsin; tryptase (1)
Bronchialkarzinom, Methylierung, MGMT, RASSF1A, RASAL1, PDCD4, MTSS1, TUSC3 (1)
BRONCHIAL LYMPH-NODE; IN-VIVO; BONE-MARROW; T-CELLS; STEADY-STATE; LANGERHANS CELLS; INHALED ANTIGEN; MACROPHAGES; RECRUITMENT; MICE; (1)
; Bronchiectasis; High-resolution computed tomography; Tree-in-bud pattern; Yellow nail syndrome (1)
BRONCHIOLITIS OBLITERANS; ACUTE REJECTION; ALLOGRAFTS; TOLERANCE; COMBINATION; CELLS; (1)
Bronchiolitis obliterans, chronische Transplantatabstoßung, Lungentransplantation, Nintedanib, PDGF, VEGF (1)
Bronchiolitis obliterans, Lungenfibrose, Lungentransplantation, Imatinib, Dasatinib, Nilotinib, PDGF (1)
BRONCHIOLITIS OBLITERANS SYNDROME; CHRONIC ALLOGRAFT-REJECTION; NITRIC-OXIDE SYNTHASE; ADHESION MOLECULES; TRACHEAL ALLOGRAFTS; RENAL-ALLOGRAFTS; SDZ-RAD; CYCLOSPORINE; EXPRESSION; PROPHYLAXIS; chronic rejection; viral infection; cyclosporin A; bronchiolitis obliterans; experimental lung transplantation (1)
BRONCHIOLITIS-OBLITERANS-SYNDROME; HEMATOPOIETIC-CELL TRANSPLANTATION; MEASURING THERAPEUTIC RESPONSE; FORCED EXPIRATORY FLOW; DRY EYE; PROGNOSTIC VALUE; PREDICTIVE-VALUE; CHRONIC GVHD; RISK-FACTORS; LUNG; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus; Early diagnosis (1)
BRONCHIOLITIS OBLITERANS SYNDROME; OXIDATIVE STRESS; CYCLOSPORINE-A; TISSUE TRANSGLUTAMINASE; COLORIMETRIC ASSAY; GROWTH-FACTOR; INFLAMMATION; FIBROBLASTS; PROTECTS; FIBROSIS; Cyclosporin A; chronic lung allograft dysfunction; nintedanib; oxidative stress; transglutaminase-2 (1)
BRONCHOALVEOLAR LAVAGE FLUID; GALACTOMANNAN; DIAGNOSIS; SERUM; SEPSIS; PERFORMANCE; INFECTIONS; PROPOSAL; REGISTRY; CULTURE; lipopolysaccharide binding protein; bactericidal; permeability-increasing protein; interleukin-8; Aspergillus; invasive pulmonary aspergillosis; bronchoalveolar lavage; galactomannan; biomarker (1)
BRONCHOALVEOLAR LAVAGE SAMPLES; POLYMERASE-CHAIN-REACTION; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; TRANSPLANT RECIPIENTS; HEMATOLOGY PATIENTS; ANTIFUNGAL THERAPY; DIAGNOSTIC-TESTS; GALACTOMANNAN; EPIDEMIOLOGY; antifungal; aspergillosis; Aspergillus; BAL; blood; cerebrospinal fluid; comparison; PCR (1)
BRONCHOALVEOLAR LAVAGE SAMPLES; WAX EMBEDDED TISSUE; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; MOLD INFECTIONS; HEMATOLOGICAL MALIGNANCIES; IMMUNOCOMPROMISED PATIENTS; TRANSPLANT RECIPIENTS; CLINICAL-APPLICATION; MOLECULAR METHODS; (1)
BRONCHOPULMONARY DYSPLASIA; RESPIRATORY-DISTRESS; PULMONARY-HYPERTENSION; PRETERM INFANTS; ENDOTHELIN-1; OUTCOMES; ANGIOGENESIS; MODEL; Chronic lung disease; Endothelin receptor blockers; Preterm; Rats; Infants; Bronchopulmonary dysplasia (1)
BRONSTED ACID CATALYSIS; DENSITY-FUNCTIONAL THEORY; MECHANISM; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; ACTIVATION; REDUCTION; MODES; TOOL (1)
BRONSTED ACID CATALYST; SILICA GARDEN; PORTLAND-CEMENT; PRECIPITATION TUBES; MAGNETIC-FIELD; HYDRATION; GROWTH; TEMPLATE; CHIMNEYS; IRELAND; compartmentalization; electrochemical potential; ion diffusion; membranes; self-assembly (1)
BRONSTED ANALYSIS; PHOSPHATE; SPECIFICITY; MECHANISMS; EVOLUTION; MUTANT; biocatalysis; chemical rescue; oligomerization; optochemical tools; protein-protein interactions (1)
Brønstedsäurekatalyse, Wasserstoffbrückenbindung, Solvothermasynthese, Brønsted Acid Catalysis, Hydrogen Bonds, Solvothermal Synthesis (1)
Brouwerscher Fixpunktsatz , Allgemeines Gleichgewicht , Nash-Gleichgewicht, , Fixed Point Theorems , General Equilibrium , Nash Equilibrium (1)
Brow lift, Facial rejuvenation, Suspension brow lift, Anatomical Lift Prantl’s Suture Suspension (ALPS), ALPS lift, Gliding Brow Lift (GBL), Facial nerve injury (1)
BROWN ADIPOSE-TISSUE; CIRCULATING OMENTIN-1 LEVELS; MESSENGER-RNA EXPRESSION; TYPE-2 DIABETES-MELLITUS; VASPIN GENE-EXPRESSION; LEPTIN RECEPTOR LEVELS; INSULIN-RESISTANCE; STROMAL CELLS; IN-VITRO; METABOLIC SYNDROME; polycystic ovary syndrome; endometriosis; adipokine; batokine; white adipose tissue; brown adipose tissue; obesity; infertility; single nucleotide polymorphism; omics (1)
BROWN ADIPOSE-TISSUE; MAMMALIAN HIBERNATION; ENDOTHELIAL-CELLS; HP COMPLEX; ADIPONECTIN; GENE; KINASE; EXPRESSION; RECEPTORS; SYSTEM; adiponectin; bovine; C1q; hibernation; liver (1)
BROWN ADIPOSE-TISSUE; TRANSCRIPTION; KINASE; FAT; RESISTANCE; (1)
BROWN-FAT-CELLS; DEPENDENT POTASSIUM CHANNELS; ATYPICAL BETA-ADRENOCEPTOR; ADIPOSE-TISSUE; ELECTRICAL-ACTIVITY; MEMBRANE RESPONSES; CATECHOLAMINES; NORADRENALINE; ACTIVATION; ADENOSINE; non-selective cation channel; adipose tissue; adrenaline; insulin; BRL 37344; isoproterenol (1)
BROWNIAN MOTORS; (3)
BROWNIAN MOTORS; TERAHERTZ RADIATION; ELECTRON FLOW; FLUID (1)
BROWNIAN MOTORS; TRANSPORT; RECTIFICATION; (1)
BROWNIAN MOTORS; TRANSPORT; spin polarised transport; spin-orbit interactions; two-dimensional electron gas (1)
BROWN-NORWAY RATS; ALLERGIC DISEASE; CHILDHOOD ASTHMA; EXPOSURE; EXPRESSION; PHENOTYPE; WHEEZE; RISK; AGE; DIFFERENTIATION; CD8(+); CD8(low); Childhood; Farm-exposure (1)
BROWN REPRESENTABILITY; TRIANGULATED CATEGORIES; PHANTOM MAPS; HOMOLOGICAL APPROACH; RING SPECTRA; THEOREM; PURITY; COHOMOLOGY; MODULES; REPRESENTATIONS; Triangulated category; Representability; Obstruction theory (1)
BRST Quantization, Electroweak Precision Physics, Gauge Symmetry, Renormalization and Regularization (1)
BRUCELLA-MELITENSIS; Brucellosis; Granulomatous disease; Stay in Mexico; Elevated transaminases; Fever; Dyspnea (1)
BRUCHS MEMBRANE IMPLICATIONS; ENDOTHELIAL-CELL MIGRATION; COMPLEMENT FACTOR-H; TENASCIN-C; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; OPTIC-NERVE; SUBSTRATE STIFFNESS; extracellular matrix; Bruch's membrane; matricellular proteins; inflammation; retinal disease; age-related macular degeneration; Sorsby fundus dystrophy; TIMP3 (1)
Brustkrebs, Biomodulation, PPARγ, TAM, E-Cadherin (1)
Brustkrebs, breast cancer, Fettgewebe, fat tissue, Peroxisom-proliferator-aktivierte Rezeptoren (PPARs), Angiopoetin-like 4 (ANGPTL4) (1)
Brustkrebs, Disseminierte Krebszellen (DCC), EpCAM (1)
Brustkrebs; Disseminierte Krebszellen; Genomisch; Treibermutationen (1)
Brustkrebs, Hochrisikogene, Chemotherapie (1)
Brustkrebs, Metastasierung, disseminierte Krebszellen, Luminal B, breast cancer, metastasis, disseminated cancer cells, luminal B (1)
Brustkrebs , Onkogen HER2/neu , Epidermaler Wachstumsfaktor-Rezeptor , Trastuzumab , Fluoreszenz-Resonanz-Energie-Transfer , Zellzyklus , Proliferation , Mammakarzinom , erbB Rezeptor , EGFR , Herceptin , Rezeptor-Interaktion , FRET , Breast cancer treatment , erbB receptor , HER2/neu , EGFR , Herceptin , Trastuzumab , receptor interaction , FRET , cell cycle , proliferation (1)
Brustrekonstruktion, BREAST-Q, Lebensqualität breast reconstruction, BREAST-Q, quality of life (1)
Bryophytes; Central Europe; Continuity; Ellenberg indicator values; Fungi; Indicator species; Lichens; Macromycetes; Woodland (1)
Bryophytes; Diaspore availability; Dispersal; Gap; Microsite availability; Species pool concept; Vascular plants (1)
Bryophytes; fungi; lichens; macromycetes; Swabian Alb; Franconian Alb; grassland management project; Sippenauer Moor; Baden-Württemberg; Bavaria (1)
bryophytes, grasslands, historical management, plant communities, temporal niche (1)
B-S MESONS; LIFETIME DIFFERENCE; CP-VIOLATION; WIDTH DIFFERENCE; LEADING LOGARITHMS; QCD CORRECTIONS; DECAYS; SYSTEM; DISTRIBUTIONS; MODEL; (1)
B-spline, truncated power basis, derivative, monotonicity, penalty, smoothing spline, R (1)
B STREPTOCOCCAL SEPSIS; HEMATOPOIETIC STEM-CELLS; TUMOR-NECROSIS-FACTOR; CORD-BLOOD; CD28 SUPERAGONISTS; COMPLEMENT-SYSTEM; IMMUNE-RESPONSE; ADVANCED CANCER; PRETERM LABOR; SEPTIC SHOCK; (1)
B SURFACE-ANTIGEN; CHRONIC HEPATITIS-B; VIRUS-INFECTION; CORE ANTIGEN; DNA; FREQUENCY; TRANSPLANTATION; CHEMOTHERAPY; REACTIVATION; POLYMERASE; HBV markers; HBV serology; hepatitis B virus; hepatocellular carcinoma; occult HBV infection (1)
B-type natriuretic peptide; heart failure; kidney; marker; N-terminal; proBNP; prognosis (1)
bubble soccer, injury, soccer, risk factor, prevention (1)
BUBBLE TEMPLATING METHOD; MESOPOROUS SILICA; CALCIUM-CARBONATE; SPHERES; PARTICLES; FABRICATION; VESICLES; COLLOIDS; NANOPARTICLES; MULTILAYERS; (1)
Buccal mucosa · Ureter · Transplants · Ureteroplasty · Oral mucosa graft (1)
Buchbesprechung, Baugestaltungssatzungen, praktischer Einsatz, Manssen (1)
Buchbesprechung, Bebauungspläne, Manssen (1)
Buchbesprechung, Bundes- und Landesrecht, Städtebau, Manssen (1)
Buchbesprechung, Effizienzanforderungen, Unternehmen, Manssen (1)
Buchbesprechung, Friederike Roer, Nachfolgeunternehmen, Bahn, Post, Bauleitplanung, Manssen (1)
Buchbesprechung, Krankenversicherung, Manssen (1)
Buchbesprechung, Staatsleistungen, Leistungsfähigkeit, Staat, Manssen (1)
Buchtrailer, Schreiben, Texte verfassen, Schreibstrategien, Lesestrategien, literarisches Lernen (1)
; Buckle surgery; Learning curve; Retinal detachment surgery; Training; Vitrectomy (1)
"Budapester Memorandum", Schwarzmeerflotte, "humanitäre Intervention", Selbstbestimmung, EMRK (1)
BUDGERIGAR MELOPSITTACUS-UNDULATUS; ZEBRA FINCH; AMPLITUDE-MODULATION; MONGOLIAN GERBIL; THRESHOLDS; SENSITIVITY; FOREBRAIN; DYNAMICS; SONGBIRD; MASKING; (1)
BUDGERIGARS MELOPSITTACUS-UNDULATUS; PRIMARY AUDITORY AFFERENTS; SCHROEDER-PHASE COMPLEXES; INNER-EAR; TAENIOPYGIA-GUTTATA; STURNUS-VULGARIS; PERIOD PATTERNS; ZEBRA FINCHES; FREQUENCY; DISPERSION; masking; bird; harmonic complex; cochlear microphonics (1)
BUD-SITE SELECTION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC-EXIT; SYMMETRY-BREAKING; GTP-BINDING; PROTEIN; PHOSPHORYLATION; COMPLEX; CDC42; (1)
Buffer allocation problem, flow production line, classification, survey, instances, FlowLineLib (1)
BUILDING-BLOCKS; BASIS-SETS; COMPLEXES; LIGAND; BEHAVIOR; POLYMERS; DESIGN; ANIONS; CU+; (1)
BUILDING-BLOCKS; BIPHENYL-DNA; CHEMISTRY; DIIMIDE; DYES; PHENANTHRIDINIUM; POLYMORPHISMS; SUBSTITUTE; TRIPLEXES; HAIRPINS; base mismatch; DNA; excimers; fluorescence; perylene bismide (1)
BUILDING-BLOCKS; COORDINATION CHEMISTRY; NMR-SPECTROSCOPY; LIGAND COMPLEX; METALLACYCLES; CP2MO2(CO)(4)(ETA(2)-P-2); PENTAPHOSPHAFERROCENE; CONSTRUCTION; METALLACAGES; ASSEMBLIES; Tungsten; Phosphorus; Copper; Silver; NMR spectroscopy (1)
BUILDING-BLOCKS; LIGAND COMPLEX; COORDINATION; PENTAPHOSPHAFERROCENE; SUPRAMOLECULE; ASSEMBLIES; CHEMISTRY; BEHAVIOR; 2D; coordination chemistry; copper; heterometallic complexes; polypnictogen complexes; WCA (1)
Building blocks · Organic electronics · Sulfur heterocycles · Synthetic methods · Upscaling (1)
Bukowina, Bukowinadeutsche, Deutschböhmen, Böhmerwald,nordmittelbairisch,mittelbairisch, bairisch, Dialekt, Sprachsiedlung, Sprachinsel (1)
BULIMIA-NERVOSA; PRURITUS; SIGNS; anorexia nervosa; skin changes; early diagnosis; anorectic hand; cutaneous manifestations (1)
BULK GAAS; elemental semiconductors; MOSFET; photoconductivity; photovoltaic effects; silicon (1)
bulk queue, general arrival stream, discrete-time modelling, circulating vertical conveyor systems (1)
BULLDOG MARCUSENIUS-MACROLEPIDOTUS; GNATHONEMUS-PETERSII MORMYRIDAE; SOUTH-AFRICAN FORM; ORGAN DISCHARGES; FISH; SEX; CAMPYLOMORMYRUS; COMMUNICATION; RECOGNITION; MORPHOLOGY; electric organ discharge; species recognition; sex difference; speciation (1)
Bullous pemphigoid, Adalimumab therapy, Ulcerative colitis (1)
Bullying-Verhalten, ambulante Familientherapie, Verminderung des Ärgers, Verbesserung der Beziehungsfähigkeit (1)
bumblebees; flower choices; bees; rationality; foraging; decision-making; cognitive biases; heuristics (1)
Bundesrepublik Deutschland ; Gesellschaft ; Bildung ; Ethik (1)
Bundesverfassungsgericht (1)
Bundesverfassungsgericht Bundestagswahl (1)
Bundeswehr · Rüstung · Militär · Verteidigung · Streitkräfte (1)
Bundeswehr · Rüstung · Ukrainekrieg · Streitkräfte · Verteidigung (1)
BUNDLE-BRANCH BLOCK; AORTIC-VALVE; SAPIEN 3; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; REPLACEMENT; GENERATION; EXPERIENCE; SYSTEM; DEPTH; Transcatheter aortic valve implantation; Conduction abnormalities; Permanent pacemaker implantation; Predictors (1)
BUNDLE GERBES; DIFFERENTIAL GEOMETRY; GAUGE-THEORY; 2-GROUP; STACKS; nonabelian gerbe; principal 2-bundle; 2-group; nonabelian cohomology; 2-stack (1)
BUNDLE GERBES; DIFFERENTIAL GEOMETRY; STRING 2-GROUP; LOOP SPACE; MODELS; Non-abelian gerbe; Non-abelian cohomology; Lie 2-group; Transgression; Loop space; String structure (1)
BUNDLE GERBES; K-THEORY; (1)
Bund Naturschutz in Bayern , Geschichte , Umwelt , Naturschutz , Naturschutzgeschichte , Bayern , Geschichte 1900�1945, Umweltgeschichte , Environmentalism , History 1900-1945 , Germany , Bavaria , Environmental History (1)
Buphthalmum salicifolium New natural products (flavonoid glucosides and dicaffeoylquinic acids from flowerheads of Buphthalmum salicifolium) Glycosides Role: BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (flavonoid from flowerheads of Buphthalmum salicifolium) Molecular structure (of flavonoid glucosides and dicaffeoylquinic acids from flowerheads of Buphthalmum salicifolium) flavonoid glycoside caffeoylquinate Buphthalmum (1)
BURDEN; MULTICENTER; PREVALENCE; TRIALS; outcomes; outcome measures; instruments; atopic dermatitis; atopic eczema; eczema; Harmonising Outcome Measures for Eczema; HOME; clinical practice (1)
BURDEN; OUTCOMES; biliary tract surgical procedures (D001662); costs and cost analysis (D003365); length of stay (D007902); liver (D008099); surgical wound infection (D013530) (1)
Bürgermeister, Gemeindevertretung, Mecklenburg-Vorpommern, Manssen (1)
BURGERS-EQUATION; RANDOM MATRICES; QCD; Matrix Models; Lattice Gauge Field Theories; 1/N Expansion (1)
BURIAL EXPERIMENT; PERSISTENCE; GERMINATION; DATABASE; ECOLOGY; TRAITS; BANKS; COMMUNITIES; LONGEVITY; MORTALITY; Soil seed bank persistence; Rumex acetosella; Soil substrate; Water table depth; Seed burial; Longevity index (1)
buridan (3)
buridan, locomotion, walking, fixation, Drosophila (1)
buridan, open data, rstat, wild-type, drosophila, locomotion, behavior (1)
BURIED POLAR RESIDUES; X-RAY-STRUCTURE; FILAMENT ORGANIZATION; SINGLE-MOLECULE; PROTEIN DESIGN; PARALLEL; COMPLEX; BINDING; coiled coil; septins; protein filament; mixed hydrophobic/hydrophilic interface; crystal structures (1)
BURKINA-FASO; SPECIES-DIVERSITY; MACROTERMES-MICHAELSENI; ACCRA PLAINS; ECOSYSTEM; MOUNDS; ORDINATION; PATTERNS; TREES; GHANA; ecosystem engineers; habitat heterogeneity; Macrotermes; microhabitat (1)
BURNING MOUTH SYNDROME; OCCUPATIONAL-HEALTH PROBLEMS; ORAL MANIFESTATIONS; CONTACT ALLERGY; DRUG-REACTIONS; RESTORATIONS; CHALLENGES; TASTE; PAIN; Dental materials; Adverse effects; Burning mouth; Taste disorders; Dry mouth; Allergy; Medication; General disease (1)
Burnout, AVEM, Stress, Entzündung, Mustertypen (1)
Burnout, Chronic work stress, Cortisol, Acute stress, FMRI, Hypothalamic-pituitary-adrenal (HPA) axis, ScanSTRESS, Regensburg Burnout Project Saliva Acute stress Burnout Chronic work stress Cortisol Fmri Hypothalamic-pituitary-adrenal (HPA) axis Regensburg Burnout Project ScanSTRESS (1)
burnout | endoscopy | evidence‐informed well‐being interventions | gastroenterology | hepatology | individual‐level interventions | organisational interventions | physician well‐being | resilience | scoping review (2)
Burnout, Lehrer, Bayern, Berlin, Gymnasium (1)
burnout; stress, chronic work stress, allosatic load, cortisol, ScanSTRESS, fMRI (1)
BURNOUT SYNDROME; STRESS; SATISFACTION; HEALTH; PHYSICIANS; Job stress; Job satisfaction; FBAS-questionnaire (1)
BURR-HOLE CRANIOSTOMY; RISK-FACTORS; DRAINAGE; MEMBRANECTOMY; RECURRENCE; chronic subdural haematom; intracranial hemorrhage; cognitive decline (1)
Bürstenbiopsie, Tenascin-C, hm Tn-C, orales Plattenkarzinom, orale Zytologie, Bürstenbiopsie, Präkanzerosen (1)
Bürstenzytologie, maligne Gallengangsstenosen, Gallengangsbiopsie, biliary brush cytology, biliary strictures, biliary biopsy, ERCP, IDUS (1)
Burstkrebs, Knochenmark, Disseminated Cancer Cells, Metastasen (1)
Business (1)
BUSINESS CITIZENSHIP; GLOBALIZATION; RESPONSIBILITY; SUBSIDIARITY; METAPHOR; SOCIETY; bourgeois; citoyen; corporate citizenship (CC); responsibility; corporate-governmental task-sharing; subsidiarity (1)
Business culture, Corporate governance, Multinational enterprise, Clothing retail trade, Political risk, Cold War (1)
Business cycle; Collateralized Debt Obligation; Correlation; Credit risk; Default probability; Point-in-time; Portfolio; Through-the-cycle (1)
BUSINESS-CYCLE; MACROECONOMIC STABILITY; AGGREGATE FLUCTUATIONS; ECONOMIC-ACTIVITY; UNITED-STATES; STOCK-PRICES; TIME-SERIES; PERMANENT; MODELS; TRENDS; unobserved components; trend; cycle; identification; Great Moderation (1)
BUSINESS-CYCLE; RATING AGENCIES; BASEL-II; PROCYCLICALITY; PROBABILITIES; REQUIREMENTS; MODELS; OPTIMIZATION; SIMULATION; DEFAULT; Asset-backed security; Economic downturn; Impairment; Regulation; Regulatory capital; Mortgage-backed security (1)
Business cycles, simulation, DSGE, housing market, commercial real estate, VAR (1)
BUSINESS MODEL INNOVATION; TECHNOLOGY; FRAMEWORK; NETWORK; STRATEGIES; IDENTIFY; INDUSTRY; disruptive innovation; disruptive potential; ex-ante method; ex-ante approach; forecasting; method validation; case studies; online lending; p2p lending; two-sided markets; multi-sided markets; business model; marketplace lending; business model innovation; Germany (1)
Business model · Networks · Diffusion · Digital innovation · Health care · Institutions (1)
Business Process (1)
business processes, mobile solutions, BPM, BPI, mobile business processes (1)
BUSINESS PROCESSES; SCIENCE RESEARCH; DESIGN SCIENCE; INDUSTRY 4.0; BIG DATA; INTERNET; SYSTEMS; THINGS; Process Execution; Internet of Things; Wearables (1)
Business Processes, Six Sigma, Business Process Improvement, BPI (1)
Business Process Improvement, BPI, modeling tool (1)
Business process improvement, knowledge codification, metamodel (1)
Business Process Management, Automated Planning, Experimental Evaluation, Task Performance (1)
Business process management, Business process execution, Operational perspective, Internet of Things, Tool support (1)
Business Process Management, Business Process Modeling, Ontology (1)
Business Process Management, Business Process, Techniques, Patterns (1)
Business Process Management, Location-Awareness, Distributed processes (1)
Business process management, multi-actor processes, process modelling (1)
Business Process Management, Operational Perspective, Resource Management, Cyber-Physical Systems (1)
Business Process Management, Process Performance Management, Enterprise Social Media (1)
Business Process Management, Process planning, Automated planning, Control Flow Structures (1)
BUSINESS PROCESS MANAGEMENT; WEB SERVICES COMPOSITION; INFORMATION-SYSTEMS; SCIENCE; SEARCH; Process model; Automated planning; Exclusive choice; Algorithm; Design science research (1)
Business Process Modeling, Business Process Management, Automated Planning, Flexibility (1)
business process monitoring - cloud computing - privacy - risk management - security - social media - social networks - software product lines - trusted computing (1)
Business value, Information systems, Literature review, Meta review (1)
BUTTERCUPS RANUNCULUS-ADONEUS; SPECIES DISTRIBUTIONS; PLOIDY LEVEL; RANGE; DIFFERENTIATION; ESTABLISHMENT; BIOGEOGRAPHY; MECHANISMS; PREDICTION; SPECIATION; Climate; Geographical distribution; GIS; Iberian Peninsula; Leucanthemum; Polyploidy (1)
buttressing effect · halogen-lithium exchange · organolithium · steric strain · aniline (1)
BUTYRATE-PRODUCING BACTERIA; LACTOBACILLUS-ROGOSAE HOLDEMAN; BENZODIAZEPINE-RECEPTOR; RAT-BRAIN; SP-NOV; BINDING; MITOCHONDRIAL; ACID; TSPO; INFLAMMATION; gut microbiome; etifoxine; neurosteroids; GABA-A transmission; Williams design; 16S rRNA amplicon sequencing; Faecalibacterium duncaniae; Roseburia hominis (1)
Butyrophilin; Human γδ T cells; Phosphoantigen; T-cell activation; T-cell receptor (1)
BUTYROPHILIN-LIKE MOLECULE; DONOR DENDRITIC CELLS; FOXP3 EXPRESSION; GLYCODELIN-A; BONE-MARROW; TRANSPLANTATION; TOLERANCE; RESPONSES; PROGENITORS; RECEPTORS; (1)
BUYER-SUPPLIER RELATIONSHIPS; COMPETITIVE ADVANTAGE; VENTURE PERFORMANCE; ENTREPRENEURIAL FIRMS; CO-OPETITION; BUSINESS; NETWORKS; POWER; PERSPECTIVE; COOPERATION; (1)
B-VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; VARICELLA-ZOSTER VIRUS; STRONGYLOIDES-STERCORALIS INFECTION; EPIDERMOLYSIS-BULLOSA-ACQUISITA; FORCE RECOMMENDATION STATEMENT; MODIFYING ANTIRHEUMATIC DRUGS; DOSE METHOTREXATE THERAPY; HEPATITIS-B; PEMPHIGUS-VULGARIS; (1)
BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; FOLLOW-UP; CIRCUIT; EXPERIENCE; OUTCOMES; PATENCY; SYSTEM; (1)
BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; OFF-PUMP; INFLAMMATORY RESPONSE; MEMBRANE-OXYGENATORS; VENOUS RESERVOIRS; BIOCOMPATIBILITY; ACTIVATION; CIRCUITS; RISK; extracorporeal circulation; minimized extracorporeal circulation; cardiac surgery; postoperative complications; anesthetic management (1)
BYPASS GRAFT-SURGERY; CORONARY-HEART-DISEASE; DEPRESSION; PROGNOSIS; MORTALITY; ANXIETY; psychiatric medication; antidepressant medication; coronary artery bypass graft; aortic valve replacement; outcome (1)
BYPASS-SURGERY; OFF-PUMP; DEVICE; Anastomotic devices; Coronary revascularization (1)
BY-PRODUCT FORMATION; OPTICAL CONTROL; DIARYLETHENE DERIVATIVES; MOLECULAR SWITCHES; PARTIAL AGONISTS; DRUG DISCOVERY; IN-VIVO; LIGHT; INHIBITORS; DESIGN; dithienylethene; dopamine; fulgimide; gpcr; photoswitch (1)
Byr2; Ras-binding domain; sequential assignment (1)
B Zell-Rekonsitution; HSCT; (1)
C11ORF95-RELA FUSIONS; PATHOLOGICAL ACTIVATION; CANCER; TARGET; YAP; SUBSET; MAMLD1; childhood; ependymoma; supratentorial; YAP1-MAMLD1 fusion (1)
; C-14; Sr-90; Th-228/232; Dating; Ivory (1)
C1 INHIBITOR; C1-INHIBITOR DEFICIENCY; MONONUCLEAR-CELLS; BETA-ENDORPHIN; EXPRESSION; WOMEN; GLOBULIN; SULFATE; adrenocorticotropic hormone; cortisol; danazol; dehydroepiandrosterone; hereditary angioedema; testosterone (1)
C2; C3 (1)
C2 DOMAIN; FAMILY; MODULATION; ACTIVATION; PLATFORM; POLARITY; REVEALS; COMPLEX; BINDING; TOOL; Smurf HECT ligases; WW domain; Auto-inhibition; Ubiquitination; Methyl NMR spectroscopy (1)
C2-SYMMETRICAL BIS(PHOSPHOLANES); ASYMMETRIC CATALYSIS; REDUCTION; DIPHOSPHINE; enantioselectivity; diastereoselectivity; hydrogenation; folic acid; leucovorin; 2-methylquinoxaline; Rhodium(I) catalysts (1)
C68, H55, J12, J26, Intensive and extensive labor supply, overlapping generations, old-age poverty (1)
C68, J24, J26, H55, Pension systems, human capital investment, numerical OLG model (1)
CA2+-ACTIVATED CHLORIDE CHANNELS; HISTONE DEACETYLASE; OXIDATIVE STRESS; ANOCTAMIN 6; CELL-DEATH; IDEBENONE; CA2+; CFTR; INHIBITION; SECRETION; ADPKD; TMEM16A; reactive oxygen species; lipid peroxidation; ferroptosis; anoctamin 1 (1)
CA2+-ACTIVATED CL-CHANNEL; ACTIVATED CHLORIDE CHANNELS; OPERATED CA2+ ENTRY; RAT SENSORY NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EPITHELIAL ANOCTAMINS; INTERSTITIAL-CELLS; MOUSE INTESTINE; CORTICAL ER; LIPID RAFTS; TMEM16A; TMEM16D; TMEM16F; anoctamin; Ca2+ signaling (1)
CA2+-ACTIVATED CL-CHANNEL; ASCITES TUMOR-CELLS; ANION CHANNELS; ESSENTIAL COMPONENT; ENDOTHELIAL-CELLS; IONIC-STRENGTH; HEK293 CELLS; A(2); ACTIVATION; TMEM16F; TMEM16F; Anoctamin 6; Volume regulation; Regulatory volume decrease; RVD; Volume-regulated anion channel; VRAC; Apoptosis (1)
CA2+-ACTIVATED CL-CHANNEL; INDEPENDENT ACTIVATION; CALCIUM; EXPRESSION; TMEM16A; PROTEIN; FAMILY; PORES; FORMS; (1)
CA2+-ACTIVATED CL-CHANNELS; COLLECTING DUCT CELLS; H+-ATPASE ACTIVITY; EPITHELIAL-CELLS; PROXIMAL TUBULES; PRIMARY CULTURES; MOUSE MODEL; KIDNEY; SECRETION; TMEM16A; Ano1; Anoctamin 1; Ca2+ -activated Cl- channels; H+-ATPase; renal proximal tubules; TMEM16A (1)
CA2+-ACTIVATED CL-CHANNELS; PROTEIN-KINASE; CHLORIDE CHANNELS; CYSTIC-FIBROSIS; SMOOTH-MUSCLE; ANOCTAMIN 6; CALCIUM; CONDUCTANCE; ACTIVATION; MODULATION; TMEM16A; calmodulin; CAMKII; calcineurin; Ca2+-activated Cl- channel; anoctamin 1; CAM (1)
CA2+-ACTIVATED K+ CHANNEL; INTERMEDIATE-CONDUCTANCE; MURINE ASTROCYTOMA; IMMUNE CELLS; DOUBLE-BLIND; TGF-BETA; GLIOBLASTOMA; RADIOTHERAPY; TEMOZOLOMIDE; MIGRATION; (1)
CA2+-ACTIVATED K+ CHANNELS; CYCLE-DEPENDENT EXPRESSION; REGULATED ANION CHANNELS; HUMAN PROSTATE-CANCER; APOPTOTIC VOLUME DECREASE; TUMOR-CELL PROLIFERATION; ACTIVATED CL-CURRENTS; GO POTASSIUM CHANNELS; INTERMEDIATE-CONDUCTANCE; CHLORIDE CHANNEL; cancer; ion channels; K+ channels; Cl- channels; proliferation; cell cycle; mitogens; oncogenic; apoptosis; growth (1)
CA2+-ACTIVATED K+ CHANNELS; FIBROBLAST GROWTH FACTOR-2; INTRA-GOLGI TRANSPORT; CANINE KIDNEY-CELLS; MALIGNANT-MELANOMA; ENDOPLASMIC-RETICULUM; MATRIX-METALLOPROTEINASE; CYCLE PROGRESSION; EPITHELIAL-CELLS; ION CHANNELS; MIA protein; KCa3.1 potassium channel; migration; directed transport; regulated secretion (1)
CA2+-ACTIVATED K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNELS; ANDROGEN RECEPTOR; BK CHANNEL; TISSUE MICROARRAYS; CELL-PROLIFERATION; EXPRESSION; GENE; ACTIVATION; (1)
CA2+-ACTIVATED K+ CHANNELS; ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-A; HEART IN-VIVO; ATP-CHANNELS; RAT-HEART; INDUCED CARDIOPROTECTION; SEVOFLURANE; INHIBITION; MICE; anaesthetics volatile; desflurane; heart; ischaemia; potassium channels (1)
CA2+-ACTIVATED K+ CHANNELS; STIMULATES CL-SECRETION; SMOOTH-MUSCLE-CELLS; INTERMEDIATE-CONDUCTANCE; PROTEIN-KINASE; INTERSTITIAL-CELLS; POTASSIUM CHANNELS; CYSTIC-FIBROSIS; MOUSE JEJUNUM; ACINAR-CELLS; Ca2+ -activated Cl- channels; anoctamin 1; exocytosis; SK4; 1-EBIO; cystic fibrosis (1)
Ca2+/Calmodulin-abhängige Proteinkinase II, akute Nachlasterhöhung, transverse aortic constriction (1)
Ca2+/calmodulin-dependent kinase II; Ryanodine receptor 2; SR Ca2+ leak; Heart failure (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; FATTY-ACID OXIDATION; COTRANSPORTER 2 INHIBITION; KETONE-BODY METABOLISM; NA+/H+ EXCHANGER; CARDIAC-HYPERTROPHY; GLUCOSE-TRANSPORTER; INSULIN-RESISTANCE; PRESSURE-OVERLOAD; LIPID-METABOLISM; Empagliflozin; SGLT2 inhibitor; CaMKII; GLUT1; Heart failure; Cardiac metabolism (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CARDIAC MYOCYTES; CARDIOMYOCYTE CONTRACTILITY; SKELETAL-MUSCLE; CALCIUM LEAK; HYPERTROPHY; INTENSITY; DISEASE; CAMKII; calcium handling; CaM kinase; exercise training; heart disease (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; RETICULUM CA2+ LEAK; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; HEART-FAILURE; PHOSPHORYLATION; MODEL; MECHANISMS; EXPRESSION; ISOFORM; CaMKII; Ca2+ handling; Heart failure (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; RETICULUM CA2+ LEAK; PRESSURE-OVERLOAD; NUCLEAR-ENVELOPE; ATRIAL MYOCYTES; II-DELTA; PHOSPHORYLATION; CARDIOMYOCYTES; ENDOTHELIN-1; ACTIVATION; calcium; CaMKII; heart failure; hypertrophy; mice (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SARCOPLASMIC-RETICULUM CA2+; T-WAVE ALTERNANS; POLYMORPHIC VENTRICULAR-TACHYCARDIA; ACTION-POTENTIAL PROLONGATION; BETA-ADRENERGIC STIMULATION; HISTONE H3 PHOSPHORYLATION; ACUTE-CORONARY-SYNDROME; LONG QT SYNDROME; LATE I-NA; alternans; arrhythmias; calcium; calcium; calmodulin-dependent kinase II; sodium (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SODIUM-CHANNEL; INDEPENDENT ACTIVATION; ALPHA-SUBUNIT; HEART; PHOSPHORYLATION; CONTRACTION; STIMULATION; TRAFFICKING; MODULATION; Calcium; calmodulin-dependent protein kinase II; Sodium channels; Adrenergic stimulation; Paclitaxel; Microtubules (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SR CA2+ LOAD; SARCOPLASMIC-RETICULUM; INTRACELLULAR PH; CONTRACTILE RECOVERY; PHOSPHOLAMBAN; ACTIVATION; HEART; PHOSPHORYLATION; ARRHYTHMIAS; acidosis; calcium signaling; CaMKII; excitation-contraction coupling; redox signaling (1)
CA2+ CHANNELS; RYANODINE RECEPTORS; CALCIUM-CHANNELS; CL-CURRENTS; CELLS; RELEASE; ION; POTENTIATION; INHIBITION; GENERATION; Retinal pigment epithelium; Ion channels; Orai; ICRAC; Calcium signaling (1)
CA-2+-DEPENDENT PHOSPHOLIPID-BINDING; SOLID-SUPPORTED MEMBRANES; N-TERMINAL DOMAIN; MEDIATED MEMBRANE; EARLY ENDOSOMES; LIPOCORTIN-I; CALCIUM; AGGREGATION; VISUALIZATION; PHOSPHORYLATION; annexins; calcium; lipid bilayers; membrane proteins; protein binding (1)
CA2+-SENSING RECEPTOR GENE; NEONATAL SEVERE HYPERPARATHYROIDISM; SENSING RECEPTOR; BENIGN HYPERCALCEMIA; DIABETES-MELLITUS; MUTATIONS; EXPRESSION; DISEASE; calcium-sensing receptor; familial hypocalciuric hypercalcemia; calcium metabolism (1)
CA4, Carboanhydrase, kolorektales Karzinom, Promotormethylierung (1)
; CABG; coronary artery; coronary artery bypass grafting; postoperative complication; sleep apnea (1)
CABSI, ABHR, TISS-28, SAPS-II, alcohol based, CVC, Alcohol-Based Handrub, alcohol-based hand rub dispensers, (1)
Ca/Calmodulin-abhängige Kinase II; CaMKII; SR-Kalziumleck; CaMKII-Inhibition (1)
CACTUS NEOBUXBAUMIA-TETETZO; SEEDLING ESTABLISHMENT; SEMIARID ENVIRONMENT; TEHUACAN VALLEY; PATCH DYNAMICS; ARID SAVANNA; TREES; VEGETATION; SOILS; FACILITATION; directed dispersal; facilitation; nurse plants; germination cue; daily temperature fluctuation; maximum temperature; fleshy-fruited plants; ornithochory; Kalahari; arid environments (1)
Cadaveric vertebral bone marrow; organ transplantation; bone marrow transplantation; mesenchymal stem cells; CFU-F (1)
CAD/CAM COMPOSITE RESIN; FIXED PARTIAL DENTURES; IN-VITRO; LABORATORY SIMULATION; MARGINAL ADAPTATION; OCCLUSAL VENEERS; RESISTANCE; SYSTEMS; FAILURE; FORCE; CEREC; All-ceramic crowns; Minimal; Artificial aging; Fracture strength (1)
CAD/CAM Rauheit Oberflächenenergie (1)
CAD-CAM , Zirkoniumdioxid , Bruchfestigkeit , Randschluss , Metallkeramik , Zahnkrone , Zirkoniumoxydkeramik , Lasersintern , CAD-CAM , Zirkoniumdioxid , laser sintered , fracture resistance , marginal adaptation (1)
CADHERIN-MEDIATED ADHESION; APICAL CONSTRICTION; DROSOPHILA-MELANOGASTER; ACTOMYOSIN CONTRACTILITY; CONVERGENT EXTENSION; ACTIN CYTOSKELETON; PLANAR POLARITY; GENE-EXPRESSION; DORSAL CLOSURE; SHROOM; (1)
cadmium sulfate aq liq structure cond aq cadmium sulfate permittivity aq cadmium sulfatete (1)
; CAEBV; EBV-specific T cells; allogeneic stem cell transplantation; anti-T-lymphocyte globulin (1)
CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PAZ DOMAIN; C-ELEGANS; MACROPHAGE ACTIVATION; SLICER ACTIVITY; RISC; COMPLEX; INTERFERENCE; Argonaute proteins; gene silencing; microRNA; phosphorylation; RISC (1)
caesarean scar defect; contrast hysterosonography; isthmocele; uterine niche; uterotomy closure technique; wound healing. (1)
Caesarean section, postoperative infection, postpartum infection, prophylactic antibiotics, timeframe of antibiotic application, wound infection (1)
CAFFEINE; COMPLEXES; caffeine; crystal structure; photoluminescence; platinum; zinc (1)
cage compounds, tripledecker complexes, polypnictogen ligands, phosphorus, arsenic, E₄ activation, supramolecular chemistry, self-assembly, three-component reactions (1)
CAG PATHOGENICITY ISLAND; GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; VACUOLATING CYTOTOXIN; GASTRODUODENAL DISEASE; INTERLEUKIN-12 PRODUCTION; NEISSERIA-MENINGITIDIS; CYTOKINE PRODUCTION; PEPTIC-ULCERATION; MONGOLIAN GERBIL; (1)
Cahn–Hilliard, diffuse interface model, low Mach number limit, Navier–Stokes, two-phase flow (1)
Cahn–Hilliard equation, Biot’s equations, Poroelasticity, Existence analysis, Mixed boundary conditions, Maximal regularity (1)
Cahn–Hilliard equation, Biot’s equations, Poroelasticity, Well-posedness, Maximal regularity. (1)
Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Non-degenerate mobility, Uniqueness, Regularity, Convergence to steady states (1)
CAHN-HILLIARD EQUATION; DISCRETIZATION; dynamic boundary conditions; PDAE; splitting methods; bulk-surface splitting; parabolic equations (1)
Cahn&-Hilliard equation; dynamic boundary conditions; relaxation by Robin boundary conditions; gradient flow; finite element analysis (1)
CAHN-HILLIARD EQUATION; INCOMPRESSIBLE FLUIDS; WEAK SOLUTIONS; EXISTENCE;   Two-phase flow; Navier-Stokes equation; diffuse interface model; mix-tures of viscous fluids; Cahn-Hilliard equation; non-local operators (1)
CAHN-HILLIARD EQUATION; LUBRICATION APPROXIMATION; PARABOLIC EQUATION; EXISTENCE; EVOLUTION; BEHAVIOR; partial differential equations; degenerate parabolic equation; thin liquid film; surfactant spreading; free surface; fluid interface (1)
Cahn-Hilliard equation; Nonlocal Cahn-Hilliard equation; Nonlocal operators; Nonlocal-to-local convergence; Singular limit (1)
CAHN-HILLIARD EQUATION; PHASE-FIELD MODEL; FINITE-ELEMENT APPROXIMATION; GEOMETRIC EVOLUTION-EQUATIONS; SHARP; MOTION; FILMS; CURVATURE; EXISTENCE; DYNAMICS; Solid-state dewetting; Cahn-Hilliard equation; Anisotropy; Sharp-interface limit; Weak solutions; Finite element method (1)
CAHN-HILLIARD EQUATION; PHASE FIELD MODEL; SINGULAR LIMIT; SIMULATION; CONVERGENCE; BOUNDARY; Reaction-diffusion system; singular perturbation; interface motion; matched asymptotic expansion; tumor-growth model; phase-field model; gradient flow; stabilized Crank-Nicolson method; convex-splitting scheme (1)
CAHN-HILLIARD; EQUATIONS; EVOLUTION; Two-phase flow; diffuse interface model; sharp interface limit; Cahn-Hilliard equation; free boundary problems (1)
CAHN-HILLIARD FLUIDS; PHASE-FIELD MODEL; HELE-SHAW CELL; ORDER-PARAMETER; SPACES; RECONNECTION; PINCHOFF; MIXTURE; BESOV; two-phase flow; free boundary value problems; diffuse interface model; mixtures of viscous fluids; Cahn-Hilliard equation; inhomogeneous Navier-Stokes equation (1)
CAHN-HILLIARD FLUIDS; PHASE-FIELD MODEL; HELE-SHAW CELL; RECONNECTION; PINCHOFF; Two-phase flow; diffuse interface model; Cahn-Hilliard equation; free boundary value problems (1)
CAHN-HILLIARD; MOTION; FLOW; surface diffusion; gradient flow; stability of stationary solutions; eigenvalues; isoperimetric problems (1)
Cahn-Hilliard, primal-dual active set method, semi-smooth Newton method, preconditioning (1)
CAHN-HILLIARD SYSTEM; 3 SPATIAL DIMENSIONS; BOUNDARY CONTROL; EXISTENCE; GROWTH; MODEL; Quasilinear parabolic equation; Allen-Cahn equation; Anisotropy; Optimal control; Implicit discretization; Convergence analysis (1)
CAHN-HILLIARD SYSTEM; OPTIMAL DISTRIBUTED CONTROL; DARCY MODEL; SIMULATION; CHEMOTAXIS; INVASION; Optimal control with PDEs; calculus of variations; tumor growth; Cahn-Hilliard equation; Brinkman equation; first-order necessary optimality conditions; second-order sufficient optimality conditions; uniqueness of globally optimal solutions (1)
CAHN-HILLIARD SYSTEM; OPTIMAL DISTRIBUTED CONTROL; WELL-POSEDNESS; MIXTURE MODEL; DARCY SYSTEM; CHEMOTAXIS; EQUATION; Tumor growth; Cancer treatment; Free terminal time; Distributed optimal control; Cahn-Hilliard equation; Well-posedness (1)
Cahn--Hilliard; tumour growth; viscoelasticity; Oldroyd-B; finite element method; numerical analysis; diffuse-interface; sharp interface (1)
Cahn-Larché, Cahn-Hilliard, sharp interface limit, asymptotic analysis (1)
CAI; Innovationssoftware; computer aided innovation (1)
Calcaneusfraktur, Calcaneocuboidgelenk, Fraktur, Frakturlinienverlauf, Frakturklassifikation (1)
Calcaneusfrakturen, Plattenosteosynthese, minimal-invasiv, SF-36, AOFAS-Score, Pedographien (1)
CALCAREOUS GRASSLAND; LOCAL ADAPTATION; SALVIA-PRATENSIS; POPULATION-SIZE; S-COLUMBARIA; VULGARIS L; DIVERSITY; EXTINCTION; PHENOLOGY; HABITATS; Selection; Land use; Calcareous grasslands; Flowering-time; Genetic diversity; Phenology (1)
calcareous grasslands, dormancy, longevity index, soil seed bank, light requirements for germination, alternating temperature requirements for germination, burial depth (1)
CALCAREOUS GRASSLANDS; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; CONSERVATION; CONSEQUENCES; DYNAMICS; TRAITS; RESTORATION; RICHNESS; FITNESS; Conservation genetics; European grasslands; Genetic diversity; Landscape ecology; Land use (1)
Calcareous grassland; soil seed bank; species richness; seed mass (1)
CALCAREOUS GRASSLANDS; PLANT CONSERVATION; HISTORY; LAND; COMMUNITIES; SCALE; CHRONOSEQUENCES; SUBSTITUTION; HYPOTHESIS; VEGETATION; Arable-to-grassland succession; Landscape dynamics; Soil nutrients; Space-for-time; Species frequencies; Substitute habitat (1)
CALCAREOUS GRASSLANDS; PLANT; POPULATION; LITTER; SIZE; biodiversity; covariation; fragmentation; island biogeography; SGDC (1)
CALCAREOUS GRASSLANDS; POPULATION; METHYLATION; PLANTS; SAXIFRAGACEAE; HETEROGENEITY; CONSERVATION; PERSPECTIVE; DISPERSAL; DIVERSITY; calcareous grasslands; ecotypes; epigenetics; habitat differentiation; Linum catharticum; litter meadows (1)
CALCINEURIN INHIBITION; HUMAN BILE; BLOOD; KIDNEY; RECIPIENTS; LIVER; EXCRETION; THERAPY; (1)
CALCINEURIN INHIBITOR; ORGAN ALLOCATION; RISK-FACTORS; DYSFUNCTION; CONVERSION; MULTICENTER; MONOTHERAPY; THERAPY; IMPACT; Everolimus; Early initiation; Liver transplantation; HCC; MELD (1)
Calcineurin inhibitors, Hepatitis, Immunosuppression, Liver transplantation (1)
CALCINEURIN INHIBITORS; MYCOPHENOLIC-ACID; RECIPIENTS; INFECTION; CYTOMEGALOVIRUS; SURVIVAL; GERMANY; HEV; THERAPY; SAFETY; (1)
CALCIUM ALGINATE GELS; ADSORPTION; GELATION; POLYSACCHARIDES; MORPHOLOGY; SIMULATION; polyelectrolytes; ionotropic gels; Brownian dynamics simulation (1)
CALCIUM; ANOCTAMINS; ACTIVATION; SECRETION; SIGNALS; ANO1; CFTR; Cystic fibrosis transmembrane conductance regulator; Cystic fibrosis; CF; TMEM16A; Anoctamin 1; TMEM16F; Anoctamin 6; Ca2+-activated Cl- channel; Phospholipid scramblase (1)
CALCIUM BINDING GLYCOPROTEIN; CYLINDROTHECA FUSIFORMIS; DIATOM CELL WALL; SILICA DEPOSITION VESICLE (1)
CALCIUM-BINDING PROTEINS; CLAUSTROCORTICAL CONNECTIONS; INTERNEURONS; PARVALBUMIN; EXPRESSION; TRANSPORT; CALBINDIN; CORTEX; calcium-binding proteins; calretinin; claustrum; endopiriform nucleus; rat (1)
CALCIUM-CARBONATE; BARIUM CARBONATE; ORIENTED ATTACHMENT; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BLOCK-COPOLYMER; PHASE; CRYSTALLIZATION; STABILIZATION; TRANSFORMATION; core-shell nanoparticles; barium carbonate; silica; biomimetic self-assembly; biomorphs; layer-by-layer mineralization; amorphous precursor phases (1)
CALCIUM-CARBONATE; BARIUM CARBONATE; RICH ENVIRONMENTS; BIOMINERALIZATION; SYSTEMS; NANOSTRUCTURES; MINERALIZATION; PRECIPITATION; MORPHOGENESIS; NANOCRYSTALS; Silica biomorphs; Biomimetic self-assembly; Cooperative precipitation; Crystal growth; Nanomaterials; Barium carbonate (1)
Calcium carbonate, Barium carbonate, Silica, ACC, Silica-Carbonate Biomorphs, Autocatalytic self-assembly, Core-shell nanoparticles, Prenucleation clusters, Homogeneous nucleation, Nanocrystalline materials, Energy-dispersive X-ray diffraction, Biomimetic mineralization (1)
CALCIUM-CARBONATE PARTICLES; PRECIPITATION; MORPHOLOGIES; GEOMETRY; CACO3; (1)
CALCIUM-CHANNEL BLOCKERS; DRUG-DRUG INTERACTIONS; PHARMACOKINETIC CONSIDERATIONS; IN-VITRO; RISPERIDONE; CYP2D6; GENOTYPE; ANTIPSYCHOTICS; METABOLISM; DEPRESSION; therapeutic drug monitoring; venlafaxine; amlodipine; ramipril; cytochrome P450; interaction; CYP3A4; pharmacokinetics (1)
CALCIUM-CHANNEL BLOCKERS; UREA-SALT MIXTURES; ACID-ESTERS; CYCLOCONDENSATION REACTION; POTENT MIMICS; SOLVENTS; ANTAGONISTS; 3,4-DIHYDROPYRIMIDIN-2(1H)-ONES; DERIVATIVES; INHIBITOR; green protocol; mild conditions; no additional catalyst; solvent free; triple role of melt (1)
CALCIUM-CITRATE; WATER DYNAMICS; RELAXATION; COMPLEXES; RANK; METABOLISM; POTASSIUM; STABILITY; CHEMISTRY; CONSTANTS; (1)
calcium, dietary minerals, maternal nutrition, pregnancy, vegetarian diet (1)
Calcium , Durchflusscytometrie , Fluoreszenz , Radioaktivität , Aequorin , CRE , Histaminrezeptor , Ligand <Biochemie> , Biologische Aktivität , G-Protein gekoppelter Rezeptor , chimäres G-Protein , Fura-2 , pharmakologische In-vitro-Assays , HEK293 Zellen , G-protein coupled receptor , chimeric G-protein , fura-2 , pharmacological in vitro assays , HEK293 cells (1)
CALCIUM; FORM; ISK; K+; K(V)LQT1; PROTEINS; TMEM16A; KCNE1; KCNQ1; Channel regulation; Voltage dependence; Ca2+ activated Cl- channel (1)
Calcium • Heart failure • Human cardiomyocytes • Semaglutide (1)
CALCIUM HYDROXYLAPATITE; COLLAGEN INJECTION; PARALYSIS; CORD; BIOMATERIALS; SURGERY; CANINE; GELS; (1)
CALCIUM-PHOSPHATE CEMENT; UNSTABLE INTERTROCHANTERIC FRACTURES; OSTEOPOROTIC COMPRESSION FRACTURES; HIP FRACTURE; INTERNAL-FIXATION; MINERAL DENSITY; PERCUTANEOUS VERTEBROPLASTY; TROCHANTERIC FRACTURES; OPEN REDUCTION; FAILURE LOAD; hip; fracture; osteoporosis; cement; reinforcement; augmentation; femoroplasty (1)
CALCIUM-PHOSPHATE; DENTAL COMPOSITES; ION RELEASE; NANOPARTICLES; bioreactor; secondary caries; caries model; DCPD; micro-CT (1)
CALCIUM-PHOSPHATE NANOPARTICLES; PHOSPHORESCENT PROBES; INTRACELLULAR OXYGEN; DISSOLVED-OXYGEN; LIVE CELLS; CANCER; NANOSENSORS; FLUOROMETRY; FLUOROPHORE; COMPLEXES; (1)
CALCIUM-SENSING RECEPTOR; ACID-PHOSPHATASE; OSTEOBLAST DIFFERENTIATION; BISPHOSPHONATE RISEDRONATE; BONE-RESORPTION; MOVEMENT; EXPRESSION; INHIBITION; OSTEOPOROSIS; SYSTEM; Strontium ranelate; Tooth anchorage; Cone-beam computed tomography; Orthodontic tooth movement; Quantitative real time PCR; Root resorption (1)
CALCIUM-SENSING RECEPTOR; MINERALIZATION IN-VITRO; BONE-FORMATION; EXTRACELLULAR CALCIUM; TRANSCRIPTION FACTOR; CELL REPLICATION; GENE-EXPRESSION; RANELATE; CBFA1; DIFFERENTIATION; Strontium; Cleidocranial dysplasia; Runx2; Osteoblast; Hydroxyapatite (1)
CALCULATION ALGORITHMS; RADIATION-THERAPY; PECTUS EXCAVATUM; IRRADIATION; OPTIMIZATION; VMAT; Breast cancer; Funnel chest; Pectus excavatum (1)
calculations, computations, endogenous, locomotion, computer-generated, codes (1)
CALF VITREOUS HYALOCYTES; PROLIFERATION; HOECHST-33258; COLLAGEN; CULTURE; GEL; DNA; EYE; hyalocyte; cell culture; FACS; cell adhesion (1)
"Calibration", "Cluster Analysis", "Computers, Molecular", "Gene Expression Profiling", "Humans", "Internet", "Phenotype", "Protein Array Analysis", "Software", "User-Computer Interface" (1)
California Channel Islands, environmental activism, ecological crisis, T.C. Boyle: When the Killing’s Done (1)
CALLOUS-UNEMOTIONAL TRAITS; ANTERIOR CINGULATE CORTEX; ANTISOCIAL-BEHAVIOR; SUBSTANCE USE; CHILDREN; ADOLESCENTS; PSYCHOPATHOLOGY; PERSONALITY; ACTIVATION; DISORDERS; Taylor Aggression Paradigm; Externalizing spectrum; fMRI; Anterior cingulate cortex (1)
CALLOUS-UNEMOTIONAL TRAITS; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; PSYCHOPATHIC TENDENCIES; ANTISOCIAL-BEHAVIOR; DISRUPTIVE BEHAVIOR; ANIMATED SHAPES; MENTAL STATES; MIND; ADOLESCENTS; Empathy; autism spectrum disorder; conduct disorder; callous-unemotional traits; development (1)
CALMETTE-GUERIN BCG; TERM-FOLLOW-UP; UROTHELIAL CARCINOMA; DEPRIVATION THERAPY; STAGE; PROGRESSION; GRADE; RECURRENCE; GUIDELINES; PREDICTS; androgen receptor; bladder cancer; KRT5; KRT20; mRNA; NMIBC; PCR (1)
CALMODULIN-BINDING DOMAIN; PLANT SAUR GENES; REGULATED GENES; GLUTAMATE-DECARBOXYLASE; SYNTHESIS INHIBITORS; MESSENGER-RNAS; GROWTH; ACID; ARABIDOPSIS; COLEOPTILES; (1)
CALMODULIN-BINDING; STRUCTURAL BASIS; FLUORESCENT; INHIBITION; ANALOGS; PROTEINS; SITE; (1)
calmodulin; heart failure; myocardium; neurons; sarcoplasmic reticulum (1)
CALORIC RESTRICTION; L-CARNITINE; GAMMA-BUTYROBETAINE; FATTY-ACIDS; INTENSITY; APOPTOSIS; SYSTEM; CELLS; INFLAMMATION; COMBINATION; apoptosis; exercise; fasting; immune function; lymphocyte (1)
CALORIC STIMULATION; PARIETAL CORTEX; DIRECTION; MOTION; CONNECTIVITY; PARCELLATION; RETINOTOPY; ACTIVATION; MECHANISMS; REGIONS; functional MRI; pericallosal; retrosplenial; vestibular; visual motion (1)
CALORIC STIMULATION; TEMPOROPARIETAL JUNCTION; PARIETAL CORTEX; PERSPECTIVE; SELF; ROTATION; MECHANISMS; TRANSFORMATIONS; EXPERIENCE; BRAIN; (1)
calprotectin; biomarker; critical care; bloodstream infections; COVID-19 (1)
Calprotectin, Cholesterol, Inflammation, Cholangitis (1)
Calprotectin, Inflammatory bowel disease, Disease activity, Primary sclerosing cholangitis (1)
CALVE-PERTHES-DISEASE; CORE DECOMPRESSION; OSTEOCHONDRITIS-DISSECANS; AVASCULAR NECROSIS; OSTEONECROSIS; HIP; PRECISION; ACCURACY; NAVIGATION; DIAGNOSIS; core decompression; osteonecrosis; osteochondritis dissecans; precision; CAOS; adiposis (1)
cambium; chilling temperatures; conifers; forcing temperatures; phenological models; wood phenology (1)
CAMBRIDGE STRUCTURAL DATABASE; AB-INITIO; DISTORTION; DFT (1)
CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL-REACTION PATHS; CRYSTAL; DISTORTION (1)
CAMBRIDGE STRUCTURAL DATABASE; CRYSTAL-STRUCTURES; amino acids; chirality; conformation; peptides; valine (1)
CAM; CLASSIFICATION; PHYSICIANS; THERAPIES; complementary and alternative medicine; CAM; individual health services; out-of-pocket payment (1)
CaMKII, Arythmie, heart failure (1)
CaMKII delta, Autophoyphorylierungsfähigkeit (1)
CaMKII, ethanol, arrhythmias, Ca leak, Ca sparks (1)
CaMKII; heart failure; SGLT2 inhibitors (1)
CaMKII, OSAS, Schlafapnoe, Herzinsuffizienz, Vorhofflimmern (1)
campo de altitude; campo rupestre; canga; dispersal season; dispersal syndrome; inselberg; seed dormancy; seed mass; seed viability (1)
Campus Management (1)
CAMPYLOBACTER-JEJUNI COLONIZATION; MEAT QUALITY; LARVAE OIL; ACID; FEED; SUPPLEMENTATION; CHICKENS; MASS; Broilers; Cecal microbiota; Hermetia illucens; Insect fat; Liver lipidome; Medium-chain fatty acids (1)
Campylobacter jejuni , Genexpression , Transforming Growth Factor , Tryptophan , Zytoskelett , Darmepithelzellen , CaCo-2 , Invasion , cytoskeleton , intestinal epithelial cells , CaCo-2 , Invasion (1)
CAMPYLOBACTER-JEJUNI; TRAVELERS DIARRHEA; FLAGELLIN; VACCINE; COLONIZATION; PROTEINS; CELLS; SILAC; Escherichia coli; Surface proteins; Vaccine; Proteomics (1)
CanA, Pyrodictium abyssi, Cannulae (1)
CANARY-ISLANDS; SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; ASTERACEAE; EVOLUTION; NUCLEAR; CHLOROPLAST; BIOGEOGRAPHY; CLASSIFICATION; INFERENCE; Arabian Peninsula; ITS; Macaronesia; Mid-Atlantic archipelagos; Phylogeny; Phytogeography (1)
CANCELLATION SYSTEMS; ALGORITHMS; QUALITY; Assistive technology; hearing aids; phase cancellation; sound quality (1)
CANCELLOUS BONE SCREWS; ARTHRODESIS; QUALITY; IOFIX; X-post; Lag screw; Compression; Arthrodesis; Fusion (1)
CANCER; ADENOCARCINOMA; MANAGEMENT; DIAGNOSIS; pancreas; structured reporting; template; MRI; CT (1)
CANCER; APOPTOSIS; PROTEIN; BONE; REVEALS; TARGET; (1)
CANCER; BIOETHICS; EDUCATION; DILEMMAS; BEHAVIOR; IMPACT; radio-oncology; medical ethics; medical education; survey; casuistic bioethics (1)
CANCER BIOLOGY; ANGIOGENESIS; ACID; PRODUCTS; REPAIR; CELLS; HPTLC; Hyalobiuronic acid; Hyaluronan; HPTLC; Amino-modified silica; Densitometric quantification (1)
CANCER CACHEXIA; MALIGNANT-MELANOMA; MASS-SPECTROMETRY; CELLS; PROTEOME; RECEPTOR; INFLAMMATION; IDENTIFICATION; PROGRESSION; EXPRESSION; (1)
CANCER; CARCINOMA; RESOLUTION; THYMOMA; CELL; CLASSIFICATION; EXPRESSION; RESISTANCE; DIAGNOSIS; CYCLE; thymoma; thymic carcinoma; HRMAS H-1-NMR; metabolomics; biomarker (1)
Cancer care; Knowledge transfer; Low-income countries; Middle-income countries; Education programmes; Quality; National cancer control plan (1)
CANCER CARE; ONCOLOGY; HEALTH; MEDICINE; IMPACT; (1)
CANCER-CELL-GROWTH; BREAST-CANCER; MUTATED ERBB4; ISOFORMS; SURVIVAL; TARGET; HER4 (1)
CANCER-CELL-LINES; HISTONE DEACETYLASE INHIBITORS; HUMAN CUTANEOUS MELANOMA; ACUTE MYELOID-LEUKEMIA; MICROPHTHALMIA TRANSCRIPTION FACTOR; DNA METHYLTRANSFERASE INHIBITORS; TUMOR-SUPPRESSOR GENES; C-MYC ONCOPROTEIN; HUMAN MTA1 GENE; PROMOTER HYPERMETHYLATION; malignant melanoma; epigenetics; methylation; histone modification; chromatin remodelling (1)
CANCER CELL-LINES; SODIUM/IODIDE-SYMPORTER; NA+/I-SYMPORTER; IN-VIVO; SALIVARY-GLAND; BREAST-CANCER; TC-99M PERTECHNETATE; PROSTATE-CANCER; GASTRIC-MUCOSA; MAMMARY-GLAND; Sodium iodide symporter; Re-186-Perrhenate; Rhenium-186; Neuroendocrine tumours; Radionuclide therapy (1)
CANCER CELL-LINES; STEROID-RECEPTORS; POSITIVE SELECTION; KI-67 EXPRESSION; CARCINOMA; BREAST; DIFFERENTIATION; PROTEIN; OVARIAN; MARKER; Icb-1 gene; C1orf38; Endometrial cancer (1)
CANCER-CELL-LINES; XANTHOHUMOL; FLAVONOIDS; L.; HOP; PRENYLFLAVONOIDS; ACTIVATION; APOPTOSIS; SURVIVAL; DEATH; (1)
CANCER CELLS; COLON-CANCER; PROSTAGLANDIN E-2; AUTOCRINE LOOP; MESSENGER-RNA; ANTIBODY A12; ANGIOGENESIS; VIVO; METASTASIS; ACTIVATION; cyclooxygenase-2; pancreatic cancer; insulin-like growth factor-I receptor; IRS-1; signaling (1)
CANCER CELLS; EXPRESSION; CHEMORESISTANCE; RESISTANCE; APOPTOSIS; BETA-1; READS; (1)
CANCER-CELLS; GENETIC ALTERATIONS; TUMOR-CELLS; MICROGLIA; SURVIVAL; LOOP; AKT; IDENTIFICATION; EXTRAVASATION; COLONIZATION; brain metastases; breast cancer; PTEN; microenvironment; astrocytes (1)
CANCER-CELLS; RECEPTOR; ANTAGONISTS; VASOPRESSIN; ACTIVATION; AGONISTS; GROWTH; PROLIFERATION; CONTRACTILITY; ADHESION; oxytocin; Gapmer-induced exon skipping; spheroid; tight junction; intracellular signaling (1)
CANCER-CELLS; THERAPEUTIC TARGET; MOUSE MODELS; LUNG-CANCER; METABOLISM; LIVER; MICE; GROWTH; ROLES; HOMEOSTASIS; beta-catenin; AKT; c-Met; de novo lipogenesis; FASN; targeted therapies (1)
cancer, cholangiocarcinoma, in vitro cancer models, 3D (three-dimensional) models, organoids, tumor spheres, CAM model, personalized medicine (1)
CANCER; CLASSIFICATION; PROGRESSION; GUIDELINES; RECURRENCE; CARCINOMA; SYSTEM; Bladder; Cancer; Carcinomas; Grade; WHO; Nonmuscle-invasive; Urothelial (1)
Cancer; COX2; Dendritic cells; Human; Immune dysfunction; Immunotherapy; Myeloid-derived suppressor cells; PGE2; Transplantation (1)
CANCER; Cre recombinase; herpesvirus; hit-and-run; scenario; mouse model; vaccine (1)
CANCER DETECTION; TRANSRECTAL ULTRASOUND; SYSTEMATIC BIOPSY; ANTIGEN; ELASTOGRAPHY; PROJECT; MEN; Prostate cancer; Real-time sonoelastography (RTE); Detection rate; Primary biopsy; Re-biopsy (1)
CANCER; DIAGNOSIS; Ovarialkarzinom; Nachsorge; Rehabilitation; Palliation; Psychoonkologie; Ovarian cancer; Follow-up; Rehabilitation; Palliation; Psycho-oncology (1)
Cancer, Elicitin, Phythophtora, MAPK, H2O2, Microtubule destruction, Warburg effect (1)
; cancer; EORTC sexual health; EORTC SHQ-22; questionnaire; questionnaire development; sexual health (1)
cancer epidemiology, meta-analysis, obesity, ovarian neoplasm, overweigh (1)
Cancer epidemiology; Predictive markers; Type 2 diabetes (1)
CANCER; EVOLUTION; APOPTOSIS; BIOLOGY; SYSTEMS; anakoinosis; computational model; cancer; drug repurposing; biomodulatory therapy (1)
CANCER EXOSOMES; ENHANCE ANGIOGENESIS; GLIOMA-CELLS; NEUTROPHILS; SECRETION; INNATE; MACROPHAGES; ACTIVATION; PROTEINS; MICROVESICLES; tumor-derived exosomes; small extracellular vesicles; angiogenesis; cancer; tumor microenvironment (1)
CANCER; EXPRESSION; ANTAGONISTS; CARCINOMAS; AFFINITY; TUMORS; neuropeptide Y; radiochemistry; radioligands; receptors; antagonists (1)
CANCER; EXPRESSION; TGF-BETA-1; BLOCKADE; EVASION; HEAD; (1)
CANCER; EXPRESSION; VERSICAN; CALDESMON; GROWTH; PROGRESSION; FIBROSIS; COLLAGEN; TUMORS; fibrous capsule; EMT; capsule components; protective border (1)
cancer; gene expression; immunity; prognosis; regulation (1)
Cancer genetics · Cancer progression model · Continuous-time Markov chains · Glioblastoma · Huge combinatorial state spaces · Low-rank tensor formats · Probabilistic graphical models · Proportional hazards · Reconstruction of latent processes (1)
Cancer; Glycolysis; Mitochondrial activity; Tom40 (1)
Cancer, heterogeneity, bioninformatics, microarray (1)
CANCER; IDENTIFICATION; METASTASIS; EXTENSION; MICRORNAS; EXPRESSION; DISCOVERY; PAPILLARY; SURVIVAL; MARKER; (1)
cancer immunotherapy, RNAi screening, RNA-binding proteins, cell adhesion assay (1)
CANCER; LISTS (1)
Cancer, Machine learning, Mathematical modeling, Networks, Software, Tumor evolution (1)
CANCER; MED12; prostate cancer; mutation analysis; Sanger sequencing; microdissection (1)
Cancer; Melanoma; Metastasis; Tumour immunology (1)
Cancer metabolism; Non-small-cell lung cancer (1)
cancer; metastasis; innate immune system; adaptive immune system; immune editing; tumor immune surveillance; IL-15; cancer therapy; cytokine therapy; immunotherapy; exhaustion (1)
cancer, metastasis, single cell, dissemination, stem cells, culture, bone marrow, suppression, Balb neuT, in vitro culture, primary culture (1)
Cancer, metastasis, translocations, (1)
cancer, MYC, NSAID (1)
CANCER; NOMOGRAM; urinary bladder; urothelium; carcinoma; mortality; Germany (1)
; cancer; oncology; communication; questionnaire; quality of life (1)
CANCER PAIN; SYMPTOM CONTROL; CARE-UNIT; MANAGEMENT; GERMANY; NAUSEA; Anaesthesiology; Palliative medicine; Interdisciplinary co-operation; Cancer pain therapy; Palliative medical competence (1)
CANCER; PATHWAYS; CHOLANGIOCARCINOMA; COMBINATION; ACTIVATION; SORAFENIB; MLN0128; FUTURE; GROWTH; PI3K; hepatocellular carcinoma; MEK inhibitor; pan-mTOR inhibitor; PD901; MLN0128; cell proliferation; apoptosis (1)
CANCER-PATIENTS; HOME-CARE; CHILDREN; ONCOLOGY; MALIGNANCY; PHYSICIANS; DYSPNEA; DEATH; PAIN; hematology/oncology; palliative care; quality of life (1)
CANCER-PATIENTS; MENTAL-HEALTH; DISTRESS; DEPRESSION; ANXIETY; NEEDS; PREVALENCE; CAREGIVERS; SURVIVORS; GERMANY; Health services research; Psycho-oncology; Uptake; Rural; Survey (1)
CANCER-PATIENTS; NEGATIVE AFFECT; BLOOD-PRESSURE; EORTC QLQ-C30; POPULATION; QUESTIONNAIRES; ONCOLOGY; THERAPY; TRIALS; quality of life; clinical practice; integrated outcome model (1)
CANCER-PATIENTS; OF-LIFE; INFORMATION; PREFERENCES; END; RESPONSIBILITY; SCHIAVO,TERRI; ATTITUDES; ONCOLOGY; PEOPLE; family; clinical ethics; radio-oncology; autonomy; medical decision-making; values; end of life decisions (1)
CANCER-PATIENTS; PALLIATIVE RADIOTHERAPY; RADIATION-THERAPY; INFORMED CONSENT; CARE; COMMUNICATION; EXPECTATIONS; ONCOLOGISTS; patient information; radiotherapy; score; satisfaction; agreement; questionnaire; doctor-patient relationship (1)
CANCER PREVENTION; REDOX MECHANISM; RETINOIC ACID; LUNG-CANCER; CELLS; VEGETABLES; RESISTANCE; RECEPTORS; LEUKEMIA; (1)
cancer progression model; collider bias; selection bias. (1)
Cancer progression model · Selection bias · Collider bias (1)
cancer progression models, Mutual Hazard Networks, Markov chains, metastasis, cancer genomics, lung cancer (1)
; cancer-related fatigue; counselling; care; diagnostics; management (1)
CANCER-RESEARCH-NETWORK; CELL LUNG-CANCER; PRIMARY SITE; PRIMARY TUMORS; CHEMOTHERAPY; EPIDEMIOLOGY; COMBINATION; CISPLATIN; ETOPOSIDE; DOCETAXEL; neoplasms; unknown primary; randomized controlled trial; clinical trial, phase II; medical oncology; anti-neoplastic-combined chemotherapy protocols (1)
CANCER; RESECTION; CARDIA; AEG type II; Siewert classification; Cardia; Transhiatal extended gastrectomy; Thoracoabdominal esophagectomy (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; FUMITREMORGIN-C; P-GLYCOPROTEIN; IN-VITRO; TRANSPORTER; PACLITAXEL; INHIBITION; TARIQUIDAR; ABC transporter; breast cancer resistance protein; MCF-7 cells; solid phase synthesis; Suzuki coupling (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; IN-VITRO; DRUG-RESISTANCE; TRANSPORTERS; EXPRESSION; CELLS; MODULATORS; REVERSAL; DERIVATIVES; ABCG2 transporter; BCRP; Inhibitors; Multidrug resistance; Hoechst33342; ATPase (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG TRANSPORTER ABCG2; P-GLYCOPROTEIN; INHIBITORS; POLYSPECIFICITY; CYTOTOXICITY; REVERSAL; Tariquidar; chalcone; ketone; ABCG2; modulator (1)
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN ABCB1; REVERSES MULTIDRUG-RESISTANCE; TYROSINE KINASE INHIBITOR; MEDIATED DRUG-RESISTANCE; TRANSPORTER IN-VITRO; STEM-LIKE CELLS; G MEMBER 2; MARINE NATURAL-PRODUCTS; SELECTIVE INHIBITORS; ABC transporter; ABCG2/BCRP; multidrug resistance; ABC inhibitor; ABC modulator (1)
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN; FUMITREMORGIN-C; DRUG TRANSPORT; IN-VITRO; BCRP/ABCG2; SUBSTRATE; CELLS; LOCALIZATION; CHOLESTEROL; (1)
CANCER; RISK; HEAD; Smoking; medical information; risk factor; prognosis; MPOWER (1)
Cancer screening, Personality, Mammography, Prostate cancer, Health screening (1)
CANCER-SPECIFIC MORTALITY; SERIES; Bladder cancer; Distant recurrence; Local recurrence; Time to recurrence; Outcome; Transitional cell carcinoma; Comorbidity scores (1)
CANCER-SPECIFIC MUTATIONS; BENIGN SKIN TUMORS; SEBORRHEIC KERATOSES; ACTIVATING MUTATIONS; EPIDERMAL NEVI; HIGH-FREQUENCY; BLADDER; dermatosis papulosa nigra; FGFR3; PIK3CA; stucco keratosis (1)
CANCER-SPECIFIC SURVIVAL; INVASIVE BLADDER-CANCER; TEMPLATE-BASED LYMPHADENECTOMY; CISPLATIN-INELIGIBLE PATIENTS; TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; RADICAL NEPHROURETERECTOMY; ONCOLOGIC OUTCOMES; RENAL PELVIS; PREOPERATIVE HYDRONEPHROSIS; Urothelial carcinoma; Upper tract; Neoplasm; Risk factors; Ureter; Renal pelvis; Diagnosis; Cytology; Ureteroscopy; Management; Nephroureterectomy; Chemotherapy; Systemic treatment; Follow-up; Survival; Guidelines (1)
CANCER-SPECIFIC SURVIVAL; NEOADJUVANT CHEMOTHERAPY; EXTERNAL VALIDATION; RISK STRATIFICATION; URINARY-BLADDER; TRIAL; LYMPHADENECTOMY; METAANALYSIS; RECURRENCE; PREDICTION; adjuvant chemotherapy; urothelial carcinoma of bladder; lymph node positive; radical cystectomy; survival (1)
CANCER-SPECIFIC SURVIVAL; THERAPY; YOUNGER; IMPACT; Bladder cancer; Urothelial carcinoma; Radical cystectomy; Age; Overall survival (1)
CANCER-SPECIFIC SURVIVAL; URINARY-BLADDER; MORTALITY; EPIDEMIOLOGY; (1)
CANCER; STAT6; GROWTH; CELLS (1)
CANCER STEM-CELLS; BRAIN EXTRACELLULAR-MATRIX; COLLECTIVE INVASION; DIFFUSE GLIOMA; GLIOBLASTOMA; MIGRATION; MECHANISMS; IDENTIFICATION; TEMOZOLOMIDE; PLASTICITY; (1)
CANCER STEM-CELLS; BRAIN EXTRACELLULAR-MATRIX; SINGLE-CELL; MESENCHYMAL DIFFERENTIATION; MOLECULAR-MECHANISMS; COLLECTIVE INVASION; PERIVASCULAR NICHE; RADIATION RESPONSE; GLIOMA MIGRATION; INITIATING CELLS; glioma; glioblastoma; migration; invasion; microenvironment; genetic program (1)
CANCER STEM-CELLS; BREAST-CANCER; VASCULOGENIC MIMICRY; GENETICAL EVOLUTION; IMMUNE SURVEILLANCE; SOCIAL-BEHAVIOR; 1ST REPORT; METASTASIS; GROWTH; ANT; (1)
Cancer stem cells, CAMTA1, Nkx2.2, glioblastoma, tumor suppressor (1)
CANCER STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; PREDICT PROGNOSIS; GLUTAMATE RELEASE; GLIOBLASTOMA; EXPRESSION; TEMOZOLOMIDE; IDH1; (1)
CANCER STEM-CELLS; EP-CAM EXPRESSION; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; PROGNOSTIC MARKER; GALLBLADDER CARCINOMA; ADHESION MOLECULE; BREAST-CANCER; COLON-CANCER; PAPILLA; (1)
CANCER STEM-CELLS; HEPATIC INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; HUMAN GLIOBLASTOMA; IN-VITRO; SIGNALING PATHWAYS; BREAST-CANCER; GROWTH; AMPK; TRANSFORMATION; glioma; BTIC; STAT3; Stattic; metformin (1)
CANCER STEM-CELLS; IN-VITRO MODEL; AUTOMATED SELECTIVE DISSOCIATION; MULTICELLULAR TUMOR SPHEROIDS; 3-DIMENSIONAL CULTURE MODELS; GENE-EXPRESSION ANALYSIS; DNA-MISMATCH-REPAIR; PHOTODYNAMIC THERAPY; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; (1)
CANCER STEM-CELLS; LARGE GENE LISTS; RESOURCES; PREDICTION; PROFILES; ONTOLOGY; HCC; P53; oncogenomics; bioinformatics; liver cancer; systems biology; HCC (1)
CANCER STEM-CELLS; LATENT TGF-BETA; MATRIX METALLOPROTEINASE-2; THROMBOSPONDIN-1; EXPRESSION; GLIOBLASTOMA; MALIGNANCY; PROTEINS; MOTILITY; BINDING; (1)
CANCER STEM-CELLS; TRANSCRIPTIONAL REPRESSION; METASTATIC MELANOMA; BREAST-CANCER; BINDING; PLU-1; IDENTIFICATION; PROGRESSION; EXPRESSION; LEUKEMIA; (1)
CANCER; SUBTYPES; THERAPY; PROGRESSION; MORTALITY; SURVIVAL; GATA3; ERBB2; STAGE; (1)
CANCER-SURGERY; INTRAOPERATIVE AUTOTRANSFUSION; IRRADIATION (1)
CANCER SURVIVORS; BREAST-CANCER; PROSTATE-CANCER; MENTAL-HEALTH; MISSING DATA; COUPLES; DISTRESS; CAREGIVERS; TRANSPLANTATION; PREDICTORS; Couples; dyadic coping; hematological cancer; longitudinal study; partner; psycho-oncology; quality of life (1)
Cancer; Survivorship; Social prescribing; Efficacy; tertiary prevention (1)
CANCER-TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; TISSUE MICROARRAY; EXPRESSION; MELANOMA; HEAD; IMMUNOTHERAPY; GENES; TARGETS; VACCINATION; MAGE-A antigens; Immunotherapy; Oral squamous cell carcinoma; Tumor antigens (1)
CANCER-THERAPY; FLOW-CYTOMETRY; PROTEIN IMPORT; IN-VITRO; PENETRATING PEPTIDES; DNA MUTATIONS; CELL-DEATH; ANTICANCER THERAPY; ALZHEIMERS-DISEASE; MAMMALIAN SIRTUINS; Intracellular targeting; Mitochondria; Drug delivery; Targeting strategies; Nanocarriers; Mitochondrial diseases (1)
CANCER-THERAPY; GOLD NANORODS; CONVERSION EFFICIENCY; TARGETED DELIVERY; CARBON NANOTUBES; GRAPHENE OXIDE; LUMINESCENCE; NANOCRYSTALS; CHEMOTHERAPY; COMBINATION; (1)
CANCER-THERAPY; HDAC INHIBITORS; BETA; (1)
CANCER; TRIAL; Endometrial cancer; Lymphadenectomy; Outcome; Overall survival; Recurrence (1)
CANCER; TUMORS; ADULTS; SIZE; SURVIVAL; STAGE; LESS; RISK; renal cell carcinoma; long-term follow-up; nephron-sparing surgery; radiological imaging (1)
CANCRUM ORIS NOMA; DEFECTS; CHILDREN; cancrum oris; noma; reconstruction; split scar flap; results (1)
CANDIDA-ALBICANS BIOFILMS; DIELECTRIC BARRIER DISCHARGE; STREPTOCOCCUS-MUTANS; PRESSURE PLASMA; BACTERICIDAL EFFICACY; SODIUM-HYPOCHLORITE; TEMPERATURE PLASMA; OSTEOBLAST GROWTH; NONTHERMAL PLASMA; PERI-IMPLANTITIS; cold atmospheric plasma; non-thermal plasma; antimicrobial; dentistry; Streptococcus mutans; Enterococcus faecalis; Candida albicans; periodontal disease; peri-implant disease; in vitro (1)
CANDIDA-ALBICANS BIOFILMS; LECTIN; Alternative in vivo model; biofilm; Candida; Galleria mellonella; implant-associated infection (1)
CANDIDA-ALBICANS PHOSPHOLIPOMANNAN; SACCHAROMYCES-CEREVISIAE; PROTEIN; YEAST; VIRULENCE; GROWTH; STARVATION; VIABILITY; NIDULANS; POLARITY; Aspergillus fumigatus; Glycosphingolipids; MIPC; Innate immune response; Mannosylation; Germination (1)
Candida albicans, photodynamic inactivation, TMPyP (1)
CANDIDATE GENE; OSTEOBLAST; WNT; HERITABILITY; TOOTH; TWINS; bone; genes; malocclusion; polymorphisms (1)
CANDIDATE GENES; RISK; BAG3; VARIANTS; COMMON; POPULATIONS; MUTATION; DISEASES; CLCNKA; DNA; Dilated cardiomyopathy; Heart failure; Genome wide association study; CLCNKA; HSPB7; BAG3 (1)
CANDIDATE RECOMBINANT VACCINE; RHEUMATOID-ARTHRITIS; CHRONIC ARTHROPATHY; CYTOKINE PRODUCTION; SYNOVIAL MEMBRANES; BONE-MARROW; RESPONSES; PREGNANCY; IMMUNITY; DISEASES; human parvovirus B19; memory; pregnancy; prolonged symptoms; Th cell; vaccine (1)
CANDIDATE TUMOR-SUPPRESSOR; EXTRACELLULAR-MATRIX; BRAIN; MIGRATION; INVASION; CANCER; PROTOCADHERINS; GLIOBLASTOMAS; FIBROBLASTS; INTEGRATION; Collagen XVI; Glioblastoma; Invasion; Protocadherin; Integrin; Kindlin; Activation (1)
CANDIDATUS KUENENIA STUTTGARTIENSIS; AMMONIUM-OXIDIZING BACTERIA; ELECTRON-TRANSPORT CHAIN; COMPLETE GENOME SEQUENCE; BIOGENESIS SYSTEM I; FERROGLOBUS-PLACIDUS; RESPIRATORY-CHAIN; HYPERTHERMOPHILIC ARCHAEUM; HETERODISULFIDE REDUCTASE; HALOBACTERIUM-SALINARIUM; cytochrome c; Archaea; Ignicoccus hospitalis; ANME; anammox planctomycetes; bioinformatics; molecular modeling (1)
CANDIDATUS NOSTOCOIDA-LIMICOLA; ACTIVATED-SLUDGE; GENUS TETRASPHAERA; TOMOGRAPHY; BACTERIUM; (1)
CANDIDIASIS-ECTODERMAL DYSTROPHY; PRIMARY BILIARY-CIRRHOSIS; DISEASE TYPE-I; MYASTHENIA-GRAVIS; T-CELLS; NEGATIVE SELECTION; PROTEIN EXPRESSION; MESSENGER-RNA; AUTOANTIBODIES; ANTIBODIES; AIRE; thymomas; polyendocrinopathy syndrome type I (1)
CANINE KIDNEY-CELLS; POTASSIUM CHANNELS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; DOMAIN; PH; IDENTIFICATION; ENDOCYTOSIS; RECEPTORS; TUBULES; ion channel; small G protein; trafficking; recycling endosomes; apical compartment (1)
Cannabinoide , Rezeptor , Ligand <Biochemie> , Pharmakologie , Blassfarbener Igelkopf , GTPase-Assay , GTPgammaS-Assay , Kopplung , G-Protein , Testsystem , GPCR , Cannabinoidrezeptor , Echinacea , Alkamide , THC , GTPase assay , GTPgammaS assay , coupling , G-protein (1)
cannabinoid receptors, GTPase Assay, fusion proteins, RGS proteins (1)
Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed moderate affinity for human cannabinoid rec Ovary ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed weaker affinity for recombinant human cannabinoid receptor 2 in Chem-1 and Chinese hamster ovary cell) Camellia sinensis Human Leaf ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed while (+)-catechin, (-)-epicatechin did not show affinity for recombinant human CB1 and CB2 in Chem-1 and CHO cell) Central nervous system (central nervous cannabinoid receptor was targeted by Camellia sinensis catechin in Chem-1 and Chinese hamster ovary cell) Camellia leaf recombinant human cannabinoid receptor ovary catechin epigallocatechin (1)
CANONICAL CORRESPONDENCE-ANALYSIS; DETRENDED CORRESPONDENCE-ANALYSIS; ELLENBERG INDICATOR VALUES; SEED DISPERSAL; COMMUNITY ECOLOGY; PUTTING THINGS; BIODIVERSITY; POPULATIONS; COEXISTENCE; HYPOTHESIS; (1)
Canon law, Ho diocese (1)
Capability Maturity Model ISO standards formal specification CMMi SPICE compliant development integrated decision model rationale management requirement traceability requirements specification software process improvement and capability determination (1)
Capacitance Classical transport Edge states Electrical conductivity Electronic structure Hall effect High magnetic fields Integer quantum Hall effect Landau levels Magnetotransport Quantum transport Surface states Topological insulators Topological materials Transport phenomena (1)
CAPACITATIVE CALCIUM-ENTRY; SMOOTH-MUSCLE-CELLS; CHANNELS; STIM1; ACTIVATION; EXPRESSION; HYPERGLYCEMIA; VASODILATION; DYSFUNCTION; INFLUX; diabetes; high glucose; small mesenteric arteries; store-operated calcium entry; vascular smooth muscle; ZDF (1)
capacitive communication, capacitive near-field communication, capacitive sensing, intrabody communication (1)
capacitive sensing; pervasive interfaces; proximity sensing; smart environments; (1)
CAP; Cold atmospheric plasma, Enterococcus faecalis; Candida albicans; Biofilme (1)
Capecitabin , Dickdarmkrebs , metastasiertes kolorektales Karzinom , chronomodulierte Chemotherapie , Hand-Fuß-Syndrom , capecitabine , metastatic colorectal cancer , chronomodulated chemotherapy , hand-foot-syndrome (1)
CAPE FLORISTIC REGION; LONG-DISTANCE DISPERSAL; SCALE SPATIAL DYNAMICS; CLIMATE-CHANGE; SOUTH-AFRICA; BIODIVERSITY HOTSPOT; HABITAT MODELS; SIZE; LEVEL; WIND; abundance-occupancy relationship; evolutionary species age; macroecology; mechanistic model; phylogenetic comparative analysis; plant metapopulation dynamics; population extinction; serotinous shrubs; species range size; wind-driven seed dispersal (1)
CAPE PROTEACEAE; FIRE SEASON; RECRUITMENT; SHRUBLANDS; fire; fynbos; graminoids; overstorey-understorey interactions; Proteaceae; seedling growth (1)
CAPE PROTEACEAE; SEED-GERMINATION; WOODY-PLANTS; STORAGE; fire climate; fire management; phenology; seedling recruitment; seroting (1)
CAPILLARY-ELECTROPHORESIS; Capillary electrophoresis; CE(SDS); Mass spectrometry; Monoclonal antibody; Two-dimensional (1)
Capillary electrophoresis, Electrochemical detection, Electrochemical reduction, Mass spectrometry, Non-aqueous media (1)
capillary electrophoresis | electrochemistry | mass spectrometry | tyrosine (1)
CAPILLARY-ELECTROPHORESIS; FLUORESCENCE DETECTION; NANOPARTICLES; BINDING; EFFICIENT; FLAVIN; FUNCTIONALIZATION; QUANTIFICATION; COORDINATION; RECOGNITION; chelates; fluorescence spectroscopy; molecular recognition; nanoparticles; polymerization (1)
capillary electrophoresis, mass spectrometry, hyphenation, fast, small volume, instrumental, catecholamines, hyaluronan, organotin speciation, organoarsenic speciation, capillary batch injection, injection efficiency (1)
CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; TERNARY-SYSTEMS; WATER; PRESERVATIVES; ACID; TOOL; EKC; Surfactant-free microemulsion; MEEKC; Electrospray ionization mass spectrometry; Hydrophobic and hydrophilic neutral compounds; Electrokinetic chromatography (1)
CAPILLARY-ELECTROPHORESIS; PROTEINS; DYES; SEPARATIONS; REAGENTS; Microchip electrophoresis; Fluorescence label; Protein detection (1)
CAPILLARY-ELECTROPHORESIS; VOLTAMMETRIC BEHAVIOR; ASSISTED INJECTION; OXIDATION; DNA; DIMER; CYTOSINE; GUANINE; COMBINATION; MECHANISM; (1)
CAPILLARY ENDOTHELIAL-CELLS; PLEXUS EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; IN-VITRO; TIGHT JUNCTIONS; TRANSPORT; DYNAMICS; CULTURE; MODEL; Impedance analysis; Transepithelial electrical resistance (TEER); Co-cultures; MDCK; Label-free; Cell-based assays; Barrier function (1)
CAPILLARY-GRAVITY WAVES; GLOBAL BIFURCATION; EQUATORIAL FLOWS; FREE-SURFACE; EDGE WAVES; REGULARITY; ANALYTICITY; EXISTENCE; Euler equations; Traveling waves; Stratified fluid; Singular density gradient (1)
CAPILLARY MEMBRANE DYSFUNCTION; 2-DIMENSIONAL ELECTROPHORESIS; EZRIN/RADIXIN/MOESIN PROTEINS; DIFFERENTIAL EXPRESSION; STRESS; PERMEABILITY; CELLS; ABNORMALITIES; CYTOSKELETON; INCREASES; Experimental heart failure; Proteomics; Lung (1)
CAPILLARY WALL; ELECTROPHORETIC MOBILITY; RAT-KIDNEY; TRANSPORT; CHARGE; PERMSELECTIVITY; MODEL; POLYCATIONS; PROTEINURIA; FILTRATION; (1)
capital allocation, credit risk, per-unit risk, credit portfolio model, multi-period risk measure, heterogeneous portfolios (1)
Capital city; public goods; urban growth (1)
Capital markets; Corporate governance; Extra-financial information; Human capital; Information dynamics; Innovation capital; Intangibles; Ohlson (1995) model; Residual income; Valuation models (1)
CAPITAL STRUCTURE; PERFORMANCE; OUTREACH; SUSTAINABILITY; EFFICIENCY; NETWORKS; NGOS; Crowdfunding; Microentrepreneurs; Microcredit; Financial intermediation (1)
CAPNOCYTOPHAGA-OCHRACEA ATCC-33596; STREPTOCOCCUS-SANGUIS H-1; PLATE FLOW CHAMBER; ACTINOMYCES-NAESLUNDII; ORAL MICROBIOME; QUANTITATIVE METHOD; CO-ADHESION; IN-VITRO; COAGGREGATION; BACTERIA; (1)
CAPPED GOLD NANOPARTICLES; INTENSE OPTICAL-ACTIVITY; CIRCULAR-DICHROISM; METAL NANOPARTICLES; NANOCLUSTERS; PLASMON; TRANSITIONS; ABSORPTION; LIGANDS; Chirality; Cysteine; Molecular spectroscopy; Silver nanoparticles; Surface modification (1)
CAPPUCCINO; MICROTUBULE; PROTEINS; END; Spir; Gene expression; Actin nucleation (1)
CAPSULODESIS; OUTCOMES; SLAM; mediocarpal collapse; scapholunate ligament reconstruction (1)
CAPTCHA, Usability, Facial features, Gender classiffcation, Age classification, Face recognition reverse Turing test (1)
CAPTCHA, Usability, Nutzertest, Klassifikation, Kategorisierung, Test, Sicherheit (1)
CAPTURE MICRODISSECTION; CDNA MICROARRAY; CANCER; CARCINOMA; CONSTRUCTION; (1)
CARBAMAZEPINE; drug-induced pseudolymphoma; Cimicifuga racemosa; phytotherapeutical agents (1)
CARBAMOYL-PHOSPHATE SYNTHETASE; AMIDOTRANSFERASE DOMAIN; ESCHERICHIA-COLI; AMMONIA-CHANNEL; FORCE-FIELD; PROTEIN; COMPLEX; ENZYMES; STATE; MAB; (1)
Carbanions; Reductive radical-polar crossover; Deracemization (1)
CARBAPENEM-RESISTANT; IDENTIFICATION; GENE; Broth microdilution; Colistin resistance; Enterobacterales; Gradient strip; Semi-automated system (1)
CARBENE ACTIVATION; PHOSPHORUS; OXIDATION; ELEMENTS; COMPLEX; organophosphorus compounds; P-4 activation; phosphorus; radicals (1)
CARBENE ANALOG; STRUCTURAL-CHARACTERIZATION; BETA-DIKETIMINATO; LONDON DISPERSION; SOLID-STATE; COMPLEXES; COMPOUND; GALLIUM; CHEMISTRY; ELEMENTS; (1)
carbene analogues; metal-metal interactions; bridging ligands (1)
CARBENE-LIKE CHEMISTRY; BOND COVALENT RADII; PHOSPHINIDENE COMPLEXES; PHOSPHINOPHOSPHINIDENE (BU2P)-BU-T-P; PHOSPHORUS ANALOGS; TRAPPING REACTION; REACTIVITY; OXIDE; COORDINATION; TUNGSTEN(VI); (1)
CARBENE-LIKE CHEMISTRY; BOND COVALENT RADII; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; PHOSPHORUS ANALOGS; URANIUM COMPLEX; MULTIPLE BOND; TRIPLE BONDS; U-IV=C; ELEMENTS; density functional calculations; multiple bonds; phosphides; phosphinidene; uranium (1)
CARBENE MIGRATORY INSERTION; ARYLBORONIC ACIDS; PALLADIUM(II) CATALYSIS; 3+2 CYCLOADDITION; HETPHOX LIGANDS; BOND FORMATION; BASE-FREE; REARRANGEMENT; EFFICIENT; METAL; donor-acceptor cyclopropanes; Heck coupling; 1,2-dihydropyridines; 2H-pyrans; 2,3-dihydro-1H-azepines; 1,4-cyclohexadienes (1)
carbenes · boron · germanium · phosphorus · inorganic hydrides (1)
CARBOCYCLIC NUCLEOSIDES; ETHYLENE BIOSYNTHESIS; ACYCLIC NUCLEOSIDES; INHIBITORY ACTIVITY; ANTIVIRAL ACTIVITY; ANALOGS; NMR; (1)
CARBODIIMIDE-REACTIVE PROTEIN; NA+-TRANSLOCATING F1F0-ATPASE; METHANOSARCINA-MAZEI GO1; C SUBUNIT OLIGOMER; ESCHERICHIA-COLI; ACETOBACTERIUM-WOODII; F-TYPE; PROPIONIGENIUM-MODESTUM; ILYOBACTER-TARTARICUS; CLOSTRIDIUM-PARADOXUM; A(1)A(o) ATP synthase; Archaea; hyperthermophile; Na+; Pyrococcus (1)
CARBOHYDRATE-BINDING PROTEIN; HUMAN COLON-CANCER; CROHNS-DISEASE; MONOCLONAL-ANTIBODY; HUMAN NEUTROPHILS; STELLATE CELLS; MESSENGER-RNA; BOWEL-DISEASE; EXPRESSION; ADHESION; Crohn's disease; epithelial cells; fibroblasts; fistula; galectin-3 (1)
carbohydrate, cost of mating, geometric framework of nutrition, protein, regulated intake point, sexual selection (1)
; carbohydrates; conformation analysis; glucans; helical structures; NMR spectroscopy (1)
carbon 14 D16726 indole ethyl carbon 14 (1)
carbon accounting, climate change, emission allowances, emissions trading system, industrial ecology, information asymmetry (1)
carbon accounting, greenhouse gas emissions, municipalities, climate changes (1)
CARBON CATABOLITE REPRESSION; SUGAR PHOSPHOTRANSFERASE SYSTEM; 2-DIMENSIONAL NMR-SPECTROSCOPY; SEQUENTIAL BACKBONE ASSIGNMENT; ISOTOPICALLY ENRICHED PROTEINS; X-RAY STRUCTURE; ESCHERICHIA-COLI; CHEMICAL-SHIFT; ENTEROCOCCUS-FAECALIS; SECONDARY STRUCTURE; (1)
CARBON-CENTERED RADICALS; PHOTOREDOX CATALYSIS; AQUEOUS-MEDIA; AMINO-ALCOHOLS; NADH MODEL; WATER; 1-BENZYL-1,4-DIHYDRONICOTINAMIDE; DERIVATIVES; GENERATION; ARYLATION; (1)
CARBON-DIOXIDE ASSIMILATION; 4-HYDROXYBUTYRYL-COA DEHYDRATASE; 3-HYDROXYPROPIONATE CYCLE; ACETYL-COENZYME; HYDROGEN; PATHWAY; CARBOXYLASE; SYNTHETASE; EVOLUTION; REDUCTASE; 3-hydroxypropionate; 4-hydroxybutyrate cycle; Sulfolobales; Metallosphaera sedula; crotonyl-CoA hydratase; 3-hydroxybutyryl-CoA dehydrogenase (1)
CARBON-DIOXIDE ASSIMILATION; AMMONIA-OXIDIZING ARCHAEA; NITROSOPUMILUS-MARITIMUS; FIXATION CYCLE; COENZYME-A; PATHWAY; OXIDATION; REDUCTASE; CLONING; GROWTH; 3-hydroxypropionate/4-hydroxybutyrate cycle; 3-hydroxypropionyl-CoA dehydratase; Metallosphaera sedula; Nitrosopumilus maritimus; autotrophs; crotonyl-CoA hydratase (1)
CARBON-DIOXIDE; CHEMICAL SENSORS; PLASTICIZER; MICROSENSOR; SEAWATER; BREATH; CO2; optical pCO(2) sensors; phosphazene base; neutral base; humidity sensor (1)
Carbon dioxide; Energy transfer; Decay time sensing (1)
CARBON-DIOXIDE; HOMOALLYLIC ALCOHOLS; CYCLIC CARBONATES; STEREOSELECTIVE FUNCTIONALIZATION; DIASTEREOSELECTIVE SYNTHESIS; CONJUGATE ADDITION; STEP ECONOMY; AMINATION; CATALYSTS; CO2; alkenes; allylic oxidation; photoredox catalysis; selenium-pi-acid catalysis; 1,3-dioxan-2-ones (1)
CARBON-DIOXIDE LASER; PULSED-DYE-LASER; MULTIPLE ECCRINE-HIDROCYSTOMAS; SEBACEOUS GLAND HYPERPLASIA; VERRUCOUS EPIDERMAL NEVUS; DERMATOSIS PAPULOSA NIGRA; BROOKE-SPIEGLER-SYNDROME; HOGG-DUBE-SYNDROME; ND-YAG LASER; XANTHELASMA-PALPEBRARUM; ablational/fractional laser device; hamartoma; xanthelasma; cyst (1)
CARBON-DIOXIDE LASER; RECALCITRANT VERRUCAE; VIRAL WARTS; Verrucae vulgares; long-pulsed tunable dye laser (LPTDL) (1)
CARBON-DIOXIDE; OPEN CHOLECYSTECTOMY; RANDOMIZED-TRIAL; MURINE MODEL; PNEUMOPERITONEUM; PRESERVATION; MACROPHAGES; APOPTOSIS; SEPSIS; INFLAMMATION; Laparoscopy; Laparotomy; Pneumoperitoneum; Immune function; Mouse model; Lymphocyte subsets; T-lymphocytes; Regulatory; Cytokines (1)
CARBON-DIOXIDE; OXYGEN; MICROELECTRODE; SENSORS; PERFORMANCE; MICROSCALE; BIOFILMS; (1)
CARBON-DIOXIDE; REDUCTIVE CARBOXYLATION; ORGANONICKEL COMPLEXES; COUPLING REACTIONS; ELECTRON-TRANSFER; HALIDES; IBUPROFEN; ACIDS; DERIVATIVES; PHOTOREDOX; (1)
CARBON-DIOXIDE REMOVAL; POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; INTERVENTIONAL LUNG ASSIST; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; 6 ML/KG; FAILURE; EXACERBATIONS; COPD; (1)
CARBON-DIOXIDE REMOVAL; RESPIRATORY-DISTRESS-SYNDROME; ARTERIOVENOUS CO2 REMOVAL; CRITICALLY ILL PATIENTS; GAS-EXCHANGE; BLOOD-FLOW; FAILURE; OXYGENATION; SUPPORT; INJURY; Acute respiratory distress syndrome; extracorporeal carbon dioxide removal; interventional lung assist; oxygen transfer (1)
carbon dioxide - sensor - fluorescence (1)
CARBON-DIOXIDE SENSOR; FLUORESCENCE; OXYGEN; CO2; PH; carbon dioxide; fiber optic chemical sensor; capillary microsensor (2)
CARBON-DIOXIDE; SENSOR; OPTODES; frequency domain demodulation; decay time sensing; oxygen optode (1)
CARBON-DIOXIDE SENSOR; RESONANCE ENERGY-TRANSFER; METAL-COMPLEXES; CHEMICAL SENSORS; DISSOLVED-OXYGEN; PH; TEMPERATURE; PHOTOPHYSICS; TECHNOLOGY; FIBER; sensing; fluorescence; luminescence lifetime; signal referencing (1)
CARBON-DIOXIDE; VISIBLE-LIGHT; CATALYZED CARBOXYLATION; REDUCTION POTENTIALS; ALKENES; CO2; CARBONYLATION; RADICALS; HALIDES; SYSTEM; (1)
Carbon Dots, Multicolor Imaging, Nanoparticles, Carbon (1)
CARBON DOUBLE-BONDS; CLICK CHEMISTRY; 1,3-DIPOLAR CYCLOADDITIONS; AZABIS(OXAZOLINE) LIGANDS; HUISGEN CYCLOADDITION; TERMINAL ALKYNES; BIS-SILYLATION; ISOCYANIDE; TRIAZOLE; POLYMER; (1)
CARBON DOUBLE-BONDS; MOLYBDENUM ISONITRILE COMPLEXES; TERMINAL OLEFINS; BIS-SILYLATION; LIGAND; DISCOVERY; isonitriles; methyl ketones; palladium; styrenes; Wacker oxidation (1)
CARBON ELECTRODE; NANOPARTICLES; APOFERRITIN; BIOSENSOR; IMMUNOASSAY; PLATFORM; BINDING; ASSAY; Electrophysiological cortisol sensor; Salivary stress testing; Glassy carbon electrode surface  modification; (S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid (ANTA); R-AFTN nanoprobe; Antigen-antibody reaction (1)
Carbon footprint; Economic impact assessment; Integrated steel mill; Low-carbon steel production; Decarbonization scenarios; Linear programming model (1)
CARBON FOOTPRINT; HEALTH-CARE (1)
CARBON FOOTPRINT; HEALTH; Climate change; Environment and public health; Waste management; Recycling; Intensive care medicine (1)
CARBONIC-ANHYDRASE; CAMP; EXPRESSION; ERYTHROCYTES; MEMBRANE; (1)
CARBONIC-ANHYDRASE-I; GROWTH-FACTOR; SIGNALING PATHWAYS; MASS-SPECTROMETRY; CANCER-THERAPY; KINASE; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; MOLECULE; metal-chelates; emission spectroscopy; protein binding; phosphate binding; protein-protein interaction; molecular recognition (1)
CARBONIC-ANHYDRASE-IX; PHASE-III TRIAL; AUTOLOGOUS DENDRITIC CELLS; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; TUMOR-CELLS; CANCER-PATIENTS; IN-VITRO; DIAGNOSTIC BIOMARKER; RADICAL NEPHRECTOMY; autologous tumor cell vaccine; dendritic cell-based vaccine; genetically modified vaccine; immunomodulation; peptide-based vaccine; renal cell carcinoma; vaccination therapy (1)
CARBONIC-ANHYDRASE-XIV; PIGMENT EPITHELIUM; PROTEOMIC ANALYSIS; AQUEOUS-HUMOR; EXOSOMES; CELLS; ASTROCYTES; EXPRESSION; SECRETION; PROTEINS; neuroglia; exosomes; tetraspanin; gliosis; SNARE complex; secretome; vitreous body; microvillus (1)
CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; ELEVATED CO2; ABSCISIC-ACID; PLANTS; PHOTOSYNTHESIS; DENSITY; LIGHT; CONDUCTANCE; GROWTH; Stomatal pore area index (SPI); Potential conductance index (PCI); Plant functional traits; Stomata; Delta C-13; Altitude (1)
CARBON LOCK-IN; RENEWABLE ENERGY; TECHNOLOGICAL-CHANGE; INSTITUTIONAL CHANGE; INNOVATION SYSTEMS; SOCIAL-MOVEMENTS; FORMAL-STRUCTURE; UNITED-STATES; INDUSTRY; POLICIES; Environmental groups; Institutional theory; Renewable energy technologies (1)
CARBON-MONOXIDE; ALTERNATING COPOLYMERIZATION; CATALYSTS; LIGANDS; STYRENE; POLYMERIZATION; PALLADIUM(II); (1)
CARBON-MONOXIDE; LIVER; EXPRESSION; THERAPY; PROTEIN; cirrhosis; portal hypertension; heme oxygenase; gene therapy; adeno-associated virus (1)
CARBON-MONOXIDE; OXYGENASE-1; GENE; INJURY; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-10; REJECTION; HEARTS; bilirubin; major histocompatibility complex class II; heme oxygenase-1; endothelial cells; interferon-gamma (1)
CARBON-MONOXIDE RELEASE; THERAPEUTIC APPLICATIONS; COORDINATION; EXAMPLE; (1)
carbon monoxide; resolvin; cyclooxygenase; lipoxygenase (1)
Carbon Nanofibers Laser-Induced Carbonization Electrochemical Sensor Electrochemistry (1)
carbon nanotube; CNT; quantum dot; mechanical charge detection; fabrication development; molybdenum rhenium alloys; Kondo effect; carbon nanotube overgrowth; overgrowth; CNT stamping; superconductivity; low temperature physics; semiconductor physics; nano-electromechanics (1)
CARBON NANOTUBE GROWTH; QUALITY FACTOR; carbon nanotubes; coplanar waveguide resonator; filter; optomechanics (1)
CARBON NANOTUBES (1)
carbon nanotubes, CNT, shot noise, Franck-Condon (1)
CARBON NANOTUBES; CONDUCTING POLYMERS; GOLD NANOPARTICLES; METAL; OXIDE; POLYELECTROLYTES; ADSORPTION; RESISTANCE; CONTACT; BULK; Graphene; Palladium; Nanoparticle; Sensor; Layer-by-layer (1)
carbon nanotubes, coplanar resonators, nano-electro-mechanics (1)
carbon nanotubes, electrical conductivity, multiple shell transport (1)
Carbon nanotubes Electron diffraction Image Processing (1)
CARBON NANOTUBES; ELECTRON-GAS; LOCALIZATION; CONSTRICTION; PHYSICS; STATES; (1)
Carbon Nanotubes, Electronic transport, Quantum Dot, Electron wave interference (1)
carbon nanotubes; electron transport; contact effects (1)
CARBON NANOTUBES; JOSEPHSON CURRENT; ANDREEV REFLECTION; LUTTINGER-LIQUID; SUBGAP CONDUCTANCE; ELECTRON-GAS; TRANSPORT; JUNCTIONS; BILLIARDS; METAL; (1)
Carbon nanotubes; Luttinger liquid; Coulomb blockade (1)
CARBON NANOTUBES; PRESSURE; CONTACT; FIELD; (1)
CARBON NANOTUBES; SPIN; ALLOYS; TRANSITION; TRANSPORT; PALLADIUM; MOMENTS; SYSTEM; NI; (2)
CARBON NANOTUBES; SUPERLATTICES; NANORIBBONS; ARRAYS; FABRICATION; PRESSURE; PERIODS; ORBITS; Graphene; boron nitride; ballistic transport; nanopatterning antidots (2)
CARBON NANOTUBES; TRANSPORT; carbon nanotubes; Coulomb blockade; Fabry– Pé rot interference; Kondo effect; mixed valence regime; quantum dots (1)
CARBON NANOTUBES; TRANSPORT; FIELDS; STATE; EDGE; (1)
carbon nanotubes, transport spectroscopy, nano-mechanics, nano-electro-mechanics, quantum dot, Kondo effect, NEMS (1)
CARBON NANOTUBES; TUNNELING SPECTROSCOPY; ELECTRON CONDUCTION; SINGLE-WALL; GOLD ATOMS; TRANSMISSION; TRANSISTORS; TRANSPORT; MODEL; FORMALISM; carbon nanotubes; electronic transport; Green functions (1)
CARBON NANOTUBE; WATER/OIL INTERFACE; HYDROGEN-PEROXIDE; ORGANIC-SOLVENTS; HYBRID FOAM; SURFACES; OXIDE; EPOXIDATION; SUPERCAPACITORS; NANOPARTICLES; 3D graphene foams; heterogeneous catalysis; phytic acid; super-amphiphilic (1)
Carbon nitrides; DFT; High bulk modulus; ELF (1)
CARBON-NITROGEN INTERACTIONS; WATER-USE EFFICIENCY; PHOTOSYNTHETIC CAPACITY; SEMINATURAL VEGETATION; TERRESTRIAL BIOSPHERE; STOMATAL CONDUCTANCE; EUROPEAN FORESTS; PLANT; FLUXES; TRANSPIRATION; (1)
CARBON-RICH BRIDGES; X-RAY CRYSTAL; RUTHENIUM COMPLEXES; THEORETICAL INVESTIGATIONS; ELECTRONIC COMMUNICATION; ACETYLIDE COMPLEXES; OXIDATION-STATES; SIGMA-ACETYLIDES; IRON; METAL; (1)
CARBON-SILICON BOND; CROSS-COUPLING REACTIONS; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; STEREOGENIC SILANES; CENTERED CHIRALITY; CRYSTAL-STRUCTURES; SI BOND; ARYL; REAGENTS; alkyllithium compounds; chirality; density functional calculations; nucleophilic substitution; silanes (1)
CARBON; SINGLE; BLOCKADE; OSCILLATIONS; TRANSPORT; DOTS; (1)
Carbonylation, Palladium, Carbon Monoxide, CO-Surrogate, Olefins (1)
; carbonyl complex; crystal structure; photo-luminescence; rhenium; salophen (1)
carbonyl complexes; cobalt; iron; redox chemistry; gallium (1)
Carbonyl complexes; Phosphaalkynes; Tungsten (1)
carbonyl complex | liquid ammonia | QTAIM | transition metalate | X-ray diffraction (1)
CARBONYL-COMPOUNDS; CRYSTAL-STRUCTURE; MOLYBDENUM; COMPLEXES; ELEMENTS; LIGANDS; CORE; (1)
Carbonyl homologation • Photochemistry • Hydrazone • Diazo compounds • Büchner-Curtius-Schlotterbeck reaction (1)
Carbonylkomplexe; Phosphaalkine; Wolfram (1)
CARBONYL SULFIDE; SPECTRA; ATOMS; CLUSTERS; LINE; (1)
Carborane; Fullerene; Phosphor; Selbstorganisation; Supramolekulare Chemie (1)
CARBOXYLIC-ACIDS; ALPHA,BETA-UNSATURATED ALDEHYDES; NUCLEOPHILIC CARBENES; ACTIVATED CARBOXYLATES; GAMMA-BUTYROLACTONES; DIRECT ANNULATIONS; EFFICIENT; ALCOHOLS; GENERATION; CONVERSION; (1)
CARBOXYLIC-ACIDS; GENERATION; REACTIVITY; PHOTOLYSIS; ACTIVATION; CATALYST; CHLORIDE; iron chloride; HAT; hydroacylation; photocatalysis; acyl radical (1)
CARBOXYLIC-ACIDS; METATHESIS POLYMERIZATION; ALKYLATING REAGENTS; DIAZODICARBONYL COMPOUNDS; CONTINUOUS-FLOW; ONE-POT; EFFICIENT; ESTERIFICATION; CATALYSTS; NANOPARTICLES; (1)
carboxylic acids; styrene; photocatalysis (1)
CARBOXY-TERMINAL FRAGMENT; EXTRACELLULAR DOMAIN; OPEN-LABEL; TRASTUZUMAB; TRIAL; MICROENVIRONMENT; MULTICENTER; LAPATINIB; RECEPTOR; P95HER2; (1)
CARCINOEMBRYONIC ANTIGEN LEVEL; COLORECTAL-CANCER; MANAGEMENT; Urachus; Urachal carcinoma; Adenocarcinoma Biomarkers; CEA; Prognosis (1)
CARCINOEMBRYONIC ANTIGEN; SURFACE GLYCOPROTEIN; MR 34,000; B-CELL; EXPRESSION; THERAPY; EPCAM; CEA; UNICAR-T-CD123; CARCINOMA; colorectal cancer; CAR T-cells; AND-gate targeting; CEA; EpCAM (1)
; Carcinogenesis; cellular biology; genomics; molecular genetics (1)
carcinogenesis; HPV; lung cancer; meta‐analysis (1)
CARCINOMA CELL-LINE; IN-VITRO; 500-1000 TIMES; MESSENGER-RNA; NUDE-MICE; DOXORUBICIN; POTENT; 2-PYRROLINODOXORUBICIN; RECEPTORS; INHIBITION; (1)
Carcinoma Cervix (cervical carcinoma prepn and antitumor, antioxidant structure activity of natural and non-natural prenylated chalcones) Antioxidants Antitumor agents Human Structure-activity relationship (prepn and antitumor, antioxidant structure activity of natural and non-natural prenylated chalcones) antitumor antioxidant prenylated chalcone prepn structure activity (1)
CARCINOMA; DWIBS; CT; head and neck carcinoma; staging; metastases (1)
Carcinoma (inhibitors of, aminoalkylating compds. as) (1)
CARCINOMA IN-SITU; DNA METHYLATION; PROMOTER HYPERMETHYLATION; PROTOCADHERIN PCDH10; MOLECULAR SUBTYPES; CPG METHYLATION; RECEPTOR STATUS; EARLY EVENT; PATTERNS; FREQUENT; estrogen receptor-positive; EpiTyper MassArray; CpG island array; methyl-CpG immunoprecipitation; DMR; ductal carcinoma in situ (1)
CARCINOMA IN-SITU; DUCTAL CARCINOMA; EARLY DISSEMINATION; TUMOR EVOLUTION; HETEROGENEITY; METASTASIS; MUTATIONS; NETWORKS; PLATFORM; DATABASE; breast cancer; cancer evolution; omics data integration; machine learning; forward and backward evolution (1)
CARCINOMA IN-SITU; GERM-CELL TUMORS; SPERMATOGONIA; DIAGNOSIS; TESTIS; ORCHIDOPEXY; A-dark spermatogonia; carcinoma in situ (CIS); cryptorchidism; male infertility; semithin section; testicular germ cell tumor; testicular intraepithelial neoplasia (TIN) (1)
CARCINOMA; LUNG; SURGERY; extended lung resection; extracorporeal circulation; ex situ sleeve resection (1)
Carcinoma (of mammary gland, interferon and lymphotoxins effect on) Neoplasm inhibitors (carcinoma, interferons and lymphotoxins as, of mammary gland) Mammary gland (neoplasm, carcinoma, interferons and lymphotoxins effect on) Lymphokines and Cytokines Role: BIOL (Biological study) (tumor necrosis factor-beta , mammary gland carcinoma response to interferon and) Interferons Role: BIOL (Biological study) (gamma , mammary gland carcinoma response to lymphotoxin and) breast cancer inhibition interferon lymphotoxin mammary carcinoma inhibition interferon lymphotoxin (1)
CARCINOMA; OUTCOMES; Urachal cancer; Recurrence; Urethra; Urothelial; Adenocarcinoma (1)
CARCINOMA; PROGRESSION; RECURRENCE; (1)
CARCINOMA; SURVIVAL; STAGE; DELAY; SURVEILLANCE; RECURRENCE; DIAGNOSIS; PROGNOSIS; EORTC risk tables; Muscle invasion; Prognosis; Risk stratification; Urothelial carcinoma of the bladder (1)
CARCINOMA; TRIAL; PLUS; (1)
CARDIAC ABNORMALITIES; CONTROLLED-TRIAL; FAT; OBESITY; EXTENT; LEVEL; Coronary artery disease; Epicardial adipose tissue; Inflammation; Vitamin D; Vitamin D receptor; CYP27B1; CYP24A1 (1)
CARDIAC ALLOGRAFT-REJECTION; ANTIBODY-MEDIATED REJECTION; INTERNATIONAL SOCIETY; PHOTOCHEMOTHERAPY; PREVENTION; GUIDELINES; RECIPIENTS; DIAGNOSIS; EFFICACY; REGISTRY; heart transplantation; rejection; prevention; extracorporeal photopheresis; observational (1)
CARDIAC ALLOGRAFT VASCULOPATHY; ANTI-HLA ANTIBODIES; MEDIATED REJECTION; PEDIATRIC HEART; INTERNATIONAL SOCIETY; KIDNEY-TRANSPLANT; RISK-FACTORS; DESENSITIZATION STRATEGIES; ANTITHYMOCYTE GLOBULIN; UNACCEPTABLE ANTIGENS; DSA; Heart transplantation; Donor-specific; Antibody-mediated; Anti-HLA (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CALCINEURIN INHIBITOR WITHDRAWAL; CYTOMEGALOVIRUS-INFECTION; RENAL-FUNCTION; MYCOPHENOLATE-MOFETIL; RISK-FACTORS; SDZ RAD; RECIPIENTS; CYCLOSPORINE; SIROLIMUS; MANDELA; Everolimus; Randomized; Heart; Transplantation (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CYCLOSPORINE-A; IN-VITRO; IMMUNOSUPPRESSIVE REGIMENS; MAMMALIAN TARGET; MITOMYCIN-C; RAPAMYCIN; PROLIFERATION; DYSFUNCTION; ACTIVATION; adhesion molecules; calcineurin inhibitors; mTOR inhibitors; E-selectin; ICAM-1; VCAM-1 (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CYTOMEGALOVIRUS-INFECTION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION; ACUTE REJECTION; RECIPIENTS; CYCLOSPORINE; NOMENCLATURE; PREVENTION; SIROLIMUS; Cardiac allograft vasculopathy; cyclosporine; everolimus; heart transplantation; mycophenolate mofetil; randomized (1)
CARDIAC-ARREST; BUPIVACAINE; RESUSCITATION; VASOPRESSIN; EMULSION; MODEL (1)
CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; INTENSIVE-CARE; ADVERSE EVENTS; QUALITY; SURVIVAL; SYSTEM; In-hospital cardiac arrest management; In-hospital cardiac arrest; Cardiac arrest team (CAT); Medical emergency team (MET); Cardiopulmonary resuscitation (1)
CARDIAC-ARREST CARE; REGIONALIZATION; (1)
CARDIAC-ARREST; DOCUMENTATION; QUALITY; EVENTS; SYSTEM; COUNCIL; Quality management; Cardiopulmonary resuscitation; Intensive care unit; Medical documentation; Patient data management systems (1)
; Cardiac arrest; Extracorporeal life support; Extracorporeal cardiopulmonary resuscitation; Extracorporeal membrane oxygenation; Resuscitation; Education (3)
CARDIAC-ARREST; INTERNATIONAL SOCIETY; TRANSPLANTATION; RECIPIENT; SURVIVAL; CRITERIA; IMPACT; REGISTRY; AGE; heart transplantation acceptance; quality; survival; donor hear (1)
CARDIAC-ARREST; SURVIVAL; (1)
CARDIAC-ARREST; SURVIVORS; DEATH; Unconsciousness; Therapeutic communication; Anesthesia; Non-pharmacological; Intraoperative awareness (1)
cardiac-assist device; cardiopulmonary resuscitation; cerebrovascular disorders; extracorporeal circulation (1)
CARDIAC-CATHETERIZATION; RADIATION-EXPOSURE; COMPUTED-TOMOGRAPHY; PATIENT; RISK; NEURORADIOLOGY; DOSIMETERS; RADIOLOGY; DETECTOR; PRODUCT; (1)
CARDIAC CHAMBER; EXERCISE; DISEASE; QUANTIFICATION; PREVENTION; ANOMALIES; HEART; Sudden cardiac death; echocardiography; coronary artery; soccer; athletes; adolescent (1)
CARDIAC COMPRESSION; RESECTION; rheumatoid arthritis; constrictive pericarditis; extra-articular disease (1)
CARDIAC-HYPERTROPHY; CONTRACTILE RESPONSE; INHIBITION PROTECTS; HEART-FAILURE; CA2+ LEAK; CAMKII; DELTA; MICE; PHOSPHORYLATION; OVEREXPRESSION; CaMKII; TAC; Pressure overload; Cardiac hypertrophy; Heart failure (1)
CARDIAC-HYPERTROPHY; HEART-FAILURE; PHOSPHATIDYLINOSITOL 3-KINASE; CARDIOVASCULAR-DISEASE; MESSENGER-RNA; IGF-I; INSULIN; PRESSURE; PATHWAY; LEPTIN; hyperinsulinemia; diabetes mellitus type II; ANP; hypertrophy; obesity (1)
CARDIAC-HYPERTROPHY; MYOCARDIAL HYPERTROPHY; LAMBETH CONVENTIONS; PRESSURE-OVERLOAD; MOUSE MODEL; CAMKII; DELTA; ARRHYTHMIAS; OVEREXPRESSION; CARDIOMYOPATHY; beta-adrenergic blockers; calcium; calmodulin-dependent protein kinase type 2; heart failure (1)
Cardiac Implantable Electronic Devices, Lead dislodgement, Lead migration, Ratchet, Reel, Twiddler (1)
CARDIAC-INSUFFICIENCY BISOPROLOL; CONVERTING ENZYME-INHIBITOR; EVALUATION TRIAL CARMEN; NT-PROBNP; PLASMA-LEVELS; DOUBLE-BLIND; THERAPY; CARVEDILOL; ENALAPRIL; MILD; brain natriuretic peptide; adrenergic beta-antagonists; carvedilol; angiotensin-converting enzyme inhibitors; enalapril; prognosis; congestive heart failure (1)
CARDIAC MACROPHAGES; INFLAMMATION; DISTINCT; PROGENITORS; EXPRESSION; CELLS; Monocyte; Macrophage; Inflammation; Myocardial infarction; Single-cell RNA-seq (1)
CARDIAC MYOCYTES; REPERFUSION INJURY; ENDOTHELIAL-CELLS; CA2+ RELEASE; CYCLIC-GMP; ACTIVATION; KINASE; CAMP; RECEPTORS; CALCIUM; urocortin; cardiac myocyte; eNOS phosphorylation; nitric oxide (1)
CARDIAC NA+/H+ EXCHANGER; GLUCOSE TRANSPORTERS; GENE-EXPRESSION; DOWN-REGULATION; HEART; EMPAGLIFLOZIN; INHIBITION; NHE1; HYPERTROPHY; ACTIVATION; COVID-19; Infection; Heart; GLUT1; NHE1 (1)
CARDIAC-OUTPUT ASSESSMENT; PULSE PRESSURE VARIATION; WAVE-FORM AMPLITUDE; RESPIRATORY VARIATIONS; MONITOR; FLOTRAC(TM); PARAMETERS; ABILITY; SYSTEM; fluid responsiveness; major abdominal surgery; pleth variability index; pulse oximeter plethysmography; stroke volume variation (1)
cardiac remodeling; hypertension; inflammation; metformin; microbiome; short‐chain fatty acids (1)
CARDIAC-RESYNCHRONIZATION THERAPY; RAPID VENTRICULAR-TACHYCARDIA; ANTIARRHYTHMIC-DRUG THERAPY; PRIMARY PREVENTION; RANDOMIZED-TRIAL; ICD; SURVIVAL; SHOCKS; REDUCTION; ENALAPRIL; Defibrillator; Mortality; Novel; Programming (1)
CARDIAC RYANODINE RECEPTOR; HEART-FAILURE PROGRESSION; VENTRICULAR MYOCYTES; PHOSPHORYLATION; OVEREXPRESSION; CONTRACTILITY; HYPERTROPHY; DYSFUNCTION; MYOCARDIUM; RELEASE; CaMKII; SR Ca2+ leak; Heart failure; Arrhythmias (1)
CARDIAC SARCOPLASMIC-RETICULUM; SODIUM-CALCIUM EXCHANGER; HEART-FAILURE; VENTRICULAR MYOCYTES; NA/CA EXCHANGE; NA+-CA2+ EXCHANGER; SPARKS; FIBRILLATION; EXPRESSION; RELEASE; Na+/Ca2+ exchanger; NCX; HFpEF; SAR296968 (1)
CARDIAC-SURGERY; ANTIBIOTIC-PROPHYLAXIS; PENETRATION; TISSUE; Moxifloxacin; Cardiopulmonary bypass; Pharmacokinetics (1)
CARDIAC-SURGERY; INFLAMMATORY RESPONSE; AGE; minimized extracorporeal circulation; coronary artery bypass surgery; postoperative outcome; elderly; conventional extracorporeal circulation (1)
CARDIAC-SURGERY; PERICARDIAL ADHESIONS; SUBSTITUTE; EXPERIENCE; STERNOTOMY; REPAIR; RABBIT; (1)
CARDIAC-SURGERY; RISK; CRITERIA; COMPLICATIONS; ASSOCIATION; MANAGEMENT; ADULTS; VALVES; IMPACT; infective endocarditis; mortality; valve histopathology; NT-proBNP; ROC analysis; sensitivity; specificity (1)
CARDIAC-SURGERY; RISK; OUTCOMES; PARADOX; ADULTS; ECMO; (1)
CARDIAC-SURGERY; SYSTEM; RISK; MORTALITY; SURVIVAL; DIALYSIS; OUTCOMES; DAMAGE; PUMP; (1)
CARDIAC TRANSCRIPTION; ADDICTIVE BEHAVIOR; ASSOCIATION; WITHDRAWAL; VALIDATION; EXPRESSION; PREVENTION; PREFERENCE; PROMOTERS; GENETICS; genetic association study; alcohol; GATA4; atrial natriuretic peptide; acamprosate (1)
CARDIAC TRANSPLANTATION; FUNCTIONAL-CAPACITY; AMBULATORY PATIENTS; PROGNOSTIC VALUE; VE/VCO2 SLOPE; DEAD SPACE; FAILURE; RECIPIENTS; INTOLERANCE; PREDICTORS; heart transplantation; peak VO2; ventilatory efficiency; VE/VCO2-slope; body weight (1)
; cardiac tumor; cardiac lymphangioma; cardiac surgery (1)
CARDIFF PUERPERAL MOOD; POSTNATAL DEPRESSION; GENDER-DIFFERENCES; BREAST-MILK; ESTROGEN; WOMEN; CORTISOL; ATTACKS; ONSET; CHILDBEARING; panic disorder; pregnancy; postpartum; estrogen; progesterone (1)
Cardiocondyla, ant males, morphology, ergatoid males, Hymenoptera, Formicidae, external genitalia (1)
Cardiocondyla, ants, reproductive tactics, fighting males, inbreeding, outbreeding, life-span, reproductive success, son mating, sex ratio, caste determination (1)
CARDIOCONDYLA ANTS; SOCIAL INSECTS; REPRODUCTION; SPERM; DROSOPHILA; SELECTION; COSTS; INVESTMENT; EVOLUTION; COURTSHIP; Cardiocondyla; life span; reproduction; trade-off (1)
CARDIOCONDYLA ANTS; TACTICS; QUEENS; REPRODUCTION; WROUGHTONII; HYMENOPTERA; COMPETITION; STRATEGIES; OBSCURIOR; SELECTION; (1)
CARDIOCONDYLA-ELEGANS; GENETIC DIVERSITY; LIFE-SPAN; HYMENOPTERA; RELATEDNESS; MATE; Formicidae; Hymenoptera; mating behavior; outbreeding; polyandry; population structure (1)
; Cardiocondyla; ergatoid males; Indo-Malayan region (1)
CARDIOCONDYLA; REPRODUCTIVE COMPETITION; MATING; ERGATOID MALES (1)
Cardiocondyla, seminal fluid, male accessory gland proteins, representational difference analysis, 2D-SDS-PAGE, serpin, ejaculatory bulb specific protein, protein disulfide isomerase, NHE-RF, Selenophosphate synthetase 1 (1)
CARDIOGENIC-SHOCK; LIFE-SUPPORT; SEPSIS; SURVIVAL; INFLAMMATION; REMOVAL; THERAPY; INJURY; cardiac failure; extracorporeal life support; intensive care; resuscitation (1)
CARDIOPULMONARY BYPASS; ACTIVATED PLATELETS; AGGREGATION; DYSFUNCTION; RECEPTORS; COMPLEX; heart surgery; extracorporeal circulation; platelet function; flow cytometry; heparin effects (1)
CARDIOPULMONARY BYPASS; ACUTE STROKE; BRAIN TEMPERATURE; CEREBRAL-ISCHEMIA; CARDIAC-SURGERY; FOREBRAIN ISCHEMIA; MILD HYPERTHERMIA; HYPOTHERMIA; MANAGEMENT; NORMOTHERMIA; aortic surgery; temperature monitoring; antegrade cerebral perfusion; hypothermia; circulatory arrest; tympanic; rectal; bladder (1)
CARDIOPULMONARY BYPASS; BLOOD-FLOW; CARDIAC-SURGERY; ABDOMINAL COMPLICATIONS; INDOCYANINE GREEN; EXPERIENCE; (1)
CARDIOPULMONARY BYPASS; EJECTION FRACTION; HEART-FAILURE; FOLLOW-UP; ON-PUMP; REVASCULARIZATION; DYSFUNCTION; MANAGEMENT; SURVIVAL; SYSTEM; cardiomyopathy; cardiovascular surgery; coronary bypass surgery (1)
CARDIOPULMONARY BYPASS; IN-VITRO; MODIFIED THROMBELASTOGRAPHY; EXTRACORPOREAL-CIRCULATION; CYTOCHALASIN-D; CROSS-LINKING; BLOOD; COAGULATION; FIBRIN; STRENGTH; cardiac surgery; coagulation; extracorporeal circulation; Factor XIII; ROTEM (1)
CARDIOPULMONARY BYPASS; MEMBRANE OXYGENATORS; INFLAMMATORY RESPONSE; CENTRIFUGAL PUMP; ROLLER-PUMP; FOLLOW-UP; BLOOD; ISOFLURANE; EXPERIENCE; IMPELLER; (1)
CARDIOPULMONARY BYPASS; MEMBRANE-OXYGENATORS; NITROUS-OXIDE; HIGH-RISK; PROPOFOL; SEVOFLURANE; ISOFLURANE; MULTICENTER; HUMANS; DYSFUNCTION; (1)
CARDIOPULMONARY BYPASS; MODEL; EXPRESSION; INFECTION; ISCHEMIA; STROKE; MOUSE; (1)
CARDIOPULMONARY BYPASS; POPULATION PHARMACOKINETICS; CHILDREN; ADULTS; SEIZURES; FIBRINOLYSIS; PARAMETERS; MODELS; tranexamic acid; antifibrinolytic agents; pharmacokinetics; cardiac surgical procedures; congenital heart defects (1)
CARDIOPULMONARY BYPASS; PRESSURE WAVE; REPRODUCIBILITY; AGREEMENT; SURGERY; (1)
CARDIOPULMONARY BYPASS; THORACIC-SURGERY; COMPLICATIONS; THERAPY; ARREST; Aneurysm; dissecting; Extracorporeal circulation; Water-electrolyte balance; Blood transfusion (1)
CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HEALTH-CARE; VENTRICULAR-FIBRILLATION; ADVERSE EVENTS; DEFIBRILLATION; resuscitation protocol; emergency reporting; emergency team; IHEP (in-hospital emergency protocol; in-hospital emergency (1)
CARDIOPULMONARY-RESUSCITATION; CARDIOGENIC-SHOCK; REGULARIZATION; SEPSIS; ECMO; ECLS; VA-ECMO; cardiogenic shock; eCPR; prognosis (1)
Cardiopulmonary resuscitation, Extracorporeal circulation, Extracorporeal life support, Out-of-hospital, cardiac arrest (1)
CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; SURVIVAL; GUIDELINES; COUNCIL; Cardiac arrest; ECPR; In-hospital; Out-of-hospital; Neurological outcome; Mortality (1)
CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; SURVIVAL; METAANALYSIS; ASSOCIATION; GUIDELINES; DURATION; DONATION; TRENDS; ADULTS; Cardiac arrest; ECPR; In-hospital; Out-of-hospital; Survival; Neurological outcome (1)
CARDIOTHORACIC TRANSPLANT RECIPIENTS; ENDOPLASMIC-RETICULUM KINASE; BONE-MARROW NICHE; BREAST-CANCER; MALIGNANT-MELANOMA; IN-VIVO; LATE RECURRENCE; METASTATIC OUTGROWTH; EXTRACELLULAR-MATRIX; CELLULAR QUIESCENCE; (1)
CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ALL-CAUSE; MORTALITY; POPULATION; EXERCISE; RISK; exercise; clinical medicine; global health; chronic disease; cardiovascular; type 2 diabetes; cancer; hypertension; HIV; AIDS; health promotion; noncommunicable disease (1)
CARDIOVASCULAR-DISEASE; CARDIAC ABNORMALITIES; OBESITY; IL-15; ATHEROSCLEROSIS; IL-15R-ALPHA; EXPRESSION; CHAIN; CELL; PATHWAY; (1)
cardiovascular disease; chronic kidney disease; epidemiology nephrology referral (1)
cardiovascular disease, neurological rehabilitation, stroke, arterial stiffness, carotid artery, intima-media thickness (1)
CARDIOVASCULAR-DISEASE; PREGNANCY; APHERESIS; ENDOGLIN; RISK; PLASMAPHERESIS; TRANSFUSION; DEFINITION; ECLAMPSIA; REMOVAL; therapeutic plasma exchange; preeclampsia; soluble fms-like tyrosine kinase 1; placental growth factor; soluble endoglin (1)
cardiovascular diseases; cell attachment; cell migration; inflammatory disease; integrin (1)
CARDIOVASCULAR EVENTS; SYMPATHETIC ACTIVITY; HYPERTENSION; MECHANISMS; DAMAGE; INDEX; Sleep apnea; Blood pressure; CPAP therapy; Endothelial dysfunction; Erectile dysfunction (1)
; Cardiovascular fingolimod effects; Multiple sclerosis; Baroreflex gain; Valsalva maneuver; Baroreflex resetting (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; 2011 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; ATRIAL-FIBRILLATION; DIAGNOSIS; HEART; MUTATIONS; GENOTYPE; MYBPC3; PATHOGENESIS; Hypertrophic cardiomyopathy; HCM; Hereditary cardiac disease; Left ventricular hypertrophy; MYBPC3; MYH7 (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; FUNCTIONAL RECOVERY; PROGNOSTIC VALUE; INFARCTION; PREDICTION; VIABILITY; (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; VENTRICULAR EJECTION FRACTION; INFARCT SIZE; PROGNOSTIC-SIGNIFICANCE; VOLUME INDEX; RECOVERY; REPERFUSION; IMPROVEMENT; MORTALITY; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Prognosis; Late systolic recovery; Perfusion imaging; Late enhancement imaging (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; OBSTRUCTIVE SLEEP-APNEA; ADIPOSE-TISSUE; HEART-FAILURE; HYPOXIA; DISEASE; OBESITY; STRESS; RISK; Sleep apnea; Hypoxia; Epicardial fat; Myocardial infarction; Magnetic resonance imaging (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; PERCUTANEOUS CORONARY INTERVENTION; DISTURBED CARDIAC REPOLARIZATION; ST-SEGMENT RESOLUTION; MICROVASCULAR OBSTRUCTION; PROGNOSTIC VALUE; LEVEL ANALYSIS; FAT THICKNESS; SIZE; ASSOCIATION; Epicardial adipose tissue; Acute myocardial infarction; Microvascular obstruction; ST-deviation; Infarct size; Myocardial salvage index (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; SPECKLE-TRACKING ECHOCARDIOGRAPHY; CARDIAC MR; DIAGNOSIS; DEFORMATION; INFARCTION; PATTERNS; SOCIETY; ADULTS; Myocarditis; CMR; Speckle tracking; Regional longitudinal strain (1)
CARDIOVASCULAR REACTIVITY; EXPOSURE THERAPY; SOCIAL PHOBIA; ANXIETY; FEAR; (1)
CARDIOVASCULAR REACTIVITY; GENDER-DIFFERENCES; SALIVARY CORTISOL; ORAL-CONTRACEPTIVES; PROSOCIAL BEHAVIOR; DECISION-MAKING; RISK-TAKING; LIFE STRESS; RESPONSES; SUPPORT; (1)
Cardiovascular risk, cardiovascular diseases, ECG, Mobile Health (1)
CARDIOVASCULAR RISK-FACTORS; BASE-LINE CHARACTERISTICS; CORONARY-ARTERY-DISEASE; COAGULATION-FACTOR-V; MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; PROTEIN-C; DESIGN; METAANALYSIS; CLOPIDOGREL; coronary artery disease; genetic association studies; thrombosis; prognosis; single nucleotide polymorphism; myocardial infarction; secondary prevention (1)
CARDIOVASCULAR RISK-FACTORS; CALCINEURIN-INHIBITORS; KIDNEY-TRANSPLANTATION; CHRONIC REJECTION; UNITED-STATES; IMMUNOSUPPRESSION; MULTICENTER; (1)
CARDIOVASCULAR RISK-FACTORS; MARIJUANA USE; MELLITUS; HEALTH; cannabis; diabetes (1)
CARDIOVASCULAR RISK; HEALTH INTERVIEW; DIABETES-MELLITUS; ADULTS; OBESITY; SMOKING; WEIGHT; Cardiometabolic health; Birth cohort study; Health behavior; Lifestyle (1)
CARDIOVERTER-DEFIBRILLATOR PATIENTS; RESYNCHRONIZATION THERAPY SYSTEMS; ATRIAL-FIBRILLATION; FOLLOW-UP; TRIAL; PACEMAKERS; CARE; HF; HOSPITALIZATIONS; DIAGNOSTICS; home health monitoring; telemedicine; commercial telemedicine (1)
CARDIOVERTER-DEFIBRILLATORS; ELECTROMAGNETIC-INTERFERENCE; PERMANENT PACEMAKERS; MEDIA PLAYERS; TELEMETRY; (1)
CARE; (1)
CARE; Admission times; Clinical psychiatry; Diagnostic groups; Circadian rhythms; Mental crisis (1)
CARE; DRG; quality assurance; coding; DGGG; MDC; adaptation (1)
CAREER CONCERNS; CONTRARIAN BEHAVIOR; INTERNET EXPERIMENT; EARNINGS FORECASTS; SECURITY ANALYSTS; INFORMATION; CASCADES; INVESTMENT; Reputation; Herding; Imitation; Financial markets; Experiment (1)
CAREER CONCERNS; MORAL HAZARD; INFORMATION; EMPLOYMENT; PRINCIPAL; OPTIONS; AGENTS; FIRMS; Knowledge workers; Moral hazard; Limited commitment; Ex post outside option (1)
CARE; FUTURE; HOSPITALS; MEDICINE; Emergency department; In hospital emergency medicine; Patient care; Medical qualification (1)
Care Giver, Health Information Exchange, Healthcare Information, Storage Structure, Target Format (1)
CARE; MANAGEMENT; DIAGNOSES; ADULTS; epilepsy; headache; neurological emergency room; seizures; stroke (1)
CARE; QUALITY; BREAST; colorectal cancer; longterm survival; organ cancer centers; evidence-based medicine (1)
CARE TRANSFORMATION; PRIVACY; TRUST; PHEALTH; INFORMATION; MANAGEMENT; SECURITY; MODEL; eHealth; data democratization; health data infrastructure; privacy-enhancing technologies (1)
CARE UTILIZATION; PREGNANT-WOMEN; ANTENATAL CARE; DETERMINANTS; ADULTS; RISK; Supplementary prenatal screening and diagnostics; Andersen's Behavioural Model of Health Services Use; Birth cohort (1)
CARE; WELL; GENDER; WAR; healthcare professionals; COVID-19 pandemic; preparedness; hospital; qualitative study; leadership; crises; staff shortage (1)
CARE; WELL; MATERNITY; START; epidemiology; maternal medicine; community child health; public health (1)
CARE WORKERS; BEHAVIOR-CHANGE; TRANSMISSION; ADHERENCE; FEEDBACK; PERCEPTIONS; TECHNOLOGY; GUIDELINES; ATTITUDES; VISITORS; (1)
CARIES; DEMINERALIZATION; PREVALENCE; PROGRAM; Fluorides; Topical; White Spots; Gingivitis; Orthodontics (1)
caries, gingivitis, nutritional status, obesity, children (1)
CARIES; MICROANALYSIS; SUBSTITUTE; TOOTH; MODEL; enamel; dentin; elemental composition; murine; bovine; human; EDX; WDX (1)
CARINII-PNEUMONIA; HIV; COLONIZATION; DIAGNOSIS; EFFICACY; THERAPY; LUNGS; PCR; HIV; Organ transplantation; Stem cell transplantation; Immunocompromised host; Autoimmune diseases (1)
Cariostatic agents · Toothpastes · Fluorides · Lanthanoid series elements · Cell survival · Cell death (1)
CARLO DOSE CALCULATION; IMRT OPTIMIZATION; INTENSITY MODULATION; DELIVERY TIME; SHOOT IMRT; ALGORITHM; BEAMS; STEP; MLC; DEGENERACY; IMRT; segmentation; fluence smoothing (1)
CAR, Magnetic separation, Isolation, Purification, MACS (1)
CARNOSIC ACID; BUTYLATED HYDROXYANISOLE; NATURAL ANTIOXIDANTS; PHENOLIC-COMPOUNDS; GREEN EXTRACTION; HIV-1 INTEGRASE; ESSENTIAL OIL; ROSEMARY; HYDRODISTILLATION; CARCINOGENICITY; Antioxidants; Rosemary; Essential oil; Steam distillation; Hydro distillation; DPPH; Antioxidant activity (1)
CAROLIS-DISEASE; ABNORMALITIES; (1)
CAROTID-ARTERY OCCLUSION; CEREBROVASCULAR-DISEASE; VERTEBROBASILAR SYSTEM; COLLATERAL PATHWAYS; ACUTE STROKE; SONOGRAPHY; ENDARTERECTOMY; BENEFIT; FLOW; ultrasonography; duplex scanning; contrast media; SonoVue (R) (1)
CAROTID-ARTERY STENOSIS; MULTISLICE CT; INJURED PATIENTS; AORTIC-ANEURYSM; HELICAL CT; WORK-UP; POLYTRAUMA; ANGIOGRAPHY; COLONOGRAPHY; MANAGEMENT; CT spiral; trauma; diagnostic radiology (1)
CAROTID-BODY PARAGANGLIOMA; VONHIPPEL-LINDAU DISEASE; SDHD GENE; HEREDITARY PARAGANGLIOMA; FAMILIAL PARAGANGLIOMA; MATERNAL TRANSMISSION; LINE MUTATIONS; PHEOCHROMOCYTOMA; SUSCEPTIBILITY; PREVALENCE; (1)
Carotid stenosis; Stroke; Endarterectomy; carotid (1)
Carotisdissektion, Halsgefäßverletzung, Polytrauma, carotid artery dissection, CAD, BCVI (1)
; Carpal injuries; Scapholunar ligament; Lunotri; Ultrasound; Validation (1)
Carpal tunnel syndrome, anatomische Variation, Thenar- und Hypothenar-Muskulatur (1)
CARPAL-TUNNEL-SYNDROME; MEDIAN NERVE; SONOGRAPHY; LESIONS; ELBOW; Nerve entrapment; Neuropathy; Electroneurography; Electromyography; Neurosonography (1)
CARPAL-TUNNEL SYNDROME; ULTRASOUND; DIAGNOSIS; US; peripheral nerve median nerve; sonography; ultrasound; morphology (1)
carpology; caryology; Leuantheminae; typification (1)
CARPOMETACARPAL JOINT; HYALURONIC-ACID; KNEE OSTEOARTHRITIS; CLINICAL-TRIAL; FORMULATIONS; INJECTION; PLACEBO; (1)
CARRIER MULTIPLICATION; TEMPERATURE-DEPENDENCE; BAND-STRUCTURE; SEMICONDUCTOR; DYNAMICS; BIEXCITONS; TOOL (1)
CARRIERS; GAS; (1)
CARRIER STATE; T-CELLS; RECIPIENTS; EXPRESSION; BLOOD; (1)
CAR T cell; adoptive T cell therapy; checkpoint; stimulation; exhaustion (1)
CAR-T cell; adoptive T cell therapy; gluconate; citrate; melanoma; tumor microenvironment (1)
CAR T cell, Living drug, Adoptive immunotherapy, Pharmacokinetics (1)
CAR T-cells; B-cell acute lymphoblastic leukemia (B ALL); large B-cell lymphoma (LBCL); multiple myeloma (MM); cytokine release syndrome (CRS); immune effector cell associated neurotoxicity syndrome (ICANS) (1)
CAR T cells, kidney cancer, renal cell carcinoma, allogeneic, CD70, VHL (1)
CAR T cells, transplant, leukemia, memory stem T cells (1)
cartilage, AP-2 epsilon, osteoarthritis (1)
cartilage defect, chondrocyte, MACT, matrix‐associated autologous chondrocyte transplantation, osteochondral lesion, transplant (1)
CARTILAGE DEFECTS; OSTEOARTHRITIS PATHOPHYSIOLOGY; OSTEOGENIC DIFFERENTIATION; MATRIX PRODUCTION; STROMAL CELLS; IN-VITRO; COCULTURE; TISSUE; INTERLEUKIN-1-BETA; OSTEOBLASTS; (1)
cartilage, knee, children, adolescents, osteochondritis dissecans, joint (1)
CARTILAGE PRESSURE; WEDGE; FLEXION; ARTHROPLASTY; REVISION; ALTERS; MOTION; HTO; Kinematics; Femoral rollback (1)
cartilage repair; repair; osteotomy; procedures; microfracture; procedures; cartilage transplantation; grafts (1)
CARTILAGE REPAIR TISSUE; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; HIGH-RESOLUTION; FEMOROACETABULAR IMPINGEMENT; ARTHROSCOPIC TREATMENT; OSTEOARTHRITIS; IMPLANTATION; HYDROGEL; hip-preserving surgery; hip arthroscopy; matrix-associated autologous chondrocyte transplantation; MACT; cartilage defect; femoroacetabular impingement (1)
CARTILAGE REPAIR TISSUE; OSTEOCHONDRAL DEFECTS; FOLLOW-UP; PERIOSTEUM; OUTCOMES; Knee; cartilage; autologous chondrocyte implantation; spheroids; osteoarthritis; ACI (1)
Cartilage tissue engineering, auricular reconstruction, differentiation, growth factors (1)
; CAR-T; Lymphoma; Relapse; Allogeneic hematopoietic cell; transplantation (1)
CartoonComic Graphic Novel Sachcomic Infocomic Rechtsvisualisierung Bildwissenschaft Sehen und Verstehen (1)
CAR-T-Zelle, Immuntherapie, IRF4 (1)
Cas12a, CRISPR/Cas, FRET (1)
CASCADE LASERS; ELECTROLUMINESCENCE; SCATTERING; (1)
CASCADE LASERS; LOW-THRESHOLD; TEMPERATURE; ELECTROLUMINESCENCE; EMISSION; DOTS; (1)
CASCADE LASERS; MU-M; SEMICONDUCTOR-LASER; OPERATION; LUMINESCENCE; TEMPERATURE; EMISSION; (1)
CASCADE STRUCTURE; ELECTRON-GAS; MU-M; ELECTROLUMINESCENCE; TEMPERATURE; OPERATION; (1)
Case-Based-Learning, fallbasiertes Lernen, E-Learning, Thoraxchirurgie, Lehrforschung (1)
case-by-case framework, educational assessment, protective factors, risk factors, learning difficulties, inclusive education (1)
Case report, Cutaneous squamous cell carcinoma, Bone involvement, Head and neck, Radiotherapy, Cemiplimab (1)
Case report, Cutaneous squamous cell carcinoma, Bone involvement, Head and neck, Radiotherapy, Cemiplimab (1)
Case report, Intramyocardial dissecting haematoma, Haematoma of ventricular septum, Spontaneous remission (1)
Case report, VA-ECMO, Impella, COVID19, ISCLS (1)
case studies, corporate sustainability, employee share ownership, employee shareholder associations, Germany, organizational democracy (1)
case study, emotional and behavioral problems, trauma, learning difficulties, case-by-case framework for educational assessment, protective factors, risk factors, special education, inclusive education, problem-based learning (PBL), teacher personality (1)
case study, learning difficulties, case-by-case framework for educational assessment, protective factors, risk factors, special education, inclusive education, problem-based learning (PBL) (2)
Cash Cow; Dienstleistungsportfolio; Bibliothek (1)
CASK, CaMKII, LTCC, heart failure (1)
CASK, CaMKII, Später Natriumstrom (1)
Caspase-2, Alzheimer’s disease, neurodegenerative disorders, tauopathies, dementia, caspase‐2 inhibitors, synaptic dysfunctions, dendritic spines, protein cleavage, structure-based design, tau cleavage, histamine H₂ receptor, H₂ ligands, receptor subtype selectivity, dopamine D2long receptor, dopamine D3 receptor, carbamoylguanidines, aminothiazoles, aminothiadiazoles, GPR3, UR-MB-355, orphan, GPCR, oGPCR, AF64394, pathway-independent, BRET-based assay (1)
Caspase-8, 14.7K, Adenovirus, Interaktion, Apoptose, adenoviral protein, apoptosis (1)
Ca; SR Ca; CaMKII; ROS; Kardiomyopathie; Doxorubicin (1)
CASSETTE TRANSPORTER 1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; HEPATIC ABCA1; LOW HDL; HYPOALPHALIPOPROTEINEMIA; INACTIVATION; DEFICIENCY; MUTATIONS; MICE; (1)
CASSETTE TRANSPORTER A1; BINDING-PROTEINS; CELL-SURFACE; KINASE CK2; ACTIVATION; EXPRESSION; APPL1; DIMERIZATION; PATHWAYS; REVEALS; Adiponectin; PDZ-protein; Hepatocyte; Syntrophin (1)
CASSETTE TRANSPORTER ABCA4; CONE-ROD DYSTROPHY; MACULAR DEGENERATION; RETINAL DYSTROPHIES; BIOCHEMICAL DEFECTS; TRANSCRIPTOME; REVEALS; ALLELES; PROTEIN; CELLS; Stargardt disease; ABCA4; mutation screening; genetic risk score (1)
CASSIA-ANGUSTIFOLIA; IDENTIFICATION; stability control; sennosides; degradation pathways; Cassia senna; Leguminosae; ICH guidelines (1)
CASTE DETERMINATION; MITOCHONDRIAL-DNA; INTRASPECIFIC PARASITISM; SYMPATRIC SPECIATION; SOCIAL HYMENOPTERA; SOLENOPSIS-INVICTA; UNRELATED QUEENS; KIN SELECTION; FORMICIDAE; POLYMORPHISM; (1)
CASTE DETERMINATION; SOLENOPSIS-INVICTA; HONEY-BEE; FIRE ANT; POLYMORPHISM; EVOLUTION; POPULATIONS; HERITABILITIES; LONGISPINOSUS; CONSTRAINTS; alternative life histories; body size; heritability; phenotypic plasticity; social insects; threshold character (1)
Caste differentiation, germ cell development, urate, embryogenesis (1)
CASTELNUOVO-MUMFORD REGULARITY; CODIMENSION 2; RINGS; (1)
; Castelnuovo-Mumford regularity; rational points in projective spaces over finite fields; Hilbert function; index of stability (1)
casual interaction, interactive surface, mobile device, nfc, smartphone (1)
casual-leisure, diary study, information needs, television (1)
Catalysis, Katalyse, Hydrogenation, Hydrierung, Cross Coupling, Kreuzkupplung (1)
Catalysis; Organometallic Chemistry; Hydrogenation Reactions; Metal Hydrides; Nanoparticles; 3d Metals; Iron Group; Cobalt; Kinetic Poisoning Experiments (1)
Catalyst preparation, deep eutectic solvents, supported metal catalysts, electrochemistry, electrochemical CO2 reduction (1)
Catalysts, Hydrocarbons, Molecular structure, Oxidation, Selenium (1)
Catalysts, Noncovalent interactions, Reactivity, Thermodynamic properties (1)
CATALYTIC-ACTIVITY; PD NANOPARTICLES; FACILE SYNTHESIS; HECK; PERFORMANCE; EFFICIENT; REDUCTION; NANOBEADS; GRAPHENE; SUPPORTS; Pd nanoparticles; Nitrobenzene; heterogeneous catalysis; Hydrogenation; immobilization (1)
CATALYTIC-ACTIVITY; STEREOSELECTIVITY; BROMINATION; (1)
CATALYTIC ASYMMETRIC ALDOL; L-PROLINE; AQUEOUS-MEDIA; ZINC-PROLINE; AMINO-ACID; MICHAEL ADDITION; INCREASED REACTIVITY; VERSATILE CATALYSTS; ORGANIC-MOLECULES; ENAMINE CATALYSIS; aldol reaction; aldehydes; cobalt; diastereoselectivity; ketones (1)
CATALYTIC ASYMMETRIC DEAROMATIZATION; INTRAMOLECULAR IPSO-HALOCYCLIZATION; PHENOL DEAROMATIZATION; CYCLIZATION; PHOTOOXIDATION; OXIDATION; SPIROLACTONIZATION; STRATEGIES; (1)
CATALYTIC ASYMMETRIC DEPROTONATION; CHIRAL PHOSPHORUS LIGANDS; PHOSPHINE OXIDES; ENANTIOSELECTIVE SYNTHESIS; BRONSTED ACID; DIASTEREOSELECTIVE SYNTHESIS; ORGANOMETALLIC REAGENTS; BORANE COMPLEXES; ALDOL REACTIONS; HYDROGENATION; alkali metals; cleavage reactions; phosphorus; P-stereogenic compounds; structure elucidation (1)
CATALYTIC ASYMMETRIC-SYNTHESIS; ENERGY-TRANSFER; ENANTIODIFFERENTIATING PHOTOISOMERIZATION; ENHANCED DIASTEREOSELECTIVITY; CYCLIZATION REACTIONS; EXCITED THIOXANTHONE; INTERNAL-CONVERSION; CHIMERIC BEHAVIOR; PRODUCT CHIRALITY; CYCLOPROPANATION; enantioselectivity; hydrogen bonds; photochemistry; time-resolved spectroscopy; xanthones (1)
CATALYTIC MECHANISM; STRUCTURAL BASIS; INHIBITION; PROTEIN; STIMULATION; ACTIVATOR; SUBUNITS; PURINE; CELLS; BASAL; Adenylyl cyclase; Diterpenes; Divalent cations; Forskolin; Molecular modelling (1)
Catalytic multicomponent reactions, tetrahydroquinolines, pyrrolidinones, pyrazoles (1)
catalytic; palladium; 2,3-dihydrofuran; anti-aldol (1)
CATALYTIC RESIDUES; PROTEIN-SEQUENCE; LIGAND-BINDING; PREDICTION; EVOLUTIONARY; SITES; SERVER; CONSERVATION; ANNOTATION; LIBRARY; (1)
CATALYZED AEROBIC OXIDATION; SINGLET OXYGEN; ELECTRON-TRANSFER; SECONDARY-AMINES; PHOTOSENSITIZING PROPERTIES; INFRARED-EMISSION; MOLECULAR-OXYGEN; REDOX PROPERTIES; SUPEROXIDE ION; COMPLEXES; (1)
CATALYZED ALLYLIC ALKYLATION; FACE AROMATIC INTERACTIONS; DOUBLE-MUTANT CYCLES; PI-PI-INTERACTIONS; MOLECULAR RECOGNITION; ASYMMETRIC CATALYSIS; CONJUGATE ADDITION; BIDENTATE LIGANDS; MONODENTATE PHOSPHORAMIDITES; P-31 NMR; intermolecular interactions; NMR spectroscopy; phosphoramidite ligands; transition-metal complexes (1)
CATALYZED ALLYLIC SUBSTITUTIONS; MRI CONTRAST AGENTS; IN-VITRO; BUILDING-BLOCKS; AMINO-ACIDS; ANTIBACTERIAL ACTIVITIES; CHEMOTACTIC PEPTIDES; CHELATE COMPLEXES; DNA RECOGNITION; IMAGING AGENTS; solid-phase peptide synthesis; metal complexes; single amino acid chelates; peptide receptors (1)
CATALYZED ASYMMETRIC REACTIONS; BIS(OXAZOLINE) LIGANDS; BIPHASIC CATALYSIS; MICHAEL ADDITION; RECYCLABLE ORGANOCATALYST; ALDOL REACTION; COMPLEXES; CYCLOPROPANATION; PERFLUOROALKYL; OLEFINS; azabis(oxazolines); click reaction; fluorous tags; immobilization; kinetic resolution; nitroaldol reaction (1)
CATALYZED AZIRIDINATION; OLEFINS; ARYLATION; CARBONYLATION; REARRANGEMENT; RADICALS; MILD; (1)
CATALYZED CLAISEN REARRANGEMENT; ALLYL VINYL ETHERS; BISMUTH TRIFLATE; ACID; CONSTITUENTS; FACILE; CORE; (1)
CATALYZED CONJUGATE ADDITION; ASYMMETRIC ALLYLIC SUBSTITUTION; DIALKYLZINC REAGENTS; COPPER-COMPLEXES; CRYSTAL-STRUCTURE; DIETHYL-ETHER; LIGANDS; AGGREGATION; ALKYLATION; ENONES; (1)
CATALYZED CONJUGATE ADDITION; REAGENTS; CONSTRUCTION; LIGANDS; NMR; (1)
CATALYZED COUPLING REACTIONS; IONIC LIQUIDS; HALIDES; REAGENTS; ARYL; ORGANOSTANNANES; SOLVENTS; carbohydrates; green chemistry; palladium; Stille coupling; turnover number (1)
CATALYZED CROSS-COUPLINGS; METAL CHARGE-TRANSFER; RADICAL REACTIONS; PHOTOCHEMICAL PROPERTIES; KINETIC CHARACTERISTICS; AROYLOXYL RADICALS; ORGANIC-MOLECULES; CHLORO COMPLEXES; COPPER; CYCLOPROPYLAMINES (1)
CATALYZED DECARBONYLATIVE DEHYDRATION; CORRELATED MOLECULAR CALCULATIONS; ALIPHATIC CARBOXYLIC-ACIDS; GAUSSIAN-BASIS SETS; GAMMA-VALEROLACTONE; COMPLEXES; DECARBOXYLATION; DEOXYGENATION; EFFICIENCY; CONVERSION; Fatty acids; Palladium; Renewable feedstock; GVL; Decarbonylative dehydration; DMPU; Computational chemistry; DFT (1)
CATALYZED DEPOLYMERIZATION; SELECTIVE SYNTHESIS; SILICON; CONDENSATION; MODEL; BOND; SILICATES; BEHAVIOR; ACCESS; POLYSILOXANES; molecular scissors; Si-O-Si cleavage; silicon; siloxanes; synthetic methods (1)
CATALYZED DIRECT CARBOXYLATION; ACID-MEDIATED CARBOXYLATION; CARBON-DIOXIDE; VISIBLE-LIGHT; REDUCTIVE CARBOXYLATION; AROMATIC-COMPOUNDS; BONDS; HYDROCARBOXYLATION; BETA; PALLADIUM; (1)
CATALYZED ENANTIOSELECTIVE DIBORATION; C BOND FORMATION; BENZALDEHYDE LYASE; ASYMMETRIC DIHYDROXYLATION; ENZYMATIC CARBOLIGATION; ACYLOIN CONDENSATIONS; 2-HYDROXY KETONES; HYDROXY KETONES; SIMPLE ALKENES; REDUCTION; (1)
CATALYZED HYDROCYANATION; ELECTRON-TRANSFER; CARBON RADICALS; RIBOFLAVIN; NITRILE; ACTIVATION; MECHANISM; OXIDATION; OLEFINS; CYANIDE; (1)
CATALYZED OLEFIN METATHESIS; RUTHENIUM CARBENE COMPLEXES; CROSS-METATHESIS; STEREOSELECTIVE-SYNTHESIS; ORGANIC-SYNTHESIS; ENYNE METATHESIS; ENANTIOSELECTIVE SYNTHESIS; POLY(ETHYLENE GLYCOL); RECYCLABLE CATALYST; RCM; homogeneous catalysis; metathesis; microwave irradiation; ring-closing metathesis; ruthenium; tetrasubstituted olefin (1)
CATALYZED SYNTHESIS; INTERMOLECULAR HYDROPHOSPHINATION; IONIC LIQUIDS; EASY ACCESS; ARYL; COMPLEXES; CONVENIENT; ALKENES; LIGAND; ALKYL; alkylation; arylation; phosphane; phosphorus; photocatalysis (1)
CATALYZED TRANSESTERIFICATION REACTIONS; KINETIC ASYMMETRIC TRANSFORMATION; ORGANIC-SOLVENTS; SERINE PROTEASES; CEPACIA LIPASE; AB-INITIO; PSEUDOMONAS-CEPACIA; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ENANTIOSELECTIVITY; bioorganic chemistry; Candida antarctica lipase B; molecular dynamics; molecular modeling; organic chemistry (1)
catanionic mixtures, surfactant, physicochemical characterization (1)
Catanionics; ionische Flüssigkeiten; surface active ionic liquids, alkylethercarbonsäuren (1)
CATECHOL-O-METHYLTRANSFERASE; 5-HT2A PROMOTER POLYMORPHISM; D4 RECEPTOR GENE; ASSOCIATION ANALYSIS; TRANSPORTER DENSITY; CANDIDATE GENES; DRD4 GENE; COMT; ADOLESCENTS; VARIANTS; genetics; family-based association study; obsessive-compulsive disorder; OCD; psychiatric disorders; dopaminergic system (1)
CATECHOL-O-METHYLTRANSFERASE; ASSOCIATION; (1)
CATECHOL-O-METHYLTRANSFERASE; BREAST-CANCER; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; ALPHA POLYMORPHISM; HUMAN MYOMETRIUM; RISK-FACTORS; LEIOMYOMA; ASSOCIATION; PROMOTER; Single nucleotide polymorphisms; estrogen receptor beta; uterine fibroids (1)
CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET POLYMORPHISM; AFFECT-MODULATED STARTLE; PANIC DISORDER; ANXIETY DISORDERS; GENE VARIATION; PREPULSE INHIBITION; PERSONALITY-TRAITS; VAL158MET GENOTYPE; PREFRONTAL CORTEX; COMT; Catechol-O-methyltransferase; Val158met; L-dopa; Genetic (1)
CATECHOL-O-METHYLTRANSFERASE; HEART-TRANSPLANT RECIPIENTS; KIDNEY-TRANSPLANTATION; RAT-LIVER; ORGAN-TRANSPLANTATION; PRETREATMENT; IMPACT; PURIFICATION; INTEGRITY; CRITERIA; (1)
CATECHOL-O-METHYLTRANSFERASE; POSITRON-EMISSION-TOMOGRAPHY; RAT PREFRONTAL CORTEX; VAL(158)MET GENOTYPE; PSYCHOSOCIAL STRESS; DOPAMINE RELEASE; COGNITIVE FUNCTION; PSYCHOLOGICAL STRESS; GENETIC-VARIATION; MET GENOTYPE; COMT Val158Met polymorphism; Dopamine; Acute stress; Cortisol; Working memory (1)
CATEGORIES; (1)
CATEGORIES; HOMOLOGY; LOCALIZATION; SPECTRA; (1)
CATEGORIES; PROPERTY; Adams stacks; Colimits; Weakly Tannakian categories (1)
CATEGORIES; RECOGNITION; EVOLUTION; PICTURES; SIGNALS; color; memory; binding; subjective confidence; red; green; blue; yellow (1)
CATEGORY; VOLUME; COHOMOLOGY (1)
CATHEPSIN-B; BETA-GLUCOCEREBROSIDASE; JUXTAGLOMERULAR CELLS; PROCESSING ENZYME; MOUSE PRORENIN; DEFICIENT MICE; MORPHOLOGY; GRANULES; RECEPTOR; LIMP-2; Renin; Lysosomes; LIMP-2; SCARB2; LAMP-1; LAMP-2 (1)
CATHEPSIN-B; PHYTOPHTHORA-INFESTANS; C1A CYSTEINE; GENE FAMILY; CELL-DEATH; ARABIDOPSIS; INHIBITORS; SENESCENCE; CYSTATIN; PROTEOME; root; apoplast; PLCP; organ specific; salicylic acid (1)
CATHETER ABLATION; DISEASE; IMPACT; atrial fibrillation; CAD extent; CAD origin; coronary artery disease; coronary artery sclerosis; prevalence (1)
CATHETER-DIRECTED THROMBOLYSIS; SURGICAL REVASCULARIZATION; MECHANICAL THROMBECTOMY; ARTERIAL-OCCLUSION; INITIAL TREATMENT; THERAPY; OUTCOMES; COMPLICATIONS; SURGERY; Acute limb ischemia; bleeding; lysis; safety; thrombectomy; urokinase (1)
CATHETERIZATION; Adrenal venous sampling; Pheochromocytoma; Plasma free metanephrines; Ga-68-DOTATOC-PET/CT (1)
CATHETER; MULTICENTER; CONDUCTION; Adenosine; Atrial fibrillation; Catheter ablation; Lasers; Recurrence (1)
CATHETER-RELATED BACTEREMIA; METHICILLIN-RESISTANT; UNITED-STATES; VASCULAR ACCESS; RISK-FACTORS; MULTICENTER; DIALYSIS; EUROPE; SURVEILLANCE; HOSPITALS; bacteraemia; cost of illness; haemodialysis; MRSA; renal failure; Staphyloccocus aureus (1)
Catholicism, Queer Literature, English Literature, Victorian Literature, Victorian Culture, Queer Studies, Temporality, Time Studies (1)
cation complexation amphiphilic cage mol adsorbed monolayer (1)
CATIONIC MICELLES; CETYLTRIMETHYLAMMONIUM BROMIDE; SURFACTANT SOLUTIONS; COMPUTER-SIMULATION; AQUEOUS-SOLUTIONS; FORCE-FIELD; HYDRATION; BINDING; SODIUM; MODEL; (1)
CATIONIC MICELLES; HYDRATION; DYNAMICS; TRIFLATE; SURFACTANTS; INTERFACE; COUNTERIONS; BINDING; MICELLIZATION; SPECTROSCOPY; (1)
CATIONIC PORPHYRIN; DRUG-RESISTANCE; PHOTOINACTIVATION; MUTATIONS; EVOLUTION; OXYGEN; antifungal; photodynamic; porphyrin; Candida albicans; microscopy (1)
CATION-PI INTERACTIONS; EXTRACTION; MODEL; COSMO; Solubilization; Curcumin; Quaternary Ammonium Compounds; Natural Deep Eutectic Solvents; COSMO-RS; NMR (1)
Cations,Hydration,Ions,Molecules,Salts (1)
Cations; Hydration; Ions; Salts; Solution chemistry (1)
Cations, Hydrocarbons, Hydrogenation, Ligands, Magnesium (1)
Cations; Hydrocarbons; Hydrogenation; Ligands; Magnesium (1)
cations | N–Si bonding | phosphinimines | silicon | small ring systems (1)
Cations, Phosphorus, Pnictogen, Transition Metal, Polyphosphorus (1)
CAT STRIATE CORTEX; VISUAL-CORTEX; COMPLEX CELLS; TRANSPARENT MOTION; APPARENT MOTION; SINGLE CELLS; RESPONSES; DISCRIMINATION; NORMALIZATION; PERCEPTION; (1)
CAUCHY HYPERSURFACES; TIME FUNCTIONS; SPACETIMES; foliation; Lorentzian; time function; globally hyperbolic (1)
Cauchy problem, parallel spinors, generalized Killing spinors, Ricci-flat metrics (1)
CAULIFLOWER MOSAIC-VIRUS; DOMINANT SELECTABLE MARKER; O-GLYCOSYLATION; IN-VIVO; EXPRESSION; DNA; CELLS; TRANSFORMATION; CHLOROPLAST; PROTEIN; Cauliflower mosaic virus; Chlamydomonas reinhardtii; Gaussia princeps; luciferase; promoter (1)
CAULIFLOWER-MOSAIC-VIRUS; HUMAN TAP PROTEIN; GENE-EXPRESSION; COAT PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT; BINDING; REPLICATION; INTERACTS; CAULIMOVIRUS; ELEMENT (1)
causal fermion systems, black hole, mass, momentum, energy, energy-momentum vector, kausale Fermionensysteme, Schwarzes Loch, Masse, Impuls, Energie, Energie-Impuls-Vektor (1)
Causal fermion systems; causal variational principles; causal action principle (1)
causal fermion systems, modified measure theories, quantum gravity, effective theory (1)
causal inference; causality; model validation; machine learning; data science (1)
causality theory, globally hyperbolic, isometric embedding, conformal embedding (1)
; Causality; vertical production process; trade in parts and components; revealed comparative advantage; F10; O52 (1)
Causal variational principles; existence theory; topological measure theory (1)
causal variational principles, fermionic projector, discrete space-time, generation of causal structure, minimizing measure (1)
causal variational principles; surface layer integrals; complex structures; bosonic Fock spaces; Hilbert space structures on jets (1)
CAUSE ICHTHYOSIS VULGARIS; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; ATOPIC-DERMATITIS; GENOMIC STRUCTURE; TIGHT JUNCTIONS; WATER-LOSS; SKIN; GENE; LIPOXYGENASES; - (1)
CAUSE PSEUDOXANTHOMA ELASTICUM; TANDEM MASS-SPECTROMETRY; CELL-ENVELOPE PROTEINS; PERMEABILITY BARRIER; FATTY-ACID; CERAMIDE; GENE; ENZYMES; APOPTOSIS; MUTATIONS; adenosine triphosphate binding cassette transporters; epidermal lipids; keratinocyte differentiation; lipid transport (1)
CAUSES CONGENITAL DISORDER; GLYCOSYLATION TYPE IA; HYPERTROPHIC CARDIOMYOPATHY; SACCHAROMYCES-CEREVISIAE; DOLICHOL KINASE; PHOSPHATE; PROTEIN; PHOSPHORYLATION; BIOSYNTHESIS; ASSOCIATION; (1)
CAUSE-SPECIFIC MORTALITY; IMMIGRANT WOMEN; UNITED-STATES; TURKISH; HEALTH; MIGRANTS; ORIGIN; EASTERN; EUROPE; TRENDS; Cancer screening; Migration; Sociodemography; Social epidemiology; Health services (1)
C-AXIS CONDUCTIVITY; SUPERCONDUCTING FILMS; (1)
C-AXIS CONDUCTIVITY; SUPERCONDUCTING FILMS; YBa2Cu3O7-delta; vortices; pinning; self-field; laser heating (1)
; Cayley graphs; Graph isomorphisms; Rigidity (1)
CB2 RECEPTOR; BRAIN; RATS; PAIN; MICE; EXTRACT; DIET; ANTIOXIDANT; EXPRESSION; CYANIDIN; anthocyanidin; anthocyanin; cannabinoid receptor; pain; inflammation; neuroprotection (1)
C BOND-CLEAVAGE; BIMETALLIC HYDRIDE COMPLEXES; RAY CRYSTAL-STRUCTURES; MOLECULAR-STRUCTURE; BIS(MU-SILYLENE) COMPLEX; PENTAHYDRIDE COMPLEX; FLUXIONAL BEHAVIOR; REACTIVITY; LIGAND; NMR; (1)
C BOND-CLEAVAGE; CHARGE-TRANSFER PHOTOCHEMISTRY; TRANSITION-METAL; MERGING PHOTOREDOX; NICKEL CATALYSIS; DECARBOXYLATIVE ARYLATION; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; N-HETEROCYCLES; EXCITED-STATES; 3d transition metals; dissociative ligand-to-metal charge transfer; inner-sphere electron transfer; photoredox catalysis; visible-light-induced homolysis (1)
C BOND FORMATION; BIOMATERIALS; FILAMENTS; SEQUENCE; keratin; biopolymer; C-C bond formation; nitroaldol reaction; Henry reaction (1)
C BOND FORMATION; ENANTIOSELECTIVE HENRY REACTIONS; HIGH CATALYTIC-ACTIVITY; EGG-BOX MODEL; CALCIUM; NANOPARTICLES; LIPASES; BEADS; GELS; 4-NITROPHENOL; (1)
C BOND FORMATION; HENRY REACTION; PROTEIN CAGES; REDUCTION; MAGNETOFERRITIN; 4-NITROPHENOL; PROMISCUITY; NITROPHENOL; TRANSITION; PARTICLES; gels; gold; nanoparticles; proteins; reduction (1)
C BOND FORMATION; HYDROXYNITRILE LYASE; GELATIN; ACID; RNA; (1)
C BOND FORMATION; SUPPORTED PALLADIUM NANOPARTICLES; COVALENT ORGANIC FRAMEWORK; GRAFTED COLLAGEN FIBER; SUZUKI-MIYAURA; GOLD NANOPARTICLES; HENRY REACTION; IN-SITU; SILVER NANOPARTICLES; HETEROGENEOUS CATALYST; Biohydrogels; Biomaterials; Catalysis; Metal nanoparticles; Heterogeneous catalysts; Recyclable (1)
C-C BOND; PHOTOCHEMICAL-REACTIONS; ORGANIC-SYNTHESIS; DIPHENYL-1-PYRENYLPHOSPHINE; PHOTOCATALYSIS; COMPLEXES; CHEMISTRY; PALLADIUM; PHOSPHINE; CATALYSTS; cross-coupling; palladium; phosphane ligands; photocatalysis; photochemistry (1)
CC-chemokines; chemokine receptors; glomerulonephritis; mouse; nephrotoxic glomerulonephritits (1)
C-C; GAMMA-FE2O3 NANOPARTICLES; ORGANIC-SYNTHESIS; SUZUKI-MIYAURA; PALLADIUM-FREE; LIGAND-FREE; CHEMISTRY; CHITOSAN; COMPLEX; HECK (1)
CCP; ASSAYS; 2ND-GENERATION; AUTOANTIBODIES; PROTEINS; BIOMARKERS; VIMENTIN; 2ND; RA; Rheumatoid factor; Anti-CCP; Rheumatoid arthritis (1)
CCR4-NOT DEADENYLASE COMPLEX; HUMAN ARGONAUTE PROTEINS; NUCLEAR IMPORT RECEPTOR; MESSENGER-RNA; BINDING PROTEIN; TRANSLATIONAL REPRESSION; PRIMARY MICRORNAS; STRUCTURAL BASIS; GW182 PROTEINS; CRYSTAL-STRUCTURE; microRNA; RBP; m6A; gene silencing; deadenylation (1)
CCR6, TH17-Zellen (1)
CCR7, CCL21,Chemokine, Mesangium, Glomerulogensis, Glomerulus, Niere, Physiologie, Morphologie, Funktion, Maus (1)
C-C; SYNTHETIC APPLICATIONS; STABILIZED CARBANIONS; ELECTRON-TRANSFER; PHOTOCATALYTIC E; Z ISOMERIZATION; BORONIC ESTERS; BOND FORMATION; Z-ALKENES; LIGHT (1)
CD103(+) DENDRITIC CELLS; REGULATORY T-CELLS; INTESTINAL HOMEOSTASIS; EXPERIMENTAL COLITIS; BACTERIAL-INFECTION; LAMINA-PROPRIA; MACROPHAGES; INFLAMMATION; MICE; RECOGNITION; (1)
CD11B EXPRESSION; OXIDATIVE BURST; BUPIVACAINE; LIDOCAINE; ROPIVACAINE; NEUTROPHILS; CYTOTOXICITY; PHAGOCYTOSIS; MODULATION; MIGRATION; local anesthetics; granulocytes; immune modulation; surgical trauma; inflammation (1)
CD133, Tumorstammzellen, Kolonkarzinom, tumor stem cells, colon carcinoma (1)
CD13; Ezetimib; detergent-resistant microdomain (1)
; CD14 gene; Alcoholic liver disease; Chronic hepatitis C infection (1)
CD163, Adiponektin, Monozyt, Typ 2 Diabetes mellitus (1)
CD163, CD36, kidney cancer, lipids, macrophages (1)
CD163; heme oxygenase-1; inflammatory cytokines (1)
CD34(+) FIBROCYTES; IN-SITU; INTRAEPITHELIAL NEOPLASIA; BREAST-LESIONS; EXPRESSION; CARCINOMAS; BENIGN; Penile squamous cell cancer (PSC); Stromal remodeling (SR); CD34(+) fibrocytes; alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts; Differential diagnosis; Prognostic outcome (1)
CD4+CD25+ regulatory t-cells, dendritic cells, IBD, IL-10, IL-12 (1)
CD4(+) T-CELLS; BONE-MARROW; IN-VIVO; ALLERGIC INFLAMMATION; LUNG FIBROBLASTS; MAST-CELLS; REJECTION; RESPONSES; IL-4; INTERLEUKIN-4; basic (laboratory) research; science; heart transplantation; cardiology; immunobiology; immunosuppression; immune modulation; fibrosis; immune regulation; rejection: chronic; signaling; signaling pathways; heart (allograft) function; dysfunction (1)
CD4 T-CELLS; LANGERIN(+) DENDRITIC CELLS; KEYHOLE LIMPET HEMOCYANIN; FOLLICULAR-HELPER-CELLS; B-CELLS; LYMPH-NODE; IN-VIVO; DIFFERENTIATION; BCL-6; ACTIVATION; B cells; Follicular helper; Germinal center reaction; Langerhans cells; Leishmania major; T cells (1)
CD4(+) T-CELLS; ROR-GAMMA-T; URIC-ACID; RAPAMYCIN INHIBITION; NALP3 INFLAMMASOME; MAMMALIAN TARGET; DENDRITIC CELLS; GVHD; TRANSPLANTATION; IMMUNITY; (1)
CD55, Cromer blood group, decay-accelerating factor, high incidence antigen, SERF (1)
CD80 COSTIMULATORY MOLECULE; IFN-GAMMA; COLONY FORMATION; SUPPRESSES HEAD; MURINE MODEL; SINGLE-ARM; OPEN-LABEL; EXPRESSION; RESISTANCE; PD-1; interferon-gamma induced protein 10 (IP-10); CXCL10 (C-X-C motif ligand 10); interferon-gamma (IFN-gamma); vascular endothelial growth factor A (VEGF); interleukin 6 (IL-6); head and neck squamous cell carcinoma (HNSCC); ex vivo chemo-sensitivity assay; colony formation (1)
CD8, CD28, T suppressor cells, T regulatory cells, TCR, MHC class-I, antigen recognition (1)
CD8+ T cell, Preeclampsia, sFLT1, vascular remodeling, decidua (1)
CD8 T-CELLS; CMV INFECTION; ELISPOT-ASSAY; ORGAN TRANSPLANT; RISK-STRATIFICATION; MEMORY T; NK CELLS; DISEASE; RESPONSES; PROTECTION; CMV-specific cell-mediated immunity; cytomegalovirus; IFN- ELISpot; immunomonitoring; invitro diagnostic; kidney or renal transplantation (1)
CD8 T cells, Effektorfunktionen, Metabolismus, Tumor (1)
CD8(+) T-CELLS; ENDOTHELIAL-CELL; RECEPTOR STIMULATION; LIVER SIEVE; RAT-LIVER; ACTIVATION; TOLERANCE; CIRRHOSIS; MICE; PSEUDOCAPILLARIZATION; hepatitis; hepatocyte; liver sinusoidal endothelial cell; fenestration; mice (1)
CD8(+) T-CELLS; HEPATOCELLULAR-CARCINOMA; FAVORABLE PROGNOSIS; MEMORY PHENOTYPE; LIVER-DISEASE; IMMUNOTHERAPY; CANCER; PATHWAY; B cell; immune infiltrate; tumor microenvironment; gene expression; immunoglobulin (1)
CD8(+) T-CELLS; HYPOXIA-INDUCIBLE FACTORS; SECRETED LACTIC-ACID; GLUCOSE-METABOLISM; SYNOVIAL-FLUID; LACTATE-DEHYDROGENASE; AEROBIC GLYCOLYSIS; DENDRITIC CELLS; IFN-GAMMA; C-MYC; acidification; GLUT; immunotherapies; lactate; T cell; Warburg (1)
CD8(+) T-CELLS; IDENTIFY PATIENTS; QUANTIFERON-CMV; RECONSTITUTION; RECIPIENTS; INFECTION; DISEASE; CD4(+); RESPONSES; ASSAY; (1)
CD8(+) T-CELLS; IMMUNE EVASION; TUMOR-CELLS; B7 FAMILY; B7-H1 EXPRESSION; CANCER; PD-L1; MECHANISM; RESPONSES; MOLECULE; PD-L1; acute myeloid leukemia; PD-1; IFN (1)
CD8(+) T-CELLS; INFILTRATING LYMPHOCYTES; IMMUNE-RESPONSE; METASTASES; CARCINOMA; CANCERS; PH; effector phase inhibition; lactic acid; T cell receptor signaling; adoptive T cell therapy; cytotoxic T cells (1)
CD8(+) T-CELLS; KIDNEY-TRANSPLANT RECIPIENTS; LINKED IMMUNOSORBENT SPOT; SOLID-ORGAN TRANSPLANTATION; IFN-GAMMA; DENDRITIC CELLS; NK CELLS; RENAL-TRANSPLANTATION; ELISPOT-ASSAY; INFECTION; Cytomegalovirus; CMV; IE-1; pp65; Cell-mediated immunity; IFN gamma ELISpot; T Track (R) CMV; QuantiFERON (R) CMV; iTAg (TM) MHC Tetramers; Hemodialysis (1)
CD8 T-CELLS; KIDNEY-TRANSPLANT RECIPIENTS; SOLID-ORGAN TRANSPLANTATION; LINKED IMMUNOSORBENT SPOT; CYTOMEGALOVIRUS-SPECIFIC CD4(+); NK CELLS; RENAL-TRANSPLANTATION; FUNCTIONAL IMPAIRMENT; DENDRITIC CELLS; PREGNANT-WOMEN; Cytomegalovirus; CMV; IE-1; pp65; Cell-mediated immunity; ELISpot; CD4(+); CD8(+); T helper (Th); Cytotoxic T lymphocyte (CTL); Natural killer (NK); NKT-like (1)
CD8(+) T-CELLS; LEUKOCYTE RECRUITMENT; FETAL TOLERANCE; RESIDENT MEMORY; EXPRESSION; EFFECTOR; RISK; INFECTION; CANCER; PROMOTES; fetal tolerance; feto-maternal interface; decidual CD8+T cells; immune tolerace; Immune regulation; pregnancy; exhaustion (1)
CD8(+) T-CELLS; PRIMARY BILIARY-CIRRHOSIS; PLACEBO-CONTROLLED TRIAL; EXPRESSING FAS LIGAND; EX-VIVO EXPANSION; RESPONSES IN-VIVO; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; METASTATIC MELANOMA; CD95 LIGAND; antigen-presenting cell; apoptosis; artificial; killer artificial antigen-presenting cell; T cell (1)
CD8(+) T-CELLS; REGULATORY ELEMENTS; CHROMATIN; IMMUNOTHERAPY; ALIGNMENT; (1)
CD8(+) T-CELLS; SOLID TUMORS; B7-H1; PD-1; PATHWAY; LIGAND; PHASE; SUPPRESSION; LYMPHOCYTES; EXPRESSION; PD-1; PD-L1; T cells; Tumor microenvironment (1)
CD8 T cell, Staphylococcus epidermidis, Immunmodulation (1)
CD95/Fas, reverser Signalweg, neuronale Apoptose, CD95/Fas, reverse signaling, neuronal apoptosis (1)
CD9-DEFICIENT MICE; ARABIDOPSIS; FUSION; MEMBRANE; CHLAMYDOMONAS; ATTACHMENT; GUIDANCE; EGGS; (1)
CD antigens Role: BSU (Biological study, unclassified), BIOL (Biological study) (CD54, TNFalpha induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Cell adhesion molecules Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 (intercellular adhesion mol. 1), TNFalpha induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Structure-activity relationship (antioxidant synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Structure-activity relationship (inflammation-inhibiting synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Antioxidants (pharmaceutical synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Anti-inflammatory agents Cytotoxicity Human (synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Chalcones Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the ph chalcone deriv synthesis condensation reaction antioxidant antiinflammatory agent chalcone deriv synthesis condensation reaction cytotoxicity chalcone deriv synthesis condensation reaction (1)
CD antigens Role: BSU (Biological study, unclassified), BIOL (Biological study) (CD54 xanthohumol feeding does not impair organ function and homeostasis in mice) Cell adhesion molecules Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 (intercellular adhesion mol. 1) xanthohumol feeding does not impair organ function and homeostasis in mice) Proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (blood xanthohumol feeding does not impair organ function and homeostasis in mice) Toxins Role: BSU (Biological study, unclassified), BIOL (Biological study) (endotoxins xanthohumol feeding does not impair organ function and homeostasis in mice) Liver disease (fibrosis xanthohumol feeding does not impair organ function and homeostasis in mice) Fibrosis Injury (hepatic xanthohumol feeding does not impair organ function and homeostasis in mice) Liver disease (injury xanthohumol feeding does not impair organ function and homeostasis in mice) Collagens Role: BSU (Biological study, unclassified), BIOL (Biological study) (type I xanthohumol feeding does not impair organ function and homeostasis in mice) Animal organ Biomarkers Blood serum Colon Growth Heart Hepatitis Hepatotoxicity Homeostasis Human Humulus lupulus Kidney Liver Lung Pancreas Spleen Thymus gland (xanthohumol feeding does not impair organ function and homeostasis in mice) Albumins Cytokines Enzymes Gene Interleukin 1alpha Monocyte chemoattractant protein-1 Transforming growth factor beta Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (xanthohumol feeding does not impair organ function and homeostasis in mice) xanthohumol feeding organ function homeostasis toxicity xanthohumol feeding (1)
Cdc5, cell cycle, SAC, APC, Cdk1 (1)
CdMnTe,DMS,FQHE,QHF (2)
CDO, Structured Credit, Financial Crisis, Risk (1)
CD-ROM-Netz; Forschungszentrum Jülich (1)
CDSE QUANTUM DOTS; UP-CONVERSION; ON SENSOR; FLUORESCENCE; PHOTOLUMINESCENCE; NANOCRYSTALS; PHOSPHORS; PATHWAYS; GLUCOSE; SURFACE; luminescence; mercury; nanoparticles; photochemistry; quenching; rare earths (1)
CD-Spektroskopie , Fluoreszenz-Resonanz-Energie-Transfer , Konformation , DNS-Bindung , Inhibitorproteine , Zelldifferenzierung , Chemische Synthese , , Id3 Protein , SPPS , HLH motif (1)
; CDT; Biomarker; Alcoholism (1)
CdTe, CdMnTe, FQHE, Spin-Transistor, 2DEG (1)
CEACAM1 Preterm birth Preterm premature rupture of membranes Immune tolerance Pregnancy complications (1)
CED, Korrelation verschiedener diagnostischer Modalitäten, Befallsmuster (1)
cefazolin; microdialysis; obesity; pharmacokinetics; population analysis; surgical antibiotic prophylaxis (1)
ceftazidime; meropenem; piperacillin; flucloxacillin; ultrafiltration (1)
Ceftolozan/Tazobactam, kontinuierliche Infusion, Stabilität, PK/PD (1)
CELIAC-DISEASE; PURPURA; PALMAR; SKIN; (1)
CELL-ACTIVATING FACTOR; KIDNEY-TRANSPLANT FAILURE; MEDIATED REJECTION; AUTOIMMUNE-DISEASE; SJOGRENS-SYNDROME; IMMUNE-RESPONSE; HLA ANTIBODIES; EXPRESSION; BAFF; NEOGENESIS; Donor specific antibodies; Humoral rejection; Renal transplantation; Non-adherence; Leukocyte infiltration; BAFF (1)
CELL-ACTIVATION; GLYCOLYSIS; GLYCOSYLATION; CATABOLISM; INHIBITORS; THYMIDINE; MOUSE; (1)
CELL-ADHESION; BINDING-SITE; A-DOMAIN; ALPHA(2)BETA(1) INTEGRIN; MONOCLONAL-ANTIBODIES; IV COLLAGEN; ALPHA-2-BETA-1; RECEPTOR; MIGRATION; SKIN; (1)
CELL-ADHESION; ENDOTHELIAL-CELLS; GENERATION; UROKINASE; LP(A); ACID; OVEREXPRESSION; PROTEOLYSIS; MECHANISM; DISEASE; (1)
CELL-ADHESION MOLECULE-1; DSS-INDUCED COLITIS; BOWEL-DISEASE; LYMPHOCYTE ADHESION; ULCERATIVE-COLITIS; CROHNS-DISEASE; MICE; EXPRESSION; ICAM-1; OLIGONUCLEOTIDES; MAdCAM-1; experimental chronic colitis; in vivo microscopy (1)
CELL-ADHESION MOLECULE-1; MUCOSAL VASCULAR ADDRESSIN; CENTRAL-NERVOUS-SYSTEM; EXPRESSION; MADCAM-1; AMELIORATION; INFLAMMATION; INHIBITION; PREVENTION; MICROBIOTA; MAdCAM-1; lymphocyte homing; intestine; EAE/MS; neuroinflammation (1)
CELL-ADHESION MOLECULE; CARCINOEMBRYONIC ANTIGEN FAMILY; BLOOD-VESSEL FORMATION; BILIARY GLYCOPROTEIN; GROWTH-FACTOR; TUMOR ANGIOGENESIS; C-CAM; COLORECTAL CARCINOMAS; PROSTATE-CANCER; VEGF; (1)
CELL-ADHESION MOLECULE; HYPOTHALAMIC SUPRAOPTIC NUCLEUS; VASOPRESSIN-SECRETING NEURONS; SYNAPTIC PLASTICITY; OSMOTIC STIMULATION; POLYSIALIC ACID; ADULT-RAT; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; STRUCTURAL PLASTICITY; PERIPHERAL RELEASE; adhesion molecules; hypothalamo-neurohypophysial system; lactation; neuron-glial interactions; plasticity (1)
cell‐based assays | cell‐based sensing | electric cell‐substrate impedance sensing | impedance analysis | label‐free | PEDOT:PSS | polymer electrodes | screen printed electrodes | virus neutralization | virus titration (1)
CELL-CARCINOMA; BLADDER; FUSIONS; BGJ398; ASSOCIATION; GUIDELINES; INHIBITOR; REVEALS; adjuvant cisplatin-based chemotherapy; adjuvant therapy; cisplatin-therapy refusal; FGFR3; FGFR inhibitor; fusions or rearrangements; infigratinib; muscle-invasive urothelial carcinoma; mutations; neoadjuvant cisplatin-based chemotherapy; phase III; PROOF 302; upper tract urothelial carcinoma; urothelial bladder carcinoma; urothelial carcinoma (1)
CELL CARCINOMA; COMPUTED-TOMOGRAPHY; RADICAL NEPHRECTOMY; IMPACT; ULTRASOUND; EXPERIENCE; CANCER; MASSES; MRI; CM; cancer-specific survival; clinical tumor size; CT; pathological tumor size; renal cell carcinoma (1)
CELL CARCINOMA SYNDROME; MUIR-TORRE-SYNDROME; CARNEY-COMPLEX; COWDEN SYNDROME; GORLIN-SYNDROME; KINASE; LOCALIZATION; MUTATIONS; DISEASE; PATIENT; (1)
CELL-CELL ADHESION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN-OLIGODENDROCYTE-GLYCOPROTEIN; MULTIPLE-SCLEROSIS PATHOLOGY; DIFFERENTIAL EXPRESSION; AXONAL-INJURY; MOUSE-BRAIN; GLIAL SCAR; RAT; MOLECULE; N-cadherin; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Remyelination (1)
CELL-CELL-ADHESION; UP-REGULATION; TUMOR-CELLS; GROWTH; INVASION; IDENTIFICATION; PROGRESSION; ACTIVATION; ISOFORM; CATENIN; malignant melanoma; P-cadherin; migration; invasion; metastasis; antisense (1)
Cell culture; Cell isolation; Cell-based Assays; Immunology; Model Organisms (1)
Cell culture - Cell wall, primary cellulose (polymerization) - Mesophyll - Nicotiana (cell wall) - Protoplast (1)
cell culture, neurinoma, S-100, typ IV collagen (1)
Cell culture; Tissue culture; Tissue engineering; Biomaterial; MINUSHEET® tissue carrier; Perfusion culture; Gradient perfusion culture; Artificial polyester interstitium (1)
cell culture, tissue culture, tissue engineering, culture medium, perfusion culture, gradient perfusion culture, minusheet, transport of culture medium, elimination of gas bubbles, cells and biomaterials, cells and extracellular matrix, artificial interstitium (1)
CELL-CYCLE ARREST; CCAAT/ENHANCER-BINDING-PROTEIN; HELIX TRANSCRIPTION FACTORS; POLO-LIKE KINASES; DNA-DAMAGE; CANCER CHEMOPREVENTION; GLUTATHIONE DEPLETION; GINGIVAL FIBROBLASTS; NEGATIVE REGULATOR; ROS PRODUCTION; dental resin; dimethacrylate; TEGDMA; oxidative stress; gene expression; affymetrix (1)
CELL-CYCLE ARREST; HUMAN PULP CELLS; DNA-DAMAGE; MAP-KINASES; DIFFERENTIAL ACTIVATION; GLUTATHIONE DEPLETION; PROTEIN-KINASES; GENE-EXPRESSION; APOPTOSIS; TEGDMA; Resin monomer; TEGDMA; Stress response; Transcription factor (1)
CELL-CYCLE ARREST; MALIGNANT-MELANOMA; ACTIVITY MIA; TELOMERASE ACTIVITY; BETA-GALACTOSIDASE; PROTEIN; EXPRESSION; GENE; ACTIVATION; CANCER; melanocyte; melanoma inhibitory activity; oncogene-induced senescence; p21; senescence; telomerase (1)
CELL-CYCLE ARREST; PLASMA POLYMERIZATION; PROTEIN ADSORPTION; FUNCTIONAL-GROUPS; FOCAL ADHESION; TITANIUM; PROLIFERATION; BIOMATERIALS; CHEMISTRY; TOPOGRAPHY; human osteoblasts; calcium ion signaling; titanium surface modification; amino polymer; polyelectrolyte multilayer; zeta potential; surface charge; wettability (1)
CELL-CYCLE ARREST; SIGNAL TRANSDUCER; PROSTATE-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; IN-VITRO; EXPRESSION; ACTIVATION; INVASION; ADENOCARCINOMA; (1)
cell cycle, Cdc14, Phosphatase, Net1, inhibition, truncation (1)
Cell cycle - Cell wall (lysis) - Chlorella - beta-1,4-Mannanase (1)
Cell cycle - Cell wall (lysis) - Chlorella (cell wall) - Endo-mannanase (1)
CELL-CYCLE CHARACTERISTICS; MITOCHONDRIAL-DNA DAMAGE; IONIZING-RADIATION; ESCHERICHIA-COLI; SP-NOV; REPAIR; RESISTANCE; SURVIVAL; ARCHAEA; GAMMA; Ignicoccus hospitalis; Radiation; Survival; Genome integrity; Extremophiles; VBNC (1)
CELL-CYCLE; GENE; RNA interference; polymalatase; polynucleate cells; plasmodium; microinjection (1)
CELL-CYCLE; INHIBITORY-ACTIVITY; EPITHELIAL-CELLS; BREAST-TUMORS; CANCER CELLS; BRK; EXPRESSION; P27; LOCALIZATION; DEREGULATION; (1)
cell cycle; mitotic entry; APC/C; SCF; Rca1; Dap (1)
CELL-CYCLE PROGRESSION; GENE-EXPRESSION; UVEAL MELANOMA; OF-VIEW; PHOSPHORYLATION; PATHWAY; COMPLEXES; KINASES; POINTS; SITES; cell cycle; immunohistochemistry; malignant melanoma; retinoblastoma protein; tumor progression; tumor suppressor gene (1)
CELL-CYCLE PROGRESSION; RIBOSOMAL DNA-TRANSCRIPTION; SMALL-SUBUNIT PROCESSOME; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CHROMOSOME SEGREGATION; CYTOPLASMIC MATURATION; CDC14 PHOSPHATASE; IMMUNOPHILIN FPR3; BUDDING YEAST; (1)
CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; IN-VIVO; PROTEIN; KINASES; SUBUNIT; RNA; COMPLEX; (1)
CELL-CYCLE REGULATORS; B MESSENGER-RNAS; AURORA-KINASE-A; GYNECOLOGIC CANCERS; GENE-EXPRESSION; NUDE-MICE; FORM-A; CARCINOMA; CARCINOGENESIS; IDENTIFICATION; Endometrial cancer; Estrogen receptor alpha; Progesterone receptor; Splice variant; Gene expression (1)
CELL-DEATH; CYTOCHROME-C; TRANSPLANTATION; MITOCHONDRIA; REPERFUSION; BYPASS; GENES; (1)
CELL-DEATH; FRONTOTEMPORAL DEMENTIA; DENDRITIC SPINES; APOPTOSIS; MISLOCALIZATION; DYSFUNCTION; MUTATION; FAMILY; NEDD2; GENE; Caspase-2; Alzheimer ? s disease; neurodegenerative disorders; tauopathies; dementia (1)
CELL-DEATH; IN-VITRO; APOPTOSIS; CASPASE-3; CHEMOSENSITIVITY; CHEMOTHERAPY; MECHANISMS; CISPLATIN; IDENTIFICATION; MITOCHONDRIA; Breast cancer; TNBC; PI3K/AKT inhibitor; PARP; Caspase; RIP-1 (1)
CELL-DEATH; IRON; EXPRESSION; Ferroptosis; Immune cells; Renal ischemia and reperfusion injury (1)
CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; GLUTATHIONE; IRON; 5-LIPOXYGENASE; PHOSPHOLIPIDS; INFLAMMATION; CARDIOLIPIN; DISRUPTION; (1)
CELL-DEATH; SERINE PROTEASES; SEPTIC SHOCK; SEPSIS; INFLAMMATION; INTERLEUKIN-1-BETA; ACTIVATION; APOPTOSIS; STIMULATION; MECHANISMS; macrophage; neutrophil extracellular traps; IL-1 beta; lipopolysaccharide; NETosis; damage-associated molecular pattern molecules (1)
CELL DEPLETION THERAPY; B-LYMPHOCYTE STIMULATOR; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; EFFICACY; NEPHRITIS; INFECTIONS; CYCLOPHOSPHAMIDE; VASCULITIS; BELIMUMAB; Systemic lupus erythematosus; rituximab; efficacy; safety; B lymphocytes; cohort studies (1)
CELL-DERIVED CARDIOMYOCYTES; EMBRYONIC STEM-CELLS; SENSITIVE FLUORESCENT PROTEINS; SHOCK-INDUCED ARRHYTHMOGENESIS; ISOLATED RABBIT HEART; CYTOCHALASIN-D; 2,3-BUTANEDIONE MONOXIME; OPTICAL PROBE; IN-VIVO; BLEBBISTATIN; arrhythmias; cardiac; electrophysiology; heart; myocytes; cardiac; optical imaging; optogenetics; stem cells (1)
CELL-DERIVED EXOSOMES; BRONCHOALVEOLAR LAVAGE FLUID; HUMAN MIDDLE-EAR; CHRONIC RHINOSINUSITIS; MEMBRANE-VESICLES; NASAL POLYPS; T-CELLS; SECRETION; BIOGENESIS; RELEASE; small extracellular vesicles; exosomes; inflammatory airway diseases; chronic rhinosinusitis; otitis media; lung diseases; bronchial diseases; inflammation (1)
CELL-DERIVED FACTOR; ALLOGRAFT-REJECTION; CC-CHEMOKINE; GENE POLYMORPHISMS; HIV-1 INFECTION; IN-VITRO; EXPRESSION; RECIPIENTS; VARIANT; DISEASE; CCR2; CCR5; graft survival; rejection; SDF1 (1)
CELL-DERIVED FACTOR; HEMATOPOIETIC STEM/PROGENITOR CELLS; CHEMOKINE RECEPTORS; ISCHEMIC-INJURY; BONE-MARROW; FACTOR-I; T-CELLS; ADHESION; CXCR4; CHEMOTAXIS; human renal allograft rejection; immunohistochemistry; SDF-1 (1)
CELL-DIFFERENTIATION; GENE-EXPRESSION; BINDING-PROTEIN; TRANSCRIPTION; ACTIVATION; RECEPTOR; IL-4; INDUCTION; MECHANISM; CYTOKINES; Alternative macrophage activation; Cytokine response; Gene regulation; Mutant mouse strain; Transcriptional profiling (1)
CELL-DIVISION; CORTICAL MICROTUBULES; ACTIN CYTOSKELETON; HORMONAL-CONTROL; GROWTH; GENE; STRESS; DIFFERENTIATION; MORPHOGENESIS; ACTIVATION; (1)
CELL-DIVISION; OUTER-MEMBRANE; HYPERTHERMOPHILIC ARCHAEA; ELECTRON-MICROSCOPY; FUMARATE REDUCTASE; SP-NOV; ORIGIN; EUKARYOTES; LIFE; ULTRASTRUCTURE; Archaea; ultrastructure; 3D; eukaryogenesis; FIB/SEM; electron tomography; symbiosis; membranes (1)
CELL ENTRY; LENTIVIRAL VECTOR; SPIKE PROTEIN; 229E; NL63; INFECTION; OC43; HKU1; MECHANISMS; SARS-COV-2; SARS-CoV-2; COVID-19; coronavirus; pseudotyped virus; neutralization (1)
CELL; EVOLUTION; BROAD; SPIKE; COVID-19; neutralizing antibodies; spike protein; SARS-CoV-2; variants of concern (1)
CELL-FATE; ARABIDOPSIS-THALIANA; MORPHOGEN GRADIENT; INDOLEACETIC-ACID; PATTERN-FORMATION; EMBRYO SAC; WILD-TYPE; EGG CELL; TRANSPORT; MAIZE; Arabidopsis; Auxin; Female gametophyte; Gradient; Maize; Modelling (1)
CELL FATE SPECIFICATION; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; C-ELEGANS; PHYLOGENETIC ANALYSIS; PRONEURAL CLUSTERS; NEUROGENIC GENES; SENSORY ORGANS; EVOLUTION; EXPRESSION; (1)
CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; PYROCOCCUS-FURIOSUS; RNA-POLYMERASE; IN-VITRO; SULFOLOBUS-ACIDOCALDARIUS; METHANOCOCCUS-VANNIELII; ANTIBIOTIC-RESISTANCE; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; (1)
CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; RNA-POLYMERASE; PYROCOCCUS-FURIOSUS; SULFOLOBUS-SOLFATARICUS; PREINITIATION COMPLEX; INITIATION COMPLEX; STRUCTURAL BASIS; TFIIE-ALPHA; DNA-BINDING; (1)
CELL-FREE TRANSCRIPTION; THERMOCOCCUS-LITORALIS; ABC TRANSPORTER; BIOCHEMICAL-ANALYSIS; CRYSTAL-STRUCTURE; DNA-BINDING; SYSTEM; METABOLISM; INITIATION; (1)
CELL IMMUNE-RESPONSES; VIRUS ANKARA; ENVELOPE GLYCOPROTEIN; MUCOSAL CHALLENGE; VIRAL VECTORS; BOOST VACCINE; IFN-GAMMA; DNA; AIDS; IMMUNIZATION; HIV/AIDS; clade B vaccine; poxvirus vectors; MVA; NYVAC; immune response; mouse models (1)
CELL LINE C666-1; HISTONE DEACETYLASE; DNA METHYLATION; NUCLEAR ANTIGEN-2; CONTROL REGION; IN-VIVO; EXPRESSION; CHROMATIN; TRANSCRIPTION; GENES; (1)
CELL-LINE; NEURONS; ACTIVATION; EXPRESSION; UPSTREAM; BEHAVIOR; DISEASE; CULTURE; ANXIETY; oxytocin; spheroid; proliferation; OXTR; V1aR; cytoskeleton (1)
CELL-LINES; EXPRESSION; ESTROGEN; DIFFERENTIATION; ASSOCIATION; 1ST-INTRON; OVARIAN; RISK; Breast cancer; Single nucleotide polymorphism; icb-1; C1orf38 gene (1)
CELL-LINES; IN-VITRO; METABOLISM; HYPOXIA; LACTATE; ANTIBODIES; TUMORS; MCT1; GLUT1; Glycolysis; Melanoma; HK1; HK2; MCT1; MCT4; LDH-A; Cyclin D1 (1)
CELL-LINES; PRINCIPLES; APOPTOSIS; CARCINOMA; LIGHT; photodynamic therapy; prostate cancer; 5-aminolevulinic acid (1)
CELL LUNG-CANCER; CHOLESTEROL; CD147; NIVOLUMAB; COMBINATION; BIOMARKERS; CACHEXIA; PD-1; immunotherapy; PD-1+ monocytes; metabolism; hormones; immune cells; cholesterol; testosterone; free androgen index; hemoglobin (1)
CELL LUNG-CANCER; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; METASTASIS; CRIZOTINIB; ALK; NSCLC; TP53; p53; NT5DC2; CAFs (1)
CELL LUNG-CANCER; FOLLOW-UP ANALYSIS; RIGHT HEART; SURGERY; PNEUMONECTOMY; OUTCOMES; PREDICTORS; SURVIVAL; Quality of life; Pulmonary resection; Lung cancer; Postoperative course (1)
CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; TRANSCRIPTION FACTOR-I; KRAS MUTATIONS; 1ST-LINE TREATMENT; CLINICAL-RESPONSE; TTF-1 EXPRESSION; GENE-MUTATIONS; NEVER-SMOKERS; OPEN-LABEL; (1)
CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; EXPRESSION; LNCRNA; PROLIFERATION; PROGRESSION; PROGNOSIS; INTERACTS; ROLES; WNT7A; endometrial adenocarcinoma; long non-coding RNA; DSCAM-AS1; transcriptome (1)
CELL LUNG-CANCER; HEPATOCYTE GROWTH-FACTOR; IN-SITU HYBRIDIZATION; ADENOID CYSTIC CARCINOMA; C-MET; ACQUIRED-RESISTANCE; PROGNOSTIC-FACTORS; KINASE INHIBITORS; SIGNALING PATHWAY; BREAST-CANCER; Salivary gland cancer; MET; EGFR; PTEN; Prognosis (1)
CELL LUNG-CANCER; INHIBITOR; CARCINOMA; AT13387; ACK1; TUMORIGENESIS; EXPRESSION; KINASE1; BIOLOGY; ACK1; HSP90; Lung cancer; SIAH2; STAT1; STAT3 (1)
CELL LUNG-CANCER; OF-LIFE CARE; EARLY PALLIATIVE CARE; PROSPECTIVE COHORT; END; CHEMOTHERAPY; DEATH; AGGRESSIVENESS; INDICATORS; INTENSITY; Quality measurement; End of life care; Lung cancer; Palliative care; Registry data (1)
CELL LUNG-CANCER; PHASE-III TRIAL; 2ND-LINE CHEMOTHERAPY; ETOPOSIDE; CISPLATIN; REGIMEN; G3; COMBINATION; DOXORUBICIN; CARCINOMAS; neuroendocrine neoplasms; high-grade neuroendocrine carcinoma; mixed-neuroendocrine-non-neuroendocrine neoplasm; mixed adeno-neuroendocrine carcinoma; epirubicin; cyclophosphamide; vincristine (1)
CELL LUNG-CANCER; PHASE-II TRIAL; COLORECTAL-CANCER; ONCOLOGY-GROUP; ADVANCED HEAD; MUTATIONS; GEFITINIB; GENE; CHEMOTHERAPY; ERLOTINIB; Epidermal growth factor receptor; KRAS; Mutation screening; Salivary gland carcinomas; EGFR-targeted therapy (2)
CELL LUNG-CANCER; PHASE-II TRIAL; EGFR MUTATIONS; GEFITINIB; ERLOTINIB; RECURRENT; THERAPY; EXON-19; NECK; GENE; epidermal growth factor receptor; mutation screening; salivary gland carcinomas; targeted therapy (1)
CELL LUNG-CANCER; PHASE-II TRIAL; POTENT INHIBITORS; DERIVATIVES; MUTATIONS; GEFITINIB; LAPATINIB; ACIDS; ASSAY; (1)
CELL LUNG-CANCER; POLYMERASE-CHAIN-REACTION; MATRIX GLA PROTEIN; P53 GENE-MUTATIONS; ABERRANT PROMOTER METHYLATION; CIRCULATING TUMOR DNA; EFFUSION CYTOLOGY; BREAST-CANCER; SERUM DNA; CHROMOSOME 3P; (1)
CELL LUNG-CANCER; PREDICTIVE BIOMARKER; PROGNOSTIC-FACTORS; OPEN-LABEL; OROPHARYNX; IMMUNOTHERAPY; PEMBROLIZUMAB; MULTICENTER; NIVOLUMAB; DISTINCT; Neuroendocrine carcinoma; Human papillomavirus; PD-L1; Head and neck; Immunotherapy (1)
CELL LUNG-CANCER; PROMOTER POLYMORPHISM; TUMOR-FORMATION; P53; CARCINOMA; TP53; GENE; EXPRESSION; RISK; CHEMORADIOTHERAPY; Mdm2 SNP309; Bladder cancer; p53; Invasion (1)
CELL LUNG-CANCER; RANDOMIZED PHASE-III; 2ND-LINE TREATMENT; DOUBLE-BLIND; OPEN-LABEL; WEEKLY DOCETAXEL; WILD-TYPE; ERLOTINIB; TRIAL; CHEMOTHERAPY; Atezolizumab; Nivolumab; Overall survival; Pembrolizumab; Programmed cell death 1 ligand 1 (1)
CELL LUNG-CANCER; TETRANUCLEOTIDE REPEATS; MISMATCH REPAIR; URINARY-TRACT; TUMORS; EXPRESSION; MUTATIONS; ovary; carcinoma; microsatellite instability; EMAST (1)
CELL LUNG-CANCER; TRANSBRONCHIAL NEEDLE ASPIRATION; CLINICAL-PRACTICE GUIDELINES; DISSEMINATED TUMOR-CELLS; ENDOBRONCHIAL ULTRASOUND; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; THORACIC SURGEONS; HUMAN-MELANOMA; BONE-MARROW; Non-small cell lung cancer (NSCLC); Lymph node metastasis; Melanoma antigen (MAGE); Endobronchial ultrasound-guided fine-needle aspiration (EBUS-TBNA); Mediastinoscopy (1)
CELL LUNG-CANCER; TTF-1 EXPRESSION; PLUS CARBOPLATIN; (1)
CELL LYMPHOMA; GLUTAMINE-METABOLISM; BREAST-CANCER; C-MYC; HODGKIN LYMPHOMA; GENE-EXPRESSION; GLUCOSE-UPTAKE; ACTIVATION; PROLIFERATION; PATHWAY; (1)
cell microarrays, cell-based microarrays, in vitro toxicology, cell-based assays, cell-based biosensors, cytotoxicity (1)
Cell migration, fibroblasts, corticosteroids, triamcinolone, scratch assay (1)
CELL MIGRATION; IN-VITRO; EXPRESSION; BRAIN; LAMININ-8; TARGET; HETEROGENEITY; EFFICACY; INVASION; PATHWAYS; (1)
CELL-MIGRATION; PROTEIN; H-4-RECEPTOR; SPECIFICITY; ACTIVATION; EXPRESS; NEURONS; CYCLASE (1)
Cell migration, Wound healing, Photosensitizer, Singlet oxygen, Reactive oxygen species, Phototoxicity, Metastasis (1)
CELL MOTILITY; ACTIN; MIGRATION; (1)
Cell Movement *Chemotaxis Cyclic AMP/pharmacology Dictyostelium/growth & development/*physiology Image Processing, Computer-Assisted Microscopy, Phase-Contrast Support, Non-U.S. Gov't (1)
CELL NUCLEAR ANTIGEN; IMAGE-ANALYSIS; RAT-PROSTATE; PROLIFERATION; EXPRESSION; CARCINOMA; IMMUNOCYTOCHEMISTRY; CASTRATION; ANALYZER; SECTIONS; androgenic reactions; androgen receptor; prostate; seminal vesicle; densitometry; morphometry; proliferation markers (1)
CELL NUCLEAR ANTIGEN; PROLIFERATION-RELATED ANTIGEN; DNA POLYMERASE-DELTA; SEMINIFEROUS EPITHELIUM; STEM-CELL; ELECTRON-MICROSCOPY; AUXILIARY PROTEIN; HOLSTEIN BULLS; KI-67 PROTEIN; GERM-CELLS; primordial germ cells; prespermatogonia; spermatogonial stem cells; Sertoli cells; testis; bovine (1)
CELL-PENETRATING PEPTIDES; BREAST-CANCER-TREATMENT; LINEAR POLYETHYLENIMINE; UNILAMELLAR VESICLES; POLY(ACRYLIC ACID); TUMOR-GROWTH; POLYMERS; DELIVERY; BILAYERS; PERMEABILIZATION; (1)
cell-penetrating peptides · charge-mediated uptake · nanoparticles · stimuli-responsive · surface chemistry (1)
CELL-PENETRATING PEPTIDES; L-ASPARTIC ACID; POLY(BETA-L-MALIC ACID); INTRACELLULAR DELIVERY; AMINO-ACIDS; POLYMER; SHIFTS; TRYPTOPHAN; INHIBITION; ANTIBODIES; pH-dependent copolymer; Polymalic acid; Drug delivery; Membranolysis; Endosome escape; Cytoplasmic delivery (1)
CELL-PENETRATING PEPTIDES; MOLECULAR-DYNAMICS SIMULATIONS; LIPID-BILAYERS; PORE-FORMATION; FREE-ENERGY; TAT PEPTIDE; WATER; ARGININE; PERMEATION; POTENTIALS; (1)
CELL PHONE CONVERSATIONS; SLEEPINESS; FATIGUE; PERFORMANCE; TIME; EEG; VALIDATION; SYMPTOMS; TASK; Vigilance; Fatigue; Monotony; Driving; Self assessment; Fatigue countermeasures (1)
CELL POLARITY PATHWAY; REED-STERNBERG CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; SIGNALING PATHWAYS; GENE-EXPRESSION; BREAST-CANCER; MIGRATION; PROLIFERATION; (1)
cell polarity, pollen tube, root hair, Armadillo Repeat Only (2)
CELL-PROLIFERATION; CHANNELS; CALCIUM; RECEPTOR; DIFFERENTIATION; TRPC4; skin tumors; melanoma; squamous cell carcinoma; basal cell carcinoma (1)
CELL-PROLIFERATION; GASTRIC-CANCER; LUNG-CANCER; TKTL1; PROGRESSION; GENE; OVEREXPRESSION; CARCINOMAS; METABOLISM; ACTIVATION; Colorectal cancer; Aerobic glycolysis; Hypoxia; Pentose phosphate way (1)
CELL-PROLIFERATION; RICH EXTRACTS; APC(MIN) MICE; COLITIS; INHIBITION; RISK; EXPRESSION; VEGETABLES; APOPTOSIS; BILBERRY; Anthocyanin; Colorectal cancer; Inflammation; Endoscopy; Administration of azoxymethan and dextran sodium sulfate model (1)
CELL-PROLIFERATION; SIGNALING PATHWAY; BETA-CATENIN; SIZE-CONTROL; ORGAN SIZE; YAP; HOMEOSTASIS; CLASSIFICATION; HEPATOBLASTOMA; REGENERATION; Intrahepatic cholangiocarcinoma; Hippo pathway; TAZ; AKT; Notch; TEAD transcription factors (1)
CELLS (1)
CELLS ABLATION; LIVER; (1)
CELLS; ANALOGS; antifungal; anticancer; 1,4-napthoquinone derivatives; antifungal drugs; carcinoma cell lines (1)
CELLS; CADMIUM; ASSAY; RISK; ELECTROPHORESIS; GENOTOXICITY; CHROMIUM; CANCER; TRACT; metal compounds; ethanol; genotoxicity; salivary gland tissue; comet assay (1)
CELL SELF-RENEWAL; GROWTH-CONTROL; SIZE-CONTROL; IN-VIVO; KIBRA; PATHWAY; DROSOPHILA; EXPRESSION; GENOME; MEMORY; KIBRA; WWC family; Hippo pathway; LATS kinase; YAP; organ size (1)
CELL SELF-RENEWAL; MYELOID CANCERS; MAMMALIAN DNA; TET PROTEINS; STEM-CELLS; 5-METHYLCYTOSINE; METHYLATION; GENOME; DIFFERENTIATION; CONVERSION; Epigenetics; active DNA demethylation; differentiation (1)
CELLS; EXPRESSION; (1)
CELLS; EXPRESSION; MIGRATION; ACTIVATION; POLARIZATION; MACROPHAGES; PROTECTS; RATS; neurodegeneration; microglia activation; neuroprotection; proteoglycans (1)
CELLS; GUIDANCE; TISSUE; repellent factors; Netrin; migration; proliferation; RA; OA (1)
CELLS IN-VITRO; TRANSFECTION EFFICIENCY; LYSOSOMOTROPIC AGENTS; DNA TRANSFECTION; NONVIRAL VECTOR; POLYETHYLENIMINE; VIVO; COMPLEXES; SIZE; POLY(ETHYLENIMINE); low molecular weight linear polyethylenimines; endolysosomal escape capacity; nuclear entry; flow cytometry; confocal laser scanning microscopy (1)
CELLS IN-VIVO; MALIGNANT-MELANOMA; INTERLEUKIN-6-DEFICIENT MICE; TRANSCRIPTION FACTORS; RETINOIC ACID; LIVER-INJURY; TGF-BETA; PROTEIN; DIFFERENTIATION; ENDOTOXIN; (1)
CELLS; Laser-scribed graphene; Cell-electrode junction; Cell-based assays; Cell-based sensors; Impedance spectroscopy; Electric cell-substrate impedance sensing; ECIS (1)
CELLS; Leishmania donovani; Visceral leishmaniasis; Cytokines; Chemokines; Whole blood assay (1)
CELLS; MAMMARY; GENE; INVASION; MOTILITY; SERPIN; ETS; prostate cancer; Maspin protein expression; p53-dependent Maspin regulation; prognostic significance (1)
CELLS; Norris; Norrie disease; Wnt (1)
CELL-SPECIFIC EXPRESSION; SENSITIVE PROTEIN GENE; MOUSE TYROSINASE GENE; RETINOIC ACID; INHIBITING ACTIVITY; MALIGNANT-MELANOMA; MICROPHTHALMIA; PROMOTER; IDENTIFICATION; CARTILAGE; cell-specific expression; melanoma; MIA; transcription factor (1)
CELL-SURFACE GLYCANS; GLYCOSPHINGOLIPIDS; DERIVATIVES; GLYCOLIPIDS; ADHESION; glycolipids; molecular dynamics; NMR spectroscopy; sialyl Lewis X; synthesis design (1)
CELL-SURFACE GLYCOPROTEIN; BREAST-CANCER; CLINICAL-IMPLICATIONS; CARCINOMA; PROTEIN; ALPHA; PROLIFERATION; ZEBRAFISH; SIGNATURE; PATTERNS; Endometrial adenocarcinoma; PTEN; SCUBE2 gene; steroid hormone receptor (1)
CELL-SURFACES; GENE DELIVERY; DNA COMPLEXES; MICROSCOPY; FRET; POLYETHYLENIMINE; EFFICIENCY; PLASMID; LASER; non-viral gene delivery; polyethylenimine; fluorescence resonance energy transfer; confocal laser scanning microscopy; flow cytometry (1)
Cell survival, Dental pulp, Cytotoxicity, Composite resins, Dental materials, Self-adhesive composite (1)
cell transplantation; dental pulp necrosis; periapical periodontitis; regenerative endodontics; tissue engineering (1)
CELL TRANSPLANTATION; PHASE-II; LYMPHOMA; THERAPY; CYCLOPHOSPHAMIDE; COMBINATION; MTOR; metronomic low dose chemotherapy; everolimus; piogliatazone; etoricoxib; anakoinosis; r; r Hodkin's disease (1)
CELL TRANSPLANTATION; PREVENTION; VEDOLIZUMAB; BIOMARKER; CYCLOPHOSPHAMIDE; BLOCKADE; THERAPY; BLOOD; TRIAL; SCORE; (1)
CELL TUMOR HYPOGLYCEMIA; IGF BINDING-PROTEINS; FACTOR-II; HORMONE; EXPRESSION; SERUM; SECRETION; LINES; (1)
; cell-type deconvolution; loss-function learning; model adaptation; R package (1)
cell type-specific expression, cell-specific gene regulation, cellular composition, deconvolution (1)
CELLULAR-ASSAYS; Biochemistry; Issue 156; G-protein coupled receptor (GPCR); impedance; label-free; cell-based assay; concentration-response relationship; agonist; antagonist; histamine (1)
CELLULAR-AUTOMATA; Nagel-Schreckenberg-model; two-lane traffic; cellular automata (1)
CELLULAR-AUTOMATA; RULES; Nagel-Schreckenberg-model; nonequilibrium physics; time development; trucks; cellular automata (1)
CELLULAR CYTOTOXICITY; MEDIATED CYTOTOXICITY; RELEASE-ASSAY; ANNEXIN-V; CELLS; APOPTOSIS; PHOSPHATIDYLSERINE; FLUOROMETRY; EXPRESSION; MELANOMA; cell-mediated cytotoxicity; flow cytometry; PKH-26; cytotoxic T lymphocytes; apoptosis (1)
CELLULAR-DIFFERENTIATION; TUMOR MICROVESSELS; ALPHA-FETOPROTEIN; CT; AGENT; SONOGRAPHY; PATTERNS; DENSITY; LESIONS; BR1; (1)
CELLULAR-DRUG DELIVERY; DIABETIC-NEPHROPATHY; GLOMERULAR-FILTRATION; GOLD NANOPARTICLES; MESANGIAL CELL; SIZE; MECHANISMS; GLOMERULONEPHRITIS; CLEARANCE; SYSTEMS; Nanomedicine; Kidney Targeting; Mesangial Cells; Glomerulus; Quantum Dots (1)
CELLULAR FIBRONECTIN; MESSENGER-RNAS; FIBROBLASTS; ADHESION; MIGRATION; SEGMENT; DOMAIN; ALPHA; RAT; MODULATION; fibronectin isoforms; integrin alpha 5 beta 1; colonic lamina propria fibroblasts; migration; fibrosis (1)
CELLULARITY; CRITERION; CATEGORY; MANIFOLD; (1)
CELLULAR SENESCENCE; Dental follicle cells; Cellular senescence; p53; E2F-1; Osteogenic differentiation (1)
CELLULOMONAS-FIMI CENC; TRYPTOPHAN RESIDUES; THERMOPHILIC BACTERIA; LINKER SEQUENCES; ESCHERICHIA-COLI; GENERAL ROLE; HYDROLYSIS; PROTEINS; CLONING; POLYSACCHARIDES; (1)
Cellulose - Cell wall - Cotton fibre - Glucans - Gossypium - Hemicelluloses (1)
CELLULOSE; SOLVENT; SYSTEM; MODEL; POLYSACCHARIDES; COEFFICIENTS; CHITIN; vapor pressure; osmotic coefficient; Pitzer's model; MSA-NRTL model; chemical model; N,N-dimethylacetamide; lithium chloride; lithium bromide (1)
Cell wall; Chlorella; 4-O-methyl-D-xylose (1)
Cell wall (composition); Chlorella (1)
CELL-WALL INVERTASE; SIGNAL-TRANSDUCTION PATHWAYS; LEAF SENESCENCE; APOPLASTIC INVERTASE; CHENOPODIUM-RUBRUM; ARABIDOPSIS-THALIANA; CARNATION PETALS; SINK METABOLISM; GENE-EXPRESSION; TOBACCO PLANTS; (1)
CELL-WALL POLYSACCHARIDES; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR TREHALOSE; CHEMICAL-STRUCTURE; PENICILLIUM; IMMUNODOMINANT; STABILITY; PROTEINS; FUSARIUM; oligosaccharides; galactofuranose; D-1,4-anhydrogalactitol; Nostoc commune; enzymes; heat protection; Escherichia coli; desiccation (1)
Cell wall (polysaccharides) - Polysaccharides (cell wall) - Protoplast - Root - Zea (root, cell wall) (1)
CELL-WALL; PROTEINS; LOCATION; GELS; (1)
CELL-WALLS; PHOSPHORYLATION; PHOTOPHOSPHORYLATION; PEPTIDOGLYCAN; Archaea; Carbon reactions; Photophosphorylation in vivo; Three forms of life; Carl Woese (1)
Celtic; Celticism; Ireland; Scotland; nationalism; identity; ancestry; The British Isles; Hallstatt; La Tène; Samuel Ferguson; James Macpherson; Ossian; Fingal; tourism (1)
CELT, Lipotransfer, Lip augmentation, Lips, Autologous fat grating, Stem cells, Mesenchymal stem cells (1)
cemented, constrained, infection, knee, revision, unconstrained (1)
CEMENTED FEMORAL STEMS; FOLLOW-UP; REPLACEMENT; BONE; FIXATION; IMPLANTS; PLATE; Intramedullary locking hip stem; Biomechanics; Primary stability; Non cemented hip stem (1)
CENP-A NUCLEOSOMES; HISTONE H3 VARIANT; E3 UBIQUITIN LIGASE; IN-VIVO; BUDDING YEAST; S2 CELLS; KINETOCHORE FORMATION; CHECKPOINT CONTROL; NONHISTONE SCM3; LIVING CELLS; Centromere; Cid; Cenp-A; Cenp-C; Cal1; Cell cycle; Mitosis; S phase; Drosophila (1)
CENSORED QUANTILE REGRESSIONS; BUSINESS-CYCLE; LABOR-MARKET; WEST-GERMANY; EMPLOYMENT; TIME; EXPERIENCES; Lifetime unemployment; Censored quantile regressions; Occupation-specific human capital (1)
CENTER-DOT-H; COMPACT EFFECTIVE POTENTIALS; TRANSITION-METAL CENTERS; ZETA-VALENCE QUALITY; EXPONENT BASIS-SETS; HYDROGEN-BONDS; ORGANOMETALLIC COMPOUNDS; INTERMOLECULAR INTERACTIONS; TOPOLOGICAL ANALYSIS; CRYSTAL-STRUCTURES; lithium dimethylcuprate; monomer; oligomers; C-H center dot center dot center dot Cu and C-H center dot center dot center dot C hydrogen bonds; C-H center dot center dot center dot H dihydrogen bonds; stabilization energy; quantum chemical calculations; density functional theory; PBE functional (1)
CENTER-DOT-OP; SCALAR COUPLINGS; ELECTRON-TRANSFER; RING ENLARGEMENT; BETA; REARRANGEMENT; EXPANSION; RADICALS; KETONES; Hydrogen-Bonds; Nucleofugality; Photoredox-Catalysis; Rearrangements; Selenium(III) (1)
CENTER-DOT-S; AZOMETHINE YLIDES; MOLECULAR-STRUCTURE; HYDROGEN-BONDS; CRYSTAL-STRUCTURE; DERIVATIVES; THIOKETONES; ACID; (1)
CENTER-DOT-TL; MAIN-GROUP ELEMENTS; OXIDATIVE ADDITION; BETA-DIKETIMINATO; LONDON DISPERSION; BOND ACTIVATION; COMPLEXES; INDIUM; GALLIUM; ALUMINUM(I); bridging ligands; carbene analogues; indium; metal-metal interactions; thallium (1)
CENTER LASERS; ABSORPTION; absorption cross-section integral; F-2(+) decomposition; LiF : F-2(-) colour centres; oscillator strength (1)
CENTER LASERS; RHODAMINE 6G; LIGHT-PULSES; FLUORESCENCE; BEHAVIOR; DODCI; RANGE; DYES; colour centres; F-2(-) centres; LiF crystal; fluorescence quantum yield; fluorescence lifetime; stimulated emission cross-section (1)
CENTERS; CURRENTS; ORDER; NbSe2; phase slip lines; phase slip centers; 2D superconductivity; excess current; layered superconductor; critical current (1)
CENTERS; DYES; BAND; colour centres; LiF crystal; F-2 centres; saturable absorption; excited-state absorption; two-photon absorption; colour centre concentration (1)
CENTERS; SURGERY; (1)
CENTER VORTICES; P-VORTICES; GRIBOV COPIES; CONFINEMENT; MONOPOLES; RELEVANCE; LATTICES; QCD; (1)
CENTILE CURVES; WAIS-R; MODEL; continuous norming; data smoothing; curve fitting; norm scores; norm generation (1)
CENTRAL AUDITORY PATHWAY; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; TONOTOPIC ORGANIZATION; POSTNATAL-DEVELOPMENT; ANATOMY; HEARING; LESIONS; SYSTEM; GROWTH; evolution; brain; auditory cell size (1)
Central banks; previous termMonetary policynext term; Neutrality of previous termmonetary policynext term; Wage setting (1)
Central bank; Wage setting; Inflation; Unemployment (1)
CENTRAL CARBOHYDRATE-METABOLISM; RIBULOSE MONOPHOSPHATE PATHWAY; TRANSFER-RNA GENES; METHANOBACTERIUM-THERMOAUTOTROPHICUM; SULFOLOBUS-SOLFATARICUS; BINDING-PROTEIN; PYROBACULUM-AEROPHILUM; IGNICOCCUS-HOSPITALIS; ACIDIANUS-AMBIVALENS; DNA-REPLICATION; (1)
central conductor, completed group algebras, extensions of lattices, Fitting invariants (1)
CENTRAL CORE DISEASE; RYANODINE RECEPTOR GENE; CLINICAL GRADING SCALE; VITRO CONTRACTURE-TEST; SUSCEPTIBLE SWINE; CHROMOSOME 19Q12-13.2; CALCIUM-RELEASE; METABOLIC TEST; DELAYED-ONSET; RYR1 GENE; Intraoperative complications; Ryanodine receptor; Hypermetabolism; Mutation; Dantrolene (1)
CENTRAL CORNEAL THICKNESS; REFRACTIVE ERROR DEVELOPMENT; PREMATURE-INFANTS; OPTICAL-COMPONENTS; OCULAR GROWTH; BIRTH-WEIGHT; HUMAN-EYE; RETINOPATHY; MYOPIA; CHILDREN; retinopathy of prematurity; low gestational age; low birth weight; cornea; axial length (1)
CENTRAL-EUROPE; ICE AGES; FRAGMENTED POPULATIONS; RANUNCULUS-PYGMAEUS; MOLECULAR EVIDENCE; SAXIFRAGA-CERNUA; SEED PRODUCTION; ALPINE PLANTS; EASTERN ALPS; SIZE; Draba aizoides; Glacial relict; AFLP; Reproduction; Population size (1)
CENTRALITY DEPENDENCE; PARTICLE DISTRIBUTIONS; NUCLEAR COLLISIONS; PHASE-TRANSITION; TRANSVERSE FLOW; HADRON; SIGNATURE; EXPANSION; SPECTRA; relativistic heavy-ion collisions; elliptic flow; hydrodynamic model (1)
CENTRAL MELANOCORTIN SYSTEM; GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; ENERGY HOMEOSTASIS; ADIPOSE-TISSUE; FOOD-INTAKE; NEURITE OUTGROWTH; LOCI; FTO; INTEGRATION; BDNF; ETV5; FAIM2; FTO; GNPDA2; KCTD15; LYPLAL1; MCR4; MTCH2; NEGR1; NRXN3; TMEM18; SEC16B; TFAP2B; ZDF-rats (1)
CENTRAL-NERVOUS-SYSTEM; 2-HYDROXYGLUTARATE; CLASSIFICATION; DIAGNOSTICS; 1P/19Q; TUMORS; glioma; IDH mutation; F-18-FET; H-1-MRS; D-2-hydroxyglutarate; linear support vector machine; glycine; myo-inositol (1)
CENTRAL-NERVOUS-SYSTEM; ACTIVATION; PET; TSPO; COMPLICATIONS; MARKER; MODEL; Cognitive function; F-18-GE-180; Imaging; Immunosuppression; Translocator protein (TSPO) (1)
CENTRAL-NERVOUS-SYSTEM; ACUTE LYMPHOBLASTIC-LEUKEMIA; LEUKOENCEPHALOPATHY; METHOTREXATE; REMISSION; CHILDREN; RELAPSE; allogeneic stem cell transplantation; intrathecal prophylaxis; malignant blood disease (1)
CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; CELL-PROLIFERATION; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; TRANSGENIC MICE; DENTATE GYRUS; IMPAIRS NEUROGENESIS; VOLUNTARY EXERCISE; OLFACTORY-BULB; neurogenesis; running; dentate gyrus; Huntingtin; neuronal precursor; doublecortin (1)
CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; IN-VITRO; MOUSE EMBRYOS; BROMODEOXYURIDINE; 5-BROMODEOXYURIDINE; DNA; PROLIFERATION; SENESCENCE; EXPOSURE; Neural progenitors; Neurogenesis; Cell culture; Cell labeling; Rat (Fischer 344) (1)
CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC RAT MODEL; ADULT NEURAL STEM; R6/2 MOUSE MODEL; ALZHEIMERS-DISEASE; TGF-BETA; MICE; BRAIN; GENE; Adult neurogenesis; Huntington disease; Neural stem cells; Neuronal differentiation; Proliferation; Transforming growth factor-beta (1)
CENTRAL-NERVOUS-SYSTEM; ANTERIOR OPTIC TUBERCLE; MOTH MANDUCA-SEXTA; DORSAL RIM AREA; SCHISTOCERCA-GREGARIA; INSECT BRAIN; IMMUNOREACTIVE NEURONS; COMPOUND EYE; GABA; IMMUNOCYTOCHEMISTRY; sky compass navigation; synaptic transmission; microglomeruli; GABA; insect brain; Schistocerca gregaria (1)
CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; CELL-MIGRATION; SCAR FORMATION; TRACT AXONS; MICROCAPSULES; ASTROCYTES; GROWTH; ACTIVATION; OUTGROWTH; regeneration; astroglia; biomaterial; spinal cord injury; alginate; cell transplantation (1)
CENTRAL-NERVOUS-SYSTEM; BAP1 MUTATIONS; NF2 GENE; CLASSIFICATION; CHILDREN; GRADE; PROGNOSIS; GERMLINE; FEATURES; SMARCE1; Meningioma; Methylation profile; Targeted sequencing; NF2 (1)
CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTOR; BONE-MARROW; MOLECULAR SIGNATURES; ENDOTHELIAL-CELLS; BRAIN-INJURY; IN-VIVO; MICE; CCR2; EXPRESSION; bone marrow chimeras; CCL2; CCR2; intracerebral hemorrhage; monocytes; neuroinflammation (1)
CENTRAL-NERVOUS-SYSTEM; CHURG-STRAUSS-SYNDROME; GIANT-CELL ARTERITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; DEFINED PRIMARY ANGIITIS; HEPATITIS-B VIRUS; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; LUPUS-ERYTHEMATOSUS; BEHCETS-DISEASE; (1)
CENTRAL-NERVOUS-SYSTEM; COLONY-STIMULATING FACTOR; CYTOKINE GM-CSF; HUMAN ENDOTHELIAL-CELLS; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; THERAPEUTIC TARGET; LEUKOCYTE ADHESION; MONONUCLEAR-CELLS; HUMAN BASOPHILS; (1)
CENTRAL-NERVOUS-SYSTEM; CRUSTACEAN CARDIOACTIVE PEPTIDE; ECDYSIS-TRIGGERING HORMONE; PERIOD GENE; BEHAVIORAL RHYTHMS; VISUAL-SYSTEM; DISCONNECTED MUTANTS; NEUROSECRETORY-CELLS; TEMPORAL EXPRESSION; RHODNIUS-PROLIXUS; period; timeless; clock; cycle; pigment-dispersing factor; photoreception (1)
CENTRAL-NERVOUS-SYSTEM; DYNAMIC F-18-FET PET; LOW-GRADE GLIOMA; RESPONSE ASSESSMENT; PROGNOSTIC-SIGNIFICANCE; LUNG; C-11-METHIONINE; NEUROONCOLOGY; ADENOCARCINOMA; ASCT2; LAT1; FET PET; Glioma; Molecular imaging (1)
CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; FUNCTIONAL RECOVERY; PRECURSOR CELLS; CORTICOSPINAL TRACT; IN-VIVO; PROLIFERATION; REGENERATION; CNS; axon; CNS; glia; rat; regeneration; retroviral; transplantation (1)
CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DIETARY SALT INTAKE; MULTIPLE-SCLEROSIS; BACTERIAL PEPTIDOGLYCAN; SODIUM-INTAKE; T-CELLS; DISEASE; ACTIVATION; REACTIVITY; Gut microbiota; multiple sclerosis; experimental autoimmune encephalomyelitis; short‐ chain fatty acids; dietary high‐ salt (1)
CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSGENIC MICE; MOUSE MODEL; MENINGEAL INFLAMMATION; LESIONS; COMPLEMENT; REMYELINATION; PATHOLOGY; DISEASE; Progressive multiple sclerosis; Cortical demyelination; Experimental autoimmune encephalomyelitis; Inflammatory monocytes (1)
CENTRAL-NERVOUS-SYSTEM; EXPRESSION; (1)
CENTRAL-NERVOUS-SYSTEM; EXPRESSION; CNS; DIAGNOSIS; BIOMARKER; Intracranial germ cell tumors; Liquid biopsy; miR-371; miR-372; miR-367; miR-302d (1)
CENTRAL-NERVOUS-SYSTEM; EXTRANEURAL METASTASES; PREVIOUS CRANIOTOMY; EXTRACRANIAL METASTASES; MALIGNANT ASTROCYTOMA; ABSENCE; MULTIFORME; GLIOMAS; TUMORS; DEHISCENCE; glioblastoma; hearing disturbance; surgery; vertigo; superior canal dehiscence syndrome (1)
CENTRAL-NERVOUS-SYSTEM; FIBROBLAST GROWTH FACTOR-2; DENTATE GYRUS; RAT HIPPOCAMPUS; FACTOR GENE; FACTOR-I; BRAIN; NEURONS; ASTROCYTES; NEOCORTEX; neurogenesis; stem cell; adult; hippocampus; progenitor; precursor; microenvironment; signaling (1)
CENTRAL-NERVOUS-SYSTEM; FRONTAL MIDLINE THETA; FALSE DISCOVERY RATE; GAMMA-BAND ACTIVITY; EEG CHANGES; OSCILLATIONS PREDICT; CORTICAL ACTIVATION; MEMORY PERFORMANCE; QUANTITATIVE EEG; MOTOR IMAGERY; EEG; meditation; consciousness; thoughtless emptiness; decreased neural processing (1)
CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; STEM-CELLS; REGENERATION; RAT; ASTROCYTES; FIBROBLASTS; TRANSPLANTS; GUIDANCE; TISSUE; astrocyte; cell adhesion; rat; stem cell; transplantation (1)
CENTRAL-NERVOUS-SYSTEM; GAMMA-INTERFERON; IFN-GAMMA; CHOLESTEROL; CLEARANCE; UBIQUITINATION; CURVATURE; RECEPTORS; INFECTION; REDUCTASE; Targeted nanoparticles; Biodistribution; Preferential uptake; Targeting efficiency; Interferon-& gamma;; Cholesterol-25-hydroxylase (CH25H); Nano-bio interactions (1)
CENTRAL-NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; MARROW-DERIVED MICROGLIA; BETA-AMYLOID DEPOSITION; NF-KAPPA-B; BONE-MARROW; HEMATOPOIETIC-CELLS; STEM-CELLS; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; (1)
CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-ALPHA; GLIOBLASTOMA CELLS; CANCER-CELLS; MATRIX-METALLOPROTEINASE; CADHERIN EXPRESSION; MALIGNANT GLIOMA; OB-CADHERIN; PROMOTES; MIGRATION; CDH11; glioblastoma; glioma; invasion; PCSK6; SH3GL3 (1)
CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; REGULATORY T-CELLS; GANGLION-CELLS; OPTIC-NERVE; STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; DENDRITIC CELLS; IN-VIVO; INTRAOCULAR-PRESSURE; (1)
CENTRAL-NERVOUS-SYSTEM; H-3 RECEPTOR; HIGHLY POTENT; HIGH-AFFINITY; BRAIN; CIPROXIFAN; LIGANDS; CLONING; DERIVATIVES; INHIBITION; histamine; H-3 receptor; proxifan; antagonist; ciproxifan; imoproxifan (1)
CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; TUMORS; CLASSIFICATION; EPIDEMIOLOGY; SURVEILLANCE; PERFORMANCE; PREDICTORS; SURVIVAL; ADULTS; pilocytic astrocytoma; central nervous system tumors; sodium fluorescein; neuro-oncology; YELLOW 560 filter; fluorescence-guided neurosurgery (1)
CENTRAL-NERVOUS-SYSTEM; HUMAN HEMATOPOIETIC STEM; RETINOIC ACID RECEPTORS; MARKER; CANCER; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; RADIOTHERAPY; INHIBITION; glioblastoma; neurospheres; tumor stem cells (1)
CENTRAL-NERVOUS-SYSTEM; HUMAN PAX6 GENE; LENS DEVELOPMENT; CELL-DIFFERENTIATION; MOLECULAR-GENETICS; RIEGER-SYNDROME; APHAKIA MICE; MOUSE; EXPRESSION; FOXE3; Pax6; BMP7; Peters' anomaly; coloboma (1)
CENTRAL-NERVOUS-SYSTEM; I INTERFERON SIGNATURE; PERIPHERAL-BLOOD CELLS; TGF-BETA; IMMUNE-RESPONSES; CUTTING EDGE; TRANSCRIPTION FACTOR; MONONUCLEAR-CELLS; DENDRITIC CELLS; EXPRESSION; EAE; multiple sclerosis; immune regulation; T cell responses; T helper 1 (1)
CENTRAL-NERVOUS-SYSTEM; INITIATING CELLS; PRECURSOR CELLS; BRAIN-TUMORS; GLIOBLASTOMA; SURVIVAL; CLASSIFICATION; GLIOMAS; ORIGIN; oligodendroglial tumor; cancer stem cells; CD133; prognosis (1)
CENTRAL-NERVOUS-SYSTEM; IN-VITRO; CNTF; VIVO; OLIGODENDROCYTES; BRAIN; ASTROGLIOGENESIS; NEUROGENESIS; REGENERATION; POTENTIATION; neural progenitors; mesenchymal stem cells; oligodendrocyte differentiation; ciliary neurotrophic factor (1)
CENTRAL-NERVOUS-SYSTEM; IN-VIVO; EXPRESSION; GLIOMA; FOXP3; VACCINATION; EXPANSION; SURVIVAL; MICROENVIRONMENT; IMMUNOTHERAPY; brain tumor; immunotherapy; PD-L1; regulatory T cell; tumor-infiltrating lymphocyte (1)
CENTRAL-NERVOUS-SYSTEM; LOCOMOTOR RECOVERY; CORTICOSPINAL TRACT; ADULT BRAIN; CELLS; NEURONS; PROLIFERATION; PLASTICITY; TRANSECTION; APOPTOSIS; (1)
CENTRAL-NERVOUS-SYSTEM; MACROPHAGE INFLAMMATORY PROTEIN-2; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; MICROGLIAL CELLS; BLOOD; RECRUITMENT; CHEMOKINES; CYTOKINES; SUBSETS; (1)
CENTRAL-NERVOUS-SYSTEM; MALIGNANT GLIOMA; VALPROIC ACID; PHASE-I; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; PRERADIATION CHEMOTHERAPY; INTERFERON-GAMMA; PONTINE GLIOMA; CHILDREN; glioblastoma; diffuse intrinsic pontine glioma; chemotherapy; resection; children (1)
CENTRAL-NERVOUS-SYSTEM; MAMMALIAN SPINAL-CORD; PROGENITOR CELLS; HUMAN BRAIN; IN-VITRO; NEURONAL PROGENITORS; NEUROTROPHIC FACTOR; SUPPLEMENTED MEDIUM; PARKINSONS-DISEASE; PRECURSOR CELLS; (1)
CENTRAL-NERVOUS-SYSTEM; MICROENVIRONMENT; EXPRESSION; CANCER; PROGRESSION; SUBTYPES; REVEALS; CLASSIFICATION; IDENTIFICATION; PROMOTER; TSPO; Glioma; PET; Imaging; Promotor methylation; RNA seq; Immunohistochemistry; Intratumoral heterogeneity; Microglia; Myeloid cells (1)
CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MICROGLIA; MICE; CNS; ENCEPHALITIS; COMPLEMENT; ACTIVATION; INTERVENTION; MACROPHAGES; (1)
CENTRAL-NERVOUS-SYSTEM; MYELODYSPLASTIC SYNDROME; IMPROVES SURVIVAL; GLIOBLASTOMA; CHEMOTHERAPY; SECONDARY; THERAPY; TUMORS; Children; Glioblastoma; High-grade glioma; Secondary haematological malignancies (1)
CENTRAL-NERVOUS-SYSTEM; MYELOID SUPPRESSOR-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; MYELIN BASIC-PROTEIN; CD8(+) T-CELLS; INFLAMMATORY MONOCYTES; ALZHEIMERS-DISEASE; PROMOTES RECOVERY; DENDRITIC CELLS; (1)
CENTRAL-NERVOUS-SYSTEM; NATURALLY PRESENTED PEPTIDES; MULTIPLE-SCLEROSIS; MONOCLONAL-ANTIBODY; RECONSTITUTION; THERAPY; immunotherapy; mechanism of action; multiple sclerosis; alemtuzumab; autoantigen; T cell; CD4; MHC ligandome (1)
CENTRAL-NERVOUS-SYSTEM; OLIGODENDROGLIAL TUMORS; EUROPEAN ORGANIZATION; IDH2 MUTATIONS; PROCARBAZINE; VINCRISTINE; CLASSIFICATION; LOMUSTINE; GLIOBLASTOMA; PROGRESSION; (1)
CENTRAL-NERVOUS-SYSTEM; ORGANOTYPIC CULTURES; REMYELINATION; TRANSPLANTATION; PROLIFERATION; REPAIR; MODEL; IMMUNOSUPPRESSION; DEMYELINATION; DISEASE; Mesenchymal stem cells; Neural progenitors; Oligodendrocyte differentiation; Hippocampal slice culture; Multiple Sclerosis (1)
CENTRAL-NERVOUS-SYSTEM; PHOTOCHROMIC AGONIST; DERIVATIVES; PHOTOREGULATION; PHOTOSWITCHES; PHOTOCONTROL; PHARMACOLOGY; DISCOVERY; DEPLETION; GLUTAMATE; azobenzene; 5-HT3R; ion currents; photopharmacology; serotonin (1)
CENTRAL-NERVOUS-SYSTEM; PIGMENT-DISPERSING FACTOR; CIRCADIAN-RHYTHMS; PEPTIDOMICS; EXPRESSION; LARVAL; BRAIN; PEPTIDES; GENE; QUANTIFICATION; Neuropeptidomics; MALDI-TOF; Drosophila melanogaster; Neuropeptides; Pigment dispersing factor; Tandem mass spectrometry; NPLP1; Neuropeptide-like precursor 1 (1)
CENTRAL-NERVOUS-SYSTEM; PROTEIN 18 KDA; BENZODIAZEPINE-RECEPTOR; F-18-FET PET; BINDING; BRAIN; RADIOTRACER; MODEL; ASSOCIATION; RADIOLIGAND; TSPO PET; amino acid PET; FET PET; glioma; contrast enhancement; spatial correlation (1)
CENTRAL-NERVOUS-SYSTEM; QUALITY-OF-LIFE; CRANIOSPINAL RADIATION-THERAPY; AVERAGE-RISK MEDULLOBLASTOMA; ADJUVANT CHEMOTHERAPY; ONCOLOGY-GROUP; BRAIN-TUMOR; PHASE-III; CHILDHOOD; CHILDREN; cognition; imaging; health-related quality of life; medulloblastoma; radiochemotherapy (1)
CENTRAL-NERVOUS-SYSTEM; RADIATION-THERAPY; CARCINOMA; CHEMOTHERAPY; CHILDREN; SURVIVAL; CLASSIFICATION; METAANALYSIS; CARBOPLATIN; INFANTS; Choroid plexus tumors; Chemotherapy; Irradiation; Li-Fraumeni syndrome (1)
CENTRAL-NERVOUS-SYSTEM; RECEPTORS; NEUROINFLAMMATION; CORTEX; TRANSMISSION; ACTIVATION; ASTROCYTES; CELLS; GAMMA; INHIBITION; bestrophin-1; GABA; GABA transporter 1; inflammation; LPS; microglial cells (1)
CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASE; MIDDLE CEREBRAL-ARTERY; LONG-TERM SURVIVAL; RAT-BRAIN; PERMEABILITY FACTOR; UP-REGULATION; FACTOR VEGF; HIPPOCAMPAL NEUROGENESIS; NEURONAL PROGENITORS; (1)
CENTRAL-NERVOUS-SYSTEM; RHABDOID TUMORS; IMMUNOHISTOCHEMICAL ANALYSIS; PREDISPOSITION SYNDROME; HSNF5/INI1; MEDULLOEPITHELIOMA; INI1/SMARCB1; EXPRESSION; PHENOTYPE; CHILDREN; Atypical teratoid/rhabdoid tumor; Choroid plexus carcinoma; Ependymoma; Medulloepithelioma; Primitive neuroectodermal tumor; SMARCB1 (1)
CENTRAL-NERVOUS-SYSTEM; SELECTIN GLYCOPROTEIN LIGAND-1; DENDRITIC CELLS; INFLAMMATORY MONOCYTES; BACTERIAL-INFECTION; MULTIPLE-SCLEROSIS; TISSUE MACROPHAGES; GONDII TACHYZOITES; INTERFERON-GAMMA; CUTTING EDGE; (1)
CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD SARCOIDOSIS; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSE; IMAGING MANIFESTATIONS; NEUROLOGICAL DISEASES; BARRIER FUNCTION; CNS SARCOIDOSIS; LOCAL SYNTHESIS; CSF; Sarcoidosis; Neurosarcoidosis; Cerebrospinal fluid; MRI; Gadolinium; Leptomeningeal enhancement (1)
CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; IDH2 MUTATIONS; BRAIN; TEMOZOLOMIDE; TUMORS; RADIOTHERAPY; INHIBITION; RISK; diabetes; metformin; survival; glioma (1)
CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; PARKINSONS-DISEASE; HUMAN BRAIN; GROWTH; NEURONS; GRAFTS; TISSUE; RAT; DIFFERENTIATION; axon; CNS; regeneration; spinal cord injury; stem cell (1)
CENTRAL-NERVOUS-SYSTEM; T-CELL; DENDRITIC CELLS; KEY REGULATOR; SECONDARY; HOMEOSTASIS; DEFICIENT; ORGANOGENESIS; DIFFERENTIATE; ORGANIZATION; (1)
CENTRAL-NERVOUS-SYSTEM; T-CELLS; HUMAN-MELANOMA; ANTIGEN; IMMUNOTHERAPY; ASTROCYTOMAS; MAGE-1; IDENTIFICATION; GLIOBLASTOMAS; LYMPHOCYTES; brain tumor; pediatrics; qPCR; MAGE; NY-ESO-1; immune target (1)
CENTRAL-NERVOUS-SYSTEM; TEMOZOLOMIDE; CELLS; MICROENVIRONMENT; CLASSIFICATION; IMMUNOTHERAPY; EXPRESSION; GENERATION; SUBTYPES; THERAPY; brain cancer; tumor organoids; GBM; next-generation sequencing; single-cell RNA sequencing (1)
CENTRAL-NERVOUS-SYSTEM; TEMOZOLOMIDE; RADIOTHERAPY; CLASSIFICATION; MUTATIONS; IDH; MGMT; Prognosis; Outcome; Registry; Wildtype (1)
CENTRAL-NERVOUS-SYSTEM; TEMPLATED AGAROSE SCAFFOLDS; FUNCTIONAL RECOVERY; GENE-EXPRESSION; ANISOTROPIC HYDROGELS; MAMMALIAN-CELLS; TISSUE-REPAIR; GROWTH; TRANSPLANTATION; GRAFTS; Alginate hydrogel; Spinal cord injury; Schwann cells; Brain-derived neurotrophic factor; Axonal regeneration; Regulated gene expression; Biomaterial; AAV5 (1)
CENTRAL-NERVOUS-SYSTEM; TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; RESPONSE ASSESSMENT; HUMAN ASTROCYTOMAS; F-18-FET PET; BRAIN; TRACER; TUMORS; GRADE; TSPO; [F-18]GE180 PET; Glioma; Survival; Prognostic biomarker (1)
CENTRAL-NERVOUS-SYSTEM; TUMOR-INITIATING CELLS; HIGH-GRADE GLIOMA; MALIGNANT GLIOMA; BRAIN-TUMORS; RECURRENT GLIOBLASTOMA; GENE-EXPRESSION; MGMT GENE; IN-VITRO; RESISTANCE; (1)
CENTRAL-NERVOUS-SYSTEM; WHOLE-BRAIN RADIOTHERAPY; NON-HODGKIN-LYMPHOMA; 1ST-LINE TREATMENT; CENTER EXPERIENCE; RADIATION-THERAPY; RESPONSE CRITERIA; CLINICAL-TRIALS; PLUS RITUXIMAB; FOLLOW-UP; (1)
CENTRAL PENTAPHOSPHOLYL LIGAND; RAY CRYSTAL-STRUCTURE; ORGANOMETALLIC COMPOUNDS; COORDINATION; REACTIVITY; MOLECULES; OXIDATION; COMPOUND; ELEMENTS; BONDS; iron; phosphorus; polyphosphides; samarium; triple-decker complexes (1)
CENTRAL SCOTOMA; VISUAL-ACUITY; TEXTURE-DISCRIMINATION; SPATIAL-FREQUENCY; BRAIN ACTIVATION; RETINAL LOCUS; READING SPEED; HUMAN ADULTS; VISION; FIXATION; perceptual learning; fMRI BOLD; cortical plasticity; visual cortex; macular degeneration (1)
CENTRAL SEROUS CHORIORETINOPATHY; MACULAR DEGENERATION; Serous; Vascularized; Fibrovascular; Macular degeneration; Prognosis (1)
CENTRAL SLEEP-APNEA; CARDIOVASCULAR-DISEASE; MORTALITY; Heart failure with sleep apnoea; Adaptive servo-ventilation; Randomized controlled trial (1)
CENTRAL SLEEP-APNEA; HEART-FAILURE; FLUID SHIFT; OBESITY; COPD; DESATURATION; MORTALITY; T90; nocturnal hypoxemia; sleep apnea; heart failure (1)
CENTRAL SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; CARDIOPULMONARY RESUSCITATION; BREATHING DISORDERS; COMPRESSION; central sleep apnea; Cheyne-Stokes respiration; heart failure; hyperpnea (1)
CENTRAL SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; CHEYNE-STOKES RESPIRATION; CHRONIC HEART-FAILURE; EJECTION FRACTION; DAYTIME SLEEPINESS; THERAPY; SERVOVENTILATION; HF; Adaptive servo-ventilation; Sleep-disordered breathing; Heart failure; Cheyne-Stokes respiration; Central sleep apnea (1)
central spin models, quantum integrability, hyperfine interaction, exact methods (1)
CENTRAL VENOUS CATHETERS; MISPLACEMENT; (1)
CENTRAL VENOUS CATHETERS; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; LOW-DOSE WARFARIN; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; PATIENTS RECEIVING CHEMOTHERAPY; CANCER-ASSOCIATED THROMBOSIS; CLINICAL-PRACTICE GUIDELINES; DIAGNOSED MULTIPLE-MYELOMA; PLACEBO-CONTROLLED TRIAL; cancer; thrombosis; prophylactic anticoagulation; DOACs; Khorana risk score (1)
CENTRAL VENOUS CATHETERS; POSITIONAL CONTROL; GUIDE-WIRE; ECG; ELECTROCARDIOGRAPHY; PLACEMENT; central venous catheter; position control; costs; guide wire; fluid column (1)
Centrifugation; Hydrotrope; DFT; Theory (1)
CEO-chair separation, codetermination, directors’ ownership, executive remuneration, family ownership, former executives, market-to-book ratio, non-executive directors, ownership concentration, return on assets, shareholder protection. (1)
cephalometric analysis; correlation; personalised orthodontics; principal component analysis; skeletal malocclusion (1)
Cephalosporin, Beta-lactamase inhibitor, Zavicefta, HPLC-UV, Plasma protein binding, Therapeutic drug monitoring (1)
ceramic implants, biological complications, osseointegration, survival rates, success rates (1)
CERAMIC INLAYS; resin cement; self-adhesive; marginal adaptation; thermocycling and mechanical loading; all ceramic; molar crown; dentin (1)
ceramide; phospholipids; gene expression; trimer; lipidomic (1)
CERAMIDE SYNTHASES; SECRETORY SPHINGOMYELINASE; INDUCED APOPTOSIS; MILD STRESS; SYSTEM; DISEASE; CELLS; STEATOHEPATITIS; SUSCEPTIBILITY; HOMEOSTASIS; chronic psychosocial stress; acid sphingomyelinase; ceramide; sphingolipid metabolism; chronic subordinate colony housing (CSC); liver metabolism (1)
CERCERIS-ARENARIA HYMENOPTERA; FEMALE EUROPEAN BEEWOLVES; ANT CATAGLYPHIS-NIGER; DIGGER WASP; HYPOPHARYNGEAL GLANDS; PIMPLA-TURIONELLAE; SOLITARY WASP; HONEY-BEES; SECRETION; FUNGI; Postpharyngeal gland; 3D reconstruction; Comparative morphology; Prey preservation; Antimicrobial; Antifungal; Crabronidae; Philanthinae; Beewolves (1)
CEREBELLAR-ATAXIA; DEGENERATION; GENE; ataxia; SCA28; AFG3L2 (1)
CEREBELLAR GRANULE NEURONS; DOMAIN K+ CHANNEL; CAROTID-BODY; ARTERIAL CHEMORECEPTORS; INHALATION ANESTHETICS; VENTILATORY RESPONSES; PH SENSITIVITY; GLOMUS CELLS; OXYGEN; CO2; TASK potassium channels; Chemoreception; Whole body plethysmograph; Hyperoxia (1)
CEREBELLAR MEDULLOBLASTOMA; MOLECULAR SUBGROUPS; PROGNOSTIC-FACTORS; MRI FINDINGS; CT; CHEMOTHERAPY; MULTICENTER; SURVIVAL; EMPHASIS; FEATURES; Adult; Medulloblastoma; Magnetic resonance imaging; Computed tomography; Contrast enhancement (1)
CEREBRAL ABSCESSES; SIGNAL; DISCRIMINATION; METASTASIS; INTENSITY; SEQUENCES; GLIOMAS; IMAGES; cerebral abscess; magnetic resonance imaging; diffusion-weighted imaging; brain tumors; ADC (1)
Cerebral amyloid angiopathy, Intracerebral hemorrhage, Acute ischemic stroke, Cerebral microbleedings, Cortical superficial siderosis- long term outcome (1)
CEREBRAL AMYLOID ANGIOPATHY; STROKE CARE TEMPIS; INITIAL CONSERVATIVE TREATMENT; TELEMEDIC PILOT PROJECT; INTRACEREBRAL HEMORRHAGE; RANDOMIZED-TRIAL; EARLY SURGERY; BAVARIA; IMPLEMENTATION; NEUROLOGISTS; frequency; intracranial hemorrhage; location; risk factors; TeleStroke; TEMPiS (1)
CEREBRAL ANEURYSM; LONG-TERM; ANGIOGRAPHY; MANAGEMENT; RECURRENCE; RISK; aneurysm clipping; insufficient closing force; indocyanine green videoangiography (1)
CEREBRAL ANEURYSMS; BYPASS-SURGERY; REVASCULARIZATION; Giant aneurysm; Cerebral bypass; MCA aneurysm (1)
cerebral aneurysms, outcome, scoring system (1)
CEREBRAL-ARTERY INFARCTION; BRAIN PERFUSION; ACUTE STROKE; CONTRAST ENHANCEMENT; HEALTHY-VOLUNTEERS; PARAMETERS; KINETICS; AGENTS; TIME; FLOW; harmonic imaging; brain perfusion; transcranial sonography; ultrasound contrast agents; microcirculation (1)
CEREBRAL-ARTERY INFARCTION; QUALITY-OF-LIFE; TERRITORY INFARCTION; LESION LOCATION; DECOMPRESSIVE HEMICRANIECTOMY; MOOD DISORDERS; STROKE; DEPRESSION; CRANIECTOMY; PROGNOSIS; long-term; outcome; hemicraniectomy; MCA; infarction (1)
CEREBRAL-ARTERY OCCLUSION; CORTICAL BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; FOCAL ISCHEMIA; REPERFUSION; PRESSURE; BRAIN; cerebral ischemia; focal; disease models; animal; rats; middle cerebral artery occlusion; carotid artery; internal (1)
CEREBRAL-ARTERY OCCLUSION; ISCHEMIC BRAIN-INJURY; FUNCTIONAL RECOVERY; MICE; MACROPHAGES; ACTIVATION; MONOCYTES; CELLS; MECHANISMS; MICROGLIA; inflammation; macrophages; models; animal; monocytes; stroke (1)
CEREBRAL-ARTERY OCCLUSION; NEUROTROPHIC FACTOR; BEHAVIORAL ALTERATIONS; NEONATAL HYPOXIA; ANIMAL-MODEL; EXPRESSION; RATS; PATHOPHYSIOLOGY; ISCHEMIA; INTERMITTENT; BDNF; Schizophrenia; Neurodevelopment; Perinatal hypoxia; Sensorimotor gating (1)
CEREBRAL-ARTERY OCCLUSION; RAT MODEL; MUSCLE TAMPONADE; ISCHEMIA; DENERVATION; brain ischemia; disease models; animal; rats; adverse effects; external carotid artery; masticatory muscles; magnetic resonance imaging; computed tomography angiography; vascular surgery (1)
CEREBRAL AUTOREGULATION; INTRACRANIAL COMPLIANCE; NEUROCRITICAL CARE; INJURY; PRESSURE; (1)
CEREBRAL BLOOD-FLOW; ACUTE SUBDURAL-HEMATOMA; INCREASED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN INJURY; SYSTEMIC VASCULAR-RESPONSES; LASER-DOPPLER SPECTROSCOPY; SEVERE HEAD-INJURY; TISSUE OXYGEN; COMPUTERIZED-TOMOGRAPHY; HYDROGEN CLEARANCE; trauma; mass lesion; ischemia-reperfusion; laser Doppler flowmetry; partial pressure of oxygen; magnetic resonance imaging; rat (1)
CEREBRAL BLOOD-FLOW; CHOLINESTERASE-INHIBITORS; PREFRONTAL CORTEX; ASSESSMENT SCALE; WORKING-MEMORY; VERBAL FLUENCY; MODERATE; DEMENTIA; EFFICACY; ANTAGONIST; Alzheimer's disease; rivastigmine; memantine; neuropsychological tests (1)
CEREBRAL BLOOD-FLOW; CIRCULATION; AUTOREGULATION; AGREEMENT; volume flow; internal carotid artery; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; COLOR DUPLEX MEASUREMENT; ULTRASONIC ASSESSMENT; CAROTID-ARTERY; ACUTE STROKE; VOLUME; VISUALIZATION; ECHOCARDIOGRAPHY; QUANTIFICATION; INTENSITY; contrast media; magnetic resonance imaging, perfusion-weighted perfusion; m ultrasonography; Doppler, transcranial (1)
CEREBRAL BLOOD-FLOW; HIGH-RESOLUTION MEASUREMENT; TRACER BOLUS PASSAGES; CONTRAST AGENTS; MAGNETIC-SUSCEPTIBILITY; VOLUME MAPS; INJECTION; brain, MR; contrast media, comparative studies gadolinium magnetic resonance (MR), contrast media (1)
CEREBRAL BLOOD-FLOW; INDOCYANINE GREEN; DYE-DILUTION; HEMODYNAMICS; CIRCULATION; DISEASE; TIME; indocyanine green; near infrared spectroscopy; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; INTRACRANIAL ANEURYSMS; VASOSPASM; METABOLISM; TOMOGRAPHY; INHALATION; SCALE; CBF; SAH; transcranial Doppler ultrasonography; hyperemia; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; CORTICAL SPREADING DEPRESSION; VOXEL-BASED MORPHOMETRY; BRAIN-STEM ACTIVATION; CLUSTER HEADACHE; MIGRAINE ATTACKS; CONJUNCTIVAL INJECTION; NEURALGIFORM HEADACHE; ANGINA-PECTORIS; (1)
CEREBRAL-BLOOD-FLOW; PSYCHOSOCIAL STRESS; PREFRONTAL CORTEX; HORMONAL CYCLE; FUNCTIONAL MRI; SELF-ESTEEM; WOMEN; RISK; SEX; INDIVIDUALS; Conscientiousness; Stress; Cortisol; fMRI; Insula; Amygdala (1)
CEREBRAL BLOOD-FLOW; SENSORIMOTOR CORTEX; FUNCTIONAL MRI; BASAL GANGLIA; FINGER MOVEMENTS; IMAGING EVIDENCE; PET; STIMULATION; LATERALIZATION; NEUROANATOMY; fingertapping; fMRI; hemiparkinsonism; neuroleptic treatment; schizophrenia (1)
CEREBRAL-BLOOD-FLOW; SOMATOSENSORY-EVOKED POTENTIALS; NEAR-INFRARED SPECTROSCOPY; TRANSCRANIAL DOPPLER; STUMP PRESSURE; REGIONAL ANESTHESIA; GENERAL-ANESTHESIA; SELECTING PATIENTS; RANDOMIZED-TRIAL; ENDARTERECTOMY; carotid endarterectomy; neuromonitoring; regional anesthesia; general anesthesia (1)
CEREBRAL BLOOD-VOLUME; SQUAMOUS-CELL CARCINOMA; ARM CT MEASUREMENT; HEPATOCELLULAR-CARCINOMA; RADIATION-THERAPY; LIVER METASTASES; Y-90 RADIOEMBOLIZATION; RESIN-MICROSPHERES; TUMOR VASCULARITY; TARGETED THERAPY; flat-panel detector; flat-detector CT perfusion; CT perfusion; VX2 tumor; angiography (1)
CEREBRAL-CORTEX; EXPRESSION; RAT; ACTIVATION; APOPTOSIS; PROTEINS; NEURONS; DEATH (1)
cerebrale Amyloidangiopathie, Indexereignis, Langzeitverlauf (1)
CEREBRAL HEMODYNAMICS; SONOGRAPHY; Doppler ultrasound; blood flow volume; subarachnoid hemorrhage (1)
CEREBRAL INFARCTION; PRACTICAL SCALE; HEMICRANIECTOMY; SURGERY; INJURY; (1)
CEREBRAL METASTASES; AGGRESSIVE TREATMENT; CLINICAL-TRIALS; RADIOTHERAPY; MULTICENTER; IRRADIATION; FOTEMUSTINE; THERAPY; TUMORS; temozolomide; brain metastases; metastatic melanoma (1)
CEREBRAL OXYGENATION; OXIMETRY; BULB; near-infrared spectroscopy (NIRS); rSo(2); tissue Po-2 (tipo(2)); frequency analysis; multitaper analysis; modeling (1)
CEREBRAL PERFUSION-PRESSURE; IDIOPATHIC INTRACRANIAL HYPERTENSION; END-EXPIRATORY PRESSURE; CORD ISCHEMIA; SONOGRAPHIC ASSESSMENT; PSEUDOTUMOR CEREBRI; EXPERIENCE; Ultrasound; eye; optic nerve sheath diameter; thoracoabdominal aortic aneurysm repair; spinal ischemia (1)
CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; LUNG INJURY; PROSTACYCLIN; VENTILATION; HYPERCAPNIA; MORTALITY; THERAPY; EDEMA; brain injury; acute respiratory distress syndrome; jugular bulb oxymetry; lung protective ventilation; intracranial pressure (1)
CEREBRAL STATE INDEX; BISPECTRAL INDEX; SUGGESTIBILITY; MECHANISMS; PATTERNS; IMPACT; VALUES; NORMS; hypnotic susceptibility; suggestibility; bispectral index; cerebral state index; trance (1)
CEREBROCORTICAL NERVE-TERMINALS; LONG-TERM DEPRESSION; MEDIAL PREFRONTAL CORTEX; MGLU7 RECEPTOR; BETA-ARRESTIN; SYNAPTIC PLASTICITY; MICE LACKING; RAT-BRAIN; PSYCHIATRIC-DISORDERS; ADRENERGIC-RECEPTORS; mGlu7 receptors; alpha(1)-adrenergic receptor; Stress; Cross-talk; G proteins (1)
; Cerebrospinal fluid; Borna disease virus 1 (BoDV-1); Viral encephalitis (1)
CEREBROSPINAL-FLUID; CEREBRAL-CORTEX; CELL LOSS; MOTOR; (1)
CEREBROSPINAL-FLUID; CHILDHOOD; childhood cancer; ependymoma; methotrexate; pharmacokinetics (1)
CEREBROSPINAL-FLUID; CONCISE GUIDE; CELLS; CNS; LYSOPHOSPHATIDYLCHOLINE; MYELINATION; DETERMINANT; PATHOLOGY; PATHWAY; Experimental autoimmune encephalomyelitis; FGFR; infigratinib; multiple sclerosis; neuroinflammation; remyelination (1)
CEREBROSPINAL-FLUID LEAKS; TRAUMATIC OPTIC NEUROPATHY; FRONTAL-SINUS FRACTURES; ANTERIOR SKULL BASE; CAROTID-ARTERY INJURY; ABDUCENT NERVE PALSY; MINOR HEAD TRAUMA; BLUNT CEREBROVASCULAR INJURIES; ORBITAL COMPARTMENT SYNDROME; MODIFIED LOTHROP PROCEDURE; frontobasal trauma; frontal sinus trauma; carotid trauma; cerebrospinal fluid leak; dural lesion; traumatic optic neuropathy; endoscopic endonasal (1)
; Cerebrospinal fluid; Lumbar puncture complication; Reactive pleocytosis (1)
CEREBROSPINAL-FLUID; NUCLEUS-ACCUMBENS; SOCIAL-BEHAVIOR; LATERAL SEPTUM; MICROTUS-OCHROGASTER; INTERMALE AGGRESSION; INDIVIDUAL VARIATION; VASOPRESSIN RELEASE; MATERNAL-BEHAVIOR; TRAIT ANXIETY; Oxytocin mRNA; Oxytocin receptor binding; Aggressiveness; Paraventricular nucleus; Central amygdala; Bed nucleus of the stria terminalis (1)
CEREBROSPINAL-FLUID; POPULATION PHARMACOKINETICS; CONTINUOUS-INFUSION; INTRAVENTRICULAR VANCOMYCIN; CLINICAL-PRACTICE; BRAIN-BARRIER; PENETRATION; MENINGITIS; VENTRICULITIS; ANTIBIOTICS; meningitis; ventriculitis; central nervous infection; meropenem; vancomycin; pharmacokinetics; pharmacodynamics; target attainment (1)
CEREBROSPINAL-FLUID; UP-REGULATION; WHITE-MATTER; RECEPTOR 1; CITICOLINE; PHOSPHATIDYLCHOLINE; BRAIN; DEMYELINATION; METABOLISM; MEMBRANE; astrocytes; CDP-choline; cuprizone; microglia; multiple sclerosis; oligodendrocytes (1)
Cerebrotendinous xanthomatosis, LDL apheresis, 7α Hydroxy-4-cholesten-3-one (1)
Cerebrum; Cathepsin B; Cathepsin L; Lysosome; iTRAQ™; LC-MS/MS (1)
Cerium chloride, Enamel, Fluoride (1)
Cerium, Human bone marrow derived mesenchymal, stromal cells, Adipogenesis, Osteogenesis, Viability, Proliferation, Reactive oxygen species (1)
CERIUM(IV) AMMONIUM-NITRATE; 9-MESITYL-10-METHYLACRIDINIUM CATION; NO3-CENTER-DOT; ACETONITRILE; MECHANISM; OXIDATION; NO3; CYCLIZATIONS; CHEMISTRY; PRODUCTS; (1)
cerium · LMCT · N-oxides · photocatalysis · radicals (1)
CERNA; GENETICS; FRONTIER; LNCRNAS; PROTEIN; CLIP; colorectal cancer; lncRNA; ZFAS1; CDK1 (1)
; Certification; Cancer center; Cancer registry; Quality management; Tumor characteristics (1)
Certification, Outcome quality, Health services research, Healthcare-related data, Specialized treatment (1)
; Certification; Quality management; Clinic selection; Seal of approval; Patient (1)
; cervical cancer; cervical intraepithelial neoplasia (CIN); gynaecology; screening (1)
; cervical cancer; cervix; precancerous cervix; cancer register; gynaecology (1)
; Cervical cancer; Minimal-invasive surgery; Open surgery; Radical hysterectomy (1)
; Cervical cancer; Nodal status; Lymphadenectomy; Outcome; Overall survival; Therapy (1)
; Cervical cancer; Radio(chemo)therapy; Adjuvant therapy; Risk groups (1)
cervical cerclage; preterm birth prevention; twin pregnancy; cervical insufficiency; pregnancy outcomes (1)
CERVICAL DYSTONIA; RESPECTIVE POTENCIES; BLEPHAROSPASM; FORMULATIONS; CROSSOVER; botulinum toxin; Dysport; Botox; dose equivalence; randomized controlled trial (1)
CERVICAL ESOPHAGUS; CANCER; hypopharynxcarcinoma; laryngohypopharyngoesophagectomy; gastric pull-up (1)
CERVICAL INLET PATCH; UPPER THORACIC ESOPHAGUS; BAND IMAGING ENDOSCOPY; CLINICAL CHARACTERISTICS; HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; MUCOSA; ADENOCARCINOMA; ASSOCIATION; DIAGNOSIS; Gastric heterotopia; Inlet patch; Esophagus; Preneoplasia; Intestinal metaplasia; Barrett's esophagus (1)
CERVICAL LESIONS; FLOWABLE COMPOSITES; BOND STRENGTH; RESTORATIONS; INLAYS; DENTIN; SURVIVAL; ETCH; Partial ceramic crowns; Self-adhesive resin cements; Universal adhesive; CAD/CAM; Clinical study; Selective enamel etching (1)
CERVICAL LESIONS; RESIN COMPOSITES; FOLLOW-UP; FLOWABLE COMPOSITES; BOND DURABILITY; PERFORMANCE; ENAMEL; SURVIVAL; DENTIN; LONGEVITY; Class II; Filtek one; Self-adhesive; RBC; Bulk-fill (1)
Cervical mucus, NMR, Fertility, Sterility (1)
CERVICAL NERVE INJURIES; STENOSIS; ANESTHESIA; carotid surgery; retrojugular access; eversion endarterectomy; cranial nerve injury (1)
CERVICAL PHYSICAL-THERAPY; COCHLEAR NUCLEUS; ASSOCIATION; HYPERACUSIS; STRESS; PAIN; Decision tree; Diagnosis; Somatic; Somatosensory; Tinnitus (1)
CERVICAL PRIMARY AFFERENTS; SAGITTAL SINUS; SPINAL-CORD; STIMULATION; MIGRAINE; HEADACHE; NEURONS; NUCLEUS; PAIN; SENSITIZATION; cluster headache; GON; nerve block; nociceptive blink reflex; occipital nerve; trigeminal nerve (1)
CERVICAL-SPINE DYSFUNCTIONS; CHRONIC SUBJECTIVE TINNITUS; MYOFASCIAL PAIN SYNDROME; COCHLEAR NUCLEUS; CLINICAL-TRIALS; RTMS; MECHANISMS; MANAGEMENT; DISORDERS; THERAPY; rPMS; rTMS; tinnitus; brain stimulation; muscle magnetic stimulation; chronic tinnitus (1)
CERVICAL-SPINE INJURIES; TORTICOLLIS; SUBLUXATION; MANAGEMENT; Grisel's syndrome; Non-traumatic atlanto-axial dislocation; Pediatric cervical spine trauma; Treatment guideline (1)
CERVICAL-SPINE; MANAGEMENT; CT; SURGERY; Aorta; computed tomography (CT) angiography; trauma; adults; dissection (1)
Cervical vertebral maturation stages · Orthopantomograms · Lateral cephalograms · Individualized diagnostics · Tooth mineralisation stages (1)
CERVICOGENIC HEADACHE; DOUBLE-BLIND; MIGRAINE PATIENTS; STIMULATION; PAIN; REFLEX; NEURONS; MANAGEMENT; AFFERENTS; THRESHOLD; cluster headache; nociceptive blink reflex; occipital nerve block; trigeminal nerve (1)
CERVICOGENIC SOMATOSENSORY TINNITUS; CHRONIC NECK PAIN; FUNCTIONAL INDEX; BOURNEMOUTH QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; PHYSICAL-THERAPY; EXERCISE PROGRAM; HOSPITAL ANXIETY; OFFICE WORKERS; RELIABILITY; Somatic tinnitus; Smartphone application; Blended physiotherapy; Telerehabilitation; Randomised controlled trial (1)
Cesarean Scar Defect (CSD), Endometriosis, Uterine Scar Defect, Retrograde Menstruation, Laparoscopy, Cesarean Section Complications, Uterine Niche Hypermenorrhea, Dyspareunia, Retroflexio Uteri (1)
CE(SDS); Mass spectrometry; Protein analysis (1)
CESIUM; alkali metal; ammoniate; crystal structure; liquid ammonia; selenide (1)
Cesium; Crystal structure; Polychalcogenides; Raman spectroscopy; Selenogallate (1)
CESSATION; RISK; dialysis; renal transplantation; smoking; waiting list (1)
CETYLTRIMETHYLAMMONIUM BROMIDE; PHASE-BEHAVIOR; ELECTRON-MICROSCOPY; ANIONIC SURFACTANT; AQUEOUS MIXTURES; CRYO-TEM; SULFATE; SOLUBILIZATION; blastulae; catanionics; vesicles; salt effects (1)
CEUS, Bosniak classification, renal masses, renal cell carcinoma, renal perfusion abnormalities, fokal pyelonephritis, renal abcsess, pseudotumor, renal infarction (1)
CEUS; intraoperative CEUS; CEUS lung cancer (1)
CEUS; Trauma; Simulation (1)
C-F BOND; ELECTRON-TRANSFER REACTIONS; FACILE ACCESS; MEDICINAL CHEMISTRY; HYDRODEFLUORINATION; FLUORINE; FUNCTIONALIZATION; ALPHA,ALPHA,ALPHA-TRIFLUOROTOLUENE; DERIVATIVES; ALKYLATION; (1)
CFD · Intracranial aneurysm · Intraoperative · Rupture risk evaluation · Thin-walled regions · Local risk assessment (1)
C-FOS EXPRESSION; ELEVATED-PLUS-MAZE; CHRONIC VARIABLE STRESS; CHRONIC SOCIAL STRESS; PITUITARY-ADRENOCORTICAL AXIS; ANXIETY-RELATED-BEHAVIOR; FORCED SWIM TEST; MALE-RATS; TRANSCRIPTION FACTOR; CHRONIC RESTRAINT; Zif-268; c-Fos; chronic psychosocial stress; chronic subordinate colony housing; immediate early gene; lateral septum (1)
C-FOS EXPRESSION; MATERNAL AGGRESSION; CONDUCT DISORDER; SYRIAN-HAMSTERS; SEX-DIFFERENCES; GENDER-DIFFERENCES; HUMAN BRAIN; HYPOTHALAMIC AGGRESSION; ARGININE-VASOPRESSIN; INTERMALE AGGRESSION; (1)
C-FOS EXPRESSION; PITUITARY-ADRENOCORTICAL AXIS; MEDIAL PREFRONTAL CORTEX; FORCED SWIMMING TEST; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA EXPRESSION; IMMEDIATE-EARLY GENE; STRIA TERMINALIS; ANIMAL-MODEL; BED NUCLEUS; antidepressant; c-Fos mapping; forced swim; HAB; HPA axis; paroxetine; stress coping (1)
C-FOS; INTERMALE AGGRESSION; VASOPRESSIN RELEASE; HYPOTHALAMIC VASOPRESSIN; NEURONAL ACTIVATION; MATERNAL AGGRESSION; PREFRONTAL CORTEX; STRIA TERMINALIS; SOCIAL DEFEAT; BED NUCLEUS; Abnormal aggression; Anxiety; Nucleus accumbens; Neuronal activation; Dopamine; Aggression (1)
CFRP, surface characterization, automotive (1)
CFTR; CHANNEL; ACTIVATION; TMEM16A; PROTEIN; COLON; CAMP; CA2+; EXPRESSION; TRANSPORT; TMEM16A; TMEM16F; TMEM16K; Anoctamin 1; Anoctamin 6; Anoctamin 10; Ano1; Ano6; Ano10; Ca2+-activated Cl- channels; Colon; Small intestine; Ileum; Jejunumchloride secretion (1)
CFTR, Cystic fibrosis transmembrane conductance regulator, AMPK, PKA, ion transport, phosphorylation, AMP-activated protein kinase, S573C, pancreatitis, pancreas, chloride secretion, acid, proton, F508del-CFTR, CaCC, TMEM16A (1)
CFTR INHIBITION; HCO3-SECRETION; ALPHA-SUBUNIT; CELL LINE; AMILORIDE; IDENTIFICATION; HOMEOSTASIS; CRACM1; CALU-3; CFTR inhibitors; Off-target effects; Store-operated calcium entry; Orai1; ENaC; In silico modelling (1)
; CFTR modulators; Theranostics; Rare mutations; Intestinal organoids; Precision medicine (1)
C. G. Jung;Hollywood;Joseph Campbell;Storytelling;John D. Rockefeller;Mary Mellon;Bollingen Foundation;Philanthropy;Sigmund Freud;Psychoanalyse;Orson Welles;Carl Jung;CG Jung;Psychoanalysis;Christopher Vogler;George Lucas;Star Wars (1)
cGMP, cGKII, AQP2, Niere, Sammelrohr (1)
cGMP, cGK-I-Komplexe, InsP3R-I-Phosphorylierung, IRAG (1)
cGMP, cGKI,TAL (1)
cGMP - cGMP-dependent protein kinases - cGKI substrate proteins - Affinity purification - Co-immunoprecipitation - cGMP-agarose (1)
cGMP, cinaciguat, diabetic nephropathy, mesangial cells, PKG, sGC activator (1)
CGMP-GATED CHANNEL; ALPHA-SUBUNIT; TOTAL COLOURBLINDNESS; COLOR-VISION; ACHROMATOPSIA; GENE; PINGELAPESE; LOCUS; EYE; (1)
cGMP; kinase; PKG; inhibitor (1)
CGRP, Substanz P,Rheumatoide Arthritis, Nervenfaser (1)
cGVHD, mTOR-Inhibitoren, Everolimus (1)
C-H activation; Cyclopentadienes; Intermediates; P ligands; Tungsten (1)
C-H ACTIVATION; MOLECULAR-STRUCTURES; TRIPHOSPHA-FERROCENES; COORDINATION CHEMISTRY; CRYSTAL-STRUCTURE; COMPLEX; LIGANDS; FE(ETA(5)-C5H5)(ETA(5)-P(3)C(2)BU(2)(T)); STABILIZATION; SYSTEMS; mesityl; Phosphorus; phospholyl; iron; triphosphaferrocene (1)
C-H ACTIVATION; TRANSFER-DEHYDROGENATION; DIHYDROGEN FORMATION; HYDROFORMYLATION; CARBONYLATION; RHCL(CO)(PME3)2; MECHANISM; 1-HEXENE; BENZENE; COMPLEX; Aldehydes; Alkane dehydrogenation; CO2 recycling; Hydroformylation; Photocatalysis; Rhodium; Ruthenium (1)
CHADOX1 NCOV-19; SARS-CoV-2; vaccination; population-based cohort; immunogenicity; neutralizing antibodies; Comirnaty; Spikevax; Vaxzevria; variants of concern VoC (1)
CHAGAS-DISEASE REACTIVATION; IRON SUPEROXIDE-DISMUTASE; SOD INHIBITORS; CHRONIC PHASES; CRUZI; DISCOVERY; INFANTUM; PATIENT; GROWTH; BEHAVE; Azines and benzoazines; imidazole; in vitro trypanosomicidal and leishmanicidal activity; Fe-SOD inhibition (1)
CHAIN AMINO-ACIDS; CHOLESTEROL ABSORPTION; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; RISK; OBESITY; CANCER; IDENTIFICATION; HETEROGENEITY; METAANALYSIS; BMI; Adiposity; Metabolomics; Epidemiology; Obesity (1)
CHAIN AMINO-ACIDS; PLACEBO-CONTROLLED TRIAL; PREVENTS BONE LOSS; DOUBLE-BLIND; PARENTERAL-NUTRITION; ENTERAL NUTRITION; RANDOMIZED-TRIALS; BISPHOSPHONATE TREATMENT; CIRRHOTIC-PATIENTS; EMPIRICAL-EVIDENCE; (1)
CHAIN CYTOKINES IL-2; EFFECTOR DIFFERENTIATION; MEMORY; INTERLEUKIN-2; EXHAUSTION; EXPRESSION; RECEPTOR; TIM-3; PD-1; IMMUNOTHERAPY; (1)
CHAIN DEFECT EMISSION; GREEN EMISSION; KETO DEFECT; ORIGIN; STATES; ELECTROLUMINESCENCE; SEMICONDUCTORS; RECOMBINATION; POLYFLUORENES; DEGRADATION; (1)
CHAIN DEHYDROGENASE/REDUCTASE FAMILY; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ANGSTROM RESOLUTION; 17-BETA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; PROTEIN MODELS; Sniffer; carbonyl reductase; X-ray crystal structure; NADP(+); MAD (1)
CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIUM; AKKERMANSIA-MUCINIPHILA; ADIPOSE-TISSUE; B-CELLS; T-CELLS; SP NOV.; MICROBIOTA; GUT; INFLAMMATION; (1)
CHAIN FATTY-ACIDS; DIFFERENTIAL EXPRESSION ANALYSIS; AUTOIMMUNE ENCEPHALOMYELITIS; NERVOUS-SYSTEM; GUT MICROBIOTA; BUTYRATE; BACTERIA; METABOLITES; SEQUENCES; (1)
CHAIN FATTY-ACIDS; HDAC INHIBITORS; MICE DEFICIENT; INFLAMMATORY RESPONSES; INNATE IMMUNITY; GRANZYME-A; INTERLEUKIN-1-BETA; ACTIVATION; RECEPTOR; ARTHRITIS; (1)
CHAIN FATTY-ACIDS; IDENTIFICATION; BIOSYNTHESIS; FIBROBLASTS; MUTATIONS; TRANSPORT; SPECTRUM; PLASMA; STATE; ALD; ABCD1 gene; bile acids; peroxisomal beta-oxidation; X-linked adrenoleukodystrophy (1)
CHAIN FATTY-ACIDS; PEPTIDE-1 SECRETION; GUT-MICROBIOME; DIET; RECEPTORS; IMMUNE; glucagon-like peptide 1; gut microbiota; Holdemanella biformis; obesity; type 2 diabetes; vagal afferent neurons (1)
CHAIN FATTY-ACIDS; SODIUM-BUTYRATE; IN-VITRO; PERIODONTAL-DISEASE; FIBROBLASTS; PROPIONATE; EXPRESSION; MECHANISM; GROWTH; Dental follicle cells; Butyrate; Osteogenic differentiation; Alkaline phosphatase; Proliferation (1)
CHAIN-LENGTH; DYNAMIC LOCALIZATION; POLYMER SYNTHESIS; DICHROISM; LUMINESCENCE; SPECTROSCOPY; PHOTOPHYSICS; ABSORPTION; EXCITATION; SPECTRA; Chirality; Circular Dichroism; Circular Polarization of Luminescence; Helical Ladder Polymers; Spiro Bisfluorene Linkers (1)
CHAIN-LENGTH; TEMPERATURE; IMIDAZOLIUM; RELAXATION; POLAR; SPECTROSCOPY; DYNAMICS; SOLVENTS; (1)
CHAIN MONTE-CARLO; BAYESIAN COMPUTATION; STATISTICAL-INFERENCE; DYNAMICAL-SYSTEMS; ESTIMATORS; FOREST; MODELS; Intractable likelihood; saddlepoint approximation; synthetic likelihood; simulation-based inference; implicit statistical model; density estimation (1)
CHAIN MONTE-CARLO; CONSTRAINED PARAMETER; FEEDFORWARD NETWORKS; ECONOMETRIC-MODELS; PRICE; ELASTICITIES; REGRESSION; sales response; hierarchical Bayes; multilayer perceptron; neural networks; marketing (1)
CHAIN MONTE-CARLO; GENERALIZED-METHOD; BAYESIAN-ANALYSIS; UNKNOWN NUMBER; MIXTURE-MODELS; INSTRUMENTS; COMPONENTS; MOMENTS; WEAK; Endogeneity; Instrumental variable methods; Bayesian estimation; Retailing; Marketing (1)
CHAIN-MONTE-CARLO; MARKOV-CHAIN; DISTRIBUTIONS; INFERENCE; Markov chain Monte Carlo; Multimodality; Tempering; Thermodynamic integration (1)
CHAIN-REACTION ASSAY; PLAGUE; SEQUENCE; Yersinia pestis; real-time PCR (1)
CHAIN-REACTION ASSAY; VIRUS; PERSISTENCE; DIAGNOSIS; VACCINES; (1)
CHAIN-REACTION PCR; RAPID DIAGNOSIS; ROCHALIMAEA-HENSELAE; MANAGEMENT; INFECTIONS; keratitis; Bartonello henselae; cat scratch disease; PCR (1)
CHAIRS; BACK; office work setting; system ergonomy; monitor; seated posture; EU norms (1)
CHALCOGEN CARBONYL-COMPOUNDS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; MIXED-CHALCOGENIDE; REDOX POTENTIALS; METAL-CLUSTERS; IRON; LIGANDS; REACTIVITY; CONSTRUCTION; (1)
CHALCOGENIDE CLUSTERS; COORDINATION CHEMISTRY; MOLECULES; SYMMETRY; SIZE; SUPRAMOLECULE; ALUMINUM; CORE; (1)
Chalcogenogallates, high-temperature investigations, alkali metals, crystallization kinetics, in situ investigations (1)
chalcogens; cluster compounds; coordination chemistry; dinuclear complexes (1)
chalcogens · electrophilic substitution · molybdenum · phosphorus · triple decker complexes (1)
chalcones, alpha-substitution, Michael-acceptors (1)
CHALK GRASSLAND VEGETATION; SPECIES-RICH GRASSLAND; EX-ARABLE LAND; CALCAREOUS GRASSLANDS; SOIL; DISPERSAL; FEASIBILITY; RESTORATION; GERMINATION; MANAGEMENT; ants; dry grassland; mosaic of herbaceous communities; seed bank; seed rain; steppe (1)
Chalkogene; Clusterverbindungen; Koordinationschemie; Zweikernkomplexe (1)
Chalkogenidometallate, Plumbidcluster, Ammoniakate, Zintl-Ionen, Röntgendiffraktometrie (1)
Chalkogenohypodiphosphate, Strukturaufklärung, Festkörperchemie, Perowskit, Thallium, Kohlenstoffgruppe, Stickstoffgruppe, Seltenerdmetall, Silber, Kupfer, AX2-Verbindungen, Chalcogenohypodiphosphates, Solid state chemistry, crystal structure, structure analysis (1)
C-H ALKYLATION; SANGUINARINE REDUCTASE; 4-ALKYL-1,4-DIHYDROPYRIDINES; CHELERYTHRINE; REAGENTS; ENZYME; BOND (1)
CHALLENGE; Ontology; Policy; HIS; Architecture; pHealth; Privacy (1)
CHALLENGES; EFFICACY; HIV; vaccine; envelope-specific antibodies; epitope variant recognition; immunogen structure; immunogen sequence (1)
CHALLENGING BEHAVIORS; MENTAL-HEALTH; RESTRAINT USE; RISK MARKERS; PEOPLE; STAFF; INTERVENTIONS; SECLUSION; FAMILIES; STRESS; intellectual disabilities; developmental disabilities; challenging behaviours; employee stress; coercive measures; residential institutions (1)
CHAMERION-ANGUSTIFOLIUM ONAGRACEAE; MINORITY CYTOTYPE EXCLUSION; INBREEDING DEPRESSION; SELF-INCOMPATIBILITY; PLANTS; EVOLUTION; ESTABLISHMENT; POPULATIONS; POLYPLOIDY; AUTOTETRAPLOIDS; Crossing experiments; Flow cytometry; Hybridization; Polyploidy; Triploid block (1)
C-H AMINATION; PHOTOREDOX CATALYSIS; HYDRAZONYL RADICALS; ORGANIC-SYNTHESIS; ALKENES; HETEROCYCLES; TRANSITION; ALKYNES; HYDROAMINATION; REARRANGEMENT; (1)
CHANGE BLINDNESS; FACES; (1)
Change, Work teams, Dynamic, Team learning, Team performance (1)
CHANNEL ACTIVITY; MOLECULAR-BASIS; DYSTROPHY GENE; CA2+ CHANNELS; BEST-DISEASE; ION CHANNELS; CRAC CHANNEL; LIGHT PEAK; MUTATIONS; PROTEIN; Bestrophin-1; Endoplasmic reticulum Ca2+ store; Orai-1; Store-operated calcium entry (1)
CHANNEL DELETION; SEX-DIFFERENCES; EXPRESSION; SECRETION; GLOMERULOSA; PREVALENCE; MUTATIONS; ZONATION; TASK1; MODEL; (1)
CHANNEL ELECTRODES; FORCED-CONVECTION; Electrochemistry; Forced convection; Oxidations; Reductions; Scanning electrochemical microscopy (1)
CHANNEL; FAMILY; EXPRESSION; SECRETION; GENE; Ca2+ activated Cl- channel; bestrophin 1; bestrophin 2; vmd2; Cl- conductance; airways; epithelium (1)
CHANNEL RYANODINE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; PROTEIN-KINASE-II; CA2+ RELEASE; INTRACELLULAR CA2+; PRESSURE-OVERLOAD; IMPROVES; MICE; PHOSPHORYLATION; ATRIAL; (1)
CHANNELS; vapor pressure osmometry; Emf; activity of water; activity coefficients; osmotic coefficients; N-Boc-L-histidine; N-Boc-L-histidine methyl ether; zwitterions; ionic form of amino acid; dissociation constant (1)
CHAOS; (1)
CHAOS; IONIZATION; HELIUM; ATOM; LOCALIZATION; ELECTRON; PULSES; SINGLE; (1)
Chaos; Nonlinear Dynamics; Classical mechanics (1)
CHAOTIC EIGENFUNCTIONS; NODAL LINES; (1)
CHAOTIC QUANTUM TRANSPORT; LOCALIZED SCATTERERS; INTEGRABLE BILLIARDS; METALLIC CONDUCTION; SPATIAL VARIATION; UNITARY-GROUP; MATRIX THEORY; CAVITIES; SURFACES; CURRENTS; (1)
CHAOTIC SCATTERING; SEMICLASSICAL APPROACH; MATRIX THEORY; QUANTUM; (1)
CHAOTIC SYSTEMS; ATTRACTORS; BILLIARDS; (1)
CHAOTIC SYSTEMS; HYPERBOLIC SYSTEMS; QUANTUM MOTION; ATOM-OPTICS; BILLIARDS; FIDELITY; DECAY; APPROXIMATION; DECOHERENCE; ATTRACTORS; (1)
chaotropic effect; hydrophobic effect; polyoxometalates; polymeric surfactants; small angle scattering; salt effects (1)
CHARACTERS; (1)
CHARACTER VARIETIES; 3-MANIFOLDS; MANIFOLDS; 3-manifold; essential surface; character variety; Bruhat-Tits building; separable subgroup (1)
Charcot, sympathische Nervenfaser, sensible Nervenfaser, Substanz P, sympathetic nerve fiber, sensory nerve fiber, substance P (1)
CHARGED COLLOIDS; LIPID EXTRACTION; MOLECULAR SOLUTIONS; BINARY-MIXTURES; SEDIMENTATION; MICROEMULSIONS; ULTRACENTRIFUGE; EQUILIBRIUM; SCATTERING; PROFILES (1)
CHARGED CURRENT INTERACTIONS; QUARK-ANTIQUARK ASYMMETRY; LEPTON SCATTERING; NOMAD EXPERIMENT; SU(3) BREAKING; NUCLEON SEA; FRAGMENTATION; POLARIZATION; RENORMALIZATION; BARYONS; (1)
CHARGE-DENSITY ANALYSIS; ELECTRONIC-STRUCTURE; SOLID-STATE; BASIS-SETS; COMPLEXES; SIGMA; HALOGEN; QUALITY; SURFACE; BOND; pi-hole interactions; charge transfer; quinone; charge density; Atoms In Molecule; analysis. (1)
CHARGED EXCITONS; TRIONS; ION; (1)
CHARGE-DISTRIBUTIONS; HADRON STRUCTURE; SCATTERING; EQUATIONS; PROBE; Lattice field theory simulation; QCD Phenomenology (1)
CHARGE-DISTRIBUTIONS; QCD; RENORMALIZATION; IMPROVEMENT; Lattice QCD; Chiral Lagrangians (1)
CHARGED SPHERICAL-PARTICLES; SPONTANEOUS VESICLES; ELECTROSTATIC INTERACTION; SOLVENT RELAXATION; LAMELLAR PHASES; COUNTERION; HYDRATION; FORCES; MEMBRANES; MIXTURES; (1)
CHARGE FLUCTUATION MODEL; IN-OIL MICROEMULSIONS; X-RAY-SCATTERING; ETHYLAMMONIUM NITRATE; ELECTRICAL-CONDUCTIVITY; MICELLE FORMATION; NONIONIC SURFACTANTS; AGGREGATION BEHAVIOR; INTERFACIAL-TENSION; REVERSE MICELLES; (1)
CHARGE; LIGANDS; PALLADIUM; STATE; Photochemistry; p-Quinone; Rhodium(I); Iridium(I); Palladium(II) (1)
CHARGE READ-OUT; (1)
Charge sensing, quantum dots, spin qubits, reflectometry, silicon, Si/SiGe (1)
CHARGE SEPARATION; GRAPHENE; SPINTRONICS; TRANSPORT; LIFETIMES; (1)
CHARGE-STATE; MOLECULES; THIANTHREN; RESOLUTION; CRYSTAL; (1)
CHARGE-STATE; RESOLUTION; MOLECULE; INSULATORS; FIELD; (1)
CHARGE-STATE; SURFACES; MOLECULES; ANISOTROPY; RESOLUTION; ENERGY; (1)
charge structure electrolyte polyelectrolyte dielec structure function electrolyte polyelectrolyte DNA charge structure exptl theory polystyrenesulfonate charge structure exptl theory (1)
charge structure factor triethylphenylammonium tetraphenylborate DMF (1)
CHARGE-SYMMETRY; VIOLATION; NUCLEON; BREAKING; MASSES; SYSTEM; lattice QCD plus QED; isospin splittings; decuplet (1)
CHARGE-SYNDROME; MENTAL-RETARDATION; MUTATIONS; GENE; EXCLUSION; SPECTRUM; TRANSLOCATION; DIAGNOSIS; DELETION; REVEALS; mandibulo-facial dysostosis; microcephaly; developmental delay; microtia; choanal atresia (1)
CHARGE-TRANSFER; COMPLEXES; COORDINATION; CHLORIDE; STATES; Luminescence; Fluorescence; Rhenium(I); Lumazine; Folic acid (1)
CHARGE-TRANSFER; CONDUCTANCE; JUNCTION; (1)
CHARGE-TRANSFER EXCITATION; HYDROTRIS(3,5-DIMETHYL-1-PYRAZOLYL)BORATE; BINDING; Coordination chemistry; Dialkyl carbonates; Copper; Photocatalysis; Artificial photosynthesis (1)
CHARGE-TRANSFER EXCITATION; MAIN-GROUP ELEMENTS; ARENE REPLACEMENT REACTIONS; COORDINATION-COMPOUNDS; METAL; PHOTOCHEMISTRY; METALLOCENES; FERROCENE; LIGAND; LUMINESCENCE; electronic spectra; photoreactivity; cyclopentadienyl complexes (1)
CHARGE-TRANSFER EXCITATION; MOLECULAR-ORBITAL METHOD; 3-DIMENSIONAL AROMATICITY; CLOSO-CARBORANES; ELECTRONIC-STRUCTURE; BORANE ANIONS; COMPLEXES; LUMINESCENCE; CLUSTERS; PHOTOCHEMISTRY; electronic spectra; metal-centered excited states; photoluminescence; phosphorescence; thallium; borane (1)
CHARGE-TRANSFER EXCITATION; PERFLUOROALKYL IODIDES; DEPENDENT ENZYMES; LIGHT; MEGLUMINE; ALKYLATION; ARYLATION; DELIVERY; SULFAMERAZINE; CYCLODEXTRINS; Arylation; EDA Complex; Meglumine; Photochemistry; Water (1)
CHARGE-TRANSFER EXCITATION; PHOTOCHEMICAL PROPERTIES; ELECTRONIC ABSORPTION; MCD SPECTRA; PHOTOLUMINESCENCE; SPECTROSCOPY; RHODIUM(I); IRIDIUM(I); EMISSION; ORBITALS; absorption spectra; emission spectra; charge transfer; photochemistry; phosphine complexes (1)
CHARGE-TRANSFER EXCITATION; RAY CRYSTAL-STRUCTURE; EXCITED-STATE; SPECTROSCOPIC PROPERTIES; PHOSPHINE COMPLEXES; METAL-COMPLEXES; SOLID-STATE; PHOTOCHEMISTRY; LUMINESCENCE; PHOTOOXIDATION; photochemistry; gold complexes; electronic spectra (1)
CHARGE-TRANSFER EXCITATIONS; DENSITY-FUNCTIONAL THEORY; ORGANIC-DYES; ELECTRON INJECTION; PHOTOVOLTAIC PERFORMANCE; TIO2 FILMS; DONOR; EFFICIENCY; DESIGN; ABSORPTION; Dye-sensitized solar cell; Squaraine dye; Absorption spectrum; Charge transfer; Electron injection (1)
CHARGE-TRANSFER EXCITATION; TRANSITION-METALS; OSMIUM-TETROXIDE; ACTIVATION; FUNCTIONALIZATION; PHOTOREACTIVITY; PHOTOCHEMISTRY; OXIDATION; COMPLEXES; BONDS; Rhenium Complexes; Photochemistry; Methane; Catalysis (1)
CHARGE-TRANSFER; OXIDES; PHOTOLUMINESCENCE; COMPLEXES; charge transfer; rhenium complexes (1)
CHARGE-TRANSFER; PHOTOCHEMISTRY; COMPLEXES; CYCLOOCTATETRAENE; LUMINESCENCE; SPECTROSCOPY; EXCITATION; electronic spectra; MLCT; IL; phosphorescence; platinum complexes; cyclooctatetraene complexes (1)
CHARGE-TRANSFER; SINGLET OXYGEN; EXCITED-STATES; UP-CONVERSION; ACCEPTOR; RECOMBINATION; SENSITIZERS; GENERATION; DESIGN; BORON; (1)
CHARGE-TRANSFER; SPECTROSCOPIC PROPERTIES; BODIPY DYES; FLUORESCENCE; PHOTOMULTIPLIER; LUMINESCENCE; CONFORMATION; DERIVATIVES; STATE; (1)
CHARGE-TRANSFER; SQUARAINE DYES; METAL-IONS; FLUORESCENT CHEMOSENSOR; AQUEOUS-MEDIA; RECOGNITION; BEHAVIOR; PHOTOCHEMISTRY; COMPLEXATION; AGGREGATION; aggregation; calcium; chromophores; host-guest systems; sensors (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; AQUEOUS-SOLUTION; METAL; LIGAND; NO; LUMINESCENCE; INTRALIGAND; COMPLEXES; CHEMISTRY; electronic spectra; LMCT; hyponitrite complexes; silver complexes; photochemistry; nitric oxide (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; COMPLEXES; LUMINESCENCE; PHOSPHORESCENCE; INTRALIGAND; DRUGS; METAL; electronic spectra; luminescence; phosphorescence; intraligand states; photochemistry; silver; sulfadiazine; argyria (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; CRYSTAL-STRUCTURES; EXCITED-STATES; COMPLEXES; METAL; LUMINESCENCE; PHOTOPHYSICS; MONONUCLEAR; ABSORPTION; electronic spectra; intraligand excited states; phosphorescence; silver complexes; phosphine complexes; heavy-atom effect (1)
CHARGE-TRANSPORT; ELECTRICAL-TRANSPORT; ELECTRONIC STATES; LONG-RANGE; MOLECULES; SINGLE; POLY(DA)-POLY(DT); POLY(DG)-POLY(DC); LOCALIZATION; WIRE; (1)
CHARGE-TRANSPORT; ELECTROLYTES; IODIDE; MICROELECTRODE; PERFORMANCE; CONVERSION; STABILITY; MIXTURES; CRYSTAL; SALTS; Diffusion coefficient; Ionic liquids; Non-Stokesian transport; Dye-sensitized solar cells (1)
charge transport; fullerenes; Landauer theory; modeling; nanotechnology (1)
CHARGE-TRANSPORT; ORGANIC-SOLVENTS; DISK ELECTRODES; REDOX COUPLE; STEADY-STATE; ELECTROLYTES; IODIDE; ULTRAMICROELECTRODES; ELECTROCHEMISTRY; PERFORMANCE; microelectrode; diffusion coefficient; ionic liquids; non-Stokesian transport behaviour (1)
CHARGE-TRANSPORT; POLYFLUORENE; DIODES; (1)
CHARGE-TRANSPORT; SINGLE; CONTACTS; DEVICES; (1)
CHARLSON COMORBIDITY INDEX; BREAST-CANCER; ADJUVANT TREATMENT; COLORECTAL-CANCER; CO-MORBIDITY; AGO PATTERN; OPEN-LABEL; SURVIVAL; CARE; REPRODUCIBILITY; Endometrial cancer; Guideline adherence; Overall survival; Comorbidities (1)
CHARLSON COMORBIDITY INDEX; COVID-19; PROCALCITONIN; PNEUMONIA; COVID-19; Antibiotics; Antibiotic stewardship; Procalcitonin; LEOSS (1)
CHARLSON COMORBIDITY INDEX; HIP-ARTHROPLASTY; TOTAL KNEE; COMPLICATIONS; MANAGEMENT; MORBIDITY; SURGERY; DELAY; periprosthetic fracture; periprosthetic femur fracture; geriatric trauma; mortality; Charlson comorbidity index (1)
CHARLSON COMORBIDITY INDEX; RISK-FACTORS; MAJOR HEAD; MOTOR SUBTYPES; CANCER; SYMPTOMS; delirium; head neck squamous cell carcinoma; HNSCC; free flap; Charlson Comorbidity Index (1)
C-H ARYLATION; CROSS-COUPLING REACTION; VISIBLE-LIGHT; ARENEDIAZONIUM SALTS; PHOTOREDOX CATALYSIS; TRANSITION-METALS; PALLADIUM CATALYSIS; RADICAL CHEMISTRY; PSCHORR REACTION; CARBON-MONOXIDE; arylation; catalysis; diazonium salts; radicals; visible light (1)
C-H ARYLATION; ELECTRON-TRANSFER; DELAYED FLUORESCENCE; LIGHT PHOTOCATALYSIS; ORGANIC-SYNTHESIS; REDOX POTENTIALS; METAL-FREE; FUNCTIONALIZATION; TRANSFORMATIONS; FRAGMENTATION; aryl halides; defunctionalization; organocatalysis; photocatalysis; triplet states; two-photon process (1)
C-H ARYLATION; ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; STEREOSELECTIVE-SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; SINGLE-LAYER; ACID; PHOTOCATALYSIS; DECARBOXYLATION; PHOTOCHEMISTRY; butenolides; green chemistry; photoredox catalysis; semipinacol rearrangement; sensitization; spirocyclization (1)
C-H ARYLATION; PHOTOREDOX CATALYSIS; EOSIN-Y; DIAZONIUM SALTS; HECK REACTIONS; BOND FORMATION; ARYL; ALKYNES; ORGANOCATALYSIS; 5-LIPOXYGENASE; (1)
C-H ARYLATION; PHOTOREDOX CATALYSIS; SUBSTITUTED INDOLES; MEERWEIN ARYLATION; PSCHORR REACTION; METHYL KETONES; METAL-FREE; ETHERS; PHOTOCATALYSIS; HALIDES; (1)
C-H ARYLATION; VISIBLE-LIGHT; METAL-FREE; PHOTOREDOX CATALYSIS; REDUCTIVE DEHALOGENATION; 5-DEAZAFLAVIN; ACTIVATION; RADICALS; FLAVIN; electron transfer; heavy atom effect; photocatalysis; reduction chemistry; spin-correlation (1)
Chase, Data Provenance, Research Data Management, System Demo (1)
chatbot; ChatGPT; cypher language; graph database; knowledge graphs; LLM; natural language interface; Neo4j; question answering (1)
chatbot, language analysis, depressive disorders, ChatGPT, BERT (1)
Chatbots, Design Science Research, Rigor Cycle, Systematic Literature Review, Design Features, Productivity (1)
chatbots, language style transfer, shakespeare, styled conversational interface, conversational agent, dialogue system (1)
ChatGPT, artificial intelligence, AI, chatbots, law, legal, lawsuits, litigation (1)
ChatGPT, LLM, Generative AI, Chat Bot, Security, Privacy, Workplace, Employee Behavior (1)
ChatGPT; OpenAI; Artificial intelligence; Medical education; Clinical decision-making; Medical licensing exams (1)
ChatGPT; United States Medical Licensing Examination; artificial intelligence; USMLE; USMLE Step 1; OpenAI; medical education; clinical decision-making (1)
C-H BONDS; COPPER-CATALYZED REACTIONS; COUPLING REACTIONS; ORGANIC-SYNTHESIS; CONVENIENT REAGENT; CROSS-COUPLINGS; DIAZO-COMPOUNDS; C(SP(3))-H FUNCTIONALIZATION; 3+2 CYCLOADDITIONS; NITROXYL RADICALS; carbon-hydrogen functionalization; oxidations; radicals; peroxides; heterocycles (1)
C-H BONDS; LIGHT PHOTOREDOX CATALYSIS; HYDROGEN-PRODUCTION; FUNCTIONALIZATION; ARYLATION; PHOTOCHEMISTRY; ALKYLATION; CO2; heterogeneous photocatalysis; carbon nitride; hydrogen atom transfer; C(sp(3))-H arylation; dual photo nickel; drug molecule functionalization (1)
C-H BONDS; SELECTIVE PHOTOCHEMICAL FLUORINATION; SELECTFLUOR; ACTIVATION; REDUCTION; VERSATILE; AMIDES; (1)
C-H BORYLATION; ARYL HALIDES; METAL-FREE; (1)
C-H; C(SP(3))-H BONDS; ATOM TRANSFER; FUNCTIONALIZATION; DEUTERATION; ALDEHYDES; EQUIVALENTS; ALLYLATION; TRITIATION; ALCOHOLS; photoredox catalysis; carbanion; site-selectivity; isotope labeling; amino alcohols; C-H functionalization (1)
CHD1 CHROMATIN REMODELER; GENE-EXPRESSION; ENDOMETRIAL CARCINOMA; DROSOPHILA; COMPLEXES; ISWI; BINDING; SWI/SNF; NURD; PROTEIN; (1)
CHD3;CHD4;PU.1 (1)
Checkpoint expression, Checkpoint secretion, Soluble factors, Checkpoint therapy, Breast cancer (BC), Tumor phenotype, Immune checkpoint, Tumor markers (1)
CHECKPOINT INHIBITOR; RECIPIENT; CANCER; Nivolumab; Pembrolizumab; Ipilimumab; rejection; transplant failure (1)
chelate ligands * cyclo-P4 ligands * P4 butterfly complexes * P4 transformation * phosphorus (1)
CHELATION-ASSISTED HYDROESTERIFICATION; CARBON-MONOXIDE; METHYL FORMATE; ALKENES; EFFICIENT; CARBONYLATION; HYDROCARBAMOYLATION; COMPLEXES; ETHYLENE; LIGANDS; (1)
Chemerin, CMKLR1, HCC, NASH (1)
Chemerin, CMKLR1, NAFLD, NASH (1)
chemerin, hepatocellular carcinoma, isoforms, chemokin-like receptor 1, liver (1)
; Chemerin; Synovium; Fibroblast; Arthritis (1)
CHEMICAL-BOND; AMMONIA 1/2; PHOSPHIDES; HEPTAPHOSPHIDE; ANIONS; ELEMENTS; METAL; P-11(3-); P-4(2-); LITHIUM; Polyphosphide; Caesium; Crystal structure; Liquid ammonia (1)
chemical bond, artificial atom, quantum corral, atomic force microscopy, KWANT, scanning tunneling microscopy, angular momentum, Bessel states, perturbation, surface state, adatom, CO terminated tip, metal tip, qPlus sensor, electron confinement (1)
Chemical bonding, Electronic structure, Interactions & forces, Interatomic & molecular potentials, Surface states, Atomic force microscopy, Noncontact atomic force microscopy (1)
CHEMICAL CAMOUFLAGE; GENES; ANTS; RECOGNITION; cuticular hydrocarbons; chemical mimicry; cleptoparasitism; Eumeninae; balancing selection (1)
chemical communication, ecosystem service, host finding, Hymenoptera, insecticides, natural enemies, non-target species, olfaction, Pteromalidae, sexual communication, sublethal effects, wing fannin (1)
Chemical communication Scolytinae Bark beetles Invasive species GC/MS Climate (1)
; chemical composition; EDX; caries prevention (1)
CHEMICAL-CONSTITUENTS; STRUCTURE ELUCIDATION; MANGOSTANA; Garcinia schomburgkiana; Guttiferae; 6-O-Demethyloliverixanthone; Schomburgxanthone; Xanthones; Cytotoxicity (1)
CHEMICAL GARDENS; CALCIUM-CARBONATE; GROWTH; TUBES; kinetics; self-assembly; silica gardens; X-ray absorption spectroscopy; X-ray diffraction (1)
CHEMICAL GARDENS; SILICA GARDEN; PRECIPITATION; GROWTH; MECHANISM; SYSTEM; TUBES; RAMAN; CRYSTALLIZATION; DIFFUSION; calcium carbonate; chemical gardens; electrochemical potential; membranes; prebiotic chemistry (1)
CHEMICAL GARDENS; TUBULAR STRUCTURES; TUBES; GROWTH; SYSTEM; FLOW; (1)
chemical library | diazo compounds | difunctionalization | flow chemistry | photochemistry (1)
CHEMICAL LIBRARY SYNTHESIS; PEPTIDE-SYNTHESIS; ACTIVE ESTERS; SOLID-PHASE; N-HYDROXYSUCCINIMIDE; FUNCTIONAL POLYMERS; PALLADIUM CATALYST; PARALLEL SYNTHESIS; COUPLING REAGENTS; ORGANIC-SYNTHESIS; acylation; metathesis; magnetic nanobeads; polymerization; supported catalyst (1)
CHEMICALLY-MODIFIED GRAPHENE; ROOM-TEMPERATURE; SENSORS; NANOSHEETS; TRANSPORT; NANOCOMPOSITES; TRANSPARENT; PERFORMANCE; REDUCTION; SHEETS; (1)
CHEMICALLY-MODIFIED GRAPHENES; IMPEDIMETRIC APTASENSOR; DNA HYBRIDIZATION; AMPLIFICATION; LABEL; ELECTRODE; PROTEIN; NANOPARTICLES; SPECTROSCOPY; RECOGNITION; Aptamer; Sandwich; Cytochrome c; SEM; Gold-nanoparticles electrochemical impedance spectroscopy (1)
chemical microarrays;combinatorial materials research;conducting polymers;materials;sensors (1)
CHEMICAL MIMICRY; OBLIGATE PREDATOR; HYMENOPTERA; FORMICIDAE; RECOGNITION; COLONIES (1)
Chemical Photocatalysis; Visible Light ; Photoactive Materials; Sustainable Chemistry; Enantioselective Synthesis; Organic synthesis; Photoactive materials; Photokatalyse; Time-resolved spectroscopy (1)
Chemical physics, Electronic and spintronic devices, Electronic devices, Molecular electronics (1)
CHEMICAL-REACTION; MOTION; TAUTOMERIZATION; ISOMERIZATION; (1)
CHEMICAL-REACTION PATHS; DENSITY; DISTORTION; (1)
Chemical reactions Hydrolysis Monomers Peptides and proteins Transition states (1)
Chemical reactions; Ketones; Nitrogen compounds; Reactivity; Substituents (1)
CHEMICAL SENSES; SMELL; SENSITIVITY; DYSFUNCTION; CELLS; ageusia; COVID-19; gustation; smell; taste (1)
CHEMICAL SENSES; TASTE; COVID-19; SMELL; (1)
CHEMICAL SENSORS; DISSOLVED-OXYGEN; TEMPERATURE; TRANSDUCER; ABSORPTION; BIOSENSORS; PROBE; WATER; Oxygen; Irreversible sensing; Sensor materials; Optical sensing; Indigo dyes; Leuco dyes (1)
CHEMICAL SENSOR; TUNABLE COLORS; DYES; photonic crystal; sensor; PDMS; solvent polarity; water sensor (1)
CHEMICAL-SHIFT ANISOTROPY; OP HYDROGEN-BONDS; CENTER-DOT-OP; QUANTITATIVE MEASUREMENT; ORGANOZINC REAGENTS; SCALAR COUPLINGS; LIGANDS; 1,4-ADDITION; RELAXATION; HMBC; (1)
CHEMICAL-SHIFT; CELL-WALL; ORIENTED MACROMOLECULES; SECONDARY STRUCTURE; AMINO-ACID; ASSIGNMENT; PEPTIDES; C-13; SPECTROSCOPY; COMBINATION; (1)
Chemical shift, NMR spectroscopy, optimization, shift prediction, probability, statistics, conformers, BMBR, AUREMOL, chemische Verschiebung, NMR-Spektroskopie, Optimierung, Verschiebungs-Vorhersage, Wahrscheinlichkeit, Statistik, Konformationen (1)
CHEMICAL-SHIFTS; HIGH-RESOLUTION; NMR; PROTEINS; H-1; DENATURATION; SENSITIVITY; DEPENDENCE; LYSOZYME; DYNAMICS (1)
CHEMICAL-SHIFT; STAPHYLOCOCCUS-CARNOSUS; (BETA/ALPHA)(8) BARREL; HISTIDINE BIOSYNTHESIS; PROTEIN INTERACTIONS; STRUCTURAL EVIDENCE; BIENZYME COMPLEX; ASSIGNMENT; EVOLUTION; CAVITIES; ImGP-synthase; HisF; Thermotoga maritime; NMR spectroscopy; substrate channeling; NH3; xenon (1)
CHEMICAL-SHIFT TENSOR; SOLID-STATE NMR; ACID N-OXIDE; HYDROGEN-BOND; THEORETICAL INTERPRETATION; PHOSPHINE OXIDES; PHOSPHORIC-ACIDS; BASIS-SETS; AB-INITIO; COMPLEXES; (1)
CHEMICAL-SHIFT TENSOR; WASTE-WATER; HEAVY-METAL; AQUEOUS-SOLUTIONS; SBA-15 SILICA; STATE NMR; REMOVAL; ACID; ADSORPTION; GEL; Ionic interaction; ssNMR; sol-gel synthesis; Hybrid material; Metal uptake (1)
CHEMICAL-STRUCTURE; ATOM; atomic force microscopy; molecular electronics; radicals; scanning tunneling microscopy; single-molecule studies (1)
CHEMICAL-STRUCTURE; RESOLUTION; MOLECULES; STEPS; (1)
Chemical synthesis, Hydrocarbons, Organic reactions, Organic synthesis, Pharmaceuticals (1)
CHEMICAL-VAPOR-DEPOSITION; A-PLANE GAN; EPITAXIAL LATERAL OVERGROWTH; SELECTIVE-AREA GROWTH; BULK INGAN FILMS; QUANTUM-WELLS; EMITTING-DIODES; PIEZOELECTRIC FIELDS; SIDE FACETS; NONPOLAR; InGaN; light-emitting devices; quantum wells; III-V semiconductors (1)
CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS; MOLYBDENUM-DISULFIDE; MOS2 TRANSISTORS; GROWTH; GRAPHENE; PHASE; OPTOELECTRONICS; ELECTRONICS; TRANSITION; anisotropic; band gaps; black arsenic; black phosphorus; infrared semiconductors; layered materials (1)
CHEMICAL-VAPOR-DEPOSITION; SPINTRONICS; COPPER; (1)
CHEMICAL WARFARE AGENTS; FLUORESCENT CHEMOSENSOR; SUPRAMOLECULAR GELS; PROTON-TRANSFER; ION DETECTION; THIOUREA; RECEPTOR; BINDING; ENERGIES; EMISSION; fluoride; anion recognition; sensor; N,N '-disubstituted urea; charge-transfer complex; association constant; absorption spectroscopy; fluorescence spectroscopy (1)
Chemical warfare agents; Micro liquid chromatography; High-resolution tandem-mass spectrometry; Human skin (1)
Chemie, Disziplingeschichte, Sozialgeschichte; Universitäten: Greifswald, Halle, Göttingen, Jena; XVIII Jh. (1)
Chemie, Elektrochemie, Instrumentelle Analytik, SECM, Rastersondentechniken (1)
Chemie , Fluorimetrie , fluorimetrisch , G-Protein-gekoppelter Rezeptor , Assay , Wirkstoff , Test , fluorimetric , G Protein-coupled receptor , assay (1)
CHEMILUMINESCENCE MICROSCOPY; LUMINESCENCE; BIOSENSOR; ENZYMES; ACID; VISUALIZATION; SPECTROSCOPY; NANOPARTICLE; IMMUNOASSAY; DIAGNOSTICS; glucose oxidase; enzyme imaging; fluorescent probe; time-resolved imaging; enzyme activity assay (1)
Chemiluminescence, Point-of-Care Diagnostics, Liposomes (1)
Chemische Kommunikation , Hautflügler , Rasterelektronenmikoskopie , Bienenwolf , Goldwespen , Sexuelle Selektion , Kutikula , Sexuallockstoff , Postpharynxdrüse , sex-pheromone , postpharyngeal gland , chemical mimicry , chemical insignificance , mating system , Philanthus , Crabronidae , Hedychrum , Chrysididae (1)
Chemische Laboratorien; Organisation der Forschung; Semiotik des Laboratoriumsbaues (1)
chemische Sensoren, leitfähige Polymere, Graphen, elektrochemische Transistoren, Chemoresistoren (1)
Chemische Synthese, Stereoselektive Synthese, Organische Synthese, Asymmetrische Synthese, Stemoamid, Lacton, Naturstoffsynthese, stemoamide, lactone, natural product synthesis (1)
CHEMISTRY; (1)
CHEMISTRY; ANTAGONISTS; AFFINITY; (1)
CHEMISTRY; MOLECULES; GUESTS; CONTAINERS; COMPLEXES; POLYMERS; DESIGN; copper; Cp ligands; phosphorus; self-assembly; supramolecular chemistry (1)
CHEMISTRY; molybdenum; silver; dithio-ligands; clusters; crystal structures (1)
Chemistry, Pharmaceutical Germany (1)
CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; CHEMOKINE RECEPTORS; ADIPOSE-TISSUE; HEPATIC STEATOSIS; EXPRESSION; MICE; DISEASE; MECHANISMS; INHIBITION; CC-chemokines; CC-chemokine receptors; Obesity (1)
chemodivergent • continuous flow • Heck reaction •photoredox catalysis • Ritter carboamidation (1)
Chemokine, Aszites, Leberzirrhose, Peritonitis, MIP-1beta (1)
CHEMOKINE RECEPTOR 2; MICROVASCULAR ENDOTHELIAL-CELLS; COLLAGEN-INDUCED ARTHRITIS; MULTIPLE-SCLEROSIS; BACTERIAL-INFECTION; BONE-MARROW; CHEMOATTRACTANT PROTEIN-1; ENCEPHALOMYELITIS EAE; BRAIN MICROVESSELS; RAT-BRAIN; autoimmune encephalitis; chemokines; monocytes; multiple sclerosis (1)
CHEMOKINE RECEPTOR CXCR3; LYMPHOCYTE-FIBROBLAST INTERACTIONS; HUMAN KIDNEY-DISEASES; T-CELLS; DIFFERENTIAL EXPRESSION; MESANGIAL CELLS; GENE-EXPRESSION; PROLIFERATIVE GLOMERULONEPHRITIS; TRANSPLANT REJECTION; INDUCIBLE PROTEIN-10; (1)
CHEMOKINE RECEPTOR EXPRESSION; ADHESION MOLECULE-1; EPITHELIAL-CELLS; HUMAN KIDNEY; PROLIFERATION; MIGRATION; ORIGIN; CHEMOATTRACTANT; VASCULATURE; SLC/CCL21; anti-Thy1; 1 glomerulonephritis; kidney development; mesangiolysis; podocytes (1)
CHEMOKINE RECEPTOR EXPRESSION; IN-VIVO; CUTTING EDGE; TH1 CELLS; LEUKOCYTE TRAFFICKING; T-HELPER-2 CELLS; UP-REGULATION; T-CELLS; MIGRATION; RECRUITMENT; chemokines; chemokine receptor; cell trafficking; inflammation (1)
Chemokine , Rezeptor , Immunisierung , Ovalbumin , Immunreaktion , Autoaggressionskrankheit , T-Lymphozyt , Durchflusscytometrie , Genexpression , CC-Chemokinrezeptor (CCR) 6 , Th17 Zellen , Antigenspezifität , Experimentelle Autoimmune Enzephalomyelitis (EAE) , Multiple Sklerose , CC-chemokine receptor (CCR) 6 , Th17 cells , antigen specificity , experimental autoimmune encephalomyelitis (EAE) , multiple sklerosis (1)
chemokines, otitis media, nontypeable Haemophilus influenzae, innate immunity, nasopharyngeal culture, mucosal flora (1)
CHEMOMETRIC ANALYSIS; SEPARATION DATA; ALIGNMENT; COMPONENTS; EXTRACTS; Alignment; Data mining; GC x GC-TOFMS; Metabolic fingerprinting; Metabolomics; Spike-in experiment (1)
chemoprophylaxis | COVID-19 | imported cases | infectious disease | malaria (1)
chemoreception; contact sex pheromone; cuticular hydrocarbons; Lariophagus distinguendus; 3-methylheptacosane; parasitic wasp; Pteromalidae (1)
CHEMOSYSTEMATIC MARKERS; CICHORIEAE; ASTERACEAE; PHENOLICS; Crepis; C; foetida; C; rubra; GC-MS; Volatile constituents (1)
CHEMOTAXIS; ACTIVATION; Angiogenesis; Beta-carotene; Chemotaxis; Microarray (1)
; Chemotaxis; FMLP; IL-8; neutrophils; PMNs (1)
chemotaxis | LOX‐1 | neutrophils | oral immunity | scanning electron microscopy (SEM) | surface epitopes (1)
Chemotaxis , Methyl-akzeptierende Chemotaxis-Proteine , Motilität , Symbiose , Sensor , Genexpression , Rhizobium meliloti , Chemorezeptor , , chemotaxis , methyl-accepting chemotaxis proteins , motility , symbiosis (1)
Chemotaxis , NMR-Spektroskopie , Bodenbakterien , Rhizobium meliloti , Signaltransduktion , CheY2 , Protein , Lösungsstruktur , Sinorhizobium meliloti , chemotaxis , response regulator , signal transduction , Sinorhizobium meliloti (1)
Chemotaxis , Polypeptidketten bindende Proteine , Geißel <Biologie> , Molekularer Motor , Rhizobium meliloti , Sinorhizobium , FliK , Sinorhizobium , chaperone , hook (1)
Chemotaxis , Real time quantitative PCR , Fibrosarkom , B-Lymphozyt , Defensine , Immunreaktion , Chemokine , Rezeptor , Maus , Mensch , Genregulation , Beta-Defensin , antimikrobielle Peptide , Chemokin-Rezeptor , Reportergen-Analyse , antibakterieller Assay , beta-defensin , antimicrobial peptide , chemokine-receptor , reporter-gene analysis , antibacterial assay (1)
CHEMOTAXIS SIGNAL-TRANSDUCTION; PROTEIN SECONDARY STRUCTURE; CHEMICAL-SHIFT INDEX; FIXJ RECEIVER DOMAIN; BACTERIAL CHEMOTAXIS; RHIZOBIUM-MELILOTI; SINORHIZOBIUM-MELILOTI; NMR-SPECTROSCOPY; ESCHERICHIA-COLI; ACTIVATED CHEY; chemotaxis; domain interaction; NMR structure; response regulator; retro-phosphorylation (1)
CHEMOTHERAPY (1)
CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; HEPATIC COLORECTAL METASTASES; ARTERIAL INFUSION; RESECTION; SURGERY; CANCER; HEPATECTOMY; TRIAL; RECURRENCE; SURVIVAL; (1)
CHEMOTHERAPY; CHILDHOOD (1)
CHEMOTHERAPY FOLLOWING CYSTECTOMY; TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; TRANSURETHRAL RESECTION; SURVIVAL; SPECIMENS; RECURRENCE; BIOMARKERS; bladder cancer; urothelial carcinoma; lymphovascular invasion; lymphatic metastasis; prognosis; survival (1)
CHEMOTHERAPY; HCC; HCC; Liver cancer; Prognostic; Signature; Gene set; Bioinformatics; Transcriptome; Profiling; Random; Swarm intelligence; Microarray; RNA Seq (1)
CHEMOTHERAPY-INDUCED AMENORRHEA; MENOPAUSAL TRANSITION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ADJUVANT THERAPY; BONE LOSS; TAMOXIFEN; LETROZOLE; HORMONE; YOUNGER; Adjuvant therapy; Aromatase inhibitors; Breast cancer; Menopause; Perimenopause; Tamoxifen (1)
CHEMOTHERAPY-INDUCED NAUSEA; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; IMAGING RESPONSE; CHOLANGIOCARCINOMA; THERAPY; MANAGEMENT; DIAGNOSIS; Chemoembolization, Therapeutic; Cholangiocarcinoma; Clinical Trial; Microspheres (1)
CHEMOTHERAPY; MORTALITY; BENEFIT; Data collection; Colonic neoplasms; Quality assurance, health care; Health care evaluation mechanisms; Health services research (1)
; Chenopodium; Amaranthaceae; 6-Methoxykaempferol; Gomphrenol (1)
CHENOPODIUM-RUBRUM; YEAST INVERTASE; EXPRESSION; PURIFICATION; SUGAR; TRANSPORTER; INDUCTION; GLUCOSE; PROTEIN; LEAVES; invertase isoenzymes; pH-optimum; substrate specificity; site directed mutagenesis (1)
CHEST TRAUMA; FLAIL CHEST; MORTALITY; BLUNT; EPIDEMIOLOGY; VENTILATION; REGISTRY; SCORE; Multiple trauma patient; Thoracic trauma; Severely injured patient; TraumaRegister; Polytrauma; Major Trauma (1)
CHEST TUBE; RECURRENCE; MANAGEMENT; DRAINAGE; pneumothorax; primary spontaneous pneumothorax; recurrence; recurrence-free time; risk factors (1)
CHEST-WALL; SURGICAL-TREATMENT; TUMORS; ROTATIONPLASTY; chondrosarcoma; osteosarcoma; limb salvage; parascapular flap; rotation plasty (1)
C-heteroatom bonds • Cyanoarenes • Nickel • Photocatalysts • Red light (1)
CHEVRON OSTEOTOMY; VALGUS; COMPLEX; BONES; sesamoid bones; arterial supply; plastination; first plantar metatarsal artery (1)
Chewing gum · Essential oil · Plaque accumulation · Gingivitis · Orthodontic treatment (1)
; chewing gums; cognition; attention; memory (1)
CHEYNE-STOKES RESPIRATION; ADAPTIVE SERVOVENTILATION; NATRIURETIC PEPTIDE; VENTILATORY RESPONSES; COMPLEX; DYSFUNCTION; Adaptive servoventilation; Central sleep apnoea; Complex sleep apnoea; Brain natriuretic peptide (1)
CHEYNE-STOKES RESPIRATION; AMBULATORY PATIENTS; CHEMOSENSITIVITY; EFFICIENCY; POLYSOMNOGRAPHY; PATHOGENESIS; IMPAIRMENT; TOLERANCE; PRESSURE; IMPACT; heart failure; sleep; exercise; ventilation (1)
CHEYNE-STOKES RESPIRATION; APNEA; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; MORTALITY; UPDATE; ASSOCIATION; DYSFUNCTION; GUIDELINES; heart failure; phenotypes; sleep apnea; sleep disorders (1)
CHEYNE-STOKES RESPIRATION; CARBON-DIOXIDE; WEDGE PRESSURE; OXYGEN; EXERCISE; central sleep apnea; heart failure; treatment; ventilation (1)
CHEYNE-STOKES RESPIRATION; CARBON-DIOXIDE; WEDGE PRESSURE; VENTILATION; BLOOD; cardiology; central sleep apnea; ventilation (1)
CHEYNE-STOKES RESPIRATION; CENTRAL SLEEP-APNEA; CARDIORESPIRATORY REFLEX CONTROL; SYMPATHETIC ACTIVITY; PROGNOSTIC VALUE; CARBON-DIOXIDE; WEDGE PRESSURE; VE/VCO2 SLOPE; OXYGEN; CHEMOSENSITIVITY; continuous positive airway pressure; exercise; heart failure; oxygen; sleep apnea; ventilation (1)
CHEYNE-STOKES RESPIRATION; CHRONIC HEART-FAILURE; TRICUSPID REGURGITATION; DEVICE; APNEALINK(TM); PATHOGENESIS; PREVALENCE; VALIDATION; PREDICTORS; Sleep apnoea; Sleep-disordered breathing; Cheyne-Stokes respiration; Mitral regurgitation; Transcatheter mitral valve repair; Edge-to-edge mitral valve repair (1)
CHEYNE-STOKES RESPIRATION; NASAL CPAP; TRIAL; CARVEDILOL; MORTALITY; SURVIVAL; (1)
CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; FAILURE PATIENTS; PROGNOSTIC IMPACT; AUTO-SERVOVENTILATION; PRACTICE PARAMETERS; EUROPEAN-SOCIETY; PREVALENCE; MORTALITY; DIAGNOSIS; Adaptive servo-ventilation; Sleep-disordered breathing; Heart failure; Central sleep apnea; Preserved ejection fraction; Sleep fragmentation (1)
CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; HEALTHY-VOLUNTEERS; APNEA; SUPPRESSION; PERFORMANCE; VENTILATION; MORTALITY; THERAPY; HYPOXIA; SERVE-HF; Sleep apnea; Adaptive servoventilation; Arrhythmias; Heart failure (1)
CHEYNE-STOKES RESPIRATION; RISK; apnea, sleep; heart failure; respiration; sleep; survival; trials (1)
CHEYNE-STOKES RESPIRATION; SYMPATHETIC-NERVE ACTIVITY; RATE-VARIABILITY; SERVOVENTILATION THERAPY; BLOOD-PRESSURE; ACTIVATION; COMPONENTS; FRIEND; HF; Central sleep apnoea; Automatic continuous positive airway pressure; Adaptive servoventilation; Heart failure; Sympathovagal balance (1)
CHEYNE-STOKES RESPIRATION; VENTRICULAR DYSFUNCTION; EJECTION FRACTION; PROGNOSTIC IMPACT; SYSTOLIC FUNCTION; APNEA; MORTALITY; DIAGNOSIS; EPIDEMIOLOGY; VENTILATION; Registry; Prevalence; Heart failure; Sleep-disordered breathing; Obstructive sleep apnea; Central sleep apnea; Cheyne-Stokes respiration; Predictors (1)
C-H FUNCTIONALIZATION; ARYL; PHOTOREDOX; CATALYSIS; ELECTROPHILES; ACIDS; (1)
C-H FUNCTIONALIZATION; ELECTRON-RICH HETEROCYCLES; PHOTOREDOX CATALYSIS; ENANTIOSELECTIVE SYNTHESIS; INDOLES; ALKALOIDS; (-)-LEUCONOXINE; HETEROARENES; ALKYLATION; ACTIVATION; C-H functionalization; indoles; indolones; photoredox catalysis; visible light (1)
C-H FUNCTIONALIZATION; HYDROGEN-ATOM TRANSFER; CARBON BOND FORMATION; HALIDES; PHOTOCATALYSIS; REAGENTS; ARYL; cross-coupling; alkyl bromides; dual catalysis; visible-light; nickel; ethers (1)
C-H FUNCTIONALIZATION; TITANIUM-DIOXIDE NANOMATERIALS; PHOTOINDUCED ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; SEMICONDUCTOR PHOTOCATALYSIS; CADMIUM-SULFIDE; BOND FORMATION; WATER; CYCLOADDITIONS; alkylation; organocatalysis; photocatalysis; semiconductors; visible light (1)
CHICK CHORIOALLANTOIC MEMBRANE; ANGIOGENESIS; SURVIVAL; OUTCOMES; SARCOMA; EMBRYO; MODEL; Osteosarcoma; sarcoma; cancer; tumor heterogeneity; intratumoral heterogeneity; CAM model; 3D-in-vivo-tumor-model (1)
CHICK CHORIOALLANTOIC MEMBRANE; CAM ASSAY; CANCER; ANGIOSARCOMA; CELLS; EXPRESSION; INVASION; OUTCOMES; GROWTH; 3D in vivo tumor model; chorioallantoic membrane (CAM); angiogenesis; tumor; laser speckle contrast imaging; image analysis software; CAM assay application; artificial intelligence; deep learning; blood circulation (1)
CHICK CHORIOALLANTOIC MEMBRANE; MICROCIRCULATION; TISSUE (1)
CHIIR 2021 Workshop; conversational search research (1)
CHIKUNGUNYA; VARIABILITY; ANOPHELES; EPIDEMIC; DEET; repellent; Aedes aegypti; essential oils; olfactory; hedonic property; Laurus nobilis (1)
CHIKUNGUNYA VIRUS-INFECTION; FARNESOID X RECEPTOR; SALT BIOTRANSFORMATIONS; MONOCLONAL-ANTIBODY; INNATE IMMUNITY; MICE; CELLS; REPLICATION; INTERFERONS; INFLUENZA; (1)
child abuse, alexithymia, psychopathology, TAS-20, CTQ, SCL-90, BSI (1)
CHILD-CARE AVAILABILITY; EASTERN-EUROPE; GENDER EQUITY; FAMILY-SIZE; INTENTIONS; WOMEN; BEHAVIOR; POLICY; PERCEPTIONS; TRANSITION; children; factorial survey; fertility attitudes; gender roles; housework; ideal number of children; income; vignettes; youth (1)
child-father attachment; secure base function; save haven function; behavioral systems; desiderata for future research on child-father attachment (1)
child; glioblastoma; HDAC; valproic acid (1)
CHILDHOOD; ALS; Pathophysiology; Molecular genetic diagnostics; Protein homeostasis; Disease-modifying treatment; Tofersen (1)
CHILDHOOD AMNESIA; NARRATIVE IDENTITY; SELF; RECOLLECTION; CHILDREN; SPAN; autobiographical memory; earliest autobiographical memories; early memory; life story; meaning-making (1)
CHILDHOOD ASTHMA; RESPIRATORY-INFECTIONS; ONSET ASTHMA; 1ST YEAR; EXPOSURE; ALLERGY; ATOPY; LIFE; ASSOCIATION; EXPRESSION; childhood asthma; epidemiology; farming; infant wheeze; 17q21 locus (1)
CHILDHOOD ATOPIC-DERMATITIS; ALLERGIC RHINITIS; PSYCHOMETRIC PROPERTIES; PREVALENCE; DISEASE; TRENDS; KIGGS; QUESTIONNAIRE; INTERVIEW; BURDEN; Quality of life; Eczema; Hay fever; Asthma; Children; Adolescents (1)
CHILDHOOD BLINDNESS; VISUAL IMPAIRMENT; CHILDREN; MICROPHTHALMOS; STUDENTS; (1)
CHILDHOOD; BURDEN; CHILDREN; pediatric asthma; uncontrolled asthma; omics; systems medicine (1)
CHILDHOOD-CANCER; NEUROBLASTOMA; COMPLICATIONS; CHILDRENS; Childhood cancer; Ototoxicity; Swiss Childhood Cancer Survivor Study; Swiss Childhood Cancer Registry; Late effects; Cancer treatment (1)
CHILDHOOD-CANCER SURVIVOR; RADIATION-THERAPY; ONCOLOGY GROUP; RADIOTHERAPY; RISK; ASSOCIATION; CARCINOMA; PROJECT; (1)
CHILDHOOD CRANIOPHARYNGIOMA; COGNITIVE PERFORMANCE; HYPOTHALAMIC DAMAGE; SURGERY; OBESITY; RISK; STRATEGIES; EXPERIENCE; MANAGEMENT; SURVIVORS; (1)
CHILDHOOD; CRITERIA; RISK; MRI; CNS; (1)
CHILDHOOD MALTREATMENT; PSYCHIATRIC-DISORDERS; MATERNAL-DEPRIVATION; BRAIN-DEVELOPMENT; PROCEDURAL PAIN; PRETERM; CHILDREN; DEPRESSION; BIRTH; AGE; Early life stress; DNA methylation; Behaviour; Hypothalamus; Brain development; Preterm birth (1)
CHILDHOOD OBESITY; AGE ESTIMATION; DIFFERENTIATION; CELLS; DEMIRJIAN; MATURITY; ERUPTION; GROWTH; Craniofacial growthm dental development; Skeletal maturation; Genetic variation; WNT; RUNX2 (1)
CHILDHOOD OVERWEIGHT; OVARIAN-CANCER; RISK; ESTROGEN; WOMEN; METAANALYSIS; PREVENTION; LACTATION; COUNTRIES; PATTERNS; Breast feeding; Health; Cancer; Breast; Hormones; Primary prevention; Europe (1)
CHILDHOOD TRAUMA; HPA AXIS; STRESS; VULNERABILITY; NEGLECT; major depressive disorder; child maltreatment; sexual abuse; neuroimaging markers; trauma (1)
CHILDHOOD TRAUMA; MENTAL-ILLNESS; SOCIAL SUPPORT; STRESS; PSYCHOLOGY; ANXIETY; WOMEN; EXPERIENCE; MODERATOR; RECOVERY; depression; self-esteem; life events; mediation (1)
Child, Hypertension (portal), Radiology (interventional), Portosystemic shunt (surgical), Tomography (xray computed) (1)
CHILD MALTREATMENT; RISK-FACTORS; YOUTH; INTERNET; ADOLESCENTS; VICTIMIZATION; WEB; CONSEQUENCES; PREVALENCE; STRATEGIES; Online sexual solicitation; Sexual victimization; Child sexual abuse; Intentional sexual experience; Online sexual behavior; Adolescent (1)
CHILD MOLESTERS; OFFENDERS; AROUSAL; PROBABILITY; INFORMATION; RECIDIVISM; PATTERNS; STROOP; TASK; self-report; sexual interest; pedophilia; viewing time; adult (1)
CHILD PORNOGRAPHY OFFENSES; PEDOPHILIA; MATURATION; hebephilia; paedophilia; child sexual abuse; prevention; DSM-5 (1)
CHILDREN (3)
CHILDREN; (2)
CHILDREN; ADOLESCENTS; aggression; family therapy; youth (1)
CHILDREN; CARCINOMA; MALIGNANCIES; CANCER; rectal carcinoma; child; second malignant neoplasm (1)
CHILDREN; CARE; general anesthesia; pediatric dentistry; children; risk factors (1)
CHILDREN; CASSETTE; STRAINS; SKIN; (1)
CHILDREN; MEDICATIONS; METHYLPHENIDATE; ADHD; hyperkinetic disorders; ADHD; child and adolescent psychiatry; KinderAGATE; pharmacoepidemiology (1)
CHILDREN; OVERWEIGHT; PERFORMANCE; Obesity; Mental rotation; Object-based transformations; Egocentric transformations (1)
CHILDREN; play therapy; child in hospital; therapeutic play (1)
CHILDREN; PREVALENCE; Tinnitus; Childhood; Adolescence (1)
children; primary tooth; genes (1)
Children; Rare diseases; Cutaneous papules; Plaques; Histology (1)
CHILDRENS CANCER GROUP; PRIMITIVE NEUROECTODERMAL TUMORS; PROSPECTIVE RANDOMIZED-TRIAL; RECURRENT MEDULLOBLASTOMA; ADJUVANT CHEMOTHERAPY; INTERNATIONAL SOCIETY; RADIATION-THERAPY; RADIOTHERAPY; VINCRISTINE; CHILDHOOD; adult; medulloblastoma; radiotherapy; chemotherapy; primitive neuroectodermal tumor; secondline therapy (1)
CHILDRENS CANCER GROUP; PROGNOSTIC-FACTORS; TUMORS SPNET; CHEMOTHERAPY; MEDULLOBLASTOMA; PINEALOBLASTOMA; RADIOTHERAPY; MULTICENTER; RADIATION; TRIAL; Brain tumor; Primitive neuroectodermal tumor (PNET); Pineoblastoma; Adults; Radiotherapy; Chemotherapy (1)
CHILDRENS PICTURE BOOKS; SEX-DIFFERENCES; META-ANALYSIS; COGNITIVE-PROCESSES; UNITED-STATES; WOMEN; SCIENCE; MEN; MATHEMATICS; BELIEFS; (1)
; Children; Splenic rupture; Image enhancement; Ultrasound; Contrast-enhanced ultrasound (1)
CHILDREN; STRABISMUS; AMBLYOPIA; RETINOPATHY; PREVALENCE; low gestational age; low birth weight; prematurity; retinopathy of prematurity; ophthalmic care (1)
CHILDREN; Suicide; Therapeutic drug monitoring; Medication; Quetiapine; Depression (1)
CHILDREN; tachycardia; atrial; Ivabradine; beta-blocker; children; case report (1)
CHILD SEXUAL-ABUSE; OFFENDERS; PARAPHILIAS; PREVENTION; BEHAVIOR; MEN; Pedophilia; Sexual deviance; Paraphilia; Child sexual abuse; Diagnosis (1)
CHIMERIC ANTIGEN RECEPTOR; ADOPTIVE IMMUNOTHERAPY; THERAPY; Chimeric antigen receptor; GMP manufacturing of CAR T cells; CD4/CD8 selection; Telomere length; Cytotoxicity (1)
CHIMERIC ANTIGEN RECEPTOR; ANTITUMOR-ACTIVITY; EFFICACY; LYMPHODEPLETION; IMMUNOTHERAPY; COMBINATION; PERSISTENCE; INHIBITION; EXPANSION; IBRUTINIB; drugs; immunotherapy; pharmaceuticals; microenvironment; combination (1)
CHIMERIC ANTIGEN RECEPTOR; B-CELLS; THERAPY; IMMUNOTHERAPY; ACTIVATION; CD19; LEUKEMIA; GLIOBLASTOMA; EXPRESSION; ANTIBODIES; (1)
CHIMERIC ANTIGEN RECEPTOR; DEPENDENT CELLULAR CYTOTOXICITY; HERCEPTIN-RESISTANT; IMMUNOTHERAPY; TRAFFICKING; XENOGRAFTS; ACTIVATION; PERTUZUMAB; JIMT-1; Breast cancer; HER2; Trastuzumab; Chimeric antigen receptor; Immunotherapy; Cell therapy; Tumor microenvironment; Extracellular matrix (1)
CHIMERIC ANTIGEN RECEPTOR; MELANOMA-ASSOCIATED ANTIGEN; GENE-EXPRESSION; MESSENGER-RNA; TUMORS; TRANSFECT; PERICYTES; DOMAIN; oncology; immunotherapy; antigen; SKOV-3; CAR-T cells; CSPG4; decitabine; ovarian cancer (1)
CHIMERIC ANTIGEN RECEPTOR; NATURAL-KILLER-CELLS; T-CELLS; TRANSGENE EXPRESSION; CANCER; ACTIVATION; IMMUNOTHERAPY; HETEROGENEITY; REMISSIONS; LIGAND; immunotherapy; NK cells; chimeric antigen receptor (CAR); tumor microenvironment; immunomodulatory cytokines; alpharetroviral vectors; "all-in-one" TRUCK; NF kappa B (1)
CHIMERIC ANTIGEN RECEPTORS; CANCER; COSTIMULATION; GENERATION; CYTOKINE; PROTEIN; TRUCKS; CAR T-cells; TRUCK; inducible; negative feedback (1)
Chimeric Antigen Receptors, CAR T cells, Synthetic Receptors, Switch Receptors Inflammation Autoimmunity (1)
CHIMERIC ANTIGEN RECEPTORS; EXTRACELLULAR SPACER DOMAIN; ANTIBODY; THERAPY; INTERLEUKIN-12; MOLECULES; AFFINITY; ACTIVATION; GENERATION; RITUXIMAB; CD8-positive t-lymphocytes; cell engineering; immunotherapy; receptors; chimeric antigen; transplantation immunology (1)
CHIMERIC ANTIGEN RECEPTORS; MEMBRANE ANTIGEN; IN-VITRO; EXPRESSION; GENOME; TARGET; IMMUNOTOXIN; ACTIVATION; DIAGNOSIS; THERAPY; (1)
CHIMERIC ANTIGEN RECEPTORS; SINGLE-CHAIN ANTIBODY; GENETIC-MODIFICATION; CD28 COSTIMULATION; STROMAL CELLS; SPACER DOMAIN; DELIVERY; THERAPY; ACTIVATION; TRAIL; CAR T cells; MSC; adoptive cell therapy; genetic immunotherapy; IL7; IL12 (1)
CHIMERIC ANTIGEN RECEPTORS; T-CELL THERAPY; ANTITUMOR-ACTIVITY; IMMUNOTHERAPY; REMISSIONS; CANCER; INTERLEUKIN-12; NFAT; glioblastoma; "all-in-one" lentiviral vector; TRUCK; G(D2)CAR; NFAT; inducible cytokines; IL12; IL18 (1)
CHIMERIC ANTIGEN RECEPTOR; VERSUS-HOST-DISEASE; ADOPTIVE TRANSFER; IN-VITRO; TRANSPLANTATION; BLOOD; EXPANSION; ALLOGRAFT; TOLERANCE; THERAPIES; minimum information model; T regulatory cells; immunotherapy; good manufacturing practice; cell therapy; immune tolerance (1)
CHINESE CHILDREN; LITERACY; LANGUAGE; COMPREHENSION; SKILL; BOOK; METAANALYSIS; EXPERIENCE; KNOWLEDGE; CONTEXT; Language development; reading; reading comprehension; story telling; vocabulary (1)
Chinese culture, Chinese market, feng shui, guanxi (1)
CHINESE-HAMSTER CELLS; TISSUE-TOLERABLE PLASMA; RANDOMIZED CONTROLLED-TRIAL; ETHYL METHANESULFONATE; ELECTROMAGNETIC-FIELDS; ULTRAVIOLET-RADIATION; MOLECULAR DOSIMETRY; LIMITING EXPOSURE; ESCHERICHIA-COLI; CHRONIC WOUNDS; Cold atmospheric plasma; Mutagenicity; Hprt; V79 cells; Bacteria; Plasma medicine (1)
CHINESE MEDICINE ACUPUNCTURISTS; CLINICAL-TRIAL; MULTICENTER; MIGRAINE; (1)
C-H INSERTION; PROTEASE INHIBITORS; CONJUGATE ADDITION; ALDOL REACTIONS; HIV PROTEASE; ONE-POT; MALEIMIDES; ANALOGS; (1)
CHIP-CHIP DATA; HUMAN B-CELLS; C-MYC; GENE ANALYSIS; TRANSCRIPTION; TUMORIGENESIS; RECRUITMENT; ACTIVATION; CANCER; IDENTIFICATION; (1)
CHIP PLATFORMS; SURFACTANTS; ELECTRODE; DEVICES; SYSTEM; NANOPARTICLES; ADSORPTION; TRAP; (1)
chiral amplification, circular dichroism, helical polymers, ladder polymers (1)
CHIRAL-AT-METAL; CRYSTAL-STRUCTURE; CONFIGURATION; EXCHANGE; (1)
CHIRAL-AT-METAL; CRYSTAL-STRUCTURES; IRON COMPLEXES; ARENE CATIONS; ACETONITRILE; REACTIVITY; CHEMISTRY; EXCHANGE; ATOMS; (1)
CHIRAL COBALT(III) COMPLEXES; INDUCED CASCADE REACTION; ASYMMETRIC-SYNTHESIS; 9-AMINO(9-DEOXY)CINCHONA ALKALOIDS; NAPROXEN DERIVATIVES; BETA-KETOESTERS; MALONIC-ACIDS; CATALYSIS; PROTONATION; COPPER(I); amino acids; asymmetric catalysis; enantioselective decarboxylation; alkaloids; amides (1)
CHIRAL DISCRIMINATION; GOLD ELECTRODES; ADSORPTION; enantioselective artificial receptors; spreader-bar technique; capacitive chemosensor; surface plasmon resonance (1)
CHIRAL FERMIONS; SQUARE-ROOT; LATTICE; EQUATION; SYMMETRY; overlap Dirac operator; quark chemical potential; sign function; non-Hermitian matrix; iterative methods (1)
CHIRAL GAUGE-THEORIES; DIRAC OPERATOR; SIGN FUNCTION; LATTICE QCD; SYMMETRY; MODEL; EQUATION; (1)
Chiralität <Chemie> , Chaos , Optische Aktivität , Nichtlineare Dynamik , Hamiltonsches System , Hund'sches Paradoxon , Hund's Paradox (1)
Chiralität <Chemie> , Doppelmuldenpotential , Paradoxon , Hund'sches Paradoxon , Hund's Paradox (1)
Chiralität <Chemie> , Elektroschwache Wechselwirkung , Doppelmuldenpotential , Optische Aktivität , Superauswahlregel , Hundsches Paradoxon , chirality , superselectionrule , electroweak interaction , doublewell potential , Hund's paradoxon , optical activity (1)
; chirality; conformation; diastereoselectivity; natural amino acids; pyramidalization (1)
Chiral Lagrangians, Phase Diagram of QCD, Matrix Models, Spontaneous Symmetry Breaking (1)
CHIRAL LIGANDS; STEREOSELECTIVE SYNTHESIS; METAL-COMPLEXES; CATALYSIS; OLEFINS; ACID; (1)
CHIRAL LOGARITHMS; SIGMA-MODEL; EQUATIONS; LOGS; renormalization group; effective field theory; leading logarithm; Landau pole; Dixon elliptic function (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; GAUGE-THEORY; FIXED-POINT; QCD; MATRIX; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; MAXIMUM-ENTROPY METHOD; ROPER RESONANCE; GAUGE-THEORY; FIXED-POINT; QCD; NUCLEON; SPECTROSCOPY; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; PENTAQUARK SEARCHES; GAUGE-THEORY; FIXED-POINT; RESONANCE; SCATTERING; COLLISIONS; STATE; MASS; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; SYMMETRY RESTORATION; NUCLEON SPECTRUM; ROPER RESONANCE; MASS-SPECTRUM; QUENCHED QCD; GAUGE-THEORY; FIXED-POINT; N-ASTERISK; (1)
CHIRAL MAGNETIC-WAVE; ANOMALOUS HYDRODYNAMICS; CHARGED FLUID; TRANSPORT; FIELD; FLOW; (1)
CHIRAL MEMORY; CATIONS; Cations; Inorganic rings; Selenium; Silicon; Structure elucidation (1)
CHIRAL PERTURBATION-THEORY; BARYON MASSES; QCD; Lattice QCD; SU(3) flavour symmetry breaking; Baryon spectrum (1)
CHIRAL PERTURBATION-THEORY; DEEP-INELASTIC SCATTERING; FORM-FACTOR; WILSON FERMIONS; ANTIQUARK ASYMMETRY; SYMMETRY-BREAKING; MATRIX-ELEMENTS; STRANGE SEA; OPERATORS; REPRESENTATIONS; (1)
CHIRAL PERTURBATION-THEORY; DOMAIN-WALL FERMIONS; LATTICE QCD; NONPERTURBATIVE RENORMALIZATION; CHARGE; OPERATORS; CURRENTS; SCALE; MASS; G(A); (1)
CHIRAL PERTURBATION-THEORY; EXPANSION; NUCLEON; MASSES; (1)
CHIRAL PERTURBATION-THEORY; FORM-FACTORS; MASS; (1)
CHIRAL PERTURBATION-THEORY; FORM-FACTORS; SCATTERING; DECAY; MASS; RENORMALIZATION; PRECISION; DYNAMICS; CHARGE; (1)
CHIRAL PERTURBATION-THEORY; GENERALIZED PARTON DISTRIBUTIONS; LIGHT HADRON MASSES; LATTICE QCD; NUCLEON; SYMMETRY; (1)
CHIRAL PERTURBATION-THEORY; GENERALIZED PARTON DISTRIBUTIONS; MATRIX-ELEMENTS; NUCLEON; (1)
chiral perturbation theory, hadron structure, generalized parton distributions, distribution amplitudes (1)
CHIRAL PERTURBATION-THEORY; INCLUDING VECTOR-MESONS; QUANTUM CHROMODYNAMICS; MOMENTUM-TRANSFER; NUCLEON; (1)
CHIRAL PERTURBATION-THEORY; LATTICE GAUGE-THEORY; MONTE-CARLO CALCULATIONS; NONPERTURBATIVE RENORMALIZATION; SYMMETRY BREAKING; PHASE-TRANSITION; HOLOGRAPHIC QCD; HADRON SPECTRUM; VECTOR-MESONS; FINITE-VOLUME; Lattice QCD; AdS-CFT Correspondence; 1/N Expansion (1)
CHIRAL PERTURBATION-THEORY; LATTICE QCD; HADRON SPECTRUM; UNITARY SYMMETRY; DELTA-RESONANCE; DECAY CONSTANTS; LEAST-SQUARES; MASS-SPECTRUM; NUCLEON; IMPROVEMENT; Lattice QCD; Hadronic Spectroscopy; Structure and Interactions; Chiral Lagrangian; Properties of Hadrons (1)
chiral perturbation theory, lattice QCD, mixing, vector mesons, baryon masses, GPDs (1)
CHIRAL PERTURBATION-THEORY; ONE-LOOP; EXPANSION; ORDER; Nucleon mass; Pion-nucleon sigma term; Sommer scale; Covariant baryon chiral perturbation theory; Finite size corrections (1)
CHIRAL PERTURBATION-THEORY; ONE-LOOP; SYMMETRY; QCD; Lattice QCD; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; QCD; SYMMETRY; (1)
CHIRAL PERTURBATION-THEORY; QUARK MASS; NUCLEON; DECAY; RENORMALIZATION; CURRENTS; RUNDEC (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; DIRAC OPERATOR; QCD; Lattice QCD; Chiral Lagrangians; QCD (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; QUARK MASS; DYNAMICAL FERMIONS; MONTE-CARLO; ANOMALOUS DIMENSION; LATTICE QCD; FIXED-POINT; RENORMALIZATION; SYMMETRY; Lattice QCD; QCD; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; SPECTRAL SUM-RULES; FINITE ISOSPIN DENSITY; QCD-LIKE THEORIES; DIRAC OPERATOR; SYMMETRY-BREAKING; BARYON DENSITY; QUARK MATTER; STATISTICS; (1)
CHIRAL PERTURBATION-THEORY; RELATIVISTIC QUARK-MODEL; PI-K SCATTERING; PARTIAL-WAVE AMPLITUDES; TRANSITION FORM-FACTORS; FINAL-STATE INTERACTION; EXOTIC MESON PRODUCTION; TREIMAN-TYPE EQUATIONS; LIGHT-BARYON SPECTRUM; ISOBAR MODEL; Hadron spectroscopy; Exotic hadrons; Three-body scattering; Resonance production (1)
CHIRAL PERTURBATION-THEORY; STRONG-COUPLING-CONSTANT; QUANTUM-FIELD THEORIES; LIGHT-QUARK MASSES; LATTICE GAUGE-THEORIES; RANDOM-MATRIX THEORY; MONTE-CARLO METHODS; QCD DIRAC OPERATOR; PI-PI-SCATTERING; CB-VERTICAL-BAR; (1)
CHIRAL PERTURBATION-THEORY; STRONG-COUPLING-CONSTANT; QUANTUM-FIELD THEORIES; LIGHT-QUARK MASSES; PION-STATE CONTRIBUTION; BROKEN-VERTICAL-BAR; MONTE-CARLO METHODS; NUCLEON SIGMA-TERM; LATTICE QCD; FORM-FACTORS (1)
CHIRAL PERTURBATION-THEORY; TWIST DISTRIBUTION AMPLITUDES; LAMBDA; NUCLEON; DECAY; QCD; Higher Twist Effects; Effective field theories; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; VECTOR-MESONS; FIELD-THEORY; INFRARED REGULARIZATION; FEYNMAN-INTEGRALS; SPIN-1 FIELDS; EVOLUTION; MASS; EQUATIONS; OPERATORS; Lattice field theory simulation; Non-perturbative renormalization (1)
CHIRAL PERTURBATION-THEORY; WILSON FERMIONS; UNITARY SYMMETRY; BARYON MASSES; QCD; IMPROVEMENT; LAMBDA; (1)
CHIRAL PHASE-TRANSITION; HYBRID MONTE-CARLO; NUMERICAL-METHODS; DIRAC OPERATOR; GAUGE-THEORIES; QUANTUM; MASSES; MODEL; (1)
CHIRAL PHASE-TRANSITION; YANG-MILLS GAS; FINITE-TEMPERATURE; DIRAC EIGENVALUES; INSTANTONS; MONOPOLES; SYMMETRY; ENERGY; THERMODYNAMICS; SPECTRUM; (1)
Chiral Phosphoric Acids · Enantioselectivity · Ion Pair Catalysis · NMR · Reaction Mechanism (1)
CHIRAL PHOSPHORUS LIGANDS; BOND COVALENT RADII; TRIDENTATE LIGANDS; TRANSITION-METAL; WHITE PHOSPHORUS; COMPLEXES; CATALYSIS; DESIGN; ALKYL (1)
CHIRAL RECOGNITION; CLAY; MONTMORILLONITE; COMPLEXES; (1)
CHIRAL STATIONARY PHASES; PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID ENANTIOMERS; HPLC-MS METHOD; MASS-SPECTROMETRY; MARFEYS REAGENT; ION-EXCHANGERS; SEPARATION; CINCHONA; ENANTIOSEPARATION; Depsipeptide; Cyclic lipopeptide; Absolute configuration; Chiral separation; Enantioselective chromatography; HPLC; GC; Chiralpak ZWIX; Chirasil L-Val; Amino acids; 3-Hydroxyalkanoic acids (1)
CHIRAL SWITCH; LIQUID-CHROMATOGRAPHY; ASYMMETRIC CATALYSIS; S-METOLACHLOR; LARGE-SCALE; RESOLUTION; PESTICIDE; HYDROGENATION; ENANTIOMERS; METABOLITES; (1)
CHIRAL-SYMMETRY BREAKING; COLOR SUPERCONDUCTIVITY; PHASE-TRANSITION; QUARK MATTER; INSTANTONS; ZERO; (1)
CHIRAL-SYMMETRY-BREAKING; GINSPARG-WILSON FERMIONS; DIRAC OPERATORS; QCD; CONSTRUCTION; HADRONS; MODES; (1)
CHIRAL SYMMETRY-BREAKING; LARGE MOMENTUM-TRANSFER; QUANTUM CHROMODYNAMICS; PROTON; QCD; NEUTRON; BARYONS; (GEV/C)(2); Q(2)=1.75; TRANSFERS; QCD; nucleon; power corrections; distribution amplitudes; electromagnetic form factors (1)
CHIRAL SYMMETRY-BREAKING; LATTICE GAUGE-THEORIES; EQUIVALENCE; Lattice QCD; Lattice Quantum Field Theory (1)
CHIRAL SYMMETRY-BREAKING; LATTICE GAUGE-THEORIES; YANG-MILLS THEORY; EQUIVALENCE; Lattice QCD; Lattice Quantum Field Theory (1)
CHIRAL-SYMMETRY-BREAKING; LATTICE GAUGE-THEORY; TOPOLOGICAL EXCITATIONS; (1)
CHIRAL-SYMMETRY-BREAKING; NONPERTURBATIVE RENORMALIZATION; VACUUM; MOMENTS; FIELD; INVARIANT; EQUATION; CURRENTS; PROTON; SPIN; Lattice QCD; Lattice Quantum Field Theory; Phase Diagram of QCD; Quark- Gluon Plasma (1)
CHIRAL-SYMMETRY-BREAKING; RANDOM-MATRIX THEORY; DYSON-SCHWINGER EQUATIONS; LATTICE GAUGE-THEORY; QCD DIRAC OPERATOR; FINITE-TEMPERATURE; INFRARED BEHAVIOR; CONFINEMENT; SPECTRUM; CONTINUUM; (1)
CHIRAL-SYMMETRY-BREAKING; RANDOM-MATRIX THEORY; SPONTANEOUS PARITY VIOLATION; BOSE-EINSTEIN CONDENSATION; COLOR-FLAVOR-LOCKING; VAFA-WITTEN THEOREM; 2-COLOR QCD; FINITE-TEMPERATURE; SPECTRAL DENSITY; GAUGE-THEORIES; Spontaneous Symmetry Breaking; Lattice Gauge Field Theories; Chiral Lagrangians (1)
CHIRAL-SYMMETRY-BREAKING; TOPOLOGICAL CHARGE; LATTICE; THERMODYNAMICS; COLLISIONS; STRENGTH; VACUUM; GAS; Lattice QCD; Phase Diagram of QCD (1)
CHIRAL-SYMMETRY; CHARACTERISTIC-POLYNOMIALS; DIRAC OPERATOR; LATTICE; MODEL; Matrix Models; Lattice QCD (1)
CHIRAL-SYMMETRY; DIRAC OPERATOR; Matrix Models; Lattice QCD (1)
CHIRAL-SYMMETRY; LATTICE QCD; TOPOLOGY; SPECTRUM; FERMIONS; EQUATION; LIMIT; MODEL; (1)
CHIRAL SYMMETRY; PHOTOPRODUCTION; THRESHOLD; J/PSI; (1)
CHIRAL-SYMMETRY RESTORATION; EXACTLY MASSLESS QUARKS; FINITE-TEMPERATURE; PHASE-TRANSITION; DIRAC OPERATOR; PLANAR LIMIT; GAUGE-THEORY; QCD; INSTANTONS; SPECTRUM; (1)
CHIRAL-SYMMETRY RESTORATION; GINSPARG-WILSON FERMIONS; DIRAC OPERATOR; CHARGE FLUCTUATIONS; INSTANTON LIQUID; ZERO MODES; QCD; CALORONS; CONFINEMENT; EIGENVECTORS; (1)
CHIRAL-SYMMETRY; SIGN-FUNCTION; MATRIX; LATTICE; Overlap Dirac operator; Quark chemical potential; Sign function; Non-Hermitian matrix; Iterative methods (1)
CHIRAL SYMMETRY; SPECTRA; LIMIT; MODEL; (1)
CHIRAL-SYMMETRY; TRANSITION; MODEL; TEMPERATURE; BREAKING; FIELDS; Lattice QCD; Phase Diagram of QCD (1)
Chirurg, Max Lebsche, Leben und Werk (1)
CHITINASE PROTEIN FAMILY; COLONIC EPITHELIAL-CELLS; MACROPHAGE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; BACTERIAL ADHESION; CARTILAGE; DISEASE; GENE; SUSCEPTIBILITY; INFLAMMATION; Liver fibrosis; YKL-40; Gene polymorphisms (1)
chitin, cellulose, dissolution, ionic liquid, deep eutectic solvent, γ-valerolactone, fiber, chitin coating, textile (1)
CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; LOV DOMAINS; SIGNAL-TRANSDUCTION; PLANT CRYPTOCHROME; BLUF DOMAIN; PHOTORECEPTOR PHOTOTROPIN; PHOT-LOV1 DOMAIN; REDOX PROPERTIES; RADICAL PAIR; (1)
Chlamydomonas reinhardtii (LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Phototropins; Role: BSU (Biological study, unclassified), BIOL (Biological study) (LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Protein motifs (LOV1, LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Proteins, Role: BSU (Biological study, unclassified), RCT (Reactant), BIOL (Biological study), RACT (Reactant or reagent) (light oxygen voltage sensitive (LOV) protein domain-contg., LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); LOV1 protein FMN methyl mercaptan adduct cysteine phototropin (1)
CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; PROTEIN; TRANSFORMATION; ORGANIZATION; ACTIVATION; SENESCENCE; PROMOTERS; DATABASE; Volvox carteri; regA; cell-type-specific gene regulation; enhancer; silencer; fruitless (1)
CHLAMYDOMONAS-REINHARDTII; VOLTAGE-DEPENDENCE; LIGHT; PHOTOTAXIS; PHOTORECEPTOR; RHODOPSINS; EYE; BACTERIORHODOPSIN; CHANNEL; (1)
CHLORACETAMIDE; chloroacetamide; preservatives; airborne allergic contact dermatitis; wall paint; patch test; biocides; antimicrobials (1)
Chlorella (symbiosis) - Glucose excretion (Chlorella, symbiosis) - Symbiosis (1)
Chlorella (symbiosis) - Maltose excretion (Chlorella, symbiosis) - Symbiosis (Chlorella-Acanthocystis) - Transport, active (1)
CHLORIDE CHANNEL; ENDOCYTIC TRAFFICKING; RECEPTOR; ACTIVATION; EXPRESSION; CLATHRIN; SURFACE; CFTR; SECRETION; BIOLOGY; secretory traffic; TMEM16A; Ca2+-activated Cl channels; cystic fibrosis; G-protein coupled receptors (1)
CHLORIDE CHANNEL; KIDNEY; GENE; RAT; MUTATIONS; COTRANSPORTER; LOCALIZATION; DEAFNESS; MEDULLA; JERVELL; Bartter syndrome; BSND; chloride channels; deafness; kidney disorder; membrane protein; tubulopathy (1)
CHLORIDE CHANNEL; PHOSPHATIDYLSERINE EXPOSURE; EXPRESSION; TMEM16A; PLATELETS; REQUIRES; CELLS; TMEM16F; anoctamin 6; Ano6; Ca2+ -activated Cl- channels; phospholipid scrambling (1)
CHLORIDE CHANNELS; PROLIFERATION; HYPOXIA; GUDMAP; MICE; FORM; albuminuria; Ano1; kidney; nephron number; TMEM16A (1)
CHLORIDE SECRETION; CALCIUM; PROLIFERATION; DISEASE; ANO1; CONTRIBUTES; ANOCTAMINS; CHANNELS; GROWTH; Pkd1; Pkd2; ADPKD; Renal cysts; TMEM16A; Anoctamin 1; Ca2+ activated Cl- channel (1)
CHLORIDE SECRETION; CL-CONDUCTANCE; ANOCTAMIN 1; CHANNEL; COLON; CFTR; DIARRHEA; ANO1; Tmem16a; anoctamin 1; Cl- secretion; mucus secretion; cystic fibrosis; Ca2+ signaling (1)
CHLORIDE SECRETION; CYSTIC-FIBROSIS; MUCIN SECRETION; ANOCTAMIN 6; MEMBRANE; ANO1; TMEM16A; TMEM16F; benzbromarone; niclosamide; Ani9; TMEM16A potentiators; Eact; PIP2 (1)
CHLORIDE SECRETION; PRIMARY CILIA; CALCIUM; POLYCYSTIN-2; ANOCTAMINS; REQUIRES; MECHANOSENSATION; ACTIVATION; ADPKD; Renal cysts; TMEM16A; Anoctamin 1; Ca2+-activated Cl- channel (1)
CHLORIDE SUBSTITUTION-REACTIONS; RUTHENIUM COMPLEXES; DIASTEREOSELECTIVITY; STEREOCHEMISTRY (1)
CHLORINATION; CHEMISTRY; CHLORIDE; ALKYNES; SUBSTITUTION; HALOGENATION; ACTIVATION; CATALYSIS; EFFICIENT; ALPHA; Chlorination; Photoredox catalysis; Oxidation; ipso-Substitution; Green chemistry (1)
CHLORINE ATOMS; EXCITED-STATE; ACETONITRILE; COMPLEXES; (1)
CHLOROALUMINATE MOLTEN-SALTS; TEMPERATURE-DEPENDENCE; REDUCTION POTENTIALS; LITHIUM; ELECTRODES; BATTERIES; ELECTROLYTES; SOLVATION; PRESSURE; DYNAMICS; (1)
Chlorococcal algae; cell wall composition (1)
CHLOROMERCURY(II) ANIONS; CATIONS; PENTACHLOROMERCURATE(II); (1)
CHLOROPHYLL CATABOLITE REDUCTASE; OXIDATIVE STRESS; 2-DIMENSIONAL ELECTROPHORESIS; 12-OXO-PHYTODIENOIC ACID; SUPEROXIDE-DISMUTASE; MASS-SPECTROMETRY; GENE-EXPRESSION; PLANT-TISSUES; CELL-DEATH; GLUTATHIONE; Oxylipins; Arabidopsis thaliana; Differential 2D-PAGE; Protein modification; Western-blotting (1)
CHLOROPHYLLIN-BASED PHOTOSENSITIZATION; SINGLET OXYGEN; PHOTODYNAMIC INACTIVATION; BACTERIAL-SPORES; SURFACE-CHARGE; ENDOGENOUS PHOTOSENSITIZERS; CLOSTRIDIUM-PERFRINGENS; STAPHYLOCOCCUS-AUREUS; HYDROGEN-PEROXIDE; SUBTILIS; (1)
CHLOROPLAST DNA; (1)
CHLOROPLAST DNA; EVOLUTION; REGIONS; DIVERSIFICATION; AMPLIFICATION; BIOGEOGRAPHY; CARPATHIANS; CHARACTERS; SAXIFRAGA; PLANTS; Asteraceae; Chloroplast DNA; Hybridisation; Polyploidy; trnL-trnF; psbA-trnH (1)
CHLOROPLAST DNA; READ ALIGNMENT; GENOME; MITOCHONDRIAL; EVOLUTIONARY; ANGIOSPERMS; POPULATION; REPEAT; REGION; RATES; (1)
CHLOROPLAST DNA; SPECIES NETWORKS; INFERENCE; ANTHEMIDEAE; COMPOSITAE; PLANTS; NRDNA; HYBRIDIZATION; BIOGEOGRAPHY; ASTERACEAE; Anthemideae; AllCoPol; BEAST2; Leucanthemopsis; polyploidy; reticulate evolution; western Mediterranean (1)
CHLOROTRIFLUOROMETHYLATION; COMPLEXES; CHLORIDES; FLUORINE; ALKYNES; (1)
CHOICE EXPERIMENTS; NONMARKET VALUATION; CONJOINT-ANALYSIS; HETEROGENEITY; Latent class mixed logit model; Economics; Heterogeneity; Estimation accuracy; D-optimality (1)
CHOICE FUNCTIONS; DEFAULT LOGIC; CONDITIONALS; CONTRACTION; REVISIONS; (1)
CHOICE; MODEL; LOYALTY; BASKET; Retailing; Marketing; Cross effects; Multi-category purchases; Multivariate probit (1)
cholangiocarcinoma; biliary tract; hydrodynamic injection; genetically-engineered mice; in vivo models (1)
Cholangiocarcinoma, Glutamine metabolism, YAP/TAZ (1)
; cholangiocarcinoma; International Classification of Diseases 11th edition (ICD-11); subtypes; diagnosis; risk factors; treatment; prognosis (1)
; Cholangiocarcinoma; protein NEDDylation; pathogenesis; tumor micro-environment; therapy (1)
cholangiocarcinoma; targeted therapy; biliary tract cancer; molecular-directed therapy (1)
; Cholangioscopy; Digital single-operator cholangioscopy; Endoscopic retrograde cholangiopancreatography; Biliary lesion; Biliary stricture (1)
Cholestasis, ALR, bile acids, SHP, HNF4a, IL1beta, Apoptosis, CYP7A1 (1)
CHOLESTASIS; UNIT; GUT; Sepsis; Cholestasis; Intensive care; Catecholamines; Ventilation (1)
CHOLESTEROL AUTOXIDATION; MEAT QUALITY; ACID; PRODUCTS; PERFORMANCE; INFLAMMATION; SITOSTEROL; TISSUES; LIVER; Broilers; Hermetia illucens; lipidome; breast muscle; heat-processing; cholesterol oxidation products; phytosterol oxidation products (1)
CHOLESTEROL-FED RABBITS; MONOCLONAL-ANTIBODY; CAROTID ARTERIES; ATHEROSCLEROSIS; INVIVO; HYPERCHOLESTEROLEMIA; CATECHOLAMINES; NORADRENALINE; ACCUMULATION; PRAVASTATIN; reserpine; atherosclerosis; hepatic LDL receptor; cholesterol and arterial walls (1)
CHOLESTEROL GOALS; SECONDARY PREVENTION; EUROPEAN COUNTRIES; LOWERING TREATMENT; MODIFYING THERAPY; ARTERY-DISEASE; GUIDELINES; MANAGEMENT; ATTAINMENT; PROGRAM; Cross-sectional study; hypercholesterolaemia prevention; pharmacotherapy; primary health care (1)
Cholesterol; Lipids; Genetics; Genome-wide association study; GWAS (1)
CHOLESTEROL-METABOLISM; CANCER; PATHWAY; DIFFERENTIATION; PROLIFERATION; AUTOIMMUNITY; EFFECTOR; IL-15; CD154; cholesterol; LDL (low-density lipoprotein); immunotherapy; PD-1; reactive oxygen species; CD154 (CD40L); central memory (T) CM; spheroid model (1)
CHOLESTEROL PRECURSORS; OXIDATION-PRODUCTS; HUMAN SERUM; ION-SOURCE; OXYSTEROLS; DISEASE; MS; PHYTOSTEROLS; METABOLISM; MS/MS; Oxysterols; APCI; Time-of-flight mass spectrometry (1)
CHOLESTEROL TRANSPORT; PHOSPHOLIPASE A(2); PROTEINS; MICE; DEGRADATION; TRAFFICKING; AUTOPHAGY; GOLGI; LIVER; VI; Annexin A6; Lipid droplets; Fatty acid; Hepatocytes; Cytoplasmic phospholipase A2 (1)
CHOLESTEROL; VESICLES; LIPIDS; LABEL; Liposomes; Electrostatic interaction; Bioanalysis; Bacteria; E. coli (1)
CHOLINE CHLORIDE; DIELECTRIC-RELAXATION; ETHYLENE-GLYCOL; IONIC LIQUIDS; ELECTRICAL-CONDUCTIVITY; VIBRATIONAL ANALYSIS; DIMETHYL-SULFOXIDE; CARBOXYLIC-ACIDS; BINARY-MIXTURES; VISCOSITY; Dielectric relaxation spectroscopy; Deep eutectic solvents; Dimethylsulfoxide; Solvation; Ion association; Micro-heterogeneity (1)
CHOLINE CHLORIDE; SOLVATION; LIQUID (1)
CHOLINE-CHLORIDE; TEMPERATURE; carbon; deep eutectic solvents; one step method; palladium; supported catalysts (1)
CHOLINE-DEFICIENT DIET; FATTY LIVER-DISEASE; MESSENGER-RNA EXPRESSION; HEPATOCELLULAR-CARCINOMA; SERUM CHEMERIN; OBESE MICE; EX-VIVO; CMKLR1; ADIPONECTIN; METABOLISM; Liver tumor; NASH; chemerin activity; CMKLR1 (1)
CHOLINE-DEFICIENT DIET; HIGH-THROUGHPUT QUANTIFICATION; ELEMENT-BINDING PROTEINS; LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; RECENT INSIGHTS; APOA-I; LIVER; METHIONINE; CHOLESTEROL; Fat mass; Non-alcoholic steatohepatitis; Cholesterol; Phospholipids; Bile acids (1)
Choline O-Acetyltransferase/*metabolism Cytoplasm/ultrastructure Lysosomes/metabolism/*ultrastructure Neoplasms, Experimental/ultrastructure Nerve Growth Factors/antagonists & inhibitors/*pharmacology Pheochromocytoma/metabolism/ultrastructure (1)
cholinergic antiinflammatory pathway, alpha 7 nicotinergic acetylcholine receptor, nicotine (1)
CHOLINERGIC ANTIINFLAMMATORY PATHWAY; COUPLED RECEPTOR KINASES; PITUITARY-ADRENAL AXIS; HEART-RATE-VARIABILITY; RHEUMATOID-ARTHRITIS; CHROMOGRANIN-A; SYNOVIAL TISSUE; CATECHOLAMINERGIC CELLS; NEUROPEPTIDE-Y; MODULATION; Autoimmunity; Adrenoceptor; Disease model; Neuroendocrine immunology; Immune system (1)
CHOLINERGIC MODULATION; RECOGNITION RESPONSES; BASAL FOREBRAIN; DIAGONAL BAND; SHORT-TERM; RELEASE; CORTEX; MAIN; RECEPTORS; SYSTEM (1)
CHOLINERGIC SYSTEM; BIOLOGICAL-SYSTEMS; HUMANS; BEES; MOLECULE; EXPRESSION; RECEPTORS; NICOTINE; TISSUES; GROWTH; (1)
CHOLINESTERASE ACTIVITY; SERUM-CHOLINESTERASE; DELIRIUM; RISK; STENOSIS; SURGERY; SYSTEM; adult intensive & critical care; anaesthesia in cardiology; adult cardiology; valvular heart disease (1)
CHOLINESTERASE-INHIBITORS; BLOOD CHOLINESTERASE; ALZHEIMERS-DISEASE; RAT-BRAIN; ACETYLCHOLINESTERASE; PHARMACOKINETICS; INFLAMMATION; METABOLISM; PARAMETERS; SURVIVAL; Butyrylcholinesterase; Acetylcholinesterase; Alzheimer's disease; Physostigmine; Neostigmine; Inflammatory disease; Rat; Ellman's reagent; Cholinesterase inhibitors (1)
CHONDRAL LESIONS; HIP; KNEE; OSTEOARTHRITIS; THICKNESS; SURFACE; REPAIR; RETURN; hip arthroscopy; microfracture; cartilage therapy; hip preserving surgery (1)
CHONDROCYTE CONSTRUCTS; IN-VITRO; TISSUE; GROWTH; GLUE; CLOTS; POLYMERIZATION; MICROSCOPY; MATRICES; TIME; fibrin; cartilage tissue engineering; chondrocyte; cell culture; viscoelasticity (1)
chondrocytes; IL-1, IL-6; p38MAPK; signal transduction; aggrecan; PI3K, JNK, ERK1/2 (1)
Chondrodermatitis nodularis chornica helicis (CNCH); chirurgisches Outcome, ambulante MKG-Praxis (1)
chondrogenesis, Gpx1, oxidative stress (1)
CHONDROITIN SULFATE; ANALYSIS REVEALS; MESSENGER-RNA; CD97; EXPRESSION; RECEPTOR; BINDING; LEUKOCYTES; DEFINITION; THERAPY; ADGRE5; CD97; MYC; ChIP-Seq; RNA-Seq; Lymphoma; BL; DLBCL (1)
CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM POTENTIATION; GLYCOPROTEIN TENASCIN-R; SPINAL-CORD-INJURY; C MESSENGER-RNA; CNS SYNAPTOGENESIS; PERISOMATIC INHIBITION; POSTNATAL-DEVELOPMENT; CEREBRAL-CORTEX; (1)
CHONDROITIN SULFATE PROTEOGLYCANS; RNA SECONDARY STRUCTURE; MESSENGER-RNA; ALZHEIMERS-DISEASE; DEFAULT EXON; GENE; SELECTION; INTRON; EXPRESSION; CELLS; (1)
Chondroitinsulfat, Experimentelle autoimmune Enzephalomyelitis, Regulatorische B-Zellen (1)
CHONDROMODULIN-I; EXTRACELLULAR-MATRIX; ANNULUS FIBROSUS; NUCLEUS PULPOSUS; SELF-RENEWAL; CELL; ANGIOGENESIS; OSTEOARTHRITIS; LOCALIZATION; REGENERATION; angiogenesis; annulus fibrous; intervertebral disc degeneration; knockout mice; nucleus pulposus; tenomodulin (1)
CHONDROMODULIN-I; RAT MODEL; REPAIR; TENOMODULIN; SCAFFOLDS; MATRIX; GENE; DISORDERS; MECHANICS; LIGAMENTS; tendon stem/progenitor cell; tendon repair; tissue engineering; thermosensitive hydrogel (1)
CHORIOALLANTOIC MEMBRANE CAM; STEM-CELLS; INTRACEREBRAL HEMORRHAGE; CANCER PROGRESSION; MATRIX METALLOPROTEINASES; CARCINOMA-CELLS; MATRIX-METALLOPROTEINASE-9; INVASION; GROWTH; MIGRATION; HNSCC; head and neck cancer; BMSC; bone marrow-derived stromal cells; angiogenesis; MMP; matrix metalloproteinase; CAM; chorioallantoic membrane; in ovo; 2D; 3D (1)
CHORIOALLANTOIC MEMBRANE; EMBRYO; CT; human renal cystic tissue; ADPKD; chorioallantoic membrane (CAM) model; mouse kidney slices; 3D in vivo model; polycystic kidney disease (1)
CHORIOALLANTOIC MEMBRANE; PROGNOSTIC-FACTORS; SOFT-TISSUE; RHABDOMYOSARCOMA; SARCOMA; CHILDHOOD; EMBRYO; Chorioallantoic membrane (CAM); in vivo tumor model; tumor profiling; rhabdomyosarcoma; sarcoma; volume measurement; 3D volume (1)
CHORIOALLANTOIC MEMBRANE TEST; CORNEAL ENDOTHELIAL TOXICITY; ARTHROSCOPIC KNEE SURGERY; HET-CAM-TEST; BUPIVACAINE; ANALGESIA; MORPHINE; ROPIVACAINE; LIDOCAINE; INJECTION; local anesthetics; tissue compatibility; HET-CAM test (1)
Chorioideremie , Heterozygotie , REP-1 Gen , Lyonisierung , chorioideremie , rep-1 gene , lyonisation (1)
CHORISMATE-UTILIZING ENZYMES; EVOLUTION; CLASSIFICATION; BIOSYNTHESIS; INFORMATION; DIVERSITY; PATHWAYS; OPERONS; GENOMES; Primary metabolism; Secondary metabolism; Enzyme evolution; Enzyme design (1)
CHOROIDAL BLOOD-FLOW; COMMERCIALLY AVAILABLE ANTISERA; KNOCKOUT MICE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; ISOMETRIC-EXERCISE; INDUCED RELAXATION; VESSELS; PROPRANOLOL; ATROPINE; (1)
CHOROIDAL EFFUSION; MANAGEMENT; TRABECULECTOMY; IMPLANT; Differential diagnosis; Radius-Maumenee syndrome; Sturge-Weber syndrome; Carotid-cavernous sinus fistula; Complications (1)
CHOROIDAL EFFUSION; PATIENT; SURGERY; IMPLANT; glaucoma; paediatric ophthalmology; Sturge-Weber syndrome (1)
CHOROIDAL NEOVASCULAR MEMBRANES; RISK; DIFFERENTIATION; SUSCEPTIBILITY; POLYMORPHISM; INCREASES; DRUSEN; GENE; complement factor H polymorphism; basal laminar deposits; age-related macular degeneration; CFH genotype; histopathology (1)
choroidal thickness, diabtic retinopathy, retinal vein occlusions, intravitreal anti-VEGF therapy (1)
CHOW GROUP; HYPERSURFACE SECTIONS; BERTINI THEOREMS; VARIETIES; SUBSCHEME; (1)
Chow groups, zero-cycles, cycle class maps (1)
CH-PI INTERACTIONS; CONFORMATIONAL-ANALYSIS; CRYSTAL-STRUCTURE; ORGANOMETALLIC COMPLEXES; HYDROGEN-BONDS; PHOSPHINE-LIGANDS; BENZENE DIMER; CF-PI; TRIPHENYLPHOSPHINE; VAN; CH/pi interactions; Triphenylphosphine; Propeller; Transition-metal complexes (1)
CH/PI INTERACTIONS; CRYSTAL-STRUCTURES; PPH3 PROPELLER; PROTEINS; DATABASE; BINDING; donor-acceptor interactions; half-sandwich iron complexes; hydrogen bonding; propellers; triphenylphosphine (1)
Christianity, religion, politics, tolerance, truth, ethics, pluralism, fundamentalism, relativism, Europe Christentum, Religion, Politik, Toleranz, Wahrheit, Ethik, Pluralismus, Fundamentalismus, Relativismus, Europa (1)
Christian nationalism; religion; politics; Capitol riot; Donald Trump (1)
Christologie, Jesus Christus, Jesus Christ, Person and offices (1)
Chromate sensors; Optical coatings; Sol-gel technique (1)
chromatin architecture, nucleosome positioning, TNFa, MNase-Seq, gene regulation, TTF-I, chromatin looping, rDNA (1)
Chromatin, Chromatindynamik, Plasmodium falciparum, Histon, Nukleosom, Remodeling (1)
Chromatin, CpG island, DNA Methylation, viral latency, lytic cycle, methylome, oncoprotein, pioneer transcription factor, tumour suppressor gene, tumour virus (1)
Chromatin, Epigenetics, DNA accessibility (1)
Chromatin, HCMV, Epigenetik, Histonmodifikationen (1)
Chromatin, Histonvarianten, Bäckerhefe (1)
CHROMATIN; IDENTIFICATION; BAF180; GENE (1)
Chromatin, Methylierung, Nucleosom, Positionierung, DNS-Krümmung, DNS-Methyltransferase, DNS, Chromatin Remodeling Komplex, chromatin remodeling complex (1)
Chromatin remodeler; Cancer; Epigenetic therapeutic potential (1)
chromatin remodeler; cancer; search mechanism; arrest model; non-coding RNA (1)
CHROMATIN-REMODELING ATPASE; TRANSCRIPTION FACTOR AP-2; HISTONE VARIANT H2A.Z; MARIE-TOOTH-DISEASE; GENE; MYELINATION; SOX10; DIFFERENTIATION; EXCHANGE; IDENTIFICATION; (1)
CHROMATIN-REMODELING COMPLEX; CHIP-SEQ; SWI/SNF; APOPTOSIS; PLK1; ESSENTIALITY; SPECIFICITY; ANNOTATION; ALIGNMENT; ELEMENTS; (1)
CHROMATIN-REMODELING COMPLEXES; DE-NOVO METHYLATION; ENZYMATIC-PROPERTIES; GENOMIC DNA; DNMT3A; METHYLTRANSFERASES; MOUSE; LSH; MUTATIONS; SEQUENCES; (1)
CHROMATIN-REMODELING COMPLEXES; DE-NOVO METHYLATION; ENZYMATIC-PROPERTIES; MOUSE EMBRYO; GENOME-WIDE; IN-VITRO; METHYLTRANSFERASES; CELLS; LSH; MECHANISM; (1)
CHROMATIN-REMODELING COMPLEXES; INOSITOL HEXAPHOSPHATE; SWI2/SNF2 PROTEIN; DNA-BINDING; Q-MOTIF; RNA; NUCLEOSOMES; HYDROLYSIS; BRG1; IP6; ADP; ATPase; chromatin; competitive inhibitor; remodeling enzyme (1)
CHROMATIN-REMODELING COMPLEX; RIBOSOMAL-RNA GENES; HUMAN PROTEIN ATLAS; DNA-DAMAGE; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; S-PHASE; HETEROCHROMATIN PROTEIN-1; INTERACTION PROTEOMICS; NUCLEOTIDE EXCISION; (1)
Chromatin Remodeling, SNF2H, SNF2L, kooperative Bindung, MNase, Zellkernarchitektur, aktive Chromatindomänen, ENCODE (1)
Chromatin remodelling; Parasite biology; Target identification; Target validation; Transcriptomics (1)
CHROMATIN; SEQ; ENHANCERS; Chromatin immunoprecipitation; ChIP-seq; ChIPmentation; High-throughput genomics; Epigenetics (1)
chromatin states, rRNA genes, transcription, replication, Hmo1, HMG-box protein NER, psoralen crosslinking (1)
CHROMATOGRAPHIC DETERMINATION; CHAMELEON LABELS; FOOD SAMPLES; FISH; PROTEINS; SENSOR; EXTRACTION; ELECTRODES; HISTAMINE; PRODUCTS; (1)
CHROMATOGRAPHIC METHOD; RIBOSOMAL DNA; PCR PRIMERS; LICHEN; IDENTIFICATION; AMPLIFICATION; INFERENCE; RDNA; TREE; Haematomma; Ramboldia; Protoparmelia; Pyrrhospora; Lecanoraceae; molecular phylogeny; systematics; taxonomy (1)
Chromatographic separation; [n]Paracyclophanecarboxylic acid derivatives; CD spectra; Absolute configuration (1)
Chromatographie, Flüssigchromatogrpahie-Tandem-Massenspektrometrie (LC-MS/MS), Gallensäuren, Glycerophospholipide, Hochdurchsatzanalyse, Hydrophile Interaktionchromatographie (HILIC), Lipidanalytik, Lipoproteine, Massenspektrometrie, Sphingolipide (1)
Chromatography, liquid, on triacetylcellulose - Circular dichroism - Configuration, absolute - 1H-N M R, in the presence of an optically active auxiliary - Rotation hindered, about a =C—C= bond - N,N,Nprime,Nprime-Tetramethyldithiooxamide (1)
CHROMATOGRAPHY MASS-SPECTROMETRY; CAPILLARY ZONE ELECTROPHORESIS; LASER-INDUCED FLUORESCENCE; TOTAL ANALYSIS SYSTEMS; MICROFABRICATED DEVICES; DOPING CONTROL; DERIVATIZATION; fluorescence; laser; microchip; native fluorescence detection; pharmaceuticals (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; ELECTROSPRAY-IONIZATION; QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS; LYSOPHOSPHATIDIC ACID; MULTIPLE PRECURSOR; BIOLOGICAL SAMPLES; MEMBRANE-LIPIDS; BARTH-SYNDROME; IDENTIFICATION; (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; GAS-LIQUID-CHROMATOGRAPHY; BILE-ACIDS; NEUTRAL STEROLS; COLON-CANCER; CHOLESTEROL; EPIDEMIOLOGY; QUANTITATION; ANTIBIOTICS; CONVERSION; (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; GAS-LIQUID-CHROMATOGRAPHY; FECAL NEUTRAL STEROLS; CHOLESTEROL PRECURSORS; PLANT STEROLS; HUMAN PLASMA; HUMAN SERUM; BILE-ACIDS; QUANTITATION; CONVERSION; Gas chromatography-triple quadrupole mass spectrometry (1)
CHROMATOGRAPHY-MASS-SPECTROMETRY; MAGNETIC-RESONANCE-SPECTROSCOPY; GUT MICROBIOTA COMPOSITION; CHAIN FATTY-ACIDS; GAS-LIQUID-CHROMATOGRAPHY; BILE-ACIDS; HUMAN FECES; CHOLESTEROL ABSORPTION; COLORECTAL-CANCER; QUANTITATIVE ISOLATION; Metabolomics; Lipidomics; Feces; Methods (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; METHYL CHLOROFORMATE DERIVATIVES; ION-EXCHANGE CHROMATOGRAPHY; GAS-CHROMATOGRAPHY; CHEMICAL DERIVATIZATION; PROPIONIC ACIDEMIA; PERFORMANCE; METABOLISM; DIAGNOSIS; SAMPLES; metabolomics; amino acids; gas chromatography-mass spectrometry; urine; plasma; alkyl chloroformate (1)
Chromatography Radioanalytics Environmental monitoring ⁹⁰Sr ⁹⁰Y, Chromatographie Radioanalytik Umgebungsüberwachung (1)
CHROMIUM COMPLEXES; METAL; CLUSTERS; BOND; Bismuth; Liquid ammonia; Cyclic tribismuthide; Piano-stool complex; Group 15 ligand; Structure elucidation (1)
Chromone , Zinkkomplexe , bioaktive Verbindungen , Chemische Synthese , Cyclische Verbindungen , Immobilisierung , Chromophore , organische-anorganische Hybride , UV-Filter , immobilisation , chromophore , organic-inorganic hybrids , chromone , UV filter (1)
chromophores, organic–inorganic hybrid composites, silica, sol-gel processes, UV filters (1)
CHROMOSOMAL IMBALANCES; PROTEIN EXPRESSION; TUMORS; CHILDREN; CARCINOMAS; NEOPLASMS; CHILDHOOD; MARKERS; atypical choroid plexus papilloma; choroid plexus carcinoma; diagnosis; gross total resection; mitotic activity; prognosis (1)
CHROMOSOMAL INSTABILITY; TUMOR PROGRESSION; CANCER; OVEREXPRESSION; GENE; EXPRESSION; BREAST; SUSCEPTIBILITY; CHEMOTHERAPY; ASSOCIATION; Aurora kinase A polymorphism; Aurora kinase B; cetuximab; HNSCC (1)
chromosomal rearrangements; cytogenetics; FISH; gene am-plification; polysomy (1)
CHROMOSOME; (1)
CHROMOSOME 10Q26; MESSENGER-RNA; HTRA1; ARMS2; SUSCEPTIBILITY; VARIANTS; COMPLEMENT; LOC387715; IMPAIR; RISK; age-related macular degeneration; genetic association studies; linkage disequilibrium; haplotypes; ARMS2/HTRA1 gene locus (1)
chromosome 16; FISH; membrane-type matrix metalloproteinases; repetitive DNA (1)
CHROMOSOME 9P21; GENOMEWIDE ASSOCIATION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; CHEMOKINES; UPDATE; Atherosclerosis; Coronary artery disease; Gene expression; Inflammation; Macrophages; Myocardial infarction (1)
CHROMOSOME CONFORMATION CAPTURE; GENOMIC INTERACTIONS; REGULATORY ELEMENTS; ALU ELEMENTS; HUMAN GENES; HUMAN-CELLS; TRANSCRIPTION; ENHANCERS; SEQUENCE; DYNAMICS; (1)
CHROMOSOME CONFORMATION CAPTURE; REMODELING COMPLEX NORC; POLYMERASE-I; TRANSCRIPTION TERMINATION; NUCLEOLAR DOMINANCE; METHYLATION; BINDING; DNA; ORGANIZATION; INITIATION; chromatin; looping; nucleolus; transcription (1)
CHROMOSOME-REPLICATION; SP-NOV; PYROBACULUM-AEROPHILUM; THERMOPHILIC ARCHAEA; NUCLEOID STRUCTURE; GENUS SULFOLOBUS; GENOME SEQUENCE; DNA-CONTENT; INITIATION; ORIGINS; (1)
CHRONIC ACTIVE HEPATITIS; CONTROLLED-TRIAL; REMISSION; CYCLOSPORINE; CHILDHOOD; DIAGNOSIS; THERAPY; DISEASE; EPIDEMIOLOGY; POPULATION; (1)
CHRONIC ALLOGRAFT NEPHROPATHY; RENAL-TRANSPLANTATION; ATOPIC-DERMATITIS; GRAFT FUNCTION; PROMOTER; SURVIVAL; DISEASE; CHEMOKINES; IMPACT; MCP-1; kidney transplantation; rantes; renal function (1)
CHRONIC ATRIAL-FIBRILLATION; HEART-FAILURE; KINASE-II; PHOSPHORYLATION; STABILIZATION; CONTRACTILITY; ARRHYTHMIAS; PROGRESSION; POPULATION; MYOCARDIUM; Heart failure; Arrhythmias; SR Ca2+ leak; CaMKII (1)
CHRONIC BACK-PAIN; NEUROPATHIC PAIN; GRAY-MATTER; SOMATOSENSORY CORTEX; FUNCTIONAL-CHANGES; MECHANISMS; LATERALIZATION; REPRESENTATION; ASYMMETRIES; INTENSITY; facial pain; chronic pain; brain morphology; brain imaging; lateralization index (1)
CHRONIC BACTERIAL PROSTATITIS; SEMINAL FLUID; PH; PHARMACOKINETICS; SECRETION; TISSUE; FLUOROQUINOLONES; CLASSIFICATION; ANTIBIOTICS; INFECTIONS; chronic bacterial prostatitis; moxifloxacin; pharmacokinetics; plasma concentrations; prostatic fluid; ejaculate (1)
CHRONIC BILATERAL STIMULATION; DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; PALLIDUM; (1)
CHRONIC BILATERAL STIMULATION; POSITRON EMISSION TOMOGRAPHY; MOTOR-ASSOCIATION CORTEX; DEEP BRAIN-STIMULATION; CEREBRAL BLOOD-FLOW; PARKINSONS-DISEASE; BASAL GANGLIA; FINGER MOVEMENTS; FUNCTIONAL MRI; (H2O)-O-15 PET; anterior cingulate cortex; deep brain stimulation; PET; Parkinson's disease; subthalamic nucleus (1)
CHRONIC COCCYDYNIA; SITTING POSITION; COCCYGECTOMY; MORPHOLOGY; INTERCOCCYGEAL; COCCYGODYNIA; SACROCOCCYGEAL; MORPHOMETRY; INJECTION; SURGERY; Os coccygis; Coccyx; Coccygodynia; Coccygectomy; Radiological classification (1)
CHRONIC DAILY HEADACHE; PLACEBO-CONTROLLED TRIAL; TENSION-TYPE HEADACHE; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; RECEPTOR ANTAGONIST; NEUROTOXIN-A; EPISODIC MIGRAINE; PEPTIDE RELEASE; INDUCED PAIN; botulinum toxin; migraine; headache; pain (1)
; Chronic disease; Anxiety; Stress; Play and playthings; Parents (1)
CHRONIC-FATIGUE-SYNDROME; CHLAMYDIA-PNEUMONIAE INFECTION; MULTIPLE-SCLEROSIS PATIENTS; HERPES-SIMPLEX-VIRUS; RICKETTSIA-HELVETICA; PERIODONTAL PATHOGENS; MYOCARDIAL-INFARCTION; BORDETELLA-PERTUSSIS; PCR ASSAYS; DNA (1)
CHRONIC-FATIGUE-SYNDROME; INFLAMMATORY MARKERS; PSYCHOSOCIAL STRESS; WORK OVERLOAD; ASSOCIATIONS; WOMEN; GLUCOCORTICOIDS; COVARIANCE; SECRETION; SYMPTOMS; (1)
; Chronic graft-versus-host disease; Abatacept; Salvage therapy; Bronchiolitis obliterans syndrome (1)
Chronic graft versus host disease · Allogeneic hematopoietic stem cell transplantation · Ruxolitinib · Steroidrefractory chronic graft-versus-host disease · JAK 1/2 inhibitor (1)
Chronic graft-versus-host disease; Atypical; National Institutes of Health Consensus Project Task Force (1)
chronic graft-versus-host disease (cGvHD), acute GvHD, aGvHD, stem cell transplantation, bone marrow transplantation (1)
CHRONIC HABITAT FRAGMENTATION; AFFECTED COASTAL MOUNTAINS; ASIAN SOUTHWEST MONSOON; FOREST FRAGMENTATION; RAPD VARIATION; NATURAL-POPULATIONS; TROPICAL TREE; NORTHERN OMAN; HOLOCENE; SEA; biogeography; fragmentation; monsoon forest; Oman; palaeo-African relict vegetation; population genetics; Yemen (1)
CHRONIC HEART-FAILURE; CHEMOREFLEX RESPONSE; HYPERCAPNIA; EXERCISE; altitude; respiration; hypoxia; hyperventilation; hemoglobin (1)
CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; CONVERTING-ENZYME-INHIBITOR; MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; RANDOMIZED TRIAL; GROWTH-HORMONE; MORTALITY; MORBIDITY; SURVIVAL; (1)
CHRONIC HEART-FAILURE; OPERATION EVEREST-II; REACTIVE HYPEREMIA; EXERCISE PERFORMANCE; SKELETAL-MUSCLE; BLOOD-PRESSURE; IMPEDANCE; FLOW; HEMODYNAMICS; CONDUCTANCE; arteries; blood flow; hypoxia; vasodilation (1)
CHRONIC HEART-FAILURE; SINGLE BREATH TEST; CHEMOREFLEX RESPONSE; CARBON-DIOXIDE; DEADSPACE; EXERCISE; HYPERCAPNIA; PATTERN; LIMITS; altitude; hypoxia; ventilation; ventilatory control; ventilatory efficiency (1)
CHRONIC HEART-FAILURE; SYMPATHETIC-NERVE ACTIVITY; ARTERIAL-HYPERTENSION; RATE-VARIABILITY; SPECTRAL-ANALYSIS; GAS-EXCHANGE; EXERCISE; MORTALITY; PATHOPHYSIOLOGY; ASSOCIATION; Exercise capacity; heart autonomic system; heart rate variability; pulmonary hypertension (1)
CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; CARDIAC MYOCYTES; INTERLEUKIN-6 FAMILY; CYTOKINE EXPRESSION; HYPERTROPHY; ACTIVATION; RECEPTOR; GP130; LIPOPOLYSACCHARIDE; cytokines; IL-6; superfusion; myocardium; immunoregulation (1)
CHRONIC HEMATOGENOUS OSTEOMYELITIS; OUTCOMES; Bone; Infection; Pediatric; Low-income; Osteomyelitis; Fracture-related infection; Fri; Sequestrum; External fixation; Debridement; Involucrum; Sepsis (1)
CHRONIC-HEMODIALYSIS PATIENTS; COLONY-STIMULATING FACTOR; HEALTH-CARE WORKERS; INTRAMUSCULAR VACCINATION; FOLLOW-UP; IMMUNOLOGICAL MEMORY; VIRUS-INFECTION; SURFACE-ANTIGEN; RENAL-FAILURE; GM-CSF; (1)
CHRONIC HEPATITIS-C; CYTOKINE-INDUCED DEPRESSION; RANDOMIZED CONTROLLED-TRIAL; CHRONIC VIRAL-HEPATITIS; QUALITY-OF-LIFE; ADJUVANT INTERFERON; CUTANEOUS MELANOMA; CANCER-PATIENTS; PSYCHOSOCIAL CHARACTERISTICS; CLINICAL TOXICITY; melanoma; depression; interferon-alpha; side effect; adherence (1)
CHRONIC HEPATITIS-C; FIBROSIS PROGRESSION; C5A; RECEPTOR; EXPRESSION; RESPONSES; REGENERATION; ANTAGONISTS; COMPONENT; GENOTYPES; (1)
CHRONIC HEPATITIS-C; MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL TARGETING SEQUENCE; LONG-TERM SURVIVAL; OXIDATIVE STRESS; GENETIC HEMOCHROMATOSIS; LIVER FIBROSIS; IRON STATUS; DISEASE; EXPRESSION; (1)
CHRONIC HEPATITIS-C; MULTIPLE-SCLEROSIS; RETINOPATHY; Retinal artery occlusion; Retinal vein occlusion; Interferon beta; Retinopathy; Multiple sclerosis (1)
CHRONIC HEPATITIS-C; PULMONARY-FIBROSIS; CHEMOKINES; INFLAMMATION; MECHANISMS; INFECTION; DISEASE; PLATELET-FACTOR-4; SUSCEPTIBILITY; PROLIFERATION; (1)
CHRONIC HEPATITIS-C; SELF-ANTIGEN; PERIPHERAL DELETION; CROSS-PRESENTATION; LIVER TOLERANCE; TRANSGENIC MICE; INFECTION; HEPATOCYTES; EXPRESSION; DIFFERENTIATION; (1)
CHRONIC HEPATITIS-C; SERUM ALANINE AMINOTRANSFERASE; CONTROLLED ATTENUATION PARAMETER; BODY-MASS INDEX; GAMMA-GLUTAMYL-TRANSFERASE; PRIMARY BILIARY-CIRRHOSIS; METASTATIC COLORECTAL-CANCER; MODERATE ALCOHOL-CONSUMPTION; NUTRITION EXAMINATION SURVEY; RAPID VIROLOGICAL RESPONSE; (1)
CHRONIC IDIOPATHIC URTICARIA; GENERAL-POPULATION; SKIN MORBIDITY; LIFE EVENTS; PSORIASIS; ITCH; PREVALENCE; RISK; CARE; HYPOCHONDRIASIS; chronic pruritus; incidence; prevalence; longitudinal; predictors; determinants (1)
CHRONIC IMIPRAMINE TREATMENT; DIPEPTIDYL-PEPTIDASE-IV; SOCIAL-INTERACTION TEST; T-CELLS; PSYCHOSOCIAL STRESS; LEUKOCYTE SUBSETS; LUNG METASTASIS; B-LYMPHOCYTES; RECRUITMENT; MODEL; (1)
chronic infection, ejaculate, hepatitis E virus (HEV), immunosuppression, Paslahepevirus balayani, STD (1)
chronic inflammatory bowel diseases; biologics; Crohn's disease; ulcerative colitis; tumor necrosis factor; hormones; cytokines (1)
CHRONIC INTERMITTENT HYPOXIA; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR FUNCTION; CORONARY-ARTERY-DISEASE; VASCULAR REACTIVITY; EJECTION FRACTION; OXIDATIVE STRESS; HEART-FAILURE; APNEA; RECOVERY; Myocardial infarction; Sleep apnoea; Magnetic resonance imaging; Heart failure (1)
CHRONIC INTESTINAL INFLAMMATION; ROR-GAMMA-T; INNATE LYMPHOID-CELLS; BOWEL-DISEASE; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; CROHNS-DISEASE; SCID MICE; ALLOGRAFT-REJECTION; (1)
CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; HUMAN DIABETIC-NEPHROPATHY; GENE-EXPRESSION; OXIDATIVE STRESS; SIGNALING PATHWAYS; RECEPTOR; CONSEQUENCES; ASSOCIATION; PROGRESSION; (1)
CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; SUBCLINICAL HYPOTHYROIDISM; IODINE; HYPERPROLACTINEMIA; THYROXINE; DIALYSIS; TRIIODOTHYRONINE; INSUFFICIENCY; THYROGLOBULIN; pituitary-thyroid axis; TSH; fT3; fT4; iodine serum concentration; prolactin; hemodialysis; goiter; nodule (1)
chronic kidney disease correlates estimated glomerular filtration rate GCKD study gout epidemiology observational study (1)
CHRONIC KIDNEY-DISEASE; CREATININE; DATABASE; POPULATION; PACKAGE; MS; Metabolic fingerprinting; LC-MS; Urine; Creatinine; Osmolality; Normalization (1)
chronic kidney disease diabetes general population kidney function kidney function decline reference values (1)
chronic kidney disease, diabetes, general population, kidney function, kidney function decline, reference values (1)
chronic kidney disease, diabetes, metabolic syndrome, mitochondrial DNA copy number (1)
CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; DESIGN; GENES; HCARG; SET; PROTEINURIA; COMPONENTS; AMERICANS; VARIANTS; (1)
CHRONIC KIDNEY-DISEASE; EUROSCORE MULTINATIONAL DATABASE; EUROPEAN CARDIAC-SURGERY; ACUTE-RENAL-FAILURE; SERUM CREATININE; RISK-FACTORS; INJURY; PREDICTION; SURVIVAL; EQUATION; (1)
CHRONIC KIDNEY-DISEASE; EXPRESSION REVERSES ANEMIA; INTRAVENOUS IRON THERAPY; AMELIORATES ANEMIA; MOUSE MODEL; HEPCIDIN SUPPRESSION; TRANSFERRIN RECEPTOR; CHRONIC-HEMODIALYSIS; ROXADUSTAT FG-4592; EPOETIN-ALPHA; (1)
CHRONIC KIDNEY-DISEASE; FRACTIONAL URATE EXCRETION; HUMAN BLOOD METABOLITES; QUALITY-CONTROL; MOLECULAR-CLONING; AMINO-ACIDS; ARRAY; GENE; OXIDASE; PROTEIN; (1)
CHRONIC KIDNEY-DISEASE; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INCIDENT HEART-FAILURE; BODY-MASS INDEX; SUSCEPTIBILITY LOCI; CHARGE CONSORTIUM; COMMON VARIANTS; ISCHEMIC-STROKE; RISK; coronary heart disease; genetics; heart failure; ischemic stroke (1)
CHRONIC KIDNEY-DISEASE; GENOME-WIDE ASSOCIATION; INCIDENT CKD; POPULATION; UROMODULIN; DESIGN; COHORT; UMOD; Uromodulin; Polymorphisms; SNP; End-stage renal disease; Kidney transplantation (1)
chronic kidney disease, genome-wide association study, membranous nephropathy (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; ALBUMIN/CREATININE RATIO; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; CYSTATIN-C; MICROALBUMINURIA; POPULATION; PREVALENCE; (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; ALLOGRAFT RECIPIENTS; SERUM CREATININE; RISK-FACTORS; FOLLOW-UP; CONVERSION; THERAPY; MULTICENTER; Calcineurin inhibitor; everolimus; liver transplantation; long-term; withdrawal (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; MISSING DATA; MULTIPLE IMPUTATION; URINARY ALBUMIN; RISK SCORES; HUNT-II; PROTEINURIA; VALUES; (1)
CHRONIC KIDNEY-DISEASE; GLYCEMIC CONTROL; DIABETIC-PATIENTS; GLYCATED ALBUMIN; HEMOGLOBIN A(1C); SERUM FRUCTOSAMINE; DIALYSIS PATIENTS; RENAL-FAILURE; MORTALITY; RISK; HbA1c; fructosamine; haemodialysis; erythropoiesis-stimulating agents; CERA; epoietin alpha (1)
CHRONIC KIDNEY-DISEASE; HEPATOCELLULAR-CARCINOMA; RECIPIENTS; EVEROLIMUS; CYCLOSPORINE; TACROLIMUS; WITHDRAWAL; EFFICACY; TARGET; IMMUNOSUPPRESSION; (1)
Chronic kidney disease, Hypoxia, Nocturnal hypoxemic burden, Kidney failure, Type 2 diabetes, Sleepdisordered, breathing, Microvascular disease (1)
chronic kidney disease; infections; mortality; relative telomere length. (1)
chronic kidney disease, kidney diseases, cardiac diseases, biomarkers, heart failure, Copeptin, MR-pro-ANP, NT-pro-BNP (1)
CHRONIC KIDNEY-DISEASE; METAANALYSIS; HYPERTENSION; RISK; GWAS; APOE; Polygenic scores; PGS; General adults; Elderly; Kidney function biomarkers; eGFR(crea); eGFR(cys) (1)
CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; INFLAMMATION; CLASSIFICATION; DRUSEN; COHORT; AXIS; relative telomere length; age-related macular degeneration (AMD); mobile elderly population; diseases of late onset (1)
CHRONIC KIDNEY-DISEASE; PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; LIVER-DISEASE; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAYS; LIPID-METABOLISM; INFLAMMATION; Innate immune receptor NLRX1; Metabolic syndrome; NAFLD; Metabolism; Fatty acid oxidation; Kidney disease (1)
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; GENOME-WIDE ASSOCIATION; SERUM CREATININE; CARDIOVASCULAR-DISEASE; REPLACEMENT THERAPY; RISK-FACTORS; ALBUMINURIA; NEPHROPATHY; PROGRESSION; Diabetes mellitus type 2; Diabetic nephropathy; Chronic kidney disease; End stage renal disease; Cardiovascular morbidity; diabetes complications; Epidemiology; Genetics (1)
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; DIABETIC-NEPHROPATHY; GENERAL-POPULATION; AFRICAN-AMERICANS; RISK; PROGRESSION; MORTALITY; VARIANTS; (1)
CHRONIC KIDNEY-DISEASE; TAMM-HORSFALL PROTEIN; GENOME-WIDE ASSOCIATION; RISK-FACTORS; CARDIOVASCULAR MORTALITY; BLOOD-PRESSURE; INCIDENT CKD; GENE; POPULATION; NEPHROPATHY; (1)
CHRONIC LIVER-DISEASE; BLOOD-DONORS; ANTIBODIES; PREVALENCE; TRANSMISSION; INFECTION; FRANCE; SWINE; (1)
CHRONIC LIVER-DISEASE; INSULIN-RESISTANCE; OXIDATIVE-STRESS; STELLATE CELLS; PREVALENCE; CIRRHOSIS; MICE; Alcoholic Liver Disease/Steatohepatitis; Nonalcoholic Liver Disease/Steatohepatitis; Toll-like Receptor; Endotoxin (1)
CHRONIC LIVER-DISEASE; LOCAL GROCERY STORES; VIRAL-HEPATITIS; BLOOD-DONORS; WILD BOAR; E VACCINE; TRANSMISSION; SWINE; RISK; DEER; hepatitis E; Germany; autochthonous hepatitis; acute hepatitis (1)
Chronic liver disease; TGF-β1; WISP1; Cirrhosis; HCC; Proliferation (1)
CHRONIC LIVER-FAILURE; DECOMPENSATED CIRRHOSIS; OUTCOMES; INFECTIONS; ACLD; chronic liver disease; cirrhosis; COVID-19; SARS-CoV-2; SBP (1)
chronic lung allograft dysfunction (CLAD), experimentelle Lungentransplantation, Nilotinib (1)
CHRONIC LYME-DISEASE; REFERRAL CENTER; DIAGNOSIS; SYMPTOMS; MANAGEMENT; Lyme borreliosis; serology; Post-Lyme disease syndrome (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL; PLASMA-CELLS; CHEMOKINE RECEPTORS; T-CELLS; EXPRESSION; APOPTOSIS; LYMPHOMA; DISEASE; CD40; CLL; pseudofollicles; prognosis; proliferation; thrombocytopenia; apoptosis (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL RECEPTOR; TYROSINE KINASE INHIBITION; THERAPEUTIC TARGET; OPEN-LABEL; IBRUTINIB; BTK; RESISTANCE; ANNOTATION; EXPRESSION; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; BLOOD MONONUCLEAR-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; DISEASE PROGRESSION; REGULATORY CELLS; CANCER; TRANSPLANTATION; EXPRESSION; SUBSETS; HOST; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; CHEMOKINE RECEPTOR; MATURATION ANTIGEN; THERAPY; MICROENVIRONMENT; EXPRESSION; IMMUNOTHERAPY; ACTIVATION; RITUXIMAB; SURVIVAL (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; CHRONIC VIRAL-INFECTION; R/BIOCONDUCTOR PACKAGE; EPIGENETIC LANDSCAPE; CHECKPOINT BLOCKADE; MOUSE MODEL; IL-10; EXHAUSTION; EXPRESSION; SUBSETS; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; MYCOSIS FUNGOIDES/SEZARY-SYNDROME; ANTI-CD52 MONOCLONAL-ANTIBODY; NON-HODGKINS-LYMPHOMAS; CARDIAC TOXICITY; CHEMOTHERAPY; COMBINATION; THERAPY; MANAGEMENT; TRIAL; Alemtuzumab; fludarabine; peripheral T-cell lymphoma (PTCL) (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; NF-KAPPA-B; GENE-EXPRESSION; T-CELL; RECURRENT MUTATIONS; BINDING PROTEINS; DNA METHYLATION; INHIBITOR; PHENOTYPE; ALIGNMENT; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; ORGANIC CATION TRANSPORTERS; NON-HODGKINS-LYMPHOMA; RANDOMIZED PHASE-III; MULTIPLE-MYELOMA; FUNCTIONAL-CHARACTERIZATION; RAT-KIDNEY; IN-VITRO; OLD DRUG; RITUXIMAB; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; VIRUS-INDUCED LYMPHOMAS; DNA METHYLATION; CELLS; IDENTIFICATION; GLIOBLASTOMA; LANDSCAPE; MIR-155; GENOME; EXPRESSION; anaplastic glioma; miR-155; IDH; NF kappa B; NOA-04 (1)
CHRONIC MESENTERIC ISCHEMIA; CROHNS-DISEASE; CAPSULE ENDOSCOPY; MR ENTEROCLYSIS; FOLLOW-THROUGH; CLINICAL-EXPERIENCE; VISCERAL ARTERIES; CT ENTEROGRAPHY; POWER-DOPPLER; HELICAL CT; MRI; CT; small bowel; IBD; mesenteric ischemia; hemorrhage (1)
CHRONIC MOUNTAIN-SICKNESS; RESPIRATORY MOTOR CONTROL; CHEMOREFLEX RESPONSE; HYPOXIA; ACCLIMATIZATION; HYPERCAPNIA; SATURATION; PLASTICITY; APNEA; RISK; autonomic nervous system; chronic mountain sickness; erythropoietin high altitude; polycythaemia sleep disturbances (1)
CHRONIC MUCOCUTANEOUS CANDIDIASIS; RECEPTOR; METABOLITES; INDUCTION; CELLS; APS-1; APECED; autoimmunity; autoantibody; cytokine; chemokine; microbiome; Lactobacillus rhamnosus GG; tryptophan; GABA (1)
CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE INHIBITORS; BCR-ABL TRANSCRIPTS; MARROW-TRANSPLANTATION; INTERFERON-ALPHA; BLAST CRISIS; THERAPY; TOXICITY; SURVIVAL; (1)
CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW-TRANSPLANTATION; EUROPEAN LEUKEMIANET; MOLECULAR RESPONSE; HEMATOPOIETIC SCT; INTERFERON-ALPHA; DOSE IMATINIB; SURVIVAL; ERA; RECOMMENDATIONS; (1)
CHRONIC MYELOGENOUS LEUKEMIA; IN-VIVO; ACTIVATION; DEPLETION; INDUCTION; PHENOTYPE; MECHANISM; (1)
CHRONIC MYELOGENOUS LEUKEMIA; TREATMENT-FREE REMISSION; QUALITY-OF-LIFE; CHRONIC-PHASE; RANDOMIZED CML; SURVIVAL; DASATINIB; NILOTINIB; THERAPY; 5-YEAR; (1)
CHRONIC MYELOGENOUS LEUKEMIA; X-LINKED THROMBOCYTOPENIA; ALDRICH-SYNDROME; WASP GENE; HEMATOPOIETIC PROGENITORS; MYELODYSPLASTIC SYNDROMES; DIFFERENTIAL-DIAGNOSIS; CONGENITAL NEUTROPENIA; ACTIN POLYMERIZATION; MYELOID-LEUKEMIA; children; juvenile myelomonocytic leukaemia; WiskottAldrich syndrome (1)
CHRONIC MYELOID-LEUKEMIA; IMATINIB MESYLATE; CLONAL EVOLUTION; CYTOGENETIC RESPONSE; INTERFERON-ALPHA; RANDOMIZED CML; PHASE CML; SURVIVAL; RECOMMENDATIONS; ABERRATIONS; Chronic myeloid leukaemia; Balanced and unbalanced karyotypes; Cytogenetics; Prognosis; Outcome (1)
CHRONIC MYELOID-LEUKEMIA; PATIENT EDUCATION; MANAGEMENT; ADHERENCE; IMATINIB; OUTCOMES; PROGRAM; IMPROVE; STRESS; Training course; Non-physician healthcare professionals; Oral and subcutaneous antitumor medications; Cancer patients (1)
CHRONIC MYELOID-LEUKEMIA; POLYMERASE-CHAIN-REACTION; MINIMAL RESIDUAL DISEASE; BONE-MARROW-TRANSPLANTATION; QUANTITATIVE RT-PCR; CHRONIC-PHASE; CYTOGENETIC RESPONSE; MOLECULAR RESPONSE; TRANSCRIPT LEVELS; FOLLOW-UP; quantitative PCR; BCR-ABL; chronic myelogenous leukemia; imatinib; interferon alpha (1)
CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC NEUTROPHILIC LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; MUTATIONS; GENETICS; DISTINCT; CML; allogeneic transplantation; atypical chronic myeloid leukaemia; Myelodyslastic/Myeloproliferative Neoplasms (MDS/MPN); Ph-negative CML: BCR-ABL1-negative (1)
Chronic pain; Interdisciplinary multimodal pain therapy; Core outcome set; Consensus process; Outcome domains (1)
CHRONIC PAIN; PSYCHOTHERAPY; THERAPY; DISORDERS; MIGRATION; GERMANY; WORKERS; HEALTH; BODY; Turkish migrants; transcultural psychotherapy; inpatient rehabilitation; treatment results; social medicine (1)
CHRONIC PAIN; WORKING-MEMORY; RHEUMATOID-ARTHRITIS; GENERAL-POPULATION; DOUBLE-BLIND; PERFORMANCE; DEPRESSION; DOPAMINE; PREVALENCE; BRAIN; Fibromyalgia; Chronic pain; Cognitive deficits; Working memory; Attention (1)
CHRONIC-PANCREATITIS; COMPLICATION; MANAGEMENT; lung abscess; liver abscess; bronchobiliary fistula; biliptysis; klebsiella; chronic pancreatitis (1)
CHRONIC-PANCREATITIS; SPINK1; CHILDREN; GENE (1)
CHRONIC-PANCREATITIS; STRICTURES; DRAINAGE; chronic pancreatitis; ERCP; prothesis of the common bile duct (1)
CHRONIC PAROXYSMAL HEMICRANIA; IDIOPATHIC STABBING HEADACHE; CHRONIC CLUSTER HEADACHE; SUNCT SYNDROME; SUBCUTANEOUS SUMATRIPTAN; HYPNIC HEADACHE; CONJUNCTIVAL INJECTION; LONG-TERM; CONTINUA; INDOMETHACIN; (1)
CHRONIC PAROXYSMAL HEMICRANIA; SUMATRIPTAN NASAL SPRAY; CLUSTER HEADACHE; PREVENTIVE TREATMENT; CLINICAL SPECTRUM; IDENTICAL-TWINS; SUNCT SYNDROME; DOUBLE-BLIND; MIGRAINE; MELATONIN; trigemino-autonomic cephalgias; cluster headache; autonomic symptoms (1)
CHRONIC PELVIC PAIN; URGE INCONTINENCE; NERVE-STIMULATION; INTERSTITIAL CYSTITIS; OVERACTIVE BLADDER; SINGLE-CENTER; MANAGEMENT; RETENTION; IMPACT; sacral neuromodulation; LUTS; bladder pain syndrome; urge incontinence; multiple sclerosis (1)
CHRONIC PORTAL-HYPERTENSION; ILEAL CROHNS-DISEASE; LIVER-CIRRHOSIS; ALPHA-DEFENSINS; TRANSIT-TIME; NOD2 GENE; IN-VIVO; OVERGROWTH; PERITONITIS; EXPRESSION; (1)
CHRONIC PRESSURE ULCERS; ACUTE KIDNEY INJURY; STEM-CELLS; BOWMANS CAPSULE; FACTOR-BB; REPAIR; CALCIUM; COMMUNICATION; POPULATION; MODULATION; (1)
chronic psychosocial stress, affective and somatic disorders, mGlu receptors, stress-protective phenotype (1)
CHRONIC PSYCHOSOCIAL STRESS; ASSESSING ANTIDEPRESSANT ACTIVITY; ELECTROCONVULSIVE SHOCK THERAPY; MAJOR DEPRESSIVE DISORDER; ANXIETY-RELATED BEHAVIOR; FORCED SWIMMING TEST; TAIL SUSPENSION TEST; BRAIN REWARD SYSTEM; ANIMAL-MODELS; BIPOLAR DISORDER; depression; cognition; animal model; stress; bipolar disorder (1)
CHRONIC PSYCHOSOCIAL STRESS; CENTRAL-NERVOUS-SYSTEM; POSITIVE ALLOSTERIC MODULATORS; ANTIDEPRESSANT-LIKE ACTIVITY; ANXIOLYTIC-LIKE ACTIVITY; LONG-TERM POTENTIATION; ELEVATED-PLUS-MAZE; EARLY-LIFE STRESS; EXCITATORY SYNAPTIC-TRANSMISSION; INFLAMMATORY-BOWEL-DISEASE; Animal models; anxiety; chronic stress; depression; mGlu receptors; stress-related disorders (1)
; Chronic psychosocial stress; Chronic subordinate colony housing (CSC); Colitis; Anxiety; CD4(+) lymphocytes; Inflammatory bowel disease (IBD); Adoptive transfer (1)
CHRONIC PSYCHOSOCIAL STRESS; CIRCADIAN VARIATION; PREGNANT RATS; POSTPARTUM; AXIS; RESPONSES; ANXIETY; CORTICOSTERONE; LACTATION; OBESITY; (1)
CHRONIC PSYCHOSOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FACTOR MESSENGER-RNA; MALE-MICE; PLASMA-CORTICOSTERONE; PSYCHOLOGICAL STRESS; CIRCADIAN REGULATION; GENE-EXPRESSION; ADIPOSE-TISSUE; social defeat stress; circadian gating of stress responses; energy homeostasis; HPA axis (1)
CHRONIC PSYCHOSOCIAL STRESS; INFLAMMATORY-BOWEL-DISEASE; COLON INFLAMMATION; MALE-MICE; HPA AXIS; HELICOBACTER-TYPHLONIUS; MATERNAL SEPARATION; RESILIENCE; MICROBIOTA; ANXIETY; Chronic psychosocial stress; Chronic subordinate colony housing (CSC); Enterohepatic Helicobacter species (EHS); Inflammatory bowel disease (IBD); Microbiota; Colitis; Stress vulnerability; Stress resilience; Inflammation; Pathobionts (1)
CHRONIC PSYCHOSOCIAL STRESS; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; MESSENGER-RNA EXPRESSION; DORSAL RAPHE NUCLEUS; EARLY-LIFE STRESS; SEROTONERGIC NEURONS; HELICOBACTER-PYLORI; SOCIAL STRESS; INTESTINAL MICROBIOTA; anxiety; chronic psychosocial stress; fear; microbiota; posttraumatic stress disorder (1)
CHRONIC PSYCHOSOCIAL STRESS; MESSENGER-RNA; ADULT-RAT; IN-VITRO; HPA AXIS; ANXIETY; BRAIN; CONSEQUENCES; LOCALIZATION; EXTINCTION; mGlu7; XAP044; chronic psychosocial stress; chronic subordinate colony housing (1)
CHRONIC PSYCHOSOCIAL STRESS; NB2 LYMPHOMA-CELLS; RAT DENTATE GYRUS; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; AGE-RELATED DECREASE; NEURAL STEM-CELLS; STIMULATED NEUROGENESIS; MATERNAL-BEHAVIOR; ADRENAL-STEROIDS; hippocampus; cell survival; proliferation; HPA axis; corticosterone; dentate gyrus (1)
CHRONIC PSYCHOSOCIAL STRESS; NEGATIVE ALLOSTERIC MODULATOR; MAJOR DEPRESSIVE DISORDER; MALE-MICE; PSYCHOLOGICAL STRESS; MGLU5 RECEPTORS; PRENATAL STRESS; MOOD DISORDERS; ANIMAL-MODEL; ENTERIC GLIA; mGlu5; Knockout; CTEP; Chronic subordinate colony housing; Chronic psychosocial stress; Stress-protective phenotype (1)
chronic psychosocial stress, oxytocin, pathologies (1)
CHRONIC PSYCHOSOCIAL STRESS; PITUITARY-ADRENAL AXIS; BEHAVIORAL CONSEQUENCES; PARAVENTRICULAR NUCLEUS; CENTRAL AMYGDALA; INDUCED COLITIS; BRAIN OXYTOCIN; DEFICIENT MICE; SOCIAL DEFEAT; MALE RATS; Oxytocin; Receptor binding; Chronic subordinate colony housing; Anxiety (1)
CHRONIC REJECTION; MYELOID CELLS-1; ADAPTER PROTEIN; TGF-BETA; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; RECEPTOR; VASCULOPATHY; EXPRESSION; FIBROSIS; Allograft survival; chronic rejection; heart transplantation; innate immunity; TREM-1 (1)
CHRONIC REJECTION; TOLERANCE; TRANSPLANTATION; ANTIBODIES; BREAKDOWN; MODELS; Kidney transplantation; B cells; Rat model; Donor-specific antibodies; Alloresponses (1)
CHRONIC REJECTION; TRANSPLANTATION; OUTCOMES; DIAGNOSIS; HEALTH; PREDICTION; MELANOMA; INSIGHTS; SURGERY; PATIENT; vascularized composite allotransplantation; VCA; facial VCA; face transplant; artificial intelligence; AI; machine learning; deep learning (1)
CHRONIC RENAL DYSFUNCTION; SERUM CREATININE; RISK-FACTORS; RECIPIENTS; SAFETY; IMPACT; MONOTHERAPY; PREDICTION; EFFICACY; TRIAL; Calcineurin inhibitor agents; conversion; everolimus; Liver transplantation; mTor inhibitor; renal function (1)
CHRONIC-RENAL-FAILURE; SMALL-ARTERY DISEASE; VASCULAR CALCIFICATION; UREMIC ARTERIOLOPATHY; MEDIAL CALCIFICATION; INTIMAL HYPERPLASIA; CUTANEOUS NECROSIS; CALCIPHYLAXIS; PARATHYROIDECTOMY; MYOPATHY; (1)
CHRONIC RESPIRATORY-FAILURE; GERMAN NATIONAL GUIDELINE; NONINVASIVE VENTILATION; OUTCOMES; SURVIVAL; TIME; (1)
CHRONIC RESTRAINT STRESS; PITUITARY-ADRENAL AXIS; MOSSY FIBER SYNAPSES; RADIAL-ARM MAZE; DENTATE GYRUS; ADULT NEUROGENESIS; FEMALE RATS; CELL-PROLIFERATION; PSYCHOSOCIAL STRESS; TRACE MEMORIES; stem cell quiescence; neurons; differentiation; spatial memory; corticosterone (1)
CHRONIC RUPTURES; FOLLOW-UP; ARTHRITIS; SYNOVECTOMY; RECONSTRUCTION; OSTEOARTHRITIS; ARTHROPLASTY; MANAGEMENT; REPAIR; Rheumatic elbow; Postoperative treatment; Synovectomy; Total elbow arthroplasty; Olecranon bursitis (1)
CHRONIC SEVERE ANEMIA; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CHRONIC HEART-FAILURE; BODY-COMPOSITION; BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; CARDIAC-HYPERTROPHY; GENERAL-POPULATION; HYPERTENSION; MASS; echocardiography; haematocrit; hypertrophy; left ventricular geometry; population; remodeling (1)
CHRONIC SOCIAL STRESS; VISIBLE BURROW SYSTEM; DSS-INDUCED COLITIS; DEFEAT STRESS; PLUS-MAZE; LYMPHOID ORGANS; PRENATAL STRESS; ANIMAL-MODEL; MALE-RATS; MICE; Anxiety; Depression; Social avoidance; Social stress; CSC; SDOC (1)
chronic stress, ambulatory assessment, cortisol awakening response, fMRI, amygdala, hippocampus, mPFC, mental health, anxiety, depression (1)
chronic stress, ambulatory assessment, neuropeptide S and neuropeptide S receptor, gene-environment interaction, polygenic scores, depression, neuroticism, quasi-experimental design, cortisol awakening response, perceived stress levels, prospective and longitudinal design (1)
; chronic stress; gender differences; risk; self-reported measures; hair cortisol (1)
chronic stress, HPA axis, pituitary, glucocorticoid receptor, negative feedback, stress vulnerability (1)
CHRONIC SUBJECTIVE TINNITUS; HOSPITAL ANXIETY; HD-TDCS; DEPRESSION; PERCEPTION; MECHANISMS; PLASTICITY; RTMS; Machine learning; Random forest classification; Tinnitus; Transcranial direct current stimulation (1)
Chronic subordinate colony housing (CSC), Social fear conditioning (SFC), Neuroinflammation, Amygdala, Animal model, Social trauma, SAD, Chronic psychosocial stress, GILZ, NFκB, Mouse strain, Treatment (1)
CHRONIC THALAMIC-STIMULATION; MOVEMENT-DISORDERS; THALAMOTOMY; MANAGEMENT; Deep brain stimulation; Tremor; Multiple sclerosis; Neurological consensus recommendations (1)
chronic tinnitus, dorsolateral prefrontal cortex, limbic system, transcranial magnetic stimulation, rTMS, neuromodulation (1)
chronic tinnitus, neuromodulation, neuroimaging, neuronal correlates, brain stimulation (1)
CHRONIC ULCERATIVE-COLITIS; COLORECTAL-CANCER; COLONOSCOPIC SURVEILLANCE; DNA ANEUPLOIDY; 5-AMINOLEVULINIC ACID; RISK-FACTORS; FOLLOW-UP; ENDOSCOPY; CARCINOMA; POLYPECTOMY; dysplasia; ulcerative colitis; Crohn's disease; surveillance (1)
CHRONIC ULCERATIVE-COLITIS; CONTROLLED TRIAL; CROHNS-DISEASE; 6-MERCAPTOPURINE; MANAGEMENT; azathioprine; Crohn's disease; ulcerative colitis; long-term immunosuppression (1)
CHRONIC WIDESPREAD PAIN; CEREBRAL BLOOD-FLOW; CHRONIC BACK-PAIN; GRAY-MATTER; STRESS; BRAIN; WOMEN; DEPRESSION; PLASTICITY; RESPONSES; fibromyalgia; chronic pain; voxel-based morphometry; neural plasticity (1)
CHRONIC WOUNDS; CELL-DEATH; EXPRESSION; SKIN; ANGIOGENESIS; REPAIR; MODEL; MICE; wound healing; gene therapy; skin; bums; growth factors (1)
; chronic wound; ulcus cruris; modern wound management; topical therapy; moist wound treatment (1)
chronische Arthritis/chronic arthritis; TNF; G-Protein-gekoppelte Rezeptoren/G protein-coupled receptors; PDE4; beta-Arrestin (1)
Chronische Hepatitis C, Epidemiologie, Diagnostik, Therapie, epidemiology, therapy, diagnostic, chronic Hepatitis C (1)
chronische Herzinsuffizienz, Ventilation, Ergoreflex, β-Blocker, chronic heart failure, ventilation, ergoreflex, β-blocker (1)
Chronische Manie, Paranoiafrage, Zeitgenössische psychopathologische Diskussion, Erbgesundheit, Exogen depressiver Reaktionstypus Chronic mania, Paranoia, Contemporary psychopathological discussion, Hereditary health, Exogenous depressive reaction (1)
Chronische Nierenerkrankung, NMR-Spektroskopie, Metabolomik, Biomarker, GCKD, AugUR (1)
Chronisch entzündliche Darmerkrankungen; CED; inflammatory bowel disease; IBD; Morbus Crohn; Colitis ulcerosa; Colitis indeterminata; Malignität; Malignancy; Malignomentstehung; Tumor; Tumorerkrankung; cancer; Biologika; biologics; Immunsuppresivum; Immunsuppressiva; immunosuppressive drug; (1)
Chronisch entzündliche Darmerkrankungen, Ceramidmetabolismus, saure Sphingomyelinase, Imipramin, Matrix Metalloproteinase-1, experimentelle Kolitismodelle, IL-1beta (1)
Chronisch Entzündliche Darmerkrankungen, Makrophagen, NALP2 und NALP3, Inflammasomkomplex (1)
chronisch-entzündliche Darmerkrankung, Monocyte chemoattractant protein-1, intestinale Makrophagen (1)
Chronischer Schmerz; Kognitiv-behaviorale Schmerztherapie; Verhaltenstherapie bei Schmerz; Schmerzbewältigungstraining; Psychologische Schmerztherapie (1)
Chronischer Stress, Schwangerschaft, Laktation, adulte hippocampale Neurogenese (1)
chronischer Stress, Tumor, MDSC, Makrophagen, Granulozyten, Adrenalin, Glucocorticoide (1)
Chronische Schmerzen, voxel- basierte Morphometrie, Neuroplastizität, mediales und laterales Schmerzsystem, chronic pain, voxel- based morphometry, brain plasticity, medial and lateral pain system (1)
chronisches Subduralhämatomvolumen, subdurale Luft, Bohrloch-Trepanation und Hämatom-Drainage. Chronic subdural hematoma volumes and subdural air, burr hole trephination and hematoma drainage (1)
chronisch kranke Kinder, Kinderkrankenhaus, Spieltherapie, systemische Familienmedizin, systemische Familientheraphie (1)
Chronisch obstruktive Lungenerkrankung, Humane Bronchialepithelzellen, BEAS 2 B, Non-neuronales cholinerges System, Muscarinerge Rezeptoren, Chemotaxis , Carbachol, Interleukin-8, TNF-α, Calciumimaging (1)
chronisch psychosozialer Stress, HPA-Achsen-Funktionalität, Nebennieren, C57BL/6-Mäuse, Hypocorticismus, chronic psychosocial stress, HPA axis functionality, adrenal gland, C57BL/6 mice, hypocorticism (1)
Chronobiologie , Taufliege , Tagesrhythmus , Rhythmus , Schrittmacher , Nervenzelle , Nervennetz , Pigmentdispergierender Faktor , circadian , Pdf , Kopplungsfaktor , Outputfaktor , Uhrproteine , circadian rhythm , Pdf , coupling factor , output factor (1)
CHRONOLOGICAL AGE; 3RD-MOLAR DEVELOPMENT; DENTAL MATURITY; RADIOGRAPHIC EVALUATION; SKELETAL MATURATION; TURKISH CHILDREN; YOUNG-ADULTS; POPULATION; HEIGHT; INTERRELATIONSHIPS; Age determination by teeth/methods; Radiography; Panoramic; European continental ancestry group; Molar; Third/growth and development/radiography; Reference standards; Tooth root/growth and development/radiography (1)
CHURG-STRAUSS-SYNDROME; HENOCH-SCHONLEIN PURPURA; GIANT-CELL ARTERITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE COLONIC ULCERS; SMALL-BOWEL INFARCTION; TERM FOLLOW-UP; POLYARTERITIS-NODOSA; WEGENERS-GRANULOMATOSIS; BEHCETS-DISEASE; vasculitis; Takayasu's arteritis; Wegener's granulomatosis; polyarteritis nodosa; microscopic polyangiitis; Behcet's disease (1)
CHURG-STRAUSS-SYNDROME; MICROSCOPIC POLYANGIITIS; GRANULOMATOSIS; VASCULITIS (1)
CIA Adrenorezeptor Kollagen Rheumatoide Arthritis (1)
CICATRISING CONJUNCTIVITIS; RITUXIMAB; KERATOPROSTHESIS; THERAPY; survey; mucous membrane pemphigoid; immunosuppression; register; Germany; therapy (1)
CICHLID FISHES; EAST-AFRICA; ADAPTIVE RADIATION; FAUNA CRUSTACEA; SPECIATION; PHYLOGENY; INDONESIA; PARATHELPHUSIDAE; PHILIPPINES; TANGANYIKA; endemism; freshwater crabs; Gecarcinucidae; Indonesia; molecular systematics; phylogeny; species flocks; Sundathelphusa molluscivora (1)
Ciclosporin; Liver transplantation; metabolites; cholestasis; rejection;M19; M1A (1)
Ciclosporin liver transplantation; metabolites; nephrotoxicity (1)
Ciclosporin; metabolism; metabolites; liver dysfunction; kidney transplantation (1)
Ciclosporin , Pharmakokinetik , Pharmakodynamik , Immunsuppression , Generika , Nahrungseinfluss , generics , food effect (1)
CIGARETTE-SMOKE; GUINEA-PIG; VASOACTIVE MEDIATORS; DISEASE; RISK; COPD; SUSCEPTIBILITY; OBSTRUCTION; DIAGNOSIS; WOMEN; Chronic thromboembolic pulmonary hypertension; Pulmonary hypertension; Pulmonary arterial hypertension; Tobacco smoke; Smoking; Risk factor (1)
CIGARETTE-SMOKING; POSTMENOPAUSAL WOMEN; PUBLIC-HEALTH; NHANES-III; OSTEOPOROSIS; ADULTS; METAANALYSIS; POPULATION; ABSORPTION; MORTALITY; (1)
CIGARETTE-SMOKING; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; TOBACCO USE; ASSOCIATION; DIAGNOSIS; SURVIVAL; RISK; HYPERMETHYLATION; MORTALITY; (1)
cilazaprilate, prodrug, transdermal therapeutic system, antihypertensive (1)
Ciliary epithelium, Ciliary muscle, Electron microscopy, Human eye (1)
Ciliary ganglion, Substance P, Calcitonin gene-related peptide, Vasoactive intestinal polypeptide, Neuropeptide Y, Tyrosine hydroxylase, Dopamine-β-hydroxylase, Human (1)
Ciliary muscle, Cynomolgus monkey, Macaca fascicularis, Owl monkey, Aotes trivirgatus, NADPH diaphorase, Nerve cell (1)
ciliary muscle, iris sphincter, gap junction, human and monkey eye, connexin43, electronmicroscopy, immunocytochemistry (1)
CILIARY NEUROTROPHIC FACTOR; CELL INTRAOCULAR IMPLANTS; AMYOTROPHIC-LATERAL-SCLEROSIS; ACUTE-PHASE RESPONSE; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; DIABETIC-RETINOPATHY; RECEPTOR-ALPHA; PHOTORECEPTOR DEGENERATION; PATHOLOGICAL ANGIOGENESIS; CNTF; OIR model; revascularization; angiogenesis; proliferative retinopathy (1)
Ciliogenesis; Correlative light and electron microscopy; STEM tomography (1)
C-INDEX; PERIOPERATIVE OUTCOMES; PADUA; MANAGEMENT; SYSTEM; TUMORS; CLASSIFICATION; ASSOCIATION; R.E.N.A.L.; Kidney neoplasms; Nephrectomy; Complications; Tumor burden (1)
cinnamates; click chemistry; micelles; photodegradation; pH-responsive (1)
CIRCADIAN CLOCK; FRUIT-FLIES; PACEMAKER NEURONS; ENDOGENOUS CLOCK; COMPOUND EYES; BRAIN; MELANOGASTER; RHYTHMS; PDF; SYNCHRONIZATION; Cryptochrome; temperature cycle; timeless; locomotor activity; immunohistochemistry moonlight (1)
CIRCADIAN CLOCK; LATITUDINAL CLINES; CRYPTOCHROME; PHOTORECEPTOR; ENTRAINMENT; PACEMAKER; PROTEIN; (1)
CIRCADIAN-CLOCK; PACEMAKER NEURONS; TRANSCRIPTIONAL REPRESSOR; LOCOMOTOR BEHAVIOR; LIGHT-ENTRAINMENT; NERVOUS-SYSTEM; MELANOGASTER; TIMELESS; RHYTHMS; PERIOD; circadian clock; cryptochrome; timeless; photoreception; immunohistochemistry (1)
CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; PACEMAKER NEURONS; LATERAL NEURONS; FUNCTIONAL-ANALYSIS; DORSAL NEURONS; COMPOUND EYES; PDF NEURONS; GENE; RHYTHMS; pigment-dispersing factor; period; timeless; internal desynchronization; circadian rhythms; neuropeptide (1)
CIRCADIAN GENE-EXPRESSION; PITUITARY-ADRENAL AXIS; TNF-ALPHA; BIOLOGICAL CLOCK; IN-VIVO; CELLS; TISSUE; RAT; NOREPINEPHRINE; SUPPRESSES; (1)
CIRCADIAN MELATONIN; RISK-FACTORS; ARTHRITIS; RHYTHMS; SLEEP; DISEASE; DISRUPTION; DURATION; EFFICACY; BIOLOGY; Rheumatic diseases; Arthritis, rheumatoid; Circadian rhythm; Transmeridian travel; Jet lag (1)
CIRCADIAN PACEMAKER NEURONS; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; ENDOGENOUS CLOCK; LATERAL NEURONS; DORSAL NEURONS; NERVOUS-SYSTEM; COMPOUND EYES; DAY LENGTH; OSCILLATORS; dual oscillator model; bimodality; lateral neurons; moonlight; timeless; period (1)
CIRCADIAN PACEMAKER NEURONS; PIGMENT-DISPERSING FACTOR; CENTRAL-NERVOUS-SYSTEM/; ACETYLCHOLINE-RECEPTORS; SUPRACHIASMATIC NUCLEUS; NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; LATERAL NEURONS; MELANOGASTER; RHYTHMS; circadian clock; glutamate receptor; vesicular glutamate transporter; neuromodulation; inhibition; locomotor activity (1)
Circadian rhythm - Mutant behavior - Optic ganglia mutant - Brain mutant - Photoreceptor (1)
CIRCADIAN-RHYTHMS; FUNCTIONAL-ANALYSIS; PACEMAKER NEURONS; LATERAL NEURONS; OWL MONKEYS; DAY-LENGTH; LIGHT; ENTRAINMENT; PERIOD; GENE; circadian rhythm; dual-oscillator model; PERIOD; synchronization; TIMELESS (1)
CIRCADIAN-RHYTHMS; MELATONIN RHYTHM; EXERCISE; CONNECTIONS; ENTRAINMENT; MODULATION; NUCLEUS; SYSTEM; RATS; Actigraphy; circadian rhythms; motor activity; rest; activity rhythm; vestibular system (1)
CIRCADIAN TRANSCRIPTION; ASSOCIATION; POLYMORPHISMS; RECEPTOR; SYMPTOMS; BETA(2)-ADRENOCEPTOR; VARIANTS; CHILDREN; REVEALS; ALPHA; childhood asthma; circadian rhythm; genetic epistasis; nighttime asthma (1)
circRNAs, colorectal cancer, circZNF609, circRNA translation (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; DYNAMICS; CAVITY; ATOMS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; FLUX QUBIT; CAVITY; DYNAMICS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; METAMATERIAL; CAVITY; ATOMS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; MICROCAVITY; RESONATOR; CAVITY; (1)
CIRCULAR-DICHROISM; BINDING-AFFINITY; FLUORESCENCE; PEPTIDES; SENSORS; ASSAY; PAIR; (1)
CIRCULAR-DICHROISM; POLARIMETRIC DETECTION; PURITY; TRIACETYLCELLULOSE; QUANTITATION; SORBENT; EXCESS; SPITE; HPLC; enantiomer separation; preparative chromatography; detection; LC; polarimetric detection; carvone (1)
CIRCULAR-DICHROISM; RACEMIZATION; chiral spirobinaphthopyrans; enantioselective liquid chromatography; tri-acetylcellulose; barriers to racemization; x-ray crystallography (1)
CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; CHEMICAL SYNTHESIS; AQUEOUS-SOLUTION; NATIVE PROTEINS; BINDING; CANCER; TRANSCRIPTION; ANGIOGENESIS; TARGETS; circular dichroism; proteins; self-aggregation; solid-phase synthesis; synthetic proteins (1)
CIRCULAR DICHROISM; SQUARE-PLANAR; COMPLEXES; CYCLOPROPANATION; EPOXIDATION; OLEFINS; Schiff base; tetradentate ligand; asymmetric catalysis (1)
CIRCULARLY-POLARIZED LUMINESCENCE; PHOTOREDOX CATALYSIS; CHIROPTICAL PROPERTIES; ELECTRON-TRANSFER; LIGHT; PHOTOCATALYSIS; ARENES; ENANTIOPURE; C-H activation; electron transfer; helicene functionalizations; organic dyes; photoredox; visible light (1)
Circular photogalvanic effect; Monopolar spin polarization (2)
circular RNA, DIS3, exosome, degradation, PIN domain, cytoplasm, decay, RNA metabolism (1)
CIRCULATING ENDOTHELIAL-CELLS; VENOUS MALFORMATIONS; VASCULAR ANOMALIES; CLASSIFICATION; SCLEROTHERAPY; EMBOLIZATION; APOLLON trial; AVM; Multimodal therapy; Vascular malformations; QoL (1)
Circulating microRNA, AMD, Choroidal neovascularization (1)
CIRCULATING SOLUBLE CD14; GRAM-POSITIVE SEPSIS; MYOCARDIAL-INFARCTION; HUMAN MONOCYTES; ORGAN FAILURE; LPS-BINDING; GENE; MICE; EXPRESSION; RELEASE; sepsis; CD14; polymorphism; infection; lipopolysaccharide (1)
CIRCULATING TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; METASTATIC BREAST-CANCER; ESOPHAGOGASTRIC CANCER; MICROMETASTATIC CELLS; PROGNOSTIC IMPACT; MELANOMA-CELLS; BONE-MARROW; HER2 STATUS; ADENOCARCINOMA; metastasis; single disseminated cancer cells; esophageal cancer; ERBB2 gene amplification; quantitative PCR (1)
CIRCULATING TUMOR-CELLS; FUSION; DNA; PLASMA; QUANTIFICATION; ABERRATIONS; RESISTANCE; DISCOVERY; MARKER; BLOOD; (1)
CIRCULATING TUMOR-CELLS; HIGHLY EFFICIENT CAPTURE; ELECTROSPUN NANOFIBERS; HETEROJUNCTION NANOFIBERS; SENSITIVE DETECTION; MICROFLUIDIC CHIP; LIQUID BIOPSIES; FREE DNA; BIOMARKERS; IMMUNOSENSOR; Cancer diagnosis; Nanofibers; Electrospinning; Miniaturized analytical systems; Point-of-care diagnostics; Liquid biopsy (1)
CIRCULATING TUMOR-CELLS; LONG NONCODING RNAS; GAMMA-CARBOXY PROTHROMBIN; SERUM ALPHA-FETOPROTEIN; COPY NUMBER ABERRATIONS; CHRONIC LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC-VALUE; GLUTAMINE-SYNTHETASE; LIQUID BIOPSY; hepatocellular carcinoma; biomarker; personalized medicine; alpha-fetoprotein; liquid biopsy; circulating tumor cells; circulating nucleic acids; exosomes (1)
CIRCULATING TUMOR-CELLS; MONOCLONAL-ANTIBODY; RADIATION-THERAPY; HUMAN-MELANOMA; IN-VITRO; DNA; RESISTANCE; GROWTH; RADIOTHERAPY; BETA-1-INTEGRIN; (1)
CIRCULATING TUMOR-CELLS; STAGE-III; SENTINEL; TRANSCRIPTOME; HETEROGENEITY; GENOME; disseminated cancer cells; melanoma; lymph node analysis; microfluidics; single cell analysis (1)
Circulation Heart ((methoxybenzamidomethyl)norephedrine and related compds. effect on) cardiovascular catechol amine deriv heart catechol amine deriv circulation catechol amine deriv blood pressure catechol amine deriv norephedrine analog heart circulation (1)
Circulation (N-aminoacyl ephedrine derivs. effect on heart) Nerves (blocking agents for, N-aminoacyl ephedrine derivs. as) Heart (circulation in, N-aminoacyl ephedrine derivs. effect on) Anesthesia (from N-aminoacyl ephedrine derivs.) LOCAL ANESTHETICS MOL CONFIGURATION LOCAL ANESTHETICS EPHEDRINES NERVE EFFECT NERVE EFFECT EPHEDRINES RECEPTOR EPHEDRINES BINDING (1)
CIRCULATORY ARREST; DISSECTION; REPLACEMENT; EXPERIENCE; REPAIR; aorta/aortic; outcomes (includes mortality and morbidity); quality of life (1)
CIRCUMSPOROZOITE PROTEIN; PLASMODIUM-FALCIPARUM; MALARIA; ANTIBODIES; STABILITY; RESPONSES; PEPTIDES; malaria; plasmodium falciparum; plasmodium vivax; vaccine; coiled-coil peptides; immune response (1)
CIRRHOSIS; POLYMORPHISM; RISK (1)
Cirrhosis; Portal hypertension; Heme oxygenase; Gene therapy; Adeno-associated virus (1)
CIRRHOTIC-PATIENTS; INFECTIONS; FAILURE; liver transplantation; waiting list; infection; mortality; pneumonia; ACLF; MELD (1)
CIRRHOTIC RATS; SMOOTH-MUSCLE; NITRIC-OXIDE; SPLANCHNIC VASODILATION; BILIARY-CIRRHOSIS; CA2+ SENSITIVITY; UP-REGULATION; CIRCULATION; KINASE; ENOS; cirrhosis; hyperdynamic circulatory syndrome; Neuropeptide Y; portal hypertension; splanchnic vasodilatation; vasoconstriction (1)
CISPLATIN-BASED CHEMOTHERAPY; RADICAL CYSTECTOMY; PERIOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; CANCER; ELIGIBILITY; TRENDS; Guideline recommendation; Muscle-invasive bladder cancer; Questionnaire; Radical cystectomy; Tumor board (1)
CISPLATIN-BASED CHEMOTHERAPY; RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; OUTCOMES; UNFIT; TRIAL; IMMUNOTHERAPY; METHOTREXATE; GEMCITABINE; VINBLASTINE; Carboplatin; Induction chemotherapy; Oligometastatic; Survival; Urinary bladder neoplasms (1)
CISPLATIN-INELIGIBLE PATIENTS; DNA METHYLATION; T-CELLS; PROSTATE-CANCER; SINGLE-ARM; BIOMARKERS; PEMBROLIZUMAB; ATEZOLIZUMAB; MULTICENTER; KEYNOTE-052; biomarker; bladder cancer; CD274; DNA methylation; immune checkpoint blockade; immunotherapy; metastatic urothelial carcinoma; PD-L1; promoter methylation (2)
CISPLATIN-INELIGIBLE PATIENTS; PD-L1 IMMUNOHISTOCHEMISTRY; SINGLE-ARM; OPEN-LABEL; MULTICENTER; Bladder cancer; Urothelial carcinoma; PD-L1 assay; PD-L1; PD-1; Checkpoint inhibition (1)
CIS-TRANS-ISOMERIZATION; VIBRATIONAL TIME-SCALE; MIXED-VALENCE STATE; CHARGE-TRANSFER; ABSORPTION-SPECTRA; RADICAL CATIONS; CYCLIC VOLTAMMETRY; CRYSTAL-STRUCTURE; RESONANCE RAMAN; AB-INITIO; (1)
CITIES; EXTERNALITIES; PRODUCTIVITY; EMIGRATION; INEQUALITY; RETURN; Regional concentration of high-skilled workers; Churning; Brain gain; Brain drain; Human capital externalities; Internal migration; Wages (1)
citrate | gluconate | malignant melanoma | pmCiC (1)
CITRIC-ACID CYCLE; YEAST FRATAXIN; MITOCHONDRIAL ACONITASE; ELECTRON-TRANSPORT; IRON HOMEOSTASIS; GENE-EXPRESSION; IN-VITRO; PROTEIN; MELANOGASTER; HOMOLOG; frataxin; aconitase; mitochondrial respiration; hyperoxia; RNAi (1)
City Growth, Knowledge Spillovers, Entrepreneurship (1)
City Logistics, Urban Consolidation Center, Urban Logistics, Delivery, Logistics (1)
City Shape, City Skew, Form Follows Function, Political Economy, Sprawl (1)
CITY SIZE; REGIONAL MIGRATION; LABOR MOBILITY; JOB MOBILITY; YOUNG MEN; UNEMPLOYMENT; PRODUCTIVITY; WAGE; PERSPECTIVE; EMPLOYMENT; inter-regional mobility; migration wage differentials; unobserved heterogeneity; propensity score matching (1)
CIVIC INTEGRATION; NATIONAL IDENTITY; WESTERN-EUROPE; IMMIGRATION; MIGRATION; Integration; Political Culture; Identity Politics; Citizenship; Systems Theory (1)
Civil Aircraft Procurement, Colonial Legacy, Global South (1)
Civil aviation, air transport, regulation, liberalisation, airfares, Germany, Lufthansa, Air, Berlin, Deutsche BA (1)
CIVIL-WAR; POLITICAL-PARTICIPATION; VIOLENT CONFLICT; RECALL; PSYCHOPATHOLOGY; TRUST; MOOD; Conflict; social attitudes; World War II (1)
C-JUN; EXPRESSION; DIFFERENTIATION; GENERATION; L-SOX5; NERVES (1)
CKD, Adenin, Mäuse, Kim1, LCN2, GFR, Expression, Lokalisation, (1)
CKD, metabolites, nephron mass, uromodulin (1)
CKD progression; eGFR slope; etiology; heterogeneity (1)
CKDu, ultrastructure, kidney, lysosomal alteration, mitochondrial swelling (1)
C-KIT; MUTATIONS; GIST; (1)
C-KIT RECEPTOR; LEUKOCYTE SURFACE-ANTIGENS; MONOCLONAL-ANTIBODIES; W LOCUS; GENE-EXPRESSION; MOUSE EMBRYO; HUMAN FETAL; TISSUES; LIGAND; LIVER; haematopoietic stem cells; c-kit; primordial germ cells; embryonic haematopoiesis; bovine (1)
C-KIT; TRICHINELLA-SPIRALIS; INNATE IMMUNITY; INTERLEUKIN-33; MICE; ACTIVATION; EXPRESSION; CYTOKINE; SURVIVAL; PROMOTE; (1)
CLADOSPIRONE BISEPOXIDE; FUNGUS; BIOSYNTHESIS; DERIVATIVES; SYSTEM; Sparticola junci; structure elucidation; ECD-TDDFT; COX inhibitory; molecular docking; antiproliferative; cytotoxic (1)
C language;computer science education;control engineering computing;educational courses;robot programming;software engineering;teaching;CS1;Robot introductory programming microlanguage;software engineering practices teaching;Karel releams;C language;graphical two-dimensional world;CS course;Education;Programming profession;Robots;Computer languages;Problem-solving;Writing (1)
Clarias gariepinus; Elektrorezeptor; Beutefang; Dressur; Nilhechte <Familie>; Elektrisches Organ; Elektrischer Sinn (1)
class field theory; higher dimensional fields; arithmetic schemes; Chow group; zero cycles; fundamental group (1)
CLASS FIELD-THEORY; MOTIVIC COHOMOLOGY; RESTRICTION ISOMORPHISM; K-THEORY; HOMOLOGY; DUALITY; RINGS; Chow groups; Kato conjectures; Class field theory; Local to global (1)
CLASS-I ANTIGEN; BRONCHIOLOALVEOLAR CARCINOMA; APOPTOSIS; STIMULATION; LYMPHOCYTES; PATHWAY; KINASE; CELLS; TAXOL; LUNGS; paclitaxel; post-transplant malignancy; antibody response; cytotoxic T lymphocytes; immunosuppression; heart transplantation (1)
CLASS-I ANTIGEN; GREEN FLUORESCENT PROTEIN; CYTOTOXIC T-LYMPHOCYTE; LIVER-TRANSPLANTATION; ORGAN-TRANSPLANTATION; GENE-THERAPY; IMMUNOSUPPRESSION; HEPATOCYTES; TOLERANCE; REJECTION; adenoviral vectors; CTL; heart transplantation; soluble MHC class I (1)
CLASS-I; ANTIRETROVIRAL THERAPY; LYMPHOCYTE ACTIVITY; PEPTIDE COMPLEXES; TYPE-1 INFECTION; IMMUNE-RESPONSES; DENDRITIC CELLS; FLOW-CYTOMETRY; IMMUNODEFICIENCY; ANTIGEN; antiretroviral therapy; CD4; CD8; cellular immunity; HIV (1)
classical and operant conditioning; blocking; overshadowing; sensory preconditioning; second-order conditioning; Drosophila melanogaster; memory; learning (1)
CLASSICAL BLADDER EXSTROPHY; QUALITY-OF-LIFE; INCONTINENT EPISPADIAS; FEMALE-PATIENTS; FOLLOW-UP; RECONSTRUCTION; CONTINENCE; POPULATION; GENITALIA; CHILDREN; exstrophy-epispadias-complex; long-term outcome; transition; adulthood (1)
CLASSICAL DENDRITIC CELLS; GM-CSF; DIFFERENTIATION; MACROPHAGES; PROGENITORS; MICROGLIA; CNS; (1)
CLASSICAL HLA ALLELES; ANALYSIS IDENTIFIES 3; OF-FUNCTION VARIANTS; CD8(+) T-CELLS; SUSCEPTIBILITY LOCI; CELLULAR ACTIVATOR; IFN-GAMMA; ASSOCIATION; POPULATION; FILAGGRIN; (1)
CLASSICAL HLA ALLELES; SUSCEPTIBILITY LOCI; FILAGGRIN MUTATIONS; REVEALS ASSOCIATION; GENETIC-VARIATION; COMMON VARIANTS; LARGE-SCALE; HAY-FEVER; RISK; DISEASE; (1)
CLASSICAL KNOT; INVARIANTS; CONCORDANCE; GENUS (1)
CLASSICALLY CHAOTIC REPELLOR; 3-DIMENSIONAL SINAI BILLIARD; SEMICLASSICAL QUANTIZATION; PERIODIC-ORBITS; SCATTERING; SYSTEMS; ATTRACTORS; RESONANCES; REVIVALS; MOTION; (1)
CLASSICAL ORTHOGONAL POLYNOMIALS; CHIRAL-SYMMETRY; GAUGE-THEORIES; LATTICE; ENSEMBLES; SPECTRA; LIMIT; Matrix Models; Lattice Gauge Field Theories; Phase Diagram of QCD (1)
CLASSICAL RECEPTIVE-FIELD; OPTIC FLOW STIMULI; CORTICAL AREAS MT; COMPLEX MOTION; VISUAL-MOTION; MST NEURONS; RESPONSE SELECTIVITY; SPATIAL ATTENTION; SPIRAL MOTION; PERCEPTION; (1)
CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; MACAQUE V1; SURROUND SUPPRESSION; CONTRAST ADAPTATION; SPATIAL SUMMATION; FUNCTIONAL ARCHITECTURE; PERCEIVED CONTRAST; INTEGRATION FIELD; ORIENTED FILTERS; lateral modulation; surround inhibition; tilt-aftereffect; spatial vision; divisive inhibition (1)
CLASSICAL TRAJECTORIES; WEAK-LOCALIZATION; SCATTERING-THEORY; QUANTUM CHAOS; SHOT-NOISE; DIVERGENCE; (1)
CLASSIC BLADDER EXSTROPHY; DATABASE; COMPLEX; CLOACA; exome analysis; molecular inversion probe; exstrophy; cloacal exstrophy (1)
CLASSIC BLADDER EXSTROPHY; QUALITY-OF-LIFE; INDEX FSFI; CYSTECTOMY; WOMEN; Bladder exstrophy-epispadias complex; Sexuality; Sexual function; Female Sexual Function Index (1)
Class I, Class III, Malocclusion, Artificial intelligence, Orthodontic diagnostics, Individualized, treatment planning (1)
CLASSIFICATION; CHALLENGES; IMAGES; artificial intelligence; machine learning; deep learning; neural networks; convolutional neural networks; pathology; clinical pathology; digital pathology; pitfalls; artifacts (1)
CLASSIFICATION CRITERIA; DIAGNOSIS; Psoriasis; Psoriasis arthritis; Questionnaires (1)
CLASSIFICATION; DIAGNOSIS; ANOMALIES; CHILDREN; Congenital vascular malformation of the tongue; slow-flow malformation; fast-flow malformation; Bleomycin-electrosclerotherapy; sclerotherapy; embolization (1)
CLASSIFICATION; DIAGNOSIS; Malignant pleural mesothelioma; Contrast enhanced MDCT; Chest imaging; Oncologic imaging; Retrospective study (1)
CLASSIFICATION; DISORDER; (1)
CLASSIFICATION; histiocytoma; orbital tumour; lid (1)
CLASSIFICATION; INSTABILITY; AC joint dislocation; acromioclavicular joint; Rockwood classification; vertical instability; shoulder girdle (1)
Classification, LLM, README, Zero-Shot, Few-Shot (1)
classification, machine learning, R language, regression, species distribution model, causal inference, predictive modelling, deep learning (1)
Classification of disease, metabolomics, molecular diagnosis, metabolic fingerprinting (1)
CLASSIFICATION; penoscrotal lymphedema; free vascularized lymph node transfer; lymphedema (1)
CLASSIFICATION; PERFUSION; RESECTION; SURGERY; THYMOMA; MALIGNANCIES; MANAGEMENT; PROPOSAL; Hyperthermic intrathoracic chemotherapy; Thymic tumour; Thymic carcinoma; Cytoreductive surgery (1)
CLASSIFICATION; pleural mesothelioma; thymoma; pleural carcinosis; pleural tumour (1)
CLASSIFICATION; RISK; STRATIFICATION; DERMATOLOGISTS; SUPERIOR; Melanoma; Skin cancer; Artificial intelligence; Neural network model; Lymph node biopsy; Sentinel; Histology; Machine learning; Biomarkers; Pathology (1)
CLASSIFICATION-SYSTEM; AMPUTATION; DIAGNOSIS; ULCERS; OSTEOMYELITIS; ONYCHOMYCOSIS; POPULATION; INFECTIONS; PREVALENCE; ISCHEMIA; Diabetes mellitus; Foot ulcer; Malum perforans; Polyneuropathies; Ischemia (1)
CLASSIFICATION; SYSTEM; CELLS; PROPOSALS; THERAPY; IMPACT; acute myeloid leukemia; urokinase-plasminogen-activator receptor; CD87; immunophenotyping; prognosis (1)
CLASSIFICATION; TUMORS; HISTOPATHOLOGY; EMPHASIS; SYSTEM; TYPE-1; KIDNEY; Renal cell carcinoma; Papillary renal cell carcinoma; Subtype; Histopathology; Immunohistochemistry; MIB1 (1)
CLASSIFICATION; undifferentiated pleomorphic sarcoma; malignant fibrous histiocytoma; WHO-classification of soft tissue tumors; orbital tumor (1)
CLASSIFYING MECHANICAL INJURIES; INTRAOCULAR-LENS IMPLANTATION; COMBINED PHACOEMULSIFICATION; EYE GLOBE; BODIES; MANAGEMENT; ENDOPHTHALMITIS; VITRECTOMY; REMOVAL; SYSTEM; intraocular metallic foreign body; ocular trauma score (1)
class I glutamine amidotransferases, allostery (1)
Class II, Filtek one, Self-adhesive, RBC, Bulk-fill (1)
CLASS-II; ORTHODONTIC TREATMENT; OVERBITE MALOCCLUSION; COLLABORATIVE CROSS; INCISOR INTRUSION; PREVALENCE; GENETICS; RELAPSE; CURVE; STABILITY; deep bite; clinical treatment strategies; genetics of deep bite; animal model; genomics approaches (1)
CLASS-II RESTORATIONS; GLASS-IONOMER CEMENTS; PRIMARY TEETH; CLINICAL-EVALUATION; PRIMARY MOLARS; RESIN; AMALGAM; SURVIVAL; LESIONS; COHORT; Resin-based composite; Compomer; Longevity; Survival; Primary molars; Class II (1)
CLASS-I MOLECULES; CD8(+) T-CELLS; DENDRITIC CELLS; F-ACTIN; RECEPTOR; THERAPY; DNGR-1; ACTIVATION; INNATE; TRANSPLANTATION; CD8(+)T cells; cDC1; cross-presentation; DNGR-1; transplantation (1)
CLASS-I MOLECULES; NK CELLS; IMMUNOGLOBULIN-SUPERFAMILY; HLA-E; INHIBITORY RECEPTORS; T-CELLS; COMPLEX; CD94; RECOGNITION; ANTIGEN; (1)
CLASS-I PRESENTATION; T-CELL RESPONSES; TAT-FUSION PROTEINS; DENDRITIC CELLS; EXOGENOUS ANTIGEN; ADAPTIVE IMMUNITY; NUCLEAR ANTIGEN; TRANSDUCTION; LYMPHOCYTES; MOLECULES; (1)
Classroom-based assessment (CBA), data-based instruction, diagnostic competencies, formative assessment, summative assessment, progress monitoring, questionnaire, teachers (1)
Classroom-based assessment, Educational assessments, Teacher assessment, Teacher education, Progress monitoring (1)
classroom management, InClass, inclusive education, special education, student teachers, special educational needs (SEN) (1)
CLASS-SWITCH RECOMBINATION; RI-ALPHA GENE; WIDE ASSOCIATION; CHILDHOOD ASTHMA; POLYMORPHISMS; PATHOGENESIS; POPULATIONS; VARIANTS; CHILDREN; ALLERGY; asthma; atopy; fine-mapping; genetic polymorphisms; immunoglobulin E (1)
Clathrate , Clathrate , Host , guest , phosphorus chalcogenide , zinc iodide (1)
CLATHRIN-MEDIATED ENDOCYTOSIS; HEART-FAILURE; DILATED CARDIOMYOPATHY; FERRIC CARBOXYMALTOSE; ALPHA-ACTININ; PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; ARP2/3 COMPLEX; RHO-KINASE; MUTATIONS; TRAFFICKING; cardiomyopathy; dilated; cardiovascular disease; heart failure; iron deficiency; sarcomere (1)
CLATHRIN-MEDIATED ENDOCYTOSIS; TYPE-1 RECEPTOR; PEPTIDES; BINDING; KIDNEY; BIODISTRIBUTION; TRANSFERRIN; ANTAGONIST; BOMBESIN; CELLS; Agonist; GPCR; ligand-receptor interaction; multivalent enhancement; multivalency; polyvalency; quantum dots; uptake (1)
Clavien–Dindo classification; postoperative complications; body contouring; reconstructive surgery (1)
CL-CHANNEL ANO1; ANOCTAMIN 6; PHOSPHATIDYLSERINE EXPOSURE; CALCIUM; CONDUCTANCE; ACTIVATION; EXPRESSION; REQUIRES; SIGNALS; CELLS; TMEM16A; TMEM16F; Anoctamin 1; Anoctamin 6; phospholipid scrambling; Ca2+ activated Cl- channel (1)
CL-CHANNEL; KIDNEY; LOCALIZATION; MEDULLA; GENE; gene expression; in situ hybridisation; real-time PCR; sodium chloride; salt homeostasis; chloride channels; loop diuretic (1)
CL-CHANNEL; TMEM16F; ACTIVATION; CA2+; TMEM16A/ANO1; EXPRESSION; ANOCTAMINS; APOPTOSIS; COMPONENT; SIGNALS; Anoctamin 6; TMEM16F; apoptosis; ferroptosis; Ca2+ signaling; cell death (1)
CLC-K1, CLCKA, Barttin, Hyperosmolarität, Dehydratation, SGK1, TonEBP, Transkriptionsfaktor (1)
CL COTRANSPORTER KCC3; CORPUS-CALLOSUM; AGENESIS; (1)
CLEAN INTERMITTENT CATHETERIZATION; NEUROGENIC BLADDER DYSFUNCTION; URINARY-TRACT-INFECTION; INTRAVESICAL OXYBUTYNIN CHLORIDE; PIPPI-SALLE PROCEDURE; SPINAL-CORD-INJURY; BOTULINUM-A TOXIN; AUGMENTATION CYSTOPLASTY; FOLLOW-UP; LATEX ALLERGY; neurogenic bladdeer; meningomyelocele; pharmacotherapy; clean intermittent catheterization; antibacterial prophylaxis; urinary tract infection; latex allergy; bowel function; urinary diversion (1)
CLEAN ROOM ENVIRONMENTS; RIBOSOMAL-RNA; PLANETARY PROTECTION; PROPIDIUM MONOAZIDE; SP NOV.; DIVERSITY; BACTERIAL; FACILITY; MARS; COMMUNITIES; Planetary protection; Spacecraft assembly facility; Microbial diversity; Herschel (1)
CLEARANCE; aging; Bcl-2; cellular senescence; immune responses; senolytics; tumor growth; vaccination (1)
CLEAR-CELL CARCINOMAS; RADIOTHERAPY; PROGNOSIS; TUMORS; Endometrial cancer; high grade; carcinosarcoma; type II (1)
CLEAR-CELL-SARCOMA; PART SARCOMA; IMMUNOHISTOCHEMICAL ANALYSIS; TENDONS; GENE; FIBROSARCOMA; APONEUROSES; NEOPLASMS; FUSIONS; VARIANT; Carcinosarcoma; Sarcoma; Histology; Molecular pathology; Soft tissue neoplasms (1)
CLEAVED-EDGE-OVERGROWTH; LATERAL CONFINEMENT; ENERGY; EXCITONS; WELLS; DOTS; (1)
Cleaved-edge-overgrowth; Superlattice; Bloch oscillations; Charge domain stability (1)
Cleaved-edge-overgrowth; Superlattice; Bloch oscillations; Magnetic field (1)
Cleaved-edge overgrowth; Vertical transistor; DC transport (1)
CLEIDO-CRANIAL DYSOSTOSIS; SURGICAL-MANAGEMENT; ADULT PATIENTS; CBFA1 GENE; PATIENT; MUTATIONS; ANOMALIES; TEETH; CCD; SON; bone development classification; craniofacial abnormalities; tooth eruption (1)
Cleidocranial Dysplasia, osteoblast, strontium, Runx2 expression (1)
; CLIA; Coronavirus; COVID-19; ELISA; Epidemiology; IgG; Immunity; Neutralisation assay; Shutdown; Soccer (1)
CLICK CHEMISTRY; BIOLOGY; RELEASE; GROWTH (1)
CLICK CHEMISTRY; DRUG-DELIVERY; MALEIMIDE; POLYMERS; HYDROLYSIS; CATALYSIS; KINETICS; RELEASE; DESIGN; (1)
click chemistry, hydrogel, antibody, controlled release, Diels-Alder reaction, thiol-ene reaction, age-related macular degeneration, microfluidics, polyanion (1)
CLICK CHEMISTRY; RECEPTOR; PEPTIDES; EXPRESSION; CANCER; BIODISTRIBUTION; GLYCOSYLATION; LIGANDS (1)
CLICK CHEMISTRY; ULTRASOUND; NANOPARTICLES; RECOGNITION; IONS; SITE; (1)
Clifford structures, homogeneous spaces, exceptional Lie groups, root systems (1)
CLIFFORD STRUCTURES; HYPERCOMPLEX; (1)
climate change adaptation | climate finance | inclusive finance | microfinance (1)
CLIMATE-CHANGE; ADAPTATION EVIDENCE; DIRECT IMPACT; TEMPERATURE; MORTALITY; CONSEQUENCES; FLUCTUATIONS; STRESS; SHOCKS; HEAT; interregional inequality; income distribution; heat waves; extreme temperature; Russia (1)
CLIMATE-CHANGE; ADAPTIVE SIGNIFICANCE; MOBBING BEHAVIOR; BODY CONDITION; PREDATOR; PSEUDOREPLICATION; INFORMATION; EXTREMES; RANGE; COSTS; Acoustic communication; Climate change; Great tit; Heat stress; Mobbing calls (1)
climate change, Alps, functional trait, specific leaf area, pollen germination, seed germination, vegetation, temperature (1)
climate change, climate‐sensitive diseases, eco‐gastroenterologist, eco‐intensivist, eco‐surgeon, greener gastroenterology, sustainable healthcare (1)
climate change | cold | crop | heat | limits | pollen | reproduction | seed | temperature | tolerance (1)
CLIMATE-CHANGE; COLD-HARDINESS; INVASIVE MOSQUITO; VECTOR-BORNE; DYNAMICS; VIRUS; SURVIVORSHIP; DESICCATION; ACCLIMATION; POPULATIONS; (1)
CLIMATE-CHANGE; ECONOMICS; UNCERTAINTY; SUSTAINABILITY; BEHAVIOR; AVERSION; Expected Utility Theory; Catastrophic risks (1)
CLIMATE-CHANGE; FUNCTIONAL TRAITS; RESTORATION ECOLOGY; REGENERATION NICHE; DORMANCY; PERSISTENCE; VEGETATION; DISPERSAL; DATABASE; CONSERVATION; Climate change; Community assembly; Dispersal; Plant functional traits; Regeneration niche; Restoration ecology; Seed germination; Seed morphology; Seed traits (1)
climate change | global warming | greenhouse gases | net zero | planetary health | sustainable healthcare (1)
CLIMATE-CHANGE; HIGH-TEMPERATURES; HEAT WAVES; HEALTH; ADAPTATION; IMPACT; COLD; VARIABILITY; STRESS; Climate change; Cold spells; Extreme weather; Heat waves; Mortality; Russia (1)
CLIMATE-CHANGE IMPACTS; LEAF DRY MASS; FUNCTIONAL TRAITS; PHOTOSYNTHETIC CAPACITY; PHENOTYPIC PLASTICITY; PLANT RESPIRATION; LOCAL ADAPTATION; NITROGEN-CONTENT; BARK THICKNESS; BUD BURST; (1)
CLIMATE-CHANGE; LAND-USE; CONSERVATION STRATEGIES; SPECIES DISTRIBUTIONS; RAIN-FORESTS; DIVERSITY; DISTURBANCE; FRAGMENTATION; EPIPHYTES; IMPACTS; Climate change; Conservation; Impact; IPBES; Land use change; South America (1)
CLIMATE-CHANGE; POLITICAL-INSTITUTIONS; ENVIRONMENTAL-POLICY; PUBLIC-GOODS; STATE; DICTATORSHIP; DECENTRALIZATION; PERFORMANCE; CAPACITY; QUALITY; Climate policy; Democracy; Autocracy; Institutions; Climate change; Social equality; Civil society participation (1)
CLIMATE-CHANGE; RANGE SHIFTS; SHADE-TOLERANCE; NICHE SHIFTS; LEAF-AREA; FOREST; REGENERATION; MIGRATION; IMPACTS; CLASSIFICATION; climate change; Europe; national forest inventories; ontogenetic niche shift; range shift; tree demography (1)
CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; CONSERVATION; VEGETATION; RARITY; SWITZERLAND; DIVERSITY; PATTERNS; SCALE; conservation biogeography; floristic data base; floristic mapping; Germany; habitat distribution; habitat frequency; habitat mapping; NATURA2000; predictive modelling; species frequency (1)
CLIMATE-CHANGE; TUBE GROWTH; SEXUAL REPRODUCTION; SEED PRODUCTION; BAVARIAN ALPS; PLANT-GROWTH; RESPONSES; PATTERNS; STRESS; FERTILIZATION; pollen germination; pollen tube growth; plant distribution; elevational gradient; biogeography; temperature; climate change (1)
CLIMATE; climate change; Planetary Health; student; health; higher education (1)
Climbing, Risk-sports, Mindfulness, Emotion-regulation (1)
CLIMB; Land use changes; Biodiversity; Phytodiversity; Functional analysis (1)
Clindamycin, Antibiotikatherapie, Osteomyelitis, Osteoradionekrose, Amoxicillin & Clavulan acid, Clindamycin, Antibiotic Osteomyelitis, Ostitis, CRMO, Hyperbaric Oxygen, HBO, Osteoradionecrosis therapy (1)
; clinical acute medicine; clinical emergency medicine; fellowship training programm; emergency department; emergency care; emergency room (1)
Clinical cancer registry, Database software selection, Data migration, Data analysis concept (1)
clinical cancer registry data | neoadjuvant chemotherapy | real-world data | triple-negative breast cancer (1)
CLINICAL CARE; EIF2AK3; PHENOTYPE; CHILDREN; MELLITUS; MUTATION; DISEASE; LIVER; EIF2AK3 mutation; Neonatal diabetes; Wolcott-Rallison syndrome; DPV registry (1)
CLINICAL CASE REPRESENTATIONS; STUDENTS SELF-EXPLANATIONS; PROBLEM-SOLVING STRATEGIES; BIOMEDICAL KNOWLEDGE; MEDICAL EXPERTISE; BASIC SCIENCE; ENCAPSULATED KNOWLEDGE; CASE CONCEPTUALIZATION; SUPERIOR PERFORMANCE; DIAGNOSTIC-ACCURACY; Case processing; Domain-specificity; Generality of expertise; Knowledge restructuring; Levels of expertise; Running head; Knowledge restructuring through case processing (1)
CLINICAL CHARACTERISTICS; BACTERIAL; FUSARIUM; LONDON; cornea; contact lens; risk factor; fungus; keratitis (1)
Clinical diagnostics; Saliva; Biomarker; Biosensor; Viral disease; Cardiovascular disease; Cancer; Drug abuse; Wearable sensors; Microfluidics (1)
clinical evaluation; dental materials; evaluator calibration; restorative procedures; standards (1)
CLINICAL EXAMINATION; TUMOR RESPONSE; MAMMOGRAPHY; ACCURACY; CHEMOTHERAPY; MRI; ULTRASONOGRAPHY; SONOGRAPHY; Automatic breast ultrasound; Neoadjuvant chemotherapy; Response control; Breast cancer; Imaging modalities (1)
CLINICAL-EXPERIENCE; ARTHROPLASTY; NAVIGATION; INCISION; MIDVASTUS; ALIGNMENT; IMPLANTATION; METAANALYSIS; PLACEMENT; total knee arthroplasty; minimal invasive; navigation; computer assisted surgery; prospective randomised trial (1)
CLINICAL-EXPERIENCE; NEEDLE; ASPIRATION; ULTRASOUND; LESIONS; SYSTEM; computed tomography (CT); fluoroscopy; percutaneous intervention; biopsies; drainages (1)
CLINICAL-EXPERIENCE; POLYGLYCOLIC ACID; UPPER EXTREMITY; RECONSTRUCTION; REGENERATION; MANAGEMENT; ALLOGRAFTS; GAP; TRANSFERS; INJURIES; Collagen; large-diameter nerve; nerve conduit; nerve reconstruction; peripheral nerve repair (1)
CLINICAL-EXPERIENCE; ULNAR NERVES; REPAIR; RECONSTRUCTION; FOREARM; BIOMATERIALS; SURGERY; INJURY; HAND; QUESTIONNAIRE; Type I collagen nerve conduit; biocompatibility; peripheral nerve repair (1)
CLINICAL-EXPERIENCE; US; BENIGN; ELASTICITY; MASSES; Breast lesions; ultrasound; elastography; breast imaging reporting and data system; invasive carcinoma of no special type (NST) (1)
CLINICAL-FEATURES; POTASSIUM-NITRATE; HUMAN TEETH; HYPERSENSITIVITY; FLUID; SENSITIVITY; TUBULES; PREVALENCE; DENTIFRICE; ABRASION; Dentine hypersensitivity; DH; Perfusion; Tubules; Dentinal fluid; Fluoride; Protein (1)
CLINICAL GALLBLADDER-DISEASE; GALL STONE DISEASE; DIABETES-MELLITUS; DANISH POPULATION; PHYSICAL-ACTIVITY; ESTROGEN; CHOLESTEROL; SMOKING; WEIGHT; cholelithiasis; cholecystectomy; epidemiology; prevalence; Germany (1)
CLINICAL HANDOVER; CHECKLIST; TRENDS; WARD; SCT; (1)
CLINICAL IMPACT; CRIZOTINIB; PROGRESSION; CHEMOTHERAPY; ALECTINIB; SURVIVAL; THERAPY; CNS; ALK; brain metastases; early access program; lorlatinib; NSCLC; ROS1; TP53 (1)
Clinical informatics, privacy, security, modeling, ontologies, HL7 (1)
CLINICAL INFORMATION; HISTORY; ACCURACY; READ; (1)
CLINICALLY IMPORTANT DIFFERENCE; MINIMALLY IMPORTANT DIFFERENCES; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; MEANINGFUL CHANGE; PAIN; ANCHOR; SCORES; QUESTIONNAIRE; STIMULATION; tinnitus; tinnitus assessment; visual analog scale; coordinated reset (CR) neuromodulation; minimal clinically identifiable difference; receiver operating characteristic (1)
CLINICALLY IMPORTANT DIFFERENCES; EUROPEAN-ORGANIZATION; MEANINGFUL CHANGE; FUNCTIONAL ASSESSMENT; STANDARD-DEVIATION; REPORTED OUTCOMES; QUESTIONNAIRE; UNIVERSALITY; CISPLATIN; HALF; Anchoring; EORTC QLQ-C30; Health-related quality of life; Minimal important difference (1)
CLINICALLY ISOLATED SYNDROMES; LONG-TERM DISABILITY; MULTIMODAL EVOKED-POTENTIALS; SPINAL-CORD LESIONS; VITAMIN-D; DISEASE-ACTIVITY; NATURAL-HISTORY; BRAIN ATROPHY; BLACK-HOLES; FOLLOW-UP; multiple sclerosis; prognosis; clinical parameters; magnetic resonance imaging (MRI); biomarkers; treatment; optical coherence tomography; evoked potentials (1)
; Clinical; Nodal stage; Primary urethral carcinoma; Prognostic; Risk factors; Survival (1)
Clinical obesity; Cancer risk; Cohort study (1)
CLINICAL-OUTCOMES; COMPETING RISK; SURVIVAL; MORBIDITY; IMPACT; MUSCLE; THERAPY; SCORE; AGE; Comorbidity; Cystectomy; ACE27; CCI; ACCI; ASA; ECOG; Urothelial carcinoma; Bladder cancer; Cancer-independent mortality (1)
clinical outcomes; complications; lithium disilicate; single crowns; survival; systematic review (2)
CLINICAL-OUTCOMES; SURGERY; UNIT; (1)
CLINICAL-PERFORMANCE; POWDER/LIQUID RATIO; RESIN CEMENT; CAST GOLD; STRENGTH; LOAD; Glass-ceramic crown; Mixing error; Composite cements; Dark curing; Storage (1)
CLINICAL PHARMACOKINETICS; ORGAN-TRANSPLANTATION; ORAL BIOAVAILABILITY; LIPID FORMULATIONS; LIPOPHILIC DRUGS; WHOLE-BLOOD; SOLUBILITY; ABSORPTION; EMULSION; EFFICACY; FK 506; Blood levels; Rats (1)
CLINICAL PHARMACOKINETICS; PLASMA; CARBAMAZEPINE; EPILEPSY; column-switching; lamotrigine; oxcarbazepine; 10-monohydroxycarbazepine; therapeutic drug monitoring (1)
CLINICAL-PRACTICE; BASE-LINE; DISEASE; PROGRESSION; SHROOM3; ADJUSTMENT; VARIANTS; EXAMPLE; RISK; BIAS; acute kidney injury; chronic kidney disease; diabetes; gene expression (1)
CLINICAL-PRACTICE GUIDELINES; FINE-NEEDLE-ASPIRATION; SUBEPITHELIAL LESIONS; SUBMUCOSAL TUMORS; TRUCUT BIOPSY; GI TRACT; ENDOSCOPY; YIELD; MULTICENTER; HISTOLOGY; abdomen; stomach; endoscopy; tumor; endoscopic ultrasound; fine-needle aspiration; subepithelial tumors; gastrointestinal stromal tumor; survey (1)
; clinical practice guidelines; guideline development; evidence-based; recommendations (1)
CLINICAL-PRACTICE GUIDELINES; HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; HEPATIC-TUMORS; TRANSPLANTATION; METASTASES; MANAGEMENT; EFFICACY; THERAPY; CANCER; irreversible electroporation; contrast enhanced ultrasound; perfusion analysis; hepatocellular carcinoma (1)
CLINICAL-PRACTICE GUIDELINES; INTERNATIONAL ASSOCIATION; PROPOSALS; DIAGNOSIS; REVISION; SYSTEM; NSCLC; thoracic surgery; lung cancer; TNM; cancer (1)
CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; MANAGEMENT; ABLATION; EFFICACY; COHORT; (1)
CLINICAL-PRACTICE GUIDELINES; MENTAL-HEALTH RESOURCES; PSYCHOSOMATIC-MEDICINE; LUNG-CANCER; OF-LIFE; DISTRESS; QUALITY; DEPRESSION; ATTITUDES; BARRIERS; Neoplasms; Clinical oncology; Health psychology; General practice; Health services research (1)
CLINICAL-PRACTICE GUIDELINES; PRIMARY CUTANEOUS MELANOMA; INTERDISCIPLINARY GUIDELINE; FOLLOW-UP; DIAGNOSIS; UPDATE; MANAGEMENT; RECOMMENDATIONS; TOOLS; cutaneous melanoma; AGREE; level of evidence; melanoma treatment; practice guideline (1)
CLINICAL-PRACTICE GUIDELINES; RECIPIENTS; DIALYSIS; KIDNEY; MANAGEMENT; CANDIDATES; DISEASE; malignancy; recipients; screening; transplantation; waiting list (1)
CLINICAL-PRACTICE; HEPATOCELLULAR-CARCINOMA; PERCUTANEOUS DRAINAGE; EFSUMB GUIDELINES; RECOMMENDATIONS; CHEMOEMBOLIZATION; Contrast enhanced ultrasound (CEUS); abdominal drainage; abdominal infections; fluid collection; computed tomography (CT); endoluminal CEUS (1)
CLINICAL-PRACTICE RECOMMENDATIONS; HEPATOCELLULAR-CARCINOMA; NODULAR HYPERPLASIA; PROSPECTIVE MULTICENTER; DIAGNOSTIC PERFORMANCE; DIFFERENTIAL-DIAGNOSIS; PRACTICE GUIDELINES; MANAGEMENT; CIRRHOSIS; PATTERN; CEUS; focal liver lesions; sonography; contrast-enhanced ultrasound; liver ultrasound (1)
CLINICAL PRESENTATION; PITUITARY-ADENOMAS; INDUCED PSYCHOSIS; PUBERTAL CHANGES; CHILDREN; ADOLESCENTS; MANAGEMENT; HYPERPROLACTINEMIA; HYPERSEXUALITY; ENDOCRINE; adverse effect; cabergoline; children; mental disorder; prolactinoma (1)
CLINICAL RATING SYSTEM; 5-YEAR FOLLOW-UP; HINGE TOTAL KNEE; QUALITY-OF-LIFE; PROSTHESIS; HIP; OUTCOMES; REPLACEMENT; MINIMUM; TKA; (1)
CLINICAL RATING SYSTEM; ARTHROPLASTY; PROPRIOCEPTION; BALANCE; PROSTHESES; JOINT; Total knee arthroplasty; Postural stability; Cruciate-retaining/cruciate-substituting implant; Biodex Balance System; One-leg stance (1)
CLINICAL-RELEVANCE; LESS-THAN-0.1 MM; TUMOR-CELLS; METASTASES; CANCER; PROGNOSIS; LOCATION; BIOPSY; (1)
CLINICAL REPORT; COMPLICATION RATES; DENTAL IMPLANTS; IN-VITRO; STRENGTH; RESTORATIONS; SURVIVAL; SIMULATION; MANAGEMENT; PATIENT; all-ceramic suprastructures; implant abutments; zirconia ceramic (1)
CLINICAL-RESEARCH; ALTMETRICS; DIAGNOSIS; IMPLANTS; OUTCOMES; QUALITY; SCIENCE; WEB; fracture-related infection; bibliometry; research scores; medical information science (1)
CLINICAL-RESEARCH; CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; METAANALYSIS; HETEROGENEITY; REGRESSION; TESTS; (1)
; clinical research/practice; clinical trial; immune regulation; immunosuppression/ immune modulation; immunosuppressive regimens; minimization/withdrawal; kidney transplantation/nephrology; kidney transplantation: living donor; monitoring: immune; translational research/science (1)
clinical research; practice; everolimus; heart transplantation; cardiology; immunosuppressant-calcineurin inhibitor (CNI); immunosuppressant-mechanistic target of rapamycin (mTOR); immunosuppression; immune modulation; tacrolimus (1)
CLINICAL ROUTINE; THERAPY; IMPACT; Economics; Decision analysis; Cost-effectiveness; Health policy and practice; Tumor board (1)
CLINICAL-SIGNIFICANCE; SURFACE-ANTIGEN; B VIRUS; ANTIBODIES; VACCINE; viral hepatitis; hepatitis A; hepatitis B; hepatitis C; hepatitis D; hepatitis E; epidemiology; serological diagnosis; vaccination (1)
CLINICAL SIGNS; HOME; ECZEMA; DERMATOLOGY; CONSENSUS; TRIALS (1)
CLINICAL STAGE-I; THORACOSCOPIC SURGERY; EARLY EXPERIENCE; LUNG RESECTION; LOBECTOMY; TECHNOLOGY; VATS; Thoracic surgery; robotics; Germany; robotic-assisted thoracic surgery (RATS) (1)
clinical study; dental pulp necrosis; immature teeth; regenerative endodontics; revitalization (1)
CLINICAL-STUDY REPORTS; ADULTS; GERMANY; OLDER; (1)
CLINICAL SUPPORT TOOLS; EXPECTED RECOVERY CURVES; PROGRESS FEEDBACK; TREATMENT FAILURE; PATIENT PROGRESS; SOCIAL SUPPORT; LIFE EVENTS; RISK; CLIENTS; THERAPISTS; Assessment for Signal Cases; progress feedback; psychotherapy; routine outcome monitoring (1)
CLINICAL-TEST PERFORMANCE; DPOAE GROWTH-BEHAVIOR; PURE-TONE THRESHOLDS; MIDDLE-EAR PRESSURE; AUDITORY-SENSITIVITY; COCHLEAR DISORDERS; IMPAIRED EARS; OTITIS-MEDIA; LEVEL; DIFFERENTIATION; Cochlear mechanics; Diagnostics; Pediatrics (1)
CLINICAL-TRIAL; PRIMARY-CARE; FUNCTIONAL RESTORATION; BEHAVIORAL-THERAPY; PHYSICAL-THERAPY; GRADED ACTIVITY; NECK PAIN; LONG-TERM; FOLLOW-UP; REHABILITATION; low back pain; psychotherapy; functional status; sick leave (1)
CLINICAL-TRIALS; ATOPIC ECZEMA; CONSENSUS; QUALITY; (1)
CLINICAL-TRIALS; ATOPIC ECZEMA; CONSENSUS; QUALITY; OMERACT; IMPROVE; DOMAINS; (1)
CLINICAL-TRIALS; HUMAN BRAIN; RESPONSES; VALENCE; HUMANS; ATTENTION; STIMULI; RECOMMENDATIONS; POTENTIALS; PERCEPTION; (2)
CLINICAL-TRIALS; INTERNATIONAL-SOCIETY; SWEDISH-POPULATION; ELDERLY-PATIENTS; REFERENCE-VALUES; BREAST-CANCER; OLDER; ONCOLOGY; QUESTIONNAIRE; SURVIVORS; Increasing age; Cancer burden; General population; Normative data; Health-related quality of life (1)
CLINICAL-TRIALS; PHASE-II; TRASTUZUMAB; PERTUZUMAB; DOCETAXEL; POWER; END; Combination therapies; clinical trials; probability of success; Bayesian; assurance (1)
CLINICAL-TRIALS; QUESTIONNAIRE; QLQ-C30; VALIDITY; TRENDS; (1)
CLINICAL-TRIALS; REDUCING WASTE; INCREASING VALUE; ATOPIC ECZEMA; SYSTEMATIC REVIEWS; CONSENSUS; PROMISE; clinical trials; Cochrane Skin; core outcome set; CS-COUSIN; dermatology; development; implementation (1)
CLINICAL-TRIALS; THE-LITERATURE; SURGERY; METAANALYSIS; THERAPY; STATISTICS; SURVIVAL; QLQ-LC13; SMOKING; quality of life; patient-reported outcomes (PRO); lung cancer; clinical trials; systematic development (1)
CL Instruments, craniectomy, CRANIOTOP, titanium cranioplasty (1)
cliometrics | economic history | Germany | German history | quantitative history | social history (1)
Cliometrics, Economic History, Germany, German History, Quantitative History, Social History (1)
Cliometrics, Quantitative history, Economic history, Social history, Germany, German history (1)
CLN7; MFSD8; SARS-CoV-2; GM1; Lipid Rafts; NCL; lysosomale Speichererkrankung (1)
CLN7, Neuronale Ceroidlipofusziose, Lysosomen, Zellmigration, Zelladhäsion (1)
CLN7, SARS-CoV-2, Cholesterol (1)
CLOACAL EXSTROPHY; ZEBRAFISH; SUPPORT; GLYCINE; urinary tract development; kidney formation; zebrafish development; cloacal malformation; functional genetics; CAKUT; bladder exstrophy-epispadias complex (1)
CLOCK GENE; CIRCADIAN-RHYTHMS; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION; PROTEIN; PHOSPHORYLATION; CRYPTOCHROME; CONTRIBUTES; FEEDBACK; PROMOTER; Drosophila; circadian rhythms; period; timeless; luciferase; reporter transgenes; posttranscriptional regulation (1)
CLOCK; PHOTOSENSITIVITY; (1)
CLOCK PROTEINS PERIOD; PHASE RESPONSE CURVES; CIRCADIAN-CLOCK; GENE-EXPRESSION; PACEMAKER NEURONS; TIMELESS PROTEIN; NERVOUS-SYSTEM; VISUAL-SYSTEM; MELANOGASTER; LIGHT; (1)
CLONAL DIVERSITY; SEED-GERMINATION; PLANT-POPULATIONS; PRIMULACEAE; DISPERSAL; GROWTH; FRAGMENTATION; CONSEQUENCES; RESTORATION; INDIVIDUALS; (1)
CLONAL EXPANSION; ANTIGEN; IL-15; LYMPHOCYTES; EXPRESSION; RECEPTORS; SUPERIOR; PROMOTES; SURVIVAL; GROWTH; cytokine; signal-3; T cell activation; chimeric antigen receptor; adoptive cell immunotherapy (1)
CLONAL HEMATOPOIESIS; TELOMERE LENGTH; APLASTIC-ANEMIA; MYELODYSPLASTIC SYNDROMES; MYELOID-LEUKEMIA; DISEASE; CANCER; AGE; (1)
CLOSED CLASSICAL ORBITS; MAGNETIC-FIELD; DILATATION TRANSFORMATIONS; UNIFORM APPROXIMATION; HAMILTONIAN-SYSTEMS; QUANTUM SPECTRA; BIFURCATIONS; POTENTIALS; RESONANCES; SCATTERING; (1)
CLOSED ORBITS; semiclassical theory; Bethe ansatz; Hamiltonian integrability; Lieb-Liniger model; asymptotic analysis (1)
CLOSED-SUCTION DRAINAGE; FAST-TRACK HIP; RISK; FRAILTY; DISLOCATION; MORBIDITY; Anesthesia; Elderly; Frailty; Knee arthroplasty; Total hip arthroplasty (1)
CLOSED TREATMENT; SURGICAL-TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; COMPLICATIONS; OUTCOMES; OSTEOSYNTHESIS; RECOVERY; MOTION; facial nerve palsy; malocclusion; mandibular condylar fracture; parotid complications; retromandibular transparotid approach (1)
; close reading; brain; mind; calculus; cybernetics; Turing Machine; computer; visualization (1)
CLOSING OLEFIN METATHESIS; RAY CRYSTAL-STRUCTURES; DIELS-ALDER REACTIONS; TRANSFER HYDROGENATION; (ETA(6)-ETA(1)-C6H5CH2CH2PR2)RU(CH3)(2) R; ALLENYLIDENE COMPLEXES; RADICAL POLYMERIZATION; CATALYTIC-SYSTEMS; VINYL MONOMERS; ARENE; ruthenium; arene complexes; X-ray; electrochemistry; thioether (1)
CLOSTRIDIUM-DIFFICILE INFECTION; HEMOLYTIC-UREMIC SYNDROME; VANCOMYCIN-RESISTANT ENTEROCOCCI; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; INFLAMMATORY-BOWEL-DISEASE; STEM-CELL TRANSPLANTATION; TERM-FOLLOW-UP; TRAVELERS DIARRHEA; TROPHERYMA-WHIPPLEI; ESCHERICHIA-COLI; (1)
CLOSTRIDIUM-DIFFICILE INFECTION; INTERVENTIONS; Antimicrobial stewardship; Anti-bacterial agents; Guidelines; local; Clostridioides difficile; Vaccination (1)
CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED CLINICAL-TRIAL; INFLAMMATORY-BOWEL-DISEASE; ACTIVE ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; ENTEROCOLITIS; REMISSION; INFUSION; THERAPY; FROZEN; Dysbiosis; Clostridium difficile; Inflammatory bowel diseases; Diabetes mellitus; Obesity, morbid (1)
; Closure; Hard coal; Competing risks; Germany; Mining (1)
CLOSURE; THEOREM; (1)
; Clothing industry; Nazi economic policy (1)
CLOTTING SYSTEM; BLOOD-FLOW; ACTIVATION; COAGULATION; ECMO; Extracorporeal membrane oxygenation; Oxygenator exchange; Oxygenator dysfunction; Thrombosis; D-dimers (1)
cloud computing, cloud security, cloud adoption, cloud migration, machine learning, supervised learning, naive bayes classifier, data classification, user centric tool (1)
Cloud Computing Datenschutz Datenschutzgrundverordnung (1)
Cloud Computing, Public Administration, Information Security Management, Security Audits (1)
Cloud, E-Government, Smart-City, Digitalisierung, Informationssicherheitsmanagement, Business Continuity Management, Risikomanagement (1)
CLOUD POINT EXTRACTION; HYDROGEL; ANHYDRIDE); pH-sensitive polymer; Hydrogel; Microextraction; Liquid chromatography; Polycyclic aromatic hydrocarbons; Urine (1)
CLOZAPINE; MYOCARDITIS; (1)
CLOZAPINE PLASMA-CONCENTRATIONS; ACID-RELATED DISORDERS; ADVERSE DRUG-REACTIONS; CYP2C19 POLYMORPHISM; O-DESMETHYLVENLAFAXINE; HEALTHY-VOLUNTEERS; PHARMACOKINETICS; LANSOPRAZOLE; CYP2D6; DESVENLAFAXINE; (1)
Cluster Algorithms; Swendsen Wang; Parallelization; Host–node–modell (1)
Cluster; Carbonyl complexes; Iron; Antimony; Selenium; Tellurium (1)
Cluster; carbonyl complexes; iron; rhodium; iridium; selenium; tellurium (1)
Cluster compounds, cage compounds, phosphorus, multiple bonding, low-valent compounds (1)
cluster compounds; electron localization functions; gallium; insertions; rhodium (1)
Cluster; Dichtefunktionalrechnungen; Fullerene; Phosphor; Tantal (1)
Clustering; Dokumentvektoren; sparse vectors; niederfrequente Terme (1)
Clustering, Genetische Daten, klinische Studien, Datenverwaltung (1)
CLUSTERS; (1)
Clusters (argon-tetracene, spectral hole burning of, in supersonic jet); Fluorescence (excitation spectra of, of tetracene and tetracene-argon complexes in supersonic jet); Spectral hole burning (of tetracene and tetracene-argon complexes in supersonic jet); Jets (supersonic, spectral hole burning of tetracene and tetracene-argon complexes in); spectral hole burning argon tetracene jet; fluorescence excitation argon tetracene jet (1)
clusters · density functional method calculations · indium · single crystal X-ray diffraction · thallium (1)
Clusters; Drops; Electronic transition; Size distributions; Superfluids (inhomogeneous line shape theory of electronic transitions for mols. embedded in superfluid helium droplets including size dependence of cluster, capture cross section, and resonance frequency); inhomogeneous line shape electronic transition mol helium droplet (1)
Clusterverbindungen, ELF (Elektronenlokalisierungsfunktion); Gallium; Insertionen; Rhodium (1)
C-MET; ACQUIRED-RESISTANCE; AKT INHIBITOR; DOUBLE-BLIND; 2ND-LINE THERAPY; SORAFENIB; CANCER; GROWTH; CELLS; ACTIVATION; Hepatocellular carcinoma; biomarkers; DNA repair; metabolic pathways; mouse models (1)
C-MET; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; THERAPEUTIC TARGET; SURVIVIN EXPRESSION; RADIATION-THERAPY; PD-L1 EXPRESSION; POOR-PROGNOSIS; IMMUNOTHERAPY; RADIOTHERAPY; Head and neck cancer; p16; c-Met; Survivin; PD-1; PD-L1 (1)
C-MET RECEPTOR; NF-KAPPA-B; IN-VIVO; MULTIDRUG-RESISTANCE; ENDOTHELIAL-CELLS; REDUCES GROWTH; EXPRESSION; CARCINOMA; ACTIVATION; INHIBITOR; Pancreatic cancer; cMET; Resistance; Survival (1)
C-MET; TYROSINE KINASE; CABOZANTINIB; IMMUNOSURVEILLANCE; OVEREXPRESSION; PROTOONCOGENE; ACTIVATION; EXPRESSION; EVEROLIMUS; MUTATIONS; cMET; Papillary renal cell carcinoma; Prognosis; Survival; Outcome (1)
cMRSA, MRSA, S.aureus (1)
; CMV; CMV-specific cellular immunity; hematopoietic stem cell transplantation; recall antigen; peptide; immune monitoring; IFN-gamma ELISpot; T cells; antigen processing and presentation; immunosuppression (1)
CMV, IE1, humanes Transkriptom, siRNA, Interferon, STAT1, STAT2, proinflammatorisch, Chemokin (1)
CMV-Retinitis, CMV-Gastroenteritis, Überlebenswahrscheinlichkeit, HIV-Infektion (1)
CMV, T cells, viral vectors, immune monitoring (1)
C-MYC; RNA sequencing (RNA-Seq); qPCR; gene expression; spike-in; external reference; calibration (1)
C-MYC; TRANSCRIPTIONAL ACTIVITY; TERMINAL DOMAIN; ALPHA-TUBULIN; CHROMATIN; GENOME; ACTIVATION; PHOSPHORYLATION; GROWTH; FERTILIZATION; (1)
CNN, Computer Vision, Tracking Pattern (1)
CNS hemangioblastoma, neurological outcome, posterior cranial fossa, von Hippel–Lindau disease (1)
CNT; carbon nanotubes; Coherent population trapping; dark states; electron interference blockade; electromechanical instabilities; quantum dots; strong feedback; (1)
CO2 reduction, Molecular catalysts, Redox-active ligands, Secondsphere interactions, Bimetallic (1)
CO2 REMOVAL; LUNG INJURY; Acute respiratory distress syndrome; Extracorporeal carbon dioxide removal; Artificial ventilation; Ventilator-induced lung injury; Predictive enrichment (1)
CO2, Sensor, ECMO (1)
C-O ACTIVATION; HETEROGENEOUS CATALYSIS; PHENOL DERIVATIVES; GRIGNARD-REAGENTS; ORGANIC-SYNTHESIS; VINYL-ACETATE; ARYL; FE; NI; COMPLEXES; alkenes; cross-coupling; enols; Grignard reaction; iron catalysis (1)
COACTIV; Expertise; Mathematics; Pedagogical content knowledge; Professional competence; Teacher; Video study (1)
COACTIV, machine learning (1)
COACTIV · Teacher · Professional competence · Expertise · Experience (1)
COAGULASE-NEGATIVE STAPHYLOCOCCI; BIRTH-WEIGHT INFANTS; INTENSIVE-CARE-UNIT; MOLECULAR EPIDEMIOLOGY; BIOFILM FORMATION; JOINT PROSTHESES; AUREUS STRAINS; INFECTIONS; IDENTIFICATION; FLORA; (1)
COAGULATION-FACTOR-XIII; VENOUS THROMBOSIS; MYOCARDIAL-INFARCTION; COMMON POLYMORPHISM; A-SUBUNIT; ASSOCIATION; ACTIVATION; HEMORRHAGE; (1)
COA REDUCTASE INHIBITORS; ISOLATED RAT HEPATOCYTES; DRUG-DRUG INTERACTIONS; IN-VITRO; ADME EVALUATION; P-GLYCOPROTEIN; CYTOCHROME-P450 3A4; VECTORIAL TRANSPORT; RISK-ASSESSMENT; LACTONE FORMS; (1)
Coarse geometry Homology theory Roe algebra Spectral theory (1)
COATED MEGAPROSTHESES; PERIPROSTHETIC INFECTION; BONE TISSUE; ENDOPROSTHESES; CONTAMINATION; REDUCTION; TRAUMA; TUMOR; IONS; periprosthetic joint infections; infection prophylaxis; Staphylococcus epidermidis; in vivo osteomyelitis model (1)
COATED MEGAPROSTHESES; PERIPROSTHETIC INFECTION; STAPHYLOCOCCUS-AUREUS; BACTERIAL-RESISTANCE; CASE SERIES; TUMOR; TIBIA; RISK; ENDOPROSTHESES; HUMERUS; Silver; Bone; Osteotomy; Humerus; Plate; Biocompatible; Infection (1)
COAT PROTEIN-S; X-RAY-ANALYSIS; MYXOCOCCUS-XANTHUS; PHYSARUM-POLYCEPHALUM; PRECURSOR STRUCTURE; ALPHA-CRYSTALLIN; TYROSINE CORNER; NONLENS MEMBER; SUPERFAMILY; STABILITY; (1)
cobalt alloys, ferromagnetic materials, iron alloys, magnetic circular dichroism, magnetic thin films, magnetisation, nickel alloys, ruthenium (1)
Cobalt, Catalysis, Hydrogenation (1)
Cobalt , Clusterverbindungen , Niob , Tellur , Nickel , Supramolekulare Chemie , Elektrochemie , Cobalt , Cluster , Niobium , Tellurium , Nickel (1)
COBALT COMPLEXES; P-4 ACTIVATION; BASIS-SETS; APPROXIMATION; PHOSPHORUS; ELEMENTS; ENERGY; LIGAND; functionalization; heterobimetallic complexes; organophosphorus ligands; oxidation; rearrangement (1)
cobalt, coordination compounds, nickel, nickel, P ligands, phosphorus (1)
cobalt, coordination compounds, nickel, P ligands, phosphorus (1)
Cobalt · Cyanides · P4Activation · Phosphorus · Pnictides (1)
cobalt, cyanides, phosphorus, pnictides, redox-active ligands (2)
Cobalt, Eisen, Photoredox Katalyse (1)
Cobalt, Nanopartikel, Heißinjektion, Reduktion, Acetat, Stearat, Hydroxid, metallisch, magnetisch (1)
Cobb, John B.; Panikkar, Raimundo; Pannenberg, Wolfhart (1)
COBORDISM; (1)
COBORDISM; COMODULES; LAWS; stable homotopy theory; algebraic stacks; formal groups (1)
COBORDISM; MANIFOLDS; Higher spectral invariants; Topological modular forms; Witten genus; String manifolds (1)
COBORDISM RING; HOMOTOPY; LOCALIZATION; RESPECT; SPECTRA; (1)
COCAINE C-1 ANALOGS; ENANTIOSELECTIVE SYNTHESIS; FUNCTIONALIZED TROPANES; CYCLOADDITION REACTIONS; ENANTIOMERICALLY PURE; ASYMMETRIC-SYNTHESIS; BINDING-AFFINITY; OPIOID RECEPTORS; NATURAL-PRODUCTS; DOPAMINE; bicyclo[3; 2; 1]octanes; cocaine analogues; furans and pyrroles; isoquinuclidines; microwave-assisted [3+2]-cycloaddition; tropanes (1)
Cochlea; Hair cell; Auditory afferents; Synapse; Transmitter; L-Glutamate (1)
Cochlear implant; Digital signal processing; Noise gating; Noise reduction; Speech recognition (1)
COCHLEAR IMPLANT ELECTRODE; LOW-FREQUENCY HEARING; ROUND WINDOW MEMBRANE; HUMAN TEMPORAL BONES; COMBINED ELECTROACOUSTIC STIMULATION; SIGNIFICANT RESIDUAL HEARING; VOICELESS STOP CONSONANTS; COMBINED SPEECH PROCESSOR; SPIRAL GANGLION NEURONS; INNER-EAR; Cochlea; Cochlear implant; Electric acoustic stimulation; Hearing aid; Binaural hearing; Bimodal hearing; Hybrid hearing; Pharmacotherapy, inner ear; Ski slope audiogram; High-frequency hearing loss; Low-frequency hearing, residual (1)
COCHLEAR NUCLEUS; PAIN; HYPERACUSIS; Diagnosis; Somatic; Somatosensory; Tinnitus (1)
COCHLEAR NUCLEUS; SOMATIC TINNITUS; TEMPOROMANDIBULAR DISORDERS; MODULATE TINNITUS; PREVALENCE; THERAPY; DYSFUNCTIONS; MOVEMENTS; SEVERITY; NECK; tinnitus; somatic; somatosensory; Delphi survey; face-to-face consensus (1)
Cochrane review; eczema; H1 antihistamines; evidence based medicine (1)
COCKLEBUR XANTHIUM-STRUMARIUM; CHLOROPLAST DNA; SESQUITERPENE LACTONES; COMPOSITAE; INTERFERENCE; INTOXICATION; CHARACTERS; ALIGNMENT; Ambrosiinae; Dugesia; Engelmanniinae; Maximum-likelihood; MrBayes; Rojasianthe (1)
Cockpit, Simulation, Situationsbewusstsein, Workload, Gebrauchstauglichkeit, Validierung, Multi-Trait/ Multi-Method-Ansatz (1)
COCKROACHES PERIPLANETA-AMERICANA; SERRATIA-MARCESCENS; METARHIZIUM-ANISOPLIAE; SECONDARY METABOLITES; NOSOCOMIAL INFECTIONS; BLATTELLA-GERMANICA; MEDICAL IMPORTANCE; POTENTIAL VECTORS; ENDOPHYTIC FUNGUS; PATHOGENIC FUNGI; (1)
COCKROACH LEUCOPHAEA-MADERAE; ACETYLTRANSFERASE-EXPRESSING NEURONS; CIRCADIAN PACEMAKER NEURONS; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; Y-LIKE; TIMELESS GENES; VISUAL-SYSTEM; MELANOGASTER; RECEPTOR; insect brain; circadian clock; neuromodulator; neurotransmitter; choline acetyltransferase (1)
COCKROACH LEUCOPHAEA-MADERAE; HORMONE-IMMUNOREACTIVE NEURONS; DROSOPHILA CIRCADIAN CLOCK; LOCOMOTOR-ACTIVITY RHYTHM; PERIOD GENE-PRODUCT; ACCESSORY MEDULLA; VISUAL-SYSTEM; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; PHOTIC REGULATION; circadian rhythm; period; timeless; PDH; PRC; model oscillator; Drosophila melanogaster; Leucophaea maderae (1)
COCKROACH NAUPHOETA-CINEREA; FORMOSAN SUBTERRANEAN TERMITE; RETICULITERMES-FLAVIPES; COPTOTERMES-FORMOSANUS; ZOOTERMOPSIS-ANGUSTICOLLIS; NEOTENIC REPRODUCTIVES; PHENOTYPIC PLASTICITY; DIPLOPTERA-PUNCTATA; METHYL FARNESOATE; GENE-EXPRESSION; Developmental plasticity; Social insect; Morphogenetic hormone; Hemimetabolous; Molt (1)
CO-CREATION; tinnitus; interprofessional training; reusable learning objects; co-creation (1)
CO-CR-MO; POLY(LACTIC ACID-CO-LYSINE); PROPERTIES RELEVANT; DIBLOCK COPOLYMERS; CELL-FUNCTION; GROWTH-FACTOR; BIOMATERIALS; TISSUE; PROTEINS; REAGENTS; biomimetic; surface modification; tissue engineering; polymer; poly(lactic acid); poly(ethylene glycol); insulin; linker (1)
Cocteau; Sophocles; Oedipus; fate; free will; Greek religion (1)
CODED DUPLEX SONOGRAPHY; REAL-TIME SONOGRAPHY; 3-DIMENSIONAL ULTRASOUND; MIDLINE SHIFT; STROKE; LIMITATIONS; DOPPLER; ADULTS; three-dimensional transcranial ultrasonography intracranial pressure; cerebrospinal fluid (1)
Codein , Propyphenazon , Pharmakokinetik , Pharmakodynamik , Cimetidin , , codeine , propyphenazone , cimetidine , pharmacodynamic , pharmacokinetics (1)
Codependence, identification, VAR, cointegration, serial correlation common features (1)
Codependence, VAR, cointegration, pseudo-structural form, serial correlation common features (1)
Co-determination; digitalisation; power position; power resources; works council (1)
coding region prediction, sequencing errors, expressed sequence tags, hidden Markov models (1)
CODONS IMMEDIATELY DOWNSTREAM; HIGH-LEVEL EXPRESSION; CELL-FREE SYSTEM; RECOMBINANT PROTEINS; INITIATION CODON; AT-CONTENT; DESIGN; DNA; synthetic genes; gene optimization; heterologous protein expression; fluorescence-based quantification; codon usage; recombinant proteins (1)
CODON USAGE BIAS; HIGHLY EXPRESSED GENES; ADAPTATION INDEX; TRANSFER-RNAS; LIFE-STYLE; GENOMES; YEAST; SELECTION; MICROORGANISMS; PREFERENCES; (1)
Codonusage, HIV, Genexpression, Codonwahl, Codonbias, (1)
CO-DOPED SRTIO3; ELECTRICAL-CONDUCTIVITY; HYDROTHERMAL SYNTHESIS; ANODE MATERIALS; LA; CERAMICS; NONMETAL; Perovskite; Photocatalysis; Water splitting; Carbon dioxide reduction; Spintronics (1)
COEFFICIENT MODELS; REGRESSION-MODELS; FRAILTY; HETEROGENEITY; LIKELIHOOD; HAZARD; discrete survival model; varying-coefficients; additive modelling; time-varying smooth effects (1)
Coeliac disease; Depression; Paediatric; Endocrinology; DPV (1)
COENZYME-A REDUCTASE; 3-HYDROXYPROPIONATE CYCLE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; CHLOROFLEXUS-AURANTIACUS; NANOARCHAEUM-EQUITANS; CITRATE SYNTHASE; SP-NOV; THERMOPROTEUS-NEUTROPHILUS; ISOLEUCINE BIOSYNTHESIS; PYRUVATE-CARBOXYLASE; (1)
COENZYME-M REDUCTASE; 3-COORDINATE NICKEL(I) COMPLEXES; TRANSITION-METAL-COMPLEXES; SPECTROSCOPIC ELUCIDATION; MOLECULAR-STRUCTURE; OXIDATION REACTIONS; MECHANISTIC ASPECTS; CORRELATION-ENERGY; CATALYTIC-ACTIVITY; MONOVALENT NICKEL; (1)
Coffee Berry Borer, CBB Chemistry, Behaviour, CBB genetics (1)
coffee; silverskin; extraction; water; cycles; enrichment (1)
cofibrantly generated model category; colimit-dense subcategory; Vopenka's principle (1)
cognition in children, evolutionary psychology, adaptive memory, episodic memory, survival processing in children (1)
cognitive aging, episodic memory, intentional forgetting, directed forgetting, cognitive control (1)
cognitive aging, inhibitory processes, inhibition-deficit hypothesis, episodic memory, retrieval-induced forgetting (1)
COGNITIVE-BEHAVIORAL THERAPY; AMBULATORY ASSESSMENT; HANDICAP INVENTORY; CIRCADIAN CLOCK; NOISE EXPOSURE; CHRONIC PAIN; DISTRESS; SENSITIVITY; LIFE; CHRONOBIOLOGY; tinnitus; stress; circadian fluctuation; time-of-day; ecological momentary assessment (1)
COGNITIVE-BEHAVIORAL THERAPY; FEAR EXTINCTION; VIRTUAL-REALITY; EXPOSURE; RENEWAL; STARTLE; MECHANISMS; DISORDERS; CONTEXT; RELAPSE; gradual extinction; virtual reality; pavlovian fear conditioning; skin conductance response; startle response; contingency ratings (1)
COGNITIVE-BEHAVIORAL THERAPY; FUNCTIONAL SOMATIC SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; SYMPTOMS; PSYCHOTHERAPY; METAANALYSIS; RELIABILITY; PREVALENCE; INTENSITY; EFFICACY; somatic symptom disorder; somatoform disorder; cognitive behavioral therapy; multimodal treatment; medically unexplained symptoms (1)
COGNITIVE-BEHAVIORAL THERAPY; LOW-BACK-PAIN; COMMITMENT THERAPY; MULTIDISCIPLINARY TREATMENT; PSYCHOTHERAPY; MODEL; VALIDITY; chronic pain; pain acceptance; early change; interdisciplinary pain treatment (1)
COGNITIVE-BEHAVIORAL THERAPY; LOW-BACK-PAIN; MULTIDISCIPLINARY TREATMENT; INTERVENTIONS; EFFICACY; OUTCOMES; NECK; Chronic pain; Group psychotherapy; Patient interaction; Treatment outcome; Transtheoretical model (1)
COGNITIVE-BEHAVIORAL THERAPY; MEDICALLY UNEXPLAINED SYMPTOMS; FUNCTIONAL SOMATIC SYNDROMES; SOMATOFORM DISORDERS; PRIMARY-CARE; COST-EFFECTIVENESS; SOMATIZATION; HYPOCHONDRIASIS; MANAGEMENT; EFFICACY; (1)
COGNITIVE-BEHAVIORAL THERAPY; MEN; Activation Likelihood Estimation; ALE; Functional Neuroimaging; Meta-Analysis; Neural Dysactivity; Sexual Dysfunction (1)
COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PHOBIA INVENTORY SPIN; IN-VIVO EXPOSURE; PUBLIC-SPEAKING; EYE-CONTACT; ENVIRONMENT; DISORDERS; FEAR; DOMINANCE; virtual reality; social skills training; social anxiety disorder; eye contact; anxiety; heart rate; electrodermal activity (1)
COGNITIVE-BEHAVIORAL THERAPY; SUDDEN GAINS; TREATMENT FAILURE; PATIENT PROGRESS; ROUTINE PRACTICE; INDIVIDUAL PSYCHOTHERAPY; PSYCHOLOGICAL TREATMENTS; CRITICAL SESSIONS; DEPRESSION; FEEDBACK; monitoring; clinical support tools; considerable change; psychotherapeutic process; psychosomatics (1)
COGNITIVE-BEHAVIORAL THERAPY; WORKING ALLIANCE; SELF-EFFICACY; MULTILEVEL MEDIATION; ADULT DEPRESSION; PSYCHOTHERAPY; DISORDER; METAANALYSIS; SYMPTOMS; SESSION; cognitive-behavioral therapy; depression; alliance; change factors (1)
COGNITIVE-BEHAVIORAL TREATMENT; ALL-CAUSE MORTALITY; MENTAL-HEALTH-CARE; LIFE LOST; ATTRIBUTABLE FRACTIONS; COST-EFFECTIVENESS; EXCESS MORTALITY; POTENTIAL YEARS; GLOBAL BURDEN; RISK-FACTOR; Alcohol consumption; Alcohol dependence; Treatment; Mortality; Europe (1)
COGNITIVE-BEHAVIOR THERAPY; ANOREXIA-NERVOSA PATIENTS; MIRROR EXPOSURE; EMOTION REGULATION; FUNCTIONAL NEUROANATOMY; VISUAL-ATTENTION; SELF-ESTEEM; OWN BODY; IMAGE; DISSATISFACTION; eating disorders; clinical neuroscience; body image; task functional imaging; human studies (1)
COGNITIVE-BEHAVIOR THERAPY; SEX-DIFFERENCES; PREDICTORS; COMORBIDITY; RELIABILITY; PREVALENCE; SYMPTOMS; WOMEN; MEN; gender differences; depression; cognitive-behavioral therapy; chronic pain (1)
COGNITIVE BIAS; MOTOR LATERALITY; EMOTIONAL STATE; BEHAVIOR; PERFORMANCE; PREFERENCE; STARLINGS; PESSIMISM; ANIMALS; WELFARE; cognitive bias; motor; sensory; laterality; optimism; pessimism; judgment task; horse (1)
COGNITIVE CONTROL; 2 FACES; MEMORY; IMPLICIT; INTEGRATION; MECHANISMS; RETRIEVAL; EXPLICIT; RULES; habit; cognitive control; directed forgetting; response compatibility (1)
cognitive control, anticipation, episodic memory, suppression, voluntary forgetting (1)
COGNITIVE CONTROL; AVERSIVE SIGNALS; SIMON TASK; ACTIVATION; DRIVEN; INTERFERENCE; INFORMATION; EXPERIENCE; ASYMMETRY; RESPONSES; Conflict adaptation; Conflict monitoring; Negative affect; Cognitive control; LRP (1)
cognitive control, cognitive flexibility, effort, time cost, associative learning (1)
COGNITIVE CONTROL; COMPONENT PROCESSES; RECONFIGURATION; SET; FLEXIBILITY; ERP; STABILITY; SELECTION; REWARD; INTERFERENCE; classifier analysis; ERPs; preparatory activity; task switching; voluntary task switching (1)
Cognitive control, Conflict adaptation, ACC, Theta, Beta (1)
cognitive control, EEG, oscillation/time frequency analyses (1)
; cognitive control; positive affect; arousal (1)
Cognitive control; Positive affect; Dopamine (1)
COGNITIVE CONTROL; POSITIVE AFFECT; FLEXIBILITY; STABILITY; PROSPECT; MODULATION; MOTIVATION; COST; Reward; Motivation; Cueing; Voluntary task switching; Cognitive control (1)
COGNITIVE CONTROL; POSITIVE AFFECT; REWARD; DOPAMINE; COST; MAINTENANCE; MECHANISMS; PROSPECT; flexibility; stability; goal-directed behavior; reward; positive affect; context control (1)
COGNITIVE-CONTROL; PREFRONTAL CORTEX; CINGULATE CORTEX; ADJUSTMENTS; ACTIVATION; REWARD; TASK; response conflict; conflict monitoring; aversive signal; cognitive control; affective counter-regulation (1)
Cognitive Control; Response Conflict; Control Adaptation (1)
cognitive control; reward; AX-CPT; positive affect; contingency (1)
COGNITIVE CONTROL; SHIELDING FUNCTION; PARADIGM; CONTEXT; RECONFIGURATION; INTERFERENCE; FLEXIBILITY; ADJUSTMENT; MAGNITUDE; RULES; Flexibility; Stability; Cognitive control; Voluntary task switching (1)
COGNITIVE CONTROL; SIMON TASK; ADAPTATION; INTERFERENCE; ADJUSTMENTS; ACTIVATION; CORTEX; MODULATIONS; MECHANISMS; RESPONSES; conflict adaptation; aversive signal; fluency of processing (1)
COGNITIVE CONTROL; STIMULUS; SET; RECONFIGURATION; SCHIZOPHRENIA; INTERFERENCE; FLEXIBILITY; DYSFUNCTION; cognitive control; learning and memory; voluntary task switching; flexibility (1)
cognitive control, voluntary task switching, associative learning (1)
cognitive control, voluntary task switching, introspection, mental effort (1)
Cognitive control, Voluntary task switching, Switch readiness (1)
COGNITIVE CONTROL; WORKING-MEMORY; ANTERIOR CINGULATE; PREFRONTAL CORTEX; ITEM STRENGTH; HUMAN-BRAIN; TASK; INHIBITION; POTENTIALS; MECHANISMS; (1)
COGNITIVE EMOTION REGULATION; POSITIVE REAPPRAISAL; STRESS; ACCEPTANCE; DEPRESSION; RUMINATION; empathy; secondary trauma; reframing; positive reappraisal; objective distancing; anxiety; depression (1)
COGNITIVE FLEXIBILITY; TASK; MECHANISMS; HONEYBEES; INTERFERENCE; PERFORMANCE; ALTERNATION; CONTRAST; DECISION; BEHAVIOR; voluntary task switching; spontaneous alternation behavior; flexibility vs. stability comparative psychology; ants (1)
COGNITIVE FUNCTION; METAANALYSIS; ALZHEIMERS; DEMENTIA; DECLINE; COHORT; TASKS; Verbal fluency tests; Cognition; Executive functions; Parkinson's disease; Memory; Psychomotor speed (1)
COGNITIVE IMPAIRMENT; AMYGDALA ACTIVATION; EXPRESSIONS; SCHIZOPHRENIA; HISTORY; DISCRIMINATION; PERCEPTION; DEPRESSION; GENDER; SCALE; (1)
cognitive impairment, cognitive reserve, Multiple sclerosis (1)
COGNITIVE IMPAIRMENT; MOLECULAR-MECHANISMS; MOUSE MODELS; DEMENTIA; RISK; POLYPHENOLS; BRAIN; CONSUMPTION; NEURODEGENERATION; ABSORPTION; Green tea; Epigallocatechin gallate; Alzheimer?s disease; Neurodegeneration; Prevention (1)
COGNITIVE-LOAD APPROACH; WORKED-OUT EXAMPLES; INDIVIDUAL-DIFFERENCES; SELF-EXPLANATIONS; VARIABILITY; SKILL; example elaboration; elaboration profile; elaboration training; interest; mental effort; prior knowledge; tolerance of ambiguity; transfer performance (1)
COGNITIVE MODEL; QUALITY INDEX; DEPRESSION; VALIDATION; SYMPTOMS; THERAPY; ADULTS; Insomnia; Dysfunctional thinking; Polysomnography; DBAS; Sleep apnea; Restless legs syndrome (1)
COGNITIVE REAPPRAISAL; INDIVIDUAL-DIFFERENCES; NEGATIVE EMOTIONS; BRAIN POTENTIALS; SUPPRESSION; CONSEQUENCES; ATTENTION; RESPONSES; VALIDATION; ACCEPTANCE; emotion regulation; electroencephalography; skin conductance response (1)
COGNITIVE TASKS; SPATIAL TRANSFORMATIONS; ATTENTIONAL DEMANDS; MOTOR EXPERTISE; WORKING-MEMORY; OLDER-ADULTS; SWAY; PERFORMANCE; REPRESENTATIONS; PERSPECTIVE; mental rotation; postural stability; embodiment; dual task (1)
Cognitive Training; Task-switching (1)
Cognitive training, WM gating policies, Task switching, Transfer, Executive functions (1)
COHERENCE; OPPOSITION; Conspiracy theory research; conceptual framework; logical relations; particularism versus generalism; probabilistic hexagon of opposition (1)
COHERENT; (2)
COHERENT BACKSCATTERING; WEAK-LOCALIZATION; ELECTROMAGNETIC POTENTIALS; ATOM LASER; SCATTERING; MAGNETORESISTANCE; INTERFERENCE; PERIODICITY; ELECTRONS; MEDIA; (1)
COHERENT CENTER DOMAINS; GAUGE-THEORY; PHASE-TRANSITION; DECONFINEMENT; PERCOLATION; CONFINEMENT; ORDER; SU(2); MODEL; (1)
COHERENT CONTROL; OSCILLATIONS; COMPUTATION; QUBIT; FIELD; (1)
COHERENT MANIPULATION; JOSEPHSON-JUNCTION; QUANTUM DYNAMICS; FLUX QUBIT; STATE; DEVICES; MOLECULES; CIRCUIT; ATOMS; STIRAP; superconducting nanocircuits; macroscopic quantum coherence (1)
COHERENT MEASURES; AVERSE; MANAGEMENT; MODELS; LDA; Risk management; multi-period risk modeling; operational risk (1)
COHERENT POPULATION TRANSFER; QUANTUM DOTS; MOLECULES; STATES; COMPUTATION; RELAXATION; TRANSPORT; SYSTEMS; SPINS; GATE; quantum dots; adiabatic passage; STIRAP; quantum control (1)
COHERENT-POTENTIAL APPROXIMATION; DOMAIN-WALLS; THIN-FILMS; RESONANCE; RELAXATION; LINEWIDTH; (1)
COHERENT-POTENTIAL APPROXIMATION; ELECTRONIC TRANSPORT; LATTICE DISTORTION; PHASE-TRANSITIONS; SCATTERING-THEORY; MAGNETIC-MOMENTS; DILUTE ALLOYS; METALS; 1ST-PRINCIPLES; FILMS; (1)
COHERENT-POTENTIAL APPROXIMATION; ELECTRONIC TRANSPORT; SPIN CALORITRONICS; DISORDERED ALLOYS; TEMPERATURE; RESISTIVITY; METALS; IRON; SPINTRONICS; THERMOPOWER; (1)
Coherent spectroscopy; Quantum wells; Two-dimensional electron gas (2)
COHERENT-STATE PROPAGATOR; TRUNCATED WIGNER METHOD; POLARIZATION ECHOES; PHASE-SPACE; SPIN; SYSTEMS; REPRESENTATION; EQUILIBRIUM; NMR; semiclassics; many-body dynamics; ultracold atoms; coherent backscattering; interference (1)
COHERENT STATES; SYSTEMS; SOLITONS; (1)
COHOMOLOGY; FORMS; Vanishing theorems; p-Adic Hodge theory; h-Topology (1)
COHOMOLOGY; HOMOLOGY; FORMS; (1)
COHOMOLOGY; HOMOLOGY; SPECTRA; Monads; Homotopy theory; Spectral sequences; Obstruction theory; Operads (1)
COHOMOLOGY; Lazard isomorphism; locally analytic group cohomology; Lia algebra cohomology (1)
COHOMOLOGY; motive; etale cohomology; Bott element (1)
CO-HOMOLOGY; POINTS; affinoid algebra; Picard group; homotopy invariance (1)
COHOMOLOGY THEORIES; HOMOLOGY; (1)
COHOMOLOGY THEORIES; STACKS; Differential K-theory; equivariant differential K-theory; orbifold; push-forward in differential K-theory; localization in equivariant differential K-theory (1)
COHOMOLOGY; Tropical geometry; Smooth tropical curves; Mumford curves; Extended skeleta; Faithful tropicalization (1)
COHORT; RISK; (1)
Cohort Studies; Follow-Up studies; Prospective studies; Biostatistics; Data interpretation; statistical (1)
Cohort study · Old-aged population · AugUR · Mortality · OCT · Central retinal volume · Risk factors (1)
CO(III) COMPLEX; DNA; POLYSTYRENE/; NUCLEASES; SITE; phosphoester hydrolysis; immobilised metal complexes; zinc (II) cyclen (1)
Coil-Ebolisation, coil embolization, Hirngefäßaneurysma, intracranial aneurysm, Subarachnoidalblutung, subarachnoid hemorrhage SAH (1)
COIL POSITION; THRESHOLD; THERAPY; TIME; EFFICACY; SHOCKS; LEADS; RISK; Implantable cardioverter defibrillator; Right-sided implantation; Intraoperative test (1)
Coinage metal • Mixed-ligand polyphosphorus complexes • Pentaphosphaferrocene • Supramolecular chemistry • White phosphorus (1)
COINFECTION; INFLUENZA; PATHOGENESIS; VIRUS; CARE; COVID-19; SARS-CoV-2; multidrug-resistant pathogens; bacterial infections; fungal infections; secondary infections; intensive care medicine; ventilation; ECMO (1)
cold atmospheric plasma (CAP); plasma-activated solutions (PASs); reactive oxygen and nitrogen species (RONS); antibacterial effects; contact lens; contact lens cleaning solutions (CLCSs) (1)
cold atmospheric plasma (CAP); plasma intensive care (PIC); pressurized air (PA); upper respiratory tract (URT); bronchoalveolar lavage fluid (BALF); immune cells (1)
cold atmospheric plasma (CAP); plasma intensive care (PIC); pressurized air (PA); upper respiratory tract (URT); human oral keratinocytes (hOK); human bronchial–tracheal epithelial cells (hBTE); human lung fibroblasts (hLF) (1)
cold atmospheric plasma (CAP); upper respiratory tract (URT); polymorphonuclear neutrophils (PMNs); cell migration; reactive oxygen/nitrogen species (RONS); NETosis; immunomodulation; ventilator-associated pneumonia (VAP) (1)
cold atmospheric plasma; malignant melanoma; acidification; nitrite; acidified nitrite; nitration; membrane damage (1)
Cold exposure, Lipidomics, Lipolysis, Liver lipidome, Phosphatidylethanolamine, PUFA (1)
Cold exposure, Lipidomics, Lysophosphatidylcholine, Phosphatidylcholine, Plasma lipidome, Sex; Sphingomyelin (1)
COLD-INDUCED THERMOGENESIS; DENDRITIC CELLS; BONE-MARROW; MACROPHAGES; MOBILIZATION; ORCHESTRATE; EXPRESSION; LIPOLYSIS; DIFFERENTIATION; RECRUITMENT (1)
COLD ISCHEMIA; PRESERVATION INJURY; IMPROVES SURVIVAL; METHYL PALMITATE; PROTECTIVE ROLE; HEPATIC-INJURY; ACTIVATION; NECROSIS; MICE; DEPRESSION; apoptosis; early graft dysfunction; ischemia-reperfusion; microcirculation; rat liver transplantation (1)
COLD ISCHEMIA TIME; GRAFT FAILURE; MORTALITY; RECIPIENTS; RISK; FRAILTY; ASSOCIATION; PREDICTOR; SURVIVAL; DIALYSIS; (1)
COLD-PRESERVATION; RENAL DYSFUNCTION; DOSE DOPAMINE; ORGAN DONOR; INJURY; HYPOTHERMIA; PREDICTORS; THERAPY; CALCIUM; CELLS; antioxidants; cardiac transplantation; dopamine; ischemia; survival (1)
COLD-SHOCK PROTEIN; BACTERIUM THERMOTOGA-MARITIMA; RESIDUAL DIPOLAR COUPLINGS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMAL-STABILITY; BACILLUS-SUBTILIS; CHEMICAL-SHIFTS; DNA-BINDING; CSPA; cold shock protein; NMR; residual dipolar couplings; thermophilic adaptation; RNA binding (1)
COLD-SHOCK PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; MOLECULAR-WEIGHT PROTEINS; TIME-SCALE DYNAMICS; METHYL-GROUP PROBES; CHEMICAL-EXCHANGE; EXCITED-STATES; R-1-RHO RELAXATION; NMR-SPECTROSCOPY; CAVITY MUTANT; Fluorine; Large complexes; Protein folding; Relaxation dispersion; Structural dynamics (2)
COLD-STORAGE; IN-VITRO; ADHESION MOLECULES; UW-SOLUTION; INJURY; TRANSPLANTATION; CULTURE; IDENTIFICATION; REPERFUSION; HYPOTHERMIA; (1)
COLD-WAR; RECONSTRUCTION; SKOPJE; East-West relations; Romania; West Germany; Switzerland; humanitarian aid (1)
COLEOPTERA-SILPHIDAE-NICROPHORUS; BURYING BEETLES; HUMAN REMAINS; DIPTERA CALLIPHORIDAE; INSECT SUCCESSION; GUT MICROBIOME; DECOMPOSITION; CARRION; NECROPHORUS; CARCASSES; Forensic entomology; Cadaver odor; Decomposition stages; EAD-active compounds; Phenol; Dimethyl trisulfide; 2-and 3-methylbutyric acid; GC/MS analysis; Coleoptera; Silphidae (1)
COLI DNA PHOTOLYASE; FLAVIN ADENINE-DINUCLEOTIDE; BLUE-LIGHT PHOTORECEPTORS; TIME-RESOLVED FLUORESCENCE; ESCHERICHIA-COLI; ELECTRON-TRANSFER; ENERGY-TRANSFER; FEMTOSECOND DYNAMICS; 2ND CHROMOPHORE; SIGNAL-TRANSDUCTION; cryptochrome; Arabidopsis thaliana; Cry3; MTHF; FAD; fluorescence spectroscopy; absorption spectroscopy; MTHF-FAD interaction; photo-reduction; photo-cycle dynamics; energy transfer (1)
COLITIS-ASSOCIATED TUMORIGENESIS; IMMUNE CELLS; EXPRESSION; MARKERS; INFLAMMATION; PROGRESSION; 1ST-LINE; GROWTH; KI-67; PCNA; Peritoneal carcinomatosis; proliferation; senescence; tumor milieu; T(H)1; T(H)17 (1)
Colitis ulcerosa , Immunreaktion , Natürliche Killerzelle , Therapie , Tiermodell , NKT-Zellen , Transferkolitis , FACS , NKT cells , transfercolitis , FACS (1)
Colitis ulcerosa , Mastzelle , Lymphotoxin , Lymphotoxin-beta-Rezeptor , ulcerative colitis , mast cell , lymphotoxin-beta-receptor (1)
COLLABORATION; (1)
collaboration, negotiation, electronic document management, information architecture, information visualization, feedback (1)
collaboration; networked enterprise; impact analysis; virtual alliance (1)
Collaboration, Ventilation, Buildings, Ducts, Design Engineering, Structural beams, Computer interfaces, Civil Engineering, Space technology, User interfaces design engineering, computer aided engineering, groupware, constraint theory, online front-ends, Internet, constraint handling (1)
collaborative design; constraint satisfaction, solution spaces; mechanical, electrical and civil engineering (1)
Collaborative Information Seeking; Generationen; qualitative Forschung; videobasierte Inhaltsanalyse (1)
COLLAGEN-GAG MATRICES; ANTERIOR CRUCIATE LIGAMENT; IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; CONTRACTILE BEHAVIOR; STROMAL CELLS; FIBROBLASTS; BONE; MYOFIBROBLASTS; OSTEOBLASTS; (1)
COLLAGEN GENE-EXPRESSION; AP-2 FAMILY; CHONDROCYTE HYPERTROPHY; ARTICULAR-CARTILAGE; MALIGNANT-MELANOMA; DNA-BINDING; GRO-ALPHA; LIMB-BUD; DIFFERENTIATION; CHONDROGENESIS; AP-2 epsilon; CXCL1; Cartilage; Hypertrophic chondrocytes; Osteoarthritis (1)
COLLAGEN-INDUCED ARTHRITIS; ACID-SENSITIVE PROTEIN; RAP-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; MIA/CD-RAP; CHONDROCYTE DIFFERENTIATION; EXPRESSION; GLYCOPROTEIN-39; CELLS; MARKER; autoantigen; rheumatoid arthritis; collagen-induced arthritis; MIA; melanoma-inhibiting activity (1)
COLLAGEN-INDUCED ARTHRITIS; ADJUVANT-INDUCED ARTHRITIS; INFLAMED KNEE JOINTS; SYNOVIAL PLASMA EXTRAVASATION; POSTERIOR ARTICULAR NERVES; PEPTIDE-CONTAINING NERVES; COUPLED RECEPTOR KINASES; RHEUMATOID-ARTHRITIS; NERVOUS-SYSTEM; BLOOD-VESSELS; Arthritis; Joint inflammation; Sympathetic joint innervation; Neuroimmune connections (1)
COLLAGEN-INDUCED ARTHRITIS; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; SYMPATHETIC NEUROTRANSMITTERS; SYNOVIAL TISSUE; IMMUNE-SYSTEM; NERVE FIBERS; T-CELLS; INFLAMMATION; MICE; Sympathetic nervous system; Spleen; Chronic experimental arthritis; Neurotransmitters; Cytokines (1)
COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-PRESENTING CELLS; IGA-RHEUMATOID-FACTOR; NEUROPEPTIDE-Y NPY; RAT VAS-DEFERENS; IN-VIVO; T-CELLS; LYMPH-NODES; TRANSCRIPTIONAL ACTIVATION; SYNOVIAL TISSUE; B cell; Rheumatoid arthritis; Sympathetic nervous system (1)
COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-PRESENTING CELLS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISEASE; TRANSGENIC MICE; GENE-TRANSFER; INDUCTION; RESISTANCE; TOLERANCE; (1)
COLLAGEN-INDUCED ARTHRITIS; ANTITUMOR NECROSIS FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; EXPRESSION IN-VIVO; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; LONG-TERM; TRANSGENE EXPRESSION; CONCOMITANT METHOTREXATE; CALCINEURIN INHIBITORS; (1)
COLLAGEN-INDUCED ARTHRITIS; AUTOANTIBODY-MEDIATED ARTHRITIS; FIBROBLAST-LIKE SYNOVIOCYTES; CXC-CHEMOKINE RECEPTORS; RHEUMATOID-ARTHRITIS; CC-CHEMOKINE; INFLAMMATORY MONOCYTES; LEUKOCYTE RECRUITMENT; AUTOIMMUNE-DISEASE; MURINE MODEL; Arthritis; Neutrophil; Monocyte; Two-photon microscopy; K/B x N serum (1)
COLLAGEN-INDUCED ARTHRITIS; BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; NERVE FIBERS; ENDOGENOUS CATECHOLAMINES; TYROSINE-HYDROXYLASE; SYNOVIAL TISSUE; T-CELLS; NEUROTRANSMITTERS; SYSTEM; (1)
COLLAGEN-INDUCED ARTHRITIS; CCR5 RECEPTOR; T-CELLS; PROGRESSION; EXPRESSION; INFLAMMATION; RESPONSES; IMMUNITY; autoimmune insulitis; regulatory T-cells; Th-1 cells; CCR2; CCR5; redundancy (1)
COLLAGEN-INDUCED ARTHRITIS; CYTOTOXIC LIGAND TRAIL; ANTI-FAS ANTIBODY; MONOCLONAL-ANTIBODIES; DECOY RECEPTOR; DEATH DOMAIN; MICE; EXPRESSION; ONCOGENES; FAMILY; (1)
COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; IL-4 PRODUCTION; MAST-CELLS; IN-VIVO; RESPONSES; ANTIGEN; IMMUNITY; INTERLEUKIN-3; PROMOTE; basophils; CD4(+); T cells; graft-versus-host disease; interleukin-4; interleukin-6; mixed lymphocyte reaction (1)
COLLAGEN-INDUCED ARTHRITIS; HUMAN SYNOVIAL FIBROBLASTS; TUMOR-NECROSIS-FACTOR; NORMAL HUMAN CARTILAGE; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; VIRAL IL-10; IN-VITRO; ANTIINFLAMMATORY CYTOKINE; ARTICULAR CHONDROCYTES; (1)
COLLAGEN-INDUCED ARTHRITIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN SYNOVIAL FIBROBLASTS; GENE-TRANSFER; CARTILAGE DESTRUCTION; OSTEOARTHRITIS; EXPRESSION; PATHWAY; IL-1RA; (1)
COLLAGEN-INDUCED ARTHRITIS; KILLER T-CELLS; GENE-EXPRESSION; MAMMALIAN-CELLS; LIVING MAMMALS; REPORTER; LUCIFERASE; DELIVERY; MICE; TRANSCRIPTION; luciferase; green fluorescent protein; trafficking; bone marrow transplantation; cytotoxicity; T cells; immunotherapy (1)
COLLAGEN-INDUCED ARTHRITIS; LABIAL SALIVARY-GLANDS; CELL-LINE; T-CELLS; EXOCRINE TISSUES; INTERFERON-GAMMA; EXPRESSION; LIGAND; MICE; APOPTOSIS; (1)
COLLAGEN-INDUCED ARTHRITIS; LEUKEMIA INHIBITORY FACTOR; RECEPTOR ALPHA-7 SUBUNIT; RHEUMATOID-ARTHRITIS; NEUROTRANSMITTER PHENOTYPE; ANTIINFLAMMATORY PATHWAY; PROTEASOMAL DEGRADATION; TYROSINE-HYDROXYLASE; SYNOVIAL TISSUE; MARKED LOSS; Cholinergic sympathetic nerve fiber; Sympathetic nervous system; Arthritis; Leukemia inhibitory factor; Progesterone (1)
COLLAGEN-INDUCED ARTHRITIS; MEMBRANE ATTACK COMPLEX; IMMUNE-COMPLEXES; OSSIFICATION CENTER; OXIDATIVE STRESS; GENE-EXPRESSION; ACTIVATION; RECEPTOR; ANTIBODY; INFLAMMATION; (1)
COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; IN-VITRO; ENDOGENOUS CATECHOLAMINES; TYROSINE-HYDROXYLASE; NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; NOREPINEPHRINE; (1)
COLLAGEN-INDUCED ARTHRITIS; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; MICE; BINDING; INFLAMMATION; RECOGNITION; MODULATION; glycosaminoglycans; plasma cells; collagen-induced arthritis (1)
COLLAGEN-INDUCED ARTHRITIS; T-CELLS; INTERLEUKIN-6 PRODUCTION; POSTGANGLIONIC NEURONS; SYNOVIAL INFLAMMATION; RHEUMATOID-ARTHRITIS; CARDIAC FIBROBLASTS; TNF-ALPHA; SECRETION; NOREPINEPHRINE; Sympathetic nervous system; Arthritis; Spleen; IL-6; TGF-beta (1)
COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; LYMPHOTOXIN BETA-RECEPTOR; ANTIGEN-PRESENTING CELLS; IGA-RHEUMATOID-FACTOR; T-CELLS; SYNOVIAL-MEMBRANE; GERMINAL-CENTERS; LYMPHOID NEOGENESIS; DEFICIENT MICE; B-cell; neuroimmunology; rheumatoid arthritis; sympathetic nervous system (1)
COLLAGEN-INDUCED ARTHRITIS; WHITE ADIPOSE-TISSUE; RHEUMATOID-ARTHRITIS; MARKED LOSS; CELLS; INNERVATION; REPELLENT; LIPOLYSIS; DISEASES; PEPTIDE; (1)
COLLAGEN LATTICES; C-SKI; FIBROBLASTS; EXPRESSION; CONTRACTION; REPAIR; CELLS; (1)
COLLAGEN-LIKE POLYPEPTIDES; UROTHELIAL CELL-LINES; HUMAN-MONOCYTES; MOLECULAR-CLONING; HUMAN RP105; B-CELLS; ACTIVATION; MD-1; DIFFERENTIATION; MATURATION; (1)
COLLAGEN TYPE-I; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; GINGIVAL FIBROBLASTS; GROWTH-FACTOR; CELLS; FIBRILLIN-2; COMPONENT; MOVEMENT; tropoelastin expression; periodontal ligament cells; pressure (1)
COLLAGEN TYPE-II; IN-VITRO; EXTRACELLULAR-MATRIX; OSTEO-ARTHRITIS; ARTICULAR CHONDROCYTES; INTEGRIN EXPRESSION; MESSENGER-RNA; CELL-ADHESION; OSTEOPONTIN; SIALOPROTEIN; (1)
COLLAPSED CONE CONVOLUTION; MONTE-CARLO; RADIOCHROMIC FILM; PHOTON ENERGY; RADIOTHERAPY; MODEL; VERIFICATION; BEAMS; (1)
COLLATERALIZED DEBT OBLIGATIONS; EMPIRICAL-ANALYSIS; DEFAULT RISK; CREDIT RISK; MARKET; DETERMINANTS; SPREADS; BONDS; RATES; SWAPS; (1)
COLLATERAL NETWORK CONCEPT; ENDOVASCULAR REPAIR; MR-ANGIOGRAPHY; CORD ISCHEMIA; THORACIC AORTA; EDITORS CHOICE; CT ANGIOGRAPHY; ADAMKIEWICZ; RISK; EXPERIENCE; (1)
COLLECTING DUCT CELLS; THICK ASCENDING LIMB; NITRIC-OXIDE SYNTHASE; NA+-K+-ATPASE; SEPTIC SHOCK; DOWN-REGULATION; DOUBLE-BLIND; DECREASED ABUNDANCE; SURFACE EXPRESSION; POTASSIUM CHANNEL; (1)
COLLECTING DUCT EPITHELIA; FIBROBLAST GROWTH-FACTOR; IN-VITRO; STEM-CELL; ELECTROLYTE ENVIRONMENT; CLINICAL-APPLICATIONS; EXTRACELLULAR-MATRIX; INTERCALATED CELLS; ARTIFICIAL TISSUES; POLYMER SCAFFOLDS; biomaterial testing; tissue engineering; differentiation; dedifferentiation; tissue carrier; perfusion culture container; electrolyte environment (1)
COLLECTING DUCT EPITHELIA; STEM-CELL NICHE; IN-VITRO; KIDNEY; DIFFERENTIATION; IDENTIFICATION; TUBULOGENESIS; MESENCHYME; AMPULLA; CULTURE; renal stem cells; epithelium; tubules; artificial interstitium; polyester fleece; perfusion culture; tissue engineering (1)
COLLECTING DUCT EPITHELIUM; MORPHOGENESIS; CELLS; ORGANOGENESIS; EXPRESSION; INDUCTION; LAMININS; COLLAGEN; CULTURE; CLONING; kidney; development; collecting duct ampulla; nephrogenic mesenchyme; extracellular matrix; P(CD)Amp1 (1)
COLLECTING DUCT; STEM-CELLS; DEVELOPING KIDNEY; NEPHRON SEGMENTS; EMBRYONIC KIDNEY; RABBIT KIDNEY; ORGAN-CULTURE; URETERAL BUD; MICRO-FIBERS; DIFFERENTIATION; (1)
COLLECTION; EFFICACY; PLASMA; Tigecycline; Population pharmacokinetics; NONMEM; Dosing; Renal replacement therapy; CVVHD; CVVHDF (1)
COLLECTIVE ACTION; Voluntary public good provision; Matching; Commitment (1)
COLLECTIVE DECISION-MAKING; CHEMICAL COMMUNICATION; HYMENOPTERA-FORMICIDAE; RECRUITMENT BEHAVIOR; FOOD RECRUITMENT; ORIENTATION; ORGANIZATION; RESPONSES; IMPRECISION; SELECTION; Ants; behavioural methods; behavioural states; motivation; pheromone trails; private information; social information; unexplained variation (1)
COLLECTIVE DECISION-MAKING; COLONY OPTIMIZATION ALGORITHM; PHEROMONE CORRECTION STRATEGY; FOOD RECRUITMENT; HYMENOPTERA; SELECTION; PROTOCOL; BEHAVIOR; TRAILS; MODEL; Agent based model; Adaptive systems; ACO; Pheromone; Collective organisation (1)
COLLECTIVE DECISION-MAKING; LASIUS-NIGER; CROWDED CONDITIONS; PATH-INTEGRATION; FOOD RECRUITMENT; TRAIL PHEROMONES; DESERT ANTS; MEMORY; FLEXIBILITY; NAVIGATION; Group decision making; Organisation; Memory; Ants; Social information; Pheromone trails (1)
COLLECTIVE DECISION-MAKING; LASIUS-NIGER; SENSITIVITY; HONEYBEES; BEHAVIOR; VARIABILITY; SELECTION; VARIANCE; CHOICES; Risk aversion; Psychophysics; Utility; Value perception; Ants (1)
COLLECTIVE DECISION-MAKING; MONOGYNOUS QUEENLESS ANT; PONERINE ANT; EUSOCIAL HYMENOPTERA; INSECT SOCIETIES; SOCIAL INSECTS; DIACAMMA SP; LEPTOTHORAX ANTS; HONEY-BEES; CONFLICT; kin conflict; worker policing; dominance; Temnothorax unifasciatus (1)
COLLECTIVE DECISION-MAKING; NEST-SITE SELECTION; HYMENOPTERA-FORMICIDAE; LEPTOTHORAX-ALBIPENNIS; WORKER REPRODUCTION; SOCIAL INSECTS; COLONIES; ORGANISMS; HISTORY; EUROPE; (1)
Collective Intelligence, Social Incentive, Banner Advert, Social Networking Platform, Advertising Budget (1)
COLLECTIVE MEMORY; FALSE MEMORY; 7 SINS; MISINFORMATION; RETRIEVAL; RECALL; TRANSMISSION; INFORMATION; INHIBITION; CONFORMITY; Social contagion; Collaboration; Collaborative memory; False memory; Shared memory; Collective memory (1)
COLLECTIVE MEMORY; HISTORY; AVAILABILITY; NARCISSISM; collective memory; national memory; national narcissism; public event memory; ethnocentrism (1)
COLLECTIVE MEMORY; REPEATED RETRIEVAL; INDIVIDUAL MEMORY; EYEWITNESS MEMORY; CONTAGION; CONFORMITY; BENEFITS; RECALL; SUGGESTIBILITY; INFORMATION; Social contagion; Collaboration; False memory; Retrieval practice; Testing effect; Collective memory (1)
COLLECTIVE MODES; CARBON NANOTUBES; ELECTRON; SPINTRONICS; BILAYER; OXIDE; (1)
COLLECTIVE MOTIONS; WATER; DYNAMICS; SPECTROSCOPY; RELAXATION; MIXTURES; REGION; H2O; D2O; (1)
COLLECTIVE NARCISSISM; SOCIAL IDENTITY; IDENTIFICATION; MODEL; IMAGE; (1)
Collective practice, deliberate practice, individual practice, music bands, popular music (1)
COLLEGE-STUDENTS; ENVIRONMENTS; ACHIEVEMENT; (1)
COLLEGE-STUDENTS; LASER; PIGMENTS; SKIN; YAG; Tattoo; Laser; Intense pulsed light source; Adverse reaction (1)
COLLIGATIVE PROPERTIES; FORCE-FIELD; SIMULATIONS; SOLVATION; ENERGY; CONDUCTANCE; POTENTIALS; HYDRATION; DILUTION; SOLVENTS; (1)
COLLINEAR EFFECTIVE THEORY; EFFECTIVE-FIELD THEORY; QCD FACTORIZATION; RESUMMATION; GAUGE; JETS; DIS; Jets; Hadronic Colliders; Parton Model; QCD (1)
collocations, corpus linguistics, poisson distribution, statistical analysis, text mining (1)
Collocations, Distant Reading, Religious Studies, Reddit, Visualization (1)
Colloides I Complex Compounds / Metals / Photochemistry / Spectroscopy, Ultraviolet (1)
COLON-CANCER CELLS; ALPHA-ELEOSTEARIC ACID; HUMAN TUMOR-CELLS; SEED OIL-RICH; LINOLEIC-ACID; LIPID-PEROXIDATION; LIQUID-CHROMATOGRAPHY; COLORECTAL-CANCER; DAIRY-PRODUCTS; LEUKEMIA-CELLS; Conjugated linoleic acid; Conjugated linolenic acid; Isomer specificity; Conversion; Colon cancer cell (1)
COLON-CANCER; IMPROVEMENT; Clinical cancer registries; Cancer; Colorectal cancer; Quality management; Health services research (1)
COLON-CANCER; PATHOLOGICAL FEATURES; GENETIC INSTABILITY; MUTATIONS; CARCINOGENESIS; CARCINOMA; HOMOLOG; TUMORS; HNPCC; IMMUNOHISTOCHEMISTRY; (1)
COLON-CANCER; PROGRESSION; MICROENVIRONMENT; BEVACIZUMAB; SIGNATURE; SURVIVAL; THERAPY; FOLFIRI; GENOME; GROWTH; Colorectal cancer (CRC); RNA-sequencing; Gene expression; Liver metastasis (1)
COLON-CARCINOMA CELLS; E-CADHERIN; C-MYC; APC; METASTASIS; MUTATIONS; PATHWAY; TARGET; ACTIVATION; TRANSITION; (1)
COLON-CARCINOMA CELLS; IDENTIFICATION; ESL-1; E-selectin; E-selectin ligand-1; hepatic stellate cells (1)
COLONIC DIVERTICULITIS; COMPUTED-TOMOGRAPHY; GUIDED DRAINAGE; DIET; PERFORATION; Diverticulitis; Diverticulosis; Hemorrhage; Fistula; Abcess (1)
COLONIC RESECTION; SURGERY; RECOVERY; METAANALYSIS; MANAGEMENT; DRAINAGE; CANCER; TRIAL; rectum resection; laparoscopy; laparoscopic surgery; fast-track (1)
Colon , Krebs <Medizin> , Microarray, Metastase , Differentielle Genexpression , colon , cancer , array-technology , metastasis , differential gene expression (1)
COLONOSCOPY; YIELD; Endoscopy; Risk factors; Elderly patient; Safety (1)
COLONY-ENHANCING FACTOR; TRYPSINOGEN ACTIVATION PEPTIDE; ADIPOSE-TISSUE; APACHE-II; CLASSIFICATION-SYSTEM; SCORING SYSTEMS; CT EVALUATION; RESISTIN; ORGAN; ADIPOCYTOKINES; (1)
COLONY SOCIAL-ORGANIZATION; ACTIVITY PATTERNS; SWEAT BEE; REPRODUCTIVE STRATEGIES; EGG LIMITATION; HALICTID BEE; SOLITARY BEE; PAPER WASP; HYMENOPTERA; TEMPERATURE; (1)
COLONY SOCIAL-ORGANIZATION; EGG LIMITATION; SWEAT BEE; REPRODUCTIVE STRATEGIES; EVOLUTIONARY ARGUMENT; VESPULA-GERMANICA; TIME LIMITATION; HALICTINE BEE; PAPER WASP; LIFE-SPAN; resource allocation; optimal investment; halictids; investment limitation; optimality model (1)
COLONY-STIMULATING FACTOR; ACUTE MYELOGENOUS LEUKEMIA; C-KIT RECEPTOR; MINIMAL RESIDUAL DISEASE; BONE-MARROW; IN-VITRO; ALPHA CHAIN; FLT3 LIGAND; CYTOSINE-ARABINOSIDE; POOR-PROGNOSIS; acute myeloid leukemia; cytokine receptors; immunophenotyping; minimal residual disease; prognosis (1)
COLONY-STIMULATING FACTOR; ADHESION MOLECULE-3-GRABBING NONINTEGRIN; DENDRITIC CELL-FUNCTION; REGULATORY T-CELLS; C-TYPE LECTINS; MOUSE DC-SIGN; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; INFLAMMATORY MONOCYTES; ALLOGRAFT-REJECTION; (1)
COLONY-STIMULATING FACTOR; ATHEROSCLEROTIC LESIONS; DENSITY LIPOPROTEIN; FOAM CELLS; CHOLESTEROL; RABBITS; ELIMINATION; MECHANISMS; EXPRESSION; TRANSPORT; 27-hydroxycholesterol; cholestenoic acid; macrophage-colony stimulating factor (1)
COLONY-STIMULATING FACTOR; BLIND SOURCE SEPARATION; ENDOPLASMIC-RETICULUM; MEDIATED PHAGOCYTOSIS; SCAVENGER RECEPTOR; GENE-EXPRESSION; NADPH OXIDASE; TGF-BETA; MACROPHAGES; THIOREDOXIN; (1)
COLONY-STIMULATING FACTOR; BONE-MARROW-TRANSPLANTATION; MOBILIZATION; INDIVIDUALS; DISEASE; CRISIS; sickle cell trait; sickle cell disease; stem cell mobilization; stem cell transplantation; stem cell harvest (1)
COLONY-STIMULATING FACTOR; CAROTID-ARTERY OCCLUSION; MAGNETIC-RESONANCE ANGIOGRAPHY; COLLATERAL VESSELS; BLOOD-FLOW; BRAIN; GROWTH; MECHANISMS; EXPRESSION; ADENOSINE; AV fistula; cerebral arteriogenesis; fluid shear stress; quantitative MRI-analysis (1)
COLONY-STIMULATING FACTOR; CAROTID-ARTERY OCCLUSION; RECEPTOR POTENTIAL CHANNELS; HYPOPERFUSED RAT-BRAIN; VESSEL GROWTH; CIRCULATION; DISEASE; FLOW; Arteriogenesis; Brain; Collateral circulation; Fluid shear stress; Trpv4; Rat (1)
COLONY-STIMULATING FACTOR; CELLS; TAMOXIFEN; CARCINOMA; BEARING; GROWTH; MICE; MXT-M-3,2 breast cancer; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]; dichloroplatinum(II); immunomodulator (1)
COLONY-STIMULATING FACTOR; CHRONIC INFLAMMATORY ARTHRITIS; CELL GROWTH-FACTOR; MAST-CELL; HISTAMINE-RELEASE; T-CELL; MACROPHAGE ACTIVATION; RHEUMATOID-ARTHRITIS; MEDIATED ARTHRITIS; DENDRITIC CELLS; (1)
COLONY-STIMULATING FACTOR; DOUBLE-STRANDED-RNA; NF-KAPPA-B; GENE-EXPRESSION; CRESCENTIC GLOMERULONEPHRITIS; DENDRITIC CELLS; MESANGIAL CELLS; FACTOR-I; DIFFERENTIAL EXPRESSION; MRL-FAS(LPR) MICE; (1)
COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; T-LYMPHOCYTES; EXPRESSION; SAFETY; BLOOD; TRANSPLANTATION; LEUKEMIA; KINETICS; Amyotrophic lateral sclerosis, ALS; Granulocyte-colony stimulating factor, G-CSF; Hematopoietic stem and progenitor cells, HSPC; Telomere length; Cytokines (1)
COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRANSIENT GLOBAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; (1)
COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; VOXEL-GUIDED MORPHOMETRY; FACTOR G-CSF; BONE-MARROW; FUNCTIONAL RECOVERY; PERIPHERAL-BLOOD; STEM-CELLS; WORKING-MEMORY; INFARCT VOLUME; (1)
COLONY-STIMULATING FACTOR; G-CSF; CENTRIFUGAL LEUKAPHERESIS; HEALTHY DONORS; SEVERE SEPSIS; DEXAMETHASONE; TRANSFUSIONS; MOBILIZATION; NEUTROPHILS; EFFICACY; (1)
COLONY-STIMULATING FACTOR; GLIOBLASTOMA-MULTIFORME; INDUCE IMMUNITY; T-CELLS; VACCINATION; ANTIGEN; IMMUNOSUPPRESSION; IMMUNOTHERAPY; RADIOTHERAPY; LEUKOCYTES; malignant glioma; dendritic cell; tumor vaccination; methionine; positron emission tomography (1)
COLONY-STIMULATING FACTOR; GROWTH FACTOR-BB; HYPERBARIC-OXYGEN; STEM-CELLS; TGF-BETA; DERMAL FIBROBLASTS; IRRADIATED SKIN; SOFT-TISSUE; MATRIX METALLOPROTEINASES; CLINICAL-APPLICATIONS; Wound healing; Radiation therapy (1)
COLONY-STIMULATING FACTOR; GROWTH-FACTOR; IFN-GAMMA; MECHANISMS; RESPONSES; INVASION; SYSTEM; INJURY; (1)
COLONY-STIMULATING FACTOR; HAIR FOLLICLE BULGE; CANCER STEM-CELLS; KERATINOCYTES; RECURRENCE; PROGENITOR; RESISTANCE; APOPTOSIS; MELANOMA; TARGETS; CD34; Oral squamous cell carcinoma; Head and neck squamous cell carcinoma; Stem cell marker; Cell cycle; Differentiation; Keratinocyte (1)
COLONY-STIMULATING FACTOR; HIGH-DOSE CHEMOTHERAPY; PERIPHERAL-BLOOD STEM; MULTIPLE-MYELOMA; BONE-MARROW; RANDOMIZED-TRIAL; MESSENGER-RNA; IN-VITRO; ERYTHROPOIETIN; CYCLOPHOSPHAMIDE; stem cells; mobilization; transplantation; erythropoietin; multiple myeloma (1)
COLONY-STIMULATING FACTOR; HUMAN RECOMBINANT IL-3; DENDRITIC CELLS; HUMAN BASOPHILS; MEDIATOR RELEASE; LUPUS NEPHRITIS; HUMAN MONOCYTES; INTERLEUKIN-3; RESPONSES; DIFFERENTIATION; (1)
COLONY-STIMULATING FACTOR; HYPOPERFUSED RAT-BRAIN; ARTERY OCCLUSION; VESSEL GROWTH; CIRCULATION; INDUCTION; DISEASE; Cerebral arteriogenesis; Arteriovenous fistula; Fluid shear stress; Quantitative magnetic resonance imaging analysis; Trpv4 (1)
COLONY-STIMULATING FACTOR; INTRACELLULAR HISTAMINE; FLOW-CYTOMETRY; T-CELLS; MACROPHAGES; INTERLEUKIN-3; ANTAGONIST; RECEPTORS; CYTOKINES; MESSENGER; monocyte; histamine; differentiation; M-CSF (1)
COLONY-STIMULATING FACTOR; MODIFIED FLUID GELATIN; CELL-DEATH; NEUTROPHILS; STORAGE; TRANSFUSIONS; MIGRATION; SURVIVAL; IMPACT; distribution; granulocyte concentrates; granulocytes; modified fluid gelatin; neutrophils; separation; storage; transfusion (1)
COLONY-STIMULATING FACTOR; MONONUCLEAR PHAGOCYTE SYSTEM; HEMATOPOIETIC STEM-CELLS; TISSUE-RESIDENT MACROPHAGES; GENE-EXPRESSION PROFILES; DENDRITIC CELLS; MONOCYTE SUBSETS; IN-VIVO; STEADY-STATE; C-FMS; (1)
COLONY-STIMULATING FACTOR; MOTOR-NEURON DISEASES; NEURODEGENERATIVE DISEASES; NEUROIMAGING BIOMARKER; HUMAN BRAIN; PATHOLOGY; MRI; TRACTOGRAPHY; PROPAGATION; PROGRESSION; magnetic resonance imaging; diffusion tensor imaging; neurodegeneration; neurodegenerative disease; DTI metrics (1)
COLONY-STIMULATING FACTOR; MRL/MP-LPR/LPR MICE; HUMAN RECOMBINANT IL-3; CD4(+) T-CELLS; DENDRITIC CELLS; HUMAN BASOPHILS; B-CELLS; HISTAMINE-RELEASE; BONE-MARROW; INTERLEUKIN-3-LIKE ACTIVITY; cytokines; glomerulonephritis; systemic lupus erythematosus (1)
COLONY-STIMULATING FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR CALCIUM; CELL BIOLOGY; RESORPTION; OSTEOPROTEGERIN; EXPRESSION; RECEPTOR; OSTEOCYTES; Bone remodelling; Osteoblasts; Osteoclasts; Runx2; Regenerative dentistry (1)
COLONY-STIMULATING FACTOR; PHASE-II TRIAL; QUALITY-OF-LIFE; G-CSF; GLIOBLASTOMA-MULTIFORME; INTERFERON-GAMMA; IN-VITRO; GM-CSF; ANAPLASTIC ASTROCYTOMA; ASPERGILLUS-FUMIGATUS; neutrophils; temozolomide; malignant glioma; drug effects; immunology (1)
COLONY-STIMULATING FACTOR; PITUITARY-ADRENAL AXIS; NECROSIS-FACTOR-ALPHA; CLOCK GENES; IN-VITRO; INFLAMMATORY CYTOKINES; BIOLOGICAL RHYTHMS; SYMPATHETIC-NERVE; MANUAL DEXTERITY; DISEASE-ACTIVITY; (1)
COLONY-STIMULATING FACTOR; PROGENITOR CELLS; STEM-CELLS; TRANSPLANTATION; THERAPY; GRAFTS; RABBIT; ATHEROSCLEROSIS; INFLAMMATION; RESTENOSIS; Cell therapy; Endothelial cells; Seeding; Vascular injury; Rats; Adventitia (1)
COLONY-STIMULATING FACTOR; SULFIDOPEPTIDE-LEUKOTRIENES; FIBROBLAST PROLIFERATION; LIPOXYGENASE PRODUCTS; MACROPHAGE ACTIVATION; PULMONARY FIBROSIS; HUMAN NEUTROPHILS; LUNG FIBROBLASTS; GROWTH-FACTOR; SUBSTANCE-P; (1)
COLONY-STIMULATING FACTOR; T-CELLS; LARGE NUMBERS; GM-CSF; GENERATION; BLOOD; DIFFERENTIATION; PROGENITORS; ACTIVATION; PRECURSORS; dendritic cell; maturation; phenotype; MLR; antigen (1)
COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR FOXP3; MONOCYTOGENES-DERIVED CD4; DENDRITIC CELLS; IN-VIVO; LAMINA-PROPRIA; MARGINAL ZONE; SPLEEN; MICE; DIFFERENTIATION; (1)
COLONY-STIMULATING FACTOR; WHOLE-LUNG LAVAGE; CHOLESTEROL; SURFACTANT; NPC2; MUTATIONS; C1; INVOLVEMENT; TRANSPORT; HE-1; infant; Niemann-Pick type C2; pulmonary alveolar proteinosis; tachypnea; therapeutic lung lavage (1)
colony structure, conflict, cuticular hydrocarbons, dominance, fertility signal, Formicidae, microsatellites, Pseudomyrmex, relatedness, ritualised aggression, worker policing, worker reproduction (1)
COLOR-CODED SONOGRAPHY; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC STROKE; DOPPLER; ANGIOGRAPHY; ECASS; cerebral arteries; diagnostic imaging; thrombolysis; ultrasonography, Doppler, duplex (1)
COLOR-CODED SONOGRAPHY; MIDDLE CEREBRAL-ARTERY; ISCHEMIC STROKE; ANGIOGRAPHY; INFARCTION; DISEASE; (1)
COLOR-CODED SONOGRAPHY; YOUNG STROKE PATIENTS; TO-LEFT SHUNTS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DOPPLER ULTRASOUND; CONTRAST ECHOCARDIOGRAPHY; CRYPTOGENIC STROKE; LIMITATIONS; PREVALENCE; DIAGNOSIS; brain, infarction; brain, US; heart, diseases; heart, US; ultrasound (US), contrast media (1)
COLOR-DOPPLER; CT; ELASTOGRAPHY; STRAIN; BENIGN; MASSES; chest computed tomography; incidental breast lesions; invasive carcinoma of no special type (NST) (1)
COLOR DOPPLER FLOW; AORTIC-VALVE AREA; IN-VITRO; BLOOD-FLOW; STENOSIS; ECHOCARDIOGRAPHY; QUANTIFICATION; SEVERITY; PLANIMETRY; REGION; catheterization; echocardiography; magnetic resonance imaging; mitral valve; regurgitation (1)
COLOR DOPPLER SONOGRAPHY; CHOROIDAL MELANOMA; ULTRASOUND; (1)
COLOR DOPPLER SONOGRAPHY; CUTANEOUS MELANOMA; FOLLOW-UP; PROGNOSTIC FACTORS; SURVIVAL; DISEASE; lymph node metastasis; melanoma; sonography; ultrasound; palpation; aftercare (1)
COLOR DOPPLER ULTRASOUND; PREOPERATIVE ASSESSMENT; CUTANEOUS PERFORATORS; DUPLEX SONOGRAPHY; FLAP PERFORATORS; ULTRASONOGRAPHY; ELEVATION; EFFICACY; IDENTIFICATION; ANGIOGRAPHY; ultrasound; perforator flap; color coded duplex ultrasound (1)
COLOR DUPLEX MEASUREMENT; CEREBRAL CIRCULATION; ANGIOGRAPHY; QUANTIFICATION; TIME; internal carotid artery flow; ultrasound; arteriovenous malformation (1)
COLOR DUPLEX SONOGRAPHY; IMPLANTABLE DOPPLER; PERFUSION; HEAD; FLUORESCENCE; SPECTROSCOPY; EXPERIENCE; REPAIR; Microvascularization; flap monitoring; buried flap; contrast enhanced ultrasound; CEUS (1)
COLOR DUPLEX ULTRASOUND; AORTIC STENT-GRAFTS; ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; FOLLOW-UP; MS-CT; SCAN; EFFICACY; OUTCOMES; Contrast-enhanced ultrasound; endovascular abdominal aneurysm repair; endoleak; surveillance (1)
COLOR DUPLEX ULTRASOUND; CLINICAL-PRACTICE RECOMMENDATIONS; ENHANCED-ULTRASOUND; COMPUTED-TOMOGRAPHY; II ENDOLEAKS; CANINE MODEL; RISK-FACTORS; UPDATE 2008; REPAIR; SURVEILLANCE; aorta; ultrasound; aneurysm (1)
COLOR; EAT; CLASSIFICATION; FAMILIARITY; PERCEPTION; TEXTURE; Food preferences; Visual features; Food recommender system; Stable patterns (1)
COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; INTENSITY; OLDER; OPTIONS; TRIALS; Dose reduction; Cancer; Colorectal cancer; Chemotherapy (1)
COLORECTAL-CANCER; BETA-CATENIN; E-CADHERIN; TRANSITION; EXPRESSION; SNAIL; METASTASIS; MECHANISMS; SURVIVAL; INSIGHTS; Squamous cell carcinoma of the penis; Lymphovascular invasion; Epithelial-to-mesenchymal transition; Immunohistochemistry; Cadherin switch; Targeted therapies (1)
COLORECTAL-CANCER; CARCINOMATOSIS; (1)
COLORECTAL-CANCER CELLS; BETA-CATENIN; EMBRYONAL RHABDOMYOSARCOMA; BREAST-CANCER; COLON-CANCER; EXPRESSION; GROWTH; DIFFERENTIATION; ACTIVATION; REPRESSION; RMS; LEF1/TCF; WNT/beta-catenin signaling (1)
COLORECTAL-CANCER; CPG ISLANDS; GENE; DNA; METHYLATION; SUSCEPTIBILITY; MUTATIONS; PROMOTER; INACTIVATION; RECURRENCE; breast cancer; functional hypermethylome screen; biomarker; detection; prognosis (1)
COLORECTAL-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; EFFICACY; Colon cancer; Colorectal cancer; Adjuvant therapy; T4 stage; UICC II (1)
COLORECTAL-CANCER; GASTROESOPHAGEAL JUNCTION; FOLINIC ACID; K-RAS; INFUSIONAL FLUOROURACIL; CISPLATIN; ADENOCARCINOMA; MUTATIONS; THERAPY; TRIAL; antibody; chemotherapy; cetuximab; EGFR; gastric cancer; KRAS mutation (1)
COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; METASTASES; ULTRASONOGRAPHY; SONOGRAPHY; TUMORS; RESECTION; AGENTS; Contrast enhanced ultrasound (CEUS); intraoperative ultrasound (IOUS); intraoperative imaging; liver lesion (1)
COLORECTAL-CANCER; IMPROVED SURVIVAL; DUKES B; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; COMORBIDITY; PREVALENCE; RECURRENCE; EFFICACY; Colon cancer; Survival; Chemotherapy; Registry; Risk factor; Adjuvant (1)
COLORECTAL-CANCER; INTRAOPERATIVE ULTRASONOGRAPHY; CIRRHOSIS; DIAGNOSIS; SURFACE; METAANALYSIS; ULTRASOUND; PET; US; liver lesion; malignancy; 3.5 MHz transducer; 7.5 MHz transducer; ultrasonography (1)
; Colorectal cancer; Mediastinal lymph node metastasis; Lymph node dissection (1)
COLORECTAL-CANCER; OPEN SURGERY; COMORBIDITY; PREVALENCE; TRIAL; Bowel cancer; Minimal invasive surgery; Health services research; Registries; Cohort studies (1)
COLORECTAL-CANCER; OPEN SURGERY; ELDERLY-PATIENTS; FOLLOW-UP; OUTCOMES; MORTALITY; THERAPY; TRIAL; Bowel cancer; Minimally invasive surgery; Elderly patients; Health services research; Registries; Cohort studies (1)
COLORECTAL-CANCER; PREOPERATIVE CHEMOTHERAPY; HEPATIC RESECTION; PERIOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; SURGERY; TUMOR; OXALIPLATIN; MANAGEMENT; CARCINOMA; Colorectal liver metastases; Synchronous liver metastases; Liver-first concept (1)
COLORECTAL-CANCER PROGRESSION; BETA-CATENIN; TGF-BETA; E-CADHERIN; COLON-CARCINOMA; CELL TRANSITION; DOWN-REGULATION; TNF-ALPHA; MIGRATION; FIBROBLASTS; Crohn's disease; fistulae; epithelial mesenchymal transition (1)
COLORECTAL-CANCER; RANDOMIZED-TRIAL; RECTAL-CANCER; LEUCOVORIN; CARCINOMA; ADENOCARCINOMA; ESOPHAGEAL; IRINOTECAN; CISPLATIN; RADIATION; oxaliplatin; fluorouracil; metastatic gastric cancer; first-line (1)
COLORECTAL-CANCER; RECTAL-CANCER; LYMPH-NODES; SURGERY; SURVIVAL; COMORBIDITY; PREVALENCE; CONVERSION; TRIAL; Bowel cancer; Minimal invasive surgery; Health services research; Registries; Cohort studies (1)
COLORECTAL CANCERS; CELL-LINES; PHENOTYPE; BAT-26; (1)
COLORECTAL-CANCER; SURVIVAL; COLONOSCOPY; ESTROGEN; GERMANY; IMPACT; AGE; Sex differences; Gender; Colon cancer (1)
COLORECTAL-CANCER; TERMINAL ILEUM; Contrast-enhanced ultrasound; Crohn's disease; quantitative perfusion analysis; inflammatory bowel disease (1)
COLORECTAL-CANCER; THERAPY; CD8(+); IMMUNOTHERAPY; LYMPHOCYTES; STATISTICS; RESERVOIR; SURVIVAL; SUBSETS; SITE; Lung cancer; bone marrow; T cells; immunotherapy (1)
COLORECTAL LIVER METASTASES; CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; HEPATOCELLULAR-CARCINOMA CELLS; SORAFENIB; CANCER; MITOCHONDRIA; CHLOROQUINE; RESISTANCE; THERAPY; STRESS; (1)
Colorectal liver metastases · GLUT1 · Immunometabolism · CD8+ T cells · Tumor microenvironment (1)
COLORECTAL LIVER METASTASES; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; SYSTEMIC CHEMOTHERAPY; 1ST-LINE TREATMENT; CIRRHOTIC-PATIENTS; B VIRUS; RESECTION; CANCER; TRANSPLANTATION; (1)
; Colorectal neoplasms; DNA mismatch repair; Microsatellite instability; Molecular pathology; Quality control (1)
; Colorectal neoplasms; Liver neoplasms; Ablation techniques; Consensus; Clinical protocols (1)
COLORECTAL SURGERY; BOWEL PREPARATION; MEDICAL-RESEARCH; CLASICC TRIAL; MULTICENTER; SURVIVAL; colorectal surgery; consensus; expert; laparoscopic; rectal cancer; total mesorectal excision (1)
Colorectal surgery; Cognitive errors; Morbidity & mortality conference; Outcome management; Content analysis (1)
COLOR GLASS CONDENSATE; EVOLUTION; Resummation; Perturbative QCD (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; DEEP-INELASTIC SCATTERING; SMALL-X; RENORMALIZATION-GROUP; TRANSVERSE-MOMENTUM; SPIN ASYMMETRIES; PERTURBATIVE QCD; PA-COLLISIONS; N-C; (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; Langevin equation; JIMWLK equation; Stochastic integration; Gluon dipole distribution (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; NUCLEUS-NUCLEUS COLLISIONS; WEIZSACKER-WILLIAMS FIELD; LARGE TRANSVERSE-MOMENTUM; DEUTERON-GOLD COLLISIONS; HIGH-ENERGY SCATTERING; HIGH-DENSITY QCD; SMALL-X; PARTON DISTRIBUTIONS; (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; WEIZSACKER-WILLIAMS FIELD; HIGH-ENERGY SCATTERING; CROSS-SECTION; SMALL-X; NONLINEAR EVOLUTION; BFKL EQUATION; LARGE NUCLEUS; LOW Q(2); (1)
COLOR GLASS CONDENSATE; NONLINEAR GLUON EVOLUTION; HEAVY-QUARK PRODUCTION; BFKL; AMPLITUDES; COHERENCE; Heavy Ion Phenomenology (1)
COLOR GLASS CONDENSATE; NONLINEAR GLUON EVOLUTION; NUCLEUS COLLISIONS; SPIN ASYMMETRIES; DRELL-YAN; (1)
COLOR GLASS CONDENSATE; QUARK-GLUON PLASMA; NUCLEUS COLLISIONS; COLLABORATION; PERSPECTIVE; (1)
COLORIMETRIC DETECTION; 5-HYDROXYTRYPTAMINE; RECOGNITION; CHEMISTRY; DISEASE; Serotonin; Dimerization; 1H NMR; High-resolution mass spectroscopy (H-RMS); Dithiobis; (Succinimidyl propionate (DTSP)); GNPs aggregation; Amine-reactive colorimetric assay (1)
colorimetric detection; ammonia; carbon monoxide; aldehyde (1)
COLORIMETRIC SENSOR ARRAY; MONITORING FRESHNESS; SHELF-LIFE; SPOILAGE; QUALITY; LABEL; pH sensor; optical; photometry; colorimetry; potentiometry; digital image (1)
COLORIMETRIC SENSOR; DERIVATIZATION; HISTAMINE; FISH; DISCRIMINATION; CHROMATOGRAPHY; POLYAMINES; PROTEINS; LABELS; ARRAY; (1)
COLORIMETRIC SENSOR; SENSITIVE DETECTION; HISTAMINE; PROBE; LAYER; FISH; VISUALIZATION; VALIDATION; VERSATILE; MEAT; Optical sensor; Biogenic amine; Colorimetry; Fluorescence; SERS; Dipstick; Food quality; Reflectometry; Chemiluminescence; Ellipsometry (1)
colors, html, visual complexity, web design, web history, websites (1)
COLOR STABILITY; RESINS; OPACITY; color stability; composites; accelerated aging (1)
COLOR TRANSPARENCY; ELECTROMAGNETIC CORRECTIONS; VECTOR-MESONS; LUND MODEL; ELECTROPRODUCTION; TARGETS; QUARKS; MATTER; FRAGMENTATION; ATTENUATION; (1)
COLOR-TRANSPARENCY; VECTOR-MESONS; COHERENCE LENGTH; WAVE-FUNCTION; SCATTERING; ELECTROPRODUCTION; LEPTOPRODUCTION; PHOTOPRODUCTION; PHOTON; QCD; (1)
COLOR-VISION; STIMULATION; PERFORMANCE; INHIBITION; PERCEPTION; BRAIN; MOOD; Transcranial magnetic stimulation; Cortical excitability; Intracortical inhibition; Colour blindness; Colour stimulation (1)
COLUMNAR DEFECTS; MAGNETIC-FIELD; NETWORK; CRYSTALS; VORTICES; FLUX (1)
Column liquid chromatography - Detection, chiroptical, polarimetric, circular dichroic - Enantiomers - Sorbents, optically active (1)
Column liquid chromatography - Triacetylcellulose - Enantiomer interconversion - Deconvolution of chromatograms (1)
Column liquid chromatography - Triacetylcellulose on silica - Triacetylcellulose, non-dilute - Enantiomers - X-ray diffraction (1)
COMBINATION; CELLS; LIFE; Glioblastoma; Relapse; Meclofenamate; Temozolomide; Second-line therapy (1)
COMBINATION THERAPY; DIFFUSION CAPACITY; GUIDELINES; DIAGNOSIS; MORTALITY; SURVIVAL; AMBRISENTAN; TADALAFIL; (1)
COMBINATION THERAPY; IMATINIB; SELEXIPAG; DIAGNOSIS; INSIGHTS; TIME; Pulmonary vascular disease; Risk factors; New therapies; Drug therapy; combination; Comorbidity (1)
COMBINATION THERAPY; SILDENAFIL; EFFICACY; endothelin-receptor antagonists; prostaglandins; pulmonary hypertension (1)
COMBINATORIAL APPROACH; ARRAYS; (1)
; combinatorial approach; high-throughput characterization; s24-technique; conductance measurements; contact resistance; electropolymerization (1)
COMBINED ANTEVERSION; COMPUTER NAVIGATION; CUP PLACEMENT; UNITED-STATES; MOTION; REPLACEMENT; DISLOCATION; ACCURACY; OSTEOARTHRITIS; POSITION; (1)
COMBINED DEXAMETHASONE/CRH TEST; ANTIDEPRESSANT EFFICACY; ALTERNATIVE MEDICINE; REMITTED DEPRESSION; TREATMENT RESPONSE; CORTISOL RESPONSE; STRESS; QUETIAPINE; DISORDER; COMPLEMENTARY; Yoga; Depression; Escitalopram; Quetiapine; Cortisol; DEX/CRH-test (1)
COMBINED DEXAMETHASONE/CRH TEST; TREATMENT-RESISTANT DEPRESSION; CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; PLACEBO-CONTROLLED TRIAL; DEX-CRH TEST; MAJOR DEPRESSION; DOUBLE-BLIND; FUMARATE MONOTHERAPY; TREATMENT RESPONSE; Major depression; Escitalopram; Quetiapine; HPA system (1)
COMBINED EPIGENETIC THERAPY; HISTONE METHYLATION; INHIBITOR 3-DEAZANEPLANOCIN; SUPPRESSOR GENES; DRUG-RESISTANCE; TARGETING EZH2; CANCER-CELLS; MECHANISMS; EXPRESSION; IDENTIFICATION; 3-Deazaneplanocin a (DZNep); B-cell lymphoma; Enhancer of zeste homolog 2 (EZH2); S-adenosyl-L-homocysteine hydrolase (AHCY) (1)
COMBINED IMMUNODEFICIENT MICE; CLASS-II GENES; CD34(+) CELLS; GAMMA-CHAIN; MOUSE MODEL; SUSCEPTIBILITY; ENGRAFTMENT; (1)
combined modality therapy; head and neck neoplasms; induction therapy; double immune checkpoint inhibition; immunotherapy; HPV-positive OPSCC; organ preservation (1)
COMBINED NIVOLUMAB; IPILIMUMAB; MONOTHERAPY; SURVIVAL; CRITERIA (1)
; Combined noise effects; Sleep disturbance; Transportation noise; Exposure-response relationship; Total Noise Investigation Innsbruck (1)
COMBINED VASCULAR RECONSTRUCTION; EX-VIVO PERFUSION; PORCINE MODEL; ISCHEMIA; REPLANTATION; SALVAGE; INJURY; hydroxyethyl starch solution; perfusion solution; extracorporeal perfusion; ischemia; free flap transfer (1)
COMBRETASTATIN A-4 ANALOGS; POTENT ANTITUBULIN AGENTS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; IN-VIVO; INHIBITORS; INDOLE; ARYLTHIOINDOLES; 3-AROYLINDOLES; DERIVATIVES; phenylindoles; breast cancer; tubulin polymerization; cell cycle arrest (1)
CoMFA; weighted field fit; alignment rules; histamine H2 receptor agonists (1)
Comic Spanien Paco Roca Dokufiktion Alzheimer (1)
COMMEMORATION; POLITICS (1)
Commentary on the Gospel of John, Begetting, Book of Divine Consolation, Meister Eckhart, Cologne Trial, Paul of Tarsus, 2 Corinthians 3:18, John 1:12-13 (1)
COMMERCIALLY PURE TITANIUM; EARLY OSSEOINTEGRATION; TREATED TITANIUM; TISSUE-RESPONSE; DENTAL IMPLANT; DIFFERENTIATION; INTEGRATION; ROUGHNESS; COATINGS; REGENERATION; bone-implant-interface; in vivo and in vitro; osteogenic differentiation; osteointegration; surface modifications; titanium implants (1)
Commercial property, modelling, tenants, retail property, shopping centres (1)
commercial real estate, machine learning, interpretable machine learning, rent forecast, automated valuation model, valuation (1)
Commiphora myrrha; Burseraceae; sesquiterpene lactone; cycloeudesmane; phytosterol; lignan; anti-inflammatory (1)
COMMIPHORA-MYRRHA; ESSENTIAL OIL; NEES ENGL.; SESQUITERPENOID DIMERS; RESINA-COMMIPHORA; CONFIGURATION; BURSERACEAE; TRITERPENES; DERIVATIVES; CHEMISTRY; myrrh; Commiphora; sesquiterpene; disesquiterpenes; triterpenes; HeLa (1)
Commission Ban, distribution, financial service (1)
COMMITMENT THERAPY; EXPOSURE; METAANALYSIS; VALIDATION; INTERVIEW; ADULTS; TRIAL; SCALE; Obsessive-compulsive disorder; Psychotherapy; Cue exposure; Response prevention; Acceptance (1)
COMMITTEE CONSENSUS STATEMENT; IMMUNOGLOBULIN-A; ULTRA-MARATHON; ALPHA-AMYLASE; CORTISOL; SPORT; SERUM; INTERLEUKIN-6; BIOMARKERS; RESPONSES; endurance; saliva; immunoglobulin; inflammation; cytokines; biomarkers (1)
Common cycles, euro area, impulse responses, structural VAR, Wald test (1)
COMMON CYCLES; VAR MODELS; UNIT-ROOT; COINTEGRATION; CONVERGENCE; TESTS; HYPOTHESIS; FEATURES; SYSTEMS; (1)
Common femoral artery, endarterectomy, endovascular procedures, claudication, critical limb ischemia (1)
COMMON FRAGILE SITES; ACUTE LYMPHOBLASTIC-LEUKEMIA; SEGMENTAL DUPLICATIONS; HUMAN-GENOME; NECK-CANCER; EVOLUTION; TRANSLOCATIONS; ABERRATIONS; EXPRESSION; MICRODISSECTION; translocation; inversion; insertion; infertility; breakpoint; fragile site; multicolor banding (1)
COMMON GENETIC VARIANT; METABOLIC SYNDROME; BODY-MASS; POLYMORPHISM; EXPRESSION; UPSTREAM; INSULIN; PROTEIN; FAT; FTO; (1)
COMMON ISSUES; THERAPY; (1)
COMMON METHOD VARIANCE; DYNAMIC CAPABILITIES; INNOVATION PERFORMANCE; ABSORPTIVE-CAPACITY; PRODUCT DEVELOPMENT; ORGANIZATIONAL CAPABILITY; SCALE DEVELOPMENT; DECISION SPEED; EMPIRICAL-TEST; ANTECEDENTS; Market knowledge sourcing; Market opportunity; Market threat; Sensing capability; Revenue growth; Digital transformation; Dynamic capabilities; Market orientation; Open innovation (1)
COMMON MOLD PATHOGENS; XYLOHYPHA-BANTIANA; DEMATIACEOUS FUNGI; IN-VITRO; CLADOSPORIUM; TRICHOIDES; AGENT; (1)
common plants, genetic variation, genbank, restoration (1)
COMMON RISK-FACTORS; CROSS-SECTION; DEFAULT RISK; RETURNS; HETEROSKEDASTICITY; SPREADS; Asset pricing; banking; spillover; errors-in-variables; individual stocks; distance-to-default (1)
COMMON-SENSE MODEL; STRESS; HEALTH; EARS; ADJUSTMENT; STRATEGIES; APPRAISAL; SYMPTOMS; OUTCOMES; BURNOUT; tinnitus; optimism; illness representations; depression; common sense model (CSM) of self-regulation (1)
COMMON-SENSE MODEL; SUN PROTECTION; SOCIAL SUPPORT; ILLNESS; MEDICATION; BEHAVIOR; HABIT; INTERVENTIONS; METAANALYSIS; FRAMEWORK; adherence; illness perceptions; photoprotection; treatment beliefs; Xeroderma Pigmentosum (1)
COMMON VARIABLE IMMUNODEFICIENCY; DNA-BINDING; SIGNAL TRANSDUCERS; C3A RECEPTOR; CONSTITUTIVE ACTIVATION; TRANSACTIVATION DOMAIN; TRANSCRIPTION FACTORS; JAK-STAT5 PATHWAY; SEXUAL-DIMORPHISM; EPITHELIAL-CELLS; (1)
COMMUNICATION; ENGAGEMENT; COVID-19; inpatient pandemic management; expert recommendations; pandemic preparedness; Delphi study (1)
Communication; Necrodialogues; Talking Dead; Mediumism (1)
COMMUNICATION-SYSTEMS; RADIOLOGY; IMPACT; PACS; RIS; KIS; workflow; cost effectiveness (1)
Communio et progressio; Massenmedien; Medienfreiheit; Kommunikationsfreiheit; Medienethik; Öffentlichkeit; Kirche; innerkirchliche Kommunikation; öffentliches Forum; Kommunikationsverfassung; Verständigung; Geheimhaltung; Medienpädagogik; (1)
Communion verses, missal, Kommunionverse, Messbuch (1)
COMMUNITIES; ARCHAEA; Nanoarchaeota; PCR; 16S rRNA; archaea; hyperthermophilic; ecology (1)
COMMUNITY-ACQUIRED PNEUMONIA; DIABETES-MELLITUS; RISK-FACTORS; HOSPITALIZATION; EPIDEMIOLOGY; HYPERGLYCEMIA; INFECTION; HEALTH; IMPACT; COHORT; glycated haemoglobin; impaired glucose tolerance; infectiology; CDC; NHANES; dose-response; non-linearity (1)
COMMUNITY-ACQUIRED PNEUMONIA; HEPATITIS-B-VACCINE; PNEUMOCOCCAL PNEUMONIA; HERPES-ZOSTER; RISK-FACTORS; IMMUNOGENICITY; ADULTS; QUANTIFICATION; HEMODIALYSIS; IMPACT; Glucose intolerance; Immunization; Streptococcus pneumoniae; Influenza, human; Herpes zoster (1)
COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZA; GENE; PCR (1)
COMMUNITY-ACQUIRED PNEUMONIA; MICROARRAY-BASED DETECTION; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; NUCLEOTIDE-SEQUENCE; SKIN INFECTIONS; FOOTBALL TEAM; GENES; VIRULENCE; community-associated MRSA; DNA microarray; evolution; exotoxins; methicillin-resistant Staphylococcus aureus; Panton-Valentine leukocidin (1)
COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SOCIETY; ADULT PATIENTS; MANAGEMENT; FREQUENCY; DIAGNOSIS; TRENDS; Lung diseases; Chest x-ray overview; Guideline recommendations; Indications; Radiation exposure (1)
Community assembly; Dispersal limitation; Ecoinformatics; Functional traits; Spatial isolation; Species pool (1)
COMMUNITY-BASED POPULATION; BLOOD-PRESSURE; METAANALYSIS; LOCI; HYPERTENSION; NEPHROPATHY; PROTEINURIA; PROGRESSION; PREDICTORS; ADJUSTMENT; (1)
COMMUNITY CAPACITY; PARTICIPATORY RESEARCH; EMPOWERMENT; health promotion; evaluation framework; capacity building; monitoring instrument; stakeholder groups; setting-based approaches (1)
COMMUNITY DYNAMICS; LINEAR-DEPENDENCE; TIME; INFERENCE; MODELS; DRIVERS; CHAOS; IMPLEMENTATION; STABILITY; FISHERIES; Time series; Interaction network; Causal inference; Feedback; Food web; Community dynamics (1)
COMMUNITY INVASIBILITY; CALCAREOUS GRASSLAND; PLANT-COMMUNITIES; SEED DISPERSAL; MICROSITE AVAILABILITY; LIMESTONE GRASSLAND; ECOLOGY; ESTABLISHMENT; RECRUITMENT; LIMITATION; bryophytes; diaspore availability; dispersal; gap; microsite availability; species pool concept; vascular plants (1)
COMMUNITY SAMPLE; PORNOGRAPHY CONSUMPTION; AROUSAL; PREVALENCE; PEDOPHILIA; PATTERNS; (1)
COMMUNITY SAMPLE; PREVALENCE; VALIDATION; MUTILATION; BEHAVIORS; THOUGHTS; SCALE; emotional reactivity; self-injurious behavior; non-suicidal self-injury; reinforcement functions; emergency; adolescents (1)
COMMUNITY; TRANSMISSION; INFECTIONS; MRSA; (1)
COMMUTATION; spectrum; closed operators; block operator matrices (1)
COMMUTATIVE RING; ALGEBRA; VALUATIONS; (1)
COMMUTATIVE RING; MATRIX ALGEBRA; Tropical algebra; Tropical categories; Tropical geometry; Tropicalization; Valuations; Valued monoids; Primary 06F05; 06F20; 14T05; 14T99; 16Y60; Secondary 06F25; 12K10 (1)
Commuting, georeferenced data, commuting decision, gender, regional differences (1)
comorbidities; fracture-related infection; periprosthetic joint infection (1)
; comorbidity; cystectomy; ACE-27; ASA; urothelial carcinoma; perioperative mortality (1)
COMORBIDITY; INPATIENTS; SYSTEM; consultation-/liaison services; quality management; documentation; general hospital; health service research; DRG (1)
Comorbid neurotic, stress-related, and somatoform, disorder (ICD-10: F4), Intermittent theta-burst stimulation (iTBS), Repetitive transcranial magnetic stimulation, (rTMS) (1)
COMPACT DELTA LITHOTRIPTER; STONE COMMINUTION; TISSUE-DAMAGE; IN-VITRO; RENAL-CALCULI; KIDNEY-STONES; URETERAL STONES; DELIVERY RATE; AIR BUBBLES; WIDE-FOCUS; Extracorporeal shock wave lithotripsy; Lithotripter; Shock wave generation; Urolithiasis (1)
compact/incompact, Meister Eckhart, Mode of Signifying, Ps.-Denys the Areopagite, Theory of Signification (1)
COMPARATIVE CYTOARCHITECTONIC ANALYSIS; CORTICOCORTICAL CONNECTION PATTERNS; VENTROLATERAL PREFRONTAL CORTEX; PREDICTIVE INFERENCES; FUNCTIONAL CONNECTIVITY; TEXT COMPREHENSION; CORTICAL ORGANIZATION; TIME-COURSE; IN-VIVO; BRAIN; language comprehension; discourse processes; fMRI; inference; dynamic causal modelling; connectivity; strategic processes (1)
COMPARATIVE GENOMIC HYBRIDIZATION; ACTIVATED POTASSIUM CHANNELS; MAXI-K CHANNELS; LARGE-CONDUCTANCE; EPITHELIAL-CELLS; UROKINASE GENE; BREAST-CANCER; BK CHANNELS; RECEPTOR; KINASE; prostate cancer; progression; amplification; BK channel; KCNMA1 (1)
COMPARATIVE GENOMIC HYBRIDIZATION; CARNEY COMPLEX; OVARY; EXPRESSION; CHROMOSOME; MOSAICISM; FEATURES; WOMAN; BOY; Sertoli cell tumours; CGH; FISH; molecular cytogenetic (1)
COMPARATIVE GENOMIC HYBRIDIZATION; CELL CARCINOMAS; ONCOCYTOMA; TUMORS; CLASSIFICATION; CHROMOSOME-1; REGION; kidney cancer; oncogytoma; genetics; comparative genomic hybridization; familial oncocytoma (1)
COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER; PROGNOSTIC-SIGNIFICANCE; CANCER RELEVANCE; WIDE ANALYSIS; R1 RESECTION; PHASE-II; AMPLIFICATION; DNA; IDENTIFICATION; CGH; PDAC; Pancreatic cancer; 4q loss; Clinical follow-up; Prognosis (1)
COMPARATIVE GENOMIC HYBRIDIZATION; HER2-POSITIVE BREAST-CANCER; BONE-MARROW; RANDOMIZED-TRIAL; GROWTH-RATE; GENETIC-HETEROGENEITY; ADJUVANT CHEMOTHERAPY; EPITHELIAL TUMORS; BRAIN METASTASES; NATURAL-HISTORY; (1)
COMPARATIVE GENOMIC HYBRIDIZATION; kidney tumors; oncocytoma; renal cell carcinoma (1)
COMPARATIVE GENOMIC HYBRIDIZATION; MINIMAL RESIDUAL CANCER; CELL SEQUENCING DATA; CUTANEOUS MELANOMA; BREAST-CANCER; MUTATION FREQUENCIES; ONCOGENIC MUTATIONS; EARLY DISSEMINATION; BRANCHED EVOLUTION; EQUIVALENCE; (1)
COMPARATIVE GENOMIC HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; TANDEM REPEAT LOCI; MICROSATELLITE MARKERS; OVARIAN CARCINOMAS; HETEROZYGOSITY; TUMORS; ELECTROPHORESIS; CANCER; ARRAY; loss of heterozygosity; HPLC; capillary electrophoresis; mass spectrometry; ovarian cancer; PCR fidelity; short tandem repeats (1)
COMPARATIVE GENOMIC HYBRIDIZATION; STANDARD REFERENCE INTERVALS; MALIGNANT-MELANOMA; EXPRESSION ANALYSIS; ERBB RECEPTORS; EWINGS-SARCOMA; CANCER; TUMORS; FAMILY; PARTS; clear cell sarcoma of soft tissue; CGH; ERBB; neuregulin; tyrosine kinase (1)
COMPARATIVE GENOMIC HYBRIDIZATION; TRANSITIONAL-CELL CARCINOMA; TUMOR-SUPPRESSOR LOCI; URINARY-BLADDER; CHROMOSOMAL IMBALANCES; 5-AMINOLEVULINIC ACID; LESIONS; FLUORESCENCE; MICRODISSECTION; CARCINOGENESIS; bladder cancer; papillary tumour; flat urothelial hyperplasia; CGH; FISH; LOH; chromosome 9 (1)
COMPARATIVE GENOMIC HYBRIDIZATION; VOIDED URINE; UROTHELIAL CARCINOMA; MULTIPROBE FISH; CYTOLOGY; MULTITARGET; ASSAY; SPECIMENS; (1)
comparative genomics; genome architecture; introgression; lateral gene transfer (1)
COMPARATIVE PHYLOGEOGRAPHY; MITOCHONDRIAL; CRUSTACEA; PACIFIC; DIFFERENTIATION; PORTUNIDAE; OCYPODIDAE; DISPERSAL; SOFTWARE; REVISION; Crustacea; Indo-Pacific; mangrove crabs; phylogeny; phylogeography (1)
Comparative studies · Educational context · Mathematical modelling competency · Method-integrative teaching style · Modelling unit · Teacher-directive teaching style (1)
COMPATIBLE SOLUTE ACCUMULATION; ESCHERICHIA-COLI; OSMOTIC-STRESS; HELICOBACTER-PYLORI; GLYCINE BETAINE; L-ASPARAGINE; SALT STRESS; ENTEROCOLITICA; TOLERANCE; BACTERIA; sodium chloride; magnesium sulfate; metabolome; compatible solutes; stress response (1)
COMPATIBLE STIMULI; VISUAL-ATTENTION; CONFIDENCE-INTERVALS; INDUCED BLINDNESS; FEEDBACK-CONTROL; FEATURE BINDING; 2-TAILED TESTS; PITCH HEIGHT; EFFECT SIZE; PERCEPTION; motorvisual; action-perception; visual attention; dual-task paradigm (1)
compensated 3D-topological insulator, BiSbTeSe2, quantum capacitance, Landau quantization, thermodynamic density of states, Coulomb glass (1)
Compensation, performance, CEO power, financial crisis, REITs (1)
COMPENSATORY ADRENAL GROWTH; STEM-CELLS; SONIC HEDGEHOG; TARGETED DISRUPTION; CANCER-CELLS; BONE-MARROW; ADULT HEART; DIFFERENTIATION; PROLIFERATION; REGENERATION; (1)
compensatory renal hypertrophy, workload hypothesis, natriuretic peptides (1)
Competence based training, Globalization, Human resource management, Multinational companies, National cultures, Training needs (1)
COMPETENCE; EDUCATION; PROGRAMS; NKLC; IMPP; medical licensing examination; educational research (1)
COMPETENCE; EXPERTISE; HOSPITALS; (1)
COMPETING RISKS; CRITICAL ILLNESS; INTENSIVE-CARE; GERMANY; PREVALENCE; REGRESSION; MORTALITY; DISCHARGE; DEMENTIA; OUTCOMES; incidence estimation; claims data; competing risks; Post-intensive care syndrome (1)
COMPETITION; STRATEGIES; NETWORK; ACCESS; Wi-Fi; WLAN; PWLAN; MNO; Hotspots; Disruptive innovation; Telecommunications; Cross-country study; Regulation; Mobile communications (1)
COMPETITIVE ABILITY; INHIBITORY CONTROL; BRAIN SIZE; PERFORMANCE; AGE; NEOPHOBIA; COGNITION; MOTOR; TOOL; CHIMPANZEES; innovative behavior; brain lateralization; glucocorticoid metabolites; behavioral traits; equine cognition (1)
COMPETITIVE CHEMILUMINESCENCE IMMUNOASSAY; CHEMI-LUMINESCENCE IMMUNOASSAY; ESTRADIOL DERIVATIVES; ESTROGEN-RECEPTOR; TESTOSTERONE DERIVATIVES; MONOCLONAL-ANTIBODIES; MOLECULAR-BASIS; SPECIFICITY; BINDING; PROGESTERONE; (1)
COMPETITIVE FERTILIZATION SUCCESS; ALTERNATIVE REPRODUCTIVE TACTICS; POSTCOPULATORY SEXUAL SELECTION; MALE CRICKETS ADJUST; DROSOPHILA-MELANOGASTER; INTRASPECIFIC VARIATION; ATLANTIC SALMON; SOCIAL INSECTS; TESTIS SIZE; LENGTH; alternative reproductive tactic; social insect; sperm length; sperm viability (1)
Complaint management, Teaching case, Business process (1)
COMPLEMENT ACTIVATION; ALTERNATIVE PATHWAY; POSITIVE REGULATOR; SEPSIS; MICE; IDENTIFICATION; DEFICIENCY; CONVERTASE; IMMUNITY; PUNCTURE; (1)
COMPLEMENTARITIES; SPECULATION; Adverse selection; Noise trading; Non-fundamental information; Payment for order flow (1)
COMPLEMENTARY-DNA; PROSTATE-CANCER; TECHNOLOGY; PROTEIN; (1)
COMPLEMENTARY SEX DETERMINATION; SOLENOPSIS-INVICTA HYMENOPTERA; MATING FREQUENCY; POPULATION-STRUCTURE; SOCIAL HYMENOPTERA; REPRODUCTIVE STRATEGIES; MICROSATELLITE ANALYSIS; WORKER REPRODUCTION; RATIO DETERMINATION; MULTIPLE PATERNITY; Formicidae; inbreeding; intranidal mating; multiple mating; local mate competition (1)
complement assay, ﬂuorescence, liposomes, SAXS, spectroscopy (1)
complement C3, drug discovery, immunomodulation, Mendelian randomization analysis, periodontitis (1)
complement C5, immunomodulation, periodontitis, drug discovery, instrumental variable analysis (1)
complement deposition, COVID-19, kidney, lung, autopsy, lectin pathway (1)
; Complement; Early-career researcher (1)
COMPLEMENT FACTOR-H; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; POLYMORPHISM; ASSOCIATION; PREVALENCE; LOC387715; JAPANESE; SMOKING; DISEASE; (1)
COMPLEMENT FACTOR-H; APOLIPOPROTEIN-E GENE; RISK-FACTORS; CIGARETTE-SMOKING; COMPONENT 3; MACULOPATHY; SUSCEPTIBILITY; VARIANT; POLYMORPHISM; PROMOTER; age-related macular degeneration; AMD; apolipoprotein E; APOE; case-control association study (1)
COMPLEMENT FACTOR-H; BEAVER DAM EYE; SUSCEPTIBILITY LOCI; GENOMEWIDE-SCAN; FAMILIAL AGGREGATION; EXTENDED FAMILIES; MACULOPATHY; RISK; POLYMORPHISM; POPULATION; age-related macular degeneration; fibulin-6; hemicentin-1; association; linkage disequilibrium; mutation; FBLN6; HMCN1 (1)
COMPLEMENT-FACTOR-H; C-REACTIVE PROTEIN; ACTIVATION; SEQUENCE; DISEASE; BINDING; MICE; complement system; factor H (FH); factor H-related protein; factor H-like protein 1; challenges; development directions (1)
COMPLEMENT FACTOR-H; DEVELOPING ALZHEIMERS-DISEASE; APOE GENE; REGULATORY REGION; LINKAGE DISEQUILIBRIUM; EPSILON-4 ALLELE; E POLYMORPHISMS; FACTOR-B; RISK; ASSOCIATION; age-related macular degeneration; AMD; apolipoprotein E; APOE; epsilon isoforms; promoter variants; case-control association study (1)
COMPLEMENT FACTOR-H; FUNDUS AUTOFLUORESCENCE PATTERNS; STARGARDT-DISEASE; GEOGRAPHIC ATROPHY; MISSENSE MUTATIONS; TRANSPORTER GENE; RISK; PROGRESSION; LIPOFUSCIN; DYSTROPHY; (1)
COMPLEMENT FACTOR-H; GRADING SYSTEM; UNITED-STATES; VITAMIN-C; PREVALENCE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; MACULOPATHY; AMD; (1)
COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; C-REACTIVE PROTEIN; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; MENINGOCOCCAL DISEASE; MONOCLONAL-ANTIBODIES; INHIBITOR ECULIZUMAB; IGA NEPHROPATHY; Complement system; Factor H; FHR; FHL-1; Biomarker (1)
COMPLEMENT FACTOR-H; HTRA1 PROMOTER POLYMORPHISM; VARIANT INCREASES; FACTOR-B; MACULOPATHY; RISK; ASSOCIATION; LOC387715; SUSCEPTIBILITY; POPULATION; age-related macular degeneration; severity; CFH; ARMS2; HtrA1; C2; CFB (1)
COMPLEMENT FACTOR-H; INCIDENT MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; ATHEROSCLEROTIC LESIONS; EYE DISEASE; FACTOR-B; POLYMORPHISM; MORTALITY; INFLAMMATION; POPULATION; Age-related macular degeneration; Coronary heart disease; Genetic risk factors; Case-control study; CFH Y402H; CFH I62V; Delta CFHR3/CFHR1; ARMS2 A69S (1)
COMPLEMENT FACTOR-H; LOW-FREQUENCY VARIANTS; RARE GENETIC-VARIANTS; HIGH-RISK; WIDE ASSOCIATION; CFI GENE; ACTIVATION; CELLS; POLYMORPHISM; DRUSEN; Age-related macular degeneration; Omics; Systems genomics; Single cell sequencing; Expression quantitative trait locus; Complement system; iPSc-RPE; Induced pluripotent stem cells; Clinical trial (1)
COMPLEMENT FACTOR-H; MACULAR DEGENERATION; CHROMOSOME 10Q26; SERINE-PROTEASE; APOLIPOPROTEIN-E; FACTOR-B; HTRA1; SUSCEPTIBILITY; GENE; HAPLOTYPE; (1)
COMPLEMENT FACTOR-H; MACULAR DEGENERATION; PREDICTION; LOCI; Genetic association studies; Risk assessment; Linear models; Obesity; Age-related macular degeneration (1)
COMPLEMENT FACTOR-H; PIGMENT EPITHELIAL-CELLS; UNUSUAL CLINICAL-FEATURES; TISSUE INHIBITOR; METALLOPROTEINASES-3 TIMP3; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; AGE; ANGIOGENESIS; EXPRESSION; Sorsby fundus dystrophy; tissue inhibitor of metalloproteases-3 (TIMP3); Timp3 gene-targeted mice; protease activity; angiogenesis (1)
COMPLEMENT FACTOR-H; RISK-FACTORS; GEOGRAPHIC ATROPHY; CHOROIDAL NEOVASCULARIZATION; FUNDUS AUTOFLUORESCENCE; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY GENES; POOLED FINDINGS; GROWTH-FACTORS; MACULOPATHY; Age-related macular degeneration; monozygotic twins; genetic risk factors (1)
COMPLEMENT FACTOR-H; TANDEM MASS-SPECTROMETRY; STRESS-INDUCED APOPTOSIS; GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; DENSITY-LIPOPROTEIN; PLASMA CERAMIDES; CHOLESTEROL-METABOLISM; CARDIOVASCULAR-DISEASE; (1)
COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE; (1)
complement, FH protein family, needs, FH-related (1)
COMPLEMENT PATHWAY; HAKATA ANTIGEN; ACTINOBACILLUS-PLEUROPNEUMONIAE; BINDING PROTEIN; IMMUNE-SYSTEM; CLONING; GENE; COLLECTINS; RECEPTORS; complement; endosomes; infection; lectin pathway (1)
Complement system, Ficolin, Innate immunity, Lectin pathway (1)
COMPLETE CYTOREDUCTIVE SURGERY; COLORECTAL-CANCER; MORTALITY ANALYSIS; RANDOMIZED-TRIAL; MORBIDITY; COLON; CHEMOHYPERTHERMIA; OXALIPLATIN; MANAGEMENT; ORIGIN; colorectal cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis (1)
COMPLETE DISTORTION CORRECTION; IMAGE-GUIDED SURGERY; FUNCTIONAL MRI; SENSORIMOTOR CORTEX; NEURONAVIGATION; INTEGRATION; ACTIVATION; SYSTEM; STIMULATION; MOVEMENT; brain tumours; real-time fMRI; t-maps; somatosensory cortex; neuronavigation (1)
COMPLETED TREATMENT ANALYSIS; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; RANDOMIZED-TRIALS; COMBINATION TRIAL; ENDOCRINE THERAPY; FOLLOW-UP; PERSPECTIVE; LETROZOLE; ARIMIDEX; Anastrozole; Cost-effectiveness analysis; Cost-utility analysis; Incremental cost-effectiveness ratio; Tamoxifen; QALY (1)
COMPLETE GENOME SEQUENCE; BACTERIAL CHEMOTAXIS; RHIZOBIUM-MELILOTI; SIGNAL-TRANSDUCTION; RHODOBACTER-SPHAEROIDES; MOTILITY; ROTATION; PATHWAY; OPERON; MOTOR; alpha-proteobacteria; sensors signal transduction; multiple chemotaxis genes; retro-phosphorelay; chemokinesis (1)
COMPLETE GENOME SEQUENCE; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; MEMBRANE-BOUND HYDROGENASE; IRON-SULFUR CLUSTERS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOSARCINA-MAZEI; CYTOCHROME-B; ACTIVE-SITE; METHANOTHERMOBACTER-MARBURGENSIS; METHANOGENIC ARCHAEA; Archaeoglobus; heterodisulfide reductase; Hmc complex; iron-sulfur proteins; sulfate-reducing bacteria (1)
COMPLETE GENOME SEQUENCE; GLUTAMATE SYNTHASE; SP-NOV; HYPERTHERMOPHILIC ARCHAEA; ELONGATION-FACTOR; ESCHERICHIA-COLI; RNA-POLYMERASE; RIBOSOMAL-RNA; EVOLUTION; TREE; Thermotoga maritima; lateral gene transfer; glutamate synthase; myo-inositol; 1P synthase; phylogeny (1)
COMPLETE HEART-BLOCK; ATRIOVENTRICULAR-BLOCK; ISOMERISM; DIAGNOSIS; POLYSPLENIA; EXPERIENCE; ASPLENIA; LIFE; MANAGEMENT; PROGNOSIS; atrial morphology; echocardiography; fetus; heterotaxy; isomerism; prenatal diagnosis (1)
COMPLETE HEART-BLOCK; DIAGNOSED IN-UTERO; NEONATAL LUPUS; SUCCESSFUL MANAGEMENT; PRENATAL-DIAGNOSIS; THERAPY; EXPERIENCE; ANTIBODIES; CHILDREN; HYDROPS; antinuclear antibodies; cardiac defects; echocardiography; fetus; heart block; heterotaxy; isomerism; prenatal diagnosis (1)
COMPLETE-INTERSECTIONS; MONOMIAL CURVES; Complete intersections; Local cohomology; Macaulay's curve (1)
COMPLETE MESOCOLIC EXCISION; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM OUTCOMES; OPEN COLECTOMY; ASSISTED RESECTION; COLORECTAL-CANCER; SURVIVAL; METAANALYSIS; MORTALITY; LIGATION; Minimal invasive surgery; Laparoscopic surgery; Colon cancer; Cancer registry; Long-term survival (1)
COMPLETE ORTHONORMAL SETS; EXPONENTIAL-TYPE ORBITALS; RANGE ADDITION THEOREMS; NUMERICAL PROPERTIES; 2-CENTER INTEGRALS; COULOMB INTEGRALS; GROUND-STATE; B-FUNCTIONS; WAVE; TRANSLATION; bound-state hydrogen eigenfunctions; Fourier transform; generalized Laguerre polynomials; hypergeometric series; Slater-type functions; reduced Bessel functions (1)
COMPLETE ORTHONORMAL SETS; NONCENTRAL INTERACTION POTENTIALS; MULTICENTER MULTIELECTRON INTEGRALS; MULTIPOLE MOMENT INTEGRALS; CORRELATED INTERACTION POTENTIALS; UNIFIED ANALYTICAL TREATMENT; FIELD GRADIENT INTEGRALS; NONSCREENED COULOMB POTENTIALS; UNIFORM ASYMPTOTIC EXPANSIONS; EXPONENTIAL-TYPE ORBITALS; Slater-type function; Addition theorem; Laguerre expansion; Power series (1)
complex aberrant karyotype; early allogeneic SCT; FLAMSA-RIC (1)
COMPLEX ANAL FISTULAS; INFLIXIMAB TREATMENT; SURGICAL-TREATMENT; SETON PLACEMENT; FOLLOW-UP; IN-ANO; COMPLICATIONS; EXPERIENCE; SURGERY; Crohn's disease; Perianal fistulas; Fistula types; Interdisciplinary treatment; Surgery; Immunomodulation (1)
COMPLEX ANAL FISTULAS; RISK-FACTORS; RECTAL-CANCER; ANTERIOR RESECTION; MULTIVARIATE-ANALYSIS; IN-ANO; SURGERY; SEALANT; INJECTION; LEAKS; Fibrin glue; Fistulae; Endoscopic treatment (1)
COMPLEX ANALYTIC SURFACES; COMPACT; Locally conformally Kahler structure; Hopf surface; Toric manifold; Twisted Hamiltonian (1)
COMPLEX CHRONIC CONDITIONS; CHILDREN; LIFE; END; PERSPECTIVES; PATTERNS; CANCER; PLACE; DEATH; hematopoietic stem cell transplantation; palliative care; palliative care services; pediatric (1)
COMPLEX CONTACT STRUCTURES; KILLING SPINORS; 1ST EIGENVALUE; LOWER BOUNDS; MONOPOLES; spin(c) Dirac operator; eigenvalue estimate; Kahlerian Killing spinor; parallel form; harmonic form (1)
COMPLEX DECONGESTIVE PHYSIOTHERAPY; LOWER-LIMB LYMPHEDEMA; BREAST-CANCER; HEALTH QUESTIONNAIRE; EDEMA; LYMPHOGRAPHY; RELIABILITY; VALIDATION; DISABILITY; OUTCOMES; LVA; Lymphedema surgery; Lymphovenous anastomosis; Quality of life; Questionnaire; Subjective feeling (1)
complex disease, AMD, early AMD, neovascular AMD, geographic atrophy AMD, genome-wide association study, histology, treatment (1)
COMPLEXES; (4)
COMPLEXES; ACID; (1)
COMPLEXES; ACTIVATION; PHOTOCHEMISTRY; CYCLOHEXADIENE; ALKANES; Dehydrogenation; Photocatalysis; Osmocene; 1,3-Cyclohexadiene (1)
COMPLEXES BEARING; X-RAY; (CPFE)-FE-BIG(CO)(2) RADICALS; MOLECULAR-STRUCTURE; SANDWICH COMPOUNDS; CRYSTAL-STRUCTURE; PI-COMPLEXES; CP-ASTERISK; LIGANDS; DERIVATIVES; (1)
COMPLEXES; BONDS; ACTIVATION; DENSITY; BORANES; (1)
COMPLEXES; CAROTENOIDS; LUMINESCENCE; Electronic Spectra; Luminescence; Photochemistry; Rhodium Complexes; Astaxanthin; Carotenoid (1)
COMPLEXES; charge transfer; imidazole complexes; thiolate complexes; zinc (1)
COMPLEXES; CHEMISTRY; OLEFINS; SURFACE; HYDROGENATION; MECHANISM; ETHYLENE; LIGANDS; metal-organic framework; hydroformylation; heterogeneous catalysis; rhodium complex; single-site catalyst (1)
COMPLEXES; CHIRALITY; LIGANDS; BENZYL; ACIDS; (1)
COMPLEXES; CLUSTERS; (1)
COMPLEXES; CLUSTERS; METALLOBORANES; REDUCTION; VERTICES; C2BN-2HN; ANIONS; charge transfer complexes; photochemistry; cobalt(III) complexes; boranates; boranes; UV spectroscopy (1)
COMPLEXES; crystal structure; ethylenediamine-N; N '-dipropionatocopper(II); adduct of mercury(II) dichloride (1)
COMPLEXES; Cyclopentadienyl complexes; Metal carbonyl; Metal-metal bond; Manganese; Tin (1)
COMPLEXES; D10; electronic spcctra; luminescence; charge transfer; copper complexes; cyclopentadienyl complexes; phosphine complexes (1)
COMPLEXES; DIOXYGEN; CHLOROPENTAAMMINEPLATINUM(IV); METAL; electronic spectra; charge transfer; photochemistry; platinum; peroxide (1)
COMPLEXES; DIRHODIUM(II); BOND; Photochemistry; Rhodium(II); Carbonate; Photoreduction of CO2; MLCT excitation (1)
COMPLEXES; DISCRIMINATION; SYSTEM; (1)
COMPLEXES; EMISSION; M11-L (1)
COMPLEXES; GROWTH; ACID; (1)
COMPLEXES; LIGANDS; (1)
COMPLEXES; LIGANDS; ACIDS; BA; (1)
COMPLEXES; luminescence; phosphorescence; osmium; mercury; heavy-atom effect (1)
COMPLEXES; MEMBRANES; WIRES; CAROVIOLOGENS; REDUCTION; SWITCHES; CENTERS; SYSTEMS; RODS; conjugation; electron transfer; mixed-valent compounds; molecular wires; polythiobenzenes (1)
COMPLEXES; MICROSCOPY; INDICATORS; CANCER; CELLS; LIGHT; Oxygen sensor; Fluorescence; Two-photon excitation; Quenching; Nanosensor; Intracellular sensing (1)
COMPLEXES; MONONUCLEAR; PROTEINS; ACID; electronic spectra; photochemistry; charge transfer; copper complexes; phenolate complexes (1)
COMPLEXES; P-4; REACTIVITY; LIGAND; BOND; lanthanides; molybdenum; polyarsenides; polystibides; reduction (1)
COMPLEXES; PENTAPHOSPHAFERROCENE; CHAINS; (1)
COMPLEXES; PH; dual lifetime referencing; DLR; copper(II); optical sensor; chemical imaging (1)
COMPLEXES; PHOSPHINOBORANE; CRYSTAL; BORANE; CHAINS; NMR; Phosphorus; Boron; Copper; Coordination chemistry; Cubane (1)
COMPLEXES; PHOTOCHEMISTRY; ACTIVATION; OSMIUM; Coordination chemistry; Osmium; Photochemistry; Dinitrogen (1)
COMPLEXES; PHOTOCHEMISTRY; VITAMIN; HEAVY; Retinoic acid; Fluorescence; Hg(II); Ag(I); Zn(II) (1)
COMPLEXES; PHOTOLUMINESCENCE; LUMINESCENCE; Fluorescence; Iron(III); Ruthenium(Ill); Osmium(III); 8-Quinolinolate; Intraligand excited states; Ligand to metal CT states (1)
COMPLEXES; PHOTOPHYSICS; LUMINESCENCE; STATES; (1)
COMPLEXES; PYRIDINE; LIGANDS; PHOTOPHYSICS; TERPYRIDINE; BIPYRIDINE; CHEMISTRY; CRYSTAL; FACILE; (1)
COMPLEXES; REACTIVITY; CARBONYL; LIGANDS; ANIONS; UNITS; carbonyl ligands; cluster compounds; cobalt; electrochemistry; tellurium (1)
COMPLEXES; RESOLUTION; CHIRALITY; LIGANDS; RU(II); CH/PI; Sandwich complexes; Diastereomers; Co-crystallization; Configuration determination; X-ray crystallography (1)
COMPLEXES; RHODIUM; EXCHANGE; Cyclopentadienyl complex; Olefin complex; Crystal structure; Rhodium (1)
COMPLEXES; SENSOR; IONS; PHOTOLUMINESCENCE; SPECTRA; lead complexes; beta-diketonate complexes; phosphorescence (1)
COMPLEXES; SENSORS; multiplexing luminescence labels; phosphorescence; nanospheres; resonance energy transfer (RET); luminescence decay time (1)
COMPLEXES; SUBSTRATE; ascorbic acid derivatives; hyaluronidase inhibitors; hyaluronan; hyaluronan lyases; bovine testicular hyaluronidase (1)
COMPLEXES; TUNGSTEN; LIGANDS (1)
complexes with elements of group 15; molybdenum compounds; multiple bonds; phosphorus compounds; tungsten compounds (1)
Complex Event Processing (CEP) Business Process Management (BPM) Event-driven BPM Event Pattern Software as a Service (SaaS) SOA EDA (1)
Complex Event Processing, Neuronale Netzwerke, Diskriminanzanalyse, Entscheidungsbaum, Betrugserkennung (1)
COMPLEX FLAGELLA; AGROBACTERIUM-TUMEFACIENS; SEQUENCE-ANALYSIS; MOTILITY GENES; FINE-STRUCTURE; CHEMOTAXIS; EXPRESSION; PLAIN; CHROMOSOME; PLASMIDS; (1)
COMPLEX; GENES; (1)
COMPLEX GEOMETRIES; INTERFACE APPROACH; SOLUBLE SURFACTANTS; SOLVING PDES; 2-PHASE FLOW; ASYMPTOTICS; ADVECTION; diffuse domain method; weighted Sobolev spaces; well-posedness; diffuse interface approximation; asymptotic analysis; bulk-surface elliptic equations (1)
COMPLEX-I; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; LEWY BODIES; AUTOPHAGY; ACCUMULATION; OLIGOMERS; MITOPHAGY; ENDOCYTOSIS; CLEARANCE; (1)
COMPLEX-II; RAT-LIVER; CANCER; SYNTHETASE; METABOLISM; EXPRESSION; TARGET; GROWTH; GENE; HCC; c-Myc; Ldha; Metabolic Reprogramming; TME (1)
complexity; self-organized criticality; meditation; states of consciousness; EEG (1)
COMPLEX MATERIALS; SELF-CONSISTENCY; SPIN-DENSITIES; EXCHANGE; CHARGE; SIMULATIONS; POTENTIALS; EXPANSION; FORMULA; STATE; density functional based tight-binding; density functional theory; DFTB (1)
COMPLEX MATERNAL REARRANGEMENT; RETINAL PIGMENTED EPITHELIUM; PARTIAL TRISOMY; EYE DEVELOPMENT; PAIRED DOMAIN; PROGENITOR CELLS; SMOOTH-MUSCLE; NEURAL RETINA; GENE; LENS; Pax6; Pax6-5a; Alternative splicing; Gene dosage; Eye; Iris; Sphincter muscle; Ciliary body; Cre/loxP (1)
complex networks, machine learning, matrix factorization, source separation, centrality measures, Input-Output network, effective parameters, microarray data analysis, graph-delayed correlation, GraDe, community detection, k-partite network, latent causes (1)
complex permittivity electrolyte soln acetonitrile (1)
COMPLEX PLEURAL EMPYEMA; Lung infection; Lung abscess; Surgery techniques; Vacuum-assisted closure; Negative-pressure wound therapy (1)
complex problem solving; multiple complex systems; Tailorshop; reasoning; intelligence; validity; structural equation modeling (1)
COMPLEX TRAITS; ASSOCIATION; (1)
Complex Type, Element Reference, Node Type, Modeling Style, Transformation Language (1)
COMPLIANCE CONSTANTS; P5X2+ X; CHEMISTRY; P-4; COMPLEXATION; SPECTROSCOPY; BR; (1)
COMPLICATED INTRAABDOMINAL INFECTION; BETA-LACTAM ANTIBIOTICS; CYSTIC-FIBROSIS; HEALTHY-VOLUNTEERS; TAZOBACTAM; PHARMACODYNAMICS; CEFTAZIDIME; EFFICACY; PHARMACOECONOMICS; COMBINATION; piperacillin; sulbactam; high-performance liquid; chromatography; beta-lactam antibiotics; time-dependent antibacterial activity; beta-lactamase inhibitor; pharmacokinetics (1)
COMPLICATED PARAPNEUMONIC EFFUSION; THORACIC EMPYEMA; MANAGEMENT; SURGERY; DECORTICATION; THERAPY; ADULTS; RISK; vacuum-assisted treatment; empyema; thoracic surgery; thoracoscopy; outcome; survival (1)
complicated urological infections, cUTI, HWI, komplizierte Harnwegsinfekte, Prostatitis, Epididymitis, Pyelonephritis, MRE, MDR (1)
COMPLICATING LIVER-CIRRHOSIS; SPIRAL COMPUTED-TOMOGRAPHY; ALPHA-FETOPROTEIN; MAGNETIC-RESONANCE; PATHOLOGICAL CORRELATION; FOCAL LESIONS; TRANSPLANTATION; SONOGRAPHY; CT; ULTRASOUND; liver; HCC; diagnostics (1)
COMPLICATING PULMONARY RESECTION; THORACIC-DUCT; LUNG-CANCER; MANAGEMENT; CARCINOMA; SURGERY; Chylothorax; Radiotherapy; Postoperative complication (1)
COMPLICATING VAGINAL HYSTERECTOMY; LOWER-EXTREMITY NEUROPATHIES; ACUTE COMPARTMENT SYNDROME; BRACHIAL-PLEXUS INJURY; LITHOTOMY POSITION; FEMORAL NEUROPATHY; PRESSURE ULCERS; NERVE INJURIES; ULNAR NEUROPATHY; RISK-FACTORS; gynecologic operations; positioning injuries; prevention (1)
COMPLICATIONS; ADULTS; STROKE; INJURY; COVID-19; Neurologic manifestations; Intensive care; Critically ill (1)
COMPLICATIONS; Anesthesia; Cardiovascular abnormalities; Radiography; thoracic; Ultrasonography; Jugular veins (1)
COMPLICATIONS; CHOLECYSTECTOMY; OUTCOMES; HEART (1)
COMPLICATIONS; DISSECTION; (1)
Complications, Evaluation algorithm, Living donor liver transplantation, Liver volumetry, Outcomes, Steatotic liver disease (1)
Complications Hypoxemia burden length of stay lung cancer Lung resection (1)
complications of liver transplantation, liver transplant, pediatric liver transplantation (1)
COMPLICATIONS; OUTCOMES; otoplasty; prominent ears; external ear (1)
COMPLICATIONS; PERFORMANCE; MANAGEMENT; SURVIVAL; SCREW; CAD/CAM; mastication; screw; torque; zirconia crowns (1)
COMPLICATIONS; REPLACEMENT; SURGERY; REASONS; Hip arthroplasty; Osteoarthritis; Femoral neck; Fracture; Mortality; Periprosthetic joint infection; Revision; Arthrosis; Degeneration (1)
COMPLICATIONS; RESECTION; PREVALENCE; RECURRENCE; LAPAROTOMY; MANAGEMENT; DRESSINGS; OUTCOMES; IMPACT; NP-SSI; SSI; NPWT; ciNPWT; Incision management; Prevena; Wound infection; HPB surgery; Randomized controlled trial (1)
COMPLICATIONS; VITRECTOMY; (1)
COMPONENT ALIGNMENT; AXIAL ALIGNMENT; REPLACEMENT; GUIDES; ERROR; INSTRUMENTATION; OSTEOTOMY; ACCURACY; TIBIA; FEMUR; TKA; Knee; Alignment; Rotation; Rods; Total knee arthroplasty; Distal cut (1)
COMPONENT ANALYSIS; KERNEL; ELECTROENCEPHALOGRAMS; ARTIFACTS; kernel principal component analysis (KPCA); pre-image; time series analysis; denoising (1)
Component-Based Banking, Modularisierung der Informationsverarbeitung, virtuelle Geschäftskonzepte (1)
Component-Based Banking, Modularization, Information Processing, Virtual Business (1)
COMPONENT; FLEXION; TRACKING; PAIN; TKA; Patellar tracking; Patellar kinematics; Computer navigation; Kinematical alignment; Mechanical alignment; Total knee arthroplasty; Total knee replacement; TKA; TKR (1)
COMPONENT POSITION; KNEE ARTHROPLASTY; FOLLOW-UP; CUP; REPLACEMENT; RELIABILITY; Total hip arthroplasty; Revision; Custom-made implant; Acetabular Paprosky III defects; 3D CT (1)
COMPONENT POSITION; ORIENTATION; REPLACEMENT; ANTEVERSION; NAVIGATION; SYSTEM; RELIABILITY; VALIDATION; MODEL; TILT; Acetabular cup orientation; 3D-CT; Radiographic software; Total hip arthroplasty; Anteversion; Inclination; Pelvic landmark (1)
COMPONENT SEPARATION TECHNIQUE; HERNIA REPAIR; RISK-FACTORS; MESH; SURGERY; diastasis recti; minimally invasive surgery; hernia (1)
Compositae - Asteraceae - Anthemideae - Castrilanthemum - molecular phylogeny - Mediterranean - ITS - trnL/trnF IGS (1)
COMPOSITE FERMIONS; ACTIVATION-ENERGIES; MAGNETIC-FIELDS; EXCITATIONS; POLARIZATION; LOCALIZATION; SKYRMIONS; INTEGER; SYSTEMS; LEVEL; (1)
COMPOSITE FERMIONS; EXCITATIONS; (1)
COMPOSITE FERMIONS; SPIN; (1)
composite hydrogels; double cross-linking hydrogels; hydrogen bonds; hydrophobic association; self-healing; stretchability; synthetic polymers; toughness (1)
COMPOSITE-MATERIALS; IN-VITRO; METHACRYLATE; MONOMERS; SENSITIZATION; PERSONNEL; ALLERGY; Allergic reaction; Nernst partition coefficient; Eluted substances; Aqueous eluate; Methanolic eluate; Polymerized specimen; Unpolymerized specimen; HEMA; TEGDMA (1)
COMPOSITE RESIN BLOCKS; OF-THE-LITERATURE; MECHANICAL-PROPERTIES; IN-VITRO; ONLAYS; PERFORMANCE; NETWORK; SURVIVAL; CRITERIA; WEAR; Dental ceramics; Polymer-infiltrated ceramic; PICN; CAD/CAM material; Clinical trial; Survival; Longevity (1)
COMPOSITE RESIN MATERIALS; VENEERS; (1)
COMPOSITE RESIN; SURFACE-ROUGHNESS; CLINICAL-PERFORMANCE; DENTAL COMPOSITES; STRENGTH; RESISTANCE; CERAMICS; FRACTURE; BLOCKS; SILICA; Polishing; Wear; CAD; CAM; Resin composite; Resin-based material; Ceramic; Zirconia-reinforced-ceramic; Lithium silicate; Lithum disilicate; Roughness; Damage; Defect (1)
COMPOSITES; Filled resins; Electron beam irradiation; Silane; Silica filler; Flexural strength (1)
compound eye, interference filter, cornea, pigment, color pattern, visual signals (1)
compound eye, interference filter, cornea, pigment, color pattern, visual signals. (1)
COMPOUND HETEROZYGOUS MUTATIONS; PAPULAR LESIONS; CONGENITAL ATRICHIA; ALOPECIA UNIVERSALIS; DIAGNOSTIC-CRITERIA; PAKISTANI ORIGIN; UNDERLIE APL; FAMILIES; SEQUENCE; IDENTIFICATION; (1)
COMPOUND HETEROZYGOUS MUTATIONS; TRANSCRIPTION INITIATION; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CATALYTIC SUBUNIT; 4H SYNDROME; POL III; VISUALIZATION; PREDICTION; MECHANISM; (1)
COMPOUND METHOD; HUMAN BONE; DEATH; TIME; THORIUM; EXPERIENCES; SKELETAL; INTERVAL; TISSUE; PLANTS; Spectrometry; Radionuclide; Bone and bones; Postmortem changes; Time factors (1)
COMPREHENSION; REVEAL; PREDICTION; GENDER; ERROR; STYLE; P600; Speaker identity; Language use; Syntax; Prediction; ERP (1)
COMPREHENSIVE 2-DIMENSIONAL SYSTEM; ELECTRICAL-FIELD STRENGTHS; FUSED-SILICA CAPILLARIES; FLOW GATING INTERFACE; ELECTROSPRAY-IONIZATION; ZONE-ELECTROPHORESIS; ELECTROCHEMICAL DETECTION; FLUORESCENCE DETECTION; MICROCOLUMN-LC; SINGLE CELLS; Capillary electrophoresis; Time-of-flight mass spectrometry; Electrospray ionization; Fused silica capillaries; High electric field strengths; Catecholamines (1)
COMPREHENSIVE CANCER CENTER; DISCLOSURE; ONCOLOGY; USAGE; CAM; Complementary medicine; Cancer; Malignancy; Alternative medicine; Tolerability (1)
Comprehensive Geriatric Assessment (CGA), Total hip arthroplasty (THA), Total knee arthroplasty (TKA), Orthogeriatric, Rehabilitation, Frailty (1)
comprehensive income, income components, International Accounting Standards, IAS, International Financial Reporting Standards, IFRS, performance reporting, United States Generally Accepted Accounting Principles, US GAAP, value relevance, German stock exchange, Germany, stock returns (1)
COMPREHENSIVE INVENTORY; SUSTAINABLE CONSUMPTION; THRIVING CIT; STAGE MODEL; MEDITATION; VALIDATION; COMPASSION; MECHANISMS; METAANALYSIS; CONSTRUCT; mindfulness; attitudes; priming paradigm; vegetarian food; sustainable food consumption; sustainability; behavioral change; intervention study (1)
COMPREHENSIVE MANAGEMENT; COMPUTED-TOMOGRAPHY; BLOWOUT FRACTURES; MAXILLARY SINUS; RECONSTRUCTION; SIZE; orbital floor fracture repair; endonasal; prelacrimal endoscopic approach to maxillary sinus (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; BREAST-CANCER; CARCINOMA; IDENTIFICATION; VALIDATION; RECURRENCE; CYSTECTOMY; PORTRAITS; PREDICTOR; SUBTYPES; Bladder cancer; muscle-invasive bladder cancer; molecular diagnostics; molecular subtyping; KRT5; KRT20 (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; ENDOMETRIAL; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; TUMORS; CARCINOMA; PROTEIN; DNA mismatch repair; Endometrial carcinoma; Immune checkpoint inhibitors; Microsatellite instability; Prognosis (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; FREQUENT GENETIC ALTERATIONS; UROTHELIAL CARCINOMA; P16 EXPRESSION; FGFR3; P53; PAZOPANIB; SUBTYPES; CLASSIFICATION; IDENTIFICATION; (1)
Comprehensive two-dimensional gas chromatography electron ionization time-of-flight mass spectrometry (GC×GC-EI-TOFMS), gas chromatography, mass spectrometry, metabolomics, metabolic fingerprinting, data mining, alignment, metabolite profiling, Umfassende 2-dimensionale Gas Chromatographie gekoppelt mit der Flugzeitmassenspektrometrie, Gas Chromatographie, Massenspektrometrie, Metabolomik, Datenauswertung (1)
COMPRESSION PLUS SURGERY; LEG ULCERS; VARICOSE-VEINS; THERAPY; DISEASE; MANAGEMENT; CONSENSUS; SOCIETY; ESCHAR; (1)
COMPRESSION SCREWS; FRACTURES; FIXATION; HYDROGEN; IMPLANTS; REMOVAL; Magnesium screws; Radiolucent zones; Children; Osteosynthesis; Osteotomy; Osteochondral refixation (1)
COMPRESSION STOCKINGS; THROMBOEMBOLISM; PREVENTION; RECURRENCE; ASPIRIN; Deep venous thrombosis; Lipid-lowering therapy; Post-thrombotic syndrome (1)
COMPRESSIVE PROPERTIES; RESIDUAL-STRESS; HEAT-TREATMENT; LASER; PREDICTION; DESIGN; STRUTS; (1)
COMPRESSUM; BACTERIA; GROWTH; CULTIVATION; TEMPERATURE; SEQUENCES; SUBSTITUTIONS; 105-DEGREES-C; PROTOZOA; PRODUCTS; marine; monoxenic culture; physiology; taxonomy; thermophilic; Vulcano Island; 18S rRNA (1)
computational biology/computational neuroscience, computer science/numerical analysis and theoretical computing, ecology/behavioral ecology, evolutionary biology/animal behavior, mathematics/nonlinear dynamics, neuroscience/behavioral neuroscience, neuroscience/motor systems, physiology/integrative physiology, physiology/motor systems, mental health/psychology (2)
computational biology, correlated mutations, covariation, classification (1)
Computational biology, neuroscience, computer science (2)
Computational biophysics, Ion transport, Kinetics (1)
computational chemistry electrophysiology integrative modeling mutagenesis optogenetics structural biology (1)
computational chemistry electrophysiology integrative modeling mutagenesis structural biology (1)
computational chemistry LMA malonaldehyde molecular dynamics simulations proton transfer QM QM/MM software tool theoretical IR spectroscopy time-resolved vibrational spectroscopy (1)
Computational diagnostics, gene expression analysis, expression profiles, micro array, gene chip, breast cancer, estrogen receptor status, Bayesian statistics, Bayesian regularization, binary regression, probit model, G-prior, singular value decomposition, predictive diagnosis, prognosis, tumor classification, uncertainty, factor regression, ridge regression, machine learning (1)
COMPUTATIONAL FLUID-DYNAMICS; ANTERIOR COMMUNICATING ARTERY; FLOW DIVERTORS; RUPTURE STATUS; SIDE BRANCHES; HEMODYNAMICS; CFD; STENTS; RISK; REPRODUCIBILITY; Challenge; Intracranial aneurysm; Morphology; Segmentation (1)
; Computational fluid-dynamics; Lattice Boltzmann methods; Many-core architectures; Performance analysis (1)
Computational Linguistics, Annotate Corpus, Annotation Level, Anaphora Resolution, Segment Element (1)
COMPUTATIONAL MODELS; POSITIVE AFFECT; MENTAL REPRESENTATION; PREFRONTAL CORTEX; DOPAMINE; STABILITY; MECHANISMS; COSTS; MAINTENANCE; BENEFITS; Meta-control; Reward; Flexibility; Stability; Task switching (1)
COMPUTATIONAL PLATFORM; COMPREHENSIVE ANALYSIS; AGC KINASES; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; PROTEINS; DATABASE; REVEALS; NETWORK; (1)
Computational trust, enterprise identity management, recertification, access control, compliance, identity and access management (1)
COMPUTATION; TRANSPORT; (1)
COMPUTATION; Two-phase flow; diffuse interface model; variable surface tension; surfactants; global existence; implicit time discretization; Navier-Stokes equations; Cahn-Hilliard equation (1)
COMPUTED TOMOGRAPHIC ANGIOGRAPHY; SOFT-TISSUE FLAP; CUTANEOUS PERFORATORS; EXPERIENCE; ARTERY; RECONSTRUCTION; FLOWMETRY; DEFECTS; ANATOMY; perforator flap plasty; imaging procedures; flap plasty; thigh; free flap plasty (1)
COMPUTED TOMOGRAPHIC COLONOGRAPHY; MAGNETIC-RESONANCE COLONOGRAPHY; CROHNS-DISEASE; CONVENTIONAL COLONOSCOPY; VIRTUAL COLONOSCOPY; CAPSULE ENDOSCOPY; COLORECTAL POLYPS; BLADDER WALL; FEASIBILITY; ENTEROCLYSIS; virtual colonoscopy; colonography; MRI; inflammatory bowel disease (1)
COMPUTED-TOMOGRAPHY; 3D CISS; MRI; CT; VISUALIZATION; (1)
COMPUTED-TOMOGRAPHY; ACUTE ABDOMEN; X-RAY; PAIN; DIAGNOSIS; EMERGENCIES; ULTRASOUND; plain abdominal radiograph; supine position; diagnostic information (1)
COMPUTED-TOMOGRAPHY ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; PREOPERATIVE MR-ANGIOGRAPHY; OSTEOCUTANEOUS FLAP; POPLITEAL ARTERY; DIAGNOSTIC PERFORMANCE; LEG ANGIOGRAPHY; HEAD; NECK; RECONSTRUCTION; MR angiography; microvascular reconstruction; free fibula transplantation; lower leg anatomy (1)
COMPUTED-TOMOGRAPHY; CLINICAL-SIGNIFICANCE; ABNORMALITIES; TRACT; CT; Bowel wall thickening; CT; Endoscopy (1)
COMPUTED-TOMOGRAPHY CT; RESONANCE-IMAGING MRI; BEDSIDE ULTRASOUND; VOLUME NAVIGATION; BIOPSY; ACCURACY; PHANTOM; FUSION; CEUS; ultrasound-guided drainage; intervention; navigation system; abscesses; drainage; training model (1)
COMPUTED-TOMOGRAPHY; DYSFUNCTION; Acute pancreatitis; Chronic pancreatitis; Computed tomography; Magnetic resonance imaging; Guidelines (1)
COMPUTED-TOMOGRAPHY; EMERGENCY-ROOM; CT; CT-spiral; decision analysis; technical aspects; trauma (1)
COMPUTED-TOMOGRAPHY ENTEROCLYSIS; CROHNS-DISEASE; PUSH ENTEROSCOPY; CARCINOID-TUMORS; CT-ENTEROCLYSIS; IMAGING METHODS; ANGIOGRAPHY; capsule endoscopy; enteroclysis; inflammatory bowel disease; Crohn's disease; gastrointestinal bleeding (1)
COMPUTED-TOMOGRAPHY; FIELD CORRECTION; C-ARM; SYSTEM; EXPERIENCE; MOBILE; IMAGER; flat panel detector (FD); FD conditioning; FD calibration; dual dynamic range; cone beam CT; lag (1)
COMPUTED-TOMOGRAPHY GUIDANCE; RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; THERMOABLATION; METASTASES; ASSISTANCE; ACCURACY; SURVIVAL; interventional radiology; robotic assistance; microwave ablation; liver tumor (1)
COMPUTED-TOMOGRAPHY; NECK DISSECTION; DIAGNOSTIC-ACCURACY; HEAD; VOLUME; CANCER; DIFFERENTIATION; COEFFICIENT; RATIONALE; Oral squamous cell carcinoma; lymph nodes; diffusion-weighted imaging (DWI); apparent diffusion coefficient; magnetic resonance imaging (MRI) (2)
COMPUTED-TOMOGRAPHY; PUBIC RAMI; RING INJURIES; CONVENTIONAL RADIOGRAPHY; EMERGENCY-DEPARTMENT; DIAGNOSIS; ACCURACY; Imaging; Pelvis; CT; Missed injury; Elderly; Blunt pelvic trauma (1)
Computed tomography, RA, Right heart failure (1)
COMPUTED-TOMOGRAPHY; RESISTIVE INDEX; PAIN; Hydronephrosis; Sonography; Hydronephrosis index; Renal colic; Intra-observer agreement (1)
COMPUTED-TOMOGRAPHY; SCAN ANALYSIS; SEPTA; MORPHOLOGY; LOCATION; HEIGHT; maxilla; hiatus; volume; septa; cadaver (1)
COMPUTER-ADAPTIVE TEST; IMPACT TEST HIT(TM); MONITORING DEPRESSION; D-CAT; VALIDATION; VALIDITY; SCL-90-R; Item Response Theory; equating; PHQ; ISR; depression self-rating scales (1)
COMPUTER-AIDED-DESIGN; PLACEMENT; STRENGTH; SYSTEM; bonding tray; 3D-printing; intraoral scanning; shore hardness (1)
COMPUTER-ASSISTED-NAVIGATION; ANTEROPOSTERIOR AXIS; ALIGNMENT; REPLACEMENT; RELEASE; Arthroplasty knee; Biomechanics; Implant fixation; Knee; Kinematics and kinetics (1)
COMPUTER-ASSISTED NAVIGATION; CONVENTIONAL TECHNIQUE; CORONAL ALIGNMENT; CUTTING ERRORS; CLINICAL-EXPERIENCE; IMPLANTATION; REPLACEMENT; INCISION; TRIAL; INSTRUMENTATION; total knee arthroplasty; minimally invasive surgery; navigation; computer-assisted surgery (1)
COMPUTER-ASSISTED NAVIGATION; SURGERY; SYSTEM; Head-mounted display; Oral implant; Accuracy; Navigation; Visualization; Augmented reality (1)
COMPUTER-ASSISTED SURGERY; AXIAL ALIGNMENT; POSTOPERATIVE ALIGNMENT; CORONAL ALIGNMENT; REPLACEMENT; NAVIGATION; ACCURACY; GUIDES; COMPONENT; ROTATION; Total knee arthroplasty; Rod; Femur; Intramedullary alignment; Alignment; Cutting block; Navigation; Pinless (1)
COMPUTER-ASSISTED SURGERY; IMAGE GUIDANCE; AIDED SURGERY; CAS; functional endoscopic sinus surgery (FESS); simulation; imaging; navigation systems; process costing (1)
COMPUTER-ASSISTED SURGERY; PROSPECTIVE RANDOMIZED-TRIAL; IN-VIVO KINEMATICS; CONVENTIONAL TECHNIQUE; ALIGNMENT; REPLACEMENT; METAANALYSIS; COMPONENTS; MOVEMENT; ROTATION; Pinless; Knee navigation; Midflexion; Kinematics; Review (1)
Computerchemie, physikalisch-organsiche Chemie, N-Heterozyklische Carbene (1)
Computergestütztes Enzymdesign, Ligandenpositionierung, Proteindesign, Ligandenbindung, PRA-Isomerase, Rosetta, Propka, DSX, computational biology, protein design, computational enzyme design, ligand binding, active sites, ligand positioning (1)
computerised pattern recognition -- learning systems -- neural nets -- optical character recognition -- optimisation -- parallel processing (1)
computerized adaptive testing, inclusive, diagnostics, assessment, formative (1)
Computerized Adaptive Testing, Special Education, Sonderpädagogik, Diagnostik, Testtheorie, Assessment, Inklusive Pädagogik, Education, Inclusive (1)
COMPUTERIZED TEST BATTERY; ATTENTIONAL PERFORMANCE; COMPONENTS; METHYLPHENIDATE; INTELLIGENCE; DIAGNOSIS; BOYS; ADHD; attention; KiTAP; TAP; validity; elementary-school age (1)
COMPUTERIZED-TOMOGRAPHY; JOINT INSTABILITY; DIAGNOSIS; COMPLEX; RELIABILITY; RADIOGRAPHY; INJURIES; Distal radioulnar joint; radioulnar translation; pronosupination; 3-D imaging; normal values; anatomic study (1)
COMPUTER-MEDIATED COMMUNICATION; EMPLOYEE CREATIVITY; MANAGEMENT TEAMS; SOCIAL NETWORKS; GROUP DIVERSITY; VIRTUAL TEAMS; KNOWLEDGE; PERFORMANCE; INFORMATION; OUTCOMES; Community of learning; Type of communication; Social network analysis; Content analysis; Hierarchical positions (1)
COMPUTER-MEDIATED COMMUNICATION; GENDER STEREOTYPES; METAANALYSIS; SCIENCE; MODEL; ATTITUDES; STUDENTS; CHOICES; WOMEN; MATH; Mentoring; Online learning; Gender; STEM; Evaluation (1)
Computer-mediated Communication, Genres, Organizational Behaviour, Social Media, Speech Acts, Structuration Theory (1)
computer modeling crystal structure Fourier transform IR (FTIR) infrared spectroscopy (IR spectroscopy) nuclear transport small GTPase spectroscopy X-ray crystallography QM/MM simulations reaction mechanism (1)
COMPUTER NAVIGATION; RANDOMIZED-TRIAL; ALIGNMENT; OUTCOMES; METAANALYSIS; REPLACEMENT; SURVIVAL; IMPROVE; PATELLA; GUIDES; Long-termresults; Navigated total knee arthroplasty (1)
COMPUTER NAVIGATION; RISK-FACTOR; METAANALYSIS; OUTCOMES; AGE; INFECTION; PAIN; TKA; (1)
Computer science and STEM education, computer science and STEM in society, computer literacy, pop-up education, educational roadshow, information security, social engineering, information security pop-up, information security roadshow (1)
Computer Science, Bioinformatics, Computational Biology, Machine Learning, Genetics (1)
Computers *Cryopreservation *Microscopy, Electron Software (1)
Computersimulation (1)
Computersimulation , Hierarchische Simulation , Monte-Carlo-Simulation , Thermoelast , Polymeres Netzwerk , Polymerlösung, Physikalische Eigenschaft , Polymer-Feld-Theorien, Mehrskalen-Modellierung, Polymere, Näherungsverfahren, Fluktuationen , Polymer field theories, multiscale modeling, polymers, beyond mean field approximations, fluctuations (1)
Computersimulation , Molekulardynamik , Matrix-Isolations-Spektroskopie , Phasenumwandlung , Edelgas , Gastmolekül , Nitrosobenzol , NPT-Simulationen, Verfahren von Martyna et al, Nose-Hoover Ketten, Verfahren von Molnar et al. , Molecular dynamics, NPT-simulation, matrix isolation spectroscopy, nitrosobenzene in rare gas matrices, phase transitions (1)
COMPUTER-SIMULATION; NUMBER; VELOCITY; UNITS; MUSCLES; Biomedical measurement; Muscles; Pathology; Rats; Signal to noise ratio; Dispersion; Computational modeling; Computer simulation; digital signal processing; modeling; neurology (1)
Computersimulation , Transportprozess , Green-Funktion , Magnetisches Tunnelelement , Tunnelmagnetowiderstand , Magnetoelektronik , Tight-Binding , Matrixsortierung , anisotroper Tunnelmagnetowiderstand , quantum transport algorithms , matrix reordering , spintronics , anisotropic tunneling magnetoresistance , graphene (1)
Computer , Strafrecht , Europarat , , computer crime, Council of Europe, penal law (1)
Computerunterstütztes Lernen; Bildverarbeitung; Lernstrategien; lineares Programm; interaktives Programm; Lernerkontrolle; Systemkontrolle; linear; selektiv; Vorwissen (1)
Computerunterstütztes Lernen; Lernstrategien; textbasiertes Lernen; bildbasiertes Lernen (1)
computer vision, film studies, distant viewing, harry potter, object detection, emotion recognition (1)
; COMT; episodic memory; imaging genetics; inhibition; retrieval-induced forgetting (1)
COMT; imaging genetics; episodic memory; retrieval-induced forgetting; inhibition (1)
Concentration camp, Displaced Persons, Jews, Lithuania, memorial sites, memory activism, migration, Nazi persecution, Poland, Ukraine (1)
Concentration camps, forced labour, labour productivity (1)
CONCENTRATION-DEPENDENCE; ELECTROLYTE-SOLUTIONS; CALCIUM NITRATE; RAMAN-SPECTRA; CONDUCTANCE; SALTS; SOUND; (1)
conceptualizing, open-loop (1)
Conceptual Metaphor; Political Discourse; newness; Frame Semantics; Presidential Rhetoric; Inaugural Address; National Identity; Event Structure Metaphor; Epideictic Genre; Political Discourse Analysis; Critical Metaphor Analysis; Ideology; Discourse Analysis; Cultural Model (1)
Conceptual Schema, Database Design, Optimization Rule, Conceptual Database, Database Maintenance (1)
CONCERNED SIGNIFICANT OTHERS; Concerned Significant Others; addiction care; outpatient; gambling; counselling (1)
CONCERNED SIGNIFICANT OTHERS; TRAINING-PROGRAM; RELATIVES; STRESS; RELIABILITY; PREVALENCE; GAMBLERS; VIOLENCE; SUPPORT; PEOPLE; affected others; disordered gambling; questionnaire; psychometric properties (1)
CONCOMITANT CARDIAC-SURGERY; MITRAL-VALVE REPAIR; SURGICAL ABLATION; SURVIVAL; DISEASE; (1)
CONCRETE REINFORCEMENT WORKERS; INTERVERTEBRAL DISC; HOUSE PAINTERS; PHYSICAL WORK; RISK-FACTORS; BACK PAIN; DEGENERATION; SYMPTOMS; (1)
cond elec ionic soln Fuoss Onsager theory ionic cond mean spherical approxn cond equil pair correlation function cond chloride soln cond theory expt (1)
CONDENSATION PRODUCT; NITROALDOL REACTION; FORMALDEHYDE; COMPLEXES; CRYSTAL; ANTITUMOR; ALDEHYDES; ALCOHOLS; CATALYST; LIGAND; Cu(II) complexes; Ru(III) complexes; Methylenebis(oxazolidine); Oxazoline; Oxazolidine; X-ray structure (1)
Condensed matter: electrical, magnetic and optical (2)
Condensed matter: electrical, magnetic and optical, Semiconductors (1)
Condensed Matter, Materials & Applied Physics, Statistical Physics, Nonlinear Dynamics, Quantum Information (1)
Condensed Matter; Mesoscopic Systems and Quantum Hall Effect; Condensed Matter; Materials Science (1)
condensed matter physics, quantum transport, spin valve, pseudospin valve, pseuodspin, exchange fields, entanglement, quantum dot, QD, double quantum dot, DQD, synthetic spin-orbit interaction, interaction, Anderson pseudospin, particle-conserving superconductivity, Josephson junctions, zero-pi transition, dot-pair amplitude, nanojunctions, single electron transistor, SET, carbon nanotubes, CNT, interference, weak coupling, cotunneling, quantum master equation, Nakajima-Zwanzig, density matrix formalism, Liouville space (1)
CONDENSED-MATTER PHYSICS; SHOT-NOISE; BLOCKADE; (1)
Condensed matter properties, Electronic transport, Magnetism, Polarization, Magnetic ordering, Semiconductors, Materials analysis, Physical optics, Magnetic equipment, Equipment and apparatus (1)
condensed matter, quantum transport, noise, shot noise, full counting statistics, FCS, interaction, nanojunctions, single electron transistor, SET, quantum dot, QD, carbon nanotubes, CNT, dark states, DS, interference, Kondo, weak coupling, master equation, symmetry, SSH, SSH model, topology, superoperator, Nakajima-Zwanzig, projector, density matrix (1)
Condensed matter; Solid-state physics; Theory of solids (1)
CONDENSED TANNINS; BARK EXTRACT; POLYMERIC PROCYANIDINS; ARABIDOPSIS-THALIANA; HYPERICUM-PERFORATUM; SECONDARY CHEMISTRY; PHENOLIC GLYCOSIDES; SALIX-MYRSINIFOLIA; S-ERIOCEPHALA; GENE ENCODES; Salix species; Salicaceae; Willow; Proanthocyanidins; Condensed tannins; Flavan-3-ols; Metabolomics; Chemotaxonomy (1)
; Conditional cooperation; Public goods game; Sequential prisoner's dilemma; Discrete behavioral types (1)
CONDITIONAL CORRELATION; A-SHARE; MODELS; HETEROSKEDASTICITY; IDENTIFICATION; VOLATILITY; China; Stock Market; Correlation; Integration; Spillover (1)
conditional error group-sequential stopping boundary sequential probability ratio test spending function underrunning analysis (1)
CONDITIONAL MACROPHAGE ABLATION; RESIDENT ALVEOLAR MACROPHAGES; RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY MONOCYTES; PULMONARY INFLAMMATION; MARGINATED MONOCYTES; CHEMOKINE PRODUCTION; BLOOD MONOCYTES; DENDRITIC CELLS; MICE; acute lung injury; LPS; monocytes; neutrophils (1)
Conditionals; Conditional logic; Connexive logic; Belief revision; Ramsey test; Difference-making; Relevance; Contingency; Aristotle; Boethius; Abelard (1)
conditionals; relevance; dependence; Ramsey Test; belief revision (1)
CONDITIONAL VALUE; COHERENT; New approach; Business valuation; Project valuation; Terminal value; Risk measure (1)
CONDITION DEPENDENCE; SPERM COMPETITION; GIFT CONSTRUCTION; SEXUAL SELECTION; MATING STATUS; WOLF SPIDER; MATE CHOICE; MALES; FEMALES; PHEROMONES; Silk; Sexual selection; Chemical signals; Nuptial gifts (1)
CONDITIONED PLACE PREFERENCE; IDENTIFICATION TEST AUDIT; POTASSIUM CHANNELS; RECEPTORS COUPLE; DOPAMINE; RELIABILITY; DISORDERS; VALIDITY; NEURONS; GENOME; alcoholism; genetics; GIRK2; stress; gene x environment; KCNJ6 (1)
CONDITIONED PLACE PREFERENCE; SUBTHALAMIC NUCLEUS; GLUTAMATERGIC NEUROTRANSMISSION; PHARMACOLOGICAL-TREATMENT; PARAVENTRICULAR NUCLEUS; ALCOHOL DEPENDENCE; WISTAR RATS; ADDICTION; BEHAVIOR; MICE; chronic alcohol; dopamine; intracerebroventricular oxytocin (1)
CONDITIONING TRIALS; INNOVATION; AGE; MOTIVATION; VULPES; BRAINS; TASKS; FOXES; RANK; SIZE; (1)
CONDUCTANCE; (1)
CONDUCTANCE; 25-DEGREES-C; (1)
CONDUCTANCE; COULOMB; (1)
conductance electrolyte assocn mean spherical approxn MSA cond electrolyte soln assocn magnesium sulfate water cond assocn MSA lithium bromide acetonitrile cond assocn MSA (1)
CONDUCTANCE FLUCTUATIONS; LOCALIZATION; SEMICONDUCTOR; WIRES; TEMPERATURE; (GA,MN)AS; FILMS; METAL; (1)
CONDUCTANCE FLUCTUATIONS; MAGNETIC-FIELD; THIN-FILMS; SEMICONDUCTORS; SCATTERING; TRANSPORT; SYSTEMS; WIRES; METAL; (2)
CONDUCTANCE; JUNCTIONS; TRANSPORT; MOLECULE; (1)
CONDUCTANCE REGULATOR-DEFICIENT; RECTAL BIOPSIES; ION-TRANSPORT; SECRETION; BICARBONATE; MUTATION; ADENOMA; P2Y(2); DEFECT; cystic fibrosis; human colon; enteroids; colonoids; rectal organoids; Ussing chamber; TMEM16a; calcium-activated; purinergic receptors; fluid secretion; anion conductance; chloride (1)
CONDUCTANCE; STATES; (1)
CONDUCTANCE; TRANSISTOR; TRANSPORT; FIELD; (1)
CONDUCTANCE; TRANSPORT; (1)
CONDUCTANCE; TRANSPORT; HYSTERESIS; (1)
CONDUCTANCE; TRANSPORT; quantum wires; Luttinger liquids; ballistic transport (1)
conducting, conservatory, deliberate practice, expertise, professional learning, talent development, university of music (1)
conducting, music reading, musical expertise, musical memory, musical practice (1)
CONDUCTING POLYMER-FILMS; SUBSTITUTED POLYANILINES; THIN-FILMS; DERIVATIVES; SENSORS; GOLD; GAS; poly-(N-methylaniline); polyaniline derivatives; electropolymerization; film morphology (1)
CONDUCTING POLYMERS; BIOLOGICAL SENSORS; CHEMICAL SENSORS; CONTACT; BULK; POLYANILINE; RESISTANCE; FILM; Gas sensor; Conducting polymer; Electrochemical transistor; Six-point resistance Measurement; Sensor recovery (1)
CONDUCTING POLYMERS; BIOSENSORS; ARRAYS; electropolymerization; chemical sensors; biological sensors; organic semiconductors; combinatorial approach; high-throughput screening (1)
CONDUCTING POLYMERS; CIRCULAR-DICHROISM; LIQUID-CRYSTALS; POLYAZULENES; SUBSTITUENTS; DERIVATIVES; SYSTEMS; LUMINESCENCE; CELL; (1)
CONDUCTING POLYMERS; ELECTROCHEMICAL PROPERTIES; REDOX SUPERCAPACITORS; 2-ELECTRON TRANSFER; BUILDING-BLOCKS; NOBEL LECTURE; POLYPYRROLE; PYRROLE; OXIDATION; POLARONS; (1)
CONDUCTING POLYMERS; ELECTROCHEMICAL RESPONSE; Polythiophene; In situ conductivity measurement; s24-Technique; Spectroelectrochemistry; Conducting polymers (1)
CONDUCTING POLYMERS; POLYPYRROLE; ELECTROPOLYMERIZATION; PYRROLE; SENSORS; FILMS; SENSITIVITY; RESISTANCE; CONTACT; BULK; Conducting polymer; Polydialkoxybipyrroles; Raman spectroscopy; Cyclic voltammetry; Conductivity (1)
CONDUCTING POLYMERS; POLYPYRROLE FILMS; CHEMICAL SENSORS; POLYANILINE; NANOPARTICLES; PALLADIUM; HYDROGEN; MICROPARTICLES; COMPOSITES; RESISTANCE; Chemosensor; Chemiresisor; Nanoparticles; Palladium; PEDOT; Hydrazine; NADH (1)
CONDUCTING POLYMERS; RADICAL CATIONS; SOLAR-CELLS; PHOTOELECTROCHEMICAL PROPERTIES; OLIGOMERS; AZULENE; OLIGOTHIOPHENES; POLARONS; SYSTEMS; STATES; (1)
CONDUCTION-BAND; WELLS; GAAS; HETEROSTRUCTURES; COHERENCE; ELECTRONS; MOBILITY; SUBBAND; (1)
CONDUCTION ELECTRONS; (2)
CONDUCTION ELECTRONS; EPITAXIAL-GROWTH; RELAXATION; PHOSPHORUS; SILICENE; METALS; LAYER; (1)
CONDUCTION ELECTRONS; QUANTUM-WELLS; SPINTRONICS; PRECESSION; RESONANCE; ALUMINUM; (1)
CONDUCTION ELECTRONS; RELAXATION; SEMICONDUCTORS; FIELD; (1)
CONDUCTION ELECTRONS; RELAXATION; SPINTRONICS; DYNAMICS; electron spin relaxation; nuclear spins; quantum dots; spin-orbit interaction; spin qubit (1)
CONDUCTION ELECTRONS; ROOM-TEMPERATURE; SPINTRONICS; GRAPHITE; SINGLE; (1)
CONDUCTION; INSULATOR; BREAKDOWN; MOBILITY; CHANNEL; BI2SE3; STATES; (Bi1-xSbx)(2)Te-3 (BST); capacitance hysteresis; capacitance measurements; low temperatures; topological insulators (1)
CONDUCTION; SECTION; FIBERS; MUSCLE; axonal lesion; neurography; peripheral nerve; trauma; Wallerian degeneration (1)
CONDUCTION VELOCITIES; LOW-TEMPERATURE; HUMAN SKIN; PAIN; THRESHOLDS; SENSATION; SENSITIVITY; MIGRAINE; MUSCLES; RELEASE; Botulinum neurotoxin; nociception; quantitative sensory testing; thermal pain (1)
CONDUCTION VELOCITY DISTRIBUTION; MUSCLE ACTION-POTENTIALS; BLOCK; AREA; conduction block; high-frequency attenuation; motor nerve conduction; normal values; temporal dispersion (1)
CONDUCTIVITY (1)
CONDUCTORS; OXIDATION; (1)
CONDUCTOR; SWAN; fundamental group; ramification; Lefschetz theorem (1)
Cone dystrophy; Retinitis pigmentosa; Color vision; Photoreceptors; Contrast sensitivity (1)
CONE-ROD DYSTROPHY; ARRAYED PRIMER EXTENSION; RETINITIS-PIGMENTOSA; TRANSCRIPTION FACTOR; MUTATION DETECTION; GUANYLYL CYCLASE; HOMEOBOX GENE; PHOTORECEPTOR; AIPL1; CRX; (1)
CONE-ROD DYSTROPHY; SYNONYMOUS VARIANTS; RETINAL DISEASE; GENE; MUTATION; METAANALYSIS; ABCA4; deep-intronic variants; next generation sequencing; smMIPs; Stargardt disease (1)
CONE SUM-RULES; FORM-FACTORS; RESONANCE PHYSICS; RADIATIVE DECAY; LIGHT; QCD; FACTORIZATION; PION; (1)
CONFERS COPPER TOLERANCE; MULTICOPPER OXIDASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ENDOSPORE COAT; CRYSTAL-STRUCTURE; CUEO; LACCASE; SPECTROSCOPY; COMPONENT; Aquifex aeolicus; copper and iron homeostasis; hyperthermophilic bacteria; metallo-oxidase; multicopper oxidases (1)
CONFIDENCE-INTERVALS; NEGATIVE MOOD; POWER; EMOTION; BODY; EXPERIENCE; DETERMINANTS; EXPRESSIONS; CONQUER; UPRIGHT; Embodied cognition; General mood; Posture; Processing speed; Processing accuracy (1)
CONFIDENCE-INTERVALS; SYNAESTHESIA; EEG; BRAIN; CONNECTIVITY; EXPERIENCES; PERCEPTION; COHERENCE; RESPONSES; DYNAMICS; (1)
CONFIGURATIONAL QUESTIONS; ZINTL ION; ELEMENTS; POLYANIONS; CLUSTERS; GE-9(3-); ANIONS; RADII; SALTS; VAN; zintl anion; germanide; low-temperature crystal structure analysis; liquid ammonia; solvate crystal (1)
Configuration Conformation and Conformers (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyp Estrogen receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (estrogen, prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Molecular structure-biological activity relationship (estrogen receptor-binding, prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) platinum chloro hydroxyphenylethylenediamine estrogen receptor binding ethylenediamine deriv platinum complex estrogen activity (1)
Configuration Interaction Singles, Festkörper, periodische Randbedingungen, Anregungsenergien, Exziton, lokale Methode (1)
Configuration interaction (with CNDO, in calcn. of two-photon dipole-forbidden transition); Molecular orbital (CNDO, in calcn. of two-photon spectra of dipole-forbidden transitions); Energy level transition (dipole-forbidden, calcn. of 2-photon, by CNDO-CI method); Spectrometry (two-photon, of dipole-forbidden transitions); two photon dipole forbidden transition (1)
Configuration (of dialkyldiphenylethylenediamines and -imidazolidine derivs.) NMR ethylenediamine imidazolidine diphenyl NMR configuration diphenylethylenediamine (1)
; configuration space; homotopy invariance; spherical tangent bundle (1)
CONFIGURATION; STABILIZATION; SUBSTITUTION; ruthenium; chirality; metal configuration; half-sandwich complexes; ammine complexes (1)
Confinement energy; Quantum wires; Cleaved edge overgrowth; Micro-photoluminescence; Strain (1)
Confinement, Field Theories in Lower Dimensions, Lattice Quantum Field Theory, Nonperturbative Effects (1)
CONFINING EXCITATION-ENERGY; QUANTUM YIELDS; NANOPARTICLES; CORE; DYNAMICS; SURFACE; EMISSIONS; DESIGN; lanthanides; luminescence; nanoparticles; near-infrared; upconversion (1)
CONFIRMATION BIAS; IMPACT FACTOR; QUALITY; POWER; (1)
CONFIRMATORY FACTOR-ANALYSIS; BEHAVIOR; SENSORS; mHealth; psychological stress; crowdsensing; ecological momentary assessment; pilot study (1)
CONFIRMATORY FACTOR-ANALYSIS; INSULIN-RESISTANCE SYNDROME; QUANTITATIVE TRAIT LOCUS; SERUM LEPTIN LEVELS; RISK-FACTORS; ADIPOSE-TISSUE; HUMAN OBESITY; SYNDROME-X; ASSOCIATION; LIPODYSTROPHY; (1)
confirmatory information processing, decision making, randomness (1)
conflict adaptation; conflict monitoring; negative affect; cognitive control; LRP (1)
CONFLICT ADAPTATION; INTERFERENCE; STIMULUS; COSTS; CUES; RECONFIGURATION; UNCERTAINTY; PARADIGM; PREDICTABILITY; FOREPERIODS; task switching; executive control; timing; preparation (1)
Conflict management; electronic negotiations; interpersonal relationship; conflict level; negotiation process; content analysis; phase analysis (1)
confocal microscopy · D1--ike receptors ·dopamine receptors · fluorescent ligands · molecular brightness (1)
confocal microscopy · D2-like receptors · dopamine receptors · fluorescent ligands · molecular brightness (1)
Conformal and W Symmetry, Renormalization and Regularization, Renormalization Group, Scale and Conformal Symmetries (1)
CONFORMAL BOOTSTRAP CALCULATION; COMPOSITE-OPERATORS; CRITICAL DIMENSIONS; EXPANSION; ETA; COMPUTATION; O(1/N2); SCHEME; (1)
CONFORMAL DEFORMATION; WARPED PRODUCTS; DIFFERENTIAL-EQUATIONS; HARMONIC MORPHISMS; TWISTED PRODUCT; METRICS; EXISTENCE; Positive scalar curvature; Constant scalar curvature; The Yamabe problem; Warped product; Umbilic product; Twisted product (1)
CONFORMAL FIELD-THEORY; 8-VERTEX LATTICE MODEL; ANALYTIC BETHE-ANSATZ; BAXTERS Q-OPERATOR; INTEGRABLE STRUCTURE; PARTITION-FUNCTION; 6-VERTEX MODEL; EQUATION; SEPARATION; SYSTEM; Yang-Baxter equation; Q-operator; BGG-resolution (1)
; Conformal Field Theory; Gauge-gravity correspondence; Lattice QCD; Quark-Gluon Plasma (1)
CONFORMAL FIELD-THEORY; HIGH-ENERGY QCD; INTEGRABLE STRUCTURE; TODA CHAIN; EQUATION; SEPARATION; REPRESENTATION; VARIABLES; MAGNETS; THEOREM; Yang-Baxter equation; Baxter operator (1)
CONFORMAL FIELD-THEORY; INTEGRABLE STRUCTURE; BETHE-ANSATZ; REPRESENTATION-THEORY; FUNCTIONAL-EQUATIONS; QUANTUM; LATTICE; MODELS; SEPARATION; VARIABLES; (1)
CONFORMAL FIELD-THEORY; INTEGRABLE STRUCTURE; EQUATION; SEPARATION; VARIABLES; MODEL; (1)
CONFORMAL FIELD-THEORY; UNIVERSAL R-MATRIX; HIGH-ENERGY QCD; XXX SPIN CHAIN; Q-OPERATOR; INTEGRABLE STRUCTURE; MULTICOLOR QCD; QUANTUM; MODEL; SYSTEM; R-matrix; quantum inverse problem method; algebraic Bethe ansatz; Baxter operator (1)
CONFORMAL RADIATION-THERAPY; RADIOTHERAPY; TISSUE; RADIOCHEMOTHERAPY; CONVOLUTION; RISK; HEAD; lung cancer; radiotherapy; calculation algorithms; collapsed cone algorithm; pencil beam algorithm (1)
Conformal symmetry; Anomalous dimensions; DVCS (1)
CONFORMAL SYMMETRY; QCD; FACTORIZATION; (1)
CONFORMAL SYMMETRY; QCD FACTORIZATION; ANOMALOUS DIMENSIONS; DECAYS; (1)
Conformal Symmetry, Renormalization Group equation, evolution equation, QCD (1)
CONFORMATIONAL-CHANGES; SYNTHASE; ENZYMES; MECHANISM; BIENZYME; BINDING; (1)
conformational dynamics · drug design · Ras protein · signal transduction (1)
CONFORMATIONAL FREE-ENERGIES; CHAIN REVERSALS; MODEL PEPTIDES; AMINO-ACIDS; TURN MIMICS; CYS-NHME; BEND; CYCLO(L-ALANYLGLYCYL-EPSILONAMINOCAPROYL); CYCLIZATION; PROTEINS; beta-Peptide; Cyclic peptide; Peptidomimetics (1)
CONFORMATIONAL STATES; BINDING DOMAIN; K-RAS; EFFECTOR INTERACTION; NUCLEOTIDE EXCHANGE; DYNAMIC PROPERTIES; PROTEIN; GTP; CANCER; COMPLEXES; (1)
CONFORMATIONAL STATES; RAS PROTEIN; GTP ANALOG; HIGH-FIELD; C-13; COMPLEX; BINDING; DOMAIN; P-31 NMR; phosphate-binding proteins; solid-state NMR; liquid-state NMR; two-dimensional techniques (1)
Conformation and Conformers (of hydroxyphenylethylenediamine sulfatoplatinum complexes) Molecular structure-biological activity relationship (estrogenic, of hydroxyphenylethylenediamine sulfatoplatinum complexes) Neoplasm inhibitors (mammary gland, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) Mammary gland (neoplasm, inhibitors, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) estrogenic platinum complex conformation (1)
Conformation and Conformers (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Estrogen receptors Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) Estrogens Role: BSU (Biological study, unclassified), BIOL (Biological study) (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Receptors Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (estrogen, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) Molecular structure-biological activity relationship (estrogenic, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Neoplasm inhibitors (mammary gland, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Mammary gland (neoplasm, inhibitors, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Molecular structure-biological activity relationship (neoplasm-inhibiting, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) phenylethyleneamine platinum complex mammary antitumor estrogenic mammary cancer inhibitor phenylethyleneamine platinum complex (1)
Conformation and Conformers; Spectra; Spectral hole burning (MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); Crystal lattice dynamics (photo-induced MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); Molecular rotation (internal, MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); tolan argon matrix photoinduced site interconversion; spectral hole burning tolan argon site (1)
Conformation (of N,N'-dibutyl-1,2-diphenylethylenediamine, partition between aq. solns. and org. solvents in relation to) Partition (of N,N'-dibutyl-alpha ,alpha '-diphenylethylenediamines between aq. soln. and org. solvents) Hydration (chemical) (N,N'-dibutyl-alpha ,alpha '-diphenylethylenediamine partition between aq. solns. and org. solvents in relation to) (1)
CONFORMATION; RECTIFIERS; TRANSPORT; BARRIER; ab initio methods; molecular electronics; nanoscale modeling; THz fields (1)
Conformation Stereochemistry (antitumor potency of diastereomeric and enantiomeric platinum diaminophenylpropane dichloro complexes in relation to) Structure-activity relationship (antitumor stereoselectivity of antitumor active [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) Amines Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (diamines, platinum complexes prepn. and stereoselectivity in antitumor activity of [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) Antitumor agents (prepn. and stereoselectivity in antitumor activity of [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) platinum diaminophenylpropane chloro prepn antitumor activity stereoselectivity antitumor activity platinum diaminophenylpropane chloro phenylpropanediamine platinum chloro prepn antitumor activity diamine platinum chloro prepn antitumor activity conformation platinum diaminophenylpropane chloro isomer (1)
Conformers EHMO Hydrolysis Isomerization Molecular mechanics Molecular structure Total energy Transition state structure (mol.-mech. and quantum chem. study of species involved in hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)-dichloroplatinum(II) complexes) Amines Role: PEP (Physical, engineering or chemical process), PRP (Properties), PROC (Process) (platinum complexes mol.-mech. and quantum chem. study of species involved in hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)-dichloroplatinum(II) complexes) amminechloroplatinum complex hydrolysis transition state simulation ethylenediaminechloro platinum complex hydrolysis mol mechanic EHMO amminechloroplatinum complex hydrolysis transition state (1)
CONGENITAL ADRENAL-HYPERPLASIA; MENSTRUAL-CYCLE; SPATIAL ABILITIES; BRAIN POTENTIALS; PERFORMANCE; GENDER; WOMEN; ACTIVATION; ATTENTION; ANDROGEN; Spatial cognition; Lateralization; Sex differences; Developmental cognitive neuroscience; Mental rotation; Event-related potentials (1)
CONGENITAL ALVEOLAR PROTEINOSIS; LUNG-DISEASE; SURFACTANT DEFICIENCY; PULMONARY SURFACTANT; LAMELLAR BODIES; II CELLS; MEMBRANE-PROTEIN; TERM INFANT; CHILDREN; NEWBORNS; neonatal pneumonia; surfactant; lamellar bodies; ABCA3 mutation; ultrastructure (1)
CONGENITAL CORNEAL ANESTHESIA; CHILDREN; BLEPHAROKERATOCONJUNCTIVITIS; TRANSPLANTATION; MANAGEMENT; ALACRIMA; ROSACEA; GLANDS; SIGNS; Dry eye syndromes; Keratoconjunctivitis; Neurotrophic keratitis; Corneal ulcer; Childhood (1)
CONGENITAL CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELL; MEDIATED-IMMUNITY; T-CELLS; TRANSPLANT RECIPIENTS; QUANTITATIVE-ANALYSIS; PROTECTION; RESPONSES; DISEASE; VIRUS; cytomegalovirus; pregnancy; cell-mediated immunity; interferon (IFN)-gamma-enzyme-assay ELISpot (1)
congenital cytomegalovirus; sensorineural hearing loss; newborn hearing screening (1)
CONGENITAL FIBROSARCOMA; SPONTANEOUS REGRESSION; GENE FUSION; TUMORS; infantile fibrosarcoma; marginal resection; surgery; therapy (1)
CONGENITAL HEART-DEFECTS; SURGICAL REPAIR; VALVE-REPLACEMENT; REOPERATION; EXPERIENCE; SURVIVAL; complete atrioventricular septal defects; surgical repair; long-term results (1)
CONGENITAL HEART-DISEASE; ASCENDING AORTA; STENOSIS; QUANTIFICATION; REGURGITATION; ECHOCARDIOGRAPHY; FEATURES; MRI; REPLACEMENT; DYSFUNCTION; aortic valve; aorta; heart (1)
CONGENITAL HEART-DISEASE; LEFT ATRIAL ISOMERISM; INFERIOR VENA-CAVA; ATRIOVENTRICULAR SEPTAL-DEFECT; ASPLENIA SYNDROME; ECHOCARDIOGRAPHIC DIAGNOSIS; CARDIOSPLENIC SYNDROMES; CARDIAC-MALFORMATIONS; HETEROTAXIC SYNDROMES; VISCERAL SITUS; atrial isomerism; azygos continuation; heart block; heterotaxy; polysplenia (1)
CONGENITAL HEART-DISEASE; SPONTANEOUS CLOSURE; PRENATAL-DIAGNOSIS; FETUS; POPULATION; color Doppler; fetal echocardiography; outcome; spontaneous closure; ventricular septal defects (1)
CONGENITAL HEART-DISEASE; STATE FREE-PRECESSION; ASCENDING AORTA; STENOSIS; MORPHOLOGY; QUANTIFICATION; ECHOCARDIOGRAPHY; REPLACEMENT; AUTOPSY; REPAIR; (1)
congenital ichthyosiform erythroderma filaggrin (FLG) gene keratin 10 (KRT10) gene keratinopathic ichthyoses (1)
; congenital insensitivity to pain with anhidrosis; CIPA; hereditary sensory and autonomic neuropathy type IV; HSAN IV; Neurotrophic Tyrosine Kinase Receptor Type 1; NTRK1; mutation cluster (1)
CONGENITAL JOINT CONTRACTURES; OSTEOGENESIS IMPERFECTA; BONE; Bruck syndrome; osteogenesis imperfecta; arthrogryposis multiplex congenita; prenatal diagnosis; ultrasound; fetus (1)
congenital lower urinary tract obstruction; incontinence; self-efficacy; kidney function; relationship (1)
CONGENITAL MUSCULAR-DYSTROPHIES; MENTAL-RETARDATION; DYSTROGLYCAN; PHENOTYPE; DISRUPTION; GENE; congenital muscular dystrophy; alpha-dystroglycanopathy; POMT1 gene (1)
; congenital muscular dystrophies; muscle-eye-brain disease; Walker-Warburg syndrome (1)
CONGENITAL MUSCULAR-DYSTROPHY; CEREBRAL CORTICAL DEVELOPMENT; SUBCORTICAL BAND HETEROTOPIA; LINKED MENTAL-RETARDATION; WALKER-WARBURG-SYNDROME; ABSENT CORPUS-CALLOSUM; DOUBLE-CORTEX SYNDROME; PERIVENTRICULAR HETEROTOPIA; AMBIGUOUS GENITALIA; MUTATIONS; (1)
CONGENITAL MUSCULAR-DYSTROPHY; HUMAN PREFRONTAL CORTEX; CEREBRO-OCULAR DYSPLASIA; EYE-BRAIN DISEASE; PRENATAL DEVELOPMENT; CORTICAL DEVELOPMENT; BIOSYNTHESIS; DYSTROGLYCAN; PHENOTYPE; DELETION; cobblestone lissencephaly; dystroglycanopathy; Golgi analysis; MRI; POMT1 gene mutation (1)
CONGENITAL MUSCULAR-DYSTROPHY; O-MANNOSYL GLYCANS; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; REICHERTS-MEMBRANE; BASEMENT-MEMBRANES; FUKUTIN GENE; MUTATIONS; (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; DEFECTIVE GLYCOSYLATION; O-MANNOSYLATION; LAMA2 MUTATIONS; MEMBRANE; GENOTYPE; DELETION; COMPLEX; Dystroglycan; DAG1; Muscle-eye-brain disease (MEB); Multicystic leucodystrophy; Cystic white matter disease; Megalencephalic leucoencephalopathy with subcortical cysts (MLC) (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; MENTAL-RETARDATION; CLINICAL SPECTRUM; MEB DISEASE; POMT1; GENE; FUKUTIN; GLYCOSYLATION; muscle-eye-brain disease; congenital muscular dystrophy; lissencephaly; polymicrogyria; epilepsy (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; FUKUTIN-RELATED PROTEIN; REDUCTIVE ALKALINE-HYDROLYSIS; EYE-BRAIN DISEASE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ALPHA-DYSTROGLYCAN; ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I; SKELETAL-MUSCLE; (1)
CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR-FILTRATION-RATE; ACETATE-SALT HYPERTENSION; CHRONIC KIDNEY-DISEASE; TRPC6 CHANNELS; DIABETIC-NEPHROPATHY; OXIDATIVE STRESS; CONSCIOUS MICE; ANGIOTENSIN-II; KNOCKOUT MICE; (1)
CONGENITAL NEPHROTIC SYNDROME; TOUCH RECEPTOR NEURONS; C-ELEGANS; SLIT DIAPHRAGM; GLOMERULAR PROTEIN; STOMATIN; DOMAIN; IDENTIFICATION; NEPHRIN; TRPC6; prohibitin-domain proteins; TRP channels; DEG/ENaC channels; slit diaphragm; mechanosensation (1)
Congenital stationary night blindness; Electroretinogram; Flicker; Functional diagnostics; Mouse model; Photoreceptor; Retinal bipolar cell; Retinal ischemia; Single-flash; X-linked juvenile retinoschisis (1)
CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; MEDICAL PROGRESS; BODY-COMPOSITION; HYPERTENSION; HYPERTROPHY; MECHANISMS; RELAXATION; DIAGNOSIS; MORTALITY; diastolic abnormalities; diastolic dysfunction; risk factors; prevalence; general population (1)
CONGESTIVE-HEART-FAILURE; CROSS-SECTIONAL SURVEY; NATRIURETIC PEPTIDES; PREVALENCE; HYPERTROPHY; DIAGNOSIS; CARE; left ventricular systolic dysfunction; general population; echocardiographic screening; prevalence; heart failure; epidemiology (1)
CONGESTIVE-HEART-FAILURE; FACTOR AP-2; DNA-BINDING; CARDIOMYOCYTE APOPTOSIS; SIGNAL-TRANSDUCTION; MAMMARY-CARCINOMA; RETINOIC ACID; PROTEIN; EXPRESSION; GENE; activator protein 2 alpha; apoptosis; human heart failure; transcription factor; rat cardiomyocytes (1)
CONGESTIVE-HEART-FAILURE; NATRIURETIC PEPTIDES; ESSENTIAL-HYPERTENSION; SEX-DIFFERENCES; HYPERTROPHY; ADAPTATION; SURVIVAL; DISEASE; HORMONE; CARE; epidemiology; gender; hypertrophy; hypertension; heart failure; natriuretic peptide; ultrasound (1)
; Congestive heart failure; recovered ejection fraction; undulating ejection fraction (1)
CONJECTURE; (1)
CONJECTURES; FUNCTORS; FORMS; (1)
CONJOINT CHOICE DESIGNS; HETEROGENEITY; Semi-Bayesian mixed logit design; Heterogeneity; Estimation accuracy; D-optimality (1)
CONJUGACY PROBLEM; SURFACE GROUPS; FINITE INDEX; KNOT-GROUPS; SUBGROUPS; SEPARABILITY; QUASICONVEXITY; MANIFOLDS; (1)
CONJUGATE ADDITION-REACTIONS; 1,3-DIPOLAR CYCLOADDITION REACTION; QUATERNARY STEREOGENIC CENTERS; CATALYZED COUPLING REACTIONS; DIELS-ALDER REACTIONS; 1,4-ADDITION REACTIONS; ORGANIC-REACTIONS; REACTION VOLUMES; ALDOL REACTION; ACTIVATION; High pressure; Organocatalysis; Biomolecules; High hydrostatic pressure; Asymmetric catalysis; High pressure activation (1)
CONJUGATE ADDITIONS; POTENT; IMIDAZOLYLPROPYLGUANIDINES; H-1-RECEPTOR; PHARMACOLOGY; AUXILIARIES; SELECTIVITY; GUANIDINES; H-3; Histamine; H-2 receptor agonist; Chiral; Enantiomers; Acylguanidine; Sf9 cells (1)
CONJUGATE BASE; GALLIUM; ACTIVATION; GROUP-13; ALUMINUM; PHOSPHINOBORANES; REACTIVITY; ADDUCTS; ROUTE; PAIRS; alanes; gallanes; main-group elements; Lewis bases; phosphorus (1)
CONJUGATED DIENES; EXCITED-STATE; ALDEHYDES; BENZENE; YLIDES; 2,3-DICHLORO-5,6-DICYANO-P-BENZOQUINONE; HYDROXYLATION; DIMERIZATION; REACTIVITY; ACRYLATES; (1)
CONJUGATED MICROPOROUS POLYMERS; C-H ARYLATION; POLYCONDENSATION; catalysis; C-H arylation; conjugated polymer; nickel; thiophene (1)
CONJUGATED MOLECULAR WIRES; RUBBER-TOUGHENED EPOXY; CYANATE-ESTER POLYMERS; CLICK CHEMISTRY; CONDUCTIVE ADHESIVES; HETEROGENEOUS CATALYSIS; FRACTURE-BEHAVIOR; THIN-FILMS; POLYMERIZATION; POLYIMIDE; adhesives; click chemistry; conducting materials; polymers; silver (1)
CONJUGATED POLYMER; MAGNETIC-FIELD; SPIN; TEMPERATURE; (1)
CONJUGATED POLYMER-MOLECULES; ENERGY-TRANSFER; SOLAR-CELLS; SPECTROSCOPY; POLYTHIOPHENE; CHAINS; REGIOREGULARITY; CONFORMATION; DIFFUSION; JUMPS; (1)
CONJUGATED POLYMERS; CONFORMATIONAL RELAXATION; ENERGY-TRANSFER; PHOTOPHYSICS; CHROMOPHORES; FLUORESCENT; EMISSION; DYNAMICS; (1)
CONJUGATED POLYMERS; CONFORMATION; SPECTROSCOPY; PHOTOPHYSICS; fluorescence; organic electronics; phase transitions; polyfluorene; single-molecule spectroscopy (1)
conjugated polymers, deuteration, isotopes, magnetic resonance, organic light-emitting diodes (1)
CONJUGATED POLYMERS; EXCITON DIFFUSION; FIELD; RECOMBINATION; TRANSITION; SIMULATION; DEPENDENCE; MORPHOLOGY; DYNAMICS; MOBILITY; (1)
CONJUGATED POLYMERS; OXYGEN; SPECTROSCOPY; GENERATION; MOLECULES; BLENDS; ENERGY; (1)
conjugated polymers - poly(arylene ethynylene)s - reductive coupling - fluorescence anisotropy (1)
CONJUGATED-POLYMER; STIMULATED-EMISSION; WAVE-GUIDES; DPOP-PPV; POLY(PHENYLENE VINYLENE); NONRESONANT N(2); CHARGE-CARRIERS; THIN-FILMS; LASER; ULTRAFAST; luminescent polymers; phenylenevinylene polymers; diphenylenevinylene polymers; neat films; fluorescence quenching; exciton-exciton annihilation; polaron pair formation; polaron pair annihilation (1)
CONJUGATE-GRADIENT ALGORITHM; TOTAL-ENERGY CALCULATIONS; OPTICAL-ABSORPTION; SN2P2S6; POLARIZATION; RAMAN; TRANSITION; SCATTERING; CHARGES; SOLIDS; (1)
CONJUGATE VACCINE; Influenza vaccination; Pneumococcal vaccination; Chronic pulmonary disease (1)
Conjunction fallacy; Pragmatic and semantic inferences; Rationality (1)
Connective-tissue cross-linking (1)
CONNECTIVE-TISSUE DISEASES; OF-THE-LITERATURE; CAPSULAR CONTRACTURE; SMOOTH SILICONE; LONG-TERM; GEL; RISK; AUGMENTATION; EXPLANTATION; STIMULATION; (1)
connective tissue growth factor; ccn2; Rho proteins; statins; mesangial cells (1)
connectivity, gene flow, landscape fragmentation, patch size, spatial structure (1)
CONNECTIVITY; HETEROGENEITY; CLASSIFICATION; ARCHITECTURE; METAANALYSIS; HYPOTHESIS; PSYCHOSIS; NETWORKS; DEFICITS; Resting-state fMRI; Functional connectome; Interindividual variability; Brain heterogeneity; Graph theory; Schizophrenia; Negative symptoms (1)
connectivity; locomotion; MRI; primates; sensorimotor (1)
Connexin 40, Angiotensin II-AT1a-Rezeptor, Doppelknockout, Renin-Angiotensin-Aldosteron-System (1)
Connexin 40, Niere, Nierenfibrose, Cx40-Knockout, PDGFRb (1)
CONSCIOUS SEDATION; TUMOR SURGERY; ANESTHESIA; PATIENT; NEUROSURGERY; REMIFENTANIL; SATISFACTION; MANAGEMENT; TOLERANCE; RESECTION; Anaesthetics; Awake craniotomy; Hypnosis; Scalp block; Sedation; Therapeutic communication (1)
CONSENSUS DECISION-MAKING; DOMINANCE HIERARCHIES; ANIMAL GROUPS; FISH SCHOOLS; INFORMATION-TRANSFER; SOCIAL RELATIONSHIPS; SELF-ORGANIZATION; MOUNTAIN BABOONS; GROUP-SIZE; LEADERSHIP; Horse; Equus ferus caballus; Distributed leadership; Herding; Departure; Rank (1)
CONSENSUS DEVELOPMENT PROJECT; ANTI-HLA ANTIBODIES; STEM-CELL TRANSPLANTATION; REGULATORY B-CELLS; DONOR-SPECIFIC ANTIBODIES; CLINICAL-TRIALS; BRONCHIOLITIS OBLITERANS; ENDOTHELIAL-CELLS; CHRONIC GVHD; T-CELLS; chronic graft-versus-host disease (cGvHD); alloantibodies; glycomics; endothelial derived particles; extracellular vesicles; epigenetic changes; microbiome; cellular biomarkers (1)
CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; NONINFECTIOUS PULMONARY COMPLICATIONS; LONG-TERM SURVIVORS; MEASURING THERAPEUTIC RESPONSE; QUALITY-OF-LIFE; BRONCHIOLITIS-OBLITERANS; CLINICAL-TRIALS; RISK-FACTORS; (1)
CONSENSUS DEVELOPMENT PROJECT; BRONCHIOLITIS OBLITERANS SYNDROME; CLINICAL-TRIALS; CHRONIC GVHD; EXTRACORPOREAL PHOTOPHERESIS; RANDOMIZED-TRIAL; PREDNISONE; CRITERIA; CYCLOSPORINE; DIAGNOSIS; Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Immunosuppressive therapy; Bone marrow transplantation (1)
CONSENSUS DEVELOPMENT PROJECT; CD19(+)CD21(LOW) B-CELLS; CLINICAL-TRIALS; CHRONIC GVHD; T-CELLS; ACTIVATING FACTOR; CRITERIA; HEALTH; TRANSPLANTATION; DIAGNOSIS; (1)
CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; DIAGNOSIS; CANCER; POPULATION; MORTALITY; CRITERIA; Total body irradiation; Acute myeloid leukemia; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Quality of life; Cognitive function (1)
CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; INTERLEUKIN-6; RESPONSES; CRITERIA; Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Tocilizumab; Interleukin-6 (1)
CONSENSUS DEVELOPMENT PROJECT; DONOR LYMPHOCYTE INFUSIONS; VERSUS-HOST-DISEASE; WORKING GROUP; MYELODYSPLASTIC SYNDROME; CLINICAL ACTIVITY; LEUKEMIA; AZACITIDINE; DIAGNOSIS; AML; Allogeneic hematopoietic stem cell transplantation; Relapse; Venetoclax; Hypomethylating agents; Azacitidine; Decitabine; DLI (1)
CONSENSUS DEVELOPMENT PROJECT; HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW; CLINICAL-TRIALS; CHRONIC GVHD; CRITERIA; DIAGNOSIS; COMPLICATIONS; RECIPIENTS; SURVIVORS; atypical cGVHD; atypical features; unclassified entities; NIH Consensus Project Task; Force; NIH consensus criteria; undefined other cGVHD; nonclassical (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; PATIENT-REPORTED OUTCOMES; LONG-TERM SURVIVAL; REFRACTORY ACUTE; STEROID-RESISTANT; CLINICAL-TRIALS; CHRONIC GVHD; EXTRACORPOREAL PHOTOPHERESIS; (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; CLINICAL-TRIALS; CHRONIC GVHD; PHARMACOKINETICS; CHEMOTHERAPY; METABOLISM; DIAGNOSIS; CRITERIA; LUPUS; Chronic graft versus host disease; Vasculitis-like cGvHD manifestation; Salvage therapy; Cyclophosphamide (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; WORKING GROUP-REPORT; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD; BRONCHIOLITIS OBLITERANS; CRITERIA; TRIALS; MULTICENTER; SURVIVAL; Chronic GVHD; Staging; Severity scoring (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CHRONIC GVHD; BRONCHIOLITIS OBLITERANS; PERIPHERAL-BLOOD; CLINICAL-TRIALS; EXCESS BAFF; EXPRESSION; LYMPHOCYTES; NAIVE; Chronic graft-versus-host disease; Biomarker; B cells (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CHRONIC GVHD; T-CELLS; CLINICAL-TRIALS; TRANSPLANTATION; IMPACT; PATHOGENESIS; DIAGNOSIS; SURVIVAL; (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; CRITERIA; VALIDATION; THERAPY; CARE; Graft-versus-host disease; Oral; Chronic; Mucosa; Budesonide; Topical; Steroid (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; THERAPEUTIC RESPONSE; NIH CRITERIA; ACUTE GVHD; DIAGNOSIS; MARROW; CGVHD; (1)
CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; HIGH-RISK; REPLACEMENT; PREDICTORS; REGURGITATION; Transcatheter aortic valve implantation; Sizing; Pacemaker; Device failure (1)
CONSENSUS GUIDELINES; Clinical pharmacological TDM report; Interaction data banks; Xenobiotics; Dose-related reference range; Therapeutic drug monitoring (1)
CONSENSUS GUIDELINES; PHARMACOKINETICS; RISPERIDONE; CLOZAPINE; TDM; PSYCHIATRY; KINETICS; SMOKING; MODELS; SYSTEM; dose-related reference range; elimination pathway table; TDM 9-field-board; clinical-pharmacological TDM report; KONBEST (1)
CONSENSUS GUIDELINES; SCHIZOPHRENIA; SMOKING; AUGMENTATION; EFFICACY; SERUM; NEUROPSYCHOPHARMACOLOGY; DEPRESSION; CLEARANCE; INDUCTION; clozapine; pharmacokinetics; sertraline; smoking; therapeutic drug monitoring (1)
CONSENSUS RECOMMENDATIONS; PROTOCOL; brain; feasibility; MRI; response; validation (1)
CONSENSUS REPORT; DENTAL-CARIES; METAANALYSIS; ASSOCIATION; WORKSHOP; DISEASES; TOBACCO; HEALTH; BIAS; cannabis; confounding; Mendelian randomization; periodontitis; risk factors (1)
CONSENSUS STATEMENT; SPORTS INJURIES; TEAM PHYSICIAN; PLAYERS; MEDICINE; BAG; Youth football; Soccer; First aid; Injury; Prevention; Team coach (1)
CONSEQUENCES; HIBERNATION; SELECTION; LIFE; Altitude; colony founding; polygyny; queen number; Temnothorax rugatulus (1)
CONSERVATION GENETICS; MARGINAL POPULATIONS; RAPD PHYLOGEOGRAPHY; ARBITRARY PRIMERS; PLANT; DIVERSITY; ALPS; OPPOSITIFOLIA; VARIABILITY; SURVIVAL; AMOVA; fragmentation; glaciations; population genetics; RAPD analysis (1)
CONSERVATION MANAGEMENT; VEGETATION MANAGEMENT; LAND-USE; BIODIVERSITY; FENS; LANDSCAPES; PERCEPTION; IMPACT; Ethnoecology; Traditional management; Knowledge preservation; Cultural landscape; Conservation area; Lowland river meadows (1)
CONSERVATION MEASURES; DETACHED HOUSES; SAVING MEASURES; Energy policy; Energy efficiency measures; Sustainable buildings; Energy costs; Financial analysis; Property value (1)
CONSERVATIVE TREATMENT; FLOATING SHOULDER; IPSILATERAL FRACTURES; INTERNAL-FIXATION; OPEN REDUCTION; GLENOID NECK; CLAVICLE; MANAGEMENT; BODY; SERIES; Scapula; scapula neck fracture; meta-analysis; surgery; treatment; nonoperative treatment; comparison of procedures (1)
CONSERVED DOMAIN DATABASE; HOUSE-DUST; BRONCHIAL-ASTHMA; RECOMBINANT; IMMUNOTHERAPY; DER-P-1; CDNA; GUT; CHITINASES; EXPRESSION; (1)
CONSERVED NONCODING SEQUENCES; HUMAN GENOME; RAB GTPASES; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; PROTEIN EVOLUTION; GENE LOSS; ASSOCIATION; EXPRESSION; DROSOPHILA; (1)
CONSERVING SURGERY; RADIATION-THERAPY; FOLLOW-UP; RECURRENCE; WOMEN; IRRADIATION; LUMPECTOMY; TAMOXIFEN; MASTECTOMY; PROGNOSIS; Radiotherapy; Breast cancer; Overall survival; Recurrence-free survival; Cancer registry (1)
consistency algorithm numeric constraint satisfaction problem short paper numeric csps mathematical expression ternary constraint exponential complexity unnecessary variable common procedure constraint satisfaction problem arity csps csp arity low arity csps several consistency algorithm present algorithm high arity csps original csp constraint satisfaction theoretical view much work discrete domain introduced auxiliary variable auxiliary variable binary csps binary operator binary form (1)
CONSISTENT COVARIANCE-MATRIX; INTERNAL MIGRATION; ASYMMETRIC SHOCKS; PANEL-DATA; UNEMPLOYMENT; MOBILITY; Interregional migration; Kazakhstan; Gravity model (1)
CONSTANT DEPENDENCE; CFT PLASMA; AdS-CFT Correspondence; Holography and quark-gluon plasmas; Black Holes in String Theory; Gauge-gravity correspondence (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; NEVEU MODEL; SYMMETRY; GROSS; (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; NEVEU MODEL; SYMMETRY; TRANSITION; GROSS; QCD; (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; PHASE-TRANSITION; CHIRAL-SYMMETRY; NEVEU MODEL; TEMPERATURE; THERMODYNAMICS; PARTICLE; GAUGE; GROSS; (1)
CONSTANT MEAN-CURVATURE; STATIONARY SOLUTIONS; CAPILLARY SURFACES; EQUATIONS; MOTION; FLOW; Partial differential equations on manifolds; surface diffusion; linearized stability of stationary solutions; gradient flow; msc (2010) 35G30; 35R35; 35B35 (1)
CONSTITUENTS; DERIVATIVES; (1)
CONSTITUENTS; Uvaria grandiflora; polyoxygenated cyclohexanes; antitubercular; cytotoxic (1)
constitutional identity; application of the Charter of Fundamental Rights of the EU; primacy of supranational law; human dignity; intangibility clause; fundamental State structures (1)
Constitutional Law, Federal Constitutional Court; areas of law; Topic Modeling; computer-assisted methods (1)
CONSTITUTIVE ACTIVITY; RECEPTOR ANTAGONIST; ACHE INHIBITOR; POTENT; DIZOCILPINE; SELECTIVITY; BRET; (1)
constitutive activity, Sf9 cells, ligand binding, H4 receptor, H4 receptor orthologs, histamine, site-directed mutagenesis, GTP(gamma)S binding, radioligand binding, JNJ7777120, clozapine, isoloxapine, VUF8430, immepip, clobenpropit, thioperamide, UR-PI376, UR-PI294 (1)
CONSTITUTIVE ANDROSTANE RECEPTOR; ACTIVATED PROTEIN-KINASE; COA REDUCTASE INHIBITORS; HUMAN HEPATOCYTES; LACTONE FORMS; MDR1 EXPRESSION; P-GLYCOPROTEIN; ACID; PHARMACOKINETICS; VARIANTS; atorvastatin; metabolites; para-hydroxy atorvastatin; PXR; CAR; induction; drug interaction (1)
CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; IN-VITRO COCKTAIL; HUMAN LIVER; REDUCTASE INHIBITORS; DRUG-INTERACTIONS; RAT HEPATOCYTES; EXPRESSION; METABOLISM; CYP2B6; (1)
CONSTITUTIVELY ACTIVATING MUTATION; PROTEIN-COUPLED RECEPTORS; IN-VITRO PHARMACOLOGY; H-1 RECEPTOR; INVERSE AGONISM; MOLECULAR-CLONING; BINDING-SITE; INTRINSIC ACTIVITY; MESSENGER-RNA; UP-REGULATION; (1)
CONSTRUCTION; TOMOGRAPHY; medical education; digitalization; PET/CT; eLearning; usability (1)
CONSTRUCTIVE INTERFERENCE; CISTERNAL SEGMENT; INNER-EAR; MP-RAGE; ENHANCEMENT; SEQUENCES; IMAGES; MRI; optic nerve; oculomotor nerve; trochlear nerve; abducens nerve (1)
CONSTRUCTIVIST PERSPECTIVE; SELF-DETERMINATION; BELIEFS; MATHEMATICS; EDUCATION; KNOWLEDGE; SCIENCE; primary education; research into teaching and learning; teachers' concepts; perceptions of self-determination; interest (1)
CONSTRUCTS; FRAMEWORK; PSYCHOPATHOLOGY; SCHIZOPHRENIA; OPPORTUNITIES; ANHEDONIA; VERSION; Diagnosis and classification; Research Domain Criteria; PD-CAN; Confirmatory factor analysis CFA; RDoC; Transdiagnostic (1)
; Consultation; Data sharing; Legislation (1)
Consultation Data sharing Legislation (1)
CONSULTATION; OUTCOMES; UNIT; Acute medicine; Intensive care; Palliative care; Quality of life; Timely integration (2)
CONSULTATION; UNIT (1)
consumatori, indicazioni geografiche ingannevoli, strumenti stragiudiziali, Verbraucher, irreführende geografische Herkunftsangaben, außergerichtliche Streitbeilegungsmittel (1)
Consumer health information; Health services research; Internet; Robotic surgery; Urology (1)
Consumer Orientation, B2B-Demand, Market Orientation, Market Structure (1)
CONSUMERS SEARCH; BEHAVIOR; INTERNET; MODEL; WEB; Topic models; Latent Dirichlet allocation; Internet usage behavior; Behavioral segmentation (1)
CONSUMPTION; BURDEN; Guideline; Alcohol; Alcohol use disorder (1)
CONSUMPTION GROWTH; PUBLICATION BIAS; LIFE-CYCLE; LONG-RUN; METAANALYSIS; REGRESSION; BEHAVIOR; PRIORS; DETERMINANTS; ELASTICITIES; Elasticity of intertemporal substitution; Consumption; Meta-analysis; Bayesian model averaging (1)
CONTACT-DERMATITIS; CARPE; DISEASE; EPIDEMIOLOGY; SEVERITY; LIFE; CARPE; Health service research; Disease burden; Healthcare situation; Routine care (1)
CONTACT-DERMATITIS; HAIRDRESSERS; ammonium persulphate; occupational disease; hairdresser; anaphylaxis (1)
CONTACT-FREE INACTIVATION; ARGON PLASMA; CHRONIC WOUNDS; PROPIONIBACTERIUM-ACNES; PRESSURE PLASMA; acne; antibiotic resistance; CAP; cold plasma (1)
contact interaction, quantum chaos, canonical ensemble, few-body systems (1)
CONTACTLESS CONDUCTIVITY DETECTION; COMPREHENSIVE 2-DIMENSIONAL SYSTEM; FLOW GATING INTERFACE; SAMPLE INTRODUCTION; LIQUID-CHROMATOGRAPHY; ZONE-ELECTROPHORESIS; FIELD STRENGTHS; MICROCOLUMN-LC; INJECTION; CZE; Capillary electrophoresis; Fast electrophoretic separations; High-throughput analysis; Microfluidics; Short capillaries (1)
CONTACTLESS CONDUCTIVITY DETECTION; ELECTROCHEMICAL DETECTION; MICROCHIP ELECTROPHORESIS; ZONE-ELECTROPHORESIS; MASS-SPECTROMETRY; BATCH INJECTION; SEPARATION; FLUORESCENCE; DICLOFENAC; CE; Capacitively coupled contactless conductivity detection; Capillary electrophoresis; Dual detection; Mass spectrometry; Phenols (1)
CONTACTLESS CONDUCTIVITY DETECTION; INDIRECT AMPEROMETRIC DETECTION; IONIZATION MASS-SPECTROMETRY; ZONE-ELECTROPHORESIS; AMINO-ACIDS; CARBON NANOTUBES; ELECTROMEMBRANE EXTRACTION; ISOLATED POTENTIOSTAT; MICROFLUIDIC DEVICE; COMPOSITE ELECTRODE; Amperometric detection; Capillary electrophoresis; Contactless conductivity detection; Electrochemical methods; Electrochemically assisted injection; Hyphenated methods; Mass spectrometry; Microchip electrophoresis (1)
CONTACTLESS CONDUCTIVITY DETECTION; MASS-SPECTROMETRIC DETECTION; ELECTROCHEMICAL DETECTION; SYSTEM; TRENDS; capillary electrophoresis; dead volume-free; dual detection; flow splitting; various capillaries inside diameter (1)
contactless monitoring; pediatric respiratory diseases; artificial intelligence; time-of-flight measurement; polysomnography; sleep medicine (1)
contact, MoS₂, nanotubes, optimization, transition metal dichalcogenides, transfer (1)
CONTACT SEX-PHEROMONE; AGRILUS-PLANIPENNIS FAIRMAIRE; EMERALD ASH BORER; HYDROCARBONS; HYMENOPTERA; COLEOPTERA; COURTSHIP; MIMICRY; BETHYLIDAE; COMPONENT; contact sex pheromone; cuticular hydrocarbons (CHCs); host shift; parasitic wasp (1)
CONTACT SEX-PHEROMONE; BREEDING STATUS; PARENTAL CARE; INSECT HYDROCARBONS; PARASITIC WASP; COMPONENTS; EVOLUTION; SELECTION; BEHAVIOR; FEMALES; Nicrophorus vespilloides; Burying beetle; Cuticular hydrocarbons; Cuticular lipids; Parental care; Mate recognition (1)
CONTACT SEX-PHEROMONE; COURTSHIP BEHAVIOR; VITRIPENNIS HYMENOPTERA; MATING-BEHAVIOR; CYTOPLASMIC INCOMPATIBILITY; LARIOPHAGUS-DISTINGUENDUS; CUTICULAR HYDROCARBONS; INSECT CUTICLE; NORTH-AMERICA; HOST GENOTYPE; parasitic wasp; chemical communication; cuticular hydrocarbons; pheromone; reproductive isolation; species discrimination; Hymenoptera; Pteromalidae (1)
CONTACT SEX-PHEROMONE; CUTICULAR LIPIDS; MASS-SPECTROMETRY; SURFACE-LIPIDS; CHEMICAL-COMPOSITION; EPICUTICULAR LIPIDS; QUEENLESS ANT; HYDROCARBONS; BEETLE; MICROEXTRACTION; Cuticular triacylglycerides; Non-volatile fatty acid derivatives; Fatty acid methyl ester; Solid phase micro extraction; Trimethyl sulfonium hydroxide; Sex pheromone (1)
CONTACT SEX-PHEROMONE; SLAVE-MAKING ANT; AGGREGATION PHEROMONE; POLYERGUS-BREVICEPS; NASONIA-VITRIPENNIS; HOST SELECTION; IDENTIFICATION; BRACONIDAE; HYMENOPTERA; COLEOPTERA; Asobara tabida; Parasitoid wasp; Sex pheromone; Methyl 6-methylsalicylate; Fatty alcohol acetate; Cuticular hydrocarbons; Sensory exploitation (1)
CONTACT; TENSION; TENDON; TEARS; Rotator cuff; Cuff repair; Single-row; Biomechanics (1)
contact-tracing app, acceptance barriers, technology acceptance model (1)
CONTAGION; TRANSMISSION; UNCERTAINTY; RETURN; TESTS; RISK; Exchange rates; New EU forex markets; Volatility; DCC model; Volatility spillover index; Portfolio weights and hedge ratios; EU debt crisis; Global financial crisis (1)
Contagion, Vulnerability, Identification, Smooth Transition Regression (1)
CONTAINING CELLS; GENE-EXPRESSION; JUXTAGLOMERULAR APPARATUS; RESPONSIVE ELEMENT; FETAL DEVELOPMENT; STIMULATED RENIN; MESSENGER-RNA; RAT KIDNEYS; INHIBITION; MOUSE; fetal kidney; transgenic mice (1)
CONTAINING GEMINI SURFACTANTS; IONIC LIQUIDS; HOFMEISTER SERIES; PHASE-BEHAVIOR; DRUG-DELIVERY; CYTOTOXICITY; MICELLES; SIZE; BIODEGRADATION; ENCAPSULATION; Choline surfactants; Ectoine surfactants; Catanionic vesicles; Cytotoxicity; Biodegradability (1)
CONTAINING PHOSPHOCARRIER PROTEIN; AQUEOUS-SOLUTIONS; SENSITIVITY; SUPPRESSION; RELAXATION; EXCHANGE; SPECTRA; C-13; (1)
CONTAINING PHOSPHOCARRIER PROTEIN; LIPID TRANSFER PROTEIN; LASER-POLARIZED XENON; XE-129 NMR; HYDROPHOBIC CAVITY; CHEMICAL-SHIFT; SYSTEM; MUTANT; WATER; I14A (1)
CONTAINING PHOSPHOCARRIER PROTEIN; MOLECULAR-DYNAMICS SIMULATION; HYDROGEN-BOND LENGTH; PHOSPHOTRANSFERASE SYSTEM; CHEMICAL-SHIFTS; SECONDARY STRUCTURE; BACILLUS-SUBTILIS; PTSH GENE; SPECTROSCOPY; LYSOZYME; high pressure; histidine containing protein; HPr; NMR spectroscopy; phosphoenolpyruvate dependent; phosphotransferase system; PTS (1)
CONTAINING PHOSPHOCARRIER PROTEIN; POTENTIAL FUNCTIONS; NMR-SPECTROSCOPY; RAS PROTEIN; CRYSTALLOGRAPHY; PREDICTION; RESOLUTION; CRYSTALS; FAECALIS; DATABASE; Chemical shift; Solution structure; Structural ensemble (1)
CONTAINING PHOSPHOCARRIER PROTEIN; PROLIFERATOR-ACTIVATED RECEPTORS; NMR STRUCTURE CALCULATION; LIGAND-BINDING DOMAIN; STRUCTURE PREDICTION; STAPHYLOCOCCUS-CARNOSUS; STRUCTURAL GENOMICS; 3-DIMENSIONAL STRUCTURE; RESOLUTION STRUCTURE; SEQUENCE ALIGNMENT; (2)
CONTAINING PHOSPHOCARRIER PROTEIN; SIGNAL CLASS RECOGNITION; STAPHYLOCOCCUS-CARNOSUS; AUTOMATED ASSIGNMENT; BAYESIAN METHOD; CROSS PEAKS; PROGRAM; N-15; HPR; Chemical shift; Peak assignment; Multidimensional NMR spectra; AUREMOL (1)
CONTAINING PHOSPHOCARRIER PROTEIN; TORSION ANGLE DYNAMICS; PREDICTION; DOMAIN; SYSTEM; (1)
; containment; COVID19; hygiene; outbreak; pediatric; SARS-CoV-2 (1)
CONTEMPORARY-AMERICAN-ENGLISH; WORD CORPUS; METAANALYSIS; LINGUISTICS; RETHINKING; CULTURE; CONTEXT; MODEL; Gifted and talented; gifted education; talent development; mentoring; quantitative text analysis; nonreactive measures (1)
CONTEMPORARY CONSIDERATIONS; STRUCTURAL DEVELOPMENT; DECISION-MAKING; PART 3; ETHICATT; MEDICINE; HISTORY; Awareness; Empathy; Relatives; Communication; End of life care (1)
; Contemporary heritage; Nuclear physics; Research reactor; Material culture; Teaching history of science; Commemorative practices (1)
CONTENT-INDUCED DELAY; PUBERTAL DEVELOPMENT; OFFENDERS; PREFERENCES; RECIDIVISM; VICTIMS; SCALE; Attention; Choice reaction time; CRT; Paraphilia; Pedophilia (1)
Context-aware, context interdependencies, service selection, decomposition of constraints, local selection (1)
Context Awareness; Business Process Modeling; Automated Planning (1)
CONTEXT-CHANGE; RETENTION INTERVAL; CHANGE ACCOUNT; GENERATION; SUBSEQUENT; SELECTION; MODEL; Recall; Retrieval practice; Semantic generation; Retention interval; Lag (1)
CONTEXT-CHANGE; RETRIEVAL; INHIBITION; MODEL; PART; List-method directed forgetting; Delay; Mental context change; Selective rehearsal (1)
Context; Collaborative filtering; Recommender system; Mobile applications; User study (1)
CONTEXT-SENSITIVITY; URBAN-ENVIRONMENT; EYE-MOVEMENTS; COGNITION; AMERICAN; JAPANESE; OBJECT; analytic and holistic perception; child development; culture-specific attention; eye tracking; maternal attention guidance; social transmission (1)
context specific proportion congruency, aversive signals, conflict adaptation (1)
CONTEXTUAL INTERFERENCE; EXECUTIVE-CONTROL; COGNITIVE CONTROL; RETENTION; METAANALYSIS; RECONFIGURATION; FACILITATION; VARIABILITY; ACQUISITION; DURATION; (1)
; contextual multi-armed bandits; mHealth for tinnitus; EMA prediction; similarity-based prediction; prediction on sparse data; prediction on time series with gaps; prediction in mHealth data (1)
CONTINGENT ATTENTIONAL CAPTURE; POSTERIOR PARIETAL CORTEX; VISUAL-ATTENTION; CEREBRAL-CORTEX; SEARCH; MECHANISMS; INTERFERENCE; DISSOCIATION; INVOLVEMENT; SPOTLIGHT; Selection; Filtering; Distraction; Functional magnetic resonance imaging; Attention (1)
Continual learning, Medical data drift, Domain shift, Concept drift, Medical image analysis Histopathology Radiology (1)
CONTINUAL REASSESSMENT METHOD; POSTMENOPAUSAL WOMEN; PRACTICAL DESIGN; FULVESTRANT; CANCER; DRUG; ANASTROZOLE; ATTRITION; EFFICACY; Efficient trials; Model-based designs; Dose-determination (1)
CONTINUING-MEDICAL-EDUCATION; NURSES KNOWLEDGE; CANCER PAIN; CARE; BARRIERS; FACULTIES; ATTITUDES; STUDENTS; THERAPY; WORKING; Pain management; Education; continuing; Education, interprofessional; Interprofessional working; Regensburg model (1)
CONTINUOUS ENANTIOSELECTIVE HYDROGENATION; SUPPORTED CHIRAL CATALYSTS; BETA-AMINO ALCOHOLS; IONIC LIQUID-PHASE; ORGANIC-SYNTHESIS; MICROREACTOR SYSTEM; MICRO REACTORS; ASYMMETRIC CATALYSIS; CHEMICAL-SYNTHESIS; SYNTHETIC CHEMIST; flow chemistry; homogeneous catalysis; ionic liquids; magnetic properties; microreactors (1)
CONTINUOUS-FLOW CONDITIONS; COUPLING REACTIONS; PD NANOPARTICLES; SELECTIVE HYDROGENATION; METAL NANOPARTICLES; ORGANIC-SYNTHESIS; COMPLEXES; FINE; ACETYLENE; CHEMICALS; (1)
Continuous flow · Photochemistry · Teaching labs · Programming · Organic synthesis (1)
CONTINUOUS-FLOW; SUPPORTED ORGANOCATALYST; RECOVERABLE CATALYSTS; KINETIC RESOLUTION; ETHYL DIAZOACETATE; POLYSTYRENE RESIN; ORGANIC-SYNTHESIS; TERMINAL ALKYNES; SOLUBLE POLYMERS; IMMOBILIZATION; copper-catalyzed azide-alkyne [3+2]?cycloaddition "click" reaction; CuAAC; iron porphyrin; olefination; polyethylene glycol (PEG); supported catalysts (1)
CONTINUOUS-INFUSION 5-FLUOROURACIL; PHASE-II; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; GASTROINTESTINAL-TRACT; PROGNOSTIC FACTORS; FOLINIC ACID; CISPLATIN; CARCINOMA; TRIAL; advanced gastric cancer; multimodal treatment; neoadjuvant chemotherapy (2)
; continuous infusion; cardiovascular drugs; syringe pumps; adverse effects (1)
CONTINUOUS PERFORMANCE-TEST; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; SUSTAINED ATTENTION; RESPONSE-INHIBITION; NORMATIVE DATA; CHILDREN; ADHD; DYSFUNCTION; INTERVENTION; ADHD; attentional functioning; adults; methylphenidate (1)
CONTINUOUS PERFORMANCE-TEST; DEFICIT/HYPERACTIVITY DISORDER; REALITY; VALIDITY; INHIBITION; TIME; IMPULSIVENESS; VARIABILITY; DIAGNOSIS; TASK; ADHD; continuous performance test; virtual reality classroom; methylphenidate (1)
CONTINUOUS PERFORMANCE-TEST; STIMULANT MEDICATION; SUSTAINED ATTENTION; ADHD CHILDREN; REACTION-TIME; VALIDITY; BEHAVIOR; POWER; TASK; GENE; ADHD; methylphenidate; alertness; vigilance; selective attention; divided attention; flexibility (1)
CONTINUOUS PERFORMANCE-TEST; SUSTAINED ATTENTION; DEFICIT DISORDER; DEFICIT/HYPERACTIVITY DISORDER; HYPERKINETIC CHILDREN; RESEARCH CRITERIA; TEACHERS RATINGS; ACTIVITY LEVEL; REACTION-TIME; METHYLPHENIDATE; ADHD; divided attention; flexibility; selective attention; alertness (1)
Continuous response, Patient benefit, Rare disease, Sequential design (1)
Continuous-time Markov chains · Bayesian inference · Uniformization · Matrix exponential · Tensors · Epidemic spread (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; CONTINUOUS-INFUSION; CYSTIC-FIBROSIS; BETA-LACTAMS; HEMODIAFILTRATION; STABILITY; FAILURE; DOSAGE; SERUM; meropenem; beta-lactam antibiotics; continuous infusion; pharmacokinetics; CVVHD; renal replacement therapy; pharmacodynamics (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; ECHINOCANDIN ANTIFUNGAL; PHARMACOKINETICS; CASPOFUNGIN; MICAFUNGIN; SUSCEPTIBILITY; ASPERGILLUS; CLEARANCE; DRUGS; PHARMACODYNAMICS; Renal replacement therapy; Echinocandins; Artificial membranes (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENTS; CLINICAL PHARMACOKINETICS; levofloxacin; pharmacokinetics; renal failure; continuous veno-venous hemofiltration (1)
CONTINUUM-LIMIT; LATTICE; SPACE; (1)
CONTINUUM-LIMIT; PERTURBATION-THEORY; LATTICE THEORIES; QCD; Lattice Quantum Field Theory; Supersymmetric gauge theory (1)
contour erasure, two-alternative forced choice (2AFC), filling-in, spatiotemporal properties (1)
CONTOUR INTEGRATION; SYMMETRY DETECTION; SPATIAL-FREQUENCY; BLUE-YELLOW; RED-GREEN; LUMINANCE; VISION; ORIENTATION; DISCRIMINATION; SELECTIVITY; (1)
CONTRACTILE DYSFUNCTION; WALL-MOTION; SHORT-TERM; INFARCTION; REGIONS; EVOLUTION; MICE; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Non-infarcted myocardium; Late enhancement imaging (1)
contract R&D; research and development; supplier opportunism; compensation preferences; negotiation power; resource dependence theory; continuous compensation; suppliers; cooperation; intellectual property rights; IPR (1)
CONTRACTS; Electricity; Forwards; Futures (1)
CONTRACTURE; TISSUE; CLASSIFICATION; SURGERY; Breast implants; Foreign body response; Capsular fibrosis; Cellular behavior; Scanning electron microscopy; Transmission electron microscopy (1)
CONTRALATERAL BREAST-CANCER; BILATERAL MASTECTOMY; EPITHELIAL LESIONS; RISK; WOMEN; MAMMOGRAPHY; EFFICACY; SMOKING; CARCINOMA; REDUCTION; breast cancer; BRCA1; prophylactic mastectomy; pre-malignant lesions; malignant lesions (1)
CONTRALATERAL HIP-FRACTURES; FEMORAL-NECK FRACTURES; ELDERLY-PATIENTS; MORTALITY; RISK; COHORT; Proximal femoral fracture; Contralateral femoral fracture; Outcome (1)
CONTRALATERAL PROPHYLACTIC MASTECTOMY; BREAST RECONSTRUCTION; PATIENT SATISFACTION; PERFORATOR FLAPS; FAMILY-HISTORY; CANCER; WOMEN; RISK; EFFICACY; STAGE; Breast reconstruction; Autologous; DIEP Flap; Bilateral (1)
Contrast adaptation; Gain control; Contrast thresholds; Retinal eccentricity (1)
contrast agent; gold; hybrid; PLGA; polymeric nanoparticles; TEM (1)
CONTRAST AGENT; HEPATOBILIARY-PHASE; HEPATIC-UPTAKE; HEPATOCELLULAR-CARCINOMA; MOLECULAR-MECHANISMS; GADOXETATE DISODIUM; GADOLINIUM CHELATE; SIGNAL INTENSITY; 3 TESLA; CIRRHOSIS; (1)
CONTRAST AGENT; IN-VIVO; RESONANCE; IRON; ATHEROSCLEROSIS; VISUALIZATION; ACQUISITION; PERFUSION; EP-2104R; RECOVERY; cardiovascular; molecular imaging; MRI; compressed sensing; undersampling (1)
contrast agent; ultrasonography; liver; intervention; microvascularization (1)
contrast approxn small angle neutron scattering nonaq electrolyte small angle neutron scattering (1)
CONTRAST-DEFINED LETTERS; ANISOMETROPIC AMBLYOPIA; SPATIAL INTERACTIONS; JUVENILE AMBLYOPIA; ACUITY; ORIENTATION; IMPROVEMENT; PLASTICITY; VISION; CORTEX; amblyopia; visual acuity; contrast sensitivity; perceptual learning; lateral masking; tRNS (1)
CONTRAST-DEFINED LETTERS; SPATIAL-FREQUENCY; VISUAL-ACUITY; TEXTURE-DISCRIMINATION; ADULT AMBLYOPIA; HUMAN VISION; FACILITATION; ARCHITECTURE; ORIENTATION; SPECIFICITY; Visual perceptual learning; Myopia; Lateral interactions; Visual acuity; Contrast sensitivity (1)
contrast discrimination; adaptation; Parkinson’s disease; multiple system atrophy; neurodegenerative diseases (1)
Contrast discrimination, Electroretinogram, Visual evoked potentials, Parkinson's disease, Neurodegenerative diseases (1)
contrast-enhanced computed tomography, preoperative imaging, soluble CD46, steatotic liver disease, surgery complications (1)
CONTRAST-ENHANCED ULTRASOUND; ANTEROLATERAL THIGH FLAP; CUTANEOUS PERFORATORS; PREOPERATIVE ASSESSMENT; DIAGNOSTIC EFFICACY; DOPPLER; ULTRASONOGRAPHY; RECONSTRUCTION; ultrasound; perforator flap; perforator mapping (1)
CONTRAST-ENHANCED ULTRASOUND; CHRONIC VIRAL-HEPATITIS; PORTAL-HYPERTENSION; DOPPLER SONOGRAPHY; TRANSIT-TIME; BLOOD-FLOW; CIRRHOSIS; DIAGNOSIS; FIBROSIS; PERFUSION; Chronic liver disease; CEUS; ICG-test; microcirculation; liver function (1)
CONTRAST-ENHANCED ULTRASOUND; CLINICAL-PRACTICE RECOMMENDATIONS; TISSUE IMAGING QUANTIFICATION; SHEAR-WAVE ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; EFSUMB GUIDELINES; CEUS; BENIGN; DOPPLER; LIVER; CEUS; shear wave elastography; perfusion; neck metastases; superficial lymph nodes (1)
CONTRAST-ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY CT; RENAL-CELL CARCINOMA; LIVER-TUMORS; HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION TACE; AORTIC ABNORMALITIES; VOLUME NAVIGATION; PROSTATE-CANCER; FOLLOW-UP; Image fusion; Real time imaging; Contrast-enhanced ultrasound; Prostate biopsy; Indications (1)
CONTRAST-ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY; PRACTICE GUIDELINES; DUPLEX ULTRASOUND; VASCULAR-SURGERY; CT ANGIOGRAPHY; 3-D ULTRASOUND; REPAIR; ENDOLEAKS; SURVEILLANCE; Aortic aneurysm diameter; EVAR surveillance; ultrasonographic imaging techniques; 3D ultrasound; 4D ultrasound; image fusion (1)
CONTRAST-ENHANCED ULTRASOUND; CROHNS-DISEASE; MR-ENTEROGRAPHY; CELIAC-DISEASE; FOLLOW-THROUGH; ENTEROCLYSIS; COLONOGRAPHY; ENDOSCOPY; MANAGEMENT; RADIATION; Small bowel; Magnetic resonance imaging; Computed tomography; Small bowel diagnosis (1)
CONTRAST-ENHANCED ULTRASOUND; DEGUM MULTICENTER TRIAL; TRANSIENT ELASTOGRAPHY; RADIOFREQUENCY ABLATION; NONINVASIVE ASSESSMENT; IMAGE FUSION; LESIONS; FIBROSIS; TUMORS; ULTRASONOGRAPHY; Diffuse liver disease; Parenchyma alterations; Ultrasound; Elastography; Contrast-enhanced ultrasound (CEUS) (1)
CONTRAST-ENHANCED ULTRASOUND; DIAGNOSTIC-ACCURACY; CEUS; BENIGN; CEUS; parametric imaging; dynamic vascularization; liver malignancies (1)
CONTRAST-ENHANCED ULTRASOUND; DOPPLER SONOGRAPHY; RECONSTRUCTION; RELIABILITY; SCIP; ultrasonic flap design; microsurgery; CCDS; superficial circumflex iliac artery perforator flap (1)
CONTRAST-ENHANCED-ULTRASOUND; DUPLEX ULTRASOUND; COMPUTED-TOMOGRAPHY; FOLLOW-UP; ENDOLEAK; RECOMMENDATIONS; ANGIOGRAPHY; GUIDELINES; OUTCOMES; SURGERY; aortic aneuyrsm; contrast-enhanced ultrasound; follow-up; endovascular treatment; endoleak (1)
CONTRAST-ENHANCED ULTRASOUND; EFSUMB GUIDELINES; CLINICAL-USE; PORTAL-VEIN; LIVER-DISEASE; RECOMMENDATIONS; ELASTOGRAPHY; UPDATE; ULTRASONOGRAPHY; CIRRHOSIS; Liver vascular imaging; high resolution flow (HR); Glazing Flow; imaging quality; artefact reduction (1)
CONTRAST-ENHANCED ULTRASOUND; FOCAL LIVER-LESIONS; MAGNETIC-RESONANCE; EFSUMB GUIDELINES; CLINICAL-PRACTICE; F-18-FDG PET/CT; NONENHANCED CT; RECOMMENDATIONS; CANCER; CEUS; PET/CT; ultrasound; complementary imaging (1)
CONTRAST-ENHANCED ULTRASOUND; FOCAL NODULAR HYPERPLASIA; DEGUM MULTICENTER TRIAL; CLINICAL-PRACTICE; COMPUTED-TOMOGRAPHY; HEPATOCELLULAR-CARCINOMA; SAFETY; TUMORS; ULTRASONOGRAPHY; COOPERATION; Contrast enhanced ultrasound (CEUS); children; liver; diagnostic value; safety (1)
CONTRAST-ENHANCED ULTRASOUND; HEPATOCELLULAR-CARCINOMA; ARTERIAL CHEMOEMBOLIZATION; HEPATIC-ARTERY; LIVER; CEUS; COMPLICATIONS; CANCER; HCC; DSM; HCC; DSM-TACE; DCE-US; TIC (1)
CONTRAST-ENHANCED ULTRASOUND; HEPATOCELLULAR-CARCINOMA; SURGICAL-TREATMENT; BILE LEAKAGE; COLORECTAL METASTASES; NONCIRRHOTIC PATIENTS; PARTIAL-HEPATECTOMY; SEGMENT-IV; EMBOLIZATION; REMNANT; (1)
CONTRAST-ENHANCED ULTRASOUND; HIGH-RESOLUTION ULTRASOUND; FREE TISSUE TRANSFER; QUANTITATIVE-EVALUATION; BONE MICROCIRCULATION; OXYGEN SENSORS; IN-VIVO; PERFUSION; CEUS; HEAD; Osseocutaneous flap; fibular free flap; mandibular reconstruction; luminescence ratiometric oxygen imaging; contrast-enhanced ultrasound; tissue microcirculation (1)
CONTRAST-ENHANCED ULTRASOUND; INVASIVE BLADDER-CANCER; PROSTATE-CANCER; DIAGNOSTIC-ACCURACY; 3-DIMENSIONAL PRINTERS; RADIOGUIDED SURGERY; RENAL MALIGNANCIES; PHYSICAL MODELS; LYMPH-NODES; METAANALYSIS; Multiparametric MRI; Radiomics; PSMA-PET; PSMA-guided surgery; 3D-Printing; iRECIST (1)
CONTRAST-ENHANCED ULTRASOUND; LIVER METASTASES; BREAST; Intraoperative ultrasound in thoracic surgery; CEUS in thoracic surgery (1)
CONTRAST-ENHANCED ULTRASOUND; LIVER; ULTRASONOGRAPHY; METASTASES; RESECTION; Contrast agent; Color-coded Doppler sonography; Elastography; Liver surgery; Intraoperative imaging (1)
CONTRAST-ENHANCED ULTRASOUND; METASTATIC LYMPH-NODES; PAPILLARY THYROID-CARCINOMA; ASPIRATION-CYTOLOGY; DIAGNOSIS; TISSUE; ACCURACY; ABLATION; SURGERY; LESIONS; (1)
CONTRAST-ENHANCED ULTRASOUND; NODULES; DIFFERENTIATION; BENIGN; RISK; Solid thyroid lesions; high-resolution ultrasound; HR-flow; elastography; CEUS; histopathology (1)
CONTRAST-ENHANCED ULTRASOUND; NODULES; IDENTIFICATION; GUIDELINES; BENIGN; solid thyroid lesions; B-mode; shear-wave elastography; CEUS; histopathology (1)
CONTRAST-ENHANCED ULTRASOUND; OSLER-WEBER-SYNDROME; ROW HELICAL CT; HEPATIC INVOLVEMENT; LIVER INVOLVEMENT; HHT; MICROVASCULARIZATION; DIAGNOSIS; CRITERIA; DISEASE; Hereditary hemorrhagic telangiectasia; Intrahepatic shunts; Contrast-enhanced ultrasound; Time-intensity-curve (1)
CONTRAST-ENHANCED ULTRASOUND; PORPHYRIA-CUTANEA-TARDA; CHRONIC HEPATITIS-C; CLINICAL-PRACTICE RECOMMENDATIONS; FOCAL FATTY INFILTRATION; PERIHEPATIC LYMPH-NODES; I ESGSD-I; CYSTIC-FIBROSIS; WILSONS-DISEASE; IMAGING FINDINGS; guidelines; Wilson's disease; schistosomiasis; PSC; PBC; viral hepatitis; autoimmune hepatitis (1)
CONTRAST-ENHANCED ULTRASOUND; PROSTATE; RECOMMENDATIONS; MANAGEMENT; SUSPICION; FUSION; CEUS; education; ultrasound; economics; medical (1)
CONTRAST-ENHANCED ULTRASOUND; QUANTITATIVE ASSESSMENT; SAFETY; CHILDREN; Contrast-enhanced ultrasound (CEUS); vascular malformations; color-coded perfusion analysis; microcirculation (1)
CONTRAST-ENHANCED ULTRASOUND; RAYLEIGH STATISTICS; MR-MAMMOGRAPHY; CRITERIA; TUMORS; DIFFERENTIATION; BENIGN; EDEMA; CEUS; Ultrasound; breast neoplasms; breast cancer; breast lesion; B mode; ASQ; sonography; diagnostic imaging; halo; peripheral rim; peripheral zone; BI-RADS (1)
CONTRAST-ENHANCED ULTRASOUND; REAL-TIME ELASTOGRAPHY; PERFUSION ANALYSIS; SYSTEMATIC BIOPSY; TARGETED BIOPSY; TISSUE DOPPLER; CEUS; SUSPICION; TUMORS; MEN; Tissue doppler imaging; TRUS; transrectal ultrasound; prostate cancer (1)
CONTRAST-ENHANCED ULTRASOUND; RECONSTRUCTIVE SURGERY; HARMONIC ULTRASOUND; FLAPS; MICROCIRCULATION; VASCULARIZATION; PERFUSION; EFFICACY; DOPPLER; TUMORS; Contrast-enhanced ultrasound; free flap; microcirculation; matrix technologies (1)
CONTRAST-ENHANCED ULTRASOUND; RENAL-CELL CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; HEPATOCELLULAR CARCINOMAS; GUIDED BIOPSY; FOLLOW-UP; TRANSARTERIAL CHEMOEMBOLIZATION; COMPUTED-TOMOGRAPHY; PARTIAL NEPHRECTOMY; Real time imaging; Contrast medium sonography; Ultrasound elastography; Tumor detection; Tumor characterization (1)
CONTRAST-ENHANCED-ULTRASOUND; SPIRAL COMPUTED-TOMOGRAPHY; LIVER-CIRRHOSIS; SONOGRAPHY; CT; DIAGNOSIS; NODULES; LESIONS; MRI; US; chemoembolization; ultrasound; tumor (1)
CONTRAST-ENHANCED ULTRASOUND; TISSUE IMAGING QUANTIFICATION; CERVICAL LYMPH-NODES; DIFFERENTIAL-DIAGNOSIS; SHEARWAVE ELASTOGRAPHY; MALIGNANT-TUMORS; SALIVARY-GLANDS; POWER DOPPLER; B-MODE; ULTRASONOGRAPHY; ultrasound; head-neck-sonography; salivary glands; cervical lymph nodes; imaging (1)
CONTRAST-INDUCED NEPHROPATHY; PREVENTION; ACETYLCYSTEINE; FAILURE; THEOPHYLLINE; acute renal failure; aminoglycoside; radiocontrast agent; non-steroidal antiphlogistic drugs; vancomycin (1)
CONTRAST-INDUCED NEPHROPATHY; TRIPLE-H THERAPY; SEVERE SEPSIS; RINGERS ACETATE; RESUSCITATION; MANAGEMENT; OUTCOMES; COMPLICATIONS; DYSFUNCTION; PREDICTOR; Hydroxyethyl starch solution; 6 % HES 103/ 0.4; Acute kidney injury; Serum creatinine; Aneurysmal subarachnoid hemorrhage; Cerebral vasospasm; Delayed cerebral ischemia; Neurosurgical intensive care (1)
CONTRAST SENSITIVITY FUNCTION; SPATIAL-FREQUENCY; VISUAL-CORTEX; LETTER IDENTIFICATION; MOTION DISCRIMINATION; LATERAL INTERACTIONS; PERIPHERAL-VISION; ADULT AMBLYOPIA; VERNIER ACUITY; ORIENTATION; Low myopia; perceptual learning; lateral interactions; contrast sensitivity; visual acuity (1)
Control; Customer loyalty; Customer satisfaction; Direct selling; Strategic planning (1)
CONTROLLABILITY; SYSTEM; Vlasov-Poisson equation; Optimal control with PDE constraints; Nonlinear partial differential equations; Calculus of variations (1)
CONTROLLED ANTIBODY RELEASE; DIELS-ALDER HYDROGELS; SUSTAINED-RELEASE; POLYVINYL-ALCOHOL) HYDROGELS; BIOORTHOGONAL REACTIONS; POLY(ETHYLENE GLYCOL); INJECTABLE HYDROGELS; GROWTH-FACTOR; MESH SIZE; DELIVERY; (1)
CONTROLLED-CLINICAL-TRIAL; CARDIOVASCULAR-DISEASE; COMPLEMENTARY THERAPY; PSYCHOLOGICAL STRESS; QUESTIONNAIRE PSQ; PHYSICAL-ACTIVITY; HEALTH-BENEFITS; GUIDED IMAGERY; RISK-FACTOR; LIFE-SPAN; stress; stress reduction; functional relaxation; psychoeducation; randomized controlled trial (1)
CONTROLLED CLINICAL-TRIAL; HUMAN INFRABONY DEFECTS; II FURCATION DEFECTS; LONG-TERM STABILITY; PERIODONTAL REGENERATION; BARRIER MEMBRANES; BACTERIAL-COLONIZATION; BIODEGRADABLE BARRIERS; BIOABSORBABLE BARRIERS; ATTACHMENT FORMATION; guided tissue regeneration; intrabony defects; microbiology; periodontal disease surgery; polydioxanon; polylactic acid; subtraction radiography (1)
CONTROLLED CORTICAL IMPACT; CEREBELLAR GRANULE CELLS; FACTOR PEDF; GROWTH-FACTOR; HEAD-INJURY; RAT; PROLIFERATION; MODEL; BDNF; EXPRESSION; PEDF; traumatic brain injury; cell death; microglia; SVZ (1)
CONTROLLED MILD HYPOTHERMIA; LARGE SCALD BURNS; RAT MODEL; SURVIVAL; TEMPERATURE; MORTALITY; VICTIMS; (1)
CONTROLLED-RELEASE POLYMERS; INTERSTITIAL CHEMOTHERAPY; DELIVERY; EROSION; BRAIN; POLYANHYDRIDES; DEGRADATION; GLIOMAS; TRIAL; brain cancer; vaccination; programmable release; biodegradable polymer; pulsatile release (1)
CONTROLLED-RELEASE; STABILIZATION; MICROSPHERES; lactic acid; oligomers; atrial natriuretic peptide; stability; acylation (1)
CONTROLLED-TRIAL; ANEURYSM REPAIR; EDITORS CHOICE; ACCESS; METAANALYSIS; ProGlide; suture-mediated closure device; endovascular; aortic repair; percutaneous (1)
CONTROLLED-TRIAL; COMMITMENT THERAPY; TREATING TINNITUS; COGNITIVE THERAPY; MEDITATION; DEPRESSION; METAANALYSIS; ACCEPTANCE; GENERATION; MANAGEMENT; Subjective tinnitus; Mindfulness-based therapy; Somatoform disorders; Self-management (1)
CONTROLLED-TRIAL; ELECTROCONVULSIVE-THERAPY; REFRACTORY SCHIZOPHRENIA; AUGMENTATION STRATEGIES; PREFRONTAL CORTEX; BRAIN-STIMULATION; RTMS; HALLUCINATIONS; METAANALYSIS; GUIDELINES; Schizophrenia; Repetitive transcranial magnetic stimulation; PANSS; Clozapine; Randomized-controlled trial (1)
CONTROLLED-TRIALS; author guidelines; CONSORT guidelines; data sharing; ethical approval; informed consent; ob-gyn journals; randomized controlled trial; registration; quality criteria (1)
CONTROLLED TRIALS; CLINICAL-TRIALS; ISSUES; DECLARATION; HELSINKI; CHILDREN; DESIGN; HEALTH; clinical trials; ethics; migraine; placebo; research design (1)
CONTROLLED TRIAL; TENNIS ELBOW; DOUBLE-BLIND; ESWT; TENDINITIS (1)
CONTROLLED-TRIAL; WITHDRAWAL-SYMPTOMS; EFFICACY; DETOXIFICATION; COMBINATION; DEPENDENCE; NALMEFENE; MULTICENTER; COMORBIDITY; GABAPENTIN; Alcohol-related disorders; Treatment guidelines; Evidence based medicine; Treatment prevalence; Withdrawal treatment (1)
Controlling (1)
Controlling, Kennzahlen, Kennzahlenbeziehungen (1)
Controlling, Kostenrechnung, Kennzahlen (1)
Controlling, Performance, Verkehr, ÖPNV (1)
CONTROLLING POSITION; DISTRACTION; SEGMENT; Le Fort III; distraction; vector; anchorage; three-dimensional computed tomography analysis (1)
CONTROL MODEL; ROLES; REFINEMENT; DISCOVERY; USER; RBAC; Access Management; Data quality; Policy optimization; Policy maintenance; Role-Based Access Control; Attribute-Based Access Control (1)
; control system; impulse-frequency response; potential bounds; variational method; partial ordering (1)
Convective Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Dynamic contact angle, Moving contact line (1)
Convective Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Strong solutions, Separation property, Yosida approximation (1)
CONVENIENT ROUTE; PHOSPHORUS; CHEMISTRY; DERIVATIVES; COMPLEXES; DICATIONS; BORANE; SALTS; PHOSPHANES; BONDS; arsenic; boron; cationic chains; phosphorus; pnictogenylboranes (1)
CONVENIENT SYNTHESIS; IMATINIB MESYLATE; STRUCTURAL BASIS; LEUKEMIA-CELLS; DOMAIN; ABL; TRANSFORMATION; ANGIOGENESIS; DERIVATIVES; STI-571; (1)
CONVENTIONAL CARDIOPULMONARY-RESUSCITATION; NEURON-SPECIFIC ENOLASE; CARDIAC-ARREST; MEMBRANE-OXYGENATION; IMPACT; METAANALYSIS; HYPOTHERMIA; MORTALITY; ADULTS; PUMPS; hemolysis; plasma-free-hemoglobin; cardiogenic shock; resuscitation; ECPR; ECLS (1)
CONVENTIONAL CARE REGIMENS; ELDERLY-PATIENTS; DNMT3A MUTATIONS; DNA METHYLATION; OPEN-LABEL; PHASE-III; 5-AZACYTIDINE; OUTCOMES; RECOMMENDATIONS; DECITABINE; (1)
CONVENTIONAL COLONOSCOPY; CT COLONOGRAPHY; VIRTUAL COLONOSCOPY; IMAGING METHODS; FEASIBILITY; PREFERENCES; TOMOGRAPHY; ACCEPTANCE; colonography; colonoscopy; Crohn's disease; enteroclysis; magnetic resonance imaging; small bowel (1)
CONVENTIONAL RADIOGRAPHY; BONE EROSIONS; ULTRASONOGRAPHY; classification; diagnostic criteria; rheumatoid arthritis; sonography; ultrasound (1)
CONVENTIONAL RADIOGRAPHY; DOPPLER ULTRASOUND; BONE EROSIONS; FINGER JOINTS; ULTRASONOGRAPHY; VASCULARIZATION; classification; diagnostic criteria; rheumatoid arthritis; sonography; ultrasound (1)
CONVENTIONAL RADIOGRAPHY; DOPPLER ULTRASOUND; DISEASE-ACTIVITY; FINGER JOINTS; ULTRASONOGRAPHY; INFLAMMATION; METACARPOPHALANGEAL; EPIDEMIOLOGY; ANGIOGENESIS; DESTRUCTION; (1)
CONVENTIONAL TECHNIQUE; CORONAL ALIGNMENT; SURGEON EXPERIENCE; LEG AXIS; ARTHROPLASTY; NAVIGATION; IMPLANTATION; TRIAL; INSTRUMENTATION; PROSTHESES; total knee replacement; computer-assisted surgery; navigation; meta-analysis (1)
CONVENTIONAL TECHNIQUE; REPLACEMENT; SURGERY; IMPLANTATION; ALIGNMENT; SYSTEM; total knee arthroplasty; computer-assisted navigation; survey (1)
Convention on the Rights of Persons with Disabilities, CRPD, human rights obligations, sources of law (1)
"Convention on the Rights of Persons with Disabilities", CRPD, "treaty body", "unmittelbare Anwendbarkeit", Auslegung (1)
CONVERGENCE ACCELERATION ALGORITHM; REDUCED BESSEL-FUNCTIONS; SHANKS TRANSFORMATION; SEQUENCE TRANSFORMATION; COULOMB INTEGRALS; DIVERGENT SERIES; EXTRAPOLATION; SUMMATION; EXPANSIONS; CONVOLUTION; Convergence acceleration algorithm; Sequence transformation; Epsilon algorithm; Rho algorithm (1)
Convergence acceleration extrapolation summation hierarchical consistency model sequences iterative transformations Levin-type transformations E algorithm generalized difference schemes operator method (1)
Convergence acceleration, Fourier series, Non-linear sequence transformations, Singularities (1)
CONVERGENCE; BEHAVIOR; MODEL; EQUILIBRIUM; SYSTEM; ATTRACTORS; EVOLUTION; MEMORY; Cahn-Hilliard equation; Dynamic boundary conditions; Long-time dynamics; Stability of global attractors; Robustness of exponential attractors (1)
CONVERGENCE; ENERGY; Semilinear parabolic equations; Quasilinear parabolic equations; Critical spaces; Navier-Stokes equations; Vorticity equations; Scaling invariance (1)
CONVERGENT EVOLUTION; FORMICA-SANGUINEA; EXUPERANTIA GENE; RAIDING BEHAVIOR; LIFE-SPAN; PROTEIN; HYMENOPTERA; MTOR; REPRODUCTION; METABOLISM; caste; dulosis; gene networks; selection; social parasitism; transcriptomes (1)
CONVERGENT FUNCTIONAL GENOMICS; SYNUCLEIN MESSENGER-RNA; MYELIN BASIC-PROTEIN; PLACEBO-CONTROLLED-TRIAL; FATTY-ACID DEPRIVATION; HEAT-SHOCK FACTOR-1; ALPHA-SYNUCLEIN; BIPOLAR DISORDER; CANDIDATE GENES; FRONTAL-CORTEX; (1)
CONVERGENT FUNCTIONAL-GROUPS; ALKALI METAL CATIONS; DODECYL-SULFATE; SODIUM IODATE; ION-BINDING; HYDRATION; ACID; CARBOXYLATE; SELECTIVITY; INTERFACES; specific-ion effects; micelle-to-vesicle transition; catanionic surfactant mixtures (1)
CONVERGENT FUNCTIONAL-GROUPS; ENANTIOSELECTIVE PROTONATION; CHIRAL IMIDES; AMIDE; Diamine; Kemp's triacid; piperidine (2)
Conversational agents, interactive search, wizard-of-oz, conversational search (1)
Conversational Agents, Large Language Models, Behaviour Change (1)
Conversational agents, Question answering, Task-based IR, LLMs (1)
conversational agents, recipe recommendation (1)
conversational search;cooking;tasks;information needs (1)
Conversational search, Evaluation (1)
conversational search; information needs; cooking (1)
Conversational Search, Information Needs, Prediction, Cooking (1)
Conversational Search;Natural Language Understanding (1)
CONVERSION; BIOMASS; TRANSFORMATION; PRETREATMENT; DISSOLUTION; DEPOLYMERIZATION; EXTRACTIONS; HYDROLYSIS; (1)
Conversion reaction, Mechanism of formation, Nanoparticle, Templating, Shandite, Parkerite, Core-Shell, Synthesis (Polyol, Sol-Gel, Solid-state), In-situ XRD, Olivine, Electrode material, Electrochemical performance, Solid-solution, LiNiPO4 Konversionsreaktionen, Bildungsmechanismus, Nanopartikel, Synthese (Polyol, Sol-Gel, Festkörper), Elektrodenmaterial, Elektrochemische Performance, Mischungsreihe (1)
CONVERSION REACTIONS; DISORDERS; NEUROLOGY; VISION; MANAGEMENT; CHILDHOOD; functional visual loss; dissociative sensory loss; hysterical blindness; conversion disorder; neuroophthalmology (1)
CONVERTING-ENZYME GENE; LEFT-VENTRICULAR HYPERTROPHY; TYPE-1 RECEPTOR GENE; INCREASED VASCULAR REACTIVITY; FAILING HUMAN HEARTS; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; IN-VITRO; ANTIHYPERTENSIVE DRUGS; DELETION POLYMORPHISM; angiotensin; angiotensin-converting enzyme; angiotensinogen; angiotensin AT(1) receptor; polymorphism; renin (1)
CONVERTING ENZYME-INHIBITION; ACUTE MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD HYPERTROPHY; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; AORTIC-STENOSIS; CARDIOMYOPATHY; RATS; CARVEDILOL; MELLITUS; beta-adrenoceptor blocker; hypertrophy rats; extracellular matrix (1)
CONVERTING ENZYME-INHIBITION; ATRIAL-NATRIURETIC-PEPTIDE; RENAL INJURY; MESANGIAL CELLS; GLOMERULOSCLEROSIS; NEPHROPATHY; EXPRESSION; MELLITUS; HYPERTROPHY; FIBROSIS; diabetes mellitus; kidney glomerulosclerosis; vasopeptidase inhibition (1)
CONVERTING ENZYME-INHIBITION; MUSCLE CELL-PROLIFERATION; LEFT-VENTRICULAR MASS; AORTIC-STENOSIS; HYPERTROPHY; CARVEDILOL; FAILURE; GROWTH; FIBROSIS; TISSUE; hypertrophy; fibrosis; extracellular matrix; beta-adrenergic receptor blocker; cell culture (1)
CONVERTING ENZYME-INHIBITION; RAT SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; ISCHEMIA-REPERFUSION; TEMPORAL CORRELATION; NITRIC-OXIDE; ANGIOTENSIN; ISCHEMIA/REPERFUSION; MECHANISMS; ENALAPRIL; intravital microscopy; enalapril; losartan; adhesion molecules; ischemia-reperfusion injury (1)
CONVERTING ENZYME-INHIBITORS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; CLINICAL STATUS; ANTAGONIST; ENALAPRIL; DESIGN; TOLERABILITY; RATIONALE; MORBIDITY; (1)
CONVERTING ENZYME-INHIBITORS; HEALTH-CARE PROFESSIONALS; CHRONIC HEART-FAILURE; SECONDARY PREVENTION; ANGIOTENSIN-II; POPULATION; STATEMENT; MORBIDITY; MORTALITY; DISEASE; ACE-inhibitors; drug use; myocardial infarction; secondary prevention (1)
CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; CARDIOVASCULAR MORBIDITY; ELITE-II; ANGIOTENSIN; MORTALITY; CAPTOPRIL; REDUCTION; Angiotensin receptor blocker; Losartan; Heart failure; Morbidity; Mortality (1)
CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC FUNCTION; MYOCARDIAL-INFARCTION; ANTAGONIST LOSARTAN; ACE-INHIBITOR; ELITE-II; MORTALITY; MORBIDITY; CAPTOPRIL; VALSARTAN; (1)
CONVERTING ENZYME; PRETERM INFANTS; ACE; GENOTYPE; GENES; RISK; Bronchopulmonary dysplasia; Intraventricular hemorrhage; Persistent ductus arteriosus; Deletion/insertion polymorphism of the angiotensin-converting enzyme; Very-low-birthweight infants (1)
CONVERTING PHOSPHOR REPORTERS; LANTHANIDE-DOPED NANOCRYSTALS; UP-CONVERSION NANOPARTICLES; CIRCULATING ANODIC ANTIGEN; LATERAL FLOW ASSAY; IMAGING IN-VIVO; FLUORESCENT; CELLS; NANOPHOSPHORS; LUMINESCENCE; (1)
CONVERTING PHOSPHOR REPORTERS; UP-CONVERSION; LUMINESCENT NANOPARTICLES; TERMINAL ALKYNES; NUCLEIC-ACIDS; NANOCRYSTALS; AZIDES; CELLS; cycloaddition; DNA; fluorescence; imaging; nanoparticles (1)
convex envelope, phase simplex, strong convexity, Lipschitz-continuity (1)
; convex polytopes; evolutions; monomial ideals (1)
CONVEX RISK MEASURES; COHERENT RISK; TERM STRUCTURES; OPTIMIZATION; INFORMATION; VALUATION; MODELS; SUBJECT; SPREADS; BONDS; Risk capital; Credit risk; Multi-period risk; Conditionally independent defaults; Copula models; Capital allocation; Risk contribution (1)
Convolution neural network, Online arithmetic, Most-significant-digit-first arithmetic, CNN acceleration, Layer fusion (1)
CONVULSIVE STATUS EPILEPTICUS; MORTALITY; PREDICTORS; THERAPIES; SEDATION; SCORE; Status epilepticus; Isoflurane; Epilepsy (1)
Cooperative effect, Main-group metals, catalysis, ditopic ligands, bimetallic complexes, magnesium, aluminium, zinc, tin, amidines, guanidines, amidoamines, bis(amidine)s, bis(guanidine)s, bis(amidoamine)s, alkaline earth metal, metal complexes (1)
cooperative learning, implementation, reading comprehension, prosocial behavior (1)
cooperative motion viscous liq relaxation structure (1)
COOPERATIVE-ONCOLOGY-GROUP; TERM FOLLOW-UP; PHASE-III; COMPARING MITOXANTRONE; DOXORUBICIN; EPIRUBICIN; THERAPY; CYCLOPHOSPHAMIDE; FLUOROURACIL; CARCINOMA; metastatic breast cancer; quality of life; single-agent treatment; survival; time to progression (1)
COORDINATED EVOLUTION; TRAUMA; ONTOLOGIES; CARE; surgical biobank; post-traumatic arthritis; osteomyelitis; semantic data integration; system theory; biomedical ontologies; knowledge representation (1)
COORDINATED PHOSPHORUS-COMPOUNDS; BINUCLEAR COPPER(I) COMPLEXES; TRANSITION-METAL-COMPLEXES; STRUCTURAL-CHARACTERIZATION; COUPLING-CONSTANTS; CRYSTAL-STRUCTURE; ORGANIC-COMPOUNDS; SIMPLE ROUTE; LIGANDS; ALKYNE; (1)
COORDINATED PHOSPHORUS-COMPOUNDS; CARBON MULTIPLE BONDS; ORGANOPHOSPHORUS COMPOUNDS; BUILDING-BLOCKS; CAGE COMPOUNDS; INTERMOLECULAR INTERACTIONS; ORGANOMETALLIC CHEMISTRY; TERT-BUTYLPHOSPHAETHYNE; ALKYNES; 2,2-DIMETHYLPROPYLIDYNEPHOSPHINE; homoleptic compounds; phosphaalkynes; side-on complexes; silver; weakly coordinating anions (1)
COORDINATED PHOSPHORUS-COMPOUNDS; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; MOLECULAR-STRUCTURE; RING CONTRACTION; METAL-COMPLEXES; BASIS-SETS; PHOSPHAALKYNES; CYCLODIMERIZATION; DIMERIZATION; cobalt; diphosphacyclobutenes; organolithium; phosphorus; sandwich complexes (1)
COORDINATED PHOSPHORUS-COMPOUNDS; PHOSPHINIDENE COMPLEXES; DOUBLE-BOND; ELEMENTS; 1,3-BUTADIENE; HETEROCYCLES; ARSINIDENE; AZIDES; arsenic; 1,3-butadienes; diazomethane; phosphinidenes; phosphorus; tungsten (1)
COORDINATED RESET NEUROMODULATION; AUDITORY PHANTOM PERCEPTION; NEURONAL OSCILLATIONS; HEARING-LOSS; PHASE SYNCHRONIZATION; THETA-OSCILLATIONS; MEMORY NETWORKS; HUMAN NEOCORTEX; WORKING-MEMORY; NEURAL-NETWORK; tinnitus pitch; oscillations; delta band activity; alpha rhythm; gamma band activity; coordinated reset neuromodulation; cross frequency coupling (1)
COORDINATED RESET NEUROMODULATION; DORSOLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; MAJOR DEPRESSION; TMS-EEG; RTMS; DISTRESS; SOUND; QUESTIONNAIRE; SCHIZOPHRENIA; ringing in the ears; TMS; EEG; plasticity; frontal cortex; temporal cortex (1)
COORDINATED RESET NEUROMODULATION; OCCIPITAL CORTEX; SYNCHRONIZATION; BRAIN; POWER; DESYNCHRONIZATION; FLUCTUATIONS; PERFORMANCE; INHIBITION; PERCEPTION; (1)
COORDINATE PHOSPHORUS ATOMS; BOND-FORMING REACTIONS; CARBENE-LIKE CHEMISTRY; P MULTIPLE BOND; TRIAMIDOAMINE COMPLEXES; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; OXO COMPLEX; U-IV=C; REACTIVITY; agostic-type interactions; phosphanides; phosphinidenes; X-ray crystallography; zirconium (1)
Coordination and cooperation platform, cyber situational awareness, incident coordination, cyber security (1)
COORDINATION BEHAVIOR; P-4 ACTIVATION; CRYSTAL-STRUCTURE; MOLECULE; ELEMENTS; arsenic; coordination chemistry; E-n ligand complexes; main-group chemistry; phosphorus (1)
COORDINATION; C-60; CP-ASTERISK-FE(ETA(5)-P-5); COMPLEXES; MOLECULES; KEPLERATE; CLUSTER; LIGAND; OXIDE; UNITS (1)
COORDINATION CHEMISTRY; (1)
COORDINATION CHEMISTRY; CLUSTERS; COMPLEXES; CARBONYL; DERIVATIVES; UNITS; cobalt; carbonyl ligands; niobium; tellurium; electrochemistry (1)
Coordination chemistry,Coordination compounds,Energy,Ions,Ligands (1)
COORDINATION CHEMISTRY; CORRELATION-ENERGY; HYDRIDES; ANALOGS; PHOSPHINOBORANES; OLIGOMERIZATION; APPROXIMATION; ACTIVATION; BORANE; ROUTE; cationic chain compounds; 13/15 compounds; pentelyltrielanes; pnictogen; triels (1)
COORDINATION CHEMISTRY; LIGAND COMPLEXES; PENTAPHOSPHAFERROCENE; DESIGN; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); METALLACYCLES; SUPRAMOLECULE; AG; argentophilicity; arsenic; self-assembly; silver; weakly coordinating anions (1)
COORDINATION CHEMISTRY; METAL-COMPLEXES; CRYSTAL; APPROXIMATION; DERIVATIVES; TUNGSTEN; ENERGY; COPPER; MO; M'; Bimetallic complexes; Metal-metal interaction; Tungsten; Coinage metal; Carbonyl ligands (1)
COORDINATION CHEMISTRY; METALLOCENE COMPLEXES; REACTIVITY; DERIVATIVES; FRAGMENTS; CHALCOGEN; CLUSTERS; CARBONYL; LIGANDS; SE; (1)
COORDINATION CHEMISTRY; METAL; ruthenium; tellurium; carbonyl ligands; cluster chemistry (1)
COORDINATION CHEMISTRY; MOLECULAR-STRUCTURE; COMPLEXES; REACTIVITY; STABILIZATION; GUANIDINES; ELEMENTS; SINGLE; AGENTS; BOND; Aluminium; Gallium; Group 13 elements; Lithium; N ligands (1)
COORDINATION CHEMISTRY; MOLECULAR-STRUCTURE; GROUP-14 METALLOLES; ORGANIC-CHEMISTRY; COBALT COMPLEXES; X-RAY; CRYSTAL; PHOSPHORUS; OXIDE; DIMERIZATION; (1)
coordination chemistry, phosphorus, organometallic chemistry, P4 activation, pentaphosphaferrocene, radical, supramolecular chemistry (1)
COORDINATION CHEMISTRY; REDUCTIVE CLEAVAGE; CO2; ACTIVATION; REACTIVITY; HYDROGENATION; DEOXYGENATION; TRANSFORMATION; CATALYSIS; CO2 fixation; cooperative effects; iron; P; N ligands; phosphinine (1)
COORDINATION CHEMISTRY; SILVER(I) CATIONS; LIGAND COMPLEXES; PHOSPHORUS; COPPER; MOLECULES; Coordination chemistry; Pentapho sphaferrocene; Coinage metal salt; Weakly coordinating anion; CPBIG (1)
COORDINATION-COMPLEXES; DIPHOSPHINE LIGANDS; CHEMISTRY; PHOSPHORUS; EXCHANGE; ANALOGS; SULFUR; BONDS; NMR; SE; (1)
COORDINATION-COMPOUNDS; AMBIENT CONDITIONS; ADDUCT FORMATION; ZINC OXINATE; PHOTOLUMINESCENCE; PHOSPHORESCENCE; Photochemistry; Hydrolysis; Zinc complexes; 8-Qinolinolate complexes (1)
COORDINATION-COMPOUNDS; COMPLEXES; PHOTOPHYSICS; LUMINESCENCE; electronic spectra; charge transfer; luminescence; cerium complexes (1)
COORDINATION-COMPOUNDS; PHOTOCHEMISTRY; ACTIVATION; COMPLEXES; OXIDATION; POLYMERIZATION; ANTIMONY(III); REDUCTION; CHEMISTRY; LEAD(II); bismuth; high-throughput screening; homogeneous catalysis; photocatalysis; radicals (1)
COORDINATION; DERIVATIVES; COMPLEXES; AFFINITY; azamacrocycles; DNA binding; ionophore; nucleophilic aromatic substitution (1)
COORDINATION; INFANTS; Motor abilities; Mental rotation; Working memory; Development; Children (1)
COORDINATION NETWORKS; BUILDING-BLOCKS; LIGAND COMPLEX; FRAMEWORKS; BEHAVIOR; DESIGN; 2D; (1)
coordination networks; flexible linkers; metallosupramolecular chemistry; pentaphosphaferrocene; supramolecules (1)
COORDINATION-NUMBER 7; CARBONYL-COMPLEXES; TUNGSTEN; BONDS; ARSANYLBORANES; MOLYBDENUM; Lewis-acid/base-stabilised phosphanylborane; Phosphorous; Boron; Halogenation; Iodine; Bromine (1)
Coordination of spontaneous volunteers, volunteer coordination system, decision support, scheduling optimization model, linear programming (1)
coordination polymer • phosphorus • silver • weakly * coordinating anion (1)
COORDINATION POLYMERS; BUILDING-BLOCKS; DIPHOSPHORUS COMPLEX; CRYSTAL-STRUCTURES; LIGAND COMPLEX; PENTAPHOSPHAFERROCENE; FRAMEWORKS; DESIGN; 2D; SUPRAMOLECULE; (1)
coordination polymers; copper; iron; phosphorus; P ligands (1)
coordination polymers; copper; molybdenum; P ligands; silver (1)
COORDINATION POLYMERS; CRYSTAL-STRUCTURES; BUILDING-BLOCKS; DIPHOSPHORUS COMPLEX; LIGAND COMPLEX; NETWORKS; 2D; DICHLOROMETHANE; SUPRAMOLECULE; ABSTRACTION; Ferrocene ligands; Hybrid polymers; Coordination modes; Copper; Ligand effects (1)
COORDINATION POLYMERS; DRUG-DELIVERY; AGENTS; SITES; fluorescence; imaging agent; longitudinal relaxivity; metal-organic frameworks (1)
COORDINATION POLYMERS; LIGAND COMPLEXES; PENTAPHOSPHAFERROCENE; SILVER(I); BEHAVIOR; CP2MO2(CO)(4)(ETA(2)-P-2); CONSTRUCTION; MOIETIES; DESIGN; CU+; antimony; arsenic; copper; heterodiatomic units; phosphorus (1)
COORDINATION POLYMERS; ORGANIC FRAMEWORKS; ADSORPTION PROPERTIES; COPPER(II) COMPLEX; BUILDING-BLOCKS; RATIONAL DESIGN; DOUBLE-LAYER; SINGLE; MOLECULES; ISOMERISM; (1)
COORDINATION POLYMERS; PHOSPHINE COMPLEXES; LIGAND; BEHAVIOR; CHAINS; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); DIMENSIONALITY; CHEMISTRY; CATIONS (1)
COORDINATION POLYMERS; SILVER(I) COMPLEXES; BIPYRIDYL LINKERS; PI INTERACTIONS; LIGAND COMPLEX; PYRIDINE; DESIGN; PENTAPHOSPHAFERROCENE; ELEMENTS; BEHAVIOR; antimony; N-donor ligands; organometallic-organic hybrid assemblies; silver; supramolecular coordination complexes (1)
COORDINATION POLYMERS; SOLIDS; (1)
COORDINATION POLYMERS; SUPRAMOLECULAR CHEMISTRY; MOLECULAR-STRUCTURES; SANDWICH COMPLEX; HYDROTHERMAL SYNTHESIS; CRYSTAL-STRUCTURES; CAGE; COPPER(I); UNITS; HEXAPHOSPHAPENTAPRISMANE; (1)
COORDINATION SPHERE; IRON COMPLEXES; P-4 ACTIVATION; LIGANDS; TRANSFORMATION; PATHWAY; CLUSTER; ANIONS; AS-6; UNIT; (1)
COORDINATION SPHERE; P-4 TETRAHEDRON; 1ST SALTS; PHOSPHORUS; CHEMISTRY; COMPLEXES; TRANSFORMATION; ACTIVATION; CLUSTERS; PATHWAY; allotropes; cage compounds; cobalt; phosphorus (1)
COORDINATION SPHERE; TRIPLE-BOND; TERMINAL PHOSPHIDE; P-4 ACTIVATION; COMPLEXES; LIGANDS; IRON; REACTIVITY; NIOBIUM; TRANSFORMATION; coordination compounds; P ligands; radicals; transition metals; white phosphorus (1)
COPD, Asthma, Medikamentenadhärenz, Medikamentenbezogene Überzeugungen (1)
COPD, Exazerbation, Nontypeable Haemophilus influenzae (NTHi), Interleukin-8 (1)
COPD · Sleep apnea · Overlap syndrome · Inpatient treatment · Outcome (1)
COPE REARRANGEMENT; AZOALKANES; SPECTROSCOPY; MOLECULES; STATE; azo compounds; cycloadditions; kinetics; photolysis; rearrangements; substituent effects (1)
Cope rearrangement (of bis(hydroxyphenyl)ethylenediamine reaction products with fluorobenzaldehyde); Neoplasm inhibitors (platinum complexes with bis(fluorophenyl)ethylenediamines); antitumor activity platinum fluorophenylethylenediamine complex platinum fluorophenylethylenediamine diastereoisomer complex ethylenediamine fluorophenyl platinum diastereoisomer complex (1)
coplanar resonator; carbon nanotube growth; rhenium; molybdenum; XPS; superconductivity (1)
COPPER-CATALYZED AMIDATION; BOND FUNCTIONALIZATION; AMINATION; AMINES; SUBSTITUTION; COUPLINGS; SECONDARY; CLEAVAGE; ADJACENT; HALIDES; C-H activation; amination; alkylation; copper catalysis; photocatalysis (1)
COPPER-CATALYZED CYCLOPROPANATION; ASYMMETRIC-SYNTHESIS; CHIRAL BIS(OXAZOLINE); METAL-COMPLEXES; DIAZO-COMPOUNDS; MECHANISM; PYBOX; CYCLOADDITION; CARBENES; INSIGHTS; asymmetric catalysis; bis(oxazolines); computational mechanistic models; copper; cyclopropanation (1)
copper complexes photoredox (1)
COPPER; DIFFUSION; CONTAMINATION; KINETICS; LIFETIME; IRON; FE; (1)
COPPER(I)-CATALYZED ASYMMETRIC CYCLOPROPANATION; POLYPYRAZOLYLBORATE COPPER(I) COMPLEXES; CHIRAL DIRHODIUM(II) CARBOXAMIDES; METAL CARBENE TRANSFORMATIONS; RESTRICTED PEPTIDE ISOSTERES; BIS(OXAZOLINE)-COPPER COMPLEXES; CATALYTIC CYCLOPROPANATION; INTRAMOLECULAR CYCLOPROPANATION; LIGANDS; OLEFINS; pyrazolylborate; optical activity; copper, rhodium and ruthenium catalysts; cyclopropanation; enantioselectivity (1)
COPPER(I) COMPLEXES; AMINE-BORANES; LIGAND; PHOSPHINOBORANE; PHOSPHORUS; CHAINS; boron; coordination; group 13/15 compounds; pnictogen; transition metal (1)
COPPER(I) COMPLEXES; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; OLED APPLICATIONS; EMISSION; LUMINESCENCE; LIGANDS; DIODES; EMITTERS; EFFICIENCY; (1)
COPPER(II) CARBOXYLATES (1)
; copper(II) complexes; crystal structure; phase transition (1)
COPPER NANOPARTICLES; SILVER NANOPARTICLES; METAL NANOPARTICLES; ALLOY NANOPARTICLES; OXIDE NANOPARTICLES; GOLD NANOPARTICLES; GREEN SYNTHESIS; PHOTOCATALYSIS; POLYMERS; NANOCOMPOSITES; Bio-based hydrogel; Bimetallic nanoparticles; Surface plasmon resonance; Plasmonic catalysis (1)
copper, photocatalysis, ATRA, difunctionalization, thiocyanation (1)
Copper, photocatalysis, homolysis, ATRA (1)
copper, photocatalysis, three-component couplings, ATRA reaction, substrate complex (1)
COPTOTERMES-FORMOSANUS SHIRAKI; LABORATORY EXPERIMENTAL GROUPS; NASUTITERMES-EXITIOSUS HILL; AUSTRALIAN GALL THRIPS; TRUE WORKER CASTE; NAKED MOLE-RAT; ZOOTERMOPSIS-NEVADENSIS; PHYLOGENETIC EVIDENCE; GENETIC-STRUCTURE; DAMPWOOD TERMITE; eusociality; evolution; indirect fitness benefit; Isoptera; soldier; sterile caste (1)
COPY-NUMBER VARIATION; CLOACAL EXSTROPHY; OEIS COMPLEX; ARRAY-CGH; EXPRESSION; DELETION; GENE; GENOME; ASSOCIATION; DUPLICATION; Bladder exstrophy-epispadias complex; Copy number variation; Genetic testing; EFNB1 (1)
COPY NUMBER VARIATION; SLEEP-DISORDERS; CATAPLEXY; GENETICS; DISEASES; RISK; 2ND; (1)
CORACOBRACHIALIS; COMPLICATIONS; musculocutaneous nerve; Latarjet procedure; coracoid transfer; coracoid process; anterior shoulder instability; twigs (1)
CORACOCLAVICULAR LIGAMENT RECONSTRUCTION; DISTAL CLAVICLE; COMPLICATIONS; FIXATION; SEPARATION; STABILITY; FRACTURE; SURGERY; REPAIR; GRAFT; Acromioclavicular joint; AC joint; Revision; Iatrogenic; AC joint instability; Lateral clavicular resection (1)
CORACOCLAVICULAR LIGAMENT RECONSTRUCTION; INTRAOBSERVER RELIABILITY; CLASSIFICATION; DISLOCATION; STABILIZATION; COMPLICATIONS; STABILITY; INJURIES; REPAIR; Acromioclavicular joint; Ac joint instability; Instability; Ac joint; Treatment; Diagnosis; Consensus; Delphi; European shoulder associates (1)
Coral banding, Climate variability, Sea surface temperature, Turbidity, Time series, Bleaching, Stress band (1)
CORAL-REEFS; BALANOMORPHA; BRACHYURA; Barnacle; Cirripedia; Persian Gulf; Gulf of Oman; Checklist; New records (1)
CORD BLOOD-GAS; TWIN DELIVERY TIME; PRETERM BIRTH; NEONATAL OUTCOMES; VAGINAL DELIVERY; PERINATAL-MORTALITY; CESAREAN DELIVERY; APGAR SCORES; 2ND TWINS; MODE; Multiple gestation; Twin gestation; Fetal outcome; Birth management; APGAR score (1)
CORD COMPRESSION; PROGNOSTIC-FACTORS; CLINICAL ARTICLE; SURGERY; SURVIVAL; MANAGEMENT; DISEASE; CANCER; Spinal metastases; Functional outcome; Neurosurgery; Spinal surgery; Laminectomy; Tumor debulking (1)
CORD COMPRESSION; TIME LIMITS; RECOVERY; MANAGEMENT; INCREASE; DRAINS; spinal epidural hematoma; functional outcome; spinal decompression surgery; risk factors (1)
COREACTANT ELECTROGENERATED CHEMILUMINESCENCE; EMISSION INTENSITY; TERTIARY-AMINES; LIGHT-EMISSION; QUANTUM DOTS; ELECTROCHEMILUMINESCENCE; SYSTEM; TRIS(2,2'-BIPYRIDYL)RUTHENIUM(II); TRIS(2,2'-BIPYRIDINE)RUTHENIUM(II); TRIS(2,2-BIPYRIDINE)RUTHENIUM(II); (1)
CORE BODY-TEMPERATURE; CIRCADIAN-RHYTHMS; DROSOPHILA-MELANOGASTER; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; PROTEINS PERIOD; BRIGHT LIGHT; OWL MONKEYS; MASKING; MUTANT; Drosophila; Masking; Period; Timeless; Dim light (1)
CORE DECOMPRESSION; SPONTANEOUS OSTEONECROSIS; FEMORAL-HEAD; OSTEOCHONDRITIS-DISSECANS; AVASCULAR NECROSIS; ACCURACY; PRECISION; ARTHROPLASTY; PLACEMENT; LESIONS; CAOS; navigation; osteochondritis dissecans; osteonecrosis; core decompression; obesity (1)
CORE-NEEDLE-BIOPSY; ATYPICAL DUCTAL HYPERPLASIA; POWER DOPPLER US; PATHOLOGICAL CORRELATION; INITIAL-EXPERIENCE; SURGICAL EXCISION; LESIONS; ULTRASOUND; VASCULARITY; BENIGN; breast neoplasms; breast biopsy; ultrasound; contrast media; harmonic imaging (1)
CORE-NEEDLE BIOPSY; QUAMADI PROJECT; FOLLOW-UP; DIAGNOSIS; CONSENSUS; Breast cancer; Early detection; Screening; Guideline; Quality indicators (1)
CORE REVERSAL; DOMAIN-WALL; DYNAMICS; NANODISKS; MOTION; (1)
CORE REVERSAL; STATE; EXCITATION; SCATTERING; NANODOTS; MODES; FIELD; (1)
CORE-SHELL MICROSPHERES; GREEN SYNTHESIS; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; ANODIC ALUMINA; HEAVY-METALS; C-S; CHITOSAN; REMOVAL; ARRAYS; Nanoporous membranes; Chitosan; Copper nanoparticles; Catalysis (1)
CORE-SHELL NANOCRYSTALS; QUANTUM DOTS; MAGNETIC-RESONANCE; SURFACE TRAPS; RELAXATION; DYNAMICS; BLINKING; LIGHT; DARK; CDS; CdSe/CdS nanocrystals; spin coherence; electron-spin resonance; light harvesting; trap states; blinking (1)
Core-Shell; Nanoparticle; Diabetic Retinopathy; Macula Degeneration; Block-Co-Polymer; Ligand; Losartan Carboxylic Acid; EXP3174; Targeting; Avidity; Freeze-Drying; Polyethylenglycol; PEG-PLA; PLGA; (1)
CORE-SHELL NANOPARTICLES; BIOSENSING APPLICATIONS; FUNCTIONALIZED SILICA; DRUG-DELIVERY; SURFACE; DNA; CONJUGATION; DIAGNOSTICS; PROBES; Silica nanoparticles; Surface modification; Near-infrared label; FRET; Surface affinity assay; Biotin (1)
CORE-SHELL NANOPARTICLES; GAS SENSOR; PARAROSANILINE; ATMOSPHERE; SAMPLER; FACILE; AIR; (1)
; CO-RMs; carbonic anhydrase inhibitor; cobalt; macrophages; inflammation; carbon monoxide (1)
CORNEAL EPITHELIAL-CELLS; ANIONIC SURFACTANTS; CHAIN-LENGTH; IN-VITRO; PHYSICAL-PROPERTIES; HOFMEISTER SERIES; AQUATIC TOXICITY; PRIMARY CULTURES; HELA-CELLS; CYTOTOXICITY; Choline ionic liquids; Biological membrane; Cytotoxicity (1)
CORNEAL SURFACE RECONSTRUCTION; DESTRUCTIVE CORNEAL; THERMAL BURNS; ARTHRITIS; DISEASE; MANAGEMENT; ULCERATION; SCLERITIS; ULCERS; amniotic membrane; transplantation; cornea; ulcer; rheumatoid arthritis (1)
; Corneal ulcer; Keratitis; Curettage; Recurrence; Antimycotic therapy (1)
Cornea, Stammzellen, ectomesenchymal, Multipotenz, Progenitorzellen (1)
CORNIFIED CELL-ENVELOPE; EPIDERMAL-KERATINOCYTES; ATOPIC-DERMATITIS; BARRIER FUNCTION; MURINE SKIN; APOPTOSIS; DEATH; PHYTOSPHINGOSINE; ACYLCERAMIDE; INHIBITION; keratinocyte differentiation; phytosphingosine; sphinganine; sphingolipid metabolism; sphingosine (1)
Corona; Covid-19; Pandemie; Sozialversicherung; Privatversicherung; Staatshaftung; Entschädigungsrecht; öffentliches Entschädigungsrecht; soziales Entschädigungsrecht; Pflichtversicherung (1)
; Corona; health promotion; digitization; expert interviews; sport clubs; sport (1)
Corona Hot-Spot Radiologie Weiden (1)
Corona, Lehre (1)
CORONAL FRACTURE; CLASSIFICATION; LOCATIONS; FRAGMENT; FAILURE; SCREW; BONE; KNEE; finite element analysis; tibial plateau fracture; Hoffa fracture; posteromedial split; internal fixation (1)
CORONARY ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; CORTICAL BLINDNESS; AGENT OVERDOSE; BLOOD; BARRIER; ENHANCEMENT; DISRUPTION; NEUROTOXICITY; blood-brain barrier; non-ionic contrast media; high doses of contrast media; dynamic spiral CT; DSA; sepsis (1)
CORONARY-ARTERY ANEURYSMS; LONG-TERM MANAGEMENT; HEALTH-PROFESSIONALS; DELAYED DIAGNOSIS; NATIONWIDE SURVEY; ASSOCIATION; STATEMENT; CHILDREN; INFANTS; RISK; Kawasaki disease; Aneurysm; Vasculitis; Coronary arteries; Immunoglobins intravenous; Echocardiography (1)
CORONARY-ARTERY-BYPASS; CARDIAC SURGICAL-PATIENTS; AORTA; REVASCULARIZATION; EXPERIENCE; MANAGEMENT; DISEASE; DEVICE; (1)
coronary artery bypass grafting (CABG); coronary artery disease; sleep apnea; postoperative complications (1)
CORONARY-ARTERY-BYPASS; SKELETAL-MUSCLE PREPARATIONS; MITRAL-VALVE-REPLACEMENT; CENTRAL CORE DISEASE; CARDIAC-SURGERY; DANTROLENE; RHABDOMYOLYSIS; DIAGNOSIS; MANAGEMENT; SWINE; (1)
CORONARY-ARTERY DISEASE; A-I; LIPOPROTEIN PARTICLES; INSTRUMENTATION; PLASMA; SERUM (1)
CORONARY-ARTERY-DISEASE; ANESTHESIA; PROPOFOL; PREVALENCE; INDUCTION; WOMEN; (1)
CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN LP(A); NIACIN; RISK; DYSLIPIDEMIA; HEPATOCYTES; EFFICACY; SEQUENCE; primary human hepatocytes; reporter assay; apolipoprotein(a); mRNA expression; atherosclerosis (1)
CORONARY-ARTERY-DISEASE; ATHEROSCLEROSIS; POPULATION; IMMUNOMODULATION; CANNABIDIOL; MECHANISMS; PRESSURE; CELLS; MICE; SNPS; genetics; CNR2; myocardial infarction; cardiovascular risk factors; polymorphism (1)
CORONARY-ARTERY-DISEASE; AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; NEAR-INFRARED SPECTROSCOPY; LOW-FREQUENCY OSCILLATIONS; ISCHEMIC-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; METABOLIC SYNDROME; ADIPOSE-TISSUE; SOLUBLE CD163; (1)
CORONARY-ARTERY-DISEASE; BALLOON ANGIOPLASTY; ELUTING STENT; IMPLANTATION; RESTENOSIS; PLACEMENT; STENOSIS; TRAPIDIL; GROWTH; (1)
CORONARY-ARTERY-DISEASE; BETA-KLOTHO; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; HYPERTENSION; GENOMEWIDE; EXPRESSION; LINKAGE; FGF-21; FAMILY; fibroblast growth factor 21; fibroblast growth factor receptor 2; cholesterol; single-nucleotide polymorphism; genome-wide association studies (1)
CORONARY-ARTERY-DISEASE; BODY-COMPOSITION; DEHYDROEPIANDROSTERONE-SULFATE; POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE; IL-6 SECRETION; OLDER-ADULTS; EXERCISE; MEN; RESPONSES; (1)
CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; NO ASSOCIATION; OBESITY; POPULATION; VARIANT; HERITABILITY; METABOLISM; OVERWEIGHT; PHENOTYPES; (1)
CORONARY-ARTERY-DISEASE; CARDIOVASCULAR MORTALITY; HEART-DISEASE; MENDELIAN RANDOMIZATION; MYOCARDIAL-INFARCTION; BEER CONSUMPTION; BRITISH MEN; LONG-TERM; STENOSIS; METAANALYSIS; alcohol consumption; aortic valve, calcification of; atherosclerosis; epidemiology; risk factors (1)
CORONARY-ARTERY DISEASE; CASSETTE TRANSPORTER 1; APOLIPOPROTEIN-A-I; METHIONINE OXIDATION; TANGIER-DISEASE; GENE; IDENTIFICATION; PROMOTER; RESIDUES; DOMAIN; ATP-binding; cassette transporter; ABCA 1; Tangier disease; HDL-deficiency syndrome (1)
CORONARY-ARTERY DISEASE; CHOLESTEROL-LOWERING THERAPY; ENDOTHELIUM-DEPENDENT VASODILATION; FOREARM RESISTANCE VESSELS; LOW-DENSITY-LIPOPROTEIN; HYPERCHOLESTEROLEMIC PATIENTS; NITRIC-OXIDE; REACTIVE HYPEREMIA; ATHEROSCLEROSIS; DYSFUNCTION; fluvastatin; microcirculation; hyperlipidaemia; capillaroscopy; laser Doppler imaging (1)
CORONARY-ARTERY-DISEASE; CHRONIC GRANULOMATOUS-DISEASE; TYPE-2 DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; LONG-TERM OUTCOMES; HEART-FAILURE; TROPONIN AUTOANTIBODIES; CARDIAC RESYNCHRONIZATION; ENDOTHELIAL FUNCTION; RADIOIODINE THERAPY; (1)
CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; DIAGNOSTIC-ACCURACY; HEART-ASSOCIATION; CALCIUM SCORES; ANGIOGRAPHY; INTERVENTIONS; MANAGEMENT; LIKELIHOOD; COST; Coronary artery disease; Multidetector computed tomography; NICE clinical guideline; Duke clinical score; Pretest probability (1)
CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; HEART-DISEASE; MACULAR DEGENERATION; LINKAGE ANALYSIS; GENOMEWIDE LINKAGE; FAMILIES; ATHEROSCLEROSIS; LOCUS; CHROMOSOME-2; association study; cardiovascular disease; complement factor H gene (CFH); genetics; myocardial infarction; polymorphism; risk factor (1)
CORONARY-ARTERY DISEASE; DNA POLYMORPHISMS; HEART-DISEASE; ASSOCIATIONS; RISK; TRIGLYCERIDE; ESTROGEN; ATHEROSCLEROSIS; VARIANTS; SEVERITY; lipoproteins; infarction; gene expression; lipid metabolism; cholesterol (1)
CORONARY-ARTERY-DISEASE; ELECTROCARDIOGRAM; VECTORCARDIOGRAM; INFARCTION; REPOLARIZATION; DIAGNOSIS; 12-LEAD; myocardial scar; coronary artery disease (CAD); patient management; vectorcardiography; risk stratification (1)
CORONARY-ARTERY-DISEASE; HEART-DISEASE; HDL CHOLESTEROL; RISK; METABOLISM; PLASMA; LIPIDS; SERUM; ATHEROSCLEROSIS; HETEROGENEITY; (1)
CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; INNATE IMMUNITY; MYOCARDIAL-INFARCTION; WEIGHT-LOSS; RISK-FACTOR; DEFICIENCY; COMPLEMENT; ATHEROSCLEROSIS; POLYMORPHISMS; Mannose-binding lectin; Metabolic syndrome; Atherosclerosis; Weight reduction (1)
CORONARY-ARTERY-DISEASE; IN-VIVO; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUES; THORACIC AORTA; RISK-FACTORS; COLLAGEN; HYPERTENSION; HEART; MACROPHAGES; MRI; molecular; contrast agent; vessel wall (1)
CORONARY-ARTERY-DISEASE; LDL-RECEPTOR GENE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; RISK; CHOLESTEROL; LOCI; PCSK9; HYPERCHOLESTEROLEMIA; (1)
CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-PERFUSION; HYPERTENSIVE PATIENTS; SESTAMIBI SPECT; CHEST-PAIN; TOMOGRAPHY; DIAGNOSIS; STENOSIS; EXERCISE; dobutamine; stress-echocardiography; MiBi-SPECT; wall motion abnormalities; perfusion (1)
CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; HEART-DISEASE; NITRIC-OXIDE; SCIENTIFIC STATEMENT; CLINICAL-CARDIOLOGY; GENDER-DIFFERENCES; EUROPEAN-SOCIETY; ESC GUIDELINES; Women-specific cardiovascular risk factors; Menopause; Coronary; microvascular dysfunction; MINOCA; Acute coronary syndrome (1)
CORONARY-ARTERY-DISEASE; NEUROPEPTIDE-Y; SIGNAL PEPTIDE; LEU7PRO POLYMORPHISM; INSULIN-RESISTANCE; CAROTID ATHEROSCLEROSIS; METABOLIC SYNDROME; PRO7 SUBSTITUTION; RAT HEPATOCYTES; HEART-DISEASE; (1)
CORONARY-ARTERY-DISEASE; NEUTRAL GLYCOSPHINGOLIPIDS; QUANTITATIVE MEASUREMENT; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHATIDIC ACID; SERUM-LIPOPROTEINS; RISK-FACTOR; BLOOD; SPHINGOMYELIN; SPHINGOSINE-1-PHOSPHATE; Lactosylceramide; Sphingoid base; Glycosylceramide; High throughput; Lipidomics; Sphingolipidomics (1)
CORONARY-ARTERY-DISEASE; PALMITATE-INDUCED APOPTOSIS; TANDEM MASS-SPECTROMETRY; FREE FATTY-ACIDS; LIPIDOMICS REVEALS; GENETIC-VARIATION; PLASMA; CERAMIDE; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; (1)
CORONARY-ARTERY-DISEASE; POPULATION; LOCUS; myocardial infarction; coronary artery disease; genetics; polymorphism; LRP8 (1)
CORONARY-ARTERY-DISEASE; PREDICT CARDIOVASCULAR EVENTS; STENT IMPLANTATION; CHEMOATTRACTANT PROTEIN-1; FEMOROPOPLITEAL ARTERY; MYOCARDIAL-INFARCTION; HUMAN ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; BALLOON; HETEROGENEITY; Angioplasty; Peripheral artery occlusive disease; Restenosis; Monocyte; Neointimal hyperplasia (1)
CORONARY-ARTERY-DISEASE; RISK; STROKE; VARIANTS; TESTS; arachidonate 5-lipoxygenase-activating protein (ALOX5AP); coronary artery disease (CAD); leukotriene A4 hydrolase (LTA4H); MAF; minor allele frequency; myocardial infarction; single nucleotide polymorphism (SNP) (1)
CORONARY-ARTERY DISEASE; SINGLE LDL APHERESIS; ENDOTHELIAL FUNCTION; HYPERCHOLESTEROLEMIC PATIENTS; DEPENDENT VASODILATATION; CHOLESTEROL REDUCTION; ANGIOTENSIN-II; ATHEROSCLEROSIS; SYNTHASE; HUMANS; (1)
CORONARY-ARTERY-DISEASE; STABLE ANGINA-PECTORIS; MICROVASCULAR DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; PREVALENCE; SYMPTOMS; Angina pectoris; myocardial ischemia; non-obstructive coronary artery disease; endothelial dysfunction; small vessel disease (1)
CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTOR MEF2A; MUTATIONS; POPULATION; POLYMORPHISMS; HERITABILITY; DEFICIENCY; FAMILIES; AUGSBURG; RISK; coronary disease; epidemiology; genetics; myocardial infarction (1)
; coronary artery surgery; coronary sinus fistula (1)
CORONARY-BYPASS SURGERY; OFF-PUMP; ON-PUMP; CARDIOPULMONARY BYPASS; REPERFUSION; ISCHEMIA; HYPOXIA; INJURY; cardiovascular diseases; microcirculation (1)
Coronary computed tomography angiography; sin-gle-source computed tomography; 64-detector row computed tomography; motion artifact reduction; deep learning-based algorithm; motion correction algorithm (1)
Coronary computed tomography angiography · Single-source computed tomography · 64-Detector row computed tomography · Motion artifact reduction · Deep learning-based algorithm · Motion correction algorithm (1)
CORONARY-HEART-DISEASE; ACTIVATING-FACTOR ACETYLHYDROLASE; PHOSPHOLIPASE A(2) ACTIVITY; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; RISK; DARAPLADIB; VARIANTS; EVENTS; Human genetics; target validation; coronary heart disease; lipoprotein-associated phospholipase A(2); darapladib (1)
CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR MORTALITY; FOLLOW-UP; COLLABORATIVE COHORT; JAPANESE MEN; US ADULTS; RISK; BEER; WINE; Alcohol; Mortality; Women's health; Cohort study (1)
CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; NUTRITION EXAMINATION SURVEY; INTERMITTENT CLAUDICATION; RISK-FACTORS; VASCULAR-DISEASE; FOLLOW-UP; SYSTEMIC ATHEROSCLEROSIS; NATIONAL-HEALTH; ASSOCIATION; Lp(a) concentrations; Apolipoprotein(a) phenotypes; Peripheral arterial disease; Ankle-brachial index; Mendelian randomization; Causality (1)
CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LINKAGE ANALYSIS; ISCHEMIC-STROKE; STATIN THERAPY; CRP LEVELS; INFLAMMATION; POLYMORPHISM; GENE; RISK; (1)
CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; PROMOTER REGION; GRAFT FUNCTION; ALL-CAUSE; GENE; INFLAMMATION; POLYMORPHISM; SURVIVAL; ATHEROSCLEROSIS; cardiovascular disease; C-reactive protein; haplotype; renal function; renal transplantation (1)
CORONARY-HEART-DISEASE; CHOLESTERYL ESTER; PLASMINOGEN; EXPRESSION; HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN(A); ATHEROSCLEROSIS; MECHANISM; LP(A); RISK; lipoprotein (a); lysosomal acid lipase; interleukin-6; blood monocyte; atherogenesis (1)
CORONARY-HEART-DISEASE; COA REDUCTASE INHIBITORS; DENSITY-LIPOPROTEIN CHOLESTEROL; TRANSFER PROTEIN GENE; SCANDINAVIAN SIMVASTATIN SURVIVAL; PLASMA PRAVASTATIN CONCENTRATIONS; PROLIFERATOR-ACTIVATED RECEPTORS; APOLIPOPROTEIN-E POLYMORPHISM; RANDOMIZED CONTROLLED-TRIALS; STATIN-ASSOCIATED MYOPATHY; HMG-CoA reductase inhibitors; pharmacogenomics; pharmacogenetics; polymorphisms (1)
CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BLOOD-PRESSURE; INTERLEUKIN-6 RECEPTOR; CLONAL HEMATOPOIESIS; ATHEROSCLEROSIS; RISK; AGE; HYPERTENSION; INHIBITOR; Cardiovascular diseases; Coronary artery disease; Inflammation; Inflammasome; NLRP3 (1)
CORONARY-HEART-DISEASE; ENVIRONMENT INTERACTION; ADIPOCYTE DIFFERENTIATION; SOCIOECONOMIC-STATUS; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; TRANSGENIC MICE; ADIPOSE-TISSUE; BLOOD-PRESSURE; RISK-FACTORS; educational attainment; lipids; cholesterol; triglycerides; genome-wide association study; meta-analysis (1)
CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; WOMEN; HEALTH; RISK; PREVENTION; STROKE; Menopause; Hormone replacement therapy; Coronary heart disease; Stroke (1)
CORONARY-HEART-DISEASE; HEALTH-CARE PROFESSIONALS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY PATIENTS; ARTERY-DISEASE; RISK-FACTORS; PREVENTION; MEN; PRAVASTATIN; statins; myocardial infarction; secondary prevention; routine care; quality of health care (1)
CORONARY-HEART-DISEASE; INFLAMMATORY CYTOKINE PRODUCTION; ACUTE PSYCHOSOCIAL STRESS; RECEPTOR-BETA-ISOFORM; JOB STRESS; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL STRESS; SCHOOL TEACHERS; CHINESE WORKERS; CARDIOVASCULAR-DISEASE; Effort-reward-imbalance; Pro-inflammatory cytokine production; Glucocorticoid sensitivity; Trier Social Stress Test (TSST); Chronic work stress (1)
CORONARY-HEART-DISEASE; JOINT TASK-FORCE; BLOOD-PRESSURE; CLINICAL-PRACTICE; HYPERTENSIVE POPULATION; RECOMMENDATIONS; PRAVASTATIN; SOCIETIES; TRIALS; MEN; myocardial infarction; primary prevention; arterial hypertension; positive family history; epidemiology; coronary risk factors (1)
CORONARY-HEART-DISEASE; LINKAGE DISEQUILIBRIUM PATTERNS; MONICA PROJECT; RISK-FACTORS; EVENT RATES; GENE; POLYMORPHISMS; HAPLOTYPES; SUSCEPTIBILITY; JAPANESE; genetics; lymphotoxin-alpha; galectin-2; myocardial infarction; coronary artery disease (1)
CORONARY-HEART-DISEASE; LONG-TERM INTAKE; GALLBLADDER-DISEASE; MEDITERRANEAN DIET; NUT CONSUMPTION; ALCOHOL-CONSUMPTION; DIGESTIVE DISEASES; METABOLIC SYNDROME; DECREASED RISK; LIPID-LEVELS; gallbladder disease; cholelithiasis; dietary pattern (1)
CORONARY-HEART-DISEASE; LOW BLOOD-PRESSURE; METABOLIC SYNDROME; MENTAL-DISORDERS; HEALTH INTERVIEW; NATIONAL-HEALTH; MOOD DISORDER; YOUNG-ADULTS; SYMPTOMS; PREVALENCE; Major depressive disorder; Bipolar disorder; Epidemiology; Hypertension; Cardiovascular risk factor (1)
CORONARY-HEART-DISEASE; MEAN PLATELET VOLUME; MYOCARDIAL-INFARCTION; COMMON VARIANTS; NOONAN-SYNDROME; RISK; GENE; EXPRESSION; MUTATIONS; SELECTION (1)
CORONARY-HEART-DISEASE; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; INTERLEUKIN-6 GENE; ISCHEMIC-STROKE; POLYMORPHISMS; ASSOCIATION; cardiovascular disease; genetic risk; meta-analysis (1)
CORONARY-HEART-DISEASE; OF-THE-LITERATURE; CIRCADIAN ACTIVITY; MOOD DISORDERS; LONG SLEEPERS; FOLLOW-UP; DURATION; PATTERNS; PRODROMES; WAKE; Bipolar disorder; Sleep; Prodromes (1)
CORONARY-HEART-DISEASE; PENTANUCLEOTIDE REPEAT POLYMORPHISM; RISK-FACTORS; APO(A) GENE; ELEVATED LIPOPROTEIN(A); SEQUENCE POLYMORPHISMS; PLASMA LIPOPROTEIN(A); LP(A) CONCENTRATION; SIZE POLYMORPHISM; WOMEN; apolipoproteins; polymorphism; myocardial infarction; women; population (1)
CORONARY-HEART-DISEASE; RADIATION EXPOSURE; PHYSICAL-ACTIVITY; UV-RADIATION; EXERCISE; HYPOXIA; IMPACT; METASTASIS; RECURRENCE; PHYSIOLOGY; altitude; climate; lifestyle; colorectal; breast; disease (1)
CORONARY-HEART-DISEASE; SELF-REPORTED SMOKING; 10-YEAR FOLLOW-UP; RENAL-FUNCTION; CIGARETTE-SMOKING; MULTIPLE IMPUTATION; GENERAL-POPULATION; DIALYSIS PATIENTS; BLOOD-PRESSURE; MISSING DATA; chronic kidney disease; kidney failure; risk factors (1)
CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; C825T POLYMORPHISM; SOCIAL-CLASS; ASSOCIATION; EXPRESSION; VARIANTS; (1)
CORONARY HEART-DISEASE; SUSCEPTIBILITY LOCUS; DIABETES-MELLITUS; GENETIC-LINKAGE; UNITED-STATES; PAIR ANALYSIS; CHROMOSOME; HYPERTENSION; PEDIGREES; DESCENT; (1)
CORONARY-OCCLUSION; BINDING; INHIBITORS; THROMBOLYSIS; PROTEINS; GEOMETRY; DATABASE; DOCKING; SYSTEM; drug side effects; argatroban; thrombin inhibition; docking; off-target interactions (1)
Coronaviren , Nucleocapsid , Immunoassay , Kawasaki-Krankheit , SARS , , coronavirus , nucleocapsid , immunoassay , kawasaki syndrome , sars (1)
CORONAVIRUS DISEASE 2019; COVID-19 PNEUMONIA; INFECTION; IMMUNOSENESCENCE; TRANSPLANTATION; MANAGEMENT; RESPONSES; IMPROVES; INJURY; CELLS; COVID-19; cytokine storm; immunological mechanisms; autoimmunity; neuroimmunology; immunotherapies; guidelines; critical care (1)
; Coronavirus disease 2019; Patient care; Personal protective equipment; Hygiene; Checklist (1)
coronavirus, endocytosis, evolution, fusion, SARS-CoV-2, tropism, variants-of-concern, viral entry (1)
CORONAVIRUS; HOSPITALIZATION; ASSOCIATIONS; ENGLAND; obesity; diabetes; hypertension; impaired metabolic health; mortality; COVID-19 (1)
CORONAVIRUS; INTERFERON; RESPONSES; INNATE; MERS-CoV; pathogenesis; immune response; SARS-CoV-2 (1)
CORONAVIRUS; PNEUMONIA; THERAPY; COV; (1)
; corona virus; SARS-CoV-2; clinical psychiatry; hospital management; pandemic; pandemia (1)
Corona virus · Sports injury · Sports medicine · ACL · Knee injury · Team sports · Lockdown · Pandemic (1)
CORONAVIRUS; THROMBOSIS; HEPARIN; AGGREGATION; INHIBITION; PNEUMONIA; ELASTASE; HISTONES; IMMUNITY; SARS-CoV-2; Endothelialitis; Immunothrombosis; Aggregated neutrophil extracellular traps; Coagulopathy (1)
Corona-Warn-App; Dispositiv; Pandemie; Subjektivierung (1)
corpora, knowledge management, named entity extraction, semantic relations, text mining, topic maps (1)
corpora; knowledge management; semantic relations; text mining; topic maps (1)
Corporate cash holdings, Return predictability, Anomaly, Mispricing, International markets (1)
CORPORATE ENVIRONMENTAL PERFORMANCE; FINANCIAL PERFORMANCE; GENDER DIVERSITY; ESG PERFORMANCE; CSR COMMITTEES; SIZE; DISCLOSURES; DIRECTORS; AGENCY; COSTS; Carbon emission; Board characteristics; Paris Climate Agreement; Gender; Cultural aspects (1)
corporate governance, Greimas, mass media, narrative change (1)
Corporate Governance, Immobilien, Deutscher Corporate Governance Kodex, Umsetzungsgrad, Kapitalgesellschaften (1)
Corporate Greenwashing; Sustainability Performance; Environmental Performance; ESG Ratings; ESG Disclosure; Information Asymmetry; Asset Pricing; Capital Market Reactions; Green Bonds; Firm Behavior; Disclosure Regulation; Sustainable Finance; Machine Learning (1)
Corporate hedging; Risk management; Default risk; Bankruptcy; Forward contracts (1)
CORPORATE POLITICAL STRATEGY; LOBBYING APPROACH; DUE-PROCESS; PARTICIPATION; BUSINESS; ACT; aggressive tax planning; BEPS; comment letter; interest groups; tax lobbying; tax policy (1)
Corporate Responsibility, Ernst Schumacher, Nachhaltigkeit, CR in Brasilien (1)
Corporate scandals, Corporate misconduct, Reputation risk, Individual investors (1)
CORPORATE SOCIAL-RESPONSIBILITY; BEHAVIOR; VALUES; QUALITY; PRICE; Sustainable consumption; retailing; consumer; perception; personal motives (1)
Corporate social responsibility, Europe, European Public Real Estate Association, Global Reporting Initiative, Quantile-regression, Real estate, Social responsibility, Sustainable real estate (1)
CORPORATE SOCIAL-RESPONSIBILITY; FINANCIAL PERFORMANCE; INVESTMENT TRUSTS; GOVERNANCE; REITS; LINK; Corporate social responsibility; Real estate; Panel data (1)
Corporate Social Responsibility, Global Reporting Initiative, Idiosyncratic Risk, Ordered Probit Regression (1)
Corporate Social Responsibility, Global Reporting Initiative, Listed Real Estate, Real Estate Investment Trusts, GRI, 2SLS (1)
Corporate social responsibility; Global Reporting Initiative; Listed real estate; Real Estate Investment Trusts; GRI; CSR; 2SLS; Instrumental Variables; Component-wise Gradient Boosting (1)
CORPORATE SOCIAL-RESPONSIBILITY; PRIVATE PROVISION; GIFT EXCHANGE; HIDDEN COSTS; RECIPROCITY; FIELD; FAIRNESS; MARKETS; WORK; PAY (1)
Corporate social responsibility, Sustainability, Cost of capital, Quantile regression, Granger causality (1)
Corporate sustainability, Event study, Regression discontinuity in time, Shareholder engagement, Sovereign wealth fund (1)
Corporate underinvestment, the underinvestment problem, corporate insurance, safety loadings, casualty loss, bond covenants (1)
CORPORATE YIELD SPREADS; PRICES; ASK; Green bonds; Liquidity; External review; Second-party opinion; Shade of green; Climate finance; Impact investing (1)
Corpus Linguistics Indexing terminology Management term extraction Information Retrieval Web Services Service oriented computing (1)
CORRELATE; Crohn's disease; Contrast enhanced ultrasound; Bowel; Clinical activity (1)
CORRELATED MOLECULAR CALCULATIONS; GAUSSIAN-BASIS SETS; INTERMOLECULAR INTERACTIONS; MODEL ENERGIES; ACCURATE; ATOMS; CHEMISTRY; CONSTANTS; EXCHANGE; FORCE (1)
CORRELATED STATES; MOIRE BANDS; ANGLE; SUPERCONDUCTIVITY; photoresistance; twisted bilayer graphene; infrared; temperature; bolometric; heating (1)
CORRELATED STATES; MOIRE BANDS; SUPERCONDUCTIVITY; ELECTRONICS (1)
CORRELATED STATES; SUPERCONDUCTIVITY; FERROMAGNETISM; INSULATOR; CRYSTAL; BANDS; (2)
Correlation-based methods • Enzyme catalysis • Molecular dynamics • Photocontrol • Unnatural amino acids (1)
CORRELATION ENERGIES; PERTURBATION-THEORY; EXCHANGE; SYSTEMS; FORMALISM; MOLECULES; SOLIDS; ATOMS; (1)
Correlation energy, Perturbation theory, Morse potential, Anharmonicity constant, Hypersurface, Spectroscopic constants (1)
Correlation;Excitons;Lasers and electrooptics;Laser excitation;Laser tuning;Electrooptical waveguides (1)
Correlation neglect; Voting; Bounded rationality; Experiment (1)
correlations (1)
Correlative; mechanistic; model; parameter fitting; process-based; review; SDM; species distribution; validation (1)
CORROSION INHIBITION; CHLORIDE-IONS; BENZOTRIAZOLE; EQCM; IMPEDANCE; NICKEL; FILMS; GOLD; ACID; CU; Copper corrosion; Adsorption kinetics; Quartz crystal microbalance; Corrosion inhibitors; Poly (vinylimidazole) (1)
corrosion, steel-reinforced concrete, monitoring, pH value, fiber optic sensor (1)
corruption, informality, business, Serbia, Croatia (1)
CORTEX HYDROLYSIS; GENE-EXPRESSION; YPEB; HEAT; CWLJ; SLEB; spore; germination; Bacillus; YlaJ; YhcN (1)
CORTICAL AREA MT; TRANSCRANIAL MAGNETIC STIMULATION; INFERIOR TEMPORAL CORTEX; WORKING-MEMORY; PERCEPTUAL MEMORY; PREFRONTAL CORTEX; EYE-MOVEMENTS; TASK; MECHANISMS; INFORMATION; Visual short-term memory; Global motion; Visual masking; Direction selectivity; Speed selectivity (1)
CORTICAL BLINDNESS; CONTRAST; ENHANCEMENT; HEMORRHAGE; CT; subdural contrast extravasation; CT (1)
CORTICAL BUTTON FIXATION; INTERFERENCE SCREW; PROXIMAL BICEPS; HEAD; ANCHOR; Loop Tenodesis; Biceps tenotomy; Biomechanical evaluation; LHB; Popeye deformity; Long head of biceps (1)
CORTICAL CARCINOMA; PERITONEAL CARCINOMATOSIS; RADICAL ADRENALECTOMY; CAUTIONARY NOTE; RESECTION; CANCER; MANAGEMENT; RECURRENCE; MITOTANE; SURGEON; Adrenal cancer; Adrenalectomy; Laparoscopy; Prognosis (1)
CORTICAL COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER NKCC1; BASOLATERAL PLASMA-MEMBRANES; STIMULATED ATPASE ACTIVITIES; INTERCALATED CELL SUBTYPES; DISTAL TUBULAR POTASSIUM; POSTNATAL MATURATION; APICAL MEMBRANE; CL COTRANSPORTERS; RAT; apical membrane voltage; tubular flow rates; bumetanide; intercalated cell; principal cell (1)
CORTICAL DEVELOPMENT; MOSAIC MUTATIONS; GENE CAUSE; FILAMIN; EPILEPSY; PHENOTYPE; MIGRATION; CHILDREN; FLN1; filamin A; periventricular heterotopia; mosaicism; epilepsy (1)
CORTICAL EXCITABILITY; CORTEX (1)
CORTICAL EXCITABILITY; LIMB AMPUTATION; REORGANIZATION; MECHANISMS; INHIBITION; transcranial magnetic stimulation; intracortical facilitation; intracortical inhibition; motor threshold; cortical silent period; cortical plasticity; chronic tinnitus (1)
CORTICAL EXCITABILITY; MODULATION; PAIN; Human; Transcranial magnetic stimulation; Cortical excitability; Streitberger needle; Acupuncture; Pain control (1)
CORTICAL MIDLINE STRUCTURES; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; DECLARATIVE MEMORY; NEGATIVITY BIAS; DEFAULT MODE; BRAIN; FMRI; INFORMATION; ACTIVATION; MCI; fMRI; emotion; memory; precuneus (1)
CORTICAL SPREADING DEPRESSION; HEADACHE; SEIZURES; HYPOTHESIS; MIGRALEPSY; DIAGNOSIS; BRAIN; EEG; VARS; visual sensations; migralepsy; clinical score (1)
CORTICAL SUBARACHNOID HEMORRHAGE; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; A-BETA; MOUSE MODEL; EFFLUX TRANSPORTER; ENDOTHELIAL-CELLS; CLEARANCE; PEPTIDE; amyloid-beta; blood-brain barrier; cerebral amyloid angiopathy; neuroimaging (1)
CORTICES IN-VITRO; POSTRHINAL CORTICES; ENTORHINAL CORTEX; PARAHIPPOCAMPAL REGION; VISUAL-CORTEX; RHINAL INTERACTIONS; STATUS EPILEPTICUS; KINDLED SEIZURES; LOBE EPILEPSY; GUINEA-PIG; Perirhinal cortex; Calcium-binding protein; Calretinin; Parvalbum in; Calbindin; Interneuron (1)
Corticoliberin , Hormon , Nagetiere , Ratte , Oxytocin , Kopulation , Angst , Angstbewältigung , Sexualverhalten , Stressreaktion , Neurobiologie , Endokrinologie , Neuroendocrinology , oxytocin , mating , behavior (1)
CORTICOSTEROID-BINDING GLOBULIN; COMPETITIVE CHEMILUMINESCENCE IMMUNOASSAY; CHEMI-LUMINESCENCE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; ANDROGEN RECEPTOR; STEREOSELECTIVE SYNTHESIS; SANDWICH IMMUNOASSAY; ESTRADIOL CONJUGATE; STAUDINGER REACTION; ENZYME-IMMUNOASSAY; (1)
CORTICOSTEROID-BINDING GLOBULIN; FEMALE MARMOSET MONKEYS; PATERNAL BEHAVIOR; STRESS-RESPONSE; PLASMA-CORTICOSTERONE; SEX-DIFFERENCES; NONINVASIVE METHOD; PARENTAL BEHAVIOR; SEASONAL-CHANGES; MICE; HPA axis; Peromyscus califomicus; Stress; Corticosterone; Fecal glucocorticoid metabolites; Diurnal rhythm (1)
CORTICOSTEROID-FREE REGIMENS; STANDARD TRIPLE REGIMEN; LONG-TERM; MYCOPHENOLATE-MOFETIL; RHEUMATOID-ARTHRITIS; CYCLOSPORINE MICROEMULSION; KIDNEY-TRANSPLANTATION; FREE IMMUNOSUPPRESSION; RANDOMIZED-TRIAL; ADVERSE EVENTS; Tacrolimus; Renal transplant; Immunosuppression; Steroid; Long term (1)
CORTICOSTEROIDS; QUALITY; LIFE; COVID-19; smell; olfaction; mometasone; olfactory training (1)
corticosterone, oxytocin, social anxiety disorder, social avoidance (1)
CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-RELATED BEHAVIOR; OXYTOCIN MESSENGER-RNA; MATERNAL-BEHAVIOR; FEMALE RATS; PHYSIOLOGICAL-ROLE; BRAIN OXYTOCIN; PREGNANT RATS; C-FOS; SECRETION; antisense; anxiety; brain; maternal behaviour; prolactin receptors (1)
CORTICOTROPIN-RELEASING-FACTOR; BIOCHEMICAL-CHARACTERIZATION; STRIA TERMINALIS; LIGAND INHIBITOR; GENE-EXPRESSION; HUMAN-PLASMA; WEIGHT-GAIN; HORMONE; AGGRESSION; ANXIETY; Anxiety-related behavior; Bed nucleus of the stria terminalis; Corticotropin-releasing factor; Corticotropin-releasing factor-binding protein; Maternal aggression; Maternal care; Stress (1)
CORTICOTROPIN-RELEASING-FACTOR; BRAIN OXYTOCIN; FOOD-INTAKE; EFFERENT PROJECTIONS; VASOPRESSIN RELEASE; EXPRESSING NEURONS; SOCIAL BEHAVIORS; CENTRAL AMYGDALA; LOCUS-COERULEUS; LACTATING RATS; anxiety; DREADD; GCaMP6s; microdialysis; neuropeptide S; oxytocin (1)
Corticotropin-releasing factor, CRF binding protein, Maternal behaviour, PVN, Stress (1)
CORTICOTROPIN-RELEASING-FACTOR; ELEVATED PLUS-MAZE; SYMPATHETIC-NERVOUS-SYSTEM; SOCIAL STRESS; MESSENGER-RNA; EXPERIMENTAL COLITIS; IMMUNE FUNCTION; BOWEL-DISEASE; RAT-BRAIN; ENDOGENOUS GLUCOCORTICOIDS; (1)
CORTICOTROPIN-RELEASING-FACTOR; FORCED SWIMMING TEST; MALE PRAIRIE VOLES; NUCLEUS-ACCUMBENS DOPAMINE; ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; HORMONE-RECEPTOR 1; SOCIAL-ISOLATION; ANIMAL-MODEL; MICROTUS-OCHROGASTER; prairie vole; passive stress-coping; forced swim test; tail suspension test; elevated plus-maze; hypothalamo-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; BRAIN OXYTOCIN; LACTATING RATS; SWIM STRESS; FEMALE RATS; VASOPRESSIN; HORMONE; EEG; oxytocin; oxytocin receptor antagonist; sleep; EEG spectral analysis; rat (1)
CORTICOTROPIN-RELEASING FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL RESPONSES; ANTERIOR-PITUITARY; MINERALOCORTICOID-RECEPTORS; REPEATED RESTRAINT; GENE-EXPRESSION; TERMINAL DOMAIN; DNA ELEMENT; MALE RATS; (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; MEDIAL PREOPTIC AREA; FACTOR RECEPTOR 2; STRIA TERMINALIS; BED NUCLEUS; SEX-DIFFERENCES; HORMONE-RECEPTOR; FEMALE RATS; STRESS; Corticotropin-releasing factor; Bed nucleus of the stria terminalis; Maternal behavior; Anxiety; Hypothalamic-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; NEUROENDOCRINE STRESS RESPONSES; PITUITARY-ADRENAL AXIS; STRIA TERMINALIS; BED NUCLEUS; BRAIN OXYTOCIN; UROCORTIN-III; PREOPTIC AREA; ANXIETY BEHAVIOR; (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; STRIA TERMINALIS; BRAIN OXYTOCIN; BED NUCLEUS; RAT-BRAIN; PARAVENTRICULAR NUCLEUS; HORMONE TRANSCRIPTION; MYOMETRIAL CELLS; LACTATING RATS; Crf; CRTC3/TORC3; intracellular signaling; oxytocin receptor; stress response (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; ANXIETY-RELATED BEHAVIOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE STRESS RESPONSES; PROLACTIN RECEPTOR IMMUNOREACTIVITY; MESSENGER-RNA EXPRESSION; MILK-EJECTION REFLEX; MATERNAL-BEHAVIOR; LACTATING RATS; agonistic behavior; anxiety; hypothalamo-pituitary-adrenal axis; maternal aggression; oxytocin; plus-maze; prolactin (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; BINDING-PROTEIN; BRAIN OXYTOCIN; PARAVENTRICULAR NUCLEUS; PARVOCELLULAR NEURONS; PERIPHERAL RELEASE; SUPRAOPTIC NUCLEUS; GABA(A) RECEPTORS; STRIA TERMINALIS; Oxytocin; Corticotropin releasing factor; Stress; HPA axis; PVN (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA EXPRESSION; ANXIETY-RELATED BEHAVIOR; ADULT-RATS; HORMONAL RESPONSES; STRIA TERMINALIS; RESTRAINT STRESS; arched back nursing; corticotropin-releasing hormone; elevated plus-maze; stress response (1)
CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTORS; BRAIN OXYTOCIN; DEFICIENT MICE; KINASE ACTIVATION; STRESS RESPONSES; SOCIAL COGNITION; CENTRAL AMYGDALA; GENE-EXPRESSION; ANXIOLYTIC-LIKE; light-dark box; MAP kinase; plus-maze; signalling; vasopressin (1)
CORTICOTROPIN-RELEASING-FACTOR; STRIA TERMINALIS; BED NUCLEUS; FACTOR-RECEPTOR; BINDING-PROTEIN; STRESS; OXYTOCIN; BRAIN; RAT; PROJECTIONS; Anxiety; Bed nucleus of the stria terminalis; Corticotropin-releasing factor; Maternal neglect; Oxytocin (1)
CORTICOTROPIN-RELEASING-FACTOR; STRIA TERMINALIS; BED NUCLEUS; MICROTUS-OCHROGASTER; SOCIAL ATTACHMENT; OLDER MEN; DEPRESSION; VASOPRESSIN; ANXIETY; BEHAVIOR; Corticotropin-releasing factor; Grieving; Partner separation; Passive stress-coping; Social loss; Stresscopin (1)
CORTICOTROPIN-RELEASING-HORMONE; CHRONIC PSYCHOSOCIAL STRESS; PLASMA ADRENOCORTICOTROPIN; NEUROENDOCRINE RESPONSES; CIRCADIAN VARIATION; PREGNANT RATS; LDL RECEPTOR; AXIS; HYPORESPONSIVENESS; STEROIDOGENESIS; Adrenal glands; cholesterol; corticosterone; HPA axis; lactation; maternal adaptations (1)
CORTICOTROPIN-RELEASING HORMONE; CIRCADIAN RHYTHMICITY; STRESS; EEG; ADRENOCORTICOTROPIN; CONSEQUENCES; cortisol; insomnia; sleep; hyperarousal; pathophysiology; hypothalamic-pituitary-adrenal-axis; interactions (1)
CORTICOTROPIN-RELEASING HORMONE; FLINDERS SENSITIVE LINE; MESSENGER-RNA EXPRESSION; FORCED SWIM TEST; CEREBROSPINAL-FLUID; MATERNAL SEPARATION; SEX-DIFFERENCES; ANIMAL-MODEL; DEPRESSION; RECEPTOR; NPY; CGRP; Neurokinin A; Neurotensin; Corticotropin releasing hormone; HAB LAB rats (1)
CORTICOTROPIN-RELEASING HORMONE; GENE-RELATED PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; SYMPATHETIC-NERVE FIBERS; TUMOR-NECROSIS-FACTOR; SYNOVIAL TISSUE; INFLAMMATORY DISEASES; TRANSCRIPTION FACTOR; UTERINE INNERVATION; MONONUCLEAR-CELLS; blastocyst implantation; emblyogenesis; rheumatoid arthritis; hormone; WNT; BMP; NOTCH (1)
CORTICOTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; CYCLE-DEPENDENT EXPRESSION; C57BL/6 MOUSE SKIN; POMC MESSENGER-RNA; REGRESSION CATAGEN; MELANOCORTIN-1 RECEPTOR; IMMUNE PRIVILEGE; HUMAN SEBOCYTES; HUMAN-PLACENTA; CRH; ACTH; alpha-MSH; proopiomelanocortin; stress (1)
CORTICOTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; DIFFERENTIAL EXPRESSION; MELANOCORTIN-1 RECEPTOR; ALLERGIC DISEASE; MAST-CELLS; HUMAN SKIN; SYSTEM; PROOPIOMELANOCORTIN; PATHOGENESIS; basophils; hypothalamic-pituitary-adrenal axis; neurohormones; neuropeptides; steroid hormones (1)
CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; NEUROENDOCRINE RESPONSES; BEHAVIORAL PARAMETERS; NEURONAL ACTIVATION; BRAIN OXYTOCIN; C-FOS; PREGNANCY; HYPORESPONSIVENESS; VASOPRESSIN; ACTH; amygdala; elevated platform; maternal defence; NGFIB; paraventricular nucleus (1)
CORTICOTROPIN-RELEASING HORMONE; NECROSIS FACTOR THERAPY; PITUITARY-ADRENAL AXIS; IMMUNE-SYSTEM; CIRCADIAN-RHYTHM; CORTISOL; DEPRESSION; FATIGUE; QUALITY; NEUROENDOCRINE; Rheumatoid arthritis; Sleep; Intensive therapy; Anti-TNF therapy; Cortisol; Hypothalamic-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING HORMONE; NEONATAL MATERNAL SEPARATION; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; LONG-EVANS RATS; GOLDEN-HAMSTERS; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE RESPONSES; GLUCOCORTICOID-RECEPTOR; anterior hypothalamus; HPA axis; maternal separation; rat; resident-intruder (1)
CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; SEPTIC SHOCK; ACUTE PHYSIOLOGY; CRITICAL ILLNESS; VIRAL-INFECTION; IN-VITRO; HPA AXIS; DEHYDROEPIANDROSTERONE; SEPSIS; glucocorticoid receptors; critical illness (1)
CORTICOTROPIN-RELEASING-HORMONE; UNDER-THE-CURVE; AWAKENING CORTISOL; LACTATING WOMEN; PRENATAL STRESS; AXIS RESPONSES; SECRETION; DELIVERY; SUPPRESSION; MECHANISMS; cortisol awakening response (CAR); hypothalamic-pituitary-adrenal (HPA) axis; pregnancy; postpartum blues; depression; stress (1)
CORTICOTROPIN-RELEASING HORMONE; VASOPRESSIN GENE-EXPRESSION; MESSENGER-RNA EXPRESSION; PERIPHERAL RELEASE; ENDOGENOUS OPIOIDS; LACTATING RATS; FEMALE RATS; PARAVENTRICULAR NUCLEUS; SUPRAOPTIC NUCLEUS; LATE PREGNANCY; (1)
CORTISOL AWAKENING RESPONSE; SALIVARY ALPHA-AMYLASE; HPA AXIS RESPONSES; MAJOR DEPRESSION; PSYCHOSOCIAL STRESS; MENTAL-DISORDERS; PUBERTAL STATUS; BECK ANXIETY; BDI-II; INVENTORY; Adolescence; depression; sleep accelerometry; cortisol awakening response; alpha-amylase (1)
CORTISOL AWAKENING RESPONSE; S RECEPTOR GENE; NEUROPEPTIDE-S; GENOTYPE; NEURONS; ANXIETY; EXTINCTION; AMYGDALA; Neuropeptide S and neuropeptide S receptor; Chronic stress; Gene -environment interaction; Cortisol awakening response; Longitudinal design (1)
Cortisol, Oxytocin, Stress response, Adolescents, Recovery, Anxiety (1)
CORTISOL RESPONSES; ADRENAL AXIS; ACUTE STRESS; HPA-AXIS; REGRESSION; Cortisol; ACTH; Stress; Reactivity; Habituation (1)
CORTISOL RESPONSES; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; HUMANS; Acute stress responses; HPA axis; Salivary cortisol; Positive/negative affect; Real-life stress (1)
CORTISOL RESPONSES; SEX-DIFFERENCES; BRAIN; NEUROENDOCRINE; VARIABILITY; ACTIVATION; AMYGDALA; GLUCOSE; SYSTEM; TASK; Amygdala; Cortisol; fMRI; Hippocampus; Medial prefrontal cortex; Negative affect (1)
Cortisol, Speichel, Schmerz, Cortisol, saliva, pain (1)
Corydalis pallida var. tenuis, C. ochotensis var. raddeana, C. incisa; Macleaya cordata; Papaveraceae; Cynanchum vincetoxicum; Asclepiadaceae; dopamine; isoquinoline alkaloids; tissue cultures; metabolism (1)
Corydalis pallida var. tenuis; Papaveraceae; Cynanchum vincetoxicum; Asclepiadaceae; dopamine; salsolinol; pyrogallol; O-methylation; metabolism (1)
CORYNEBACTERIUM-GLUTAMICUM; INDICATORS; SENSOR; GROWTH; microtiter plate; oxygen sensor; oxygen transfer; dynamic k(L)a determination; Corynebacterium glutamicum; growth (1)
CORYNEBACTERIUM-GLUTAMICUM; ORGANIC OSMOLYTES; TRANSPORTER BETP; MOLECULAR-BASIS; CARRIER BETP; BACTERIA; SPECIFICITY; PRECURSOR; EXCHANGE; SYSTEM; (1)
CORYNEBACTERIUM-ULCERANS; (1)
COSMETIC SURGERY; PROFESSIONAL PERCEPTIONS; PUBLIC PERCEPTION; REALITY; Surgery; Plastic surgery; Reconstructive surgery; Public opinion; General population (1)
COSMIC-RAY IONIZATION; INTERSTELLAR CLOUDS; FERMI-LAT; ENERGY DEPOSITION; SHOCK FRONTS; COLD MEDIA; ACCELERATION; EMISSION; TRANSPORT; HYDROGEN; astroparticle physics; radiation mechanisms: non-thermal; cosmic rays; ISM: clouds; ISM: supernova remnants; gamma rays: ISM (1)
cosmid library; flow-sorted chromosomes; high-density screening; human chromosome 11 (1)
cosmology, Einstein field equations, gravitation, oscillations, tensors, wave functions (1)
COSMO-RS; DIELECTRIC-RELAXATION; COPOLYMER; WATER (1)
COSMO-RS; MOLECULAR-DYNAMICS; BASIS-SETS; WATER; MIXTURES; ENERGY; DRUG; APPROXIMATION; HYDROCARBONS; EQUILIBRIA; (1)
COSMO-RS; SOLVENT MIXTURES; ORGANIC-SOLVENTS; INDIVIDUAL SOLVENTS; PARTITION-COEFFICIENTS; PARAMETER APPROACH; WATER MIXTURES; DIOXANE-WATER; ADIPIC ACID; DRUGS; cocrystals; COSMO-RS; liquid-phase thermodynamics; solubility prediction; solvates (1)
COSMO-RS; SOLVENT SELECTION; SOLUBILITY; POLYMORPHS; ENERGY; APPROXIMATION; COMPLEXATION; EQUILIBRIUM; PREDICTION; STABILITY; (1)
COST (1)
COSTAL CARTILAGE FRAMEWORK; TOTAL EAR RECONSTRUCTION; AURICLE; FLAP; GRAFTS; CONCHA; microtia; auricular reconstruction; retroauricular skin defect; rotation flap (1)
COST ALLOCATION; SUPPLY CHAINS; SUGGESTIONS; BENEFITS; GAME; GHG allocation; Road freight transportation; Cooperative game theory; EN-16258 (1)
COST-ANALYSIS; Iron deficiency anemia; Compensation for outlay; Anemia management; Parenteral iron therapy; Patient blood management (1)
COST-BENEFIT-ANALYSIS; NEGATIVE EQUITY; LOSS SEVERITIES; FORECLOSURE; DEFAULT; SELECTION; RISK; Cure; Loss Given Default; Liquidity Constraints; Home Equity; Mortgage; Resolution; Selection (1)
COST-EFFECTIVENESS ANALYSIS; INDIVIDUAL UTILITY; SOCIETAL CONCERNS; INNINGS ARGUMENT; CARE; PREFERENCES; ETHICS; VALUES; OREGON; LIFE; QALY; cost-effectiveness; fairness; equity weights; cost-value analysis (1)
; cost-effectiveness; DRG system; retinal surgical procedures; vitreous body surgical procedures; ppV (1)
COSTELLO-SYNDROME; GERMLINE MUTATIONS; CANCER; KRAS; CARCINOMA; BLADDER; NOONAN; FGFR3; BRAF; (1)
COSTELLO-SYNDROME; SOMATIC MOSAICISM (1)
COSTIMULATORY MOLECULES; INTESTINAL MACROPHAGES; COLORECTAL CARCINOMAS; ANTIGEN PRESENTATION; CELLS; EXPRESSION; CANCER; PROTEINASES; PROTEOLYSIS; CYTOKINES; cathepsin B; cathepsin D; cathepsin L; DSS colitis; inflammatory bowel disease; inhibition; macrophages (1)
COSTLY ARBITRAGE; PERFORMANCE; FLOWS; Open-end real estate funds; Liquidity transformation; Discount to NAV; Liquidity crisis; Uncertainty; Spillover effects (1)
Cost of capital, Property finance, Real estate (1)
COST SHARE EQUILIBRIA; NASH EQUILIBRIUM; PROVISION; UNIQUENESS; ECONOMY; INCOME; PROOF; CORE; overprovision of public goods; subscription equilibria; Warr neutrality; cost-share equilibria; Lindahl prices (1)
costs, interventions, meta-analysis, sedentary behavior (1)
COST; Stable integral simplicial volume; Rank gradient (1)
COST-UTILITY ANALYSIS; TIME; Health economics; Cost-effectiveness analysis; Cost-utility analysis; Cost-benefit analysis (1)
COSURFACTANT CHAIN-LENGTH; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; MICRO-EMULSIONS; CATALYTIC-ACTIVITY; ORGANIC-SOLVENTS; KERATIN CYSTINE; ALPHA-CHYMOTRYPSIN; DODECYL-SULFATE; SINGLET OXYGEN; anionic surfactant; reverse microemulsion; enzymatic reaction; alcohols; horse radish peroxidase; conductivity; hydration (1)
cotunneling, thermal quasiparticles, carbon nanotube, quantum dot, superconducting contacts (1)
COULOMB-BLOCKADE; (2)
COULOMB-BLOCKADE; ELECTRONIC-PROPERTIES; CARRIER MOBILITY; EFFECTIVE-MASS; MONOLAYER; TRANSITION; OSCILLATIONS; TRANSISTORS; TRANSPORT; BAND; bismuth; nanotubes; molybdenum disulfide; quantum confinement; quantum dots (1)
COULOMB-BLOCKADE; ELECTRON-SPIN; READ-OUT; DOTS; NOISE; quantum dots; quantum wires; noise; single-electron tunneling (1)
COULOMB-BLOCKADE OSCILLATIONS; ATOMIC-FORCE MICROSCOPE; CLEAVED EDGE OVERGROWTH; HALL REGIME; ELECTRONIC-STRUCTURE; ARTIFICIAL ATOMS; FLUCTUATIONS; CONDUCTANCE; SPECTRUM; ISLAND; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM-DOT; ANDREEV REFLECTION; ISLAND; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM-DOT; CONDUCTANCE; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM OSCILLATIONS; THERMOPOWER; TRANSPORT; DISSIPATION; CHANNEL (1)
COULOMB-BLOCKADE REGIME; RANDOM-MATRIX THEORY; GROUND-STATE ENERGY; PEAK SPACINGS; ADDITION SPECTRA; FLUCTUATIONS; CONDUCTANCE; STATISTICS; OSCILLATIONS; TRANSPORT; (1)
COULOMB-BLOCKADE; SPIN-BLOCKADE; SPECTROSCOPY; (1)
COULOMB-BLOCKADE; TRANSISTOR; OXIDATION; TRANSPORT; CHANNEL; (1)
COULOMB DRAG; CONDUCTANCE; HETEROSTRUCTURES; DEPENDENCE; TRANSPORT; SYSTEMS; REGIME; GASES; (1)
COULOMB DRAG; ELECTRON-GAS; SPINTRONICS; RESONANCE; (1)
COULOMB DRAG; ELECTRON-GAS; SYSTEMS; (1)
COULOMB DRAG; SEMICONDUCTORS; RELAXATION; TRANSPORT; (1)
COULOMB DRAG; SEMICONDUCTORS; SYSTEMS; FERROMAGNETS; (1)
COUMARIN DERIVATIVES; ANTIOXIDANT ACTIVITY; RESPONSIVE POLYMERS; PARTICLES; ANTITUMOR; HYDROGELS; FILMS; coumarins; drug delivery; E/Z-double bond isomerization; o-hydroxy cinnamates; polymer degradation; visible light photocatalysis (1)
coumarin; fluorescent dye; alkyne; imine; anhydride (1)
Coumarin; Prostate carcinoma; Dunning R3327-G tumour; Noble tumour; Dunning R3327-MatLu tumour; Metastases (1)
COUNCIL CLASICC TRIAL; COLORECTAL-CANCER; FOLLOW-UP; POSTOPERATIVE CHEMORADIOTHERAPY; RESECTION; MULTICENTER; MORBIDITY; IMPACT; Laparoscopic rectal surgery; Conversion; Rectal cancer (1)
"Council of Europe", Juncker-Bericht (1)
counterparty credit risk, regulatory capital, credit exposure, credit valuation adjustments (CVA), standardized approach for measuring counterparty credit risk exposures (SA-CCR), initial margin, forward sensitivities, bilateral margining (1)
counterparty credit risk; standardized approach for counterparty credit risk (SA-CCR); regulatory capital; credit exposure; equity options (1)
COUNTING HABITS; WORKING-MEMORY; NUMBER LINE; ACHIEVEMENT; PERFORMANCE; CIRCUITS; SPAN; Finger counting; Fine motor skills; Finger gnosia; Numerical skills; Embodied numerosity; Early mathematics (1)
Coupled 2DEGs; Drag-effect; Breakdown of QHE (1)
COUPLED-CLUSTER METHOD; THE-IDENTITY APPROXIMATION; QUADRATIC STEEPEST DESCENT; DENSITY FITTING APPROXIMATIONS; CORRELATED WAVE-FUNCTIONS; AB-INITIO; MODEL CC2; EXCITATION-ENERGIES; LARGE MOLECULES; ELECTRON CORRELATION; (1)
Coupled Cluster, periodic Systems, direct-local-ring CCD, embedded approach, weak-pair treatment (1)
COUPLED-CLUSTER RESPONSE; EXCITATION-ENERGIES; AB-INITIO; BASIS-SETS; RESOLUTION; GRADIENTS; SINGLES; SHELL; CCSD; (1)
COUPLED-CLUSTER THEORY; CORRELATION-ENERGY; BASIS-SETS; SYSTEMS; ATOMS; MP2; (1)
COUPLED-CLUSTER THEORY; ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; EXCITED-STATES; LARGE MOLECULES; LINEAR-RESPONSE; AB-INITIO; BASIS-SETS; MODEL CC2; APPROXIMATIONS; (1)
COUPLED-CLUSTER THEORY; PLESSET PERTURBATION-THEORY; COMPOSITE ENERGY-BANDS; ELECTRON CORRELATION; BASIS-SETS; MP2-R12 CALCULATIONS; WAVE-FUNCTIONS; WANNIER FUNCTIONS; CORRELATION CUSP; AB-INITIO; (1)
COUPLED-CLUSTER THEORY; PLESSET PERTURBATION-THEORY; DIRECT CONFIGURATION-INTERACTION; EXCITED-STATE PROPERTIES; LINEAR-RESPONSE FUNCTION; BASIS-SETS; WAVE-FUNCTIONS; DOUBLES MODEL; SINGLES; APPROXIMATIONS; (1)
COUPLED ELECTRON-TRANSFER; C-H FUNCTIONALIZATION; PHOTOREDOX CATALYSIS; METAL-FREE; AROMATIC SULFONAMIDES; OXIDATIVE NITRATION; REDOX POTENTIALS; MILD CONDITIONS; BUTYL NITRITE; PEROXYNITRITE; (1)
COUPLED ESTROGEN-RECEPTOR; TUMOR-SUPPRESSOR; GPR30; PROLIFERATION; ACTIVATION; MEMBRANE; GPER-1; GPR30; Breast cancer; Tamoxifen resistance (1)
COUPLED QUANTUM-WELLS; BOSE-EINSTEIN CONDENSATION; TRAPS; SHIFT; DOTS; (1)
COUPLED QUANTUM-WELLS; POTENTIAL TRAPS; ELECTRIC-FIELD; TRANSPORT; SEMICONDUCTOR; CONFINEMENT; (1)
COUPLED QUANTUM-WELLS; SPATIALLY SEPARATED ELECTRON; BOSE-EINSTEIN STATISTICS; FREE-CARRIERS; HOLE LAYERS; GAS; SEMICONDUCTOR; GAAS; PHOTOLUMINESCENCE; CONFINEMENT; Dipolar excitons; Electrostatic trap; Magnetic field; High exciton density (1)
COUPLED RECEPTOR KINASES; RHEUMATOID-ARTHRITIS; T-CELLS; INTERLEUKIN-10; IL-10; ACTIVATION; EXPRESSION; CYTOKINE; (1)
COUPLED RECEPTORS; TRYPTOPHAN; PHARMACOLOGY; PERFORMANCE; DEGRADATION; CONVENIENT; LIGANDS; (1)
COUPLING-CONSTANT DEPENDENCE; YANG-MILLS THEORY; AdS-CFT Correspondence; Holography and quark-gluon plasmas (1)
Coupling metrics, event driven process chain, process model quality (1)
COUPLING METRICS; INFORMATION; COHESION; SYSTEMS; DESIGN; Decomposition; Process model; Event-driven process chain (1)
Coupling metrics, metrics, development, management, process architecture (1)
coupling, process modeling, eEPC (1)
COUPLING REACTIONS; KETONE SYNTHESIS; ALDEHYDES; CHLORIDES; ARYLATION; ACYLATION; HALIDES; ACIDS; (1)
COURTSHIP BEHAVIOR; BACTERIA; BEEWOLVES; FUNGI; ANT; 3D-reconstruction; micro-CT; morphology; symbiosis; Streptomyces; actinomycetes; Philanthus (1)
COURTSHIP BEHAVIOR; NASONIA-VITRIPENNIS; HYMENOPTERA; SIGNALS; GLANDS; DROSOPHILA; WOLBACHIA; (1)
COVALENT CROSS-LINKING; EXTRACELLULAR-MATRIX; BONE REPAIR; FIBRILS; EXPRESSION; CHONDROCYTES; PHENOTYPE; XI; MATRILIN-3; PROTEIN; collagen IX; fracture repair; callus; endochondral ossification; cartilage maturation; hypertrophy (1)
COVALENT DOCKING; DRUG DISCOVERY; LIBRARIES; CLEAVAGE; FAMILY; POTENT; Alzheimer's disease; caspase-2; caspase-2 inhibitors; protein cleavage; tauopathies (1)
covalent • fentanyl • μ-opioid receptor • G-proteincoupled receptor • photopharmacology (1)
covalent • isotonitazene • μ-opioid receptor • G-protein-coupled receptor • photopharmacology (1)
COVALENT METAL-HALIDES; RAY CRYSTAL-STRUCTURES; QUANTITATIVE ASPECTS; SUBSTITUTED ANILINES; ELECTRON-DIFFRACTION; ALUMINUM TRICHLORIDE; GALLIUM TRICHLORIDE; ADDITION-COMPOUNDS; ALCL3-PYRIDINE ADDUCTS; COORDINATION-COMPOUNDS; (1)
COVALENT RADII; COORDINATION; DIPHOSPHORUS; PHOSPHORUS; COMPLEXES; TETRAFLUOROBORATE; PHOSPHAALKYNES; CHEMISTRY; VERSATILE; SINGLE; antimony; arsenic; diazonium salt; molybdenum; phosphorus (1)
COVALENT RADII; ORGANIC ISOTHIOCYANATES; CARBENE COMPLEXES; BOND; REACTIVITY; INSERTION; HETEROALLENES; ACTIVATION; SINGLE; P-4; Heterocumulenes; Nickel; Oligomerisation; Phosphorus; Pincer ligands (1)
COVALENT RADII; P-4 ACTIVATION; RING CONTRACTION; COMPLEXES; SINGLE; ELEMENTS; bond activation; nickel; phosphaalkyne oligomers; phosphatetrahedranes; phosphorus (1)
COVALENT RADII; PENTAPHOSPHAFERROCENE; LIGAND; MOLYBDENUM; REACTIVITY; P-4; COORDINATION; PHOSPHORUS; PHOSPHINES; MOLECULE; (1)
COVALENT TRIAZINE FRAMEWORKS; STRUCTURE-PROPERTY RELATIONSHIPS; CONJUGATED MICROPOROUS POLYMERS; ORGANIC FRAMEWORK; HYDROGEN EVOLUTION; CARBON NITRIDE; SURFACE-AREA; WATER; ADSORPTION; OXIDATION; covalent triazine framework; photocatalysis; hydrogen evolution reaction; molecular control; bipyridine (1)
Covariational reasoning, Bayesian reasoning, Double-tree, Unit square, Natural frequencies, SOLO taxonomy (1)
COVER CHANGE; AGRICULTURAL INTENSIFICATION; CONSERVATION STRATEGIES; TERRESTRIAL ECOSYSTEMS; SIMULATION-MODEL; SPECIES RICHNESS; BIRD COMMUNITIES; DECISION-MAKING; EXTINCTION RISK; CARBON STORAGE; agent-based models; biodiversity response; environmental change; indirect effects; integrative approaches; mechanistic models; socio-ecological systems; species richness (1)
COVERED STENT-GRAFTS; HEMODYNAMIC-FINDINGS; REFRACTORY ASCITES; TIPS; PATENCY; SONOGRAPHY; CREATION; ANTICOAGULATION; COMPLICATIONS; PREVENTION; (1)
COVERING LINK CALCULUS; BOUNDARY LINKS; WHITNEY TOWERS; INVARIANTS; CONCORDANCE; UNLINKING; NUMBER; COBORDISMS; link; unlinking number; splitting number; Alexander module; Blanchfield pairing (1)
Cover Song Detection, Music Information Retrieval, Dataset, Lyrics (1)
COVID-19 (1)
COVID-19; ANTIBODY; COVID-19; SARS-CoV-2; Antibody-mediated immunity; SARS-CoV-2-vaccination; Avidity; Surrogate neutralization (1)
COVID-19; AUTOPSY (1)
; COVID-19; Autopsy; Fungal infection; Mycosis; Macrophage activation syndrome (1)
; COVID-19; Cause of death; Case fatality ratio; Hospitalization; Pneumonia (1)
; COVID-19; Children; Brain; Neurology; Neurofilament (1)
COVID-19; CHILDREN; children; COVID-19; Germany; PCR; pooling; gargle; schools; pandemic (1)
; COVID-19; cohort study; infection risk at work; ISCO-08; KldB 2010; workplace (1)
COVID-19, Compliance, Maßnahmen, Abstandsregelungen, Kontaktbeschränkungen, Maskenpflicht, Selbstschutz, Fremdschutz, Verhaltensänderung, Studierendenbefragung (1)
COVID-19, conspiracy beliefs, risk perception, dark triad, political attitude (1)
COVID-19; COVID-19; Hygiene; Distancing rules; Pager; Waiting time management (1)
COVID-19; COVID-19; SARS-CoV-2; Prospective national cohort; Longitudinal study; Epidemiology; Cross-sectoral; Population-based (1)
COVID-19; COVID-19; SARS-CoV-2; stroke; survey; telemedicine (1)
COVID-19; CT; PNEUMONIA; COHORT; COVID-19; computed X-Ray tomography; pneumonia; artificial intelligence; lung volume measurements; laboratory tests (1)
; COVID-19; dataset; machine learning; vulnerability index (1)
CoViD-19, D-Dimer, Lungenarterienembolie, Pandemie (1)
; COVID-19; deep learning; machine learning; materials science; outcomes research; clinical practice guidelines; artificial intelligence (1)
COVID-19; DELAYS; UK; SARS-CoV-2; COVID-19; Oncologic surgery; Oncology; Patient care (1)
COVID-19; Dyspnoea; Saturation; Vaccination (1)
; COVID-19; Epidemiology; Symptom duration; Risk factors; Infection control (1)
COVID-19; extracorporeal membrane oxygenation; interhospital transfer (1)
COVID-19; Extracorporeal membrane oxygenation; Patient selection (1)
COVID-19; Germany; PCR; Pooling; Gargle; Hospital; Pandemic (1)
; COVID-19; Hospital personnel; Seroprevalence; Antibody status; SARS-CoV-2 (1)
;Covid-19 infection; BioNTech; Pfizer (BNT162b2) vaccine; Immunocompromised patients; Transplant recipients; Immunogenicity (1)
COVID-19; intensive care; mortality; free cholesterol; cholesteryl ester; bacterial infection (1)
COVID-19; liver cirrhosis; sepsis; mortality (1)
COVID-19; liver cirrhosis; sex; survival; lipopolysaccharide-binding protein (1)
COVID-19; liver cirrhosis; ventilation; diabetes; hypertension; intensive care; mortality (1)
COVID-19 - Lymphocyte - Nervous system - Post-COVID - SARS-CoV-2 (1)
COVID-19; lysophosphatidylcholine; sepsis; mortality (1)
COVID-19; Machine learning; Predictive model; Advanced stage; Complicated stage; LEOSS (1)
COVID-19, Metabolismus, T-Zellen (1)
COVID-19; Music; Salutogenesis; Stress relief; Public health communication (1)
; COVID-19; neurological manifestations; SARS-CoV-2 (1)
COVID-19, pandemic, digital transformation, digital innovation, healthcare, telemedicine, artificial intelligence, machine learning, mobile applications, big data (1)
; COVID-19 pandemic; Palliative patient; Outpatient palliative care; Protective measures; Telemedicine (1)
COVID-19 pandemic, Parental mental health, Anxiety, Depression, Pandemic-related stressors, Parents of preschool children (1)
COVID-19; Pandemic; Remdesivir; SARS-CoV-2; Steroid (1)
; COVID-19; Pandemics; Medical education; Medical students; Medical schools; Distance education; Digital teaching and learning; New Normal; Evaluation study (1)
COVID-19-Pandemie, Corona-Virus, (1)
COVID-19, Pandemie, Gliomen (1)
COVID-19-Pandemie; Psychische Belastung; Angst; Stress; Kindertagesstätten; Kita; Quarantäne; Isolation; Eltern; Kita-Beschäftigte (1)
COVID-19; pathology; biosafety; lung cancer; activity (1)
COVID-19, Physical activity, Sedentary behavior, Lockdown, Pandemic restrictions, Depression (1)
COVID-19 pneumonia; CT; morphology; severity; duration (1)
COVID-19; presepsin; SARS-CoV-2; herpes simplex virus; bacterial superinfection (1)
COVID-19; prognosis; IGFBP-2; intensive care; mortality; procalcitonin (1)
; COVID-19; quarantine; SARS-CoV-2 infection; sick leave; vaccine reactogenicity (1)
COVID-19; REHABILITATION; 31ST; Post-COVID syndrome; healthcare costs; treatment procedures; epidemiology (1)
COVID-19; RESPONSES; IMMUNITY; MEMORY; T-Track((R)) SARS-CoV-2; COVID-19; T cells; T-cell immunity; RT-qPCR; CXCL10; IFNG; SARS-CoV-2; S1 antigen; NP antigen (1)
COVID-19, SARS-CoV-2, Adrenomedullin, Interleukin-6, Acute Kidney Injury (1)
COVID-19; SARS-CoV-2; COVID-19; Liver injury; Hemophagocytic lymphohistiocytosis; Wilson's disease (1)
COVID-19; SARS-CoV-2; Germany; pool gargle; RT-qPCR; antigen test (1)
; COVID-19; SARS-CoV-2; health care workers; vaccination; immunologic response; antibodies; seroprevalence; breakthrough infections; ORCHESTRA (1)
COVID-19, SARS-CoV-2, HSV, Herpes-Simplex-Virus, Intensivmedizin, critical care, ECMO (1)
COVID-19, SARS-CoV-2, Intensivstation, Isolationsstation, erste Infektionswelle (1)
; Covid-19; SARS-CoV-2 pandemic; restructuring; university hospitals; Oto-Rhino-Laryngology (ORL); patient care (1)
COVID-19; SARS-CoV-2 pandemic; University hospitals; Otorhinolaryngology; ORL; Research; Teaching; Specialist training; Residency (1)
COVID-19; SARS-CoV-2; school-testing; pool-PCR; gargle; children; rural; urban; implementation; evaluation; transmission (1)
; COVID-19 smell taste recovery psychophysical (1)
; COVID-19; statistics & research methods; information technology (1)
COVID-19; Stroke; Telestroke; Lockdown; Thrombolysis (1)
COVID-19; treatment effect; unemployment (1)
Covid-19 T-Zellhypoaktivität T-Zelldownstreameffekt Responderzellen Hemmender Faktor Plasma (1)
COVID-19; UK (1)
COVID 19; Vaccination and immunization; Medical risk factors; Booster doses; Fear; SARS CoV 2; Hospitalizations; Vaccine development (1)
; COVID-19; vaccination; BNT162b2; immunogenicity; reactogenicity; sex (1)
; COVID-19; vaccination; BNT162b2; reactogenicity; immunogenicity; booster (1)
; Covid-19; Vaccination; Health care workers; Vaccine hesitancy (1)
COVID-19; Vaccination; Intention to vaccinate; Willingness to vaccinate; Children (1)
COVID-19; Vergleich; Prädiktoren; Intensivpatienten (1)
COVID-19, VV ECMO, Outcome (1)
COVID-19; WORKERS; CANCER; HEALTH; (1)
COVID, COVID-19, Hyperinflammation, ECMO, extrakorporale Membranoxygenierung, CRP, Interleukine, mechanische Beatmung (1)
COVID/ HNSCC/ Pandemie/ Kopf-Hals-Tumore (1)
Cox-2, Renin-Angiotensin-Aldosteron-System, Renin (1)
CP2K, input structure, molecular dynamics, ab-initio electronic structure (1)
CPAP, Compliance, OSAS, obstruktive Schlafapnoe (1)
CPAP, Schlafapnoe, Langzeitcompliance (1)
CPAP-Therapie, Herzinsuffizienz, zentrale Schlafapnoe, Herzfrequenzvariabilität, Baroreflexsensitivität, Chemoreflexsensitivität, heart failure, central sleep apnea (1)
CpBIG, phosphorus, organometallic chemistry, supramolecular chemistry, manganese, small molecule activation, fullerene, chalcogene, pentaphosphaferrocene, arsenic, radical (1)
CPET; COVID-19; postdischarge dyspnoea; post-COVID-19 syndrome (1)
CPG, central pattern generator; RPeD1, right pedal dorsal 1; RSK, ribosomal S6 kinase; US, unconditioned stimuli (1)
CpG, epigenetic control, transgene expression, epigenetische Kontrolle, Transgen-Expression, gene therapy, Gentherapie (1)
CPG ISLAND METHYLATION; MICROSATELLITE-UNSTABLE ADENOCARCINOMAS; SPORADIC COLORECTAL CANCERS; HYPERPLASTIC POLYPS; PROMOTER HYPERMETHYLATION; BETA-CATENIN; GENETIC ALTERATIONS; COLON POLYPS; DNA; INSTABILITY; gastrointestinal adenoma; methylation; sessile serrated; classical (1)
CPG METHYLATION; MICE; MODIFIERS; PATTERNS; GENES; LOCUS; CELLS; TWINS; (1)
CRAB; ATLANTIC; GRAPSIDAE; COAST; UCA; Distribution expansion; morphological variation; intraspecific variability (1)
CRAB; DECAPODA; SEXDENTATUS; Hemigrapsus sexdentatus; Brachynotus; Cyclograpsus; taxonomy; Crustacea; Decapoda (1)
CRABS; Taxonomy; Brachyura; Sulawesi; Palau; Parasesarma (1)
Crane sequencing; Place assignment; Warehouse; Test instances; Test set; Benchmark (1)
CRANIAL BASE; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; SKULL BASE; CELL-LINE; CARTILAGE; CATALASE; PROLIFERATION; (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; ANTERIOR GUIDANCE; GLENOID FOSSA; MOVEMENT; MORPHOLOGY; (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; MANDIBULAR MOVEMENTS; FACIAL GROWTH; HEIGHT; CHILDREN; kinematics; protrusion; condylar path inclination; growth changes (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; PROTRUSION; MORPHOLOGY; MOVEMENT; HEIGHT; SYSTEM; Condylar path inclination angle; Articular eminence; Temporomandibular joint; JMA-System; Growth-related changes; Children compared to adults (1)
CRANIOFACIAL MORPHOLOGY; MASTICATORY FUNCTION; SOFT DIET; cranial sutures; growth; histology; histomorphometry (1)
CRANIOFACIAL RESECTION; TUMORS; COMPLICATIONS; SINUS; quality of life; malignancies; anterior skull base; tumor (1)
craniomandibular dysfunction; occlusal appliance; splint, history; treatment protocol; dental materials (1)
Cranioplasty, computer-aided design/computer-aided manufacturing, encephalitis, intracranial pressure, meningococcal disease, meningitis, Neisseria meningitidis, W/Y-135 (1)
CRANIOSPINAL RADIATION-THERAPY; CENTRAL-NERVOUS-SYSTEM; QUALITY-OF-LIFE; BLOOD-BRAIN-BARRIER; ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; NONMETASTATIC MEDULLOBLASTOMA; INTERNATIONAL-SOCIETY; CLINICAL-TRIALS; ACUTE TOXICITY; medulloblastoma; adult; clinical trial; randomized; subgrouping; cerebrospinal fluid; magnetic resonance imaging; radiotherapy; chemotherapy; targeted therapy (1)
craniotomy meningioma polymethyl methacrylate surgical procedures, operative world health organization neurosurgical procedures craniectomy (1)
CRAZY-PAVING PATTERN; CHEST CT; COVID-19; SARS-CoV-2; Outcome; Prognostic factors; Pneumonia; Computed tomography (1)
CRC, MSI, CIN, FISH (1)
C-REACTIVE PROTEIN; ASSOCIATION TASK-FORCE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; NT-PROBNP; COST-EFFECTIVENESS; TROPONIN-T; PRACTICE GUIDELINES; COLLABORATIVE CARE; ACCF/AHA GUIDELINE; (1)
C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; EPIC-NORFOLK; SERUM-LEVELS; HEALTHY-MEN; EVENTS; ASSOCIATION; RISK; ATHEROGENESIS; (1)
C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; OF-FUNCTION MUTATION; RECEPTOR ANTAGONIST; RHEUMATOID-ARTHRITIS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; IN-VITRO; RISK; ANAKINRA; lone atrial fibrillation; interleukin polymorphism; CRP (1)
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; RECIPIENTS; MORTALITY; COMPLEMENT; ATHEROSCLEROSIS; HEMODIALYSIS; NEPHROPATHY; DEATH; C-reactive protein; Leukocytes; Acute rejection (1)
C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; INSTRUMENTATION SURGERY; WOUND-INFECTION; HIP; (1)
C-REACTIVE PROTEIN; HEART-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; SYMPTOMS; INTERLEUKIN-6; MORTALITY; ASSOCIATION; CHOLESTEROL; MECHANISMS; cardiovascular disease; cell adhesion molecules; immunology; inflammation; nervous system (1)
C-REACTIVE PROTEIN; HEART-DISEASE; RISK; SUBFRACTIONS; CHOLESTEROL; PREVENTION; MORTALITY; HISTORY; EVENTS; AGE; (1)
C-REACTIVE PROTEIN; HEMOLYTIC-UREMIC SYNDROME; ENDOTHELIAL-CELLS; BINDING-SITES; HEPARIN; VARIANT; RISK; POLYMORPHISM; REGULATOR; DRUSEN; complement age-related macular degenartion; complement control; C-reactive protein; disease mechanisms (1)
C-REACTIVE PROTEIN; HEPATIC RESECTION; PROGNOSTIC SCORE; SURVIVAL; INFLAMMATION; METASTASES; CHEMOTHERAPY; RECURRENCE; DEFINES; SYSTEM; colorectal cancer; oligometastases; clinical score; predictive score; surgical resection; liver metastases; overall survival (1)
C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; PPAR-GAMMA; CANCER; SURVIVAL; THERAPY; INTERLEUKIN-6; CHEMOTHERAPY; COMBINATION; TARGET; Metastatic renal cell carcinoma; Anti-inflammatory agents; Metronomic chemotherapy; C-reactive protein; Tumor microenvironment (1)
C-REACTIVE PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; FAT DISTRIBUTION; METABOLIC RISK; HEALTHY-SUBJECTS; PLASMA RESISTIN; Chronic inflammation; Visceral adipose tissue; Subcutaneous adipose tissue; Ultrasonography (1)
C-REACTIVE PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLASMA LEPTIN CONCENTRATIONS; BODY-MASS INDEX; CELLS IN-VITRO; HELICOBACTER-PYLORI; HEART-DISEASE; UNITED-STATES; RISK-FACTORS; CANCER-RISK; (1)
C-REACTIVE PROTEIN; OBSTRUCTIVE SLEEP-APNEA; POSITIVE-PRESSURE VENTILATION; DISORDERS; WOMEN; obesity-hypoventilation syndrome; chronic hypercapnic respiratory; failure; body-mass index; prognostic factors; survival (1)
C-REACTIVE PROTEIN; OXIDATIVE STRESS; IMMUNE-SYSTEM; INFLAMMATION; RISK; ASSOCIATION; IMMUNOSENESCENCE; TRYPTOPHAN; NEOPTERIN; PHENYLALANINE; Frailty; Immune activation; Kynurenine/tryptophan ratio; Neopterin; Phenylalanine/tyrosine ratio; C-reactive protein (1)
C-REACTIVE PROTEIN; PERSISTENT ORGAN FAILURE; CRITICALLY-ILL PATIENTS; HYPERLIPIDEMIC PANCREATITIS; PROGNOSTIC ACCURACY; EARLY PREDICTION; IONIZED CALCIUM; SERUM-CALCIUM; APACHE-II; MORTALITY; (1)
C-REACTIVE PROTEIN; PREDICTING BACTEREMIA; CANCER-PATIENTS; INFLAMMATION; NEUTROPENIA; DIAGNOSIS; MARKERS; SEPSIS; MODEL; FEVER; (1)
C-REACTIVE PROTEIN; SEPSIS; MORTALITY; OBESITY; ASSOCIATION; INFECTION; ADIPOKINE; ETIOLOGY; COVID-19; adiponectin; liver cirrhosis; sex; pancreatitis; survival (1)
C-REACTIVE PROTEIN; SERUM AMYLOID-A; CORONARY-ARTERY-DISEASE; E-DEFICIENT MICE; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; EXPRESSION; CHEMOATTRACTANT; INTERLEUKIN-6; CELLS; (1)
C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATORY RESPONSE; OPEN-HEART-SURGERY; CARDIOPULMONARY-BYPASS; CARDIOVASCULAR-SURGERY; LIVER-TRANSPLANTATION; SERUM PROCALCITONIN; KINETICS; INTERLEUKIN-6; CYTOKINES; cardiac surgery; cardiopulmonary bypass; extracorporeal membrane oxygenation; major adverse event; pediatric cardiac surgery; procalcitonin (1)
C-REACTIVE PROTEIN; UNTREATED MELANOMA; IPILIMUMAB; NIVOLUMAB; CANCER; PEMBROLIZUMAB; MUTATIONS; GENES; Ipilimumab; Pembrolizumab; Nivolumab; Immune checkpoint blockade; Uveal melanoma; Biomarker (1)
C-REACTIVE PROTEIN; VISUAL IMPAIRMENT; DRUSEN; POLYMORPHISM; ACTIVATION; DISEASE; COMMON; FORM; CRP; INFLAMMATION; (1)
CREATINE-KINASE-BB; CARDIAC TROPONIN-I; ISOENZYME ACTIVITY; BIOMARKERS; DIAGNOSIS; MARKERS; SERUM; ACID; cerebrospinal fluid; creatine kinase; fatal traumatic brain injury; postmortem biochemistry (1)
CREATINE-KINASE LEVELS; VITRO CONTRACTURE TEST; HYPER-CK-EMIA; METABOLIC TEST; INTRAMUSCULAR INJECTION; IDIOPATHIC HYPERCKEMIA; MUSCLE BIOPSY; SUSCEPTIBILITY; HALOTHANE; CAFFEINE; halothane; hyperCKemia; malignant hyperthermia; metabolic test; microdialysis (1)
; Creatine kinase; Myopathy; Organ damage; Energy metabolism; Rhabdomyolysis (1)
Creation, digital twin, simulation, smart manufacturing (1)
creativity; implicit theory of creativity; cross-cultural study; stereotypes (1)
Creativity, Virtual Reality, Room Size, Environment (1)
CREDIT CRISIS; RISK; (1)
Credit default swaps; Cross-section; Systematic risk (1)
credit default swap, structural model, default boundary, the Green function, calibration (1)
CREDIT; INFORMATION; EFFICIENCY; TESTS; Banking; Foreign entry; Mode of entry; Interest rate; Asymmetric information (1)
Creditor Protection; Company Law; Europe; European Company Law; Symposium Max Planck Institute; Ludwig Maximilians University (1)
credit risk; correlation; probability of default; loss given default; recovery; tobit model (1)
Credit risk; Credit ratings; Asset4; CSP; CSR; Sustainability (1)
Credit Risk, Credit Ratings, Probability of Default, Bank Regulation (1)
CREDIT RISK; DEFAULT; MODELS; LOANS; Bayesian estimation; Maximum likelihood estimation; Model risk; Mortgage; Value-at-risk (1)
CREDIT RISK; FINANCIAL RATIOS; SAMPLE SELECTION; TERM STRUCTURE; MIXTURE MODEL; SURVIVAL-DATA; BANKRUPTCY; RECOVERY; SPREADS; FAILURE; Finance; Risk analysis; Risk management (1)
CREDIT RISK; RECOVERY RATES; TERM STRUCTURE; DEFAULT PROBABILITIES; EMPIRICAL-EVIDENCE; CORPORATE-DEBT; BANKRUPTCY; INSURANCE; RATINGS; MODEL; (1)
credit risk, resolution time, dependency, downturn, lifetime expected loss, loss given default, probability of default (1)
CRENARCHAEON SULFOLOBUS; THERMOPROTEUS-TENAX; EUKARYAL VIRUSES; GENUS ACIDIANUS; FAMILY; SIRV1; HOST; IDENTIFICATION; ENVIRONMENTS; ORGANIZATION; (1)
Crenarchaeota , Sippenauer Moor , Schwefelquelle , Bakterien , Biozönose , Archaeen , Thiothrix , psychrophil , mikrobielle Lebensgemeinschaft , sulfidische Quellen , Crenarchaeota , Archaea , Sulfidic springs , Psychrophilic , Microbial community (1)
CREUTZFELDT-JAKOB-DISEASE; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; EPITHELIAL-CELLS; SCRAPIE ISOFORM; CULTURED-CELLS; E200K MUTATION; LIPID RAFTS; BIOCHEMICAL-PROPERTIES; NEUROBLASTOMA-CELLS; CONVERSION; Creutzfeldt-Jakob disease; detergent-resistant microdomains; Gerstmann-Straussler-Scheinker syndrome; heterozygosity; mutant PrP; PrP; PrPC (1)
CREUTZFELDT-JAKOB-DISEASE; TICK-BORNE ENCEPHALITIS; DIFFUSION-WEIGHTED MRI; CENTRAL-NERVOUS-SYSTEM; IMAGING FINDINGS; VIRUS INFECTION; MANIFESTATIONS; DIAGNOSIS; VARIANT; (1)
crisis, crisis poetry, anthologies (1)
crisis novel, dystopia, Generation X, memory, identity (1)
crisis, Spain, economy, law, society, politics, youth, culture, literature, cinema (1)
CRISPR-Cas9, Genom-Editierung, genome editing, Haplotyp, haplotype, DNA-cleavage, gene knock-out, Gen Knock-Out, gene therapy, Gentherapie, Morbus Best, Best'sche vitelliforme Makuladystrophie, vitelliform macular dystrophy, Erbkrankheit, hereditary disease (1)
CRISPR-Cas9 genome editing, Cardiomyopathy, Acquired cardiovascular disease, CaMKIIδ, Translational cardiology (1)
CRISPR/Cas9, M. Best, Haplotypen (1)
CRITERIA; ARTERIES; Continuing education; Diagnostics; Ultrasound; Surveillance; Endovascular aortic repair (1)
Critical care interhospital transfer, Cardiopulmonary failure, Veno-arterial ECMO, Out of center, Indication criteria, Outcome, Cerebral performance category (CPC), ECOG performance status (1)
Critical Discourse Analysis; Presidential Rhetoric; Twitter; U.S. politics (1)
CRITICAL FIELDS; TRANSITION; SUPERLATTICES; TEMPERATURES; MULTILAYERS; RESISTIVITY; GADOLINIUM; NIOBIUM; GROWTH (1)
criticality, many-body physics, semiclassical physics, out-of-time-ordered correlator, information scrambling (1)
CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERY-DISEASE; VEIN; REVASCULARIZATION; FEMOROPOPLITEAL; MANAGEMENT; GRAFTS; RISK; chronic limb-threatening ischemia (CLTI); dialysis; heparin-bonded expanded polytetrafluoroethylene (HePTFE); peripheral artery disease (PAD); vascular surgery; chronic kidney disease (CKD) (1)
CRITICAL LIMB ISCHEMIA; PREDICT CARDIOVASCULAR EVENTS; ACUTE MYOCARDIAL-INFARCTION; HUMAN ATHEROSCLEROSIS; EXPRESSION; HETEROGENEITY; INFLAMMATION; MARKERS; CELLS; ADHESION; (1)
; critically endangered; ecology; endemic; Veronica officinalis (1)
CRITICALLY-ILL ADULTS; DISEASE; MANAGEMENT; (1)
CRITICALLY-ILL CHILDREN; INTENSIVE-CARE-UNIT; INTRAOPERATIVE HYPERGLYCEMIA; HYPOGLYCEMIA; (1)
Critically ill; Intensive care unit; Model-informed precision dosing; Population pharmacokinetics; Sepsis; Therapeutic drug monitoring (1)
CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INFLAMMATORY RESPONSE SYNDROME; CONTRAST-INDUCED NEPHROPATHY; RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE-UNIT; SEPTIC SHOCK; REPLACEMENT THERAPY; DOUBLE-BLIND; Septic acute renal failure; Renal ischemia; Proinflammatory mediators; Nephroprotection; Renal replacement therapy (1)
CRITICALLY ILL PATIENTS; BEDSIDE CHEST RADIOGRAPHY; UNIT; TRANSPORT; CT; EFFICACY; UTILITY; computed tomography; bedside chest X-ray; intensive care unit; thoracic radiography (1)
CRITICALLY-ILL PATIENTS; BLOOD-GLUCOSE; PERITONEAL-DIALYSIS; TEST STRIPS; GLUCOMETERS; METERS; ICODEXTRIN; ACCURACY; ERROR; ANEMIA; (1)
CRITICALLY-ILL PATIENTS; CAPILLARY-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; BIOLOGICAL-FLUIDS; VALIDATED METHOD; OLD ANTIBIOTICS; HPLC-MS/MS; SAMPLES; HUMANS; Antibiotics; Fosfomycin; LC MS/MS; Pharmacokinetic; Therapeutic drug monitoring (1)
CRITICALLY-ILL PATIENTS; CYCLE ARREST BIOMARKERS; ACUTE-RENAL-FAILURE; MECHANICAL VENTILATION; OUTCOMES; MULTICENTER; TRIAL; AKI; VALIDATION; THERAPY; Early diagnosis; Health care economics; Myocardial infarction; Acute respiratory distress syndrome; Sepsis (1)
CRITICALLY-ILL PATIENTS; DEFINING ANTIBIOTIC LEVELS; HEALTH-CARE PROFESSIONALS; CEREBROSPINAL-FLUID; PROLONGED INFUSION; DOSING RESULT; UNIT PATIENTS; TAZOBACTAM; PHARMACODYNAMICS; TISSUE; Piperacillin; Cerebral microdialysis; Acute hemorrhagic stroke; Population pharmacokinetics; Probability of target attainment (1)
CRITICALLY-ILL PATIENTS; EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE LUNG INJURY; INTENSIVE-CARE; OUTCOMES; VENTILATION; EXPERIENCE; PRESSURE; PROTOCOL; VOLUME; Inter-hospital transfer; ARDS; Quality of care (1)
CRITICALLY-ILL PATIENTS; GLOMERULAR-FILTRATION-RATE; BETA-LACTAM ANTIBIOTICS; CARE-UNIT PATIENTS; CREATININE CLEARANCE; SERUM CREATININE; CYSTATIN-C; RENAL-FUNCTION; INTERMITTENT; VOLUNTEERS; critical care; nosocomial infection; pharmacodynamics; cystatin C; renal function (1)
CRITICALLY-ILL PATIENTS; HEPARIN-INDUCED THROMBOCYTOPENIA; COAGULOPATHY; Thrombocytopenia; Disseminated intravascular coagulation; Differential diagnostics; Hemorrhagic disorders; Hemostasis (1)
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; DEPENDENT PROTEIN-BINDING; TARGET SITE PENETRATION; TISSUE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; DISTRIBUTION TERMS; APACHE-II; IN-VITRO; SEPSIS; (1)
CRITICALLY-ILL PATIENTS; INTRAHOSPITAL TRANSPORT; Helicopter emergency medical service; Transport; Ventilator; Emergency room; Handover (1)
CRITICALLY-ILL PATIENTS; LIVER-MICROSOMES; UNBOUND FRACTION; PROTEIN-BINDING; THYROID-HORMONE; P-GLYCOPROTEIN; PHARMACOKINETICS; PLASMA; RIFAMPIN; PATIENT; critical illness; pharmacokinetics; Gram-positive infection; antimicrobial agents (1)
CRITICALLY ILL PATIENTS; MAJOR ELECTIVE SURGERY; PREOPERATIVE OPTIMIZATION; HEMODYNAMIC THERAPY; NONCARDIAC SURGERY; CONTROLLED-TRIAL; OXYGEN DELIVERY; HOSPITAL STAY; MORTALITY; COMPLICATIONS; Monitoring; Intraoperative: stroke volume variation; Individualized fluid therapy; Goal directed therapy; High-risk surgical patients; Postoperative complications (1)
CRITICALLY-ILL PATIENTS; NECROTIZING FASCIITIS; COMPUTED-TOMOGRAPHY; INTRAHOSPITAL TRANSPORT; ACUTE APPENDICITIS; ACUTE STROKE; CT; HEMORRHAGE; CANCER; Magnetic resonance imaging; Severely ill patients; Emergency; MRT-Indication; MRT-Diagnosis (1)
CRITICALLY-ILL PATIENTS; PROLONGED-INFUSION; POPULATION PHARMACOKINETICS; TAZOBACTAM; ANTIBIOTICS; RISK; PHARMACODYNAMICS; MICRODIALYSIS; INFECTIONS; OVERWEIGHT; piperacillin; tazobactam; target-site; obesity (1)
CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; DRUGS; PHARMACOKINETICS; PH; MICRODIALYSIS; VANCOMYCIN; DOCETAXEL; HPLC; Antiinfectives; Protein binding; Patients; Polyethersulfone; Regenerated cellulose (1)
CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; PHARMACOKINETICS; INFECTIONS; PHARMACODYNAMICS; PLASMA; IMPACT; SERUM (1)
CRITICALLY-ILL PATIENTS; PULMONARY ASPERGILLOSIS; COVID-19; MORTALITY; amphotericin B; COVID-19; COVID-19 vaccination; fungal infection; isavuconazole; mortality; mucormycosis; prevalence (1)
CRITICALLY ILL PATIENTS; PULSE-CONTOUR ANALYSIS; OUTPUT MEASUREMENT; INTRAVASCULAR VOLUME; DILUTION TECHNIQUE; CARE; SURGERY; cardiac surgery; cardiac output; preload; intrathoracic blood volume (1)
CRITICALLY-ILL PATIENTS; RENAL-FUNCTION; INTERMITTENT INFUSION; STEADY-STATE; PHARMACOKINETICS; COCKCROFT; FORMULA; 2-HOUR; MARKER; GAULT; HPLC; Pharmacokinetics; ICU; Cystatin C; Creatinine clearance; Dosing (1)
CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; LIFE-SUPPORT; DISTRESS-SYNDROME; ADULTS; RIFLE; ECMO; HEMOFILTRATION; EXPERIENCE; PROGNOSIS; acute kidney injury; acute respiratory distress syndrome; extracorporeal membrane oxygenation (1)
CRITICALLY-ILL PATIENTS; RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE-UNIT; INFECTIOUS-DISEASES SOCIETY; STRESS-ULCER PROPHYLAXIS; COMBINATION ANTIBIOTIC-THERAPY; ACUTE LUNG INJURY; RENAL-REPLACEMENT THERAPY; END-EXPIRATORY PRESSURE; EARLY ENTERAL NUTRITION; (2)
CRITICALLY-ILL PATIENTS; RESPIRATORY-FAILURE; SYSTEM; LUNG; Miniaturized extracorporeal membrane oxygenation; Inter-hospital transport; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation (1)
CRITICALLY-ILL PATIENTS; THERAPY; STATES; End-of-Life Decision-Making; Intensive Care; Advance Directives; DRG System (1)
CRITICALLY-ILL PATIENTS; VENTILATOR-ASSOCIATED PNEUMONIA; PROTEIN-BINDING; ULTRAVIOLET DETECTION; HUMAN PLASMA; HUMAN-SERUM; PHARMACOKINETICS; PHARMACODYNAMICS; ULTRAFILTRATION; VOLUNTEERS; protein binding; carbapenems; beta-lactams; pharmacokinetics; pharmacodynamics (1)
CRITICAL MICELLE CONCENTRATION; FLUORESCENT-PROBE; SURFACTANTS; SOLVENT; spectroscopy; detergent micelles; protein-detergent complexes; labeling; solvatochromic dyes (1)
CRITICAL MICELLE CONCENTRATION; RAT-LIVER MICROSOMES; FUNCTIONAL RECONSTITUTION; O-ACYLTRANSFERASE; PIG SPLEEN; DETERGENT; LYSOPHOSPHATIDYLCHOLINE; ACID; DEPENDENCE; RECEPTOR; acyltransferase; n-octyl glucopyranoside; Chaps; solubilization; photoaffinity labeling (1)
CRITICAL MICELLE CONCENTRATIONS; CATIONIC SURFACTANTS; RAYLEIGH RATIO; DTAB MICELLES; PURE LIQUIDS; SYSTEMS; BROMIDE; RELAXATION; COUNTERION; DIFFUSION; (1)
CRITICAL ROLES; GROWTH; EXPRESSION; CELLS; CCR2; peritoneum; macrophages; adhesion formation; monocytes; post-surgery (1)
CRITICAL SOLUTION TEMPERATURE; GAMMA-CYCLODEXTRIN; HOFMEISTER ANIONS; HYBRID ASSEMBLIES; WATER-STRUCTURE; TRANSITION; PNIPAM; MACROMOLECULES; IONS; HETEROPOLYANIONS; (1)
critical success factors, performance management, performance measurement, process performance management (1)
; crizotinib; anaplastic large cell lymphoma; ALK; relapse; hematology (1)
CRM-Prozesse (1)
CRM, Relationship Values (1)
Crohn disease, Fecal incontinence, Surgical flaps, Surgical stomas Morbus Crohn, Stuhlinkontinenz, Fistelverschluss, Rezidivfisteln (1)
Crohn-Krankheit , Colitis ulcerosa , Mucine , DNS-Chip , Chronische Darmentzündung , Differentielle Genexpression , Chronisch Entzündliche Darmerkrankungen , real-time RT-PCR , allelische Diskriminierung , Inflammatory Bowel Disease , mucins , DNA-microarray , real-time RT-PCR , allelic discrimination (1)
Crohn-Krankheit , Operationstechnik , Körperbild , Lebensqualität , Morbus Crohn , Ileozökalresektion , Crohns Desease , ileocolic resection (1)
CROHNS-DISEASE; ADIPOSE-TISSUE; CREEPING FAT; METABOLIC SYNDROME; INSULIN ACTION; EMERGING ROLE; ADIPOCYTOKINES; ADIPONECTIN; RESISTIN; SECRETION; (1)
CROHNS-DISEASE; COLONOSCOPY; SONOGRAPHY; SUSCEPTIBILITY; ASSOCIATION; RECURRENCE; ULTRASOUND; POUCHITIS; MUTATION; COLITIS; (1)
CROHNS-DISEASE; competence network; inflammatory bowel disease (IBID); Crohn's disease; colitis ulcerosa; research association; study centers; research into patient care; standards of organization; core facilities; database (1)
CROHNS-DISEASE; CT COLONOGRAPHY; CONVENTIONAL ENTEROCLYSIS; EXTRACOLONIC FINDINGS; VIRTUAL COLONOSCOPY; TREATMENT RESPONSE; ABDOMEN; PREVALENCE; ULTRASOUND; DISORDERS; (1)
CROHNS-DISEASE; DIVERTICULAR-DISEASE; COLONIC HEMORRHAGE; NATURAL-HISTORY; MANAGEMENT; SCINTIGRAPHY; COLECTOMY; DIAGNOSIS; PATIENT; EMBOLIZATION; lower gastrointestinal; bleeding; therapeutic strategies; surgical techniques (1)
CROHNS-DISEASE; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; CELL-PROLIFERATION; REDUCED EXPRESSION; FIBROBLASTS; INTEGRIN; FIBRONECTIN; ADHESION; ALPHA-2-BETA-1; Crohn's disease; Collagen XVI; Myofibroblast; Integrin; Fibrillin-1; Focal adhesion contact; Inflammation (1)
Crohn’s disease, fibrosis, strictures, myofibroblasts, migration, wound healing, focal adhesion kinase (1)
CROHNS-DISEASE; FRAMESHIFT MUTATION; ASCITIC FLUID; TRANSLOCATION; ASSOCIATION; SUSCEPTIBILITY; NOD2/CARD15; OVERGROWTH; PREVALENCE; MORTALITY; bacterascites; bacterial translocation; cirrhosis; mortality; NOD2 gene; spontaneous bacterial peritonitis (1)
Crohn`s disease, immunhistochemical feature, disease behavior, Morbus Crohn, Krankheitsverlauf, Immunhistochemie (1)
CROHNS-DISEASE; NATURAL-HISTORY; GROWTH FAILURE; POPULATION; CHILDREN; ISSUES; INTERVENTIONS; HYPERTENSION; DISPARITIES; PREVALENCE; (1)
CROHNS-DISEASE; PERIANAL FISTULAS; ENTEROCLYSIS; SIGN; CT; Crohn's disease; Diagnosis; Inflammatory bowel disease; Magnetic resonance imaging; Ultrasound (1)
CROHNS-DISEASE; TIME (1)
Crohn’s disease; ulcerative colitis; lysophosphatidylcholine; corticosteroid; biomarker (1)
CROHNS-DISEASE; ULCERATIVE-COLITIS; OLMSTED COUNTY; ENVIRONMENTAL-INFLUENCES; SOUTHEASTERN NORWAY; URBAN-POPULATION; EPIDEMIOLOGY; PREVALENCE; COPENHAGEN; MINNESOTA; Crohn's disease; incidence; inflammatory bowel disease; population-based cohort; ulcerative colitis (1)
CROHNS-DISEASE; VIRTUAL COLONOSCOPY; CT COLONOGRAPHY; ULCERATIVE-COLITIS; COLORECTAL POLYPS; MR ENTEROCLYSIS; PREFERENCES; ENDOSCOPY; DIAGNOSIS; ACCEPTANCE; (1)
CROP POLLINATION SERVICES; AGRICULTURAL LANDSCAPES; FUNCTIONAL DIVERSITY; PLANT TRAITS; ECOSYSTEM MULTIFUNCTIONALITY; BIODIVERSITY EVALUATION; SPECIES RICHNESS; FLOWERING PLANTS; MULTIPLE TRAITS; APPLE ORCHARDS; arable land cover; flowering plants; functional diversity; habitat richness; land use; piecewise structural equation models; pollination; species richness; wild bees (1)
Cross-border shopping; Community sorting; Regional integration; Voting; Federalism (1)
CROSS-CORRELATION SPECTROSCOPY; LINKED-IMMUNOSORBENT-ASSAY; FLUORESCENCE CORRELATION SPECTROSCOPY; ALTERNATING-LASER EXCITATION; UP-CONVERSION NANOPARTICLES; PROSTATE-SPECIFIC ANTIGEN; ULTRASENSITIVE DETECTION; QUANTUM DOTS; REAL-TIME; HOMOGENEOUS IMMUNOASSAY; digital assays; immunoassays; optical detection; signal background; single-molecule detection (1)
CROSS-CORRELATION SPECTROSCOPY; SINGLE-MOLECULE DETECTION; BIOTECHNOLOGY; DIAGNOSTICS; (1)
Cross-coupling · Chemoselective · Diarylpyridines · Electrochemical cycloaddition · Electro-flow · π-extended molecules (1)
Cross-coupling • General method • Nickel • Photoredox • Vinyl halide (1)
Cross-coupling · Photocatalysis · Phenols · Biaryls · C–O coupling · Arenes (1)
CROSS-COUPLING REACTION; FLUORESCENT LIGANDS; EFFICIENT SYNTHESIS; BINDING DOMAIN; HECK REACTION; NK2 RECEPTOR; SIDE-CHAINS; PEPTIDES; DESIGN; PEPTIDOMIMETICS; (1)
Cross-coupling reaction; mesoporous graphitic carbon nitride; Nickel; AD-HoC; sustainability (1)
CROSS-COUPLING REACTION; OLIGOTHIENYLFERROCENE COMPLEXES; COORDINATION CHEMISTRY; FERROCENE DERIVATIVES; METAL COMPLEXES; 2,5-DIMETHYLAZAFERROCENE; AZAFERROCENES; ELECTROPOLYMERIZATION; PHOSPHAFERROCENES; LITHIATION; azaferrocene; cross-coupling reaction; cyclic voltammetry; X-ray diffraction (1)
Cross-Coupling Reaction; room-temperature; Copper; 6-hydroxypicolinhydrazide (1)
CROSS-COUPLING REACTIONS; ARYL GRIGNARD-REAGENTS; ALLYL ETHERS; ALKYL-HALIDES; SELECTIVE CLEAVAGE; PROTECTING GROUPS; FACILE; COMPLEXES; OLEFINS; ISOMERIZATION; (1)
CROSS-COUPLING REACTIONS; ASYMMETRIC CATALYSIS; POLYSTYRENE RESIN; ORGANIC CATALYSTS; TERMINAL ALKYNES; CLICK CHEMISTRY; AZIDE-ALKYNE; SOLID-PHASE; COMPLEXES; LIGANDS; (1)
CROSS-COUPLING REACTIONS; ASYMMETRIC TRANSFER HYDROGENATION; FISCHER-TROPSCH SYNTHESIS; ARYL GRIGNARD-REAGENTS; ALKYL-HALIDES; COMPLEXES; HYDROSILYLATION; KETONES; NANOPARTICLES; ACETOPHENONE; domino reactions; EXAFS spectroscopy; Grignard reactions; hydrogenation; iron (1)
CROSS-COUPLING REACTIONS; CATALYTIC C-C; ARYLBORONIC ACIDS; AMINO-ACIDS; POTENT INHIBITORS; FACILE SYNTHESIS; BORONIC ACIDS; ARYLATION; AMINATION; HALIDES; biologically active compounds; boronic acid; copper; N-arylation; palladium (1)
CROSS-COUPLING REACTIONS; CATALYZED C-S; HALOGENATED NITROGEN; BOND FORMATION; VINYL HALIDES; ARYL; PHOTOREDOX; HETEROARYL; LIGAND; REGIOSELECTIVITY; AD-HoC; photoredox catalysis; visible light; nickel; cross-coupling; difunctionalization; (het)arene (1)
CROSS-COUPLING REACTIONS; FORMAL NUCLEOPHILIC-SUBSTITUTION; ALKYL GRIGNARD-REAGENTS; GEM-DIHALOCYCLOPROPANES; SODIUM-BOROHYDRIDE; CARBENE COMPLEXES; ORGANIC-SYNTHESIS; ARYL HALIDES; DERIVATIVES; CHEMISTRY; cross-coupling; small ring systems; grignard reaction; iron; reduction (1)
CROSS-COUPLING REACTIONS; GRIGNARD-REAGENTS; ANIONIC-POLYMERIZATION; REDUCTIVE ELIMINATION; EFFICIENT SYNTHESIS; BOND FORMATION; STYRENE; ALKENES; HALIDES; CARBOMETALATION; cross-coupling; Grignard reactions; iron; olefin complexes; styrenes (1)
CROSS-COUPLING REACTIONS; INTERMOLECULAR INTERACTIONS; OXIDATIVE BROMINATION; CHLORINATION; ARENES; RECOGNITION; IODOBENZENE; EFFICIENT; MODEL; MILD; halogenated phenols; halogen...halogen interactions; hydrogen bonds; molecular crystals; self-assembly (1)
CROSS-COUPLING REACTIONS; METAL NANOPARTICLES; ORGANIC-SYNTHESIS; STABILIZATION; PARTICLES; COMPLEXES; (1)
CROSS-COUPLING REACTIONS; PALLADIUM COMPLEXES; SUPERPARAMAGNETIC NANOPARTICLES; HETEROGENEOUS CATALYST; ORGANIC-SYNTHESIS; SUZUKI REACTION; AQUEOUS-MEDIA; END-GROUPS; WATER; DENDRIMERS; catalyst recycling; dendrimers; magnetic nanoparticles; palladium; Suzuki coupling (1)
CROSS-COUPLING REACTIONS; SELECTIVE OXIDATION; 2-PHASE CONDITIONS; OXOAMMONIUM SALTS; TERMINAL ALKYNES; SOLID-PHASE; ALCOHOLS; CATALYSTS; GEL; KETONES; cobalt; heterogeneous catalysis; magnetic nanobeads; nanoparticles; supported catalysts (1)
CROSS-COUPLING REACTIONS; SUPERCRITICAL CARBON-DIOXIDE; TEMPERATURE IONIC LIQUIDS; ASYMMETRIC HYDROGENATION; BOND FORMATION; SUZUKI; COMPLEXES; WATER; MICROWAVE; FLUIDS; (1)
CROSS-COUPLING REACTIONS; SUPPORTED PALLADIUM CATALYSTS; METAL NANOPARTICLES; HETEROGENEOUS CATALYSIS; PD NANOPARTICLES; COPPER-FREE; COORDINATION POLYMERS; SONOGASHIRA REACTION; REUSABLE CATALYST; HYDROGEN STORAGE; (1)
CROSS-COUPLING REACTIONS; TRANSFER RADICAL POLYMERIZATION; RHODIUM-COMPLEXED DENDRIMERS; SELF-ASSEMBLED MONOLAYERS; PLACE-EXCHANGE-REACTIONS; GOLD CLUSTER MOLECULES; MAGNETIC NANOPARTICLES; COBALT NANOPARTICLES; HYDROFORMYLATION REACTIONS; HIGHLY EFFICIENT; colloids; gold; heterogeneous catalysis; immobilization; magnetic nanoparticles; nanocatalysis (1)
CROSS-COUPLING REACTIONS; TRANSITION-METAL; BASIS-SETS; PHOSPHORUS; MG; COORDINATION; VALENCE; ACCESS; IRON; FE; (1)
CROSS-COUPLING REACTIONS; VITREOUS CARBON CATHODES; ALPHA,BETA-UNSATURATED CARBOXYLIC-ACIDS; COPPER-MEDIATED DIFLUOROMETHYLATION; PERFLUOROALKYL IODIDES; GRIGNARD-REAGENTS; RADICAL-ADDITION; ROOM-TEMPERATURE; TRIFLUOROMETHYLTHIOLATION REACTIONS; FLUOROALKYL IODIDES; (1)
CROSS-COUPLING REACTIONS; WALLED CARBON NANOTUBES; ATMOSPHERIC-PRESSURE CARBONYLATION; OPENING METATHESIS POLYMERIZATION; N-HETEROCYCLIC CARBENES; AQUEOUS-MEDIA; HECK REACTION; SUPERPARAMAGNETIC NANOPARTICLES; HOMOGENEOUS CATALYSIS; COBALT NANOPARTICLES; homogeneous catalysis; immobilization; magnetic properties; nanoparticles; N-heterocyclic carbenes (1)
CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; HEALTH-STATUS; CLINICALLY IMPORTANT; METHODOLOGICAL QUALITY; ARTHROSCOPIC SURGERY; GROIN DISABILITY; QUESTIONNAIRES; VALIDITY; Patient reported outcome (PRO); Hip arthroscopy; Femoro-acetabular impingement syndrome (FAI); Responsiveness; German International Hip Outcome Tool 12 (iHOT12); COSMIN checklist (1)
CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; HEALTH-STATUS; METHODOLOGICAL QUALITY; ARTHROSCOPIC SURGERY; GROIN DISABILITY; QUESTIONNAIRES; VALIDITY; SCORE; Patient-reported outcome (PRO); Hip arthroscopy; Femoro-acetabular impingement syndrome (FAI); Responsiveness; German International Hip Outcome Tool 33 (G-iHOT33); COSMIN checklist (1)
CROSS-CULTURAL ADAPTATION; SYSTEM; TRENDS; patient-reported outcomes; PRO; quality of life; reconciliation; translation guidelines (1)
CROSS-FACE NERVE; ASSESSMENT SCALE; GROWTH-FACTOR; MOTOR-NERVE; AXON REGENERATION; ULNAR NERVE; GRAFT; MUSCLE; ANATOMY; TRANSFERS; axons; analysis; dissection; facial injuries; surgery; facial muscles; innervation; facial nerve; anatomy and histology; humans; nerve fibers; facial paralysis; reconstructive surgical procedures (1)
CROSS-FACE NERVE; MOTOR-NERVE; MUSCLE TRANSPLANTATION; SURGICAL ANATOMY; PAROTID-GLAND; PALSY; REANIMATION; PARALYSIS; GRAFT; SMILE (1)
CROSS-LINKED COLLAGEN; TITANIUM-ALLOY; CELL-ADHESION; AMINO-GROUPS; I COLLAGEN; PROLIFERATION; BIOMATERIALS; ATTACHMENT; DIFFERENTIATION; OSTEOBLASTS; surface modification; steel; tantalum; collagen; coupling agents; cross-linking; mesenchymal stem cells (1)
CROSS-LINKING; ADHESIVE PROTEIN; MYTILUS-EDULIS; COORDINATION CHEMISTRY; BIOMIMETIC ADHESIVES; COATINGS; DOPA; FILMS; COMPLEXES; PEPTIDE; (1)
CROSS-MODAL INTEGRATION; LANGUAGE; PERCEPTION; DYNAMICS; ACCESS; CORTEX; spoken language; discrimination sensitivity; systems interaction; modular theory; embodied theory (1)
CROSS-ORIENTATION SUPPRESSION; VISUAL-CORTEX; HUMAN-VISION; METACONTRAST MASKING; INDUCED BLINDNESS; VELOCITY SIGNALS; BACKWARD-MASKING; STRIATE CORTEX; SUMMATION; SYSTEM; (1)
CROSS-SECTIONAL AREA; DISC DEGENERATION; INTERVERTEBRAL DISC; INTRADISCAL PRESSURE; UNITED-STATES; FAST BOWLERS; RISK-FACTORS; YOUNG; MRI; EPIDEMIOLOGY; horseback riding; magnetic resonance imaging; lumbar spine; degenerative disk disease (1)
CROSS-SECTIONAL AREA; WHOLE-BRAIN ATROPHY; VOLUME LOSS; CERVICAL CORD; DISABILITY; MS; PROGRESSION; RELEVANCE; LESIONS; MRI; brain; MRI; multiple sclerosis; pseudoatrophy; spinal cord (1)
cross-sectional scanning probe microscopy, scanning tunneling microscopy, atomic force microscopy, Kelvin probe force spectroscopy, tip-induced band bending, III-V semiconductor, GaAs, acceptor, iron-II-phthalocyanine molecule, gating (1)
CROSS-SECTIONAL SURVEY; INFORMED-CONSENT; CLINICAL-TRIALS; COGNITIVE DEFICITS; CANCER-PATIENTS; BRAIN-TUMORS; FORMS; PARTICIPATION; READABILITY; GLIOMA; Patient information; Informed consent; Clinical trial; Neuro-oncology; Qualitative analysis; Ethics (1)
CROSS-SECTION; COLLISIONS; EVOLUTION; PAIRS; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
CROSS-SECTION; DIVIDENDS; RISK; Return predictability; Fundamental analysis; Mispricing; Stock returns; European markets (1)
CROSS-SECTION; RETURNS; VOLATILITY; (1)
CROSS-SECTIONS; 2 LOOPS; RENORMALIZATION; GAUGE; QCD; EXPONENTIATION; RESUMMATION; NNLO; Perturbative QCD; Renormalization Group; Resummation; Effective field theories (1)
CROSS-SECTIONS; Perturbative QCD; Resummation; Conformal and W Symmetry; Wilson; 't Hooft and Polyakov loops (1)
CROSS-SECTIONS; RESUMMATION; QCD; EVOLUTION; LOOP; (1)
CROSS-SECTION; W-BOSON; PAIRS; JETS; MASS; (1)
CROUZON-SYNDROME; PRO250ARG MUTATION; CORONAL CRANIOSYNOSTOSIS; IDENTICAL MUTATIONS; PFEIFFER-SYNDROME; GENE CAUSE; FGFR2; (1)
CROWDED CONDITIONS; HARVESTER ANTS; RECRUITMENT; POGONOMYRMEX; BEHAVIOR; MATTER; (1)
Crowdfunding, Entrepreneurial finance, Updates, Investor communication (1)
Crowdfunding, Investor Communication, Entrepreneurial Finance, Sentiment Analysis, Linguistic Devices (1)
Crowdsourcing; Empirical studies in interaction design; Interactive games; Social networks; Natural language processing (1)
crowdsourcing, gamification, landmarks (1)
Crowdsourcing, Human Rights Monitoring, Machine Learning, Natural Language Processing, Social Media, Twitter, Ceasefire, Applications (1)
CROWN THIOETHER CHEMISTRY; TOTAL-ENERGY CALCULATIONS; RAY CRYSTAL-STRUCTURE; AUGMENTED-WAVE METHOD; COORDINATION CHEMISTRY; NMR-SPECTROSCOPY; REDOX PROPERTIES; BASIS-SETS; APPROXIMATION; PENTAPHOSPHAFERROCENE; density functional calculations; molybdenum; phosphorus; silver; supramolecular chemistry (1)
CRPD, Behindertenrechtskonvention, BRK (1)
CRPD, Behindertenrechtskonvention, BRK, Diskriminierung, Entscheidungsspielraum, Beurteilungsspielraum (2)
CRPD, Behindertenrechtskonvention, BRK, Rechtsbehelfserschöpfung, "local remedies rule", "treaty body", Individualbeschwerde (1)
CRPD, "Convention on the Rights of Persons with Disabilities", Behindertenrechtskonvention, BRK, BWahlG (1)
CRPD, UN-BRK, Behindertenrechtskonvention, Völkerrechtsvergleichung (1)
CRSITE3; FERROMAGNETISM; POLARIZATION; FUNDAMENTALS; SPINTRONICS; NANOSHEETS; GRAPHITE; FIELD; graphene; spintronics; heterostructures; proximity exchange (1)
CRT, Kardiale Resynchronisationstherapie, Phrenikusstimulation, Herzinsuffizienz (1)
CRUCIATE LIGAMENT INJURIES; MALE SOCCER PLAYERS; WARM-UP PROGRAM; PROFESSIONAL FOOTBALL; RISK; OSTEOARTHRITIS; METAANALYSIS; Injury; Knee; ACL; Soccer; Prevention; Training (1)
CRUCIATE LIGAMENT INJURIES; PROFESSIONAL FOOTBALL; SOCCER PLAYERS; ANTERIOR; OSTEOARTHRITIS; METAANALYSIS; SURGERY; RETURN; RISK; ACL; ACL injury; Football; Soccer; Return to sports (1)
CRUCIATE LIGAMENT INJURIES; RISK; FOOTBALL; PLAYERS; RETURN; ASSOCIATION; RECURRENCES; STATEMENT; TRENDS; ACL reconstruction; ACL revision; ACL infection; Professional athletes (1)
CRUCIATE LIGAMENT INJURIES; SPORTS INJURIES; TEAM HANDBALL; PHYSICAL PERFORMANCE; MALE FOOTBALL; SITUATIONS; RISK; LEAGUE; handball; injury prevention; contact sports (1)
CRUCIATE LIGAMENT; KINEMATICS; FLEXION; JOINT; PATIENT; PAIN; TKA; (1)
CRUCIATE LIGAMENT RECONSTRUCTION; KNEE; IMPLANTATION; SCAFFOLD; BUNDLE; SYSTEM; Cartilage defect; Navigation; Arthroscopic autologous chondrocytes transplantation (1)
CRUCIATE LIGAMENT RECONSTRUCTION; NEUROMUSCULAR CONTROL; PHYSICAL PERFORMANCE; ACL RECONSTRUCTION; LEG DOMINANCE; LOWER-LIMB; ANTERIOR; INJURY; RETURN; RISK; ACL; Severe; Knee; Injury; Rehabilitation; Return-to-sport; SpeedCourt((R)); Side; Differences; Asymmetry; Change of direction; Side-hop (1)
CRUSTACEA; ALGORITHM; EVOLUTION; INFERENCE; SELECTION; BLOCKS; Decapoda; tropical Eastern Pacific region; molecular phylogeny; 16S rRNA gene (1)
CRUSTACEA BRACHYURA GECARCINUCIDAE; SOUTHEAST-ASIA; ADAPTIVE RADIATION; DECAPODA; BIOGEOGRAPHY; POTAMONAUTIDAE; BIODIVERSITY; PHYLOGENY; DIVERSIFICATION; POPULATIONS; Brachyura; Gecarcinucidae; Parathelphusa; Endemism; Sulawesi; River systems (1)
CRUSTACEA BRACHYURA POTAMIDAE; POPULATION-GROWTH; SPECIES DISTRIBUTIONS; STATISTICAL TESTS; MODEL SIMULATIONS; DNA POLYMORPHISM; GLACIAL REFUGIA; BAYES FACTORS; IRAN; VEGETATION; Alborz Mountains; Caucasus biodiversity hotspot; glacial refugia; Iran; phylogeographic breaks; species distribution modelling (1)
CRUSTACEA; BRAZIL; (1)
CRUSTACEA; Crustacea; Thoracotremata; Parasesarma rahayuae; taxonomy; Indonesia; COX1 (1)
CRUSTACEA DECAPODA BRACHYURA; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; CRYPTIC SPECIATION; PENAEUS-MONODON; PORTUNID CRAB; PARADOX LOST; TIGER PRAWN; DNA; MITOCHONDRIAL; Genetic bottleneck; Invasion history; Taxonomic status; Mitochondrial DNA; Multiple introductions (1)
CRUSTACEA; EVOLUTION; SUBSTITUTION; SEQUENCES; GRAPSIDAE; MODEL; molecular systematics; Thoracotremata; Decapoda; Brachyura; ribosomal RNA; mangrove crabs (1)
Cryoelectron microscopy; Photosystem II (1)
Cryo-electron microscopy, stress response, Osmostress, environmental stress, ER stress (1)
CRYOELECTRON TOMOGRAPHY; ARCHAEON IGNICOCCUS; ABC TRANSPORTER; CAPILLARY TUBES; OUTER-MEMBRANE; SP-NOV; PROTEIN; DIVISION; INSIGHTS; MICROSCOPY; Crenarchaeota; Ignicoccus hospitalis; Nanoarchaeum equitans; ultrastructure; 3D reconstruction; serial sections; cytoskeleton; cell-cell interaction (1)
CRYO-EM STRUCTURE; ADENOASSOCIATED VIRUS-2; MONOCLONAL-ANTIBODIES; CELLULAR CORECEPTOR; APLASTIC CRISIS; RECEPTOR; INFECTION; NEUTRALIZATION; PERSISTENCE; MICROSCOPY; B19 parvovirus; cryo-EM; epitope; human antibody (1)
CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; BACTERIAL RIBOSOME; STRUCTURAL BASIS; SP-NOV; RNA; SUBUNIT; COMPLEX; VISUALIZATION; (1)
CRYOPRESERVATION; PREGNANCY; CYCLES; FERTILIZATION; SURVIVAL; polar body diagnosis (PBD); cystic fibrosis; monogenic disorder; vitrification (1)
CRYOPRESERVED HUMAN HEPATOCYTES; BIOMEDICAL-RESEARCH; VIVO; RECOMMENDATIONS; HEPATOTOXICITY; AVAILABILITY; METABOLISM; STRATEGIES; PREDICTION; CLEARANCE; foundation; hepatocytes; honest broker model; human tissue; informed consent; pharmaceutical research (1)
CRYOPRESERVED OVARIAN TISSUE; ANTI-MULLERIAN HORMONE; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; FEMALE CANCER-PATIENTS; TESTICULAR TISSUE; CLINICAL-PRACTICE; CHRONIC GVHD; LIVE BIRTH; (1)
CRYOPRESERVED OVARIAN TISSUE; CANCER; CHILDHOOD; STIMULATION; FAILURE; FEMALES; FEASIBILITY; AUTOGRAFT; PUBERTY; WOMEN; (1)
CRYOPRESERVED OVARIAN TISSUE; PREMENOPAUSAL BREAST-CANCER; BONE-MINERAL DENSITY; IN-VITRO MATURATION; QUALITY-OF-LIFE; ADJUVANT TREATMENT; HORMONE AGONIST; YOUNG-WOMEN; CHEMOTHERAPY; TRANSPLANTATION; (1)
Cryostats; Emission spectra; Fluorescence; Spectral hole burning; UV and visible spectra (design and performance of a miniature cryostat for emission measurements in liq. helium); miniature cryostat emission measurement liq helium (1)
cryptate soln acetonitrile mol solvent model (1)
Cryptocurrency; Blockchain; Real Estate; Time-Varying Dependence; Copula (1)
Cryptocurrency futures · Bitcoin (BTC) · Ether (ETH) · News sentiment analysis · Financial news media (1)
Cryptocurrency returns, Machine learning, Explainable artificial intelligence, Intricacy (1)
CRYPTORCHIDISM; BLADDER; Down syndrome; neurogenic bladder dysfunction; voiding dysfunction; urogenital abnormalities; long-term complications (1)
CRYPTOTERMES-SECUNDUS KALOTERMITIDAE; RETICULITERMES-FLAVIPES; SUBTERRANEAN TERMITE; POWER CALCULATIONS; GENETIC-STRUCTURE; FOOD CONDITIONS; COLONY; RELATEDNESS; EVOLUTION; EUSOCIALITY; cooperation; kinship; relatedness; social evolution; termite (1)
CRYPTOTERMES-SECUNDUS; WING DIMORPHISM; SOCIAL-BEHAVIOR; FOOD CONDITIONS; EVOLUTION; COOPERATION; CASTE; EUSOCIALITY; ISOPTERA; INSECTS (1)
CRYPT-VILLUS AXIS; COLONIC EPITHELIUM; MONOLAYER-CULTURE; BIOPSY SPECIMENS; ESTABLISHMENT; EXPRESSION; GROWTH; DIFFERENTIATION; INVITRO; MATRIX; intestinal epithelial cells; apoptosis; anoikis; cell culture; cell anchorage (1)
Crystal defects; Energy level; Lattice dynamics; Structural relaxation; Total energy; Trapping (mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); Simulation and Modeling (mol. dynamics, mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); Molecular structure (optimized, mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); anthracene trapping site argon matrix mol dynamics (1)
CRYSTAL ENGINEERING APPROACH; SUPRAMOLECULAR GELS; POROUS MATERIALS; GROWTH; CRYSTALLIZATION; METALLOGELS; TRANSITION; GELATORS; GELATION; MOFS; (1)
CRYSTAL GAAS(001) BARRIERS; SPIN INJECTION; SEMICONDUCTOR; (1)
CRYSTAL-GROWTH; LOAD-BEARING; METALLOGELS; GELS; LIGAND; (1)
Crystalline cohomology · PD de Rham cohomology (1)
Crystallographic structure, Microelectromechanical systems (MEMS), Quantum effects, Scanning probe microscopy (SPM), Sensor, Surface chemistry (1)
CRYSTALLOGRAPHIC TILT; MASK MATERIAL; LASER-DIODES; LAYERS; DEPENDENCE; DEFECTS; FILMS; (1)
crystalloid-ER, endoplasmic reticulum (ER) morphology, ER stress, ER whorls, scanning transmission electron microscopy (STEM), tomography (1)
CRYSTAL MALEONITRILEDITHIOLATE COMPLEXES; EMISSION-SPECTRA; DITHIOLENES; ABSORPTION; photochemistry; nickel complexes; palladium complexes; platinum complexes; dithiolene complexes (1)
; Crystal morphology; Metal-organic vapor phase epitaxy; Nitrides; Semiconducting gallium compounds (1)
CRYSTAL PLASTICITY; ENERGY MINIMIZATION; RELAXATION; MICROSTRUCTURES; DEFORMATION; SIMULATION; Quasiconvexity; Relaxation; Elastoplasticity (1)
CRYSTAL PLASTICITY; NEMATIC ELASTOMERS; 2-WELL PROBLEM; MICROSTRUCTURE; MINIMIZERS; BEHAVIOR; Cubic-to-tetragonal phase transformation; quasiconvexity; relaxation (1)
CRYSTAL PLASTICITY; NEMATIC ELASTOMERS; MICROSTRUCTURE; Relaxation; single crystal plasticity; microstructure; G-convergence (1)
CRYSTAL PLASTICITY; NUMERICAL-ANALYSIS; ENERGY MINIMIZATION; NEMATIC ELASTOMERS; RELAXATION; MICROSTRUCTURES; APPROXIMATION; DEFORMATION; FRAMEWORK; MODEL; Elastoplasticity; single slip; quasiconvexity; relaxation; optimal laminates (1)
CRYSTALS; SURFACES; ATOM; (1)
CRYSTALS; TETRACENE; TRANSPORT; PRESSURE; SPECTRA; TEMPERATURE; NAPHTHALENE; SOLIDS; first-principles calculations; low-frequency Raman modes; oligoacenes; polarization-orientation Raman spectroscopy; small-molecule organic semiconductors (1)
CRYSTAL-STRUCTURE; 1,2,3-TRIPNICTOLIDE ANIONS; SANDWICH COMPLEX; IRON COMPLEXES; PENTAPHOSPHACYCLOPENTADIENIDE; PHOSPHORUS; REACTIVITY; LIGANDS; FERROCENE; ANALOGS; cyclopentadienyl ligands; heterocycles; inorganic ring systems; polyarsolyl; polyphospholyl (1)
CRYSTAL-STRUCTURE; ALCL3-PYRIDINE ADDUCTS; HALIDE-COMPLEXES; PYRIDINE; ELEMENTS; DENSITY; BR; CL; COORDINATION; EXCHANGE; (1)
CRYSTAL-STRUCTURE ANALYSIS; ELECTROCHEMICAL REDUCTION; COORDINATION CHEMISTRY; ORGANIC HALIDES; ARYL HALIDES; SPECTROSCOPIC PROPERTIES; PHOTOPHYSICAL PROPERTIES; OXIDATIVE ADDITION; GRIGNARD-REAGENTS; COMPLEXES; (1)
CRYSTAL-STRUCTURE; ANNOUNCEMENT; REFINEMENT; COMPLEX; PHASES; ammoniate; antimonide; crystal structure; liquid ammonia; Zintl ion (1)
CRYSTAL-STRUCTURE; arsenidotrielates; band gap calculation; impedance spectroscopy; DFT modelling; semiconductor (1)
CRYSTAL-STRUCTURE; BETA-PEPTIDE; DNA-BINDING; CANCER; WATER; TRANSCRIPTION; FAMILY; PERSPECTIVES; DIPEPTIDES; INHIBITORS; Id proteins; protein domain recognition; helix-loop-helix; synthetic receptor; metal complex; crown ether; fluorescence spectroscopy; circular dichroism spectroscopy (1)
; crystal structure; bis(iminodiacetato)chromate(III) ion; calcium salt (1)
CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; SN-119 MOSSBAUER; ISOMER-SHIFTS; INTERMETALLIC COMPOUNDS; HGPBP14-TYPE STRUCTURE; CHARGE-TRANSFER; CHEMISTRY; LITHIUM; GOLD; Heterocluster; Polyphosphides; LCAO-DFT calculations; Band structures; Mossbauer spectroscopy (1)
CRYSTAL-STRUCTURE; CAGE COMPOUNDS; GROUP ELEMENTS; ZINTL IONS; BASIS-SETS; TIN; SN; COMPLEXES; BOND; APPROXIMATION; (1)
crystal structure; cannabidiol; Cu Kß radiation; absolute structure (1)
CRYSTAL-STRUCTURE; CLUSTER PHASES; ZINTL PHASES; SOLID-STATE; INDIUM; COMPOUND; NETWORK; CHEMISTRY; PACKING; SYSTEM; Indium; Thallium; solid state Na-23 NMR; Single Crystal; Liquid Ammonia (1)
; crystal structure; cobalt(III) complex; barium hydrocarbonate; N-(2-hydroxyethyl)iminodiacetate ion (1)
CRYSTAL-STRUCTURE; COBALT(III) COMPLEXES; (1)
CRYSTAL-STRUCTURE; COMPLEXES; (1)
; crystal structure; complexes of Cu(II) with arginine; chloromercurate(II)-ions (1)
CRYSTAL-STRUCTURE; COMPOUND; CLUSTERS; ANNOUNCEMENT; TL-11(7-); NATL; KTL; thallide; intermetallics; single crystal; X-ray structure analysis (1)
CRYSTAL-STRUCTURE; COOPERATIVE BINDING; PROTEIN; ATP; DEAD-box helicase; Ribosome assembly; RNA; Methyl group assignment (1)
CRYSTAL-STRUCTURE; COORDINATION; CHEMISTRY; DENSITY; BEF2; (1)
CRYSTAL-STRUCTURE; COORDINATION POLYMERS; PHOTOLUMINESCENCE PROPERTIES; COPPER(I) COMPLEXES; CU(I) COMPOUNDS; CLUSTERS; FLUORESCENCE; TETRANUCLEAR; PHOSPHORESCENCE; IODOCUPRATES(I); (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; PHOSPHORUS; (CUI)(3)P4SE4; MOLECULES; HALIDES; SPECTRA; RAMAN; P4SE3; phosphorus chalcogenide; copper; halide; vibrational spectroscopy; X-ray diffraction; crystal structure (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; SPECTROSCOPIC CHARACTERIZATION; (CUI)(3)P4SE4; POLYMORPHS; REFINEMENT; POLYMER; FAMILY; SCREWS; CHAINS; arsenic; cage compounds; cocrystallization; mercury; structure elucidation (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; SPECTROSCOPIC CHARACTERIZATION; MERCURY; HALIDES; (CUI)(3)P4SE4; POLYMER; FAMILY; SCREWS; CHAINS; mercury halides; molecular adducts; arsenic sulfides; crystal structures; Raman spectroscopy (1)
CRYSTAL-STRUCTURE; CU2P3I2; element modification; nanorods; NMR spectroscopy; phosphorus (1)
CRYSTAL-STRUCTURE DETERMINATION; PROTON-MAGNETIC-RESONANCE; CLOSED-SHELL ATTRACTION; N-15 NMR-SPECTROSCOPY; METAL AZIDES; CLICK CHEMISTRY; AMMONIA; NITRIDE; SPECTRA; SILVER; Liquid ammonia; Silver azide; Sodium azide; Manganese azide; Zinc azide (1)
CRYSTAL-STRUCTURE DETERMINATIONS; LEWIS-BASE ADDUCTS; METAL(I) COMPOUNDS; TETRAKIS(TRIPHENYLPHOSPHINE)-COPPER(I); (1)
CRYSTAL-STRUCTURE; DIALKYLZINC REAGENTS; MOLECULAR-DIFFUSION; CARBONYL-COMPOUNDS; COMBINED SYSTEM; DIETHYL-ETHER; M4X4 CORE; 1,4-ADDITION; REACTIVITY; ENONES; asymmetric catalysis; conjugate addition; copper; NMR spectroscopy; phosphoramidite ligands (1)
CRYSTAL-STRUCTURE; ELECTRON-DIFFRACTION; COMPLEXES; CHEMISTRY; PENTAPHOSPHAFERROCENE; FERROCENE; LIGANDS; ANIONS; DIMERIZATION; FULLERENE; arsenic; DFT calculations; iron; polyarsenides; reduction (1)
Crystal structure; Electronic state; Fluorescence; Fluorescence excitation; Fluorescence up-conversion; Hydrogen bond; Molecular structure; Optical double resonance; Oscillator strength; Reorganization energy; Solvation; Solvent polarity effect; UV and visible spectra (fluorescence study on solvation dynamics of 4-aminophthalimide in methanol); solvation dynamics aminophthalimide methanol soln fluorescence upconversion crystallog (1)
CRYSTAL-STRUCTURE; ELECTRONIC-STRUCTURE; PARKERITE; SHANDITE; NI3BI2S2; SN; Parkerite; Shandite; Corderoite; Half antiperovskites; Ordering; Group-subgroup relations; Symmetry relations; Superconductor; Single crystal structure analysis; X-ray diffraction (1)
CRYSTAL-STRUCTURE; ELECTRON LOCALIZATION; INTERMETALLIC COMPOUNDS; TERNARY COMPOUNDS; METAL; BOND; REFINEMENT; INDICATOR; SULFIDES; SYSTEM; (1)
CRYSTAL-STRUCTURE; EMISSION; SYSTEMS; COMPLEXES; STATE; electronic spectra; luminescence; copper complexes; mixed-valence compounds (1)
CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; MAGNETIC-BEHAVIOR; BUILDING-BLOCK; SE MOLECULES; P4X3 X; COMPLEXES; CHEMISTRY; P4S3; FRAGMENTATION; Arsenic; Sulfur; Copper; Halides; Coordination modes; Solid-state structures (1)
CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; METAL-COMPLEXES; CAGE MOLECULE; SE MOLECULES; P4X3 X; ADDUCT; CHEMISTRY; FRAGMENTS; LIGANDS; (2)
CRYSTAL-STRUCTURE; EXCITED-STATE; COMPLEX; platinum complexes; luminescence (1)
CRYSTAL-STRUCTURE GENERATION; RACEMIC COMPOUND FORMATION; M = NI; MOLECULAR-DYNAMICS; ACETIC-ACID; REAPPEARING POLYMORPHS; CONGLOMERATE FORMATION; STRUCTURE PREDICTIONS; CHIRAL RECOGNITION; PHASE-TRANSITIONS; chiral recognition; conglomerate crystallisalltion; molecular recognition; nucleation; polymorphism (1)
CRYSTAL-STRUCTURE; GOLD COMPLEXES; DIPHOSPHINOMETHANES; (1)
CRYSTAL-STRUCTURE; HARTREE-FOCK; AB-INITIO; ALKALI; (1)
CRYSTAL-STRUCTURE; HARTREE-FOCK; TERNARY; SULFIDE; SYSTEMS; OXOSTANNATES(II); REDETERMINATION; TRANSITION; ACCURATE; VALENCE; antiperovskite structure; type-antitype relation; shandite; band structure (1)
crystal structure; hydrogen bond; Hirshfeld surface; pyrrol -2-yl ketone; DFT (1)
CRYSTAL-STRUCTURE; INDIUM(III) HALIDES; DIARSANE COMPLEXES; GALLIUM(III); ADDUCTS; N,N,N',N'-TETRAMETHYLETHYLENEDIAMINE; ETHYLENEDIAMINE; DIPHOSPHANE; SYSTEMATICS; DENSITY; Donor-acceptor complexes; Bidentate ligands; Aluminum; Gallium; X-ray structure analysis; Thermodynamics; Density functional computations (1)
CRYSTAL-STRUCTURE; INFLAMMASOME; ACTIVATION; NEK7; REVEALS (1)
CRYSTAL-STRUCTURE; IN-VITRO; TRNASE-Z; INTRON; HALOBACTERIUM; splicing endonuclease; tRNA intron; rRNA intron; tRNA processing; rRNA processing (1)
CRYSTAL-STRUCTURE; IONIC-CONDUCTIVITY; SUPERIONIC CONDUCTOR; LI; GLASS; LN; THIOPHOSPHATES; ELECTROLYTES; BATTERIES; PHOSPHATE; Lithium-scandium hexathiohypodiphosphate; LiScP2S6; Lithium; Scandium; Lithium ion conductivity (1)
Crystal Structure, Ionic Conductor, Lithium Silver Antimony Sulfide (1)
Crystal structure; Lewis acids; Ligands; Nuclear magnetic resonance; spectroscopy; Quantum mechanics (1)
crystal structure; liquid ammonia; carbonyl metalates; pentacarbonyl molybdate; metallic salt reduction. (1)
CRYSTAL-STRUCTURE; METAL-COMPLEXES; ETA(1)-P-BASAL COORDINATION; COPPER IODIDE; CAGE MOLECULE; SE MOLECULES; P4X3 X; LIGANDS; CHEMISTRY; FRAGMENTS; Phosphorus; Sulfur; Copper; Coordination polymers; Solid-state NMR spectroscopy (1)
CRYSTAL-STRUCTURE; METALLOCENES; COMPLEXES; OXIDATION; ELECTROCHEMISTRY; FERROCENE; CHEMISTRY; SOLVENT; CATIONS; FACILE; Cyclovoltammetry; Dication; Metallocene; Nickel; Weakly Coordinating Anion (1)
Crystal structure; Molecular structure (of aminonitronaphthalene); Photoelectric emission (x-ray, of aminonitronaphthalene isomers); XPS org donor acceptor mol; photoelectron org donor acceptor mol; naphthalene amino nitro XPS; aniline nitro XPS (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethane) mol structure chloromethoxyphenyl ethane (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethane) mol structure chloromethoxyphenylethane ethane chloromethoxyphenyl structure (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethene) mol structure chloromethoxyphenylethane ethane chloromethoxyphenyl structure crystal structure chloromethoxyphenylethane (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethene) mol structure chloromethoxyphenylethene crystal structure chloromethoxyphenylethene ethene chloromethoxyphenyl structure (1)
Crystal structure Molecular structure (of diazido(methoxyphenyl)phenylethane) crystal structure azidohydroxyphenylethylenediamine platinum hydroxyphenylethylinediamine complex ethylenediamine hydroxyphenyl platinum complex azidohydroxyphenylethylenediamine prepn structure (1)
Crystal structure Molecular structure (of platinum hydroxyphenylethylenediamine diastereomeric complexes) Substitution reaction (of platinum hydroxyphenylethylenediamine diastereomeric complexes with iodide) Kinetics of substitution reaction (coordinative, of platinum hydroxyphenylethylenediamine diastereomeric complexes with iodide) Isomerism and Isomers (diastereo-, of platinum hydroxyphenylethylenediamine complexes) Neoplasm inhibitors (leukemia, platinum hydroxyphenylethylenediamine diastereomeric complexes as) crystal structure platinum hydroxyphenylethylenediamine complex leukemia inhibitor platinum hydroxyphenylethylenediamine complex kinetics substitution halo platinum hydroxyphenylethylenediamine complex platinum hydroxyphenylethylenediamine structure substitution kinetics (1)
CRYSTAL-STRUCTURE; MONOLAYER; FERROMAGNETISM; INTERFACE; GRAPHITE; (1)
CRYSTAL-STRUCTURE; MONOLAYER MOTE2; POLARIZATION; INSULATOR; MOS2; TRANSITION; SUPERCONDUCTIVITY; PHOTOLUMINESCENCE; FERROMAGNETISM; SEMICONDUCTORS (2)
; crystal structure; N-(2-hydroxyethyl)iminodiacetatocobalt(II); N,N-bis(2-carbamoyl)aminoacetatocobalt(II) (1)
CRYSTAL-STRUCTURE; PENTAMETHYLCYCLOPENTADIENYL-RHODIUM(III); CONFIGURATION; DERIVATIVES; chiral-at-metal complexes; rhodium; configurational stability; epimerization; X-ray structure analyses (1)
CRYSTAL-STRUCTURE; PHASE; CU6PS5BR; RAMAN; copper argyrodites; anharmonic refinements; ion conductors; powder diffraction structure analysis; X-ray diffraction (1)
CRYSTAL-STRUCTURE; PHASE; FORMALISMS; VIBRATIONS; SYSTEMS; (1)
CRYSTAL-STRUCTURE; PHYSICAL-PROPERTIES; TERNARY COMPOUNDS; ZRCUSIAS; SUPERCONDUCTOR; ALGORITHM; ELEMENTS; (1)
CRYSTAL-STRUCTURE; PHYSICAL-PROPERTIES; TERNARY; SN; SYSTEMS; PHASES; NICKEL; TIN; shandite; ferromagnetic phase transition; electronic structure; half metal; metal semiconductor transition (1)
CRYSTAL-STRUCTURE; PNICOGEN BONDS; SPECTRA; F-19; PENTAFLUORIDE; REACTIVITY; DENSITY (1)
crystal structure ; polymorphism ; THF solvate ; lithium complexes (1)
crystal structure; polymorphism; THF solvate; lithium complexes (1)
CRYSTAL-STRUCTURE; RED; ORIGIN; Allotropes; Phosphorus; High temperature gas balance (1)
crystal structure; reductive ammonolysis; streptozocin; rubidium cation; methyldiazotate anion. (1)
CRYSTAL-STRUCTURE; REFINEMENT; HALIDES; copper (II) complexes; amines; cyanide (1)
CRYSTAL STRUCTURE REFINEMENT; TIME-RESOLVED SPECTRA; CHIRAL RECOGNITION; TRIS(DIIMINE)-METAL COMPLEXES; RHODAMINE 6G; ELECTROLUMINESCENCE; FILMS; LIGHT; FLUOROHECTORITE; LUMINESCENCE; (1)
CRYSTAL-STRUCTURE; RING-STACKING; CHEMISTRY; INHIBITION; LADDER; (1)
crystal structure; rubidium; peroxide; ammonia disolvate. (1)
CRYSTAL-STRUCTURE; RUTHENIUM; rhenium complexes; charge transfer; quinones; diimines; substituent effects; solvatochromism (1)
CRYSTAL-STRUCTURES; BONDING ANALYSIS; TRANSITION; CARBONYL; LIGAND; cluster compounds; cobalt; niobocene; tellurium (1)
CRYSTAL-STRUCTURES; BOUND LIGANDS; DINITROGEN; STABILIZATION; REFINEMENT; PHOSPHORUS; PRODUCTS; EXCHANGE; SALTS; ACIDS; (1)
CRYSTAL-STRUCTURES; CHEMISTRY; (1)
CRYSTAL-STRUCTURES; chiral-at-metal complexes; configurational stability; epimerisation; equilibria; X-ray structure analyses (1)
CRYSTAL-STRUCTURES; chiral-at-metal complexes; configurational stability; epimerization; diastereomer equilibria; X-ray structure analyses (1)
CRYSTAL-STRUCTURES; COMPLEXES; ADDUCT; DERIVATIVES; DATABASE; GALLIUM; HALIDES; BR; crystal structure; tribromidogallium(III); trichloridogallium(III); 2,2 ':6 ',2 ''-terpyridine; solid-state structures (1)
CRYSTAL-STRUCTURES; COORDINATION-COMPLEXES; AUROPHILIC ATTRACTION; THERMAL-EXPANSION; METAL-COMPLEXES; LUMINESCENCE; CATALYSIS; PRESSURE; ANIONS; CHAINS; arsenic ligands; aurophilic interactions; gold; luminescence; phosphorus ligands (1)
CRYSTAL-STRUCTURES; ELECTRONIC-PROPERTIES; COMPUTER-PROGRAM; AB-INITIO; POLYPHOSPHIDES; PHOSPHORUS; TRANSITION; CHEMISTRY; CU; (1)
CRYSTAL-STRUCTURE; SEQUENCE ALIGNMENT; OPERON EXPRESSION; BIENZYME COMPLEX; HYPERTHERMOPHILE; BIOSYNTHESIS; DATABASE; ENZYMES; LIFE; COMMUNICATION; (1)
CRYSTAL-STRUCTURES; EXCITED-STATE; PLATINUM(II) COMPLEXES; CHARGE-TRANSFER; M-X; DIIMINE; HYDROGEN; LIGANDS; 2,2'-BIPYRIDINE; PHOTOCHEMISTRY; Terpyridine; Platinum complexes; Crystal structure; Electrochemistry; Complex as ligand (1)
CRYSTAL-STRUCTURES; HALIDES; REFINEMENT; CHAINS; SCREWS; SE; copper(I) chalcogen halides; chalcogen chains; crystal structure; IR spectroscopy; Raman spectroscopy (1)
CRYSTAL-STRUCTURES; HARTREE-FOCK; IONIC-RADII; DECOMPOSITION; CUSO4; CHALCOCYANITE; COPPER(II); DISTORTION; STATES (1)
CRYSTAL-STRUCTURES; HYDROGEN-BOND; REFINEMENT; DATABASE; (1)
CRYSTAL-STRUCTURES; HYDROSILYLATION; HYDROGENATION; ATOM; chirality; molybdenum; half-sandwich complexes; metal configuration (1)
CRYSTAL-STRUCTURES; IONS; ANIONS; crystal structure; Zintl anions; pseudomerohedral twinning; ammoniate; mixed cations; disorder (1)
CRYSTAL-STRUCTURES; METAL-HYDRIDES; HYDROGEN; SCATTERING; ALLOYS; MAGNETISM; HDDR; In situ techniques; Neutron diffraction; Metal hydrides; Intermetallic phases; Hydrogenation (1)
CRYSTAL-STRUCTURE; SN; TERNARY; SOLIDS; TIN; CHALCOGENIDES; PARAMETERS; CHEMISTRY; (1)
CRYSTAL-STRUCTURE; SOLVOTHERMAL SYNTHESES; HYDROTHERMAL SYNTHESIS; THIOANTIMONATE(III); COMPLEXES; RB2SB4S7; (1)
CRYSTAL-STRUCTURE; SOLVOTHERMAL SYNTHESIS; STRUCTURE DIRECTOR; LI2S-SB2S3 SYSTEM; DIFFRACTION; THIOANTIMONATES(III); CU3SBS3; CATION; METAL; ANION; Ion conductor; Electrode material; Crystal structure; Lithium; Thioantimonate (1)
CRYSTAL-STRUCTURES; OPTICAL NONLINEARITY; CUCLCU2TES3; CU2ZNSNS4; STANNITE; GE; SI; Diamond-like semiconductor; Magnetic properties; Mo ss bauer spectroscopy; Non-ambient X-ray powder diffraction; Rietveld refinement (1)
CRYSTAL-STRUCTURES; PERFORMANCE; BI; SUBSTITUTION; CHEMISTRY; MAPBI(3); CATIONS; BANDGAP; IMPACT; antimony; bismuth; iodine; lead; perovskite (1)
CRYSTAL-STRUCTURES; PHOTOSTIMULATED LUMINESCENCE; EXCITATION-SPECTRA; ENERGY MIGRATION; EMISSION; EU; BR; CL; DIFFRACTION; DEUTERIDES; Europium; Hydrides; Chlorides; Crystal structure; Luminescence; Dynamic Jahn-Teller effect; Trapped exciton emission (1)
CRYSTAL-STRUCTURES; PI INTERACTIONS; THIOCYANATE; LEAD(II); CHLORIDE; LIGAND; CL; Zinc(II); cation complexes; anion complexes; weak interactions (1)
CRYSTAL-STRUCTURES; PYRAZOLYL EMBRACE; AROMATIC RINGS; CHEMISTRY; PENTAPHOSPHAFERROCENE; RECOGNITION; COMPLEXES; STABILIZATION; CONSTRUCTION; MOLECULES; (1)
CRYSTAL-STRUCTURE; SR; EU; ARSENIDES; VALENCE; PHASE; CU; (1)
CRYSTAL-STRUCTURES; SILICON CLUSTERS; GROUP ELEMENTS; CHEMISTRY; ANIONS; PHOSPHORUS; SI-4(4-); Si-29 NMR; ELI-D analysis; NBO analysis; silicides; Zintl anions (1)
CRYSTAL-STRUCTURES; SOLID-STATE; CLUSTERS; LIGANDS; ANIONS; BISMUTH(III); CHEMISTRY; HALIDES; ION; cobalt; antimony; sulfur; mixed ligands (1)
CRYSTAL-STRUCTURES; SPIN-CROSSOVER; COMPLEX; CHROMIUM(II); LIGANDS; DIMERS; SPECTROSCOPY; PHOSPHORUS; REACTIVITY; CHEMISTRY; (1)
CRYSTAL-STRUCTURES; SYNTHETIC METHODS; LEWIS-ACIDS; B-N; COMPLEXES; CHEMISTRY; LIGANDS; COORDINATION; REACTIVITY; CHAINS; arsenic; bidentate ligands; boron; gold; phosphorus (1)
CRYSTAL-STRUCTURES; THERMAL-DECOMPOSITION; COMPOUND; FLUORIDE; PR; ND; SM; LN; (1)
CRYSTAL-STRUCTURES; TRANSITION-METALS; MULTIPLE BONDS; ISOCYANATES; INSERTION; ELEMENTS; niobocene; oxo ligands; heterocumulenes; cyclization (1)
CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CAP RECOGNITION; P BODIES; COMPLEX; PROTEIN; DECAY; EDC3; DYNAMICS; ELEMENTS; (1)
CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FORMIN; SPIRE; DOMAIN; CAPPUCCINO; RHO; POLYMERIZATION; MICROTUBULE; PROTEINS; Actin dynamics; Spir/formin; Nucleator complex (1)
CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; CLUSTERS; DIANIONS; SANDWICH; SILICON; SERIES; UNITS; Platinum; Carbonyl; Transition-Metallates; Zintl phases; Liquid ammonia (1)
CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; PHYSICAL-PROPERTIES; GALLIUM; KINETICS; KFES2; chalcogenogallates; polymorphism; solid solutions; in situ X-ray diffraction; synchrotron radiation; Rietveld refinement (1)
CRYSTAL-STRUCTURE; STRUCTURAL CHEMISTRY; METALLIC PHASES; ANNOUNCEMENT; CLUSTERS; REFINEMENT; COMPOUND; NA2IN; IONS; RB; Thallium; Cluster; X-Ray Structure; Alkali Metals; Zintl; Single Crystals; Liquid Ammonia (1)
CRYSTAL-STRUCTURE; STRUCTURE CRISTALLINE; APPROXIMATION; METAGERMANATE; SULFIDES; LITHIUM; SODIUM (1)
CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; PHASE RELATIONS; CU3ASS4; CHALCOGENIDES; COPPER; CONDUCTIVITY; SULFOSALTS; ENARGITE; X-ray diffraction; powder diffraction structure analysis; single crystal structure analysis; thiometallate; tetrahedral structures; wurtzite structure type; sphalerite structure type (1)
CRYSTAL-STRUCTURE; SYSTEM; TOOLS; transmission electron microscpy; nickel telluride; tin telluride; van der waals gap filling; NiAs type structure; layered compound (1)
CRYSTAL-STRUCTURE; TETRACHLOROGALLATE(III); (1)
CRYSTAL-STRUCTURE; THERMOELECTRIC PROPERTIES; LAMELLAR TELLUROSILICATE; MAGNETIC-STRUCTURE; AB-INITIO; DIFFRACTION; REFINEMENT; PROGRAM; PHASE; van der Waals; honeycomb; stacking faults; powder diffraction; TEM; DFT (1)
CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; BACTERIAL ARGONAUTE; SLICER ACTIVITY; RNA; DOMAIN; REFINEMENT; RECOGNITION; CLEAVAGE; MODEL; (1)
CRYSTAL-STRUCTURE; TITANIUM TETRACHLORIDE; ADDITION COMPOUNDS; SULFUR PHOSPHORUS; METAL HALIDES; COORDINATION; CHEMISTRY; CHLORIDE; SELENIUM; ADDUCTS; (1)
CRYSTAL-STRUCTURE; TRIHYDRATE; COMPLEXES; LIGANDS; (1)
CRYSTAL-STRUCTURE; TYROSINE KINASE; PROTEIN; COMPLEX; BINDING; VISUALIZATION; EXOCYTOSIS; DOMAINS; CELLS; (1)
CRYSTAL-STRUCTURE; VIBRATIONAL-SPECTRA; METAL-COMPLEXES; P4S3; MOLECULE; CHEMISTRY; ADDUCT; SE; BR; (1)
CRYSTAL-STRUCTURE; VIBRATIONAL-SPECTRA; SPECTROSCOPIC CHARACTERIZATION; SULFIDES; ADDUCT; MOLECULES; CAGES; P4S10; TRANSFORMATIONS; (CUI)(3)P4SE4; phosphorus; polymer; polysulfides; structure elucidation; sulfur (1)
CSF-TAU; FRONTOTEMPORAL DEGENERATION; CLINICAL-DIAGNOSIS; LARGE-SCALE; DEMENTIA; PROTEIN; MULTICENTER; A-BETA-1-42(43); IMMUNOGLOBULIN; CONSORTIUM; Alzheimer's disease; non-Alzheimer dementias; dementia; psychiatric disorders; depression; schizophrenia; cerebrospinal fluid; tau; phosphorylated tau; beta-amyloid(42); random sample (1)
C(sp2)-S Cross-Coupling (1)
CSR, Sustainability, Asset4, Risk Management, Risk Mitigation, Credit Ratings, Systematic Risk (1)
C-SUBSTITUTED PYRROLECARBALDEHYDES; MOLECULAR-ORBITAL METHODS; AB-INITIO; TETRAMETHYLAMMONIUM ION; HALOGEN BOND; BASIS-SETS; AROMATICITY; ABSORPTION; PATTERNS; PERAMINE; crystal structure; hydrogen bond; Hirshfeld surface; pyrrol-2-yl ketone; DFT (1)
CSU, Deutschlandpolitik, Franz Josef Strauß, DSU, Grundlagenvertrag (1)
; C Symbol of the Klingon Empire C Bond formation; Gelatin; Aldol reaction; Biocatalysis (1)
CT Angiographie; Aorta; Neoplasien (1)
CT ANGIOGRAPHY; ANEURYSMS; computed tomography artifacts; computed tomographic angiography; stents and prostheses (1)
CT ANGIOGRAPHY; DIAGNOSIS (1)
CT; COLONOSCOPY; DISEASE; ANGIOGRAPHY; POLYPS; (1)
C-TERMINAL DOMAIN; 7SK SNRNP COMPLEX; HUMAN LA PROTEIN; P-TEFB; TRANSCRIPTION ELONGATION; CHAPERONE ACTIVITY; STRUCTURAL BASIS; INTELLECTUAL DISABILITY; ALAZAMI SYNDROME; RIBOSOMAL-RNA; LARP7; La-related protein; Alazami syndrome; 7SK RNA; P-TEFb; MePCE; U6 snRNA; snoRNA; telomerase; RNA-binding protein; RNP (1)
C-TERMINAL DOMAIN; CORYNEBACTERIUM-GLUTAMICUM; TRANSPORTER BETP; CARRIER BETP; GLYCINE-BETAINE; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; PHASE-TRANSITIONS; K+; SPECIFICITY; (1)
C-TERMINAL FRAGMENT; SMOOTH-MUSCLE-CELLS; RECIPROCAL REGULATION; SIGNALING PATHWAY; EPITHELIAL-CELLS; BRANCHING MORPHOGENESIS; CHANNEL ACTIVITY; MAMMALIAN-CELLS; CATION CHANNEL; NITRIC-OXIDE; (1)
CT FLUOROSCOPY; COAGULATION THERAPY; RADIATION-EXPOSURE; ABLATION; INTERVENTIONS; COMPLICATIONS; METASTASES; Interventional radiology; Robotic assistance; Microwave ablation; Liver tumor; CT-guided (1)
CTGF, connective tissue growth factor, Glaukom, extrazelluläre Matrix, Aktin, Zytoskelett, intraokulärer Druck (1)
CTGF, glaucoma, trabecular meshwork, endothelin-1, angiotensin-II, IGF-1, oxidative stress, heat shock, aB-crystallin, cell viability (1)
CTLA-4 GENE POLYMORPHISM; NEGATIVE SELECTION; T-CELLS; PROMOTER; DISEASE; EXPRESSION; SUSCEPTIBILITY; REGION; CD4(+); MATURE; (1)
CT; OUTCOMES; Dual-energy computed tomography; Hard plaque imaging; Aortic aneurysm; Endovascular aneurysm repair; Endoleak (1)
CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; INSULIN-RESISTANCE; FREE-CHOLESTEROL; GENE-EXPRESSION; MACROPHAGES; MEMBRANE; ACTIVATION; SYNTHASE; DISEASE; CELLS; fatty acid metabolism; lipid mass spectrometry; phagocytes; phospholipid synthesis (1)
CT; SUPPRESSION; ALGORITHM; Metal artifact reduction; cone beam computed tomography; C-arm; flat-panel (1)
CT VISUALIZATION ALGORITHM; COMPUTED-TOMOGRAPHY; MAJOR TRAUMA; OUTCOMES; radiology; polytrauma; rib fracture; diagnosis; segmentation; sensitivity and specificity; computed tomography (1)
C-TYPE LECTIN; INDUCIBLE FACTOR 1-ALPHA; NF-KAPPA-B; GENE-EXPRESSION; INNATE IMMUNITY; SYK KINASE; MYCOBACTERIUM-TUBERCULOSIS; TARGETED DISRUPTION; NLRP3 INFLAMMASOME; CANDIDA-ALBICANS; (1)
CUBANE; DERIVATIVES; CHEMISTRY; RINGS; cage compounds; cyclopropanes; photochemistry; strained molecules; thermal isomerization (1)
Cucuteni-Trypillia cultural complex (CTCC); fortified settlement; magnetic prospection; Trypillia B1; Ukraine (1)
CUE EXPOSURE; SMOKING CUES; RESPONSE-INHIBITION; IMPLICIT COGNITION; DEPENDENCE; ANTISACCADE; ADDICTION; PSYCHOPATHOLOGY; ENVIRONMENTS; PROSACCADES; Smoking; Addiction; Attention bias; Anti-saccade task; Eye tracking; Virtual reality (1)
cue utilisation theory, innovation, reputation, signalling, marketing, product development, new products, bonding instruments, guarantees, credibility, product quality, product evaluation, product information, quality signals (1)
CU-I COMPLEXES; 1,8-NAPHTHYRIDINE-BASED DINUCLEATING LIGANDS; METAL-PERCHLORATE COMPLEXES; FLUXIONAL BEHAVIOR; ELECTROCHEMICAL PROPERTIES; DIRHODIUM(II) COMPLEX; EMISSION PROPERTIES; DIIRON COMPLEXES; EXCITED-STATE; NAPY; naphthyridine; rhenium; copper; electronic spectra; photoluminescence (1)
Cu(I) complexes and organic compounds with short-lived thermally activated delayed ﬂuorescence, organic thermally activated delayed ﬂuorescence materials with ultrafast singlet-triplet equilibration, rigidity, quantum yield, and excitation self-trapping, spin-orbit coupling and combined thermally activated delayed ﬂuorescence/phosphorescence, spin-orbit coupling, phosphorescence, and intersystem crossing (1)
CU(I) COMPLEXES; SINGLET; THERMOCHEMISTRY; EMISSION; EMITTERS; (1)
Cu-I halides; host– guest chemistry; parent pentaphosphaferrocene; phosphaferrocene; supramolecular chemistry (1)
cuing, forgetting, directed forgetting, context-dependent forgetting, proactive interference (1)
CULICOIDES-OBSOLETUS; NORTHERN EUROPE; EPIDEMIOLOGY; (1)
CULTURAL COMPETENCE; ORGAN DONATION; BRAIN-DEATH; OF-LIFE; HEALTH-CARE; CHALLENGES; RELIGION; TRANSPLANTATION; PERSPECTIVES; DISPARITIES; Religion; Culture; Attitude; Brain death; Organ donation (1)
CULTURAL-DIFFERENCES; EORTC QLQ-C30; TRANSLATION; DIF; QUESTIONNAIRE; EQUIVALENCE; INVENTORY; IDENTIFY; INDEX; BIAS; differential item functioning; EORTC QLQ-C30; health-related quality of life; literature review; qualitative analyses; translations (1)
Cultural turn, Germany, history, quantification, quantitative methods, text mining (1)
CULTURED-CELLS; THERMAL-STABILITY; HEV; RECOMBINANT; SYNDECAN-2; INFECTION; PATIENT; FAMILY; SERUM; hepatitis E virus; cell culture; A549; CEACAM; syndecan (1)
CULTURED HUMAN KERATINOCYTES; EPIDERMAL BARRIER FUNCTION; COMPOSITE REGULATORY ELEMENTS; BINDING SITE COMBINATIONS; STRATUM-CORNEUM; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; LIPID ENVELOPE; MODULE ANALYST; HUMAN SKIN; ceramides; microarray; NHEK; promoter analysis; salicylic acid (1)
CULTURED HUMAN KERATINOCYTES; UVB-INDUCED ALTERATIONS; STRATUM-CORNEUM LIPIDS; PERMEABILITY BARRIER; ABC TRANSPORTERS; SKIN BARRIER; HARLEQUIN ICHTHYOSIS; LAMELLAR GRANULES; IRRADIATION; GENE; Keratinocyte; Lipid transport; ABC transporter; UVB; Epidermal barrier (1)
Culture; Principal component analysis; Semantics; Emotions; Human learning; Etiology; Language; Language acquisition (1)
Culture, Regional Development, Bohemians, Creative Class, Dynamic Panel Methods (1)
CULTURES; Early Neolithic; Linienbandkeramik (LBK); Linear Pottery Culture (LPC); Ukraine; Moldavia; Romania (1)
CUMULATIVE REACTION PROBABILITY; SELF-ASSEMBLED MONOLAYERS; CONDUCTANCE; DEVICES; (1)
CU-NI-FE; PHASE-CONTRAST; VISUALIZATION; FIELD; Spinodal alloy; Microstructure; Magnetic measurements; Domain structure; TEM; Differential phase contrast; STEM DPC; MFM; EDXS elemental mapping (1)
CUP PLACEMENT; DISLOCATION; MOTION; RANGE; IMPINGEMENT; REPLACEMENT; ORIENTATION; COMPONENTS; ACCURACY; (1)
CUP PLACEMENT; ORIENTATION; DISLOCATION; REPLACEMENT; ALIGNMENT; SYSTEM; PROSTHESIS; WEAR; (1)
CUP; REPLACEMENT; ORIENTATION; DISLOCATION; COMPONENTS; (1)
CURCUMA-LONGA; SINGLET OXYGEN; ANTIOXIDANT ACTIVITY; FOOD COLORANTS; FATTY-ACIDS; INACTIVATION; CYTOTOXICITY; EFFICACY; PRODUCTS; WATER; Antimicrobial; Photodynamic Inactivation; Curcumin; Diferoylmethane; Cationic photosensitizer; Escherichia coli (1)
curcumin; aromas; green solvents; solubilisation; lactones; fragrances; flavours; polyphenols (1)
CURCUMIN EXCITED-STATE; PICOSECOND SPECTRAL RELAXATION; SOLVENT MIXTURES ROLE; ULTRAFAST PHOTOISOMERIZATION; INFRARED-SPECTROSCOPY; COLORIMETRIC ASSAY; FORMAZAN; DERIVATIVES; ABSORPTION; ACIDITIES; (1)
Curcumin, Mikroglia, Neurodegeneration, Transkriptom, Neuroprotektion, sekundärer Pflanzenstoff, Immunmodulation, Neuroinflammation (1)
CURIE-TEMPERATURE; GA1-XMNXAS; (GA,MN)AS; FILMS; GAAS; (1)
CURIE-TEMPERATURE; SEMICONDUCTORS; GA1-XMNXAS; MAGNETORESISTANCE; SUPERCONDUCTOR; MANGANITES; MATRIX; INVAR; FILMS; GAAS; spin-waves; nanoscale inhomogeneities; diluted magnetic systems; magnons; spin-stiffness (1)
CURRANT STEM GIRDLER; SERRATIA-MARCESCENS; PERIPLANETA-AMERICANA; NOSOCOMIAL INFECTIONS; ASPERGILLUS-OCHRACEUS; PATHOGENIC BACTERIA; BLATTELLA-GERMANICA; MEDICAL IMPORTANCE; POTENTIAL VECTORS; SEX-PHEROMONE; antibiotic; food hygiene; jewel wasp (1)
CURRENT CROSS-SECTIONS; STRUCTURE-FUNCTION F-2; LOW Q(2); LOW-X; MUON SCATTERING; PROTON COLLISIONS; RESONANCE REGION; E(+)P SCATTERING; QCD ANALYSIS; SIGMA(L)/SIGMA(T); Lepton-Nucleon Scattering (1)
CURRENT PULSES; SPIN CURRENT; EMISSION; RADIATION; EMITTERS; spintronic THz emitter; split-ring resonator; bow-tie resonator; photonic mode mapping; electro-opticsampling; localized excitation (1)
CURRENT THERAPY; RATING-SCALE; SAFETY; TDCS; (1)
CURRENT-VOLTAGE CHARACTERISTICS; ATOMIC-FORCE MICROSCOPY; MOLECULAR WIRE; JUNCTIONS; CONDUCTANCE; DEPENDENCE; MONOLAYERS; STATES; LENGTH; CARBON; (1)
CURRICULUM-BASED MEASUREMENT; DECISION-MAKING INTERVENTION; GROWTH; INSTRUCTION; STUDENTS; MODEL; TOOL; RTI; learning progress monitoring; curriculum based measurement; continuous norms; primary school; formative assessment; spelling; learning trajectories (1)
CURRICULUM-BASED MEASUREMENT; GENDER-DIFFERENCES; STRATEGY USE; MATHEMATICS; COMPUTATION; TRAJECTORIES; FLEXIBILITY; ACHIEVEMENT; PERFORMANCE; DISABILITY; learning progress monitoring; mathematics education; mental computation; latent growth curve model; continuous norming; learning progression; formative assessment; curriculum-based measurement (CBM) (1)
curriculum-based measurement, reading assessment, web-based assessment, sentence reading comprehension, special educational needs, primary school age, progress monitoring (1)
Curriculum-based measurement, Web-based assessment, Computer-based assessment, Reading fluency (1)
CURVATURE; (1)
CURVATURE; APPROXIMATION; MEMBRANES; ELASTICITY; VESICLES; SHAPE; biomembranes; multi-phase Canham-Helfrich-Evans energy; Willmore flow; parametric finite elements; stability; numerical simulations (1)
CURVATURE; K-homology; K-theory; Bounded geometry; Poincare duality (1)
curve diffusion flow, well-posedness, blow-up criterion, angle condition (1)
CURVE PROGRESSION; Deformity; Braces; Infantile scoliosis; Juvenile scoliosis; Adolescent scoliosis (1)
CURVES; (2)
CURVE SHORTENING FLOW; DIFFERENTIAL-EQUATIONS; GRADIENT FLOWS; SURFACES; APPROXIMATION; DIFFUSION; DRIVEN; SCHEME; . Mean curvature flow; higher codimension; evolving surface finite elements; backward difference formulas; error estimates (1)
CURVES; random matrix theory; quantum gravity; hyperbolic geometry; JT gravity; holography; quantum chaos (1)
CURVES; SPACE; (1)
CURVULARIA-INAEQUALIS; VANADIUM CHLOROPEROXIDASE; HYDROGEN-PEROXIDE; ENANTIOSELECTIVE SULFOXIDATION; INACTIVATION; OXIDATION; BROMOPEROXIDASE; PHOTOCATALYSIS; HALOPEROXIDASE; INHIBITION; Biocatalysis; Photocatalysis; Water splitting; Sustainable Chemistry; Halogenation (1)
customer preference measurement, conjoint analysis, CA, analytic hierarchy process, AHP, applicability, validity, paired-comparison, dominance test, new product development, NPD (1)
customer profitability, customer portfolio, customer segment valuation, financial services industry (1)
CUSTOMER RELATIONSHIP MANAGEMENT; INFORMATION-SYSTEMS; BUSINESS VALUE; QUALITY; EQUITY; SATISFACTION; NETWORK; IMPACT; IT investments; Customer relationship management; Design science; Economic model (1)
Customer relations, Process planning, Banking (1)
Customer valuation, customer lifetime va lue, customer relationship management, social influence, network effects (1)
CUSTOMIZED TITANIUM ABUTMENTS; SURFACE TREATMENTS; FRACTURE-RESISTANCE; CLEANING PROCEDURES; RETENTIVE STRENGTH; IMPLANT ABUTMENTS; FOLLOW-UP; ADHESION; PLASMA; AGENTS; (1)
CUTANEOUS AMYLOIDOSIS; Ablagerungsdermatosen; Amyloid; Zytokeratin; Immunglobulinleichtketten; Pruritus (1)
CUTANEOUS HERPES-ZOSTER; VIRUS; varicella; herpes zoster; reactive perforating collagenosis (1)
CUTANEOUS LEISHMANIASIS; MAJOR INFECTION; INFLAMMATORY RESPONSE; APOPTOTIC NEUTROPHILS; LUTZOMYIA-LONGIPALPIS; IMMUNE-RESPONSE; CUTTING EDGE; EARLY PHASES; IN-VIVO; MACROPHAGES (1)
CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; CATTLE; TUBERCULOSIS; ACTIVATION; MECHANISMS; INFECTION; DIAGNOSIS; MICROBES; COMPLEX; Bovine PMN; MDM; Zebu; Holstein Friesian; Reservoir host (1)
CUTANEOUS LYMPHOMAS; SEZARY-SYNDROME; CLASSIFICATION; HYBRIDIZATION; TISSUE; DNA; (1)
CUTANEOUS MALIGNANT-MELANOMA; BASAL-CELL CARCINOMA; RISK-FACTORS; IMAGE CLASSIFICATION; ITALIAN POPULATION; PIGMENTARY TRAITS; SUN EXPOSURE; DERMATOLOGISTS; DIAGNOSIS; FEATURES; skin cancer classification; convolutional neural networks; patient data (1)
CUTANEOUS MALIGNANT-MELANOMA; CELLS; PROGRESSION; ACTIVATION; PHENOTYPE; PATHWAYS; REVEALS; GROWTH; (1)
CUTANEOUS MALIGNANT-MELANOMA; ULTRAVIOLET-RADIATION; LACTIC-ACID; MATRIX METALLOPROTEINASE-3; CELL INVASION; IN-VIVO; EXPRESSION; METASTASIS; ACTIVATION; PROMOTES; (1)
CUTANEOUS MELANOMA; BETA-CATENIN; PROGNOSTIC-FACTOR; EXPRESSION; THERAPY; SURVIVAL; GENE; MARKER; TUMOR; PROLIFERATION; (1)
CUTANEOUS MELANOMA; CANCER SURVIVAL; UNITED-STATES; TRENDS; GENDER; SKIN; 21ST-CENTURY; THICKNESS; EUROPE; AGE; Malignant melanoma; TNM staging; Survival analysis; Skin cancer screening; Stage distribution (1)
CUTANEOUS MELANOMA; CELL-PROLIFERATION; EXPRESSION; MTAP; PROGRESSION; SURVIVAL; RISK; 5'-DEOXY-5'-METHYLTHIOADENOSINE; MECHANISMS; VARIANTS; (1)
CUTANEOUS MELANOMA; INTERLEUKIN-2; NIVOLUMAB; Melanoma; In-transit; Satellite; Immune checkpoint blockade; Targeted therapy; Prognosis; Survival; Intralesional therapy (1)
CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; INVASIVE MELANOMA; SELF-EXAMINATION; SHORT GUIDELINES; FOLLOW-UP; DIAGNOSIS; INTERVENTION; METAANALYSIS; QUEENSLAND; (1)
CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; RECOMBINANT INTERLEUKIN-2; ADJUVANT THERAPY; CISPLATIN; COMBINATION; TAMOXIFEN; CHEMOTHERAPY; RISK; CHEMOIMMUNOTHERAPY; melanoma; metastasis; interferons; interleukin 2; biochemotherapy (1)
CUTANEOUS MELANOMA; UNITED-STATES; DAMAGED SKIN; RISK; (1)
CUTANEOUS REACTIONS; AGENTS; neutrophilic eccrine hidradenitis; palmoplantar erythrodysesthesia; oral mucositis; skin changes; chemotherapy (1)
CUTANEOUS SARCOIDOSIS; THERAPY; Sarcoidosis; Diffuse cutaneous systemic sclerosis; Morphea; Granuloma; Fibrosis (1)
cutaneous squamous cell carcinoma, definitive radiotherapy, head and neck, organs at risk, surgery, VMAT (1)
cutaneous T-cell lymphomas; soluble interleukin-2 receptor; natural killer cell activity; prognostic factors (1)
cutaneous vascular malformation | gastrointestinal bleeding | gastrointestinal vascular malformation | hematochezia | vascular malformation (1)
CU-TE; SYSTEM; PHASE; GAS; copper tellurides; pyrite structure; DFF-LDA; conductivity; band and bond character; ASW-E-COV (1)
CUTICULAR HYDROCARBON PATTERNS; CAMPONOTUS-VAGUS SCOP; NESTMATE RECOGNITION; ANT; (1)
CUTICULAR HYDROCARBON PATTERNS; NEOTROPICAL PONERINE ANT; DROSOPHILA-MELANOGASTER; NESTMATE RECOGNITION; INSECT HYDROCARBONS; PHYSICAL-PROPERTIES; PREDATORY BEHAVIOR; GENETIC-VARIATION; LIPID-COMPOSITION; MASS-SPECTRA; ants; cuticular hydrocarbons; isozymes; morphometry; Pachycondyla inversa; Pachycondyla subversa; Pachycondyla villosa; Ponerinae; sympatry; taxonomy (1)
CUTICULAR HYDROCARBON PROFILES; SLAVE-MAKING ANTS; NESTMATE RECOGNITION; HARPAGOXENUS-SUBLAEVIS; POLYERGUS-BREVICEPS; CUCULUS-CANORUS; HYMENOPTERA; COLONY; FORMICIDAE; CUCKOO; acceptance thresholds; chemical mimicry; coevolutionary arms race; cuticular hydrocarbons; Leptothorax; slavemaking ants; social parasites (1)
CUTICULAR HYDROCARBONS; COURTSHIP BEHAVIOR; PTEROMALIDAE; HYMENOPTERA; COMMUNICATION; PARASITOIDS; parasitoid wasp; cuticular lipids; cuticular hydrocarbons; close-range mate recognition; courtship behaviour; Hymenoptera; Pteromalidae; Muscidifurax raptorellus; chemical signal; information; polarity (1)
CUTICULAR HYDROCARBONS; DIMORPHIC MALES; FIGHTER MALES; QUEENS; female mimicry; intraspecific chemical mimicry; alternative reproductive tactics; ant males (1)
CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; EPICUTICULAR HYDROCARBONS; ASCOMYCOTA LABOULBENIALES; CHEMICAL PROFILE; RICKIA WASMANNII; APIS-MELLIFERA; HYMENOPTERA; HOST; DISCRIMINATION; (1)
CUTICULAR-HYDROCARBONS; POGONOMYRMEX-BARBATUS; PACHYCONDYLA-INVERSA; MYRMECIA-GULOSA; FERTILITY; SIGNAL; REPRODUCTIVES; NYL; Crematogaster smithi; fertility signal; intermorphs; cuticular hydrocarbons (1)
CUTICULAR HYDROCARBONS; PREY RECOGNITION; JUMPING SPIDERS; DIGGER WASP; INNATE AVERSION; MIMICRY; HYMENOPTERA; SALTICIDAE; ARANEAE; CUES; (1)
cuticular hydrocarbons; sex pheromone; chemical communication; mate recognition; Tachinaephagus zealandicus (1)
CUTICULAR HYDROCARBONS; SOCIAL WASP; SURFACE HYDROCARBONS; POSTPHARYNGEAL GLAND; INSECT HYDROCARBONS; LARVAL PARASITOIDS; HOST RECOGNITION; KIN RECOGNITION; OLFACTORY CUES; PAPER WASP; Chrysididae; Crabronidae; cuticular hydrocarbons; Hedychrum rutilans; host location; Hymenoptera; nest marking; parasitoid; Philanthus triangulum; species recognition (1)
CUTICULAR HYDROCARBON SYNTHESIS; COCKROACH BLATTELLA-GERMANICA; BEEWOLF PHILANTHUS-TRIANGULUM; FEMALE EUROPEAN BEEWOLVES; BEETLE ONTHOPHAGUS-TAURUS; POSTPHARYNGEAL GLAND; BEES HYMENOPTERA; F HYMENOPTERA; SOLITARY WASP; BODY-SIZE; antifungal; antimicrobial; beewolf; competition; fungus; mould; multifaceted parental investment; pathogen; Philanthus triangulum; postpharyngeal gland (1)
CUTTING EFFECTIVENESS; TOOTH PREPARATION; BUILDUP MATERIALS; COMPOSITE; CROWNS; WEAR; RESTORATIONS; STRENGTH; TEETH; BURS; (1)
CUTTLEFISH SEPIA-OFFICINALIS; MESSINIAN SALINITY CRISIS; POPULATION-STRUCTURE; MEDITERRANEAN SEA; GENETIC-STRUCTURE; DNA POLYMORPHISM; BALTIC SEA; MOLECULAR PHYLOGENY; NORTHEAST ATLANTIC; DIFFERENTIATION; Cox1; 16SrRNA; Phylogeography; Messinian Crisis; Cryptic species (1)
C VIRUS-INFECTION; MARROW-DERIVED CELLS; CYTOKINE SIGNALING-1; VIRAL CLEARANCE; ACTIVATION; EXPRESSION; RESPONSES; LIVER; SUPPRESSOR; DEATH; Autoimmunity; Transgenic; Liver; Tolerance (1)
C VIRUS-RNA; CHRONIC HEPATITIS-C; INITIAL TREATMENT; VERSION 2.0; INTERNATIONAL UNITS; AMPLIFICATION ASSAY; PLUS RIBAVIRIN; INTERFERON-ALPHA-2B; QUANTIFICATION; MONITOR; HCV; RT-PCR assay; viral load; method comparison (1)
CX3CL1; humanized tumor mice (HTM); trastuzumab; HER2; breast cancer; ADAM10; ADAM17 (1)
CXCR3; MICROENVIRONMENT; IMMUNOTHERAPY; EXPRESSION; SIGNATURES; INSIGHTS; MODELS; TISSUE; CCR3; RCC; chemokines; immunotherapy; metabolism; OXPHOS; T cells; IDO; biomarker (1)
CXCR4 CHEMOKINE; SOMATOSTATIN; RECEPTORS; FAM159B; adaptor protein; antibody; immunohistochemistry; neuroendocrine; tumour (1)
CYANATE ESTER; POLYMERIZATION; COMPOSITES; CONVERSION; RESIN; BEHAVIOR; KINETICS; (1)
cyanine dye, enzymatic assay, redox indicator, NADH, imaging, multicellular tumor spheroid (1)
Cyaninfarbstoff, fluoreszente H-Aggregate, DNA, RNA, Molecular Beacon, Klick-Chemie, azyklischer Linker (1)
Cyanobacteria, D-Enzyme, Green Algae, Symbiosis (1)
Cyanobacteria (Nostoc); glucose transport; lichen (Peltigera); symbiosis (1)
Cyano Complexes of Mercury(II), Iron(II), Cobalt(I), UV Spectra, Photochemistry (1)
CYANO-GILMAN REAGENTS; RAPID-INJECTION NMR; LITHIUM DIMETHYLCUPRATE; DIETHYL-ETHER; SPECTROSCOPIC INVESTIGATIONS; COPPER(III) INTERMEDIATE; REACTION-MECHANISM; BLACK-BOX; COMPLEXES; REACTIVITY; (1)
Cyber exercise, Cyber exercise lifecycle, Cyber exercise scenario, Cyber range, Process engine, Scenario automation (1)
Cyber Exercise, Cyber Exercise Scenario, Cyber Exercise Lifecycle, Cyber Range, Process Engine (1)
Cyber Exercise, Cyber Exercise Scenario, Participant Observation, Activity Monitoring, Cyber Exercise Evaluation, Cyber Scenario Steering Innovative Security Awareness and Education; Security and Privacy Metrics; Threat Awareness; Vulnerability Analysis and Countermeasures (1)
Cyber range, Authentic learning, Cybersecurity exercise, Instructional design, Cyber defense exercise (1)
cyber range, evaluation method, cybersecurity exercise, cyber defense exercise (1)
Cyber range, Security operations center, Digital twin (1)
Cyber Range, Security Operations Center, Learning, Cybersecurity Exercise, Instructional Design (1)
Cybersecurity capability maturity model; IT-security capability maturity model (1)
Cybersecurity, Cyber Range, Incident Response, Workforce Gap, Authentic Learning, Cybersecurity Training (1)
Cybersecurity, Industrial Internet of Things (IIoT), Business Process Management (BPM), Continuous Compliance, Security-by-Design, BPMN Extension, Process Mining, IEC 62443, OPC UA, Intrusion Detection (1)
Cybersecurity · Motivation · Incentives · Nudges · Awareness · Compliance · Policy (1)
Cybersecurity, Motivation, Incentives, Nudges, Awareness, Compliance, Policy (1)
Cybersecurity Training, Cybersecurity Exercise, Cyber Range (1)
Cybersecurity, Visual Analytics, Human Factors, Domain Knowledge, Security Analytics (1)
Cyber Threat Intelligence; Collaborative Cybersecurity; Incident Response; Security Operations; Playbooks (1)
Cyber Threat Intelligence, CTI, STIX, Intelligence Exchange (1)
Cyber threat intelligence; Human awareness; Human-as-a-security-sensor; Security information and event management (SIEM) (1)
Cyber Threat Intelligence Sharing, Threat Intelligence Sharing, Security Information Sharing (1)
Cyber Threat Intelligence, Threat Intelligence, Security Information (1)
Cyber Threat Intelligence Visual Analytics Usable Cybersecurity STIX (1)
CYCLASE-A RECEPTOR; BLOOD-PRESSURE; MICE LACKING; RENOVASCULAR HYPERTENSION; JUXTAGLOMERULAR CELLS; CARDIAC-HYPERTROPHY; CHRONIC INFUSION; TRANSGENIC MICE; HEART-FAILURE; RATS; renin; atrial natriuretic peptide; B-type natriuretic peptide; hypertension; guanylyl cyclase A (1)
CYCLE ARREST BIOMARKERS; URINARY TIMP-2; ADULTS; IMPACT; Biomarker testing; Acute kidney injury; Critical care; Expert panel; Protocols; Clinical guidelines; Tissue inhibitor of metalloproteinases-2; Insulin-like growth factor binding protein 7; Biomarker technology; Diagnosis (1)
CYCLE PROGRESSION; HEDGEHOG PATHWAY; EXPRESSION; TUMOR; GLI1; MICE; DIFFERENTIATION; TRANSFORMATION; MANIPULATION; INHIBITION; CYLD; GLI1; Snail1; BCC; Bcl-3 (1)
CYCLIC ADP-RIBOSE; TIME PCR DATA; T-CELLS; I INTERFERON; GM-CSF; DENDRITIC CELLS; EXPRESSION; ACTIVATION; INDUCTION; TRPM2; (1)
CYCLICAL UNEMPLOYMENT; SECTORAL SHIFTS; GLOBALIZATION; GOVERNMENT; EXPANSION; TERMS; SIZE; (1)
cyclic amino acids, tripeptide catalysis, NPY ligands, cyclopropane ring-opening, homo-beta-proline (1)
CYCLIC-AMP ACCUMULATION; SMOOTH-MUSCLE CELLS; RAT VAS-DEFERENS; PANCREATIC-POLYPEPTIDE; MURINE SPLEEN; ADENOSINE 5'-TRIPHOSPHATE; INTERLEUKIN-6 SECRETION; PEPTIDE-YY; NORADRENALINE; LOCALIZATION; neuropeptide Y; norepinephrine; neuroimmune interaction; spleen; macrophage; cytokines (1)
CYCLIC-AMP; INHIBITION; ISOFORMS; CALMODULIN; BINDING; ANTHRAX; DRUG; CAMP; adenylyl cyclase; edema factor; fluorescence assay; terbium norfloxacin; high-throughput screening (1)
CYCLIC CHALCONE ANALOGS; NMR CHEMICAL-SHIFTS; FLUORESCENT-PROBES; E-2-BENZYLIDENEBENZOCYCLOALKANONES; DERIVATIVES; E-2-(X-BENZYLIDENE)-1-BENZOSUBERONES; E-2-(X-BENZYLIDENE)-1-TETRALONES; 2-ARYLIDENEBENZOCYCLOALKANONES; TRANSMISSION; CELLS; dimethylaminochalcone; fluorescence spectroscopy; phospholipids; lipoproteins; breast cancer cells (1)
CYCLIC COHOMOLOGY; DEHN FUNCTIONS; K-THEORY; CONJECTURE; Novikov conjecture; uniform Roe algebra; uniformly finite homology (1)
CYCLIC FATIGUE RESISTANCE; GLIDE PATH; TOOTH; FILES; BMP; INSTRUMENTS; EXPRESSION; BLUE; Tooth; Root canal; Gene; Polymorphism (1)
CYCLIC HOMOLOGY; A(1)-HOMOTOPY THEORY; EXCISION; LOCALIZATION; DESCENT; K-theory; birelative K-theory; localizing invariant; excision; cdh-descent (1)
CYCLIC HOMOLOGY; CHERN CLASSES; LOOP-SPACES; TRANSFORMATIONS; CHARACTER; MOTIVES; Chern character; K-theory; categorification (1)
CYCLIC HOMOLOGY; HOMOTOPY; COHOMOLOGY; CATEGORIES; GEOMETRY; SCHEMES; (1)
CYCLIC HOMOLOGY; Tangent groupoid; Bismut-Chern character; Chern character; JLO cocycle; cyclic cohomology; entire cohomology; Atiyah-Singer index theorem (1)
CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; RELAXIN FAMILY PEPTIDES; URETERAL OBSTRUCTION; KIDNEY FIBROSIS; TGF-BETA; CGMP; KINASE; INHIBITION; EXPRESSION; FAILURE; Phosphodiesterase 5 inhibitor; Serelaxin; cGMP-dependent protein kinase; Kidney; Interstitial fibrosis; Signaling (1)
cyclic stretch, mechanoregulation, murine macrophages, neuropetides, substance P, alpha-calcitonin gene-related peptide, neurokinin receptor, CGRP receptor, osteoclastogenesis (1)
Cyclic voltammetry; McMurry reaction; Spectroelectrochemistry; Tetraphenylethenes (1)
CYCLIN D1; EXPRESSION; INVOLVEMENT; P53; squamous cell carcinoma of the penis (SCCP); immunohistochemistry; proliferation-related biomarkers; Ki-67; mini-chromosome maintenance 2 protein (MCM2); geminin (1)
CYCLIN-DEPENDENT KINASE-5; DOUBLE-CORTEX SYNDROME; MALFORMATIVE LESIONS; CORTICAL DEVELOPMENT; PROTEIN; GENE; NEURONS; P35; EPILEPSIES; ACTIVATOR; cyclin-dependent kinase 5; doublecortin; pseudogene; reelin-pathway; ganglioglioma (1)
CYCLIN-DEPENDENT KINASE; GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE; C-MYC; AFFINITY-CHROMATOGRAPHY; PRIMARY CILIA; IN-VIVO; CISPLATIN CYTOTOXICITY; THERAPEUTIC TARGETS; CUBITUS INTERRUPTUS; casein kinase 1; cyclin-dependent kinase; kinase inhibitor; polycystic kidney disease; roscovitine (1)
CYCLIN-DEPENDENT KINASE; MAMMARY EPITHELIAL-CELLS; IFN-GAMMA; ONCOSTATIN-M; INHIBITOR P21(WAF1/CIP1); ISGF3 COMPONENTS; GENE-EXPRESSION; UP-REGULATION; FACTOR-I; C-MYC; cell cycle; chimeric receptor; cytokine resistance; cytokines; signal transduction (1)
CYCLIN-DEPENDENT KINASES; CELL-CYCLE; THERAPEUTIC TARGETS; CANCER; COMBINATION; GROWTH; TRANSCRIPTION; PALBOCICLIB; ACTIVATION; RESISTANCE; (1)
CYCLIN-DEPENDENT-KINASES; CO-OVEREXPRESSION; SORAFENIB RESISTANCE; TUMOR-SUPPRESSOR; DOWN-REGULATION; CANCER; CONTRIBUTES; EXPRESSION; MICRORNAS; CELLS; Hepatocellular carcinoma; HCC; microRNA; drug resistance; ZCCHC11 (1)
CYCLIN E2; VARIANTS; EXPRESSION; ENHANCERS; CHROMATIN; DISEASE; AUTOIMMUNITY; REGULATOR; COMPLEX; CELLS; (1)
Cyclins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (D1, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Transcription factors Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (IkB-alpha (NF-kB inhibitor alpha ), mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Animal cell line (JURKAT relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Transcription factors Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (NFAT2 (nuclear factor of activated T-cell, 2), mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) PCR (RT-PCR (reverse transcription-PCR), real-time relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Fas antigen Interleukin 2 Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Proteins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (p65, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Anti-inflammatory agents Cytotoxic agents Drug screening Human (relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) mRNA Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti- Actins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (beta -, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Interferons Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (gamma , mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) antiinflammatory cytotoxic agent screening mRNA real time RT PCR (1)
Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1 ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Animal cell line (JURKAT ajugasalicioside A induction of cell-cell contact, inhibition of cell proliferation, and regulation of mRNA levels in) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NF-kB (nuclear factor of k light chain gene enhancer in B-cells) ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Cell proliferation (ajugasalicioside A inhibition of Jurkat T cell proliferation) mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Mononuclear cell (ajugasalicioside C cytotoxicity to human cells) New natural products (ajugasaliciosides A-E (sterol glycosides) Antitumor agents (antileukemic sterol glycosides named ajugasaliciosides from Ajuga salicifolia as) Human (cytotoxicity of ajugasaliciosides to HeLa cells, Jurkat T cells, and human peripheral mononuclear blood cells) Cytotoxicity (of ajugasalicioside C to human peripheral mononuclear blood cells) Molecular structure (of ajugasaliciosides A-E (sterol glycosides) Glycosides Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (steroidal cytotoxicity, isolation, and structure of antileukemic sterol glycosides from Ajuga salicifolia) antileukemic sterol glycoside Ajuga ajugasalicioside structure (1)
Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1 curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Antitumor agents CD4-positive T cell Human Mononuclear cell (curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Gene Interleukin 2 Interleukin 6 mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Interferons Role: BSU (Biological study, unclassified), BIOL (Biological study) (gamma curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) curcumin mRNA lymphocyte monocyte gene antitumor (1)
Cycloaddition · Cyclopropanes · Thiourea · Lewis acids · Furolactam (1)
CYCLOADDITION; DESIGN; AZIDES; (1)
Cycloaddition • Doping • Luminescence • Nanoparticles • Photocatalysis (1)
CYCLOADDITION REACTION; CHEMISTRY; NUCLEOTIDE; (1)
CYCLOADDITION REACTION; CLICK CHEMISTRY; cycloaddition; energy transfer; fluorescence; megastokes; oligonucleotide (1)
CYCLOBUTANE DERIVATIVES; PHOSPHORIC-ACID; PHOTOCHEMISTRY; (1)
Cyclometalated complexes; Cytotoxic activity; Iridium; Organometallic anticancer drugs; Terpyridine ligands (1)
CYCLOMETALATED IRIDIUM COMPLEXES; LYING ELECTRONIC STATES; TEMPERATURE-DEPENDENCE; ORGANIC-MOLECULES; DECAY DYNAMICS; EXCITED-STATES; EFFICIENCY; DEVICES; EMISSION; BTP(2)IR(ACAC); (1)
CYCLOMETALATED IRIDIUM COMPLEXES; SPIN-LATTICE-RELAXATION; TIME-RESOLVED SPECTRA; HIGH-EFFICIENCY; TEMPERATURE-DEPENDENCE; ELECTRONIC STATES; ELECTROPHOSPHORESCENT DEVICES; CONJUGATED POLYMERS; ORGANIC-MOLECULES; DECAY DYNAMICS; (1)
CYCLOMETALATED IRIDIUM COMPLEXES; TRIPLET-STATE; DEVICES; SPECTROSCOPY; RELAXATION; EXCITATION; PERYLENE; EMISSION; DYNAMICS; DIODES; triplet emitter; OLED; persistent spectral hole burning; zero-field splitting; polyvinylbutyral; poly-N-vinylcarbazol; poly(9.9-dioctylfluoren-2,7-diyl); Ir(btp)(2)(acac); phosphorescence line narrowing; metal-to-ligand charge transfer; PVK; PVB; PFO; MLCT; ZFS; spin-orbit coupling; SOC (1)
CYCLOMETALATED IRIDIUM(III) COMPLEXES; EMITTING ELECTROCHEMICAL-CELLS; EFFICIENT PHOSPHORESCENT OLEDS; TRIPLET-STATE PROPERTIES; ZETA VALENCE QUALITY; GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; ATOMS LI; BLUE; DEVICES; Iridium; Cyclometalated complexes; Biuretato ligands; Crystal structure; Absorption and emission spectrum (1)
CYCLOMETALATED IRIDIUM(III) COMPLEXES; TRIPLET-STATE PROPERTIES; ELECTROCHEMICAL-CELLS; LIGHT; LIGANDS; REAGENTS; SPECTROSCOPY; OXAMIDATE; DESIGN; DIODES; Iridium; Cyclometalated complex; Crystal Structure; Absorption; Luminescence (1)
CYCLOMETALATED IR(III) COMPLEXES; GAS SHIFT REACTION; MOLECULAR-ORBITAL METHODS; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; RUTHENIUM(II) COMPLEXES; MILD CONDITIONS; DECAY DYNAMICS; TRIPLET-STATE; BLUE; (1)
CYCLOMETALATED IR(III) COMPLEXES; INTRAMOLECULAR CHARGE-TRANSFER; EXCITED-STATE; ELECTRON-TRANSFER; DI(PERYLENE BISIMIDE)S; HIGHLY EFFICIENT; ENERGY-TRANSFER; RADICAL-ANIONS; PHOTOSENSITIZERS; SINGLET; (1)
CYCLOMETALATED IR(III) COMPLEXES; LIGHT-EMITTING-DIODES; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; LABELING REAGENTS; MASS-SPECTROMETRY; STATE PROPERTIES; QUANTUM YIELDS; TRIPLET-STATE; DISCOVERY; phosphorescence; iridium complexes; screening; photodegradation; combinatorial synthesis; organic light-emitting diodes (1)
CYCLOMETALATED IR(III) COMPLEXES; TRANSITION-METAL-COMPLEXES; LIGHT-EMITTING DEVICES; ENERGY-TRANSFER; CRYSTAL-STRUCTURES; ANCILLARY LIGANDS; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; RUTHENIUM(II) COMPLEXES; POLYPYRIDINE COMPLEXES; N ligands; ligand design; nitrogen heterocycles; click reaction; 1,2,3-triazole (1)
CYCLOMETALATED PLATINUM COMPLEXES; EXTERNAL QUANTUM EFFICIENCY; IRIDIUM(III) COMPLEXES; PHOSPHORESCENT DOPANTS; COORDINATION-COMPOUNDS; ELECTRONIC STATES; EXCITED-STATES; TRIPLET-STATE; LIGANDS; FLUORESCENCE; electroluminescence; near-infrared emission; deep-red luminescence; triplet harvesting; dinuclear platinum complex (1)
CYCLOMETALATED PLATINUM COMPLEXES; SENSITIZED SOLAR-CELLS; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; IRIDIUM(III) COMPLEX; PHOSPHORESCENT STATE; DECAY DYNAMICS; EMISSION; SPECTROSCOPY; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; OLED EMITTER IR(BTP)(2)(ACAC); TRIPLET-STATE; EMISSION PROPERTIES; EXCIMER FORMATION; ELECTRON-TRANSFER; PT(II) COMPOUNDS; HIGH-RESOLUTION; SINGLE-CRYSTAL; DEVICES; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; ORGANOMETALLIC PT(II); ASYMMETRIC CATALYSIS; HIGH-RESOLUTION; LIGANDS; PHOSPHORESCENCE; SPECTROSCOPY; EFFICIENCY; EMITTERS; BEHAVIOR; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; EXCITED-STATES; IRIDIUM COMPLEXES; TRIPLET-STATE; PHOSPHORESCENT PROPERTIES; RESONANCE SPECTROSCOPY; TEMPERATURE-DEPENDENCE; ORGANOMETALLIC PT(II); RELAXATION PROCESSES; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; SPIN-LATTICE-RELAXATION; TRANSFER EXCITED-STATES; TRIPLET-STATE; ELECTROLUMINESCENT DEVICES; TEMPERATURE-DEPENDENCE; IRIDIUM COMPLEXES; CHARGE-TRANSFER; ENERGY-TRANSFER; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; TRIPLET-STATE PROPERTIES; LIGHT-EMITTING DEVICES; RESOLUTION OPTICAL SPECTROSCOPY; 3-COORDINATE GOLD(I) COMPLEXES; EFFICIENCY ROLL-OFF; EXCITED-STATE; PHOSPHORESCENT PLATINUM(II); PHOTOPHYSICAL PROPERTIES; QUANTUM YIELDS; (1)
Cyclonucleotide , Sekundärer Bote , Adenylatcyclase , Bakterien , Toxin , Exotoxin , Bacillus anthracis , Adenylylcyclase , bakterielle Adenylylcyclase-Toxine , Ödemefaktor , adenylyl cyclase , bacterial adenylyl cyclase toxins , edema factor (1)
Cyclonucleotide , Sekundärer Bote , Säugetiere , Adenylatcyclase , Bakterien , Toxin , Adenylylcyclase , Bakterielle Adenylylcyclase-Toxine , adenylyl cyclase , bacterial adenylyl cyclase toxins (1)
cyclooxygenase-1, cardiac anesthesia, ischemia-reperfusion injury, volatile anesthetics, postconditioning, cyclooxygenase-2 (1)
CYCLOOXYGENASE-2 EXPRESSION; MACULA DENSA; RENIN; CHLORIDE; HEMODYNAMICS; TRANSPORT; RELEASE; URINE; RNA; salt and water wasting; Bartter disease; Gitelman disease; loop diuretics; furosemide; hydrochlorothiazide; renin system; prostaglandins; saluresis; urinary excretion (1)
cyclooxygenase; cytokine; hepatic steatosis; NASH; suppressor of cytokine signaling (SOCS); type II diabetes (T2DM) (1)
Cyclooxygenase, Niere, interstitielle Zellen (1)
Cyclo-P₈ · DFT Rechnungen · Phosphor · Polyphosphor · Tantal (1)
Cyclopent-2-enones, prostaglandins, TEI-9826, Schwartz reagent, guaiane sesquiterpenes, teuclatriol, orientalol-F, englerin-A, one-pot economy, pseudoguaianolides, metathesis (1)
CYCLOPENTADIENYL-IRON COMPLEXES; CATALYSIS; (1)
Cyclopentadienyl, Phosphor, Arsen, Übergangsmetall (1)
CYCLOPENTENONE PROSTAGLANDIN ANALOGS; 3-COMPONENT COUPLING PROCESS; RING-CLOSING METATHESIS; CONJUGATE ADDITION; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ANTITUMOR-ACTIVITY; ALLYLIC SUBSTITUTION; LIPID MICROSPHERES; IN-VIVO; (1)
cyclophanes - azo-switches - phenylene–ethynylene–butadiynylenes - scanning tunneling microscopy - single-molecule spectroscopy (1)
cyclopropanated pyrrole, bis-beta-homoproline, tropane, pyrrolidinone (1)
cyclopropanated pyrroles, ring-opening, Heck cross-coupling, photochemistry (1)
CYCLOPROPANATION (1)
Cyclopropanation, Homo-b-proline, Paraconic acid, Aromatic heterocycles (1)
cyclopropanation, pressure, foldamers, Cyclopropanierung, Druck, Foldamere (1)
cyclopropanes; endocyclic ring-opening; fused carbocyclic cyclopropanes; Pd-catalyzed ring-opening; acid-mediated ring-opening; exocyclic ring-opening (1)
Cyclopropanes, Palladium, Heck, Ring Opening, Heterocycles (1)
Cyclopropanes, Vinylcyclopropanes, photoredox catalysis, Lactones, Cyclopentene, Rhodium, Anti-Markovnikov-Addition, chiral Phosphoric acids, DFT calculations (1)
Cyclopropanierung , Dihydrofuran , Furofurane , Asymmetrische Synthese , Synthon , Diterpene , Chemische Synthese , marine Naturstoffe , unnatürliche Aminosäuren , marine natural products , unnatural amino acids , cyclopropanation (1)
CYCLOREVERSION REACTIONS; DIARYLETHENE; CONFINEMENT; DEPENDENCE; MEMORIES; SWITCHES; ENERGY; Cage Compounds; Confinement; Photoswitches; Supramolecular Chemistry; Ultrafast Spectroscopy (1)
CYCLOSERINE FACILITATES EXTINCTION; CEREBROCORTICAL NERVE-TERMINALS; PLACE PREFERENCE; PRESYNAPTIC LOCALIZATION; POTENTIATED STARTLE; MGLUR5 ANTAGONISTS; RAT HIPPOCAMPUS; ETHANOL-SEEKING; COCAINE; MICE; AMN082; DCS; Fear extinction; L-glutamate; MPEP; mGluR5; mGluR7 (1)
cyclosporin A, budesonide, in-situ nanosuspension, micellar solution, bioavailability, biocompatibility, liquid (1)
CYCLOSPORINE (1)
Cyclosporine A; chronic lung allograft dysfunction; HUVEC; endothelial cells; cell viability; oxidative stress; reactive oxygen species; molecular hydrogen (1)
CYCLOSPORINE-A; CLINICAL PHARMACOKINETICS; AUTOIMMUNE-DISEASE; CYTOTOXIC AGENTS; FORMULATION; TOXICITY; FOOD; DRUG; (1)
CYCLOSPORINE-A; TRANSFORMING GROWTH-FACTOR-BETA-1; MAMMALIAN TARGET; MACULA DENSA; SALT INTAKE; RAPAMYCIN; INHIBITION; RENIN; COX-2; NEPHROTOXICITY; rat; everolimus; cox-2; kidney; prostaglandins; salt intake; natriuresis (1)
Cyclosporine , Nierentransplantation , Ratten , Pharmakokinetik , Pharmakodynamik , Generika , Immunsuppressiva , Generics , immunosuppressive drugs (1)
Cyclosporin, role of metabolites, liver transplantation - Metabolites of cyclosporin, in liver transplantation (1)
Cyclotetramerisierung; In-Lösung Synthese; oberflächengestützte Synthese; Phthalocyanin; Rastersondenmikroskopie (1)
Cyclotetramerization; In-solution synthesis; On-surface synthesis; Phthalocyanine; Scanning probe microscopy (1)
CYCLO-TRIPHOSPHORUS; WHITE PHOSPHORUS; NICKEL-COMPLEXES; P-4 ACTIVATION; RARE-EARTH; DINITROGEN; REACTIVITY; COBALT; LIGAND; REDUCTION; activation; reduction; transition metal; white phosphorus; yellow arsenic (1)
CYCLOTRON-RESONANCE; (1)
CYCLOTRON-RESONANCE; GAS; (1)
CYCLOTRON-RESONANCE; MAGNETIC-FIELD; ANTIDOT ARRAYS; LORENTZ MODEL; MAGNETOTRANSPORT; LOCALIZATION; MAGNETORESISTANCE; GAS; (1)
CYCLOTRON-RESONANCE; MAGNETIC-FIELD; TRANSPORT; IONIZATION; IMPURITIES (1)
CYLINDROTHECA-FUSIFORMIS BACILLARIOPHYCEAE; GREEN FLUORESCENT PROTEIN; NITRATE REDUCTASE GENE; CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTIONAL REGULATION; PHAEODACTYLUM-TRICORNUTUM; THALASSIOSIRA-PSEUDONANA; SACCHAROMYCES-CEREVISIAE; BIOGENIC SILICA; EXPRESSION; Cylindrotheca fusiformis; diatom transformation; green fluorescent protein (GFP); inducible gene expression; nitrate reductase (1)
CYLINDROTHECA-FUSIFORMIS; CELL-WALLS; NAVICULA-PELLICULOSA; INORGANIC MATERIALS; PHASE-SEPARATION; FINE-STRUCTURE; GENE FAMILY; AMINO-ACID; BIOSILICA; MORPHOGENESIS; (1)
Cyloadditions; Insertion Reactions; Multiple Bonds; P Ligands (1)
CYP-P-450, Arzneimittelinteraktion (1)
CYSTEINE PROTEASE INHIBITORS; C-H FUNCTIONALIZATION; AEROBIC OXYSULFONYLATION; (E)-ALKENYL SULFONES; PHOTOREDOX CATALYSIS; ASYMMETRIC-SYNTHESIS; ALKENES; ALKYNES; ACIDS; PHOSPHONATES; aryl sulfinates; metal-free conditions; photocatalysis; vinyl sulfones; visible light (1)
CYSTEINE PROTEASE; NEDD2 GENE; DISCOVERY; TAU; INHIBITORS; SITE; CLEAVAGE; ENCODES; DEATH; MODEL; (1)
CYSTEINE PROTEINASE-INHIBITOR; NMR-SPECTROSCOPY; ANIMAL CYSTATINS; PLANT; ORYZACYSTATIN; GENES; RICE; Saccharum officinarum cystatin; Canecystatin-1; Phytocystatin; Cysteine protease inhibitor (1)
CYSTEINE-RICH DOMAIN; B-RAF; C-RAF; PHOSPHORYLATION SITES; IN-VIVO; A-RAF; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY; BINDING-SITES; CAUSE NOONAN; (1)
CYSTEINE-RICH FAMILY; HUMAN MONOCYTES; ENDOTHELIAL-CELLS; DNA-BINDING; MACROPHAGES; CK2; IDENTIFICATION; MEMBER; SUPERFAMILY; RM3/1; CD163; isoform; casein kinase II; PKC; signaling (1)
CYSTEINE-STRING PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; CALCIUM-BINDING PROTEIN; NEUROTRANSMITTER RELEASE; NERVOUS-SYSTEM; CSP-ALPHA; TARGETED MUTAGENESIS; SYNAPTIC VESICLES; GENE-EXPRESSION; FLIES LACKING; brain proteins; CSP; synapsin; SAP47; Bruchpilot; calbindin; PDF; Eps15 (1)
CYSTEINYL-LEUKOTRIENES; ACTIVATING PROTEIN; MESANGIAL CELLS; ANGIOTENSIN-II; LOCALIZATION; LEUKOCYTES; 12/15-LIPOXYGENASE; VASOCONSTRICTION; BIOSYNTHESIS; INFLAMMATION; nephron segments; microdissection (1)
CYSTIC-FIBROSIS AIRWAYS; EPITHELIAL-CELLS; NA+ ABSORPTION; EXTRACELLULAR NUCLEOTIDES; ADENOSINE RECEPTORS; PHOSPHOLIPASE-C; ATP; INHIBITION; TRANSPORT; UTP; UDP; ADP; P2Y(6) receptor; epithelial transport; cystic fibrosis; CFTR (1)
Cystic fibrosis, Bile acids, Children, Advanced cystic fibrosis liver disease, Cystic fibrosis hepatobiliary involvement (1)
CYSTIC-FIBROSIS; CA2+; TMEM16A; CAMP; Ca2+ activated Cl- currents; CaCC; TMEM16A; Ano1; Anoctamin; CFFR; Crosstalk (1)
CYSTIC-FIBROSIS; CFTR ACTIVITY; SECRETION; ACTIVATION; TRANSPORT; FLUID; LINES; (1)
CYSTIC-FIBROSIS; FLUID SECRETION; CALCIUM; EXPRESSION; RECEPTOR; ANDROGEN; PROGRESSION; HORMONES; CFTR; GENE; TMEM16A; ADPKD; polycystic kidneys; androgen; estrogen; CFTR (1)
CYSTIC-FIBROSIS; METABOLIC ALKALOSIS; COLLECTING DUCT; HCO3; MEMBRANE; ACETAZOLAMIDE; COTRANSPORTER; ACIDIFICATION; RECLAMATION; TRANSPORT (1)
CYSTIC KIDNEY-DISEASE; JUVENILE HYPERURICEMIC NEPHROPATHY; TAMM-HORSFALL PROTEIN; HUMAN FIBRILLIN-1; LOCALIZATION; 16P12; NEPHRONOPHTHISIS; DYNAMICS; CHILDREN; BINDING; MCKD2; uromodulin; Tamm-Horsfall protein (1)
CYSTOID MACULAR EDEMA; RETINITIS-PIGMENTOSA; CONE DYSFUNCTION; DYSTROPHY; DORZOLAMIDE; UPDATE; FAMILY; GENE; VMD2; ADVIRC; BEST1; fundus autofluorescence; long-term follow-up; near-infrared autofluorescence (1)
CYSTOID MACULAR EDEMA; TOPICAL DORZOLAMIDE THERAPY; RECEIVING VITAMIN-A; RETINITIS-PIGMENTOSA; CLINICAL-TRIAL; INTRAVITREAL TRIAMCINOLONE; DOCOSAHEXAENOIC ACID; CONTINUED USE; ACETAZOLAMIDE; LESIONS; Retinitis pigmentosa; Cystoid macular edema; Retinal dystrophies; Ciliary neurotrophic factor; Docosahexaenoic acid (1)
CYTIDINE 3'-5'-CYCLIC MONOPHOSPHATE; BOMBARDMENT MASS-SPECTROMETRY; MAMMALIAN ADENYLYL-CYCLASE; SOLUBLE GUANYLYL CYCLASE; STRUCTURAL BASIS; CYCLIC CMP; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; RAT-TISSUES; CALMODULIN; (1)
CYTOCHROME-C-OXIDASE; PROTEIN-SYNTHESIS; SPINAL-CORD; RATS; RELEASE; HYPERALGESIA; HEPATOCYTES; INVOLVEMENT; PERFORMANCE; ORGANISMS; Mice; Adenosine; Nucleotides; Hypothermia; Adenosine kinase (1)
CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; ENERGY-METABOLISM; CELLS; RESISTANCE; OVEREXPRESSION; CATALASE; CARRIERS; RECEPTOR; DEFECTS; Glucocorticoid; Acute lymphoblastic leukemia; Mitochondrial transport; Mitochondrial membrane properties; Mitochondrial respiration; Apoptosis (1)
CYTOCHROME-P450 2D6; LEVOMEPROMAZINE; SCHIZOPHRENIA; MELPERONE; METABOLISM; CYP2D6; 9-HYDROXYRISPERIDONE; HALOPERIDOL; QUETIAPINE; INHIBITOR; Antipsychotics; Risperidone; Psychopharmacology; Pharmacokinetics; Therapeutic drug monitoring (1)
CYTOCHROMES P450 2D6; LONG-TERM TREATMENT; BIPOLAR DISORDER; PLASMA-CONCENTRATIONS; VALPROIC ACID; 2ND-GENERATION ANTIPSYCHOTICS; CONCOMITANT CARBAMAZEPINE; PSYCHIATRIC-DISORDERS; BODY-WEIGHT; CYP2D6; therapeutic drug monitoring; risperidone; carbamazepine; valproic acid; lamotrigine cytochrome P450; interaction; pharmacokinetics (1)
CYTOKERATIN EXPRESSION PATTERNS; GROWTH-FACTOR RECEPTOR-3; CELL-CARCINOMA; TUMOR PROGRESSION; STAINING PATTERN; EAU GUIDELINES; GRADE; DEFINE; P53; PROGNOSIS; Urinary bladder carcinoma; pT1 bladder cancer; Immunohistochemistry; Risk assessment; Recurrence; Disease progression (1)
CYTOKERATIN-POSITIVE CELLS; BONE-MARROW; TRANSGENIC MICE; MAMMARY-CARCINOMA; METASTASIS; PROGRESSION; EXPRESSION; REVEALS; MODEL; TUMOR; (1)
CYTOKERATIN-POSITIVE CELLS; BREAST-CANCER; COPY NUMBER; BONE-MARROW; DNA; CGH; AMPLIFICATION; MICROARRAYS; PCR; EXPRESSION; (1)
CYTOKERATIN-POSITIVE CELLS; DISSEMINATED TUMOR-CELLS; BREAST-CANCER; BONE-MARROW; LYMPH-NODES; MULTIVARIATE-ANALYSIS; SQUAMOUS CANCER; LUNG-CANCER; COPY NUMBER; AMPLIFICATION; (1)
CYTOKINE; CHILDREN; SERUM; IL12B; GENE; CELLS; Juvenile idiopathic arthritis; IL-12p40; IL-12B; promoter; polymorphism (1)
CYTOKINE FLOW-CYTOMETRY; GAMMA ELISPOT ASSAYS; CELL RESPONSES; CD4+T-CELL IMMUNITY; PERIPHERAL-BLOOD; INTERFERON-GAMMA; CANCER VACCINES; TETRAMER; PEPTIDE; MELANOMA; ELISPOT; Tetramer; Standardization; Interlaboratory testing (1)
CYTOKINE GENE-EXPRESSION; IMMUNE-RESPONSES; SUBSEQUENT SEPSIS; STEROID-HORMONES; MALES; MACROPHAGES; MORTALITY; ESTROGEN; PATHWAYS; GENDER; cell signaling; sex steroids; hemorrhage; immune depression; macrophages (1)
Cytokine , Genexpression , Hypoxie , Stickstoffmonoxid , Zellkultur , Adrenomedullin , Adrenomedullinrezeptor , adrenomedullin , cytokines , gene expression , hypoxia , nitric oxide (1)
cytokine-induced killer cells; cannabidiol; pancreatic cancer (1)
CYTOKINE PRODUCTION; INOS; DIFFERENTIATION; INFLAMMATION; MACROPHAGES; immunomodulation; inflammation; inhibitors; monocytes; nitric oxide (1)
CYTOKINE-RELEASE SYNDROME; HAPLOIDENTICAL DONOR TRANSPLANTATION; HEMATOLOGICAL MALIGNANCIES; PEDIATRIC-PATIENTS; PLASMA-LEVELS; CAR THERAPY; BONE-MARROW; REMISSIONS; TISAGENLECLEUCEL; EXPRESSION; (1)
cytokines | ECLS | interleukin- 6 | interleukin-8 | V-A ECMO | weaning failure (1)
cytokines; graft-versus-host disease; idiopathic pneumonia syndrome; lung; lymphocyte (1)
Cytokines, Interferon, fusion protein, proteases, CD138, CrossMab, Multiple Myeloma (1)
CYTOKINES; RESISTIN (1)
Cytokine , Stickstoffmonoxid , Promotor , Sepsis , Angiotensin II , Rezeptor , Genregulation , AT1a-Rezeptor , glatte Gefäßmuskelzellen , cytokines , nitric oxide , promoter , AT1a receptor , vascular smooth muscle cells (1)
CYTOKINE UP-REGULATION; P38 MAP KINASE; SYNAPTIC DYSFUNCTION; P38-ALPHA MAPK; IMIDAZOLES; IDENTIFICATION; OPTIMIZATION; PREDICTION; MOLECULES; ASSAY; Kinase inhibitors; Pyridinylimidazoles; Glycogen synthase kinase 3 beta; p38 alpha MAP kinase; Dual inhibitors; Alzheimer's disease (1)
CYTOLYTIC ACTIVITY; REGULATORY CELLS; ALPHA-3 DOMAIN; LPR MICE; RECEPTOR; RECOGNITION; MOLECULES; SELECTION; SPECIFICITY; LYMPHOCYTES; Tumor-specific T cells; DN T cells; Cancer vaccination; Tumor-associated antigen; T-cell receptor; Melanoma (1)
Cytomegalie-Virus , Frühe Gene , Immunreaktion , Interferon , STAT , Immunreaktion , Resistenz , Molekularbiologie , Angeborene Immunantwort , Jak-STAT-Signalkaskade , ISG , STAT2 , IE1-Protein , Innate immunity , Jak-STAT signalling , ISG , STAT2 , IE1 protein (1)
CYTOMEGALOVIRUS (1)
Cytomegalovirus · Prenatal care · Congenital infection · Pregnancy (1)
CYTOMEGALOVIRUS; PUL97; PATHOGENESIS; KINOME; PUL69; PP65; herpesviral replication; primary human fibroblasts; modulation of the host kinome; differential upregulation of cellular kinases; signature of virus-specific signalling (1)
CYTOMEGALOVIRUS RETINITIS; PROTEASE INHIBITORS; NATURAL-HISTORY; SURVIVAL; RISK; (1)
CYTOPHAGIC HISTIOCYTIC PANNICULITIS; NODULAR PANNICULITIS; FEBRILE; (1)
CYTOPLASMIC BRIDGE SYSTEM; CHLAMYDOMONAS-REINHARDTII; EXTRACELLULAR-MATRIX; EVOLUTION; DIVISION; MORPHOGENESIS; EUKARYOTES; REVEALS; PROTEIN; ORIGIN; (1)
CYTOPLASMIC INCLUSIONS; WHITE-MATTER; MOUSE MODEL; MYELIN; NEUROPATHOLOGY; CALBINDIN; CALCIUM; COORDINATION; MATURATION; PATHOLOGY; Multiple system atrophy; Cerebellar pathology; Cerebellar ataxia; Gait analysis (1)
cytoreductive surgery, HIPEC, intensive care unit, long term outcome, SAPS, SOFA (1)
cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, CRS, morbidity, mortality, zytoreduktive Chirurgie, hyperthermer intraperitoneale Chemotherapie, Morbidität, Mortalität (1)
Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy, Pancreatic tail resection, Peritoneal surface malignancy, Pancreatic fistula (1)
cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal neoplasm; pediatric neoplasm; survival analysis; multimodal therapy (1)
CYTOSOLIC DOMAINS; INHIBITION; ISOFORMS; ACTIVATION; STIMULATION; DITERPENE; MECHANISM; BINDING; PURINE; Adenylyl cyclase; Forskolin; Diterpenes; MANT-GTP; Fluorescence spectroscopy (1)
CYTOSOLIC DOMAINS; SUBSTRATE; ISOFORMS; COMPLEX; ATP; (1)
cytostatic activity/dibenzo[a,g]quinolizin-8-ones/estrogen receptor affinity/synthesis (1)
Cytotoxic agents Sulfhydryl group (glutathione and cysteine levels effect on helenanolide type sesquiterpene lactones cytotoxicity against KB cells) Sesquiterpenes Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (lactones glutathione and cysteine levels effect on helenanolide type sesquiterpene lactones cytotoxicity against KB cells) glutathione cysteine helenanolide sesquiterpene lactone cytotoxicity thiol (1)
CYTO-TOXICITY; DENTAL MATERIALS; IN-VITRO; INVITRO; CELLS; RELEASE; PULP; IL-6; dental materials; toxicity; biocompatibility; cell culture; standardization (1)
Cytotoxicity HeLa cell Human (cytotoxicity of ionic surfactant mixts. on HeLa cells) Surfactants (ionic cytotoxicity of ionic surfactant mixts. on HeLa cells) ionic surfactant cytotoxicity HeLa cell line (1)
CYTOTOXIC T-CELLS; NEUTRALIZING ANTIBODIES; EXTRACELLULAR RELEASE; DENDRITIC CELLS; RHESUS MACAQUES; BACTERIAL-DNA; INSECT CELLS; GENE-PRODUCT; BACULOVIRUS; EXPRESSION; Virus-like particles; Cytokines; Innate immunity; Monocytes; PBMC (1)
CYTOTOXIC T-CELLS; RHESUS MACAQUES; SINGLE-CYCLE; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; MUCOSAL CHALLENGE; IMMUNE-RESPONSES; GENE-TRANSFER; INFECTION; VACCINE; SIV; VLP; vaccine; immunization; HIV (1)
cytotoxic T-lymphocyte antigen 4 (CTLA-4); immunodeficencies; immune dysregulation; inborn errors of immunity (IEI); disease modifiers (1)
CYTOTOXIC T-LYMPHOCYTES; MELANOMA-REACTIVE CTL; IN-VITRO STIMULATION; DENDRITIC CELLS; CARCINOEMBRYONIC ANTIGEN; GENE-PRODUCTS; PEPTIDES; RESPONSES; GP100; MELAN-A/MART-1; MART-1/Melan-A; minigene; vaccinia virus; immunogenicity (1)
CYTOTOXIC T-LYMPHOCYTES; MINOR HISTOCOMPATIBILITY ANTIGENS; BONE-MARROW TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; PULSED DENDRITIC CELLS; ADOPTIVE IMMUNOTHERAPY; METASTATIC MELANOMA; MALIGNANT-MELANOMA; BREAST-CANCER; HOST DISEASE; allogeneic transplantation; graft versus tumor effect; cytotoxic T cells; melanoma (1)
CYTOTOXIC T-LYMPHOCYTES; RECEPTOR-MEDIATED ENDOCYTOSIS; GP96 INDUCES MATURATION; NATURAL-KILLER-CELLS; MELANOMA-CELLS; CUTTING EDGE; IN-VIVO; CHAPERONED PEPTIDES; ANTITUMOR IMMUNITY; STRESS PROTEINS; (1)
CYTOTOXIC T-LYMPHOCYTES; VIRUS-LIKE PARTICLES; ANTIGEN-PRESENTING CELLS; LONG-TERM NONPROGRESSOR; DENDRITIC CELLS; VIRAL PROTEIN; TYPE-1 INFECTION; IMMUNE-RESPONSES; RHESUS-MONKEYS; MUSCLE-CELLS; polypeptide; intracellular sorting; CTL responses (1)
D16427 carbon 14 labeled phenol araliph amino labeled (1)
D-2-hydroxyglutarate; IDH1; 2 mutation; lactonization; acute myeloid leukemia (1)
D2 RECEPTOR; D3 RECEPTOR; SCHIZOPHRENIA; APOMORPHINE; EXPRESSION; ADDICTION; MEN; alcohol dependence; dopamine receptor sensitivity; dopamine receptor gene polymorphisms; genetic predisposition for alcoholism (1)
D-2 RECEPTOR OCCUPANCY; CONVENTIONAL ANTIPSYCHOTICS; CLINICAL-RESPONSE; EXTRAPYRAMIDAL SYMPTOMS; TARDIVE-DYSKINESIA; NEUROLEPTIC DRUGS; SCHIZOPHRENIA; HALOPERIDOL; CLOZAPINE; RISPERIDONE; extrapyramidal symptoms; antipsychotics, typical, atypical; number needed to harm (1)
D3 RECEPTOR; D-2 RECEPTORS; D2; ASSOCIATION; RELAPSE; DETOXIFICATION; SCHIZOPHRENIA; LOCALIZATION; SENSITIVITY; PREFERENCE; dopamine D2 receptor gene polymorphism; dopamine D3 (DAD3) receptor gene polymorphism; alcoholism; treatment outcome; relapse (1)
D68; SURVEILLANCE; NETHERLANDS; INFECTIONS; EPIDEMIOLOGY; RHINOVIRUSES; CIRCULATION; OUTBREAK; enteroviruses; enterovirus EV-D68; respiratory infections; molecular epidemiology; paediatric patients (1)
D6 PROTEIN-KINASE; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; ROOT GRAVITROPISM; PLANT-GROWTH; AGC KINASES; TRANSPORT; TRAFFICKING; POLARITY; PHOTOTROPISM; auxin transport; protein kinase; Arabidopsis; PIN1; polarity (1)
D6 PROTEIN-KINASE; PLASMA-MEMBRANE; FUNCTIONALLY INTERACTS; ARABIDOPSIS-THALIANA; MEDIATED DEVELOPMENT; PLANT DEVELOPMENT; TWISTED DWARF1; TRANSPORT; PIN; EFFLUX; (1)
DABCO; ACID; Alkylammonium halide; Hydrogen bonding; Phase transition; Solid hydrate (1)
DABRAFENIB PLUS TRAMETINIB; STAGE-III MELANOMA; DOUBLE-BLIND; HIGH-RISK; IPILIMUMAB; PLACEBO; BRAF(V600)-MUTANT; COMBINATION; NIVOLUMAB; SURVIVAL; Melanoma; Immune Checkpoint Inhibitors; Adjuvant Drug Therapy; Recurrence; Molecular Targeted Therapy (1)
DABRAFENIB PLUS TRAMETINIB; SURVIVAL; EFFICACY; Melanoma; PD-1 resistance; MAPK; Second-line treatment; Third-line treatment (1)
Dacapo, SCF-Rca1, E3 ubiquitin ligase (1)
DAGH FLORISTIC PROVINCE; EVOLUTION; SEQUENCES; DIVERSITY; Asteraceae; nrDNA ITS; Phylogeny; Sclerorhachis platyrachis-complex; Species nova (1)
DAILY GROWTH LAYERS; DIVISION-OF-LABOR; ADULT INSECTS; FLUORESCENCE; DOMINANCE; MOSQUITOS; DIPTERA; LIVE; Age determination; Pteridines; Fluorescence; Cuticular color; Social insects; Ants (1)
DAILY-LIFE; POPULATION; DISTRESS; EMOTION; chronic tinnitus; smartphone application; ecological momentary assessment; moment-to-moment analysis; crowd sourcing; ecological validity (1)
Damage dependent chromatin remodeling DNA repair Predetection-NER-impairment Skin cancer Voriconazole (1)
DAMAGE LIKELIHOOD SCALE; LAMINA-CRIBROSA; HEMORRHAGES; COMPRESSION; PHOTOGRAPHS; SIGNS; EYES; Diagnosis; Ophthalmoscopy; Disc Damage Likelihood Scale; Optic neuropathy; Optic nerve (1)
damping ; CoFe ; cobalt; iron; magnetization dynamics; ferromagnetic resonance; FMR (1)
DANGEROUS EMERGENCIES; GROUP-SIZE; INTERVENTION; bystander effect; field experiment; negative consequences; social inhibition; theft (1)
Dantrolen, Antiarrhythmische Therapie, Herzinsuffizienz, Vorhofflimmern (1)
dark energy; dark matter; causal fermion system (1)
DARK-FIELD MICROSCOPY; SEGMENTED-FLOW; MICROFLUIDIC SYSTEM; DISSOLVED-OXYGEN; CHIP; PH; CHEMISTRY; PARAMETERS; DENSITY; BIOCHIP; Micro fluid segments; Droplet based flow; Antibiotics; Drug detection; Dose-response functions; On-line pH sensing; Cell density monitoring (1)
DARK PERIODS; SINGLE-ATOM; IONS; FLUORESCENCE; STATISTICS; TRAPS; LIGHT; (1)
Dark Triad, personality traits, psychopathology, emotion regulation, alexithymia (1)
Dark Triad, psychopathology, depression, anxiety, stress, alexithymia, mindfulness, moderation analysis (1)
Darmkrebs , Differentielle Genexpression , Methylierung , Maspin , MLH1 , quantitative Methylierungsanalyse , MGMT , P16 , Maspin , MLH1 , quantitative Methylation Analysis , MGMT , P16 (1)
Darmkrebs, Kolon-Karzinom, Laparoskopie, Krebsregister, Versorgungsforschung bowel cancer, colon carcinoma, laparoscopy, cancer registry, health services research (1)
Darwinismus , Meme , Kreativität , Kultur , Philosophie , Biophilosophie , Anthropologie , Philosophische Anthropologie , Analogie , , Darwinism , memes , creativity , culture , mind , philosophy of biology , anthropology , analogy , replicator , undirected variation , selfish meme (1)
Das Böse; Gutiérrez, Gustavo; Pannenberg, Wolfhart; Theologie (1)
DAS EIGENWERTPROBLEM; AUTOMORPHEN FORMEN; BOUNDS; FORMULA; (1)
DASH score, Nürnberger Hand score, Handverbrennungen, Lebensqualität, Verbrennungsverletzung, Erfassung von Verbrennungsfolgen (1)
D-ASPARTATE RECEPTOR; PROSTATE-CANCER; TUMOR-GROWTH; PATHWAY; ANTAGONISTS; PROPOFOL; SURGERY; PAIN; Ketamine; S-ketamine; MK 801; Proliferation; Apoptosis; Necrosis; NMDA; Pancreatic carcinoma; Cancer (1)
Data architecture · Cloud computing · Data warehouse · Data lake (1)
Data archive (1)
Database Integrity Constraints, Inclusion Dependencies, Inter-Model Linkage, Multi-Model Databases, Schema Evolution (1)
DATABASE; PREDICTION; ALIGNMENT; SEARCH; tRNA; Non-coding RNAs; PtRNAdb; Database; Data curation; Genomics (1)
Database search; mass fingerprint; mitochondrial proteomics; multidimensional HPLC; nano-LC-MS/MS; 1D-SDS-PAGE; separation; subcellular fractionation; tandem mass spectrometry; 2D-PAGE (1)
"Databases, Genetic", "Gene Expression Profiling", "Genetic Testing", "Humans", "Natural Language Processing", "Neoplasm Proteins", "Neoplasms", "Oligonucleotide Array Sequence Analysis", "Phenotype", "Reproducibility of Results", "Sensitivity and Specificity", "Structure-Activity Relationship", "Tumor Markers, Biological" (1)
DATABASES; LINKAGE; COHORT; HEALTH; data collection; epidemiologic methods; information science; mortality; vital statistics (1)
Databases, NoSQL, data migration, schema evolution,self-adapting (1)
Databases · NoSQL · Data migration · Schema evolution · Self-adapting · Self management (1)
Data cleaning · Data integration · Data engineering pipelines · Data curation (1)
DATA CURRENCY; TAXONOMY; Data quality; Data quality assessment; Data quality metric; Data consistency (1)
Data donation; Prosocial data disclosure; Data sharing; Privacy; Altruism; Ethical data use; Value of data (1)
Data engineering pipelines · Reliability · Explainability · Data bias · Degree of data changes (1)
data governance; data management; visual analytics; data storage; big data (1)
dataintegration, clustering, gene expression, microarray, embryogenesis (1)
; Data management; Patient care management; Interdisciplinary communication; International cooperation; Information sharing (1)
; data manipulation; Benford's law; digital analysis; macroeconomic data (1)
Data Mining, OpenStreetMap, Standortanalyse, Neuronales Netz, Entscheidungsbaum, Logit-Analyse (1)
Data Pipeline, Data Preprocessing, Machine Learning (1)
data preparation, data quality, data preprocessing, data wrangling, data cleaning (1)
data preprocessing, data profiles, change profiles, transparency (1)
Data Preprocessing, Graph Database, Neo4j, Graph Schema, Eye-Tracking Data, Time Series Data (1)
Data Preprocessing · Random Forest · Classification · Eye-Tracking (1)
Data Preprocessing, Random Forest, Classification, Eye-Tracking (1)
"data protection", Datenschutz, television, Fernsehen, cybercrime, internet (1)
data provenance, workflow provenance, dimensions, granularity, W7 questions, wetlab data (1)
Data quality, Currency, Metric, Fuzzy inference system, Expert estimations, Big data (1)
Data quality, currency, wikis, textual data, unstructured data, language model (1)
Data Quality, Cybersecurity, Incident Response, Evidence Collection, Human-as-a-Security-Sensor (1)
data quality, data cleaning, optimization (1)
Data quality, Data cleaning, Optimization (1)
data quality; data quality assessment; data quality metrics (1)
Data Quality, data Quality assessment, data Quality metrics, requirement for metrics (1)
Data Quality, Data Quality Effects, Customer Relationships, Customer Relationship Management (1)
Data Quality, Data Quality Management, Data Quality Metrics (2)
Data Quality, Data Quality Metrics, Design Research, Customer Valuation (1)
Data Quality (DQ), Metric, Timeliness, Customer Relationship Management (CRM) (1)
data quality, marketing effectiveness (1)
data quality, metrics, evaluation, data preparation (1)
Data Quality Metrics, Insurance Mediation Directive, Financial Services (1)
data quality, recommender systems, business process management, natural language processing (1)
Data Retention, Proxy Log (2)
Data Science, Generative Artificial Intelligence, User-Generated Content, Topic Modelling, Sentiment Analysis, Lead User Identification, Adaptive Conversational Agents, Design Science Research (1)
datasets, nlp, text generation, conversational ai (1)
DATA SETS; SPECTROSCOPY; METABONOMICS; PROTEOMICS; URINE; ALIGNMENT; VARIANCE; SPECTRA; DISEASE; BIAS; Metabolomics; NMR; Data normalization; Preprocessing; Classification (1)
data sharing; interagency working; learning disability (1)
Data stream, Anomaly detection, Log analysis, Real-time analysis (1)
Data Value, Data Quality, Data Governance, Business Information Needs, Semiconductor, Manufacturing (1)
Data warehousing - data quality - optimization (1)
Datenbanken (1)
Datenbank-Infosystem; DBIS; UR Library Services (1)
Datenbank-Infosystem; UR library services (1)
Datenqualität, Aktualität, Metrik, Messung (1)
Datenqualität, Datenqualitätsmaßnahmen, Finanzdienstleister (1)
Datenqualität, Kundenbeziehung, Datenqualitätswirkung, Customer Relationship Management (1)
Datenqualität, Metriken, praktischer Nutzen (1)
Datenschutz; Datenbesitz; Rechte an Daten; Besitzschutz (1)
Datenschutz, Digitaler Radiergummi, DRM, Digitales Rechtemanagement (1)
Datenschutz, IT-Siicherheit (1)
Datenschutz, Privacy (1)
DAX futures, exchange traded funds, indicative net asset value, index certificates, DAX index, replication quality (1)
DAY CLINIC TREATMENT; STRUCTURAL-CHANGE; DISORDERS; INVENTORY; SUCCESS; SCALE; Psychodynamic psychotherapy; Conflict processing; Defense mechanisms (1)
Day hospice, Complex intervention, Structural requirements, Effect, Everyday conditions (1)
DAYTIME SLEEPINESS; APNEA SYNDROME; ONE-NIGHT; PERFORMANCE; POLYSOMNOGRAPHY; VARIABILITY; RELIABILITY; PACEMAKER; EEG; Neuropsychological tests; Polysomnography; Sleep-disordered breathing; Sleep; Obstructive sleep apnea syndrome (1)
DAYTIME SLEEPINESS; AUTOIMMUNE-DISEASE; CHILDREN; ONSET; CATAPLEXY; COVERAGE; ENGLAND; ADULTS; Narcolepsy; Risk factors; Pandemic influenza A/H1N1/v vaccine; Germany (1)
DAYTIME SLEEPINESS; CLINICAL-USE; WAKEFULNESS TEST; SCALE; POLYSOMNOGRAPHY; MAINTENANCE; PERFORMANCE; NARCOLEPSY; PARAMETERS; ALERTNESS; multiple sleep latency test; MSLT; MSLT-30; reference values; age factors; sex factors (1)
D-(+)-biotin amphiphile galactaric acid carbohydrate derivatives Derivatives nmr (1)
DBIS (6)
DBIS, AG Systemlandschaft (1)
DBIS; Database Information System; Annual Report (3)
DBIS, Database Information System, Datenbank-Infosystem, EZB, Elekronische Zeitschriftenbibliothek, Electronic Journals Library, RVK, Regensburger Verbundklassifikation, URL, UR Library (1)
DBIS, Database Information System, Datenbank-Infosystem, EZB, Elekronische Zeitschriftenbibliothek, Electronic Journals Library, URL, UR Library (1)
DBIS; Datenbanken; User Experience DBIS; Data Bases; User Experience Erschließung, Linked Open Data, RDA, Management, betriebliche Steuerung (1)
DBIS, Datenbank-Infosystem, Database Information System, EZB, Elektronische Zeitschriftenbibliothek, Electronic Journals Library, RVK, Regensburger Verbundklassifikation, URL, UR Library (1)
DBIS, Datenbank-Infosystem, Datenbanken, database information system, databases (1)
DBIS Datenbank-Infosystem Fachreferat (1)
DBIS; Datenbank-Infosystem; Jahresbericht (2)
DBIS; Datenbank-Infosystem; Jahresbericht; 2024; 2025 (1)
DBIS; Datenbank-Infosystem; UR library services (1)
DBIS, Datenbank-Infosystem, UR Library Services (1)
DBIS; DBIS-Community; Datenbank-Infosystem; Datenbanken; UX; nutzerzentrierte Softwareentwicklung; Erschließung; Linked Open Data; RDA database infosystem; databases; user-centred software development (1)
DBIS; DBIS-Schulung; Datenbank-Infosystem; URL (1)
DBIS, User Experience, Informationsinfrastruktur (1)
DBS, IBS, deep brain stimulation, irritable bowel syndrome, OCD (1)
DBS · Parkinson’s disease · Movement disorders · Functional network · Probabilistic tractography · Dentatorubro-thalamic tract (1)
DCC, dormancy, mammary stem cells, IL-6 (1)
DCCs, bone marrow, prostate cancer (1)
DC, TNF, TNF-Rezeptoren, TNFR2, CLP, Toleranz, IL12, IL12-Familie, Organschaden, Sepsis (1)
D-DEFICIENT DIET; CRANIOFACIAL MORPHOLOGY; LOW-CALCIUM; BONE; GROWTH; RATS; THERAPY; Mandibular growth; Extracellular matrix; Collagen; Craniofacial growth (1)
D-DIMER; INTERLEUKIN-6; PROCALCITONIN; ARTHROPLASTY; ACCURACY; HIP; Biomarker; Periprosthetic joint infection; Diagnostics; Revision joint arthroplasty (1)
DEACETYLASE INHIBITOR TRICHOSTATIN; CHILDHOOD; VARIANTS; WNT; PHARMACOGENOMICS; INFLAMMATION; GENES; EOSINOPHILS; EXPRESSION; RESPONSES; (1)
DEAD-box helicase; ribosome biogenesis; molecular mechanism; RNA; NMR spectroscopy (1)
Dead Sea, dye degradation, enzymes, fIlamentous fungi, salinity, temperature (1)
DEAFNESS; ILLNESS; SARCOIDOSIS; HISTORY; DISEASE; DEATH (1)
Deafness; Magnetic resonance imaging; Ears; Inferior colliculus; Age groups; Auditory pathway; Hearing; Neurons (1)
DEAFNESS; TUBULOPATHY; EPILEPSY; SEIZURES; Ataxia; KCNJ10; Kir4; 1; KCNJ16; Kir5; 1; SeSAME; EAST syndrome (1)
DEATH 1; BLOCKADE; CLASSIFICATION; TOXICITIES; Lung cancer; Checkpoint-inhibitor pneumonitis; Immunotherapy; PD-L1; Thoracic radiotherapy (1)
DEATH; INTERVAL; PROLONGATION; PHENOTYPE; Sudden infant death; Electrocardiography screening; Long QT syndrome; Newborn; Birth cohort (1)
DEATH LIGAND-1; INFILTRATING LYMPHOCYTES; BLADDER-CANCER; SQUAMOUS-CELL; OPEN-LABEL; CARCINOMA; ATEZOLIZUMAB; MULTICENTER; IMMUNOTHERAPY; CHEMOTHERAPY; bladder cancer; urothelial cancer; immune phenotypes; PD-L1; PD-1; TILs (1)
death receptor; apoptosis; endocytosis; membrane trafficking; receptor internalisation (1)
DEATH-SYNDROME; RISK; POSITION; ADVICE; birth cohort; prevention; safe infant sleep; SIDS (1)
DEATH-SYNDROME; UNITED-STATES; RISK; POSITION; SMOKING; TRENDS; (1)
Debt securities, External finance, Regulatory competition, Tax competition, Multinational corporations (1)
DECAPODA; CRUSTACEA; SPERM; BIOGEOGRAPHY; PODOTREMATA; PHYLOGENY; TAXONOMY; spermatozoa; spermatophores; freshwater crabs; Brachyura; Potamoidea (1)
DECAPODA; CRUSTACEA; SYSTEMATICS; LEACH; Molecular diversity; Genetic differentiation; Barcoding; Cytochrome oxidase 1; Haplotype network; Morphology; Gastric ossicles; Crustacea; Decapoda; Pilumnoidea (1)
decarbonization; EU emissions trading system; impact assessment; industrial ecology; low-CO2 steel production; mixed-integer programming (1)
decarbonylation; photocatalysis; benzaldehydes (1)
decarboxylation • alkynylation • metal-free • photocatalytic • biomass (1)
decarboxylative reactions (1)
DECATUNGSTATE ANION; POLAR; photocatalysis; dehydroformylation; hydrogen atom transfer; cobalt; benzyl alcohols (1)
DECAY-ACCELERATING FACTOR; SEGMENTAL GLOMERULOSCLEROSIS; NEPHROTIC SYNDROME; MICE; dendritic cells; glomerulonephritis; podocytes; T cells (1)
DECAY CONSTANT F(D-S); PARTON DISTRIBUTIONS; SEMILEPTONIC DECAYS; VECTOR-MESONS; HEAVY MESONS; QCD; ELECTROPRODUCTION; LEPTOPRODUCTION; PROTON; (1)
DECAY; QCD; MESONS; (1)
DECAYS; RATIO; (1)
DECEASED DONOR KIDNEYS; GRAFT-SURVIVAL; RISK INDEX; SCORE; POSTTRANSPLANTATION; RECIPIENTS; NOMOGRAMS; FAILURE; 1ST; (1)
; Deceased; Resuscitation; Death; Occurrence of death; Transport (1)
Decentralized finance, Cryptocurrencies, Event study, Sentiment, GJR-GARCH regressions, Russian–Ukrainian crisis (1)
decentralized identity;decentralized authorization;attribute-based authorization (1)
DECIDUOUS FORESTS; DIVERSITY; MECHANISMS; VEGETATION; PATTERNS; PRODUCTIVITY; BIODIVERSITY; METAANALYSIS; COMMUNITIES; MAINTENANCE; Understorey vegetation; Temperate forest; Species richness; Light availability (1)
DECISION AIDS; INFORMATION; DISABILITY; DIAGNOSIS; MS; multiple sclerosis; natalizumab; progressive multifocal leukoencephalopathy; risk perception; shared decision making (1)
Decision analysis; Marketing; Multiple criteria analysis; Utility theory; Preference measurement (1)
DECISION CURVE ANALYSIS; OPERATING CHARACTERISTICS; PREVENTION TRIAL; BREAST-CANCER; ROC CURVE; MODELS; MARKER; RECLASSIFICATION; STATISTICS; CALCULATOR; Calibration; Discrimination; Net benefit; Prostate cancer prevention trial; Risk prediction; Validation (1)
DECISION-MAKING; CANCER-PATIENTS; BREAST-CANCER; PREFERENCES; ONCOLOGY; SUPPORT; CARE; Brain tumour; Information need; Patient; Relative; Patient-oriented information (1)
DECISION-MAKING; CLINICAL ETHICS; LIFE; UNIT; END; Medical ethics; Personal autonomy; Conflict; Decision making; Patient participation (1)
decision making; cognition; ants; lasius niger; iridomyrmex purpureus; expectation disconfirmation; heuristics; trail clearing; collective; (1)
DECISION-MAKING; Diffusion model; Wiener process; First passage times; Response times (1)
DECISION-MAKING EVIDENCE; IMPACT; DIVERSITY; ability differences; gender effects; team composition; team performance (1)
; Decision making; Expertise; Intuition; Rationality; Stock market forecast (1)
DECISION-MAKING; INFORMATION-THEORY; HYMENOPTERA; RECRUITMENT; NIGER; MEMORY; RECOGNITION; ORIENTATION; COLLECTION; FORMICIDAE; Motor displays; Tactile communication; Distance homing; Lasius niger; Lasius neglectus; Antennation (1)
DECISION-MAKING; LOSS AVERSION; PROSPECT-THEORY; CHOICE; ATTITUDES; WOMEN; Risk taking; Gender differences; Correlation of risks; Social reference point (1)
DECISION-MAKING; OBJECT RECOGNITION; TRACKING RESEARCH; VISUAL-ATTENTION; PERCEPTION; SEARCH; CHOICE; Eyetracking; Best practice; Experimental design; Data analysis; Researcher degrees of freedom; Internal validity; External validity (1)
DECISION-MAKING; PATIENT; CARE; Guidelines; standards; cancer clinical trials; health-related quality of life; patient-reported outcomes (1)
DECISION-MAKING; RESPONSE COMPETITION; DEPENDENT DECISIONS; TASK; INFORMATION; PERFORMANCE; PREFERENCES; ACTIVATION; SIMON; RATS; response conflict; conflict adaptation; Stroop test; prepotent response (1)
DECISION-MAKING; RISK; railway tunnels; risk acceptability; safety systems; passenger traffic (1)
DECISIONS; PREFERENCES; DECEPTION; BEHAVIOR; TEAMS; LIES; Unethical behavior; Lying; Group decisions; Gender effects; Experiment (1)
Decision support; Recommender systems; Service systems (1)
Decision support, service-oriented systems, service selection, multiple users (1)
Decision Support, Service Re-Selection, Multi-User Processes, Dependencies (1)
Decision Support System, Algorithms, Optimization, Market Engineering (1)
Decision support system; Back pain; Symptom checker; App-based decision (1)
DECISION-SUPPORT-SYSTEMS; CITATION ANALYSIS; INTELLECTUAL STRUCTURE; SOCIAL NETWORK; ANALYSIS CCA; SCIENCE; ANALYTICS; KNOWLEDGE; FRAMEWORK; JOURNALS; Ideational impact; Citation classification; Academic recommender systems; Natural language processing; Deep learning; Cumulative tradition (1)
decision theory design embedded systems formal specification program diagnostics software tools artifacts design decision model embedded systems design inconsistencies reduction redundancies reduction requirement specification requirements engineering requirements traceability management tool resource restrictions management (1)
Decision theory, IT value, IS assessment, IS evaluation (1)
Decision trees, Currency, Data quality, Big data mining (1)
DECKER-SANDWICH; BUILDING-BLOCK; CRYSTAL; LIGANDS; 1,3-DIPHOSPHACYCLOBUTADIENE; PLANAR (1)
DECKER-SANDWICH COMPLEX; DER-WAALS RADII; MOLECULAR-STRUCTURE; MERCURY; VAN; PHENYLENEMERCURY; ENHANCEMENT; DIBISMUTH; DISCRETE; CRYSTAL; (1)
DECKER SANDWICH COMPLEXES; COORDINATION BEHAVIOR; LIGAND COMPLEXES; CATIONS; PENTAPHOSPHAFERROCENE; REDOX; HEXAPHOSPHABENZENE; PHOSPHORUS; ACTIVATION; CU+; inorganic benzene; isolobal analogy; oxidation; phosphorus; triple-decker sandwich complexes (1)
DECKER SANDWICH COMPLEXES; SILVER(I) CATIONS; P-4 ACTIVATION; ELEMENTS; PHOSPHORUS; CHEMISTRY; CAGE; hexaphosphabenzene; inorganic graphene; polyphosphorus complexes; solvent-controlled reactivity; weakly coordinating anions (1)
DECKER SANDWICH COMPLEXES; SOLID-STATE NMR; ELECTRONIC-STRUCTURE; VALENCE ISOMERS; AROMATICITY; RINGS; HEXAPHOSPHABENZENE; BENZENE; BOND; coordination polymers; copper; hexaphosphabenzene; molybdenum; triple-decker complexes (1)
declaration genomics human tissue informed consent isolated cells misuse ownership surgical specimen (1)
DECLARATIVE MEMORY; ENHANCES MEMORY; CONSOLIDATION; RETRIEVAL; RECALL; forgetting; directed forgetting; sleep; delay (1)
Declarative process execution · Complex event processing · Business process management · Event-driven architecture (1)
Declarative Process Execution, Complex Event Processing, Business Process Management, Event-Driven Architecture (1)
DECOHERENCE; ENTANGLEMENT (1)
DECOMPENSATED HEART-FAILURE; LATE GADOLINIUM ENHANCEMENT; PULMONARY-DISEASE; WALL STRESS; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; IMPACT; DYSFUNCTION; COMORBIDITIES; PREVALENCE; COPD; Airway obstruction; Hyperinflation; Diastolic filling; Dyspnea; Heart failure; HFpEF (1)
Decomposition, process model, event-driven process chain (1)
DECOMPRESSIVE CRANIECTOMY; PRACTICAL SCALE; HEMICRANIECTOMY; acute subdural haematoma; craniotomy; decompressive craniectomy; outcome (1)
DECOMPRESSIVE CRANIECTOMY; PREDICTORS; HEMICRANIECTOMY; OUTCOMES; SURGERY; STROKE; IMPACT; RISK; cranioplasty; functional outcome; ischemic stroke; surgical complications; traumatic brain injury; surgical technique; vascular disorders (1)
DECOMPRESSIVE HEMICRANIECTOMY; CLINICAL-COURSE; MANAGEMENT; PAPAVERINE; EXPERIENCE; INJECTION; ISCHEMIA; THERAPY; Continuous intra-arterial nimodipine; infusion (CIAN); Intra-arterial nimodipine infusion; Cerebral vasospasm; subarachnoid hemorrhage (SAH); delayed cerebral ischemia (DCI); Outcome (1)
Decondensation factor 31, snoRNA, chromatin higher order structures (1)
deconvolution, gene expression, cellular compositions, bulkRNA-seq, scRNA-seq (1)
Decorin, TGF beta, CTGF, Primary open angle glaucoma, Trabecular Meshwork, Optic Nerve (1)
decoupling, productivity puzzle, unobserved components, time-varying coefficient, Verdoorn´s law (1)
DEDIFFERENTIATED CHONDROSARCOMA; MOLECULAR-MECHANISMS; PROGNOSTIC-FACTORS; CERVICAL-CANCER; DNA-PLOIDY; EXPRESSION; P53; HETEROZYGOSITY; PROGRESSION; ANEUPLOIDY; SOX9; transcription factor; chondrosarcoma; polyploidy; MMP13; CRISPR; Cas9 (1)
DEEP-BRAIN-STIMULATION; CARBIDOPA INTESTINAL GEL; DUODENAL LEVODOPA INFUSION; DEVICE-AIDED THERAPIES; APOMORPHINE INFUSION; SUBTHALAMIC NUCLEUS; MEDICAL THERAPY; CONVERSION; RESCUE; TRIAL; (1)
DEEP-BRAIN-STIMULATION; CHRONIC BILATERAL STIMULATION; PARKINSONS-DISEASE; BASAL GANGLIA; PREFRONTAL CORTEX; WORD COMPREHENSION; FUNCTIONAL-ANATOMY; COGNITIVE FUNCTION; GLOBUS-PALLIDUS; VERBAL FLUENCY; (1)
DEEP BRAIN-STIMULATION; FIBER TRACKING; ELECTRICAL-STIMULATION; ESSENTIAL TREMOR; ATLAS; RECONSTRUCTION; NUCLEUS; AREA; DBS; dentatorubrothalamic tract; DTI fiber tracking; surgical planning; deep brain stimulation; functional neurosurgery (1)
DEEP BRAIN-STIMULATION; FOLLOW SAFETY RECOMMENDATIONS; IN-VITRO EVALUATION; NEUROSTIMULATION SYSTEMS; CARDIAC-PACEMAKERS; MR SYSTEMS; 1.5 T; WIRES; FIELD; TEMPERATURE; magnetic resonance imaging; safety; MRI; implants; deep brain stimulation; neurostimulator; cardiac pacemaker; pacemaker leads; specific absorption rate (1)
DEEP BRAIN-STIMULATION; HYPOTHALAMIC-STIMULATION; SUICIDAL-BEHAVIOR; DEPRESSION; MIGRAINE; PAIN; DISABILITY; VARIANTS; DISORDER; TRAITS; Cluster headache; migraine; aggression; hypothalamus; FAF; impairment (1)
DEEP-BRAIN-STIMULATION; MAGNETIC-RESONANCE; PARKINSONS-DISEASE; MOVEMENT-DISORDERS; FUNCTIONAL NEUROSURGERY; GLOBUS-PALLIDUS; STEREOTACTIC LOCALIZATION; SHIFT; IMPLANTATION; SURGERY; Deep brain stimulation; Microelectrode recording; Subthalamic nucleus; Brain shift (1)
DEEP BRAIN STIMULATION.; NEUROSURGERY; EXPERIENCE; SATISFACTION; DISEASE; SURGERY; TUMORS; TRIAL; Monitoring, intraoperative; Regional anesthesia; Deep brain stimulation; Suggestion; Alertness (1)
DEEP BRAIN-STIMULATION; OBSESSIVE-COMPULSIVE-DISORDER; TREATMENT-RESISTANT DEPRESSION; NUCLEUS-ACCUMBENS; MAJOR DEPRESSION; ELECTRICAL-STIMULATION; PARKINSONS-DISEASE; OUTCOMES; STRIATUM; ATLAS; Deep brain stimulation (DBS); Diffusion tensor imaging (DTI); Medial forebrain bundle (MFB); Major depression (MD) (1)
DEEP BRAIN-STIMULATION; OCCIPITAL NERVE-STIMULATION; TERM-FOLLOW-UP; POSTERIOR HYPOTHALAMUS; SPINAL-CORD; ACTIVATION; ATTACKS; SERIES; AREA; RECEPTOR; cluster headache; hypothalamus; deep brain stimulation; pain modulation; pathophysiology (1)
DEEP-BRAIN-STIMULATION; PARKINSONS-DISEASE; MRI; LOCATION; DESIGN; VOLUME; STN; GPI; Deep brain stimulation; Subthalamic nucleus; Parkinson; Stimulation-induced side effects; Intraoperative clinical testing; Microelectrode recording (1)
DEEP BRAIN-STIMULATION; TRIGEMINAL AUTONOMIC CEPHALALGIA; ACTIVATION; ATTACKS; SECTION; cluster headache; treatment; deep brain stimulation; pathophysiology; head pain (1)
DEEP-EUTECTIC-SOLVENTS; CATION-PI INTERACTIONS; CHOLINE-CHLORIDE; LIGHT-SCATTERING; MICROEMULSIONS; WATER; natural deep eutectic solvents; curcumin; green solvents; solubilization; extraction; surfactant-free microemulsions (1)
DEEP EUTECTIC SOLVENTS; CHOLINE CHLORIDE; IONIC LIQUIDS; PHYSICAL-PROPERTIES; AQUEOUS MIXTURES; BINARY-MIXTURES; INTERMOLECULAR INTERACTION; CARBON-DIOXIDE; GLYCEROL; SOLUBILITY; (1)
deep eutectic solvents, COSMO-RS, caffeic acid phenethyl ester, pre-Ouzo effect (1)
DEEP EUTECTIC SOLVENTS; GREEN EXTRACTION; Curcumin; NADES; Surfactant-free microemulsions; Solubilization; Extraction; Green chemistry; Food; Water-free SFME (1)
DEEP EUTECTIC SOLVENTS; IONIC LIQUIDS; (1)
DEEP EUTECTIC SOLVENTS; OLIGOETHER CARBOXYLATES; THERMAL-DECOMPOSITION; UREA; CONDUCTIVITY; TEMPERATURES; DISSOLUTION; BEHAVIOR; WATER; (1)
Deep Eutectic Solvents; Phosphate; Incinerated Sewage Sludge Ash; Spinel Ferrite; Lanthanide; Extraction; Separation; Luminescence (1)
Deep eutectic solvents; sewage sludge (1)
DEEP EUTECTIC SOLVENTS; SUBCRITICAL WATER REACTIONS; FREE MICROWAVE EXTRACTION; BIO-BASED SOLVENTS; IONIC LIQUIDS; GAMMA-VALEROLACTONE; PLATFORM MOLECULE; CARBON-MONOXIDE; ETHYL LACTATE; TOXICITY; Green solvents; Ephemeral solvents; Ionic liquids; Natural deep eutectic solvents; Switchable solvents; Hydrotropes (1)
DEEP-EUTECTIC SOLVENTS; TEMPERATURE IONIC LIQUIDS; UREA-SALT MIXTURES; GLASS-TRANSITION; CARBOHYDRATE; GLUCOSE; LTTMS; carbohydrate; low-melting mixtures; deep eutectic solvent (1)
DEEP-EUTECTIC-SOLVENTS; UREA-SALT MIXTURES; CHOLINE-CHLORIDE; ROOM-TEMPERATURE; BINARY-MIXTURES; ZINC ELECTRODEPOSITION; IONOTHERMAL SYNTHESIS; GREEN SOLVENTS; HOLE THEORY; ACID; (1)
DEEP IMPURITIES; TERAHERTZ; PHOTODETECTORS; SEMICONDUCTORS; TRANSISTORS; IONIZATION; RADIATION; LASER; (1)
Deep impurities; Terahertz radiation; Tunneling (1)
DEEP IMPURITIES; TUNNELING IONIZATION; BALLISTIC TRANSPORT; SEMICONDUCTORS; RELAXATION; FIELDS; (1)
DEEP IMPURITY LEVEL; SOLID-SOLUTIONS; SEMICONDUCTORS; STATES; PBTE; (1)
DEEP-INELASTIC LEPTOPRODUCTION; SPIN-DENSITY MATRIX; MODEL CALCULATION; Z(0) DECAYS; MESONS; DISTRIBUTIONS; TRANSVERSITY; ELECTROPRODUCTION; ASYMMETRIES; SCATTERING; (1)
DEEP-INELASTIC-SCATTERING; BACKGROUND FIELD METHOD; FREE GAUGE-THEORIES; YANG-MILLS THEORY; LIGHT-CONE GAUGE; QUANTUM CHROMODYNAMICS; EVOLUTION-EQUATIONS; ONE-LOOP; DISTRIBUTION AMPLITUDES; DILATATION OPERATOR; (1)
DEEP-INELASTIC SCATTERING; CRITICAL EXPONENT-ETA; QCD BETA-FUNCTION; ARBITRARY DIMENSIONS; 1/N EXPANSION; ELECTRODYNAMICS; OPERATORS; ORDER; large N-f method; renormalization; quark mass anomalous dimension; perturbation theory (1)
DEEP-INELASTIC SCATTERING; CROSS-SECTIONS; HARD SCATTERING; NLO QCD; SMALL-X; HERA; DIS; FACTORIZATION; ALGORITHM; STATES; QCD; NLO computations; deep inelastic scattering; jets (1)
DEEP-INELASTIC SCATTERING; DIRECT PHOTON PRODUCTION; POLARIZED PROTON-BEAM; QUANTUM CHROMODYNAMICS; HEAVY QUARKONIUM; PION-PRODUCTION; ANALYZING POWER; LHC BEAMS; LEPTOPRODUCTION; FRAGMENTATION; (1)
DEEP-INELASTIC-SCATTERING; ELECTRON STORAGE-RING; STRUCTURE FUNCTIONS G(2); HERMES EXPERIMENT; PARTON DISTRIBUTIONS; NUCLEAR-POLARIZATION; MUON SCATTERING; ASYMMETRY A(2); LEADING ORDER; QCD ANALYSIS; (1)
DEEP-INELASTIC-SCATTERING; ELECTRON STORAGE-RING; SUM-RULES; HERA; POLARIZATION; POLARIMETER; TARGET; (1)
DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; COLOR GLASS CONDENSATE; DRELL-YAN; PARTON DISTRIBUTIONS; TRANSVERSE-MOMENTUM; SPIN ASYMMETRIES; SINGLE-SPIN; COLLISIONS; GAUGE; (1)
DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; ODD PARTON DISTRIBUTIONS; PROTON-PROTON COLLISIONS; SINGLE-SPIN; DRELL-YAN; HARD-SCATTERING; QUANTUM CHROMODYNAMICS; PION-PRODUCTION; ANALYZING POWER; (1)
DEEP-INELASTIC SCATTERING; GENERALIZED PARTON DISTRIBUTIONS; STRUCTURE-FUNCTION G2(X; EVOLUTION-EQUATIONS; DRELL-YAN; QUANTUM CHROMODYNAMICS; STATE INTERACTIONS; HADRON STRUCTURE; PION-PRODUCTION; QCD; (1)
DEEP-INELASTIC-SCATTERING; HARD DIFFRACTIVE ELECTROPRODUCTION; TRANSVERSE-MOMENTUM; INFINITE-MOMENTUM; LARGE NUCLEI; SMALL-X; QUANTUM ELECTRODYNAMICS; COLOR TRANSPARENCY; ENERGY-DEPENDENCE; COHERENCE LENGTH; (1)
deep-inelastic scattering; high-lumi LHC; QCD; Higgs; top and electroweak physics; nuclear physics; beyond Standard Model; energy-recovery-linac; accelerator physics (1)
DEEP-INELASTIC SCATTERING; IDENTICAL PARTICLES; MULTIPLE PRODUCTION; INTERFERENCE; ANNIHILATION; NEUTRINO; INTERFEROMETRY; FRAGMENTATION; HADRONIZATION; ENVIRONMENT; (1)
DEEP-INELASTIC SCATTERING; LARGE TRANSVERSE-MOMENTUM; PARTON ENERGY-LOSS; HADRON FORMATION; ELECTROMAGNETIC CORRECTIONS; MATTER; HERMES; FRAGMENTATION; ATTENUATION; COLLISIONS; (1)
DEEP-INELASTIC-SCATTERING; LATTICE QCD; BAG MODEL; NUCLEON; (1)
DEEP-INELASTIC-SCATTERING; LEADING NEUTRON-PRODUCTION; QUANTUM-FIELD THEORIES; MUON PAIRS; LATTICE; DECOMPOSITION; MATRIX; (1)
DEEP-INELASTIC-SCATTERING; LEPTON-NUCLEON SCATTERING; MONTE-CARLO GENERATOR; ORDER QCD ANALYSIS; QUARK DISTRIBUTIONS; POLARIZED GLUON; HERA; COLLISIONS; MESONS; PROTON; (1)
DEEP-INELASTIC SCATTERING; ODD PARTON DISTRIBUTIONS; DRELL-YAN; EXCLUSIVE ELECTROPRODUCTION; HARD-SCATTERING; HERMES; LEPTOPRODUCTION; FRAGMENTATION; POLARIMETER; EVOLUTION; (1)
DEEP-INELASTIC SCATTERING; PARTON DISTRIBUTIONS; DIMUON PRODUCTION; GLUON RADIATION; COLOR DYNAMICS; FLUX-TUBE; COLLISIONS; HADRONS; DEPENDENCE; BREMSSTRAHLUNG; (1)
DEEP-INELASTIC SCATTERING; PARTON DISTRIBUTIONS; PION-PRODUCTION; SEMIINCLUSIVE ELECTROPRODUCTION; AZIMUTHAL ASYMMETRY; STATE INTERACTIONS; MELOSH ROTATION; PROTON SPIN; SUM-RULES; DRELL-YAN; (1)
DEEP-INELASTIC-SCATTERING; PARTON DISTRIBUTIONS; TWIST-3 OPERATORS; ASYMMETRY A(2); QCD; RENORMALIZATION; INTEGRABILITY; KERNELS; PROTON; (1)
Deep Inelastic Scattering; Parton Model; QCD (1)
; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
DEEP-INELASTIC-SCATTERING; PION FORM-FACTOR; EVOLUTION-EQUATIONS; QUANTUM CHROMODYNAMICS; ANOMALOUS-DIMENSIONS; DILATATION OPERATOR; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; WAVE-FUNCTIONS; VECTOR-MESONS; (1)
DEEP INELASTIC-SCATTERING; POWER CORRECTIONS; HIGHER-TWIST; QCD; (1)
DEEP-INELASTIC-SCATTERING; SINGLE-SPIN ASYMMETRIES; VIRTUAL COMPTON-SCATTERING; MONTE-CARLO GENERATOR; TRANSVERSE-MOMENTUM DISTRIBUTIONS; LEPTON-FLAVOR VIOLATION; PARTON ENERGY-LOSS; URANIUM-SCINTILLATOR CALORIMETER; CHARGED CURRENT INTERACTIONS; NUCLEON STRUCTURE FUNCTIONS (1)
DEEP-INELASTIC-SCATTERING; STRUCTURE-FUNCTION G(2)(X; STRUCTURE-FUNCTION G2(X; EVOLUTION-EQUATIONS; TRANSVERSE SPIN; QUANTUM CHROMODYNAMICS; POWER CORRECTIONS; SUM-RULES; SINGLE-SPIN; OPERATORS; NLO Computations; QCD Phenomenology (1)
DEEP-INELASTIC SCATTERING; STRUCTURE-FUNCTION RATIOS; TOTAL CROSS-SECTIONS; OF-MASS ENERGY; ELASTIC ELECTROPRODUCTION; EXCLUSIVE RHO(0); SMALL-X; DIFFRACTIVE ELECTROPRODUCTION; INFINITE-MOMENTUM; PROTON SCATTERING; (1)
DEEP-INELASTIC-SCATTERING; STRUCTURE FUNCTIONS G(1); N-C LIMIT; SUM-RULE; QUANTUM CHROMODYNAMICS; POWER CORRECTIONS; NUCLEON; PROTON; Q(2)-DEPENDENCE; OPERATORS; (1)
DEEP-INELASTIC-SCATTERING; TO-LEADING-ORDER; NEUTRON SPIN STRUCTURE; LIGHT-QUARK SEA; STRUCTURE-FUNCTION G(1)(N); OPPOSITE-SIGN DIMUONS; N-C LIMIT; QCD ANALYSIS; FLAVOR-ASYMMETRY; ANTIQUARK DISTRIBUTIONS; (1)
DEEP-INELASTIC SCATTERING; TRANSVERSE-MOMENTUM; DRELL-YAN; LEPTOPRODUCTION; ASYMMETRIES; KAONS; (1)
DEEP-INELASTIC-SCATTERING; TRANSVERSE-SPIN ASYMMETRY; POLARIZED STRUCTURE FUNCTIONS; STRUCTURE-FUNCTION G(2)(X; STRUCTURE-FUNCTION G2(X; QUANTUM CHROMODYNAMICS; SUM-RULES; DISTRIBUTION AMPLITUDES; PRECISION-MEASUREMENT; EVOLUTION EQUATION; (1)
DEEP INELASTIC-SCATTERING; WILSON FERMIONS; LATTICE QCD; structure functions; higher twist; lattice QCD (1)
DEEP-INELASTIC SCATTERING; WILSON FERMIONS; NONPERTURBATIVE RENORMALIZATION; O(A) IMPROVEMENT; MATRIX-ELEMENTS; CONTINUUM-LIMIT; QCD; OPERATORS; SYMMETRY; SPECTRUM; lattice perturbation theory; improved actions (1)
deep learning; artificial intelligence; wound classification; arterial ulcers; venous ulcers; convolutional neural networks (1)
; Deep learning; Fully convolutional networks; Image segmentation; Transfer learning; Surface-mounted technology; Voids (1)
deep learning; herbarium specimens; object detection; TensorFlow; visual recognition (1)
; Deep learning; knot invariants; exploratory data analysis (1)
Deep Learning, Latency (1)
Deep learning, machine learning, natural language processing, conversational agent, text classification, dialogue processing (1)
; Deep learning; Optical coherence tomography; Age-related macular degeneration; Diabetic retinopathy; Artificial intelligence; Computer vision; Computer-aided diagnosis (1)
Deep learning, Stain translation, Unsupervised, Digital pathology, Breast cancer classifier, Adversarial networks (1)
DEEP PELVIC ABSCESSES; PERCUTANEOUS DRAINAGE; ENHANCED ULTRASOUND; MANAGEMENT; DIAGNOSIS; FISTULA; computed tomography; drain; systemic inflammatory response syndrome (SIRS); post-surgical complications; intervention (1)
DEEP-VEIN THROMBOSIS; 3RD HEART-SOUND; INTERNAL-MEDICINE; PHYSICAL FINDINGS; ACUTE APPENDICITIS; VENOUS-PRESSURE; HEALTH-CARE; AUSCULTATION; PATIENT; DIAGNOSIS; patient's history; physical examination; clinical finding; stethoscope; art of medicine (1)
DEEP-VEIN THROMBOSIS; 4G/5G POLYMORPHISM; PAI-1 GENE; 4G/4G GENOTYPE; RISK-FACTOR; ISCHEMIC-STROKE; FACTOR-V; DISEASE; METAANALYSIS; ASSOCIATION; Cerebral venous thrombosis; Thrombophilic risk factors; PAI-1 polymorphisms; 4G/5G alleles (1)
DEEP-VEIN THROMBOSIS; CONVENTIONAL SONOGRAPHY; PULMONARY-EMBOLISM; COMPOUND SONOGRAPHY; MR-VENOGRAPHY; TIME; ULTRASONOGRAPHY; COMBINATION; QUALITY; LESIONS; venous thrombosis; power doppler; ultrasound computed tomography (US/CT) (1)
DEEP-VEIN THROMBOSIS; INFECTIOUS-DISEASES SOCIETY; CARDIOVASCULAR RISK-FACTORS; IN-HOSPITAL MORTALITY; VENOUS THROMBOEMBOLISM; ENDOTHELIAL DYSFUNCTION; ADMISSION GLUCOSE; OXIDATIVE STRESS; ESC GUIDELINES; INFLAMMATION; Diabetes mellitus; Pulmonary embolism; Venous thromboembolism (1)
DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; PREVALENCE; DIAGNOSIS; SOCIETY; D-dimer; extracorporeal membrane oxygenation; incidence; pulmonary embolism; risk factor; thrombosis (1)
DEEP VENOUS THROMBOSIS; ACUTE KIDNEY INJURY; LOW-BACK-PAIN; RISK-FACTORS; ELDERLY-PATIENTS; POSTOPERATIVE COMPLICATIONS; PERIOPERATIVE COMPLICATIONS; UNINTENDED DUROTOMY; NONCARDIAC SURGERY; EPIDURAL HEMATOMA; Surgical and medical complications; Elective spinal surgery (1)
DEEP VENOUS THROMBOSIS; PULMONARY-EMBOLISM; INITIAL TREATMENT; THROMBOEMBOLISM; FONDAPARINUX; RISK; MANAGEMENT; DIAGNOSIS; COMPLICATIONS; PREVALENCE; Superficial vein thrombosis; Malignancy; Cancer; Risk assessment; Observational; Venous thrombosis; Low -molecular -weight heparin; Fondaparinux; Treatment (1)
DEER CERVUS-ELAPHUS; GLACIAL REFUGIA; CENTRAL-EUROPE; GENETIC CONSEQUENCES; ENVELOPE MODELS; CHALK GRASSLAND; SEED DISPERSAL; CLIMATE-CHANGE; L. APIACEAE; SAMPLE-SIZE; AFLP; genetic structure; grassland; phylogeography (1)
de-facto Organ (1)
DEFAULT-MODE NETWORK; RESTING-STATE FMRI; EVENT-RELATED POTENTIALS; BOLD SIGNAL; SIMULTANEOUS EEG/FMRI; PULSE ARTIFACT; ALPHA-RHYTHM; BALLISTOCARDIOGRAM ARTIFACT; SPONTANEOUS FLUCTUATIONS; BRAIN OSCILLATIONS; EEG-BOLD correlations; Motion artifacts; Simultaneous EEG-fMRI; Theta oscillations; Subsequent memory effect (1)
DEFAULT MODE NETWORK; SIGNAL-TO-NOISE; ENDOGENOUS TESTOSTERONE; MAOA GENOTYPE; REACTIVE AGGRESSION; SOCIAL AGGRESSION; AMYGDALA ACTIVITY; GENETIC RISK; HEALTHY-MEN; MECHANISMS; Hormones; Genetics; Anger; Default mode network; Cuneus; fMRI (1)
DEFAULT-MODE NETWORK; TRANSCRANIAL MAGNETIC STIMULATION; ELECTROMAGNETIC TOMOGRAPHY; EMOTIONAL DISTRESS; ALPHA OSCILLATIONS; PREFRONTAL CORTEX; HUMAN BRAIN; DEPRESSION; PAIN; PERCEPTION; (1)
DEFAULT PREDICTION; BETA REGRESSION; RECOVERY RATES; CORPORATE; RISK; PORTFOLIOS; BANKRUPTCY; INDUSTRY; DEBT; Continuous time-to-default; IFRS 9 and CECL; Lifetime Expected Loss; Loss Given Default; Multi-period; Term structure (1)
DEFAULT PROBABILITIES; NEGATIVE EQUITY; FRAILTY; MODELS; Asset correlation; Diversification; Mortgage portfolio; Probability of default; Rating classes; Securitisation; State space model; Systematic risk (1)
DEFECOGRAPHY; DESCENT; DEFECATION; pelvic floor; rectocele; prolaps; descending perineum; intussusception (2)
DEFECTIVE PLATELET ACTIVATION; PROTEIN-INTERACTION NETWORKS; IN-VIVO DEPLETION; GLYCOPROTEIN-VI; ARTERIAL THROMBOSIS; ADHESION MECHANISMS; RECEPTOR CLEC-2; INTEGRIN; COLLAGEN; ROLES; arterial thrombus formation; bleeding; collagen; glycoprotein VI; platelets; microfluidics (1)
DEFECTS; KNEE; JOINT; cartilage repair; translational study; survey; guidelines; animal model (1)
DEFECTS; MEDIA; (1)
DefectsSpin-orbit coupling, Transport phenomena, 2-dimensional systems, Graphene, Transition metal dichalcogenides, Density functional theory, Density matrix methods, Discrete symmetries in condensed matter, First-principles calculations, Many-body techniques, Quantum master equation, Tight-binding model (1)
Defensin, ELISA, Luciferase (1)
Defensin, mBD14, Entzündung, mBD14:Ig transgene Maus, pro-inflammatorischer Effekt, Makrophagen (1)
Defensin, RNA-seq, Fusarium graminearum, Double fertilization, Seed development (1)
DEFIBRILLATOR; IMPLANTATION; Cardiomyopathy; cardiac resynchronization; persistent left SVC; defibrillator; pacemaker (1)
defibrotide, sinusoidal obstruction syndrome, veno-occlusive disease (1)
DEFICIENCY CAUSES; DISEASE; Hyper-IgM syndrome; class-switch defect; Rituximab; primary immunodeficiency; iterative Chip-based cytometry (1)
DEFICIENT GLYCOPROTEIN SYNDROME; N-GLYCOSYLATION; CDG; IK; ABNORMALITIES; GLYCAN; IX; beta-1,4 mannosyltransferase; CDG-Ik; short chain lipid-linked oligosaccharides; seizures; microcephaly (1)
DEFICIENT GLYCOPROTEIN SYNDROME; PROTEIN O-MANNOSYLTRANSFERASES; LIPID-LINKED OLIGOSACCHARIDES; WALKER-WARBURG-SYNDROME; CAUSES CONGENITAL-DISORDER; ACTIVITY IN-VIVO; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; GENE POMT1; (1)
DEFICIENT-GLYCOPROTEIN SYNDROME; RETINITIS-PIGMENTOSA; NIGHT BLINDNESS; HIGH MYOPIA; MUTATIONS; EXPRESSION; CHANNELS; ELECTRORETINOGRAPHY; CONNEXIN36; GENES; (1)
DEFICIENT MICE; T-CELLS; LYMPHOTOXIN; ATHEROSCLEROSIS; CHEMOKINES; RECRUITMENT; ORGANOGENESIS; INFLAMMATION; DISEASE; ATHEROGENESIS; smooth muscle cells; immune response; chemokines; signaling pathways; tumor necrosis factor receptor; lymphotoxin-beta receptor (1)
DEFICIENT RABBITS; PLASMA-EXCHANGE; CHOLESTEROL; LIPOPROTEIN; THERAPY; HEPATOCYTES; PATIENT; CHILD; familial hypercholesterolemia; gene therapy; LDL receptor gene; transplantation (1)
DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FRONTAL-LOBE DYSFUNCTION; STRIATAL COGNITIVE DEFICITS; CLOSED-HEAD-INJURY; PARKINSONS-DISEASE; NEUROPSYCHOLOGICAL PERFORMANCE; VERBAL FLUENCY; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; ADHD; adulthood; problem solving; Tower of London; verbal fluency; methylphenidate (1)
DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; WORKING-MEMORY; PHYSICAL-ACTIVITY; RESPONSE-INHIBITION; 6-YEAR-OLD CHILDREN; OVERFLOW MOVEMENTS; PERFORMANCE; METHYLPHENIDATE; ADHD; children; correlation; executive functions; motor abilities (1)
DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SINGLE-NUCLEOTIDE POLYMORPHISMS; FAMILY-BASED ASSOCIATION; SEQUENCE VARIATION; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; GENOMEWIDE SCAN; CODING REGION; KNOCKOUT MICE; attention-deficit/hyperactivity disorder; haplotype; DAT1; SLC6A3 (1)
DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; MEDICATION-TREATED ADULTS; METHYLPHENIDATE TREATMENT; GERMAN VALIDATION; DOUBLE-BLIND; ADHD; DOPAMINE; CHILDREN; PLACEBO; (1)
DEFICIT-HYPERACTIVITY-DISORDER; COGNITIVE PERFORMANCE; SUBJECTIVE EXPERIENCE; ADULT ADHD; CHILDREN; EXPOSURE; NOISE; METHYLPHENIDATE; INHIBITION; DOPAMINE; (1)
DEFICIT-HYPERACTIVITY DISORDER; CONDUCT DISORDER; DEFIANT DISORDER; THAI CHILDREN; CYP2D6; SERUM; 9-HYDROXYRISPERIDONE; PHARMACOKINETICS; EFFICACY; HYPERPROLACTINEMIA; Oppositional defiant disorder; Conduct disorder; Youth; Risperidone; 9-Hydroxyrisperidone; Therapeutic drug monitoring (1)
DEFICIT/HYPERACTIVITY DISORDER; CONDUCT DISORDER; RELIABILITY; INTERVIEW; (1)
DEFICIT HYPERACTIVITY DISORDER; CORTICOSPINAL EXCITABILITY; MAGNETIC STIMULATION; MAJOR DEPRESSION; INHIBITION; METHYLPHENIDATE; CHILDREN; TRAITS; SYSTEM; Transcranial magnetic stimulation; NEO; Personality; Cortical excitability (1)
DEFICIT HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; PROSPECTIVE MEMORY; FOCUSED ATTENTION; CHILDREN; VIGILANCE; METAANALYSIS; SUBTYPES; SAMPLE; Adult ADHD; Cognition; Neuropsychological assessment; Attention; Sustained attention; Time-on-task effects (1)
DEFICIT-HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; PSYCHIATRIC STATUS; RESEARCH CRITERIA; BOYS; METHYLPHENIDATE; REGRESSION; SCORES; TASK; ADHD; childhood; adulthood; attentional functioning; vigilance; sustained attention (1)
DEFICIT/HYPERACTIVITY-DISORDER; EXECUTIVE FUNCTION; SELF-REPORT; ECOLOGICAL VALIDITY; EF TESTS; ADHD; QUESTIONNAIRE; SYMPTOMS; MEMORY; CHILDREN; Self-assessment; Cognition; Complaints.; Adult ADHD; Self-report (1)
DEFICIT-HYPERACTIVITY DISORDER; FUNCTIONAL MAGNETIC-RESONANCE; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE FUNCTION; NEAR-INFRARED SPECTROSCOPY; OSTERRIETH COMPLEX FIGURE; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; WORKING-MEMORY; Biomarker; attentention-deficit/hyperactivity disorder; olfaction; transcranial echosonography; neuroimaging; proteomics (1)
DEFICIT HYPERACTIVITY DISORDER; IN-LINE BISECTION; READING-DISABILITY; NEURAL SYSTEMS; EYE-MOVEMENTS; SPAN DEFICIT; SHORT-TERM; MEMORY; CAPACITY; TVA; (1)
DEFICIT HYPERACTIVITY DISORDER; LIQUID-CHROMATOGRAPHY HPLC; HUMAN PLASMA; PHARMACOKINETICS; BIOAVAILABILITY; SPECTROMETRY; ADOLESCENCE; DERIVATIVES; CHILDHOOD; CHILDREN; therapeutic drug monitoring; oral fluid TDM; psychostimulants; ADHD; hyperkinetic disorders (1)
DEFICIT HYPERACTIVITY DISORDER; MATERNAL SENSITIVITY; FOLLOW-UP; ADULTS; TRANSPORTER; ADDICTION; RESPONSES; Alcoholism; Attachment; Attention-deficit/hyperactivity disorder; Alcohol consumption; Withdrawal (1)
DEFICIT HYPERACTIVITY DISORDER; MODIFIED-RELEASE METHYLPHENIDATE; ONCE-A-DAY; OROS METHYLPHENIDATE; ADHD; FORMULATIONS; PHARMACOKINETICS; ADOLESCENTS; SCHOOL; (1)
DEFICIT/HYPERACTIVITY DISORDER; PERIPHERAL MARKER; LYMPHOCYTES; SCHIZOPHRENIA; NEUROBIOLOGY; INDIVIDUALS; ASSOCIATION; VARIANTS; DRD4; mRNA expression; attention deficit hyperactivity disorder (ADHD); autism spectrum disorder (ASD); dopamine receptor D4, D5 (DRD4, DRD5) (1)
DEFICIT HYPERACTIVITY DISORDER; PROMOTER REGION POLYMORPHISM; SEROTONIN TRANSPORTER GENE; PROLACTIN RESPONSE; FENFLURAMINE; PERSONALITY; ASSOCIATION; 5-HTTLPR; RECEPTOR; ABUSE; (1)
DEFICIT-HYPERACTIVITY DISORDER; PROSPECTIVE BIRTH COHORT; POPULATION-BASED SAMPLE; MENTAL-HEALTH; SLEEPING PROBLEMS; RISK-FACTOR; CHILDREN; ADHD; DERMATITIS; CHILDHOOD; atopic dermatitis; attention-deficit/hyperactivity disorder; comorbidity; epidemiology; meta-analysis; risk (1)
DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME-TASK; DORSAL NORADRENERGIC BUNDLE; CORTICAL COGNITIVE FUNCTION; PREFRONTAL CORTEX; LOCUS-COERULEUS; 6-HYDROXYDOPAMINE LESIONS; SELECTIVE ATTENTION; VIGILANCE TASK; ANIMAL-MODELS; Methylphenidate; Attention; Attention deficit hyperactivity disorder; N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine; DSP4; Rat (1)
DEFICIT HYPERACTIVITY DISORDER; STATE FUNCTIONAL CONNECTIVITY; AGE-DEPENDENT DECLINE; CEREBRAL-BLOOD-FLOW; INHIBITORY CONTROL; BRAIN ACTIVITY; RATING-SCALE; ADHD; CHILDREN; DEPRESSION; (1)
DEFICIT-HYPERACTIVITY-DISORDER; VENTRAL STRIATUM; TRANSPORTER; ADHD; BINDING; PATHOPHYSIOLOGY; DYSREGULATION; AVAILABILITY; METAANALYSIS; MEDICATION; methylphenidate; attention deficit; hyperactivity disorder (ADHD); striatum; single photon emission computed tomography (SPECT); responsivity; caudate nucleus; dopamine transporter (DAT) (1)
DEFINING BIOCHEMICAL FAILURE; RADICAL PROSTATECTOMY; TRANSRECTAL HIFU; RADIOTHERAPY; THERAPY; HIFU; localized; long-term; outcome; prostate cancer (1)
DEFINING PSYCHOLOGY; self-perception of psychology; principle of inversion; methods in psychology; operationalism; definitions of psychology (1)
deflation, inflation, hedge, ARMA, GARCH, EVT, Copula, price risk, irrationality, us mutual equity funds, performance gap, IRR, MIRR (1)
DEFORMATION POTENTIALS; GALLIUM NITRIDE; PLANE GAN; INN; SEMICONDUCTORS; LUMINESCENCE; LIFETIME; FIELDS; (1)
DEFORMATIONS; Extensions; Biextensions; Locally constant group schemes; Tori; Abelian schemes (1)
DEFUNCTIONING ILEOSTOMY; CT; ANASTOMOSIS; REVERSAL; POUCH; ileostomy; ileostomy closure; contrast enema (1)
DEGEER COLEOPTERA; PHEROMONE; DECOMPOSITION; CARRION; FLIES; Forensic entomology; Dermestes maculatus; Odour analysis; Bioassay; Piglet carcasses; Decomposition stages (1)
degenerate Cahn-Hilliard equation; elasticity; convergence; nonlinear degenerate parabolic system (1)
DEGENERATE PERTURBATION-THEORY; GAUSSIAN-BASIS SETS; OPTOELECTRONIC PROPERTIES; SELECTIVE SYNTHESIS; CARBON NANORINGS; IMPLEMENTATION; MOLECULES; CHIRALITY; N=8-13; (1)
DEGENERATION; (1)
DEGENERATION; AGE; humeral head fracture; greater tuberosity; rotator cuff; fatty degeneration (1)
DEGENERATIONS; FORMS (1)
DEGRADABLE STARCH MICROSPHERES; IRREVERSIBLE ELECTROPORATION IRE; CHEMOEMBOLIZATION DSM-TACE; ULTRASONOGRAPHY DCE-US; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; CEUS; LESIONS; QUANTIFICATION; MICROVASCULARIZATION; Dynamic contrast-enhanced ultrasound (DCE-US); liver tumors; VueBox (R); perfusion; quantitative (1)
Degradation , bioabbaubare Polymere , Bulkerosion , Oberflächenerosion , Erosionsmodell zur Klassifizierung nach Erosionsmechanismus , Degradation , biodegradable polymers , bulk erosion , surface erosion , model for classification of erosion acc. to mechansim of erosion (1)
Degradation , Galliumnitrid , Halbleiter , Facettendegradation , GaN , Hakki Paoli , degradation , GaN , laser (1)
DEGRADATION; RNAS; microRNA; miR-138; Matrin-3; RNA-binding protein; Synaptic plasticity (1)
DEGREE-4 CHARACTERISTIC CLASSES; BUNDLE GERBES; LINE BUNDLES; lifting problem; bundle gerbe; transgression; loop space (1)
DEGREE-4 CHARACTERISTIC CLASSES; BUNDLE GERBES; LOOP-SPACES; LINE BUNDLES; GEOMETRY; TOPOLOGY; 2-GROUPS; (1)
DEGREE-4 CHARACTERISTIC CLASSES; TWISTED K-THEORY; SIMPLICIAL PRESHEAVES; CLASSIFYING-SPACES; HOMOTOPY THEORIES; LINE BUNDLES; LOOP-SPACES; GERBES; GEOMETRY; CLASSIFICATION; Homotopy theory; Topos theory; Differential geometry; Algebraic topology; Principal bundles (1)
de Gruyter, Open Access Verlag, Open Access Lunch (1)
DEGUM MULTICENTER; DIAGNOSTIC-ACCURACY; FLOW CHANGES; 20 MM; BENIGN; Contrast-enhanced ultrasound sonography; CEUS; high frame rate contrast-enhanced (HiFR); liver cancer (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; DIAGNOSTIC-ACCURACY; NODULES; MALIGNANCY; GUIDELINES; BENIGN; Ultrasound; CEUS; Power Doppler Sonography; thyroid adenoma; thyroid carcinoma (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; NODULES; ACCURACY; MALIGNANCY; CEUS; power doppler; ultrasound; thyroid adenoma (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; POWER DOPPLER US; DIAGNOSTIC-ACCURACY; DIFFERENTIAL-DIAGNOSIS; BOSNIAK CLASSIFICATION; CELL CARCINOMA; CT; SONOGRAPHY; KIDNEY; CEUS; kidney; interdisciplinary ultrasound department; imaging possibilities (1)
DEGUM MULTICENTER TRIAL; HEPATOCELLULAR-CARCINOMA; CLINICAL-PRACTICE; DIAGNOSTIC-ACCURACY; LESIONS; CEUS; METASTASES; SURGERY; RESECTION; MRI; CEUS; liver tumor; MRI; histopathology; IOCEUS (1)
DEHN SURGERY; REPRESENTATIONS; INVARIANT; VARIETIES; MANIFOLDS; KNOTS; (1)
Dehnungs-h, Lernverlaufsdiagnostik, Progress Monitoring, Rechtschreiben, Skilltest (1)
Dehydration · Eosin Y photodegradation · 1,2-spin center shift · Photocatalysis (1)
DEHYDROEPIANDROSTERONE; CORTISOL; WOMEN; MEN; SULFATE; GLANDS; AGE; (1)
DEHYDROGENASES; STEREOSPECIFICITY; flavin; NADH; redox reaction; zinc cyclen complex (1)
Dehydrogenative coupling, Dynamic isomerism, NMR spectroscopy, Pentacoordinate intermediates, Silicon (1)
DEHYDROGENATIVE COUPLING REACTIONS; C-H ARYLATION; ORGANIC-SYNTHESIS; CONTINUOUS-FLOW; ORGANOCATALYSIS; PHOTOCHEMISTRY; STRATEGY; PHOTOCATALYSIS; EFFICIENT; REACTOR; (1)
DEHYDROGENATIVE COUPLING REACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; VISIBLE-LIGHT PHOTOCATALYSIS; FREE-RADICAL REACTIONS; C-H FUNCTIONALIZATION; DIELS-ALDER REACTIONS; ALPHA,BETA-UNSATURATED KETONES; ASYMMETRIC CATALYSIS; BETA-ACTIVATION; METAL-FREE; organocatalysis; photocatalysis; redox chemistry; reductive cyclization; thiourea (1)
Dekalog, Gesetz, Torah, Pentateuch, Prohibitiv, Vetitiv, Präventiv (1)
Deklamation, Bernstejn, Moissi, Wüllner (1)
Dekompositionsmodell, Wand, Weber Prozessmodellierung, Geschäftsprozessmanagement (1)
DELAYED CEREBRAL-ISCHEMIA; EXTERNAL JUGULAR-VEIN; CEREBROSPINAL-FLUID; PEPTIDERGIC INNERVATION; VASOMOTOR RESPONSES; NERVE-FIBERS; HUMAN-BRAIN; VASOSPASM; VASOCONSTRICTION; IMMUNOREACTIVITY; Neuropeptide Y; Subarachnoid hemorrhage; Cerebral vasospasm (1)
DELAYED CEREBRAL-ISCHEMIA; EXTERNAL JUGULAR-VEIN; NEUROPEPTIDE-Y; NEUROPSYCHOLOGICAL OUTCOMES; INTRACRANIAL ANEURYSMS; FOLLOW-UP; CGRP; DEPRESSION; INVOLVEMENT; VASOSPASM; Calcitonin gene-related peptide; CGRP; Health-related quality of life; Impairment; Neuropsychological outcome; Spontaneous subarachnoid hemorrhage (1)
DELAYED CEREBRAL-ISCHEMIA; REDUCING TOXICITY; ENHANCE RECOVERY; VASOSPASM; MANAGEMENT; INFUSION; MICROPARTICLES; Subarachnoid hemorrhage; Nimodipine; Plasma concentration; Arterial hypotension; Delayed cerebral ischemia (1)
DELAYED FLUORESCENCE; AMBIENT CONDITIONS; COMPLEXES; PHOSPHORESCENCE; LIGANDS; Luminescence; Fluorescence; Phosphorescence; Cu(I) complexes Ag(I) complexes; 8-Quinolinolate complexes; Luminescence quenching by oxygen (1)
DELAYED FLUORESCENCE; EXCITED-STATES; BASIS-SETS; PHOTOPHYSICS; DYNAMICS; OXYGEN; LIGAND; PHOTOCHEMISTRY; PLATINUM(II); EMISSION; (1)
DELAYED GERMINATION; THROUGH-SPACE; PLANT TRAITS; R PACKAGE; DORMANCY; EVOLUTION; POPULATION; DISTANCE; GROWTH; ADAPTATIONS; Annual; dormancy; germination; iteroparity; lifespan; longevity; perennial; seed bank; seed dispersal (1)
DELAYED GRAFT FUNCTION; NECROSIS-FACTOR-ALPHA; INFLAMMATORY MARKERS; ACUTE REJECTION; IMMUNOLOGICAL ACTIVATION; RENAL-ALLOGRAFTS; HEME OXYGENASE; RAT; EXPRESSION; SURVIVAL; brain death; cytokines; immunogenicity; inflammation; live transplantation; risk factors (1)
DELAYED OPEN CONVERSION; SURGICAL CONVERSION; SECONDARY CONVERSION; GORE EXCLUDER; ENDOGRAFT; EXPLANTATION; EVAR; INTERVENTIONS; OUTCOMES; REGISTRY; Aortic aneurysm; abdominal; Endovascular procedures; Conversion to open surgery (1)
DELAYED TOOTH ERUPTION; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; RUNX2; MUTATIONS; PATIENT; FORCES; GENE; IL-6; MICE; cleidocranial dysplasia (CCD); orthodontic tooth movement; mechanical strain; bone remodeling (1)
DELAY PHENOMENON; SAPHENOUS-VEIN; RADIAL ARTERY; THORACIC ARTERY; OSTEOMYELITIS; OXYGEN; Sternal wound infection; LIMA; sternal infection; sternum perfusion; tissue oxygenation; coronary bypass surgery (1)
D. electron-electron interactions; D. electronic transport; D. tunneling; Coulomb blockade (1)
DELEGATION; PREFERENCES; EMISSIONS; international environmental agreements; strategic delegation; Nash bargaining; majority voting; transboundary pollution (1)
DELETION; (1)
DELIBERATE PRACTICE; PERFORMANCE; ACQUISITION; ACCOUNT; deliberate practice; expertise; music; parents; peers; persons in the shadows (1)
Deliberate practice, Talent development, Skill acquisition, Expertise (1)
DELIBERATE SELF-HARM; BEHAVIOR; DEPRESSION; ANXIETY; RISK; PSYCHOPATHOLOGY; AGGRESSION; Suicide; interpersonal theory of suicide; suicide attempt; suicide prevention; belongingness; belongingness; self-harm; adolescence (1)
DELIBERATE SELF-HARM; EMOTION REGULATION; DIFFICULTIES; DEPRESSION; VALIDATION; MECHANISMS; ANXIETY; WOMEN; dialectical behavior therapy; inpatient; borderline personality disorder; emotion regulation (1)
DELIGNE COHOMOLOGY; GEOMETRY; (1)
DELIGNE COHOMOLOGY; GEOMETRY; TOPOLOGY; (1)
Delir, Demenz, Gerontopsychiatrie (1)
delirium, intensive-care medicine, incidence, oxycodone, non-cardiac surgical intensive care, medical intensive care (1)
DELIVERY PROBLEM; SUPPLY CHAINS; COST ALLOCATION; TIME WINDOWS; PICKUP; OPPORTUNITIES; SUGGESTIONS; REDUCTION; NUCLEOLUS; BENEFITS; OR in environment and climate change; Allocation; Road freight transportation; Cooperative game theory; EN-16258 (1)
DELTA-AMINOLEVULINIC-ACID; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSES; METHYL AMINOLEVULINATE; SOLAR KERATOSES; LASER; LESIONS; TRIAL; actinic keratoses; 5-aminolaevulinic acid; photodynamic therapy; protoporphyrin IX (1)
DELTA-AMINOLEVULINIC-ACID; 5-AMINOLEVULINIC ACID; IN-VIVO; SOLAR KERATOSES; LASER; SKIN; LESIONS; METHYLESTER; DERMATOLOGY; VITRO; 5-aminolaevulinic acid; actinic keratosis; photodynamic therapy; protoporphyrin IX; randomized controlled trial (1)
DELTA-AMINOLEVULINIC-ACID; ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; BOWENS-DISEASE; DOUBLE-BLIND; NORMAL SKIN; MULTICENTER; DERMATOLOGY; THRESHOLDS; (1)
DELTA-AMINOLEVULINIC-ACID; EARLY CLINICAL-EXPERIENCE; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; ENDOGENOUS PROTOPORPHYRIN; PORPHOBILINOGEN DEAMINASE; TUMOR-CELLS; SERUM IRON; ACCUMULATION; FLUORESCENCE; (1)
DELTA-AMINOLEVULINIC-ACID; HUMAN BLADDER-CARCINOMA; HIGH-GRADE DYSPLASIA; PHOTODYNAMIC THERAPY; IN-VITRO; BARRETTS-ESOPHAGUS; PORPHOBILINOGEN DEAMINASE; PORPHYRIN BIOSYNTHESIS; FLUORESCENCE DETECTION; ADENOCARCINOMA CELLS; (1)
DELTA-AMINOLEVULINIC-ACID; INDUCED PROTOPORPHYRIN; INDUCED FLUORESCENCE; AMELANOTIC MELANOMA; OPTICAL SENSORS; TUMORS; OXYGEN; PH; HYPOXIA; TISSUE; amelanotic melanoma; protoporphyrin IX; oxygen; microcirculation; tumour (1)
DELTA-AMINOLEVULINIC-ACID; INTENSE PULSED-LIGHT; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; IN-VIVO; METHYL AMINOLEVULINATE; SOLAR KERATOSES; DOUBLE-BLIND; SKIN-CANCER; PAIN; photodynamic therapy; actinic keratoses; protoporphyrin IX; methylaminolevulinate; LED system (1)
DELTA-AMINOLEVULINIC-ACID; LONG-TERM CULTURE; ACUTE INTERMITTENT PORPHYRIA; PHOTODYNAMIC THERAPY; PROTOPORPHYRIN-IX; DNA-DAMAGE; ENDOGENOUS PROTOPORPHYRIN; HYDROGEN-PEROXIDE; HYDROXYL RADICALS; CELLS; 5-aminolevulinic acid; porphyrin; photodynamic therapy/diagnosis; human hepatocyte; reactive oxygen substance; lipid peroxidation; antioxidant (1)
DELTA-AMINOLEVULINIC-ACID; PHOTODYNAMIC THERAPY; BLADDER-CANCER; BARRETTS-ESOPHAGUS; IN-VITRO; FLUORESCENCE; ESTERS; CELLS; ALA; DIAGNOSIS; 5-aminolevulinic acid; 5-aminolevulinic esters; protoporphyrin IX; fluorescence; colon (1)
DELTA-AMINOLEVULINIC-ACID; PROTOPORPHYRIN-IX; PLAQUE PSORIASIS; IN-VIVO; LIGHT; FLUORESCENCE; PHOTOTHERAPY; ACCUMULATION; DISEASE; ALA-PDT; clinical trial; inflammatory disease; visible light (1)
DELTA-AMINOLEVULINIC-ACID; THERAPY; SURGERY; FOLLOW; NM; (1)
DELTA-ELECTRON-PHONON; TEMPERATURE-DEPENDENCE; MATRIX-ELEMENTS; PSEUDOPOTENTIAL CALCULATIONS; ENERGY-GAP; SI; ABSORPTION; SEMICONDUCTORS; GE; SPINTRONICS; (1)
DELTAHEDRAL ZINTL IONS; GROUP 15 ELEMENTS; INTERMETALLOID CLUSTERS; GERMANIUM CLUSTERS; ATOMS; DERIVATIVES; POLYANIONS; SI-5(2-); GE; SN; silicides; ammonia; crystal structure; cluster compounds; Zintl ions (1)
DELTAHEDRAL ZINTL IONS; LIQUID-AMMONIA SOLUTION; ANIONS; CHEMISTRY; GE-9(4-); METAL; SN; GE; ANNOUNCEMENT; POLYANIONS; Zintl anion; liquid ammonia; crystal structure (1)
DELTA-PSI-M; IN-VITRO; MEIOTIC MATURATION; PREIMPLANTATION DEVELOPMENT; DEVELOPMENTAL SIGNIFICANCE; MICROTUBULE ORGANIZATION; FOLLICULAR DEVELOPMENT; EMBRYO DEVELOPMENT; ATP CONTENT; RAT OVARY; mitochondria; mitochondrial polarity; nitric oxide; cumulus cells; regulation of mitochondrial activity (1)
DELTA T-CELLS; IN-VIVO; TISSUE-REPAIR; TGF-BETA; PLZF; MR1; TCR; SURVEILLANCE; ACTIVATION; EXPRESSION; (1)
DELUSIONS; SCHIZOPHRENIA; RISK; ANGER; INDIVIDUALS; RELIABILITY; PSYCHOLOGY; HOMICIDE; DISORDER; CULTURE; Violence; Homicide; Schizophrenia; Moral cognition; Delusions; Hallucinations; Violence risk assessment; Neurocognition; Forensic psychiatry; Moral foundations theory (1)
DE-MAN; (1)
DEMANDS-RESOURCES MODEL; JOB DEMANDS; COPING STRATEGIES; SOCIAL SUPPORT; TELEWORKERS; STRESS; Coping; job demands; job resources; pandemic context; working from home (1)
DE-MAN; MANGROVE CRAB; MITOCHONDRIAL GENES; MOLECULAR PHYLOGENY; VICTORY DISPLAY; REDESCRIPTION; TAIWAN; DIFFERENTIATION; CLASSIFICATION; AMPLIFICATION; molecular markers; new genus; Leptarma; phylogeny; sesarmid crabs; systematics (1)
DEMENTIA (1)
DEMENTIA; DRAINAGE; Age-adjusted analysis; Chronic subdural hematoma; Detailed symptom description; Symptom relief (1)
DEMENTIA; METAANALYSIS; DIET; (1)
Demenz, Alzheimer Demenz, Vaskuläre Demenz, Gemischte Demenz, Demenzmarker (1)
DEMETHYLASE PHF8; GENOME INTEGRITY; METHYLATION; CHROMATIN; MONOMETHYLATION; QUIESCENCE; PR-SET7; CYCLE; (1)
Demineralisation, Dentin, Wachstumsfaktorfreisetzung, endodontische Spüllösungen, intrakanaläre Medikamente, Revitalisierung (1)
Demineralisierte Knochenmatrix, autologe Spongiosa, dorsale Fusion thorakolumbaler Frakturen, Pseudarthrosen (1)
DEMINERALIZATION; (1)
DEMOCRACY; INSTITUTIONS; ORIGINS; EXTENSIONS; INEQUALITY; REVOLUTION; HISTORY; DEMOCRATIZATION; COMMITMENT; FRANCHISE; Democracy; Suffrage; Colonialism; Bargaining; Coalitions; Virginia (1)
democracy, liberalism, pluralism, self-determination (1)
Democratic identity · Italy · Norway · Pluralism · Affective polarization (1)
Demografischer Wandel, Raumordnungsrecht, Baurecht (1)
demographics, race, disparities, surgical outcomes, big data, quality improvement (1)
Demokratie Anomie Defekte Demokratie Postdemokratie Demokratiekritik Kontrollverlust Exklusion (1)
Demokratie, Krise, Postdemokratie, Partizipation, Repräsentation, Legitimation (1)
DEMOSPONGE SUBERITES-DOMUNCULA; BIOGENIC SILICA; NEUTRAL PH; ACID POLYMERIZATION; MOLECULAR-SIEVES; BIOMIMETIC SYNTHESIS; NANOSPHERE FORMATION; PHASE-SEPARATION; DIATOM BIOSILICA; IN-VITRO; biomolecules; self-assembly; silica biomineralization; silaffins; silicateins; polyamines (1)
DEMOSPONGE SUBERITES-DOMUNCULA; LONG-CHAIN POLYAMINES; BIOGENIC SILICA; ELECTROSTATIC INTERACTIONS; BIOMIMETIC SILICIFICATION; CYLINDROTHECA-FUSIFORMIS; NANOSPHERE FORMATION; ACID POLYMERIZATION; PHASE-SEPARATION; MARINE DIATOMS; biomineralisation; diatoms; polyamines; polyanions; silaffins; silica (1)
denaturing high performance liquid chromatography; mutation detection; DNA heteroduplex; temperature-modulated fractionation; high-throughput (1)
DENDRITIC CELL ACTIVATION; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; LACTATE TRANSPORT; UP-REGULATION; NITRIC-OXIDE; MACROPHAGES; HYPOXIA; MECHANISMS; EXPRESSION; (1)
dendritic cell-based therapy; cytokines; hepatitis B virus subviral particles (1)
DENDRITIC CELL-DIFFERENTIATION; ACID ESTERS; NECROBIOSIS LIPOIDICA; DIMETHYLFUMARATE; ANNULARE; IMMUNOSUPPRESSION; CYTOKINES; (1)
dendritic cell; myeloid suppressor cell; nitric oxide synthase; Langerhans cells; Leishmania parasites (1)
DENDRITIC CELLS; ATOPY (1)
DENDRITIC CELLS; BINDING PROTEIN; HUMAN BLOOD; EXPRESSION; SUPPRESSION; RKIP; PROSTATE; gene expression; Raf kinase inhibitor protein; macrophage differentiation; NF kappa B; scavenger receptors; THP-1 cells (1)
DENDRITIC CELLS; BONE-MARROW; INFLAMMATORY RESPONSE; CCL2-CCR2 AXIS; PANDEMIC VIRUS; MICE; MONOCYTE; CCR2; H5N1; INFECTION; (1)
DENDRITIC CELLS; DISEASE; Cell therapy; Minimum information model; Antigen-presenting cells; Autoimmune disease; Transplantation; Tolerogenic dendritic cells; Regulatory macrophages; Reporting guidelines (1)
DENDRITIC CELLS; ELIMINATION; DISEASES; Immunology; Issue 90; Autoimmunity; Apoptosis; antigen-specific CD8+T cells; HLA-A2-Ig; Fas/FasL; KaAPC (1)
DENDRITIC CELLS; EXPRESSION; VISUALIZATION; SUBSETS; SEQ; proteomics; RNA-seq; spatial transcriptomics; multiplex imaging; physically interacting cells; dendritic cells; T cells (1)
DENDRITIC CELLS; GENE SIGNATURE; SURVIVAL; EXPRESSION; NOMOGRAM; MACROPHAGES; PREDICT; MODELS; BEVACIZUMAB; COMBINATION; ovarian neoplasms; tumor microenvironment; genes; The Cancer Genome Atlas (TCGA); immunotherapy (1)
DENDRITIC CELLS; GUT MICROBIOTA; EARLY-LIFE; DIARRHEAL DISEASE; RESPONSES; MOUSE; HOMEOSTASIS; INDUCTION; ALPHA; COLONIZATION; (1)
DENDRITIC CELLS; IN-VITRO; THERAPEUTIC APHERESIS; WRITING COMMITTEE; CLINICAL-PRACTICE; AMERICAN SOCIETY; QUALITY-CONTROL; T-CELLS; PHOTOCHEMOTHERAPY; PHOTOCHEMISTRY; 8-methoxypsoralen; apoptosis; ECP; extracorporeal photopheresis (1)
DENDRITIC CELLS; RECEPTOR; CATHELICIDIN; MONOCYTES; IMMATURE; IMMUNITY; INNATE; LL-37; Beta-defensin; G protein-coupled receptors; Pro-inflammatory cytokines; TLR agonists (1)
DENDRITIC CELLS; RELAPSE (1)
DENDRITIC CELLS; SPLENIC MACROPHAGES; A VIRUSES; INFECTION; MICE; IMMUNITY; FEVER; INFLAMMATION; REPLICATION; SEASONALITY; Influenza and dengue virus co-infection; Immune response; Lung; Monocyte; Pathogenesis; Pneumonia (1)
DENDRITIC CELLS; VACCINATION STRATEGIES; AVIAN INFLUENZA; H5N1 INFLUENZA; A VIRUSES; RESPONSES; IMMUNITY; CULTURE; LYMPHOCYTES; EPITOPES; (1)
DENDRITIC SPINES; OPTICAL TWEEZERS; MICROSCOPY; EXCITATION; NETWORK; INTEGRATION; CALCIUM; (1)
Dendritische Integration, dendritic integration, dendritic spikes, Bulbus olfactorius, Körnerzellen, granule cells, cortical pyramidal cells, Pyramidalzellen, holographic 3D glutamate uncaging, Ca²⁺-imaging, Elektrophysiologie, electrophysiology (1)
dendritische Zelle, GvHD, LPS, MDP, allogene T-Zellantwort (1)
Dendritische Zelle , Monozyten-Makrophagen-System , Genexpression , Genregulation , MCP-4 , Hep27 (DHRS2) , Promotor , CpG-Methylierung , MCP-4 , Hep27 (DHRS2) , 15-Lipoxygenase , complement C1q C-chain , folate receptor beta (1)
Dendritische Zellen, Monozyten, ATG, Antithymozytenglobulin, Indolamin-2,3-Dioxygenase, Tryptophan, allogene Stammzelltransplantation, tolerogen, Vitamin D (1)
DENDRODENDRITIC INHIBITION; SYNAPTIC AMPLIFICATION; NMDA RECEPTORS; GABA RELEASE; K+ CHANNELS; RAT-BRAIN; NECK; INTERNEURONS; MEMBRANE; SIGNALS; (1)
; dendroidal sets; connective spectra; model structure (1)
DENDROIDAL SETS; MODELS; Dendroidal sets; K-theory; operads (1)
Denosumab, Zoledronat, osteogene Differenzierung, mesenchymale Stammzellen, dentale Follikelzellen (1)
DE-NOVO BIOSYNTHESIS; FATTY-ACIDS; PARASITIC WASP; DELTA-12-DESATURASE; FEMALES; EVOLUTION; Oleic acid; Linoleic acid; Biosynthesis; Delta-12-desaturase; Sex pheromone; Nasonia (1)
DE-NOVO BIOSYNTHESIS; MALE SEX-PHEROMONE; HETEROLOGOUS EXPRESSION; FATTY-ACIDS; DELTA-12-DESATURASE; CRICKET; Fatty acids; Linoleic acid; Parasitoid wasp; Sex pheromone (1)
DE-NOVO DESIGN; INTERACTION SPECIFICITY; ENERGY FUNCTIONS; BINDING PROTEIN; STABILITY; SEQUENCE; OPTIMIZATION; ENSEMBLES; REDESIGN; ENZYMES; (1)
DE-NOVO DESIGN; PROTEINOGENIC SIDE-CHAINS; SHORT ALPHA/BETA-PEPTIDES; AQUEOUS-SOLUTION; SECONDARY STRUCTURE; AMINO-ACID; HELICAL CONFORMATIONS; HEMOLYTIC ACTIVITIES; CIRCULAR-DICHROISM; 14-HELIX STABILITY; ss-amino acids; cis-pentacine; foldamers; helical structures; peptides (1)
DE-NOVO DESIGN; PROTEIN-PROTEIN INTERACTIONS; ALPHA-HELIX MIMICRY; HUMAN SOMATOSTATIN RECEPTOR; PARALLEL SHEET STRUCTURE; GLUCAGON-LIKE PEPTIDE-1; GENE-RELATED PEPTIDE; O HYDROGEN-BONDS; NEUROPEPTIDE-Y; HETEROGENEOUS BACKBONES; (1)
DE-NOVO DESIGN; SECONDARY STRUCTURE; LINEAR PEPTIDES; MOLECULAR TOOL; ALANINE; OLIGOMERS; FOLDAMERS; alpha/beta-pepticles; beta-amino acids; foldamers; helical structures; NMR spectroscopy (1)
DE-NOVO; PROTEIN INTERACTIONS; MAINTENANCE METHYLATION; FLUORESCENT PROTEINS; CATALYTIC DOMAIN; LIVING CELLS; DNMT1; REPLICATION; GENE; EXPRESSION; DIMER; METHYLATION; DNA METHYLTRANSFERASE 1; Dnmt 1; TARGETING SEQUENCE (1)
DENSE ADJOINT MATTER; DIRAC OPERATOR; CHIRAL-SYMMETRY; MODELS; Matrix Models; Spontaneous Symmetry Breaking; Lattice QCD; Chiral Lagrangians (1)
DENSELY PACKED MONODISPERSE; UNILAMELLAR VESICLES; PHASE-BEHAVIOR; TAILED SURFACTANTS; AQUEOUS-SOLUTIONS; FATTY-ACIDS; GEL PHASE; MICELLAR; WATER; AMPHIPHILES; micelles; phase diagrams; solubility temperature; surfactant; vesicles (1)
DENSITY; (1)
DENSITY-DEPENDENCE; LIQUID METHANE; COEFFICIENTS; FLUID; TRANSPORT; VISCOSITY; Alkane; Diffusion coefficient; Flexibility; High pressure; Molecular dynamics simulation (1)
DENSITY-FUNCTIONAL CALCULATIONS; HYDROSULFIDO-BRIDGED DIIRIDIUM; ORDER REGULAR APPROXIMATION; METAL-ARENE INTERACTIONS; DIRHODIUM COMPLEXES; DIRUTHENIUM COMPLEX; MONOVALENT NICKEL; SULFIDO CLUSTERS; D(9) COMPLEXES; BOND-CLEAVAGE; (1)
density functional calculations; P ligands; phosphene; tungsten (1)
DENSITY-FUNCTIONAL CALCULATIONS; RAY-ABSORPTION SPECTROSCOPY; PHOSPHINIDENE COMPLEXES; ELECTRONIC-STRUCTURE; TERMINAL PHOSPHIDE; SHIELDING TENSORS; TRIPLE BOND; REGULAR APPROXIMATION; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; (1)
DENSITY FUNCTIONAL INVESTIGATIONS; FERROMAGNETIC PEROVSKITE BIMNO3; ELECTRONIC-STRUCTURE; GIANT MAGNETORESISTANCE; NEUTRON METHODS; JAHN-TELLER; X-RAY; OXIDES; EXCHANGE; MANGANITE; density functional theory; local spin density functional; half metallic ferromagnets; antiferromagnets; ternary manganese oxides (1)
DENSITY-FUNCTIONAL THEORY; AB-INITIO; BARE BORON; RHOMBOHEDRAL BORON; COMPLEX MATERIALS; CRYSTAL-STRUCTURE; ELEMENTAL BORON; CLUSTERS; NANOTUBES; TRANSITION; (1)
DENSITY-FUNCTIONAL THEORY; ARABIDOPSIS; SPECTRA; DISSOCIATION; CHROMOPHORE; POTENTIALS; MECHANISM; PROTEIN; INDOLE; PLANTS; (1)
DENSITY-FUNCTIONAL THEORY; ASYMMETRIC CATALYSIS; HYDROGEN-BONDS; KINETIC RESOLUTION; BRONSTED ACIDS; ORGANOCATALYSIS; ACTIVATION; DONORS; AMINES; IONS; alkylation; anions; anion acceptors; nitrogen heterocycles; organocatalysis (1)
Density functional theory (B3LYP, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); CASSCF; Charge transfer state; Cluster model; Dipole moment; Electron density; Lennard-Jones potential; Localized electronic state; Solvatochromism; Vibronic transition (charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); Fluorescence (dual, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); Molecular structure (optimized, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); fluorescence CT pyrrolylbenzonitrile phenylpyrrole cryogenic matrix (1)
DENSITY-FUNCTIONAL THEORY; BASIS-SET CONVERGENCE; AC-GLY-NHME; AB-INITIO; FORCE-FIELD; GAS-PHASE; GLYCINE DIPEPTIDES; PROTEIN STRUCTURES; N-METHYLFORMAMIDE; CHEMICAL-EXCHANGE; conformation analysis; density functional calculations; peptides; protein folding; protein structures (1)
DENSITY-FUNCTIONAL-THEORY; BENZENE DIMER; NONCOVALENT INTERACTIONS; ELECTRONIC-PROPERTIES; CATION-BINDING; TIGHT-BINDING; STACKING; ENERGIES; DNA; STABILIZATION; (1)
density functional theory calculations; Pb surfaces; stepped surfaces; vibrational spectrum; water structure (1)
DENSITY-FUNCTIONAL-THEORY; D-PI-A; HIGH-EFFICIENCY; HARTREE-FOCK; SOLVATION; MOLECULES; Dye-sensitized solar cell; Organic dye; Aggregation effects; Optical spectrum; Electronic coupling (1)
density functional theory, electronic transport, Kohn–Sham, single molecule (1)
DENSITY-FUNCTIONAL THEORY; EXCHANGE-CORRELATION-ENERGY; COULOMB ENERGIES; LIMIT; ACCURATE; Density functional theory; Lieb-Oxford bound; exchange-correlation functionals; electronic correlation (1)
DENSITY-FUNCTIONAL-THEORY; EXCITATION-ENERGY TRANSFER; PERYLENE BISIMIDE DYE; TIGHT-BINDING METHOD; STATE PROPERTIES; COMPLEX MATERIALS; RESPONSE THEORY; APPROXIMATION; SIMULATIONS; POTENTIALS; (1)
DENSITY-FUNCTIONAL THEORY; EXCITED-STATE DYNAMICS; BASIS-SETS; PROTON-TRANSFER; ENERGY; ACTIVATION; SYMMETRY; EXCHANGE; PHOTOCHEMISTRY; APPROXIMATION (1)
DENSITY-FUNCTIONAL THEORY; FRANCK-CONDON BLOCKADE; CONTROLLED QUANTUM INTERFERENCE; CURRENT-VOLTAGE CHARACTERISTICS; LANGMUIR-BLODGETT MONOLAYER; CURRENT-INDUCED FORCES; CHARGE-TRANSPORT; JUNCTION CONDUCTANCE; LENGTH DEPENDENCE; BREAK JUNCTION; (1)
DENSITY-FUNCTIONAL THEORY; GAUSSIAN-BASIS SETS; NONCOVALENT INTERACTIONS; HYDROGEN-BONDS; MOLECULAR CALCULATIONS; MAGNETIC-RESONANCE; PHOSPHINE OXIDES; PARAMETERS; COMPLEXES; ACIDITY; (1)
DENSITY-FUNCTIONAL THEORY; INDUCED STRUCTURAL-CHANGES; TRANSFER EXCITED-STATES; SPECTROSCOPIC CHARACTERIZATION; PROTON-TRANSFER; FAD-PROTEIN; AB-INITIO; APPA; DOMAIN; RECEPTOR; (1)
DENSITY-FUNCTIONAL THEORY; INTRAMOLECULAR CHARGE-TRANSFER; PHENOTHIAZINE-PYRENE DYADS; TRANSFER EXCITED-STATES; DONOR-ACCEPTOR ARRAYS; ELECTRON-TRANSFER; BASIS-SETS; IDENTITY APPROXIMATION; CONICAL INTERSECTIONS; OPTICAL CONTROL; (1)
DENSITY-FUNCTIONAL THEORY; LEVEL-CORRELATED CALCULATIONS; POLARIZED BASIS-SETS; CONFIGURATION-INTERACTION; STATIC POLARIZABILITIES; DIELECTRIC-CONSTANT; PERTURBATION; CARBON; IMPLEMENTATION; ENERGIES; (1)
DENSITY-FUNCTIONAL THEORY; LITHIUM ORGANOCUPRATE CLUSTERS; VAN-DER-WAALS; DOT-H-B; EXPERIMENTAL ELECTRON-DENSITY; BOUND HOMOMOLECULAR DIMERS; TRANSITION-METAL CENTERS; ZETA-VALENCE QUALITY; C-H; AB-INITIO; (1)
DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATION; TRIMETHYLAMINE-N-OXIDE; INTERACTION SITE MODEL; INTEGRAL-EQUATION THEORY; SPACE GAUSSIAN PSEUDOPOTENTIALS; NONUNIFORM POLYATOMIC SYSTEMS; TERT-BUTYL ALCOHOL; HYDROSTATIC-PRESSURE; QUANTUM-CHEMISTRY; (1)
DENSITY-FUNCTIONAL THEORY; NEGATIVE DIFFERENTIAL RESISTANCE; ELECTRON-TUNNELING SPECTROSCOPY; FRANCK-CONDON BLOCKADE; CURRENT-INDUCED FORCES; SPIN-ORBIT TORQUE; SINGLE-MOLECULE; CHARGE-TRANSPORT; 1ST-PRINCIPLES CALCULATIONS; RENORMALIZATION-GROUP; (1)
DENSITY-FUNCTIONAL THEORY; PROTEIN-KINASE; ORGANIC-MOLECULES; PK(A) PREDICTION; POTENT; DISCOVERY; MUSCLE; Glycogen synthase kinase-3 beta; 7-chloro-9H-pyrimido[4; 5-b]indole; protein kinase; kinase inhibitor; tofacitinib (1)
DENSITY-FUNCTIONAL THEORY; RANDOM-PHASE-APPROXIMATION; LOCALIZED WANNIER FUNCTIONS; CONSISTENT-FIELD THEORY; LONG-RANGE INTERACTIONS; DER-WAALS INTERACTIONS; AB-INITIO CALCULATIONS; NMR CHEMICAL-SHIFTS; PARTICLE MESH EWALD; PLANE-WAVES SCHEME; (1)
DENSITY-FUNCTIONAL THEORY; STEPWISE PROTONATION CONSTANTS; SOLVATION FREE-ENERGIES; COMPUTATIONAL DETERMINATION; BRIDGEHEAD DERIVATIVES; SOLVOLYSIS RATES; PREDICTION; MOLECULES; HYDROLYSIS; EQUILIBRIA; (1)
DENSITY-FUNCTIONAL THEORY; STRONG-INTERACTION LIMIT; EXCHANGE-CORRELATION-ENERGY; (1)
DENSITY-FUNCTIONAL THEORY; STRONG-INTERACTION LIMIT; PERTURBATION-THEORY; CORRELATION-ENERGY; ELECTRON-DENSITIES; EXCHANGE; 2ND-ORDER; COULOMB; SYSTEMS; CONSTANT; (1)
DENSITY-FUNCTIONAL THEORY; THIN-LAYER; DIFFUSION CONDITIONS; HARTREE-FOCK; STABILIZATION; SYSTEMS; SPECTRA; CELL; quinones; electrochemistry; FTIR spectroelectrochemistry; cell design; density functional calculations (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING; COMPLEX MATERIALS; STATE; Time dependent density functional theory; Quantum transport; Molecular electronics; DFTB (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING METHOD; EXCITED-STATES; EXCHANGE; SIMULATIONS; MOLECULES; ENERGIES; INSIGHTS; HYDROGEN; (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING METHOD; MOLECULAR JUNCTIONS; LOGIC GATES; TRANSPORT; SIMULATIONS; AU(111); DEVICES; WIRES; C-60; (1)
; Density functional tight-binding (DFTB); line defects; MoS2; non-equilibrium Green's function (NEGF) (1)
DENSITY; LATTICE; (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; HOST-MODULATION; INFLAMMATION; PROTECTION; EZETIMIBE; TARGETS; STATINS; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors; PCSK9 inhibitors; periodontitis (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; COMMERCIAL IMMUNOTURBIDIMETRIC ASSAY; TANGIER-DISEASE; REFERENCE INTERVALS; PLASMA; ABC1; MUTATIONS; CLONING; ATP-binding cassette I; coronary heart disease; high density lipoproteins; Tangier disease (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; BINDING CASSETTE TRANSPORTER-1; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSGENIC MICE; HDL CHOLESTEROL; TANGIER-DISEASE; GENE; COMMON; VARIANTS; ABCA1; cardiovascular disease; genetics; polymorphisms; risk factors; stroke (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; HDL CHOLESTEROL; LOW-FREQUENCY; BLOOD-LIPIDS; VEGF-B; METAANALYSIS; PLASMA; CONSUMPTION; INDIVIDUALS; alcohol consumption; cholesterol; gene-environment interactions; gene-lifestyle interactions; genome-wide association studies; lipids; triglycerides (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; LDL-CHOLESTEROL; BLOOD-PRESSURE; MENDELIAN RANDOMIZATION; CARDIOVASCULAR-DISEASE; METAANALYSIS; EFFICACY; THERAPY; SAFETY; LDL cholesterol; Dyslipidemia; Hypercholesterolemia; Cardiovascular risk; Statin intolerance (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; GERMAN HEALTH INTERVIEW; BLOOD-PRESSURE; ADULTS; OLDER; ASSOCIATION; PREVALENCE; MANAGEMENT; MORTALITY; COHORT; LDL-cholesterol; HbA1c; blood pressure; estimated glomerular filtration rate; urine albumin to creatinine ratio; elderly population (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; NICOTINIC-ACID RECEPTOR; DRUG-DRUG INTERACTION; ABSORPTION INHIBITOR EZETIMIBE; STATIN-ASSOCIATED MYOPATHY; COA REDUCTASE INHIBITORS; HUMAN CYTOCHROME-P450 3A; P-GLYCOPROTEIN; CLINICAL PHARMACOKINETICS; CORONARY ATHEROSCLEROSIS; cholesterol-lowering therapy; drug-drug interaction; pharmacogenetics; pharmacokinetics (1)
DENSITY-LIPOPROTEIN; CHOLESTEROL; RESPONSES; RATS; MECHANISMS; EXPOSURE; STEROIDOGENESIS; SENSITIZATION; HABITUATION; PARADIGM; Adrenal cortex; chronic subordinate colony housing; cholesterol; chronic psychosocial stress; HPA axis; scavenger receptor class B type 1 (1)
DENSITY-LIPOPROTEIN DEFICIENCY; CHOLESTEROL EFFLUX; CLUSTER; FAMILY; REARRANGEMENT; INVERSION; SEQUENCE; COMMON; Tangier disease; ABCA1; large deletion; double deletions; missense mutation; Walker A (1)
DENSITY-LIPOPROTEIN DEFICIENCY; CHOLESTEROL-LOADED MACROPHAGES; CASSETTE TRANSPORTER A1; TANGIER-DISEASE; X-RECEPTOR; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; MESSENGER-RNA; LIPID EFFLUX; EXPRESSION; ATP binding cassette transporter A1; ELISA; carotid plaques (1)
DENSITY-LIPOPROTEIN DEFICIENCY; Tangier disease; cortical opacification; corneal sensation; confocal microscopy (1)
DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; GENERAL-POPULATION; HEART-DISEASE; GENETIC-VARIANTS; MUTATIONS; LDL; CHOLESTEROL; DIAGNOSIS; NETHERLANDS; (1)
DENSITY-LIPOPROTEIN RECEPTOR; MDR1 P-GLYCOPROTEIN; CHOLESTEROL ABSORPTION; TANGIER-DISEASE; PLASMA-MEMBRANE; SR-BI; MICE; GENE; DEFICIENCY; HUMANS; (1)
DENSITY-LIPOPROTEIN RECEPTOR; SR-BI; METABOLIC SYNDROME; OBESE MICE; HDL; EXPRESSION; STEATOHEPATITIS; ATHEROSCLEROSIS; OVEREXPRESSION; ADIPOCYTOKINES; Adipokine; Liver steatosis; Fibrosis; Dyslipidemia (1)
DENSITY-LIPOPROTEIN; SERUM; DISEASE; paraoxonase; real-time fluorescence genotyping; single nucleotide polymorphisms (1)
DENSITY-MATRIX; ELECTRONS; MODEL; BLOCK; SPINS; (1)
DENSITY-MATRIX; MODEL; BLOCK; CHAIN; spin chains; ladders and planes (theory); entanglement in extended quantum systems (theory) (1)
DENSITY-OF-STATES; (1)
DENSITY-OF-STATES; HGTE; (1)
DENSITY; SETS; (1)
DENTAL AMALGAM; INDOOR AIR; MERCURY; POLLUTANTS; BLOOD; CONTAMINATION; PERFORMANCE; POPULATION; ROUEN; DUST; Arsenic; Human biomonitoring; Mercury; Museum collections; Occupational exposure; Organochlorine pesticides (1)
DENTAL ARCH; CLINICAL-APPLICATIONS; ACCURATE APPROACH; FORM; CONCORDANCE; RATIO; Individualised diagnostics; Orthodontic diagnostics; Anterior arch length; Cast analysis; Polynomial models (1)
; dental bonding; scanning electron microscopy; self-adhesive resin cements; SEM evaluation (1)
DENTAL-CARIES; BIOLOGICAL PATHWAYS; CANDIDATE GENES; ASSOCIATION; IMPACT; MARKERS; Genetics; Dental caries; Oral Health; Quality of Life (1)
dental caries, parathyroid hormone, polymorphism, single nucleotid polymorphism, children (1)
dental caries, prevention, alternative restorative material, WHO, risk assessment, recycling, dental amalgam (1)
dental ceramics, polish, wear simulation (1)
DENTAL CERAMICS; STRENGTH; ENAMEL; RESTORATIONS; TOUGHNESS; MICROLEAKAGE; FATIGUE; CEMENT; (1)
DENTAL COMPOSITE; OPTICAL-PROPERTIES; LEACHABLE COMPONENTS; CURING UNITS; ELUTION; POLYMERIZATION; RESISTANCE; CONVERSION; MONOMERS; RESINS; Light curing units; Resin-based composite; Hardness; Indentation modulus; Cell viability (1)
dental composites, Filtek Silorane, Hermes Flow, shearbondstrength, Adhesivesystem (1)
DENTAL COMPOSITES; MECHANICAL-PROPERTIES; PHOSPHATE/METHACRYLATE COMPOSITES; INTERFEROMETRY; RESTORATIONS; CONTRACTION; SURVIVAL; AMALGAM; HYBRID; (1)
dental dilacerations, dental anomaly, dental development, genes, oral cleft (1)
dentale Follikel-Vorläuferzellen, DLX3, osteogene Differenzierung, WNT-Signalweg, NOTCH-Signalweg (1)
Dentale Follikelzellen; Proteinkinase C; PKC; Osteogene Differenzierung (1)
DENTAL ENAMEL; IN-VITRO; CARIES; WATER; DEMINERALIZATION; MECHANISM; (1)
DENTAL FOLLICLE CELLS; ADIPOGENIC DIFFERENTIATION; STROMAL CELLS; PRECURSOR CELLS; IDENTIFICATION; BMP-2; Adipose tissue stem cells; BMP-signaling; WNT3A-signaling; Osteogenic differentiation (1)
DENTAL FOLLICLE CELLS; HUMAN BONE-MARROW; IN-VITRO; PERIODONTAL-LIGAMENT; PRECURSOR CELLS; STROMAL CELLS; PULP; DIFFERENTIATION; TEETH; TISSUES; stem cells; tissue engineering; differentiation; stem cell marker; implantology (1)
DENTAL FOLLICLE CELLS; IN-VITRO; ODONTOBLASTS; INTERPLAY; DYNAMICS; Stem cells from human exfoliated; deciduous teeth; Stiffness; PDMS; Differentiation; Proliferation (1)
DENTAL FOLLICLE CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; PRECURSOR CELLS; GENE-EXPRESSION; Dental follicle cells; ECM proteins; Osteogenic differentiation; FAK/ERK signalling pathway (1)
; Dental follicle cells; Osteogenic differentiation; Mineralization; Protein kinase C; Akt; NF-kappa B; Canonical Wnt signaling; beta-catenin (1)
dental follicle cells; osteogenic differentiation; signaling pathways; tooth development; tooth eruption (1)
dental follicle cells, scaffoldfree approach, ligamentogenic differentiation, tissue engineering (1)
Dental follicle cells, Senescence, Bone-morphogenetic-protein 2, Collagen 1, Alkaline phosphatase (1)
Dental follicle; Dental stem cells; Senescence; Osteogenic differentiation (1)
DENTAL FOLLICLE PRECURSOR; DIFFERENTIATION IN-VITRO; NEURAL STEM-CELLS; PROGENITOR CELLS; MULLER CELLS; IDENTIFICATION; REPLACEMENT; INHIBITOR; PROTEIN; GROWTH; Dental follicle cells; Phosphoproteomics; Neural differentiation; Focal adhesion kinase (1)
Dentalimplantate, Biofilm, Titan, Zirkoniumdioxid, Zirkon, Streptococcus sanguinis, Staphylococcus epidermidis, Rauheit, Hydrophobizität, initiale Biofilmbildung (1)
DENTAL IMPLANTS; CLINICAL-EVALUATION; ORAL REHABILITATION; IRRADIATED PATIENTS; ENDOSTEAL IMPLANTS; RADIOTHERAPY; CONSENSUS; CRITERIA; THERAPY; Head and neck cancer; Radiotherapy; Implants; Survival; Success; Bone resorption (1)
DENTAL IMPLANTS; CLINICAL-EVALUATION; OSSEOINTEGRATED IMPLANTS; SURVIVAL; RADIOTHERAPY; THERAPY; BONE; RECONSTRUCTION; RESECTION; SURGERY; dose; head and neck cancer; implant‐ specific; modulated; radiotherapy; success (1)
DENTAL IMPLANTS; CLINICAL-PERFORMANCE; FRACTURE-RESISTANCE; TITANIUM IMPLANTS; CERAMIC CROWNS; MAXILLA; SOFT; RESTORATION; OUTCOMES; SYSTEMS; biomaterials; ceramic implants; titanium; two-piece implants; zirconia (1)
DENTAL IMPLANTS; POLYETHERETHERKETONE; TITANIUM; PEEK; Bond; Veneering; Conditioning (1)
Dentalkeramik, Empress2, Cercon, RelyX Unicem, adhäsive Befestigung (1)
Dentalkeramik , Inlay , Rissbildung , Kavitätenpräparation , Cerec 3 , Cerec 3 , crack formation (1)
DENTAL PROSTHESES FDPS; SINGLE CROWNS; PARTIAL DENTURES; LITHIUM DISILICATE; CERAMIC CROWNS; FOLLOW-UP; SURVIVAL; METAL; RATES; ANTERIOR; Zirconia; All-ceramic; Monolithic; Survival; Temporomandibular disorder; Wear-resistance (1)
Dental prosthesis design, Digital Dentistry, Crown design software, Preparation design (1)
Dental Pulp, Dentin, 3D Printing, Fibroblasts, Materials Test (1)
dental pulp | heat-shock proteins | inflammation | interleukin- 6 | Streptococcus mutans | transcriptome (1)
dental pulp, immunity, pulpitis, inflammation, dentin, dental caries, cytokines, chemokines (1)
dental pulp; odontoblast; tertiary dentine; immune response; carious lesion; pulpitis (1)
Dental Pulp Stem Cells, Human Amniotic Epithelial Stem Cells, Pulp Regeneration, Dentine Matrix Proteins, Pulparegeneration (1)
DENTAL RESIN COMPOSITES; LEACHABLE COMPONENTS; BIS-GMA; HPLC ANALYSIS; IN-VITRO; GINGIVAL FIBROBLASTS; OXIDATIVE STRESS; HUMAN EXPOSURE; INDOOR DUST; BULK-FILL; materials testing; dental materials; indirect composite; urethane dimethacrylate; bisphenol A; bisphenol A-glycidyl methacrylate (1)
DENTAL RESIN MONOMERS; GLUTATHIONE DEPLETION; GINGIVAL FIBROBLASTS; 2-HYDROXYETHYL METHACRYLATE; INDUCED APOPTOSIS; ROS PRODUCTION; CYCLE ARREST; TEGDMA; CELLS; CYSTEINE; TEGDMA; Dental monomers; Cytotoxicity; N-acetylcysteine (1)
DENTAL RESIN MONOMERS; IN-VITRO; ULTRAFINE PARTICLES; PROTEIN ADSORPTION; TEMPERATURE RISE; HUMAN PULP; COMPOSITES; CELLS; TOXICITY; RELEASE; Clinical risk assessment; Dentin barrier test; Pulp healing; Antibacterial subtances (1)
DENTAL RESTORATIVE MATERIALS; FILLER VOLUME FRACTION; BOND STRENGTH; RESISTANCE; POLYMERIZATION; PERFORMANCE; MECHANISMS; SIMULATORS; CONVERSION; ABRASION; Resin-based composite; Experimental materials; In vitro wear resistance; Profilometry (1)
DENTAL RESTORATIVE MATERIALS; HUMAN GINGIVAL FIBROBLASTS; HUMAN ORAL CELLS; IN-VITRO; LEACHABLE COMPONENTS; 2-HYDROXYETHYL METHACRYLATE; 2,3-EPOXYMETHACRYLIC ACID; OXIDATIVE STRESS; DNA-DAMAGE; MONOMERS; Native saliva; Protein binding; Plasma proteins; Elution; Composite components (1)
dental stem cells; lipidomics; metabolism; protein kinase C (1)
DENTAL VARIATION; BRACKETS; ORTHODONTICS; POPULATIONS; 3D analysis; extraoral scan; lingual brackets; lingual surface; morphological variations; orthodontics (1)
DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; EARLY EXPERIENCE; PRENATAL STRESS; MATERNAL-CARE; FEMALE RATS; STIMULATION; AGE; BEHAVIOR; BrdU; enriched environment; mouse; neonatal handling; progenitor cells; stem cells (1)
DENTATE GYRUS; OLFACTORY-BULB; APOPTOSIS; PROLIFERATION; NEURONS; HIPPOCAMPUS; neural stem cells; neurogenesis; apoptosis; bromodeoxyuridine; subventricular zone; olfactory bulb; hippocampus (1)
Dentin, autologe Wachstumsfaktoren, regenerative Endodontie, Ultraschallansätze, transforming growth factor- ß1, Revitalisierung, dentale Stammzellen, Spüllösungen (1)
DENTIN BARRIER TEST; CYTO-TOXICITY; GLASS-IONOMER; INVITRO; CEMENTS; PULP; (1)
Dentin Bonding Agent, Dental Caries, Self-etch, Total-etch, Fracture mode (1)
Dentin, Desinfektion, Enterococcus faecalis, artifizielle Infektion, NaOCl, CHX, disinfection, artificial infection, in vitro (1)
Dentine bonding agent · Dental caries · Self-etch · Total etch · Fracture mode (1)
Dentinmatrixproteine, TGF-ß1, Endodontie, dentin matrix proteins, endodontics, Cell-Homing (1)
DENTIN MATRIX PROTEINS; SV40-MEDIATED IMMORTALIZATION; REPLICATIVE SENESCENCE; TELOMERASE ACTIVATION; HUMAN FIBROBLASTS; STEM-CELLS; SIALOPROTEIN; LINES; BONE; GENE; characterization; human pulp cells; immortalization; SV40 T-Ag (1)
DENTIN; microleakage; marginal integrity; cement (1)
Dentin; Pulp; Regeneration; Tissue engineering; Regenerative medicine (1)
DENTIN; SURFACE; AGENTS; Self-adhesive cement; Alloy-based restorations; Prospective clinical study; Zinc phosphate cement (1)
Denture base · Denture tooth · TCML · Aging · 3D printing · Milling · CAD/CAM · Denture · Bonding (1)
Denture base material, Auto-curing, Milling, Three-dimensional printing, Artificial aging, Surface properties (1)
DENTURE BASE; RESIDUAL MONOMER; HEAT-TREATMENTS; COMPOSITES; RESINS; RESISTANCE; POLYMERS; LEVEL; (1)
DENTURE STOMATITIS; PERFORMANCE; RETENTION; PROTOCOLS; chemical cleansing; chewing simulation; Novaloc (R); polyaryl ether ketone; polyether ether ketone; retention force (1)
DENTURES; veneer; double crown; removable denture (1)
deoxygenation, natural product synthesis, catalysis (1)
Deoxyribonucleic acid formation (by neoplasm, platinum-peptide ester complexes inhibition of, neoplasm inhibition in relation to) Deoxyribonucleic acids Role: PRP (Properties) (interaction of, with platinum-peptide ester complexes, neoplasm inhibition in relation to) Neoplasm inhibitors (platinum-peptide ester complexes) Molecular structure-biological activity relationship (neoplasm-inhibiting, of platinum-peptide ester complexes) antitumor platinum peptide complex structure antitumor activity platinum complex (1)
Deoxyribonucleic acid formation (inhibition of, of human mammary carcinoma, by platinum complexes of diaminoethanes) Neoplasm inhibitors (carcinoma, platinum complexes of diaminoethanes as, in human mammary gland) Mammary gland (neoplasm, carcinoma, treatment of, with platinum complexes of diaminoethanes, in human) aminoethane platinum complex prepn antitumor (1)
DEOXYXYLULOSE PHOSPHATE-PATHWAY; CELL-RECEPTOR-GAMMA; NONPEPTIDE ANTIGENS; NONMEVALONATE PATHWAY; BIOSYNTHETIC-PATHWAY; MEVALONATE PATHWAY; ESCHERICHIA-COLI; GENOME SEQUENCE; DELTA CELLS; PYROPHOSPHATE; deoxyxylulose phosphate; gamma delta T-cell activation; 1-hydroxy-2-methyl-but-2-enyl 4-diphosphate; isoprenoid biosynthesis (1)
Deoxyxylulose phosphate-pathway non-mevalonate pathway isoprenoid biosynthesis nonmevalonate pathway infectious-disease terpenoid biosynthesis 4fe-4s protein gene-cluster lytb protein enzyme (1)
DEPENDENT AGGREGATION BEHAVIOR; DENSELY PACKED MONODISPERSE; SENSITIVE LIPOSOMES; AQUEOUS MIXTURES; PHASE-BEHAVIOR; UNILAMELLAR VESICLES; GEL PHASE; SURFACTANTS; DELIVERY; MICELLE; (1)
DEPENDENT ANION CHANNEL; RED-BLOOD-CELLS; CHLORIDE CHANNELS; PLASMA-MEMBRANE; CFTR; EXPRESSION; REGULATOR; LAEVIS; VOLUME; TRANSPORT; CFTR; hydrolysis; hemolysis; gadolinium (1)
DEPENDENT AUXIN GRADIENTS; REPRODUCTIVE DEVELOPMENT; ENDOSPERM DEVELOPMENT; ARABIDOPSIS; CYTOKININ; TRANSPORT; ENCODES; GROWTH; ORGANOGENESIS; INFLORESCENCE; auxin; cytokinin; DR5; embryo patterning; endosperm development; PINFORMED1 (PIN1); two-component system (ICS); Zea mays (1)
DEPENDENT CELLULAR CYTOTOXICITY; MESENCHYMAL TRANSITION; ANTI-HER2 ANTIBODY; IMMUNE ESCAPE; FC-RECEPTORS; THERAPY; HER2; CHEMOTHERAPY; CARCINOMA; MECHANISM; (1)
DEPENDENT CELLULAR CYTOTOXICITY; NATURAL-KILLER-CELLS; IN-VIVO; MONOCLONAL-ANTIBODIES; BREAST-CANCER; NK-CELL; GROWTH; IL-15; MOUSE; HIV-1; humanized tumor mice; immune-based therapies; breast cancer; NK cells; ADCC (1)
DEPENDENT CUSHINGS-SYNDROME; DIFFERENTIAL-DIAGNOSIS; PITUITARY; Hypercortisolism; Cushing's disease; Inferior petrosal vein sampling (1)
DEPENDENT ELECTRIC-FIELD; DAMPED 2-STATE SYSTEM; SPIN-BOSON SYSTEM; STRUCTURED ENVIRONMENT; SUPERCONDUCTING QUBIT; TUNNELING DYNAMICS; QUANTUM DYNAMICS; DRIVEN; STATES; TIME; (1)
DEPENDENT ELECTRON TRANSMISSION; MOLECULES; SELECTIVITY; (1)
DEPENDENT HYPERTENSION; AORTIC ENDOTHELIUM; GENE-EXPRESSION; ANGIOTENSIN-II; IN-VIVO; MOUSE; ARTERIOLES; PRESSURE; VASODILATION; ASSOCIATION; aorta; connexins; endothelial cells; hypertension; kidney; myocytes, smooth muscle; renin (1)
DEPENDENT HYPERTENSIVE-RATS; ANGIOTENSIN-SYSTEM; MESSENGER-RNA; TUBULAR RENIN; EXPRESSION; MICE; MOUSE; TRANSCRIPTION; KIDNEY; ENHANCEMENT; renin; kidney development (1)
DEPENDENT K+ CHANNEL; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; T1 DOMAIN; INACTIVATION; MEMBRANE; SUBUNIT; STATE; (1)
DEPENDENT KINASE INHIBITORS; INTRINSICALLY UNSTRUCTURED PROTEINS; QUANTITATIVE PCR DATA; GAMETOPHYTE DEVELOPMENT; RETINOBLASTOMA PROTEIN; POLLEN DEVELOPMENT; MALE GAMETOGENESIS; PROLIFERATION; DIVISION; EXPRESSION; (1)
DEPENDENT KINASE INHIBITORS; SIMPLE INDOLE ALKALOIDS; C-H ARYLATION; 2,3-DISUBSTITUTED INDOLES; BIOLOGICAL EVALUATION; PHOTOREDOX CATALYSIS; ALPHA-BROMOCHALCONES; METAL-FREE; CYCLIZATION; DERIVATIVES; (1)
DEPENDENT MEMORY; EPISODIC MEMORY; RECOLLECTION; RECOGNITION; RETRIEVAL; STIMULI; RECALL; BRAIN; EVENT; episodic memory; context-dependent memory; environmental context change; memory development; cognitive development (1)
DEPENDENT PERTURBATION-THEORY; 2-PHOTON DOUBLE-IONIZATION; NONSEQUENTIAL DOUBLE-IONIZATION; 2-ELECTRON ATOMS; CONFIGURATION-INTERACTION; HYDROGENIC THRESHOLDS; AUTOIONIZATION STATES; RESONANCE PARAMETERS; QUANTUM-SYSTEMS; CROSS-SECTIONS; Atomic spectra; Helium; Autoionization; Resonances; Two-electron atoms; Spectral methods (1)
DEPENDENT PROBE AMPLIFICATION; GENOME-WIDE ASSOCIATION; 4TH COMPONENT; RISK-FACTORS; 2 PARTS; SUSCEPTIBILITY; DISEASE; VARIANTS; POLYMORPHISMS; PATHOGENESIS; Age-related macular degeneration; AMD; C4; Complement; Copy number variation (CNV); Multiallelic; Genetic association (1)
DEPENDENT PROTEIN-KINASE; ANTHRACIS EDEMA FACTOR; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; BACULOVIRUS SYSTEM; GUANYLYL CYCLASE; CANCER CELLS; I-BETA; CGMP; IRAG; (1)
DEPENDENT PROTEIN-KINASE; BETA(2) ADRENERGIC-RECEPTOR; FORMING NADPH OXIDASE; CYCLIC-AMP; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; COUPLED RECEPTORS; ADENYLATE-CYCLASE; OXIDATIVE BURST; ACTIVATION; (1)
DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; SMALL-RNA; POSTTRANSCRIPTIONAL REGULATION; G-ALPHA(S) PATHWAY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENE; RISC; DEGRADATION (1)
DEPENDENT PROTEIN-KINASE; CARDIAC-HYPERTROPHY; MICRORNAS; FISSION; FUSION; DRP1; PHOSPHORYLATION; TRANSLOCATION; INHIBITION; EXPRESSION; (1)
DEPENDENT PROTEIN-KINASE; HEART-FAILURE; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; IN-VIVO; TRANSCRIPTIONAL PATHWAYS; HISTONE DEACETYLASE-4; BINDING PROTEINS; MICE; MYOCYTES; calcineurin; CaMKII; cardiac hypertrophy; heart failure; signal transduction (1)
DEPENDENT PROTEIN-KINASE; MYOSIN-BINDING SUBUNIT; CGMP KINASE; BLOOD-PRESSURE; I-ALPHA; SIGNALING COMPLEX; LEUCINE-ZIPPER; SUBSTRATE IRAG; PKGI-ALPHA; CELLS; Inositol trisphosphate receptor-associated cGMP kinase I substrate; Nitric oxide; Atrial natriuretic peptide; cGMP-dependent protein kinase I; Smooth muscle relaxation (2)
DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; BLOOD-PRESSURE; CYCLIC-GMP; DEFICIENT MICE; IRAG; RELAXATION; RECEPTOR; BETA; PHOSPHATASE; cGMP kinase isozymes; PKG; nitric oxide; smooth muscle; blood pressure (1)
DEPENDENT PROTEIN-KINASE; RECEPTOR; AGGREGATION; JAW1; cGKI; cGMP; IP3R; IRAG; IRAG1; IRAG2; Jaw1; LRMP; phosphorylation; PKGI; platelet aggregation; platelets (1)
DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE RELAXATION; CYTIDYLATE CYCLASE; BACULOVIRUS SYSTEM; MAMMALIAN-TISSUES; MONOPHOSPHATE; EXPRESSION; IRAG; 5'-MONOPHOSPHATE; VASORELAXATION; cCMP; cGMP; Cyclic nucleotide; Signal transduction; Smooth muscle; Platelet (1)
DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLYL CYCLASE; CYCLIC-GMP; BLOOD-PRESSURE; CRYSTAL-STRUCTURE; COMMON VARIANTS; PULMONARY-HYPERTENSION; NATRIURETIC-PEPTIDE; CARDIAC-HYPERTROPHY; HYDROGEN-SULFIDE; cGMP; Guanylyl cyclases; Guanylate cyclases; cGMP-dependent protein kinase; sGC stimulator; sGC activator; Natriuretic peptides; Pulmonary hypertension (1)
DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; LIGHT-CHAIN PHOSPHATASE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GTPASE-ACTIVATING PROTEIN; CA2+-ACTIVATED K+ CHANNEL; BLOOD-PRESSURE REGULATION; CYSTEINE-RICH PROTEIN-2; LEUCINE-ZIPPER MOTIF; LIM-ONLY PROTEIN; inositol trisphosphate receptor-associated guanosine 3 ',5 '-cyclic monophosphate-kinase substrate substrate; nitric oxide; guanosine 3 ',5 '-cyclic monophosphate-dependent protein kinase (1)
DEPENDENT PROTEIN-KINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; LIGHT-CHAIN PHOSPHORYLATION; NITRIC-OXIDE; CYCLIC-GMP; CGMP KINASE; GASTRIC FUNDUS; RAT AORTA; MYOSIN PHOSPHATASE; GUANYLYL CYCLASE; Fundus; Relaxation; NANC; Nitric oxide; cGMP (1)
DEPENDENT PROTEIN-KINASE; VERY-KIND; DENDRITE GROWTH; EXCHANGE FACTOR; MICROTUBULE; CAPPUCCINO; ACTIVATION; SUBUNIT; GTPASES; OOCYTE; (1)
DEPENDENT RADICAL ENZYME; ACETYL-COA CARBOXYLASE; S-ADENOSYLMETHIONINE; PLASMA-MEMBRANE; PYRUVATE-CARBOXYLASE; SCAFFOLD PROTEINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SCHIZOSACCHAROMYCES-POMBE; IN-VIVO; (1)
DEPENDENT SCHRODINGER-EQUATION; RUNGE-KUTTA METHODS; DIFFERENTIAL-EQUATIONS; NUMERICAL-INTEGRATION; LASER; PHYSICS; HELIUM; STIFF; (1)
DEPENDENT SCHRODINGER-EQUATION; SURFACE PHOTOCHEMISTRY; QUANTUM DYNAMICS; PHOTODESORPTION; DIFFRACTION; RELAXATION; EXCITATION; MOLECULES; AMMONIA; (1)
DEPENDENT ULCERATIVE-COLITIS; CROHNS-DISEASE; CONTROLLED-TRIAL; CORTICOSTEROID-THERAPY; ORAL METHOTREXATE; AZATHIOPRINE; INFLIXIMAB; REMISSION; 6-MERCAPTOPURINE; MULTICENTER; Vidofludimus; Ulcerative colitis; Crohn's disease; IBD; Clinical trial (1)
DEPRESSED OLDER-ADULTS; LATE-LIFE DEPRESSION; PRIMARY-CARE; PSYCHIATRIC-TREATMENT; SOCIAL DISTANCE; ATTITUDES; HEALTH; PEOPLE; METAANALYSIS; RECOGNITION; Age-period-cohort; psychotherapy in old age (1)
DEPRESSION (1)
Depression, affektive Störung, Kognition, Neuropsychologie, Kognitionspsychologie, Fahrtauglichkeit, Fahreignung, Fahrprobe, Fahrverhaltensprobe, Verkehrspsychologie, Aufmerksamkeitsfunktionen, kognitive Beeinträchtigungen, affective disorder, cognition, neuropsychology, cognitive psychology, driving performance, psychometric performance, fitness to drive, cognitive impairment, driving ability, driving test (1)
DEPRESSION; ANXIETY; NEUROTICISM; INVENTORY; SEVERITY; RELEVANT; SYMPTOMS; (1)
Depression, depressive Episode, Müdigkeit, Fatigue, Tagesschläfrigkeit, Hypersomnolenz, Schlafstörung, Schlafapnoe, Epworth Schläfrigkeitsskala, ESS, Fatigue Schwereskala, FSS (1)
Depression, electroconvulsive therapy, brain-derived neurotrophic factor, functional magnetic resonance imaging, inflammation (1)
; depression; e-mail; consultation; destigmatization; Internet (1)
DEPRESSION-LIKE BEHAVIOR; TRAIT ANXIETY; MOUSE MODEL; GLUCOCORTICOID-RECEPTOR; EXPRESSING NEURONS; PANIC DISORDER; MESSENGER-RNA; GLYOXALASE-I; RATS; AMYGDALA; anxiety; basolateral amygdala; fear; paraventricular nucleus; promoter fragmentation (1)
DEPRESSION-LIKE BEHAVIOR; VASOPRESSIN RELEASE; NUCLEUS-ACCUMBENS; EARLY DEPRIVATION; POSTPARTUM; CARE; PUPS; ALTERS; MOTHER; MECHANISMS; maternal separation; medial preoptic area; oxytocin receptor; passive stress-coping behavior; prelimbic cortex (1)
DEPRESSION; MANAGEMENT; IMPACT; LIFE; PAIN; qualitative analysis; fracture-related infection; emotional impact; psychological resources; multidisciplinary management (1)
depression, mental health, sport, exercise, prevention, treatment (1)
Depression, mitochondria, antidepressant resistance, mitochondriopathy, iPSC, neurons, astrocytes (1)
depression, music therapy, meta-analysis, neuropsychology, psychosomatic medicine, neurophysiology, anxiety, stress (1)
Depression, narcolepsy, cataplexy, daytime sleepiness (1)
DEPRESSION-RELATED BEHAVIOR; CHRONIC SOCIAL STRESS; ANIMAL-MODELS; STRAIN DIFFERENCES; MICE; RECEPTOR; DESPAIR; DRUGS; IMIPRAMINE; IMMOBILITY; (1)
; depression; self-esteem; cognitive behavioural group therapy (1)
depression; sleep deprivation; relapse; repetitive transcranial magnetic stimulation (1)
Depression; Therapieeffekte; Erfolgsfurcht; Misserfolgserwartung; Leistungsmotivation (1)
Depressive disorder, contrast sensitivity, dopamine, schizophrenia (1)
DEPRESSIVE-DISORDERS; MIGRANT WOMEN; DOUBLE-BLIND; HEALTH-CARE; PSYCHOTHERAPY; SOMATIZATION; CULTURE; AGGRESSION; TOPIRAMATE; SYMPTOMS; immigrants; chronic somatoform disorders; anger; bioenergetic exercises; body-oriented psychotherapy (1)
Depressive disorders; sleep; adolescence; cortisol; amylase (1)
DEPRESSIVE-LIKE BEHAVIORS; CHRONIC MILD STRESS; NEUROBEHAVIORAL CHANGES; FECAL MICROBIOTA; BRAIN; ANXIETY; OBESITY; MOUSE; GLP-1; RESISTANCE; Depression; diet; intestinal microbiota; obesity; leptin; gut hormones; peptide YY; depression-like behavior (1)
DEPRESSIVE MOOD REACTIONS; ACHIEVEMENT-MOTIVATION; VULNERABILITY; PERFORMANCE; COMPONENTS; STUDENTS; MODEL; test emotions; test anxiety; Test Emotions Questionnaire; learning; academic achievement (1)
DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; GERMANY; ASTHMA; SEVERITY; DETERMINANTS; METAANALYSIS; POPULATION; PREVALENCE; IMPACT; Chronic obstructive pulmonary disease (COPD); determinants; health-related quality of life (HRQOL); Short-Form 12 ( SF-12) (1)
DEPRESSIVE SYMPTOMS; YOUNG-PEOPLE; HELP-SEEKING; CHILDREN; PREVENTION; DISORDERS; INTERVENTIONS; ASSOCIATION; PREVALENCE; STUDENTS; Adolescents; Mental health problems; Risk behaviours; School-based screening; Service use (1)
DEPRESSOR ANGULI ORIS; ZYGOMATICUS MAJOR MUSCLE; QUANTITATIVE ULTRASONOGRAPHY; PERFORATOR FLAP; NEURAL ANATOMY; BELLS-PALSY; NERVE; MANAGEMENT; RECONSTRUCTION; Depressor Anguli Oris; zygomaticus major; high-resolution ultrasound; facial reanimation; synkinesis; natural smile; facial surgery; facial symmetry; facial palsy; smile restoration (1)
DEPRIVATION; INHIBITOR; cMyc; natural killer cell; metabolism; polyamines; SREBP (1)
DEPRIVATION; RECOGNITION; EXPRESSIONS; RESIDENTS; RESPONSES; VALENCE; BRAIN; Sleep deprivation; Emotion processing; Facial EMG (1)
DEPTH-SENSING MICROINDENTATION; TOOTH-COLORED RESTORATIVES; COMPOSITE RESTORATIONS; AMALGAM RESTORATIONS; SURFACE HARDNESS; FLUORIDE RELEASE; POSTERIOR TEETH; WEAR-RESISTANCE; PERMANENT TEETH; CEMENTS; Clinical study; Glass ionomer cement; Retrospective; Class I; Class II (1)
de Rham realization of the polylogarithm, universal vectorial extension, Poincaré bundle, elliptic curves (1)
DERIVATIVE CHROMOPHORES; ELECTROOPTICS; PHOTOPOLYMERS; FLUORESCENCE; (1)
DERIVATIVES (1)
derivatives pricing, embedded decisions, acceptance sets, time consistency, transaction costs, early exercise, discrete hedging, American option, good-deal bounds, utility indifference pricing, utility-based pricing, marginal pricing, shadow pricing, hedging, continuous time finance, exchange-traded commodities, commodities, pricing, financial innovation, pricing efficiency (1)
DERIVATIVES; TRANSFORMATIONS; 1,2,4-Triazoles; Alkylation; Regioselectivity; Single-crystal X-ray diffraction (1)
DERIVING ATOMIC CHARGES; ELECTROSTATIC POTENTIALS; INTERFACIAL COMPOSITIONS; ASSOCIATION COLLOIDS; ARENEDIAZONIUM SALTS; FORCE-FIELD; BASIS-SETS; AB-INITIO; DENSITY; MECHANISM; (1)
DERMAL DENDRITIC CELLS; IMMUNE-RESPONSES; LANGERHANS CELLS; NEEDLE-FREE; T-CELLS; VACCINATION; IMMUNIZATION; EXPRESSION; ADJUVANT; DELIVERY; Skin penetration; Hair follicle; Antigen delivery; Transcutaneous vaccination; Nanoparticles (1)
dermale Fibrose, Keratinozytenwachstumsfaktor, c-jun (1)
DERMAL SHEEP COLLAGENS; ARTICULAR-CARTILAGE DEFECTS; IN-VITRO; CONTRACTILE BEHAVIOR; GAG MATRICES; CANINE CHONDROCYTES; PHYSICAL-PROPERTIES; LINKING TREATMENTS; CELLS; CARBODIIMIDE; crosslinking; collagen; tissue engineering; DSC; degradation; mechanical properties (1)
DERMATITIS IMPACT SCALE; INITIAL VALIDATION; QUALITY; INSTRUMENTS; INFANTS; ECZEMA; INDEX; (1)
DERMATITIS IMPACT SCALE; PATIENT-REPORTED OUTCOMES; ATOPIC-DERMATITIS; METHODOLOGICAL QUALITY; COSMIN CHECKLIST; INDEX CDLQI; INTERNATIONAL DEVELOPMENT; CLINICAL-APPLICATION; INITIAL VALIDATION; SWEDISH CHILDREN; (1)
DERMATOLOGISTS; MELANOMA; ALGORITHMS; dermatology; artificial intelligence; label noise; skin cancer; melanoma; nevi (1)
DER-WAALS COMPLEXES; JET SPECTROSCOPY; NANODROPLETS; ANTHRACENE; MOLECULES; CLUSTERS; FLUORESCENCE; SOLVATION; DYNAMICS; ATOMS; (1)
DER-WAALS COMPLEXES; KOHN-SHAM ORBITALS; BASIS-SETS; BASE-PAIRS; VAN; GEOMETRIES; ACCURACY; MODEL; DIMER; MP2; (1)
DER-WAALS COMPLEXES; SUPERFLUID-HELIUM; LIQUID-HELIUM; AROMATIC-MOLECULES; DROPLETS; SPECTROSCOPY; CLUSTERS; VAN; SOLVATION; ATOMS; (1)
DER-WAALS HETEROSTRUCTURES; FEW-LAYER RES2; MONOLAYER MOS2; DIODES; HETEROJUNCTION; TRANSISTORS; CRYSTALS; MODES; ReS2; band gap transition; photoemission spectroscopy; GW band structure calculations; van der Waals materials (1)
DER-WAALS HETEROSTRUCTURES; HGTE QUANTUM-WELLS; TRANSITION; SURFACE; SPINTRONICS; METAL; SEMICONDUCTOR; DEVICES; BANDGAP; STATE; (1)
DER-WAALS HETEROSTRUCTURES; MONOLAYER; EXCITONS; STACKING; (1)
DER-WAALS HETEROSTRUCTURES; PHASE-TRANSITIONS; 1T-TAS2; MONOLAYER; PSEUDOPOTENTIALS; STATE; PURE; charge density wave; proximity effects; spin-orbit coupling; exchange coupling; graphene; van der Waals heterostructures; transition metal dichalcogenides (1)
DER-WAALS HETEROSTRUCTURES; QUANTUM TRANSPORT; CRYSTALS; (1)
DER-WAALS HETEROSTRUCTURES; RAMAN-SCATTERING; MONOLAYER MOS2; moire phonons; moire superlattice; Raman scattering; transition-metal dichalcogenides; interlayer excitons (1)
DER-WAALS HETEROSTRUCTURES; SINGLE-LAYER MOS2; MONOLAYER WSE2; SEMICONDUCTOR; WS2; PHOTOLUMINESCENCE; HETEROJUNCTIONS; TRANSITIONS; GRAPHITE; CRYSTALS; (1)
DER-WAALS HETEROSTRUCTURES; TRANSITION-METAL DICHALCOGENIDES; MONOLAYER MOS2; ENERGY-TRANSFER; 2-DIMENSIONAL MATERIALS; CHARGE-TRANSFER; VALLEY POLARIZATION; TUNGSTEN DISULFIDE; ELECTRIC-FIELD; LAYER MOS2; (1)
DER-WAALS INTERACTIONS; ADAPTED PERTURBATION-THEORY; MOLECULAR TORSION BALANCE; INTERMOLECULAR INTERACTIONS; FREE-ENERGIES; AROMATIC STACKING; REFRACTIVE-INDEX; SCREENING MODEL; SOLVATION; CHEMISTRY; aprotic solvents; dispersion forces; molecular recognition; non-covalent interactions; solvent effects (1)
DER-WAALS INTERACTIONS; SURFACE-TENSION; PHOSPHOLIPID-BILAYERS; AQUEOUS-SOLUTIONS; ELECTROLYTES; HYDRATION; FORCES; SPECIFICITY; PERMEATION; POTENTIALS; (1)
DER-WAALS RADII; COORDINATION POLYMERS; ARGENTOPHILIC INTERACTIONS; SUPRAMOLECULAR STRUCTURES; BONDING RELATIONSHIPS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; BUILDING-BLOCKS; BASIS-SETS; DESIGN; Antimony; Argentophilic Interactions; Self-Assembly; Silver; Weakly Coordination Anions (1)
DESCENT; COMPLEXES; (1)
DESCENT; DEFECATION; defecography; magnetic resonance imaging; pelvic floor; enterocele (1)
DESERT ANTS; DECISION-MAKING; PUBLIC INFORMATION; MELOPHORUS-BAGOTI; PATH-INTEGRATION; TRAIL PHEROMONES; SEARCH BEHAVIOR; VISUAL CUES; ORIENTATION; COMMUNICATION; Route learning; Information conflict; Private information; Odour learning (1)
DESERT ANTS; LASIUS-NIGER; PATH-INTEGRATION; OLFACTORY MEMORY; TRAIL PHEROMONES; BLOCKING; NAVIGATION; HONEYBEES; BEHAVIOR; SEARCH; Episodic memory; Ant; Cognition; Route learning; Navigation; Cue integration (1)
DESICCATION-SENSITIVITY; STORAGE BEHAVIOR; TROPICAL FOREST; RECALCITRANT SEEDS; ECOLOGICAL ASPECTS; SIZE; GERMINATION; PATTERNS; TOLERANCE; MASS; altitudinal gradient; climate change; ecophysiology; Himalayas; monsoon; seed desiccation; seed dispersal; seed germination ecology; tree (1)
DESIGN; Biosamples; Cohort study; MRI; Quality assurance; Response proportion (1)
Design Decision, Integrity Constraint, Heuristic Rule, Database Design, Cardinality Constraint (1)
design methodology, evaluation, technology development (1)
Design Patterns; Multimedia Information Systems; Multimedia Engineering; ISO 14915 (1)
DESIGN; PEPTIDOMIMETICS; ACIDS; peptidomimetics; peptides; heterocycles; lactams; bicyclic dipeptides; amino acids (1)
DESIGN; Realm of Maps; geomedia; map workroom; short film; cartographical story; medium means; map design; historico-geographical space; Southeast Europe; video-sharing platform (1)
DESIGNS; basket trial; Bayesian hierarchical model; error control; information borrowing; master protocol (1)
Design Science, Pattern, Evaluation, Business Process, Business Process Improvement (1)
DESIGN SCIENCE RESEARCH; MULTINOMIAL NAIVE BAYES; SENTIMENT ANALYSIS; BIG DATA; METHODOLOGY; ANALYTICS; CLASSIFICATION; CHALLENGES; KNOWLEDGE; USABILITY; Social media analysis; Sentiment analysis; Classification; Mixed method approach (1)
DESIGN SCIENCE RESEARCH; SOCIAL MEDIA; INFORMATION; PRODUCT; COMMUNITIES; PLATFORMS; CREATION; NETNOGRAPHY; PERSPECTIVE; ANATOMY; Lead user; Innovation process; Digital platforms (1)
DESIGN SCIENCE RESEARCH; SYSTEMS; MODELS; MANAGEMENT; READINESS; SEARCH; VIEW; Maturity model; Capabilities; Continuous maturity assessment; Maturity appraisal (1)
DESIGN SCIENCE; SECURITY; API; design principles; IAM; IdM; RBAC; REST; SCIM (1)
DESIGN SCIENCE; TRUST; ATTACKS; EBAY; Trust; reputation systems; Information security; Visual analytics (1)
Design Space, Living Room, Explore Design Space, Neighbourhood Relationship, User Interpretation (1)
DESIGN; STATE (1)
Design Thinking, Designthinking, Innovation management, Innovatiosmanagement, Innovationsprozesse, Innovationsprozess, Innovation process, Case study research, (1)
Design Thinking; Prototyping; Mensch-Maschine-Interaktion; Usability Engineering; Designprozesse; Designwissen; Software Engineering; Sehen und Verstehen (1)
DESIGN; VARIABILITY; BEHAVIOR; MODELS; control charts; design optimization; ecological momentary assessments; intraindividual studies (1)
desmoid, tumor,nirogacestat,therapy,sarcoma (1)
DESMOPLASTIC MALIGNANT-MELANOMA; ANTITUMOR IMMUNE-RESPONSE; ACQUIRED-RESISTANCE; ACTIVATION PROTEIN; PD-L1 EXPRESSION; CANCER; GROWTH; CELLS; MATRIX-METALLOPROTEINASE-9; OPPORTUNITIES; (1)
DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RAPID DETECTION; PSEUDOMONAS-SPP.; CARBA; RESISTANCE; TESTS; ANTIBIOTICS; PERFORMANCE; IMIPENEM; Ambler class; carbapenemases; Enterobacterales; phenotypic testing (1)
DESQUAMATIVE INTERSTITIAL PNEUMONIA; RESPIRATORY BRONCHIOLITIS; SMOKING; DISEASES; Nicotine abuse; Desquamative interstitial pneumonia (DIP); Smoking-related interstitial lung disease (SR-ILD) (1)
DESULFOARCULUS-BAARSII; DESULFOVIBRIO-VULGARIS; TREPONEMA-PALLIDUM; ACTIVE-SITE; ARCHAEOGLOBUS-FULGIDUS; PYROCOCCUS-FURIOSUS; PULSE-RADIOLYSIS; RUBREDOXIN OXIDOREDUCTASE; OXYGEN DETOXIFICATION; PROTEIN; superoxide reductase; neelaredoxin; desulfoferrodoxin; Nanoarchaeum; detoxification (1)
DESULFOARCULUS-BAARSII; IGNICOCCUS-HOSPITALIS; TREPONEMA-PALLIDUM; CRYSTAL-STRUCTURE; MECHANISM; NEELAREDOXIN; DISMUTASE; ARCHAEA; (1)
DESULFOVIBRIO-DESULFURICANS ATCC-27774; NONHEME IRON PROTEIN; RBO GENE-PRODUCT; ESCHERICHIA-COLI; GIGAS; RUBREDOXIN; DISMUTASE; DESULFOFERRODOXIN; DESULFOREDOXIN; PURIFICATION; (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; DISSIMILATORY SULFITE REDUCTASE; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; HMC OPERON; RESPIRATION; SEQUENCE; SUBUNIT; CLONING; Archaeoglobus fulgidus; heterodisulfide reductase; Hmc complex; iron-sulfur proteins; sulfate-reducing bacteria (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; ESCHERICHIA-COLI HEMOFLAVOPROTEIN; SULFATE-REDUCING PROKARYOTES; IRON-SULFUR CLUSTER; PROSTHETIC GROUPS; HETERODISULFIDE REDUCTASE; DESULFURICANS ESSEX; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; DIFFRACTION DATA; dissimilatory sulfate reduction; sulfite reductase; siroheme; molecular evolution (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; OXIDATION-REDUCTION POTENTIALS; ELECTRON SPIN RESONANCE; AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; METAL-COMPLEXES; SELECTIVE RECOGNITION; STACKING INTERACTIONS; CYCLIC VOLTAMMETRY; CRYSTAL-STRUCTURES; enzyme models; macrocycles; electron transfer; molecular recognition; electrochemistry (1)
DESYNCHRONIZING BRAIN-STIMULATION; AUDITORY PHANTOM PERCEPTION; RESIDUAL INHIBITION FUNCTIONS; NEURAL ACTIVITY; HEARING-LOSS; THALAMOCORTICAL DYSRHYTHMIA; SUBTHALAMIC NUCLEUS; THRESHOLD SHIFT; SYSTEMS; CORTEX; Alpha band activity; Coordinated reset neuromodulation; Delta band activity; Electroencephalography; Gamma band activity (1)
DETECTED MAGNETIC-RESONANCE; EXCITED-STATE PROPERTIES; LIGHT-EMITTING MATERIALS; LYING ELECTRONIC STATES; TIME-RESOLVED SPECTRA; TRIPLET-STATE; HIGH-EFFICIENCY; ELECTROPHOSPHORESCENT DEVICES; TEMPERATURE-DEPENDENCE; CHARGE-TRANSFER; organic light-emitting diodes; phosphorescence; platinum; Schiff bases; triplet state (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING DEVICES; ELECTRONIC STATES; CHARGE-TRANSFER; IR(III) COMPLEXES; PT(II) COMPOUNDS; TRIPLET-STATE; SPECTROSCOPY; RELAXATION; (2,2'-BIPYRIDINE)IRIDIUM(III); (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; CONJUGATED POLYMER; BETA-PHASE; ORGANIC SEMICONDUCTORS; CHARGE SEPARATION; OPTICAL DETECTION; MEH-PPV; ELECTROLUMINESCENCE; PHOTOPHYSICS; (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; CONJUGATED POLYMER; FILMS; (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; HIGH-FIELD; TRIPLET EMITTERS; THIN-FILMS; SPECTROSCOPY; EPR; DEVICES; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); TRANSPORT; (1)
DETECTED MAGNETIC-RESONANCE; ORGANIC SPINTRONICS; C-60; PHOTOCONDUCTION; SEMICONDUCTORS; POLYMER; (1)
DETECTED MAGNETIC-RESONANCE; TIME-RESOLVED SPECTRA; EXCITED-STATES; ELECTRONIC STATES; CHARGE-TRANSFER; CRYSTAL-STRUCTURE; HIGH-PRESSURE; EMISSION; PLATINUM(II); SPECTROSCOPY; spin-lattice relaxation; zero-field splitting; direct process; Orbach process; Raman process; transition metal complexes; electron-phonon coupling; Shpol'skii matrices; pt(2-thpy)(2); Pt(2-thpy)(CO)(Cl); pt(phpy)(2); metal organic platinum compounds (1)
DETECTING COLORECTAL POLYPS; CONTRAST BARIUM ENEMA; EXTRACOLONIC FINDINGS; ADVANCED NEOPLASIA; PRIMARY 2D; COLONOGRAPHY; METAANALYSIS; CONSENSUS; PERFORMANCE; EXPERIENCE; (1)
detection of phosphate, fluorescence, NIR (1)
DETECTOR; HETEROSTRUCTURES; MOBILITY; STRESS; (1)
DETECTORS; (1)
DETECTORS; ratchet effect; metal-oxide-semiconductor field-effect-transistors; high-frequency transport (1)
DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; YEAST; TRANSPORT; PROTEINS; MICRODOMAINS; POLARIZATION; ARABIDOPSIS; Confocal microscopy; plasma membrane; raft-like micro domains (1)
detergent-resistant membranes; monocytes; flow cytometry; receptor cluster (1)
DETERMINANT; (1)
determinant functor, K-theory, exact category, Waldhausen category, triangulated category, Grothendieck derivator (1)
DETERMINANTS; ADHERENCE; FRAMEWORK; WORKERS; Hand hygiene; Observed behavior; TPB; HAPA; TDF (1)
Determinismus; Europa; Freiheit; Neurowissenschaften; Philosophie; Pluralistische Gesellschaft; Religiöser Pluralismus; Theologie; Willensfreiheit (1)
DEUTERON FORM-FACTOR; SIN(2) THETA(W); CROSS-SECTIONS; PARTON MODEL; SMALL-X; PHYSICS; NUTEV; ASYMMETRY; SYMMETRY; BEHAVIOR; (1)
DEUTERON STRUCTURE FUNCTIONS; TO-LEADING ORDER; HIGH STATISTICS MEASUREMENT; XF(3) STRUCTURE-FUNCTION; QCD ANALYSIS; MUON SCATTERING; HIGH-X; QUANTUM CHROMODYNAMICS; ELECTRON-SCATTERING; ASYMPTOTIC FREEDOM; (1)
Deutsch als Zweitsprache; DaZ; frühkindliche Mehrsprachigkeit, Sprachförderung; Elementarbereich (1)
Deutsch als Zweitsprache - Sprachförderung - Migration - Lehramtsausbildung - Mehrsprachigkeit (1)
Deutsche Minderheit, Ungarn, Mitteleuropa, Geschichte, Kultur, Tradition (3)
Deutsch: epitheliale mesenchymale Transition (EMT), kolorektale Lebermetastasen, kolorektales Karzinom, Tumormikromilieu, E-Cadherin, fibröse Kapsel, PCR-Array, Immunhistochemie, Wnt Pathway, Englisch: epithelial to mesenchymal transition (EMT), colorectal liver metastasis, colorectal carcinoma, tumor microenvironment, E-Cadherin, Wnt Pathway, fibrous capsule, PCR array, immunohistochemistry (1)
Deutsche Sprache; Sprachgeschichte; Bedeutungsübertragung; Namenforschung (1)
DEUTSCH-JOZSA ALGORITHM; COMPUTATION; STATES; NMR; COMPUTER; IMPLEMENTATION; SUPERPOSITION; QUBIT; (1)
DEUTSCH-JOZSA ALGORITHM; SEARCH ALGORITHM; COMPUTATION; IMPLEMENTATION; COMPUTER; UNIVERSAL; GATES; (1)
Deutschland (14)
Deutschland <DDR> / Nationale Volksarmee , Nationale Volksarmee , DDR , Militärreform , NVA , Wiedervereinigung , National People's Army , GDR , "Military Reform" , NPA , reunification (1)
Deutschland / Opferrechtsreformgesetz , Adhäsionsprozess , Täter-Opfer-Ausgleich , Schadensersatz , Strafverfahren , , adhesive procedure , criminal law , compensation , victim's law (1)
Deutschland; Osteuropa; Zuwanderung; Integration; Landeskundekurs; Sprachkurs (1)
deutsch: Multiple Sklerose, Peptid, T-Zellen, Vitamin D; englisch: Multiple sclerosis, peptide, T cells, Vitamin D (1)
Deutschunterricht ; Schreib- und Lesefähigkeit ; Schulleistungsmessung ; Schülerbeurteilung ; Förderung (1)
Deutschunterricht ; Unterrichtsplanung ; Vorbereitungsdienst (2)
Deutschunterricht ; Unterrichtsplanung ; Vorbereitungsdienst, kompetenzorientierter Deutschunterricht, kognitive Aktivierung, Aufgabenentwicklung, Unterrichtsplanung, Lernziele, Kompetenzaufbau, Diagnose und Förderung, Feedback und Leistungsbewertung, fachdidaktische Methoden, Referendariat, Lehramtsstudium, Unterrichtsreflexion (1)
DEVELOPING KIDNEY; EMBRYONIC KIDNEY; ORGAN-CULTURE; CELLS; (1)
DEVELOPING RAT-BRAIN; CRITICALLY-ILL CHILDREN; NEURONS IN-VITRO; INDUCED APOPTOTIC NEURODEGENERATION; POSTOPERATIVE BEHAVIORAL OUTCOMES; KETAMINE-INDUCED NEUROAPOPTOSIS; MEDIAL PREFRONTAL CORTEX; PEDIATRIC INTENSIVE-CARE; CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; Neurons; Neurodegeneration; Brain; Learning; Behavior (1)
DEVELOPING RAT-BRAIN; CULTURED HIPPOCAMPAL-NEURONS; APOPTOTIC NEURODEGENERATION; NETWORK OSCILLATIONS; EARLY EXPOSURE; CALCIUM WAVES; CELL-DEATH; KETAMINE; DEFICITS; NEWBORN; Benzodiazepines; GABA(A) receptor; Neurotoxicity; Neuronal differentiation (1)
DEVELOPING RAT-BRAIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; SPONTANEOUS CA2+-OSCILLATIONS; APOPTOTIC NEURODEGENERATION; NETWORK OSCILLATIONS; GABAERGIC NEURONS; EARLY EXPOSURE; CELL-DEATH; KETAMINE; (1)
DEVELOPING RHEUMATOID-ARTHRITIS; ALCOHOL-CONSUMPTION; B-CELLS; HELPER-CELLS; BONE LOSS; DIFFERENTIATION; IL-21; RISK; EXPRESSION; BCL6; (1)
DEVELOPMENTAL COORDINATION DISORDER; METHYLPHENIDATE RITALIN; DIAGNOSTIC-CRITERIA; ADHD; COMORBIDITY; PERFORMANCE; MEDICATION; PATTERNS; methylphenidate; automated movements; stimulant medication (1)
DEVELOPMENTAL COORDINATION DISORDER; SCHOOL-AGE-CHILDREN; DEFICIT/HYPERACTIVITY DISORDER; SUSTAINED ATTENTION; MOTOR CONTROL; OVERFLOW MOVEMENTS; ACTIVITY LEVEL; SUBTLE SIGNS; ADHD; METHYLPHENIDATE; ADHD; attention and NSS (1)
DEVELOPMENTAL-DISABILITIES; INTELLECTUAL DISABILITY; LEARNING-DISABILITIES; CARE COORDINATION; DUAL DIAGNOSIS; INPATIENT CARE; HEAVY USERS; ADULTS; PEOPLE; DISORDERS; mental retardation; psychiatric hospital; psychiatry (1)
Developmental dyslexia; Visual attention; Processing speed; Spatial bias; Whole-report; Partial-report (1)
developmental dyslexia, visual attention, processing speed, visual short term memory, spatial bias, top–down control, whole- and partial-report task (1)
DEVELOPMENTAL DYSPLASIA; NEONATAL HIP; CONGENITAL DISLOCATION; RISK-FACTORS; PAVLIK HARNESS; ULTRASOUND; DIAGNOSIS; INSTABILITY; SONOGRAPHY; MANAGEMENT; Pediatric orthopedics; Hip dysplasia; Newborn hip luxation; Open hip reduction; Treatment algorithm (1)
DEVELOPMENTAL ENDOTHELIAL LOCUS-1; POPULATION; VARIANTS; RARE; ASSOCIATION; PREVALENCE; GENETICS; PROTEIN; GROWTH; MUTATION; Subarachnoid hemorrhage; Intracranial aneurysms; Disease gene identification; Exome sequencing; EDIL3 (1)
developmental pediatrics; mental health; child and adolescent psychiatry; convention on the rights of the child; article 24-the rights of the child; sleep; vigilance; disruptive behaviors (1)
DEVELOPMENTAL PLASTICITY; EVOLUTION; HYMENOPTERA; DIMORPHISM; CASTE; EXPRESSION; QUEENS; MARGIN; LARVAE; CUT; ants; phenotypic plasticity; wing development (1)
Development; Chicken; Primary auditory neurones; Cochlear ganglion; Auditory physiology; Bird (1)
DEVELOPMENT COST ESTIMATION; REAL OPTIONS; INFORMATION-TECHNOLOGY; MEAN REVERSION; DEVELOPMENT-PROJECTS; SOFTWARE; INVESTMENT; MANAGEMENT; RISK; UNCERTAINTY; Make-or-buy decisions; Web services; Real option theory; Sell option; Web service market (1)
Development; Maturation; Cochlear nucleus morphology; Somal growth (1)
Development; Maturation; Deprivation; Deafness; Cochlear nucleus morphology (1)
DEVELOPMENT SUBSIDIES; KNOWLEDGE SPILLOVERS; EMPIRICAL-EVIDENCE; TECHNOLOGY; PATENTS; PERFORMANCE; INCENTIVES; RESOURCES; LESSONS; POLICY; Public policy, R&D funding; Innovation; Renewable energy (1)
DEVICE-RELATED INFECTION; CLUMPING FACTOR-A; IN-VITRO; CAPSULAR POLYSACCHARIDE; REDUCED VIRULENCE; STRAIN NEWMAN; EFFLUX PUMP; BINDING; PATHOGENESIS; DAPTOMYCIN; (1)
DEVICES; (1)
DEVICES; POLARIZATION; SPINTRONICS; RESISTANCE; INJECTION; DIODE; gallium arsenide; nonlocal resistance; spin Hall effect; spin injection (1)
; Dexamethasone; glucocorticoid; aneurysm; subarachnoid hemorrhage; inflammation; clinical trail (1)
DEXAMETHASONE-SUPPRESSION TEST; CORTICOTROPIN-RELEASING-FACTOR; DELAYED SLEEP PHASE; GABA-A RECEPTOR; NEUROACTIVE STEROIDS; CEREBROSPINAL-FLUID; TOURETTES-SYNDROME; SUCCESSFUL AUGMENTATION; FLUOXETINE TREATMENT; ANXIETY DISORDERS; Obsessive-compulsive disorder (OCD); Circadian rhythm; Hormone dysregulation; Delayed sleep phase; Agomelatine; Chronotherapy (1)
DEXPRAMIPEXOLE; EMPOWER; DISEASE; MODEL; ALS; (1)
dexterity | factor structure | fine motor skills | graphomotor skills | writing (1)
DEXTRAN SODIUM-SULFATE; DSS-INDUCED COLITIS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; CELL-PROLIFERATION; TUMOR-METASTASIS; CROHNS-DISEASE; BOWEL-DISEASE; BETA-CATENIN; AZOXYMETHANE; Azoxymethane; chronic psychosocial stress; colitis; colorectal cancer; inflammation; regulatory T cells (1)
DEXTRAN SULFATE SODIUM; CD4(+) T-CELLS; INTERLEUKIN 10-DEFICIENT MICE; NORMAL LUMINAL BACTERIA; IFN-GAMMA PRODUCTION; NF-KAPPA-B; EXPERIMENTAL COLITIS; EPITHELIAL-CELLS; INTERFERON-GAMMA; MURINE COLITIS; (1)
DEXTRAN SULFATE SODIUM; CHRONIC PSYCHOSOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; COTTON-TOP TAMARIN; PHYSICAL HEALTH CONSEQUENCES; COLONIC EPITHELIAL BARRIER; CHRONIC ULCERATIVE-COLITIS; INTIMATE PARTNER VIOLENCE; ANXIETY-RELATED BEHAVIOR; CELL-MEDIATED-IMMUNITY; Chronic psychosocial stress; HPA axis; Corticosterone; Colitis; IBD; Glucocorticoids; Colonic barrier function (1)
DEXTRAN SULFATE SODIUM; HLA-B27 TRANSGENIC RATS; EXPERIMENTAL ULCERATIVE-COLITIS; CHRONIC INTESTINAL INFLAMMATION; ACTIVE CROHNS-DISEASE; CONTROLLED TRIAL; INTERLEUKIN-10-DEFICIENT MICE; IMMUNODEFICIENT MICE; IL-2-DEFICIENT MICE; DEFICIENT MICE; (1)
DEXTRAN SULFATE SODIUM; INFLAMMATORY BOWEL-DISEASE; ULCERATIVE-COLITIS; ENDOGENOUS GLUCOCORTICOIDS; INTERFERON-GAMMA; ACUTE STRESS; PLUS-MAZE; MICE; RAT; INTERLEUKIN-10; adrenal insufficiency; chronic psycho-social stress; colitis; corticosterone; chronic subordinate colony (CSC) housing; inflammation (1)
DEXTRAN SULFATE SODIUM; TUMOR-NECROSIS-FACTOR; ENTERIC NERVOUS-SYSTEM; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; HUMAN-MONOCYTES; SUBSTANCE-P; SYNOVIAL TISSUE; INDUCED COLITIS; BOWEL-DISEASE; (1)
DFT • Ab initio • Charge density • Topological analysis (1)
DFTB, approximate DFT, range-separated hybrid functionals, delocalization problem, bond-length alternation, fundamental gap, static polarizability, polarons (1)
DFT, neutron diffraction, XRD, solid state (1)
DFT-Rechnungen; Eisen; Metallocene; Phosphor; Polyphosphorliganden (1)
D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; METHANOGENIC BACTERIA; SP-NOV; ARCHAEON; RNA; DATABASE; REVEALS; SYSTEM; GRAPHS; hyperthermophile; strictly anaerobic; motile; Gram-positive; chemolithoautotroph; Methanothermaceae; Euryarchaeota; GEBA (1)
Diabetes, Diabetesberatung, diabetes counseling, diabetes nursing (1)
Diabetes mellitus , Altersdiabetes , Lipoproteidstoffwechsel , , diabetes mellitus (1)
Diabetes mellitus, perkutane transluminale Koronarangioplastie (PTCA), Komplikationen, Stent (1)
Diabetes mellitus Typ 2, Diabetes Epidemiologie, Diabetische Nephropathie, Kutane Autofluoreszenz, AGE Advanced Glycation Endproducts, AGE-reader (1)
DIABETES-MELLITUS; URETERAL STONES; TISSUE-DAMAGE; RENAL INJURY; COMMINUTION EFFICIENCY; BLOOD-PRESSURE; KIDNEY; HYPERTENSION; DELIVERY; UROLITHIASIS; shock wave physics; indications; reimbursement; outpatient; inpatient (1)
DIABETIC FATTY RATS; GLUCOSE-PRODUCTION; IN-VIVO; SKELETAL-MUSCLE; PERFUSED LIVER; CONSCIOUS DOG; RESISTANCE; HYPERGLYCEMIA; ACIDS; SUPPRESSION; insulin resistance; high-fat diet; liver perfusion (1)
DIABETIC FOOT ULCERS; IN-VIVO; ANGIOGENESIS; REPAIR; VITRO; SKIN; (1)
DIABETIC MACULAR EDEMA; ADVERSE DRUG-REACTIONS; GERMAN HEALTH INTERVIEW; RETINAL VEIN OCCLUSION; CORONARY-HEART-DISEASE; GROWTH-FACTOR THERAPY; INTRAVITREAL INJECTION; SYSTEMIC SAFETY; RANIBIZUMAB; PREVALENCE; (1)
DIABETIC MACULAR EDEMA; MICROPULSE DIODE-LASER; PIGMENT EPITHELIUM; TIME REGIMEN; PHOTOCOAGULATION; RPE; AUTOFLUORESCENCE; DEGENERATION; EXPOSURE; DISEASES; RPE; laser photocoagulation; SRT; threshold determination; photoreceptors; selective retina treatment (1)
DIABETIC OB/OB MICE; GENE-EXPRESSION; SERUM LEPTIN; ADIPOSE-TISSUE; INDUCIBLE FACTOR-1; METABOLIC SYNDROME; INSULIN-SECRETION; HYPOBARIC HYPOXIA; RAT ADIPOCYTES; MESSENGER-RNA; Leptin; Insulin; Adipose tissue; Diabetes (1)
diabetische Kardiomyopathie, Salzsensitivität, metabolisches syndrom, Eplerenon, Aldosteron, kardiale Fibrosierung, diabetic cardiomyopathy, salt sensitivity, metabolic syndrome, eplerenone, aldosterone, cardiac fibrosis (1)
diabetische Nephropathie, dialysepflichtige typ 2 Diabetiker, Dialyefilter, Membranfluss, Biokompatibilität, Überleben, diabetic nephropathy, dialysis patients with diabetes type 2, dialysis membrane, membrane flux, dialyzer biocompatibility, survival (1)
Diabetische Nephropathie, Proteinurie, NMR-Spektroskopie (1)
Diabetische Nephropathie; sGC-Aktivator; Mesangialzellen (1)
diabetische Retinopathie (DRP), altersbedingte Makuladegeneration (AMD), konditionelle Defizienz des TβR2 Diabetic retinopathy (DRP), age-related maculopathy (AMD), conditional deletion of Tgfbr2 (1)
DIABODY; FORMAT; bispecific antibody; cancer immunotherapy; mCD3E; mEGFR; hinge (1)
diachronic linguistics, historical linguistics, corpus linguistics, syntax, null subjects, pro-drop, finiteness, expletive subjects, Russian, Polish, Czech (1)
DIAGNOSED MULTIPLE-MYELOMA; HIGH-DOSE CYCLOPHOSPHAMIDE; COLONY-STIMULATING FACTOR; NON-HODGKINS-LYMPHOMA; PLUS G-CSF; PROGENITOR CELLS; RANDOMIZED-TRIAL; STAGING SYSTEM; THERAPY; CHEMOTHERAPY; multiple myeloma; stem cell mobilization; stem cell transplantation; CD34 (1)
DIAGNOSES; INTERVIEWS; CIDI; diagnostic techniques; pda computers; ICD-10 (1)
DIAGNOSIS; (1)
DIAGNOSIS; Abscess-forming retroperitoneal actinomycosis; Diagnostics; Therapy; Differential diagnosis (1)
DIAGNOSIS; ALGORITHMS; Melanoma; Artificial intelligence; Diagnostics; Skin cancer (1)
DIAGNOSIS; CHILDREN; Nutcracker syndrome; Duplex ultrasound; Flank pain; Renal vein; Superior mesenteric artery (1)
DIAGNOSIS; COUNTRIES; THERAPY (2)
DIAGNOSIS; COUNTRIES; THERAPY; (1)
DIAGNOSIS; COVID-19; Corona; Pandemics; Expert systems; Epidemiology; Temperature measurement; Telephone sets; coronavirus; expert system; mobile app (1)
DIAGNOSIS; GVHD; conjunctiva; cornea; lids; ocular GvHD; patient-centred care (1)
DIAGNOSIS; MANAGEMENT; keratitis; Bartonella henselae; cat scratch disease; PCR (1)
DIAGNOSIS; RECEPTOR; FAILURE; EVENTS; NUMBER; KIM-1; ACE2; KIM-1; COVID-19; NAG; Acute kidney injury (1)
; Diagnosis Related Group; Hospitals; Length of stay; Revision surgery; Staphylococcal infections (1)
DIAGNOSIS-RELATED GROUPS; (1)
; Diagnosis-related groups (DRG); percutaneous transluminal angioplasty (PTA); cost analysis; interventional procedures (1)
DIAGNOSIS; Squamous cell carcinoma; Pyoderma gangrenosum; Chronic wound; Immunosuppression; Marjolin's ulcer (1)
DIAGNOSTIC-APPROACH; MUTATIONS; PHENOTYPE; HYPOPLASIA; SPECTRUM; INFANTS; Lissencephaly; Microcephaly; Holoprosencephaly; Pontocerebellar hypoplasia; Brain malformation (1)
DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; PICKS-DISEASE; FEATURES; DEGENERATION; CONSENSUS; (1)
DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; IGG; GUIDELINES; ALLOTYPES; VARIANTS; (1)
DIAGNOSTIC-CRITERIA; PRESSURE; ULTRASOUND; HYPERTENSION; HEADACHE; LEAKS; Spontaneous intracranial hypotension; orthostatic headaches; spinal CSF leak; spinal microsurgery; optic nerve sheath diameter; transorbital sonography; gravitational challenge (1)
DIAGNOSTIC INFERENCES; NATURAL FREQUENCIES; INFORMATION; REPRESENTATION; JUDGMENT; COVARIATION; STRATEGIES; NUMERACY; frequency net; natural frequencies; conditional probabilities; joint probabilities; Bayesian reasoning (1)
Diagnostic markers; Liver fibrosis (1)
DIAGNOSTIC NUCLEAR-MEDICINE; RADIATION-EXPOSURE; GERMANY; QUERY; nuclear medicine; radionuclide therapy; PET; PET/CT; SPECT; SPECT/CT; frequency statistics (1)
DIAGNOSTIC PERITONEAL-LAVAGE; ATTENUATION; ascites; abdominal injuries; trauma; hemorrhage; computed tomography (1)
DIAGNOSTIC REFERENCE LEVELS; NATIONAL-SURVEY; Hybrid imaging; CTDI; DLP; dose reference levels (DRL) (1)
; Diagnostic stewardship; Urinary tract infection; Reduction of antibiotics; Antibiotic resistance; microbial; Microbiome (1)
DIAGNOSTICS; Valve insufficiency; crosses; CCDS (color-coded duplex sonography); V-flow (1)
Diagnostik, Assessment, Tests, Sonderpädagogische Diagnostik, Pädagogische Diagnostik, Förderdiagnostik, Förderplanung, Assistiven Technologien, Statustests, Dynamisches Testen, Formative Diagnostik, Lernverlaufsdiagnostik, Verhaltensbeobachtung, Differenzierung, Mobile Sonderpädagogische Dienste, MSD, Rechnenlernen, Leseförderung, funktionale Diagnostik (1)
Diagnostik; Förderung; Hauptschule; Lernprozess; Kompetenzorientierung; Modularer Unterricht; Deutschunterricht; Schreibkompetenz; Modul; Modularisierung; Bayern; Deutschland (1)
Diagnostik, Inklusion, Förderschule, Kompetenzen, Lernschwierigkeiten, Förderbedarf, Unterstützungsbedarf, sonderpädagogischer Schwerpunkt Lernen, Intervention, Lernverlaufsdiagnostik (1)
Diagnostische Kompetenz, Fragebogen, Lernausgangslage, Lernschwierigkeiten, Lernverlaufsdiagnostik, Statusdiagnostik, Schulleistungsdiagnostik (1)
Diakonie; Evangelische Theologie; Flucht; Geschichte; Migration; Orthodoxe Theologie; Vertreibung (2)
Diakonie, Philanthropie, Kongress, Regensburg 2013 (2)
DIALECTICAL BEHAVIOR-THERAPY; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PERSONALITY-DISORDER; HARMING BEHAVIOR; DSM-IV; RELIABILITY; THOUGHTS; VALIDITY; ADULTS; MINI; Nonsuicidal self-injury; Randomised controlled trial; Adolescents; Psychotherapy (1)
dialectology, Bavarian, ISO 639-3:bar, dialect lexicon, crowdsourcing, social media, Facebook (1)
dialect; urban identity; city of Regensburg; language and identity; linguistic enclave; cultural memory (1)
Dialektik, dialectics, Plato, Platon, Hegel, Science of Logic, Wissenschaft der Logik, Parakonsistenz, Paraconsistency, Widerspruch, contradiction, Parmenides (1)
Dialektologie , Bairisch , Altbayern , Mundart , Verein , Mundarten-Pflege , Cultivation of dialects (1)
Dialkyldithiocarbamatethallium(I) - Luminescence - Metal-metal interaction (1)
Dialog; Dialogsystem; Sprachverarbeitung (1)
Dialogsystem; Sprachverarbeitung (1)
diamond; grinder; composite; zirconia; cutting efficiency (1)
DIAMOND-LIKE-CARBON; ATOMIC-FORCE MICROSCOPY; VACUUM-ARC; DISCHARGE METHOD; ION-BOMBARDMENT; THIN-FILMS; DEPOSITION; COATINGS; ENERGY; BEAMS; (1)
DIAMOND-LIKE-CARBON; DEPOSITION; FORCE; MICROSCOPE; WEAR; (1)
diamond-like semiconductors, lithiumsulfides, coppersulfides, silversulfides (1)
Diamond Open Access journals, Electronic Journals Library (EZB) (1)
Diamond Open Access Journals EZB CRAFT-OA (1)
DIAPHRAGM INTRAOCULAR-LENS; TRAUMATIC ANIRIDIA; RECONSTRUCTION; PROSTHESIS; APHAKIA; DEVICES; IOL; (1)
DIAPHRAGMS; PODOCYTE; SURFACE; PV-1; MECHANISMS; COMPONENT; PATHWAYS; INJURY; MOUSE; IMAGE; diabetic kidney disease; endothelial damage; PLVAP; diabetic models; glomerular hypertrophy (1)
diaphragm weakness; weaning; mechanical ventilation; ventilator-induced diaphragmatic dysfunction (1)
DIAPHYSEAL FOREARM FRACTURES; KIRSCHNER; CHILDREN; fracture-related infection; FRI; radius; K-wire; spacer (1)
DIAQUA(1,2-DIPHENYLETHYLENEDIAMINE) PLATINUM(II) SULFATES; INDUCED PROTOPORPHYRIN-IX; DNA ADDUCT FORMATION; PHOTODYNAMIC THERAPY; CISPLATIN RESISTANCE; UROTHELIAL CELLS; TUMOR; REPAIR; LINES; CARCINOMA; porphyrin-platinum complex; bladder cancer; photodynamic therapy; chemotherapy; selective accumulation (1)
DIAQUA(1,2-DIPHENYLETHYLENEDIAMINE) PLATINUM(II) SULFATES; INHIBITING PROPERTIES; ANTICANCER DRUGS; SERUM-ALBUMIN; MAJOR ADDUCT; IN-VITRO; CISPLATIN; DNA; CIS-DIAMMINEDICHLOROPLATINUM(II); CYTOTOXICITY; reactivity; inactivation kinetics; drug accumulation; anti-breast cancer activity (1)
DIAQUODIMERCURY(I) CATION; AZIDE COMPLEXES; MERCURY(I); ACETONITRILE; KINETICS; electronic spectra; mercury; catalysis; colloidal gold; amalgam (1)
DIARRHEA; COLITIS; IMPACT; Clostridium difficile infection; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Immunosuppressive therapy (1)
DIARYLETHENE DERIVATIVES; DEACETYLASE; PHOTOCYCLIZATION; RECEPTORS; AGONIST; SIRT2; (1)
DIARYLETHENE DERIVATIVES; PHOTOCHEMICAL CONTROL; INHIBITORS; LIGHT; PHOTOCYCLIZATION; MEMORIES; SWITCHES; DITHIENYLETHENES; MALEIMIDES; ANHYDRIDE; Photochromism; Photoswitches; Diarylmaleimides; Photoisomerization (1)
diarylethenes, GABA amides, cycloaddition (1)
diarylheptanoids, neuroprotection, glutamate (1)
Diarylmethanes, Stereoablation, Stereoconvergence, Antihistamines, Selenium-Catalysis (1)
diary studies, chat bot, ethnographic methods, information behavior, research methods (1)
; diaspora; emigration; Kingdom of Yugoslavia; migration policies; minorities; nation building; nationalism (1)
DIASTOLIC BLOOD-PRESSURE; ADIPOSE-TISSUE; FAT DISTRIBUTION; OBESE-PATIENTS; INSULIN-RESISTANCE; M235T POLYMORPHISM; GENETIC-VARIATION; BODY-FAT; HYPERTENSION; REDUCTION; adipose tissue; aldosterone; angiotensinogen; hypertension; obesity; renin (1)
diastolic function,exercise,isometrichandgrip,pulmonarycirculation,rightheart catheter (1)
diastolische Dysfunktion, Gewichtsreduktion, Adipositas per magna (1)
DIATOM BIOSILICA; PEPTIDES; GROWTH; MODEL; biornimetic synthesis; diatoms; nanostructures; polyarnines; silica (1)
DIATOM BIOSILICA; SILICA; DEPOSITION; PROTEINS; PEPTIDES; (1)
; diatom cell wall; NMR assignments; pleuralin; PSCD (1)
DIATOM CELL-WALLS; AMINO-ACID; BIOSILICA; POLYAMINES; PEPTIDES; bioinorganic chemistry; diatoms; mass spectrometry; proteins; silicates (1)
DIATOM CELL-WALLS; AMINO-ACID; SPICULES; TISSUES; PROTEIN; SILICA; (1)
Diatom, Haslea ostrearia - Naviculaceae - pennate, anti-HSV-1 activity - anti-HIV-1 activity - anticoagulant activity (1)
DIATOM PHAEODACTYLUM-TRICORNUTUM; CHLAMYDOMONAS-REINHARDTII CHLOROPLAST; LUCIFERASE REPORTER GENE; PROTEIN EXPRESSION; ESCHERICHIA-COLI; USAGE; TRANSFORMATION; ADAPTATION; YEAST; GFP; (1)
DIATOM THALASSIOSIRA-PSEUDONANA; BIOSILICA; MORPHOGENESIS; POLYAMINES; biomineralization; diatoms; mass spectrometry; posttranslational modifications; silaffin proteins (1)
DIATOM THALASSIOSIRA-PSEUDONANA; MORPHOGENESIS; POLYAMINES; MORPHOLOGY; BIOSILICA; (1)
Diazo compounds • Enzyme catalysis • Photocontrol • Spiro compounds • Unnatural amino acids (1)
diazo compounds · photochemistry · reaction mechanisms (1)
DICATIONS; (1)
DICATIONS; <22>ANNULENE; (1)
Dicer, Loquacious, Ago, Brat, Drosophila, Post-transcriptional gene regulation, FCCS, Single molecule pulldown (1)
Dichtefunktional , , (1)
Dichtefunktional , Nichtlineare Berechnung , Nichtlineare Absorption , Linienbreite , Ramantensor , density-functional theory , nonlinear calculation , nonlinear absorption , linewidth , Raman tensor (1)
Dichtefunktionalrechnungen; Koordinationspolymere; Phosphor; Silber; Strukturaufklärung (1)
Dichtefunktionalrechnungen; Phosphaalkine; Phosphinidenkomplexe; Phosphor; Wolfram (1)
Dichtefunktionalrechnungen; Phosphene; P-Liganden; Wolfram (1)
Dickdarmkrebs , Differentielle Genexpression , Gewebe , Ultraviolettlaser , Array , lasergesteuerte Mikrodissektion , colon carcinoma , differential gene expression , tissue , laser-mediated microdissection , array (1)
Dickkopf 3 Anti-BAFF-antibody Rat transplant model Kidney transplantation (1)
Diclofenac, Diclofenacamid, Laktat, CD4+ T-Zellen (1)
diclofenac, drug-dependent antibodies, drug-induced haemolysis, immunehaemolytic anaemia (1)
DICOM, Domain Specific Language, Medical Imaging, DQL, Query Language (1)
Dictyostelium/physiology/*radiation effects/ultrastructure *Light Movement/radiation effects Pseudopodia/*radiation effects Support, Non-U.S. Gov't (1)
Didaktik, Mathematik, Relative Häufigkeit, Wahrscheinlichkeit, Flipped Classroom, Stochatische Unabhängigkeit (1)
Diebstahl, Rechtsgut, Eigentum, Gewahrsam, Persönlichen Freiheit, Staatsbürgerliches Recht/Larceny, Legal Interest, Ownership, Possession, Personal Freedom, Civic Right (1)
- Die im Jahr 2007 implementierte AWMF S3-Leitlinie zum exokrinen Pankreaskarzinom hat zu einer häufigeren Durchführung der adjuvanten Chemotherapie beim resezierten Pankreaskarzinom in der Routineversorgung geführt - Die Rate an durchgeführten adjuvanten Chemotherapien hat sich erhöht. - Die adjuvante Chemotherapie führt in der Routineversorgung zu einer Verbesserung des Gesamtüberlebens (1)
dielec methylformamide methylacetamide DMSO acetonitrile propylene carbonate dielec relaxation amide dielec (2)
dielec permittivity lossy liq (1)
dielec permittivity trifluoromethanesulfonic acid hydrate (1)
dielec property liq mixt permittivity relaxation hydrogen bond mixt ion recombination liq mixt (1)
dielec property nonaq electrolyte soln review permittivity dielec nonaq electrolyte soln review (1)
dielec relaxation aq sodium carbonate soln (1)
dielec relaxation aq sodium potassium fluoride solvation aq sodium potassium fluoride ion pair aq sodium potassium fluoride (1)
dielec relaxation glycine water mol dynamics (1)
dielec relaxation soln mol process review (1)
dielec relaxation spectrometer electrolyte soln reflectometer time domain dielec relaxation electrolyte (1)
dielec relaxation spectroscopy electrolyte soln review (1)
dielec relaxation terahertz dynamics OKE ionic liq mesoscopic aggregation (1)
dielec relaxation water (1)
dielec spectra hydrogen bonding liq water dielec relaxation methanol dielec relaxation ethanol dielec relaxation propanol dielec relaxation (1)
dielec spectrum polar solvent ionic liq mixt chem speciation (1)
Dielectrical properties, Intracranial tumors, Glioblastom, Tumor treating fields (1)
DIELECTRIC BARRIER DISCHARGE; RESISTANT STAPHYLOCOCCUS-AUREUS; ATMOSPHERIC-PRESSURE PLASMAS; FULL-FACIAL REJUVENATION; SKIN REGENERATION; NONTHERMAL PLASMA; ESCHERICHIA-COLI; BLOOD-COAGULATION; NITRIC-OXIDE; INACTIVATION; chronic wounds; cold atmospheric plasmas; disinfection; infected ulcers; infection; microbiology; plasma medicine; sterilization (1)
DIELECTRIC-PROPERTIES; 1ST PRINCIPLES; AB-INITIO; PEROVSKITE; 1ST-PRINCIPLES; ILMENITE; CRYSTAL; PBTIO3; TRANSITION; PHASES; (1)
DIELECTRIC-RELAXATION; AQUEOUS-SOLUTION; ION ASSOCIATION; MOLAR VOLUMES; EARTH-METAL; FRICTION; N,N-DIMETHYLACETAMIDE; SPECTROSCOPY; COEFFICIENTS; DISPERSION; (1)
DIELECTRIC-RELAXATION; DYNAMICS SIMULATIONS; HYDRATION SHELLS; WATER-MOLECULES; SPECTROSCOPY; SOLVATION; MIXTURES; SODIUM; NA+; CONDUCTIVITY; Dielectric relaxation; Sodium chloride; Ion-cloud relaxation; Ion association; Ion hydration (1)
DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; DISPERSION; FRICTION; complex formation; dielectric relaxation; ion hydration; ion pairs; liquids (1)
DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; MOLECULAR-DYNAMICS; WATER-STRUCTURE; X-RAY; ASSOCIATION; DISPERSION; POTASSIUM; SOLVATION; RB+; (1)
DIELECTRIC-RELAXATION; ETHYLAMMONIUM NITRATE; ENERGY RELAXATION; WATER; SPECTROSCOPY; HYDRATION; AMMONIA; (1)
DIELECTRIC-RELAXATION; RAMAN-SCATTERING; WATER; LIQUIDS; SPECTROSCOPY; TRANSITION; DYNAMICS; IONS; PERMITTIVITY; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ACTIVE IONIC LIQUIDS; PHASE-BEHAVIOR; ALKYLTRIMETHYLAMMONIUM CHLORIDES; CATIONIC SURFACTANTS; AQUEOUS-SOLUTIONS; LOW-FREQUENCY; SALT; MICELLIZATION; THERMODYNAMICS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; AQUEOUS-ELECTROLYTE-SOLUTIONS; WATER MIXTURES; SOLVATION DYNAMICS; POLAR SOLVATION; BINARY-MIXTURES; LIQUIDS; SYSTEM; ASSOCIATION; SOLVENTS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; COIL-TO-GLOBULE; HOMOPOLYMER CHAIN; LIGHT-SCATTERING; SINGLE-CHAIN; WATER; HYDRATION; TEMPERATURE; COLLAPSE; BEHAVIOR; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; CRYSTALLINE POLY(HYDROXYMETHYL) COMPOUNDS; AQUEOUS-SOLUTIONS; CARBON-DIOXIDE; ELECTROLYTE-SOLUTIONS; HEAT-CAPACITIES; WATER; TRIS(HYDROXYMETHYL)AMINOMETHANE; CO2; 2-AMINO-2-HYDROXYMETHYL-1,3-PROPANEDIOL; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; DE-NOVO DESIGN; ELECTROLYTE-SOLUTIONS; WATER REORIENTATION; DYNAMICS; ENVIRONMENTS; ASSOCIATION; FRICTION; SYSTEMS; PROTEIN; Dielectric relaxation spectroscopy; Trifluoroacetate; Acetate; Ion hydration; Ion association; Ion-cloud relaxation (1)
Dielectric relaxation spectroscopy (DRS), alkylcarboxylates, electrolytes, aqueous solution, ion hydration, ion association, hydrophobic hydration, ion-cloud relaxation, Dielektrische Relaxationsspektroskopie, Alkylcarboxylate, Elektrolyte, wässrige Lösungen, Ionenhydratation, Ionenassoziation, hydrophobe hydratation, Ionenwolkenrelaxation (1)
Dielectric relaxation spectroscopy (DRS), choline, colloids, ion hydration, ion association, ion-cloud relaxation, Grosse’s model (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; CONCENTRATED-SOLUTIONS; PROTEIN DENATURATION; SOLVENT RELAXATION; CHLORIDE SOLUTIONS; SODIUM-CHLORIDE; 298.15 K; HYDRATION; ASSOCIATION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; MUTANS STREPTOCOCCI; COLLECTIVE DYNAMICS; WATER SOLUTIONS; HYDRATION; SORBITOL; MIXTURES; REORIENTATION; VISCOSITIES; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; VIBRATIONAL SPECTROSCOPY; REORIENTATION DYNAMICS; HOFMEISTER SERIES; HYDRATION SHELLS; WATER-STRUCTURE; ASSOCIATION; COEFFICIENTS; MULTILAYERS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; EXTENDED RISM EQUATION; ELECTROLYTE-SOLUTIONS; WATER; SOLVATION; ACID; NEUROTRANSMITTERS; BINDING; MODEL; PAIR (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; FOLGE CHEMISCHER RELAXATION; ELECTROLYTE-SOLUTIONS; MOLECULAR-DYNAMICS; WATER; SODIUM; PROTONATION; SCHALLABSORPTION; SCATTERING; ANIONS; (1)
Dielectric Relaxation Spectroscopy; Hydration; Ion Binding; Neurotransmitter; Solvation; DRS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; HYDROPHOBIC HYDRATION; AQUEOUS-SOLUTIONS; AMINO-ACIDS; L-GLUTAMATE; GABA; DYNAMICS; WATER; CONFORMATION; ENANTIOMERS; Neurotransmitter; GABA; AABA; Hydration; Dielectric spectroscopy; Statistical mechanics (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; INTERACTION SITE MODEL; AQUEOUS-ELECTROLYTE SOLUTIONS; HYDROPHOBIC HYDRATION; STATISTICAL-MECHANICS; COMPATIBLE SOLUTES; RENAL OSMOLYTES; INORGANIC-IONS; WATER; ZWITTERION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; LOCAL ENERGY FLUCTUATIONS; PARTIAL MOLAR ENTHALPIES; ETHANOL-WATER MIXTURES; GLASS-FORMING LIQUIDS; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; TERTIARY BUTANOL; HYDROPHOBIC HYDRATION; COMPLEX PERMITTIVITY; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; LOW-MOLECULAR-WEIGHT; POLYETHYLENE GLYCOLS; POLY(ETHYLENE OXIDE); POLY(OXYETHYLENE) MELTS; MAGNETIC-RELAXATION; DIMETHYL ETHER; 298.15 K; MIXTURES; HYDRATION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MOLECULAR-DYNAMICS SIMULATIONS; CHAMELEON-LIKE NATURE; AMBER FORCE-FIELD; AQUEOUS-SOLUTION; CATIONIC MICELLES; SULFOBETAINE MICELLES; WATER REORIENTATION; AIR/WATER INTERFACE; TRIFLATE MICELLES; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MOLECULAR-DYNAMICS SIMULATIONS; RELEVANT INORGANIC-IONS; INTERACTION SITE MODEL; ELECTROLYTE-SOLUTIONS; AQUEOUS PROLINE; AMINO-ACIDS; WATER; AGGREGATION; ZWITTERION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MONOCLONAL-ANTIBODY; VIRIAL-COEFFICIENTS; VISCOSITY; PREDICTION; WATER; AGGREGATION; ASSOCIATION; MODULATION; MECHANISMS; protein-protein interactions; monoclonal antibody; dipolar interaction; protein hydration (1)
DIELECTRIC-RELAXATION; SPECTROSCOPY; PERMITTIVITY; HYDRATION; MODEL; (1)
dielectric relaxation spectroscopy, phosphates, ion specific hofmeister effects, sodium chloride, ion pairing, ion-pair relaxation, ion-cloud relaxation (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; POTASSIUM-CHLORIDE SOLUTIONS; ELECTROLYTE-SOLUTIONS; ION-PAIR; MOLECULAR-ORGANIZATION; CARBOXYLATE ANIONS; DYNAMICS; WATER; ACID; REORIENTATION; (1)
DIELECTRIC-RELAXATION; SUPRAMOLECULAR CHEMISTRY; ELECTROLYTE-SOLUTIONS; DYNAMICS; WATER; SPECTROSCOPY; ASSOCIATION; NH4+; IONS; (1)
DIELECTRIC-RELAXATION; WATER REORIENTATION; DYNAMICS; IONS; SPECTROSCOPY; MOLECULES; HDO; (1)
dielectric spectroscopy, optical Kerr-effect spectroscopy, dynamics, relaxation, libration, ionic liquids, dielektrische Spektroskopie, optische Kerr-Effekt Spektroskopie, Dynamik, ionische Flüssigkeiten, Relaxation, Libration (1)
dielectric spectroscopy, structure, dynamics, dielectric constant, ionic liquids, polar solvents, electrolyte solutions, ion pairing Dielektrische Spektroskopie, Struktur, Dynamik, statische Dielektrizitätszahl, ionische Flüssigkeiten, polare Lösemittel, Elektrolytlösungen, Ionenpaarbildung (1)
Dielektrische Relaxation , Micelle , Mikroemulsion , Gegenion , Wasser-in-Öl-Emulsion , Leitfähigkeit , Natriumdodecylsulfat , Pentanole , , Dielectric relaxation spectroscopy , micelles , microemulsions , counterions , bulk water , bound water , conductivity , sodium dodecyl sulfate (1)
Dielektrische Relaxation, Spektroskopie, Dynamik, Dielektrizitätszahl, Ionische Flüssigkeit, dielectric relaxation, spectroscopy, dynamics, dielectric constant, permittivity, ionic liquids (1)
DIELS-ALDER REACTION; (1)
Diels–Alder reaction; Click chemistry; Drug delivery; Biomaterials; Polymers; Dendrimers; Surface functionalization; Bioconjugation; Nanoparticles; Hydrogels (1)
DIELS-ALDER REACTION; ENANTIOSELECTIVE CATALYSIS; CRYSTAL-STRUCTURE; EXPANDED PHOSPHANES; 2 DIASTEREOMERS; SINGLE-CRYSTAL; DELTACYCLENES; NORBORNADIENE; CYCLOADDITION; RESOLUTION; (1)
DIELS-ALDER REACTION; ENANTIOSELECTIVE CATALYSIS; EXPANDED PHOSPHANES; DELTACYCLENES; NORBORNADIENE; RESOLUTION; NI; PD; molybdenum; chirality; secondary phosphorus; pi-stack; triple-decker (1)
DIELS-ALDER REACTION; EXCITED-STATES; ANNULAR INTERACTION; GROUND-STATE; <10>ANNULENES; BENZENE; SPECTRA; (1)
DIELS-ALDER REACTION; MECHANISM; IMINES; 3,3'-SUBSTITUENTS; (1)
DIELS-ALDER REACTIONS; 1,4-BENZOXAZINE DERIVATIVES; CYCLIZATION PROCESS; BENZOQUINONES; ANALOGS; 3,4-DIHYDRO-2H-1,4-BENZOXAZINES; DEAROMATIZATION; BENZOXAZOLES; ARYLATION; (1)
DIELS-ALDER REACTIONS; 2-PYRIDYL DERIVATIVES; THERMAL CYCLIZATION; INDOLIZINES; ALKALOIDS; Baylis-Hillman reaction; 1,4-oxazepin-7-ones; amino alcohols; aromatic aldehydes; lactonization; hydrogenation (1)
DIELS-ALDER REACTIONS; azo compounds; cycloadditions; cyclopropenes; nitrogen heterocycles; 1,2,4,5-tetrazines (1)
DIELS-ALDER REACTIONS; C-H AMINATION; ARYL IODIDES; METAL-FREE; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; NITROGEN NUCLEOPHILES; ALDOL REACTIONS; DRUG DISCOVERY; NOBLE-METALS; visible-light; photocatalysis; N-arylation; dehydrogenation; sulfoximines; radical reactions; cross-coupling (1)
DIELS-ALDER REACTIONS; CHIRAL LEWIS-ACIDS; BIS(OXAZOLINE) COPPER(II) COMPLEXES; ENANTIOSELECTIVE ALDOL ADDITIONS; ALPHA-HYDROXY ESTERS; OXAZOLINE LIGANDS; PYRUVATE ESTERS; METAL-COMPLEXES; ALKENE AZIRIDINATION; ALLYLIC ALKYLATIONS; bis(oxazoline) ligands; metal-bis(oxazoline) complexes; coordination geometry; asymmetric catalysis; stereochemical models (1)
DIELS-ALDER REACTIONS; DRUG-DELIVERY SYSTEMS; CROSS-LINKING; SUSTAINED-RELEASE; HYDROGELS; DEGRADATION; TIME; water-free; protein delivery system; in situ gelation; inverse electron demand Diels-Alder reaction; four-armed poly(ethylene glycol) (1)
DIELS-ALDER REACTIONS; ELECTRONICALLY MATCHED 2-PYRONES; CATALYZED DECARBONYLATIVE ADDITION; H BOND FUNCTIONALIZATION; ONE-POT SYNTHESIS; ALPHA-PYRONES; METHYL-COUMALATE; STEREOSELECTIVE-SYNTHESIS; SELECTIVE SYNTHESIS; COUPLING REACTIONS; Cross-coupling reactions; Cycloaddition; 2-Pyrone; Ring-opening reactions; Synthetic methods (1)
DIELS-ALDER REACTIONS; IN-VITRO; COUPLING REACTIONS; ANTITUMOR-ACTIVITY; PYRROLIC COMPOUNDS; PROTOPORPHYRIN-IX; COMPLEXES; HEMATOPORPHYRIN; LIGANDS; DERIVATIVES; photodynamic tumor therapy; porphyrin platinum conjugates; benzoporphyrins; acetylene-substituted porphyrins; MDA-MB-231 cell line (1)
DIELS-ALDER REACTIONS; MULTICOMPONENT COUPLING REACTIONS; ONE-POT SYNTHESIS; ORGANIC-SYNTHESIS; ALPHA,BETA-UNSATURATED ALDEHYDES; OXIDATIVE AROMATIZATION; MICHAEL ADDITION; MOLECULAR-OXYGEN; CONJUGATED NITROALKENES; CYCLOADDITION REACTIONS; (1)
DIELS-ALDER REACTIONS; NATURAL AMINO-ACIDS; BIORENEWABLE SOURCES; CHIRAL-AMINO; LIQUIDS; DESIGN; MIXTURES; TOXICITY; SALTS; RECOGNITION; ionic liquids; amino acids; natural products; solvent effects; carbohydrates; green chemistry (1)
DIELS-ALDER REACTIONS; ORGANIC-REACTIONS; WITTIG REACTIONS; ENAMINO KETONES; DIASTEREOSELECTIVITY; REACTIVITY; ACTIVATION; ESTERS; ENANTIOSELECTIVITY; CYCLOADDITIONS; Horner-Wadsworth-Emmons reaction; Michael addition; domino reaction; beta-amino esters; beta-thio esters; beta-thio nitriles; high-pressure (1)
DIELS-ALDER REACTIONS; PHOSPHINE-LIGANDS; SOLVENT; HYDROFORMYLATION; HYDROGENATION; DIHYDROXYLATION; IMMOBILIZATION; SELECTIVITIES; CATALYSIS/; MECHANISM; asymmetric catalysis; ionic liquids (1)
DIELS-ALDER REACTIONS; TEMPERATURE IONIC LIQUIDS; PERCHLORATE-DIETHYL-ETHER; LITHIUM PERCHLORATE; SUPERCRITICAL FLUIDS; ORGANIC-REACTIONS; N-ALKYLUREAS; SOLVENT; WATER; SELECTIVITY; (1)
Dienstleistungen in Bibliotheken (1)
DIESEL-ENGINE; RAPESEED OIL; ETHANOL; MICROEMULSIONS; PERCOLATION; SCATTERING; ADDITIVES; BLENDS; EMISSIONS; MIXTURES; (1)
DIESEL EXHAUST PARTICLES; GENE-EXPRESSION; DNA-ADDUCTS; CANCER; ACTIVATION; CELLS; INKS; CARCINOGENS; METABOLISM; EXPOSURE; (1)
DIESEL FUELS; MARKER; SOLVENT-YELLOW-124; VALIDATION; KEROSENE; OILS; Solvent dyes; Marker dyes; Petrol sample; Fuel; Electrochemical detector; Liquid chromatography; Dyes (1)
DIETARY-CHOLESTEROL ABSORPTION; STEROL-DEPENDENT REGULATION; MESSENGER-RNA EXPRESSION; ABC TRANSPORTER; MULTIDRUG-RESISTANCE; MEMBRANE-PROTEIN; GENE-EXPRESSION; RT-PCR; CLONING; MACROPHAGES; (1)
DIETARY-FAT CLEARANCE; HOMEOBOX GENE; TARGET GENES; CDX2; EXPRESSION; EPITHELIUM; ACARBOSE; PROTEIN; METAPLASIA; DISEASE; metabolic learning; intestine (1)
dietary fiber; gut microbiome; inulin; metabolomics; multi-omics; obesity; resistant maltodextrin; weight loss (1)
DIETARY FIBER; KAPPA-B; INHIBITION; PREVENTION; APOPTOSIS; PRODUCTS; PATHWAY; DISEASE; CELLS; JUICE; Anthocyanins; Bilberries; Dextrane sodium sulphate-colitis; Inflammatory bowel disease; Inflammation (1)
DIETARY GLYCEMIC INDEX; FAMILY-BASED TREATMENT; INSULIN-RESISTANCE; CHILDHOOD OBESITY; UNITED-STATES; OVERWEIGHT; EXERCISE; INTERLEUKIN-18; ADIPONECTIN; PERCENTILES; (1)
DIETARY-SODIUM; TISSUE SODIUM; NA+ STORAGE; SPOT URINE; MRI; BALANCE; ELECTROLYTE; MACROPHAGES; ACTIVATION; DEPOSITION; multiple sclerosis; sodium magnetic resonance imaging; skin; experimental autoimmune encephalomyelitis (1)
Dietary stress; lipocalin gene family; ApoD; developmental time; Drosophila melanogaster (1)
Dietary supplements, General practice, Cross-sectional, Survey, CAM (1)
dietary supplements, periodic health examination, communication, primary care, survey (1)
diethyl phthalate; environmental sensing; nanohole array; nanosphere lithography; surface plasmon resonance (1)
DIETITIANS; ACADEMY; breastfeeding; credentialing; health education; infant nutritional sciences; lactation; nutritionists; preceptorship; professional education (1)
diet, late-onset multiple sclerosis, life style factors (1)
DIET QUALITY; CONSUMPTION; ADOLESCENTS; EPIDEMIC; CHILDREN; IMPACT; (1)
diets, global health, meta-analysis, obesity, planetary health, sustainability (1)
DIFFEOMORPHISMS; GEOMETRY; FLOWS; Area-preserving and Hamiltonian diffeomorphisms; topological entropy; quasimorphisms; braid groups; mapping class groups; conjugation-invariant norms (1)
DIFFERENCE-FREQUENCY-GENERATION; THIN-DISK OSCILLATOR; FEMTOSECOND PULSES; MU-M; OPTICAL RECTIFICATION; SPECTROSCOPY; TRANSIENTS; EFFICIENT; GASE; AMPLIFICATION (1)
; Differential cohomology; Sheaves on manifolds; Stable infinity categories (1)
differential diagnoses, multiple sclerosis, duplex ultrasound, cerebrospinal fluid, cranial MRI, multiple sclerosis mimics (1)
DIFFERENTIAL-EQUATIONS METHOD; MASSIVE FEYNMAN DIAGRAMS; VERTEX-TYPE DIAGRAMS; MASTER INTEGRALS; PAIR PRODUCTION; SCALE DIAGRAMS; 6TH ROOT; ONE-LOOP; POLYLOGARITHMS; EXPANSION; (1)
DIFFERENTIAL EVOLUTION; DATA ASSIMILATION; SIMULATION; CARBON; Bayesian inference; Sequential Monte-Carlo (SMC); Mechanistic models; Model calibration; Particle filters; Equifinality (1)
DIFFERENTIAL GENE-EXPRESSION; HONEY-BEE; JUVENILE-HORMONE; APIS-MELLIFERA; DNA METHYLATION; CHEMORECEPTOR SUPERFAMILY; POPULATION-GENETICS; SEX DETERMINATION; WASP NASONIA; HYMENOPTERA; social insect; caste differences; nonmodel organism; de novo genome assembly (1)
DIFFERENTIAL GENE-EXPRESSION; NUTRITION; BEHAVIOR; BIOLOGY; WORKERS; ANTS; SIZE; WASP (1)
DIFFERENTIAL GENE EXPRESSION, Piscirickettsia salmonis, CULTURE SYSTEMS, SURVIVAL MECHANISMS, PATHOGENICITY (1)
Differentialgeometrie; Holonomie; Zusammenhang (1)
Differential geometry (1)
Differential geometry, Lorentzian Geometry, Parallel Spinor, Special Holonomy (1)
Differential hypoxia, Harlequin syndrome, V-AV-ECMO, Case report (1)
; differential K-theory; Chern classes (1)
DIFFERENTIAL K-THEORY; INDEX; COHOMOLOGY; THEOREM; GERBES; (1)
DIFFERENTIAL-OPERATORS; ESSENTIAL SPECTRUM; MIXED ORDER; (1)
DIFFERENTIAL-OPERATORS; ESSENTIAL SPECTRUM; MIXED ORDER; MATRICES; SYSTEM; Hilbert space; evolution problem; Navier-Stokes equations; normal oscillations (1)
DIFFERENTIAL SCANNING CALORIMETRY; GLOBULAR-PROTEINS; LIGHT-SCATTERING; DENATURED STATE; STABILITY; KINETICS; BEHAVIOR; THERMODYNAMICS; AGGREGATION; CULTIVATION; Photo-activated adenylate cyclase (PAC); BLUF domain; Amoeboflagellate Naegleria gruberi; Flavin; Protein unfolding; Apparent protein melting temperature; Protein melting time; Protein melting enthalpy; Protein melting entropy; Light attenuation; Light scattering; Fluorescence behavior; Measurement standard of protein melting temperature (1)
DIFFERENTIAL SCANNING CALORIMETRY; ORGANOMETALLIC COMPOUNDS; THERMODYNAMIC PROPERTIES; STANDARD ENTHALPIES; HEAT-CAPACITIES; COSMO-RS; SUBLIMATION; CHEMICALS; PENTACHLOROPHENOL; HEXACHLOROBENZENE; (1)
DIFFERENTIATED MICRODOMAINS; LUMINAL SURFACE; ANIONIC SITES; TRABECULAR MESHWORK; PERMEABILITY; PATHWAYS; DIAPHRAGMS; FENESTRAE; FERRITIN; PV-1; outflow; aqueous humor; Schlemm's canal; PV-1; fenestrated capillaries (1)
differentiated thyroid cancer; radioiodine therapy; targeted therapy; tyrosine kinase inhibitors (1)
DIFFERENTIATING FRONTOTEMPORAL DEMENTIA; ITERATIVE RECONSTRUCTION ALGORITHMS; DIMENSIONAL PATTERN-CLASSIFICATION; COGNITIVE IMPAIRMENT; IMAGE-RECONSTRUCTION; BRAIN IMAGES; F-18-FDG PET; FDG PET; SPECT; REGISTRATION; Computer aided diagnosis; feature extraction and selection; SPECT brain imaging; support vector machines (1)
DIFFERENTIATION (1)
DIFFERENTIATION; ANOCTAMINS; CULTURE; CA2+; CFTR; TMEM16F; exocytosis; goblet cell metaplasia; Notch signaling; TMEM16A (1)
DIFFERENTIATION; CELLS; EXPRESSION; GRAFT; bone tissue reconstruction; naringin; hydroxyapatite; scaffold; collagen; osteogenesis (1)
DIFFERENTIATION COMPLEX; STEM-CELLS; GENE; P63; PROTEINS; differentiation; epidermis; LINC00941; long non-coding RNA; SPRR5 (1)
DIFFERENTIATION; EXHAUSTION; EFFECTOR; EXPRESSION; STATES; PD-1; RECONSTITUTION; DYSFUNCTION; INFECTION; CHROMATIN; (1)
DIFFERENTIATION; GROWTH; EXPRESSION; LINES; PROLIFERATION; INTESTINE; MYOFIBROBLASTS; ESTABLISHMENT; RECEPTORS; PHENOTYPE; colon; organotypic culture; LIF (1)
DIFFERENTIATION IN-VITRO; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; BIOMARKER; Dental follicle cells; Muller cells; Retinal progenitor cells; Neurospheres; Proteomics (1)
Differentiation, neuronal, human dental follicle cells (1)
DIFFERENTIATION; ORTHODONTICS; APOPTOSIS; Cephalometry; estrogens; genetic polymorphism; maxillofacial abnormalities (1)
DIFFERENTIATION-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA AGONISTS; OXIDIZED LDL; EXPRESSION; ATHEROGENESIS; STIMULATION; MACROPHAGES; COMPLEMENT; ACTIVATION; blood monocyte; adipophilin; enzymatically modified low density lipoprotein; proliferator activated receptor gamma; free fatty acid (1)
DIFFERENTIATION-SPECIFIC ELEMENT; SPONTANEOUSLY HYPERTENSIVE RATS; CONVERTING-ENZYME INHIBITION; MESSENGER-RNA EXPRESSION; ACTIVATED RECEPTOR-GAMMA; GENE-EXPRESSION; HUMAN ADIPOCYTES; II RECEPTORS; HUMAN PREADIPOCYTES; HORMONAL-REGULATION; renin-angiotensin system; adipose-tissue; obesity; hypertension; insulin resistance; adipogenesis (1)
DIFFERENTIATION; STONES; (1)
Differentielle Genexpression , Melanom , Tumormarker , RNA-Fingerprinting , cDNA-Array , RT-PCR , Melanomprogression , melanoma , gene expression profiling , RNA arbitrarily primed PCR , microarray (1)
DIFFERENT METABOLIC PATHWAYS; DIVERGENT EVOLUTION; STRUCTURAL EVIDENCE; PROTEIN; STABILITY; BARREL; FOLD; HISTIDINE; SEQUENCES; FUSION; chimeric proteins; gene duplication; histidine biosynthesis; TIM-barrel (1)
DIFFERENT METABOLIC PATHWAYS; TIM-BARREL FOLD; (BETA-ALPHA)(8)-BARREL ENZYMES; THERMOTOGA-MARITIMA; ESCHERICHIA-COLI; INDOLE-3-GLYCEROL PHOSPHATE; ANTHRANILATE ISOMERASE; CATALYTIC-ACTIVITY; EFFICIENT ENZYMES; PROTEIN EVOLUTION; ()(8)-barrel; enzyme evolution; protein design; tryptophan biosynthesis (1)
DIFFERENT PERFLUOROCHEMICAL AGENTS; TERM VITREOUS REPLACEMENT; DISLOCATED LENSES; SUBSTITUTES; RABBIT; TOLERANCE; PERFLUOROPHENANTHRENE; VITRECTOMY; PRIMATES; SILICONE; (1)
DIFFERENT STIMULUS INTENSITIES; D-ASPARTATE ANTAGONIST; 1ST 2 WEEKS; MAJOR DEPRESSION; CLINICAL-RESPONSE; ECT; EFFICACY; ANTIDEPRESSANTS; METAANALYSIS; MEDICATION; (1)
DIFFERENT SURFACE COLLECTIONS; SURROUND ARTICULATION; APPEARANCE DEPENDS; ILLUMINANT CHANGES; NATURAL IMAGE; LIGHTNESS; DISCRIMINATION; BRIGHTNESS; PRINCIPLES; LUMINANCE; (1)
DIFFERENT SURFACE FINISHES; IN-VITRO; LINING MATERIALS; STAPHYLOCOCCUS-AUREUS; ACRYLIC RESINS; FREE-ENERGY; ADHERENCE; STOMATITIS; ROUGHNESS; GROWTH; biofilm; Candida; denture hygiene; liner (1)
DIFFERENT TEMPERATURES; HEAT; (1)
Differenzierung , Elektronentransportkette , Rieske FeS-Protein , Cytochrom b6f-Komplex , Cyanobakterien , Heterocyste , cytochrome b6f complex, Rieske FeS protein (1)
DIFFICILE-ASSOCIATED DISEASE; CELL TRANSPLANT RECIPIENTS; INFECTION; EPIDEMIOLOGY; ASSOCIATION; MORTALITY; IMPACT; microbiota; alpha diversity; Clostridium difficile infection; Clostridiales; 3-indoxyl sulfate; biomarker (1)
DIFFICULTIES QUESTIONNAIRE; ALLERGIC DISEASES; ASTHMA; CHILDHOOD; SYMPTOMS; PREVALENCE; DISORDERS; STRENGTHS; BURDEN; COMORBIDITY; (1)
DIFFICULTIES QUESTIONNAIRE; CORTICAL THICKNESS; DSM-IV; VOLUME; METAANALYSIS; DISORDERS; CHILDHOOD; BEHAVIORS; STRENGTHS; CHILDREN; Brain development; Psychopathology; Externalizing; Internalizing; Adolescence (1)
DIFFICULTIES QUESTIONNAIRE SDQ; ALCOHOL-USE; SUICIDAL-BEHAVIOR; SUBSTANCE USE; HARM; STRENGTHS; PSYCHOPATHOLOGY; POPULATION; PREVALENCE; VALIDITY; Risk-taking behavior; Self-injurious behavior; Adolescents; Borderline personality disorder; Longitudinal; SEYLE study (1)
DIFFICULT LIFE SITUATIONS; HEALTH-PROMOTION; PARTICIPATION; PREVENTION; OUTCOMES; PROGRAM; physical activity; empowerment; community-based participatory research; women's health; low socioeconomic status; ethnic minority; qualitative research; health promotion (1)
DIFFRACTION; INTERFERENCE; SLIT; Bohmian mechanics; diffraction; walking droplet; quantum trajectories (1)
DIFFRACTIVE DISSOCIATION; 2 JETS; HERA; (1)
DIFFRACTIVE J/PSI ELECTROPRODUCTION; GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; DEEP-INELASTIC-SCATTERING; HIGH-ENERGY FACTORIZATION; BFKL POMERON; POMERANCHUK SINGULARITY; ELASTIC PHOTOPRODUCTION; GLUON DISTRIBUTIONS; WAVE-FUNCTION; (1)
DIFFUSE; DIAGNOSIS (1)
DIFFUSE-INTERFACE MODEL; 2-DIMENSIONAL BUBBLE DYNAMICS; NAVIER-STOKES EQUATIONS; BENCHMARK COMPUTATIONS; NEWTON METHOD; FREE-ENERGY; SYSTEM; FLUIDS; APPROXIMATIONS; DENSITIES; Two-phase flow; Diffuse-interface models; Stable discretization scheme; Cahn-Hilliard Navier-Stokes model; Adaptive meshing (1)
DIFFUSE INTERFACE MODEL; ACTIVE-TRANSPORT; WELL-POSEDNESS; DARCY SYSTEM; Tumor growth; phase field model; Cahn-Hilliard equation; reaction-diffusion equations; chemotaxis; weak solutions; Dirichlet boundary conditions; well-posedness; asymptotic analysis; singular potentials (1)
DIFFUSE INTERFACE MODEL; FINITE-ELEMENT APPROXIMATION; PHASE FIELD MODEL; MIXTURE MODEL; SIMULATION; SYSTEM; CANCER; FLOW; CALIBRATION; EXPRESSION; Tumour growth; diffuse interface model; Cahn-Hilliard equation; chemotaxis; Darcy's flow; matched asymptotic expansions; stability analysis; finite element computations (1)
DIFFUSE INTERFACE MODEL; FREE-BOUNDARY PROBLEMS; SINGULAR POTENTIALS; MATHEMATICAL-MODEL; TREATMENT TIME; SYSTEM; SIMULATION; INVASION; FLOWS; Brinkman's law; Cahn-Hilliard equation; Chemotaxis; Darcy's law; Limit of vanishing viscosities; Multiphase model; Tumor growth (1)
DIFFUSE INTERFACE MODEL; LONG-TIME BEHAVIOR; HELE-SHAW CELL; MIXTURE MODEL; RECONNECTION; SIMULATION; PINCHOFF; Tumour growth; phase field model; Cahn-Hilliard equation; reaction-diffusion equations; chemotaxis; weak solutions; well-posedness (1)
DIFFUSE INTERFACE MODEL; LONG-TIME BEHAVIOR; ISOGEOMETRIC ANALYSIS; WELL-POSEDNESS; TUMOR-GROWTH; SYSTEM; EQUATIONS; CELL; RECONNECTION; SIMULATION; Hole Shaw-flows; multi-phase flows; Cahn-Hilliard model; diffuse interfaces; sharp interface limit; isogeometric analysis (1)
DIFFUSE-INTERFACE MODEL; MOVING CONTACT; 2-PHASE FLOW; DYNAMICS; LINE; (1)
DIFFUSE INTERFACE MODEL; NUMERICAL-SIMULATION; GINZBURG-LANDAU; MIXTURE MODEL; SOLID STRESS; DARCY MODEL; SEPARATION; APPROXIMATION; CHEMOTAXIS; VALIDATION; Tumour growth; Cahn-Hilliard equation; Mechanical effects; Linear elasticity; Elliptic-parabolic system; Existence and uniqueness (1)
DIFFUSE INTERFACE MODEL; ORDER-PARAMETER; FLUIDS; FLOW; Two-phase flow; Navier-Stokes equations; Diffuse interface model; Mixtures of viscous fluids; Cahn-Hilliard equation; Degenerate mobility (1)
DIFFUSE INTERFACE MODELS; 2-PHASE FLOW; COMPLEX GEOMETRIES; DOMAIN APPROACH; SURFACTANTS; FORMULATION; DYNAMICS; SCHEMES; Fluid-structure interaction; Phase-field; Diffuse interface; Viscoelasticity; Contact problem; Fully Eulerian (1)
DIFFUSE INTERFACE MODEL; TREATMENT TIME; SOLID STRESS; GROWTH; SIMULATION; CHEMOTHERAPY; VALIDATION; SEPARATION; SELECTION; INVASION; sparse optimal control; tumor growth; Cahn-Hilliard equation; linear elasticity; mechanical effects; elliptic-parabolic system; optimality conditions (1)
DIFFUSE INTERFACE MODEL; TUMOR-GROWTH; 2-PHASE FLOWS; SYSTEM; EQUATION; VALIDATION; Tumour growth; Brinkman's law; Darcy's law; singular potentials; stationary solutions; Cahn-Hilliard inpainting (1)
DIFFUSE INTERFACE MODEL; VARIATIONAL APPROACH; WELL-POSEDNESS; WEAK SOLUTIONS; EQUATION; SYSTEM; FLUIDS; APPROXIMATION; REGULARITY; Two-phase flows; Navier-Stokes-Cahn-Hilliard system; Bulk-surface interaction; Dynamic boundary conditions (1)
DIFFUSE INTERFACE MODEL; WEAK SOLUTIONS; 2-PHASE FLOWS; FLUIDS; SYSTEM; EXISTENCE; EQUATION; 35B40; 35Q30; 35Q35; 76D03; 76D05; 76D45; 76T06 (1)
DIFFUSE INTERFACE MODEL; WEAK SOLUTIONS; EXISTENCE; FLUIDS; Two-phase flow; Navier-Stokes equation; Diffuse interface model; Mixtures of viscous fluids; Cahn-Hilliard equation (1)
DIFFUSE INTERFACE MODEL; WELL-POSEDNESS; DARCY SYSTEM; GROWTH; CHEMOTAXIS; SIMULATION; TIME; (1)
Diffuse large B-cell lymphoma; miRNA signature; prognostic biomarker; risk group stratification; survival (1)
DIFFUSION CAPACITY; CLINICAL CHARACTERISTICS; EMPHYSEMA SYNDROME; PROGNOSTIC-FACTORS; CONTROLLED-TRIAL; FIBROSIS; COPD; SILDENAFIL; PRESSURE; SURVIVAL; Pulmonary hypertension; Lung disease; COPD; Pulmonary fibrosis; Therapy (1)
DIFFUSION CAPACITY; HEART-FAILURE; SURVIVAL; CAPILLARY; DIAGNOSIS; pulmonary arterial hypertension; phenotypes; cluster; survival; mortality (1)
DIFFUSION CAPACITY; TOBACCO-SMOKE; THERAPY; AMBRISENTAN; TADALAFIL; MORTALITY; SURVIVAL; (1)
DIFFUSION-COEFFICIENT; INTERSTITIAL COPPER; ENHANCED SOLUBILITY; PRECIPITATION; IMPURITIES; KINETICS; WAFERS; BORON; IRON; CONTAMINATION; (1)
DIFFUSION-COEFFICIENT; VISCOSITY; DICYANAMIDE; SALTS; (1)
DIFFUSION DECISION-MODEL; COGNITIVE CONTROL; ATTENTIONAL CONTROL; FLANKER TASK; CONFLICT; MEMORY; FLEXIBILITY; ACTIVATION; PARAMETERS; PROSPECT; Simon; Proportion congruency effect; Congruency sequence effect; Drift diffusion model; Reward; Fast-dm (1)
Diffusion , Diffusionsprozess , GaSb , Zn-Diffusion , Thermophotovoltaik , beschleunigte Alterung , GaSb , Zn diffusion , thermophotovoltaics , accelerated aging , accelerated degradation (1)
Diffusion imaging · Signal harmonization · Data synthesis · Spherical signals · Deep learning (1)
DIFFUSION-LIMITED AGGREGATION; SCANNING PROBE MICROSCOPY; SURFACE; NETWORKS; atomic force microscopy; hydrogen bonds; nitrogen heterocycles; scanning tunneling microscopy; self-assembly (1)
diffusion pptn iron silica (1)
diffusion, precipitation, chemical garden, silica garden, crystallization, membrane, cell potential, chemical gradient, kinetics (1)
DIFFUSION; SYSTEMS; STRESS; MOTION; TRANSITIONS; MODELS; Structural topology optimization; linear elasticity; phase-field method; first order conditions; matched asymptotic expansions; shape calculus; numerical simulations (1)
DIFFUSION TENSOR TRACTOGRAPHY; MEDIAL FOREBRAIN-BUNDLE; MRI TRACTOGRAPHY; ESSENTIAL TREMOR; PARKINSONS-DISEASE; TRACT; NEUROSTIMULATION; PROPAGATION; RELIABILITY; ACCURACY; deep brain stimulation; dentate-rubro-thalamic tract; deterministic tractography; movement disorders; probabilistic tractography (1)
DIFFUSION TENSOR TRACTOGRAPHY; NUCLEUS VENTRALIS INTERMEDIUS; RUBRO-THALAMIC TRACT; FIBER TRACKING; SUPPRESSION; ACCURACY; EFFICACY; MRI; essential tremor; dentatoru-brothalamic tract; diffusion tensor imaging; deterministic fiber tracking; deep brain stimulation (1)
DIFFUSION TENSOR TRACTOGRAPHY; RUBRO-THALAMIC TRACT; FIBER TRACKING; VENTRALIS INTERMEDIUS; TREMOR (1)
Diffusion , Wärmeleitung , Harmonische Funktion , Stochastische Analysis , Differentialgeometrie , Bismut-Formel , Wärmeleitungshalbgruppe , Diffusionshalbgruppe , Martingalmethoden , Stochastische Differentialgeometrie , Bismut formula , heat semigroup , harmonic function , martingale methods , stochastic differential geometry (1)
DIFFUSIVE CONDUCTORS; SEMICLASSICAL THEORY; SUPPRESSION; SCATTERING; (1)
DIGITAL 3-DIMENSIONAL PHOTOGRAMMETRY; QUALITY-OF-LIFE; ORTHOGNATHIC SURGERY; REPORTED OUTCOMES; ANTHROPOMETRIC PRECISION; INTEROBSERVER ERROR; CENTERED OUTCOMES; CLINICAL-TRIALS; SATISFACTION; FACE; (1)
Digital and Social Media in Enterprise Digital and Social Media social media, success factors, key performance indicators (1)
Digital and Social Media in Enterprise esn user types value-adding users (1)
digital assays, immunoassays, optical detection, signal background, single-molecule detection (1)
Digital assets, Blockchain, Metaverse, Virtual land, Real estate, Wavelets (1)
digital business models; digital manufacturing; Industrie 4.0; IIoT; Industrial Internet of Things; German Mittelstand; Germany; technology; hybrid products; case study. (1)
digital communication | EMG | emoticons | emotion | psychophysiology | social interaction | virtual agents (1)
; Digital complementary assets; regulation; digital transformation; digital innovations; discontinuous innovations; health care; innovation adoption; telemedicine (1)
Digital Divide, Information Society, ICT Global Index, ICT Measurement, E-Readiness (1)
; Digital documentation of findings; Ultrasound training; Structured reporting; Quality of findings; Completeness of findings (1)
Digitale Forensik, Cybersecurity, Readiness, Digital Forensics Readiness, IT-Sicherheit, IoT, Internet of Things, Internet der Dinge (1)
Digitale Haltungsprävention; Grundschulkinder (1)
Digitale Infrastruktur, Web Applikation, Neuronale Netze, Pathologie, Lymphome (1)
Digitale Kulturwissenschaft; Topic Modeling; Social Media Analyse; Inhaltsanalyse; Modellierung; Kontextsetzung; Identifizierung; Text; DHd2022 (1)
Digitale Medien · Lernunterstützung · Kognitive Theorie des multimedialen Lernens (CTML) · Hypermedia · Intelligente Tutorielle Systeme · Spielbasiertes Lernen (1)
DIGITAL EPILUMINESCENCE MICROSCOPY; TELEDERMATOLOGY; DIAGNOSIS; IMAGES; TELEMEDICINE; PHOTOGRAPHS; MELANOMAS; (1)
Digital era , Digital scientific information , Electronic information environment , Electronic information , e-sciences , Scholarly communication future , Scholarly communication history , Science communication , Scientific platforms (1)
Digitaler Religionsunterricht, Dialog, interreligiöses Lernen, E-Learning, Dialogkultur, Angehende Religionslehrer*innen, universitäre Lehramtsausbildung (1)
digitale Spaltung , Informationstechnik , Informationsgesellschaft , Medienkompetenz , digital divide , information society , ICT , ICT-skill (1)
Digital Finance, Decentralized Finance, DeFi, FinTech, Blockchain, Security Token, STO, Tokenization, Machine Learning, Natural Language Processing, ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, Corporate Scandals, Asset Pricing, Payout, Dividends, Stock Repurchases (1)
Digital Finance, FinTech, Blockchain, GDPR, Security Token, STO, Tokenization (1)
DIGITAL FOOTPRINTS; SOCIAL MEDIA; IRT MODELS; TRAITS; ACCURATE; STYLE; assessment; interpretability; machine learning; overfitting; personality (1)
Digital Forensic Readiness; Forensic Readiness (1)
Digital Forensics, Enterprise Forensics, Privacy-Aware, Privacy-Preserving, Privacy (2)
Digital Forensics, Industrial Ccontrol Systems, Digital Twins (1)
Digital Forensics; Internet of Things; IoT Forensics; Forensics Readiness; Influencing Factors; Survey; Review (1)
Digital Forensics; Visual Analytics; Live Forensics; Visualization Design (1)
Digital Forensics; Workshop; Peer Instruction; Serious Games; Capture the Flag (1)
digital health; human rights; privacy; dignity; autonomy; digital economy; neoliberalism; modeling; system analysis; artificial intelligence (1)
DIGITAL HOLOGRAPHIC MICROSCOPY; CA2+-ACTIVATED CL-CHANNELS; REGULATED ANION CHANNEL; ESSENTIAL COMPONENT; CHLORIDE CHANNELS; ANOCTAMIN 6; DEATH; PROTEIN; NECROSIS; VRAC; Cell death; Necroptosis; Apoptosis; TMEM16F; Anoctamin 6; Chloride channel (1)
Digital Humanities; Corpus Annotation; Presentation; Usability Engineering; Texttechnologie: Corpuslinguistik; Software-Ergonomie (1)
digital humanities; digital Libraries; elektronische Bücher; elektronisches Publizieren; Personal Information Management; Bildwissenschaft; Sehen und Verstehen (1)
Digital Humanities, Digital Shakespeare, Visualization, Text Analysis, Distant Reading (1)
Digital Humanities, Information Behaviour, Work Activity Classification, Grounded Theory, Eye-Tracking, Scholarly Work, Future of Work (1)
Digital Humanities; Mittelalter; Archivwesen; Römisch-katholische Kirche; Ordensgeschichte (1)
Digital Humanities; virtuelle Forschungsumgebungen; personal information management; wissenschaftliche Forschung; scholarly research; grounded theory; Informationsverhalten; information behavior (1)
digital image analysis, hypertrophy, nuclear morphometry, tachycardiomyopathy, texture (1)
Digitalisation · Basic income · Further training · Robot tax · Social security (1)
Digitalisierung, Hauptversammlung, Aktienrecht (1)
Digitalisierung, Industrie 4.0, KMU (1)
Digitalisierung, Rechtswissenschaft, Legal Tech, Rechtsdidaktik, Curriculum, Rechtsinformatik, Rechtsreferendariat (1)
Digital Library (1)
; digital multiplexed gene expression profiling; nCounter; diffuse large B-cell lymphoma; children; adolescents (1)
Digital Musicology, Statistical Musicology, User Centered Design, Visualization, Distant Hearing (1)
digital natives; web 2.0; social media; HRM; Personalmanagement (1)
Digital Platforms, Coopetition in Digital Markets, Financial Innovation (1)
Digital; Publishing; Revolution (1)
DIGITAL RADIOGRAPHY; AMORPHOUS-SILICON; OBSERVER PERFORMANCE; LESIONS; thorax radiography; radiography, comparative studies; radiography, digital; amorphous silicon; dose reduction (1)
digital radiography; flat-panel detector; amorphous silicon; detective quantum efficiency (1)
Digital rights management (4)
Digital rights management, Legal aspects of information security (4)
Digital rights management, Security in general (overviews/surveys) (1)
Digital Shadow, Industrial Robot, Joint Friction, Asset Administration Shell, SysML, Model-based Software Engineering (1)
Digital Shadow , Injection molding , Production planning and control , Method , Data , Software Engineering (1)
; digital signatures; quality assurance; suppliers; cryptography theory (1)
digital simulation -- electrolytes -- free energy -- liquid structure -- numerical methods -- statistical mechanics -- electrolyte solutions -- optimized techniques -- computer simulations -- analytical equations -- statistical mechanics -- free energy data -- neutron scattering experiments -- structural data -- dielectric measurements -- spectroscopic method -- electrolyte diffusion -- transport properties (1)
digital, start-up, knowledge spillover, university, business incubator, rural, (1)
Digital storage; Electronic document delivery; Electronic publishing; Information management; Information retrieval; Libraries (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; COST-EFFECTIVENESS ANALYSIS; OCCLUSIVE DISEASE; CONVENTIONAL ANGIOGRAPHY; PRELIMINARY EXPERIENCE; MAGNETIC-RESONANCE; PERIPHERAL VESSELS; RUNOFF VESSELS; BYPASS GRAFTS; AORTA; MR-angiography; MR, peripheral vessels; peripheral arterial occlusive disease; arteries, stenosis or obstruction (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; EXTREMITY OCCLUSIVE DISEASE; BREATH-HOLD; PHASE-CONTRAST; FOLLOW-UP; ARTERIES; ULTRAFAST; TIME; AORTOGRAPHY; PLACEMENT; aneurysm; abdominal aorta; peripheral arteries; MRA; DSA (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; LOWER-EXTREMITY; CONTRAST AGENT; ARTERIOGRAPHY; FEASIBILITY; DISEASE; MEDIA; TABLE; (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; 16-SLICE COMPUTED-TOMOGRAPHY; ILIAC ARTERY STENTS; VASCULAR STENTS; VITRO EVALUATION; FOLLOW-UP; STENOSIS; SUSCEPTIBILITY; PLACEMENT; (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; MR-ANGIOGRAPHY; FEASIBILITY; AGENT; MR-guided; MR angiography; intra-arterial; angioplasty (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; X-RAY ANGIOGRAPHY; MR-ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; STENOSIS; ENDARTERECTOMY; ULTRASOUND; AGREEMENT; DSA; angiography; elliptic centric view ordering; magnetic resonance imaging; supra-aortic arteries (1)
digital; Taiwan; Bibliothek (1)
Digital Transformation, Cloud Computing, Information Security Management, Public Administrations, Cybersecurity, GermanyThe digital transformation of public administration is becoming increasingly important for Europe’s compet- itiveness. Cloud services are being used more and more to manage this transformation. However, public administration has long ignored this paradigm, resulting in major challenges to securely managing cloud so- lutions. Meanwhile, the number of successful cyberattacks on IT infrastructure in this sector has increased significantly in recent months. This empirical study examines the current state of public cloud services and the related information security challenges and responsibilities of over 500 local German governments. Based on these findings, recommendations are made to improve the security of public cloud services in this domain. (1)
Digital transformation Industrial innovation management Selling capability Knowledge adoption Salesperson adoption Sales and innovation performance (1)
digital twin, cyber threat intelligence, simulation, security analysis (1)
Digital Twin, Integration, Challenges (1)
Digital Twin, Model Classification, Manufacturing, Cyber-physical Systems (1)
Digital Twin , Model-Driven Engineering , Systems Engineering , Cyber-Physical Systems (1)
Digital Twin; Production; Sustainability; Knowledge Graphs; Model-Driven Engineering; Ontology Engineering (1)
digital twin, security (1)
Digital Twin, Security Analytics, Internet of Things, Cybersecurity (1)
digital twin, security operations center, security framework, security information and event management (1)
Digital twin security operations cybersecurity survey literature review (1)
Digital Twins, Models-meet-data, Domain-specific Language, Query Language, Data Integration (1)
; Digital twin; Virtualization; System-of-systems; Enterprise asset management; Lifecycle management; Internet of Things (1)
Diglossia; language biography; language loyalty; language ideology; language shift; Bohemia; Czech; German (1)
DIGOXIN; GLYCOSIDES; PHARMACOKINETICS; HOSPITALIZATION; GUIDELINES; REDUCTION; MORTALITY; Cardiac glycosides; Digitoxin; Heart failure; Clinical trial; Dose titration (1)
DIGOXIN; MORTALITY; HOSPITALIZATION; ASSOCIATION; ENALAPRIL; SURVIVAL; GUIDELINES; WITHDRAWAL; REDUCTION; INSIGHTS; Heart failure; Cardiac glycosides; Digitalis; Digitoxin; Clinical trial (1)
DIHYDROAZULENES; SUBSTITUENTS; BEHAVIOR; photochromism; dihydroazulene; vinylheptafulvene; reaction kinetics; femtosecond laser spectroscopy (1)
DIHYDROAZULENE/VINYLHEPTAFULVENE PHOTOCHROMISM; ELECTROGENERATED CHEMILUMINESCENCE; MOLECULAR SWITCHES; ELECTRON-TRANSFER; FLUORESCENCE; LUMINESCENCE; SYSTEM; DYE; DITHIENYLETHENE; PHOTORECEPTORS; boron dipyrromethene; electrochemiluminescence; fluorescence; molecular switches; photochromism (1)
DIIMINE COMPLEXES; LIGANDS; TRANSITION; SOLVENT; rhenium; diimine ligands; charge transfer; solvatochromism; substituent effects (1)
DIIMINE DITHIOLATE COMPLEXES; EXCITED-STATE; RESONANCE RAMAN; THIOLATE LIGANDS; PLATINUM(II); CHROMOPHORES; DYNAMICS; CRYSTAL; (1)
DIKETOPIPERAZINE FORMATION; BETA-AMINO; REDUCTIVE DEPROTECTION; PROTECTING GROUPS; ALPHA-AMINO; ALLYL GROUP; TRANSPROTECTION; SUPPRESSION; DIPEPTIDES; ANALOGS; (1)
DILATATIONAL TRACHEOSTOMY; METAANALYSIS; TRACHEOTOMY; EXTUBATION; critical care; hemodynamics; intracranial pressure; pulmonary gas exchange; tracheostomy (1)
DILATATION OPERATOR; EVOLUTION-EQUATIONS; QCD; (1)
Dilatative Kardiomyopathie, DCM, automatischer implantierbarer Cardioverter Defibrillator, AICD, maligne Herzrhythmusstörungen, Primärprävention, Sekundärprävention, plötzlicher Herztod (1)
Dilated cardiomyopathy; Heart failure; GWAS; Imputation; 4C-sequencing; Genetic risk score (1)
DILATED CARDIOMYOPATHY; TRANSPLANT RECIPIENT; HIGH PREVALENCE; VIRAL GENOMES; INFECTION; PERSISTENCE; DNA; DYSFUNCTION; INFARCTION; BIOPSY; Parvovirus B19; Cellular immune response; Humoral immune response; Cardiomyopathy; Myocarditis (1)
DILATED CORONARY-SINUS; VISCERAL HETEROTAXY; VENOUS CONNECTIONS; CARDIAC DEFECTS; HEART-DISEASE; ABNORMALITIES; TRISOMY-18; FETUSES; aneuploidy; cardiac defect; echocardiography; fetus; heterotaxy; persistent left superior vena cava; prenatal diagnosis (1)
DILOCARCINUS-PAGEI STIMPSON; SEXUAL-DIMORPHISM; SHAPE DIFFERENCES; RIVER CRAB; GEOMETRIC MORPHOMETRICS; ALLOMETRIC GROWTH; FLUVIATILE HERBST; RELATIVE GROWTH; DECAPODA; BRACHYURA; drainage systems; geometric maturity; sexual dimorphism; traditional morphometry (1)
DILUTE ALLOYS; LATTICE DISTORTION; FMR LINEWIDTH; RELAXATION; RESONANCE; CONDUCTIVITY; EXCHANGE; DYNAMICS; (1)
DILUTED MAGNETIC SEMICONDUCTORS; ABSORPTION; PARAMETERS; DENSITY; MODEL; GAAS; (1)
DILUTED MAGNETIC SEMICONDUCTORS; ELECTRICAL SPIN INJECTION; III-V SEMICONDUCTORS; MOLECULAR-BEAM EPITAXY; FERROMAGNETIC-SEMICONDUCTOR; OPTICAL ORIENTATION; NONMAGNETIC SEMICONDUCTORS; EQUILIBRIUM ELECTRONS; CARRIER TRANSPORT; ROOM-TEMPERATURE; (1)
DILUTED MAGNETIC SEMICONDUCTORS; GAAS NANOWIRES; MAGNETOTRANSPORT PROPERTIES; HETEROSTRUCTURES; (GA,MN)AS; (1)
DILUTE MAGNETIC-ALLOYS; GAPLESS FERMI SYSTEMS; LARGE-N EXPANSION; PERTURBATION-THEORY; STATIC PROPERTIES; DOUBLE OCCUPANCY; CE COMPOUNDS; IMPURITIES; PHOTOEMISSION; VALENCE; (1)
DILUTE MAGNETIC SEMICONDUCTORS; ANGLE-RESOLVED PHOTOEMISSION; GA1-XMNXAS; BULK; TEMPERATURE; LEVEL; (1)
DILUTION ACTIVITY-COEFFICIENTS; GAUSSIAN-BASIS SETS; COSMO-RS; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; THERMODYNAMIC PROPERTIES; ATOMS LI; ENERGY; APPROXIMATION; TEMPERATURE; CHEMISTRY; (1)
DIMENSIONAL ELECTRON-GAS; KONDO; CONDUCTANCE; SIGNATURES; DEVICES; (1)
DIMENSIONAL ELECTRON-GAS; LANDAU-LEVEL; SPIN; (1)
DIMENSIONAL ELECTRON-GAS; LUTTINGER LIQUID; SUPERLATTICE; TRANSPORT; CONDUCTANCE; MODEL; (1)
DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE; OSCILLATIONS; FQHE; composite fermions; modulated 2DEGs (1)
DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; MAGNETOTRANSPORT; ORBITS; FIELDS; (1)
DIMENSIONAL ELECTRON-GAS; MODEL; (1)
DIMENSIONAL LIE-GROUPS; NON-ABELIAN EXTENSIONS; L-INFINITY-ALGEBRAS; UNIVERSAL COMPLEXIFICATIONS; PRINCIPAL BUNDLES; 2-GROUPS; STACKS; (1)
DIMENSIONAL PATTERN-CLASSIFICATION; SUPPORT VECTOR MACHINES; FDG-PET; COGNITIVE IMPAIRMENT; BRAIN PERFUSION; F-18-FDG PET; SPECT; DEMENTIA; IMAGES; PERFORMANCE; Principal-component analysis; Support-vector-machine; Computer-aided diagnosis; Alzheimer's disease (1)
DIMENSIONAL SYSTEMS; OPTICAL ORIENTATION; ELECTRON-GAS; PHOTON-DRAG; SPIN; FIELD; SEMICONDUCTOR; PARALLEL; CURRENTS; LAYER; (1)
dimension reduction, nonlinear elasticity, von Kármán plate equation, wave equation, elastodynamics (1)
Dimension reduction; Nonlinear elasticity; Wave equation; Γ-Convergence; (1)
DIMENSION REDUCTION PROBLEMS; NONLINEAR ELASTICITY; LOWER SEMICONTINUITY; EQUI-INTEGRABILITY; MEMBRANE THEORY; CONVERGENCE; QUASICONVEXITY; HOMOGENIZATION; RELAXATION; INTEGRALS; Dimension reduction; thin films; PDE constraints; A-quasiconvexity; Gamma-convergence (1)
DIMENSIONS; Cyber threat intelligence; Threat intelligence sharing; Data quality; Threat intelligence formats; Information security visualization (1)
Dimerisierung, dimerisation, Oligomerisierung, oligomerisation, Bestophin, VMD2, Morbus Best, Best Disease, AVMD, ADVIRC, ARB, AMD, Kanal, Channel, Chloridkanal, choride channel, RPE, Retina, Auge, eye (1)
Dimerization (of piperidineacetonitrile with tert-butylmagnesium chloride) nitriles aminodipiperidinocrotono crotononitriles amino piperidino piperidinocrotononitriles amino (1)
DIMERS; (1)
Dimers Role: PRP (Properties), SPN (Synthetic preparation), PREP (Preparation) (hydrogen-bonded in dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate crystals) Hydrogen bond (in dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate crystals) Crystal structure Molecular structure (of dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate) mol structure dibenzodiazepinone acylated deriv crystal structure dibenzodiazepinone acylated deriv hydrogen bond dimer dibenzodiazepinone acylated deriv (1)
Dimethylfumarat; ABT-199; Kolorektales Karzinom (1)
dimethyl fumarate (DMF); EZH2; histone methylation; lymphoma; Polycomb Repressive Complex 2 (PRC2) (1)
DIMETHYL-SULFOXIDE SOLUTION; DENSITY-FUNCTIONAL THEORY; POLARIZABLE CONTINUUM MODEL; THEORETICAL AB-INITIO; PROTON AFFINITY; 1ST-PRINCIPLE PREDICTIONS; ORGANIC SUPERBASES; AQUEOUS-SOLUTION; HIGH BASICITY; PK(A) VALUES; pK(a); acetonitrile; acidity; COSMO; COSMO-RS; density functional theory (1)
DIMETHYLTHYMINE CYCLOBUTANE DIMER; REDOX-PHOTOSENSITIZED REACTIONS; VISIBLE-LIGHT; ELECTRON-TRANSFER; RING-CLEAVAGE; DIARYLCYCLOBUTANES; REACTIVITY; CYCLOREVERSION; MONOMERIZATION; PHOTOLYASE; cyclobutanes; cycloelimination reactions; electron transfer; photocatalysis; time-resolved spectroscopy (1)
DIMORPHIC MALES; CARDIOCONDYLA; EVOLUTION; COMPETITION; Ergatoid ants; monogyny; Cardiocondyla stambuloffii; Cardiocondyla koshewnikovi (1)
DIMORPHIC MALES; Cardiocondyla; male polymorphism; population structure; colony structure; polygyny (1)
DIMORPHIC MALES; DISPERSAL; EVOLUTION; MIMICRY; QUEENS; (1)
DIMORPHIC SEEDS; CLIMATE-CHANGE; CHENOPODIUM-ALBUM; SALINE CONDITIONS; MEDICINAL-PLANTS; HALOPHYTE SEEDS; DESERT; TEMPERATURE; SALSOLA; LIGHT; germination; Haloxylon salicornicum; perianth color; salinity tolerance; temperature (1)
DINUCLEAR IRIDIUM(III) COMPLEXES; TRANSITION-METAL-COMPLEXES; PLATINUM(II) COMPLEXES; EXCITED-STATES; TRIPLET-STATE; BASIS-SETS; POLYMER; EMISSION; PHOSPHORESCENCE; LIGANDS; (1)
DINUCLEAR IRON(III) COMPLEX; SELECTIVE DETERMINATION; HOMOVANILLIC ACID; MIMETIC ENZYME; LUMINESCENCE; TETRACYCLINES; SUBSTRATE; BIOASSAYS; REAGENT; LIGAND; hydrogen peroxide; europium; tetracycline; luminescence assay (1)
DINUCLEAR RHODIUM COMPLEXES; BRIDGING PHOSPHANES; MOLECULAR-STRUCTURE; STRUCTURAL CHARACTERIZATION; SUPRAMOLECULAR CHEMISTRY; COORDINATION BEHAVIOR; TERTIARY PHOSPHANES; CONJUGATED SYSTEMS; BONDING MODE; AG-I; (1)
DINUCLEAR RHODIUM COMPLEXES; SUPRAMOLECULAR ASSEMBLIES; COORDINATION BEHAVIOR; NITROGEN-HETEROSUPERBENZENE; CONJUGATED SYSTEMS; MOLECULAR CLIPS; PT-II; PD-II; CHEMISTRY; DRIVEN; Heterocycles; N; P ligands; Pi interactions; Polyaromatic fragments; Supramolecular chemistry (1)
DINUCLEAR RHODIUM COMPLEXES; WEAKLY COORDINATING ANIONS; NONCLASSICAL BONDING MODES; X-RAY; STRUCTURAL-CHARACTERIZATION; PALLADIUM(I) DIMERS; TERTIARY PHOSPHANES; MOLECULAR-STRUCTURE; CONJUGATED SYSTEMS; CRYSTAL-STRUCTURE; bridging ligands; coordination modes; gold; P ligands; silver (1)
DIODE; HETEROSTRUCTURE; MAGNETIZATION; ACCUMULATION; SPINTRONICS; (GA,MN)AS; VALVE; GAAS; gallium arsenide; gallium compounds; magnetoelectronics; manganese compounds; spin polarised transport; spin valves; tunnel diodes (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; LONG-TERM OUTCOMES; 5-YEAR FOLLOW-UP; INTRAOCULAR-PRESSURE; INTRAVITREAL BEVACIZUMAB; EXFOLIATION SYNDROME; DISPERSION SYNDROME; DIABETES-MELLITUS; RUBEOSIS IRIDIS; AHMED GLAUCOMA; Laser iridotomy; Treatment; Increased intraocular pressure; Prophylaxis; Panretinal laser coagulation (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; PANRETINAL PHOTO-COAGULATION; OPEN-ANGLE GLAUCOMA; RUBEOSIS IRIDIS; INTRAVITREAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; DIABETES-MELLITUS; AHMED GLAUCOMA; PHOTOCOAGULATION; RETINOPATHY; secondary glaucoma; neovascular glaucoma; diabetic retinopathy; central retinal vein occlusion; Schwartz-Matsuo syndrome; therapy (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; PANRETINAL PHOTO-COAGULATION; RUBEOSIS IRIDIS; AHMED GLAUCOMA; ANGLE NEOVASCULARIZATION; INTRAVITREAL BEVACIZUMAB; TRANSSCLERAL CYCLOPHOTOCOAGULATION; OCULAR NEOVASCULARIZATION; RETINAL PHOTOCOAGULATION; IRIS NEOVASCULARIZATION; Neovascular glaucoma; rubeosis iridis; pathogenesis; diagnosis; treatment (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; TRABECULECTOMY AB INTERNO; INTRAOCULAR-PRESSURE; MITOMYCIN-C; CLINICAL-OUTCOMES; DEEP SCLERECTOMY; IRIS MELANOMA; UNITED-STATES; RISK-FACTORS; MANAGEMENT; Uveitis; Trauma; Vitrectomy; Carotid-cavernous sinus fistula; Ocular pressure (1)
DIODE-LASER; EFFICACY; epilation; long-pulsed Nd : YAG-laser (1)
DIODE-LASER PHOTOCOAGULATION; ENDOTHELIAL GROWTH-FACTOR; THRESHOLD RETINOPATHY; INTRAVITREAL BEVACIZUMAB; MULTICENTER TRIAL; ZONE-I; CRYOTHERAPY; ROP; POPULATION; INJECTION; retinopathy of prematurity; anti-VEGF; bevacizumab; vascular endothelial growth factor (1)
; Diode laser photocoagulation; Ranibizumab; Avascular retinal areas; Retinal detachment; Vascular endothelial growth factor (1)
DIODE-LASER; TIME REGIMEN; PHOTOCOAGULATION; INJURY; RPE; THRESHOLD; DAMAGE; NANOSECOND; EXPOSURE; LESIONS; (1)
DIODES; OXIDATION; (1)
DIPEPTIDYL-PEPTIDASE-IV; RENAL-CELL CARCINOMA; ENDOTHELIAL-CELLS; CD13/APN TRANSCRIPTION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; DOWN-REGULATION; EXPRESSION; TUMOR; CANCER; (1)
DIPHENYL DITELLURIDE; ABSORPTION-SPECTRA; COMPLEXES; TRANSITIONS; CHLORIDE; Electronic spectra; Photochemistry; Phosphorescence; Luminescence; Charge transfer; Tellurium (1)
Diphosphenes · Photoisomerization · Photoswitch · Quantum Chemical Calculations · Structure Elucidation (1)
Diphosphetkomplex, Silylen, Übertragungsreaktion, Asn-Ligandkomplexe, diphosphete complex, silylene, transfer reaction, Asn ligand complexes (1)
dipolar glass polymer; dielectric materials; glass transition temperature (1)
DIPOLAR HARD-SPHERES; ELECTRORHEOLOGICAL FLUIDS; FERROFLUIDS; ORDER; CLUSTERS; DYNAMICS; (1)
DIPOLAR INTERACTIONS; TRIPLET EMITTERS; organic semiconductors; conducting polymers; magnetoresistance; magnetic field effects; poly(styrene-sulfonate)-doped poly(3,4-ethylenedioxythiophene) (PEDOT:PSS) (1)
Dipole (-induced-dipole interactions, in aniline- and toluene-argon complexes, electrostatic stabilization energies in relation to); Stabilization energy (electrostatic, of aniline- and toluene-argon complexes, dipole-induced-dipole interactions in relation to); Laser radiation (fluorescence excitation by, in aniline-argon and -neon complexes, excited state energetics in relation to); Fluorescence (laser-induced, of aniline-argon and -neon complexes, excited state energetics in relation to); fluorescence laser aniline neon argon; excited state energy aniline neon (1)
Dipole moment (of iodine chloride); Fluorescence (laser-induced, from iodine chloride); elec dipole moment iodine chloride; pendular spectra laser induced fluorescence (1)
dipstick, biogenic amine, food analysis (1)
DIRAC EIGENVALUE; OPERATOR; SURGERY; METRICS; (1)
DIrac equation, decay estimate, null directions, asymptotically flat spacetimes, hyperbolic equation, Lippmann-Schwinger equation (1)
Dirac -Equation; Kerr -Newman -geometry; Black holes; Quantum mechanics in curved space-time; Eddington-Finkelstein-Coordinates (1)
DIRAC-FERMIONS; BERRY PHASE; (1)
DIRAC FERMIONS; QUANTUM; CONDUCTION; EMERGENCE; POINTS; NUMBER; (1)
DIRAC FERMIONS; SUPERCONDUCTIVITY; STATES (1)
Dirac harmonic maps, index theory (1)
; Dirac-harmonic maps; Twistor spinors (1)
Dirac Landau levels, Surfaces with constant negative curvature (1)
DIRAC OPERATOR; COLOR SUPERCONDUCTIVITY; PARTITION-FUNCTIONS; CHIRAL-SYMMETRY; CRITICAL FIELD; MATTER; MODEL; SPECTRUM; LATTICE; THERMODYNAMICS; Chiral Lagrangians; Phase Diagram of QCD; Matrix Models; Spontaneous Symmetry Breaking (1)
DIRAC OPERATOR; ELLIPTIC-SYSTEMS; KILLING SPINORS; RICCI CURVATURE; EIGENVALUE; HYPERSURFACES; EXISTENCE; UNIQUE; (1)
DIRAC OPERATOR; HARMONIC SPINORS; EIGENVALUE; Dirac operator; Eigenvalue; Surgery (1)
DIRAC OPERATOR; HOLONOMY; STABILITY; (1)
DIRAC OPERATOR; LATTICE QCD; CHIRAL-SYMMETRY; SQUARE-ROOT; FERMIONS; SIMULATIONS; ALGORITHMS; DYNAMICS; LOCALITY; QUARKS; Lattice quantum chromodynamics; Overlap fermions; Hybrid Monte Carlo (1)
Dirac operator, Lp-spectrum, Green function, hyperbolic space, product spaces (1)
DIRAC OPERATOR; SCALAR CURVATURE; EIGENVALUE; MANIFOLDS; Dirac operator; mass endomorphism; surgery (1)
DIRAC OPERATOR; SCALAR CURVATURE; YAMABE PROBLEM; EIGENVALUE; MANIFOLDS; BOUNDS; Conformal differential geometry; Spin geometry (1)
DIRAC OPERATORS; MANIFOLDS; SPECTRUM; SYMMETRY; GAPS; variational principle for eigenvalues; estimates for eigenvalues; asymptotic distribution of eigenvalues; quadratic numerical range; magnetohydrodynamics; warped product of spin manifolds; Dirac operator (1)
DIRAC OPERATOR; Spin geometry; Geometric evolution equation; Gradient flow; Berger spheres; Collapse; Stability (1)
Dirac operator, surgery, dirac spectrum, spin geometry, eigenvalues (1)
DIRAC OPERATOR; YAMABE PROBLEM; SCALAR-CURVATURE; EIGENVALUE; MANIFOLDS; (1)
Diracsche Löchertheorie , Dirac-Vakuum , Dirac-Gleichung , relativistische Quantenmechanik , mathematische Physik , Variationsproblem , Dirac-See , Dirac sea , relativistic quantum mechanics , mathematical physics , variational principle (1)
Dirac spinors, Baryogenesis, Causal fermion systems, Modified Dirac dynamics, Matter-antimatter asymmetry problem, Minkowski spacetime (1)
Direct acting antivirals; Hepatitis C; Liver cirrhosis; Adipokine (1)
DIRECT ANTERIOR APPROACH; ACETABULAR COMPONENT; OSTEOLYSIS; WEAR; VALIDATION; MIGRATION; FAILURE; Liner exchange; Polyethylene wear; Revision arthroplasty; Dislocation; EBRA (1)
DIRECT APERTURE OPTIMIZATION; CARLO DOSE CALCULATION; VOLUME CONSTRAINTS; IMRT OPTIMIZATION; RADIATION-THERAPY; ALGORITHM; BEAMS; CONVERGENCE; DEGENERACY; COLLIMATOR; (1)
DIRECT APERTURE OPTIMIZATION; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; DOSE CALCULATION; PHOTON; IMRT; ALGORITHM; BEAM; OBJECTIVES; TUMORS; (1)
DIRECT APERTURE OPTIMIZATION; MODULATED ARC; HELICAL TOMOTHERAPY; THERAPY; IMRT; CANCER; SYSTEM; IMAT; Tomotherapy; VMAT (1)
DIRECT APERTURE OPTIMIZATION; MODULATED ARC THERAPY; DOSE CALCULATION; CONFORMAL RADIOTHERAPY; IMRT; UNCERTAINTY; ALGORITHM; CANCER; RISK; Inverse Monte Carlo; optimization; IMAT; anal carcinoma (1)
DIRECT-APERTURE OPTIMIZATION; QUALITY-OF-LIFE; NECK-CANCER; SALIVARY FUNCTION; GLAND FUNCTION; ARC THERAPY; SHOOT IMRT; HEAD; RADIOTHERAPY; IRRADIATION; intensity modulated radiation therapy (IMRT); direct machine parameter optimization (DMPO); direct aperture optimization (DAO); head and neck cancer; parotid sparing (1)
DIRECT BEHAVIORAL EVIDENCE; NESTMATE RECOGNITION; FIRE ANTS; LEPTOTHORAX-NYLANDERI; TEMNOTHORAX ANTS; COLONY STRUCTURE; HYMENOPTERA; HYBRIDIZATION; FORMICIDAE; EVOLUTION; colony odor; cuticular hydrocarbons; hybridization; Temnothorax (1)
direct behavior rating; test; sensitivity over time; rating; school; classroom behavior; progress monitoring (1)
DIRECT COPPER ELECTRODEPOSITION; DIFFUSION BARRIER; LINER MATERIALS; NUCLEATION; SECM; CU; INTERCONNECTS; DEPOSITION; CORROSION; GROWTH; Scanning electrochemical microscopy; Electrodeposition; Copper; Nucleation; Semiprecious thin-film material (1)
DIRECT COPPER ELECTRODEPOSITION; LINER MATERIALS; NUCLEATION; DEPOSITION; BARRIERS; GROWTH; LAYERS; TAN; Scanning electrochemical microscopy; Hydrogen evolution reaction; Thin film metals; Substrate generation-tip collection mode (1)
DIRECT CORTICAL STIMULATION; FUNCTIONAL MRI; LANGUAGE LATERALIZATION; BRAIN-TUMORS; TEST-RETEST; MOTOR; REPRODUCIBILITY; RELIABILITY; LOCALIZATION; ACTIVATION; Functional MRI; Motor cortex; Language; Brain function; Clinical fMRI (1)
DIRECT-COSMO-RS; SCREENING MODEL; REAL SOLVENTS; BASIS-SETS; PREDICTION; APPROXIMATION; MOLECULES; CHARGE; ATOMS; (1)
DIRECT-CURRENT STIMULATION; NONVERBAL FLUENCY; ELECTRICAL-STIMULATION; SEMANTIC FLUENCY; DESIGN FLUENCY; CORTEX; TASK; TDCS; SCHIZOPHRENIA; DYSFUNCTION; (1)
DIRECT-CURRENT STIMULATION; PRIMARY MOTOR CORTEX; PREFRONTAL CORTEX; FUNCTIONAL MRI; VISUAL-CORTEX; HUMAN BRAIN; RECOGNITION MEMORY; CATEGORY KNOWLEDGE; WORKING-MEMORY; SYSTEMS; Transcranial direct current stimulation; Transcranial random noise stimulation; Prototype distortion task; Visual categorization; Dorsolateral prefrontal cortex (1)
DIRECT-CURRENT STIMULATION; REMITTED 1ST-EPISODE PSYCHOSIS; NONINVASIVE BRAIN-STIMULATION; ANXIETY DISORDERS; MOOD DISORDERS; PSYCHIATRIC-DISORDERS; MAINTENANCE TREATMENT; LIFETIME PREVALENCE; RESEARCH PRIORITIES; EXPOSURE THERAPY; (1)
DIRECT-CURRENT STIMULATION; SUPERIOR PARIETAL CORTEX; VOXEL-BASED MORPHOMETRY; SHAM-CONTROLLED TRIALS; SOCIAL COGNITION; FUNCTIONAL CONNECTIVITY; CYTOARCHITECTONIC AREAS; DOUBLE-BLIND; METAANALYSIS; DISORDER; major depressive disorder; depression; right temporoparietal junction; resting state; connectivity; functional magnetic resonance imaging (1)
; Direct detection; mecA; methicillin-resistant Staphylococcus aureus; MRSA; PCR; SCCmec (1)
; Direct detection; mecA; Methicillin-resistant Staphylococcus aureus; MRSA; PCR; SCCmec (1)
DIRECTED DNA METHYLATION; LOCUS-C CHROMATIN; PAF1 COMPLEX; P-TEFB; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; PLANT-GROWTH; SH2 DOMAIN; PROTEIN; (1)
DIRECTED DNA METHYLATION; RNA-POLYMERASE-II; SPT4-SPT5 COMPLEX; NONCODING RNA; ELONGATION; IV; SPT4/SPT5; CHROMATIN; SUBUNITS; REQUIRES; SPT4/SPT5L; Chromatin; Gene expression; RNA-directed DNA methylation (RdDM); RNA polymerase V (1)
DIRECTED EVOLUTION; OLEFIN; STREPTAVIDIN; ATROPISOMERISM; CHEMISTRY; Metathesis; Atropisomerism; Biocatalysis; Biotransformations; Artificial Metalloenzymes (1)
Directed Forgetting, List Output Order, Serial List Position, Reset of Encoding, Interference (1)
directed forgetting, response latencies, selective forgetting, gerichtetes Vergessen, Antwortlatenzen, selektives Vergessen (1)
DIRECTED HEMODYNAMIC THERAPY; SURGICAL-PATIENTS; METAANALYSIS; OPTIMIZATION; MANAGEMENT; CARE; Blood pressure; Cardiac surgery; Coagulation; Haemodynamic management; Postoperative haemorrhage (1)
DIRECTED LIGANDS; INHIBITION; TARGET; POTENT; IDENTIFICATION; OPTIMIZATION; THERAPEUTICS; INVOLVEMENT; AGONISTS; BINDING; histamine H-3 receptor; sigma-1 receptor; sigma-2 receptor; piperazine derivatives; piperidine derivatives; dual targeting compounds; molecular docking; dynamics; functional characterization (1)
DIRECTED ORTHO-METALATION; RAY CRYSTAL-STRUCTURES; MEDIATED MANGANATION(II); FUNCTIONALIZED ARENES; AMIDE CHEMISTRY; OXYGEN CAPTURE; SOLVENT-FREE; ALKALI; COMPLEXES; MANGANESE(II); (1)
DIRECT FUNCTIONALIZATION; COUPLING REACTION; RING EXPANSION; BASIS-SETS; IMIDES; OXIDATION; AMIDES; AMINES; APPROXIMATION; LENALIDOMIDE; (1)
DIRECT-INTERVIEW FAMILY; PANIC DISORDER; COMMUNITY SAMPLE; PHOBIA; CHILDHOOD; ABUSE; TWIN; HERITABILITY; FEARS; PSYCHOPATHOLOGY; social phobia; social anxiety disorder; developmental trauma; parental rearing styles; genetic transmission (1)
DIRECTIONAL ATTRACTIVE FORCES; AQUEOUS-ELECTROLYTE SOLUTIONS; ACTIVITY-COEFFICIENTS; OSMOTIC COEFFICIENTS; GUANIDINIUM CHLORIDE; IONIC INTERACTIONS; AMINO-ACIDS; THERMODYNAMIC PROPERTIES; HYDROCHLORIDE SOLUTIONS; VAPOR-PRESSURES; (1)
DIRECTIONAL ATTRACTIVE FORCES; ELECTROLYTE SOLUTIONS; PERTURBATION-THEORY; MOLECULAR-DYNAMICS; WATER ACTIVITY; SALT-SOLUTIONS; IONIC LIQUIDS; FLUIDS; ACID; EQUATION; Osmotic coefficient; Electrolyte perturbed-chain statistical associating fluid theory; Equation of state; (S)-Aminobutanedioic acid sodium salt; Aminomethanamidine (guanidinium) hydrochloride; Electrolyte; Activity coefficient (1)
DIRECTION; SENSE; Pedestrian navigation; Indoor user interface; Map presentation; Adaptive interfaces (1)
DIRECT LATERAL APPROACH; TOTAL HIP-REPLACEMENT; GREATER TROCHANTER; SURGICAL TECHNIQUE; REPAIR; PAIN; MAXIMUS; MEDIUS; MUSCLE; TEARS; Hip abductor mechanism; Total hip replacement; Gluteal repair; Muscle transfer; Mass rupture (1)
DIRECT ORAL ANTICOAGULANTS; MOLECULAR-WEIGHT HEPARINS; ED AMERICAN-COLLEGE; CHILDBEARING POTENTIAL GUIDANCE; DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; RISK-FACTORS; ANTITHROMBOTIC THERAPY; INDUCED THROMBOCYTOPENIA; POSTPARTUM PERIOD; venous thromboembolism; thromboprophylaxis; pregnancy; postpartum; risk assessment; heparin (1)
DIRECT REPEAT LOCUS; TANDEM DNA REPEATS; VARIABLE-NUMBER; NUCLEOTIDE POLYMORPHISMS; SPACER OLIGONUCLEOTIDES; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; STRAIN DIFFERENTIATION; GLOBAL DISTRIBUTION; COPY NUMBERS; (1)
DIRECT THROMBIN INHIBITOR; FACTOR XA INHIBITOR; ATRIAL-FIBRILLATION; LIQUID-CHROMATOGRAPHY; COAGULATION ASSAYS; MASS-SPECTROMETRY; PHARMACOKINETICS; WARFARIN; PHARMACODYNAMICS; THERAPY; dose-related range; assumed therapeutically effective concentrations; direct oral anticoagulants; apixaban; rivaroxaban; dabigatran; ultra-high performance liquid chromatography (1)
direct-touch, FTIR, mouse emulation, multi-touch, shadow tracking, tabletop interfaces (1)
diritto di recesso, consumatore, contratti porta a porta, contratti a distanza, right of withdrawal, consumer, off-promises contracts, distance contracts (1)
DIS3, Circular RNAs, Degradation, RNA Exosome (1)
DISABILITY; DIAGNOSIS; motivation fur psychotherapy; depression; pension application; therapy results (1)
disability, future, participation, temporality, youth (1)
Disassembly line balancing; Collaborative robots; Cobots; Profit-oriented (1)
; disaster medical response; disaster control; terrorism; natural disasters; large-scale catastrophe (1)
DISCHARGE RATES; ELECTROMYOGRAPHY; Electromyography; Neurography; DGKN-certificate; nerve conduction velocity; conduction block (1)
Disc herniation, outcome, radicular pain, urgent discectomy (1)
DISCONTINUED CARDIOPULMONARY-RESUSCITATION; NO NEUROLOGIC SEQUELAE; SPONTANEOUS-RECOVERY; AUTO-PEEP; ELECTROMECHANICAL DISSOCIATION; INTRAOPERATIVE RESUSCITATION; VENTRICULAR-FIBRILLATION; UNEXPECTED RETURN; DECISION-MAKING; DEFINE PATIENTS; Lazarus phenomenon; Resuscitation; Spontaneous return of circulation after cessation of resuscitation (1)
discount rates, uncertainty, risk aversion (1)
DISCOURSE; gender-based violence; journalistic texts; cultural patterns; cultural standards; interculturality; discourse analysis (1)
DISCREPANCY; INEQUALITY; RADIOGRAPHS; FEMUR; (1)
DISCRETE FAMILY SYMMETRY; SUSY GAUGE-THEORIES; FLAVOR SYMMETRY; STANDARD MODEL; B-DECAYS; LIFETIME DIFFERENCE; LEADING LOGARITHMS; FERMION MASSES; BETA-FUNCTION; UNIFICATION; (1)
DISCRETE SPACE-TIME; (1)
DISCRETE SPACE-TIME; FERMION SYSTEMS; SPHERE; (1)
DISCRETE SPACE-TIME; FIELD-THEORY; SINGULARITY STRUCTURE; SYMMETRY; EXPANSION; (1)
DISCRETE SPACE-TIME; PRINCIPLE; GRAVITY; FOAM; (1)
discrete spectrum; self-adjoint holomorphic operator; power series expansion; recurrence relation (1)
DISCRIMINATION; DISCLOSURES; BEHAVIOR; ERRORS; Peer-to-peer lending; Soft information; Funding probability; Probability of default (1)
DISEASE (1)
DISEASE; (1)
DISEASE 2019 COVID-19; VENOUS THROMBOEMBOLISM; DISPARITIES; PNEUMONIA; GENDER; JAPAN; CARE; COVID-19 disease severity; cardiovascular disease; comorbidities; coagulation; inflammation; PSM; biomarker; ethnicity; race (1)
DISEASE-ACTIVITY; HEALTH; PREVALENCE; Social support; Stress-buffering hypothesis; Depression; Rheumatoid arthritis (1)
DISEASE; Anti-GBM disease; relapse; Acute kidney injury; Kidney biopsy; Antibodies; monoclonal; Plasma exchange (1)
DISEASE; CANCER; BLOOD; IMMUNOSENESCENCE; GENETICS; RISK; (1)
DISEASE; CARE; RISK; Telestroke; COVID-19; lockdown; stroke; thrombolysis (1)
DISEASE; CARRIAGE; OUTBREAK; RECRUITS; Neisseria meningitidis; chemoprophylaxis; epidemiology; carriage (1)
DISEASE; CLASSIFICATION; DIAGNOSIS; von Willebrand disease; Classification; Diagnosis; Therapy; Physiology (1)
DISEASE; CONTROVERSIES; ENDOSCOPY; MARKERS; Ulcerative colitis; Contrast-enhanced ultrasound (CEUS); Histopathological scoring; C-reactive protein (1)
DISEASE; CYTOKINES; IMMUNITY; interferon-gamma receptor-1 deficiency; Mycobacterium peregrinum infection; disseminated mycobacterial disease; infection and interferon-gamma receptor-1 deficiency (1)
disease etiology; sex; UICC score; survival (1)
DISEASE; folliculitis; genetic; hair loss; immune system; therapy (1)
DISEASE GCKD; ALL-CAUSE; RISK; TRYPTOPHAN; HAZARDS; DESIGN; (1)
DISEASE GENE ABCR; RECESSIVE RETINITIS-PIGMENTOSA; CONE-ROD DYSTROPHY; FUNDUS-FLAVIMACULATUS; TRANSPORTER GENE; RETINAL DYSTROPHIES; DARK-ADAPTATION; DEGENERATION; ELECTRORETINOGRAPHY; LIPOFUSCIN; (1)
DISEASE GENE ABCR; TANGIER-DISEASE; MUTATIONS; (1)
DISEASE; GENE; Parkinson disease; Niemann-Pick C disease; Parkinsonism; Genetics; Lysosomal storage; Gaucher disease (1)
DISEASE; IL-3 (1)
DISEASE; IMPLANTATION; MULTICENTER; HEMOSTASIS; SYSTEM; MitraClip; mitral valve repair; PASCAL; von Willebrand factor (1)
DISEASE; MODEL; EVEROLIMUS; CONVERSION; TRIAL; (1)
DISEASE-MODIFYING THERAPIES; PLACEBO-CONTROLLED PHASE-3; DOUBLE-BLIND; GLATIRAMER ACETATE; ORAL TERIFLUNOMIDE; INTERFERON-BETA; ALEMTUZUMAB; ADHERENCE; MS; BG-12; disease modifying therapies; multiple sclerosis; real-world data; relapsing-remitting multiple sclerosis; treatment switch (1)
DISEASE; PATHOGENESIS; INVOLVEMENT; SCLERODERMA; WALL; (1)
DISEASE PROGRESSION; NATURAL-HISTORY; MESSENGER-RNA; EYE DISEASE; FACTOR-H; COMPLEMENT; RISK; AMD; ARMS2; NEUROGENESIS; (1)
DISEASE RESISTANCE; CELL-DEATH; SALICYLIC-ACID; SNARE-PROTEIN; ENZYME AMSH3; ARABIDOPSIS; GENE; RECOGNITION; DEFENSE; AUTOIMMUNITY; (1)
DISEASE RESISTANCE; GROUP FACILITATION; COLONY STRUCTURE; HYMENOPTERA; REPRODUCTION; BEHAVIOR; INSECT; FORMICIDAE; DOMINANCE; FITNESS; Altruism; self-removal; lethal infection; disease management; Terminal investment; Ants; Temnothorax (1)
DISEASE RESISTANCE; HYGIENIC BEHAVIOR; VARROA-DESTRUCTOR; FOOD CONDITIONS; APIS-MELLIFERA; SOCIAL INSECT; IMMUNITY; HYMENOPTERA; PERFORMANCE; EXPRESSION; co-evolution; termite; mite; adaptive; parasite; behaviour (1)
DISEASE RESISTANCE; METARHIZIUM-ANISOPLIAE; SOCIAL IMMUNITY; INSECT; DIVERSITY; EVOLUTION; PATHOGENS; HONEYBEES; DYNAMICS; SURVIVAL; Metarhizium; Indirect transmission; Direct transmission; Epidemiology; Parasite transmission; Social immunity (1)
DISEASE-SUSCEPTIBILITY GENE; MONOSACCHARIDE TRANSPORTER; BACTERIAL-BLIGHT; H+/HEXOSE COTRANSPORTER; SUCROSE TRANSPORTER; SECRETED EFFECTOR; SMUT FUNGUS; ROOT HAIRS; MAIZE; ARABIDOPSIS; (1)
DISEASES; YIELD; Fever of unknown origin; FUO; inflammation of unknown origin; IUO (1)
DISEASE TYPE-C; CHOLESTEROL; ADULT; MIGLUSTAT; THERAPY; BRAIN; MANIFESTATIONS; EXPRESSION; DIAGNOSIS; GENE; Inborn errors of metabolism; Niemann-Pick disease type C; organic psychosis (1)
DISEASE VIRUS (1)
DISEASE VIRUS; EXPRESSION; RESERVOIR; GERMANY; BRAINS; SHREWS; CELLS; MICE; Virus; Bornavirus; Borna disease virus (BoDV-1); Zoonosis; Encephalitis (1)
DISEASE; whole genome sequencing; variant detection; structural variants; non-coding variants; bioinformatics (1)
disiloxanes; intermolecular interactions; Hirshfeld surface analysis; molecular models; silicon; X-ray crystallography (1)
disinfection, EDTA, laser, root canal, sodium hypochlorite, ultrasonic (1)
DISINTEGRATION; NANOMATERIALS; NANOCRYSTALS; MECHANISM; ENERGY; PHASE; SHELL; chemical stability; colloidal stability; nanoparticles; surface modification; upconversion (1)
DISK-DRIVE INDUSTRY; 3G VS. WIFI; COMPLEMENTARY ASSETS; CORPORATE CONTEXT; TECHNOLOGY; TELECOMMUNICATIONS; STRATEGIES; MARKET; PERFORMANCE; SUBFIELDS; (1)
DISK HERNIATION; Cervical radiculopathy; Cervical spine surgery; Cloward's method; Frykholm's method (1)
DISK HERNIATION; RADICULOPATHY; cervical disc herniation; foraminotomy; prognostic factors (1)
Diskriminierungsverbot Drittwirkung Gleichheitssatz (1)
Diskurstheorie , Dialogisches Prinzip , Institutionenökonomie , Sozialpolitik , Katholische Soziallehre , Polen , Transformation , Katholische Kirche , , discurse ethics , institutional economics , social policy , catholic social doctrine , Poland , transition , self-help groups (1)
DISLOCATIONS; JOINT; MANAGEMENT; acromioclavicular injury; therapy; survey (1)
DISLOCATIONS; REPAIR; CLASSIFICATION; SUTURE; Elbow; Dislocation; Reattachment; Common extensor muscle origin; Common flexor muscle origin (1)
DISLOCATIONS; STABILITY; DYNAMICS; MOTION; STATES; (1)
DISLOCATION-STRUCTURES; ENERGY MINIMIZATION; FINITE STRAINS; MICROSTRUCTURES; DEFORMATION; single-crystal plasticity; relaxation; microstructure (1)
DISLOCATION-STRUCTURES; MICROSTRUCTURES; DEFORMATION; STRAINS; Branching; single-crystal plasticity; microstructure (1)
Disodium-pentakis- (cyano-C) -nitrosyl-ferrate(2), Enamine Intermediates, Simon-Awe Complexes, Legal Complexes (1)
DISORDERED GRAPHENE; TRANSPORT; CAVITIES; (1)
DISORDERS; MPL515 (1)
disorders of cornification, desmoglein-1, keratoderma, palmoplantar (1)
DISORDERS; Psychometric Assessment of Symptoms; Questionnaire Development; ISR (1)
DISORDER; tinnitus; gradient boosting machine; mobile health; machine learning; multimodal data; explainable machine learning (1)
DISPERSAL MUTUALISM; ANT MYRMICA; SEX-RATIOS; FATE; POPULATION; STRATEGIES; FOOD; ant-plant mutualism; caste determination; colony growth; elaiosome; myrmecochory; Myrmica rubra (1)
DISPERSION COEFFICIENTS; HELIUM; RANGE; (1)
DISPERSION FORCES; SURFACE; PROTEINS; PH; MEMBRANES; ELECTROLYTES; EQUILIBRIUM; MODULATION; POTENTIALS; STABILITY; (1)
Dispersion interaction · Metalation · Steric hindrance · Pyridine · Organolithium (1)
DISPLACED FRACTURES; FIXATION; FLUOROSCOPY; Acetabular fractures; Minimal-invasive; Cadaveric study; Screw placement (1)
DISPLACED INTRAARTICULAR FRACTURES; COMPUTED-TOMOGRAPHY; SURGICAL-TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; GAIT ANALYSIS; CLASSIFICATION; MOTION; Calcaneal fracture; Calcaneocuboid; Pedography; SF-36; Outcome (1)
DISPLACED INTRAARTICULAR FRACTURES; OPERATIVE TREATMENT; SURGICAL TECHNIQUE; LOCKING PLATE; MODEL; FIXATION; SCREWS; STABILITY; FOOT; Calcaneal fracture; Plate design; Biomechanics (1)
displays, gauges, F-zips, crystalline cohomology, syntomic site, Witt vectors (1)
DISPOSITIONAL OPTIMISM; HEALTH; ORIENTATION; DISORDER; AROUSAL; self-efficacy; sexual interest in children; pedophilia; flexibility; questionnaire validation (1)
disruptive innovation; disruptive potential; ex-ante assessment; digital platforms; two-sided platforms; business model innovation; dominant design; dominant business model; online lending; marketplace lending; FinTech; regulated service industries (1)
disruptive innovation, health care, Germany (1)
disruptive innovation, health care, Germany, USA (1)
disruptive innovations, digital innovations, health care, innovation adoption and usage, motivation-ability framework, telemedicine (1)
disseminated cancer cells (DCCs), single-cell analysis, comparative genomic hybridization (CGH), array CGH, single-cell aCGH (1)
disseminated tumor cell; metastasis; early dissemination; bone marrow; lymph node; lung cancer; biomarker (1)
DISSEMINATED TUMOR-CELLS; BONE-MARROW; PROGNOSTIC IMPACT; SURVIVAL; GENOME; TRANSCRIPTOME; STATISTICS; disseminated cancer cells; lung cancer; metastatic precursor cells; sphere culture (1)
DISSEMINATED TUMOR-CELLS; BREAST-CANCER; ADHESION MOLECULE; ERYTHROID-CELLS; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; POSITIVE CELLS; ANTIBODY 9C4; STEM-CELLS; IN-VITRO; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER PATIENTS; MULTIPLE DISPLACEMENT AMPLIFICATION; CYTOKERATIN-POSITIVE CELLS; COPY NUMBER VARIATION; BONE-MARROW; GENETIC-ANALYSIS; ESOPHAGEAL CANCER; CLONAL EVOLUTION; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; MAMMARY-GLAND DEVELOPMENT; MINIMAL RESIDUAL CANCER; CDNA MICROARRAY DATA; CARCINOMA IN-SITU; ARRAY CGH DATA; BONE-MARROW; MOUSE MODEL; STEM-CELLS; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; METASTATIC BREAST-CANCER; BONE-MARROW; IN-VIVO; EARLY DISSEMINATION; SOLUBLE GP130; STEM-CELLS; RECEPTOR; IL-6; (1)
DISSEMINATED TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; BONE-MARROW; STEM-CELLS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; PANCREATIC-CANCER; RANDOMIZED-TRIAL; GENETIC-ANALYSIS; Breast cancer; Micrometastasis; Metastasis; Disseminated tumour cell; Circulating tumour cell (1)
DISSEMINATED TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; LUNG-CANCER; BONE-MARROW; METASTASIS; IMPACT; SPREAD; MICROMETASTASES; SURVIVAL; LESS; early metastasis; disseminated cancer cell; prognosis; molecular evolution of NSCLC (1)
DISSEMINATED TUMOR-CELLS; LIVER-TRANSPLANTATION; IMMUNOSUPPRESSION; CANCER; TRIAL; MTOR; (1)
DISSEMINATED TUMOR-CELLS; LUNG-CANCER; ADHESION MOLECULE; BREAST-CANCER; RECURRENCE; TRANSCRIPTOME; GENOME; Disseminated cancer cell; Metastasis; Early dissemination; Bone marrow; Lung cancer; Biomarker (1)
DISSEMINATED TUMOR-CELLS; MINIMAL RESIDUAL CANCER; BONE-MARROW; RADICAL PROSTATECTOMY; PERIPHERAL-BLOOD; SINGLE-CELL; HETEROGENEITY; TRANSCRIPTOME; PROGRESSION; MORTALITY; (1)
DISSEMINATED TUMOR-CELLS; PRIMARY COLORECTAL CANCERS; BREAST-CANCER; BONE-MARROW; CLONAL EVOLUTION; IN-SITU; ADHESION MOLECULE; GENOMIC ANALYSIS; GENETIC-ANALYSIS; DIVERSITY; (1)
Disseminierte Tumorzellen, Brustkrebs, Metastasen, Minimale Resterkrankung, Einzelzellisolation (1)
disseminierte Tumorzellen , Brustkrebs , SASH1, PLAGL1, Metastasierung , luminal , trippel negativ (1)
Dissertation, Decision Problems, Information Security (1)
DISSIPATION; CALIBRATION; Nanowire; magnetic force microscopy; nanomagnetism; torque magnetometry; MnAs nanocrystal; sequential crystallization (1)
DISSIPATION; TRANSPORT; (1)
DISSIPATIVE 2-STATE SYSTEM; TUNNELING DYNAMICS; OHMIC DISSIPATION; ELECTRON-TRANSFER; 2-LEVEL SYSTEM; QUANTUM-STATE; DRIVEN; MODEL; SIMULATION; (1)
DISSIPATIVE ENVIRONMENT; BOND BREAKING; DYNAMICS; SURFACE; DESORPTION; HYDROGEN; EXCITATION; MECHANISM; SILICON; (1)
DISSIPATIVE QUANTUM DYNAMICS; PHOTON-STIMULATED DESORPTION; DRIVEN SURFACE-REACTIONS; METAL-SURFACES; WAVE-PACKET; MEDIATED PHOTODESORPTION; NO; CO; EXCITATION; PT(111); (1)
DISSIPATIVE STRUCTURES; PATTERNS; DIFFUSION; CHANNELS; SYSTEM; capillaries in gels; dissipative structures; coupling of reaction; diffusion and convection; rate constants (1)
DISSOCIATION; BONDS; antibodies; binding strength; biophysics; dynamic force spectroscopy (1)
DISSOCIATION-CONSTANTS; CITRIC-ACID; CO-IONS; SALT; SERIES; BINDING; ANIONS; Hofmeister effects; ion specificity; horseradish peroxidase; enzyme kinetics; electrostatics (1)
DISSOCIATION-CONSTANTS; ELECTROLYTE MIXTURES; TARTARIC-ACIDS; MIXED ELECTROLYTES; DIBASIC ACIDS; PART III; CONDUCTIVITY; STEREOISOMERS; TARTRATES; AMMONIUM; (1)
Dissociation, Sense of ownership, Rubber hand illusion, Arousal, Emotion (1)
DISSOLVED ALIPHATIC-AMINES; MEMBRANES; ALCOHOLS; SENSORS; (1)
DISSOLVED-OXYGEN; INDICATORS; PLATFORM; OPTODES; optical oxygen sensor; optical pH sensor; MTP; enzyme activity; respiratory activity (1)
DISSOLVED-OXYGEN; MOLECULAR-OXYGEN; LIVE CELLS; NANOSENSORS; ENDOCYTOSIS; PORPHYRIN; SENSORS; GROWTH; PROBES; (1)
DISSOLVED-OXYGEN; PROTON-TRANSFER; BINDING-SITE; SYSTEM; CRYSTALLIZATION; ENVIRONMENT; GENERATION; Microfluidic segments; Droplet-based flow; Sensor particles; Flow-through measurement; Microfluorometry (1)
dissoziales Verhalten bei Mädchen, nachbarschaftliches Umfeld, familiäre Faktoren, Erziehungsverhalten (1)
DISTAL CONVOLUTED TUBULE; CHLORIDE CHANNEL GENE; THICK ASCENDING LIMB; BARTTERS-SYNDROME; MACULA DENSA; MESSENGER-RNA; MUTANT MICE; HENLES LOOP; MOUSE MODEL; RAT-KIDNEY; Bartter's syndrome; chloride channels; Clckb; gene targeting (1)
DISTAL CONVOLUTED TUBULE; NA+,K+-ATPASE GAMMA-SUBUNIT; CALCIUM-SENSING RECEPTOR; ROMK POTASSIUM CHANNEL; CENTRAL-NERVOUS-SYSTEM; RENAL MAGNESIUM LOSS; BARTTERS-SYNDROME; SECONDARY HYPOCALCEMIA; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; Kir4.1; Salt-losing syndrome; Distal convoluted tubule; Channelopathy; Potassium channel; Kidney; K channel; Transport; Epilepsy (1)
DISTAL CONVOLUTED TUBULE; RECTIFYING K+ CHANNEL; BASOLATERAL MEMBRANE; NACL COTRANSPORTER; POTASSIUM CHANNELS; KIR5.1; MUTATIONS; KIR4.1; EXPRESSION; LOCALIZATION; (1)
DISTAL CONVOLUTED TUBULE; SODIUM-CHLORIDE COTRANSPORTER; II BARTTERS-SYNDROME; SENSORINEURAL DEAFNESS; NA CHANNELS; MOUSE MODEL; K+; EXPRESSION; NCC; CL; collecting duct; connecting tubule; dietary potassium; diuretics; hypokalemia; potassium homeostasis (1)
DISTAL CONVOLUTED TUBULE; WIDE LINKAGE ANALYSIS; NA-CL COTRANSPORTER; BARTTERS-SYNDROME; K+ CHANNEL; POTASSIUM CHANNEL; BLOOD-PRESSURE; HYPOKALEMIC ALKALOSIS; BASOLATERAL MEMBRANE; KNOCK-OUT; (1)
DISTAL-CONVOLUTED TUBULE; ZINC-FINGER REPRESSOR; CLC-K2 MESSENGER-RNA; THIN ASCENDING LIMB; GENE PROMOTER; RAT-KIDNEY; SENSORINEURAL DEAFNESS; SURFACE EXPRESSION; MOUSE KIDNEY; MICE LACKING; Bartter syndrome; Barttin; chloride channel; diabetes insipidus (1)
distal; diametaphysär; Radiusfraktur; (1)
Distale Ischiadicusblockade; elektrische Reizschwelle; diabetische Polyneuropathie; sciatic nerve; electrical stimulation threshold; diabetic polyneuropathy (1)
Distale Radiusfraktur; Hemmende Wachstumsstörung; Kirschner-Draht-Osteosynthese; Ulnavarianz; Epiphysenfuge (2)
distale Radiusfraktur Kind, K-Drähte epicutan und percutan (1)
distale Radiusfraktur, Langzeitergebnis, DASH-Score (1)
distale Radiusfraktur, winkelstabile Plattenosteosynthese, postoperative Nachbehandlung, Mobilisation (1)
; distal radius fracture; epidemiology; circadian rhythm (1)
Distal radius fracture, Schede position, Paediatric fracture management, Conservative treatment (1)
DISTAL RADIUS; PLACEMENT; NOVICES; HAND; Haptic force feedback; K-wire; orthopedic; serious games; surgical simulation; virtual reality (1)
DISTAL ULCERATIVE-COLITIS; ACTIVE CROHNS-DISEASE; MODIFIED RELEASE BUDESONIDE; PREDNISOLONE RETENTION ENEMAS; ORAL BUDESONIDE; 5-AMINOSALICYLIC ACID; HYDROCORTISONE ACETATE; RECTAL BIOAVAILABILITY; MAINTENANCE TREATMENT; MULTICENTER TRIAL; (1)
DISTANCE CHARGE-TRANSPORT; RANGE OXIDATIVE DAMAGE; RADICAL-CATION MIGRATION; FLASH-QUENCH TECHNIQUE; DOUBLE-HELICAL DNA; SELF-ASSEMBLED MONOLAYERS; DRIVING-FORCE DEPENDENCE; MEDIATED HOLE-TRANSPORT; MOLECULAR WIRE BEHAVIOR; PROTEIN CROSS-LINKING; (1)
DISTANCE DEPENDENCE; DELTA-E-1/2 VALUES; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; LOW-BARRIER; DELOCALIZATION; OXIDATION; SYSTEMS; PROBES; MODEL; (1)
Distance education; information society; library (1)
DISTANCE SEED DISPERSAL; COMPLEX TERRAIN; PLUMED SEEDS; STEADY WINDS; TREE SEEDS; SHORT-TERM; MODEL; POPULATION; FALL; CONSEQUENCES; diaspore morphology; dispersal distance spectra; dispersal probability; falling velocity; long-distance dispersal; seed dispersal; seed morphology; simulation model; wind dispersal model; wind dispersal potential (1)
DISTANCE SEMANTICS; MINIMAL CHANGE; RAMSEY TEST; Enthymeme; Argument; Interpretation; Charity; Belief revision (1)
DISTANCES; MODELS; MECHANISMS; SHADOWS; SHEEP; (1)
Distance training, self-regulated learning, teacher training, higher education, computer anxiety, Computer attitude, intrinsic motivation, Cognitive Load Theory (1)
distant play; parasocial resistance; unnatural temporality; literary gaming; bookish play; The Longing; idle game; interpassive play; philosophical play (1)
DISTILLATION; STATES; (1)
DISTINCT CLINICOPATHOLOGICAL FEATURES; SERUM CARCINOEMBRYONIC ANTIGEN; LYMPH-NODE DISSECTION; MICROSATELLITE INSTABILITY; T-CELLS; INTESTINAL METAPLASIA; CANCER; EXPRESSION; LIGAND; ADENOCARCINOMAS; (1)
DISTINGUISHING TRANSIENT OSTEOPOROSIS; PROSTACYCLIN ANALOG ILOPROST; MARROW-EDEMA; PROXIMAL FEMUR; HIP-JOINT; NECROSIS; MANAGEMENT; DEATH; KNEE; Bone marrow edema; Osteonecrosis; Iloprost; Core decompression (1)
Distomo, Staatenimmunität (1)
DISTRACTION; RETRIEVAL; emotion regulation; humor; reappraisal; memory; coping (1)
DISTRESS; acute tinnitus; chronic tinnitus; questionnaire; causes for progression; predictors (1)
Distressed Real Estate Assets, Zwangsversteigerung, Immobilien, notleidende Immobilien, Bewertung, Immobilienverwertung, foreclosure, Zwangsversteigerungsabschlag (1)
DISTRESS-SYNDROME (1)
DISTRESS-SYNDROME; TRANSFUSION REQUIREMENTS; VENTILATION; ARDS; ECMO; Cardiohelp (1)
DISTRESS; WOMEN; PREVALENCE; WORK; CARE; Psychosocial counseling; Social service counseling; Certification; German Cancer Society; Quality indicators (1)
distributed events, information behaviours, information needs, mobile assistance system (1)
distributed events; information needs; mobile tourist assistance system;route customization; route generation (1)
distributed events, mobile assistance system, recommender (1)
Distributed Ledger, Incident Detection, Blockchain, Human-as-a-Security-Sensor (1)
distributed ledger,permissioned blockchain,information security,security monitoring,insider threat (1)
Distributed ledger, Permissioned blockchain, Information security, Visual analytics, Security monitoring (1)
Distributed ledgers; Blockchain; Digital twin; Industry 4.0; Decentralized application (1)
DISTRIBUTED PRACTICE; SKILL ACQUISITION; SLEEP; RETENTION; TRIAL; Curriculum planning; Massed learning; Medical education; Spaced learning; Spacing effect (1)
distributed trust concepts, measuring etrust, Internet voting (1)
distributed user interface; access control; anonymous credentials, Idemix, WallShare, IdeREST (1)
Distributed user interfaces, cloud deployment, cloud security, decision making, mission-critical situations (1)
Distributed user interfaces; usability testing and evaluation; security and privacy; HCI; mobile devices; WallShare (1)
Distributional fairness; Value added; Value added statement; CSR reporting; EVG&D; GRI (1)
DISTRIBUTION AMPLITUDES; QUANTUM CHROMODYNAMICS; EVANESCENT OPERATORS; SUM-RULES; NUCLEON; APPROXIMATION; INTEGRABILITY; GAUGE; (1)
Distribution, Distributionslogistik, Konsumgüter, FMCG (1)
distribution, granulocyte concentrates, granulocytes, modified fluid gelatin, neutrophils, separation, storage, transfusion (1)
Distribution logistics; Retailing logistics; Fast-moving consumer goods (FMCG); Distribution network analysis; Facility location (1)
DISTRIBUTION MODELS; SEXUAL REPRODUCTION; SAMPLE-SIZE; DISTRIBUTIONS; PERFORMANCE; EVOLUTION; PREDICTION; DIVERSITY; BIOLOGY; RARE; climate change; invasive species; niche modeling; tropics (1)
Distribution network; CO2 emissions; Road freight transportation; Traffic congestion; Online navigation service (1)
Distribution network, Distribution logistics, Urbanization, Fast-moving consumer goods (1)
distribution small org cation aq soln tetrabutylammonium bromide aq soln cation distribution heavy water tetrabutylammonium bromide cation distribution neutron scattering tetrabutylammonium bromide aq soln (1)
DISTRIBUTIONS; QUARK; (1)
Districting, Distribution, Service area, Mixed Integer Programming, In-night express (1)
DISTURBANCE; VEGETATION; PREDICTIONS; RESPONSES; ECOLOGY; TRAITS; PLANTS; plant strategy scheme; grazing; mulching; controlled burning; succession (1)
DISULFIDE BOND FORMATION; TIEFFARBIGKEIT 9-SUBSTITUIERTER ACRIDINE; LIGHT-HARVESTING ARRAYS; NEAR-INFRARED NIR; SPECTROSCOPIC PROPERTIES; CHARGE-TRANSFER; CROWN ETHERS; FLUORESCENCE PROBES; DIFLUORIDE BODIPY; TRIAD COMPOUNDS; boron-dipyrromethene; electrochemiluminescence; fluorescence; molecular switches; redox chemistry; thiol/disulfide chemistry (1)
disulfide ethylene diamine phthalocyanine coupling agent silicon chip copper leadframe epoxy adhesion promoter (1)
disulfides; photocatalysis; sulfones; sulfoxides; thiols; visible light (1)
DISULFONAMIDE-TI(O-ISO-PR)4-DIALKYL ZINC SYSTEM; CATALYTIC ASYMMETRIC ADDITION; AROMATIC-ALDEHYDES; DIALKYLZINCS; COMPLEXES; ALKYLATION; CYCLOPROPANATION; REAGENTS; (1)
DITHIOCARBAMATE COMPLEXES; OXIDATIVE STRESS; METHYLMERCURY; HGS; LIGAND; BINDING; INJURY; ACID; crystallography; fungi; mercuric sulfide; microparticles; nanoparticles (1)
DITHIOOXAMIDE COMPLEXES; LUMINESCENCE; crystal structure; dithiooxamide; photoluminescence; rhodium(III) (1)
Dithranol (anthralin) — Acetates Thymidine incorporation — DNA (1)
Dithranol — Metabolization in epidermis — Dithranol-Brown — Copper (1)
DIURNAL-VARIATION; CIRCADIAN-RHYTHM; MILD EXERCISE; SLEEP; NEURONS; OREXIN/HYPOCRETIN; RESPONSES; RECOVERY; LEVEL; Thermoregulation; Core body temperature; Hypocretin-1; Physical activity; Dorsal hypothalamus (1)
DIVALENT OSMIUM COMPLEXES; TRANSFER EXCITED-STATES; LIGHT-EMITTING-DIODES; ELECTROLUMINESCENT DEVICES; CHARGE-TRANSFER; TEMPERATURE-DEPENDENCE; POLYPYRIDYL COMPLEXES; DECAY DYNAMICS; GAP LAW; EMISSION; (1)
DIVALPROEX SODIUM; CARBAMAZEPINE; AGITATION; BEHAVIOR; TRIAL; WOMEN; ANGER; (1)
Diversification, Risk Concentration, CDO, Structured Credit (1)
Diversifizierung, Bibliotheksdienstleistungen (1)
DIVERSITY; IDENTIFICATION; CULTIVATION; BACTERIAL; ARCHAEAL; FACILITY; BACILLUS; CELLS; TOOL; Culture collection; Extremophilic microorganisms; Planetary protection (1)
DIVERSITY-ORIENTED SYNTHESIS; ENANTIOSELECTIVE CONJUGATE ADDITION; INHIBITORS; DISCOVERY; PROTEASE; gamma-lactam; maleimide; organocatalysis; parallel synthesis; reductive amination (1)
Diversity, Real estate education, Group composition, Real estate projects (2)
Divided attention, Discrimination, Contrast, Spatial frequency, Uncertainty (1)
Divided attention, Perceptual discrimination, Short-term memory, Spatial frequency (1)
DIVIDED ATTENTION; REDUNDANT-SIGNALS; NULL HYPOTHESIS; REACTION-TIME; CONFIDENCE-INTERVALS; NON-INFERIORITY; TESTS; EQUIVALENCE; COACTIVATION; STATISTICS; Divided attention; Cognitive architecture; Noninferiority; Model testing and validation (1)
DIVIDED ATTENTION; SEPARATE ACTIVATION; REDUNDANT SIGNALS; MODEL INEQUALITY; REACTION-TIME; COACTIVATION; TARGETS; Divided attention; Multisensory processing; Race model (1)
DIVISIA INDEX; CHOICE; AXIOMATIZATION; PREFERENCE; INFLATION; UTILITY; MODEL; Average rate of change; Time preference; Discount rate; Path-dependence (1)
DIVISIBLE GROUPS; REPRESENTATIONS; GL(N); SPACES; CONJECTURE; FIELD; Shimura varieties; p-adic uniformization; l-adic cohomology (1)
DIVISION-2 MALOCCLUSION; CRANIOFACIAL GROWTH; FACIAL TYPES; PREDICTION; OVERBITE; CHILDREN; PATTERN; MATURATION; IMPLANT; AGE; Orthodontics; Cephalometry; Malocclusion; Angle Class II; Tooth inclination; Retrospective studies (1)
DIVISION-OF-LABOR (2)
DIVISION-OF-LABOR; (1)
DIVISION-OF-LABOR; AGE POLYETHISM; COLONY SIZE; HONEY-BEES; FORMICIDAE; HYMENOPTERA; BADIUS; NEST; SOCIOGENESIS; SOCIOMETRY; Age polyethism; forager; Pogonomyrmex rugosus; nest maintenance workers; recruited foragers (1)
DIVISION-OF-LABOR; ARGENTINE ANT; R PACKAGE; PREDICTABILITY; FLEXIBILITY; FORMICIDAE; COLONIES; BEHAVIOR; SUCCESS; TRAITS; Invasive species; plasticity; social insects; variation (1)
DIVISION-OF-LABOR; ASCOMYCOTA LABOULBENIALES; RICKIA-WASMANNII; AGE POLYETHISM; ENTOMOPATHOGENIC FUNGI; HYMENOPTERA-FORMICIDAE; SOCIAL INSECTS; HOST BEHAVIOR; MANIPULATION; EVOLUTION; Parasite; Laboulbeniales; Rickia wasmannii; Locomotion; Fat content; Velocity (1)
DIVISION-OF-LABOR; BEES APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SUCROSE RESPONSIVENESS; SPATIAL-EXPRESSION; NATURAL VARIATION; INSECT SOCIETIES; GENE-EXPRESSION; NITRIC-OXIDE; FOOD-INTAKE; honeybee; division of labour; sucrose responsiveness; foraging gene/PKG (1)
DIVISION-OF-LABOR; BEES APIS-MELLIFERA; PHEIDOLE-DENTATA; HONEY-BEES; CARDIOCONDYLA-OBSCURIOR; SOCIAL INSECTS; BEHAVIORAL-DEVELOPMENT; LIFE-SPAN; AGE; HYMENOPTERA; Group demography; Social insects; Aging; Task performance; Colony productivity (1)
DIVISION-OF-LABOR; DEFECATION BEHAVIOR; WASTE MANAGEMENT; HYMENOPTERA; SANITATION; FORMICIDAE; DISEASE; BROOD; (1)
DIVISION-OF-LABOR; DEFENSE SYSTEM; HYMENOPTERA-FORMICIDAE; CHEMICAL COMMUNICATION; NESTMATE RECOGNITION; BEHAVIORAL-RESPONSES; QUEEN PHEROMONE; APIS-MELLIFERA; CUTTING ANT; FIRE ANT; Age polyethism; Platythyrea punctata; (S)-(-)-Citronellal; (S)-(-)-Actinidine (1)
DIVISION-OF-LABOR; DISEASE RESISTANCE; MANIPULATION; TRANSMISSION; PATHOGENS; PARASITES; BEHAVIOR; IMMUNITY; INSECTS; WORKERS; (1)
DIVISION-OF-LABOR; FUNGAL CELL-WALLS; LEAF-CUTTING ANTS; METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; WASTE MANAGEMENT; SOCIAL-BEHAVIOR; HONEY-BEES; EAT-ME; INSECT; (1)
DIVISION-OF-LABOR; FUNGUS METARHIZIUM-ANISOPLIAE; HONEY-BEE COLONIES; LEAF-CUTTING ANTS; TERMITE ZOOTERMOPSIS-ANGUSTICOLLIS; DISEASE RESISTANCE; SOCIAL INSECTS; ENTOMOPATHOGENIC FUNGUS; HYGIENIC BEHAVIOR; BOMBUS-TERRESTRIS; Host-parasite interactions; Sanitary brood care; Experience; Grooming; Platythyrea punctata; Metarhizium fungus (1)
DIVISION-OF-LABOR; HARVESTER ANT; PLASTICITY; SOCIETIES; BEHAVIORS; COLONIES; (1)
DIVISION-OF-LABOR; HONEY-BEE; LIFE-SPAN; GENOTYPIC VARIABILITY; FORAGING BEHAVIOR; SOCIAL INSECTS; PONERINE ANT; COLONY SIZE; POLYETHISM; FLEXIBILITY; Division of labor; Colony activity; Age polyethism; Lifespan; Platythyrea punctata (1)
DIVISION-OF-LABOR; HONEY-BEE; TRADE-OFF; EVOLUTIONARY-THEORIES; NESTMATE RECOGNITION; SOMATIC MAINTENANCE; LIVE LONGER; ANT QUEENS; GROUP-SIZE; REPRODUCTION; lifespan; tempo of ageing; sociality; Cardiocondyla (1)
DIVISION-OF-LABOR; HONEY-BEE WORKERS; DIFFERENTIAL GENE-EXPRESSION; APIS-MELLIFERA L.; LIFE-SPAN; EVOLUTIONARY-THEORIES; JUVENILE-HORMONE; NATURAL-SELECTION; AGE POLYETHISM; SPERM STORAGE; longevity reproductive success; senescence; caste dimorphism; social insects; ants (1)
DIVISION-OF-LABOR; JAPANESE QUEENLESS ANT; PLATYTHYREA-PUNCTATA; APIS-MELLIFERA; INSECT COLONIES; PONERINE ANT; HONEY-BEES; POGONOMYRMEX-CALIFORNICUS; REPRODUCTIVE DIVISION; PRISTOMYRMEX-PUNGENS; Ponerinae; Division of labor; Behavioral reversion; Dominance hierarchy; Senescence (1)
DIVISION-OF-LABOR; LIFE-SPAN; DROSOPHILA-MELANOGASTER; DIMORPHIC MALES; REPRODUCTION; LONGEVITY; VITELLOGENIN; EXPRESSION; INCREASES; EVOLUTION; (1)
DIVISION-OF-LABOR; METARHIZIUM-ANISOPLIAE; TERMINAL INVESTMENT; LIFE-SPAN; NATURAL-SELECTION; IMMUNE CHALLENGE; CARBON-DIOXIDE; APIS-MELLIFERA; EXPECTANCY; ACTIVATION; terminal investment; social insect; infection; reproduction (1)
DIVISION-OF-LABOR; PHEROMONAL INHIBITION; LEPTOTHORAX-ACERVORUM; EVOLUTIONARY-THEORIES; POPULATION-STRUCTURE; SOLENOPSIS-INVICTA; CARDIOCONDYLA ANTS; POLYGYNE COLONIES; HONEY-BEE; NUMBER; Cardiocondyla; longevity; monogyny; mortality; polygyny; queen number (1)
DIVISION-OF-LABOR; PROTEIN-KINASE-C; IN-VITRO ANALOG; DROSOPHILA-MELANOGASTER; BIOGENIC-AMINES; TARGETED EXPRESSION; FUNCTIONAL DYNAMICS; CONDITIONED REFLEX; MUSHROOM BODIES; ZEBRA FINCH; Troy D; Zars; Drosophila melanogaster; engram; place learning; operant learning; mushroom body; temperature sensation (1)
DIVISION-OF-LABOR; QUEENLESS ANT; SOCIAL-STATUS; HYMENOPTERA; FERTILITY; reproductive conflict; dominance hierarchy; fertility signal; cuticular hydrocarbons; formicidae (1)
DIVISION-OF-LABOR; SOCIAL INSECTS; PERSPECTIVE; FORMICIDAE; POLYGYNY; VILLOSA; genetic diversity; division of labour; ants (1)
DIVISION-OF-LABOR; SOCIAL INSECTS; POLYBIA-OCCIDENTALIS; AGE POLYETHISM; ANT; ORGANIZATION; SPECIALIZATION; HYMENOPTERA; WORK; PRODUCTIVITY; (1)
DIVISION-OF-LABOR; TEMPORAL POLYETHISM; APIS-MELLIFERA; AGE POLYETHISM; LIFE-SPAN; DOMINANCE; PLASTICITY; HONEYBEE; BEHAVIOR; INSECT; Ponerinae; Age-based polyethism; Behavioral reversion; Division of labor; Waste management; Sanitary behavior (1)
DIVISION-OF-LABOR; WASTE MANAGEMENT; WORKER REPRODUCTION; LIFE-SPAN; HYMENOPTERA; DOMINANCE; HIERARCHIES; DEFECATION; DUMP; BEES; Defecation; Hygienic behavior; Temnothorax; Ants; Sanitary behavior (1)
Dixit-Stiglitz; optimum product diversity; monopolistic competition; search unemployment (1)
DKK3; non-invasive monitoring; living kidney transplantation (1)
DL-PROTOLICHESTERINIC ACID; SUBSTITUTED GAMMA-BUTYROLACTONES; ALPHA-METHYLENE BUTYROLACTONES; CHIRAL HOMOENOLATE REAGENTS; OLEFIN CROSS-METATHESIS; STEREOSELECTIVE-SYNTHESIS; (-)-ROCCELLARIC ACID; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; NATURAL-PRODUCTS; asymmetric synthesis; lactones; metathesis; natural products; total synthesis (1)
; dm0088; osrmtime; osrmprepare; mqtime; traveltime3; OSRM; OpenStreetMap; Google Maps; MapQuest; geospatial analysis; ArcGIS; travel time; travel distance; public road network (1)
DME, Diabetic Macular Edema, DMÖ, Diabetisches Makulaödem, PDR, Proliferative Diabetische Retinopathy, Proliferative Diabetic Retinopathy, Ranibizumab, VEGF, anti-VEGF (1)
DMF solute solute solvent interaction spectroscopy solute solute solvent interaction (1)
DMF, Zelltod, BH3-Mimetika (1)
DMM, Osteoarthritis, Bisphosphonate, Alendronate, VDIPEN, ADAMTS-5, Subchondral bone, Cartilage, Micro/nano-CT, Osteoclasts, Chondrocytes, NK1-R, MMP-13 (1)
D-MODULES; DIRECT IMAGE; IRREGULARITY; COHOMOLOGY; Gauss-Manin systems; D-modules (1)
DMRT1; Asthma; Kindesalter; geschlechtsspezifisch; Makrophagen; Alveolarmakrophagen; Expression; (1)
DNA, Bacterial/genetics/metabolism Genome, Bacterial Haemophilus influenzae/*genetics Models, Genetic Models, Statistical *Mutagenesis Support, Non-U.S. Gov't (1)
DNA BARCODES; BIOLOGICAL IDENTIFICATIONS; MOLECULAR PHYLOGENY; MENIPPE-MERCENARIA; CRUSTACEA DECAPODA; MARINE INCURSIONS; MTDNA SEQUENCES; STONE CRABS; RIVER PRAWN; SPENCE BATE; (1)
DNA-BINDING; DERIVATIVES; OLIGONUCLEOTIDES; SPECIFICITY; PROBES; Anthracene; Nucleic bases; Luminescence; Bioimaging (1)
DNA-BINDING; MESSENGER-RNA; IN-VITRO; PROTEIN; MIA; TRANSCRIPTION; PHOSPHORYLATION; PROGRESSION; ASSOCIATION; RECEPTORS; (1)
DNA-BINDING PROPERTIES; GROUP CHROMOSOMAL-PROTEINS; TRANSCRIPTION FACTOR DOF2; TANDEM HMG BOXES; HISTONE H1; NMR-SPECTROSCOPY; DROSOPHILA-MELANOGASTER; REGIONS FLANKING; KINASE CK2; CHROMATIN; Chromatin; Intrinsically Disordered Protein; Nuclear Magnetic Resonance (NMR); Phosphorylation; Protein Kinase C (PKC); HMGB Protein; Acidic Regulatory Domain; Casein Kinase 2 (CK2); Paramagnetic Relaxation Enhancement; Protein Kinase C (1)
DNA-BINDING; PROSTATE-CANCER; GENOMIC DATA; PROTEIN; TRANSCRIPTION; CHROMATIN; DOMAIN; SIGNALS; PTOV1; HMGA1; AT-hook; GPBP1; microscale thermophoresis; protein-RNA interaction; PTOV1; RNA-binding domain; Tip5 (1)
DNA-BINDING PROTEINS; MOBILITY GROUP PROTEINS; CELL-CYCLE; HMG-BOX; ARABIDOPSIS-THALIANA; LINKER HISTONES; CHROMATIN; PLANTS; INTERACTS; FAMILY; Arabidopsis; chromatin; high mobility group (HMG)-box domain; HMGB; mitotic chromosome; rDNA; selective proteolysis (1)
DNA-BINDING SITES; ADIPOSE CELL LINE; FACTOR SP1; GENE; ACTIVATION; DIFFERENTIATION; EXPRESSION; DOMAINS; FAMILY; REPRESSION; CORS-26; promoter; SP-1; Pit-1; PPAR-gamma; cartilage; adipocyte (1)
DNA-BINDING; TUMOR-SUPPRESSOR; MUTATIONS; CANCER; SITE; (1)
DNA; C–C bond formation; nitroaldol reaction; Henry reaction; buffer solutions (1)
DNA COPY NUMBER; BENZODIAZEPINE-RECEPTOR; THERAPEUTIC TARGET; BRAIN MACROPHAGES; ACTIVATION; EXPRESSION; METABOLISM; ASTROCYTES; CALCIUM; VDAC1; translocator protein 18 kDa; mitochondria; inflammation; CRISPR; Cas9; respirometry; metabolic profile; glycolysis; OxPhos; calcium imaging (1)
DNA, Cyanin Farbstoff, Fluoreszenz, Nanopartikel, Bioanalytik (1)
DNA-DAMAGE CHECKPOINT; CYCLIN-DEPENDENT KINASES; INHIBITORY PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; MITOTIC ENTRY; FISSION YEAST; HUMAN MYT1; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME CONDENSATION; (1)
DNA-DAMAGE CHECKPOINTS; ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHESIS; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; ASPARTATE TRANSCARBAMOYLASE; ESCHERICHIA-COLI; S-PHASE; GENE; IDENTIFICATION; (1)
DNA-DAMAGE; DYSFUNCTION; FIBROBLASTS; HOMEOSTASIS; SIGNATURE; ACTIVATOR; HEALTH; LENGTH; CELLS; SPAN; Cellular senescence; Citrate; Human aging; Metabolism; Telomeres (1)
DNA-DAMAGE; SENESCENCE; FIBROBLASTS; COPD; EMPHYSEMA; HAYFLICK; CANCER; Cellular senescence; Fibroblasts; Cancer; Smoking; Air pollution (1)
DNA-DAMAGE; STEM-CELLS; REGENERATION; Dental follicle cells; Cellular senescence; AMP-kinase; Autophagy; Metformin (1)
DNA Demethylation, monocytes, dendritic cells (1)
DNA-DNA HYBRIDIZATION; GENUS ACINETOBACTER; NOSOCOMIAL PATHOGENS; BAUMANNII; BACTEREMIA; IDENTIFICATION; EPIDEMIOLOGY; SEQUENCES; OUTBREAK; STRAINS; (1)
DNA, dsRNA formulation, Halyomorpha halys, ribonucleases, RNAi (1)
DNA formation ([Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Estrogens Role: BAC (Biological activity or effector, except adverse), BPR (Biological process), BSU (Biological study, unclassified), MFM (Metabolic formation), BIOL (Biological study), FORM (Formation, nonpreparative), PROC (Process) ([Aqua-1-(2,6-dic Structure-activity relationship (antitumor [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Antitumor agents (mammary gland [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Mammary gland (neoplasm, inhibitors [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) antitumor breast phenylethylenediamine platinum complex (1)
DNA-looping; CpG-methylation; histone; chromatin; oriP (1)
DNA methylation, DNA demethylation, Epigenetics, Hematopoiesis, PU.1 (1)
DNA-METHYLATION; GATA3 EXPRESSION; NOTCH; PROTEIN; HOMEOSTASIS; ACTIVATION; SPECIALIZATION; INFLAMMATION; TOLERANCE; INFECTION; (1)
DNA METHYLATION; GENE-EXPRESSION; CANCER-CELLS; GERM-LINE; MAMMALIAN DEVELOPMENT; X-CHROMOSOME; Y-CHROMOSOME; BORIS; CTCF; DEREPRESSION; DNA methylation; epigenetics; gene regulation; methylation profiling (1)
DNA METHYLATION; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; TUMOR PROGRESSION; CELL-LINES; GENE; HYPERMETHYLATION; EXPRESSION; METASTASIS; SUPPRESSOR; tumor suppressor candidate 3; lung cancer; prognosis; survival; quantitative methylation analysis (1)
DNA METHYLATION; HISTONE DEMETHYLASE; COHESIN COMPLEX; PROTEIN; GENE; EXPRESSION; SYNAPSIS; DOMAIN; HETEROCHROMATIN; MECHANISMS; Arabidopsis thaliana; crossover; epigenetics; histone modification; meiosis (1)
DNA METHYLATION; INTRAEPITHELIAL NEOPLASIA; CELL TRANSDIFFERENTIATION; ABERRANT METHYLATION; PROTEIN-KINASE; CANCER; BIOLOGY; PROLIFERATION; GENETICS; PATHWAY; genome-wide screen; CpG island methylation; chronic pancreatitis; pancreatic intraepithelial neoplasia; pancreatic cancer (1)
DNA METHYLATION; ISLAND METHYLATION; CANCER EPIGENETICS; GENE; LEUKEMIA; HYPERMETHYLATION; TARGETS; PROFILE; (1)
DNA METHYLATION; NAIVE PLURIPOTENCY; MAMMALIAN DNA; DEMETHYLATION; ERASURE; 5-METHYLCYTOSINE; EXPRESSION; INSIGHT; TDG; (1)
DNA METHYLATION; PERIPHERAL-TISSUES; A EXPRESSION; CELL-LINE; IN-VITRO; APOPTOSIS; ADENOCARCINOMAS; IDENTIFICATION; ADENOMAS; GROWTH; (1)
; DNA methylation; reporter gene analysis; CpG-free vector; methylation analysis; in vitro methylation (1)
DNA METHYLATION; T-CELLS; WOMEN; DIET; EXPRESSION; REGIONS; CD40LG; GENES; MODEL; Systemic lupus erythematosus; nutrition; methylation; CD40-ligand; T-cells; disease activity (1)
DNA METHYLATION; UBIQUITIN-LIKE; CANCER; PROTEIN; DNMT1; PROLIFERATION; CONTRIBUTES; EPIGENETICS; INHIBITION; REGULATOR; UHRF1; Hepatoblastoma; DNMT1; USP7; Histone methylation; DNA methylation; Epigenetic silencing; Tumor suppressor genes; Biomarker (1)
DNA MINOR-GROOVE; SEQUENCE-SPECIFIC RECOGNITION; CROSS-LINKED LEXITROPSINS; SOLID-PHASE SYNTHESIS; DOUBLE-HELICAL DNA; PYRROLE-IMIDAZOLE POLYAMIDES; NETROPSIN-LIKE MOLECULES; ANTITUMOR AGENT CC-1065; COVALENT PEPTIDE DIMERS; BASE-PAIR SEQUENCES; DNA binding; heterocycles; molecular recognition; oligoamides (1)
DNA MISMATCH REPAIR; HMLH1 PROMOTER; COLON-CANCER; BETHESDA GUIDELINES; REPLICATION ERRORS; BREAST-CANCER; CPG ISLANDS; INSTABILITY; EXPRESSION; PATTERNS; (1)
DNA MISMATCH REPAIR; MUTATION; TUMORS; PROFILES; PATTERNS; HOMOLOG; MSH6; microsatellite instability; mismatch repair deficiency; polymerase chain reaction; immunohistochemistry; endometrial cancer (1)
DNA; MUTATIONS; CHIP; MitoChip; mitochondrial DNA; mutation detection; heteroplasmy; phylogeny (1)
DNA, Oligonukleotide, oligonucleotides, Fluoreszenz, fluorescent labels, DNA-Konjugate, metal mediated base pair, Ladungstransfer, charge transfer, Terpyridin, Hydroxychinolin, Bodipy, Aminopyren (1)
DNA points accumulation for imaging in nanoscale topography | docking strand design | localization precision | nanoscopic resolution | super-resolution microscopy (1)
DNA-POLYMERASE-ALPHA; MICROGRAM QUANTITIES; SLIME-MOLD; BETA-POLY(L-MALATE); HISTONES; PROTEINS; NUCLEI; cell cycle; growth rate; Physarum polycephalum; plasmodium; polymalic acid (1)
DNA-POLYMERASE-ALPHA; PHYSARUM-POLYCEPHALUM; PLASMODIUM; polymalatase; polymalate; depolymerase; synthetic substrates; inhibitors (1)
DNA-POLYMERASE-ALPHA; POLYACRYLAMIDE GELS; BETA-POLY(L-MALATE); PROTEINS; POLYMALATASE; HISTONE; PRIMASE; COMPLEX; Physarum polycephalum; plasmodium; polymalic acid; polymalatase; reconstituting nuclei (1)
DNA-POLYMERASE-ALPHA; POLY-L-MALATE; PHYSARUM-POLYCEPHALUM; CELL-CYCLE; POLYACRYLAMIDE GELS; SUBUNIT STRUCTURE; RICH PROTEIN; PLASMODIUM; ACID; SEQUENCE; Physarum polycephalum; poly(malic acid); poly(malic acid) binding proteins; affinity chromatography; poly(malate)-aminohexyl-sepharose; myxomycete; plasmodium; nuclear synchrony; molecular mimicry; poly(aspartic acid) (1)
DNA-POLYMERASE-ALPHA; SLIME-MOLD; POLYCEPHALUM; BETA-POLY(L-MALATE); PLASMODIA; POLY(BETA-L-MALATE); PROTEINS; CYCLE; Recombinant expression in Escherichia coli and yeast; Glycosylation; Zymogen; Hydrolase activation by phosphorylation; Plasma membrane protein tyrosine kinase; Secretion; Membrane damage; Plasmodium physiology; Biotechnology; Nanoconjugates (1)
DNA-POLYMERASE-IOTA; B-CELL LYMPHOMAS; LOSS-OF-HETEROZYGOSITY; COPY-NUMBER; MALIGNANT-LYMPHOMA; EXPRESSION; CANCER; HYBRIDIZATION; GENE; MYC; Burkitt's lymphoma; genomic imbalance; MYC; uniparental disomy (1)
DNA; POLYMORPHISM; HUMANS; GENE; mtDNA; heteroplasmy; PAX6; ptosis; nystagmus; pyrosequencing (1)
DNA; PROTEIN; OPTIMIZATION; CELLS; (1)
DNA; RECOGNITION; COMPLEXES; SENSORS; SWITCHES; electronic spectra; luminescence; platinum complexes (1)
DNA remodeling; HNSCC; nPD-L1; nucleartrafficking; subcellular protein fractionation; vimentin immunotherapy (1)
DNA-REPAIR DEFICIENCY; COCKAYNE-SYNDROME; SKIN-CANCER; TRICHOTHIODYSTROPHY; HETEROGENEITY; PREVENTION; STRATEGIES; DISORDERS; MUTATIONS; DAMAGE; Genodermatosis; Light sensitivity; Poikiloderma; Tumors; Light protection (1)
DNA-REPAIR ENZYMES; NUCLEOTIDE BASE RECOGNITION; EFFICIENT RECOGNITION; AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; THYMINE DERIVATIVES; ZINC(II) COMPLEX; RECEPTORS; FLAVIN; BINDING; (1)
DNA-REPAIR GENE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE PROMOTER; SQUAMOUS-CELL CARCINOMA; HUMAN TUMOR-CELLS; MESSENGER-RNA; O6-METHYLGUANINE-DNA METHYLTRANSFERASE; COLORECTAL TUMORIGENESIS; GASTRIC-CARCINOMA; CPG METHYLATION; LUNG-CANCER; O-6-methylguanine-DNA methyltransferase (MGMT) Hypermethylation; Carcinogenesis; Barrett's metaplasia; Barrett's adenocarcinoma (1)
DNA-REPAIR PROTEINS; RECA PROTEIN; COMPLEX-FORMATION; ESCHERICHIA-COLI; PARALOGS; PURIFICATION; Chlamydomonas reinhardtii; Rad51C; homologous recombination; biochemical activities of DNA transferases (1)
DNA-SEQUENCE; METHYLATION; CHROMATIN; BINDING; TRANSCRIPTION; STABILITY; (1)
DNA-SEQUENCE; REGULATORY ELEMENTS; METHYLATION; ISLANDS; GENOME; CELLS; TRANSCRIPTION; MACROPHAGE; INDUCTION; MODEL; (1)
DNA-SYNTHESIS; HEART; BRAP; PROLIFERATION; ARREST; ADULT; RISK; IDENTIFICATION; HYPERTROPHY; TRANSITION; BRAP; Cell cycle; p21(Cip); Cardiomyocyte proliferation; Cardiac development; Knockout mice (1)
DNA; THYMINE; FLUORESCENCE; DERIVATIVES; ENERGY; ASSEMBLIES; SYSTEMS; PROBES; SET; confocal microscopy; luminescence; nucleobases; oligonucleotide binding; pyrene; X-ray (1)
DNA TOPOISOMERASE-IV; CIPROFLOXACIN RESISTANCE; WILD-TYPE; GYRA; MUTATIONS; GRLA; CLINAFLOXACIN; TROVAFLOXACIN; MOXIFLOXACIN; SPARFLOXACIN; (1)
DNA/TRANSFERRIN-PEI COMPLEXES; MOLECULAR-WEIGHT; IN-VIVO; GLYCOL)-BLOCK-POLYETHYLENIMINE COPOLYMERS; EXTENDED CIRCULATION; GLYCOL) COPOLYMERS; BLOCK-COPOLYMERS; DNA CONDENSATION; DELIVERY-SYSTEMS; NUCLEIC-ACIDS; Polyplexes; Poly(ethylene imine); PEGylation; Linear diblock copolymer; Degradation; Stability (1)
DNA; TRANSPORT; CONDUCTION; JUNCTIONS; SYSTEMS; (1)
DNA triplex, triplex stability, nuclear matrix, rDNA organization, Tip5 (1)
DNA VACCINES; BAROMETRIC PLETHYSMOGRAPHY; IGE PRODUCTION; MOUSE MODEL; T-CELLS; IMMUNOTHERAPY; RESPONSES; ATOPY; RESPONSIVENESS; SENSITIZATION; RNA vaccines; DNA vaccines; self-replicating vaccines; type I allergy; vaccination (1)
DNS-Bindung , Inhibitorproteine , Chemische Synthese , Konformationsanalyse , Zelldifferenzierung , , peptide synthesis and characterization (1)
DNS , Gentransfer , Polyethylenimin , Nanopartikel , Transfektion , Plasmid , , DNA , gene transfer , polyethylenimine , nanoparticle , transfection (1)
DNS-Methyltransferase, Chromatin, Nucleosom, Plazenta, HeLa-Zelle, Ubiquitin-Protein-Ligase, Ubiquitin-spezifische-Protease, Dnmt1, Kernextrakt, Dnmt3a, Dnmt3b, DNA methylation, ubiquitin-specific-protease, ubiquitin-ligase, Dnmt1, Dnmt3 (1)
DNS-Methyltransferase, DNA-Methylierung, DNA-Demethylierung, Chromatinmodifikationen, DNA methylation, DNA demethylation, chromatin modification (1)
DNS , Pyren , Ladungstransfer , Polychromophores System , DETEQ-Konzept , Fluoreszenzsonden , metallvermitteltes Basenpaar , Thio-2´-desoxyuridin , M-DNA , Ethidium , ß-Indol , DETEQ concept , fluorescence probes , metal-mediated basepair , thio-2´-deoxyuridine , M-DNA , pyrene (1)
DNS-Reparatur , DNS-Schädigung , DNS-Doppelstrangbruch , DNS , Ros , Zellzyklus , Apoptosis , Biokompatibilität , Dentalwerkstoff , oxidativer DNA-Schaden , TEGDMA , ATM , MAP-Kinasen , Zellzyklus , DNA-Schaden , ATM , MAP , oxidative DNA damage , TEGDMA , ATM , MAP kinases , cell cyclus (1)
DNS-Schädigung , DNS , Ladungstransfer , Detektion , SNP , Oligonucleotide , Thymin , Thymidin , Guanin , Guanosin , Desoxyuridine , Pyren , Indol , Ethidium , DETEQ-Konzept , Fluoreszenzsonden , Basenfehlpaarungen , SNP-Detektion , DNA , fluorescence probes , SNP-Detection , DETEQ concept (1)
DNS-Sonde , Fluoreszenzmarkierung , Multiplex , Membranproteine , Polymorphismus , ABCA1 , SNP , DNA , Multiplex , Hochdurchsatz , ABCA1 , SNP , DNA , Multiplex , High-throughput (1)
DOAJ EZB Diamond Cooperation E-Journals (1)
Docking, scoring, protein-protein-complexes, bioinformatics, HADDOCK, PROCOS (1)
; Dockyard workers; general strike; Koper; Capodistria; Italo-Yugoslav border region; public violence; self-management; Trieste (1)
DOCOSAHEXAENOIC ACID; BLOOD FRACTIONS; VEGETABLE-OILS; DOUBLE-BLIND; AMINO-ACIDS; FATTY-ACID; PROTEIN; DIGESTIBILITY; PERFORMANCE; BENEFITS; amino acids; duckweed; fatty acids; Lemnaceae; phytosterols; protein; Wolffia (1)
DOCTORS; electronic letter of discharge; diagnosis related groups (DRG); documentation of diagnosis; coding (1)
DOCTORS; psychiatry; psychotherapy; documentation; quality management (1)
DODECYL-SULFATE; PHASE-BEHAVIOR; IONIC MICELLES; KRAFFT POINT; SURFACTANTS; MIXTURES; VESICLES; PRECIPITATION; TRANSITION; MICROSTRUCTURES; Catanionic surfactant mixtures; Solubility temperature; Supersaturation (1)
DOG CANIS-FAMILIARIS; HUMAN DEMONSTRATOR; RANK; ENHANCEMENT; PERFORMANCE; ATTENTION; BEHAVIOR; TASK; Social enhancement; Equus caballus; Human demonstrator; Interspecies-specific learning; Social learning (1)
DOGS CANIS-FAMILIARIS; OBJECT-CHOICE TASK; EXPERIMENTER-GIVEN CUES; FOLLOW GAZE DIRECTION; SOCIAL CUES; CHIMPANZEES UNDERSTAND; LEARNING-ABILITY; YOUNG HORSES; GUIDE DOGS; PET DOGS; Human-horse interaction; Horse; Attention-reading; Position; Familiarity (1)
Doing Gender; Gender; Geschlechtergrenzen; Mittelalter; Moderne; Rezeption; Hartmann; Hartmann von Aue; Der arme Heinrich; Ricarda Huch; Margarete Kubelka; Der arme Heinrich Rosenkranz; Markus Werner; Bis bald; Tankred Dorst; Ursula Ehler; Die Legende vom armen Heinrich (1)
Dokumentarfilm, ekstatische Wahrheit, Stilanalyse, Werner Herzog (1)
Dokument , Heinichen , status causae , Heinichen , status causae (1)
DOLICHOL; DEFICIENCY; MUTATIONS; TRANSFERASE; YEAST; BIOSYNTHESIS; ENZYMES; STEPS; SERUM; CDG; (1)
DOLICHOL-PHOSPHATE-MANNOSE; N-LINKED GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; DEFECTIVE GLYCOSYLATION; GLYCOPROTEIN SYNDROME; MUSCULAR-DYSTROPHIES; MAMMALIAN-CELLS; BIOSYNTHESIS; PROTEIN; GENE; (1)
DOMAIN IDENTIFICATION; BOUNDARY MEASUREMENTS; INVERSE PROBLEM; STABLE DETERMINATION; UNIQUE DETERMINATION; ELLIPTIC-EQUATIONS; CRACK DETECTION; STABILITY; elliptic equation; cavity identification; Cauchy data (1)
DOMAIN K+ CHANNELS; MEMBRANE; CELLS; ENDOSOMES; DYNAMIN; TREK-1; LOCALIZATION; PHARMACOLOGY; CONDUCTANCE; MODULATION; (1)
DOMAIN K+ CHANNEL; VENTILATORY RESPONSE; IN-VITRO; RHYTHM GENERATOR; NEURONS; MODULATION; MECHANISMS; HYPOXIA; OXYGEN; MEDULLA; breathing; central chemoreceptors; K2P; KCNK5; ventral medullary surface (1)
DOMAIN; MICROSCOPE; (1)
Domain Model, Design Solution, Case Adaptation, Neighbourhood Relationship, Shape Grammar (1)
DOMAIN POTASSIUM CHANNELS; BACKGROUND K+ CHANNEL; TRP CHANNELS; SENSORY NEURONS; CAPSAICIN RECEPTOR; ION-CHANNEL; DIRECT ACTIVATION; CATION CHANNEL; CALCIUM-IONS; PAIN; (1)
DOMAINS; (2)
DOMAINS; SYSTEM; (1)
DOMAIN-STRUCTURES; THIN FOILS; DETECTOR; MICROSCOPY; (1)
DOMAIN-WALL; MAGNETORESISTANCE; EXCHANGE; DYNAMICS; (1)
DOMAIN-WALL MOTION; MAGNETIZATION DYNAMICS; FERROMAGNETS; FILMS; (1)
DOMAIN-WALLS; MAGNETIZATION; DYNAMICS; MAGNITUDE; (1)
DOMESTIC CATS; FELIS-CATUS; HOUSE CATS; ECOLOGICAL CONSEQUENCES; REGRESSION-MODELS; PREY COMPOSITION; RURAL-AREAS; URBAN; EVOLUTIONARY; PATTERNS; depredation; domestic cats; personality traits; urbanization (1)
DOMESTIC FIRMS; ECONOMIC-DEVELOPMENT; MULTINATIONAL FIRMS; TECHNOLOGY-TRANSFER; BACKWARD LINKAGES; GROWTH EVIDENCE; TRADE; INDIA; COMPETITION; INPUTS; (1)
DOMESTIC INVESTORS; EQUITY FLOWS; ASYMMETRIC INFORMATION; PORTFOLIO FLOWS; IDENTIFICATION; EXPECTATIONS; PERFORMANCE; EXPERIENCE; CONTAGION; DYNAMICS; (1)
domestic law; empowerment; legitimacy; stakeholder approach (1)
Domestic Violence · Uzbekistan · Legal Transplants · Restorative Justice · Judicial Activism · Legal Semiotics (1)
DOMINANCE HIERARCHY; COMPETITION; COLONIES; LIFE; BEES; REPRODUCTION; SIBLICIDE; EVOLUTION; MALES; Cardiocondyla; Siblicide; Fatal fighting; Nest inheritance; Local resource competition (1)
dominance hierarchy | genetic relatedness | haplotypes | Leptothorax gredleri | ovary development | social parasitism (1)
dominance hierarchy, selfish worker policing, queen policing, kin conflict, ant, reproductive conflict, cuticular hydrocarbons, fertility signalling, queen pheromones, worker reproduction, honest signal, Temnothorax, cost of colony productivity (1)
dominant energy condition; general relativity; initial value pair; index difference; Dirac-Witten operator (1)
DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED PROTEIN; CHROMOSOME 3Q REGION; CLINICAL-FEATURES; LINKAGE ANALYSIS; COILED-COILS; KJER TYPE; LOCUS; FAMILY; YEAST; (1)
DOMINANT RETINITIS-PIGMENTOSA; DEGENERATION SLOW GENE; MACULAR DYSTROPHY; RDS GENE; PHOTORECEPTOR PERIPHERIN/RDS; ARG195LEU MUTATION; NEOVASCULARIZATION; MEMBRANES; DELETION; MODEL; central areolar choroidal dystrophy (CACD); peripherin; RDS gene; codon 307; frame-shift mutation; age-related macular degeneration (AMD) (1)
DOMINANT RETINITIS-PIGMENTOSA; OCULAR ALBINISM TYPE-1; CLINICAL-FEATURES; RHODOPSIN GENE; CELLS; (1)
DOMINANT RETINITIS-PIGMENTOSA; TREACHER-COLLINS-SYNDROME; RIBOSOMAL TRANSLOCASE; CLEFT-PALATE; RNA; MUTATIONS; PROTEIN; HOMOLOG; SNU114P; GENE; (1)
DOMINANT SELECTABLE MARKER; CHLAMYDOMONAS-REINHARDTII; GENE-EXPRESSION; CHROMATIN STRUCTURE; MASS-SPECTROMETRY; NITRATE REDUCTASE; REPORTER-GENE; LIFE-CYCLE; PROTEIN; ARYLSULFATASE; (1)
DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; FOREIGN GENE; EXPRESSION; PROTEINS; VECTORS; FUSION; TOOL; DNA; antisense; green algae; paromomycin; rbcS2 (1)
DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; GENE-EXPRESSION; REPORTER GENE; PROMOTER; RECOMBINATION; PURIFICATION; LUCIFERASE; ELEMENTS; TOOLS; (1)
Donaueschingen, Donaueschinger Kammermusikfeste, Neue Musik Berlin, Deutsche Kammermusik Baden-Baden, Donaueschinger Musikage, Hindemith, Herrmann, Burkard, Strobel. Haas, Erdmann, Neue Musik, Jöde, Musikantengilde, Rundfunk, Filmmusik, Hörspiel, Gemeinschaftsmusik, Gebrauchsmusik, Lehrstück, Brecht, Schönberg, Berg, Bekker (1)
DONOR-ACCEPTOR ARRAYS; ABSORPTION-SPECTROSCOPY; PHOTOCHROMISM; DYNAMICS; SYSTEMS; (1)
DONOR-ACCEPTOR ARRAYS; CHARGE SEPARATION; MOLECULAR SWITCH; OPTICAL CONTROL; SYSTEMS; REORGANIZATION; UNITS; PHOTOSYNTHESIS; LUMINESCENCE; PHENOXAZINE; (1)
DONOR-ACCEPTOR ARRAYS; CHARGE SEPARATION; OPTICAL CONTROL; SYSTEMS; SOLVENT; ENERGY; (1)
DONOR-ACCEPTOR BOND; CRYSTAL-STRUCTURES; SOLID-STATE; ENERGY; ADDUCTS; antimony pentachloride; pyridine; acetonitrile; molecular complexes; structure (1)
DONOR-ACCEPTOR BOND; NEUTRAL LEWIS-BASES; TITANIUM TETRACHLORIDE; ADDITION-COMPOUNDS; COMPLEXES; ADDUCTS; COORDINATION; EXCHANGE; CHLORIDE; DENSITY; titanium tetrachloride; diethyl ether; donor-acceptor complexes; ethoxytrichlorotitanium; titanium dioxide (1)
DONOR-ACCEPTOR CYCLOPROPANES; DIELS-ALDER REACTIONS; ALDOL-TYPE REACTION; CARBONYL-COMPOUNDS; 2,2-DIALKOXYCYCLOPROPANECARBOXYLIC ESTERS; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-SYNTHESIS; BUILDING-BLOCKS; ARYLATION; STRATEGY; 2H-pyrans; arylpyridines; dihydropyridines; donor-acceptor cyclopropanes; Heck coupling (1)
DONOR LIVER-TRANSPLANTATION; BILIARY RECONSTRUCTION; RISK-FACTORS; COMPLICATIONS; STRICTURES; MANAGEMENT; ERCP; double balloon enteroscopy; endoscopic retrograde cholangiography (1)
DONOR LIVER-TRANSPLANTATION; EN-Y HEPATICOJEJUNOSTOMY; BILE-DUCT INJURIES; NONCORRECTABLE BILIARY ATRESIA; HEPATIC PORTOENTEROSTOMY; FOLLOW-UP; RECONSTRUCTION; HEPATICODUODENOSTOMY; RISK; STRICTURES; Biliodigestive anastomosis; Hepaticjejunostomy; Hepaticojejunostomy; Percutaneous transhepatic cholangiography and biliary drainage; Anastomotic stenosis; Bile leakage (1)
DONOR LIVER-TRANSPLANTATION; PORTAL-VEIN STENOSIS; COMPLICATIONS; abdomen; embolization; transplantation; needle tract; intrahepatic; intrasplenic (1)
DONOR LIVER-TRANSPLANTATION; VENOUS STENOSIS; STENT PLACEMENT; COMPLICATIONS; MANAGEMENT; THROMBOSIS; SURGERY; BIOPSY; percutaneous transhepatic and transsplenic portal vein access; puncture tract embolization; Amplatzer Vascular Plug (1)
DONOR LUNG; GRAFT PRESERVATION; ACTIVATION; ORGANS; DAMAGE; (1)
DONOR-RISK-INDEX; DISEASE MELD; SURVIVAL; MODEL; EUROTRANSPLANT; DONATION; POLICY; SCORE; liver transplantation; allocation; incentive (1)
DONOR-SITE MORBIDITY; FREE-TISSUE TRANSFER; CHRONIC OSTEOMYELITIS; AMPUTATION STUMP; BONE-GRAFT; DEFECTS; EXTREMITY; RESECTION; MUSCLE; FIBULA; first metatarsal; parascapular flap; osteocutaneous flap; osteomyelitis of the foot; complex trauma of the foot; tumors of the foot (1)
DONOR-SITE MORBIDITY; NECK-CANCER; PRIMARY SURGERY; FREE-FLAP; OROPHARYNGEAL CANCER; ONCOLOGIC SURGERY; FOREARM FLAP; HEAD; IMPACT; CARCINOMA; Oral carcinoma; Microvascular reconstruction; Health-related quality of life; University of Washington Quality of life questionnaire (1)
DONOR-SPECIFIC ANTIBODIES; CALCINEURIN INHIBITOR MINIMIZATION; RECIPIENTS RECEIVING TACROLIMUS; PROSPECTIVE RANDOMIZED-TRIAL; HUMAN-LEUKOCYTE ANTIGEN; DE-NOVO SIROLIMUS; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; HLA ANTIBODIES; CHRONIC REJECTION; (1)
DOPA-INDUCED DYSKINESIA; EXOGENOUS L-DOPA; DOPAMINERGIC SYSTEM; ALPHA-SYNUCLEIN; EXPRESSION; NEURONS; TRANSPORTER; HYPERINNERVATION; TERMINALS; DORSAL; Parkinson's disease; alpha-synuclein; Dopamine; Serotonin; Striatum; L-DOPA-induced dyskinesia (1)
DOPAMINE-BETA-HYDROXYLASE; GENOTYPE-CONTROLLED ANALYSIS; ISOFORM TPH2 GENE; LINKAGE DISEQUILIBRIUM; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS; HAPLOTYPE ANALYSIS; BIPOLAR DEPRESSION; MAJOR DEPRESSION; MOOD DISORDERS; DBH genetic variants; Alcohol dependence; Alcohol dependence and depression; Suicide attempt history; Association genetic variants; Gender differences (1)
Dopamine; Cognitive control; Eyeblink rate (EBR); Gender; DRD4 exon III polymorphism (1)
Dopamine D2 receptor gene (DRD2), -141CIns/Del allele, DRD2 polymorphism, DRD2 promoter region, alcoholism dependence, Cloninger typology, alcohol withdrawal (1)
DOPAMINE-D-2 RECEPTOR OCCUPANCY; POPULATION PHARMACOKINETICS; RISPERIDONE; TOLERABILITY; FORMULATION; (1)
DOPAMINE-D-2 RECEPTOR OCCUPANCY; STATE PLASMA-LEVELS; SCHIZOPHRENIC-PATIENTS; P-GLYCOPROTEIN; DOUBLE-BLIND; PHARMACOKINETICS; 9-HYDROXYRISPERIDONE; PET; ANTAGONISM; PROFILE; Antipsychotic drug; Inter-individual variation; Paliperidone; Pharmacokinetics; Risperidone; Therapeutic drug monitoring; Trough serum concentrations (1)
DOPAMINE D2 RECEPTOR; PATHWAY GENE POLYMORPHISMS; SER311CYS POLYMORPHISM; MOLECULAR VARIANT; SCHIZOPHRENIA; ASSOCIATION; SUSCEPTIBILITY (1)
DOPAMINE-D4 RECEPTOR LIGANDS; INDUCE PENILE ERECTION; BINDING EXPERIMENTS; HIGH-AFFINITY; CELL-LINE; MALE RATS; APOMORPHINE; EFFICACY; AGONISTS; PHARMACOLOGY; Penile erection; Erectile dysfunction; Azulene; Dopamine D-4; Partial agonists (1)
Dopamine, Neuron, Drosophila melanogaster (1)
DOPAMINE-RECEPTOR INACTIVATION; VINYL SULFONES; VISIBLE-LIGHT; METAL-FREE; DECARBOXYLATIVE SULFONYLATION; (E)-ALKENYL SULFONES; (E)-VINYL SULFONES; MEDIATED SYNTHESIS; ORGANIC-SYNTHESIS; CINNAMIC-ACIDS; alkyl sulfinates; photocatalysis; reaction mechanisms; transient spectroscopy; vinyl sulfones (1)
DOPAMINERGIC NEURON DEGENERATION; ALPHA-SYNUCLEIN AGGREGATION; TARGETED GENE-EXPRESSION; OXIDATIVE STRESS; DJ-1 MUTANTS; MITOCHONDRIAL PATHOLOGY; TYROSINE-HYDROXYLASE; CELL-DEATH; MUTATIONS; PATHWAY; Parkinson's disease; Drosophila; alpha-Synuclein; Parkin; PINK1; Rotenone; Oxidative stress (1)
DOPAMINE TRANSPORTER BINDING; EMISSION COMPUTED-TOMOGRAPHY; PARKINSONS-DISEASE; I-123-FP-CIT SPECT; ALZHEIMERS-DISEASE; LEWY BODIES; DEMENTIA; DIAGNOSIS; DECLINE; TREMOR; (1)
DOPANT; NANOWIRES; (1)
DOPED DIAMOND ELECTRODES; ADVANCED OXIDATION PROCESSES; HYDROXYL RADICALS; FENTON REACTION; WATER-TREATMENT; FEEDBACK MODE; REDUCTION; SECM; INTERROGATION; PLATINUM; Boron-doped diamond; Hydrodynamic scanning electrochemical microscopy; Reactive oxygen species; Tip-substrate voltammetry (1)
DOPED DIAMOND ELECTRODES; ATOMIC-FORCE MICROSCOPY; PROBE; MICROELECTRODES; FABRICATION; DELIVERY; Electrochemistry; Redox reactions; Cyclic voltammetry; Scanning electrochemical microscopy; Scanning ion conductance microscopy; Boron-doped diamond (1)
DOPED GRAPHENE; (1)
DOPED GRAPHENE; SUPERCONDUCTIVITY; (1)
DOPED NAYF4 NANOCRYSTALS; UP-CONVERSION FLUORESCENCE; OPTICAL CHEMICAL SENSORS; EMISSION; NANOPHOSPHORS; BIOSENSORS; ER3+; (1)
DOPED TOPOLOGICAL INSULATOR; SPIN; FERMION; REALIZATION; TRANSITION; SEMIMETAL; SYMMETRY; GRAPHENE; TORQUE; MODEL; (1)
; doping; electron beam lithography; graphene; phonons; Raman spectra; sputter etching (1)
doping, electron beam lithography, graphene, phonons, Raman spectra, sputter etching (1)
Doppelbesteuerungsabkommen, Tschechien, Rechtsformwahl (1)
Doppelkodierung; Luke 18.1-8; Luke 18.9-14; gender ideals; Greco-Roman legalterminology; wisdom literature (1)
Doppelkonsonanten, Lernverlaufsdiagnostik, Rechtschreibung, Rechtschreiben, Rechtschreibtest, Skilltest (1)
DOPPLER-ECHOCARDIOGRAPHY; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; CONTROLLED-TRIAL; SHORT-TERM; PRESSURE; FIBROSIS; EMPHYSEMA; COPD; NIFEDIPINE; Hypertension, pulmonary; Lung disease; COPD; Fibrosis, pulmonary (1)
DOPPLER-ECHOCARDIOGRAPHY; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; SHORT-TERM; PRESSURE; FIBROSIS; EMPHYSEMA; COPD; NIFEDIPINE; DIAGNOSIS; pulmonary hypertension; COPD; emphysema; pulmonary fibrosis (1)
DOPPLER-ECHOCARDIOGRAPHY; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DIAGNOSIS; GUIDELINES; ADULTS; Pulmonary hypertension; Echocardiography; Right heart catheterization (1)
DOPPLER SONOGRAPHY; ERYTHROCYTES; EPIDEMIOLOGY; ULTRASOUND; STENOSIS; OSMOLAR; Renal perfusion; radiographic contrast media; contrast agent; CCDS; color coded Doppler sonography; contrast induced Nephropathy; CIN (1)
Doppler, Ultraschall, Hoden, Kinder, Jugendliche, Resistive Index, intratestikuläre Arterien, Duplex, Volumen (1)
Dormancy, Phylogeography, AFLP, Longevity, Ageing, Calcarous grassland, Seed, Soil seed persistence, X-ray, Ex situ (1)
DORSAL AUGMENTATION; SURGICAL CLOSURE; REPAIR; TEMPOROPARIETAL; RHINOPLASTY; FLAP; costal cartilage; nasal septal perforations; rhinologic procedures; diced cartilage; fascia graft (1)
DORSAL COCHLEAR NUCLEUS; MECHANISMS; PLASTICITY; HYPERACTIVITY; MODULATION; DEPRESSION; SYMPTOMS; COMPLEX; INPUTS; (1)
DORSAL COCHLEAR NUCLEUS; STIMULATION; MODULATION; tinnitus; temporomandibular joint; somatic; risk factor; patho-physiology; hearing (1)
DORSAL COCHLEAR NUCLEUS; TENSION-TYPE HEADACHE; THALAMOCORTICAL DYSRHYTHMIA; HEARING-LOSS; MIGRAINE; DEPRESSION; SEVERITY; PAIN; QUESTIONNAIRE; POPULATION; (1)
DORSAL COCHLEAR NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; LOCUS-COERULEUS NEURONS; DOUBLE-BLIND; LATERALIZED TINNITUS; MODULATING TINNITUS; INDUCED INHIBITION; HEARING-LOSS; BRAIN-STEM; GUINEA-PIG; Tinnitus; Phantom perception; Somatosensory system; Muscle relaxants (1)
DORSALIS-PEDIS FLAP; CLINICAL-APPLICATION; SENSORY NERVE; HAND; RECONSTRUCTION; INJURIES; TRAUMA; REPAIR; Complex hand injuries; hand trauma; nerve graft; vein graft; donor site; nerve interposition; microsurgery (1)
DORSAL PRESERVATION; GRAFTS; PUSH; evidence-based medicine; rhinoplasty; biases in rhinoplasty; quality of life (1)
DORSAL RIM AREA; DROSOPHILA CENTRAL COMPLEX; ANTERIOR OPTIC TUBERCLE; CENTRAL-NERVOUS-SYSTEM; SCHISTOCERCA-GREGARIA; ANTENNAL LOBES; INSECT BRAIN; SYNAPTIC RELATIONSHIPS; NEURAL ORGANIZATION; POLARIZED SKYLIGHT; insect brain; central complex; gamma-aminobutyric acid; locustatachykinin; synaptic organization; desert locust (1)
DORSAL-ROOT GANGLIA; CORTICOTROPIN-RELEASING FACTOR; ARTHROSCOPIC KNEE SURGERY; INFLAMMATORY PAIN; INTRAARTICULAR MORPHINE; INFLAMED TISSUE; IMMUNE CELLS; SPINAL-CORD; IMMUNOHISTOCHEMICAL LOCALIZATION; PERIPHERAL ANTINOCICEPTION; (1)
DORSAL-ROOT GANGLION; SENSORY GANGLIA; RECEPTORS; MECHANISM; NEURONS; COMMUNICATION; HEMICHANNELS; ASTROCYTES; ACTIVATION; EXPRESSION; Gliotransmitter; Glutamate; Satellite glial cell; Trigeminal ganglion; Exocytosis (1)
dorsojugulär, retrojugular, carotid endarterectomy, CEA, Carotis Endarterektomie (1)
DORSOLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; DOUBLE-BLIND; RTMS; MEMORY; PAIN; GENERATION; HUMANS; PET; Neuropsychiatry; transcranial magnetic stimulation; PET; tinnitus; randomized clinical trial (1)
DORSOLATERAL PREFRONTAL CORTEX; DEPRESSION SCALE; HOSPITAL ANXIETY; FUNCTIONAL INDEX; MODULATION; QUESTIONNAIRE; VALIDATION; DUTCH; NEUROMODULATION; SUPPRESSION; tinnitus; neuromodulation; noninvasive brain stimulation; transcranial direct current stimulation (tDCS); high-definition transcranial direct current stimulation (HD tDCS); treatment (1)
DORSOLATERAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; WORKING-MEMORY; SPACE; brain imaging; dorsolateral prefrontal cortex; functional magnetic resonance imaging; oculomotor control; saccade sequences working memory (1)
DORSOLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELD; SPATIAL WORKING-MEMORY; EVENT-RELATED FMRI; LESIONS; MOVEMENTS; TASK; PET; brain imaging; memory-guided saccades; oculomotor control; prefrontal cortex; voluntary saccades; working memory (1)
DORSOLATERAL PREFRONTAL CORTEX; MAGNETIC STIMULATION; MAJOR DEPRESSION; BRAIN-STIMULATION; MOTOR CORTEX; TDCS; STATE; EXCITABILITY; SENSITIVITY; SYMPTOMS; Transcranial electric stimulation; Random noise stimulation; Non-invasive; Brain stimulation; Depression; Affective disorder (1)
DORSOLATERAL PREFRONTAL CORTEX; NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; MAJOR DEPRESSION; CHILDREN; ADHD; (1)
DORSOLATERAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; ATTENTIONAL CONTROL; DIVIDED ATTENTION; FMRI; ACTIVATION; MECHANISMS; attention; cognitive flexibility; response shifting; task speed; presentation time; fMRI; prefrontal cortex; parietal cortex; basal ganglia; striatum; reaction time; verbal stimulation; figural stimulation (1)
DORSOLATERAL PREFRONTAL CORTEX; THETA-BURST STIMULATION; LOW-FREQUENCY RTMS; OBSESSIVE-COMPULSIVE DISORDER; PRIMARY MOTOR CORTEX; SHAM-CONTROLLED-TRIAL; NONINVASIVE BRAIN-STIMULATION; MAJOR DEPRESSIVE DISORDER; UPPER-LIMB HEMIPARESIS; DOUBLE-CONE COIL; Cortex; Indication; Neurological disease; Neuromodulation; Noninvasive brain stimulation; Psychiatric disease; TMS; Treatment (1)
DOSAGE COMPENSATION; OCTOPAMINE RECEPTOR; TRANSGENIC RESCUE; TYRAMINE; NEURONS; INSECT; FLY; MODULATION; LOCOMOTION; DOPAMINE; (1)
DOSE BOLUS INTERLEUKIN-2; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; PHASE-III; 5-FLUOROURACIL; CANCER; COMBINATION; VACCINE; RISK; adjuvant; immunotherapy; renal cell carcinoma (1)
DOSE CALCINEURIN INHIBITOR; COMBINED MYCOPHENOLATE-MOFETIL; SOLID-ORGAN TRANSPLANTATION; RISK-FACTORS; INFECTIOUS COMPLICATIONS; INDUCTION-THERAPY; CLINICAL-TRIAL; DYSFUNCTION; FAILURE; CONVERSION; Clinical immunosuppression; Cyclosporine A; 'Bottom-up' immunosuppression; Renal impairment; Liver transplantation; mTOR inhibitor (1)
DOSE-CALCULATION ALGORITHM; QUALITY ASSURANCE; PROSTATE-CANCER; VERIFICATION; RADIOTHERAPY; OPTIMIZATION; TOMOTHERAPY; COLLIMATOR; DOSIMETRY; DELIVERY; intensity-modulated radiation therapy (IMRT); quality assurance; commissioning; system combination (1)
DOSE CALCULATION; PHOTON BEAMS; RADIOTHERAPY; IMPLEMENTATION; ALGORITHM; DISTRIBUTIONS; OPTIMIZATION; ACCURACY; DELIVERY; DOCUMENT; IMRT; Monte Carlo simulation; Film dosimetry; QA (1)
DOSE CALCULATION; RADIATION-THERAPY; OPTIMIZATION; ALGORITHM; DISTRIBUTIONS; RADIOTHERAPY; TIME; Monte Carlo; inverse treatment planning; IMRT; optimization (1)
DOSE DUAL THERAPY; 2ND-LINE TREATMENT; QUADRUPLE THERAPY; 1ST-LINE TREATMENT; TREATMENT FAILURE; RANDOMIZED-TRIAL; INFECTION; LEVOFLOXACIN; METAANALYSIS; PREVALENCE; Helicobacter pylori; moxifloxacin; levofloxacin; fluoroquinolones; rifabutin; esomeprazole; metronidazole; clarithromycin; resistance; CYP2C19 polymorphism (1)
Dose-finding, combination study (1)
Dose-finding, combination therapies, model-free designs, phase I trials (1)
Dose-finding; dose-escalation; backfilling; phase I trials; model-based; late-onset toxicity (1)
Dose-finding, Late-onset activity, Late-onset toxicities, Model-Based, Phase I trials (1)
dose-finding, late-onset toxicities, late-onset activity, dual agent, phase I trials, model-based (1)
DOSE INTERFERON-ALPHA-2B; CELL CARCINOMA; BREAST-CANCER; GENE DELETION; METHYLATION; P14(ARF); LINES; INVASION; PROMOTER; BLADDER; (1)
DOSE-OPTIMIZATION TRIAL; PLANTAR FASCIITIS; RADIATION-THERAPY; MULTICENTER TRIAL; RADIOTHERAPY; Heel spur; Plantar fasciitis; Calcaneodynia; Radiotherapy; Re-irradiation (1)
DOSE RADIATION-THERAPY; OPTIMIZATION TRIAL; RADIOTHERAPY; INFLAMMATION; IRRADIATION; PREVALENCE; DIAGNOSIS; ARTHRITIS; THUMB; KNEE; Osteoarthritis; Arthrosis; Osteoarthrosis; Radiotherapy; Re-irradiation (1)
DOSE-RESPONSE METAANALYSIS; NIH-AARP DIET; MASS INDEX; GASTRIC ADENOCARCINOMA; ANTHROPOMETRIC FACTORS; WAIST CIRCUMFERENCE; COLORECTAL-CANCER; PANCREATIC-CANCER; ABDOMINAL OBESITY; UNITED-STATES; CHANCES consortium; ageing; cohort; obesity; body fat distribution; cancer; prevention (1)
DOSE-RESPONSE METAANALYSIS; POOLED ANALYSIS; MULTIPLE IMPUTATION; PRIMARY-CARE; MISSING DATA; LUNG-CANCER; OBESITY; ADIPOSITY; FATNESS; SIZE; Body mass index; Waist circumference; Body size; Body fat distribution; Adiposity; Obesity; Cancer; Electronic health records (1)
DOSE-RESPONSE METAANALYSIS; WAIST-HIP RATIO; MASS INDEX; ANTHROPOMETRIC FACTORS; OBESITY; FATNESS; PREVENTION; ADIPOSITY; SUBTYPE; COHORT; body fat distribution; obesity; breast cancer; endometrial cancer; ovarian cancer; Mendelian randomization (1)
DOSE-RESPONSE METAANALYSIS; WEIGHT CHANGE; ADIPOSE-TISSUE; FOLLOW-UP; OBESITY; HEIGHT; MORTALITY; INSULIN; PROGRESSION; COHORT; Body mass index; body weight; disease progression; fatal outcome; prostatic neoplasms; weight change (1)
DOSE-RESPONSE METAANALYSIS; WHITE-MATTER INTEGRITY; NEUROTROPHIC FACTOR; INDIVIDUAL-DIFFERENCES; CARDIOVASCULAR HEALTH; OLDER-ADULTS; EXERCISE; RISK; QUESTIONNAIRE; ASSOCIATION; Physical activity; Anterior cingulate cortex; Hippocampus; Prefrontal cortex; Temporal lobe; Gray matter; White matter; Brain volumes; MRI (1)
DOSE URSODEOXYCHOLIC ACID; PRIMARY BILIARY-CIRRHOSIS; GENOME-WIDE ASSOCIATION; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; NATURAL-HISTORY; RISK-FACTORS; CLINICAL PRESENTATION; CROHNS-DISEASE; SINGLE-CENTER; Risk Stratification; Immune-Mediated Liver Disease; Autoimmune Liver Disease; Cholestasis (1)
DOSE-VOLUME; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; CANCER; HISTOGRAMS; TOXICITY; COMPLICATIONS; EXPERIENCE; INSTITUTIONS; IMRT; prostate; rectal wall; rectal volume; dose-volume histogram (1)
Dosis, Augenlinse, Algorithmus, pencil beam, collapsed cone (1)
Dotierter Halbleiter , Drei-Fünf-Halbleiter , Galliumarsenid / Aluminiumarsenid / Mischkristall , Akzeptor <Halbleiterphysik> , Donator <Halbleiterphysik> , Halbleiterphysik , Defektelektron , Spinrelaxation , Sättigbare Absorption , Infrarotabsorption , Intersubband-Absorption , Spinaufspaltung , kp-Theorie , Heterointerface , inter-subband absorption , spin splitting , kp-theory , heterointerface (1)
DOT; INTERFEROMETER; (1)
DOTS; SPECTRUM; COULOMB; (1)
DOT; TRANSISTOR; (1)
DOUBLE-BLIND (1)
DOUBLE-BLIND; AGGRESSION (1)
DOUBLE-BLIND; DONEPEZIL; CESSATION; DEMENTIA; 24-WEEK; CERAD; Alzheimer's disease; clinical trial; cognition; functional communication; memantine; once-daily; open-label (1)
DOUBLE-BLIND; HYPERALGESIA; NEUROTOXINS; NOCICEPTION; RELEASE; MUSCLES; botulinum toxin; capsaicin; inflammation; nociception; quantitative sensory testing; thermal pain (1)
DOUBLE-BLIND; INTERLEUKIN-6; PNEUMONIA; CYTOKINES; RECEPTOR; ARTHRITIS; BIOLOGY; SEPSIS; WUHAN; COVID-19; SARS-CoV-2; Dipeptidyl-peptidase 3; IL-6; Pulmonary infiltrates; Artificial intelligence (1)
DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB; MONOTHERAPY; DABRAFENIB; SURVIVAL; VEMURAFENIB; COBIMETINIB; TRAMETINIB; PLACEBO; Melanoma; Immune checkpoint inhibition; PD-1; CTLA-4; Targeted therapy; LDH; Response; Progression; Survival (1)
DOUBLE-BLIND; MULTICENTER; PREVENTION; REDUCTION; SEPRAFILM; MEMBRANE; VASCULARIZATION; MYOMECTOMY; FIBROSIS; EFFICACY; peritoneal adhesion; barrier materials; adhesion prevention; histomorphology; mesothelial cells (1)
DOUBLE-BLIND; PERSONALITY-DISORDER; borderline personality disorder; men's health; aggression; treatment; topiramate; weight loss (1)
DOUBLE-BLIND; PLACEBO; AMITRIPTYLINE; INVENTORY; (1)
DOUBLE-BLIND; REMEDIATION; SCHIZOPHRENIA; METAANALYSIS; IMPAIRMENT; EFFICACY; MEMORY; TRIAL; TIME; electroconvulsive therapy; depression; neuropsychology; verbal memory; attention; working memory; executive function (1)
DOUBLE-BLIND; SLEEP PROBLEMS; INDIVIDUALS; DEFINITION; DISABILITY; MODAFINIL; THERAPY; IMPACT; SCALE; MS; coffee; caffeine; multiple sclerosis; fatigue (2)
DOUBLE-BLIND; TOLERABILITY; MULTICENTER; POPULATION; PREVALENCE; ABSORPTION; IMPACT; zolmitriptan; migraine; nasal spray; efficacy; total symptom relief (1)
DOUBLE-BLIND TRIAL; ACUTE EXACERBATION; BIPOLAR PATIENTS; PLACEBO; SCHIZOPHRENIA; OLANZAPINE; EFFICACY; HALOPERIDOL; DIVALPROEX; SCALE; anticonvulsants; antipsychotics; bipolar disorder; mania; zotepine (1)
DOUBLE-BLIND TRIAL; PYLORI INFECTION; TISSUE-TYPE; SPIRAL ORGANISMS; DUODENAL-ULCER; MUCOSA; ERADICATION; ANTRUM; CURE; REGRESSION; (1)
DOUBLE-BLIND; TRIAL; SURVIVAL; CHEMOTHERAPY; MULTICENTER; PLACEBO; MONOTHERAPY; ADVANTAGE; CARCINOMA; THERAPY; chemotherapy; 5-fluorouracil; gemcitabine; irinotecan; pancreatic cancer (1)
DOUBLE-BLIND; YOUNG-ADULTS; DE-POINTES; PROPHYLAXIS; AMITRIPTYLINE; COMORBIDITY; FLUOXETINE; PROPRANOLOL; VENLAFAXINE; HEADACHE; depression; antidepressant; migraine; amitriptyline; headache (1)
DOUBLE CHIRAL LOGS; SIGMA-MODEL; LOOPS; FORM; (1)
DOUBLE-CORTEX SYNDROME; SUBCORTICAL BAND HETEROTOPIA; GENE; MUTATION; (1)
DOUBLE-CORTEX SYNDROME; SUBCORTICAL LAMINAR HETEROTOPIA; DOUBLECORTIN; MIGRATION (1)
DOUBLE EPIDURAL CATHETER; POSTOPERATIVE ANALGESIA; PERITONEAL PERFUSION; LAPAROSCOPIC SURGERY; INTRAVENOUS MORPHINE; PNEUMOPERITONEUM; PRESSURE; OXYGENATION; SCOLIOSIS; (1)
DOUBLE-HELICAL DNA; CHARGE-TRANSPORT; LAMBDA-DNA; BEHAVIOR; MODEL; MIGRATION; DYNAMICS; DISORDER; SOLVENT; DEVICES; (1)
DOUBLE-HELICAL DNA; CHARGE-TRANSPORT; MOLECULES; MODEL; (1)
DOUBLE-IONIZATION; 2-ELECTRON ATOMS; DOUBLE-EXCITATION; DRIVEN HELIUM; STRONG FIELDS; WAVE-PACKETS; STATES; HE; (1)
DOUBLE-LAYER CAPACITORS; IONIC LIQUIDS; ELECTROCHEMICAL CAPACITORS; NONAQUEOUS ELECTROLYTES; PROPYLENE CARBONATE; CONDUCTANCE; SALTS; CATIONS; (1)
DOUBLE-LAYER CAPACITORS; IUPAC TECHNICAL REPORT; THERMOPHYSICAL PROPERTIES; PHYSICOCHEMICAL PROPERTIES; PHYSICAL-PROPERTIES; TRANSPORT-PROPERTIES; BINARY-MIXTURES; DICYANAMIDE ANION; AQUEOUS-SOLUTIONS; CATIONS; (1)
DOUBLE-LAYERS; QUANTUM; INSTABILITY; INTEGER; COLLAPSE; SYSTEM; quantum Hall effect; ferromagnetism; hysteresis (1)
Double layer two-dimensional electron gas; Integer quantum Hall effect; Drag; Spin (1)
DOUBLE-LUMEN CANNULA; LUNG TRANSPLANTATION; LIFE-SUPPORT; PERCUTANEOUS CANNULATION; FAILURE; BRIDGE; ECMO; respiratory support; canulation (1)
double parton scattering, double parton distributions, multiparton scattering (1)
DOUBLE-PARTON SCATTERING; HADRON-HADRON SCATTERING; INFINITE-MOMENTUM FRAME; ROOT S=1.8 TEV; (P)OVER-BAR-P COLLISIONS; QUANTUM ELECTRODYNAMICS; 4-JET EVENTS; MULTIPARTON PROCESSES; PERTURBATION-THEORY; MASS DIVERGENCES; Hadronic Colliders; QCD Phenomenology (1)
DOUBLE-PARTON SCATTERING; HIGH-ENERGY PP; TRANSVERSE-SPIN ASYMMETRIES; DRELL-YAN; (P)OVER-BAR-P COLLISIONS; MASS DIVERGENCES; BOSON PRODUCTION; HADRON STRUCTURE; JET PRODUCTION; HIGGS-BOSON; Hadronic Colliders; QCD (1)
DOUBLE-PROTON-TRANSFER; DENSITY-FUNCTIONAL THEORY; CONCERTED MECHANISM CONTROVERSY; EXCITED-STATE DYNAMICS; MODEL BASE-PAIRS; 7-AZAINDOLE DIMER; PHOTOINDUCED TAUTOMERIZATION; ENZYMATIC CATALYSIS; FORMAMIDE-WATER; AB-INITIO; (1)
DOUBLE PROTON-TRANSFER; EXCITED-STATE TAUTOMERIZATION; EXPERIMENTAL MATRIX-ISOLATION; KINETIC HH/HD/DD ISOTOPE; HARMONIC FORCE-FIELD; FREE-BASE PORPHYRIN; INFRARED-SPECTRA; SOLID-STATE; POLYCRYSTALLINE PORPHYCENE; PHOTODYNAMIC THERAPY; (1)
DOUBLE-PROTON-TRANSFER; LASER EXCITATION FLUORESCENCE; MODEL BASE-PAIRS; EXCITED-STATE; ENZYMATIC CATALYSIS; 7-AZAINDOLE DIMER; 1-AZACARBAZOLE; DYNAMICS; 3-METHYLPENTANE; TEMPERATURE; Hydrogen Bond; Strong Hydrogen Bonding; Double Proton Transfer; Tautomers (1)
DOUBLE-QUANTUM DOT; COHERENT MANIPULATION; SPINS; SEMICONDUCTORS; Organic light-emitting diodes; conducting polymers; spin-dependent recombination; electron paramagnetic resonance; spin collectivity (1)
DOUBLE-QUANTUM DOT; DETECTOR; (1)
DOUBLE-QUANTUM DOT; MAGNETIC-RESONANCE; ELECTRON-SPIN; (1)
DOUBLE-QUANTUM-WELLS; (1)
DOUBLE-QUANTUM-WELLS; BOSE-EINSTEIN CONDENSATION; ELECTRON-SYSTEMS; HALL SYSTEMS; Bose-Einstein condensate; bilayer; total filling factor one (1)
DOUBLE-QUANTUM-WELLS; ELECTRON-SYSTEMS; (1)
DOUBLE-REFRACTION; SPIN; SPINTRONICS; WELLS; (1)
DOUBLE-STRAND BREAKS; STABLE NUCLEAR TRANSFORMATION; HOMOLOGOUS RECOMBINATION; NITRATE REDUCTASE; SELECTABLE MARKER; DNA INTEGRATION; STEM-CELLS; GENOME; RESISTANCE; EXPRESSION; homologous recombination; Chlamydomonas; endogeneous genes; NIT1; ARG7; gene targeting; NHR; HR; linearized plasmids (1)
DOUBLE-STRAND BREAKS; TRIETHYLENE GLYCOL DIMETHACRYLATE; UNPOLYMERIZED RESIN MONOMERS; HUMAN GINGIVAL FIBROBLASTS; CELL-CYCLE ARREST; N-ACETYL CYSTEINE; INDUCED APOPTOSIS; GENE-EXPRESSION; PROTEIN-KINASE; HOMOLOGOUS RECOMBINATION; Dental resin; TEGDMA; DNA oxidation; ATM; p38; ERK1/2 (1)
DOUBLE-STRANDED DNA; ELECTRICAL-TRANSPORT; CONDUCTANCE; ACID; DNA; molecular nanoelectronics; scanning probe microscopy; theoretical modeling (1)
DOUBLE-STRANDED DNA; INDUCED FLUORESCENCE DETECTION; NUCLEIC-ACIDS; CAPILLARY-ELECTROPHORESIS; BINDING; NORFLOXACIN; PROBES; ASSAY; ENHANCEMENT; DYES; UV-vis spectrometry; luminescence; terbium; quinolones; difloxacin; DNA (1)
DOUBLE-STRANDED HELICES; COORDINATION POLYMERS; CARBON; MOLECULES; DESIGN; NANOTUBES; COMPLEXES; CHEMISTRY; NETWORKS; CHANNELS; (1)
DOUBLE-STRANDED POLYNUCLEOTIDES; MACROCYCLIC ZINC(II) COMPLEXES; HIGHLY SELECTIVE RECOGNITION; PHOSPHATE DIESTER HYDROLYSIS; LASER-INDUCED LUMINESCENCE; CARBONIC-ANHYDRASE; AQUEOUS-SOLUTION; MESSENGER-RNA; COBALT(III)-PROMOTED HYDROLYSIS; PHOSPHODIESTER HYDROLYSIS; (1)
DOUBLE-STRANDED POLYNUCLEOTIDES; MACROCYCLIC ZINC(II) COMPLEXES; PARA-BENZOQUINONE DERIVATIVES; HYDRIDE-TRANSFER REACTIONS; FLAVOENZYME ACTIVITY; GLUTATHIONE-REDUCTASE; SELECTIVE RECOGNITION; ESCHERICHIA-COLI; ELECTRON-TRANSFER; MOLECULAR RECOGNITION; (1)
DOUBLE-STRANDED-RNA; DENDRITIC CELLS; TARGETED DISRUPTION; INTERFERON-BETA; EXPRESSION; MACROPHAGES; INDUCTION; ACTIVATION; DEFENSE; FAMILY; (1)
DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; RISC-LOADING COMPLEX; BINDING PROTEIN; HUMAN ARGONAUTE2; TRBP; PACT; DICER; INTERFERENCE; RECOGNITION; (1)
DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; WIDE IDENTIFICATION; HOST-RESISTANCE; HUMAN ARGONAUTE; GENE; TARGET; APOPTOSIS; READTHROUGH; TERMINATION; Argonaute 1; breast cancer; endogenous dsRNA; interferon response; translation readthrough (1)
DOUBLE-STRANDED-RNA; SMALL INTERFERING RNAS; SMALL NUCLEOLAR RNAS; EMBRYONIC STEM-CELLS; MICRORNA BIOGENESIS; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL REPRESSION; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; miRNA; Small RNAs; miRNA-like small RNAs; Non-coding RNAs; Regulation of gene expression (1)
DOUBLY-LABELED WATER; ESTIMATING ENERGY-EXPENDITURE; ACTIVITY DIARY; HEART-RATE; ACTIVITY QUESTIONNAIRES; ACTIVITY MONITORS; FREQUENCY QUESTIONNAIRE; EPIDEMIOLOGIC RESEARCH; ACCELEROMETER OUTPUT; SEDENTARY BEHAVIORS; web-based method; validity; reliability; usability; lifestyle behavior; physical activity; sedentary behavior (1)
DOVITINIB; TRIAL; Bladder; Cancer; Urothelial carcinoma; Cystectomy; FGFR3; Expression; Mutation (1)
Dowanol DPnB solvo surfactant adsorption foam (1)
DOWN-REGULATION; MOLECULAR TARGETS; ANTAGONIST SFRP1; CERVICAL-CANCER; EXPRESSION; HYPERMETHYLATION; PATHWAY; GROWTH; GENES; PROLIFERATION; astrocytoma; brain tumor; epigenetic; glioblastoma; miRNA (1)
DOWN SUPPRESSION DEFICIT; MENSTRUAL-CYCLE PHASE; COGNITIVE FUNCTION; EPISODIC MEMORY; VERBAL MEMORY; EMOTIONAL STORY; YOUNG-WOMEN; ESTROGEN; ESTRADIOL; BRAIN; cognitive aging; estrogen; learning and memory; estradiol (1)
Downward nominal wage rigidity; Kernel-location approach; Kernel density estimation (1)
; Downward nominal wage rigidity; Wage stickiness; European community household panel; ECHP; Histogram-location approach; European union; Euro area (1)
Doxorubicin, CaMKII, Kardiotoxizität (1)
DPOAE GROWTH-BEHAVIOR; MIDDLE-EAR; THRESHOLD ESTIMATION; COCHLEAR DISORDERS; OTITIS-MEDIA; LEVEL; CHILDREN; DIFFERENTIATION; MECHANISMS; FREQUENCY; Otoacoustic emission; DPOAE; Conductive hearing loss; Pediatric audiology (1)
DQ, data quality, data quality assessment, metric, metric-based, probability-based, currency metric (1)
DRAINAGE EVOLUTION; VICTORIA-FALLS; FISH; MORPHOLOGY; GENETICS; systematics; morphometrics; electric organ discharges; molecular genetics; allopatric speciation (1)
DRAIN PLACEMENT; RISK-FACTORS; INFECTIONS; HEMORRHAGE; ANTIBIOTICS; SAFE; hydrocephalus; ventriculitis; CSF shunt; neurosurgical intensive care (1)
Dramenanalyse, Quantitative Dramenanalyse, Digital Humanities (1)
Drametrics, Distant Reading, Computational Literary Studies, Drama Analysis, Statistics, Tool, Visualization (1)
Drei-Fünf-Halbleiter , Heterostruktur , Terahertzbereich , Halbleiteroberfläche , Oszillator , Magnetowiderstand , Übergitter , Oberflächenübergitter , Blochoszillator , Ladungsträgerdomänen , Negative differentielle Leitfähigkeit , Transport , surface superlattice , Bloch oscillator , shunted , Quantum Hall Effect , NDC (1)
Dreimonatskoliken, infantile colic (1)
DRELL-YAN; DISTRIBUTION AMPLITUDES; SPIN ASYMMETRIES; VECTOR-MESONS; QCD; EVOLUTION; (1)
DRELL-YAN; EVOLUTION-EQUATIONS; BACK JETS; RENORMALIZATION; SPIN; LOOP; PAIR; Perturbative QCD; Effective Field Theories (1)
DRELL-YAN; HADRONIC COLLISIONS; CROSS-SECTIONS; TUNGSTEN; QCD; (1)
DRELL-YAN; PARTON DISTRIBUTIONS; BOSON; QCD; (1)
DRELL-YAN PROCESS; PARTON DISTRIBUTIONS; HADRONIC COLLISIONS; TRANSVERSE-MOMENTUM; ELASTIC-SCATTERING; SMALL-X; DEPENDENCE; QCD; QUARK; SATURATION; (1)
DRELL-YAN PROCESS; SINGLE SPIN; ASYMMETRIES; HADRONS; Factorization theorem; Gauge invariance; Drell-Yan process (1)
DRELL-YAN PROCESS; TRANSVERSE SPIN ASYMMETRIES; ODD PARTON DISTRIBUTIONS; FINAL-STATE INTERACTIONS; LEPTON PAIR PRODUCTION; QUANTUM CHROMODYNAMICS; ENERGY-LOSS; LEPTOPRODUCTION; QCD; DEPENDENCE; (1)
DRELL-YAN PRODUCTION; PARTON DISTRIBUTIONS; CROSS-SECTIONS; RENORMALIZATION; EXPONENTIATION; EVOLUTION; LOOP; (1)
Dressed Second Order (DSO); quantum master equation; irreducible tunneling processes; reduced density matrix; diagrammatic language; charge fluctuations; quantum dot; tunneling current; single electron transistor (SET); single impurity Anderson model (SIAM); infinite Coulomb interaction; (1)
; DRG; calculation; photodynamic diagnostic (1)
DRG-Erlös, Trauma versus Elektiv, Polytrauma (1)
DRG-SYSTEM 2008; HISTORICAL DEVELOPMENT; Central patients admission unit; Appropriateness evaluation protocol; Inpatient care; Outpatient care; Inappropriate admission (1)
DRIED BLOOD SPOTS; CARBAMYLATED HEMOGLOBIN; GLYCATION; HPLC; IDENTIFICATION; HEMODIALYSIS; PROTEOMICS; VARIANTS; PROTEINS; HBA(1C); (1)
DRINKING-WATER; ANTIMICROBIAL ACTIVITY; DIVALENT-CATIONS; SINGLET OXYGEN; STAPHYLOCOCCUS-AUREUS; SWEAT COMPOSITION; TAP WATER; IN-VITRO; MAGNESIUM; PHOTOINACTIVATION (1)
DRINKING-WATER; HOT-WATER; ENVIRONMENTAL-SAMPLES; LEGIONNAIRES-DISEASE; MASS-SPECTROMETRY; IDENTIFICATION; PNEUMOPHILA; COLONIZATION; PREVALENCE; HOSPITALS; Biodiversity; Drinking water quality; ISO 11731; MALDI biotyper (1)
DRIVEN; (3)
DRIVEN; DYNAMICS; (2)
DRIVEN; MULTILAYER; FILMS; EXCITATION; (1)
DRIVER BEHAVIOR; TRAFFIC FATALITIES; ECONOMIC-GROWTH; QUESTIONNAIRE; ACCIDENT; VIOLATIONS; ERRORS; INVOLVEMENT; COUNTRIES; QATAR; Driving behavior; Driving behavior questionnaire; Oman; University students; University staff; Errors; Violations (1)
Driver Distraction Steering Angle (1)
Driver’s Workload; Workload Estimation; In-Vehicle Information Systems (1)
driving simulation, monitors, HMD, presence, realism, simulator sickness (1)
DRM, kioskbasiertes System, digitale Lehrbücher (1)
DRONEDARONE; MANAGEMENT; ARRHYTHMIAS; COMBINATION; AMIODARONE; RHYTHM; PREVENTION; PROTECTION; GUIDELINES; OUTCOMES; Antiarrhythmic drug; Atrial fibrillation; Atrial flutter; Ranolazine; Electrophysiology; Cardioversion; controlled trial (1)
Drop-jump, Side-Hop, Elite-Jugenhandballspieler, Verletzungen des vorderen Kreuzbandes, Pre-Season Testungen (1)
DROPLET PROTEIN; CELLS; GENE; LIPOLYSIS; TARGET; CANCER; CYCLOOXYGENASE-2; MICROENVIRONMENT; OVEREXPRESSION; INFLAMMATION; foam cell; lipid droplets; hypoxia-inducible factor-1 (1)
DROPLETS; SOLVATION; BAND; (1)
Drops; Nanoparticles (nanodroplets, structure and dynamics of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); Binding energy; Cluster structure; Conformational transition; Isomers; Potential energy surface; Vibrational predissociation; Vibronic excitation; Vibronic transition (of phthalocyanine-Argonn (n = 1-4); complexes studied in helium superfluid nanodroplets); Fluorescence excitation; Superfluids; Van der Waals clusters (structure and dynamics of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); Luminescence (visible, of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); phthalocyanine argon cluster fluorescence excitation helium nanodroplet (1)
drops, nonlinear dynamics, walking droplets, quantum mechanics (1)
DROSHA (1)
drosophila, behavior, spontaneous (1)
DROSOPHILA-BRAIN-TUMOR; EMBRYONIC STEM-CELLS; E3 UBIQUITIN LIGASE; SELF-RENEWAL; LET-7 MICRORNA; CAENORHABDITIS-ELEGANS; BINDING PROTEINS; TARGET GENE; LIN-41; COMPLEXES; (1)
Drosophila, cell polarity, protein PATJ (1)
DROSOPHILA CENTRAL BRAIN; DUAL OLFACTORY PATHWAY; MUSHROOM BODIES; CENTRAL COMPLEX; SUBESOPHAGEAL GANGLION; HONEYBEE BRAIN; APIS-MELLIFERA; ANTENNAL LOBES; POSTEMBRYONIC LINEAGES; SCHISTOCERCA-GREGARIA; neuropile compartements; Cardiocondyla obscurior; neuroanatomy; fiber tracts; hymenoptera (1)
Drosophila, epithelial polarity, Crb complex, Baz/PAR-aPKC complex, dynamics (1)
Drosophila, FoxP, CRISPR/Cas9, Neurogenetics, Behaviour (1)
Drosophila melanogaster; aggression; fighting behaviour; amine; mushroom body (1)
DROSOPHILA-MELANOGASTER; ARACHNE; (1)
DROSOPHILA-MELANOGASTER; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; VISUAL-SYSTEM; PACEMAKER NEURONS; NERVOUS-SYSTEM; PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS; DISCONNECTED MUTANTS; activity rhythm; clock; cycle; period; pigment-dispersing factor; timeless (1)
DROSOPHILA-MELANOGASTER; CENTRAL COMPLEX; LOCOMOTOR BEHAVIOR; DOPAMINE-RECEPTOR; FLIGHT; OCTOPAMINE; MEMORY; NEURONS; REWARD; CRICKETS; behavioural flexibility; octopamine; dopamine; decision-making; Drosophila; invertebrates (1)
Drosophila melanogaster • circadian rhythm • mutant behaviour • rhythm mutant • genetics • behavioural genetics • optic lobes (1)
DROSOPHILA-MELANOGASTER FEMALES; ACCESSORY-GLAND PRODUCTS; DIVISION-OF-LABOR; LIFE-SPAN; EVOLUTIONARY-THEORIES; EGG-PRODUCTION; REPRODUCTION; COST; SENESCENCE; MALES; (1)
DROSOPHILA-MELANOGASTER FEMALES; SEMINAL FLUID PROTEIN; SEXUAL CONFLICT; INBREEDING DEPRESSION; SOCIAL INSECTS; ANTAGONISTIC COEVOLUTION; CARDIOCONDYLA-OBSCURIOR; OUTBREEDING DEPRESSION; POPULATION CROSSES; DIMORPHIC MALES; longevity; outbreeding depression; sexual cooperation; social insects (1)
DROSOPHILA-MELANOGASTER FEMALES; SEMINAL FLUID PROTEINS; SEX-PEPTIDE; MATING-FREQUENCY; SPERM VIABILITY; APIS-MELLIFERA; SOCIAL INSECTS; KIN SELECTION; EVOLUTION; BEE; (1)
Drosophila melanogaster; Friedreich’s ataxia; frataxin; iron; oxidative stress; metal homeostasis; lipid metabolism; endoplasmic reticulum; genetic screens; drug screens (1)
DROSOPHILA-MELANOGASTER; FUNCTIONAL ASSIGNMENTS; COURTSHIP BEHAVIOR; CRITICAL RESIDUES; DESATURASE GENE; VITRIPENNIS; MOTHS; BIOSYNTHESIS; PTEROMALIDAE; SPECIFICITY; (1)
Drosophila melanogaster, metal homeostasis, dMTF-1, methallothioneins, copper, zinc, in vivo modeling, human diseases (1)
Drosophila melanogaster; Oogenese; Sxl; Bam; Bgcn; Mai-P26; nanos (1)
Drosophila melanogaster, perineurial glia, T4/T5-Neuron (1)
Drosophila melanogaster, Riboflavin, Malpighische Gefäße, ABC-Transporter, Lipide in Drosophila, riboflavin, Malpighian tubules, ABC-transporters, Drosophila lipids (1)
DROSOPHILA-MELANOGASTER; THERMAL TOLERANCE; ION HOMEOSTASIS; FRUIT-FLY; DIACYLGLYCEROL KINASE; COLD-ACCLIMATION; LOW-TEMPERATURE; CLIMATE-CHANGE; INSECTS; DIPTERA; Chill-coma recovery; Chilling-injury; Medfly; Lipid profiles; Fatty acid composition; Sterol esters (1)
Drosophila , Neuropathologie , Nervendegeneration , Glia , , swiss-cheese , neuropathy-target-esterase , sws , nte (1)
DROSOPHILA PARASITOIDS; LEPTOPILINA-HETEROTOMA; CHEMICAL DEFENSE; CUTICULAR LIPIDS; EVOLUTION; HYMENOPTERA; ODOR; WASP; HYDROCARBONS; STRATEGIES; (1)
Drosophila, Parkinson-Krankheit, Oxidativer Stress, Dopamin, alpha-Synuclein, alpha-Synuclein-Aggregation, Parkinson's disease, alpha-Synuclein, oxidative stress, dopamine, alpha-Synuclein-aggregation (1)
Drosophila, proboscis-extension, starvation, method, sucrose preference test (1)
DROSOPHILA TAKEOUT GENE; BIG BRAIN; JUVENILE-HORMONE; HONEY-BEE; HODOTERMOPSIS-SJOSTEDTI; RETICULITERMES-FLAVIPES; SOCIAL EXPLOITATION; FOOD CONDITIONS; APIS-MELLIFERA; FOLLICLE CELLS; caste determination; gene expression; reproduction; social insects; termites; reproductive division of labor (1)
Drosophila , visuelles System , Gliazellen , Lamina , Migration , axonale Projektion , Ubiquitin spezifische Protease , Photorezeptoren , Zielfindungsprozess , Gliazellmigration , axonal projection , ubiquitin specific protease , photoreceptors , target finding process , glial cell migration (1)
DROSOPHILA WHITE GENE; CHROMOSOME 21Q22.3; HUMAN HOMOLOG; DIETARY-CHOLESTEROL; MOLECULAR-CLONING; HALF-TRANSPORTER; PROTEIN COMPLEX; PLASMA-MEMBRANE; SITOSTEROLEMIA; BINDING; adaptor proteins; Drosophila ABC transporters; gene regulation; macrophage; beta-sitosterolemia; vesicular transport (1)
DROSOPHILA-WHITE GENE; SUBSTRATE-SPECIFICITY; MULTIDRUG TRANSPORTER; RESISTANCE PROTEIN; HUMAN HOMOLOG; INSECT CELLS; MACROPHAGES; ATPASE; EYE; MELANOGASTER; ABC half-transporter; ABCG1; ABCG4; heterodimer; Sf9 cells; drug-stimulated ATPase activity; dominant negative (1)
DROSOPHILA WHITE GENE; TANGIER-DISEASE; CHROMOSOME 21Q22.3; MOLECULAR-CLONING; MAMMALIAN-CELLS; HUMAN HOMOLOG; CHOLESTEROL; EXPRESSION; MUTATIONS; REGION; ATP-binding cassette transporter G1; genomic organization; promoter region; cholesterol transport; Sp1; sterol regulatory element binding protein (1)
DROUGHT-INDUCED TREE; VEGETATION MODELS; CLIMATE-CHANGE; INVENTORY DATA; SCOTS PINE; GAP; UNCERTAINTY; PREDICT; TIME; KEY; Bayesian calibration; data integration; dynamic vegetation model; forest inventory; growth; stand dynamics; tree mortality (1)
DRS alc water mixt cooperative mol dynamics review (1)
DRUG-COMBINATION; COMPETING DESIGNS; CLINICAL-TRIALS; combination study; dose-finding; dose-schedule; partial ordering (1)
DRUG-DELIVERY; ALGINATE; HYDROGELS; RELEASE; STABILITY; FORCES; (1)
DRUG-DELIVERY; ANTIMICROBIAL PEPTIDES; LIPID-BILAYERS; POLYMERS; DISRUPTION; INHIBITORS; VESICLES; BINDING; PORES; Polymalic acid; Membrane permeation; Carpet model; Barrel-stave model; Endosomolytic drug delivery (1)
DRUG-DELIVERY APPLICATIONS; CROSS-LINKING; INTERFACIAL PHOTOPOLYMERIZATION; PROTEIN DELIVERY; CLICK CHEMISTRY; PEG HYDROGELS; T-JUNCTION; STEP; MICROSPHERES; MECHANISM; Microgel; Click chemistry; Thiol-ene reaction; Protein delivery; Microfluidics; Controlled release (1)
DRUG-DELIVERY; CANCER-CHEMOTHERAPY; MALIGNANT GLIOMA; SOLID TUMOR; GLIOBLASTOMA; THERAPEUTICS; PERMEABILITY; EXPRESSION; ANTIBODIES; RESISTANCE; anti-TfR mAb; nanoconjugate; pH-dependent membrane disruption; polymalic acid; targeted drug delivery; temozolomide (1)
DRUG-DELIVERY; LIPOSOMES; CHOLESTEROL; PHOSPHOLIPIDS; POSTINSERTION; ASSAY; NANOPARTICLES; NANOCAPSULES; PEGYLATION; EFFICIENCY; Liposomes; Surface modification; Nanovesicle; Nanoparticle (1)
DRUG-DELIVERY; MICROCHIP; MATRICES; implants; controlled release; pulsatile release; triglyceride; convolution (1)
DRUG-DELIVERY; NANOPARTICLES; PARTICLES; OXYGEN; Polyvinyl butyral; Nanoparticles; Fluorescent microbeads; Live cell imaging; Cytotoxicity (1)
DRUG DELIVERY; RELEASE; POLYANHYDRIDES; KINETICS; MATRICES (1)
DRUG-DELIVERY SYSTEM; DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; NANOPRECIPITATION METHOD; POTENTIAL TARGET; COMET ASSAY; IN-VITRO; PROTEIN; APOPTOSIS; TUMOR; sorafenib; nanoparticles; A549 cell lines; MCF-7 cell lines; anticancer activities (1)
DRUG-DELIVERY SYSTEMS; BONE AFFINITY; ALENDRONATE; BISPHOSPHONATES; MICE; VIVO; (1)
DRUG-DELIVERY SYSTEMS; LIQUID-CRYSTALLINE PHASES; DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; SUBMICRON PARTICLES; SOLVENT RELAXATION; MICROEMULSIONS; DISPERSIONS; BEHAVIOR; SPECTROSCOPY; (1)
DRUG-DELIVERY SYSTEMS; MOLECULAR-DYNAMICS SIMULATIONS; BLOCK-COPOLYMER; PNEUMOCOCCAL MENINGITIS; TERMINATED PAMAM; GENE DELIVERY; IN-SITU; VESICLES; NANOPARTICLES; CARRIER; Dendrimers; Aggregates; Free energy; Molecular dynamic simulation (1)
DRUG-DELIVERY SYSTEMS; PHASE INVERSION DYNAMICS; HYDROLYTIC DEGRADATION; PART II; MICROSPHERES; BIOMATERIALS; LEUPROLIDE; ACYLATION; IMPLANT; ACID); Poly(D,L-lactide-co-glycolide); Degradation; Stability; In situ forming depot (1)
Drug delivery, Targeting, Control by design, Protein corona, Endosomal escape, Nanoparticle exocytosis, Nanoparticle uptake, Switchable nanoparticles, Nanoparticle activation, pH-Responsive, Enzyme-responsive, Redox-responsive, Extrinsically-activitable nanoparticles, In vivo, Targeted drug delivery (1)
DRUG-DELIVERY; TRASTUZUMAB RESISTANCE; DOWN-REGULATION; TUMOR GROWTH; PHASE-II; CELLS; CHEMOTHERAPY; EXPRESSION; HERCEPTIN; APOPTOSIS; (1)
DRUG-DEPENDENCE; GENE; SCHIZOPHRENIA; CONSUMPTION; POPULATION; EXPRESSION; DISEASES; CLUSTER; VARIANT; GIRDIN; alcohol dependence; alcohol-metabolizing enzymes; complex traits; genome-wide association; population differences; population-specific alleles (1)
Drug discovery Natural products (active substances from biol. active natural products) review natural product drug discovery (1)
Drug-drug interaction (DDI), Clinical decision support systems (CDSS), Adverse drug reaction (ADR), Expenditure of time, Chronic pain, Polypharmacy (1)
drug-drug interactions, cephalosporins, 5-fluorouracil, sepsis, oncology, adverse, drug reactions (1)
DRUG-DRUG INTERACTIONS; HCV INFECTION; SOFOSBUVIR; RIBAVIRIN; DACLATASVIR; RECIPIENTS; CYCLOSPORINE; SIMEPREVIR; TACROLIMUS; (1)
DRUG-DRUG INTERACTIONS; HUMAN SERUM-ALBUMIN; CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; CANCER-PATIENTS; ALPHA-1-ACID GLYCOPROTEIN; CLINICAL-PHARMACOLOGY; ALLOSTERIC MODULATION; ANTICANCER DRUGS; PHARMACOKINETICS; albumin; alpha-1-acid glycoprotein; drug-drug interactions; anti-infective agents; ultrafiltration; cancer (1)
DRUG-DRUG INTERACTIONS; PROLONGED-INFUSION; METHOTREXATE; ANTIBACTERIAL; PHARMACOKINETICS; CEPHALOSPORINS; MITOXANTRONE; PENICILLIN; TOXICITY; AGENTS; Drug-drug interaction; Pharmacodynamics; Antibiotics; Anti-cancer agents; Antagonism; Apoptosis; Colon cancer; 5-fluorouracil; Ceftazidime; Cefepime (1)
DRUG-DRUG INTERACTIONS; RAT-LIVER; IN-VITRO; CONVENTIONAL ANTIPSYCHOTICS; CONCISE GUIDE; METABOLISM; PHARMACOLOGY; NEUROLEPTICS; ENZYMES; CYP2D6; antipsychotic polypharmacy; CYP2D6; CYP3A4; cytochrome P450; interaction; perazine; pharmacokinetics; risperidone; therapeutic drug monitoring (1)
DRUG-DRUG INTERACTIONS; SERUM CONCENTRATIONS; ADJUNCTIVE TREATMENT; PARTIAL AGONIST; ADD-ON; RISPERIDONE; SCHIZOPHRENIA; PHARMACOKINETICS; COMEDICATION; EFFICACY; aripiprazole; cytochrome; duloxetine; interaction; pharmacokinetics; therapeutic drug monitoring (1)
DRUG-DRUG INTERACTIONS; STEADY-STATE; SERUM CONCENTRATIONS; CYP2D6; ANTIPSYCHOTICS; SCHIZOPHRENIA; EFFICACY; 9-HYDROXYRISPERIDONE; METABOLISM; PSYCHIATRY; drug monitoring; cytochrome P-450 CYP2D6; risperidone/administration and dosage; risperidone/metabolism; risperidone/pharmacokinetics (1)
DRUG-ELUTING BEADS; ARTERIAL CHEMOEMBOLIZATION; LOCOREGIONAL THERAPY; TUMOR RESPONSE; LIVER-LESIONS; SURVIVAL; EMBOLIZATION; CANCER; GUIDELINES; MANAGEMENT; Real-time image fusion; CEUS; HCC; TACE; treatment response (1)
DRUG-ELUTING BEADS; TRANSARTERIAL CHEMOEMBOLIZATION; EFFICACY; PHARMACOKINETICS; MODEL; TACE; DEB; Chemoembolization; Doxorubicin; Drug carriers; Hepatocellular carcinoma; Microspheres (1)
DRUG-ELUTING BEADS; TUMOR RESPONSE; DOXORUBICIN; SURVIVAL; TOXICITY; MRECIST; CANCER; TRIAL; LIVER; TACE; HCC; embolization; degradable starch microspheres; safety (1)
DRUG-ELUTING STENTS; BARE-METAL STENTS; DELIVERY; THROMBOSIS; ANGIOPLASTY; PREVENTION; INHIBITION; EFFICACY; ARTERIES; LESIONS; balloon; drug-eluting stents; restenosis; angioplasty; revascularization (1)
DRUG-ELUTING STENTS; BARE-METAL STENTS; FOLLOW-UP; SIROLIMUS; DELIVERY; THROMBOSIS; LESIONS; IMPLANTATION; PREVENTION; INSIGHTS; drug-coated balloon; long-tern follow-up; paclitaxel (1)
DRUG-ELUTING STENTS; TYROSINE KINASE INHIBITOR; RAT CAROTID-ARTERY; REDUCES NEOINTIMA FORMATION; PORCINE CORONARY-ARTERIES; GROWTH-FACTOR; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL; LOCAL-DELIVERY; PREVENTION; Restenosis; Stent; PDGF; Bis(1H-2-indolyl)methanone; Rabbit (1)
DRUG FEVER; THERAPY; COMPLICATIONS; DISEASES; YIELD; Fever of unknown origin; Malignant diseases; Fever episodes; Infection; Non-infectious inflammatory diseases (1)
DRUG HARMS; ABUSE; ALCOHOL; MISUSE; GABAPENTIN; DEPENDENCE; RANKING; PREGABALIN; TOBACCO; Illegal drugs; Legalization; Cannabis; Ketamine; Opioids; Gabapentinoids; Non-Steroidal Anti-Inflammatory Drugs; Analgesics (1)
DRUG-INDUCED AGRANULOCYTOSIS; RISK; SAFETY; CELLS; (1)
DRUG-INDUCED AKATHISIA; D3 RECEPTOR GENE; CLINICAL CHARACTERISTICS; EXTRAPYRAMIDAL SIGNS; LOCOMOTOR-ACTIVITY; PREVALENCE; CLOZAPINE; SYMPTOMS; SYSTEM; IRON; akathisia; risk factors; dopamine D3 receptor variant (1)
DRUG-INDUCED APOPTOSIS; IRRADIATION-INDUCED APOPTOSIS; RECURRENT MALIGNANT GLIOMA; IN-VIVO; PI3K INHIBITOR; TEMOZOLOMIDE; SUNITINIB; CELLS; RAPAMYCIN; GDC-0941; RIST therapy; glioblastoma; orthotopic mouse model (1)
drug-induced haemolysis, drug-dependent anti-bodies, rifampicin, tuberculosis, immune haemolytic anaemia (1)
DRUG-INDUCED HEADACHE; 5-HYDROXYTRYPTAMINE(1B) RECEPTORS; SEROTONIN RECEPTORS; PARTIAL AGONIST; PHARMACOLOGY; MIGRAINE; OVERUSE; BINDING; NEURONS; DIHYDROERGOTAMINE; 5-HT1 receptor; drug overuse; protein extravasation; triptan; vasoconstriction (1)
drug-induced hemolysis; drug-induced acute renal failure; drug-dependentantibodies; diclofenac; immune hemolytic anemia (1)
Drug interactions (chemosensitivity of malignant melanoma to regional hyaluronidase/vinblastine therapy); Neoplasm inhibitors (melanoma, chemosensitivity of malignant melanoma to regional hyaluronidase/vinblastine therapy); vinblastine hyaluronidase interaction melanoma inhibition; antitumor vinblastine hyaluronidase interaction (1)
DRUG-LIKENESS; H3 RECEPTOR; BODY-WEIGHT; FOOD-INTAKE; IN-VITRO; DERIVATIVES; TARGET; IDALOPIRDINE; PHARMACOLOGY; INHIBITION; Histamine H-3 receptor; Non-imidazole histamine H3R ligands; Piperazine derivatives, Selective ligands; Molecular docking; Anti-obesity agents (1)
Drug metabolism, prodrugs, cilazapril, candesartan, transdermal delivery, transdermal therapeutic system, TTS, skin permeation, toxicity, reactive metabolites, reactive intermediates, trapping reaction, glutathione, LC-MS (1)
DRUG-METABOLIZING-ENZYMES; PREGNANE-X RECEPTOR; HUMAN HEPATOCYTES; NUCLEAR RECEPTORS; ENDOGENOUS LIGAND; RESPONSE ELEMENTS; GENE-EXPRESSION; FATTY-ACIDS; INDUCTION; CAR; (1)
DRUG-METABOLIZING-ENZYMES; XENOBIOTIC RECEPTOR; RESPONSE ELEMENTS; HUMAN HEPATOCYTES; GENE-EXPRESSION; TARGET GENES; PPAR-ALPHA; PXR; BINDING; CAR; Pregnane X receptor; Liver X receptor; Hepatocytes; Gene regulation; Ligand-independent repression (1)
Drug mixing methods, Drug dilution, Solution homogeneity, Syringe pump infusions, Medication safety (1)
DRUG OVERDOSE; ORAL FLUID; FOMEPIZOLE; ETHYLENE; PATIENT; GLYCOL; Intoxication; Decontamination; Screening; Toxicology; Antidotes (1)
DRUG-RELEASE; PROTEIN-RELEASE; VACCINE DELIVERY; PEPTIDE; SIZE; NANOPARTICLES; MICROSPHERES; COMPLETENESS; PARAMETERS; DIFFUSION; PLGA; In situ-forming implants; Particle release; Controlled release; Delivery system (1)
DRUG-RELEASE; TRIGLYCERIDE MATRICES; PARTICLE-SIZE; IN-VITRO; IMPLANTS; SYSTEM; MICROPARTICLES; MICROSPHERES; PERCOLATION; KINETICS; confocal microscopy; controlled release of proteins; diffusion; lipid matrices; molecular weight; release mechanism (1)
DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SHIKIMATE DEHYDROGENASE; MULTIDRUG-RESISTANT; INHIBITORS; LIGANDS; TB; Pyridine; Quinoline; X-ray; In vitro; Tuberculosis (1)
drug targeting, hydrophobic drugs, polyethylene glycol derivatives, polymeric micelles, FRET (1)
Drug therapy Randomized controlled trials SARS-CoV-2 Viral infection (1)
DRUG-TREATMENT; (1)
DRUG-USE; SLEEP DISTURBANCES; GENERAL-POPULATION; RECEPTOR AGONISTS; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; DIAGNOSIS; OPIOIDS; ADULTS; benzodiazepines; dependence; insomnia; sleep; therapy; opioids (1)
DRY EYE; CONJUNCTIVA; TEARS; dry eye; ocular insert; alginates; EGF (1)
DRY EYE DISEASE; CYCLOSPORINE-A; PENETRATION; FORMULATION; RABBITS; Surfactant micelles; In-situ nanosuspension; Cyclosporine A; Dry eye disease; Biocompatibility; Bioavailability (1)
DRY EYE DISEASE; FILM; PROTEIN; FLUID; WORKSHOP; WATER; Dry eye disease; Dry eye syndrome; Meibomian gland dysfunction; Lacrimal functional unit; Lacrimal apparatus; Ocular surface; Tear film; Urea transporter (1)
DRY EYE DISEASE; TEAR FILM; WORKSHOP; PROTEIN; FLUID; WATER; Dry eye disease; Dry eye syndrome; Meibomian gland dysfunction; Lacrimal functional unit; Lacrimal apparatus; Ocular surface; Tear film; Urea transporter (1)
DRY-MATTER CONTENT; ELLENBERGS INDICATOR VALUES; DISTRIBUTION MODELS; LEAF-SIZE; MOISTURE; VEGETATION; TOLERANCE; PATTERNS; NITROGEN; DATABASE; Environmental gradients; Habitat affinities; Habitat fertility; Leaf dry matter content; Leaf size; Seed size; Shade; Specific leaf area; Soil moisture; Soil nutrients; Understorey plants; Wetlands (1)
DRY-MATTER CONTENT; LEAF LIFE-SPAN; TROPICAL RAIN-FOREST; RELATIVE GROWTH-RATE; LITTER DECOMPOSITION RATES; LONG-DISTANCE DISPERSAL; WOOD SPECIFIC-GRAVITY; SEED SIZE; HYDRAULIC ARCHITECTURE; STOMATAL CONDUCTANCE; biodiversity; ecophysiology; ecosystem dynamics; ecosystem functions; environmental change; plant morphology (1)
DRY MOUTH; HEALTH; INVENTORY; SYMPTOMS; DRYNESS; SALIVA; GOHAI; Xerostomia; Hyposalivation; Quality of life (1)
Dry sandy grasslands, seed ecology, germination, dormancy, seed bank, genbank, Aluminium toxicity (1)
DSA; angiography; DSA; step translation; lower extremity (1)
DSC, Wärmestrom, Polymerisationswärme, Polymerisationszeit, Polymerisationstemperatur, Reaktionsverhalten, zahnärztliche Werkstoffe, Monomere, polymerization, dental materials (1)
DSGE, EMU, Monetary Policy, Structural Breaks (2)
DSGE, EMU, monetary policy, structural breaks, quadratic adjustment costs, Bayesian methods (1)
DSGE, Monetary Policy, EMU (1)
D SUPPLEMENTATION; DEPRESSION; TRIAL; SYMPTOMS; METAANALYSIS; MORTALITY; WOMEN; RISK; Vitamin D deficiency; Prevention; Cholecalciferol; Hypertension; Psychiatric diseases (1)
DTC, DCC, disseminierte Tumorzellen, Mammakarzinom, Metastasierung (1)
DUAL ADDITIVE CODES; CLASSIFICATION; multipartite entanglement; quantum error correcting codes; absolutely maximally entangled states; quantum weight enumerators (1)
DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; GUIDELINE FOCUSED UPDATE; PLACEBO-CONTROLLED TRIAL; HAS-BLED SCORE; ARTERY-DISEASE; NETWORK METAANALYSIS; DOUBLE-BLIND; RISK SCORES; ISAR-SAFE; Dual antiplatelet therapy; DAPT score; second-generation drug-eluting stent; stent thrombosis (1)
DUAL-ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTIONS; CLINICAL-TRIALS; IMPLANTATION; EFFICACY; THROMBOSIS; DURATION; DISCONTINUATION; GUIDELINES; RISK; Clopidogrel; Double-blind; Dual antiplatelet therapy; Drug-eluting stent; Randomized trial; Stent thrombosis (1)
DUAL-ANTIPLATELET THERAPY; PLACEBO-CONTROLLED TRIAL; LONG-TERM DURATION; DOUBLE-BLIND; IMPLANTATION; METAANALYSIS; EFFICACY; INTERVENTION; MULTICENTER; TICAGRELOR; (1)
Dual cross-link hydrogels, Parenteral drug delivery, Hybrid cross-linking, Sustained release, Polymers, Tissue engineering (1)
dual detection; two-dimensional separation; capillary electrophoresis; mass spectrometry; (1)
Dual-energy CT, Lung, Density, Contrast enhancement (1)
DUALITIES; Spacetime Singularities; AdS-CFT Correspondence; Gauge-gravity correspondence; Models of Quantum Gravity (1)
DUALITY; (2)
DUALITY; Feynman propagators; quantum of length; quantum gravity (1)
dual photocatalysis, ligand-to-metal charge transfer, hydroformylation, photo-flow reactor, photocyclopropanation, iodoamination (1)
DUAL-SPECIFICITY PHOSPHATASE; PROTEIN-TYROSINE PHOSPHATASES; INNATE IMMUNITY; MOLECULAR-MECHANISMS; SEPSIS; VHR; EXPRESSION; CANCER; CELLS; ACTIVATION; (1)
DUAL SUPERMESITYL STABILIZATION; PHOSPHORUS TRIPLE BOND; TRANSITION-METAL; TRICOORDINATE PHOSPHORUS; COMPLEXES; CHEMISTRY; GROUP-15; PLANAR; LIGAND; ANION; (1)
DUAL-TASK INTERFERENCE; BIOLOGICAL MOTION PERCEPTION; COORDINATE SPATIAL RELATIONS; RESPONSE-COMPATIBLE STIMULI; VISUAL-ATTENTION; PREMOTOR THEORY; TIME-COURSE; MOVEMENT KINEMATICS; FEATURE INTEGRATION; SHIELDING FUNCTION; motorvisual priming; dual task; ideomotor theory; binding; planning and control model; action-effect blindness; categorical perception (1)
Dual task; multitasking; proactive vs. reactive control; crosstalk; reward prospect (1)
DUAL-TASK PERFORMANCE; CONFLICT-ADAPTATION; STROOP INTERFERENCE; PREFRONTAL CORTEX; EXECUTIVE CONTROL; SIMON TASK; TIME; ADJUSTMENTS; INTEGRATION; ACTIVATION; (1)
DUAL-VENDOR ENVIRONMENT; RADIATION-THERAPY; FLUENCE OPTIMIZATION; IMRT; RADIOTHERAPY; DELIVERY; MOTION; CARCINOMA; BOOST; PLAN; VMAT; Volumetric modulated arc therapy; Optimization; Prostate; Simultaneous integrated boost (1)
DUAL-WAVELENGTH; ABSORPTION; CLEARANCE; RADIATION; NDYAG; MODEL; (1)
Dubrovnik, Croatian nationalism, Serbian nationalism, Roman Catholicism (1)
DUCHENNE MUSCULAR-DYSTROPHY; INDUCED MUSCLE DAMAGE; SKELETAL-MUSCLE; CONTRACTILE FUNCTION; GENE-EXPRESSION; CYCLIN D1; GROWTH; DIFFERENTIATION; PROLIFERATION; MICE; (1)
DUCHENNE MUSCULAR-DYSTROPHY; MICE; GENE; STRENGTH; LOCUS; Duchenne muscular dystrophy; mdx mouse; Wire hanging test; Noninvasive function test; Muscle impairment (1)
DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; SKELETAL; PATHOLOGY; UTROPHIN; CARRIERS; Duchenne muscular dystrophy; mdx mouse; muscle impairment; CK level; diagnostic methods; serum biomarker for muscle imparment (1)
DUCHENNE MUSCULAR-DYSTROPHY; TOOTH DISEASE TYPE-1A; SKELETAL-MUSCLE; GROWTH-FACTOR; MYOBLAST DIFFERENTIATION; TISSUE-CULTURE; SOLEUS MUSCLES; UP-REGULATION; GENE; PROLIFERATION; (1)
Ductus Bellini Karzinom, Nierenzellkarzinom, DSS (1)
Duldungsverfügung; Duldungsanordnung; Art. 76 BayBO (1)
Duldungsverfügung; Duldungsanordnung; privatrechtsgestaltender Verwaltungsakt; § 1004 BGB (1)
Duloxetin, Cymbalta, Anwendungsbeobachtung, SSNRI, Antidepressivum, AGATE (1)
Dunkeladaptation, Ophtalmologie, Licht, prospektive Studien, Pupille, Pupillenweite, Pupillengröße, Refraktive Chirurgie, Laser, LASIK, LASEK, dark adaptation, ophthalmological diagnostic techniques, iris, light, prospective studies, pupil, pupil size, pupil diameter, refractive surgery (1)
Dünndarmadenokarzinom, Systemtherapie, Small bowel adenocarcinoma, retrospektive Kohortenstudie (1)
DUPLEX-DOPPLER SONOGRAPHY; URINARY-TRACT OBSTRUCTION; COMPUTED-TOMOGRAPHY; POTENTIAL ROLE; ULTRASOUND; ULTRASONOGRAPHY; DIAGNOSIS; UROPATHY; KIDNEYS; PAIN; acute hydronephrosis; acute renal colic; hydronephrosis index; interobserver variability; renal resistive index; urolithiasis (1)
DUPLEX STRUCTURE; NUCLEOSIDE; APOPTOSIS; CYTOTOXICITY; PRODUCT; ASSAYS; MTT; DNA; Phenanthrene; GNA; Luminescence; Anticancer; Antiplasmodial activity (1)
Duplicate detection, Record linkage, Entity Resolution, Data quality (1)
; Dural calcification; Brain calcification; Tentorium calcification; Tertiary hyperparathyroidsm (1)
DURAL TEARS; POSTOPERATIVE MANAGEMENT; COMPLICATION RATE; LUMBAR; PROTOCOL; Tears; Fistula; Neurosurgery (1)
DURATION JUDGMENTS; GERMAN VERSION; PERCEPTION; LIFE; Passage of time judgments; Subjective experience of time; Contextual change hypothesis; Storage size metaphor; Autobiographical memory (1)
Durchflusszytometrie, Fluoreszenzligand, Radioligand, G-Protein gekoppelter Rezeptor, Histaminrezeptor, Quadratsäureamid, GPCR, Histamine, pharmacological tools, Piperidinomethylalkylamine, flow cytometry, fluorescent ligand, H2-receptor, H3-receptor, structure-activity relationship, squaramide (1)
DUSP4, MKP-2, IQGAP2, Maspin, kolorektales Karzinom, colorectal cancer, CRC (1)
DUST MITE ALLERGEN; CRYSTAL-STRUCTURE; AGGREGATION; CELLS; Aggregation; rBlo t 12; nBlo t 12; Dimer; House dust mite; Mite extract (1)
DUTCH KINDERGARTNERS; PANELS METAANALYSIS; PHONEMIC AWARENESS; LITERACY SKILLS; ORAL LANGUAGE; SPECIAL-ISSUE; COMPREHENSION; INSTRUCTION; VOCABULARY; LEARNERS; Reading age; Reading achievement; Phonemic awareness; Reading comprehension; Early reading (1)
DVT, CBCT, Digitale Volumentomografie, Cone Beim Computer Tomography (1)
DWELLING OLDER PERSONS; MUSCULOSKELETAL PAIN; SELF-EFFICACY; CES-D; ADULTS; DEPRESSION; PROGRESSION; POPULATION; SYMPTOMS; ILL; depression in elderly; musculoskeletal pain; health related quality of life; integrative psychotherapy (1)
DWI, auditory cortex, extrastriate body area, fMRI, fiber tractography, multisensory processing, structural connectivity, superior temporal sulcus (1)
DX5+NKT-Zellen; Apoptose; CD4+Cd62Lhigh-Zellen; immunregulatorische Zellen; Caspase-3; Proliferationshemmung; NKT-Zellen; Naive Cd4+-Zellen; Cd4Cd62Llow-Zellen (1)
DX-center; Persistent photoconductivity; Ionization; Tunneling (1)
DYE-LASER; CLINICAL-EVALUATION; VEINS; NM; long pulsed alexandrite laser; effectiveness; larger leg veins; safety (1)
Dye-sensitized • Interfacial photoelectrochemistry • Photoelectrocatalysis • Photoelectrode • Semiconductor (1)
DYES; PHTHALOCYANINE; SOLVATION; MOLECULES; SPECTRUM; BORON; ab initio calculations; BODIPY; dyes/pigments; vibrational spectroscopy (1)
DYES; REAGENTS; (1)
Dynaktin, p150, Glued, DCTN1, Motoneuronerkrankung, Motoneuron, Drosophila, ALS, Amyotrophe Lateralsklerose, Motoneuropathie, dHMN7B, lower motoneuron disease, dynactin, glued (1)
dynamical stability, variational stability, standard planar double bubbles, Surface diffusion flow, gradient flow, Fully nonlinear parabolic systems, General nonlinear boundary conditions, (1)
DYNAMIC BOUNDARY-CONDITIONS; ALLEN-CAHN EQUATION; HILLIARD EQUATION; ROBIN; MODEL; APPROXIMATION; CONVERGENCE; OPERATOR; Poisson equation; Laplace-Beltrami equation; bulk-surface coupling; Robin boundary condition; Dirichlet boundary condition; regularity theory; eigenvalue problem (1)
; dynamic causal modeling; face perception; effective connectivity; fusiform face area; lateral occipital cortex; occipital face area (1)
DYNAMIC FORCE MICROSCOPY; SINGLE-MOLECULE; RESOLUTION; (1)
Dynamic functional connectivity, Multivariate, Empirical mode decomposition, Filter-bank, Multiscale, fMRI, Resting-state, Scale-invariance (1)
DYNAMIC LIGHT-SCATTERING; CALIBRATED POLYSTYRENE BEADS; SSC COLLABORATIVE WORKSHOP; FLOW-CYTOMETRY; ADDITIVE SOLUTIONS; CIRCULATING MICROPARTICLES; BIOLOGICAL MICROPARTICLES; PATHOGEN INACTIVATION; INTERNATIONAL SOCIETY; APHERESIS PLATELETS; (1)
DYNAMIC LIGHT-SCATTERING; NANO-DROPLET FORMATION; DETERGENTLESS MICROEMULSIONS; MESOSCALE SOLUBILIZATION; PHASE-BEHAVIOR; SYSTEMS; MEDIA; WATER; MIXTURES; MORPHOLOGIES; Microemulsion; Enzyme; Activity; Surfactant-free; Surfactantless; Detergentless; Horseradish peroxidase; ABTS; HRP; Mesoscale structuring (1)
DYNAMIC LIGHT-SCATTERING; SODIUM DODECYL-SULFATE; HEXADECYLTRIMETHYLAMMONIUM SALT-SOLUTIONS; AQUEOUS MICELLAR-SOLUTIONS; ANGLE NEUTRON-SCATTERING; SPHERE ROD TRANSITION; WATER-INSOLUBLE DYE; CETYLTRIMETHYLAMMONIUM BROMIDE; DODECYLTRIMETHYLAMMONIUM BROMIDE; INTERMICELLAR INTERACTIONS; Hofmeister series; Specific-ion effects; Catanionic mixtures (1)
DYNAMIC LIGHT-SCATTERING; X-RAY-SCATTERING; SPECTROSCOPY; SYSTEMS; MICROEMULSIONS; ENVIRONMENTS; SURFACTANTS; CUMULANTS; H-1-NMR; BINDING; Brij-30 reverse micelle; Ionic additives; Chemical shift; Free and bound water; Sizes of water droplets; Binding constant (1)
DYNAMIC MASS REDISTRIBUTION; FREE OPTICAL BIOSENSOR; BETA-GAMMA-SUBUNITS; CONSTITUTIVE ACTIVITY; COUPLED RECEPTORS; H-1 RECEPTOR; ADP-RIBOSYLATION; CELLULAR-ASSAYS; INVERSE AGONISM; CELLS; label-free; dynamic mass redistribution (DMR); G protein coupled receptors (GPCRs); histamine receptors; signaling pathways; G protein inhibitors; G protein knock-out (1)
DYNAMIC-MECHANICAL PROPERTIES; TISSUE; MODEL; POLYCAPROLACTONE; MINERALIZATION; POROSITY; SIZE; bone tissue engineering; scaffolds; polycaprolactone; laydown pattern; rat skull defect (1)
DYNAMIC NUCLEAR-POLARIZATION; ASYMMETRIC ALDOL REACTIONS; PROLINOL ETHER ENAMINES; BRONSTED ACID CATALYSIS; EXCITED PROTEIN STATES; MAGNETIZATION-TRANSFER; CEST SPECTROSCOPY; FORMATION PATHWAY; IN-VIVO; MRI; (1)
DYNAMIC NUCLEAR-POLARIZATION; ELECTRON-TRANSFER PROCESSES; BRONSTED ACID CATALYSIS; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; HYDROGEN-BONDS; MOLECULAR MACHINES; ARYL HALIDES; PHOTOCATALYSIS; IRRADIATION; conPET; NMR spectroscopy; photochemistry; photoswitches; UV; Vis spectroscopy (1)
DYNAMIC POLYMERS; BUILDING-BLOCKS; HYDROGELS; LIGAND; COATINGS; STABILIZATION; COORDINATION; AGGREGATION; ORGANOGEL; CHEMISTRY; (1)
DYNAMIC PROPERTIES; CARBON; X-ray tomography; Silica; Styrene butadiene rubber; Dispersion (1)
DYNAMICS; 2D perovskites; excitons; diffusion; exciton-phonon interaction (1)
DYNAMICS; Causal variational principles; Algebraic quantum field theory; Causal fermion systems (1)
DYNAMICS; DRIVEN; MN2AU; MOTION; Domain wall; Antiferromagnets; Spin-orbit coupling; Special relativity; Magnetization dynamics (1)
DYNAMICS; INTRABAND; ELECTRONS; INTERBAND (1)
dynamics liq acetonitrile (1)
DYNAMICS; MOTION; (1)
DYNAMICS; MOTION; FIELD; STATE; (1)
DYNAMICS; MOTION; PERMALLOY; DOTS; (1)
dynamics of causal fermion systems, causal action principle, correction terms in unified physical theory, Hamiltonian time evolution, Noether’s theorems (1)
; Dynamic software updates; mobile robotics; safety-critical systems; aerial drones (1)
DYNAMICS; PHOTOEMISSION; SPECTROSCOPY; EMISSION; (1)
DYNAMICS; PHOTOPHYSICS; MORPHOLOGY; PROBE; (1)
DYNAMICS; PROPAGATION; (1)
DYNAMICS; RESOLUTION; MOTION; (1)
DYNAMICS; REVEALS; KEY; (1)
DYNAMICS; SIZE; (1)
DYNAMICS; STATE; (2)
DYNAMICS; TISE2; PROBE; (1)
Dynamic stochastic optimisation; Treasury management; Market price of risk; Change of measure; Scenario generation (1)
DYNAMICS; TRANSPORT; TRIONS; (1)
DYNAMIC SURFACE-TENSION; ELECTROLYTES; SALT; Hofmeister series; self-assembly; nucleolipids; phosphatidylnucleosides; molecular recognition (1)
Dynamische Geomorphologie , Talbildung , Fluss , Donau , , fluvial geomorphodynamic , valley development , river , Danube (1)
Dynamische Hüftgelenkschraube , Biomechanik , DHS , PFN A , Gamma 3-Nagel , biomechanische Untersuchungen , biomechanical research , dynamic hip screw , gamma 3- nail , helix blade PFN A (1)
Dynamische Keilfilter, Strahlentherapie (1)
DYRK1B; heart failure; sleep-disordered breathing; cardiovascular disease; hypoxia (1)
DYSCHROMATOSIS; lentiginosis; progressive hyperpigmentation (1)
DYSCHROMATOSIS-UNIVERSALIS-HEREDITARIA; HUMAN PIEBALDISM; PHYLLOID HYPERMELANOSIS; MOUSE; HYPERPIGMENTATION; MELANOCYTES; MOSAICISM; PHENOTYPE; PATTERNS; COLORS; (1)
DYSFUNCTION (1)
DYSFUNCTIONAL BELIEFS; PSYCHOPHYSIOLOGICAL INSOMNIA; QUESTIONNAIRE; THERAPY; AROUSAL; INDEX; POPULATION; PERCEPTION; ATTITUDES; VALIDITY; Sleep; Psychophysiological insomnia; Psychological symptoms; Scale; PSQI (1)
DYSFUNCTION; CHEMOKINES; CX(3)CR1; TISSUE; CELLS; (1)
DYSFUNCTION; PREVALENCE; SMELL; TASTE; COVID-19; Smell; Olfaction; Hyposmia; Parosmia; Coronavirus disease 2019 (1)
Dysgnathie; Retromolare sagittale Unterkieferspaltung; Patientenzufriedenheit; Umstellungsosteotomie; Fernröntgenseitenbilder; orthognathic surgery; Kondylenposition; condyle position; lateral cephalometric x-rays; x-rays (1)
DYSON-SCHWINGER EQUATIONS; INFRARED BEHAVIOR; CONTINUUM-LIMIT; SET; (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS THEORY; GHOST PROPAGATORS; GLUON PROPAGATOR; QUARK CONFINEMENT; BEHAVIOR; QCD; PHYSICS; Strong coupling; Landau gauge; Gluon and ghost propagators; Infrared behavior (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS-THEORY; QUARK CONFINEMENT; ABELIAN DOMINANCE; COLOR CONFINEMENT; LATTICE; QCD; PROPAGATOR; (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS THEORY; ZERO-MOMENTUM MODES; GRIBOV AMBIGUITY; CONFINEMENT; QUANTIZATION; TRANSITION; SU(3); PHASE; (1)
dysplastic nevus, melanocytes, melanoma, female, lower leg (1)
Dysport; Botox; dose equivalence; biological activity (1)
dysprosium, terbium, ionic liquids, electrochemical deposition, grain boundary diffusion, electroplating, magnets (1)
DYSPROSIUM TRIANGLES; ION MAGNET; RELAXATION; BEHAVIOR; COMPLEX; EXCHANGE; MAGNETIZATION; BISTABILITY; AXIALITY; SURFACE; ab initio calculations; dysprosium; organometallics; single-molecule magnets; sulfur (1)
Dystonia, TMEM16C, Anoctamin 3, ANO3, Ca2+ signaling, K+ channels (1)
DYSTROPHY; VMD2; Autosomal dominant vitreoretinochoroidopathy (ADVIRC); BEST1 (1)
DYT1, TOR1A, torsion dystonia, recurrent major depression, genetic variation (1)
DYT1, torsions dystonia, recurrent major depression (1)
E1B 55-KILODALTON ONCOPROTEIN; E1B-58KD TUMOR-ANTIGEN; 5 E4ORF3 PROTEIN; WILD-TYPE P53; TRANSCRIPTIONAL REPRESSION; P53-DEPENDENT APOPTOSIS; MONOCLONAL-ANTIBODIES; SUMO-1 MODIFICATION; INFECTED-CELLS; CELLULAR P53; E1B-55kDa; PML; p53; nucleocytoplasmic shuttling (1)
E1B-58KD TUMOR-ANTIGEN; TRANSCRIPTIONAL REPRESSION; 55-KILODALTON ONCOPROTEIN; P53-DEPENDENT APOPTOSIS; CELLULAR PROTEIN; P53 ACETYLATION; E4ORF6 PROTEIN; E1B PROTEIN; CELLS; PML; (1)
(E)-1-HYDROXY-2-METHYL-BUT-2-ENYL 4-DIPHOSPHATE; PHOSPHORYLATED ANTIGENS; TUMOR-CELLS; PYROPHOSPHATE; STIMULATION; RECOGNITION; PRENYLTRANSFERASES; BIOSYNTHESIS; SYNTHASE; RECEPTOR; B30.2 domain; BTN3A1; HMBPP; phosphoantigen; photoaffinity label (1)
E2F TRANSCRIPTION FACTORS; IN-VITRO; NEGATIVE REGULATOR; ECTOPIC EXPRESSION; MELANOCYTIC TUMORS; CARCINOMA-CELLS; RETINOIC ACID; HUMAN BREAST; GENE; PROTEIN; melanoma; cDNA expression array; metastasis; invasion; Boyden chamber (1)
E3 UBIQUITIN LIGASE; ENHANCED DISEASE SUSCEPTIBILITY; LEAF SENESCENCE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ABSCISIC-ACID; SIGNALING PATHWAY; STRESS RESPONSES; PLASMA-MEMBRANE; 26S PROTEASOME; (1)
E3 UBIQUITIN LIGASE; NUCLEAR IMPORT; RHO-GTPASES; VESICLE TRAFFICKING; POLARIZED GROWTH; SEED DEVELOPMENT; BETA-CATENIN; CELL-GROWTH; PLANT-CELLS; BREFELDIN-A; (1)
E3 UBIQUITIN LIGASES; CELL-PROLIFERATION; RNF126; PROMOTES; TBL1XR1; PROGRESSION; STATISTICS; GROWTH; Biological Markers; Cell Proliferation; Ovarian Neoplasms (1)
EA1-box; peptide signaling; fertilization; embryogenesis; maize; rice; pollen tube guidance; ligand-receptor interaction (1)
EAGLES-SYNDROME; PROCESS LENGTH; PAIN; CALCIFICATION; OSSIFICATION; ANGULATION; CT; Elongated styloid process; Eagle's syndrome; Styloid length; Temporomandibular disorders; TMD (1)
EALES-DISEASE; SARCOIDOSIS; ASSOCIATION (1)
EARLY ALLOGRAFT DYSFUNCTION; BILIARY COMPLICATIONS; DONOR LIVERS; MULTICENTER; VALIDATION; PREVENTION; STRICTURES; RECIPIENTS; RECOVERY; SURVIVAL; bile duct damage; biliary tree regeneration; liver transplantation (1)
EARLY ALZHEIMERS-DISEASE; WORKING-MEMORY PARADIGM; VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; APOLIPOPROTEIN-E; SYSTEMATIC METAANALYSES; ASSOCIATION WORKGROUPS; INDIVIDUAL-DIFFERENCES; DIAGNOSTIC GUIDELINES; CORTICAL ACTIVATION; Mild cognitive impairment; Alzheimer's disease; Functional magnetic resonance imaging; Working memory; Apolipoprotein E; Aging (1)
early brain development, visual system, higher cognition, neuromodulation, steady-state visually evoked potentials (SSVEPs) (1)
EARLY BREAST-CANCER; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; CONTINUED TAMOXIFEN; 1ST-LINE THERAPY; PHASE-III; ANASTROZOLE; BIOMARKERS; LETROZOLE; (1)
EARLY BREAST-CANCER; FOLLOW-UP; SURVEILLANCE; SURVIVAL; PROGRAM; IMPACT; Personalised screening; Risk prediction; Simulation; Healthcare efficiency; Medical decision making; cancer registries (1)
EARLY BRLF1 PROMOTER; CIS-ACTING ELEMENTS; LYTIC CYCLE GENES; DNA-REPLICATION; TRANSCRIPTION FACTOR; BZLF1 GENE; PRODUCTIVE CYCLE; DIVERGENT PROMOTER; RTA PROTEIN; EBV GENOME; (1)
Early childhood allergy prevention, randomised controlled trial, living systematic review (1)
Early childhood memory; childhood amnesia; senses; visual dominance (1)
EARLY CYCLOSPORINE WITHDRAWAL; CALCINEURIN INHIBITOR; RENAL-FUNCTION; KIDNEY-TRANSPLANTATION; CHRONIC REJECTION; INTERSTITIAL PNEUMONITIS; TUMOR PROGRESSION; RAPAMYCIN; RECIPIENTS; THERAPY; Sirolimus; liver transplantation; consensus conference (1)
EARLY CYCLOSPORINE WITHDRAWAL; KIDNEY-TRANSPLANTATION; ALLOGRAFT SURVIVAL; RECIPIENTS; IMMUNOSUPPRESSION; HISTOLOGY; REPLICATION; IMPROVEMENT; CONVERSION; REJECTION; Randomized clinical trial; Sirolimus; Kidney transplantation; Calcineurin inhibitor free immunosuppression (1)
EARLY ESOPHAGEAL CANCER; ENDOSCOPIC MUCOSAL RESECTION; HUMAN-PAPILLOMAVIRUS INFECTION; MULTICENTER CASE-CONTROL; HIGH-INCIDENCE AREA; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; GASTRIC-CANCER; RISK-FACTORS; ESOPHAGOGASTRIC TUMORS; oesophageal cancer; risk factors; surveillance; iodine staining; photodynamic therapy; endoscopic mucosal resection (1)
EARLY EXPERIENCE; LIVER; AGENT; US; METASTASES; SONOGRAPHY; ultrasound; contrast harmonic imaging; liver; biopsy; BR1 (1)
Early growth response gene 1 (EGR1), stem cells from apical papilla (SCAPs), dental follicle precursor cells (DFCs), distal-less homeobox 3 (DLX3), bone morphogenetic protein 2 (BMP2) (1)
EARLY HEPATOCELLULAR-CARCINOMA; MULTICENTER PHASE-III; GADOXETIC-ACID; NODULAR HYPERPLASIA; HISTOPATHOLOGIC FINDINGS; CONTRAST AGENT; SPIRAL CT; GADOBENATE DIMEGLUMINE; INITIAL OBSERVATIONS; HEPATIC ADENOMA; (1)
EARLY HEPATOCELLULAR-CARCINOMA; SOLID-ORGAN TRANSPLANTATION; DONOR LIVER; BILIARY COMPLICATIONS; PREDICTS MORTALITY; MILAN CRITERIA; WAITING-LIST; RECIPIENTS; CHOLANGIOCARCINOMA; SURVIVAL; (1)
EARLY INFECTIOUS COMPLICATIONS; FEBRILE NEUTROPENIC PATIENTS; CEFTAZIDIME PLUS AMIKACIN; COMBINATION THERAPY; MULTIPLE-MYELOMA; CANCER-PATIENTS; DOUBLE-BLIND; MEROPENEM; FEVER; LYMPHOMA; autologous stem cell transplantation; febrile neutropenia; meropenem; piperacillin; tazobactam; monotherapy (1)
EARLY INFLAMMATORY ARTHRITIS; MUSCULOSKELETAL ULTRASOUND; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; ULTRASONOGRAPHY; PHYSICIAN; ACCURACY; UTILITY; arthritis; diagnosis; medical history taking; physical examination; rheumatoid; ultrasonography (1)
early integrated palliative care, Palliativmedizin, NSCLC (1)
EARLY INVASIVE MANAGEMENT; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; HEART-FAILURE; CONSERVATIVE STRATEGIES; TACTICS-TIMI-18 TRIAL; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; GLOBAL REGISTRY; ARTERY-DISEASE; (1)
Early Iron Age; Hallstatt period; rectangular farmstead; Herrenhof; Bavaria; Landshut; Altheim; settlement system; social structure; magnetic prospection Frühe Eisenzeit; Hallstattzeit; Rechteckgehöft; Herrenhof; Bayern; Landshut; Altheim; Siedlungssystem; Sozialstruktur; Magnetprospektion (1)
EARLY-LIFE HISTORY; FRESH-WATER CRABS; BROMELIAD CRAB; ZOEAL DEVELOPMENT; CARIBBEAN REGION; TERRESTRIAL LIFE; WESTERN JAMAICA; MANGROVE CRAB; GENUS SESARMA; GRAPSIDAE; bromeliads; fresh water; larval development; mangroves; Thoracotremata (1)
EARLY-LIFE STRESS; CORTISOL RESPONSES; SALIVARY CORTISOL; QUESTIONNAIRE; CHILDREN; VALIDATION; INVENTORY; MANAGEMENT; ENDOCRINE; VERSION; Trier Social Stress Test; Virtual reality; Ambulatory Assessment; Cortisol; Stress mechanisms; Coping; Children and adolescents; Relaxation; Eye-tracking (1)
EARLY-LIFE STRESS; NEUROENDOCRINE RESPONSES; HYPOTHALAMIC VASOPRESSIN; CONDITIONED FEAR; MEDIAL AMYGDALA; C57BL/6 MICE; HIGH ANXIETY; RATS; OXYTOCIN; BEHAVIOR; Early life stress; Social fear conditioning; Cued fear conditioning; Social memory; Non-social memory; Anxiety (1)
EARLY-LIFE STRESS; RECEPTOR-BINDING; HYPOTHALAMIC VASOPRESSIN; STRIA TERMINALIS; BRAIN OXYTOCIN; ABNORMAL FORMS; BED NUCLEUS; RAT-BRAIN; INVOLVEMENT; RELEASE; Aggression; Early life stress; Oxytocin; Sex differences; Social behavior; Vasopressin (1)
Early Neolithic; Bandkeramik (LBK); magnetometer prospection; longhouses; settlement structures; Moldova; Ukraine (1)
Early Neolithic; Linienbandkeramik (LBK); Linear Pottery Culture; Transdanubian LBK; Alfold LBK; longhouse; sieve; anthropomorphic figurine; zoomorphic figurine; Transylvania; Romania (1)
„Early-onset“ kolorektales Karzinom · Paraneoplastisches Syndrom · Vorsorge · Polypektomie · Kollagenose (1)
EARLY-ONSET PARKINSONISM; MUTATIONS; GENE; DNA; AMPLIFICATION; POLYMORPHISM; PINK1; (1)
EARLY-ONSET SCOLIOSIS; IDIOPATHIC SCOLIOSIS; NATURAL-HISTORY; CONGENITAL SCOLIOSIS; GROWTH; FUSION; Deformity; Operability; Growth phase; Progression; Spinal curvatures (1)
; Early orthodontic treatment; Body posture; Rasterstereography; Frä nkel type II appliance (1)
EARLY OSTEOARTHRITIS; FEMORAL-NECK; OSTEOPLASTY; ARTHROSCOPY; MANAGEMENT; DIAGNOSIS; Hip; Femoroacetabular impingement; Minimally invasive surgical procedures; Arthroscopy; Limited anterior approach (1)
Early phase trials Phase I Dose-finding Dose escalation/de-escalation Protocol guidance SPIRIT-DEFINE SPIRIT (1)
EARLY PLAQUE-FORMATION; BACTERIAL-COLONIZATION; FREE-ENERGY; STREPTOCOCCUS-MUTANS; ELECTRON-MICROSCOPY; MICROBIAL COLONIZATION; ORAL STREPTOCOCCI; DENTAL IMPLANTS; PURE TITANIUM; HUMAN-ENAMEL; biofilm; dental implant; live; dead staining; surface free energy; surface roughness; Streptococcus sanguinis (1)
Early Repolarization; Metabolisches Syndrom; Adipositas; Repolarisation; Elektrokardiogramm; Gewichtsreduktionsstudie; Optifast; (1)
EARLY RHEUMATOID-ARTHRITIS; LOW-DOSE PREDNISOLONE; RANDOMIZED-TRIAL; ESTROGEN-RECEPTORS; JOINT DESTRUCTION; DISEASE-ACTIVITY; DOWN-REGULATION; MESSENGER-RNA; DOUBLE-BLIND; INFLAMMATION; (1)
EARLY SEEDLING GROWTH; D-ONONITOL PRODUCTION; RICE GENOTYPES; INCREASED SALT; ABSCISIC-ACID; STRESS; TOLERANCE; PLANTS; GERMINATION; SEQUENCE; Abiotic stresses; drought; salinity; tolerance; Saccharum officinarum; gas exchange parameters; transgenic tobacco (1)
early-stage cervical carcinoma, adjuvante Radiochemotherapie, Hysterektomie (1)
EARLY WEIGHT-BEARING; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; SURGICAL REPAIR; MECHANOBIOLOGY; EPIDEMIOLOGY; STIFFNESS; COLLAGEN; INJURY; SPEED; Achilles tendon healing; Achilles tendon biomechanical properties; shear wave elastography (1)
; Eastern Europe; Growth; Exports; Investment; Identification (1)
Eastern Europe, Growth, Exports, Investment, Identification (1)
EASTERN FREE STATE; GREAT-KAROO; KLIP RIVER; ENVIRONMENTAL-CHANGE; SEMIARID KAROO; SAVANNA BIOME; DESERTIFICATION; WONDERKRATER; LIVESTOCK; MEANDERS; Floodplain formation; Fluvial geomorphology; Environmental change; Gourits River basin; Cape region; South Africa (1)
EASTERN WEDDELL SEA; SOUTHERN-OCEAN; MITOCHONDRIAL LINEAGES; PROMACHOCRINUS-KERGUELENSIS; FISHES PERCIFORMES; GENE-SEQUENCES; CLIMATE-CHANGE; PACK ICE; DEEP-SEA; NOTOTHENIOIDEI; (1)
EAST Syndrom, SeSAME Syndrom, KCNJ10, Kir4.1, distaler Tubulus (1)
EATING-DISORDER; ATTENTION BIAS; OBESE CHILDREN; BRAIN; ACTIVATION; REWARD; SENSITIZATION; POTENTIALS; GUIDELINES; PICTURES; Overweight; Obesity; Adolescents; Food stimuli; Event-related potentials; Alpha band oscillations (1)
Eating disorders, Anorexia nervosa, Bulimia nervosa, Binge eating disorder, Assessment (1)
eating disorders, compulsive exercise, exercise, athletes, social function (1)
EATING-DISORDERS; GAIN; ADULTS; PHQ-9; Depression; Weight gain; Anorexia nervosa; Inpatient treatment; Body mass index (1)
eating disorders; genetic correlation; substance use (1)
EATING-DISORDERS; NEGATIVE AFFECT; IMAGE; THERAPY; EMOTION; WOMEN; ASSOCIATIONS; PARTS; MOOD; body dissatisfaction; bulimia nervosa; eating disorders; emotion; visual attention (1)
EATING-DISORDERS; SOCIAL SUPPORT; ONLINE SUPPORT; INTERNET USE; SCHIZOPHRENIA; CAREGIVERS; SUICIDE; ILLNESS; PEOPLE; RISKS; self-help; internet; bipolar affective disorder; mental health care (1)
EATING-DISORDER SYMPTOMATOLOGY; FIGURE RATING-SCALE; GERMAN VERSION; AUTOMATIC ACTIVATION; IMAGE; DISSATISFACTION; QUESTIONNAIRE; VALIDITY; ASSOCIATIONS; RELIABILITY (1)
EAU GUIDELINES; GENDER; PROGRESSION; UPDATE; STAGE; gender; lymphovascular invasion; prognosis; radical cystectomy; time periods; urothelial carcinoma of the bladder (1)
EAU GUIDELINES; RISK-FACTORS; COMPLICATIONS; MORBIDITY; MORTALITY; GENDER; COHORT; WOMEN; (1)
EBNA-1 GENE-TRANSCRIPTION; LIGATION-MEDIATED PCR; GENOMES; ACTIVATION; EXPRESSION; LYMPHOMA; SEQUENCE; ENHANCER; Epstein-Barr virus; DNA methylation; protein-DNA interaction; latency promoter; nasopharyngeal carcinoma (1)
E-Business Integration, Krankenversicherungen (1)
EBUS-TBNA, Lymphadenopathie, Staging, Bronchialkarzinom, endobronchial Ultraschall-gesteuerte transbronchiale Nadelaspiration (1)
E-CADHERIN EXPRESSION; NEURAL CREST CELLS; MALIGNANT-MELANOMA; N-CADHERIN; WAARDENBURG-SYNDROME; TUMOR PROGRESSION; UP-REGULATION; DIFFERENTIATION; MIGRATION; SNAIL; de-differentiation; melanoblast-related cells; melanocytes; melanoma; SNAIL (1)
E-CADHERIN EXPRESSION; TH17 CELLS; ENDOCRINE TUMORS; SURVIVAL; CANCER; GROWTH; MICROENVIRONMENT; OVEREXPRESSION; PROGRESSION; CARCINOMA; Neuroendocrine Tumors Of The Pancreas; Tnm Classification; Risk Stratification; Lymph Node Metastasis; E-Cadherin; B-Catenin; Cyclin D1; Il-17a (1)
E-CADHERIN; GLUCOCORTICOID-RECEPTOR; COLON-CARCINOMA; GENE-REGULATION; CELL-DENSITY; RHO GTPASES; CANCER; ACTIVATION; EXPRESSION; PATHWAY; c-Jun; melanoma; cytoskeleton; ETS-1; Rho (1)
E-cadherin, MMPI, brain metastases, colonization, adherens junctions (1)
E-CADHERIN; POSITIVE SELECTION; BREAST; EXPRESSION; LACTOFERRIN; ADHESION; OVARIAN; LINES; CARCINOMA; APOPTOSIS; Clorf38 gene; icb-1 gene; differentiation; cancer cell line; breast cancer (1)
ECCRINE; (1)
ECHOCARDIOGRAPHICALLY GUIDED PERICARDIOCENTESIS; portal vein thrombosis; cardiac tamponade; liver failure; reversible causes of cardiac arrest (1)
ECHOCARDIOGRAPHIC-ASSESSMENT; RIGHT HEART; GUIDELINES; DIAGNOSIS; OUTCOMES; ADULTS; Pulmonary hypertension; Pulmonary arterial hypertension; Chronic thromboembolic pulmonary hypertension; Riociguat; Soluble guanylate cyclase stimulator; Right atrial area; Right heart size; Right ventricular function; Echocardiography (1)
ECHOCARDIOGRAPHY; DEFINITIONS; EXPERIENCE; MORTALITY; DURATION; THERAPY; (1)
ECHP European Community Household Panel; Histogram-location approach; Lohnstarrheit, nominal (1)
ECHR GATT WTO ECJ (1)
ECHR privacy internet "information society" "freedom of communication" "Freedom of religion" torture "death penalty" Bankovic (1)
ECIS, electric cell‐substrate impedance sensing, label‐free, neutralizing antibody, reporter gene assay, virus neutralization assay, virus titer (1)
ECJ ECHR UNO "Security Council" Bosphorus Yusuf Kadi (1)
Eckhart <Meister> (1260-1328) (1)
ECMextracellular matrix HCVhepatitis C virus HSChepatic stellate cells MCP-1monocyte chemotactic protein-1 (1)
ECMO; abdominal compartment syndrome; ECLS; decompressive laparotomy; prevalence (1)
; ECMO; Anticoagulation; Argatroban; Heparin; Thrombosis; Bleeding; Costs (1)
ECMO, Cannula colonization, Biofilm, Sonication, Bloodstream infection (1)
ECMO, E-CPR, ECLS (1)
ECMO, extrakorporale Membranoxygenierung, ARDS, akutes schweres Lungenversagen, acute respiratory distress syndrome, Erwachsene, miniaturisiertes ECMO System (1)
ECMO; Extrakorporale Membran Oxygenierung; Extracorporeal membrane oxygenation; Membranoxygenator; Neutrophil Extracellular Traps; NET; NETs; (1)
ECMO; Ischämie; Hämorrhagie (1)
ECMO, Lungenversagen, Immunhistochemie, Fluoreszenzmikroskopie (1)
ECMO; Membrane Lung; CFD; Histolgy; MDCT; µCT; (1)
ECMO, membrane lung, μCT, MDCT, shear induced clotting, vWF, histological evaluation (1)
ECMO, Membranoxygenator, Oxygenator, Wartungszyklus, Durability (1)
ECMO; Nitric Oxide; FTIR-ATR; Kontaktwinkel (1)
ECMO; platelet activation; platelet adhesion; hemolysis; thrombosis (1)
ECMO, platelet, dysfunction, artificial surface, thrombocytopenia, coagulation disorder (1)
; ECMO; recirculation; ultrasound dilution; cannula; configuration; hemolysis; risk factor (1)
; ECMO; score; RESP score; SAVE score; validation; ECLS (1)
ECMO, thrombosis, clot, histology, extracorporeal membrane oxygenation, pump head, Thrombusbildung, extrakorporale Membranoxygenierung, Pumpenkopf (1)
ECMO, venoarterial, quality of life, Lebensqualität, extracorporeal, ECPR (1)
; ECMO; veno-artero-venous; differential hypoxia; low cardiac output (1)
ECMO, VV-ECMO, PLA, PNA, PMA, P-Selektin, Thrombose (1)
eco-geogram; Rickenella; Loreleia; habitats; substrates; cultures; endangerment (1)
ECOLOGICAL APPROACH; EXECUTIVE FUNCTIONS; NEGATIVE AFFECT; SHORT BOUTS; BRAIN; PERFORMANCE; WORK; NEUROPLASTICITY; INTERVENTIONS; PERSPECTIVES; Exercise; workplace health promotion; coordination training; cognition; executive functions; working memory; divergent thinking (1)
ECOLOGICAL CONSTRAINTS; HAPLODIPLOID ANALOGY; REPRODUCTIVE SKEW; DELAYED DISPERSAL; GROUP-SIZE; EVOLUTION; EUSOCIALITY; HYPOTHESIS; CONFLICT; CASTE; cooperation; dispersal; termite; Cryptotermes secundus; food availability (1)
ECOLOGICAL CONSTRAINTS; HELPING-BEHAVIOR; EVOLUTION; BIRDS; RECOGNITION; MECHANISM; Aegithalos caudatus; cooperative breeding; home range; kin selection; minimum convex polygon; convex hull peeling (1)
ECOLOGICAL INFERENCE; PARTY COMPETITION; SPATIAL THEORY; BEHAVIOR; Switching motives; Open-ended question; Hybrid multinomial Dirichlet model; Federal elections in Germany; Bavarian State election 2018; Right-wing populist parties (1)
; ecological modeling; explainable artificial intelligence; habitat suitability modeling; interpretable machine learning; species distribution model; xAI (1)
ECOLOGICAL MOMENTARY ASSESSMENT; ACADEMIC EMOTIONS; ACHIEVEMENT EMOTIONS; SELF-CONCEPT; APPRAISAL; STUDENTS; MATHEMATICS; DIMENSIONS; PSYCHOLOGY; MOTIVATION; Emotion; Appraisal; Control; Value; Enjoyment; Pride; Contentment; Experience sampling method (1)
ECOLOGICAL MOMENTARY ASSESSMENT; REAL-TIME; PSYCHOPATHOLOGY; YOUTH; Ecological momentary assessment; Functional conditional framework; Maintenance models; Affective symptoms; Self-injurious behavior (1)
ECOLOGICAL MOMENTARY ASSESSMENT; TECHNOLOGY; medical analytics; condition prediction; ecological momentary assessment; visual analytics; time series (1)
ECOLOGICAL RATIONALITY; DIAGNOSTIC INFERENCES; NATURAL FREQUENCIES; REPRESENTATION; GIGERENZER; HOFFRAGE; RISK; DIFFICULTIES; INSTRUCTION; UNCERTAINTY; Bayesian reasoning; 2 x 2 table; natural sampling tree; natural frequencies; visual representation (1)
ecology, electric organ discharges, genetic differentiation, morphology, phylogeography, speciation (1)
E-Commerce (1)
E-Commerce, Erfolgskontrolle, Versand, Bestellabwicklung, Zahlungsverfahren, E-Payment (1)
E-Commerce in Deutschland, Vertriebsmanagement und Web-Controlling, Zahlungsabwicklung, Risiko- und Forderungsmanagement, Versandabwicklung und Verkauf ins Ausland (1)
E-Commerce; Leitfaden; Umfrageergebnis (1)
E-Commerce; Leitfaden; Zahlungsverfahren (1)
e-commerce, logistics, logistical development, chinese market, online pure player, multichannel player, knapsack problem, genetic algorithm, optimization software (1)
E-Commerce, Online-Retailing, Distribution (1)
E-Commerce, Recommender System, Attribute Weights, Configuration System, Decision Support (1)
Econometrics, Factor Models, Unobserved Components models, Long Memory (1)
ECONOMIC DECISION-MAKING; ULTIMATUM GAME; COGNITIVE REFLECTION; INTERNET EXPERIMENT; FAIRNESS; LEGISLATION; RECIPROCITY; COMPETITION; BEHAVIOR; MARKETS; (1)
Economic expectations, experience, risk, uncertainty, pre-modern agriculture, pre-modern trade, pre-modern finance (1)
Economic experiments; effect size; experimental design; incentives; power analysis; sample size; JEL Codes: C9; D9 (1)
Economic experiments, Experimental design, Automation, Artificial intelligence (1)
ECONOMIC-GROWTH; EUROPEAN REGIONS; INVESTMENT; STATES; Convergence clubs; Natural resources; Regression tree; Kazakhstan (1)
ECONOMIC-GROWTH; EXPORT VARIETY; TRADE LIBERALIZATION; EMPIRICAL-EVIDENCE; OECD COUNTRIES; TECHNOLOGY; TRANSITION; DIFFUSION; QUALITY; Product variety; Diffusion; Adoption; Technical change (1)
Economic growth; R&D; Human capital (1)
ECONOMIC-HISTORY (1)
Economic History, economic policy, economic miracle (1)
; Economic history; Financial markets; Liquidity; Sovereign bonds; WWI (1)
Economic power and growth; Regional inequalities; Convergence (1)
Economics, Experiments, Behavioral, Carbon Information, Moral Licensing, Gender Differences (1)
econophysics, Ising model, financial market, many assets (1)
ECOSYSTEM PROCESSES; PLANT-COMMUNITIES; PHYLOGENETIC DIVERSITY; MULTIPLE TRAITS; FLORAL TRAITS; BIODIVERSITY; GRASSLAND; NECTAR; SERVICES; FOREST; (1)
Ecosystems, P5 medicine, reference architecture, concepts, knowledge representation, modeling, integration, standards (1)
ECP, Extracoporale Photopherese, Gerätevergleich, Apherese, Monozyten, Lymphozyten, Cobe Spectra, Spectra Optia, Amicus, Therakos UVAR XTS (1)
ECPR, Coronary artery disease, Outcome (1)
ECSTASY MDMA USERS; EARLY DEVELOPMENTAL-STAGES; WORKING-MEMORY DEFICITS; HEAVY CANNABIS USERS; COGNITIVE PERFORMANCE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ALCOHOL-CONSUMPTION; RECREATIONAL USERS; NEUROCOGNITIVE DEFICITS; SENSATION SEEKING; ecstasy; cannabis; alcohol; executive functions; working memory; impulsivity (1)
ECTODERMAL DYSPLASIA; PERMANENT TEETH; OLIGODONTIA; HYPODONTIA; MANAGEMENT; DENTISTRY; MUTATION; PAX9; (1)
ECTOMYCORRHIZAL FUNGI; AGARICS; SHAPE; INVERTEBRATES; CONSERVATION; SUCCESSION; RESPONSES; DATABASE; DECLINE; CLIMATE; Cystidia; Fruit body longevity; Fruiting season; Hymenium area; Lifestyle type; Spore ornamentation (1)
ECTOPARASITOID NASONIA-VITRIPENNIS; MALE SEX-PHEROMONE; LIQUID-CHROMATOGRAPHY; LIPID-METABOLISM; FATTY-ACID; BIOSYNTHESIS; HYMENOPTERA; MECHANISMS; HONEYDEW; IMPACT; biosynthesis; fatty acids; glucose; parasitic wasp (1)
ECTOPIC BREAST-CANCER; TISSUE (1)
ECTOPIC OSSIFICATION; REPLACEMENT; PREVENTION; SODIUM; JOINT; (1)
ECTOPIC PREGNANCY; DISEASE; PAIN; (1)
ECULIZUMAB; IMPACT; Myasthenia gravis; COVID-19; Immunosuppressive therapies; Outcome; German myasthenia gravis registry (1)
Eczema; Atopic dermatitis; Measurement instruments; Health-related quality of life; Quality of life; Validity; Reliability; Responsiveness; Interpretability (1)
eczema, lichen planus, lichen sclerosus, lichen simplex chronicus, vagina, Vulva (1)
Eczema; Measurement instruments; Health-related quality of life; Quality of life; Validity; Reliability; Responsiveness; Interpretability (1)
ED-BPM – Event-Driven Business Process Management, Business Process Management, Complex Event Processing, Standards, Use Case, NEAL – Notification Event Architecture for Logistics, ISO – International Organization for Standardization (1)
ED-BPM - Event-Driven Business Process Management, LBS - Location-based Services, CEP - Complex Event Processing, GPS - Global Positioning System (1)
EDEMA FACTOR; INHIBITORS; TOXIN; NUCLEOTIDES; DERIVATIVES; RECEPTORS; PURINE; Adenylyl cyclase; MANT-nucleotide; Fluorescent-label; Triphosphate analog (1)
Edge analytics; Industry 4.0; Smart sensors; Machine learning (1)
EDGE CHANNELS; BACKSCATTERING; SEMICONDUCTORS; INJECTION; (1)
EDGE CHANNELS; SYSTEMS; CONDUCTANCE; REGIME; (1)
EDGE STATES; graphene nanoribbons; topological states; impurity disorder; Lifshitz model; Anderson model (1)
Edge states Magnetotransport Quantum Hall effect Quantum transport Surface states Topological insulators Transport phenomena Nanowires Point contacts Quantum wires Hall bar Landauer formula Resistivity measurements Shubnikov-de Haas effect Tight-binding model (1)
Edge states; Quantum Hall effect; Screening (1)
EDGE STATES; SYSTEMS; (1)
Edge strength; Marginal Stability; CAD/CAM; Composite; Ceramic (1)
EDGE; TRANSPORT; SYSTEMS; RIBBONS; STATE; (1)
edible insects for food, food production and consumption, responsible consumption and production, sustainability, food security (1)
Edition, Editionsrichtlinien, Stadtrat, Rat Stadt Dresden, Sachsen, Herzog Georg Albrecht, Stadtbuch, Stadtbuchforschung, Überlieferungsbestand, Parallelüberlieferung, Forschung, Dresdner Stadtschreiber, Stadtarchiv, Eintragepraxis, Altendresden, Residenzstadt, Stadtbrand, Verfassungsgeschichte, Verwaltungsgeschichte (1)
Editorial; Romanische Studien; Europa; Romania (1)
Editorial; Romanische Studien; Open Access (1)
editor; source code; IDE; development environment; programming; gesture; touch; touchscreen; tablet; mobile; natural interaction (1)
EDUCATIONAL-ATTAINMENT; CITIES; IMPACT; Religion; Attitude; Economic growth; Cultural capital; Culture-based development (1)
educational capital, innovation, learning capital, learning resources, STEMM, talent development (1)
Educational-Escape-Rooms, Core Practices, Lehrerbildung, Professionalisierung, Aufgabenentwicklung (1)
EDUCATIONAL-INNOVATION; EMPLOYEE CREATIVITY; PERFORMANCE; INTERDEPENDENCE; REFLEXIVITY; KNOWLEDGE; CONTEXT; LEADERSHIP; ORGANIZATIONS; ANTECEDENTS; Team learning; Task interdependence; Innovative work behaviour; Vocational education; Interdisciplinary work teams; Team reflexivity (1)
Educational Objectives (1)
EDUCATION; CBL; E-learning; Learner-centered learning; Medical teaching; Pulmonary nodule (1)
EDUCATION; CLASSROOM; FUTURE; Radiation oncology teaching; Medical studies; New licensing regulations (1)
Education, Debridement, Sustainability, 3D-Printing, Burn, Teaching (1)
; Education for emergency physicians; Emergency medicine; Emergency department; Qualification; Optimal patient care (1)
Education, Human capital, Study loans, Uninsured labor market risk, Incomplete markets, Overlapping generations (1)
EDUCATION; IMPACT; teaching in Nuclear Germany; curriculum design; teaching methods; status survey (1)
education, master degree, physician, neonate, baby, child (1)
EDUCATION; MULTIMEDIA; INTERNET; INSTRUCTION; WEB; MANAGEMENT; CURRICULA; SEMINAR; LECTURE; computer assisted learning (CAL); long-term evaluation; problem based learning; dermatological curriculum; learner acceptance; education software (1)
EDUCATION; planetary health; education; literacy; model; sustainability (1)
Education; Psychology; Science, technology and society (1)
EDUCATION; SOCIETY; Advanced training; Speciality of internal medicine and rheumatology; Training location; Clinical sector; Outpatient sector (1)
EDUCATION; TRAINEES; SYSTEMS; Competency-based medical education; Entrustable professional activities; Development of expertise; Dual process theory; CanMEDS roles framework (1)
Education • wage inequality • unemployment • R&D growth models • growth without scale effects (1)
EEG ALPHA OSCILLATIONS; TEMPORAL PREPARATION; RESPONSE PREPARATION; ADVANCE INFORMATION; PREFRONTAL CORTEX; SPATIAL ATTENTION; TASK; INHIBITION; STIMULUS; SYSTEM; Expectancy; Time; EEG; LRP; Motor cortex (1)
EEG ASYMMETRY; CORTICAL ACTIVITY; BRAIN ASYMMETRY; INDIVIDUAL-DIFFERENCES; INHIBITION SYSTEMS; ALPHA ASYMMETRY; NEGATIVE AFFECT; SAMPLE-SIZES; ANGER; DEPRESSION; alpha rhythm; EEG; emotion; individual differences; motivation (1)
EEG; Cortex; Theta oscillations; Episodic memory retrieval; Recollection; Interference (1)
EEG; DESYNCHRONIZATION; INTENTION; ACT; NEUROSCIENCE; MOVEMENTS; AWARENESS; PATTERNS; VOLITION; CORTEX; Beta oscillation; Event-related desynchronization; Decision; Volition (1)
EEG; fMRI; memory encoding; method of loci; mnemonics; theta oscillations (1)
EEG; MIGRAINE; TOPOGRAPHY; FEATURES; EEG; brain mapping; intermittent photic stimulation; IPS; global field power ratios (1)
EEG POWER SPECTRA; GROWTH-HORMONE; DEPRESSION; OSCILLATIONS; CYCLE; Renin; Sleep; Sleep deprivation; CRH; GHRH (1)
EEG-Umlage, Verfassungsmäßigkeit, Ausgleichsregelung, Erneuerbare Energien Gesetz, Wirtschaft und Verwaltung, Manssen (1)
EEG-Umlage, verfassungswidrig, Energiewirtschaft, et, Energiewirtschaftliche Testfragen, Manssen (1)
EEG-Umlage, Verfassungswidrigkeit, Sonderabgabe, Manssen (1)
EF-1A; Raf kinases; signal transduction; apoptosis; ubiquitin; mass spectrometry (1)
EFFECTIVE BLOCH EQUATIONS; SEMICONDUCTOR SYSTEMS; POLARIZATION; MEMORY; (1)
EFFECTIVE CHARACTERISTIC-POLYNOMIALS; GROUND-STATE ENERGY; ANHARMONIC-OSCILLATOR; PERTURBATION EXPANSION; CYCLIC POLYENES; HUBBARD-MODEL; PPP MODEL; SUMMATION; SERIES; convergence acceleration; summation; extrapolation; perturbation theory; anharmonic oscillators (1)
EFFECTIVE CORE POTENTIALS; CHEMICAL-VAPOR TRANSPORT; CRYSTAL-STRUCTURE; MOLECULAR CALCULATIONS; PHOSPHIDE TELLURIDE; PHOSPHORUS; DIAZENIDES; TI2PTE2; PYRITE; ATOMS; Phase stability; Density functional calculations; Gas balance; Thermodynamic modelling; Structure prediction (1)
EFFECTIVE CORE POTENTIALS; ELECTROCHEMICAL PROPERTIES; MOLECULAR CALCULATIONS; BASIS-SETS; DENSITY; 1,10-PHENANTHROLINE; SPECTROSCOPY; ABSORPTION; RESOLUTION; DISCOVERY; Cyclometalated complexes; Rhodium; Iridium; Phosphorescence; Cytotoxicity (1)
EFFECTIVE CORE POTENTIALS; HETEROJUNCTION PHOTOVOLTAIC DEVICES; MOLECULAR-ORBITAL METHODS; RIGID NITROGEN LIGAND; SET MODEL CHEMISTRY; GAUSSIAN-TYPE BASIS; TERTIARY PHOSPHINE; ORGANIC-MOLECULES; TOTAL ENERGIES; DENSITY; Copper; Electronic spectra; Solvatochromism; Charge transfer (1)
EFFECTIVE CORE POTENTIALS; MAIN-CHAIN ATOMS; MOLECULAR CALCULATIONS; AB-INITIO; CYANURIC ACID; CHARGE-DISTRIBUTION; ELECTRON-DENSITY; HYDROGEN-BONDS; REFINEMENT; RESOLUTION; carbonyl center dot center dot center dot carbonyl interactions; maleimidato ligand; DFT; AIM; X-ray structures (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR CALCULATIONS; TRIPHOSPHA-FERROCENES; CRYSTAL; COMPLEX; CHEMISTRY; LIGANDS; DENSITY; ANALOGS; (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURES; CRYSTAL-STRUCTURES; ORGANIC-MOLECULES; LIGANDS; DINUCLEAR; CATALYSIS; (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR-ORBITAL METHODS; PI-CONJUGATED POLYMERS; LIGAND CHARGE-TRANSFER; GAUSSIAN-TYPE BASIS; CRYSTAL-STRUCTURES; 1,2-DIIMINETRICARBONYLRHENIUM(I)CHLORIDE COMPLEXES; ELECTRONIC-SPECTRA; ORGANIC-MOLECULES; PHOTOPHYSICS; Electronic spectra; Luminescence; Rhenium complexes; Rhodium complexes; Multichromophore systems; Phenyleneethynylene ligands (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS-BORON BONDS; METAL-METAL BOND; MOLECULAR CALCULATIONS; CATALYZED FORMATION; COMPLEXES; PHOSPHINE; PHOSPHANYLALANE; DENSITY; BORANE; DFT calculations; mechanism; group 13/15 compounds; X-ray structure analysis (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS-BORON BONDS; MOLECULAR CALCULATIONS; CATALYZED FORMATION; CONJUGATE BASE; BORYLPHOSPHINE; DERIVATIVES; PHOSPHINES; CHAINS; ROUTE; boron; density functional calculations; Lewis bases; phosphorus (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS TRIPLE BOND; PHOSPHINIDENE COMPLEXES; TERMINAL PHOSPHINIDENE; MOLECULAR CALCULATIONS; CRYSTAL-STRUCTURES; STEREOSELECTIVE FORMATION; P-C; METAL; RING; arsenic; heterocycles; isonitriles; pentelidenes; phosphorus; X-ray diffraction (1)
EFFECTIVE CORE POTENTIALS; TRIPLET-STATE PROPERTIES; LIGHT-EMITTING DEVICES; VANILLIN SEMICARBAZONE; MOLECULAR CALCULATIONS; CRYSTAL-STRUCTURE; BASIS-SETS; BLUE; DESIGN; RHODIUM(III); Iridium; Semicarbazones; Cyclometallated compounds; Biological activity (1)
EFFECTIVE FIELD-THEORY; (1)
EFFECTIVE-FIELD-THEORY; HEAVY-QUARK; MASS; SPECTRUM; MATRIX; NRQCD; MODEL; STATE; (1)
EFFECTIVE-FIELD-THEORY; LIFETIME DIFFERENCE; LEADING LOGARITHMS; WIDTH DIFFERENCE; TOP-QUARK; MESONS; QCD; OSCILLATIONS; COLLIDER; DECAYS; Beyond Standard Model; Heavy Quark Physics; CP violation; Standard Model (1)
EFFECTIVE FIELD-THEORY; QCD SUM-RULES; COEFFICIENT FUNCTIONS; ANOMALOUS DIMENSION; MASS CORRECTIONS; MATCHING QCD; FORM-FACTORS; RENORMALIZATION (1)
EFFECTIVE INTERACTION POTENTIALS; EARTH METAL-IONS; MOLECULAR-DYNAMICS; BIOMOLECULAR SIMULATIONS; ACTIVITY-COEFFICIENTS; POLARIZABLE WATER; AQUEOUS-SOLUTIONS; HYDRATED IONS; LIQUID WATER; SPC/E WATER; caesium compounds; free energy; Lennard-Jones potential; liquid structure; molecular dynamics method; osmosis; potassium compounds; sodium compounds; solvation (1)
EFFECTIVE INTERACTION POTENTIALS; MOLECULAR-DYNAMICS SIMULATIONS; EARTH METAL-IONS; AQUEOUS-SOLUTIONS; TETRAMETHYLAMMONIUM CHLORIDE; MONTE-CARLO; SPC/E WATER; TETRAETHYLAMMONIUM BROMIDE; ACTIVITY-COEFFICIENTS; HYDRATION; (1)
EFFECTIVE IONIC-RADII; CRYSTAL-STRUCTURE; (1)
EFFECTIVE IONIC-RADII; CRYSTAL-STRUCTURE; PHOSPHORUS OXYNITRIDE; NITRIDO-SODALITES; MESOPOROUS MATERIALS; POWDER DIFFRACTION; INORGANIC HOSTS; AMIDE IONS; PHASE; REFINEMENT; oxonitridophosphate; zeolite; structure elucidation; NMR-spectroscopy; ion conductivity (1)
EFFECTIVE MASSES; ENHANCEMENT; ABSORPTION; CARRIERS; ENERGY; 2D perovskites; excitons; phase transition; diffusion (1)
EFFECTIVE-MASS; GE; HETEROSTRUCTURES; SEMICONDUCTORS; TRANSPORT; MOBILITY; (1)
EFFECT OHD-OKE; INTERMOLECULAR DYNAMICS; TEMPERATURE-DEPENDENCE; NANOSTRUCTURAL ORGANIZATION; PHYSICAL-PROPERTIES; MOLECULAR-DYNAMICS; GLASS-TRANSITION; SPECTROSCOPY; SOLVATION; CHLORIDE; (1)
EFFECTOR FUNCTIONS; CONFORMATIONAL DYNAMICS; CORONAVIRUS; TOMOGRAPHY; PROTECTION; RECEPTOR; SPIKES; (1)
EFFECTOR FUNCTIONS; MOUSE MODEL; NEUTRALIZING ANTIBODY; IN-VIVO; PROTECTION; RECEPTOR; DISEASE; ALPHAVIRUSES; ARTHRITIS; BINDING; (1)
EFFECT-SITE CONCENTRATION; BISPECTRAL INDEX; COMPOSITE INDEX; ANESTHESIA; PHARMACOKINETICS; ALFENTANIL; SEDATION; PREDICTION; INFUSION; SYNERGY; Propofol; Sufentanil; Drug interactions; Electroencephalography (1)
effektive Niedrigenergietheorie, QCD, Quantenchromodynamik, endliches Volumen, kleine Quarkmassen (1)
Effektivität • Fachdidaktik • Fachunterricht • Physik • Physikdidaktik • Physikunterricht • Unterrichtsqualität (1)
Effektivität, Katamnese, Legalbewährung, Maßregelvollzug, Prädiktoren, Suchtrückfälligkeit, Therapieabbrecher, Therapieevaluation, Validität (1)
EFFICACY; mouthwash; antiseptic; COVID-19; SARS-CoV-2; viral load; infectivity (1)
EFFICACY; SARS-CoV-2; Antiseptic agents; Mouthrinse; Benzalkonium chloride; Capsid protection assay; Mouthwash (1)
EFFICACY; TRIAL; GLUCOCORTICOIDS; INTERLEUKIN-6; METHOTREXATE; SECRETION; CELLS; IL-6; (1)
EFFICACY TRIAL; SOUTH-AFRICA; FOLLOW-UP; RESPONSES; MAGNITUDE; BREADTH; PRIME; ALVAC; (1)
EFFICIENCY; EMISSION; PHOSPHORESCENCE; MECHANISM; TADF; EMITTERS; (1)
EFFICIENCY; RETURNS; TESTS; RISK; Asset pricing; Factor model; Mispricing; Profitability; Investment (1)
EFFICIENCY WAGES; KINK POINTS; UNEMPLOYMENT; TAX; INEQUALITY; EMPLOYMENT; INCOME; GERMANY; IMPACT; Public policy; Commuting; Taxation; Wages (1)
EFFICIENT; ADHESION; EXTL2; TOOL; asthma exacerbations; EXTL2; GWAS; PANK1; single-nucleotide polymorphism (1)
Efficient designs, enrichment, joint modelling, longitudinal data, time-to-event data (1)
Efficient frontiers, Nondominated surfaces, Parametric quadratic programming, Portfolio selection, Stability sets, Hyperbolic platelets (1)
EFFICIENT IMPLEMENTATION; EFFECT TRANSISTORS; EQUATIONS; SEMICONDUCTORS; SCHEMES; SYSTEM; (1)
EFFICIENT PORTFOLIOS; VECTOR MAXIMIZATION; SHARPE RATIO; PERFORMANCE; SET; (1)
EFFICIENT PRIVATE PROVISION; COOPERATION; ALTRUISM; PUNISHMENT; (1)
EFFICIENT PRIVATE PROVISION; ENVIRONMENTAL AGREEMENTS; GOVERNMENT SUBSIDIES; FISCAL FEDERALISM; COLLECTIVE ACTION; POLICIES; TRADE; partial cooperation; coalition formation; public goods; matching; Pareto-optimality (1)
EFFICIENT PRIVATE PROVISION; GOVERNMENT SUBSIDIES; VOLUNTARY PROVISION; COLLECTIVE ACTION; AGENTS; MODEL; Aggregative games; Matching mechanisms; Public goods; Warr neutrality (1)
EFFICIENT PRIVATE PROVISION; Public goods; Matching; Pareto optimality (1)
EFFICIENT SYNTHESIS; A-I; PALLADIUM; CATALYSIS; PTEROCARPANS; DERIVATIVES; CYCLIZATION; COMPLEXES; pterocarpan; asymmetric Heck oxyarylation; ionic liquid; chiral ligand (1)
EFFICIENT SYNTHESIS; FUNCTIONALIZATION; HETEROARENES; RALOXIFENE; ACCESS; PD; DERIVATIVES; THIOPHENE; COUPLINGS; INDOLES; (1)
EFFORTFUL CONTROL; 5-FACTOR MODEL; SELF-REGULATION; EGO RESILIENCY; UNIFIED THEORY; LIFE-COURSE; ATTACHMENT; DISORDERS; TRAITS; MALTREATMENT; personality development; personality disorder; developmental psychopathology; attachment research; self-regulation (1)
EFFORT-REWARD IMBALANCE; NATIONWIDE SURVEY; STRESS; HEALTH; PHYSICIANS; RESIDENTS; ERRORS; young physician; gratification crisis; working conditions; economic influence; psychosocial workstrain; specialty training (1)
EFFORT-REWARD IMBALANCE; STRESS-RELATED EXHAUSTION; RISK; DISEASE; HEALTH; DEPRESSION; MACARTHUR; DISORDER; Allostatic load; Burnout; Chronic work stress; Effort -reward imbalance; Regensburg Burnout Project; Depression (1)
EFFORT-REWARD IMBALANCE; TRAINING CONDITIONS; INTERNAL-MEDICINE; NATIONWIDE SURVEY; JOB-SATISFACTION; STRESS; QUESTIONNAIRE; ASSOCIATION; RESIDENTS; INTENTION; Physicians; Nurses; Stress factors; Health; Consequences (1)
e-Financial supply chain (1)
EFSUMB GUIDELINES; CLINICAL-PRACTICE; ULTRASOUND CEUS; RECOMMENDATIONS; Corona virus; contrast enhanced ultrasound sonography (CEUS); COVID-19; liver; kidney (1)
EFSUMB GUIDELINES; CLINICAL-USE; LIVER; RECOMMENDATIONS; DIAGNOSIS; FIBROSIS; shear-wave elastography; shear-wave dispersion; attenuation imaging; hepatic steatosis; liver MRI; PDFF (1)
EFSUMB GUIDELINES; CLINICAL-USE; TRANSIENT ELASTOGRAPHY; RECOMMENDATIONS; LESIONS; CEUS; MICROVASCULARIZATION; DIAGNOSIS; intraoperative ultrasound; shear wave elastography; CEUS; liver tumor surgery (1)
EFSUMB GUIDELINES; LIVER-CIRRHOSIS; CLINICAL-USE; PART 1; DIAGNOSIS; ELASTOGRAPHY; FIBROSIS; HCV; RECOMMENDATIONS; STEATOSIS; hepatitis C; model for end-stage liver disease score; fibrosis; aminotransferase (1)
EFSUMB GUIDELINES; SARS CORONAVIRUS; INFECTION; ACE2; RECOMMENDATIONS; MECHANISMS; THROMBOSIS; PROGNOSIS; INJURY; Contrast enhanced ultrasound (CEUS); parametric imaging; COVID-19; small bowel (1)
EFSUMB POSITION STATEMENT; DEGUM MULTICENTER TRIAL; COMPUTED-TOMOGRAPHY CT; THERMAL TUMOR ABLATION; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; TRANSARTERIAL CHEMOEMBOLIZATION; QUANTITATIVE-EVALUATION; DIAGNOSTIC-ACCURACY; PEDIATRIC PRACTICE; Image fusion; Real-time imaging; Contrast-enhanced ultrasound; Hepatocellular carcinoma; Tumor vascularization (1)
EFTR, Endoskopische Vollwandresektion, FTRD, Endoskopie, untere Gastrointestinaltrakt, Adenome, Frühkarzinome (1)
EGFR, RAS, PIK3R1, FGFR2, seborrhoische Keratose, oncogene Mutation, seborrheic keratosis, oncogenic mutation (1)
; egg; embryo; fertilization; pollen; seed; self-incompatibility (1)
EGG-WHITE LYSOZYME; DRUG-DELIVERY APPLICATIONS; CONJUGATE ADDITION; TRIGGERED RELEASE; DEXTRAN HYDROGELS; GROWTH-FACTOR; IMMOBILIZATION; DESIGN; PEGYLATION; CHALLENGES; compatibility; crosslinking; drug delivery systems; hydrogels; proteins (1)
EGMR, EMRK, "margin of appreciation", Diskriminierungsverbot (1)
EGMR, Menschenrechte, Sicherungsverwahrung, Rückwirkung, Rückwierkungsverbot, Grundgesetz, Menschenrechtskonvention (1)
EGMR Privatsphäre Persönlichkeitsschutz Meinungsfreiheit Pressefreiheit Caroline "Schutz informationstechnischer Systeme" (1)
EGMR Überlastung (1)
ego depletion, self-control, explicit attitudes, implicit attitudes, vegetarian nutrition, sustainable behavior, dual-process models (1)
eGovernment; eInclusion; Rahmenbedingungen; europäisch; national; regional (1)
e-government, privacy, security, trust, digital rights management, network of excellence (1)
EHCR; Health network; Security infrastructure; Health professional card; TTP services; PKI (1)
EHD1, inner ear, cochlea, sensorineural hearing loss, stria vascular (1)
EHD1; Mutation; männliche Infertilität (1)
EHD1, proximal tubule, endocytosis (1)
Ehe, "gleichgeschlechtliche Lebensgemeinschaft", "eingetragene Partnerschaft", Leihmutterschaft, Kindeswohl, Vaterschaftsfeststellung, Adoption, Umgangsrecht, Sorgerecht, Kindesentführung, Transgender, Erbrecht, Beurteilungsspielraum (1)
Ehescheidung , Unterhalt , Spanien , Scheidungsunterhalt , Nachehelich , Maintenance , postnuptial , Spain (1)
EHLERS-DANLOS-SYNDROME; CLINICAL-PRACTICE-GUIDELINES; SYNDROME TYPE-IV; ANEURYSM REPAIR; LIFE EXPECTANCY; MARFAN-SYNDROME; EDITORS CHOICE; MANAGEMENT; SURGERY; EXPERIENCE; (1)
EHR; Advanced architectures; Security services; Security infrastructure (1)
EHR; ISO Reference Model – Open Distributing Processing (RM-ODP); HL7; CEN ENV 13606 “Electronic Health Record communication” (1)
EHR; Model-driven architecture; Components; Constraint models; Authorisation; Privilege management; Access control; Security infrastructure (1)
EHR systems; Architecture; Interoperability; Standards (1)
e-Humanities; eHumanities; digital humanities; nicht-numerische Datenverarbeitung; Curriculum; Informationswissenschaft; Medieninformatik (1)
e-Humanities; virtuelle Forschungsumgebungen; Text Mining; Intertextualität (1)
EHV, NYVAC, MDDC, monocyte derived dendritic cells, HIV Vakzine, HIV Impfstoff (1)
Eichtheorie, Gauge Theory, Niedrigdimensionale Topologie, Low Dimensional Topology (1)
Eichtheorie , Nichtabelsche Eichtheorie , Topologie , NMR-Bildgebung , Parallelrechner , Quantenchromodynamik , Gitter-Eichtheorie , SU(2) , lattice , QCD , SU(2) , fMRI , parallelization (1)
Eichtransformation , Quantenchromodynamik , Renormierung , Eichtheorie , Quark <Physik> , Gluon , Transporttheorie , , nuclear physics , high energy physics , quark-gluon plasma , gauge theories , kinetic theory (1)
Eigennamen, Personennamen, Appellative, etymologisch, Transonymisierung, Usbekisch (1)
EIGENVALUE; (1)
EIGENVALUE ACCUMULATION; (1)
EIGENVALUES; FORMULA; STATES; Tetranacci polynomials; Fibonacci decomposition; complex wavevectors; transcendental momentum quantization; bulk-boundary correspondence; (engineering) next nearest neighbor hopping (1)
EIGENVALUES; OPERATORS; (1)
EIGENVALUES; PERIMETER; MINIMIZERS; REGULARITY; DIRICHLET; DERIVATIVES; FUNCTIONALS; EXISTENCE; RESPECT; Eigenvalue optimization; shape optimization; topology optimization; PDE constrained optimization; phase-field approach; first order condition; sharp interface limit; Gamma-limit; finite element approximation (1)
Eighteenth century, Transylvania, Transylvanian Saxons, property, probate, inheritance, last wills and testaments, historical demography, social class, HISCO, HISCLASS, gender, historical inequality (1)
Einfache Heuristiken, One-reason decision making, Rekognitionsheuristik, Take The Best, ökologische Rationalität (1)
E INFECTION; PORK; (1)
Einflussfaktor (1)
Eingabevalidierung, Evaluation, Barrierefreiheit, Plausibilisierung, Validatoren, Software Engineering, eGovernment (1)
Einkomponentenvorstufen, Cobalt-Phosphor-Cluster, Nanopartikel (1)
Einkristall-Röntgendiffraktometrie, Cu-Kβ, Röntgenoptik, R, R Studio, Datenanalyse, Rigaku Oxford Diffraction, Zintl, Zinn, Bismut, Ammoniak / Single-crystal diffractometry, Cu-Kβ, x-ray optics, comparison, data analysis, R, RStudio, Rigaku Oxford Diffraction, Zintl, Tin, Bismuth, Ammonia (1)
Einschätzung der Bedeutung von Entspannungsangeboten in Deutschland; Entwicklung eines Fragebogens zur Bedeutung von Entspannungstechniken in Deutschland; Entspannungsverfahren, Entspannungstechniken, Entspannungsmethoden, Deutschland entspannt, Psychosomatik relaxation techniques, relaxation methods, questionaire on relaxation techniques used in germany, germany relaxes, development og a questionaire for the use of relaxations techniques (1)
Einschluss · Käfigverbindungen · Photoschalter · Supramolekulare Chemie · Ultraschnelle Spektroskopie (1)
Einseitiger Behandlungsabbruch (1)
EINSTEIN CONDENSED GAS; CRITICAL VELOCITY; QUANTUM TURBULENCE; MK TEMPERATURES; HE-4; HELIUM; LAMINAR; ONSET; DYNAMICS; Quantum turbulence; Superfluid helium; Oscillatory flow; Critical velocity; Vortex shedding; Bose-Einstein condensates (1)
EINSTEIN CONDENSED GAS; MAGNETIC MICROTRAPS; CORRELATED DISORDER; MATTER-WAVES; POTENTIALS; DELOCALIZATION; FLUCTUATIONS; TRANSITION; CONDUCTORS; SCATTERING; (1)
Einstein manifold, Lorentzian manifold, Gravitational wave (1)
EINSTEIN-METRICS; Ricci solitons; Moduli space; Linearized equation; Integrability (1)
Einstellungen; Lehrer; Integration; Sonderpädagogik; Behinderung; Befragung (1)
Einzelfallraster, pädagogische Diagnostik, protektive Faktoren, Risikofaktoren, Lernschwierigkeiten, Inklusion (1)
Einzelhandel, Bauleitplanung, Manssen (1)
Einzelhandel, Immobilien, Manssen (1)
Einzelmolekülelektronik, Metall-Molekül-Wechselwirkungen, Platin, Silane, Silber, Silver, Gold, Platine, Silane, Single-Molecule Electronics (1)
Einzelmolekül-FRET Messungen, Einzelmolekül-Pulldown (SiMPull), Amber-Supressionsstrategie, Single molecule FRET, single-molecule pull-down (SiMPull), amber suppression method (1)
Einzelmolekül-Untersuchungen NV-Zentren Optisch-detektierte Magnetresonanz Rastersondenmikroskopie (1)
Einzelpartikelspektroskopie, Quantenemitter, Photophysik, Nanopartikel, Exziton-Exziton-Annihilation, Anrege-Abfrage-Spektroskopie /Single particle spectroscopy, quantum emitters, photophysics, nanoparticles, exciton exciton annihilation, pump-probe spectroscopy. (1)
Einzelpartikelspektroskopie, Quantenemitter, Photophysik, Nanopartikel / Single particle spectroscopy, quantum emitters, photophysics, nanoparticles (1)
Einzelzellen, Amplifikationen, NSCLC, nicht-kleinzelliges Lungenkarzinom, qPCR, singe cells, amplifications, EGFR, FGFR1, ERBB2, MET, non small cell lung cancer (1)
Eisen · Funktionalisierung · Nukleophile · Polyarsenideinheiten · Arsen (1)
Eisen; Koordinationspolymere; Kupfer; Phosphor; P-Liganden (1)
EISENMENGER SYNDROME; ARTERIAL-HYPERTENSION; CLINICAL-ASPECTS; SINGLE-CENTER; ANTICOAGULATION; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; MANAGEMENT; THERAPIES; Congenital heart disease (CHD); Eisenmenger syndrome; pulmonary hypertension; registry; targeted treatment (1)
Eisenproteide , Nichthäm-Eisenproteide , Dihydrooxazole , Homogene Katalyse , CD-Spektroskopie , Ultraviolettspektroskopie , Chirale Verbindungen , Oxazolin , Bis(oxazolin) , oxazoline , bis(oxazoline) (1)
Eisen , Seltenerdmetall , Mehrschichtsystem , Magnetspeicher , Magnetismus , , magnetism , multilayer , rare earth , magnetic memory (1)
Eisenstein Kohomologie, Eisenstein Klassen, Eisenstein Reihen, Polylogarithmus, Hilbert-Blumenthal Varietät Eisenstein cohomology, Eisenstein series, polylogarithm, Hilbert-Blumenthal variety (1)
Eisenstein-Kronecker series, real-analytic Eisenstein series, polylogarithm, de Rham cohomology, syntomic cohomology, p-adic interpolation (1)
Eiszeit , Pflanzen , Genetische Variabilität , Diversität , Glazialrelikt , Seltenheit , diversity , relict , plant , glaciation (1)
EJACULATORY DUCT OBSTRUCTION; IPSILATERAL RENAL AGENESIS; SEMINAL-VESICLE CYST; LAPAROSCOPIC EXCISION; DIAGNOSIS; (1)
EJECTION FRACTION; HEART-FAILURE; METABOLIC SYNDROME; CARDIAC-FUNCTION; ECHOCARDIOGRAPHY; VOLUME; ASSOCIATION; DIAGNOSIS; IMPACT; left atrial enlargement; obesity; obstructive sleep apnea; weight loss (1)
EKD-Schrift, Replik (1)
EKG Screening, Geburtskohortenstudie, Neugeborene, Long QT Syndrom (1)
ELASTASE-INDUCED ANEURYSM; PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; DISRUPTING DEVICE; DIVERTOR; MODEL; COMPLICATIONS; DIVERSION; COVERAGE; RABBITS; Stent; Flow diverter; Aneurysm; Rabbit aneurysm model (1)
ELASTIC BENDING ENERGY; LIPID-BILAYERS; HARMONIC MAPS; VESICLE MEMBRANES; FLOW; EQUATIONS; PHASE; CONFIGURATIONS; APPROXIMATION; ALGORITHM; Biomembrane; orientational order; curvature (1)
ELASTIC CURVES; EXISTENCE; EVOLUTION; L-2-FLOW; SOBOLEV; SPACES; curve diffusion; surface diffusion; contact angles; weighted Sobolev spaces; blow-up criteria (1)
elastic flow, Willmore flow, Navier boundary conditions, clamped boundary conditions, parametric finite elements, tangential movement, anisotropy (1)
elastic flow, Willmore flow, parametric finite elements, tangential movement, curve networks, junctions, nonlinear splines (1)
ELASTIC PROPERTIES; WILLMORE FLOW; MEMBRANES; BILAYERS; ENERGY; PHASE; MODEL; CONFIGURATIONS; APPROXIMATION; ALGORITHM; Finite elements; surfaces; biomembranes; surfactants; director fields (1)
ELASTIC SURFACE PULSES; ACOUSTIC-WAVES; SOLITONS; (1)
elastography | graft fibrosis | liver fibrosis | liver stiffness measurement | pediatric liver transplantation | shear wave elastography (1)
ELASTOGRAPHY; SILICONE; Breast implant; ultrasound; magnetic resonance imaging; capsular contracture (1)
Elastomer , Reibungskoeffizient , Gummielastizität , Hystereseverlust , Rauigkeit , Verlustmodul , Elastomer , Friction Coefficient , Rubber Elasticity , Roughness , Loss Modulus (1)
Elbow; Cell-based therapy; Tendinopathy; PRP; Injection (1)
Elbow, Trauma, Olecranon, ORIF, Trauma, Fracture, Monteggia, Trans-olecranon (1)
Elderly patients · Adjuvant chemotherapy · Neoadjuvant chemotherapy · Breast cancer (1)
ELDERLY-PATIENTS; KNEE; HEMIARTHROPLASTY; RISK; hip arthroplasty; hemiarthroplasty; PMMA; bone cement; periprosthetic joint infection; revision; femoral neck fracture; antibiotic-loaded bone cement; antibiotics (1)
ELDERLY-PATIENTS; RISK-FACTORS; HIP; MORTALITY; OLDER; ARTHROPLASTY; SURGERY; IMPACT; CARE; periprosthetic joint infection; orthogeriatric infection; multimorbidity; Barthel index; multidisciplinary treatment (1)
; elderly polytrauma; anticoagulation; mortality (1)
E-Learning, GRIPS, Didaktik, Lernen, Logistik (1)
ELECTIVE ORTHOPEDIC-SURGERY; ANTITUMOR NECROSIS FACTOR; TOTAL HIP-ARTHROPLASTY; INFECTIOUS COMPLICATIONS; COMBINATION THERAPY; ARTHRITIS PATIENTS; POSTOPERATIVE COMPLICATIONS; HEALING COMPLICATIONS; CYTOKINE PRODUCTION; METHOTREXATE; Elective surgery; Rheumatoid arthritis; DMARD; Infections; Wound healing (1)
ELECTRICAL CARDIOVERSION; COGNITIVE FUNCTION; POPULATION; IMPAIRMENT; Atrial fibrillation; Cognitive impairment; Dementia; Brain volume; Cerebral blood flow; Brain perfusion (1)
Electrical conductivity, Electrical properties, Fermi surface, Landau levels, Magneto-optics, Magnetotransport, Photoconductivity, Plasmonics, Layered semiconductors, Narrow band gap systems, Boltzmann theory, Fermi liquid theory, Resistivity measurements, Terahertz spectroscopy (1)
Electrical conductivity, Electrodes, Magnetic properties, Mathematical methods, Tunneling (1)
Electrical conductivity; Energy levels; Metal nanoparticles; Nanoparticles; Tunneling (1)
ELECTRICAL-CONDUCTIVITY; TEMPERATURE-DEPENDENCE; PRESSURE-DEPENDENCE; 1-METHYL-3-OCTYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; PHYSICOCHEMICAL PROPERTIES; THERMOPHYSICAL PROPERTIES; PHYSICAL-PROPERTIES; HEAT-CAPACITIES; FUEL-CELLS; TETRAFLUOROBORATE; (1)
ELECTRICAL-CURRENT THERAPY; SHAM-CONTROLLED TRIALS; CEREBRAL-BLOOD-FLOW; VISUAL-ATTENTION; MAGNETIC STIMULATION; INDUCED NEUROPLASTICITY; COGNITIVE CONTROL; MOOD DISORDERS; METAANALYSIS; SERTRALINE; Major depression; Non-invasive brain stimulation; Selective serotonin reuptake inhibitor; Non-response; tDCS (1)
ELECTRICAL DETECTION; (1)
ELECTRICAL DETECTION; ROOM-TEMPERATURE; INJECTION; VALVE; (1)
ELECTRICAL DETECTION; SURFACE-STATE; PHOTOCURRENTS; POLARIZATION; GENERATION; CURRENTS; (1)
ELECTRICAL DETECTION; TRANSPORT; SUPPRESSION; UNIVERSALITY; PRECESSION; (1)
ELECTRICAL DOUBLE-LAYER; INTERACTION SITE MODEL; INTEGRAL-EQUATION THEORY; MOLECULAR-DYNAMICS SIMULATIONS; ELECTROLYTE SOLUTION INTERFACE; ELECTROCHEMICAL DOUBLE-LAYER; DENSITY-FUNCTIONAL THEORY; NONUNIFORM POLYATOMIC SYSTEMS; ORNSTEIN-ZERNIKE EQUATION; AMBIENT AQUEOUS-SOLUTION; (1)
ELECTRICAL DOUBLE-LAYER; IONIC LIQUIDS; singlet integral equations; ionic liquid; restricted primitive model; capacitance (1)
ELECTRICAL DOUBLE-LAYER; PLATINUM-ELECTRODE; REDOX COUPLE; MOLTEN-SALTS; CAPACITANCE; CONVERSION; PERFORMANCE; INTERFACES; EFFICIENCY; STABILITY; (1)
ELECTRICAL DOUBLE-LAYERS; DENSITY-FUNCTIONAL THEORY; NONUNIFORM POLYATOMIC SYSTEMS; POISSON-BOLTZMANN EQUATION; GOUY-CHAPMAN THEORY; MONTE-CARLO; CHAIN APPROXIMATION; INTEGRAL-EQUATION; CLASSICAL FLUIDS; INTERFACES; electrical double layer; integral equations; reference interaction site model; electrolytes; hypernetted chain approximation (1)
Electrical energy, Energy, Plasmons, Quantum mechanics, Plasmonics (1)
ELECTRICAL-FIELD STRENGTHS; SINGLE CELLS; FLUORESCENCE DETECTION; QUANTITATIVE-ANALYSIS; ZONE-ELECTROPHORESIS; CANCER BIOLOGY; SEPARATIONS; DOPAMINE; REPAIR; Capillary electrophoresis; Counter-electroosmotic; Time-of-flight mass spectrometry; High electric field strength; Hyaluronan; Bovine testicular hyaluronidase (1)
ELECTRICAL NOISE; WIRES; FILMS; CUMN; BI; (1)
ELECTRICAL PROMONTORY STIMULATION; HEARING-LOSS; OTOACOUSTIC EMISSIONS; DOUBLE-BLIND; BRAIN-STEM; SUPPRESSION; EAR; IMPLANTATION; FREQUENCY; MODEL; tinnitus; electric stimulation; cathodal stimulation; anodal stimulation; auditory percept; ear; sensorineural hearing loss (1)
ELECTRICAL-PROPERTIES; (CUI)(2)CU3SBS3; CUCLCU2TES3; AG5TE2CL; HALIDES; PHASE; (1)
Electrical properties, Electronic structure, First-principles calculations, Lattice dynamics, Luminescence, Optoelectronics, Phonons, Spin-orbit coupling, Trions, Valleytronics (1)
Electrical properties Magnetotransport Topological insulators (1)
ELECTRICAL-PROPERTIES; MIXED CONDUCTOR; SILVER; TRANSPORT; NANOIONICS; STABILITY; SYSTEMS; (1)
ELECTRICAL-PROPERTIES; SEMICONDUCTOR; SPINTRONICS; MOBILITY; GAS; black phosphorus; phosphorene; spin relaxation; spin-orbit coupling; spin caloritronics (1)
ELECTRICAL-PROPERTIES; SPECTROSCOPIC CHARACTERIZATION; IODIDE; (CUI)(3)CU2TES3; (CUI)(2)CU3SBS3; CUCLCU2TES3; CU2P3I2; RAMAN; lithium; antimony; chalcogens; halogens; crystal structures (1)
ELECTRICAL PULSE GENERATION; COPLANAR TRANSMISSION-LINES; OPTOELECTRONIC MEASUREMENT; ILLUMINATION; DISPERSION; FIELD; gallium arsenide; III-V semiconductors; photoconducting switches; photoconductivity; photoemission; solid-state plasma; time of flight spectra (1)
ELECTRICAL PULSE GENERATION; TRANSMISSION-LINES; EPITAXIAL GRAPHENE; DYNAMICS; SPECTROSCOPY; MICROSCOPY; (1)
ELECTRICAL SPIN INJECTION; MAGNETIC SEMICONDUCTORS; FERROMAGNETISM; TRANSPORT; FIELD; METAL; Triangular Esaki barrier; Tunneling probabilities; Spin efficiency (1)
ELECTRICAL SPIN-INJECTION; METAL/TUNNEL BARRIER CONTACT; LIGHT-EMITTING-DIODES; SEMICONDUCTOR HETEROSTRUCTURE; QUANTUM DOTS; SILICON; MAGNETIZATION; TRANSISTORS; PROPOSAL; (1)
ELECTRICAL SPIN INJECTION; MOLECULAR-BEAM EPITAXY; FERROMAGNETIC-RESONANCE; POLARIZED CURRENT; FILMS; GAAS; FE; SEMICONDUCTOR; (1)
ELECTRICAL SPIN INJECTION; MOLECULAR-BEAM EPITAXY; MAGNETIC-PROPERTIES; CORE-SHELL; SEMICONDUCTORS; SILICON; ORIENTATION; FLOW; MnAs segment; GaAs nanowire; deterministic epitaxial growth; room-temperature ferromagnet; sequential crystallization; single-domain (1)
ELECTRICAL SPIN INJECTION; SEMICONDUCTORS; SPINTRONICS; (1)
ELECTRICAL SPIN INJECTION; TRANSPORT; GAAS; SEMICONDUCTOR; HYDROGEN; BARRIER; (1)
ELECTRICAL-STIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; MICROPHOTODIODES; BLIND; (1)
ELECTRICAL-STIMULATION; EXCITABILITY; DYSRHYTHMIA; COGNITION; TINNITUS; RTMS; Transcranial random noise stimulation; tRNS; Auditory steady state response; Auditory cortex (1)
ELECTRICAL-STIMULATION; RABBIT RETINA; ELECTRODES; retina implant; micro-photodiode array; micro-electrode; electrical stimulation; biocompatibility; biostability (1)
ELECTRICAL-STIMULATION; RABBIT RETINA; retinal prostheses; subretinal microphotodiodes; retina implants; photoreceptor replacement; biocompatibility (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; ARTIFICIAL VISION; INTRACORTICAL MICROSTIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; BLIND; PROSTHESIS; MICROPHOTODIODES; PERCEPTION; (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; ARTIFICIAL VISION; INTRACORTICAL MICROSTIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; RETINAL PROSTHESIS; BLIND; MICROPHOTODIODES; FEASIBILITY; blindness; visual prosthesis; retina; implant; electrode; electrical stimulation; visual cortex responses; pig (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; DEGENERATED PHOTORECEPTORS; ARTIFICIAL VISION; BLIND; RABBIT; ARRAYS; RESPONSES; ELECTRODE; (1)
Electrical transport; Gallium arsenide; Heterojunctions; Semiconductor-semiconductor heterostructures (1)
ELECTRIC-CURRENT; MAGNETIC-FIELD; HALL; SYSTEMS; FLUCTUATIONS; ORIENTATION; CHARGE; SEMICONDUCTORS; POLARIZATION; RESONANCE; (1)
electric domains; ferroelectric materials; ferromagnetic materials; Kerr magneto-optical effect; magnetic anisotropy; magnetic domains; magnetic hysteresis; magnetoelastic effects; remanence; (1)
ELECTRIC-FIELD; CONDENSATION; SEMICONDUCTOR; CONFINEMENT; (1)
ELECTRIC-FIELD; EXCITONS; (1)
Electric field Magnetic field (spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields) Dipole moment Energy level Energy level Magnetic moment Wave function (spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) Electron configuration and Electron density (hybridization, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) Fluorescence (laser-induced, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields) Energy level transition (vibrational, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) spectroscopy pendular mol elec magnetic field iodine chloride laser induced fluorescence hybridization energy level transition chloride hyperfine splitting wave function chloride (1)
ELECTRIC FISHES MORMYROIDEA; PHYLOGENETIC-RELATIONSHIPS; RIVER; COMPLEX; AFRICA; SOUTHERN; allopatric speciation; parapatric; geographic cline; electric organ discharges; southern Africa (1)
ELECTRIC FISH POLLIMYRUS; SOUND PRODUCTION; ACOUSTIC COMMUNICATION; INDIVIDUAL RECOGNITION; LAKE MALAWI; ISIDORI; DISCHARGES; BEHAVIOR; PISCES; FORM; acoustic communication; electric fish; reproduction; species recognition; variability; vocalisation (1)
Electricity; Contract for Difference; Implied Area Forward; Risk Premium (1)
ELECTRIC-MAGNETIC DUALITY (1)
Electric Organ Discharge (EOD); waveform; communication signal; variability; sexual dimorphism (1)
ELECTRIC ORGAN DISCHARGE; GNATHONEMUS-PETERSII MORMYRIDAE; SOUTH-AFRICAN FORM; ALLOPATRIC DIFFERENTIATION; MACROLEPIDOTUS MORMYRIDAE; REPRODUCTIVE-BEHAVIOR; POLLIMYRUS-ISIDORI; FISH; COMMUNICATION; COURTSHIP; Electric organ discharge; Electrocommunication; Reproductive cycle; Sexual attraction; Male advertisement signal; Regularized discharge pattern (1)
electric organ discharge; Gymnotiformes, signal waveform discrimination; amplitude spectrum, phase spectrum; frequency difference; jamming avoidance response; beat analysis; sensory mechanism; Eigenmannia (1)
Electric organ discharge; Pulse waveform; Intraspecific variability; Water conductivity; Communication signal (2)
ELECTRIC ORGAN DISCHARGES; CYTOCHROME-B SEQUENCES; POLLIMYRUS-ISIDORI; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; CLARIAS-GARIEPINUS; FISHES MORMYRIDAE; EVOLUTION; FORM; COMMUNICATION; teleostei; Mormyridae; Marcusenius; systematics; morphometrics; electric organ discharges; molecular genetics; southern Africa (1)
electric organ discharge; sexual dimorphism; waveform analysis (1)
Electric organ discharge; Signal detection; Phase sensitivity; Electrosensory stimulus-intensity threshold; Jamming avoidance response (1)
ELECTRIC ORGAN DISCHARGES; SOUTH-AFRICAN FORM; P-MARIANNE; ALLOPATRIC DIFFERENTIATION; PHYLOGENETIC-RELATIONSHIPS; MARCUSENIUS-PONGOLENSIS; COMMUNICATION SIGNAL; FISHES MORMYRIDAE; SEXUAL SELECTION; SOUND PRODUCTION; speciation; parapatric; cline; hybridization; electric organ discharge; DNA sequence analysis; genomic fingerprinting (1)
ELECTRIC ORGAN DISCHARGES; UPPER ZAMBEZI RIVER; GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI; OSTEOGLOSSOMORPHA MORMYRIDAE; WATER CONDUCTIVITY; SEX-DIFFERENCES; P-MARIANNE; WAVE-FORMS; FISH; systematics; morphometrics; electric organ discharges; molecular genetics; allopatric speciation (1)
ELECTRIC-POWER TRANSMISSION; FUTURES MARKETS; HEDGING EFFECTIVENESS; RISK; VOLATILITY; DYNAMICS; RETURNS; MODEL; COST; Electricity; Contract for Difference; Implied area forward; Risk premium (1)
Electric spin orientation; Spin–orbit splitting; Spin relaxation (2)
ELECTROCATALYTIC OXIDATION; CARBON ELECTRODES; GLUCOSE-OXIDATION; ALKALINE; PLATINUM; MECHANISM; MEDIA; gold nanoparticles; electrochemical; glucose detection (1)
ELECTROCATALYTIC REDUCTION; DIOXIDE REDUCTION; CAPTURE; CU; ETHYLENE; ELECTROREDUCTION; NANOCRYSTALS; INSIGHTS; ETHANOL; copper oxide catalysts; catalyst preparation; calcination; deep eutectic solvents; electrochemical CO2 reduction (1)
ELECTROCHEMICAL APTASENSOR; HEMIN/G-QUADRUPLEX; THROMBIN; GENERATION; NANOTUBES; ASSAYS; DNA; Aptamer; Liposomes; Interdigitated electrodes; Nanoparticles; Impedance; Capacitance; Laser-induced graphene (1)
; Electrochemical biosensor; Silver nanoparticle; Gold nanoparticle; Blood analysis; DPV (1)
ELECTROCHEMICAL CO2 REDUCTION; CARBON-DIOXIDE; FORMIC-ACID; CATALYSTS; ELECTROREDUCTION; TEMPERATURE; SELECTIVITY; ELECTRODES; CAPTURE; HYDROCARBONS; catalyst preparation method; copper; deep eutectic solvents; electrochemistry; pyrolysis (1)
ELECTROCHEMICAL DETECTION; ELECTROSPRAY-IONIZATION; SEPARATION; MICROCHIP; CE; MS; SOLVENTS; ELECTROCHEMILUMINESCENCE; FLUORESCENCE; (CD)-D-4; Contactless conductivity detection; Electrospray ionization; Mass spectrometry; Dual detection; Non-aqueous capillary electrophoresis (1)
ELECTROCHEMICAL DETECTION; HEART-FAILURE; SILVER; PAPER; Electrochemical biosensor; Silver nanoparticle; Microfluidic; Blood analysis; Differential pulse voltammetry (1)
ELECTROCHEMICAL DETECTION; METABOLITES; opipramol (1)
ELECTROCHEMICAL DETECTION; PLASMA; Capillary zone electrophoresis; Electrochemistry; Extraction; Trimetazidine (1)
ELECTROCHEMICAL DETECTION; PROTEINS; (1)
ELECTROCHEMICAL ENERGY-STORAGE; ASYMMETRIC SUPERCAPACITORS; MESOPOROUS CARBON; THIN-FILM; NANOWIRE ARRAYS; NANOTUBES; GRAPHENE; OXIDE; NANOPARTICLES; EFFICIENT; (1)
ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; NANOPOROUS-GOLD; HORSERADISH-PEROXIDASE; POINT; BIOSENSOR; IMMUNOSENSOR; MICROELECTRODE; APTASENSOR; MORPHOLOGY; INTERFACE; Parathyroid hormone; Nanostructures; Disk electrode; Antibody; Impedance; Immunosensor; EIS; DPV (1)
Electrochemically assisted injection, mass spectrometry, capillary electrophoresis, nitroaromatics, graphene electrodes (1)
ELECTROCHEMICAL OXIDATION; SPECTROMETRY; CHLORIDE; BIOTRANSFORMATION; DEGRADATION; IONIZATION; PATHWAYS; REMOVAL; DRUGS; Emerging pollutants; Electrochemical degradation; Photodegradation; Transformation products; High-resolution mass spectrometry (1)
ELECTROCHEMICAL PROPERTIES; TRANSPARENT; ELECTRODES; PEDOTPSS; FILMS; (1)
ELECTROCHEMICAL REDUCTIVE CLEAVAGE; DISSOCIATIVE ELECTRON-TRANSFER; TRANSFER RADICAL-ADDITION; CARBON-HALOGEN BOND; PHOTOREDOX CATALYSIS; ALPHA-BROMOCHALCONES; MERGING PHOTOREDOX; CHAIN REACTIONS; ANION-RADICALS; HECK REACTION; (1)
electrochemical sensor; microfluidic-based sample preparation; clinical sample analysis (1)
ELECTROCHEMICAL SUPERCAPACITORS; ASYMMETRIC SUPERCAPACITORS; NANOSTRUCTURED MNO2; MANGANESE-DIOXIDE; NANOTUBE ARRAYS; ENERGY-STORAGE; THIN-FILMS; GRAPHENE; HYBRID; NANOPARTICLES; MnO2 spheres; cobalt nanobeads; low cost; high performance; symmetrical supercapacitor (1)
electrochemistry, biosensor, bacteriophage, laser-induced graphene, food safety, bacterial detection, microbial detection, bioassay (1)
Electrochemistry, Complementary study, Capillary electrophoresis, Differential pulse voltammetry, Electrochemical detection, Quality control, Mass spectrometry (1)
Electrochemistry · Energy harvesting · Late-stage functionalization · Radicals · Self-sustaining (1)
Electrochemistry · Interfacial Studies · Lithium-Ion Batteries · Scanning Probe Microscopy · Solid Electrolyte Interphase (1)
Electrochemistry · Interfacial Studies · Lithium-Ion Batteries · Scanning Probe Microscopy · Surface Analysis (1)
; Electrochemistry; Lithium-ion cell; Mass spectrometry; Material science; Gas analysis; Response time (1)
electrochemotherapy, ECT, reversible electroporation, percutaneous, liver, hepatic, metastases, interventional oncology, bleomycin, hepatocellular carcinoma (1)
ELECTROCHROMIC MATERIALS; COORDINATION-COMPLEXES; TCNE; CHEMISTRY; EXCHANGE; MAGNETS; (1)
ELECTROCORTICAL STIMULATION; PREFRONTAL CORTEX; VERB GENERATION; WADA TEST; DEVELOPMENTAL DYSLEXIA; BRAIN ACTIVATION; PET ACTIVATION; WORKING-MEMORY; LATERALIZATION; FMRI; Lateralization; Broca's; Presurgical; Semantic; Generation (1)
ELECTRODE-ELECTROLYTE INTERFACE; CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; ASSISTED INJECTION; BIOTRANSFORMATION REACTIONS; COUPLED ONLINE; IN-VITRO; METHANOL ELECTROOXIDATION; POTENTIAL METABOLITES; OXIDATIVE-METABOLISM; hyphenated techniques; electrochemistry; mass spectrometry; liquid chromatography; capillary electrophoresis (1)
electroencephalography; motor-evoked potentials; neuroplasticity; repetitive transcranial magnetic stimulation; TMS-EEG; TMS-evoked EEG potentials (1)
ELECTROGENERATED CHEMILUMINESCENCE; ELECTROCHEMILUMINESCENCE ECL; LIGHT-EMISSION; SYSTEM; TRIS(2,2'-BIPYRIDYL)RUTHENIUM(II); OXIDATION; (1)
ELECTROGENERATED CHEMILUMINESCENCE; HYDRAZIDES; DENSITY; BIOLUMINESCENCE; ALDEHYDES; SYSTEM; NANOPARTICLES; DERIVATIVES; DIENOPHILES; CHEMISTRY; ab initio calculations; chemiluminescence; conical intersections; luminols; steric gearing (1)
ELECTROGENIC GLUTAMATE UPTAKE; BRAIN ISCHEMIA; MULLER CELLS; RELEASE; ASTROCYTES; ACTIVATION; EXPRESSION; PLASTICITY; MODULATION; MECHANISMS; glutamate; gliotransmitter; ischemia; Muller cell; retina (1)
electrokinetic surface properties, zeta-potential, dendrimers, self-assembled monolayers (SAM), protein adsorption, bacterial adhesion, biomaterials, anti-microbial coatings Elektrokinetische Oberflächeneigenschaften, zeta-Potential, Dendrimere, Selbst-organisierende Monoschichten (SAM), Proteinadsorption, Bakterielle Adhäsion, Biomaterialien, Antibakterielle Beschichtung (1)
Electroluminescence; Spin dynamics; Spin optoelectronics; Organic LEDs; Organic semiconductors; Phosphorescence; Quantum master equation (1)
ELECTROLUMINESCENT DEVICES; POLYMERIC MATRIX; STATE PROPERTIES; LIGHT; PHOSPHORESCENCE; PRESSURE; SENSORS; FILMS; MOLECULES; LIGAND; Iridium; Phosphorescence; Temperature sensitivity; Oxygen sensitivity; Density functional calculations (1)
ELECTROLYSIS; WATER; (1)
Electrolyte conductance - single ion conductance - ion-pair formation - non-coulombic interactions - 1-propanol solutions - alkali metal salts - tetraalkylammonium salts (1)
ELECTROLYTE ENVIRONMENT; PEANUT LECTIN; DIFFERENTIATION; CELLS; PROTEINS; MESENCHYME; EXPRESSION; BINDING; CORTEX; SALT; kidney; collecting duct; epithelia; COX 1 and 2; differentiation; perfusion culture; electrolytes (1)
ELECTROLYTE MIXTURES; PROTEIN DENATURATION; WATER; SODIUM; STABILITY; ACID; CONDUCTIVITY; TEMPERATURE; RELAXATION; CONSTANTS; (1)
ELECTROLYTES; CATIONS; LITHIUM; COMPLEXATION; CONDUCTIVITY; POLYETHERS; POTASSIUM; CATALYSIS; SOLVENTS; ETHERS; green chemistry; ionic liquids; oligoether carboxylate; toxicity; Walden plot (1)
Electrolytes, Liquid-Liquid Extraction, 5-Hydroxymethylfurfural, Glycerol (1)
electrolyte soln elec field kinetic process (1)
electrolyte soln structure dielec relaxation (1)
electrolyte soln transport diffusion electrolyte soln elec cond electrolyte soln statistical mechanic electrolyte soln (1)
ELECTROLYTE SOLUTION INTERFACE; MOLECULAR-SOLVENT MODEL; ORNSTEIN-ZERNIKE EQUATION; METAL-LIQUID INTERFACE; INTEGRAL-EQUATION; CHARGED SURFACES; RISM THEORY; SYMMETRY REDUCTION; LENNARD-JONES; HARD-SPHERE; (1)
ELECTROLYTE-SOLUTIONS; COMPLEX PERMITTIVITY; ION ASSOCIATION; SPECTROSCOPY; HYDRATION; MIXTURES; SYSTEM; (1)
ELECTROLYTE-SOLUTIONS; CONDUCTANCE; -45-DEGREES-C; 25-DEGREES-C; TEMPERATURES; SALTS; (1)
ELECTROLYTE-SOLUTIONS; LIQUID WATER; TETRAMETHYLAMMONIUM CHLORIDE; RELAXATION SPECTROSCOPY; TETRAALKYLAMMONIUM IONS; HYDROPHOBIC INTERACTION; TEMPERATURE-DEPENDENCE; NONAQUEOUS SOLVENTS; VAPOR-PRESSURE; DYNAMICS; (2)
ELECTROLYTE-SOLUTIONS; LITHIUM ION; RELAXATION SPECTROSCOPY; DISSOCIATION-CONSTANTS; WATER; CHLORIDE; SULFATE; PAIR; LIQUIDS; PERMITTIVITY; (1)
ELECTROLYTE-SOLUTIONS; LITHIUM PERCHLORATE; N-METHYLFORMAMIDE; PAIR; N,N-DIMETHYLFORMAMIDE; CONDUCTANCE; FRICTION; SOLVENTS; PERMITTIVITY; SPECTROSCOPY; ion association; solvation; dielectric relaxation (1)
ELECTROLYTE-SOLUTIONS; MICELLES; COUNTERION; BROMIDE; PERMITTIVITY; AGGREGATION; SCATTERING; FREQUENCY; IONS; (1)
ELECTROLYTE-SOLUTIONS; SALT; THERMODYNAMICS; ETHANOL; EQUILIBRIA; 2-PROPANOL; SYSTEMS; LIBR; LICL; isopiestic; osmotic coefficient; vapor pressure (1)
ELECTROLYTE-SOLUTIONS; SPECTROSCOPY; IMIDAZOLIUM; RELAXATION; DYNAMICS; PERMITTIVITY; (1)
ELECTROLYTE-SOLUTIONS; SURFACTANTS; BINDING; LIQUID; MICROEMULSIONS; INTERFACE; STABILITY; SALTS; salt effects; cloud points; hydrotropes; nonionic surfactants (1)
ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; CARBONATE SOLUTIONS; TRANSPORT; LIPF6; CONDUCTANCE; CATION; ANION; NMR; (1)
ELECTROLYTE-SOLUTIONS; WATER+1,4-DIOXANE MIXTURES; SODIUM-CHLORIDE; TEMPERATURES; COEFFICIENTS; CONDUCTANCE; 5-DEGREES-C; MODEL; electrolyte conductivity; electrolyte solutions; magnesium sulfate; chemical model; mean spherical approximation (MSA) (1)
ELECTROLYTES; TEMPERATURE; WATER; borates; electrolytes; ionic liquids; room-temperature molten salts; synthetic methods (1)
ELECTROMAGNETICALLY INDUCED TRANSPARENCY; INVERSION; (1)
ELECTROMAGNETIC FORM-FACTORS; DEEP-INELASTIC SCATTERING; ELASTIC ELECTRON-SCATTERING; DYSON-SCHWINGER EQUATIONS; RELATIVIZED QUARK-MODEL; DISTRIBUTION AMPLITUDES; EXCLUSIVE PROCESSES; ASYMPTOTIC FREEDOM; SYMMETRY-BREAKING; SCHEMATIC MODEL; Baryon spectra and structure; Diquark correlations; Dyson-Schwinger equations; Lattice quantum chromodynamics; Quantum chromodynamics; Quark models (1)
ELECTROMAGNETIC FORM-FACTORS; LARGE MOMENTUM-TRANSFER; QCD SUM-RULES; WAVE-FUNCTIONS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; 3-QUARK OPERATORS; HIGHER TWIST; (1)
ELECTROMAGNETIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; NUCLEON; PROTON; PHOTOPRODUCTION; QUARK; MODEL; PI-0; QCD; (1)
ELECTROMAGNETIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; THRESHOLD; NUCLEON; ELECTROPRODUCTION; QCD; chiral symmetry; electroproduction (1)
ELECTROMAGNETIC POTENTIALS; MICROSCOPY; HOLOGRAPHY; (1)
Electromagnetic radiation; Light Neurophysiology; Pharmaceuticals; Receptors (1)
Electromagnetic tracking, Particle filtering, Empirical mode decomposition, Singular spectrum analysis, Similarity measure (1)
Electromagnetic tracking, Particle filtering, Singular spectrum analysis, Ensemble empirical mode decomposition, Hartigan dip test, Alpha-stable distributions (1)
ELECTROMAGNETIC-WAVE EXCITATION; DOUBLE-BARRIER STRUCTURE; GAAS/ALGAAS HETEROSTRUCTURES; STATES; REGIME; FIELD; (1)
ELECTROMYOGRAPHIC ACTIVITY; NEGATIVE EMOTION; DECISION-MAKING; ADAPTATION; TASK; ADJUSTMENTS; DRIVEN; PERFORMANCE; CONGRUENCY; ERIKSEN; conflict processing; EMG; emotion; motivation (1)
ELECTRON; (1)
ELECTRON-BEAM IRRADIATION; IN-VITRO; WEAR; POLYETHYLENE; COMPOSITES; STRENGTH; HARDNESS; Electron-beam irradiation; Polymer brackets; Polymer crosslinking (1)
ELECTRON-CAPTURE DISSOCIATION; ALIPHATIC CLAISEN REARRANGEMENT; O-NITROBENZYL DERIVATIVES; NONSTATISTICAL DYNAMICS; KINETIC INVESTIGATIONS; PHOTOLABILE PRECURSORS; THERMAL-REACTIONS; INTRAMOLECULAR DYNAMICS; PHOTOCHEMICAL REDUCTION; ACTIVATION PARAMETERS; computational chemistry; dynamics; mentoring; physical organic chemistry; reactive intermediates; reactivity; trajectories (1)
electron coherence, Mach-Zehnder, interferometer, quantum noise (1)
Electron configuration; Energy level excitation (of manganese dicarbonyl cyclopentadienyl dinitrogen complex); Ionization potential and energy (inner-shell, of nitrogen in free state and coordinated to manganese with dicarbonyl and cyclopentadienyl); core ionization nitrogen manganese coordinated; carbonyl cyclopentadienyl manganese nitrogen ionization (1)
Electron configuration; Fluorescence; Magnetic circular dichroism; Ultraviolet and visible spectra (of hairpin polyenes); Molecular orbital (PPP-CI, of hairpin polyenes); Energy level excitation (singlet, of hairpin polyenes); polyene hairpin UV fluorescence; excited singlet hairpin polyene; electron configuration hairpin polyene; MO hairpin polyene (1)
Electron configuration (of nitrianilines and related compds.); Molecular orbital (CNDO/S, of nitroaniline and related compds.); Energy level (triplet, of nitroaniline and related compds.); triple energy level nitroaniline; MO nitroaniline (1)
ELECTRON CORRELATION METHODS; AB-INITIO; LINEAR COMBINATION; WANNIER FUNCTIONS; BASIS-SETS; PROGRAM; (1)
ELECTRON CORRELATION METHODS; CHEMICAL-SHIFT CALCULATIONS; HARTREE-FOCK CALCULATIONS; ANALYTIC 2ND DERIVATIVES; COUPLED-CLUSTER SINGLES; AB-INITIO; FITTING APPROXIMATIONS; MAGNETIC-PROPERTIES; BASIS-SETS; CONSTANTS; (1)
ELECTRON CORRELATION METHODS; COUPLED-CLUSTER THEORY; AUXILIARY BASIS-SETS; HIGH-PRESSURE PHASE; SOLID CO2; PERTURBATION-THEORY; APPROXIMATE INTEGRALS; MOLECULAR-CRYSTALS; MP2 CALCULATIONS; HARTREE-FOCK; (1)
ELECTRON CORRELATION METHODS; DENSITY FITTING APPROXIMATIONS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; FAST MULTIPOLE METHOD; TRIPLES CORRECTION T; FORMULATION; HYDROGEN; ONIOM; MP2; (1)
ELECTRON CORRELATION METHODS; DENSITY-FUNCTIONAL THEORY; WANNIER FUNCTIONS; LINEAR-COMBINATION; CORRELATION-ENERGY; TITANIUM-DIOXIDE; EXTENDED SYSTEMS; CLUSTER; SOLIDS; APPROXIMATIONS; Local Correlation; Density Fitting; Titanium Dioxide (1)
ELECTRON CORRELATION METHODS; EXCITED-STATES; CONFIGURATION-INTERACTION; POLARIZATION PROPAGATOR; LOCAL TREATMENT; WAVE-FUNCTION; HARTREE-FOCK; SINGLES; EXPANSION; HYPERPOLARIZABILITIES; (1)
ELECTRON CORRELATION METHODS; LOCALIZED WANNIER FUNCTIONS; INITIO CORRELATION METHOD; GAUSSIAN-BASIS SETS; AB-INITIO; DENSITY FUNCTIONALS; MOLECULAR-DYNAMICS; GRAPHITE; ENERGY; APPROXIMATION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; BASIS-SETS; CONFIGURATION-INTERACTION; INTERACTION ENERGIES; WAVE-FUNCTIONS; PNO-CI; ORBITALS; TRIPLES; FORMULATION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; AUXILIARY BASIS-SETS; APPROXIMATE INTEGRALS; LINEAR-COMBINATION; WANNIER FUNCTIONS; PERIODIC-SYSTEMS; EXTENDED SYSTEMS; ENERGY; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; DNA-BASE PAIRS; CONFIGURATION-INTERACTION; BASIS-SETS; CHOLESKY DECOMPOSITIONS; CORRELATION ENERGIES; CORRECTION T; PNO-CI; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; DENSITY FITTING APPROXIMATIONS; CORRELATION ENERGIES; ORBITAL BASIS; MP2; TRIPLES; SYSTEMS; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; DENSITY FITTING APPROXIMATIONS; LOCALIZED WANNIER FUNCTIONS; GROUND-STATE PROPERTIES; COUPLED-CLUSTER THEORY; AB-INITIO; MOLECULAR-CRYSTALS; CONFIGURATION-INTERACTION; FUNCTIONAL THEORY; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; EXCITATION-ENERGIES; WAVE-FUNCTIONS; BASIS-SETS; IDENTITY APPROXIMATION; LARGE MOLECULES; DOUBLES MODEL; AB-INITIO; RESOLUTION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; GAUSSIAN-BASIS SETS; AB-INITIO; CORRELATION-ENERGY; COHESIVE ENERGY; DIFFRACTION; PROGRAM; SCATTERING; COMPLEXES; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; LAPLACE TRANSFORM; AB-INITIO; IDENTITY APPROXIMATION; ENERGY CALCULATIONS; MODEL CC2; MP2; INTEGRALS; RESOLUTION; Local Correlation; Laplace Transform; Response Theory (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; TRIPLES CORRECTION T; CONFIGURATION-INTERACTION; AB-INITIO; EFFICIENT REFORMULATION; CHOLESKY DECOMPOSITIONS; INTERACTION ENERGIES; NATURAL ORBITALS; WAVE-FUNCTIONS; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; TRIPLES CORRECTION T; CONVERGENCE ACCELERATION; LARGE MOLECULES; EXCITED-STATES; AB-INITIO; IDENTITY APPROXIMATION; ENERGY CALCULATIONS; MODEL CC2; (1)
ELECTRON CORRELATION METHODS; TRIPLES CORRECTION T; ORBITALS; ENERGIES; GROUP-11; SYSTEMS; STATES; CCSD; (1)
electron correlations; Laplace transforms; least squares approximations; organic compounds; perturbation theory (1)
ELECTRON-DEFICIENT POLYFLUOROARENES; CROSS-COUPLING REACTIONS; ARYL DIAZONIUM SALTS; STRYCHNOS-NUX-VOMICA; C-H ARYLATION; EOSIN-Y; POTASSIUM POLYFLUOROBENZOATES; FLUORINATED AROMATICS; IPSO SUBSTITUTION; ORGANIC-SYNTHESIS; perfluorophenyl; photocatalysis; visible light; metal-free conditions; C-H arylation; transient spectroscopy (1)
ELECTRON; DENSITY; compensated 3D-topological insulator; BiSbTeSe2; quantum capacitance; Landau quantization; thermodynamic density of states; Coulomb glass (1)
Electron density; Ethers; Rearrangement; Silicon; Stability (1)
ELECTRON-DENSITY; MOLECULAR-STRUCTURE; CHARGE-DENSITY; NEUTRON-DIFFRACTION; DATA-BANK; L-ALANINE; CRYSTALLOGRAPHY; HYDROQUINONE; REFINEMENT; ENERGIES (1)
ELECTRON-DENSITY PROPERTIES; H BOND; NMR; THERMODYNAMICS; EQUILIBRIUM; THERMOCHEMISTRY; PARAMETERS; KINETICS; DISTANCE; MODEL; (1)
ELECTRON-DIFFRACTION; (1)
ELECTRON-DONOR INITIATORS; ARYL HALIDES; PHOTOREDOX CATALYSIS; EPSILON-CAPROLACTONE; ARYLDIAZONIUM SALTS; ARENEDIAZONIUM IONS; CARBON-MONOXIDE; ACYL RADICALS; ALKYL IODIDES; ASCORBIC-ACID; (1)
ELECTRON-ELECTRON COLLISIONS; CONDUCTION-BAND; HETEROSTRUCTURES; SCATTERING; ANISOTROPY; MECHANISM; MOBILITY; DEVICE; LAYERS; WELLS; (1)
ELECTRON-ELECTRON SCATTERING; DIFFUSIVE CONDUCTORS; POINT CONTACTS; UNIVERSALITY; SUPPRESSION; TRANSPORT; GAS (1)
ELECTRON-ELECTRON SCATTERING; OPTICAL PHONON-SCATTERING; CASCADE LASERS; WELL WIRES; SEMICONDUCTOR; RELAXATION; EMISSION; TRANSPORT; RATES; (2)
ELECTRON; EXCITONS; WELLS; BINDING; SYSTEMS; PLASMA; (1)
ELECTRON-GAS; (3)
ELECTRON-GAS; 2 DIMENSIONS; CONSTRICTION; QUANTIZATION; LOCALIZATION; PERCOLATION; FIELD; B=0; (1)
ELECTRON-GAS; BASIS-SETS; TRANSPORT; EDGE; ATOMS; FUNCTIONALIZATION; APPROXIMATION; ENERGY; STATE; (2)
ELECTRON-GAS; CONDUCTIVITY; TRANSPORT; SYSTEMS; METALS; SUPERCONDUCTORS; FLUCTUATIONS; FIELD; (1)
ELECTRON-GAS; HETEROSTRUCTURES; INJECTION; (1)
ELECTRON-GAS; PHOTON-DRAG; (2)
ELECTRON-GAS; PLASMONS; OSCILLATIONS; EXCITATION; LIMITS (1)
ELECTRON-GAS; RELAXATION; GAAS; aluminium compounds; gallium arsenide; gallium compounds; III-V semiconductors; optical Kerr effect; photoconductivity; photoluminescence; semiconductor quantum wells; spin dynamics; time resolved spectra; wide band gap semiconductors (1)
ELECTRON-GAS; RESONANCE; SEMICONDUCTORS; GAAS; (1)
ELECTRON-GAS; SEMICONDUCTORS; SPINTRONICS; (1)
ELECTRON-GAS; SEMICONDUCTORS; TEMPERATURE; RESONANCE; (1)
ELECTRON-GAS; SPINTRONICS; INTERFACE; (1)
ELECTRON-GAS; STATES (1)
ELECTRON G-FACTOR; SEMICONDUCTOR NANOSTRUCTURES; TRANSPORT-PROPERTIES; INAS; PHOTOLUMINESCENCE; HETEROSTRUCTURE; (1)
ELECTRON G-FACTOR; SPIN RELAXATION; QUANTUM-WELLS; HETEROSTRUCTURES; ANISOTROPY; DYNAMICS; EXCITONS; (1)
ELECTRON-HOLE EXCITATIONS; CRITICAL-POINT PARAMETERS; INTERBAND CRITICAL-POINTS; PARTICLE BAND-STRUCTURE; QUASI-PARTICLE; TEMPERATURE-DEPENDENCE; DIELECTRIC FUNCTION; ENERGY CALCULATIONS; OPTICAL-PROPERTIES; GREENS-FUNCTION; (1)
ELECTRON-HOLE EXCITATIONS; LAYER MOS2; FEW-LAYER; BAND-GAP; MONOLAYER; SINGLE; SPECTROSCOPY; SEMICONDUCTORS; MODULATION; TRANSITION; high pressure; two-dimensional materials; density functional theory; TMDCS; modulated spectroscopy (1)
ELECTRON-HOLE LIQUID; CONDENSATION; (1)
ELECTRON-HOLE LIQUID; RADIATIVE RECOMBINATION; SILICON; GE; LUMINESCENCE; SPINTRONICS; SEMICONDUCTORS; ACCEPTORS; GERMANIUM; DONORS; (1)
ELECTRON-HOLE RECOMBINATION; SOLAR-CELLS; VIBRATIONAL-RELAXATION; GAP LAW; MU-S; SEMICONDUCTORS; EFFICIENCY; INTERPLAY; CAPTURE; CATIONS; (1)
ELECTRONIC-ABSORPTION-SPECTRA; STATE PROTON-TRANSFER; SPECTROSCOPIC PROPERTIES; PHOSPHORESCENCE; HYDROXYANTHRAQUINONES; LIGANDS; LINKAGE; electronic spectra; fluorescence; alizarin; metal complexes (1)
Electronic and spintronic devices, Ferroelectrics and multiferroics, Two-dimensional materials (1)
ELECTRONIC ARCADE GAMES; THRESHOLD SHIFTS; LISTENING DEVICES; ACOUSTIC TRAUMA; PREVALENCE; DAMAGE; DISCOTHEQUES; CHILDREN; HAZARD; OHRKAN; Adolescent; hearing loss; noise; leisure time (1)
ELECTRONIC CIGARETTES; SIZE DISTRIBUTION; AEROSOL; COMPONENTS; ASSOCIATION; MAINSTREAM; NICOTINE; ELEMENTS; LIQUIDS; TOBACCO; Electronic-cigarettes; Atomizer; Heavy metals; Analytical methods; Nanoparticles; And COVID-19 (1)
electronic coupling, macrocycles, organic electronics, single-molecule spectroscopy (1)
ELECTRONIC DATA CAPTURE; RESPIRATORY-DISTRESS-SYNDROME; CLINICAL-TRIALS; INFORMED-CONSENT; UNIT; RECRUITMENT; online survey; quality management; health care research; study acceptability (1)
ELECTRONIC-ENERGY TRANSFER; CONJUGATED POLYMER-CHAINS; MOLECULE FLUORESCENCE; ROOM-TEMPERATURE; SPECTROSCOPY; DYNAMICS; BLINKING; PHOTOPHYSICS; CHROMOPHORES; NUMBER; conjugated polymers; photoluminescence; photon statistics; photophysics; single-molecule spectroscopy (1)
ELECTRONIC-ENERGY TRANSFER; MOLECULE FLUORESCENCE; PHOTON STATISTICS; ROOM-TEMPERATURE; SPECTROSCOPY; DYNAMICS; EXCITONS; DEVICES; FIELD; (1)
Electronic excitation Fluorescence Solvation Superfluids (quantum solvation of phthalocyanine in superfluid helium droplets) quantum solvation phthalocyanine helium droplet superfluid fluorescence (1)
ELECTRONIC EXCITED-STATES; GAUSSIAN-BASIS SETS; HARTREE-FOCK; EXTENDED SYSTEMS; LINEAR-COMBINATION; FUNCTIONAL THEORY; WANNIER FUNCTIONS; COUPLED-CLUSTER; GREENS-FUNCTION; COULOMB PROBLEM; (1)
ELECTRONIC EXCITED-STATES; PLESSET PERTURBATION-THEORY; COMPOSITE ENERGY-BANDS; WANNIER FUNCTIONS; HARTREE-FOCK; EXTENDED SYSTEMS; COUPLED-CLUSTER; GREENS-FUNCTION; LINEAR-COMBINATION; FUNCTIONAL THEORY; (1)
ELECTRONIC EXCITED-STATES; POLARIZATION PROPAGATOR; PERTURBATION-THEORY; LARGE MOLECULES; CONFIGURATION-INTERACTION; TRANSITION-PROBABILITIES; EXCITATION-ENERGY; EQUATION; MODEL; CC2; (1)
Electronic Government , Elektronische Unterschrift , Qualifizierte elektronische Unterschrift , Öffentliche Verwaltung , E-Government (2)
Electronic healthcare record; Security; Privilege management; Role management; Authorisation; Access control; Enhanced TTP services (1)
Electronic Health Record (EHR); Privilege management; Access control; Policy management; Healthcare Privacy and Security Classification System (HCS) (1)
Electronic health record; meta-languages; components; model-driven architecture (1)
ELECTRONIC HELPING-BEHAVIOR; GROUP-SIZE; INCREASED RESPONSIBILITY; SITUATION; COMPETENCE; EVOLUTION; DIFFUSION; ALTRUISM; NUMBER; NORMS; bystander effect; bystander intervention; dangerous emergencies; helping; meta-analysis (1)
electronic library; Forschungszentrum Jülich; Spezialbibliotheken; Wissenschaftliche Bibliotheken; Bundesrepublik Deutschland (1)
Electronic literature, electronic literatureS, postcomparative media, accessibleism, ableism, India (1)
ELECTRONIC NETWORKS; SEEKING; MEDIA; CLASSIFICATION; REPOSITORIES; COMMUNITIES; RELIABILITY; EVOLUTION; FRAMEWORK; BEHAVIOR; Enterprise Social Networks; User roles; Knowledge contribution; Knowledge sharing; Knowledge seeking (1)
Electronic patient records; Healthcare systems; Middleware concepts (1)
Electronic Patient Record, Standards, Communication (1)
ELECTRONIC POPULATION ANALYSIS; MOLECULAR WAVE FUNCTIONS; BOND-VALENCE PARAMETERS; SHARING BO4 TETRAHEDRA; CRYSTAL-STRUCTURE; ABSOLUTE-STRUCTURE; THERMAL-EXPANSION; BETA-MB4O7 M; AB-INITIO; REFINEMENT; (1)
Electronic properties and devices, Nanomaterials (1)
Electronic properties and materials (1)
ELECTRONIC-PROPERTIES; BAND-STRUCTURE; BERRYS PHASE; CHIRALITY; GRAPHITE; (1)
ELECTRONIC-PROPERTIES; BAND-STRUCTURE; HALL; PLASMONS (1)
ELECTRONIC-PROPERTIES; ELASTIC PROPERTIES; MONOLAYER MOS2; PHOTOLUMINESCENCE; ENERGY; single-layer molybdenum disulfide; atomically thin crystal; strain engineering; bandstructure; biaxial strain (1)
ELECTRONIC-PROPERTIES; INTERFACE; CRYSTAL; graphene; heterostructures; proximity spin-orbit coupling; spintronics; topological insulators (1)
ELECTRONIC-PROPERTIES; OPTICAL-PROPERTIES; DARK EXCITONS; SEMICONDUCTOR; WSE2; SPIN; OPTOELECTRONICS; GENERATION; BIEXCITONS; ABSORPTION; (1)
ELECTRONIC-PROPERTIES; QUANTUM-WELLS; FREE CARRIERS; BERRYS PHASE; PHOTON DRAG; SEMICONDUCTORS; GRAPHITE; PRESSURE; LIGHT; FIELD; (2)
ELECTRONIC-PROPERTIES; REVERSAL; GRAPHENE; WAVES; DIFFRACTION; HOLOGRAPHY; SYSTEMS; SPACE; (1)
ELECTRONIC-PROPERTIES; TRIONS; excitons; free-carrier screening; transition-metal dichalcogenides; two-dimensional semiconductors (1)
Electronics and devices, Instrumentation and measurement (1)
Electronics and devices; Optics, quantum optics and lasers (1)
ELECTRONICS; DEFECTS; (1)
ELECTRONIC SPECTRA; AMBIENT CONDITIONS; OPTICAL-PROPERTIES; EXCITED-STATES; COMPLEXES; PHOSPHORESCENCE; XANTHONE; PHOTOLUMINESCENCE; SOLVENT; FLUORESCENCE; electronic spectra; phosphorescence; tellurium (1)
electronic spectra; charge transfer; photochemistry; iron complexes; sulfur compounds (1)
Electronic spectra; Photochemistry; Ruthenium complexes; Osmium complexes (1)
; electronic spectroscopy; molecules; molecular complexes; microsolvation; helium droplets; zero phonon line; phonon wing (1)
Electronics, photonics and device physics; Nanotechnology (1)
ELECTRONICS; RIBBONS; (1)
Electronic state; Translational energy (UV-photodissocn. of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy of NO fragment); Photolysis (dynamics, rotational and vibrational states of NO fragment in photolysis of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy); Rotational energy; Singlet state excitation; Vibrational energy (rotational and vibrational states of NO fragment in photolysis of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy); photodissocn nitrosobenzene fluorescence excitation spectroscopy nitrogen oxide photofragment; photolysis dynamics nitrosobenzene photofragment isotropic velocity distribution (1)
ELECTRONICS; TRANSPORT; REGIME; PHASE; FIELD; SPIN; (1)
ELECTRONIC-STRUCTURE; ANTIPEROVSKITES; NICKEL; MAGNETORESISTANCE; TIN; Half-metallic Ferromagnet; Shandite; Half Anti Perovskite (HAP); DFT (1)
ELECTRONIC-STRUCTURE CALCULATIONS; FUNCTIONAL THEORY; BASIS-SETS; TRANSPORT; GRAPHENE; (1)
ELECTRONIC-STRUCTURE; CARBON NANOTUBES; WIRES; SPECTROSCOPY; TRANSPORT; DEVICES; TIPS; (1)
ELECTRONIC-STRUCTURE; CHARGE-TRANSFER; COMPLEXES; 2,1,3-BENZOSELENADIAZOLE; 2,1,3-BENZOTHIADIAZOLE; LUMINESCENCE; electronic spectra; MLCT; rhenium; selenium; sulfur; 1,2-diimine (1)
ELECTRONIC-STRUCTURE; COMPLEXES; 9,10-DIHYDROFULVALENE; PHOTOREACTIVITY; CYCLOBUTADIENE; SPECTROSCOPY; RUTHENOCENE; DERIVATIVES; REACTIVITY; EXCITATION; Photochemistry; Photoluminescence; Reductive elimination; Osmocene; Osmium complexes; Cyclopentadienyl complexes (1)
ELECTRONIC-STRUCTURE; COULOMB; SPECTROSCOPY; DOTS; BLOCKADE; LIQUID; (1)
ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; HALF ANTIPEROVSKITES; PARKERITE; NI3BI2S2; MGB2; Parkerite; Superconductivity; DFT; Band structure; Chemical bonding (1)
ELECTRONIC-STRUCTURE; DYNAMICS; (1)
ELECTRONIC-STRUCTURE; ENERGY; (1)
ELECTRONIC-STRUCTURE; EXCHANGE; SPECTRA; OXIDES; (1)
ELECTRONIC-STRUCTURE; NANOWIRES; STABILITY; (1)
Electronic structure (of nitrosobenzene); Ultraviolet and visible spectra (of nitrosobenzene isolated in solid argon); Ultraviolet and visible spectra (near-UV, of nitrosobenzene isolated in solid argon); Bleaching (photochem., of nitrosobenzene); Energy level transition (radiative, lifetimes, of nitrosobenzene); nitrosobenzene solid argon UV electronic structure (1)
ELECTRONIC-STRUCTURE; PHOTOEMISSION; FREQUENCY; FIELD; (1)
ELECTRONIC-STRUCTURE; QUANTUM DIFFUSION; SYSTEMS; TRANSPORT; CONDUCTANCE; CRYSTALS; TUBULES; (1)
ELECTRONIC-STRUCTURE; SEMICONDUCTORS; FERROMAGNETISM; EXCHANGE; MN; (1)
ELECTRONIC-STRUCTURE; SIMULATIONS; LIFETIME; STATES; (1)
ELECTRONIC-STRUCTURE; SINGLE-LAYER; INTERLAYER; (1)
ELECTRONIC-STRUCTURE; SPIN; carbon nanotubes; magnetoconductance; Aharonov-Bohm effect; spin-orbit interaction (1)
ELECTRONIC-STRUCTURE; SPIN; PHTHALOCYANINE; SURFACE; ADSORPTION; CHALLENGES; COMPLEXES; SUBSTRATE; EXCHANGE; INSIGHTS; (1)
ELECTRONIC-STRUCTURE; SULFUR PROTEINS; PHOTOCHEMISTRY; CLUSTERS; SPECTRA; Iron complexes; Disulfide complexes; Photoredox reactions; MLCT; LMCT (1)
ELECTRONIC-STRUCTURE; WANNIER FUNCTIONS; APPROXIMATIONS; ENERGY; (1)
Electronic transition; Laser induced fluorescence; Phonon; Superfluids (inhomogeneous broadening of zero phonon line of phthalocyanine in superfluid helium droplets); zero phonon phthalocyanine superfluid helium droplet inhomogeneous broadening (1)
ELECTRONIC TRANSPORT; DIRAC; REFLECTION; JUNCTION; PARADOX; MODEL; GAS; (1)
Electronic transport; Mesoscopic systems; Proximity effect (1)
electronic transport; molecular electronics; reduced density matrix; scanning tunneling microscopy (1)
ELECTRON-INDUCED DESORPTION; QUANTUM DYNAMICS; PHOTODESORPTION; NO; EQUATIONS; PT(111); OPTICS; METALS; MODEL; (1)
Electron interference; Quantum point contact; Quantum Hall effect (1)
ELECTRON INTERFEROMETERS; QUANTUM; (1)
ELECTRON LOCALIZATION FUNCTION; CHEMICAL-BOND; AMMONIA 1/2; X-RAY; PHOSPHORUS; CHEMISTRY; TRIPHOSPHIDE; ANIONS; SPECTROSCOPY; AROMATICITY; (1)
ELECTRON LOCALIZATION FUNCTION; CORRELATED MOLECULAR CALCULATIONS; STABLE HOMOPOLYATOMIC ANIONS; SOLID-STATE STRUCTURE; GAUSSIAN-BASIS SETS; CRYSTAL-STRUCTURES; CHEMICAL-BOND; TOPOLOGICAL ANALYSIS; STRUCTURAL-CHARACTERIZATION; ZINTL COMPOUNDS; cage compounds; main group elements; phosphorus; structure elucidation; tin (1)
ELECTRON LOCALIZATION FUNCTION; CRYSTAL-STRUCTURES; HOMOPOLYATOMIC ANIONS; TOPOLOGICAL ANALYSIS; SILICON CLUSTERS; ZINTL ANIONS; SOLID-STATE; IONS; ANNOUNCEMENT; AMMONIATE; Zintl anions; Silicon; Cluster compounds; Ab initio calculations; ELF (Electron Localisation Function) (1)
ELECTRON LOCALIZATION FUNCTION; MAIN-GROUP ELEMENTS; CRYSTAL-STRUCTURES; COORDINATION CHEMISTRY; SOLID-STATE; NONCOVALENT INTERACTIONS; THERMAL-DECOMPOSITION; TOPOLOGICAL ANALYSIS; ALKOXIDE CAGES; PNICOGEN BOND; antimony(III) complexes; DFT computations; electronic structure; pnictogen bonds; structural analysis (1)
ELECTRON LOCALIZATION FUNCTION; STRUCTURAL CHEMISTRY; CHEMICAL-BOND; POLYPHOSPHIDES; PHOSPHORUS; PHOSPHIDES; COMPLEXES; RB4P6; P(N); (1)
ELECTRON LOCALIZATION; OPTICAL-PROPERTIES; POLARONS; STATE; MICROSCOPY; BIPOLARONS; OLIGOMERS; DYNAMICS; SOLITONS; (1)
ELECTRON LOCALIZATION; PHOSPHORUS; CHEMISTRY; TRANSFORMATION; ELEMENTS; BR; CP; bromine; chlorine; halogenation; hexaphosphabenzene; iodine; phosphorus (1)
ELECTRON-MAGNON INTERACTIONS; ITINERANT FERROMAGNETISM; ROOM-TEMPERATURE; ORBIT TORQUE; (1)
ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY; SYNAPTIC-LIKE MICROVESICLES; AMINO-ACIDS; GLUTAMATERGIC SYNAPSES; GLUTAMINE-SYNTHETASE; NMDA RECEPTORS; ANION CHANNEL; ASTROCYTES; TERMINALS; ASPARTATE; astrocyte; Bergman glia; electron microscopy; rodent; immunohistochemistry (1)
ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; IGNICOCCUS-HOSPITALIS; SALMONELLA FLAGELLA; HELICAL FILAMENTS; PROTEIN; MODEL; PILUS; RECONSTRUCTION; VISUALIZATION; archaea; flagellar filaments; helical polymers; cryo-EM (1)
ELECTRON-MICROSCOPY; IGNICOCCUS-HOSPITALIS; COLLOIDAL GOLD; PHAEODACTYLUM-TRICORNUTUM; ULTRASTRUCTURAL ANALYSIS; TANNIC-ACID; PROTEIN; MEMBRANE; LIGHT; PRESERVATION; (serial) immunogold labeling; Archaea; Diatoms; Epon 812-osmium tetroxide (1)
ELECTRON-MICROSCOPY; INDIFFERENT GONAD; MESONEPHROS; RECEPTOR; EMBRYOS; SYSTEM; MOUSE; ULTRASTRUCTURE; HISTOGENESIS; OVARY; gonadal origin; nephrostomial tubules; pronephros; mesonephros; bovine; Gymnophiona (1)
ELECTRON-MICROSCOPY; PROTEIN SEQUENCES; SHAPED VIRUS; COILED COILS; SULFOLOBUS; HOST; THERMOPROTEUS; ENVIRONMENTS; ARCHITECTURE; PARTICLES; virus; archaea; hyperthermophile; genome (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ALGA CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; TRIPLET-STATE; ARABIDOPSIS NPH1; FLASH-PHOTOLYSIS; PHOTORECEPTOR PHOTOTROPIN; CHLOROPLAST RELOCATION; ADIANTUM PHYTOCHROME3; STRUCTURAL-CHANGES; (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ENVELOPE MODULATION SPECTROSCOPY; GTP-BINDING PROTEINS; P21 RAS; TRIPHOSPHATE CONFORMATION; SIGNAL-TRANSDUCTION; MOLECULAR SWITCH; HYDROLYSIS; GDP; P21(RAS); EPR; ENDOR; P-31 NMR; Ras; conformational states (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ENVELOPE MODULATION SPECTROSCOPY; NUCLEAR DOUBLE-RESONANCE; GTP-HYDROLYSIS; P21 RAS; 3-DIMENSIONAL STRUCTURES; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; MOLECULAR SWITCH; NMR-SPECTROSCOPY; (1)
ELECTRON-PARAMAGNETIC-RESONANCE; P21 PROTEINS; MOLECULAR SWITCH; BINDING; SPECTRA; FORMS; SITE; MN2+; ION; (1)
ELECTRON POPULATION ANALYSIS; PSEUDOATOM DATA-BANK; CHARGE-DENSITY; SMALL-MOLECULE; CRYSTAL-STRUCTURES; INVARIOM DATABASE; FACTOR FORMALISM; BOND LENGTHS; SCATTERING; DIFFRACTION; quantum crystallography; aspherical atom refinement; transferable aspherical atom model; TAAM; MATTS; Hirshfeld atom refinement; HAR; NoSpherA2; disorder; structure refinement (1)
ELECTRON; RECONSTRUCTION; ALIGNMENT; Electron tomography; STEM tomography; Dual-axis tomography (1)
ELECTRONS; (1)
ELECTRON-SCATTERING; PROTON; DIFFERENCE; (1)
ELECTRONS; CdHgTe films; cyclotron resonances; magnetospectroscopy; surface states; terahertz; topological Volkov-Pankratov states (1)
ELECTRONS; NOISE; (1)
ELECTRON-SPIN; (2)
ELECTRON-SPIN; CONDUCTION ELECTRONS; RELAXATION; FILMS; STATE; PARAMAGNETISM; SPINTRONICS; (1)
ELECTRON-SPIN; READ-OUT; QUANTUM (1)
ELECTRON-SPIN-RESONANCE; MAGNETIC TUNNEL-JUNCTIONS; III-V SEMICONDUCTORS; SI/SIGE QUANTUM-WELLS; ROOM-TEMPERATURE FERROMAGNETISM; DOUBLE-BARRIER HETEROSTRUCTURES; ZINCBLENDE-TYPE SEMICONDUCTORS; PHOSPHORUS-DOPED SILICON; SELF-CONSISTENT ANALYSIS; FIELD-EFFECT TRANSISTOR; spintronics; magnetic semiconductors; spin injection; spin relaxation; spin transistor; spin-orbit coupling (1)
ELECTRON-SPIN-RESONANCE; SYNTHETIC CLAY-MINERALS; RAY-POWDER PATTERNS; CRYSTAL-STRUCTURE; MOSSBAUER-SPECTROSCOPY; PHYSICAL-PROPERTIES; LAYERED SILICATE; HIGH-TEMPERATURE; ECHO MODULATION; GLASS-CERAMICS; pillared clays; intercalation; hectorite structure (1)
ELECTRON SPINS; LOCKING; SEMICONDUCTOR; (1)
ELECTRON-SPIN; SPECTROSCOPY; BLOCKADE; SPECTRUM; COULOMB; (1)
ELECTRON-SPIN; WIRES; (1)
ELECTRONS; QUANTUM; STATES; (1)
ELECTRONS; REFLECTION; JUNCTION; (1)
ELECTRONS; SPIN; (1)
ELECTRON STORAGE-RING; (LAMBDA)OVER-BAR POLARIZATION; HERA; POLARIMETER; DECAYS; (1)
ELECTRON STORAGE-RING; OPPOSITE-SIGN DIMUONS; ORDER QCD ANALYSIS; LEADING-ORDER; NEUTRINO; HERA; BREAKING; EVENTS; PROTON; (1)
ELECTRON-SYSTEM; (1)
ELECTRON-SYSTEMS; WELLS; (1)
ELECTRON-TRANSFER; ARYL HALIDES; REDUCTION; TETRAKIS(DIMETHYLAMINO)ETHYLENE; TRANSITION; ROUTE; LIGHT; (1)
ELECTRON-TRANSFER; BUILDING-BLOCKS; THIAZOLE ORANGE; BIPHENYL-DNA; DERIVATIVES; DYES; FLUORESCENCE; DIIMIDE; WATER; ACID; Chromophores; DNA; Fluorescence; Oligonucleotides; Nitrogen heterocycles (1)
ELECTRON-TRANSFER; CHARGE-TRANSFER; REDUCTION; DYNAMICS (1)
ELECTRON-TRANSFER; CHARGE-TRANSPORT; PHENANTHRIDINIUM; NUCLEOSIDES; FLUORIDE; ANALOGS; dNA; indole; oligonucleotide; base analogue (1)
ELECTRON-TRANSFER DEOXYGENATION; SECONDARY ALCOHOLS; C-O bond activation; deoxygenation; photochemistry; photoredox catalysis; visible light (1)
ELECTRON-TRANSFER; DEPENDENT CONDUCTANCE; JUNCTION CONDUCTANCE; TRANSMISSION; RESISTANCE; COLOR; DYES; Polymethine; cyanine; single-molecule; conductance decay; molecular wires (1)
ELECTRON-TRANSFER DISSOCIATION; SUPPORT VECTOR MACHINES; RESOLUTION PROTEOME/PEPTIDOME ANALYSIS; TAMM-HORSFALL PROTEIN; MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; BIOMARKER DISCOVERY; PROTEOMIC ANALYSIS; 2-DIMENSIONAL ELECTROPHORESIS; SEQUENCE-ANALYSIS; (1)
ELECTRON-TRANSFER; DNA PHOTOLYASE; CRYSTAL-STRUCTURE; QM/MM METHODS; FAD COFACTOR; DIMER REPAIR; FORCE-FIELD; AB-INITIO; THYMINE; OXETANE; (1)
ELECTRON-TRANSFER; EXCITED-STATE; SINGLE; SOLUBILITY; OXYGEN; MICROSCOPY; MOLECULES; BLINKING; DYNAMICS; PROBES; (1)
ELECTRON-TRANSFER; HEME ENZYMES; COMPLEXES; OXIDATION; MECHANISM; MODELS; BOND; porphyrins; radical cations; oxidations; photochemistry; enzyme models (1)
ELECTRON-TRANSFER; ketone; scandium complexes; acetylacetonate ligands (1)
ELECTRON-TRANSFER MECHANISM; AROMATIC-SUBSTITUTION; CARBOXYLIC-ACIDS; DERIVATIVES; FUNCTIONALIZATION; ACTIVATION; COMPLEXES; CHEMISTRY; ALKENES; (1)
ELECTRON-TRANSFER; METAL-FREE; RADICALS; BOND; HETEROARENES; GENERATION; ARYLATION; PHENOLS; (1)
ELECTRON-TRANSFER; NUCLEIC-ACIDS; STRAND SCISSION; DNA; COMPLEXES; DAMAGE; POTENTIALS; CHEMISTRY; MECHANISM; REDUCTION; porphyrins; gold; pyrene; photocatalysis; DNA; photonuclease activity (1)
ELECTRON-TRANSFER; OLIGONUCLEOTIDE PROBES; MOLECULAR BEACON; DNA; NUCLEOSIDES; HYBRIDIZATION; PHOTOPHYSICS; DISTINCTION; CYTOSINE; ANALOGS; electron transfer; fluorescence; molecular beacons; oligonucleotides; peptide nucleic acids (1)
ELECTRON-TRANSFER OXIDATION; ALKYL RADICALS; COPPER(2) COMPLEXES; ORGANIC-SYNTHESIS; FACILE SYNTHESIS; ALKENES; TRIFLUOROMETHYLATION; MECHANISM; HALIDES; LIGANDS; photoredox catalysis; copper; ATRA; iodoperfluoroalkylation; visible light (1)
electron transfer · photocatalysis · photoredox processes · reaction mechanisms · ultrafast spectroscopy (1)
electron transfer · photocatalysis · pyrene ·reaction mechanism (1)
ELECTRON-TRANSFER; PHOTOCHEMISTRY; COMPLEX; charge transfer; sulfidic anions; UV spectra (1)
ELECTRON-TRANSFER PHOTOOXYGENATION; VERSATILE BUILDING-BLOCKS; SINGLET-OXYGEN; PHOTOREDOX CATALYSIS; ORGANIC-DYES; HIGHLY EFFICIENT; EXCITED-STATE; LIGHT; PHOTOOXIDATION; DICYANOANTHRACENE; organophotocatalysis; mechanistic switchover; Marcus theory; anti-Kasha photochemistry; non-covalent assemblies (1)
ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; P-BENZOQUINONE; BENZENE; HYDROXYLATION; OXIDATION; ARENES; 2,3-DICHLORO-5,6-DICYANO-P-BENZOQUINONE; REACTIVITY; COMPLEXES; Cross coupling; DDQ; Dehydrogenative coupling; Photooxidation; Quinones (1)
ELECTRON-TRANSFER PROCESSES; CDSE NANOPARTICLES; PHOTOCATALYTIC DEGRADATION; CORE/SHELL NANOCRYSTALS; PHOTOVOLTAIC DEVICES; CADMIUM-SULFIDE; RECENT PROGRESS; WATER; CARBON; BOND; (1)
ELECTRON-TRANSFER PROCESSES; DONOR-ACCEPTOR SYSTEMS; EXCITED-STATE PHOTODYNAMICS; PERYLENE-PORPHYRIN DYADS; MOLECULAR TWEEZERS; ENERGY-TRANSFER; PICOSECOND TIMESCALE; OPTICAL CONTROL; SOLVENT; DYNAMICS; (1)
ELECTRON-TRANSFER; PYRIMIDINE NUCLEOSIDES; FLUORESCENT-PROBE; TRANSFER DYNAMICS; RNA; DUPLEX; OLIGONUCLEOTIDES; AGGREGATION; INJECTION; STACKING; DNA; fluorescent probes; nucleobases; oligonucleoticles; pyrene (1)
ELECTRON-TRANSFER REACTIONS; DENSITY-FUNCTIONAL THEORY; MOLECULAR MECHANICAL METHODS; CYTOCHROME-C-OXIDASE; AB-INITIO; HOLE TRANSFER; STRUCTURAL FLUCTUATIONS; BIOLOGICAL MOLECULES; MATRIX-ELEMENTS; QM/MM METHODS; (1)
ELECTRON-TRANSFER REACTIONS; FLAVIN-SENSITIZED PHOTOOXIDATION; SINGLET-OXYGEN; PHOTOSENSITIZED OXIDATION; ASYMMETRIC-SYNTHESIS; CHIRAL SULFOXIDES; ORGANIC SULFIDES; MOLECULAR-OXYGEN; BENZYL ALCOHOLS; DIETHYL SULFIDE; flavins; photooxidation; singlet oxygen; sulfides; sulfoxidation (1)
ELECTRON-TRANSFER REACTIONS; GLYCOL-WATER MIXTURES; NON-DEBYE SOLVENTS; ETHYLENE-GLYCOL; DIELECTRIC-RELAXATION; DIFFERENT TEMPERATURES; TRANSPORT-PROPERTIES; AQUEOUS-SOLUTIONS; MERCURY; ELECTROREDUCTION; (1)
ELECTRON-TRANSFER REACTIONS; POLARON BINDING-ENERGY; AUGMENTED-WAVE METHOD; PHOTOELECTRON-SPECTROSCOPY; SOLVENT REORGANIZATION; TRANSPORT; JUNCTIONS; DEVICES; STATE; FILM; (1)
ELECTRON-TRANSFER SENSORS; AMMONIUM CATION-BINDING; PIVOT LARIAT ETHERS; TERMINAL ALKYNES; FLUORESCENT; POTASSIUM; SODIUM; INDICATOR; SWITCHES; CALCIUM; crown compounds; fluorescence; gels; potassium; sensors (1)
ELECTRON TRANSFER SPECTRA; LANTHANIDE COMPLEXES; EU3+; EU2+; PHOTOREDUCTION; REDUCTION; YIELD; electronic spectra; photochemistry; europium; azide complexes (1)
ELECTRON-TRANSFER; STATE; RESOLUTION; ADSORPTION; SURFACE; SENSOR; SWITCH; CU; (1)
ELECTRON-TRANSFER; TAUTOMERIZATION; DISSOCIATION; DYNAMICS; MOTION; CO; MANIPULATION; MICROSCOPY; DESORPTION; OXIDATION; (1)
ELECTRON TRANSPORT; (1)
ELECTRON-TRANSPORT; ABSORPTION-SPECTRA; ATOMIC-RESOLUTION; CHARGE-STATE; SINGLE; PENTACENE; SURFACE; MICROSCOPE; SCATTERING; ANISOTROPY; Insulating film; Molecular electronics; Scanning tunneling microscopy; Single molecule (1)
ELECTRON-TRANSPORT; CHARGE-TRANSPORT; TRANSMISSION; RESISTANCE; JUNCTIONS; CIRCUITS; POLYMERS; SOLITONS (1)
ELECTRON-TRANSPORT; CONDUCTANCE; RESISTANCE; ROTATION; single-molecule junctions; destructive quantum interference; d-pi hybridization; ferrocene (1)
ELECTRON-TRANSPORT; HALOBACTERIUM-SALINARIUM; NANOARCHAEUM-EQUITANS; ANAEROBIC RESPIRATION; POLYACRYLAMIDE-GELS; COLLOIDAL SULFUR; SYSTEM-I; MEMBRANE; PROTEINS; BACTERIA; (1)
ELECTRON-TRANSPORT; SPIN; INTERFERENCE; TRANSITIONS; (1)
ELECTRON-TRANSPORT; SUPER-LATTICES; OSCILLATIONS; FREQUENCY; EMISSION; (1)
ELECTRON-TRANSPORT; WIGNER CRYSTAL; (1)
Electron-vibron coupling, gate asymmetry, negative differential conductance, slow channel, Franck-Condon factor, bistability, quantum switching, memory effects, lifetime of state, parameters space, Plasmon-vibron excitations, polaron excitations (1)
ELECTRON WAVE-GUIDES; TRANSPORT; EDGE; CONDUCTION; RESONANCES; ZIGZAG; BEND; (1)
Electrooptical effect; Electrooptical effect (dichroism, elec. linear dichroism with a simple interpretation in terms of mol. pendular states); Energy level (elec. linear dichroism with a simple interpretation in terms of mol. pendular states); Dichroism; Dichroism (elec., elec. linear dichroism with a simple interpretation in terms of mol. pendular states); iodine chloride elec linear dichroism; mol pendular state iodine chloride dichroism (1)
Electro-optic devices; Bragg reflector; Optical waveguides (1)
electrophiles, enones, reactivity, phosphoantigen, protein tagging, covalent protein labeling (1)
ELECTROPHORESIS; ALKALOIDS; TROPANE; Detection performance; Electrochemical detection; NACE; UV detection (1)
electrophotocatalysis, hydrogen atom transfer, photoelectrochemistry, photoredox catalysis, preassembly (1)
electrophotochemistry; C(sp3)−H bond activation; sustainability; enantioselective; late-stage functionalization (1)
ELECTROPHYSIOLOGICAL CHARACTERIZATION; VISUAL-SYSTEM; COMPOUND EYES; CRYPTOCHROME; BRAIN; MELANOGASTER; PERIOD; PHOTORECEPTORS; LOCOMOTOR; BEHAVIOR; Hofbauer-Buchner eyelet; photosensitivity; Drosophilia melanogaster; CRY; circadian synchronization (1)
Electrophysiology, Optical electrophysiology, Electric field dependent molecular effects, Voltage sensitive dyes and nanoparticles, Genetically encoded voltage indicators (GEVIs), Voltage-gated ion channels and phosphatases, Microbial rhodopsin-based voltage indicators (1)
electroreception, Eigenmannia sp.; beat analysis; jamming avoidance response; stimulus-intensity threshold; electric organ discharge (1)
ELECTRORESISTANCE; POLARIZATION; FIELD; EMISSION; PHYSICS; (1)
electrosensory; electroreception; signal waveform; phase difference; amplitude spectrum; sexual dimorphism; Eigenmannia (1)
electrosensory thresholds, electrosensory tuning, weakly electric fish, Knollenorgan, fish larvae, ontogeny, Mormyridae, Pollimyrus isidori (1)
ELECTROSPRAY-IONIZATION; Electrochemistry; mass spectrometry; electrochemical flow cells; disposable electrodes; fast detection; mechanistic studies (1)
ELECTROSTATIC CATALYSIS; CHEMICAL-REACTION; TAUTOMERIZATION; DISSOCIATION; MOTION; (1)
electrostatic doping, exciton, intervalley trions, MoSe2, trion, twisted-homobilayers, vdW heterostructures, hybrid states (1)
ELECTROSTATIC FORCE MICROSCOPY; (1)
ELECTROSTATIC FORCE MICROSCOPY; FIELD-EFFECT TRANSISTORS; KETO DEFECT SITES; PHOTOVOLTAIC DEVICES; MOLECULAR-DYNAMICS; PERFORMANCE; MORPHOLOGY; TRANSPORT; FILM; HETEROJUNCTIONS; Development and application of multiscale simulation algorithm for the study of photovoltaic behavior of donor-acceptor-type polymer solar cells; Photocurrent contribution from intersegmental mixing at donor-acceptor interface; Lamellar-like PFB-F8BT blend with F8BT phase in reduced and photo-oxidized form (1)
ELECTROSTATIC FORCE MICROSCOPY; POWER CONVERSION EFFICIENCY; INTERNAL QUANTUM EFFICIENCY; LIGHT-EMITTING DEVICES; KETO DEFECT SITES; MOLECULAR-DYNAMICS; EFFECT TRANSISTORS; PERFORMANCE; MORPHOLOGY; BLEND; Parametrized field-based multiscale solar-cell algorithm; Inter-mixing of polymer blend components; Exciton dissociation process; Charge transport process; Photooxidation; Polyfluorene-based bulk heterojunction (1)
ELECTROSTATIC FORCE; SURFACE; RESOLUTION; GOLD; (1)
ELECTROWEAK SYMMETRY-BREAKING; QUARK-LEPTON GENERATIONS; ULTRA HEAVY FERMIONS; TO-LEADING ORDER; CP-VIOLATION; QCD CORRECTIONS; 4TH GENERATION; CKM MATRIX; B-DECAYS; PRECISION-MEASUREMENTS; (1)
elektive koronare Bypassoperation, schlafbezogene Atmungsstörungen, postoperative Lebensqualität, hypoxische Last, hypoxie-bedingte koronare Kollateralisierung, elective coronary artery bypass grafting, sleep-disordered breathing, postoperative quality of life, hypoxic burden, hypoxia-induced coronary collateralization (1)
Elektrochemie, Lithium-Ionen-Batterien, Elektrochemische Rastermikroskopie (1)
Elektrochemie; Lösungen; Transporterscheinungen (1)
Elektrochemie; Massenspektrometrie; Kapillarelektrophorese; Kopplung; (1)
Elektrochemilumineszenz;Liposome;Luminol (1)
elektrochemisch assitierte Injektion, Kapillarelektrophorese, Massenspektrometrie, Ferrocen, Guanosin, Rutin, Quercetin, oxidativer Stress (1)
Elektrochemische Doppelschicht , Elektrolytische Leitfähigkeit , Cyclovoltammetrie , Impedanzspektroskopie , Kondensator , nichtwässrige Elektrolyte , Doppelschichtkondensator , nonaqueous electrolyte , double layer capacitor (1)
Elektrochemische Doppelschicht , Organischer Elektrolyt , Cyclovoltammetrie , ImpedanzspektroskoKondensatorpie , Imidazoliumsalze , Tetraalkylammoniumsalz , , Doppelschichtkondensator , electrochemical double-layer , organic electrolyte , cyclovoltammetry , impedance spectroscopy , imidazolium salts , tetraalkylammonium salts (1)
Elektrochemische Rastermikroskopie, Ultramikroelektrode, Zellen (1)
Elektrochemischer Sensor, Analytik, Glukose, Wasserstoffperoxid (1)
Elektrodiagnose, Elektroenzephalographie, Hypnotika und Sedativa, Propofol, Intensivmedizin, mechanische Beatmung, electrodiagnosis, electroencephalography, hypnotics and sedatives, propofol, critical care, artificial respiration (1)
Elektroencephalographie , Inhibition , Kognition , Gedächtnis , Wiedererkennen , Recognition memory , EEG , Retrieval-induced forgetting (1)
Elektroläsion, Indomethazin, Mikroglia, Minocyclin, neurale Stammzellen, NMDA, subventrikuläre Zone, Transplantation electrolysis, indomethacin, microglia, minocycline, neural stem cells, NMDA, subventricular zone, transplantation (1)
Elektrolytlösung , Organischer Elektrolyt , Lithiumbatterie , Lithiumborat , Lithiumaluminate , Lithium , Cyclovoltammetrie , Elektrolytische Leitfähigkeit , Lithiumphosphate , Überführungszahl , Polymergelelektrolyt , Lithium electrolytes , polymer gel electrolytes , transference number , cyclic voltammetry , lithium ion battery (1)
Elektronenmikroskopie; Phasenkontrastmikroskopie, STEM, Transmissionselektronenmikroskopie, DPC, Feldmessung, PSD (1)
Elektronen,Pencil Beam,Monte Carlo, Algorithmus (1)
Elektronentransfer , Nichtlineare Optik , Triarylamine , Cyclovoltammetrie , Spektroelektrochemie , Intervalenzverbindungen , Gemischtvalente Verbindungen , Elektrochemische Polymerisation , Übergang zwischen Robin/Day Klasse II/III , HRS-Messung , mixed valence compounds , nonlinear optics , electrochemical polymerisation , Robin/Day Class II/III transition , electron transfer (1)
Elektronische Bibliotheken; Elektronische Zeitschriften (1)
elektronische Bücher elektronisches Publizieren Multimedia digitale Biblioken Hypermedia Mensch-Maschine-Interaktion Web Services service-oriented architecture (1)
Elektronischen Zeitschriftenbibliothek (EZB) (1)
Elektronische Publikationen, elektronisches Publizieren, Open Access, Repositorium (1)
Elektronische Publikationen; Sicherheit; Open Access (1)
Elektronischer Transport , Green-Funktion , Nichtgleichgewicht , Transportprozess , Mesoskopisches System , 0.7-Anomalie , Spinratsche , electronic transport , Green function , nonequilibrium , 0.7 anomlay , spin ratchet (1)
Elektronischer Transport , Kohlenstoff-Nanoröhre , Kohlenstoff , Graphit , Starke Kopplung , Elektronenstruktur , Magnetfeld , Elektrischer Kontakt , , carbon , electronic structure , quantum transport , computational physics (1)
Elektronisches Papier, Elektronische Tinte, E Ink, Gyricon Media, Displays, Mobile Endgeräte, Elektronische Zeitung (1)
Elektronische Zeitschrift , Elektronische Bibliothek , Vascoda , OpenURL , Zugriffsrecht, Rechteverwaltung , (1)
Elektronische Zeitschriftenbibliothek Datenbank-Infosystem UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Datenbank-Infosystem, UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Datenbank-Infosystem, UR Library Services, EZB, DBIS (2)
Elektronische Zeitschriftenbibliothek EZB , Datenbank-Infosystem DBIS, UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Mir@bel, openCost, Journals Online & Print (JOP), AG Systemlandschaft E-Ressourcen, UR Library Services (1)
Elektronische Zeitschriftenbibliothek; Mir@bel; UR Library Services (1)
Elektronische Zeitschriftenbibliothek, OpenCost (1)
Elektronische Zeitschriftenbibliothek ; UR Library Services (1)
; Elektronische Zeltschriftenbibliothek; electronic journals; access; usage statistics; library cooperation (1)
elektronisch; Informationsressourcen (1)
elektronisch; Wissenschaftskommunikation (1)
Elektron-Proton-Streuung , Formfaktor , Spin , Proton , Vakuumzustand , Anomalie <Quantenfeldtheorie> , Instanton , Protonspin , Spinverteilung , DLCQ , axiale Anomalie , Polarisation , Proton , Spin , Structure Functions , DLCQ , Zero Modes (1)
Elektroorganische Synthese , Organosiloxane , Nitroxylradikal , Elektrokatalyse , Cyclovoltammetrie , Mediator , Ferrocen , Voltammetrie , Diffusionskoeffizient , Graphitfilz , electrosyntheses , carbon felt , modified electrodes , nitroxyl radicals , siloxanes (1)
Elektrophsyiologische Untersuchung, Activated clotting time, Catheter ablation, Heparin, EPU (1)
Elektrophysiologie, MUNIX, CMAP, Motorische Einheit, Myopathie, ALS/Electrophysiology, motor unit, Myopathy (1)
Elektroporation, Impedanzanalyse, adhärente Zellen / electroporation, impedance analysis, adherent cells (1)
Elektrospray-Ionisation , Mikrochip-Elektrophorese , Lab on a Chip , , ESI mass spectrometry , microchipelectrophoresis , Lab on a Chip (1)
ELEMENTAL COMPOSITIONS; ION-SOURCE; GC-MS; IDENTIFICATION; (1)
ELEMENTAL PHOSPHORUS; WHITE PHOSPHORUS; P-4 ACTIVATION; CHEMISTRY; FUNCTIONALIZATION (1)
ELEMENTARY SCHOOLCHILDREN; FOLLOW-UP; PAIN; COHORT; ADOLESCENCE; Back pain; Prevention; Children; Back education; Controlled (1)
ELEMENTARY-SCHOOL-CHILDREN; RECIPROCAL-EFFECTS MODEL; OF-FIT INDEXES; ACADEMIC-ACHIEVEMENT; MEASUREMENT INVARIANCE; NATIVE LANGUAGE; SEGMENTED ASSIMILATION; MAXIMUM-LIKELIHOOD; IMMIGRANT STUDENTS; MISSING DATA; Language learners; Motivation; engagement; Comprehension; Fluency; Methodological perspectives; Cognitive; Bilingualism; Literacy Acquisition; Motivation; Engagement; Factor Analysis; LISREL; Causal Modeling; 2-Childhood (1)
ELEMENTARY-SCHOOL; MISSING DATA; STUDENTS; STRATEGY; INSTRUCTION; METAANALYSIS; DISABILITIES; ACHIEVEMENT; PROSPECTS; GRADERS; self-regulated learning; strategy instruction; text reduction strategies; reading comprehension; intervention study (1)
ELEMENTARY-SCHOOL; SEX-DIFFERENCES; PERFORMANCE; BELIEFS; INTELLIGENCE; METAANALYSIS; ADOLESCENTS; PERCEPTIONS; SCIENCE; VALUES; mathematics; giftedness; gender differences; academic self-concept; interest; motivation (1)
ELEMENT-BINDING PROTEIN-1C; FATTY-ACIDS; NUCLEAR RECEPTORS; GENE-EXPRESSION; CANCER-CELLS; PPAR-ALPHA; IN-VIVO; APOA-I; CHOLESTEROL; LXR; CLA; Gene expression; LXR; Macrophages; Nuclear receptor (1)
ELEMENT-BINDING PROTEIN; ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; ETHANOL-CONSUMPTION; KINASE-A; ENVIRONMENTAL-INFLUENCES; INITIAL SENSITIVITY; TRAIT MARKER; CAMP; ANXIETY; ADCY7; adenylyl cyclase; alcohol dependence; gender; genetics; sex (1)
; element modifications; phosphorus; structure elucidation (1)
ELEMENTS; NANODISKS; FIELD; magnetic properties of nanostructures; numerical simulation studies; magnetoelectronics (1)
ELEMENTS; PROTEIN; Borna disease virus 1 (BoDV-1); epidemiology; encephalitis; diagnostics; ELISA; indirect immunofluorescence assay (iIFA); solid organ transplantation; linear epitope mapping; molecular mimicry; endogenous Borna-like elements (1)
ELEMENTS; SUBSYSTEM; AAF; (1)
ELEPHANT-NOSE FISH; ACOUSTIC COMMUNICATION; INDIVIDUAL RECOGNITION; POMACENTRUS-PARTITUS; ISIDORI MORMYRIDAE; AGONISTIC BEHAVIOR; VOCALIZATION; SENSITIVITY; MECHANISMS; HEARING; acoustic communication; reproduction; spectral analysis; electric fish; vocalisation; aggression (1)
ELEVATED ATMOSPHERIC CO2; WATER-USE EFFICIENCY; CLIMATE-CHANGE; SAP FLOW; BIOCHEMICAL LIMITATIONS; SPATIAL INTERPOLATION; MESOPHYLL CONDUCTANCE; AILANTHUS-ALTISSIMA; FRAXINUS-EXCELSIOR; BAYESIAN-ANALYSIS; Black locust; Climate change; Ecophysiological models; Inverse modeling; Mediterranean riparian forests (1)
ELEVATED LIVER-ENZYMES; PLATELET COUNT SYNDROME; HEMOLYSIS; DIAGNOSIS; HELLP-syndrome; Molar pregnancy; Fetal triploidy; Omphalocele; Pregnancy (1)
ELEVATED PLUS-MAZE; MAJOR DEPRESSION; ADJUSTMENT DISORDER; REUPTAKE INHIBITOR; PERSISTENT PAIN; ANIMAL-MODEL; PERCEPTION; STRESS; PAROXETINE; SEROTONIN; thermal pain; animal model; major depressive disorder; anxiety; psychiatry; antidepressant; HAB (1)
ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; FORMALIZED DATA FEEDBACK; CARDIOGENIC-SHOCK; 12-LEAD ELECTROCARDIOGRAM; EARLY REVASCULARIZATION; SYSTEM DELAY; TASK-FORCE; REPERFUSION; ST-segment elevation myocardial infarction (STEMI); Percutaneous coronary intervention (PCI); Cardiogenic shock; Out-of-hospital cardiac arrest; Contact-to-balloon time; Mortality (1)
ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; TO-BALLOON TIME; PERCUTANEOUS CORONARY INTERVENTION; EMERGENCY-DEPARTMENT BYPASS; FORMALIZED DATA FEEDBACK; PRIMARY ANGIOPLASTY; FIELD TRIAGE; MORTALITY; MANAGEMENT; ST-segment elevation myocardial infarction (STEMI); percutaneous coronary intervention (PCI); feedback interventions; quality control measures; treatment times; mortality (1)
ELEVATION MYOCARDIAL-INFARCTION; TO-BALLOON TIME; PRIMARY PCI; DOUBLE-BLIND; INTERVENTION; CLOPIDOGREL; PRASUGREL; TRIAL; ENOXAPARIN; TICAGRELOR; (1)
ELEVATION MYOCARDIAL-INFARCTION; TP-E/QT RATIO; QT INTERVAL; HEART-FAILURE; PROGNOSTIC IMPLICATIONS; RECORDING DEVICE; APNEA; DISEASE; APNEALINK(TM); PREVALENCE; Sleep apnea; TpTe; QT; Cardiac repolarization; Cardiac arrhythmias; Coronary artery bypass graft surgery (1)
Elfenbein, Elefanten, Datierung, 14C, 228Th, 232Th, Artenschutz, elephants, ivory, dating, wildlife conservation (1)
ELISA, Host cell proteins, affinity purification, mass spectrometry, polyclonal antibodies. (1)
ELISpot, Adenovirus, HSV-1, VZV (1)
Elispot / Lyme Borreliose / T-Zell-Diagnostik (1)
ELLENBERG INDICATOR VALUES; CALCAREOUS GRASSLANDS; FIELD-MEASUREMENTS; MINERAL-NUTRITION; SPECIES-RICHNESS; ORGANIC-ACIDS; VEGETATION; TOLERANCE; IRON; COEXISTENCE; Aluminium toxicity; Ellenberg indicator value; Environmental filtering; Root growth rate; Sandy grassland species; Soil pH; soil reaction (1)
ELLENBERG INDICATOR VALUES; NORTHWEST EUROPEAN FLORA; LIFE-HISTORY TRAITS; SPECIES-RICHNESS; ENVIRONMENTAL VARIABLES; VEGETATION STRUCTURE; NITROGEN DEPOSITION; FIELD-MEASUREMENTS; SHORT-TERM; BUD BANK; Semi-natural grasslands; Management treatments; Functional traits; Assembly rules; Vegetation response (1)
ELLENBERG INDICATOR VALUES; SEED MASS; WATER; GROWTH; PLANTS; TRAITS; SIZE; ALLOCATION; EMERGENCE; HABITATS; Biomass allocation; evolutionary adaptation; moisture gradient; regeneration niche; seed nutrient composition; shoot; root ratio (1)
ELLIPTIC BETA-INTEGRALS; MELLIN-BARNES INTEGRALS; YANG-BAXTER EQUATION; WILSON; Baxter operators; separation of variables (2)
Elliptic boundary value problems; pseudodifferential boundary operators; extension theory; M-functions; symbol smoothing; nonsmooth domains; nonsmooth coeffcients (1)
elliptic curves over number fields; Weierstrass class; integral Kahler differentials (1)
ELLIPTIC DIFFERENTIAL-OPERATORS; SYMMETRIC-SPACES; RIEMANNIAN-MANIFOLDS; BOUNDED GEOMETRY; LAPLACIAN; DYNAMICS; (1)
ELLIPTIC EIGENVALUE PROBLEMS; WAVE-GUIDES; HOMOGENIZATION; CURVATURE; spectral analysis; Gamma-convergence; quantum waveguides; dimension reduction; homogenization; 81Q15; 78A50; 35P20; 49J45; 49R05 (primary) (1)
elmustin carbon 14 (1)
ELONGATION-FACTOR TFIIS; STRUCTURAL BASIS; SUBUNIT; FIDELITY; MECHANISM; COMPLEX; ARCHITECTURE; TERMINATION; RESOLUTION; REQUIRES; (1)
El reino, La mano invisible, cinema and economy, Aristotelian poetics (1)
ELUTING STENTS (1)
email re-finding, evaluation, personal search, user study (1)
e-mail, spam, e-mail infrastructure, anti-spam measures, spamming options (1)
e-mail, spam, filtering, blocking, LMAP, SMTP account (1)
Embeddedness; shipbuilding; Croatia; Poland; socialism; varieties of capitalism (1)
EMBOLIC CONSOLIDATIONS; EFSUMB GUIDELINES; CLINICAL-PRACTICE; ULTRASONOGRAPHY; RECOMMENDATIONS; COVID-19 infection; lung- Contrast-enhanced ultrasound (CEUS); pleural affection; peripheral embolic consolidation (1)
EMBOLIZATION; EXPERIENCE; HEMORRHAGE; (1)
EMBOLIZATION; intercostal artery; aneurysm; rupture; endovascular repair; coil embolization; stent-graft (1)
EMBRYO CHORIOALLANTOIC MEMBRANE; ANGIOGENESIS; TISSUES; CAM; Breast cancer primary material; breast cancer; CAM model; 3D-in-vivo-tumor-model (1)
EMBRYONIC STEM-CELLS; ARTIFICIAL INTERSTITIUM; PROXIMAL TUBULES; RABBIT KIDNEY; CULTURE; TUBULOGENESIS; ALDOSTERONE; DISEASE; CLONING; SYSTEM; (1)
EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PARKINSONS-DISEASE; AXONAL GROWTH; RAT MODEL; VECTOR; NEURONS; GRAFTS; DELIVERY; neural progenitor cells; retrovirus; lentivirus; gene therapy; transplantation; transgene silencing (1)
EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; DNA METHYLATION; DEVELOPMENTAL REGULATORS; INSTRUCTIVE MECHANISM; BURKITTS-LYMPHOMA; DEFINED FACTORS; HUMAN CANCER; GENE; EXPRESSION; (1)
EMBRYONIC STEM-CELLS; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEIN; MESSENGER-RNAS; DIFFERENTIAL REGULATION; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; microRNAs; Dicer; Drosha; Argonaute; gene silencing (1)
EMBRYONIC STEM-CELLS; ONCOSTATIN-M; HUMAN INTERLEUKIN; IN-VITRO; ES CELLS; GROWTH; STAT3; DIFFERENTIATION; PLURIPOTENCY; MELANOBLASTS; Melanoma; LIF; Stem cell marker (1)
EMBRYONIC STEM-CELLS; PRECURSOR CELLS; TRANSCRIPTION FACTOR; MICRORNAS; PROLIFERATION; MECHANISMS; EXPRESSION; INVASION; GENE; DLX3; Osteogenic differentiation; microRNAs; Human dental follicle cell; miRNA101 (1)
EMBRYONIC STEM-CELLS; PROTECTS DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; GENE-TRANSFER; COENZYME Q(10); TRANSPLANTATION; MODEL; INHIBITOR; MUTATIONS; LINE; Parkinson's disease; diagnosis; neuroprotection; growth factors; cell replacement (1)
EMBRYONIC STEM-CELLS; QUANTITATIVE MASS-SPECTROMETRY; MESSENGER-RNA DECAY; TRANSLATIONAL REPRESSION; MICRORNA BIOGENESIS; STRESS GRANULES; MIRNA TARGETS; COMPLEXES; PROTEOMICS; BINDING; (1)
EMBRYONIC STEM-CELLS; RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; HISTONE VARIANT H3.3; STRAND BREAK REPAIR; DNA-DAMAGE; COMPLEX NORC; ANOMALOUS DIFFUSION; PROTEIN EXPRESSION; NEURAL DEVELOPMENT; Chromatin remodeling; Nucleosome translocation; Histone modifications; Diffusion-controlled target location (1)
EMBRYONIC STEM-CELLS; SITE-SPECIFIC INTEGRATION; DNA METHYLATION; MAMMALIAN-CELLS; DIRECT CONVERSION; ENDOGENOUS GENES; INDUCIBLE SYSTEM; VITAMIN-C; ES CELLS; TETRACYCLINE; (1)
EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; TUMOR-NECROSIS; CANCER; PROGRESSION; CHEMOTHERAPY; PATHWAY; AML; (1)
EMBRYONIC STEM-CELLS; TRITHORAX GROUP PROTEINS; HUMAN DENTAL FOLLICLE; HOX GENES; HISTONE H3; MOLECULAR RECOGNITION; BIVALENT PROMOTERS; PRECURSOR CELLS; COMPASS FAMILY; DE-SUMOYLATION; (1)
Emerenz Meier, Bairisch, latenter Dialekt, Textgrammatik (1)
; Emergencies; heat therapeutic use; hypothermia therapy; rewarming methods; technology assessment (1)
EMERGENCY ACTION; CALL (1)
EMERGENCY CARDIOVASCULAR CARE; NEONATAL RESUSCITATION; CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL CONSENSUS; GUIDELINES; BABIES; BIRTH; MORTALITY; INTERVENTIONS; VENTILATION; (1)
EMERGENCY-DEPARTMENT VISITS; OUTDOOR AIR-POLLUTION; BET V 1; AIRBORNE POLLEN; CLINICAL SYMPTOMS; DRUG CONSUMPTION; BIRCH POLLEN; ASTHMA; EXPOSURE; RHINITIS; Aeroallergens; Conjunctivitis; Pollen; Rhinitis; Systematic review; Pollen thresholds (1)
EMERGENCY MEDICAL-SERVICES; HELICOPTER; CARE; German emergency air rescue service; Air medical service; Night; Primary mission; Helicopter (1)
; emergency medicine; drug therapy; patient safety; pharmacovigilance; hydroxyethyl starch (1)
EMERGENCY RESPONSE; OPERATIONS MANAGEMENT; OR/MS RESEARCH; SETUP TIMES; ALLOCATION; EARTHQUAKE; OR in disaster relief; Disaster operations management; Scheduling; Branch-and-price (1)
EMERGENCY RESPONSE; RESCUE UNITS; MANAGEMENT; ALLOCATION; COORDINATION; Disaster response; Decision support; Optimization; Resource allocation; Scheduling; Collaboration (1)
EMERGENCY-ROOM; INJURIES; (1)
emerging disease clinical trial | group-sequential stopping boundary | primary endpoint change | type I error rate spending function (1)
EMERGING ECONOMIES; BUSINESS; STRATEGY; Central and Eastern Europe; management journals; managerial discourses; publications (1)
EMERGING ECONOMY; ENTRY MODES; EASTERN-EUROPE; INTERNATIONALIZATION; FDI; FIRMS; MULTINATIONALS; CAPABILITIES; STRATEGIES; DEPENDENCE; Outward foreign direct investment; Post-socialist economies; Springboard theory; Slovenia; Eclectic paradigm (1)
EMERGING PHOTOLUMINESCENCE; BLOCH ELECTRONS; BERRY PHASE; WSE2; SEMICONDUCTORS; POLARIZATION; EXCITATIONS; EXCITONS; GRAPHENE; MOS2; spin-valley; valley Zeeman; spin-mixing; TMDC; valleytronics; straintronics; strain (1)
Emetophobia, Vomit phobia, Fear of vomiting, Specific phobia, Meta-analysis, Disgust, Anxiety (1)
EMISSION-COMPUTED-TOMOGRAPHY; NONINVASIVE DETECTION; RANDOMIZED-TRIAL; STRESS PERFUSION; PROGNOSTIC VALUE; ANGIOGRAPHY; CONTRAST; ISCHEMIA; WOMEN; INTERVENTION; Cardiovascular magnetic resonance; Scintigraphy; Coronary disease; Perfusion; Ischemia (1)
EMISSION MATRIX SPECTROSCOPY; GRAPHENE OXIDE; CARBON; DELIVERY; SEAWATER; DOTS; Graphite oxide; pH-dependence; Fluorescence; Excitation-emission matrix; Nano materials (1)
EMISSION MICROSCOPY; TUNNEL TRANSISTORS; FILMS; MAGNETOCURRENT; SPECTROSCOPY; LAYERS; (1)
EMISSION MICROSCOPY; TUNNEL TRANSISTORS; THIN-FILMS; MAGNETORESISTANCE; MAGNETOCURRENT; SUPERLATTICES; GAAS(001); EXCHANGE; LAYERS; NI; (1)
EMISSION; phosphorescence; triplet states; Pt-porphin; Pd-porphin; Shpol'skii matrix; n-alkanes; temperature activation; Arrhenius plot; molecular thermometer (1)
EMISSION; SEMICONDUCTORS; SHIFT; InGaN; quantum wells; photoluminescence (1)
Emission spectra; Solvation (spectroscopic investigation of solvation of org. mols. in superfluid helium droplets); Hydrocarbons Role: CPS (Chemical process), PEP (Physical, engineering or chemical process), PRP (Properties), PYP (Physical process), PROC (Process) (spectroscopic investigation of solvation of org. mols. in superfluid helium droplets); spectroscopic solvation org mol superfluid helium droplet (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTOR; MUTATED PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; TRIPLET FORMATION; FLAVIN; DYNAMICS; PHOTOTROPIN; ABSORPTION; PROTEIN; phototropin; phot; LOV domains; Chlamydomonas reinhardtii; blue-light photoreceptor; flavin mononucleotide; flavin-C(4a)-cysteinyl adduct; photo-cycle; quantum yield of adduct formation (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTORS; PHENOTHIAZINE-PYRENE DYADS; INTRAMOLECULAR ELECTRON-TRANSFER; CHLAMYDOMONAS-REINHARDTII; RHODOBACTER-SPHAEROIDES; ARTIFICIAL PHOTOSYNTHESIS; SUPRAMOLECULAR SYSTEMS; SENSORY PHOTORECEPTORS; STRUCTURAL-CHANGES; isoalloxazine; flavin; phenothiazine; pyrene; triad; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; forster-type energy transfer; reductive electron-transfer; oxidative electron transfer; charge recombination; blue-light photoreceptor model; cryptochrome model (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BORIC-ACID GLASS; ROSE-BENGAL; THIN-FILMS; ABSORPTION; LASER; ERYTHROSIN; EOSIN; POLYMER; TEMPERATURE; Fluorescein; Dibromofluorescein; Eosin Y; Erythrosine B; Rose bengal; Bio-films; Phosphorescence; Delayed fluorescence (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; ORGANIC ELECTROLUMINESCENT DEVICES; LIGHT-EMITTING DEVICES; LASING CHARACTERIZATION; ENERGY-TRANSFER; NEAT FILMS; THIN-FILMS; ABSORPTION; DYE; TPD; Triphenylamine dimer TPD; Neat thin films; Doped thin films; Luminescence behaviour; Fluorescence behaviour; Phosphorescence behaviour (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; RHODOBACTER-SPHAEROIDES; SIGNAL-TRANSDUCTION; PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; BINDING DOMAIN; PHOTOTROPIN; ABSORPTION; PHOTORECEPTOR; PHOTOREDUCTION; LOV domain mutants; flavin mononucleotide (FMN); flavin semiquinone; flavin hydroquinone; photo-reduction; blue-light photoreceptor; chlamydomonas reinhardtii; photo-cycle (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; COMPUTED-TOMOGRAPHY; PET/CT; MANAGEMENT; Positron-emission tomography-computed tomography; Diagnosis; Imaging; Accuracy; Treatment change; Non-muscle invasive bladder cancer (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; Inflammation; PET; image interpretation (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; MUCINOUS ADENOCARCINOMA; Urachus; Staging; Carcinoma; Imaging; Metastasis (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY; CARCINOMA; bladder cancer; urothelial carcinoma; imaging; staging; CT; FDG PET/CT; radical cystectomy; neoadjuvant chemotherapy; lymph node; metastasis (1)
EMITTING DIODE LIGHT; 5-AMINOLEVULINIC ACID; SOLAR KERATOSES; FOLLOW-UP; IN-VITRO; GUIDELINES; VIVO; DERMATOLOGY; MANAGEMENT; SCALP; (1)
EMITTING-DIODES; GAUSSIAN-PROCESSES; DESIGN; ENHANCEMENT (1)
EMITTING ELECTROCHEMICAL-CELLS; EFFECTIVE CORE POTENTIALS; MOLECULAR CALCULATIONS; IMAGING MICROSCOPY; CRYSTAL-STRUCTURE; BASIS-SETS; LIGANDS; STATE; ABSORPTION; RESOLUTION; Rhodium; Iridium; Cyclometalated complexes; Phosphorescence; Cytotoxicity studies (1)
EMITTING ELECTROCHEMICAL-CELLS; PHOTOPHYSICAL PROPERTIES; CU(I) COMPLEXES; STATE; HETEROSTRUCTURES; NANOPLATELETS; EXFOLIATION; CATIONS; SINGLET; emitter encapsulation; improved emission quantum yield; improved thermal stability; layered silicate; optoelectronic devices; TADF emitters (1)
EMOTIONAL AROUSAL; NEGATIVE AFFECT; RETRIEVAL; MOOD; RETENTION; RECONSOLIDATION; PSYCHOLOGY; STRENGTH; BENEFITS; PROGRAM; Testing effect; knowledge acquisition; emotions; moods; learning strategies (1)
Emotional Competence, Emotional Intelligence, Teacher Emotions, Teacher Training, Teachers, Teacher trainees, Training Evaluation, Emotionale Kompetenz, Emotionale Intelligenz, Lehreremotionen, Lehrkräfte, Lehramtsstudierende (1)
emotional competence, validity, test–retest reliability, exploratory structural equation modelling, measurement invariance (1)
emotional comptence, dealing with emotions in the team, team learning, work teams, team activities (1)
EMOTIONAL DISTRESS; COPING STYLE; SEVERITY; ACCEPTANCE; SUFFERERS; BELIEFS; Tinnitus; Illness representations; Self-instructions; Adjustment; Coping; Common Sense Model (CSM) of self-regulation (1)
emotional embodiment | kama muta | motor control | postural sway (1)
Emotionales Erleben, Selbstgesteuertes Lernen, eLearning, volitionale Regulation, motivationale Defizite (1)
EMOTIONAL FACIAL EXPRESSIONS; DIFFERENTIAL NEURAL RESPONSE; POSITRON-EMISSION-TOMOGRAPHY; HUMAN AMYGDALA; IMPAIRED RECOGNITION; FRONTAL-CORTEX; BASIC EMOTIONS; DISGUST; PERCEPTION; ACTIVATION; surprise; facial expression; fMRI; novelty; medial temporal lobe; disgust; insula (1)
EMOTIONAL RESPONSES; SOCIAL-INTERACTION; MUSCLE REACTIONS; EXPRESSIONS; MIMICRY; GUIDELINES; DURATION; PICTURES; OTHERS; FACES; facial muscles; faces; incompatibility; rating (1)
Emotion, Annotation, Digital Humanities, Computational Literary Studies, German Drama, Sentiment Analysis, Emotion Analysis, Corpus (1)
emotion, consciousness; brain oscillations; affective states; visual masking (1)
Emotionen; Lernstrategien; Selbstreguliertes Lernen (1)
Emotion, Literaturwissenschaft, Emotionsklassifikation, Machine Learning, Drama (1)
Emotion perception, Image classifier, NSSI, Adolescents, Visual spatial frequencies, Emotional competence, Emotion regulation (1)
EMOTION REGULATION; NEURAL REPRESENTATION; CATEGORY REPRESENTATIONS; PREFRONTAL CORTEX; ANXIETY; NEUROTICISM; CONSCIENTIOUSNESS; DYSREGULATION; EXTROVERSION; ATTENTION; affective science; Big Five; clustering; emotions; individual differences; personality (1)
EMOTION REGULATION; PSYCHOSOCIAL STRESS; NEGATIVE AFFECT; TRAIT ANXIETY; NEURAL BASES; HEART-RATE; SUPPRESSION; CHILDREN; REGISTRATION; RESPONSES; NSSI; MIST; Resting-state; Adolescents; Stress; Emotion regulation (2)
Emotionsattribution, Kinder, fMRT, Moral (1)
Emotions, Children, Mental health and psychiatry, Psychometrics, questionnaires, Medical risk factors, Language, Speech (1)
Empagliflozin; HFpEF; PKG; Diastolic function; Oxidative stress (1)
Empathetic Dialogue, Weight Loss, Motivation, Conversational AI (1)
; empathy; doctor-patient-communication; doctors as patients; cancer; oncology; introspection; role change (1)
Empfehlungsgenerierung, inhaltsbasiertes Filtern, kollaboratives Filtern, hybride Empfehlungssysteme, Filmähnlichkeit, Vektoren (1)
EMPIRICAL-ANALYSIS; BAYESIAN-ANALYSIS; MARKOV-CHAIN; PRICE; BEHAVIOR; NETWORKS; choice model; neural networks; probit model; hierarchical Bayesian modeling; marketing (1)
Empirical asset pricing, Mispricing, Fundamental analysis, International markets (1)
EMPIRICAL-EVIDENCE; RECOVERY RATES; BASEL III; CHAPTER-11; BANKRUPTCY; DEFAULT; COSTS; DURATION; MODELS; Bank loans; Default resolution time; Credit risk; Systematic effects; Latent factors (1)
EMPIRICAL-EVIDENCE; RECOVERY RATES; GIVEN-DEFAULT; REGRESSION; RISK; LGD; Risk management; Bank loans; Credit risk; Random effects (1)
Empirical Mode Decomposition; Contour Integration; EEG; IMF; ERP; ERM (1)
Empirical Mode Decomposition; Eye tracking; Gaze Behavior; Sifting process (1)
EMPIRICAL MODE DECOMPOSITION; HIGH-RESOLUTION EEG; SOURCE LOCALIZATION; ELECTROMAGNETIC TOMOGRAPHY; INVERSE PROBLEM; BRAIN; DENSITY; NUMBER; NOISE; (1)
EMPIRICAL MODE DECOMPOSITION; INDEPENDENT COMPONENT ANALYSIS; ULTRA-HIGH RISK; MAJOR DEPRESSION; MISMATCH NEGATIVITY; HILBERT SPECTRUM; QUANTITATIVE EEG; CONSTRAINED ICA; BRAIN ACTIVITY; PSYCHOSIS; constraint independent component analysis; ensemble empirical mode decomposition; independent modes; electroencephalography; depression; schizophrenia (1)
; Empirical mode decomposition; Neuromonitoring; Online analysis (1)
Empirical Mode Decomposition, neuromonitoring, time series analysis, online analysis, EMD (1)
EMPIRICAL MODE DECOMPOSITION; SINGULAR-SPECTRUM ANALYSIS; INTERSTITIAL BRACHYTHERAPY; SIMULTANEOUS LOCALIZATION; MUTUAL-INFORMATION; TIME-SERIES; DYNAMICS; IRRADIATION; PEARSONS; PROSTATE; (1)
EMPIRICAL MODE DECOMPOSITION; TIME-SERIES; FMRI DATA; CONNECTOME; NETWORKS; ALGORITHMS; dynamic functional connectivity; multivariate; empirical mode decomposition; filter-bank; multiscale; fMRI; resting-state; scale-invariance (1)
Empirische Untersuchung; Schulentwicklung; Lehrerfortbildung; Motivation; Didaktik; Curriculum; Hochschullehrer; Hochschullehrerin; Hochschule; Fortbildung; Online; Deutschland (1)
employee codetermination, employee voice, supervisory boards, Germany, conflict resolution, large firms, corporate governance, company boardrooms, power structures, information handling, consensus (1)
EMPLOYEE CREATIVITY; ORGANIZATIONS; KNOWLEDGE; PERSPECTIVE; LEADERSHIP; CONFLICT; DYNAMICS; MODELS; IMPACT; Team learning behaviour; team reflexivity; knowledge sharing; innovative work behaviour; work teams; cross-lagged-panel (1)
Employee Ownership, Employee-owned Company, Power, Small and Medium-sized Enterprises, Company Crisis, East Germany (1)
employee-stock-ownership, employees' perspective, semantic analysis, discourse analysis (1)
EMPLOYMENT; DECISIONS; IMPACT; Youth unemployment; Education mismatch; Multinomial logit model; Multilevel analysis (1)
EMPLOYMENT; GLOBALIZATION; INVESTMENT; INNOVATION; WORKERS; IMPACT; WAGES; FDI; Offshoring; Unemployment; North-South trade (1)
EMPLOYMENT; UNIONS; (1)
Empowerment, Gesundheitsförderung, Evaluation, Studiendesign, systematische Übersichtsarbeit empowerment, health promotion, evaluation, study design, systematic review (1)
EMRK (1)
EMRK; EGMR; Kruzifix (1)
EMRK, Eigentum, Kulturgüter (1)
EMRK, EU, Beitritt (1)
EMRK, "Europäische Grundrechtecharta", EGMR, EuGH (1)
EMRK, Grundrechtsschranken, Beurteilungsspielraum, Demokratietheorie, Minderheitenschutz (1)
EMRK; Kirchliches Arbeitsrecht (1)
EMRK Privatsphäre Informationsgesellschaft Internet Religionsfreiheit Folter Bankovic "Recht auf Leben" Todesstrafe Daschner Gäfgen Schutzpflichten Diskriminierungsverbot Gleichheitssatz Burka-Verbot Menschenhandel (1)
EM STRUCTURE DETERMINATION; HIGH-LEVEL EXPRESSION; BEAM-INDUCED MOTION; KIDNEY-DISEASE; CRYO-EM; ELECTRON CRYOMICROSCOPY; CATION CHANNEL; N-GLYCOSYLATION; PKD2; MECHANISMS; (1)
EMT, CSC, sphere, Mammakarzinom, breast cancer (1)
EMT-Marker, Harnblasenkarzinom, Urothelkarziom, Prognose (1)
EMULSIFICATION INTERNAL GELATION; HUMAN-IMMUNOGLOBULIN-G; ALGINATE BEADS; IMMOBILIZATION MATERIAL; SUSTAINED-RELEASE; DELIVERY; STABILIZATION; FORMULATION; PHARMACOKINETICS; ENCAPSULATION; (1)
Emulsion; Chloride; Optical sensor; Co-extraction; pH independence (1)
ENAMEL COLOR; ORTHODONTIC ADHESIVES; BASE-LINE; DISCOLORATION; RELIABILITY; REPRODUCIBILITY; REPEATABILITY; ACCURACY; REMOVAL; GUIDE; (1)
ENAMEL MATRIX PROTEINS; GENE-EXPRESSION; IN-VITRO; TGF-BETA; BMP; INTERLEUKIN-1-BETA; TRANSCRIPTION; MODULATION; ACTIVATION; PROFILES; biomechanics; bone morphogenetic protein-2; bone morphogenetic protein receptors; enamel matrix derivative; inflammation; periodontal ligament (1)
ENANTIODIFFERENTIATING 4+4 PHOTOCYCLODIMERIZATION; DIRECTED PHOTOREVERSIBLE LIGATION; CYCLODEXTRIN INCLUSION COMPLEXES; PHOTOINDUCED ELECTRON-TRANSFER; TOPOCHEMICAL REACTION CONTROL; ASSEMBLED COORDINATION CAGE; SOLID-STATE PHOTOREACTIONS; GENERATED O-QUINODIMETHANE; NORRISH-YANG CYCLIZATION; GAMMA-CYCLODEXTRIN; (1)
ENANTIOMERS; CHIRALITY; IDENTIFICATION; RECOGNITION; PERCEPTION; SWEAT; (1)
ENANTIOSELECTIVE AEROBIC OXIDATION; BRONSTED ACID; 2+2 PHOTOCYCLOADDITION; PHOTOREDOX CATALYSIS; ASYMMETRIC-SYNTHESIS; ELECTRON-TRANSFER; SHEDDING LIGHT; ACTIVATION; ANIONS; PERFLUOROALKYLATION (1)
ENANTIOSELECTIVE ALDOL ADDITIONS; SUPPORTED BIS(OXAZOLINE)-COPPER COMPLEXES; C(2)-SYMMETRIC COPPER(II) COMPLEXES; POLYMER-BOUND BIS(OXAZOLINE); OXAZOLINE-CONTAINING LIGANDS; DIELS-ALDER REACTIONS; CYCLOPROPANATION REACTIONS; ASYMMETRIC HYDROGENATION; ELECTROSTATIC INTERACTIONS; LEWIS-ACIDS; asymmetric catalysis; azabis(oxazolines); cyclopropanation; Mukaiyama aldol; supported catalysts (1)
ENANTIOSELECTIVE ALPHA-TRIFLUOROMETHYLATION; PHOTOINDUCED ELECTRON-TRANSFER; SENSITIZED SOLAR-CELLS; PHOTOREDOX CATALYSIS; PHENACYL HALIDES; DOMINO REACTIONS; XANTHENE DYES; ORGANIC-DYES; ALDEHYDES; ALKYLATION; asymmetric alkylation; cooperative catalysis; organocatalysis; photocatalysis; xanthene dyes (1)
ENANTIOSELECTIVE CATALYSIS; MACROPOROUS POLYMERS; COPPER-COMPLEXES; CHIRAL LIGANDS; BIS(OXAZOLINE); PHASE; EFFICIENT; SUPPORT; OLEFINS; asymmetric cyclopropanation; azabis(oxazolines); copper; immobilization; N ligand; polymer-supported catalyst (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; BRONSTED ACID CATALYSIS; THERMODYNAMIC STABILITY; COMPLEXES; FORCES; BALANCE; BONDS; MOTIF (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; FACE AROMATIC INTERACTIONS; MONODENTATE PHOSPHORAMIDITE; MOLECULAR RECOGNITION; LONDON DISPERSION; LIGANDS; BALANCE; HYDROGENATION; FORCES; CHEMISTRY; conformational analysis; NMR spectroscopy; noncovalent interactions; phosphoramidites; supramolecular balance (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; RHODIUM-CATALYZED HYDROGENATION; COMBINATORIAL HOMOGENEOUS CATALYSIS; ASSEMBLED BIDENTATE LIGANDS; TRANSITION-METAL-COMPLEXES; MONODENTATE PHOSPHORAMIDITES; ASYMMETRIC HYDROGENATION; ALLYLIC ALKYLATION; NONCOVALENT INTERACTIONS; STACKING INTERACTIONS; asymmetric catalysis; NMR spectroscopy; phosphoramidites; stereoselection mode; supramolecular chemistry (1)
ENANTIOSELECTIVE CYCLOPROPANATION REACTIONS; ENERGY DECOMPOSITION ANALYSIS; BIS(OXAZOLINE)-COPPER COMPLEXES; ASYMMETRIC CYCLOPROPANATION; HETEROGENEOUS CATALYSTS; RECOVERABLE CATALYSTS; METAL-COMPLEXES; LIGANDS; REAGENTS; OLEFINS; (1)
ENANTIOSELECTIVE GAS-CHROMATOGRAPHY; ESSENTIAL OILS; NATURAL FLAVORS; DAMASCENA MILL; ENANTIOMERS; CHEMISTRY; FRAGRANCE; Second-Year Undergraduate; Analytical Chemistry; Organic Chemistry; Textbooks/Reference Books; Constitutional Isomers; Diastereomers; Enantiomers; Gas Chromatography; Mass Spectrometry; Stereochemistry (1)
ENANTIOSELECTIVE GAS-CHROMATOGRAPHY; STEREOISOMERIC FLAVOR COMPOUNDS; NOBEL LECTURE; METOLACHLOR; ODOR; MANAGEMENT; CHEMISTRY; BEHAVIOR; (1)
ENANTIOSELECTIVE GOLD CATALYSIS; OXIDATIVE ADDITION; COMPLEXES SYNTHESIS; GOLD(III); 1,5-ENYNES; LIGANDS; BOND; 2-arsaethynolate; 2-phosphaethynolate; arsenic; nickel(I) compounds; phosphorus (1)
ENANTIOSELECTIVE HYDROSILYLATION; ASYMMETRIC CATALYSIS; TERTIARY PHOSPHINE; CONFIGURATION; DERIVATIVES; CHEMISTRY; KETONES; ALKYL; (1)
Enantioselective, Nucleophilic Dearomatization, Anion-Binding-Catalysis (1)
ENANTIOSELECTIVE PHOTOCHEMICAL-REACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; CONVERGENT FUNCTIONAL-GROUPS; DIELS-ALDER REACTION; HYDROGEN-PEROXIDE; MOLECULAR RECOGNITION; CATALYTIC-SYSTEM; REDOX PROPERTIES; OXIDATION; AMINES; flavin; guanidine; Kemp's acid; photocatalysis; template (1)
ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ORGANOTITANIUM REAGENTS; NUCLEOPHILIC-ADDITION; CARBONYL-COMPOUNDS; FACILE SYNTHESIS; PARACONIC ACIDS; SINGLET OXYGEN; BIELSCHOWSKYSIN; ORGANOBORANES; (1)
ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; STABILIZED VINYLCARBENOIDS; CATALYZED DECOMPOSITION; RHODIUM CARBENOIDS; TURNOVER NUMBERS; RH(II) CATALYST; PYRROLES; DIRHODIUM(II); CONVERSION; (1)
ENANTIOSELECTIVE SYNTHESIS; CONSTRUCTION; STRATEGY; ESTERS; RINGS; radical reactions; radicals; natural products; cyclizations; lactones (1)
ENANTIOSELECTIVE SYNTHESIS; PHOTOREDOX CATALYSIS; AMINO-ACID; ABSOLUTE-CONFIGURATION; PHOSPHORUS LIGANDS; DUAL-CATALYSIS; HECK REACTION; OXYGEN; ELECTROPHILES; ALKYLATION; enantioselectivity; photoredoxcatalysis; chiralselenium-pi-acids; alkenolides; 3-pyrrolines; 1,1 '-spirobiindane (1)
ENANTIOSELECTIVE SYNTHESIS; PHOTOREDOX CATALYSIS; LEONTOPODIUM-ALPINUM; ALCOHOLS; ALKENOLS; OXALATES; COMPLEX; SYSTEM; ALKYL; Photocatalysis; Photochemistry; Radical reactions; Heterocycles; Electron transfer (1)
ENANTIOSELECTIVE SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; CARBOCYCLIC NUCLEOSIDES; ORGANIC-SYNTHESIS; CHEMISTRY; FURANS; CYCLOPENTENONES; PROSTAGLANDIN; INTERMEDIATE; DERIVATIVES; green chemistry; organic synthesis in water; microwave chemistry; carbohydrates; biomass; furfuryl alcohol (1)
ENANTIOSELECTIVE TOTAL-SYNTHESIS; NF-KAPPA-B; CONVERTING-ENZYME INHIBITORS; UBIQUITIN-ACTIVATING ENZYME; FARROWIA SP. E-1941; BIOLOGICAL-PROPERTIES; FUNGAL METABOLITES; BUILDING-BLOCKS; FLUOSTATIN-C; DIMER; Epoxyquinone natural products; Diels-Alder reaction; Stereoselective reduction; Wittig olefination; Oxycylization (1)
ENANTIOSELECTIVE TOTAL-SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; CATALYZED CYCLOCARBONYLATION; PARACONIC ACIDS; LACTONES; LIBRARIES; ALDEHYDES; KETONES; (+)-BLASTMYCINONE; DIAZOACETATES (1)
enantioselectivity · hydrogen bonds · photochemistry · time-resolved spectroscopy · xanthones (1)
Enantioselectivity; Phosphotriesterase; Non-canonical amino acid; Rational design; Photoregulation; Genetic code expansion; Photoxenoprotein engineering (1)
EN-BLOC RESECTION; UROTHELIAL CARCINOMA; TUMOR RESECTION; EAU GUIDELINES; HEXAMINOLEVULINATE; LASER; bladder cancer; en bloc; hexaminolevulinate; photodynamic diagnosis; hydrodissection; transurethral; trial; #BladderCancer; #blcsm (1)
ENCEPHALITIS; MENINGOENCEPHALITIS; TBE; CSF; pleocytosis (1)
encephalitis; neurofilament; children; brain; neuron; NfL (1)
ENCEPHALITOZOON-CUNICULI INFECTION; KILLER CELL-ACTIVITY; IMMUNE-RESPONSE; MURINE ENCEPHALITOZOONOSIS; RESPIRATORY BURST; REACTIVE NITROGEN; GAMMA; MICE; INTESTINALIS; INTERFERON; microsporidia; encephalitozoon; nitric oxide; cytokines; TNF-alpha; INF-gamma; IL-10 (1)
ENCEPHALITOZOON-INTESTINALIS; IN-VITRO; CUNICULI; INFECTION; QUANTIFICATION; VIABILITY; PARASITES; AGENTS; HELLEM; SPORES; microsporidia; Encepbalitozoon cuniculi; flow cytometry; FCM (1)
enchondrale Ossifikation, Synchondrosis sphenooccipitalis, extrazelluläre Matrix, Kollagen, Wachstumszentrum (1)
enclosures; Linear Pottery Culture/Linienbandkeramik (LBK); Middle Neolithic; Münchshöfen culture; magnetometer survey; Bavaria (1)
Encoding, Levels of processing, Strategy, Adaptive memory, Long term memory, desynchronization (1)
endangered species, eDNA, land use, macrophytes, Myriophyllum alterniflorum, sediment pollution, irrigation meadows (1)
END-EXPIRATORY PRESSURE; RADICAL PROSTATECTOMY; GENERAL-ANESTHESIA; DRIVING PRESSURE; BODY-MASS; LUNG; OVERWEIGHT; MORTALITY; COMPLICATIONS; VENTILATION; Lung compliance; Driving pressure; Obesity; Peak inspiratory pressure; Robotic-assisted laparoscopic prostatectomy; Steep Trendelenburg position (1)
Endgröße, Endokrinologie, Knochenalter, Roche, Wainer, Thissen, Bayley, Pinneau, Wachstumshormon, Kleinwuchs, Hochwuchs, konstitutionelle Entwicklungsverzögerung (1)
Endiine , Makrocyclische Verbindungen , Cyclisation , Substituenteneffekt , , Enediyne , macrocycle , cyclization reaction , substituents effects (1)
ENDOBUTTON FIXATION; GRAFT FIXATION; NITRIC-OXIDE; BONE; PATHOLOGY; FAILURE; KNEE; proinflammatory cytokines; bone morphogenic protein 2; nitric oxide; anterior cruciate ligament reconstruction; bone tunnel enlargement (1)
Endocannabinoidsystem, Rheumatoide Arthritis, Fibroblasten (1)
ENDOCARDITIS; RECOMMENDATIONS; ANGIOPLASTY; PREVENTION; (1)
endocrine plasticity, erythropoietin, HIF-2α stabilization, pre-glomerular vascular smooth muscle cells, prolyl-4-hydroxylases, renal contractile pericytes, renin (1)
endocrine tumor; tumor of the adrenal gland; pheochromocytoma; adrenal cyst; cancer diagnosis (1)
ENDODONTICALLY TREATED TEETH; ALVEOLAR BONE LOSS; IN-VITRO; PROSTHETIC TREATMENT; CANAL TREATMENT; ABUTMENT TEETH; TOOTH; POST; OUTCOMES; FERRULE; Dental caries; Dental cements; Dental restoration failure; Dental restoration; Permanent; Tooth; Nonvital; Resin cements; Nonvital tooth; Nonvital teeth; Endodontically treated teeth; Endodontically treated tooth (1)
ENDODONTICALLY TREATED TEETH; failure mode; finite element method; positive locking; post-and-core restoration; tooth (1)
ENDODONTICALLY TREATED TEETH; FIBER-REINFORCED COMPOSITE; ALL-CERAMIC CROWNS; STRUCTURALLY COMPROMISED TEETH; FRACTURE-RESISTANCE; CORE SYSTEMS; DIFFERENT POST; MAXILLARY INCISORS; SURVIVAL RATE; CLINICAL-PERFORMANCE; (1)
ENDODONTICALLY TREATED TEETH; FINITE-ELEMENT-METHOD; FRACTURE STRENGTH; STRESS-ANALYSIS; TAPERED POSTS; ROOT CANALS; RETENTION; SYSTEMS; RESISTANCE; EFFICACY; positive locking; post and core restoration; root; tooth (1)
ENDODONTICALLY TREATED TEETH; IN-VITRO; MARGINAL ADAPTATION; DENTIN; SIMULATION; COMPOSITE; STRENGTH; FIBER; chewing simulation; composite; dentin; fracture load (1)
ENDODONTICALLY TREATED TEETH; IN-VITRO WEAR; RESIN COMPOSITE; MECHANICAL-PROPERTIES; DENTAL COMPOSITES; CONTACT WEAR; RESISTANCE; CROWNS; RESTORATIONS; SIMULATION; wear; abrasion; hardness; core; composite (1)
ENDODONTICALLY TREATED TEETH; STRESS-DISTRIBUTION; SURVIVAL RATE; CORE SYSTEMS; STRENGTH; DESIGN; DENTIN; INCISORS; FATIGUE; CROWNS; fracture resistance; marginal fit; post and core; glassfibre post; ceramic post (1)
ENDODONTIC SEALERS; ASSAY; MUTAGENICITY; BIOCOMPATIBILITY; SALMONELLA; AH Plus; root canal sealing cement; epoxy resin; mutagenicity; micronucleus test (1)
END-OF-LIFE; CARE; EDUCATION; MEDICINE; Palliative care; Emergency medicine; Recommendations; Education and training; End of life decision (1)
END-OF-LIFE; ILL CANCER-PATIENTS; CELL TRANSPLANTATION; MEDICAL STAFF; CARE; PREFERENCES; PERSPECTIVES; BARRIERS; OUTCOMES; Advance directives; Tumor diagnosis; Patient autonomy (1)
Endogenes Wirtschaftswachstum , Außenhandel , Arbeitslosigkeit , Produktwettbewerb , Entscheidung bei Unsicherheit , Gehalt , Lohn , Einkommenstheorie , endogenes Wirtschaftswachstum , unsicheres Arbeitseinkommen , Vorsorgesparen , intergenerationelle Verteilung , trade liberalization , endogenous growth , labor income risk , precautionary saving , intergenerational distribution (1)
Endogenes Wirtschaftswachstum , Dynamische Stabilität, , endogenous growth , stability (1)
Endogenes Wirtschaftswachstum , Wachstumstheorie , Technischer Fortschritt , Spill-over-Effekt , Forschung und Entwicklung , , endogenous growth , transitional dynamics , indeterminacy (1)
Endogenes Wirtschaftswachstum , Wettbewerb , Deregulierung, Armutsfalle , Handelsliberalisierung, endogeneous growth , competition , deregulation , poverty trap , trade liberalization (1)
ENDOGENOUS BACTERIAL ENDOPHTHALMITIS; (1)
ENDOGENOUS CATECHOLAMINE SYNTHESIS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; T-CELLS; ANTAGONIST; MODULATION; AGONIST; LYMPHOCYTES; METABOLISM; PHYSIOLOGY; (1)
endogenous growth, transitional dynamics, indeterminacy, open economy (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; ECONOMIC-INTEGRATION; STABILITY; Endogenous Growth; Transitional Dynamics; Indeterminacy (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; TRANSITIONAL DYNAMICS; ECONOMIC-GROWTH; 2-SECTOR MODEL; EQUILIBRIUM; STABILITY; growth without scale effects; transitional dynamics (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; UNEMPLOYMENT; STABILITY; IMITATION; MODELS; North-South trade; endogenous growth; labor market flexibility (1)
Endoleak, endovaskuläre Aortenversorgung, abdominelles Aortenaneurysma (1)
ENDOLEAKS; CEUS; ultrasound; intensive care unit (1)
Endolysin, Bakteriophagen, Enterococcus faecalis, Enterococcus faecium, VRE (1)
ENDOMETRIAL STROMAL SARCOMAS; EPITHELIOID CELL TUMORS; MTOR INHIBITION; GENE FUSION; TFE3; ACTIVATION; NEOPLASMS; Genetic translocation; Immunohistochemistry; Lymphangioleiomyomatosis; Perivascular epithelioid cell neoplasms; TOR serine-threonine kinases (2)
; endometriosis; urinary bladder endometriosis; ureter involvement; laparoscopy; psoas hitch (1)
Endometriumcarcinom, Lymphadenektomie, Stadium IB (1)
Endometrium-Karzinom, high-grade, adjuvante Therapie, Lymphonodektomie (1)
ENDOPLASMIC-RETICULUM BODY; ARABIDOPSIS CULLIN ATCUL1; GREEN FLUORESCENT PROTEIN; ER-BODY; BETA-GLUCOSIDASE; AUXIN RESPONSE; ALTERNARIA-BRASSICICOLA; TRANSCRIPTION FACTOR; SPECIFIER PROTEINS; TLR4-MD-2 COMPLEX; (1)
ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; CHLORIDE CHANNEL; RETRIEVAL SIGNAL; EPITHELIAL-CELLS; CL SECRETION; PROTEINS; DEGRADATION; MATURATION; ER; (1)
ENDOPLASMIC-RETICULUM; INHIBITS APOPTOSIS; MEDIATED APOPTOSIS; CALCIUM-RELEASE; XIAP; NECROSIS; ACTIVATION; PROTEINS; BAX; MODULATION; TRAIL; SMAC mimetic; death receptor; hypoxia (1)
ENDOPLASMIC-RETICULUM PROTEIN; PATHOGEN CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYL-TRANSFERASE; ALPHA-DYSTROGLYCAN; GOLGI-APPARATUS; FINE STRUCTURE; GLYCOSYLATION; RAT; SPERMIOGENESIS; glycosylation; mannosyltransferase; PMT; POMT; testis (1)
ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; CHLORIDE CONDUCTANCE; CA2+; MEMBRANE; MECHANISMS; EXPRESSION; Bestrophin; Ca2+-activated Cl- currents; CaCC; Ca2+-activated K+ currents; SK4; TMEM16A; Pak2; Purinergic receptors; Endoplasmic reticulum; ER; Ca2+ store (1)
ENDOPLASMIC-RETICULUM STRESS; AIRWAY EPITHELIAL-CELLS; SIGNAL TRANSDUCER; IGE LEVELS; EXPRESSION; GENE; CHILDREN; ACTIVATION; INTERLEUKIN-8; POPULATION; Asthma; association study; polymorphism; ORMDL3; chromosome 17q21; promoter activity; T(H)2 cytokine; upstream stimulatory factor; transcriptional regulation (1)
ENDOPLASMIC-RETICULUM STRESS; ER STRESS; CARCINOMA; CANCER; ACTIVATION; APOPTOSIS; INHIBITOR; MUTATIONS; MECHANISM; PATHWAY; chemotherapy; adrenolytic; somatic mutations; cholesterol; lipids; SOAT (1)
ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID SYNTHESIS; MULTIPLE-MYELOMA; BONE-MARROW; ENDOTHELIAL-CELLS; TUMOR-SUPPRESSOR; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; HUMAN FIBROBLASTS; INDUCIBLE FACTORS; (1)
ENDOPLASMIC-RETICULUM STRESS; HIGH-THROUGHPUT QUANTIFICATION; LIVER-DISEASE PATHOGENESIS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LEUCINE-ZIPPER; ETHANOL; INJURY; ACID; Lieber-DeCarli diet; Lipidomics; Macrophages; Phospholipids; Sphingolipids; Bi-clustering; Louvain communities (1)
ENDOPLASMIC-RETICULUM STRESS; LIPID DROPLET FORMATION; ADIPOSE-SPECIFIC PHOSPHOLIPASE; TANDEM MASS-SPECTROMETRY; MESENCHYMAL STEM-CELLS; EICOSAPENTAENOIC ACID; 15-HYDROPEROXYEICOSAPENTAENOIC ACID; 3T3-L1 ADIPOCYTES; ARACHIDONIC-ACID; ADIPOGENIC DIFFERENTIATION; SVF; Adipogenesis; Lipidomics; Microarray; EPA; Eicosanoids (1)
ENDOPLASMIC-RETICULUM STRESS; LOW-DENSITY LIPOPROTEINS; LIVER-DISEASE; LIPIDOMIC ANALYSIS; NONALCOHOLIC STEATOHEPATITIS; MCA-RH7777 CELLS; ARACHIDONIC-ACID; INDUCED OBESITY; MOUSE; RAT; PLA2G6; Phospholipidomes; Fatty acid homeostasis; High-fat diet; NASH; Phospholipid remodeling (1)
ENDOPLASMIC-RETICULUM STRESS; LYSOSOME-RELATED ORGANELLES; CHEDIAK-HIGASHI-SYNDROME; PULMONARY-FIBROSIS; OXIDATIVE STRESS; PROTEIN-C; HERMANSKY-PUDLAK-SYNDROME-1 HPS1; COMPLEX-3 BLOC-3; SYNDROME TYPE-1; II PNEUMOCYTES; pulmonary surfactant; biogenesis of lysosome-related organelle complex; adaptor protein-3; apoptosis; cathepsin D (1)
ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; MITOCHONDRIAL FOLATE; THERAPEUTIC TARGET; PATHWAY; SERINE; CANCER; EXPRESSION; REGULATOR; PROMOTES; (1)
ENDOPLASMIC-RETICULUM STRESS; OBSTRUCTIVE SLEEP-APNEA; INDUCIBLE FACTOR-I; MITOCHONDRIA; HEART; CONSEQUENCES; INJURY; ER; ACTIVATION; PREVENTION; sleep disordered breathing; intermittent hypoxia; hypoxia inducible factor-1; mitochondria associated-ER membrane; cardiomyocyte death (1)
ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; LINKED GLYCOSYLATION; OXIDATIVE STRESS; SERINE-PROTEASE; REGULATES APOPTOSIS; CYTOCHROME-C; BCL-2 FAMILY; DNA-DAMAGE; (1)
ENDOPLASMIC-RETICULUM STRESS; REPRESSED MESSAGE-1; APOPTOSIS; CELLS; Androgen signaling; Epispadias; Gene analysis; PARM1; Whole mount in situ hybridization (1)
ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; OLIGOSACCHARYLTRANSFERASE COMPLEX; INDUCED APOPTOSIS; MITOCHONDRIAL FISSION; REGULATES APOPTOSIS; MEDIATED APOPTOSIS; CYSTEINE PROTEASES; MESSENGER-RNA; BUDDING YEAST; (1)
ENDOPLASMIC-RETICULUM STRESS; SERINE/THREONINE PHOSPHATASES; CATALYTIC SUBUNITS; HYPERTROPHY; INHIBITION; EXPRESSION; DISEASE; MUSCLE; Protein phosphatase 1 (PP1) isoforms; Human heart failure; Atrial fibrillation; Beta-blocker; Endoplasmic reticulum stress response (1)
ENDOPLASMIC-RETICULUM STRESS; SUCRASE-ISOMALTASE EXPRESSION; UNFOLDED PROTEIN RESPONSE; TUMOR-NECROSIS-FACTOR; BOWEL-DISEASE; MEMBRANE-PROTEINS; BARRIER FUNCTION; TIGHT JUNCTIONS; E-CADHERIN; TNF-ALPHA; ER stress; Inflammation; Inflammatory bowel disease; Brush border membrane; Caco-2 cells (1)
ENDOPLASMIC-RETICULUM STRESS; TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; UNFOLDED PROTEIN RESPONSE; FACTOR-KAPPA-B; GENE-EXPRESSION; TRANSITION PERIOD; P53-DEPENDENT APOPTOSIS; INFLAMMATORY CONDITIONS; DIETARY POLYPHENOLS; Transcriptomics; Lipidomics; Dairy cow; Early lactation; Liver; Polyphenols; Grape seed and grape marc meal extract; Endoplasmic reticulum stress; Inflammation (1)
ENDOPLASMIC-RETICULUM STRESS; TRANSLATION; DIFFERENTIATION; EXPRESSION; BORTEZOMIB; SURVIVAL; REVEALS; IMPACT; (1)
; Endoprosthesis; Infection; Definition; Diagnostics; Treatment (1)
Endoprothese, minimal Invasivität, Hüfte, Postoperatives Schmerzmanagement (1)
ENDORECTAL ADVANCEMENT FLAP; MUSCLE TRANSPOSITION; VAGINAL FISTULA; TRANSPERINEAL REPAIR; SURGICAL-TREATMENT; PERINEAL; MANAGEMENT; OPTION; graciloplasty; recurrent fistula; anovaginal; rectovaginal; Crohn's disease (1)
ENDOSCOPE (1)
ENDOSCOPIC DACRYOCYSTORHINOSTOMY; ENDONASAL DACRYOCYSTORHINOSTOMY; OBSTRUCTION; MANAGEMENT; OUTCOMES; SYSTEM; Lacrimal apparatus; Nasolacrimal duct; Dacryocystorhinostomy; Natural orifice endoscopic surgery; Postoperative complications (1)
ENDOSCOPIC ENDONASAL SURGERY; RECURRING RHINOSINUSITIS; SURGICAL-MANAGEMENT; OSTEOPLASTIC FLAP; FAT OBLITERATION; NASAL; COMPLICATIONS; SEQUENCE; DISEASES; STATE; frontal sinus surgery; osteoplastic frontal sinus surgery; endonasal frontal sinusotomy; type I drainage; type II drainage; type III drainage (1)
ENDOSCOPIC EXTRAPERITONEAL; RETROPUBIC PROSTATECTOMY; SINGLE-CENTER; CANCER; LYMPHADENECTOMY; COMPLICATIONS; EXPERIENCE; MORBIDITY; OUTCOMES; SURGERY; Fenestration; Laparoscopic; endoscopic; Prostatectomy; Lymphocele; Prostate cancer (1)
ENDOSCOPIC GASTROSTOMY; GASTROENTEROSTOMY; sonography; ultrasound; gastrostomy (1)
ENDOSCOPIC GASTROSTOMY; RADIOLOGIC GASTROSTOMY; FLUOROSCOPIC GUIDANCE; SURGICAL GASTROSTOMY; TUBE PLACEMENT; NECK-CANCER; GASTROJEJUNOSTOMY; EXPERIENCE; HEAD; GASTROENTEROSTOMY; computed tomography (CT); gastrostomy; percutaneous intervention; early, late, minor, major complications; success rate; nutrition (1)
ENDOSCOPIC GASTROSTOMY; SURGICAL GASTROSTOMY; ENTERAL NUTRITION; TRAUMA PATIENTS; TUBE PLACEMENT; PEG; HEAD; NECK; GASTROJEJUNOSTOMY; COMPLICATIONS; Enteral feeding; Feeding tube; Gastrostomy; Laparoscopic; PEG; PLAG; Percutaneous (1)
ENDOSCOPIC HEMOSTASIS; HEMORRHAGE; MANAGEMENT; VASOPRESSIN; DIAGNOSIS; SURGERY; FAILURE; ULCERS; small bowel bleeding; upper gastrointestinal bleeding; gastrointestinal bleeding; gastro-entero-pancreatic tumours (1)
ENDOSCOPIC INDEX; VALIDATION; SEVERITY; BEHAVIOR; Illness Index Severity; MRI; Response to Therapy; Prognosis (1)
ENDOSCOPIC MEDIAL MAXILLECTOMY; SURGERY; COMPLICATIONS; EMBOLIZATION; REPAIR; ONYX; Otorhinolaryngologic surgical procedures; Middle cranial fossa; Paranasal sinus diseases; Pterygopalatine fossa; Sphenoid sinus (1)
ENDOSCOPIC MODIFIED LOTHROP; DRAF TYPE-III; SEPTAL FLAP; OUTCOMES; EFFICACY; Draf III procedure; frontal sinus surgery; modified Lothrop procedure; mucosal flap; stenosis (1)
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; SECONDARY SCLEROSING CHOLANGITIS; ANTIBIOTIC-PROPHYLAXIS; SEPTIC COMPLICATIONS; GASTROINTESTINAL ENDOSCOPY; EXCRETION; PRESSURE; TRACT; BILE; Endoscopic retrograde cholangiography (ERC); Intraductal antimicrobial prophylaxis; Infectious complications; Biliary obstruction; Secondary sclerosing cholangitis (1)
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; SPHINCTEROTOMY-INDUCED PANCREATITIS; NONDILATED BILE-DUCTS; ODDI DYSFUNCTION; BILIARY SPHINCTEROTOMY; RISK-FACTORS; PROSPECTIVE MULTICENTER; THERAPEUTIC ERCP; STENT PLACEMENT; COMPLICATIONS; (1)
ENDOSCOPIC SINUS SURGERY; AIR-TRAVEL; BAROTRAUMA; PNEUMOCEPHALUS; MANAGEMENT; DIVERS; INCIDENTS; AVIATORS; FLIGHT; Aerosinusitis; Sinusitis; Barotrauma; Epidemiology; Flight attendant (1)
ENDOSCOPIC SINUS SURGERY; AIR-TRAVEL; BAROTRAUMA; PNEUMOCEPHALUS; MANAGEMENT; DIVERS; PATHOPHYSIOLOGY; INCIDENTS; AVIATORS; PILOTS; (1)
ENDOSCOPIC SINUS SURGERY; ASTHMA; PHENOTYPES; ALLERGY; ASSOCIATION; INTOLERANCE; POPULATION; OMALIZUMAB; MANAGEMENT; ENDOTYPES; CRS; CRSwNP; Eosinophilie; Sinusitis; T2-Inflammation; Mepolizumab (1)
ENDOSCOPIC SINUS SURGERY; BAROTRAUMA; MANAGEMENT; AVIATORS; PILOTS; Sinusitis; Paranasal sinuses; Drug therapy; Flight attendant; Balloon dilatation (1)
ENDOSCOPIC SINUS SURGERY; POSITION PAPER; ODOR IDENTIFICATION; NORMATIVE DATA; ASTHMA; PREVALENCE; PLACEBO; SAFETY; DISCRIMINATION; RECURRENCE; chronic rhinosinusitis; CRSwNP; biologicals; eosinophilic inflammation; mepolizumab (1)
ENDOSCOPIC SINUS SURGERY; QUALITY-OF-LIFE; ADULT CHRONIC RHINOSINUSITIS; ODOR IDENTIFICATION; ORAL STEROIDS; DOUBLE-BLIND; CORTICOSTEROIDS; HEALTH; EFFICACY; IMPACT; nasal polyp (NP); prednisolone; chronic rhinosinusitis; postoperative; long-term; randomized controlled trial (1)
Endoscopy, KINEVO, microinspection tool, QEVO, surgical microscope (1)
Endoskopie, Geriatrie, Komplikationen, Sedierung, ÖGD, Koloskopie, ERCP, Endosongraphie (1)
endoskopischen Therapie, endoskopische Submukosadissektion [ESD], endoskopische Mukosaresektion [EMR], Neoplasien im Ösophagus (low-grade intraepithelial neoplasia [LGIN], high-grade intraepithelial neoplasia [HGIN], frühe Barrett-Adenokarzinomen, frühe Plattenepithelkarzinome, Magenfrühkarzinome. (1)
Endoskopische Submukosadissektion; ESD; Magenfrühkarzinom; Resektionskriterien (1)
ENDOSPERM DEVELOPMENT; GAMETE FUSION; RNA-SEQ; POLLEN; PROLIFERATION; MUTANT; BLOCK; TRANSCRIPTOMICS; CYCLE; FATE; Arabidopsis; double fertilization; egg cell; preferential fertilization (1)
Endosymbiont, Wolbachia, Cytoplasmic incompatibility (1)
Endosymbiose, Cardiocondyla obscurior, Westeberhardia, Kooption, Endosymbiosis, Rekombination, Cooption, Recombination (1)
Endothel , Hämoxygenase , Knochenmarktransplantation , Maus , GvHD , endothelial , heme oxygenase , bone marrow transplantation , murine , GvHD (1)
ENDOTHELIAL-CELL ADHESION; GENE-TRANSFER; IN-VITRO; CARTILAGE; DESTRUCTION; MIGRATION; SYNOVIOCYTES; PATHOGENESIS; OSTEOARTHRITIS; PROLIFERATION; (1)
Endothelial cell apoptosis; Circulating endothelial cells; Cardiopulmonary bypass; OPCAB surgery (1)
ENDOTHELIAL-CELL; EXPRESSION; KLF15; WNT; TRANSCRIPTION; DIFFERENTIATION; PATHWAY; ROLES; fetal gene reprogramming; heart failure; hypertrophic heart remodeling; vascular cells; Wnt signaling (1)
ENDOTHELIAL-CELLS; GAP-JUNCTIONS; BLOOD-FLOW; EXPRESSION; ARTERIOLES; DILATIONS; CX40; baroreceptor mechanism; connexin 40; hypertension; inducible gene deletion; renin (1)
ENDOTHELIAL-CELLS; HUMAN BETA-DEFENSIN-3; ADAPTIVE IMMUNITY; MESSENGER-RNA; IN-VITRO; EXPRESSION; INTERLEUKIN-8; CARCINOMA; MIGRATION; INNATE; (1)
ENDOTHELIAL-CELLS; IN-VIVO; VASCULAR INTEGRITY; ANGIOGENESIS; INHIBITION; MIR-126; KIDNEY; GENE; GLOMERULONEPHRITIS; RESPONSIVENESS; E-selectin; VCAM-1; glomeruli; arterioles; (post) transcriptional control (1)
ENDOTHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; MOLECULAR-BIOLOGY; EPITHELIAL-CELLS; TUMOR INVASION; MESSENGER-RNA; RETINOIC ACID; BREAST-CANCER; GENE FAMILY; EXPRESSION; malignant melanoma; Ets-1; proliferation; migration; invasion (1)
ENDOTHELIAL-CELLS; PLATELET-ADHESION; AORTIC VALVES; TISSUE; EXPERIENCE; GLUTARALDEHYDE; BIOPROSTHESES; MODEL; CALCIFICATION; REPLACEMENT; endothelial cells; decellularized bovine pericardium; functional analysis; preseeding; fibroblasts; cardiovascular tissue engineering; hemocompatibility (1)
ENDOTHELIAL-CELLS; POSTNATAL ARTERIOGENESIS; GENE-EXPRESSION; DENDRITIC CELLS; RBP-J; NOTCH; POLARIZATION; ACTIVATION; MONOCYTES; ANGIOGENESIS; (1)
ENDOTHELIAL-CELLS; RAT-LIVER; PAL-E; PHENOTYPIC HETEROGENEITY; NMR-SPECTROSCOPY; PV-1; SIEVE; CAPILLARIES; METABOLISM; MECHANISMS; (1)
ENDOTHELIAL-CELLS; RECEPTORS; BRAIN; EXPRESSION; ISOFORMS; (1)
ENDOTHELIAL DYSFUNCTION; ANGIOTENSIN-II; GLOBAL BURDEN; NITRIC-OXIDE; HYPERTENSION; DISEASE; ACTIVATION; MECHANISMS; KIDNEY; HEART; Ageing; Blood pressure; Endothelin; Hypertension; Smooth muscle (1)
ENDOTHELIAL DYSFUNCTION; OLDER-ADULTS; FAILURE; EXERCISE; MORTALITY; DIAGNOSIS; GUIDELINES; MANAGEMENT; SOCIETY; BENEFIT; depression; heart transplantation; physical activity; waiting list (1)
ENDOTHELIAL GLYCOCALYX; HYDROXYETHYL STARCH; PERMEABILITY; FLOW; PH; (1)
ENDOTHELIAL GROWTH-FACTOR; ACTIVATED T-CELLS; C-FOS; NUCLEAR-FACTOR; IN-VITRO; PROPOFOL; INHIBITION; ANGIOGENESIS; SENSITIVITY; MIGRATION; Propofol; NFATc2; Sp1; cFos; pancreatic cancer; cancer; proliferation; cell cycle (1)
ENDOTHELIAL GROWTH-FACTOR; ADHESION MOLECULE-1; LEISHMANIA-MAJOR; IN-VIVO; CD11B(+) MACROPHAGES; TUMOR ANGIOGENESIS; ANTIGEN; LYMPHANGIOGENESIS; EXPRESSION; CANCER; (1)
ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; CHOROIDAL BLOOD-FLOW; MACULAR DEGENERATION; FACTOR-I; TRANSPUPILLARY THERMOTHERAPY; IGFBP-3 SECRETION; UP-REGULATION; ION CHANNELS; FACTOR-BETA; (1)
ENDOTHELIAL GROWTH-FACTOR; ALTERNATIVE COMPLEMENT PATHWAY; ANTI-ALPHA-5-BETA-1 INTEGRIN ANTIBODY; BEVACIZUMAB AVASTIN THERAPY; D MONOCLONAL-ANTIBODY; CHOROIDAL NEOVASCULARIZATION; INTRAVITREAL INFLIXIMAB; AMYLOID-BETA; AUTOIMMUNE-DISEASES; RETINAL DISEASES; Age-related macular degeneration; Therapeutic antibody; Intravitreal; Anti-angiogenic; Anti-complement system; Anti-inflammatory; Anti-amyloid beta; Clinical studies (1)
ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; ANGIOPOIETIN-1; EXPRESSION; IMMUNOLOCALIZATION; RECEPTOR; CELLS; TIE-2; endometrium; angiogenesis; VEGF; angiopoetins; activity (1)
ENDOTHELIAL GROWTH-FACTOR; ANTI-VEGF TREATMENT; CARE; RANIBIZUMAB; STRATEGIES; Age-related macular degeneration; Healthcare access; Anti-VEGF; Therapy delay; Therapy dropout (1)
ENDOTHELIAL GROWTH-FACTOR; APNEALINK(TM); MORTALITY; IMPACT; coronary collaterals; hypoxic preconditioning; myocardial infarction; sleep-disordered breathing (1)
ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; DEVELOPING RAT-KIDNEY; CONTAINING CELLS; ANGIOTENSIN-SYSTEM; JUXTAGLOMERULAR APPARATUS; ELECTRON-MICROSCOPY; FETAL DEVELOPMENT; GENE-EXPRESSION; PDGF-B; renal vessel; alpha-smooth muscle actin; juxtaglomerular cell; branching; three-dimensional reconstruction (1)
ENDOTHELIAL GROWTH-FACTOR; CALCIUM-CHANNEL; BRAIN NEURONS; ION CHANNELS; CULTURED RAT; CELLS; RPE; STIMULATION; ACTIVATION; SECRETION; retinal pigment epithelium; Ca2+channel; expression; patch-clamp (1)
ENDOTHELIAL GROWTH-FACTOR; CELL-SUSPENSION GRAFTS; BLOOD-BRAIN-BARRIER; NEURONS IN-VITRO; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; STRIATAL REINNERVATION; HEMIPARKINSONIAN RATS; VENTRAL-MESENCEPHALON; BEHAVIORAL RECOVERY; Cell transplantation; Parkinson's disease; Two-step grafting; Cell survival; Graft-derived angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; CLINICAL-TRIAL; HHT PATIENTS; FACTOR VEGF; EPISTAXIS; THERAPY; MANIFESTATIONS; EXPRESSION; MANAGEMENT; SEVERITY; Bevacizumab; Avastin; Hereditary haemorrhagic telangiectasia (HHT); Epistaxis; VEGF; Retrospective (1)
ENDOTHELIAL GROWTH-FACTOR; COLLAGEN-INDUCED ARTHRITIS; LOOP-HELIX PROTEINS; RHEUMATOID-ARTHRITIS; CELL-PROLIFERATION; INDUCED ACTIVATION; TETRASPANIN CD82; BONE DESTRUCTION; HYPOXIA; ANGIOGENESIS; (1)
ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; HUMAN-BREAST-CANCER; NEUROBLASTOMA-DERIVED GANGLIOSIDES; INDEPENDENT PROGNOSTIC-FACTOR; ANTIGEN-PRESENTING FUNCTION; EPIDERMAL LANGERHANS CELLS; HYPOXIA-INDUCIBLE FACTORS; STEADY-STATE CONDITIONS; CD4(+) T-CELLS; antigen presenting cells; dendritic cells; cancer vaccination; tumor immune escape; tumor-specific T cells (1)
ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR B; MACULAR DEGENERATION; MACROPHAGE ACTIVATION; FRACTALKINE RECEPTOR; OXIDATIVE STRESS; BRUCHS MEMBRANE; NEOVASCULARIZATION; INFLAMMATION; INDUCTION; (1)
ENDOTHELIAL GROWTH-FACTOR; CORONARY SMOOTH-MUSCLE; NITRIC-OXIDE RELEASE; ACTIVATED PROTEIN-KINASE; OBESE AFRICAN-AMERICANS; CHRONIC HEART-FAILURE; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; MESSENGER-RNA; PHARMACOLOGICAL-PROPERTIES; Beta-adrenoceptor antagonists; vascular function; endothelium; nitric oxide; hypertension; heart failure; coronary artery disease (1)
ENDOTHELIAL GROWTH-FACTOR; DNA-BINDING ACTIVITY; ACTIVATED T-CELLS; NUCLEAR FACTOR; FACTOR FAMILY; C-MYC; CANCER; EXPRESSION; DIFFERENTIATION; PATHWAY; NFATc2; Sp1; Pancreatic carcinoma; Binding partner; Cancer (1)
ENDOTHELIAL GROWTH-FACTOR; EMBRYO CHORIOALLANTOIC MEMBRANE; CHICK-EMBRYO; FLOW VISUALIZATION; DOPPLER; EXPRESSION; PERFUSION; VEGF; REPRODUCIBILITY; SARCOMA; LASCA; In-ovo-tumor-model; CAM assay; Sarcoma; Rhabdomyosarcoma; Angiogenesis; Tumor; Cancer; Perfusion; Microcirculation (1)
ENDOTHELIAL GROWTH-FACTOR; EPH RECEPTORS; TUMOR-GROWTH; IN-VIVO; FACTOR VEGF; CANCER; EPHRINS; INHIBITION; THERAPY; DISEASE; (1)
ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS; IDIOPATHIC PULMONARY-FIBROSIS; C-KIT; INHIBITOR; RAT; RESPONSES; EFFICACY; PATHWAY; DISEASE; Chronic lung allograft rejection; CLAD; immunochemistry; organ transplant; tyrosine kinase (1)
ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR 2; TUMOR-GROWTH; PEPTIDE VACCINATION; CLINICAL-TRIAL; BONE-MARROW; IMMUNOTHERAPY; ANGIOGENESIS; MICROENVIRONMENT; ADENOCARCINOMA; anti-angiogenesis; immune-oncology; human CD8(+) T cells; oral vaccination; pancreatic cancer; Salmonella typhi; VEGFR2 (1)
ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; C-SRC; CELL-LINE; CARCINOMA; GEMCITABINE; METASTASIS; ACTIVATION; SURVIVAL; DOMAIN; (1)
ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; 3-DIMENSIONAL GROWTH; MULTICELLULAR TUMOR; SPHEROID FORMATION; CARCINOMA; EXPRESSION; PATHWAY; microgravity; prostate cancer; VEGF signaling; cytoskeleton; focal adhesion; extracellular matrix (1)
ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; MELANOMA INHIBITORY-ACTIVITY; BLOOD-VESSEL FORMATION; LYMPHATIC METASTASIS; VEGF-A; TUMOR LYMPHANGIOGENESIS; FACTOR EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; Angiogenesis; Lymphangiogenesis; VEGF; VEGF-C; VEGF-D; MIA; OSCC (1)
ENDOTHELIAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; RETINAL VASCULATURE; SIGNALING PATHWAY; BIPOLAR DISORDER; BETA-CATENIN; FACTOR VEGF; NORRIN (1)
ENDOTHELIAL GROWTH-FACTOR; HUMAN COLON-CANCER; FACTOR-I; CELL-LINES; FACTOR EXPRESSION; CARCINOMA CELLS; AUTOCRINE LOOP; FACTOR 1-ALPHA; BREAST-CANCER; K-RAS; (1)
ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; METASTATIC COLORECTAL-CANCER; HUMAN PANCREATIC-CANCER; TUMOR PROGRESSION; PHOSPHOINOSITIDE 3-KINASE; PLUS IRINOTECAN; FACTOR 1-ALPHA; BREAST-CANCER; PATHWAY; gastric cancer; angiogenesis; mammalian target of rapamycin; rapamycin; tumor growth (1)
ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; MULTICELLULAR SPHEROIDS; FUNCTIONAL MATURATION; PERIPHERAL-BLOOD; CARCINOMA TISSUE; PRESENTING CELLS; LANGERHANS CELLS; HUMAN-MONOCYTES; T-CELLS; (1)
ENDOTHELIAL GROWTH-FACTOR; INTERNAL ELASTIC LAMINA; NITRIC-OXIDE SYNTHASE; CIRRHOTIC RATS; BACTERIAL TRANSLOCATION; BLOOD-FLOW; IN-VIVO; INCREASED ANGIOGENESIS; CAROTID-ARTERY; PRESSURE; mesenteric arteries; vasodilation (1)
ENDOTHELIAL GROWTH-FACTOR; INTERSTITIAL COLLAGENASE; UTERINE ENDOMETRIUM; STROMAL CELLS; PERITONEAL ENDOMETRIOSIS; ECTOPIC ENDOMETRIUM; TISSUE INHIBITORS; STEROID-HORMONES; MENSTRUAL-CYCLE; NUDE-MICE; Chorioallantoic membrane; endometrium; endometriosis; matrixmetalloproteinase; MMP (1)
ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; SERUM CONCENTRATIONS; PHARMACOKINETICS; REACTIVATION; THERAPY; INFANTS; INJECTION; AVASTIN; VEGF; (1)
ENDOTHELIAL-GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE ACETONIDE; EPITHELIUM-DERIVED FACTOR; CHOROIDAL NEOVASCULARIZATION SECONDARY; METASTATIC COLORECTAL-CANCER; ISCHEMIA-INDUCED RETINOPATHY; BEVACIZUMAB AVASTIN; PHOTODYNAMIC THERAPY; OCULAR NEOVASCULARIZATION; DIABETIC-RETINOPATHY; age-related macular degeneration; anecortave acetate; antiproliferation; bevacizumab; choroidal neovascularisation; integrins; pegaptanib; photodynamic therapy; ranibizumab; RTK inhibitors; small interfering RNA; squalamine lactate; triamcinolone acetonide; vascular endothelial growth factor; VEGF-Trap (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; CARTILAGE; RECEPTORS; NEUROPILIN-1; PHENOTYPE; APOPTOSIS; osteoarthritis; semaphorin-3A; neuropilin-1; chondrocyte metabolism; MMP13; AKT signaling (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; PIGMENT EPITHELIUM; VEGF; RELEASE; VIVO; ANGIOGENESIS; INTEGRINS; Lipid nanocapsules; Intracellular availability; Poorly soluble drugs; Cyclosporin A; Itraconazole; Neovascular ocular diseases (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO DETECTION; C-MET EXPRESSION; HPDL CELLS; HYPOXIA; RECEPTOR-2; MEDIATE; TISSUE; VEGF; Periodontal ligament; Vascular endothelial growth factor receptor-2; Molecular magnetic resonance imaging; Hypoxia; Animal models (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; GENE-EXPRESSION; UP-REGULATION; HYPOXIA; MELANOCYTES; ACTIVATION; TRANSCRIPTION; CONTRIBUTES; INVOLVEMENT; NF-kappa B; ROS; Melanoma; Tumor angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; PULMONARY-HYPERTENSION; DIVERGENT REGULATION; NITRIC-OXIDE; INDUCTION; GLOMERULONEPHRITIS; RECEPTOR; DISEASE; CELLS; vascular endothelial growth factor; platelet-derived growth factor; chronic hypoxia; renal growth factors (1)
ENDOTHELIAL GROWTH-FACTOR; KIDNEY-GRAFT RECIPIENTS; CYCLOSPORINE-A; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; MYCOPHENOLATE-MOFETIL; MEDICAL PROGRESS; KAPOSIS-SARCOMA; (1)
ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR HYPERTROPHY; ENDOCHONDRAL BONE-FORMATION; ARTICULAR CHONDROCYTES; CHONDROITIN SULFATE; MATRIX COMPONENTS; INDUCED APOPTOSIS; GLIAL-CELLS; FACTOR VEGF; IN-VIVO; Chondrocytes; Apoptosis; Cytoskeleton; Extracellular matrix; Growth factors; Microgravity (1)
ENDOTHELIAL GROWTH-FACTOR; LINDAU TUMOR-SUPPRESSOR; IN-VIVO; PROLYL HYDROXYLASES; EXPERIMENTAL GLOMERULONEPHRITIS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESANGIAL CELLS; RENAL FIBROSIS; HIF-ALPHA; cell transformation; erythropoietin; glomerular cells; renin; von Hippel-Lindau (1)
ENDOTHELIAL GROWTH-FACTOR; LIVER-TRANSPLANTATION; DENDRITIC CELLS; CANCER; CYCLOSPORINE; CARCINOMA; INTERLEUKIN-10; ANGIOGENESIS; PROGRESSION; RECIPIENTS; (1)
ENDOTHELIAL GROWTH-FACTOR; LONG-TERM SURVIVAL; SOLID HUMAN TUMORS; ENDOGLIN CD105; MICROVESSEL DENSITY; ADJUVANT CHEMOTHERAPY; INTERNATIONAL CONSENSUS; MONOCLONAL-ANTIBODIES; EXPRESSION; CELLS; High-risk breast cancer; Angiogenesis; High-dose chemotherapy; Immunohistochemistry; Molecular subtypes (1)
ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; FACTOR-C EXPRESSION; MOLECULAR REGULATION; GASTRIC-CANCER; COLON-CANCER; GENE MIA2; LYMPHANGIOGENESIS; ANGIOGENESIS; PROLIFERATION; apoptosis; VEGF; integrin; MAPK (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; BEVACIZUMAB AVASTIN; CEREBROVASCULAR ACCIDENTS; PHARMACOKINETICS; INJECTIONS; LUCENTIS; (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DISEASE; bevacizumab (Avastin); pegaptanib (Macugen); ranibizumab (Lucentis); ocular cells; antiproliferative (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INTRAVITREAL RANIBIZUMAB; DOSING REGIMEN; BEVACIZUMAB; THERAPY; IMPACT; Neovascular age-related macular degeneration; Spectral Domain Optical Coherence Tomography; Anti-vascular endothelial growth factor therapy; Clinical decision-making (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL ADENOCARCINOMA; PHASE-III; HEPATOCELLULAR-CARCINOMA; ANTIANGIOGENIC THERAPY; FACTOR VEGF; TUMOR; ANGIOGENESIS; MIGRATION; CANCER; leiomyosarcoma; receptor tyrosine kinase; small molecule inhibitor; PTK787/ZK222584; tumor; angiogenesis; VEGF; VEGF receptor (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; P70 S6 KINASE; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; TUMOR-GROWTH; CELLS; CAPECITABINE; CARCINOMA; (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; PAPILLARY THYROID-CANCER; SODIUM/IODIDE SYMPORTER EXPRESSION; TYROSINE KINASE INHIBITOR; HUMAN-BREAST-CANCER; HUMAN COLON-CANCER; PROSTATE-CANCER; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; Proteomics; biomarker; thyroid cancer; breast cancer; colorectal cancer; prostate cancer (1)
ENDOTHELIAL GROWTH-FACTOR; MICROVESSEL DENSITY; THYMIDINE PHOSPHORYLASE; UTERINE LEIOMYOMA; ANGIOGENESIS; EXPRESSION; INHIBITION; PROTEIN-1; PARACRINE; TISSUE; angiogenesis; myxoma; sarcoma; morphometry; vascular endothelial growth factor (1)
ENDOTHELIAL GROWTH-FACTOR; NEWLY-DIAGNOSED GLIOBLASTOMA; HIGH-GRADE GLIOMA; RECURRENT MALIGNANT GLIOMA; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; SINGLE-AGENT BEVACIZUMAB; RADIATION-THERAPY; ANTIANGIOGENIC THERAPY; TUMOR PROGRESSION; PLUS IRINOTECAN; glioma; radiotherapy; bevacizumab; angiogenesis; VEGF (1)
ENDOTHELIAL GROWTH-FACTOR; PHASE-II; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; STANDARD TREATMENT; MALIGNANT GLIOMA; OPEN-LABEL; GENE; RADIOTHERAPY; CONCOMITANT; (1)
ENDOTHELIAL GROWTH-FACTOR; PHOSPHOLIPID TRANSFER PROTEIN; BETA(3)-ADRENERGIC RECEPTOR GENE; LYMPHOCYTE-ACTIVATION GENE-3; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; DENSITY-LIPOPROTEIN CONVERSION; TISSUE-SPECIFIC EXPRESSION; TYROSINE-HYDROXYLASE GENE; APOLIPOPROTEIN-E GENE; ZNF202; SCAN; SDP1; PPARs; HDL (1)
ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; CORE VESICLE EXOCYTOSIS; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATIVE KV1.3 CHANNELS; CALCIUM-CHANNELS; CHLORIDE CHANNEL; MEMBRANE; PROTEIN; EFFECTOR; Rab GTPase; Rab27a; Ca(v)1.3; Protein interaction; Voltage dependence; MyRIP (1)
ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; HUMAN BRUCHS MEMBRANE; INDUCED RETINAL NEOVASCULARIZATION; CERIUM OXIDE NANOPARTICLES; MACULAR DEGENERATION AMD; TARGETED DRUG-DELIVERY; INDUCED RAT MODEL; LASER-INDUCED CNV; CHOROIDAL NEOVASCULARIZATION; Nanoparticles; Age-related macular degeneration; Proliferative diabetic retinopathy; Retinopathy of prematurity; Drug delivery; Gene delivery; EPR effect; RGD peptide (1)
ENDOTHELIAL GROWTH-FACTOR; PLATELET-ACTIVATING-FACTOR; POLYMERASE-CHAIN-REACTION; GENE FAMILY; EXPRESSION; CELLS; CANCER; THERAPY; DISEASE; NEOANGIOGENESIS; Ets 1; arthritis; real-time PCR; in situ hybridization; immunohistochemistry (1)
ENDOTHELIAL GROWTH-FACTOR; PLATELET-RICH PLASMA; MORPHOGENETIC PROTEIN-7; STROMAL CELLS; HYDROXYAPATITE; ANGIOGENESIS; bone substitutes; mesenchymal stem cells; green fluorescent protein; confocal scanning laser microscopy; cell migration; cell polarity (1)
ENDOTHELIAL GROWTH-FACTOR; POSITIVE DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; HIGH LACTATE LEVELS; MULTICELLULAR TUMOR; HUMAN MACROPHAGES; BREAST-CARCINOMA; PERIPHERAL-BLOOD; UP-REGULATION; CANCER-CELLS; spheroid; immune escape; dendritic cell; monocyte; lactic acid; lactate; tumor microenvironment (1)
ENDOTHELIAL GROWTH-FACTOR; PRELIMINARY BIOLOGICAL EVALUATION; PAMAM DENDRIMERS; POLY(AMIDOAMINE) DENDRIMERS; RETINAL NEOVASCULARIZATION; TYPE-1 RECEPTOR; HUMAN PLASMA; BINDING; PHARMACOKINETICS; FLUORESCENCE; angiotensin receptor blocker; half-life extension; PEGylation; PAMAM dendrimers; EXP3174; multivalency (1)
ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; SIMULATED MICROGRAVITY; CARCINOMA CELLS; EXTRACELLULAR-MATRIX; ANTITUMOR-ACTIVITY; BIOLOGICAL FUNCTIONS; INCREASES APOPTOSIS; TISSUE INHIBITORS; HUMAN-LYMPHOCYTES; growth factors; microgravity; protein kinases; extracellular matrix (1)
ENDOTHELIAL GROWTH-FACTOR; RECURRENT EPISTAXIS; CONTROLLED-TRIAL; YOUNGS PROCEDURE; TRANEXAMIC ACID; BEVACIZUMAB; LASER; DISEASE; THERAPY; CLOSURE; Hereditary hemorrhagic telangiectasia; HHT; Temporary nasal occlusion; tNO; Nd: YAG laser therapy; Epistaxis (1)
ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; TUMOR PROGRESSION; RAPAMYCIN; CANCER; CYCLOSPORINE; EFFICACY; THERAPY; TARGET; MODEL; (1)
ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; POTENTIAL BIOMARKERS; NATURAL-HISTORY; IN-VITRO; EXPRESSION; CELLS; ANGIOGENESIS; GENETICS; cmiRNA regulation; age-related macular degeneration; laser-induced choroidal neovascularization; biomarker (1)
ENDOTHELIAL GROWTH-FACTOR; RHEUMATOID-ARTHRITIS PATIENTS; COLLAGEN-INDUCED ARTHRITIS; METASTASIS; LIGAND-21; ANTIGEN; ALPHA; MICE; IL-6; Chemotactic factors; Cytokines and inflammation; Fibroblast; Inflammation; CCR7; Angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; ROS 17/2.8 CELLS; SIMULATED MICROGRAVITY; INCREASES APOPTOSIS; MAMMALIAN-CELLS; ANGIOTENSIN-II; JURKAT CELLS; ADHESION; OSTEOPONTIN; WEIGHTLESSNESS; Thyroid cancer; Extracellular matrix; Apoptosis; Cytoskeleton; Weightlessness; Microgravity; Hypergravity; Vibration (1)
ENDOTHELIAL GROWTH-FACTOR; SMOOTH MUSCLE ACTIN; MACULAR DEGENERATION; TRANSGENIC MICE; VISUAL FUNCTION; FACTOR-BETA; CHOROIDAL NEOVASCULARIZATION; IN-VIVO; CELLS; EXPRESSION; Age-related macula degeneration; Transforming growth factor-beta; Transgenic mice; Photoreceptor apoptosis; Angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; EPI-NCSC; MULTIPOTENT; DIFFERENTIATION; MAINTENANCE; RECOVERY; MODEL; TRANSPLANTATION; (1)
ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; TUMOR-CELLS; SUNITINIB; CANCER; RECEPTORS; MIGRATION; IDENTIFICATION; RESISTANCE; PATTERN; (1)
ENDOTHELIAL GROWTH-FACTOR; SUBCHONDRAL VASCULAR SYSTEM; C-TERMINAL DOMAIN; STROMAL CELLS; ENDOCHONDRAL OSSIFICATION; OSTEOARTHRITIC CARTILAGE; PARATHYROID-HORMONE; HUMAN COLLAGENASE-3; GENE-EXPRESSION; UP-REGULATION; mesenchymal stem cells; chondroprogenitor cells; articular cartilage; regenerative medicine; regulatory factors (1)
ENDOTHELIAL GROWTH-FACTOR; Surrogate marker; Peripheral vascular disease; Angiogenesis; Arteriogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; SURVIVAL; IMPACT; VARIABLES; Renal cell carcinoma; Thrombocytosis; Preoperative platelet level; Nephrectomy; Prognosis; Cancer-specific survival (1)
ENDOTHELIAL GROWTH-FACTOR; TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TRANS 3,4,5,4'-TETRAMETHOXYSTILBENE DMU-212; CHEMOPREVENTIVE AGENT RESVERATROL; SQUAMOUS-CELL CARCINOMA; COLON-CANCER CELLS; IN-VITRO; ELLAGIC ACID; TUMOR-GROWTH; 4-HYDROXYBENZYL ALCOHOL; angiogenesis; natural phenolic compounds; structure-activity relationship; synthesis (1)
ENDOTHELIAL GROWTH-FACTOR; TRANSPLANTATION; BIOPSIES; DYSFUNCTION; (1)
ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; VASCULAR-PERMEABILITY FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; EXPERIMENTAL LIVER METASTASIS; FACTOR-ALPHA; CELL GROWTH; FACTOR RECEPTOR; IN-VIVO; ANGIOGENESIS; (1)
ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; LYMPH-NODE METASTASIS; BREAST-CANCER; IN-VITRO; SIMULATED MICROGRAVITY; PROGNOSTIC MARKER; PHASE-II; CARCINOMA; LINES; Thyroid cancer; Sunitinib; Cytokines; Radiation; VEGF; Gene expression (1)
ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; NUDE-MICE; THERAPY; ANGIOGENESIS; CARCINOMA; RADIATION; APOPTOSIS; DISEASE; vascular targeting; pancreatic cancer; cytoskeleton; orthotopic tumor model; dorsal skinfold chamber (1)
ENDOTHELIAL GROWTH-FACTOR; VASCULAR SMOOTH-MUSCLE; PDGF-B; TUMORS; RECRUITMENT; EXPRESSION; CARCINOMA; PERICYTES; CELLS; BETA; haemangiopericytoma; Hashimoto's disease; pericyte; PDGF receptor; VEGF receptor (1)
ENDOTHELIAL GROWTH-FACTOR; VESSEL THROMBOSIS; FACTOR EXPRESSION; CANCER-THERAPY; IN-VIVO; SIROLIMUS; CELLS; TRANSPLANTATION; MICROANGIOPATHY; PATHWAY; (1)
ENDOTHELIAL PROGENITOR CELLS; COLON-CANCER CELLS; GAMMA-LIGANDS; GROWTH-FACTOR; METRONOMIC CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; ANGIOSTATIC THERAPY; ADVANCED MELANOMA; COX-2 INHIBITORS; CLINICAL-TRIALS; PPAR; stroma; cancer; targeting; biomodulation; metronome chemotherapy; thiazolidinedione (1)
ENDOTHELIAL PROGENITOR CELLS; IN-VITRO HEMOCOMPATIBILITY; STAINLESS-STEEL STENT; PROTEIN ADSORPTION; VASCULAR GRAFTS; HUMAN THROMBOMODULIN; ADSORBED FIBRINOGEN; PLATELET-ADHESION; CARDIOPULMONARY BYPASS; ARTIFICIAL SURFACES; tissue engineering; cardiovascular; biomaterials; biofunctionalization (1)
ENDOTHELIAL PROGENITOR CELLS; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; BONE-MARROW; STIMULATING FACTOR; FUNCTIONAL RECOVERY; BRAIN-INJURY; STROKE; RATS; cerebral ischemia; elastase; granulocyte colony-stimulating factor; hematopoietic stem cell mobilization; pluripotent stein cells (1)
ENDOTHELIN-1; CYCLOSPORINE; Tacrolimus; Secondary glaucoma; Aplastic anemia; Transientmyopia; Bilateral angle closure glaucoma (1)
ENDOTHELIN-1 GENE; HYPOXIA; EXPRESSION; SIGNAL; MECHANOTRANSDUCTION; MACROPHAGES; MECHANISMS; RECEPTORS; SUCCINATE; FIBROSIS; (1)
Endothelin, Reninsystem, knock-out, pharmakologischer Antargonismus (1)
Endothelin, retina, photoreceptors, neuroprotection (1)
Endothelium - Bradykinin - ECIS - Permeability - Transcellular transport (1)
ENDOTHELIUM-DEPENDENT RELAXATION; ARTERY-OCCLUSION; MULTICENTER; ARTERIOLES; arterioles; betulinic acid; ischemia-reperfusion injury; reactive oxygen species; retina (1)
Endothelzellen, Polyurethan, Titanbeschichtung, Perfusionsanlage, ventrikuläre Unterstützungssysteme, Gefäßprothesen, endothelial Cells, Polyurethane, titaniferously coating biocompatibility, bioreactor, ventricular assist devices, vascular grafts (1)
Endothermic energy transfer; Photoluminescence; Phosphorescence; Ir(ppy)3; PtOEP; OLED (1)
ENDOTOXIN-INDUCED CHOLESTASIS; NITRIC-OXIDE SYNTHASE; KUPFFER CELLS; ANTIARRHYTHMIC DRUGS; ORGANIC-ANIONS; PERFUSED LIVER; CARDIAC-OUTPUT; HEPATOCYTES; TRANSPORT; SEPSIS; excretion rate; extraction rate; gadolinium chloride; indocyanine green; lipopolysaccharides; perfused liver (1)
ENDOVASCULAR ANEURYSM REPAIR; ABDOMINAL AORTIC-ANEURYSM; CT ANGIOGRAPHY; FOLLOW-UP; COMPUTED-TOMOGRAPHY; II ENDOLEAK; SURVEILLANCE; EVAR; EMBOLIZATION; METAANALYSIS; contrast-enhanced ultrasound; follow-up-check; endovascular management of aorta; aortic aneurysms; endovascular ultrasound; neovascularisation of carotid plaque (1)
ENDOVASCULAR ANEURYSM REPAIR; CAROTID-ARTERY DISSECTION; CODED DUPLEX SONOGRAPHY; DOPPLER SONOGRAPHY; FOLLOW-UP; B-FLOW; ANGIOGRAPHY; EXPERIENCE; PITFALLS; Dissection; contrast-enhanced ultrasound; MS-CT (1)
ENDOVASCULAR ANEURYSM REPAIR; COMPUTED-TOMOGRAPHY; DUPLEX ULTRASOUND; SURVEILLANCE; ENDOLEAK; CT; Kontrastmittelsonographie; Farbkodierte Duplexsonographie; Aortenaneurysma; Endoleakklassifikation; Ultraschallausbildung (1)
ENDOVASCULAR ANEURYSM REPAIR; ENDOGRAFT FIXATION; STENT-GRAFTS; NECK ANATOMY; II ENDOLEAK; SYSTEM; COMPLICATIONS; INTERVENTION; PREVENTION; MIGRATION; endoanchors; hostile neck; EVAR; TEVAR; type I endoleak (1)
ENDOVASCULAR INTERVENTIONS; VASCULAR INTERVENTIONS; MR-ANGIOGRAPHY; FIELD-STRENGTH; PLACEMENT; CATHETERS; ARTIFACTS; FERROMAGNETISM; VISUALIZATION; ANGIOPLASTY; magnetic resonance, guidance; magnetic resonance, rapid imaging; stents and prostheses (1)
ENDOVASCULAR MANAGEMENT; BIFURCATION; STENOSES; ANEURYSM; OUTCOMES; Occlusive disease; Atherosclerosis; Infrarenal; Aorta; Covered stent; Endograft (1)
ENDOVASCULAR REPAIR; GRAFT; ANEURYSM; DISSECTION; MANAGEMENT; ENDOLEAKS; ARTERY; Scallops; Stentgraft with fenestration; Stentgraft with branches; Aortic arch; Endovascular (1)
ENDOVASCULAR REPAIR; INTERNATIONAL REGISTRY; DISSECTION IRAD; EXPERIENCE; aortic dissection; type B dissection; post-dissection aneurysm; thoracoabdominal aortic aneurysm; fenestrated stent-graft; branched stent-graft; thoracic endovascular aortic repair (1)
ENDOVASCULAR REPAIR; MANAGEMENT; SOCIETY; aortic stent prosthesis; endovascular treatment; type-B-dissection (1)
ENDOVASCULAR REPAIR; REPLACEMENT; ANEURYSM; RECONSTRUCTION; DISSECTION; ARTERY; SHUNT; (1)
ENDOVASCULAR REPAIR; STENT; EXPERIENCE; abdominal aortic aneurysm; celiac artery; fenestrated stent-graft; juxtarenal aneurysm; renal arteries; superior mesenteric artery; suprarenal aneurysm; visceral arteries (1)
ENDOVASCULAR REPAIR; STENT-GRAFTS; ENDOGRAFT; ENDOLEAK; COMPLICATIONS; DURABILITY; EXPERIENCE; MIGRATION; OUTCOMES; EVAR; Fenestrated Anaconda aortic cuff (1)
; endovascular techniques; Academy for Research and Education of the German Society for Vascular Surgery; training; certification (1)
ENDOVASCULAR TREATMENT; COIL EMBOLIZATION; COVERED STENTS; SINGLE-CENTER; FOLLOW-UP; TRANSARTERIAL EMBOLIZATION; ARTERIOVENOUS-FISTULAS; DETACHABLE BALLOONS; EXPERIENCE; MANAGEMENT; CCF; Endovascular; Flow diverter; Pipeline; p64 (1)
END-POINT DEFINITIONS; SAPIEN 3 ULTRA; AORTIC-VALVE; 30-DAY OUTCOMES; EVOLUT PRO; REPLACEMENT; IMPLANTATION; PROSTHESIS; aortic stenosis; femoral; MSCT; TAVI; transoesophageal echocardiogram (1)
END-STAGE ANKLE; ARTHRODESIS; ARTHROPLASTY; REPLACEMENT; OUTCOMES; Arthrosis; Ankle prosthesis; Arthrodesis; Joint replacement; Prosthetic models (1)
Enediynes, Bergman cyclisations, Electronic substituent effects, Alkynes, DNA cleavage agents, Antibiotics, Cytotoxic compounds (1)
Energieeffizienz, Energiesicherheit, ökologische Effizienz, Effizienzsteigerung, Nachhaltigkeit, Russland, Energiesuffizienz, Energiestrategie (1)
ENERGIES; MODEL; Solvation; Distribution coefficients; COSMO-RS; SAMPL5; Molecular modeling; Molecular simulation (1)
Energieübertragung, elektrische Energie, Leitungsverlust, Wärmeverlust, Transformator, Hochspannung, Niederspannung (2)
ENERGY COMPTON-SCATTERING; NUCLEON POLARIZABILITIES; MAGNETIC POLARIZABILITIES; LAMB SHIFT; PHOTONS; 50-MEV (1)
ENERGY DECOMPOSITION SCHEME; REACTION FORCE; GAS-PHASE; FLUORIDE; BOND; EFFICIENT; MICROSOLVATION; POLYSULFATES; ORBITALS; ETHERS; (1)
Energy efficiency, Carbon emissions, Corporate energy management, Corporate real estate management (CREM), Multiple regression, Wholesale and retail stores (1)
ENERGY EFFICIENCY; LOSS AVERSION; INFRASTRUCTURE; DIFFUSION; CHOICE; PREFERENCES; UNCERTAINTY; TECHNOLOGY; INNOVATION; ECONOMICS; Market failure; Alternative fuels; Natural gas vehicles (1)
ENERGY-ELECTRON DIFFRACTION; CO; SPECTROSCOPY; ALPHA-CR2O3; FILMS; CR2O3(111)/CR(110); CHROMIUM; FTIR; (1)
ENERGY-EXPENDITURE; SEASONAL-VARIATION; SELF-REPORTS; CUT-POINTS; TIME; VALIDITY; QUESTIONNAIRE; HOUSEHOLD; RELIABILITY; CALIBRATION; Energy expenditure; Sitting time; Behaviour change; Measurement; Exposure assessment; Ecological momentary assessment; Public health (1)
ENERGY FUNCTIONS; PREDICTION; EPISTASIS; SPECIFICITY; STABILITY; EVOLUTION; (1)
ENERGY-GAP STRUCTURE; ANDREEV REFLECTION; JOSEPHSON-JUNCTION; MAGNETIC-FIELDS; BILLIARDS; PROXIMITY; ARRAY; MAGNETOTRANSPORT; CONDUCTANCE; ELECTRODES; (1)
ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTIONS; (1)
ENERGY-GAP STRUCTURE; SUPERCURRENT; QUANTIZATION; CURRENTS; ballistic transport; critical currents; Doppler shift; III-V semiconductors; indium compounds; Josephson effect; metal-insulator boundaries; niobium; semiconductor quantum wells (1)
ENERGY IDENTITIES; REGULARITY; (1)
ENERGY IDENTITIES; SPINORS; MANIFOLDS; HYPERSURFACES; REGULARITY; EQUATIONS; SURFACES; OPERATOR; SURGERY; METRICS; (1)
Energy imports, Successive oligopolies, Storage, Trade policy (1)
ENERGY-LEVEL ALIGNMENT; METAL WORK FUNCTION; CHARGE-TRANSPORT; CONDUCTANCE; CONTACTS; PHOTOEMISSION; INTERFACES; AU; (1)
Energy level excitation; Molecular orientation (of iodine chloride, magnetic pendular states of); Magnetic field (pendular alignment of paramagnetic mols. in uniform); Magnetic moment (pendular alignment of paramagnetic mols. in uniform magnetic fields); Fluorescence (laser-induced, of iodine chloride, magnetic pendular states of); pendular alignment paramagnetic mol magnetic field (1)
Energy level (excited singlet states, in biphenylene); Fluorescence (of biphenylene excited singlet states); Optical absorption (picosecond, of biphenylene excited singlet states); singlet state biphenylene fluorescence (1)
Energy level (forbidden, in polar polyene systems, 2-photon transition in relation to); Photon (transition of 2, in polar mols.); Energy level transition (two-photon, of polar mols., mechanism of); two photon transition polar mol (1)
ENERGY-LOSS; ELECTROMAGNETIC CORRECTIONS; SCATTERING; HADRONS; DISTRIBUTIONS; DEUTERIUM; MATTER; ELECTROPRODUCTION; LEPTOPRODUCTION; COLLISIONS; (1)
ENERGY-LOSS; FRAGMENTATION FUNCTIONS; COLOR TRANSPARENCY; FLUX-TUBE; MATTER; HADRONS; ELECTROPRODUCTION; BREMSSTRAHLUNG; SCATTERING; MODEL; (1)
ENERGY-LOSS SPECTROSCOPY; OF-THE-LITERATURE; TRANSMISSION ELECTRON-MICROSCOPY; CIRCULATING FIBROCYTES; ULTRAFINE PARTICLES; CONTRAST AGENTS; DERMOPATHY; FAILURE; EXPOSURE; CELLS; (1)
ENERGY-METABOLISM; RAT HEARTS; SYSTEM; CARDIOMYOPATHY; INFARCTION; FAILURE; myocardium; creatinine kinase; lactate dehydrogenase; isoenzymes; LV dysfunction (1)
ENERGY MINIMIZATION; CRYSTAL PLASTICITY; RELAXATION; DEFORMATION; MODELS; Elastoplasticity; Single slip; Quasiconvexity; Relaxation (1)
ENERGY MINIMIZATION; ELASTICITY; MICROSTRUCTURES; CONVERGENCE; F=(FFP)-F-E; CONSTRAINTS; DERIVATION; LIMIT; (1)
ENERGY MINIMIZATION; FINITE; MICROSTRUCTURES; EVOLUTION; APPROXIMATION; PRINCIPLES; POTENTIALS; Pressure-dependent plasticity; Relaxation; Convex envelope; Microstructures (1)
ENERGY-MOMENTUM-TENSOR; CHIRAL PERTURBATION-THEORY; GAUGE FIELD-THEORIES; LATTICE QCD; FINITE-VOLUME; HADRON MASSES; HIGGS-BOSON; SCATTERING; SCALAR; DECAY; (1)
ENERGY-MOMENTUM TENSOR; GRADIENT-FLOW; (1)
Energy performance certificates, Green premia, Energy efficiency, Retrofits, Value effect, Extreme Value Regression, Generalized Additive Models, Tail Risk, Risk Management (1)
Energy Policy, Energy efficiency measures, Sustainable buildings, Energy costs, Financial analysis, Property value (1)
ENERGY REFLECTANCE MEASUREMENTS; CONDUCTIVE HEARING-LOSS; HUMAN MIDDLE-EAR; INTRASUBJECT VARIABILITY; NETWORK MODEL; OTITIS-MEDIA; ADULTS; FREQUENCY; DIAGNOSIS; BEHAVIOR; (1)
ENERGY-REPRESENTATION; FORCE-FIELD; MICELLES; WATER; SOLVATION; MIXTURES; (1)
ENERGY; RS; APPROXIMATION; SIMULATION; TURBOMOLE; Molecular simulation; COSMO-RS; Liquid-liquid equilibria; Solubility; Lower critical solution temperature (1)
ENERGY THEOREM; PROOF; MASS; (1)
ENERGY-TRANSFER; BICHROMOPHORIC MOLECULES; QUANTUM COHERENCE; ORGANIC PHOTOVOLTAICS; PHOTON STATISTICS; EXCITON MODEL; POLY(3-HEXYLTHIOPHENE); LIGHT; CHROMOPHORES; FLUORESCENCE; (1)
Energy transfer; Decay time; Chloride sensor (1)
ENERGY-TRANSFER; DIFFUSION; PATHWAYS; EMISSION; ANNIHILATION; STATISTICS; MOLECULES; DYNAMICS; EMITTERS (1)
ENERGY-TRANSFER; ELECTRONIC EXCITATIONS; CONJUGATED POLYMERS; MOLECULAR-DYNAMICS; PHOTOPHYSICS; LOCALIZATION; POLARIZATION; RELAXATION; MODELS; (1)
ENERGY-TRANSFER; EMISSION; SPECTROSCOPY; DYNAMICS; CHROMOPHORES; PATHWAYS; single molecules; plasmonic enhancement; photon antibunching; time-correlated single photon counting (1)
energy transfer in light-harvesting complexes, FMO-complex, 2d echo spectroscopy, wave packet approach, ballistic transport, Aharonov-Bohm interferometer (1)
ENERGY-TRANSFER; LADDER POLYMER; TRIPLET; FLUORESCENCE; CHROMOPHORES; EMISSION; RECOMBINATION; POLY(3-HEXYLTHIOPHENE); PHOSPHORESCENCE; DISSOCIATION; conjugated polymers; exciton annihilation; exciton diffusion; photon statistics; single-particle spectroscopy (1)
ENERGY-TRANSFER; LIGHT; SUBSTITUTION; TRANSITION; REDUCTION; ARYLATION; COMPLEXES; IODIDES; C-H arylation; electron transfer; energy transfer; photocatalysis; polycyclic aromatic hydrocarbons (1)
ENERGY-TRANSFER; LUMINESCENCE; GLUCOSE; PROBE; TERBIUM(III); LIFETIME; heavy metal quenching; time-resolved fluorescence imaging; single photon counting technique; europium tetracycline hydrogen peroxide ternary complex; copper determination (1)
ENERGY-TRANSFER MEASUREMENTS; TRASTUZUMAB HERCEPTIN; ZD1839 IRESSA; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; TRANSFER EFFICIENCY; CARCINOMA-CELLS; TUMOR-CELLS; EGF; FLOW; breast cancer treatment; erbB-receptors; HER2/neu; EGFR; Herceptin; receptor interaction; FRET; cell cycle; proliferation (1)
ENERGY-TRANSFER; POLYMER-CHAINS; CONFORMATION; FLUORESCENCE; EXCITONS; FILM; intramolecular strain; macrocycles; organic electronics; single-molecule spectroscopy (1)
ENERGY-TRANSFER; TRIPLET-STATE; ACETYLACETONE; COMPLEXES; TERBIUM; LIFETIME; FILMS; EXCITATION; MECHANISM; DYNAMICS; Time-gated fluorimeter; Luminescence quantum yield; Luminescence lifetime; Phosphorescence reference standard; Terbium(III)-acetylacetonate chelate; Phosphorescence quantum yield calculation (1)
energy transport, charge transport, polymer solar cells (1)
ENGAGED PARTICIPATION; INTERNET USE; LITERACY; CHILDREN; ONLINE; ASTHMA; RECRUITMENT; SEEKING; NEEDS; allergy prevention; babies; infants; evidence; health information; parents; decision-making (1)
ENGINEERED ADIPOSE-TISSUE; STEM-CELLS; 3T3-L1 CELLS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; TERMINAL DIFFERENTIATION; IV COLLAGEN; PREADIPOCYTES; ADIPOCYTES; Ascorbic acid; Adipogenesis; Mesenchymal stromal cells; Differentiation; Collagen (1)
ENGINEERED CARTILAGE; KNEE; DEFECTS; TISSUE; MODELS; REHABILITATION; MICROFRACTURE; IMPLANTATION; OUTCOMES; (1)
ENGINEERED NANOPARTICLES; REFRACTIVE-INDEX; SENSORS; surface plasmon resonance; imaging; nanoparticle; sensor (1)
Engineering Method, Model-Driven Engineering, Digital Twin, Software Architecture, Manufacturing (1)
ENGLAND (1)
Englisch , Roman , Gouvernante <Motiv> , Geschichte 1798-1898 , Governess , Alterität , Konformität , britischer Roman 1798 - 1898 , governess , alterity , conformity , British novel 1798-1898 (1)
ENGLISHES; (1)
English in education; language attitudes; nativization; features; sociolinguistic profile; variety status; World Englishes (1)
ENGLISH-LANGUAGE LEARNERS; TRAINING PHONOLOGICAL AWARENESS; 2-YEAR FOLLOW-UP; KINDERGARTEN INTERVENTION; INSTRUCTION INTERACTIONS; EXPLICIT INSTRUCTION; SPANISH INTERVENTION; LITERACY ACQUISITION; PANELS METAANALYSIS; WORD RECOGNITION; reading intervention; long-term; comprehension; decoding; phonics; phonemic awareness; fluency (2)
ENGULFMENT RECEPTOR DRAPER; CELL CORPSE ENGULFMENT; PREFRONTAL CORTEX; D-SERINE; SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; POSTMORTEM BRAIN; SCHIZOPHRENIA; GLIA; DEPRESSION; astrocytes; neuropsychiatric disorders; pruning; synapse remodelling (1)
ENHANCED ANTIOPIATE ACTIVITY; ASYMMETRIC-SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; EFFICIENT SYNTHESIS; PEPTIDE MOLECULES; ORGANIC-SYNTHESIS; TASTE PROPERTIES; BUILDING-BLOCKS; CYCLOPROPANE; ALANINE; alpha-amino acids; beta-amino acids; beta-alanine; aminocyclopropanecarboxylic acid (1)
ENHANCED ANTITUMOR-ACTIVITY; COLON-CARCINOMA CELLS; MULTICELLULAR SPHEROIDS; GROWTH-INHIBITION; IN-VITRO; PRECLINICAL EVALUATION; ANTINEOPLASTIC AGENTS; COLORECTAL-CANCER; MONOLAYER-CULTURE; TUMOR SPHEROIDS; cell-based assay; 3-D culture; spheroid; antitumor drug testing; cell viability (1)
ENHANCED FLUORESCENCE; SENSORS; COMPLEX; ETHERS; METALS; STATES; IONS (1)
ENHANCED LUMINESCENT INTENSITY; OPTICAL-PROPERTIES; QUANTUM YIELDS; CORE; NANOCRYSTALS; PARTICLES; PERSPECTIVES; OPTOGENETICS; CHALLENGES; MORPHOLOGY; (1)
ENHANCED MR-ANGIOGRAPHY; CONTRAST AGENT; RENAL-INSUFFICIENCY; FEASIBILITY; GADODIAMIDE; STENOSES; adults; angiography; magnetic resonance angiography (MRA); magnetic resonance imaging (MRI); pelvis; vascular (1)
ENHANCED MR-ANGIOGRAPHY; FOLLOW-UP; MULTICENTER TRIAL; NITINOL STENT; PALMAZ STENT; BALLOON; ANGIOPLASTY; MANAGEMENT; EXPERIENCE; STENOSES; arteries; peripheral; arteries, transluminal angioplasty; arteries, stents and prostheses; interventional procedures (1)
ENHANCED PHOTOCATALYTIC ACTIVITY; CARBON NITRIDE; VISIBLE-LIGHT; POLY(HEPTAZINE IMIDES); TRANSIENT PHOTOCURRENT; FLAVIN PHOTOOXIDATION; HYDROGEN-PRODUCTION; CHARGE-TRANSFER; SEMICONDUCTOR; CATALYSIS; Carbon nitride; Photocatalysis; CO2; Flavins; Heterojunctions (1)
ENHANCED RAMAN-SCATTERING; COMPLEX MATERIALS; JUNCTIONS; TRANSPORT; TIME; NANOSTRUCTURES; APPROXIMATION; SPECTROSCOPY; CONDUCTION; PLASMONS; (1)
ENHANCED RAMAN-SCATTERING; NOBLE-METALS; LIGHT; GENERATION; INTERFERENCE; MICROSCOPY; EXCITATION; DYNAMICS; (1)
ENHANCED RAMAN-SCATTERING; RESONANCE SPECTROSCOPY; METAL NANOPARTICLES; OPTICAL-PROPERTIES; FIELD; LIGHT; FILMS; LOCALIZATION; MICROSCOPY; SERS; (1)
ENHANCED RECOVERY; ACL RECONSTRUCTION; KNEE; TELEREHABILITATION; HISTORY; GAME; serious gaming; knee trainer; games; experimental; exercise therapy; physical and rehabilitation medicine; anterior cruciate; ligament reconstruction; knee injuries (1)
enhanced recovery after surgery (ERAS); on-table extubation; elective cardiac surgery; cardiac anesthesia; nausea and vomiting; postoperative cognitive dysfunction; patient satisfaction (1)
Enhanced recovery after surgery (ERAS), PROMS (patient reported outcome measures), Total knee arthroplasty (TKA), Knee isokinetic muscle strength, Biodex (1)
enhanced recovery after surgery (ERAS®), thoracic surgery, lung surgery, perioperative care, fast-track surgery (1)
Enhanced recovery after surgery (ERAS®); thoracic surgery; perioperative care; fast-track surgery (1)
Enhanced recovery after surgery (ERAS) · Total hip arthroplasty (THA) · Randomized clinical trial (RCT) · Timed up and go test (TUG) (1)
; Enhanced recovery; Local infiltration analgesia; Inpatient length of stay; Treatment quality; Organizational processes (1)
ENHANCED SHOT-NOISE; QUANTUM POINT CONTACTS; ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTIONS; METAL; TRANSPORT; SUPERCURRENT; WIRES (1)
ENHANCED SPONTANEOUS EMISSION; INTERFACE ROUGHNESS; OPTICAL HYPERLENS; ALLOY-DISORDER; MOLECULES; METAL; SCATTERING; NANOTUBES; SURFACE; INDEX; (1)
ENHANCED ULTRASONOGRAPHY; HEPATOCELLULAR-CARCINOMA; PROSPECTIVE MULTICENTER; HEPATIC METASTASES; ULTRASOUND; SONOGRAPHY; LESIONS; PHASE; DISEASE; AGENTS; liver tumors; malignant tumor; contrast harmonic imaging; quantitative contrast enhancement (1)
ENHANCED ULTRASOUND CEUS; CLINICAL-PRACTICE RECOMMENDATIONS; DEGUM MULTICENTER TRIAL; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC PERFORMANCE; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; HEPATIC-LESIONS; ULTRASONOGRAPHY; SONOGRAPHY; CEUS; MRI; HCC; liver-specific contrast media; focal liver lesions (1)
ENHANCED ULTRASOUND CEUS; FOCAL LIVER-LESIONS; DOPPLER PROBE; EXPERIENCE; QUANTIFICATION; RECONSTRUCTION; COMPLICATIONS; SARCOMA; SURGERY; HEAD; microcirculation; perfusion; free flaps; pedicled flaps; perforator flaps; flap monitoring (1)
ENHANCED ULTRASOUND CEUS; LESIONS; US; ANGIOGENESIS; MODEL; Abdomen; contrast-enhanced ultrasound (CEUS); BR55 (R); SonoVue (R); humanized tumour mice (HTM) (1)
ENHANCEMENT; NANOPARTICLES; SENSITIVITY; SENSOR; BIOSENSOR; THROMBIN; (1)
ENHANCE; PREQUESTIONS; RETENTION; BENEFITS; LEARNERS; ERRORS; TESTS; LONG; testing effect; pretesting effect; repeated guessing; elaboration (1)
ENHANCER-BINDING PROTEIN; EPIDERMAL BARRIER; NITRIC-OXIDE; IN-VIVO; SODIUM; TRANSCRIPTION; RECEPTORS; INDUCTION; STRESS; TISSUE; (1)
ENHANCING HUMORAL RESPONSES; NEUTRALIZING ANTIBODIES; GERMINAL CENTER; VACCINE; CELLS; HIV vaccine; silica nanoparticles; stabilized envelope trimer; Env (1)
Enlarged vestibular aqueduct, Hearing loss, Pathogenic variants, SLC26A4, TJP2 (1)
En Ligand Complexes, Transfer Reactions, Polypnictogen, Phosphorus, Arsenic, Atimony (1)
eNOS, iNOS, NO, Isofluran, Sevofluran, Hypoxie, zerebrale Vasodilatation, humane zerebrale Endothelzellen, isoflurane, sevoflurane, hypoxia, cerebral vasodilatation, human cerebral endothelial cells (1)
ENRICHED ACOUSTIC ENVIRONMENT; AUDITORY-CORTEX; HEARING-LOSS; REORGANIZATION; FLUCTUATIONS; EXCITABILITY; TRAUMA; BRAIN; Plasticity, neuronal; Biofeedback; Tinnitus; Electroencephalography; Magnetoencephalography (1)
ENRICHED ACOUSTIC ENVIRONMENT; DOUBLE-BLIND; CLINICAL GUIDELINES; HEARING-AIDS; COMPLEXITY; MELATONIN; THERAPY; AMPLIFICATION; METAANALYSIS; STIMULATION; tinnitus; evidence; meta-analysis; treatment guidelines; evidence-based medicine; living guideline; decision support system (1)
ENRICHMENT CULTURES; ENVIRONMENTS; MICROARRAY; IDENTIFICATION; COMMUNITIES; CULTIVATION; RESISTANCE; BACTERIA; FACILITY; UNIFRAC; (1)
EN-Schlagwörter: Salience; Landmarks; Survey; In-Situ study; PLS Path Modeling; Structural Equation Models DE-Schlagwörter: Salienz; Landmarken; Fragebogen; In-Situ Experiment; PLS Path Modeling; Strukturgleichungsmodellierung (1)
ENSEMBLES; Non-negative matrix factorization (NMF); Rule extraction; Interpretability; Industrial process monitoring (1)
ENSURING QUALITY INFORMATION; BRAIN-TUMOR INFORMATION; HEALTH INFORMATION; INTERNET; RESOURCES; LANGUAGE; (1)
ENTANGLEMENT; (1)
ENTANGLEMENT; LOCALIZATION; ENTROPY (1)
ENTANGLEMENT MEASURES; DENSITY-MATRICES; SEPARABILITY; STATES; CRITERION; FRACTION; (1)
ENTANGLEMENT MONOTONES; SYSTEMS; STATE; (1)
ENTANGLEMENT; QUBIT; (1)
Entanglement spectrum, Graphene, Graphene bilayers (1)
Enteignung / Entschädigung , Rückgabe , Eigentum , Petitionsausschuss , Ombudsmann , Eigentumsrecht , Immobilien , EMRK , expropriation , return , property , reprivatization (1)
Enteignung, Entschädigung, Zwangsverkauf, Rückübertragung (1)
ENTERAL NUTRITION; ESPEN GUIDELINES (1)
ENTERICA SEROVAR TYPHIMURIUM; STREPTOMYCIN-PRETREATED MICE; III SECRETION; EFFECTOR PROTEINS; EPITHELIAL-CELLS; BACTERIAL INTERNALIZATION; INTRACELLULAR REPLICATION; DEPENDENT MECHANISM; EMBRYO FIBROBLASTS; VESICLE TRANSPORT; (1)
ENTERIC NERVOUS-SYSTEM; RAT MYENTERIC PLEXUS; NOREPINEPHRINE RELEASE; FACTOR-ALPHA; BLOOD-FLOW; IL-6 SECRETION; MURINE SPLEEN; TNF-ALPHA; CLASS-II; NERVES; (1)
Enterobacterales; Pseudomonas aeruginosa; metallo-beta-lactamases; ceftazidime-avibactam; zinc; antimicrobial susceptibility testing; Phoenix; Micronaut (1)
Enterobacter cloacae , Transkriptionsfaktor , efflux , Antibiotikaresistenz , Rob , efflux , antimicrobial resistance , Enterobacter cloacae (1)
ENTEROCOCCAL SURFACE PROTEIN; FUSOBACTERIUM-NUCLEATUM; DENTAL BIOFILM; SUBGINGIVAL MICROBIOTA; SUPRAGINGIVAL PLAQUE; PHOTODYNAMIC THERAPY; INITIAL COLONIZATION; STREPTOCOCCUS-MUTANS; ETHIDIUM MONOAZIDE; FAECALIS; Poly-species biofilm; Actinomyces naeslundii; Fusobacterium nucleatum; Enterococcus faecalis; Real-time PCR (1)
ENTEROCOCCUS-FAECALIS BIOFILM; RESISTANCE; THERAPY; DISINFECTANTS; ANTISEPTICS; COMBINATION; MECHANISMS; EMERGENCE; LTPR; cold atmospheric plasma; biofilm; binary combination; antibacterial effects (1)
ENTEROCOCCUS-FAECALIS; CALCIUM HYDROXIDE; DENTINAL TUBULES; ENDODONTIC TREATMENT; ANTIMICROBIAL EFFICACY; SCANNING-ELECTRON; BOVINE DENTIN; CHLORHEXIDINE; DISINFECTION; BACTERIA; Enterococcus faecalis; NaOCl; photodynamic therapy; root canal disinfection (1)
ENTEROCOCCUS-FAECALIS; DISINFECTION; LASER; smear layer; dentin; disinfection; ultrasonics; lasers; sodium hypochlorite; ethylenediaminetetraacetic acid (1)
ENTEROCOCCUS-FAECALIS; IN-VITRO; EX-VIVO; CALCIUM HYDROXIDE; SINGLET OXYGEN; THERAPY; BIOFILM; TEETH; MEDICAMENTS; MECHANISMS; photodynamic; Enterococcus faecalis; endodontics; optical fiber; transmission (1)
ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; CONJUGATION FUNCTIONS; SUBINHIBITORY CONCENTRATIONS; INDUCIBLE CONJUGATION; NUCLEOTIDE-SEQUENCE; PAD1; PROTEIN; REGION; CELLS; (1)
Enterprise Application Integration (EAI) - zentrale Koordination - Anreizsetzung - Netzwerkeffekte (1)
Enterprise Blockchains, blockchain, consortium, distributed ledger, DLT, lifecycle (1)
Enterprise Social Network, Benefit, Case Study, Qualitative Content Analysis (1)
Enterprise Social Network; Business Process Management; Capabilities (1)
Enterprise social network; Esn; Framework; Topic analysis (1)
Enterprise Social Network, Online Social Network, Knowledge Management, Formal Hierarchies, Network Evolution (1)
Enterprise Social Network, Social Network Analysis, Social Software, CSCW (1)
Enterprise Social Network, Success Measurement, Social Capital (1)
ENTHALPY-ENTROPY COMPENSATION; NONIONIC SURFACTANTS; MICELLE FORMATION; PHASE-BEHAVIOR; TEMPERATURE-DEPENDENCE; TRITON X-100; WATER; ETHERS; MIXTURES; AMPHIPHILES; (1)
Enthaltungspflicht, Medizin-Duden, Treu und Glauben, Wettbewerbsverbot (1)
Enthusiasm; Instructional quality; Teacher motivation; Mathematics (1)
ENTNER-DOUDOROFF PATHWAY; ARCHAEON SULFOLOBUS-SOLFATARICUS; BROAD SUBSTRATE-SPECIFICITY; ATP-DEPENDENT HEXOKINASE; GLYCERATE KINASE; KEY-ENZYME; GLUCOSE-DEHYDROGENASE; THERMOTOGA-MARITIMA; THERMOPROTEUS-TENAX; METABOLIC PATHWAYS; carbohydrate metabolism; EntnerDoudoroff pathway; glycerate kinase; metabolomics; thermophiles (1)
entomopathogene Pilze, Zytotoxizität, Sekundärmetabolite, Isaria cateniannulata, Beauvericin A, Beauvericin J, Lateritin (1)
Entrepreneurship; networks; firm growth; performance (1)
entrepreneurship; new ventures; cooperative arrangements; interfirm arrangements (1)
ENTROPY; (1)
ENTROPY; DYNAMICS; MECHANICS; (1)
Entropy Principle, Risk Neutral Density, Probability of Default, Financial Stability Indicator, Credit Default Swaps (1)
ENTRY FACTORS; ACE2; NECROPTOSIS; DOWNSTREAM; EXPRESSION; TMPRSS2; SYSTEM; MLKL; (1)
Entscheidungsanmerkungen, Entscheidungsbesprechungen (3)
Entscheidungsanmerkungen; Entscheidungsbesprechungen (3)
Entscheidungsmodell, betriebliche Informationssysteme (1)
Entspannung, Atmung, Schmerzwahrnehmung, Sympathikotonus, autonomes Nervensystem, elektrodermale Aktivität, Stimmung, breathing, respiration, relaxation, pain perception, sympathetic tone, autonomous nervous system, skin conductance level, mood (1)
Entspannung , Gesundheitsförderung , Schulsport , Entspannungsverfahren , relaxation , health promotion , relaxation techniques , physical education (1)
Entspannung; Zähneputzen; Blutdruck; Stress; Entschleunigtes Atmen; Yoga, SURE; Mundgesundheit; psychisch; Biofeedback; (1)
Entwicklung (1)
Entwicklung eines neuen Forschungsansatz, Personalentwicklung als Instrument der Unternehmensführung/-Entwicklung, Beschreibung des Konzeptes der triadischen Beziehungen in der Personalentwicklung (1)
Entwicklungsbiologie , Maus , Stammzelle , Knockout <Molekulargenetik> , Embryonalentwicklung , Genexpression , Transkriptionsfaktor , , transcription factor , ES cells , stem cells , Sall4 , TBS (1)
Entwicklungsbiologie , Zelldifferenzierung , Maus , Leber , In vitro , Markierungsgen , Embryonale Stammzelle , Leberepithelzelle , Organogenese , Embryonale Stammzellen , Hepatozyten , transgene Zelllinien , cell differentiation , in vitro , mouse , hepatocytes , reporter cell lines (1)
Entwicklungspsychologie , Erfahrungswissen , Gesellschaftliches Bewusstsein , Kompetenz , Entwicklung , Kulturelle Entwicklung , Altersweisheit , Gesellschaftliche Altersrollen , plurale Alterskultur , spezifische Alterskultur , cultural development , development of competition , psychology of development , expertise , social cognition , wisdom of old age (1)
Entzündung, Autoimmunerkrankung, p75TNFR, TNF, maus-TNF-Inhibitor, anti-TNF-Medikation, Biologicals, inflammation, autoimmune disease, p75TNFR, TNF, mouse-TNF-Inhibitor, anti-TNF-Medication, Biologicals (1)
Entzündungsreaktion, negative Regulation, Lymphotoxin-beta-Rezeptor, tripartite motif protein 30 (TRIM30), Toll-like receptor (TLR), LPS-Toleranz, NFkappaB, TNF-receptor associated factor (TRAF), Makrophagen (1)
ENUCLEATION; INJURIES; EYE; PSYCHOSIS; CHILDREN; autoaggression; autoenucleation; drugs; guilt; paranoid; parasuicide; psychosis; schizophrenia; self-mutilation; suicide (1)
ENVELOPE PROTEIN; ENDOGENOUS RETROVIRUSES; NEURAL-NETWORKS; EXPRESSION; PEPTIDE; SYNCYTIN; SEQUENCE; PROLIFERATION; FUSION; FAMILY; adenovirus vector; human endogenous retrovirus type W (HERV-W); immunosuppressive domain; Syncytin-1 (1)
ENVIRONMENTAL CONTEXT; (1)
ENVIRONMENTAL CONTEXT; LIST-METHOD; RECOGNITION MEMORY; INHIBITORY CONTROL; STATE; DISRUPTION; RETENTION; RETRIEVAL; IMPLICIT; ACCOUNT; directed forgetting; context-dependent forgetting; encoding/retrieval mismatch; selective; rehearsal; retrieval inhibition (1)
ENVIRONMENTAL CONTRIBUTIONS; NICOTINE DEPENDENCE; LINKAGE DISEQUILIBRIUM; FAMILIAL TRANSMISSION; RISK-FACTORS; GABRA2 GENE; MALE TWINS; DRUG-USE; RECEPTOR; POPULATION; genetics; candidate genes (1)
ENVIRONMENTAL DISCLOSURES; STATEMENT; LEGITIMACY; VOLUNTARY; HISTORY; WATER; Distributional fairness; Value added; Value added statement; CSR reporting; EVG&D; GRI (1)
ENVIRONMENTAL-FACTORS; STERILE GERMINATION; GAP DETECTION; LIGHT; DISPERSAL; DORMANCY; NITRATE; GROWTH; Potamogeton; pondweed; aquatic habitat; seed germination; adaptation (1)
Environmental impact; Financial due diligence; Investment appraisal; Legal due diligence; Property market; Risk assessment (1)
ENVIRONMENTAL-POLICY; POLITICAL-INSTITUTIONS; GLOBAL GOVERNANCE; POLLUTION-CONTROL; SUSTAINABILITY; RATIFICATION; COOPERATION; COMPETITION; CONVENTION; COUNTRIES; climate change policy; democracy; democracy quality; environmental policy; measures of democracy (1)
ENVIRONMENTAL-POLLUTANTS; GEL-ELECTROPHORESIS; POLYVINYL-CHLORIDE; TESTICULAR CANCER; PHTHALATE-ESTERS; IN-VITRO; DI(2-ETHYLHEXYL)PHTHALATE; PLASTICIZERS; MEMBRANE; INFANTS; phthalates; genotoxicity; human mucosal cells and lymphocytes; microgel electrophoresis assay (1)
ENVIRONMENTAL RISK-FACTORS; TRICHURIS-SUIS THERAPY; CROHNS-DISEASE; INDUCED COLITIS; TAPEWORM INFECTION; CONTROLLED-TRIAL; TRANSFER MODEL; T-CELLS; EPIDEMIOLOGY; MICE; Crohn's disease; hepatitis A; hygiene; ulcerative colitis; worm infestations (1)
ENVIRONMENTAL RISKS; AGRICULTURAL SOILS; BIOLOGICAL-CONTROL; HONEY-BEE; NEONICOTINOIDS; INSECTICIDES; GLYPHOSATE; DISPERSAL; RESIDUES; ant colony fitness; Cand; Westeberhardia cardiocondylae; endosymbiont; glyphosate; neonicotinoid; pesticide; social insect; Wolbachia (1)
ENVIRONMENTAL SIGNALING PATHWAY; IN-VIVO PHOSPHORYLATION; BACILLUS-SUBTILIS; CRYO-EM; GENE-EXPRESSION; SERINE KINASE; PROTEIN; SYSTEM; RSBR; TRANSDUCTION (1)
ENVIRONMENTAL SURFACES; VIRUS; INFECTION; SURVIVAL; EPIDEMIC; (1)
ENVIRONMENTAL SUSTAINABILITY; FOOTPRINT; REDUCE; STEP; climate change; energy efficiency; planetary boundaries; prescription practices; sustainability (2)
ENVIRONMENTAL TOBACCO-SMOKE; RESIDENTIAL RADON EXPOSURE; MULTICENTER CASE-CONTROL; UNITED-STATES; LIFETIME NONSMOKERS; FAMILY HISTORY; DISEASE; MEN; GERMANY; CHINA; lung cancer; women; environmental tobacco smoke; occupation; diet; nonsmokers (1)
Environment, Environmental economics, Green economics, Game theoretic, Game theory, Games, Mixed strategy, Two player, Public goods game, Strategic game (1)
ENVIRONMENT INTERACTION; GENOTYPE IMPUTATION; NICOTINE METABOLISM; RISK LOCI; METAANALYSIS; ARCHITECTURE; CHOLESTEROL; CIGARETTES; VARIANTS; SUSCEPTIBILITY; (1)
ENVIRONMENTS; ROUTE; Pedestrian navigation system; landmarks; routing; preferences; user evaluation (1)
Enynes;Macrocycles;Coordination chemistry;Crown compounds;Radicals (1)
EN-Y RECONSTRUCTION; IRON VITAMIN B12; TOTAL GASTRECTOMY; GASTRIC-CANCER; METABOLIC CONSEQUENCES; BACTERIAL OVERGROWTH; PANCREATIC FUNCTION; MINERAL METABOLISM; NUTRITIONAL-STATUS; BONE DISORDERS; gastrectomy; gastrointestinal transit; malnutrition; micronutrients; anemia; osteopathy (1)
Enzymaktivität , Farbstoff , Tensid , UV-VIS-Spektroskopie , , enzyme activity , dye , surfactant , UV-VIS spectroscopy (1)
ENZYMATIC-ACTIVITY; INFECTION; ARTHRITIS; A(2); DNA; (1)
ENZYMATIC-ACTIVITY; PHASE-BEHAVIOR; SYSTEMS; SURFACTANTS; SOLUBILIZATION; DEHYDROGENASE; SOLVENTS; ENZYMES; LIPASE; (1)
ENZYMATIC AMPLIFICATION; CULTIVATION; METHANOGEN; BACTERIA; SYSTEM; Archaea; Crenarchaeota; hyperthermophilic; marine; chemolithoautotrophic (1)
ENZYMATIC-REACTIONS; MICELLAR CATALYSIS; COUPLING REACTION; WATER; TPGS-750-M; SALTS; Cascade reaction; Heck reaction; Enzyme catalysis; Micellar catalysis; Mesoscopic structuring; Green solvent engineering (1)
ENZYMATIC RESOLUTION; ORGANIC-CHEMISTRY; AMINO-ACIDS; KINETIC RESOLUTION; NMR-SPECTROSCOPY; CHROMATOGRAPHY; (1)
Enzym-Biosensor , Sauerstoff , Optischer Sensor , Wasserstoffionenkonzentration , Harnsäure , Glucose-Sensor , Lanthanoide , Verzögerte Fluoreszenz , Europium-Tetracycline-Komplex , europium-tetracycline complex , time-resolved luminescence measurement (1)
ENZYME-ACTIVITY; CHEMICAL-MODIFICATION; SWITCHES; PHOTOREGULATION; LIGHT; carbonic anhydrase; enzyme catalysis; inhibitors; molecular switches; photochromism (1)
enzyme alc dehydrogenase Brij35 ethanol pentanol (1)
enzyme catalysis, enzyme evolution, promiscuity, N2,N2-dimethylguanine hydrolase, amidohydrolase superfamily, shortest path map analysis, conformational heterogeneity, xenobiotics (1)
enzyme design, enzyme mechanism, enzyme inhibitors, light regulation, ancestral sequence reconstruction (1)
enzyme design, organophosphate hydrolase (1)
enzyme evolution, Enzymevolution, protein evolution, Proteinevolution, superfamilies, Superfamilien, chorismate-utilizing enzymes, Chorismat-umsetzende Enzyme, ancestral sequence reconstruction, Rekonstruktion anzestraler Sequenzen, bi-functionality, Bifunktionalität, enzyme catalysis, Enzymkatalyse, nucleophile specificity, Nukleophilspezifität, enzyme channels, Tunnel in Enzymen, protein-protein interactions, Protein-Protein Interaktionen, protein interfaces, Proteinkontaktflächen, protein structure, Proteinstruktur (1)
Enzyme evolution, Histidinol phosphate phosphatase, directed evolution, ancestral sequence reconstruction, functional annotation, alanine scan, haloacid dehalogenase superfamily (1)
Enzyme-free sensors · Pt/Ni nanocatalysts · Laser-induced carbon nanofibers · Glucose · Physiological pH · Locally generated hydroxide (1)
Enzyme immobilization; Films; Optical biofilms; Polypyrroles; Prussian Blue (1)
ENZYME-IMMUNOASSAY; CUTANEOUS MELANOMA; BREAST-CANCER; IN-VITRO; EXPRESSION; TUMOR; CELLS; PROGNOSIS; CARCINOMA; INVASION; (1)
ENZYME-IMMUNOASSAY; US MILITARY; ORAL FLUID; PREVALENCE; VALIDATION; ELISA; SPECIMENS; SPICE; ASSAY; METABOLITES; abstinence control; drug screening; immunoassay; LC-MS/MS; synthetic cannabinoids; urine analysis (1)
ENZYME-INHIBITORS; BINDING-SITES; PHOSPHOLIPID-BILAYERS; POLYMERS; MEMBRANES; RECOGNITION; ADSORPTION; ANTIBODIES; RECEPTORS; PROTEINS; Non-covalent imprinting; Template induced patterning; Functionalized vesicles; Specific recognition sites; FRET; Emission titrations (1)
enzyme kinetics; single molecule enzymology; fluorescence microscopy; femtoliter array (1)
ENZYME-LINKED IMMUNOSPOT; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; HEALTHY-INDIVIDUALS; ELISPOT ASSAY; ADOPTIVE TRANSFER; CMV INFECTION; BONE-MARROW; ANTIGEN; allogeneic hematopoietic stem cell transplantation; CMV-specific T cells; monitoring; real-time polymerase chain reaction (1)
ENZYME MOLECULES; ESCHERICHIA-COLI; CATALYZED-HYDROLYSIS; DYNAMIC DISORDER; WILD-TYPE; PROTEIN; GALACTOSIDASE; EVOLUTION; THERMOSTABILITY; EVOLVABILITY; (1)
ENZYME MOLECULES; HYDROGEN-PEROXIDE; MICROFABRICATED ARRAYS; ENZYMOLOGY; REACTIVITY; MECHANISM; RESORUFIN; COMPOUND; (1)
Enzym , Enantioselektivität , Magnetpartikel , Immobilisierung , Penicillin amidase , Immobilisation magnetic matrices , Enzym immobilisation , Penicillin amidase (1)
ENZYME; PHOSPHOTRIESTERASE; SITE; EVOLUTION; DEGRADATION; VERSATILITY; MUTAGENESIS; HYDROLASES; SUBSTRATE; TOXICITY; (1)
Enzyme, Protein design, ASR, Allostery (1)
ENZYME REPLACEMENT THERAPY; CEREBRAL BLOOD-FLOW; ALPHA-GALACTOSIDASE; PAINFUL CRISES; CARBAMAZEPINE; HETEROZYGOTE; DYSFUNCTION; INVOLVEMENT; DIAGNOSIS; MUTATION; (1)
ENZYME-RESPONSIVE NANOPARTICLES; ANGIOTENSIN-II GENERATION; DELIVERY-SYSTEMS; ACE-INHIBITORS; BINDING; MULTIVALENCY; ACCUMULATION; PHARMACOLOGY; AFFINITY; HEART; virus-mimetic nanoparticles; influenza A; heteromultivalent; target specific; enzyme responsive (1)
Enzymes, ether lipids, Geranylgeranylglyceryl Phosphate Synthase, GGGPS, Heptaprenylglyceryl Phosphate Synthase, HepGPS, PcrB, Bacillus subtilis, Flavobacterium johnsoniae, Methanothermobacter thermautotrophicus, protein structure, crystallization, oligomerization, quarternary structure, dimerization, hexamerization, anchor amino acid, homology, functional assignment, key enzyme, evolution of Archaea, membrane lipids, phylogenetics, sequence similarity network, substrate specificity, stereo-selective catalysis, protein engineering, unnatural amino acid, non-canonical amino acid, p-azido-L-phenylalanine, protein cross-linking, PresCont, Rosetta, radioactive labelling, protein analytics, (βα)8-barrel (1)
enzymes · luminescence · paper-based microfluidics · point-of-care testing · sweat analysis (1)
ENZYMES; OXYGEN; (1)
Enzyminhibitor , Struktur-Aktivitäts-Beziehung , Hyaluronsäure , Rekombinantes Protein , Hyaluronidasen , Vitamin C-Derivate , Hyal-1 , PH-20 , bovine testikuläre Hyaluronidase , ascorbic acid derivatives , indole-3-butyric acid , glucurono-6,3-lactone , hyaluronate lyase (1)
enzymology, protein biochemistry, protein-protein interactions, antibiotics, folate biosynthesis, tryptophan biosynthesis (1)
EORTC QLQ-C30; Differential item functioning; Quality of life; Clinical importance; Clinical trials (1)
EORTC QLQ-C30; EORTC QLQ-LC29; Hornheider Screening-Instrument; HSI; Hornheide Screening Instrument; Lebensqualität; quality of life; Lungenkrebs; lung cancer; Zusammenhang; Zusammenhänge; correlation; Psychoonkologischer Betreuungsbedarf; need for psychosocial support; Betreuungsbedarf; psychosocial support; klinischer Alltag; daily clinical routine; psychosoziale Belastung; psychosocial distress; Patientenversorgung; patient care; Pulmologie; pulmonology; klinische Studie; clinical study; (1)
EORTC RISK TABLES; TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; EXTERNAL VALIDATION; FOLLOW-UP; PREDICTION; TA; T1; ABERRATIONS; multicolor fluorescence insitu hybridization; non-muscle invasive bladder cancer; prognostic model; progression; recurrence (1)
EORTC RISK TABLES; UROTHELIAL CARCINOMA; MOLECULAR MARKERS; SURVIVAL; STAGE; DELAY; PROGRESSION; RECURRENCE; DIAGNOSIS; TUMOR; Bladder cancer; Risk stratification; EORTC risk tables; Prognosis; Progression; Radical cystectomy (1)
EOSINOPHILIC GRANULOMA; PEDIATRIC-PATIENT; MANAGEMENT; NECK; HEAD; CT; (1)
eosinophilic granulomatosis | eosinophils | polyangiitis | shock | small bowel ischemia (1)
Eosinophils, Histamine H4-receptor, Chemotaxis, Intracellular calcium concentration, Functional selectivity (1)
eosin Y photochemistry transient absorption spectroscopy terpenes (1)
EP2DS-17; Manuscript; LaTeX-2e; Style files (1)
EP COLLIDER HERA; PARTON DISTRIBUTIONS; QCD CORRECTIONS; PHOTON; COLLISIONS; JETS; (1)
EPHEBOMYRMEX; POGONOMYRMEX; HARVESTER ANTS; WING REDUCTION; QUEEN POLYMORPHISM (1)
; Ephrin-B2; Crohn's disease; IBD; IEC-6; Wound healing; Epithelial restitution (1)
; Ephrin-B; IEC-6; Wound healing; Gene expression; c-Fos; Egr-1/2; COX-2 (1)
EPICANTHUS INVERSUS SYNDROME; BLEPHAROPHIMOSIS; PTOSIS; TRANSLOCATION; GENE; T(3-4)(Q23-P15.2); PATIENT; 3Q23; (1)
epicardial adipose tissue, hypertrophy, left ventricular mass, older adults, populationbased (1)
EPICARDIAL ADIPOSE-TISSUE; OBESITY; IL-33; FAT; CELLS; ECHOCARDIOGRAPHY; INFLAMMATION; SECRETION; ATRIAL; ST2; (1)
EPIDEMIOLOGIC CATCHMENT-AREA; MANIC-DEPRESSIVE ILLNESS; QUALITY-OF-LIFE; SOCIOECONOMIC-STATUS; MENTAL-DISORDERS; UNITED-STATES; EDUCATIONAL-ATTAINMENT; I DISORDER; CLINICAL CHARACTERISTICS; PSYCHIATRIC-DISORDERS; (1)
EPIDEMIOLOGIC CHARACTERISTICS; TEMPORAL TRENDS; SURGERY; RISK; PREVALENCE; IMPACT; MYOPIA; retinal detachment; incidence; myopia; pseudophakia (1)
EPIDEMIOLOGIC FINDINGS; MAJOR DEPRESSION; INTERVENTION; PREVALENCE; WOMEN; WEB; MEN; SEX; gender-specific psychiatry; help-seeking behavior; Internet; depression (1)
Epidemiologie von und Lebensqualität (KOOS, IKDC, EQ -5D -Score) nach Kniegelenksluxationen (1)
EPIDEMIOLOGY; EFFICACY; BLIND; RTMS; TMS; depression; bipolar disorder; rtms; repetitive transcranial magnetic stimulation; non-invasive brain stimulation; neurostimulation (1)
Epidemiology, female sexual dysfunction, female sexual difficulties, meta-analysis, prevalence, systematic review (1)
Epidemiology, Genetic association study, Genetics research, Metabolomics, Population genetics (1)
EPIDEMIOLOGY; Guillain-Barre syndrome; Hepatitis E virus; Subgenotype 3c (1)
epidemiology, healthcare costs, inpatient care, post-COVID syndrome, treatment procedures (1)
EPIDEMIOLOGY; PREVALENCE; CARE; (1)
EPIDEMIOLOGY; SPONDYLODISCITIS; pyogenic vertebral osteomyelitis; mortality; risk-factors (1)
EPIDERMAL-CELL DIFFERENTIATION; OVULE DEVELOPMENT; ROOT EPIDERMIS; SUBCELLULAR-LOCALIZATION; PATTERN-FORMATION; SHOOT MERISTEM; MOVEMENT; GENES; TRANSCRIPTION; EXPRESSION; Arabidopsis; Plasmodesmata; Signal transduction; Tissue morphogenesis; Receptor-like kinase; STRUBBELIG; QUIRKY (1)
EPIDERMAL DIFFERENTIATION COMPLEX; PROMOTES PROLIFERATION; PANCREATIC-CANCER; CERNA HYPOTHESIS; EXPRESSION; PROTEINS; LNCRNAS; cancer; ceRNA; post-transcriptional regulation; protein-RNA interaction; RNA-RNA interaction; transcriptional regulation (1)
EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EXPRESSION; TYROSINE KINASE INHIBITOR; MAMMARY EPITHELIAL-CELLS; CULTURED-MAMMALIAN-CELLS; SMALL INTERFERING RNAS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS; MESSENGER-RNA; LUNG-CANCER; AG1478; epidermal growth factor receptor; gene expression analysis; glioma; siRNA (1)
EPIDERMAL GROWTH-FACTOR; HEPATIC STIMULATOR SUBSTANCE; RAT HEPATOCYTES; PRIMARY CULTURE; INDUCIBLE EXPRESSION; SIGNAL-TRANSDUCTION; NUCLEAR RECEPTORS; DRUG-METABOLISM; DOWN-REGULATION; MESSENGER-RNA; (1)
EPIDERMAL-GROWTH-FACTOR; IN-SITU HYBRIDIZATION; GENE COPY NUMBER; ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMAS; FACTOR RECEPTOR GENE; POOR-PROGNOSIS; BREAST-CANCER; COLORECTAL-CANCER; CYTOPLASMIC EXPRESSION; Salivary gland cancer; EGFR; HER2; Survivin; pSTAT3; Prognosis (1)
EPIDERMAL-GROWTH-FACTOR; MACROPHAGE-STIMULATING PROTEIN; FINGER TRANSCRIPTION FACTOR; HUMAN COLON-CARCINOMA; TYROSINE KINASE; GREEN TEA; (-)-EPIGALLOCATECHIN GALLATE; EPITHELIAL-CELLS; UP-REGULATION; RON; epigallocatechin-3-gallate; recepteur d'origine nantais; Egr-1; gastric cancer (1)
EPIDERMAL GROWTH-FACTOR; MEDIATED ENDOCYTOSIS; INTERFERON-GAMMA; BINDING-SITES; Y-5 RECEPTOR; FOOD-INTAKE; PROTEIN; MEMBRANE; PEPTIDES; LIGAND; Y1 antagonist; Y1 agonist; chaotropic agent; transferrin; endosome; lysosome (1)
EPIDERMAL-GROWTH-FACTOR; MOLECULAR SUBGROUPS; FACTOR RECEPTOR; NUCLEAR; CELLS; RAF; CLASSIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; actin cytoskeleton; cell migration; ERK; MAPK; medulloblastoma; PI3K; Rac1 (1)
EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; GAMMA-FIBRINOGEN GENE; HUMAN HEPATOCYTES; HEPATOTROPHIC FACTOR; IN-VITRO; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; PROTEINS; Augmenter of liver regeneration; Inflammation; Acute phase; Haptoglobin; Fibrinogen beta; STAT3 (1)
EPIDERMAL GROWTH-FACTOR; NF-KAPPA-B; ORNITHINE DECARBOXYLASE; TISSUE REGENERATION; PRIMARY CULTURE; HEPATOMA-CELLS; DNA-SYNTHESIS; RAT-LIVER; METABOLISM; EXPRESSION; liver regeneration; polyamines; ornithine decarboxylase; hepatotrophic growth factor; augmenter of liver regeneration; immediate early gene; c-myc (1)
EPIDERMAL-GROWTH-FACTOR; NONMELANOMA SKIN CANCERS; RAS ONCOGENE MUTATIONS; FACTOR RECEPTOR; ACTIVATION; TUMORS; EXPRESSION; CETUXIMAB; cutaneous squamous cell carcinoma; EGFR; HRAS; skin; somatic mutation (1)
EPIDERMAL GROWTH-FACTOR; PERIODONTAL HEALTH; SJOGRENS-SYNDROME; EXPRESSION; GLAND; ACTINOMYCES; RECEPTORS; ALBUMIN; DISEASE; SERUM; cyclosporin; gingiva; overgrowth; saliva; proteins; cytokines (1)
EPIDERMAL-GROWTH-FACTOR; RECEPTOR-POSITIVE TUMORS; HIGH-AFFINITY BINDING; CELL-LINES; NUDE-MICE; PEPTIDE-HORMONES; AEZS-108 AN-152; DOXORUBICIN; SOMATOSTATIN; THERAPY; LHRH receptor-positive cancers; Targeted chemotherapy; Breast cancer; Ovarian cancer; Endometrial cancer; AEZS-108; Doxorubicin; EP-100 (1)
EPIDERMAL-KERATINOCYTES; HEAT-SHOCK; EXPRESSION; PROTEIN; PSORIASIS; UVB; MODULATION; CYTOKINES; STRESS; LIGHT; cDNA-array; keratin 6; keratin 17 (1)
EPIDERMAL LANGERHANS CELLS; CIGARETTE-SMOKING; PSORIASIS; DERMATOSES; DERMATITIS; DENSITY; ALCOHOL; HAND; psoralen; hyperkeratotic; dyshidrotic; UV; dermatitis (1)
EPIDERMAL LANGERHANS CELLS; REAL-TIME PCR; LYMPH-NODE; IN-VIVO; CONTACT HYPERSENSITIVITY; CUTANEOUS LEISHMANIASIS; IMMUNOLOGICAL MEMORY; IMMUNE-RESPONSE; MAJOR INFECTION; MICE; (1)
EPIDERMAL NEVI (1)
EPIDERMAL NEVI; PREVALENCE; FREQUENCY; EXPOSURE; SUNLIGHT; RISK; familial; FGFR3; PIK3CA; seborrhoeic keratosis (1)
EPIDERMAL NEVUS; MOSAICISM; HAPPLE; (1)
EPIDERMAL NEVUS; MUTATIONS; TUMORS; (1)
EPIDERMAL NEVUS; ONCOGENIC PIK3CA; FGFR3 MUTATIONS; (1)
; epidermoid cyst; cerebellopontine angle; retrosigmoidal craniotomy; cranial nerves (1)
EPIDERMOLYTIC HYPERKERATOSIS; GENETIC-BASIS; VITAMIN-D; DIFFERENTIATION; KERATIN-10; ETRETINATE; PSORIASIS; EFFICACY (1)
EPIDURAL ANALGESIA; ANESTHESIA; CHILDREN; Peridural anaesthesia; Perioperative pain management; Bladder exstrophy; Reconstructive surgery; Pediatric urology (1)
EPIDURAL STEROID INJECTIONS; PAIN; THERAPY; MANAGEMENT; SAFETY; RADICULOPATHY; COMPLICATIONS; Cervical vertebrae; Lumbar vertebrae; Local anesthesia-Pain management; Injection (1)
epigenetic, DNA methylation, metastasis, methylimmunoprecipitation, breast cancer, cancer progression (1)
EPIGENETIC INACTIVATION; BLADDER-CANCER; PATHWAY; MEDULLOBLASTOMAS; PROLIFERATION; COMPONENT; CELLS; beta-catenin; choroid plexus carcinoma; choroid plexus papilloma; pathogenesis; Wif-1 (1)
Epigenetic regulation, Cyprinus carpio, ribosomal cistron during the acclimatization process (1)
Epigenetics, DNA methylation, Breast cancer, Metastasis (1)
epigenetics, DNA methylation, mouse (1)
Epigenetics, DNA methylation, Myelodysplastic syndromes (1)
Epigenetik , DNA , Methylierung , Gewebe , Allel , Epigenetik , DNA Methylierung , Methylierungsanalyse , Vererbung , zelltypspezifisch , allelespezifisch , DNA methylation , methylation profiling , inheritance , cell type-specific , allele-specific (1)
Epigenetik, DNA-Methylierung, Tumorsuppressorgene, epigenetics, DNA methylation, tumor (1)
Epigenomik, DNA Methylierung (1)
Epilepsie, Frühe Neuzeit, Medizingeschichte, Pädiatrie (1)
EPILEPSY; DAMAGE; SEIZURES; INJURY; Anterograde amnesia; Hippocampal atrophy; Intoxication; Theophylline (1)
EPILEPSY; lamotrigine; bipolar disorder; mood stabilizer; TDM; therapeutic reference range (1)
EPILUMINESCENCE MICROSCOPY; SURFACE MICROSCOPY; WESTERN AUSTRALIA; MELANOMA; DIAGNOSIS; SUN; (1)
Epimyrma; Leptothorax; Formicidae; larval gonad tissue; sex determination; histology (1)
EPIPHRENIC DIVERTICULA; THORACOSCOPIC RESECTION; ZENKERS DIVERTICULUM; MANAGEMENT; SURGERY; MYOTOMY; epiphrenic esophageal diverticula; laparoscopic surgical approach (1)
EPIPHYTIC BRYOPHYTES; STRATEGIES; VEGETATION; MOSSES; PATTERNS; LICHENS; SOILS; FORMS; autecology; functional traits; habitat; indicator values; life form; liverworts; mosses; sexual reproduction; vegetative propagation (1)
epiretinale Gliose, vitreomakuläre Grenzfläche, vitreomakuläre Adhäsion, vitreomakuläre Traktion, Makulaforamen, Häufigkeiten, Risikofaktoren, epiretinal gliosis, vitreomacular interface, vitreomacular adhesion, vitreomacular traction, macular hole, frequencies, risk factors, OCT, SD-OCT (1)
EPISCLERAL VENOUS-PRESSURE; LASER TRABECULAR ABLATION; MESHWORK; LTA; Schlemm's canal; glaucoma; implant; silicone (1)
EPISODICALLY CONSUMED FOODS; FREQUENCY QUESTIONNAIRE; INTAKE DISTRIBUTIONS; MEASUREMENT ERROR; EPIC-POTSDAM; VALIDATION; NUTRIENTS; MODEL; EPIDEMIOLOGY; SELECTION; nutritional epidemiology; dietary assessment; statistical modelling (1)
EPISODIC-LIKE MEMORY; MENTAL TIME-TRAVEL; COGNITION; CACHE; ANTICIPATION; REMEMBER; RECALL; TESTS; CUES; object affordance; cognition; inference; future-oriented behavior; latent learning (1)
EPISODIC MEMORY; ADAPTIVE MEMORY; PHASE SYNCHRONIZATION; PROXIMATE MECHANISMS; TERM-MEMORY; THETA; EEG; RETRIEVAL; EVENT; GAMMA; Encoding; Levels of processing; Strategy; Adaptive memory; Long term memory; Desynchronization (1)
episodic memory, context-dependent memory, environmental context change, memory development, cognitive development (1)
episodic memory, directed forgetting, individual differences, working memory capacity, inhibition, cognitive development (1)
episodic memory, directed forgetting, intentional forgetting, encoding, retrieval, inhibition (1)
episodic memory, directed forgetting, intentional forgetting, inhibition, context-dependent forgetting, cognitive development (1)
episodic memory, forgetting, directed forgetting, selectivity (1)
Episodic memory · Forgetting · Directed forgetting · Time-dependent forgetting (1)
EPISODIC MEMORY; FREE-RECALL; RECOGNITION MEMORY; THETA OSCILLATIONS; GAMMA OSCILLATIONS; WORKING-MEMORY; CONTEXT CHANGE; ALPHA; MODEL; EEG; learning; encoding; retrieval; testing; brain oscillations (1)
EPISODIC MEMORY; FREE-RECALL; RETRIEVAL; INHIBITION; FORGOTTEN; ACCOUNT; ADULTS; MODEL; List-method directed forgetting; Item recognition; Reset of encoding (1)
Episodic Memory, Part-List Cuing, Context Reactivation, Encoding (1)
episodic memory, retrieval cues, forgetting, context reactivation, collaborative inhibition (1)
episodic memory, retrieval-induced forgetting, working memory capacity, individual differences, inhibition (1)
EPISODIC MEMORY RETRIEVAL; LONG-TERM RETENTION; THETA OSCILLATIONS; NEURAL SIGNATURES; ENHANCE RETENTION; CONTEXT ACCOUNT; EEG; DESYNCHRONIZATION; DYNAMICS; BRAIN; EEG brain oscillations; Feedback learning; (Reversed) testing effect (1)
EPISODIC MEMORY RETRIEVAL; MEDIATOR EFFECTIVENESS HYPOTHESIS; WORKING-MEMORY; PREFRONTAL CORTEX; FUNCTIONAL MRI; RETENTION; FMRI; METAANALYSIS; BENEFITS; RECALL; fMRI; forgetting; long-term learning; retrieval; testing effect (1)
EPISODIC MEMORY RETRIEVAL; PREFRONTAL CORTEX; ANTICIPATORY ANXIETY; MONITORING HYPOTHESIS; VOLUNTARY SUPPRESSION; ANTERIOR CINGULATE; FUNCTIONAL-ANATOMY; PAIN; ACTIVATION; SYSTEMS; (1)
episodic memory, retrieval, restudy, inhibition, context reactivation (1)
Episodic memory; Visual importance; Looking at nothing (1)
Episodisches Gedächtnis , Funktionelle NMR-Tomographie , Inhibition , Vergessen , kognitive Kontrolle , präfrontaler Kortex , fMRI , episodic memory , cognitive control , inhibition , forgetting , prefrontal cortex (1)
Episodisches Gedächtnis, Inhibition, abrufinduziertes Vergessen, Elektroenzephalografie, Antwortlatenzen, episodic memory, inhibition, retrieval-induced forgetting, electroencephalography, response latencies (1)
Episodisches Gedächtnis , Inhibition , Strategiestörung , Part-List Cuing , abrufinduziertes Vergessen , Episodic memory , inhibition , strategy disruption , part-list cuing , retrieval-induced forgetting (1)
Episodisches Gedächtnis, selektives Erinnern, Part-List Cuing, abrufinduziertes Vergessen, gerichtetes Vergessen, kontextabhängiges Vergessen, episodic memory, part-list cuing, part-list retrieval, retrieval-induced forgetting, directed forgetting, context-dependent forgetting (1)
Episodisches Gedächtnis , Theta-Aktivität , Alpha-Rhythmus , Vergessen , Elektroencephalogramm , , Episodic memory , forgetting , electroencephalogram , alpha , theta (1)
Episodisches Gedächtnis, Vergessen, Abruf, erneutes Lernen, Kontext (1)
; epispadias; bladder exstrophy; historical overview; operation techniques (1)
EPISPADIAS COMPLEX BEEC; OF-THE-LITERATURE; FAMILIES; DYSREGULATION; IMPUTATION; PROJECT; GUDMAP; GENES; SALL1; PLAYS; (1)
EPISPADIAS COMPLEX; RECONSTRUCTION; CHILDREN; Initial closure; Osteotomy; Bladder neck surgery; Long termresults; Urinary tract (1)
Epispadie, isolierte Epispadie, Langzeitergebnisse, Blasenekstrophie-Epispadie-Komplex (1)
EPISTAXIS; BEVACIZUMAB; MANAGEMENT; hereditary hemorrhagic telangiectasia; Morbus Osler; Rendu-Osler-Weber syndrome; Osler Calendar; orphan disease; epistaxis; arteriovenous malformations; organ manifestation; screening; laser therapy (1)
EPISTAXIS; LASER; MANAGEMENT; CHALLENGE; (1)
EPISTAXIS; RESCUES; ALK-1 mutation; FK506; Morbus Osler; tacrolimus; VEGF (1)
EPISTEMIC CLOSURE; FAIL; Knowledge; Closure; Transmission arguments (1)
EPISTEMIC ENTRENCHMENT; PLAUSIBILITY MEASURES; BELIEF REVISION; LOGIC; belief revision; theory change; sphere semantics; epistemic entrenchment; AGM approach; iterated revision; non-prioritized revision; severe withdrawal; irrevocable revision; irrefutable revision (1)
Epistemische Gerechtigkeit; Fricker; Wissenschaft; Universität; Wissenschaftliche Bildung; Sozialepistemologie; Diversität; Wissenschaftskommunikation; Nutzengerechtigkeit; Gerechtigkeit; Gültigkeit wissenschaftlicher Erkenntnisse; Partizipation; Partizipationsgerechtigkeit Epistemic justice; Fricker; Science; University; Scientific education; Social epistemology; Diversity; Science communication; Justice; Validity of science; Participation; (1)
epistemische Überzeugungen, FEE, Moschner & Gruber, Fragebogen zur Erfassung epistemischer Überzeugungen (1)
Epistemological beliefs; epistemic beliefs; learning beliefs; questionnaire; educational diagnostics (1)
EPISTEMOLOGICAL BELIEFS; KNOWLEDGE; SCIENCE; IMPACT; SELF; NEED; Argument quality; argumentative thinking; self-explanation; training intervention (1)
EPITAXIAL FE FILMS; BRILLOUIN-ZONE INTEGRATIONS; MAGNETIC ANISOTROPIES; ULTRATHIN FILMS; SPIN INJECTION; SEMICONDUCTOR; SPINTRONICS; INTERFACE; GAAS(001); AU; (1)
EPITAXIAL FE FILMS; CO-NI ALLOYS; SURFACE ANISOTROPY; WAVE RESONANCE; THIN-FILMS; CU(100); MULTILAYERS; CU(111); COBALT; PHASE; (1)
EPITAXIAL FE FILMS; MAGNETIC-ANISOTROPY; DOMAIN-WALLS; GAAS(001); VOLUME; TORQUE; (1)
EPITAXIAL FE FILMS; SUBSTRATE SURFACE RECONSTRUCTION; SPIN INJECTION; GAAS(001); SEMICONDUCTOR; STRESS; VOLUME; (1)
EPITAXIAL GRAPHENE; DEEP IMPURITIES; SEMICONDUCTORS; IONIZATION; (1)
EPITAXIAL GRAPHENE; FORCE MICROSCOPY; LAYER; REACTIVITY; RESOLUTION; GRAPHITE; SENSOR; graphene; self-assembly; stripe structure; ambient environment; atomic force microscopy (1)
EPITAXIAL GRAPHENE; IRRADIATION; SIO2; (1)
EPITAXIAL LATERAL OVERGROWTH; ALGAN/GAN HETEROSTRUCTURES; THREADING DISLOCATIONS; SAPPHIRE SUBSTRATE; ELECTRON-GAS; X-RAY; MOBILITY; SURFACE; GAN/ALGAN; DENSITY; atomic force microscopy; high resolution x-ray diffraction; nucleation; metalorganic vapor phase epitaxy; nitrides; high electron mobility transistors (1)
EPITAXIAL LATERAL OVERGROWTH; DISLOCATION DENSITIES; HOMOEPITAXIAL GAN; LASER-DIODES; SI(111); STRAIN; FILMS; characterization; defects; dislocation; etching; GaN (2)
Epitaxial lift-off; Quantum Hall effect; Curved electron gases (1)
epitaxy, GaAs, nanowires, magnetic heterostructures (1)
epithelial barrier function | impedance spectroscopy | microphysiometry | oxygen consumption rate | ratiometric optical imaging | respiratory activity | transepithelial electrical resistance (1)
EPITHELIAL-CELL EXPRESSION; PERIPHERAL-BLOOD MONOCYTES; BOWEL-DISEASE MUCOSA; FACTOR KAPPA-B; COLONIC MACROPHAGES; SIGNALING PATHWAYS; DROSOPHILA TOLL; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; (1)
EPITHELIAL-CELL LINES; FACTOR-KAPPA-B; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; GENETIC DIVERSITY; INTERLEUKIN-1 POLYMORPHISMS; GASTRODUODENAL DISEASE; MONGOLIAN GERBIL; ARP2/3 COMPLEX; IN-VITRO; (1)
EPITHELIAL-CELL POLARITY; APICAL-BASAL POLARITY; TIGHT-JUNCTION; PLANAR POLARITY; DISCS LOST; PHOTORECEPTOR MORPHOGENESIS; ZONULA ADHERENS; AXIS ELONGATION; VINCULIN GENE; COMPLEX; (1)
EPITHELIAL-CELL POLARITY; ZONULA ADHERENS FORMATION; TIGHT JUNCTION PROTEIN; APICAL-BASAL POLARITY; CRUMBS COMPLEX; STRUCTURAL BASIS; MEMBRANE; LOCALIZATION; BAZOOKA; PHOSPHORYLATION; Crumbs; Stardust; PAR-6; Drosophila; epithelial polarity (1)
EPITHELIAL-CELLS; 2-PHOTON MICROSCOPY; SUBPODOCYTE SPACE; TYPE-2 RECEPTOR; BLOOD-PRESSURE; RAT KIDNEYS; MICROPUNCTURE; PERMEABILITY; PROTEINURIA; PODOCYTES; angiotensin II; AT receptors; glomerular filtration barrier; mulitphoton microscopy; proteinuria (1)
EPITHELIAL-CELLS; RAT MODEL; 1 GENE; PKD1; RAPAMYCIN; PROGRESSION; PATHWAY; GROWTH; INACTIVATION; CYSTOGENESIS; (1)
EPITHELIAL-CELLS; RECONSTRUCTION; IMPLANTATION; (1)
Epitheliale mesenchymale Transition (EMT) – Goosecoid – Snail – humanes hepatozelluläres Karzinom (HCC) – Expressionslevel / Epithelial mesenchymal Transition EMT – Goosecoid – Snail – human hepatocellular carcinoma (HCC) – expression level (1)
EPITHELIAL MESENCHYMAL INTERACTIONS; MOUSE KIDNEY; INTEGRIN ALPHA-8-BETA-1; NEPHROGENIC MESENCHYME; EXPRESSION; MORPHOGENESIS; DIFFERENTIATION; IDENTIFICATION; PROTEINS; CULTURE; kidney; development; lectins; histochemistry; two-dimensional electrophoresis (1)
EPITHELIAL-MESENCHYMAL INTERFACE; BRANCHING MORPHOGENESIS; NEPHRON INDUCTION; RABBIT KIDNEY; MOUSE KIDNEY; CELLS; EXPRESSION; IDENTIFICATION; NEPHROGENESIS; PROTEOGLYCAN; stem cells; kidney; collecting duct; development; soybean agglutinin (SBA); tissue transglutaminase (Tgase2); matrix metalloproteinase-9 (MMP-9); rabbit (New Zealand) (1)
EPITHELIAL-MESENCHYMAL INTERFACE; DEVELOPING MOUSE KIDNEY; STEM-CELLS; EMBRYONIC KIDNEY; BRANCHING MORPHOGENESIS; POLYESTER INTERSTITIUM; POSTNATAL-DEVELOPMENT; NEPHRON INDUCTION; RABBIT KIDNEY; ORGAN-CULTURE; Kidney; Stem/progenitor cell niche; Extracellular matrix; Interstitium; Electron microscopy (1)
EPITHELIAL-MESENCHYMAL TRANSITION; ACTIVATED PROTEIN-KINASE; HIPPOCAMPAL SLICE CULTURES; GROWTH-FACTOR-BETA; CANCER STEM-CELLS; TGF-BETA; DIABETIC-NEPHROPATHY; PATHWAY-ACTIVITY; GLIOMA INVASION; HIGH GLUCOSE; AMPK; BTIC; glioblastoma; metformin; mTOR; SMAD; TGF-beta(2) (1)
EPITHELIAL-MESENCHYMAL TRANSITION; BORDER CELL-MIGRATION; MYOSIN-VI; C-ELEGANS; CANCER; EXPRESSION; FAMILY; METASTASIS; MARKERS; MIRNAS; (1)
EPITHELIAL-MESENCHYMAL TRANSITION; CELL-ADHESION MOLECULE; UVOMORULIN-CATENIN COMPLEX; BREAST-CANCER CELLS; KAPPA-B; P-CADHERIN; TUMOR PROGRESSION; GASTRIC-CANCER; ALPHA-CATENIN; UP-REGULATION; E-cadherin; NF kappa B; N-cadherin regulation; cell contact (1)
EPITHELIAL-MESENCHYMAL TRANSITION; GENOME-WIDE ANALYSIS; LARGE GENE LISTS; TUMOR-SUPPRESSOR; TRANSCRIPTION-FACTOR; C-MYC; GASTRIC-CANCER; BREAST-CANCER; WILD-TYPE; DIFFERENTIAL REGULATION; (1)
EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; CANCER-CELLS; OSTEOPROTEGERIN EXPRESSION; TUMOR; MIGRATION; HEAD; RESORPTION; REGULATORS; RECEPTOR; oral squamous cell carcinoma; OSCC; MMP-27; OPG; RANKL; mandibular bone invasion (1)
EPITHELIAL-MESENCHYMAL TRANSITION; MIGRATION INHIBITORY FACTOR; DISULFIDE BOND FORMATION; SULFHYDRYL OXIDASE; TUMOR PROGRESSION; HUMAN HEPATOCYTES; HEPATOMA-CELL; HEPATOTROPHIC FACTOR; INTERMEMBRANE SPACE; AUGMENTOR; (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; MAMMALIAN SEPTIN; FILAMENT FORMATION; HEPATIC-FIBROSIS; ACTIN-FILAMENTS; PLATELET SEPTIN; ORGANIZATION; COMPONENT; INSIGHTS; PARTNER; immunohistochemistry; kidney; renal fibrosis; septin 8 (Sept8) knockout mouse; unilateral ureteral obstruction (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; MATRIX-METALLOPROTEINASE; TUMOR PROGRESSION; RETINOIC ACID; CELL INVASION; UP-REGULATION; NEURAL CREST; RHO-GTPASES; malignant melanoma; cDNA expression array; epithelial-mesenchymal transition (EMT); snail; E-cadherin (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; SQUAMOUS-CELL CARCINOMAS; E-CADHERIN EXPRESSION; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; DROSOPHILA-MELANOGASTER; PANCREATIC-CANCER; BREAST-CANCER; PRIMARY HEAD; Lgl; Hugl-2; Snail; EMT; MET; tumour suppression (1)
EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; EXPRESSION; METASTASIS; EMT; MICROENVIRONMENT; HEPATOCYTES; BIOMARKERS; INDUCTION; CATENIN; (1)
EPITHELIAL-MESENCHYMAL-TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; E-CADHERIN; LUNG FIBROBLASTS; NATURAL-HISTORY; CROSS-TALK; TGF-BETA; EXPRESSION; CANCER; CELLS; Crohn's disease; fistulae; SNAILI; TNF; epithelial mesenchymal transition (1)
EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; INTERACTION MAP; NERVOUS-SYSTEM; GLIAL-CELLS; EXPRESSION; MELANOGASTER; CARCINOMA; GENE; LINES; (1)
EPITHELIAL NA+ CHANNEL; THICK ASCENDING LIMB; CONVOLUTED TUBULE CELLS; RAT-KIDNEY; HYPEROSMOTIC STRESS; SURFACE EXPRESSION; K CHANNELS; BARTTIN; SGK1; LOCALIZATION; barttin; cell shrinkage; water deprivation; osmoregulation (1)
EPITHELIAL OVARIAN-CANCER; ADVANCED GASTRIC-CANCER; LOCO-REGIONAL TREATMENT; COLORECTAL-CANCER; CONSENSUS STATEMENT; SURGICAL DEBULKING; PSEUDOMYXOMA PERITONEI; SYSTEMIC CHEMOTHERAPY; PROGNOSTIC INDICATORS; SURFACE MALIGNANCY (1)
EPITHELIAL OVARIAN; SURGICAL CYTOREDUCTION; IMPROVED SURVIVAL; CARCINOMA; SURGERY; DISEASE; METAANALYSIS; SENSITIVITY; PREDICTORS; PACLITAXEL; ovarian cancer; neoadjuvant chemotherapy; surgery; docetaxel; CA 125; ascites (1)
EPITHELIAL SODIUM-CHANNEL; COLLECTING DUCT; VOLUME RETENTION; ACTIVATION; ENDOCYTOSIS; MECHANISMS; EXCRETION; ALBUMIN; PLASMIN; CELLS; epithelial sodium channel; focal segmental glomerulosclerosis; hypertension; nephrotic syndrome (1)
EPITHELIAL SODIUM-CHANNEL; EXPERIMENTAL NEPHROTIC SYNDROME; AQUAPORIN-1 WATER CHANNELS; THICK ASCENDING LIMB; RENAL ENAC SUBUNITS; NA+-K+-ATPASE; COLLECTING DUCT; TRANSCRIPTIONAL REGULATION; PHOSPHATE-TRANSPORT; PROXIMAL TUBULES; collecting duct; ENaC; lipids; proteases; proteinuria; proximal tubule (1)
EPITHELIAL SODIUM-CHANNEL; SERINE-PROTEASE ACTIVITY; COLLECTING DUCT CELLS; SURFACE EXPRESSION; BLOOD-PRESSURE; RAT-KIDNEY; ACTIVATION; PLASMIN; MARKER; IDENTIFICATION; Epithelial sodium channel; Proteolysis; Adrenal; Nephrotic syndrome; Aldosterone synthase (1)
EPITHELIAL SODIUM-CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; NA+ CHANNEL; LUNG-DISEASE; ION CHANNELS; HUMAN GENOME; CFTR; TRANSPORT; AMILORIDE; CELLS; (1)
EPITHELIAL SUBSTITUTE SUPRATHEL(R); THERMALLY INJURED HANDS; VENOUS LEG ULCERS; SKIN SUBSTITUTE; PAIN; STRATEGIES; EFFICACY; CHILDREN; MEPITEL; Suprathel; Biatain; Mepitel; wound healing; pain; split-thickness skin graft; donor site (1)
EPITHELIUM CORYNE TUBULOSA; FIBROBLAST GROWTH-FACTORS; CYSTEINE-RICH DOMAIN; ELECTRON-MICROSCOPY; MANNOSE RECEPTOR; BINDING; LECTIN; CELL; CHONDROITIN; SULFATE; (1)
EPITHELIUM-DERIVED FACTOR; EPIDERMAL-GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; PIGMENT-EPITHELIUM; ENDOTHELIAL-CELLS; ARTERY OCCLUSION; STROKE; PERMEABILITY; PEDF; ANGIOGENESIS; blood-brain barrier; epidermal growth factor; ischemia/reperfusion injury; magnetic resonance imaging; pigment epithelium-derived factor; stroke (1)
Epithelzelle, Apoptosis, Rezeptor, Cytokin , Interleukin-11 , Interleukin-11, colon (1)
EP; Lepton-Nucleon Scattering (1)
EPOPROSTENOL PROSTACYCLIN; SECONDARY; NIFEDIPINE; SURVIVAL; THERAPY; DISEASE; exercise test; hypertension; prostaglandins; pulmonary (1)
EPOPROSTENOL THERAPY (1)
EPOXYEICOSATRIENOIC ACID METABOLISM; HYPERPOLARIZING FACTOR; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; NITRIC-OXIDE; CYTOCHROME-P450 METABOLITES; CORONARY-ARTERIES; BLOOD-PRESSURE; KNOCKOUT MICE; INHIBITION; angiotensin; lipids (1)
EPOXYEICOSATRIENOIC ACIDS; L-CARNITINE; DISEASE; HIV; PHOSPHATIDYLCHOLINE; HYPERREACTIVITY; DYSFUNCTION; EPOXYEICOSANOIDS; ATHEROSCLEROSIS; OUTCOMES; Microbiome; trimethylamin-N-oxide; platelets; endothelial cells; atherosclerosis (1)
EPOXY; TENSILE; adhesives; hydrophilic polymers; polysaccharides (1)
EPR; Authorisation; Access control; Security infrastructure; Health professional cards; TTP services (1)
EPrints , Article Processing Charge , APC (1)
Epsilon factor; twist formula; cohomological characteristic class; Kuenneth formula (1)
EPSTEIN-BARR-VIRUS; ADOPTIVE TRANSFER; LYMPHOPROLIFERATIVE DISEASE; ADENOVIRUS INFECTIONS; 3RD-PARTY DONORS; CYTOMEGALOVIRUS; EBV; IMMUNITY; GANCICLOVIR; PROPHYLAXIS; (1)
EPSTEIN-BARR-VIRUS; CELLULAR MICRORNA MIR-146A; HUMAN GAMMA-HERPESVIRUSES; MAREKS-DISEASE VIRUS; RNA-INTERFERENCE; B-CELLS; BURKITTS-LYMPHOMA; BINDING PROTEIN; GENE-EXPRESSION; NUCLEAR EXPORT; Epstein-Barr virus; EBV; MicroRNA; MiRNA; BHRF1; BART; Tumorigenesis; Transformation; Gene regulation; Apoptosis; Latency (1)
Epstein-Barr virus; EBV; EBER; microRNA; DICER; Lupus antigen; La; ebv-miR-BART16; hsa-miR-142; IL1A; RAC1; TOMM22; ADCY9 (1)
Epstein-Barr-Virus , Genexpression , Transkription <Genetik> , Translation <Genetik> , , BPLF1 gene , Epstein Barr Virus (1)
EPSTEIN-BARR-VIRUS; IMMUNE DYSREGULATION; ANTIBODIES; PREVALENCE; DEFICIENCY; cytotoxic T-lymphocyte antigen 4 (CTLA-4); immunodeficencies; immune dysregulation; inborn errors of immunity (IEI); disease modifiers (1)
EPSTEIN-BARR-VIRUS; INFECTED B-CELLS; HODGKINS-DISEASE; BURKITTS-LYMPHOMA; NUCLEAR MATRIX; DELETION; EXPRESSION; REGION; ONCOGENESIS; PATTERNS; (1)
Epstein-Barr-Virus , Latenz , Lyse <Biologie> , Genregulation , Replikation , , Replication , regulation , lytic , latency , epstein-barr virus , (1)
Epstein-Barr-Virus , Latenz , Replikation , Replikationsursprung , , epstein-barr-virus , replication , origin of replication , latency (1)
EPSTEIN-BARR-VIRUS; LYMPHOBLASTOID CELL-LINES; LATENT CYCLE PROMOTER; BAMHI W PROMOTER; GENE-EXPRESSION; NASOPHARYNGEAL CARCINOMA; B-CELLS; DNA METHYLATION; BURKITTS-LYMPHOMA; GASTRIC-CARCINOMA; CpG island; DNA methylation; epigenetic regulation; histone modification; hit and run oncogenesis; methylome; pioneer transcription factor; Polycomb repressor complex; tumor suppressor (1)
EPSTEIN-BARR-VIRUS; MEMBRANE-PROTEIN 1; ENCODED LATENT MEMBRANE-PROTEIN-1; CELLULAR MICRORNA MIR-146A; CPG METHYLATION; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; LINE C666-1; IN-VIVO; EXPRESSION; miR-146a; B cell lines; DNA methylation; Euchromatic histone modification; CpG island; Cell type specific expression (1)
EPSTEIN-BARR-VIRUS; MERKEL CELL POLYOMAVIRUS; RECOMBINATION-ACTIVATING GENES; BURKITTS-LYMPHOMA CELLS; HERPES-SIMPLEX-VIRUS; ENCODED LATENT MEMBRANE-PROTEIN-1; NASOPHARYNGEAL CARCINOMA-CELLS; CLASSICAL HODGKINS-DISEASE; INDUCED CYTIDINE DEAMINASE; HUMAN TUMOR-CELLS; Epstein-Barr virus; Tumor virus; Recombination; Chromatin; DNA-methylation; Transformation; Tumor suppressor gene (1)
Epstein–Barr virus, Oligonu-cleotide library, Target epitope screening,T-cell immunology, TCR antigen identification (1)
Epstein-Barr-Virus , Posttranskriptionelle Regulation , Transkription , Lokalisation , EBER-Gene , FISH , EBV , EBER-genes (1)
EPSTEIN-BARR-VIRUS; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; RISK-FACTORS; RECIPIENTS; DISORDERS; INFECTIONS; IMMUNITY; THERAPY; PTLD; (1)
Epstein-Barr-Virus , Transplantation , Immunsuppression , Polymerase-Kettenreaktion , Messenger-RNS , Nierentransplantation , Periphere Stammzellentransplantation , Replikation , real-time PCR , TaqMan , RT-PCR , virale Expressionsmuster , cytotoxische T-Zellen , viral expression pattern , cytotoxic T-lymphocyte , immunosuppression (1)
EPSTEIN-GLASER RENORMALIZATION; FRAMEWORK; BOSON; LHC; (1)
EPSTEIN-GLASER RENORMALIZATION; FRAMEWORK; SPACE; (1)
EPSTEIN-GLASER RENORMALIZATION; Quantum field theory; regularization; axial anomaly (1)
EQCM, Lithium-Ionen-Batterien, Elektrolyte, Ionische Flüssigkeiten (1)
eQTL; expression quantitative trait loci; pleiotropic variants; gwas; genome wide association studies; genetic correlation; complex diseases; complex traits (1)
Equanimity, Postural sway, Emotion regulation, Attention network, Postural stability, Embodiment, Executive control, Affective style, Balance, Mindfulness (1)
EQUATION; (1)
EQUATION; CONVERGENCE; MODEL; EQUILIBRIUM; MOTION; DOMAIN; BULK; Cahn-Hilliard equation; dynamic boundary conditions; gradient flow (1)
EQUATION-OF-STATE; GAUGE-THEORIES; HIGH-TEMPERATURES; PHASE-TRANSITION; CONFINEMENT; QCD; LIBERATION; SYMMETRY; (1)
EQUATION-OF-STATE; SURFACTANT FILMS; LIPID-BILAYERS; HOFMEISTER SERIES; MONOVALENT ANIONS; DRESSED MICELLES; MICROEMULSIONS; MICROSTRUCTURE; MIXTURES; SYSTEMS; (1)
EQUATION-OF-STATE; TEJA CUBIC EQUATION; PC-SAFT; ZEOTROPIC MIXTURES; LIQUID-EQUILIBRIUM; POWER-GENERATION; MOLECULAR DESIGN; SELECTION; OPTIMIZATION; HEAT; (1)
EQUATION; PHASE; Cahn-Hilliard equation; fourth order parabolic equation; finite element approximation; second order time discretization; 35K35; 35K55; 65L-50; 65M12; 65M15; 65M60; 82B26 (1)
EQUATIONS (1)
EQUATIONS; EVOLUTION; FLOW; Surface diffusion flow; Triple junctions; Stability analysis; Lojasiewicz-Simon gradient inequality (1)
EQUATIONS; SOBOLEV; SPACES; OPERATOR; FLUIDS; BESOV; SHEAR; Two-phase flow; Navier-Stokes system; Free boundary problems; Mullins-Sekerka equation; convergence to equilibria (1)
EQUIDISTRIBUTION; POINTS; (1)
EQUILIBRIA; MARKETS; Capacity; Investment; Cournot competition; Price cap (1)
EQUILIBRIUM CONSTRAINTS; MATHEMATICAL PROGRAMS; STATIONARITY; SYSTEMS; MODEL; vector-valued Allen-Cahn system; parabolic obstacle problems; linear elasticity; MPCCs; mathematical programs with complementarity constraints; optimality conditions (1)
Equilibrium thermodynamics and statistical mechanics; Green's function methods; Heterojunctions; Magnetic phenomena; Semiconductor-semiconductor heterostructures; Semiconductor-semiconductor interfaces (1)
EQUIMOLAR CONDENSATION; STRUCTURAL ELUCIDATION; EFFICIENT SYNTHESIS; PROCYANIDINS; CATECHIN; PROANTHOCYANIDINS; TANNINS; BARK; (1)
EQUINE DOMINANCE; HIERARCHIES; STABILITY; STALLION; PATTERNS; PONIES; learning; dominance relationship; horse; human-animal relationships (1)
EQUINE ENCEPHALITIS-VIRUS; NEUTRALIZING MONOCLONAL-ANTIBODIES; INFECTIOUS CDNA-CLONES; SEMLIKI-FOREST-VIRUS; CHIKUNGUNYA VIRUS; SINDBIS VIRUS; HEPARAN-SULFATE; ENCEPHALOMYELITIS VIRUS; EFFECTOR FUNCTIONS; WILD-TYPE; (1)
Equines Herpesvirus 1 , Gentransfer , Virusvektor , virales Vektorsystem , heterologes Prime/ Boost Verfahren , mukosale Immunantwort , Equine Herpesvirus 1 , viral vector system , gene transfer , heterologous prime/ boost , mucosal immune response (1)
EQUITY; CONSTRAINTS; RESPOND; PRICES; HOME; Consumption; Housing wealth; Home-equity credit; Liquidity constraint; E21; R22; G21 (1)
Equity crowdfunding, Crowdinvesting, Small business finance, Securities regulation, Investor protection (1)
Equity crowdfunding, Crowdinvesting, Startups, Securities issuance, Investment dynamics, Entrepreneurial finance (1)
equity gap; gender; reversed gender achievement gap; learning and educational capital; Saudi Arabia; secondary school (1)
EQUITY; UTILITARIANISM; GENERATIONS; CONTINUITY; OPTIMALITY; DOMINANCE; UTILITY; CHOICE; sustainability; ethical preferences; Suppes-Sen grading principle (1)
EQUIVALENCE-RELATIONS; RANK GRADIENT; Integral foliated simplicial volume; cost of groups (1)
EQUIVARIANT STABLE-HOMOTOPY; K-THEORY; CLASSIFYING-SPACES; MACKEY FUNCTORS; TATE COHOMOLOGY; RING; HOMOLOGY; LOCALIZATION; NILPOTENCY; EXTENSIONS; (1)
EQUUS-CABALLUS; BEHAVIOR; INNOVATION; BRAINS; crowdsourcing; horse; innovation; mule; management; tool use (1)
EQUUS-CABALLUS; CULTURAL TRANSMISSION; EQUINE TEMPERAMENT; BEHAVIOR PATTERNS; CANIS-FAMILIARIS; DOMESTIC HORSES; COLOR-VISION; FERAL HORSES; IMITATION; DISCRIMINATION; Horse; Social learning; Sociality; Ecology; Social relationships (1)
EQUUS-FERUS-PRZEWALSKII; HUSTAI NATIONAL-PARK; SOCIAL-BEHAVIOR; MOUNTAIN BABOONS; HABITAT USE; DOMINANCE; HORSES; STRESS; LEADERSHIP; AGGRESSION; Alpha male; Horse; Equus ferus przewalskii; Bachelor group; Group structure (1)
EQUUS-PRZEWALSKII; BEHAVIOR; DOMINANCE; HERD; AGGRESSION; MECHANISMS; MANAGEMENT; HARASSMENT; PATTERNS; BABOONS; feral horses; mutual grooming; social bonds; social bond analysis; spatial proximity (1)
ERADICATION; INFECTION; (1)
Erbbaurecht, Erbpacht, Erbbauzins, institutional investor, ground rent, leasehold, marriage value (1)
Erbbaurecht, Institutionelle Investoren, Erbbauzins, Volleigentum, Überrenditen (1)
ERBB RECEPTORS; MOLECULAR-MECHANISM; HER3 EXPRESSION; ADVANCED HEAD; NECK-CANCER; ORAL-CAVITY; PHASE-III; CARCINOMA; EGFR; FAMILY; growth factor receptor; EGFR; c-Met; p16; oropharyngeal squamous cell cancer OPSCC; targeted therapy; immunohistochemistry; HPV (1)
ER-BETA; GENE-EXPRESSION; BINDING PROTEIN-4; SPLICE VARIANTS; MESSENGER-RNA; ALPHA; PROLIFERATION; OVARIAN; ACTIVATION; CARCINOGENESIS; estrogen receptor beta; splice variant; COS-1 cell (1)
ER-BETA; MESSENGER-RNAS; LIPOCALIN 2; CYCLIN D1; CARCINOMA; ALPHA; GROWTH; ACTIVATION; PROSTATE; DISEASE; Estrogen receptor beta; Ovarian cancer; Estrogen receptor beta agonists (1)
ERC, ERCP, Cholangiographie, infektiöse Komplikation, Post-ERCP-Cholangitis, Antibiotikaprophylaxe, Kontrastmittel, Galleabflussstörung, SSC, Cholangitis, Endoskopie, post-ERC infectious complication, contrast media, biliary obstruction (1)
ERECTILE DYSFUNCTION; INFORMED-CONSENT; PLACEBO GROUPS; BETA-BLOCKERS; DOUBLE-BLIND; METAANALYSIS; RESPONSES; TRIALS; PAIN; MECHANISMS; (1)
ERECTILE-DYSFUNCTION; NITRIC-OXIDE; INTERMITTENT HYPOXIA; CPAP TREATMENT; RISK-FACTOR; DISORDERS; THERAPY; INFLAMMATION; ASSOCIATION; PREDICTORS; Erectile Dysfunction; Sleep Apnea; CPAP Treatment; Sexual Dysfunction; Intermittent Nocturnal Hypoxemia (1)
ERECTILE DYSFUNCTION; RESPONSES; PAIN; THERAPY; Placebo effect; Nocebo effect; Drug effects; Risk disclosure; Communication (1)
erectile dysfunction, vigilance performance, daytime sleepiness, erektile Dysfunktion, Vigilanzleistung, Tagesschläfrigkeit (1)
ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; INTERNATIONAL INDEX; GERMAN VERSION; HEALTH-STATUS; DYSFUNCTION; ANASTOMOSIS; VALIDATION; PROCTOCOLECTOMY; inflammatory bowel disease; complications; psychology; male; humans; personal satisfaction; sexual behavior; sexual dysfunction; physiology; etiology (1)
Erfahrungsorientiertes Lernen (1)
Erfolgsangst , DAI , Leistungsangst , Studie , Schüler , Student , Selbstbild , Leistungsmotivation , Lerntraining , fear of success , test anxiety , training, pupils , self concept (1)
; ergonomics; engineering psychology or human factors; man-machine interaction; critical dose effects; critical incidents (1)
ERGONOVINE STRESS ECHOCARDIOGRAPHY; HUMAN 5-HT4 RECEPTOR; OVEREXPRESSION; HEART; PHOSPHOLAMBAN; IMPROMIDINE; MYOCARDIUM; METABOLISM; Ergometrine; Human atrium; Mouse atrium; Mouse ventricle (1)
erhöhtes extrazelluläres Wasser, Serumspiegel von ANP, Bioimpedanz, rheumatoide Arthritis (1)
Erklären, Core Practices, Lehrkräftebildung; Erklärkompetenz; Lehrerbildung; Unterrichtsqualität; FALKE Forschungsprogramm; Professionelles Erklären; Fachdidaktikenvergleich; Peer-to-Peer-Lernen; Empirische Bildungsforschung; Hochschuldidaktische Interventionen; Professionalisierung von Lehramtsstudierenden (1)
Erklären, politische Bildung, Sachunterricht, sozialwissenschaftlicher Sachunterricht, Qualitätskriterien, core practice (1)
Erklärqualität, Erklärtiefe, Beobachterperspektive (1)
Erklärvideo, Lehramtsausbildung, fachdidaktisches Seminar, Interdisziplinarität, Erklärkompetenz fördern (1)
Erklärvideo, Lehramtsausbildung, fachdidaktisches Seminar, Interdisziplinarität, Erklärkompetenz fördern, Flipped Classroom (1)
Ermessen , Ermessensentscheidung , Verwaltungsrecht , Tschechische Republik , Verwaltungsstreitverfahren , Gewerberecht , , discretion , administration , administrational procedure , administrational courts , trade law (1)
ERM, Systemlandschaft, E-Ressourcen, EZB, ZDB (1)
Erneuerbare Energien, Gesetz, Energiewende, Industriegesellschaft, Manssen (1)
Erneuter Intensivaufenthalt nach Herzchirurgie, Komplikationen nach herzchirurgischen Eingriffen, Risikofaktoren für erneuten Intensivaufenthalt nach Herzchirurgie (1)
Erpressung; Verstellung; Erstsprache; Fehleranalyse; Fehlerprofil (1)
ERROR-CORRECTION; ALGORITHMS; CIRCUITS; NETWORKS; (1)
Error management; culture; basic need; satisfaction; servant; leadership; self-determination theory; autonomous motivation; serial mediation (1)
error orientation, personal initiative, psychological safety, readiness to change, reflection, reflective practice, self-determination, self-efficacy, workplace change, workplace learning (1)
ERROR-RELATED NEGATIVITY; PREFRONTAL CORTEX; COGNITIVE CONTROL; MOVEMENT PREPARATION; HUMAN BRAIN; MOTOR; EEG; SELECTION; DYNAMICS; DESYNCHRONIZATION; ACC; Motor cortex; Theta; Beta; Conflict; Response priming (1)
Erste Juristische Staatsprüfung, 2002, Manssen (1)
Erste Juristische Staatsprüfung, 2004, Manssen (1)
Erste Juristische Staatsprüfung, 2009, Manssen (2)
Erste Juristische Staatsprüfung, Wahlfachgruppe 6, 1999/1, Manssen (1)
Erstsprachdidaktik, Zweitsprachdidaktik, Deutsch als Zweitsprache (DaZ), Sprachdidaktik, Spracherwerb Deutsch, DaZ-Lernende, sprachliche Voraussetzungen, Stolpersteine im Spracherwerb, Lehramtsstudium, Referendariat, Schulpraxis, sprachdidaktische Grundlagen (1)
Erstuntersuchung, Neonatologie, Geburtshilfe (1)
Ertragsmanagement, Versicherungen, Data Warehousing (1)
Erwachsenenbildung (1)
Erwachsenenbildung, Interesse, Kompetenz, Autonomie, soziale Eingebundenheit, Grundbedürfnisse, Individualisierung, adaptiver Unterricht, adult education, interest, competence, autonomy, social relatedness, basic needs, individualization, adaptive teaching (1)
Erwachsenenbildung/Weiterbildung, Learning and Professional Development, Expertiseforschung, Professionalisierung pädagogischer und sozialpädagogischer Berufe, Übergang von Bildungs- in das Beschäftigungssystem, Bewerbung (1)
Erwartungen, Kompetenzen, Leadership, Transformational leadership, Ethical leadership, Expectations, Employees, Occupations, Hierarchy, Autonomy, MLQ, ELW-D, competencies (1)
ERWINIA-CAROTOVORA; EXPRESSION; SPORULATION; SYSTEM; (1)
ER-YAG LASER; NONSURGICAL TREATMENT; BACTERIAL-COLONIZATION; PLAQUE REGROWTH; TITANIUM IMPLANTS; THERAPY; SURFACE; DISEASES; VITRO; MOUTHRINSE; antimicrobial agent; implant surface; oral bacteria; peri-implantitis (1)
ERYTHROCYTE SEDIMENTATION-RATE; C-REACTIVE PROTEIN; MORTALITY; DISEASE; RISK (1)
ERYTHROPOIETIN (1)
erythropoietin, hypoxia signalling, interstitial fibroblasts, PHD inhibition, prolyl-4-hydroxylases, renal endocrine functio (1)
erythropoietin, hypoxia signalling, phenotype shift,prolyl 4-hydroxylases, renal interstitial cells, renin (1)
ERYTHROPOIETIN-PRODUCING CELLS; ACUTE-KIDNEY-INJURY; ASPARAGINYL HYDROXYLASE; TRANSCRIPTIONAL ACTIVITY; RAT KIDNEYS; FACTOR FIH; IN-VIVO; PATHWAY; MICE; RNA; cell biology and structure; hypoxia; immunohistochemistry; podocyte; tubule cells (1)
ERYTHROPOIETIN PRODUCTION; INJURY; EXPRESSION; MICE; MECHANISMS; HYPOXIA; CELLS; CYCLOOXYGENASE-2; DISRUPTION; LIPOCALIN; Proenkephalin-A; kidney damage; interstitial fibrosis; chronic kidney disease; renal function (1)
Erythropoietin, renale interstitielle Fibroblasten, Erythropoietin-produzierende Zellen, HIF-2, Vhl-Deletion (1)
Erythrozyt , Embryonalentwicklung , Huhn , Genregulation , IFR1 , TOB , Tis7 , terminale Differenzierung , Erythrozyten , Hühnerembryo , IFR1 , TOB , Tis7 , terminal differentiation , erythrocytes , chicken embryo (1)
Erzählen lernen, literarische Fragmente, narratives Schreiben, Erzählkompetenz, Schreibdidaktik, Deutschunterricht, Textproduktion (1)
Erzählkompetenz, Schreibkompetenz, schriftliches Erzählen, Schreibprozess, literale Vorerfahrungen, Textqualität, Erzählkriterien, Textebene, Schreibdidaktik, Unterrichtspraxis, Praxisbeispiele, Deutschunterricht (1)
Erziehung, Schule, Muttersprache, Integration, Ü-Klasse, Wochenendschule (1)
ESCALATING COMMITMENT; DE-ESCALATION; INFORMATION; DECISION; COMPLETION; PSYCHOLOGY; sunk cost effect; choice dilemma; escalation of commitment; judgment and decision making; behavioral economics (1)
ESCALATING IMMUNOMODULATORY THERAPY; CLINICALLY ISOLATED SYNDROMES; PRACTICAL APPLICATION; PREDICT CONVERSION; DISABILITY; CRITERIA; MRI; ABNORMALITIES; PATHOGENESIS; PROGRESSION; (1)
ESCALATION METHODS; RANDOMIZED-TRIALS; ADAPTIVE DESIGNS; INTERVAL DESIGN; CONSENSUS; GUIDELINES; STATEMENT; PROTOCOL; OUTCOMES; UPDATE; (1)
Eschatologie (2)
ESCHERICHIA-COLI; ACTIVE-TRANSPORT; LIGAND-BINDING; SYSTEM; SPECTROSCOPY; MUTANTS; folding; ligand binding; maltose-binding protein; stability; Thermotoga maritima (1)
ESCHERICHIA-COLI; ACYL MIGRATION; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; ARCHAEA; BACTERIA; MALTOSE; ACETYLTRANSFERASE; ACYLTRANSFERASES; TRANSACETYLASE; acetyl coenzyme A (acetyl-CoA); acetyltransferase; enzyme; lipid ether; phosphatase; maltose (1)
ESCHERICHIA-COLI; ARCHAEAL; RECOGNITION; ENDONUCLEASE; 3'-TERMINUS; SYNTHETASE; SEQUENCES; INVITRO; ORIGIN; (1)
ESCHERICHIA-COLI; ARCHAEBACTERIUM SULFOLOBUS; TOTAL RECONSTITUTION; EXPANSION SEGMENTS; RNA MODIFICATION; BACILLUS-STEAROTHERMOPHILUS; EUKARYOTIC RIBOSOMES; PROTEIN-COMPOSITION; SUBUNITS; EVOLUTION; archaea; ribosome; ribosome biogenesis; ribosomal RNA; ribosomal proteins; RNA modifications (2)
ESCHERICHIA-COLI; ATP SYNTHASE; ELECTRON-MICROSCOPY; NANOARCHAEUM-EQUITANS; SIGNAL PEPTIDES; MOLECULAR-BASIS; BACTERIAL; ARCHAEBACTERIA; EVOLUTION; ENVELOPE; (1)
ESCHERICHIA-COLI; BACTEREMIA; PATIENT; TOXIN; GENES; PCR; (1)
Escherichia-coli biosynthesis precursor protein thiamin 4-diphosphocytidyl-2c-methyl-d-erythritol d-1-deoxyxylulose isoprenoids terpenoids catalyzes (1)
ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BASAL BODY; GENE-EXPRESSION; RESPONSE REGULATOR; PROTEUS-MIRABILIS; TYPHIMURIUM; MOTILITY; DIFFERENTIATION; CHEMOTAXIS; (1)
ESCHERICHIA-COLI; CELL-DIVISION; DRUG DISCOVERY; SHUT-OFF; GENE; EXPRESSION; TUBERCULOSIS; FTSZ; TRANSFORMATION; REPRESSOR; (1)
ESCHERICHIA-COLI; CODON; PREDICTION; EFFICIENCY; GENOME; (1)
ESCHERICHIA-COLI; C-TYPE; HYDROGENOBACTER-THERMOPHILUS; YEAST ISO-1-CYTOCHROME-C; EXPRESSION; CLONING; GENES; BIOGENESIS; PERIPLASM; MUTATIONS; (1)
ESCHERICHIA-COLI DBPA; COOPERATIVE BINDING; ATP UTILIZATION; YXIN; CORE; NUCLEOTIDE; MECHANISM; SITE; enzyme regulation; DEAD-box helicase; ribosome assembly; molecular mechanism; NMR spectroscopy (1)
ESCHERICHIA-COLI; DEOXYINOSINE 3-ENDONUCLEASE; DNA; ENDONUCLEASE; RECOGNITION; MUTATIONS; SPECIFICITY; PROTEINS; (1)
ESCHERICHIA-COLI; DNA; MYCOBACTERIUM; TUBERCULOSIS; SEPTICEMIA; (1)
ESCHERICHIA-COLI; DRINKING-WATER; PARTICLE FILTERS; MEMBRANE; ENUMERATION; SEPARATION; COLIFORMS; FOOD; OPTIMIZATION; CELLS; (1)
ESCHERICHIA-COLI ENDOTOXIN; SALT EXPORT PUMP; NUCLEAR FACTOR-1-ALPHA; MOLECULAR CHAPERONES; SHOCK RESPONSE; LIVER; SEPSIS; EXPRESSION; GENE; CHOLESTASIS; (1)
ESCHERICHIA-COLI; IDENTIFICATION; YEAST; Metabolomics; GC-MS; Adherent cells; Detachment; Extraction; Amino acids (1)
ESCHERICHIA-COLI INFECTION; CUTTING EDGE; PROINFLAMMATORY IL-17(+); DIFFERENTIAL REGULATION; GENE-EXPRESSION; RECEPTOR; RELA; PATHWAY; MEMBER; ALPHA; (1)
ESCHERICHIA-COLI; INFRARED-SPECTROSCOPY; HYDROPHOBIC INTERIOR; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; PK(A) VALUES; AMINO-ACIDS; MECHANISM; TRANSPORTERS; PROTEIN; transport proteins; membrane proteins; proton transport; surface-enhanced infrared spectroscopy; major facilitator superfamily; transport; membrane transport; spectroscopy; glucose transport; major facilitator family; pK value (1)
Escherichia coli K12, Staphylococcus cohnii, contact killing, copper containing and alloyed materials (1)
ESCHERICHIA-COLI; LABELED OLIGONUCLEOTIDES; ANGSTROM-RESOLUTION; SP-NOV; MICROORGANISMS; IDENTIFICATION; CELLS; GENUS; (1)
ESCHERICHIA-COLI; MISMATCH REPAIR; DNA GLYCOSYLASE; CELL-DIVISION; SP-NOV; GENE; PROTEIN; CANCER; MUTATIONS; ARCHAEAL; (1)
ESCHERICHIA-COLI; MITOCHONDRIAL NADH; BACTERIAL; PROTEIN; PURIFICATION; TRANSLOCATION; DEHYDROGENASE; FLEXIBILITY; INHIBITORS; STABILITY; (1)
ESCHERICHIA-COLI; NTCA; GENE; DIFFERENTIATION; EXPRESSION; REGULATOR; ENVELOPE; IDENTIFICATION; MATURATION; HETR; (1)
Escherichia coli (platinum complexes screening for neoplasm-inhibitory activity in) Neoplasm inhibitors (platinum-bis(oligopeptide ester) complexes as, screening of, in Escherichia coli) platinum complex antitumor screening Escherichia (1)
Escherichia-coli precursor thiamin d-1-deoxyxylulose 5-phosphate pyridoxol thiazole (1)
ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; CHAPERONE ACTIVITY; BINDING-SITE; EXPRESSION; SYSTEM; TRANSCRIPTION; MECHANISM; HELICASES; INTRONS; Cell-free protein synthesis; S30 extract; RNA chaperone; RNA helicase; mRNA secondary structure; Micro RNA (1)
ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; COMPLEX FLAGELLA; INTERMITTENT ROTATION; MECHANICAL FORCE; MELILOTI; MOTILITY; SPEED; TRANSFORMATIONS; CHEMOTAXIS; (1)
ESCHERICHIA-COLI RIBOSOMES; RNA-PROCESSING COMPLEXES; SMALL-SUBUNIT PROCESSOME; SMALL NUCLEOLAR RNA; EUKARYOTIC RIBOSOME; U3 SNORNP; RIBONUCLEOPROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SSU PROCESSOME; (1)
ESCHERICHIA-COLI RIBOSOMES; YEAST SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT RECEPTOR; ANGSTROM RESOLUTION; TRANSLATION INITIATION; BIOGENESIS FACTORS; 50S SUBUNIT; RNA; MATURATION; BINDING; (1)
ESCHERICHIA-COLI; RIFAMPICIN RESISTANCE; RNA-POLYMERASE; BETA-SUBUNIT; MUTANTS; (1)
Escherichia coli, Saccharomyces cerevisiae, biotin transport, vitamin, biotin sensing, membrane transport, gene regulation, biotin, transport mechanism, histone (1)
ESCHERICHIA-COLI; STABILITY; PROTEINS; RESOLUTION; BINDING; METHOTREXATE; ISOMERASE; VOLCANII; FOLATE; STATE; conformational flexibility; dihydrofolate reductase; dimerization; thermostability; Thermotoga (1)
ESCHERICHIA-COLI THIOREDOXIN; INTRAPROTEIN ELECTRON; DNA PHOTOLYASE; CHLAMYDOMONAS PHOTOTROPIN; RIBONUCLEOTIDE REDUCTASE; FLAVIN MONONUCLEOTIDE; RECEPTOR PHOTOTROPIN; VERSATILE PEROXIDASE; PLANT CRYPTOCHROME; PULSE-RADIOLYSIS; (1)
ESCMID-ASTERISK GUIDELINE; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; STEWARDSHIP PROGRAM; MEDICAL-CENTER; MANAGEMENT; DIAGNOSIS; CANDIDA; AMERICA; Antibiotic stewardship; Antifungal stewardship; Antifungal drugs; Pharmacoepidemiology; Hematology (1)
ESCRT-III, membrane remodeling, nucleotide hydrolysis, photosynthesis, thylakoid biogenesis, stress response, Synechocystis, Chlamydomonas, cryo-EM, cryo-electron tomography, CLEM (1)
ESG controversies · Corporate controversies · Board structure · Corporate scandals · Within-between model · Hybrid regression model (1)
ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, Corporate Scandals, Portfolio Choice, Asset Pricing, Payout, Dividends, Stock Repurchases (1)
ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, SR mutual funds, Board (1)
ESG · Corporate social responsibility · Corporate social performance · Controversy (1)
ESG ETF · Performance · Sensitivity · ESG strategy · COVID-19 pandemic · Russian–Ukraine conflict · Paris agreement · Taxonomy (1)
ESG scores, Greenwashing, Greenwashing indicator, Information asymmetry, Analysts coverage (1)
ESG; sustainability; asset pricing; fund flows (1)
ESG; UN SDGs; sustainability reports; corporate environmental reporting; resilience; sustainable industrialization; biodiversity (1)
ESHRE PGD; MOSAICISM; EMBRYO; CYCLES; PGD; Trophectoderm; Polar body; Preimplantation diagnostics; Genetic testing (1)
ESKD; UACR; eGFR; mortality in CKD; osteopontin. (1)
ESOPHAGEAL EPITHELIAL-CELLS; MOLECULAR-CLONING; KAPPA-B; EXPRESSION; TRYPSIN; ROLES; PAR-2; IL-8; Gastroesophageal reflux disease; Interleukin-8; Inflammation; Protease-activated receptor-2; Epithelial immune response (1)
ESR; ENDOR; Phenanthrenesemiquinones; Steric effects (1)
ESSENTIAL COMPONENT; ANION CHANNEL; CELLS; DECREASE; CHLORIDE; ACTIVATION; EPITHELIUM; PROTEIN; CRYPTS; VRAC; LRRC8A; VRAC; Volume-activated anion channels; Volume regulation: regulatory volume decrease; RVD, apoptotic volume decrease; AVD (1)
ESSENTIAL COMPONENT; BEST-DISEASE; MISSENSE MUTATIONS; KNOCKOUT MICE; ANION CURRENT; CHANNELS; GENE; IDENTIFICATION; PROTEIN; CONDUCTANCE; bestrophin 1; volume-regulated anion channel; induced pluripotent stem cell; retinal pigment epithelium; mouse sperm (1)
ESSENTIAL COMPONENT; PACEMAKER ACTIVITY; INTERNAL STORE; CA2+ RELEASE; KINASE-II; CALCIUM; PROTEIN; PHOSPHORYLATION; MECHANISM; CHANNELS; (1)
ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; PLASMA ENDOTHELIN; ATHEROSCLEROSIS; ASSOCIATION; LYS198ASN; VARIANT; (1)
ESSENTIAL OIL (1)
ESSENTIAL OIL COMPOSITION; TURMERIC OIL; BY-PRODUCT; L.; DEGRADATION; KINETICS; SOLVENT; Curcumin; Surfactant-free microemulsions; Extraction; Green chemistry; Food; High purity; Water-solubility (1)
ESSENTIAL OIL; L.; BIOAVAILABILITY; CYCLODEXTRINS; STABILITY; SOLVENT; MEDIA; WATER; Meglumine; Pyroglutamic acid; Extraction; Curcumin (1)
essential spectrum; mixed order ODE systems; MHD (1)
; essential spectrum; perturbed operator; magnetohydrodynamics (1)
; Essential spectrum; perturbed operator; magnetohydrodynamics (1)
Essentielle Hypertonie , Sekundäre Hypertonie , Renin-Angiotensin-System , Immunsuppression , Tacrolimus , Cyclooxygenase , NO-Synthase , Cyclosporin A , cyclooxygenase , NO-synthase , cyclosporin A (1)
Essstörungen, Risikofaktoren, Einflüsse der Medien, Schlankheitsideal (1)
ESTABLISHED EXPERIMENTAL COLITIS; TOLL-LIKE RECEPTOR; PROTEIN-KINASE; BOWEL-DISEASE; MURINE MODEL; INDUCTION; FIBROSIS; CELLS; GSK3; ANTIBODIES; (1)
Esther (book of), dominionism, new apostolic reformation, political violence (1)
ESTIMATING ANIMAL DENSITY; LYNX LYNX-LYNX; RED DEER; ROE DEER; HABITAT SELECTION; NATIONAL-PARK; GROUP-SIZE; FOREST; POPULATION; CAPTURE; population density estimation; camera traps; animal movement; behavioral responses; sensitivity analysis (1)
Estimation error Parameter risk Hedging (1)
ESTIMATOR; MATRIX; (1)
estradiol, androgen receptor, anti-Müllerian hormone, polycystic ovary phenotype (1)
ESTROGENIC CHEMICALS; SEMINAL-VESICLES; IMAGE ANALYZER; EXPOSURE; PROSTATE; RATS; MICE; IMMUNOCYTOCHEMISTRY; REEVALUATION; HYPERTROPHY; bisphenol A; prostate; seminal vesicle; immunohistochemistry; morphometry; densitometry; androgen receptor regulation; PCNA; MIB-5; proliferation markers (1)
; Estrogen; Odontogenesis; Tooth morphology; Gene expression (1)
ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; HEALTH INITIATIVE MEMORY; CORONARY-HEART-DISEASE; UP HERS-II; REPLACEMENT THERAPY; ESTROGEN/PROGESTIN REPLACEMENT; CARDIOVASCULAR-DISEASE; OVARIAN-CANCER; HOT FLASHES; (1)
ESTROGEN-RECEPTOR AFFINITY; AROMATASE ACTIVITIES; POTENT INHIBITORS; DERIVATIVES; ESTRADIOL; ANALOGS; (1)
ESTROGEN-RECEPTOR AFFINITY; POTENT INHIBITORS; (P-O-SULFAMOYL)-N-ALKANOYL TYRAMINES; AROMATASE ACTIVITIES; PROLIFERATION; EXPRESSION; ESTRADIOL; DERIVATIVES; ENZYME; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; steroid sulfatase; breast cancer; phenylindole sulfamate; enzyme inhibition (1)
ESTROGEN-RECEPTOR-ALPHA; CANDIDATE GENES; POLYMORPHISMS; RISK; ASSOCIATION; DEMENTIA; WOMEN; OSTEOPOROSIS; REPLACEMENT; SYMPTOMS; Alzheimer's disease; estrogen receptors; genetic risk (1)
ESTROGEN-RECEPTOR-ALPHA; R6/2 MOUSE MODEL; DARPP-32 PHOSPHORYLATION; NEUROLOGICAL DISEASE; SOCIAL-INTERACTION; GENDER-DIFFERENCES; GENE-EXPRESSION; CEREBRAL-CORTEX; MOTOR DEFICITS; IN-VITRO; (1)
ESTROGEN-RECEPTOR-ALPHA; SEX-HORMONE DISTURBANCES; GROWTH-PLATE; AROMATASE DEFICIENCY; GENE-EXPRESSION; BONE-GROWTH; ESTRADIOL; MECHANISMS; CHILDHOOD; ANDROGEN; mandible; maxilla; oestrogen receptor alpha; oestrogen receptor beta; oestrogens (1)
ESTROGEN-RECEPTOR-ALPHA; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; CELL-CARCINOMA; HIGH-RISK; CANCER; PROLIFERATION; SURVIVAL; BETA; CLASSIFICATION; NMIBC; ERBB2; ESR1; MKI67; Stage; Grade (1)
ESTROGEN-RECEPTOR-BETA; ALPHA ER-ALPHA; MESSENGER-RNA; BREAST-CANCER; DIFFERENTIAL EXPRESSION; PROGESTERONE-RECEPTOR; REPLACEMENT THERAPY; SPLICE VARIANTS; IDENTIFICATION; PROLIFERATION; (1)
ESTROGEN-RECEPTOR-BETA; BLIND CONTROLLED TRIAL; SMOOTH MUSCLE ACTIN; CYCLICAL MASTALGIA; NIPPLE DISCHARGE; LUMINAL KERATINS; COLLAGEN-IV; CANCER RISK; TAMOXIFEN; LESIONS; benign breast disease; ER beta expression; nipple discharge; mastodynia (1)
ESTROGEN-RECEPTOR-BETA; FOLLICLE-STIMULATING-HORMONE; MESSENGER-RNA EXPRESSION; GRANULOSA-CELLS; DOWN-REGULATION; PROGESTERONE ANTAGONISTS; MICE; NEUROENDOCRINE; GONADOTROPINS; ONAPRISTONE; Antiestrogen; Tamoxifen; Hormone levels; Rat; Antiovulatory effect (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; BREAST-CANCER; GROWTH-FACTOR; ASSOCIATION; RISK; ALPHA; VARIANTS; DISEASE; ABSENCE; Ovarian cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case-control study (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; ER-ALPHA; POSTMENOPAUSAL WOMEN; HAPLOTYPE ANALYSIS; ESTRADIOL LEVELS; RISK; ASSOCIATION; VARIANTS; PROSTATE; Breast cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case control study (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; TR2 ORPHAN RECEPTOR; SERUM ADIPONECTIN; APOPTOSIS; GROWTH; ALPHA; RISK; PCR; IDENTIFICATION; adiponectin; mammary epithelial cell; breast cancer cell line; gene regulation (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; TRANSITIONAL-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; UROTHELIAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; GENE AMPLIFICATION; MOLECULAR TAXONOMY; URINARY-BLADDER; BREAST-CANCER; Non-muscle-invasive bladder cancer; ERBB2; Estrogen receptor; HER2; Urothelial carcinoma (1)
ESTROGEN-RECEPTOR-BETA; PURIFIED SOY ISOFLAVONES; GENE-EXPRESSION; PROSTATE-CANCER; PROTEIN; BINDING; LINES; INHIBITION; APOPTOSIS; LIGAND; breast cancer; estrogen receptor-beta; genistein; HER2; trastuzumab (1)
estrogen receptor beta, splice variants, delta 4, matched pairs (1)
ESTROGEN-RECEPTOR-BETA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENVIRONMENTAL RISK-FACTORS; CROHNS-DISEASE; ULCERATIVE-COLITIS; POSTMENOPAUSAL WOMEN; CLINICAL-COURSE; MESSENGER-RNA; GENDER BIAS; GASTROINTESTINAL-TRACT; Epidemiology; Estrogen; Menopause; Puberty (1)
ESTROGEN RECEPTOR-BETA; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; HORMONE-RECEPTORS; LUMINAL SUBTYPES; GENE-EXPRESSION; ERBB2; CLASSIFICATION; CHEMOTHERAPY; MULTICENTER; (1)
ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; PROGESTERONE-RECEPTOR; ADENYLATE-CYCLASE; ENDOCRINE THERAPY; HIGHLY POTENT; PEPTIDE-YY; ANTAGONIST; ALPHA; TARGETS; (1)
ESTROGEN-RECEPTOR; HUMAN GENOME; SRC-1; COACTIVATOR; ASSOCIATION; GENE; POLYMORPHISMS; DISEASE; (1)
ESTROGEN-RECEPTOR MODULATORS; APOPTOSIS-INDUCING ACTIVITY; ELECTRON-TRANSFER; DIASTEREOSELECTIVE FORMATION; NUCLEOSIDE ANALOGS; MIXED-VALENT; ACTIVE-SITE; FERROCENE; FERROCIFEN; CHEMISTRY; Metallocenes; Cyclic voltammetry; IR spectroscopy; X-ray diffraction (1)
ESTROGEN-RECEPTOR; NEOADJUVANT CHEMOTHERAPY; PROGESTERONE-RECEPTOR; DISCORDANCE; TAMOXIFEN; IMPACT; Recurrent disease; Breast cancer; Receptor discordance; Hormone receptor (1)
ESTROGEN-RECEPTOR; OVARIAN-CANCER; MICRORNA PRECURSORS; REGULATED MICRORNA; RNA-INTERFERENCE; TUMOR INVASION; TARGET SITE; SP PROTEINS; EXPRESSION; CELLS; Breast cancer risk; MicroRNA; SNP; Case-control study (1)
ESTROGEN-REGULATED GENES; MESSENGER-RNA; POSTTRANSLATIONAL MODIFICATIONS; PROGESTERONE-RECEPTOR; MICROARRAY ANALYSIS; PROTEIN; CELLS; METALLOTHIONEIN; RESISTANCE; CARCINOMA; survival; estrogen receptor; LIV-1; tamoxifen (1)
Estrogen Related Receptor γ, Ovarialkarzinom, EMT, MET (1)
Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (diphenylpyridylbutenes as inhibitors of, antitumor activity of) Neoplasm inhibitors (diphenylpyridylbutenes as, antiestrogenic activity of) diphenylpyridylbutene estrogen pyridylbutene deriv antiestrogen antitumor butene deriv antiestrogen antitumor (1)
Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its Estrogen receptors Role: PRP (Properties) (prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its platinum complexes) Receptors Role: PRP (Properties) (estrogen, prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its platinum complexes) estrogen activity dichlorohydroxybenzylamine platinum complex (1)
Estrogens Role: BIOL (Biological study) (and inhibitors, butestrols and metabutestrols as) Neoplasm inhibitors (bis(hydroxymethylphenyl)butane as, of mammary gland) Receptors Role: BIOL (Biological study) (for estrogen, butestrols and metabutestrols binding by) Molecular structure-biological activity relationship (antiestrogenic, of butestrols and metabutestrols) Molecular structure-biological activity relationship (estrogen receptor-binding, of butestrols and metabutestrols) Mammary gland (neoplasm, bis(hydroxymethylphenyl)butane inhibition of) antiestrogen butestrol metabutestrol prepn estrogen receptor binding butestrol metabutestrol antitumor butanebis hydroxymethylphenyl structure activity butestrol metabutestrol antiestrogen (1)
Estrogens Role: BIOL (Biological study) (bis(hydroxyphenyl)phenylethene as) Crystal structure (of bis(hydroxyphenyl)phenylethene) Estrogens Role: BIOL (Biological study) (antiestrogens, bis(hydroxyphenyl)phenylethene as) Receptors Role: BIOL (Biological study) (estrogen, bis(hydroxyphenyl)phenylethene affinity for) Estrogens Role: BIOL (Biological study) (receptors, bis(hydroxyphenyl)phenylethene affinity for) hydroxyphenylphenylethene crystal structure antiestrogen estrogen activity (1)
Estrogens Role: BIOL (Biological study) ([(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, structure in relation to) Conformation and Conformers (of [(halohydroxyphenyl)ethylenediamine]platinum(II) complexes) Crystal structure (of [(halohydroxyphenyl)ethylenediamine]platinum(II) complexes, estrogenicity in relation to) Molecular structure-biological activity relationship (estrogenic, of [(hydroxyphenyl)ethylenediamine]platinum(II) complexes) Neoplasm inhibitors (mammary gland, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) Mammary gland Prostate gland (neoplasm, inhibitors, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) Neoplasm inhibitors (prostate gland, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) phenylethylenediamine platinum complex estrogenic crystal structure conformation phenylethylenediamine platinum complex estrogenic activity mammary cancer inhibitor phenylethylenediamine platinum complex (1)
Estrogens Role: PRP (Properties) ((dichlorohydroxyphenyl)phenylethylenediamines and their platinum sulfato complexes) Neoplasm inhibitors (platinum complexes with (dichlorohydroxyphenyl)phenylethylenediamines) antitumor activity platinum phenylethylenediamine complex estrogenic property platinum phenylethyleneidamine complex amine phenylethylenedi platinum complex (1)
Estrogens Role: RCT (Reactant), RACT (Reactant or reagent) (and inhibitors, metahexestrol derivs.) Molecular structure-biological activity relationship (antiestrogenic, of metahexestrol derivs.) Molecular structure-biological activity relationship (estrogenic, of metahexestrol derivs.) Coupling reaction (reductive, of phenylpropanols and propiophenones, mesohexestrol derivs. by) metahexestrol deriv prepn estrogen antiestrogen hexanediol diphenyl deriv (1)
Estrogens Role: USES (Uses) (inhibitors, bis(fluorohydroxyphenyl)dimethylbutane derivs.) bisfluorohydroxyphenyldimethylbutane deriv prepn antiestrogen activity estrogen inhibitor fluorohydroxyphenyldimethylbutane deriv (1)
Estrogens Role: USES (Uses) (inhibitors, dihydroxy(trifluoropropyl)benzanilide) hydroxybenzanilide trifluoropropyl trifluoropropylbenzanilide prepn antiestrogen (1)
ESTRO-SIOG GUIDELINES; LYMPHADENECTOMY; COMPLICATIONS; EXTENT; MEN; RISK; RECOMMENDATIONS; INTERMEDIATE; SURVIVAL; INVASION; Pelvic lymph node dissection; Guidelines; Adherence; Prostate cancer; Prostatectomy (1)
ESWT, Plantarfasciitis, Pilotstudie, Dosierungen, randomisiert (1)
(ETA(6)-ETA(1)-C6H5CH2CH2PR2)RU(CH3)(2) R; ALLENYLIDENE COMPLEXES; RING; METATHESIS; CATALYSTS; LIGANDS; ALPHA,OMEGA-DIENES; ELECTROCHEMISTRY; PH; CY; ruthenium; crystal structure; H-bridge; electrochemistry (1)
Étale duality, relative logarithmic de Rham-Witt sheaves, purity, semi-stable schemes, ramification, class field theory. (1)
étale duality, semistable, cohomology, ramification (1)
ETALE REALIZATION; SHEAVES; Stable homotopy theory; Homotopy theory of schemes; Motivic cohomology; Rigidity; Pro-homotopy theory; Etale realization (1)
Etalkohomologie , Klassenkörpertheorie , Konstruktive Galois-Theorie , Hasseprinzipien , geometric inverse Galois theory , geometric class field theory , Hasse principles (1)
ETA'-MESON MASS; PSEUDOSCALAR MESONS; RESONANCE PHYSICS; DECAY CONSTANTS; QCD; (1)
Etatsituation, wissenschaftliche Bibliotheken (1)
ETCH-AND-RINSE; LUTING MATERIAL; PREPARATION DESIGN; MARGINAL INTEGRITY; BOND STRENGTH; RESIN CEMENT; SELF-ETCH; IN-VITRO; ENAMEL; INLAYS; Partial ceramic crowns; Multi-mode adhesive; Self-adhesive resin cement; Prospective clinical study; FDI criteria (1)
etching; GaN; ICP-OES; KOH; LED (1)
ethanol cosurfactant microemulsion region extension (1)
ethanol; ranolazine; sodium (1)
ETHER; azacrown ether; macrocycle; cyclization (1)
ether lipids, Archaea, geranylgeranylglyceryl phosphate synthase, oligomerization (1)
ether lipids, Archaea, geranylgeranylglyceryl phosphate synthase, oligomerization, biocatalysis (1)
ethical conflicts, intensive care medicine, physicians, nurses, ICU, intensive care unit (1)
ETHICAL DILEMMAS; TRIAGE; PHYSICIANS; DISEASE; COHORT (1)
Ethical Values, Requirements Engineering, Responsible Software Development, Artificial Intelligence (1)
ETHICS; (1)
Ethik; Ethikberatung; Medizinethik; Normative Ethiken (1)
Ethik; Lebensformen; Habermas; Jaeggi; Koppetsch; Intimität; Ehe; Partnerschaft; Paarbeziehungen; Politik; Recht; immanente Kritik; Lebensformenpolitik; (1)
Ethik; Lebensformen; Intimität; Ehe; Partnerschaft; Moraltheologie; Sozialethik; Sünde; Paarbeziehungen; Politik; Lebensformenpolitik; Christentum; Kirche; (1)
Ethik; Universität; Selbstverwaltung; Organisation; Theologie; Autonomie; Freiheit, Wissenschaft; Wissenschaftsfreiheit; Bildung; Anwendung; Ethikkomitee; Wissen; Arbeit am Wissen; Wahrheit; Weltanschauung; Religion; wissenschaftliche Kommunikation; epistemische Rationalität; gute wissenschaftliche Praxis; Transzendenz; (1)
Ethik; Universität; Wissenschaft; Religion; Wahrheit; Organisation; multisystemisch; Bildung; Selbstverwaltung; Wissenschaftsgesellschaft; Wissensgesellschaft; Verantwortung; Anwendung; Ökonomisierung; (1)
ETHIONINE-SUPPLEMENTED DIET; CD8(+) T-CELLS; OVAL CELLS; CHOLINE-DEFICIENT; KNOCKOUT MICE; INTERFERON-GAMMA; RECEPTOR CX3CR1; MOUSE-LIVER; PROLIFERATION; REGENERATION; Liver regeneration; Macrophages/Kupffer cells; Liver inflammation; Cytokines; Tumour necrosis factor alpha (TNF alpha); Choline-deficient ethionine supplemented (CDE) diet (1)
Ethnobotanik , Krebsforschung , Phytochemie , Vanuatu , Screening , Heilpflanzen , , ethnobotany , screening , phytochemistry , cancer , Vanuatu (1)
Ethnopharmacological survey, Phytochemical characterization, Myrica salicifolia (1)
ETHYLAMMONIUM NITRATE; ELECTROLYTE-SOLUTIONS; ROOM-TEMPERATURE; RAMAN-SCATTERING; RELAXATION SPECTROSCOPY; SUPERCOOLED LIQUIDS; PHYSICAL-PROPERTIES; MOLECULAR-DYNAMICS; MOBILE PHASES; ORGANIC SALTS; (1)
Ethyl chloroformate, 3-phenylisochromans, 2-phenylbenzofurans, intramolecular nucleophilic substitution (1)
ethylenediamines diphenyl cytostatic cytostatic diphenylethylenediamines diphenylethylenediamines cytostatic diaminodiphenylethanes cytostatic amines araliph cytostatic anticancer ethylenediamines (1)
ETHYLENEDIAMINETETRAACETIC ACID; SALT; crystal structure; calcium dihydroethylenediaminetetraacetate (1)
ETHYLENE-GLYCOL; 298.15 K; 1,2-PROPYLENE GLYCOL; UREA SOLUTIONS; WATER; ENTHALPIES; MIXTURES; AMIDE; PHENYLALANINE; 25-DEGREES-C; (1)
ethyl methylimidazolium cyanamide fluoroborate ionic liq mixt excess property (1)
ETIFOXINE; RECEPTOR; MODULATION; DISORDERS; BINDING; TARGET; RATS; TSPO ligands; benzodiazepines; pregnenolone; neurosteroids; anxiolytic (1)
Etomidate, Polytrauma, Rapid Sequence Induction, Pneumonie (1)
ETS-1 TRANSCRIPTION FACTOR; TUMOR PROGRESSION; E-CADHERIN; METASTATIC MELANOMA; SIGNAL-TRANSDUCTION; DOWN-REGULATION; CELL INVASION; UP-REGULATION; IN-VIVO; C-KIT; integrin; Ets-1; AP-2; malignant melanoma; melanocytes; cancer; migration (1)
EU Agenturen Rechtsschutz Meroni (1)
EUBACTERIUM-COPROSTANOLIGENES ATCC-51222; BILE-ACIDS; GUT MICROBIOME; CARBOHYDRATE; FECES; BACTERIUM; PATTERNS; (1)
EU; Brexit; Visegrad Four; European council; European parliament (1)
EUKARYAL VIRUSES; DNA-POLYMERASES; SULFOLOBUS; GENOMES; SIRV1; DUTPASE; FAMILY; LIPOTHRIXVIRUS; THERMOPROTEUS; ENVIRONMENTS; virus; Archaea; hyperthermophile; linear DNA genome (1)
EUKARYAL VIRUSES; SULFOLOBUS; SEQUENCES; SIRV1; LIPOTHRIXVIRUS; ENVIRONMENTS; INITIATION; DIVERSE; PROTEIN; BLAST; virus; archaea; hyperthermophile; linear genome; Pyrobaculum; Thermoproteus (1)
EUKARYAL VIRUSES; SULFOLOBUS; SIRV1; THERMOPROTEUS; REPLICATION; FAMILY; SIFV; (1)
EUKARYOTIC TOPOISOMERASE-I; TRANSFER-RNA SYNTHETASE; DNA TOPOISOMERASE; REVERSE GYRASE; GENE ORDER; PROTEIN; PREDICTION; PHYLOGENY; BACTERIAL; EVOLUTION; (1)
EUKARYOTIC TRANSLATION INITIATION; EXPRESSION; SORAFENIB; PREDICTS; FAMILY; hepatocellular carcinoma; translation inhibitors; targeted therapies (1)
EUKARYOTIC TRANSLATION INITIATION-FACTOR-2; GENE-EXPRESSION; CAPTURE MICRODISSECTION; MELANOMA; IDENTIFICATION; TYROSINASE; RNA; RETINOBLASTOMA; CLASSIFICATION; MICROARRAYS; cDNA amplification; laser microdissection; melanoma; profiling; tissue biopsies (1)
EURODIAB IDDM COMPLICATIONS; PROGRESSION; DURATION; DIAGNOSIS; (1)
Eurofighter, Flugzeug, Cockpit, Evaluation, Piloten, Konzept, Bewertung, Laien, Domänenexperte, Mensch-Maschine-Umwelt-System, Mensch-Maschine-System, Schnittstelle, Informationsverarbeitung, Zusatzaufgabe, Leistung, Workload, Belastung, Beanspruchung, Situationsbewusstsein, Raumbewusstsein, mentales Modell, Panoramadisplay, Großflächendisplay, Kugelprojektion, exozentrisch, egozentrisch, koplanar, Antizipation, Positionsschätzung, Positionsantizipation, Konfliktantizipation, Orientierung, Performance Operator Characteristic, evaluation, pilots, concept, assessment, laymen, subject matter experts, aircraft, highly agile, eurofighter, cockpit, man-machine-system, man-machine-environment-system, interface, information processing, additional task, performance, workload, situation awareness, spatial awareness, mental model, panoramic display, wide area display, sperical projection, exocentric, egocentric, coplanar, anticipation, position estimation, position anticipation, conflict anticipation, orientation (1)
EUROMED-ETS; Trusted third parties; World Wide Web (1)
Europaausschuss (1)
Europa; Geschichte; Lutherische Theologie; Slowakei; Univerzita Komenského v Bratislave (1)
Europäische Identität, Interesse an Europa, Interkulturelle Pädagogik, Bildungspolitik, Europäische Schulen, Grundschule, Sekundarstufe, Curriculum, Unterricht, Interventionsstudie, empirische Forschung, Messinstrumente, Pädagogische Interessentheorie, Selbstbestimmungstheorie, Modell der Identitätsregulation nach Haußer European identity, interest in Europe, Europe, intercultural learning, educational policies, European Schools, primary school, secondary school, curriculum, intervention study, empirical research, measuring instruments, pedagogical interest theory, self-determination theory, Hausser model of identity regulation (1)
Europäische Integration , Integration , Europarecht , Globalisierung , Europäische Union , Souveränität , Russland , Rechtswissenschaft , , integration , EU , international organisation , globalisation , sovereignty (1)
Europäischer Gerichtshof für Menschenrechte, Migration, Non-refoulement (1)
"Europäischer Stabilitätsmechanismus", "Demokratische Legitimation", Demokratiedefizit, "no bail out", "Pringle-Urteil" (1)
Europäische Union / AGB-Richtlinie , Deutschland / AGB-Gesetz , Beweislast , Italien , mißbräuchliche Klauseln , Verbraucherverträgen , Italy , unfair terms and conditions , consumer contracts (1)
Europäische Union , Betrug , Kriminalität , Verfassung , Olaf , Europol , Eurojust , Europäische Staatsanwaltschaft , Olaf , Europol , Eurojust , European Prosecutor (1)
Europäische Union / Charta der Grundrechte , Grundrechtsschutz , Schweden , Meinungsfreiheit , Grundrecht , Vergleich , Regeringsformen , Verfassungstradition , Auslegung der Charta , Abwehrrechte , subjektive Rechte , Kongruenz , fundamental rights , fundamental rights Charta of Nice , Sweden , freedom of opinion , interpretation of the Charta (1)
Europäische Union, Erweiterung, Evangelische Theologie, Ostmitteleuropa, Evangelische Kirche (1)
Europäische Union, Terrorismus, Terrorismusbekämpfung (1)
Europa, Psychotherapieausbildung, Vergleich, psychotherapy, training, Europe (1)
EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DISEASE; IMPLANTATION; GUIDELINES; REPLACEMENT; MANAGEMENT; UPDATE; von Willebrand factor; Acquired von Willebrand syndrome; Bicuspid aortic valve; Aortic stenosis; Transcatheter aortic valve implantation (1)
"European Court of Human Rights", ECHR, EGMR, "MGN Limited", "von Hannover", "Lillo-Stenberg", Couderc, "advisory opinion", "freedom of the press", Pressefreiheit (1)
European Court of Justice, Court behavior, Preliminary reference procedure (1)
European data protection, governing, privacy (1)
EUROPEAN DERMATOLOGY FORUM; CRYOTHERAPY; GUIDELINES; PATIENT; (1)
EUROPEAN-ORGANIZATION; HEALTH; COMMUNICATION; ASSESSMENTS; SURVIVAL; OUTCOMES; Quality of life; colorectal cancer; complex intervention; randomised controlled trial; study protocol (1)
EUROPEAN-ORGANIZATION; RECTAL-CANCER; FUNCTIONAL ASSESSMENT; INSTRUMENT; ONCOLOGY; TRIALS; Questionnaire; Quality of life; Colorectal cancer; EORTC; Validation (1)
EUROPEAN ORGANIZATION; THERAPY; TAMOXIFEN; breast cancer; module development; patient-reported outcome (PRO); quality of life (1)
European Pharmacopeia (Ph Eur), Chinese Pharmacopoeia (ChP), Traditional Chinese Medicine (TCM), TCM monographs, herbal drugs and quality control (1)
"European Pharmacopoeia"; Europarat; Arzneibuch (1)
EUROPEAN-SOCIETY; ESC GUIDELINES; DIAGNOSIS; MANAGEMENT; THERAPY; STATE; Acute heart failure; Decompensated chronic heart failure; 12-lead electrocardiogram; Echocardiography; X-ray imaging (1)
EUROPEAN STRUCTURAL FUNDS; NIGHTTIME LIGHTS; ECONOMIC-GROWTH; REGIONAL POLICY; IMPACT; CONVERGENCE; IMAGERY; UNION; VIEW; Regional development; EU cohesion policy; Remote Sensing (1)
European Union; HAV; capacity building; foodborne diseases; hepatitis A virus; sequence analysis; surveys and questionnaires (1)
Europe, Market timing, Underpricing, SEO, Equity offering, Offer price discount (1)
Europium, neutron diffraction, magnetic properties (1)
EUROQOL; COMBINATION; NONUNIONS; TITANIUM; SPACERS; polymethyl methacrylate (PMMA); coated implants; temporary arthrodesis; quality of life; psychological outcomes; periprosthetic joint infection; fracture-related infection (1)
EUROTRANSPLANT AREA; Extended donor criteria; liver transplantation; marginal donor; rescue allocation (1)
Euryarchaeota , Sippenauer Moor , In-vitro-Kultur , Zelloberfläche , Archaea , mikrobielle Perlenkettengemeinschaft , SM1 Euryarchaeon , Archaea , microbial string-of-pearls community , SM1 Euryarchaeon (1)
EUSOCIAL HALICTINE BEE; CUTICULAR HYDROCARBONS; REPRODUCTIVE STATUS; SEX-PHEROMONE; MALACHURUM HYMENOPTERA; NESTMATE RECOGNITION; SOCIAL INSECTS; POISON GLAND; FORMICIDAE; FEMALES; Hymenoptera; Sexual communication; Chemical signalling; Cuticular hydrocarbons (1)
EUSOCIAL HYMENOPTERA; LEPTOTHORAX ANTS; PONERINE ANT; DIACAMMA SP; REPRODUCTION; QUEEN; BEHAVIOR; COLONIES; WASP; CONFLICT; Dominance hierarchy; Selfish worker policing; Queen policing; Kin conflict (1)
EUSOCIAL HYMENOPTERA; NESTMATE RECOGNITION; INSECT SOCIETIES; SOCIAL INSECTS; CUTICULAR-HYDROCARBONS; LEPTOTHORAX-NYLANDERI; QUEEN INFLUENCE; APIS-MELLIFERA; PONERINE ANT; FERTILITY; Cuticular hydrocarbons; Worker policing; Fertility signalling; Fertility reversion (1)
EUSOCIAL HYMENOPTERA; PRIMARY POLYGYNY; APIS-MELLIFERA; REPRODUCTIVE SKEW; HONEYBEES APIS; QUEENLESS ANT; CF. INVERSA; BEHAVIOR; EVOLUTION; RELATEDNESS; reproductive conflicts; worker policing; egg discrimination; Pachycondyla inversa (1)
EUSOCIAL HYMENOPTERA; REPRODUCTIVE STATUS; DINOPONERA-QUADRICEPS; WORKERS; PHEROMONES; FORMICIDAE; COLONIES; CONFLICT; chemical communication; fertility signal; 3,11-dimethylheptacosane; electroantennographic detection; ant; Pachycondyla inversa (1)
EUSOCIAL SWEAT BEE; COLONY SOCIAL-ORGANIZATION; LASIOGLOSSUM-MALACHURUM; BODY-SIZE; HYMENOPTERA; MODEL; CYCLE; SURVIVAL; WASP; ANT; Hibernation; Lasioglossum malachurum; Cost of nest founding; Lipid store (1)
EU-Staaten (1)
EVACUATION PROCTOGRAPHY DEFECOGRAPHY; DESCENT; CONFIGURATION; PROLAPSE; ADULTS; dynamic MRI; proctology; combined pelvic floor disorders; diagnosis (1)
EVAL SYSTEM; TIME-COURSE; INERTIA; PERFORMANCE; HYPERSOMNIA; BEHAVIOR; STATES; (1)
Evaluation , Annotation , Information Retrieval , Information-Retrieval-System , Benutzer , Multimedia , Informations- und Dokumentationswissenschaft , CBIR , benutzerorientiert , ALIPR , Content-based Image Retrieval , tagging (1)
-Evaluation der objektiven und subjektiven Kurzzeiteffekte der transkraniellen Elektrostimulation (tES) auf die Vigilanz von Patienten mit Hypersomnien im Rahmen einer prospektiven doppelverblindeten placebokontrollierten Pilotstudie -Komplementäre, nichtmedikamentöse Behandlungsalternative für Patienten mit Narkolepsie und Idiopathischer Hypersomnie -Erweiterung des Verständnisses von transkranieller Gleichstromstimulation (tDCS) und Rauschstromstimulation (tRNS) in der Behandlung von Patienten mit zentralen Störungen mit Tagesschläfrigkeit (1)
Evaluation, Empirische Studie, Moodle, Systematisches Instruktionsdesign, Four Level Frame Work, Lehrer, Erziehungswissenschaften, Virtuelle Lehrerfortbildung, E-Learning, Medienpädagogik, Psychologie, Fortbildung, Weiterbildung (1)
; Evaluation; Objective judgement; Quality (judgement); Value judgement (1)
EVALUATION QUESTIONNAIRE; EEG; REPLACEMENT; MECHANISMS; MENOPAUSE; DELIVERY; SPECTRA; CYCLE; Progesterone; Sleep; Menopause; Intranasal; MPP22; Zolpidem (1)
Evaluationsmethodik; Reallabor; Rechtsinformatik; transdisziplinäre Forschung; Mensch-Maschine-Interaktion; qualitative Inhaltsanalyse; Legal Design Thinking (1)
evaluatives Konditionieren, sexuelle Präferenz, Ätiologie (1)
Evangelikale Theologie; Hille, Rolf (1)
Evangelische Theologie (1)
Evangelische Theologie, Evangelischer Theologe, Geschichte 1780-2000, Geschichte 1800-2000, Theologie, Geschichte 1900-2000, Geschichte 1800-1900 Weitere Schlagwörter : Christentum; Dogmatik; Geschichte; Theology, Doctrinal; History; 19th century; Theologians; History; 19th century; Theology, Doctrinal; History; 20th century; Theologians; History; 20th century (1)
Evangelische Theologie; Geschichte 1830-1914; Religion (1)
EVAR, Komplikationen, Prothesenarten (1)
EVENT FILES; RESPONSE EPISODES; PERCEPTION; DURATION; PITCH; REPRESENTATION; COMPATIBILITY; COGNITION; DYNAMICS; ABSOLUTE; Feature binding; Partial-repetition costs; Binding of temporal features; Timing; Time perception (1)
EVENT FILES; VISUAL-ATTENTION; EPISODIC RETRIEVAL; PERCEPTION; INTEGRATION; SPEECH; EMOTION; CORTEX; RULES; SETS; Feature binding; Partial repetition costs; Social-affective features; Task shielding; Voice perception (1)
EVENT-RELATED FMRI; ANTISACCADE TASK-PERFORMANCE; LATENT-VARIABLE ANALYSIS; FRONTAL EYE FIELDS; ADULT LIFE-SPAN; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; NEUROPATHOLOGICAL PROFILE; mild cognitive impairment; Alzheimer's disease (AD); ageing; inhibition functions; anti-saccades; fMRI (1)
EVENT-RELATED FMRI; FACIAL EXPRESSIONS; HUMAN BRAIN; MULTISENSORY INTEGRATION; INFLUENCE RECOGNITION; COMBINED PERCEPTION; TIME-COURSE; VOICE; FACE; ATTENTION; Multisensory; Emotion; Facial expression; Vocal expression; Response conflict; Attention (1)
EVENT-RELATED FMRI; HUMAN AMYGDALA; NEURAL SYSTEMS; FALSE BELIEF; ACTIVATION; ATTENTION; BRAIN; MIND; RESPONSES; STIMULI; Theory of Mind; precursor functions; emotion decoding; amygdala (1)
EVENT-RELATED FMRI; POSITRON EMISSION TOMOGRAPHY; HUMAN BRAIN; TEMPORAL CORTEX; HAND ACTIONS; GRASP REPRESENTATIONS; PREMOTOR CORTEX; MOBIUS-SYNDROME; HUMAN AMYGDALA; FUNCTIONAL MR; (1)
Event-related fMRI, Prosaccades, Antisaccades, Frontal eye fields (1)
EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; EMOTION; SELF; EXPRESSIONS; AMYGDALA; MODULATION; ATTENTION; COGNITION; PICTURES; Face processing; ERPs; Context; Top-down (1)
EVENT-RELATED POTENTIALS; COGNITIVE CONTROL; EXECUTIVE CONTROL; EPISODIC MEMORY; RECOGNITION MEMORY; UNWANTED MEMORIES; WORKING-MEMORY; EEG; INHIBITION; DYNAMICS; (1)
EVENT-RELATED POTENTIALS; EMOTIONAL STROOP TASK; AFFECTIVE WORD LIST; VARIABLE FOREPERIOD PARADIGM; TEMPORAL PREPARATION; NONSPECIFIC PREPARATION; AUTOMATIC VIGILANCE; SUBJECTIVE EXPERIENCE; PREPARATORY INTERVAL; TRANSMISSION DELAY; time-based expectancy; emotion; expectation; preparation; anticipation (1)
EVENT-RELATED POTENTIALS; EVOKED MAGNETIC-FIELDS; HEARING-LOSS; COMPUTATIONAL MODEL; NOISE EXPOSURE; OLDER-ADULTS; AUDIOGRAM; ATTENTION; IMPAIRMENT; PREVALENCE; Tinnitus; EEG; Speech in noise; N2; Oddball (1)
EVENT-RELATED POTENTIALS; LATE POSTERIOR NEGATIVITY; ERROR-RELATED NEGATIVITY; RECOGNITION MEMORY; EPISODIC MEMORY; PHASE RESET; THETA OSCILLATIONS; PARIETAL CORTEX; BRAIN ACTIVITY; RESPONSES; episodic memory; source memory; event-related potential; ERP old/new effect; late posterior negativity; phase locking; oscillation (1)
Event-related potentials, Memory, Spatial frequency, Human (1)
Event related potentials, Spatial frequency discrimination, Perceptual memory, Hemispheric asymmetry (1)
EVENT-RELATED POTENTIALS; THERAPEUTIC SUGGESTIONS; CONSCIOUS SEDATION; MEDICAL PROCEDURES; FOCUSED ANALGESIA; PLASTIC-SURGERY; HYPNOSIS; PAIN; MECHANISMS; RECOVERY; Suggestion; Communication; Anxiety; Pain; Regional anaesthesia (1)
EVENT-RELATED POTENTIALS; TRANSCRANIAL MAGNETIC STIMULATION; PSYCHOLOGICAL REFRACTORY PERIOD; SIMPLE REACTION-TIME; NONSPECIFIC PREPARATION; MOTOR PREPARATION; WARNING SIGNAL; UNINTENTIONAL CONTRIBUTIONS; PERCEPTUAL LATENCY; ATTENTION; Temporal processing; Attention; Motor control (1)
EVENT-RELATED POTENTIALS; VISUAL-ADAPTATION; HUMAN BRAIN; PERCEPTION; RECOGNITION; HUMANS; SYSTEM; P300; REPRESENTATIONS; IDENTIFICATION; (1)
EVENT-RELATED POTENTIALS; WORD FORM AREA; TIME-COURSE; LETTER PERCEPTION; CHINESE CHARACTERS; WRITING SYSTEM; ERP; N170; FACES; LATERALIZATION; Visual character processing; Visual similarity; Second language learning; Neural specialization; Neural recycling (1)
EVENT-RELATED POTENTIALS; WORKING-MEMORY TASK; THETA-OSCILLATIONS; ELECTROPHYSIOLOGICAL CORRELATE; SYNCHRONIZATION ERS; EVOKED-RESPONSE; BRAIN DYNAMICS; BAND POWER; PERFORMANCE; AMPLITUDE; additive power; alpha activity; EEG; EPP; phase-resetting (1)
Event Study, Information Security, Investment Announcements, Stock Price Reaction, Value of Information Security Investments (1)
Event study, Nuclear accidents, Fukushima-Daiichi, Fama-French model, Bootstrap (1)
everolimus and lung transplantation, bronchioltis obliterans, chronic rejection after lung transplantation, everolimus and bronchiolitis obliterans, BOS, bronchiolitis obliterans syndrome (1)
EVEROLIMUS PLUS EXEMESTANE; BREAST-CANCER; (1)
; Everyday moral decision-making; Acute psychosocial stress; Salivary cortisol; Salivary alpha-amylase; Gender; Agreeableness (1)
EVIDENCE-BASED MEDICINE; guideline; clinical pathway; clinical algorithm; tuberculosis (1)
evidence-based medicine; level of evidence; randomised controlled study (1)
EVIDENCE-BASED MEDICINE; LOW-GRADE ASTROCYTOMAS; GLIOBLASTOMA-MULTIFORME; SURGICAL RESECTION; MALIGNANT GLIOMAS; PROGNOSTIC FACTORS; SUPRATENTORIAL GLIOMAS; RESIDUAL TUMOR; SURGERY; EXTENT; extent of resection; evidence based medicine; brain tumor; outcome; method; age; Karnofsky index (1)
Evidence Based Medicine; Systematic Review; Information Behaviour; Information Retrieval (1)
EVIDENCE-BASED PATHOLOGY; ACETYLCHOLINE-RECEPTOR; INHIBITORY PROTEIN; MUCOCUTANEOUS CANDIDIASIS; AUTOIMMUNE-DISEASE; DIAGNOSTIC-VALUE; SELF-TOLERANCE; CLASS-II; APOPTOSIS; CD4(+); (1)
Evidentialität, epistemische Modalität, typlogische Untersuchung (1)
evidenzbasierte Leseförderung, Lesekompetenz, Leseunterricht, Leseflüssigkeit, Lesestrategien, Dekodierfähigkeit, Wortschatzförderung, Lesemotivation, Lesediagnostik, Förderprogramme, Deutschdidaktik, Grundschule und Sekundarstufe (1)
Evidenz, Implementationsforschung, Sonderpädagogik, empirische Forschung, Schulische Praxis (1)
E-VIRUS-ANTIBODIES; BLOOD-DONORS; GERMANY; TRANSMISSION; INFECTION; SEQUENCE; FRANCE; Hepatitis E; HEV; anti-HEV IgG; seroprevalence; serology; diagnostic sensitivity; commercial assays; acute infection; southeastern Germany (1)
E VIRUS HEV; INFECTION; UPDATE; (1)
E VIRUS-INFECTION; ANTIVIRAL ACTIVITY; PREGNANT-WOMEN; CAPSID PROTEIN; ZOO ANIMALS; C VIRUS; SOFOSBUVIR; RIBAVIRIN; GENOTYPE; THERAPY; diagnostics; drugs; hepatitis E; infection; vaccines; zoonoses (1)
E VIRUS-INFECTION; FAILURE; FRANCE; SPAIN; WOMEN; WOMAN; Hepatitis E virus; Pregnancy; Acute hepatitis; Autochthonous hepatitis E (1)
E VIRUS-INFECTION; LIVER-TRANSPLANT RECIPIENTS; THERAPY; acute liver failure; hepatitis E; HEV; ribavirin; transplantation; treatment (1)
E VIRUS-INFECTION; ORGAN TRANSPLANT RECIPIENTS; NON-B HEPATITIS; ANTIBODY PREVALENCE; BLOOD-DONORS; PHYLOGENETIC ANALYSIS; SOUTHEASTERN GERMANY; NON-A; TRANSMISSION; DISEASE; Hepatitis E; Genotyping; Seroprevalence; Wild boar (1)
E VIRUS SEROPREVALENCE; PHYLOGENETIC ANALYSIS; UNITED-STATES; BLOOD-DONORS; ANTIBODIES; INFECTION; (1)
E VIRUS TRANSMISSION; INFECTION; GERMANY; FRANCE; antibody dynamics; anti-HEV IgG; hepatitis E virus; negative seroconversion; reinfection (1)
Ev.o, Entwicklungsverläufe outpatient, Förderschwerpunkt geistige Entwicklung, Verhaltensstabilisierung, Herausforderndes Verhalten, Geistige Behinderung (1)
Ev.o, Entwicklungsverläufe outpatient, Leitfaden, pädagogische Handlungsräume, herausforderndes Verhalten, Förderschwerpunkt geistige Entwicklung, geistige Behinderung, sozio-emotionale Kompetenzen (1)
EVOKED POTENTIAL INDEX; BISPECTRAL INDEX; SEVOFLURANE CONCENTRATION; MONITOR; ALGORITHMS; RECOVERY; DEPTH; anaesthesia general; electrodiagnosis, electroencephalography; hypnosis, anaesthetic; surgical procedures operative, monitoring intraoperative; child, preschool; child (1)
EVOKED-POTENTIALS; ISCEV STANDARD; GENE-THERAPY; VISION; UPDATE; TRIAL; EEG; Visual electrophysiology; Open data format; Standards; Biomedical signals; Data archiving (1)
EVOKED-POTENTIALS; OBJECTIVE PERIMETRY; PATTERN-REVERSAL; ASYMMETRY; PATHWAYS; GLAUCOMA; DAMAGE; CATS; (1)
EVOKED-POTENTIAL TOPOGRAPHY; HUMAN VISUAL-CORTEX; AMYGDALA ACTIVATION; TIME-COURSE; SELECTIVE ATTENTION; CUED SHIFTS; FEAR; PHOBIA; DISORDER; BRAIN; fear conditioning; social anxiety; EEG; social stimuli; steady-state visually evoked potentials (1)
EVOLUTION; (1)
EVOLUTIONARY CLASSIFICATION; IGNICOCCUS-HOSPITALIS; CAS SYSTEMS; CD-HIT; ALIGNMENT; ACCURATE; BACTERIA; PHYLOGENY; INSIGHTS; GENOMES; (1)
EVOLUTIONARY-DEVELOPMENTAL THEORY; FETAL-GROWTH; PSYCHOSOCIAL STRESS; BEHAVIORAL-PROBLEMS; BODY-SIZE; BIOLOGICAL SENSITIVITY; CARDIOVASCULAR-DISEASE; INDIVIDUAL-DIFFERENCES; CORTISOL RESPONSES; MENTAL STRESS; stress reactivity; Perceived Stress Reactivity Scale (PSRS); fetal growth; prenatal adversity; fetal programming; Developmental Origins of Health and Disease (DOHaD); birth weight; Hertfordshire Cohort Study; older age; elderly (1)
evolutionary ecnomics, social worlds, neoclassic economics, empirical research (1)
evolutionary economics; sociology; pragmatism (1)
EVOLUTIONARY HISTORY; SEQUENCE VARIATION; L. COMPOSITAE; MOLECULAR PHYLOGENY; NRDNA; CHARACTERS; CLASSIFICATION; MODEL; Anthemis; Asteraceae; Nomenclature; nrDNA ITS; Taxonomy (1)
Evolution benchmarks · Schema transformation · NoSQL (1)
EVOLUTION; COMBINATION; FRAGMENTS; ENZYMES; FOLD; (1)
EVOLUTION; cooperation; ecological costs; kin selection; nepotism; relatedness; social insects (1)
EVOLUTION; DATABASE; CLASSIFICATION; IDENTIFICATION; SEQUENCES; SYMMETRY; MODEL; ancient modules; domain evolution; fold space; protein evolution (1)
EVOLUTION; DYNAMICS; CONSERVATION; ANTIBODIES; CHORISMATE; SYNTHASE; (1)
EVOLUTION-EQUATIONS; CCFR DATA; ASYMMETRY; Conformal symmetry; renormalization; higher twists (1)
EVOLUTION-EQUATIONS; CONVERGENCE; MEMBRANES; ENERGY; SHAPE; Willmore energy; Canham-Helfrich energy; gradient flow; geometric flow; Willmore flow; Helfrich flow; Helfrich equation; Stokes system; linear elliptic system; fluid dynamics; biological membrane; lipid bilayer; well-posedness; stability (1)
EVOLUTION-EQUATIONS; GAUGE-THEORIES; SYMMETRY; Perturbative QCD; Renormalization Group; Conformal and W Symmetry (1)
EVOLUTION-EQUATIONS; QCD FACTORIZATION; FORM-FACTORS; HEAVY-QUARK; SUM-RULES; OPERATORS; SYMMETRY; DECAYS; QCD Phenomenology (1)
evolution; infancy; sensitivity; psychological security; cultural development (1)
Evolution language, Schema Evolution, Graph Database, Neo4j, Schema Management, Schema Extraction, Profiles (1)
Evolution; Leucanthemum; Rhodanthemum, species delimitation, hybridization, polyploidization, (1)
EVOLUTION; Population structure; Social parasitism; Slave-making; Formicoxenini (1)
EVOLUTION; SEQUENCES; TREES; Basidiomycotina; Bovistella; Calvatia; capillitium; gasteromycetes; Geastrum; Lycoperdon; Morganella; Mycenastrum; Myriostoma; Vascellum (1)
Evolutionspsychologie , Anschlussmotiv , Organisationspsychologie , Soziale Schließung , Soziale Exklusion , Interpersonale Balance , social exclusion , interpersonal balance (1)
Evolution von Datenbanken, NoSQL-Datenbanken, Graph-Datenbanken, Schema-Extraktion, Inklusionsabhängigkeiten in Multi-Modell Datenbanken, Monitoring von Data-Engineering-Workflows, Data und Workflow Provenance (1)
e-voting, Internet voting, Internet election, security, verifiability, RIES, Estonia, Neuchâtel (1)
eWOM, online consumer reviews, AI, LLM, XAI (1)
EXACT CATEGORIES; ALGEBRAIC-INTEGERS; FINITE-FIELD; U-THEORY; RINGS; FORMS; Hermitian K-theory; Devissage (1)
EXACT CHIRAL-SYMMETRY; MAGNETIC-FIELD; LATTICE QCD; RENORMALIZATION; VIOLATION; Chiral magnetic effect; Chiral separation effect; Chiral magnetic conductivity; Axial anomaly (1)
; Exact controllability; Wave equation; Variable coefficients; Carleman estimate (1)
EXACT EXTENDED SUPERSYMMETRY; YANG-MILLS; TWISTED SUPERSPACE; DIMENSIONS; FERMIONS; SYMMETRY; Field Theories in Lower Dimensions; Extended Supersymmetry; Lattice Quantum Field Theory (1)
EXACTLY MASSLESS QUARKS; (1)
EXACTLY MASSLESS QUARKS; B-C; HEAVY BARYONS; (1)
EXACTLY MASSLESS QUARKS; CHIRAL FERMIONS; LATTICE; SYMMETRY; THEOREM; (1)
EXACTLY MASSLESS QUARKS; LATTICE; QCD vacuum structure; Lattice gauge theory; High energy physics; Quantum chromodynamics (1)
EXACTLY MASSLESS QUARKS; RANDOM-MATRIX THEORY; QCD; OPERATOR; FERMIONS; (1)
EXACTLY MASSLESS QUARKS; STATES; (1)
EXACTLY MASSLESS QUARKS; STRONG MAGNETIC-FIELD; SYMMETRY-BREAKING; CATALYSIS; LATTICE; (1)
EXACT SUPERSYMMETRY; DIMENSIONS; MODEL; 2D; Supersymmetric gauge theory; Lattice Gauge Field Theories; Field Theories in Lower Dimensions (1)
Examination; Cryptorchidism; Hormone therapy; Orchidopexy; Retractile testis; Screening (1)
exanthema; acute anuric renal failure; drug-in duced acute interstitial nephritis (1)
EXCESS CEMENT; (1)
EXCESS GIBBS ENERGY; LIQUID-MIXTURES; MODEL; PREDICTION; (1)
EXCESSIVE DAYTIME SLEEPINESS; CORONARY-ARTERY-DISEASE; RESTLESS LEGS SYNDROME; ENDOTHELIAL DYSFUNCTION; RISK-FACTORS; PSYCHOMOTOR VIGILANCE; SEXUAL DYSFUNCTION; VASCULAR-DISEASE; HEART-DISEASE; CLOCK TEST; Erectile Function; Erectile Dysfunction; Sexual Dysfunction; Endothelial Dysfunction; Vigilance Performance; Sustained Attention; Daytime Sleepiness (1)
EXCESSIVE DAYTIME SLEEPINESS; MACKWORTH CLOCK-TEST; HEALTHY 80-YEAR-OLDS; WAKEFULNESS TEST; CLINICAL-USE; PERFORMANCE; FATIGUE; TASK; 20-YEAR-OLDS; MAINTENANCE; Vigilance Daytime sleepiness; Age effects; Visual monitoring; Reference data (1)
EXCESS MOLAR VOLUMES; HEAT-CAPACITIES; BINARY-MIXTURES; CYCLIC ETHERS; DIMETHYL ETHER; 298.15 K; ADIABATIC COMPRESSIBILITIES; CROWN-ETHERS; WATER; ENTHALPIES; hydrophobic hydration; glycol ethers; cyclic ethers; apparent heat capacity; excess volume (1)
excess mortality, COVID-19, German federal states, vaccination, trust in institutions (1)
EXCHANGE-CORRELATION-ENERGY; LOCAL KINETIC-ENERGY; GENERALIZED GRADIENT APPROXIMATION; ADIABATIC CONNECTION; ELECTRONIC-STRUCTURE; ASYMPTOTIC-BEHAVIOR; QUANTUM-MECHANICS; HARTREE-FOCK; SYSTEMS; THERMOCHEMISTRY; (1)
EXCHANGE-CORRELATION ENERGY; RARE-GAS DIMERS; ELECTRON-GAS; WAVE-FUNCTIONS; GROUND STATE; PAIR-DENSITY; HELIUM; ATOMS; MOLECULES; SYSTEMS; (1)
EXCHANGE-CORRELATION KERNEL; DIELECTRIC-CONSTANT; LINEAR-RESPONSE; EXCITATIONS; (1)
Exchange interaction Phase diagrams Proximity effect Spin-orbit coupling Spintronics 2-dimensional systems Bilayer graphene Strongly correlated systems Van der Waals systems Random phase approximation k dot p method (1)
EXCHANGE INTERACTIONS; THIN-FILMS; SEMICONDUCTORS; (GA,MN)AS; MN; (1)
EXCHANGE INTERACTION; VALLEY POLARIZATION; SPIN; MOS2; DYNAMICS; HEAVY; (1)
EXCHANGE MASS-SPECTROMETRY; PYROCOCCUS-HORIKOSHII OT3; DISULFIDE BONDS; TRIOSEPHOSPHATE ISOMERASE; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; FRAGMENT COMPLEMENTATION; (BETA/ALPHA)(8) BARREL; TRYPTOPHAN SYNTHASE; THERMOTOGA-MARITIMA; protein design; enzyme evolution; (beta alpha)(8)-barrel; half barrel; stability screen (1)
EXCHANGE-RATES; BOND MARKET; WAR; MODELS; RISK; (1)
EXCHANGE-RATE VOLATILITY; TIME PRICE DISCOVERY; RATES; POLICY; INTERVENTIONS; INFLATION; STOCK; RISK; ECB; Exchange rate; Macroeconomic news; Central bank communication; Monetary model; Central Europe; European Union (1)
EXCHANGE-RATE VOLATILITY; TRADING VOLUME; MACROECONOMIC ANNOUNCEMENTS; DISTRIBUTIONS HYPOTHESIS; RETURN VOLATILITY; DIRECT-INVESTMENT; INFORMATION; MODELS; HETEROSKEDASTICITY; COMOVEMENTS; Information; Uncertainty; Spillover; Simultaneous equations; Identification (1)
EXCHANGE RESIN; CHEMILUMINESCENCE; OXIDATION; CATALASE; COLUMN; H2O2; hydrogen peroxide; fluorescent probe; europium; tetracycline; time-resolved fluorometry (1)
EXCHANGER; OUTCOMES; DISEASE; TRIAL; Empagliflozin; Heart failure; CaMKII; Calcium; Ca leak (1)
Exchange Spring Coupling; Fe/Dy Bilayer; Microstructured Magnetic Films; Thin Magnetic Films; AMR Effect; Spin-Galvanic Effect; III-IV Semiconductor; GaAs 2DEG; Spin Esaki Diode; Spin Injection (1)
EXCHANGE SPRING FILMS; RECORDING MEDIA; ABSORPTION; MOMENTS; (1)
EXCHANGE SPRING FILMS; RECORDING MEDIA; FERH; REFLECTIVITY; TRANSITION; magnetic films; magnetic phase transitions; x-ray resonant magnetic scattering (1)
Exchange Traded Funds, Index Certificates, DAX Index, DAX Futures, Price Setting, Product Quality (1)
EXCHANGE; TRILAYERS; (2)
EXCISION-REPAIR; OVARIAN-CANCER; POLYMORPHISMS; GENES; NUCLEOTIDE; BRCA1; BRCA2; ERCC4; breast cancer (1)
EXCITATION; (2)
EXCITATION; DYNAMICS; FIELD; STATE; (1)
EXCITATION-ENERGIES; COMPLEX MATERIALS; EXCITED-STATES; APPROXIMATION; SIMULATIONS; EXCHANGE; TDDFT; MOLECULES; OVERLAP; SYSTEMS; (1)
EXCITATION; MOTION; (1)
EXCITATION; PERMALLOY; DYNAMICS; MOTION; DOTS; rotating magnetic fields; vortex core reversal; vortex dynamics (1)
EXCITATIONS; (1)
Excitatory amino acids - CPP - 3-((±)-2carboxypiperazin-4-yl)-propyl-1-phosphonic acid - NMDA receptor antagonist - Dopamine - MPTP - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - Common marmosets - Substantia nigra degeneration - Parkinsonism (1)
EXCITED HYDROGEN-ATOMS; STRONG LASER FIELD; MICROWAVE IONIZATION; QUANTUM-MECHANICS; 2-ELECTRON ATOMS; STATES; RESONANCE; DYNAMICS; SYSTEMS; CONFIGURATIONS; (1)
EXCITED MOLECULAR-FIELD; QUINTET S=2 STATES; SYSTEMS; IONS; CHEMISTRY; UNITS; S=3/2; ESR; (1)
EXCITED-STATE ABSORPTION; PICOSECOND LIGHT-PULSES; LASER EXCITATION; EOSIN-Y; PHOTOPHYSICAL PROPERTIES; DYE SOLUTIONS; MODE-LOCKING; C-70; C-60; SPECTROSCOPY; triplet saturable absorption; triplet-singlet intersystem crossing; triplet-singlet intersystem absorption; triplet photoionization; two-photon absorption; eosin Y; erythrosin B; rose bengal; fullerene molecule C-70 (1)
EXCITED-STATE; ARYL HALIDES; PHOSPHORANYL RADICALS; REDUCTION; CATALYSIS; EFFICIENT; conPET; e-PRC; photocatalysis; photochemistry; photoredox; radical ions (1)
EXCITED-STATE; carbonyl complex; MLCT triplets; photoluminescence; quinaldate; rhenium (1)
EXCITED-STATE; COMPLEXES; CYCLOPHANES; EFFICIENT; SPECTRA; BORON; electronic spectra; luminescence; rhenium complexes; cyclophane (1)
EXCITED-STATE; COMPLEXES; LUMINESCENCE; (1)
EXCITED-STATE; COMPLEXES; LUMINESCENCE; 4,4 '-bipyridine; 8-quinolinolate; crystal structure; photoluminescence; rhenium(I) (1)
EXCITED-STATE DYNAMICS; F-2(-) COLOR-CENTERS; ACTION-POTENTIALS; DEPENDENT ABSORPTION; RHODAMINE 6G; UV-B; INDICATORS; BEHAVIOR; NEURONS; DYE; QuasArs; Archaerhodopsin 3; genetically encoded voltage sensors (GEVIs); absorption spectroscopic characterization; fluorescence spectroscopic characterization; apparent protein melting temperature; thermal stability; thermal isomerization; thermal deprotonation (1)
EXCITED-STATE PROPERTIES; CHARGE-TRANSFER; ROOM-TEMPERATURE; IMIDO COMPOUNDS; FLUID SOLUTION; LUMINESCENCE; COMPLEXES; TANTALUM; SPECTRA; rhenium complexes; luminescence (1)
EXCITED-STATE PROPERTIES; CHARGE-TRANSFER; SPECTRA; PT(2-THPY)(2); EXCITATION; EMISSION; (1)
EXCITED-STATE PROPERTIES; CYCLOPROPENYL COMPLEX; CRYSTAL; BENZENE; Luminescence; MLCT; Platinum(0); Cyclopropenium ligand; Phenylphosphine ligands (1)
EXCITED-STATE PROPERTIES; ELECTRONIC-SPECTRA; METAL-COMPLEXES; AZULENE; PHOTOREACTIVITY; ABSORPTION; PHOTOLUMINESCENCE; SPECTROSCOPY; EMISSION; BEHAVIOR; electronic spectra; LLCT; ILCT (1)
EXCITED-STATE PROPERTIES; METAL-BASED MATERIALS; ELECTRONIC-SPECTRA; OPTICAL-PROPERTIES; MOLECULAR DESIGN; COMPLEXES; PHOTOREACTIVITY; COORDINATION; COPPER(I); EMISSION; absorption spectra; emission spectra; charge transfer; photochemistry (1)
EXCITED-STATE PROPERTIES; TRANSITION-METALS; COMPLEXES; SPECTROSCOPY; CHROMOPHORES; electronic spectra; photoluminescence; charge transfer; rhodium (1)
EXCITED-STATES; ANTIAROMATICITY; <10>ANNULENES; aromaticity; delocalization; laser spectroscopy; VB methods (1)
EXCITED-STATES; COMPLEXES; AZULENE; LIGAND; METAL; electronic spectra; MLCT; ILCT; luminescence; photochemistry; iridium; azulene (1)
EXCITED-STATES; ELECTRON; EXCHANGE; MOLECULES; IMPLEMENTATION; SIMULATIONS; EXCITATIONS; COMPLEXES; SYSTEMS; SOLIDS; (1)
EXCITED-STATES; FLASH-PHOTOLYSIS; FLAVIN MONONUCLEOTIDE; INFRARED-SPECTROSCOPY; ELECTRONIC-STRUCTURE; SOLVATION DYNAMICS; RIBOFLAVIN; FLUORESCENCE; DERIVATIVES; PHOTOCHEMISTRY; Lumiflavin; pH dependent absorption; pH dependent fluorescence; Fluorescence quantum yields; Fluorescence lifetimes; Ground-state ionization equilibrium constants; Relaxation dynamics (1)
EXCITED TRIPLET DIPHENYLCARBENE; GENERAL FORCE-FIELD; DIFFUSION-CONTROLLED REACTION; AUXILIARY BASIS-SETS; PICOSECOND LASER; MOLECULAR-DYNAMICS; SINGLET; INTERCONVERSION; PHOTOCHEMISTRY; AUTOMATION; (1)
Exciton BEC; Bilayer; Total filling factor one (1)
EXCITON BINDING-ENERGIES; STRAINED-LAYER SUPERLATTICES; 2-PHOTON ABSORPTION; POLARIZATION DEPENDENCE; PRESSURE-DEPENDENCE; HETEROSTRUCTURES; SPECTROSCOPY; TRANSITIONS; STATES; GAP; (1)
EXCITON BINDING-ENERGY; BANDGAP RENORMALIZATION; GRAPHENE; LAYERS; TMD; graphene; van der Waals heterostructures; tr-ARPES; ultrafast charge transfer; photovoltaics (1)
Exciton Bose–Einstein condensate; Bilayer; Total filling factor one (1)
exciton, dielectric disorder, perovskite, exciton diffusion, exciton radius (1)
EXCITON-EXCITON ANNIHILATION; CONJUGATED POLYMERS; POLY(P-PHENYLENE VINYLENE); POLY(PARA-PHENYLENE VINYLENE); PRIMARY PHOTOEXCITATIONS; CONDUCTING POLYMERS; STIMULATED-EMISSION; THIN-FILMS; LASER-DYE; LUMINESCENCE; amplified spontaneous emission; emitting exciton size; fluorescence lifetime; fluorescence quantum yield; luminescent polymers; optical constants; PPV; wave-guided travelling-wave lasing (1)
exciton, exciton propagation, diffusion, dielectric disorder, TMDC monolayer, halo effects (1)
EXCITON LOCALIZATION; ENERGY-TRANSFER; POLYMER-CHAINS; CHROMOPHORES; STATE (1)
EXCITON POLARITONS; WAVE-GUIDES; CONDENSATION; MICROCAVITY; CRYSTALS; (1)
excitons; gallium arsenide; III-V semiconductors; indium compounds; nanostructured materials; photoluminescence; semiconductor quantum dots; (1)
Excitons; Lateral superlattices; Trapping; Storage of light (1)
EXCITONS; LAYER; POLARIZATION; WSE2; transition metal dichalcogenides; two-dimensional magnets; van der Waals heterostructures; proximity effects; magneto-optics (1)
Excitons Spin optoelectronics Spintronics Trions Valleytronics Magnetic semiconductors Transition metal dichalcogenides Van der Waals systems (1)
Excitons Valley degrees of freedom Transition metal dichalcogenides (1)
EXCLUSIVE PROCESSES (1)
EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; WAVE-FUNCTIONS; FORM-FACTORS; RENORMALIZATION; OPERATORS; (1)
EXCLUSIVE PROCESSES; EVOLUTION; NUCLEON; MESONS; (1)
EXCLUSIVE PROCESSES; FORM-FACTORS; EQUATIONS; MOMENT; (1)
exclusive processes; form factor; sum rules;mesons;distribution amplitudes; (1)
EXCLUSIVE PROCESSES; PARTON; FACTORIZATION; DECAYS; (1)
EXCLUSIVE PROCESSES; POSITION-SPACE; PARTON PHYSICS; WAVE-FUNCTIONS; QCD; RENORMALIZATION; OPERATORS; EVOLUTION; MASS; (1)
EXCLUSIVE PROCESSES; WAVE-FUNCTION; ASYMPTOTIC-BEHAVIOR; 3-QUARK OPERATORS; HIGHER TWIST; SUM-RULES; OCTET; RENORMALIZATION; BARYONS; PROTON; (1)
EXCLUSIVE PROCESSES; WILSON FERMIONS; WAVE-FUNCTIONS; MASS-SPECTRUM; GAUGE-THEORY; SPECTROSCOPY; SIMULATIONS; OPERATORS; BETA=6.2; NUCLEON; (1)
EXECUTIVE CONTROL; ITEM RECOGNITION; INHIBITION; MEMORY; MECHANISMS; STRENGTH; RECALL; (1)
EXECUTIVE FUNCTION; MENTAL-ROTATION; ATTENTION; SKILLS; PERFORMANCE; DEFICITS; SEARCH; Autism spectrum disorder; Visual perception; Mental rotation; Theory of mind (1)
EXECUTIVE FUNCTIONS; CHILDREN; PROGRAM; INTERVENTIONS; Mindfulness; Emotion regulation; Primary school; Elementary school; Education system (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; ACADEMIC-PERFORMANCE; LOW-INCOME; LANGUAGE; PRESCHOOL; ACHIEVEMENT; IDENTIFICATION; INTERRELATION; COMPREHENSION; Early literacy; Grapho-motor skills; Early reading; Fine motor skills; Reading (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; PERFORMANCE; LANGUAGE; BRAIN; COMPREHENSION; INFORMATION; ACHIEVEMENT; CHILDREN; FMRI; Fine motor skills; Mental imagery; Embodied cognition; Grounded cognition; Mental simulation (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; PRESCHOOL; ACHIEVEMENT; LANGUAGE; IDENTIFICATION; INTERRELATION; COMPREHENSION; VOCABULARY; ABILITIES; (1)
Executive Functions; Cognitive Training; Task-Switching (1)
EXECUTIVE FUNCTIONS; MIGRAINE PATIENTS; FMRI; METAANALYSIS; STIMULATION; ASSOCIATION; DEPRESSION; DEFICITS; TRAIL; TASKS; Cluster headache; neuropsychology; Trail Making Test; executive function; Stroop Task; migraine (1)
EXERCISE; BEHAVIOR; PARTICIPATION; INTERVENTIONS; OUTCOMES; GENDER; stages of change; health promotion; cluster analysis; gender; men (1)
EXERCISE INDUCES ANGIOGENESIS; VISUAL WORD RECOGNITION; BRAIN STRUCTURE CHANGES; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; WORKING-MEMORY; MOTOR CORTEX; FORM AREA; LANGUAGE; SPEECH; Learning; Brain plasticity; Brain morphology; Language processing; Longitudinal study (1)
EXERCISE INTENSITY; MESSENGER-RNA; SPRINT INTERVAL; BIOGENESIS; IMPROVEMENTS; PERFORMANCE; EXPRESSION; INCREASES; APOPTOSIS; CAPACITY; mitochondrial biogenesis; exercise; PHF20; TFAM; mitochondrial remodeling (1)
Exertion protocol, Belastungsprotokoll, Fatigue, Fatigability, Minderbelastbarkeit (1)
EXFOLIATED DECIDUOUS TEETH; STEM-CELLS; IN-VIVO; GROWTH; VITRO; TRANSPLANTATION; REGENERATION; MIGRATION; TOOTH; (1)
EXFOLIATION; NANOSHEETS; WS2; DELAMINATION; PHASE; METAL; (1)
EXFOLIATION SYNDROME; PSEUDOEXFOLIATION SYNDROME; ENDOPLASMIC-RETICULUM; PROMOTER ACTIVITY; GLAUCOMA; VARIANTS; GENE; LENS; MECHANISMS; EXPRESSION; (1)
exfoliertes Graphen, epitaktisches Graphen, Spintronik, Spintransport, magnetische Momente, Spinrelaxation, Spinpräzession, Diffusionskonstente, Spinlebensdauer, nichtlokale Messung, exfoliated graphene, epitaxial graphene, spintronics, spin transport, magnetic moments, spin relaxation, spin precession, diffusion constant, spin lifetime, nonlocal measurement (1)
EXHALED BREATH; SPECTROSCOPY; SPECTROMETER; IR; Photoacoustic spectroscopy; Quantum cascade laser; Spectral simulation; Breath analysis; Acetone (1)
EXHALED NITRIC-OXIDE; SEVERE EOSINOPHILIC ASTHMA; INNATE LYMPHOID-CELLS; EXACERBATED RESPIRATORY-DISEASE; CLINICAL-PRACTICE GUIDELINE; ENDOSCOPIC SINUS SURGERY; REAL-WORLD EXPERIENCE; CHRONIC RHINOSINUSITIS; ALLERGIC RHINITIS; DOUBLE-BLIND; Alarmine; CRS; CRSwNP; epitheliale Immunregulation; T2-Inflammation; Tezepelumab; TSLP (1)
EXHALED NITRIC-OXIDE; SPIROMETRY; HEALTH; POPULATION; QUALITY; COPD; STANDARDIZATION; PREVALENCE; COUNTRIES; SMOKING; Spirometry; FeNO; German National Cohort; Asthma; COPD (1)
EXHAUSTIBLE RESOURCES; INTERGENERATIONAL EQUITY; CAPITAL ACCUMULATION; HARTWICKS RULE; MAXIMIN PATHS; SUSTAINABILITY; PRODUCT; POPULATION; DEPLETION; GROWTH; national income accounting; dynamic welfare (1)
EXHAUSTIBLE RESOURCES; OPTIMAL-GROWTH; INEQUALITY AVERSION; EQUITY; UTILITY; SUSTAINABILITY; DEPLETION; (1)
EXISTENCE; EQUATIONS; Maxwell-Stefan diffusion; Reversible mass-action kinetics; Maximal L-p-regularity (1)
EXISTENCE; SPACES; (1)
EXOGENOUS OXYTOCIN; INHIBITORY INFLUENCE; PROLACTIN RECEPTOR; PLASMA-CORTISOL; BRAIN OXYTOCIN; PREGNANT RATS; INDUCED ACTH; NORMAL MEN; RELEASE; VASOPRESSIN; (1)
exo-Methylen-γ-Butyrolacton, Michael-Addition, Peptidkupplung, Prodrug (1)
Exom-Sequenzierung, Herzinfarkt, dilatative Kardiomyopathie, hypertrophische Kardiomyopathie (1)
exoskeleton, nurses, physical strain, acceptance, Exoskelette, Pflege, Akzeptanz, physische Belastung (1)
Exosomen, Tumormikroumgebung, HNSCC, Tumor-infiltrierende Immunzellen, Extrazelluläre Vesikel (1)
EXOSOMES (1)
EXOSOMES; ADENOSINE; extracellular vesicles; exosomes; HNSCC; tumor-infiltrating immune cells; tumor microenvironment (1)
EXOSOMES; CANCER; EXPRESSION; HIF-1-ALPHA; BIOMARKERS; PATHWAY; small extracellular vesicles; exosomes; hypoxia; proteomics; HNSCC (1)
EXOSOME SECRETION; OXIDATIVE STRESS; CELLS; TUMOR; MUTATIONS; LANDSCAPE; exosomes; glioma; immune suppression; isocitrate dehydrogenase (IDH); small extracellular vesicles (1)
exosomes; extracellular vesicles (EVs); exosome isolation; biomarkers; drug delivery; tumor-derived exosomes (TEX) (1)
EXPANDABLE METALLIC STENTS; PALLIATIVE TREATMENT; ULTRAFLEX STENT; LASER THERAPY; CARCINOMA; PLACEMENT; CANCER; TRIAL; OBSTRUCTION; STRICTURES; esophageal carcinoma; esophageal perforation; postoperative esophageal leaks; self-expanding plastic stent (1)
expandable vertebral body replacement; vertebral osteomyelitis; bony fusion rate; anterior column reconstruction; spondylodiscitis (1)
EXPANDED CRITERIA; RENAL-TRANSPLANTATION; UNITED-STATES; INHIBITORS; SURVIVAL; TRIAL; Immunosuppression; Kidney Transplantation; Tacrolimus (1)
EXPANDED POLYTETRAFLUOROETHYLENE GRAFT; KNEE; VEIN; REVASCULARIZATION; LESIONS (1)
EXPANDED POLYTETRAFLUOROETHYLENE MEMBRANES; AUTOLOGOUS PLATELET CONCENTRATE; HUMAN INTRABONY DEFECTS; BONE SIALOPROTEIN; BEAGLE DOGS; CONNECTIVE-TISSUE; LIGAMENT CELLS; ALVEOLAR BONE; MONOCLONAL-ANTIBODIES; GINGIVAL FIBROBLASTS; bone; bone sialoprotein; cementum; collagen; extracellular matrix; fibronectin; immunohistochemistry; osteopontin; periodontal ligament; periodontitis; regeneration (1)
EXPECTANCY BIAS; VIRTUAL-REALITY; FEAR; PERCEPTION; STIMULI; ASSOCIATIONS; PERFORMANCE; ATTENTION; PARADIGM; DISORDER; Spider phobia; Perceptual bias; Size perception; Virtual reality; Exposure therapy; Skin conductance response (1)
Expectations Hypothesis, Holding Premium, Persistence, Cointegration, GARCH (1)
EXPECTATIONS HYPOTHESIS; INTEREST-RATES; LONG; COINTEGRATION; TESTS; RISK; expectations hypothesis; risk premium; reaction function (1)
Expectations Hypothesis, Risk Premium, Policy Reaction Function (1)
Expectations Hypothesis, Risk Premium, Policy Reaction Function, Persistence, Transitory Shocks (1)
EXPECTED SHORTFALL; risk capital allocation; gradient allocation principle; coherent risk measures; coherent capital allocations (1)
EXPECTED STOCK RETURNS; BOOK-TO-MARKET; RISK-FACTORS; GROWTH; MOMENTUM; SIZE; EXTRAPOLATION; EQUILIBRIUM; PERFORMANCE; INFORMATION; Value premium; Global diversification; Net asset value; Investment strategy (1)
EXPECTED STOCK RETURNS; CROSS-SECTIONAL RETURNS; ASSET PRICING MODEL; BOOK-TO-MARKET; INTERNATIONAL EVIDENCE; EMPIRICAL-EVIDENCE; AVERAGE RETURNS; SHARE ISSUANCE; COMMON-STOCKS; RISK; alternative three-factor model; classic three-factor model; international markets (1)
EXPECTED STOCK-RETURNS; CROSS-SECTION; INDIVIDUAL STOCKS; MARKET; VOLATILITY; MOMENTUM; SIZE; RISK; PROFITABILITY; SEASONALITY; Maximum daily return; Cross-sectional return predictability; International markets; Idiosyncratic volatility; Cash flow volatility; Profitability (1)
EXPECTED STOCK RETURNS; REAL-ESTATE; DIVIDEND YIELDS; HORIZON; PORTFOLIOS; GROWTH; TERM; (1)
EXPERIENCE (1)
EXPERIENCE; (1)
EXPERIENCE; COLOR; Time perception; Time production; Virtual reality (1)
EXPERIENCE; IMPLANT; wrist arthoplasty; Swanson silicone spacer; modular physiological total wrist arthropasty; rheumatoid arthritis (1)
Experience Level (1)
EXPERIENCE; OUTCOMES; HEPATECTOMY; CHILDREN; GRAFTS; Living donor liver transplantation; Body mass index; MELD score; Hospital mortality; Adults (1)
EXPERIENCE; RELATIVES; ADULT; CARE; (1)
EXPERIENCE; STAY; Hospital stay; Joint replacement; Motivation; Patient satisfaction; Preoperative exercise (1)
EXPERIENCES; THERAPY; DEPRESSION; HANDICAP; LOUDNESS; DIVORCE; BELIEFS; SCHEMAS; ABUSE; DEATH; Tinnitus loudness; pure tone hearing thresholds; hyperacusis; uncomfortable loudness levels; psychological assessment (1)
EXPERIENCE; THERAPY; HYPERPLASIA; MORBIDITY; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; APOPTOSIS-INDUCING LIGAND; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; T-CELL; MONOCLONAL-ANTIBODIES; IL-6-DEFICIENT MICE; TNF SUPERFAMILY; TWEAK; Fn14; EAE; multiple sclerosis; inflammation (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; DA RATS; PSYCHOLOGICAL STRESS; ADVERSE EXPERIENCES; IMMUNE-RESPONSE; BRAIN STRUCTURE; stress; exploratory behavior; cytokines; physical stimulation; development (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ELEVATED PLUS-MAZE; PITUITARY-ADRENAL AXIS; MATERNAL-CARE; DA RATS; CYTOKINE EXPRESSION; STRESS; RESPONSES; EXPERIENCE; EXPOSURE; development; lipopolysaccharide; mother-pup interaction; home cage activity; anxiety; exploration; response to novelty; stress; corticosterone; NPY; IL-6; IL-10; IFN-gamma; periodontal disease; Lewis rats (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS; COLONY-STIMULATING FACTOR; ANIMAL-MODEL; T-CELLS; REACTIVE ASTROCYTES; PERIPHERAL-BLOOD; IMMUNE INVASION; DENDRITIC CELLS; C57BL/6 MICE; EAE; multiple sclerosis; inflammatory monocytes; PPAR (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; TRANSFORMING GROWTH FACTOR-BETA-1; T-CELL ACTIVATION; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; ORAL TOLERANCE; FACTOR-BETA; DEMYELINATING DISEASES; CHEMOKINE REGULATION; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; OXIDE MEDIATES IMMUNOSUPPRESSION; DELAYED-TYPE HYPERSENSITIVITY; PERSISTENT LCMV INFECTION; CELL RECEPTOR PEPTIDE; MYELIN BASIC-PROTEIN; NITRIC-OXIDE; DENDRITIC CELLS; APOPTOTIC CELLS; I INTERFERON; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; MULTIPLE-SCLEROSIS; CUTTING EDGE; MYCOBACTERIUM-TUBERCULOSIS; LEWIS RATS; MICROBIAL LIPOPROTEINS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; B-CELL DEPLETION; MULTIPLE-SCLEROSIS; COMMON MARMOSETS; T-CELLS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; CNS MYELIN; DEMYELINATION; MOG; Common marmoset; Autoimmunity; Multiple sclerosis; Refinement; MOG (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NF-KAPPA-B; LEUKOCYTE EXTRAVASATION; AXONAL-INJURY; IN-VIVO; CELLS; ACTIVATION; BLOOD; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR CCR2; RHEUMATOID-ARTHRITIS; BLOOD MONOCYTES; BONE-MARROW; MAST-CELLS; CHEMOATTRACTANT PROTEIN-1; MONONUCLEAR-CELLS; MICE LACKING; T-CELLS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; ADIPOSE-TISSUE; NERVOUS-SYSTEM; MONOCYTES; IMMUNOMETABOLISM; DIFFERENTIATION; HETEROGENEITY; MACROPHAGES; ACTIVATION; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; DENDRITIC CELLS; FAS LIGAND; T-CELL; APOPTOSIS RESISTANCE; DIFFERENTIATION; LYMPHOTOXIN; ACTIVATION; LIGHT; TL1A; FasL; EAE; DcR3; IL-17 (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEART-RATE-VARIABILITY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; COLLAGEN-INDUCED ARTHRITIS; MAO INHIBITOR PHENELZINE; COUPLED RECEPTOR KINASES; BLOOD MONONUCLEAR-CELLS; PITUITARY-ADRENAL AXIS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LEUKOCYTE PROTEASE INHIBITOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; KAPPA-B-ALPHA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; GROWTH-FACTOR; DEMYELINATING DISEASE; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CENTRAL-NERVOUS-SYSTEM; HUMAN RANTES PROMOTER; CC CHEMOKINES; CYTOKINE EXPRESSION; MULTIPLE-SCLEROSIS; MICE; GLYCOSAMINOGLYCANS; SULFATE; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; METAANALYSIS; CCL5; Chemokine (C-C motif) receptor 5; Chemokine (C-C motif) ligand 5; RANTES; Major depressive disorder; Cognitive impairment; Cambridge Neuropsychological Test Automated Battery (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODIES; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; MULTIPLE PATHWAYS; LUPUS NEPHRITIS; EXPRESSION; GROWTH; FN14; FAMILY; TWEAK; Fn14; Inflammation; Chemokines; Mesangial cells (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTORS; CEREBROSPINAL-FLUID; BETA-CHEMOKINES; AIDS DEMENTIA; MCP-1 LEVELS; EXPRESSION; multiple sclerosis; chemokines; chemokine receptors; CCR2; CCL2/MCP-1 (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ADHESION MOLECULE; MICROARRAY DATA; MYELOID CELLS; LYMPHOCYTES; MIGRATION; ANTIGEN; CNS; INFECTIONS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PSORIASIFORM SKIN INFLAMMATION; T-CELL SUBSETS; DENDRITIC CELLS; INTERFERON-GAMMA; LYMPH-NODES; TH17 CELLS; DIFFERENTIATION; PROMOTE; ARTHRITIS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TUMOR-NECROSIS-FACTOR; IL-17-PRODUCING T-CELLS; PATHOGENIC T(H)17 CELLS; CHEMOKINE RECEPTOR 2; ROR-GAMMA-T; IFN-GAMMA; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; CUTTING EDGE; (1)
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; PLASMACYTOID DENDRITIC CELLS; CENTRAL-NERVOUS-SYSTEM; LYMPH-NODES; MONONUCLEAR PHAGOCYTES; RESIDENT MICROGLIA; MOUSE; MIGRATION; RECRUITMENT; ACTIVATION; (1)
EXPERIMENTAL COLITIS; BACTERIAL-DNA; INTERFERON-GAMMA; CPG MOTIFS; KAPPA-B; SIGNALING PATHWAYS; DENDRITIC CELLS; MONOCYTIC CELLS; BOWEL-DISEASE; MICE; GSK3-beta; TLR; experimental colitis; intestinal inflammation (1)
EXPERIMENTAL COLITIS; LYMPHOID-TISSUES; EXPRESSION; CELLS; LIGHT; TNF; LT beta R activation; Conditional LT beta R-deficient mice; TRIM30 alpha; DSS-induced intestinal inflammation (1)
EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; NECROSIS-FACTOR-ALPHA; GLOMERULAR INJURY; TNF-ALPHA; NEPHRITIS; RECEPTOR; kidney; inflammation (1)
EXPERIMENTAL CUTANEOUS LEISHMANIASIS; REAL-TIME PCR; DENDRITIC CELLS; BALB/C MICE; IN-VIVO; MACROPHAGES; MICROSCOPY; GAMMA; (1)
Experimental economics, behavioral economics, auctions, elections, public goods, cognitive biases (1)
Experimental Economics, Behavioral Economics, Round-Number Bias, Real Estate, Focal Point, Moral Balancing (1)
EXPERIMENTAL HEART-FAILURE; CONVERTING ENZYME-INHIBITION; NITRIC-OXIDE; MYOCARDIAL-INFARCTION; KIDNEYS; SYSTEM; HYPERTROPHY; COMPONENTS; ACTIVATION; renal renin; renal endothelin-1; renal endothelin-3; renal eNOS; renal bNOS; renin regulation; experimental supravalvular aortic stenosis congestive heart failure (1)
EXPERIMENTAL MURINE COLITIS; SULFATE-INDUCED COLITIS; ULCERATIVE-COLITIS; LY6C(HI) MONOCYTES; INTESTINAL MUCUS; INTERFERON-GAMMA; DENDRITIC CELLS; CROHNS-DISEASE; BOWEL-DISEASE; LYSOPHOSPHATIDYLCHOLINE; (1)
EXPERIMENTAL MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASES; COLLAGEN DEGRADATION; PRESSURE-OVERLOAD; RECEPTOR BLOCKADE; ANGIOTENSIN-II; RAT MYOCARDIUM; EXPRESSION; FAILURE; INHIBITOR; ischemia; reperfusion; osteopontin; fibronectin; matrix metalloproteinases (1)
EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS; ALLOGRAFT-REJECTION; TRACHEAL ALLOGRAFTS; RECIPIENTS; REPRODUCTION; EXPRESSION; PREVENTION; MANAGEMENT; ANTIGENS; RISK; adhesion molecules; chronic rejection; infection; lung transplantation; obliterative bronchiolitis (1)
EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; CHEMOKINE RECEPTOR 2; NECROSIS-FACTOR-ALPHA; DICHLOROMETHYLENE DIPHOSPHONATE; HOST-DEFENSE; BONE-MARROW; IN-VIVO; NEUTROPHIL; MACROPHAGES; CCR2; (1)
experimental psychology, experimental method, methodology, replication crisis, epistemology, complexity (1)
Experimental psychology, methodology, epistemology / Experimentelle Psychologie, Methodologie, Epistemologie (1)
EXPERIMENTAL REALIZATION; SINGLE PHOTONS; (1)
Experimental Replication (1)
EXPERIMENTATION; THERAPY; TISSUE; (1)
experimentelle Herzinsuffizienz, Proteomik, Lunge, experimental heart failure, proteomics, lung (1)
experimentelle Leishmaniose, myeloide Suppressorzellen, myeloid-derived suppressor cell, MDSC, CCR2 (1)
EXPERT CONSENSUS STATEMENT; LIVER-FUNCTION; STAGE B; STRATEGIES; DIAGNOSIS; CHEMOEMBOLIZATION; CIRRHOSIS; SURGERY; Hepatocellular carcinoma; BCLC; Liver resection; Liver cancer; Portal hypertension (1)
EXPERT CONSENSUS; SUPPORT; OUTCOMES; SHOCK; ASSOCIATION; BIAS; mechanical circulatory support; extracorpo-real membrane oxygenation; extracorporeal life support; postcardiotomy cardiogenic shock; cardiac surgery; acute heart failure (1)
Expertenparadigma, Experten-Paradigma, professionelle Kompetenz, Expertiseforschung, Lehrkräfte, Kognitionspsychologie (1)
Expertise (1)
Expertise, deliberate practice, Soziale Netzwerke, Musik (1)
Expertise; Faculty development; Standardized clinical examination; Teacher training; Teaching effectiveness (1)
EXPERTISE; KNOWLEDGE; Changes; Conceptual change; Others; Professional learning; Transitions (1)
EXPERTISE; PSYCHOTHERAPY; EXPERIENCE; THERAPISTS; DIAGNOSIS; ACCURACY; MEDICINE; QUALITY; PATIENT; NOVICE; Counseling; Expertise; Illness script; Knowledge restructuring; Professional learning (1)
Expertise research · Competence research · Paradigmatic approaches · Teachers’ professional development · Teacher professionalism · Teacher knowledge · Superior performance · Expert teachers (1)
Expertise research · Expert teacher · Teaching · Expertise development (1)
EXPERTISE; TEACHERS; classical music; deliberate practice; ensemble; practice activities; popular music (1)
Expertise , Wissen , Beratung , Wissenschaft , Wissenschaftliche Weiterbildung , Wissenschaft / Methode , Beratungssystem , Unternehmensberatung , Management , Kompetenz , Erfahrung , Expertiseforschung , Managementberatung , Unternehmensberater , Kompetenz in der Beratung , Beratungskompetenz , Competence , expertise , consulting , counseling , knowledge (1)
Expert opinions · Disease concepts · Neurolaw · Neuropsychology · Reliability · Education (1)
expert software, success factors, complex domains, Expertensoftware, komplexe Domänen, Erfolgsfaktoren, Usability, Software Design, Kundeneinbindung, User Centered Design, Conjoint Analysis, Grounded Theory, product success (1)
EXPIRATORY FLOW LIMITATION; MECHANICAL VENTILATION; RESPIRATORY-FAILURE; MORBID-OBESITY; DISTURBANCES; GASTROPLASTY; TERM; chronic ventilatory failure; non-invasive positive pressure ventilation; obesity hypoventilation syndrome; pulmonary function test; restrictive ventilatory disorder (1)
Explainable AI; Text analytics; Language models; BERT; Linguistic rules; Online consumer reviews (1)
Explainable AI, Uncertainty-Aware Explanation, Taxonomy, AI-Augmented Decisions (1)
Explainable artificial intelligence, XAI, local explanation, sensitivity (1)
Explainable e-services · Public e-services · Public sector · Design science research · Design principles (1)
EXPLANATIONS; MATHEMATICS; KNOWLEDGE; STUDENTS; modeling; self-explanations; examples; argumentation (1)
EXPLOSIVES; ELECTRODES; Capillary electrophoresis; Electrochemically assisted injection; Mass spectrometry; Mass voltammetry; Nitroaromatic compounds (1)
EXPONENTIAL FUNCTION; SUBANALYTIC SETS; PFAFFIAN SETS; FIELD; CLASSIFICATION; NUMBERS; SERIES; PAIRS; (1)
EXPONENTIAL FUNCTION; SUBANALYTIC SETS; REAL FIELD; EXPANSIONS; SERIES; (1)
EXPONENTIATION; PAIR; Perturbative QCD; Renormalization Group; Wilson; 't Hooft and Polyakov loops (1)
; Exports; Worker flows; Transition rates; Cointegrated SVAR model (1)
EXPOSURE; ACCELERATION; PERFORMANCE; SCENARIO; GAMES; adolescent; brain injury; child; repetitive; soccer (1)
EXPOSURE ASSESSMENT; MEASUREMENT ERROR; URANIUM MINERS; WOMEN; SWEDEN; DETECTORS; MODELS; case-control study; lung neoplasm; radon; tobacco smoke (1)
EXPOSURE; IMPACT; MOTIVATION; DISSONANCE; EMOTIONS; BEHAVIOR; leadership; selective exposure; decision-making (1)
EXPOSURE RATE; TRANSMISSION; CHILDREN; SARS-CoV-2; surveillance; children; elementary school; preschool; PCR; seroprevalence (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; ACROPHOBIA; ENVIRONMENTS; OUTCOMES; DESENSITIZATION; METAANALYSIS; AGORAPHOBIA; TECHNOLOGY; COMPONENTS; anxiety; fear behavior; virtual reality; presence; immersion; acrophobia (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; PRESENCE QUESTIONNAIRE; PUBLIC SPEAKING; FLIGHT PHOBICS; SPIDER PHOBIA; SOCIAL PHOBIA; FEAR; ENVIRONMENTS; IMMERSION; virtual reality; perception; fear; anxiety; emotion; presence (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; PUBLIC SPEAKING; ENVIRONMENTS; IMMERSION; IMPACT; METAANALYSIS; RELIABILITY; REACTIVITY; EMOTIONS; Virtual reality; Presence; Exposure therapy; Behavioral avoidance test; Anxiety disorders; Specific phobia (1)
EXPOSURE THERAPY; PSYCHOPHYSIOLOGICAL ASSESSMENT; VIRTUAL-REALITY; PHOBIC PATIENTS; RESPONSES; Fear; Claustrophobia; Exposure; Perceptual cues; Conceptual information; Virtual reality (1)
EXPOSURE THERAPY; VIRTUAL-REALITY; COGNITIVE THERAPY; ANXIETY; PSYCHOTHERAPY; SYSTEM; STATE; modification of dysfunctional beliefs; cognitive therapy; avatar therapy; virtual avatar; depression (1)
EXPRESSING INHIBITORY INTERNEURONS; SOURCE-DENSITY ANALYSIS; POPULATION RESPONSES; AWAKE MONKEY; FREQUENCY; MICROCIRCUIT; ACTIVATION; MECHANISMS; REPRESENTATION; CONNECTIVITY; Auditory processing; Cortical microcircuits; Lateral inhibition; Neural mass model (1)
EXPRESSION (2)
EXPRESSION; BETAGLYCAN; CLONING; TGF-beta III receptor gene; TGFBR3; polymorphism; chromosome 1p33-p32 (1)
EXPRESSION; blood monocytes; CD14 MicroBeads; purity (1)
EXPRESSION; CANCER; CELLS; EFFEROCYTOSIS; CLEARANCE; LANDSCAPE; APOPTOSIS; ANALOGS; ORIGIN; MERTK; (1)
EXPRESSION; CARCINOMAS; PROGNOSIS; MELANOMA; SURVIVAL; MARKER; TUMORS; KOC; (1)
EXPRESSION; DOUBLECORTIN; NEUROGENESIS; CELLS; MIGRATION; GROWTH; BRAIN; CNS; (1)
EXPRESSION; DYSFUNCTION; MYOCARDIUM; EVOLUTION; CONTEXT; Heart failure; Atrial remodelling; Proteomics; Energetics; Interatrial differences (1)
EXPRESSION; FIBROSIS; CELLS; INFLAMMATION; MCP-1; four-and-a-half LIM-domain protein 2; FHL2; cholestatic liver injury; bile acids (1)
EXPRESSION; FIBROSIS; ETS-1; LINES; Hepatocellular carcinoma; ZNF267; Kruppel-like factor (1)
EXPRESSION; GLUT1; polymorphism; hepatocellular carcinoma; HCC (1)
EXPRESSION; GROWTH; HEPATOTOXICITY; PROLIFERATION; Stem cells; Hepatocytes; Differentiation; Gene array; Bioinformatics; Transcriptomics; Gene networks (1)
EXPRESSION; IDENTIFICATION; PATHOPHYSIOLOGY; ACIDOSIS; DISEASE; apoptosis; Gm12121; in situ hybridization; LINC01187; long non-coding RNAs; renal diseases (1)
EXPRESSION; INTENSITY; PROTEIN; PGC-1-ALPHA; PERFORMANCE; BIOGENESIS; INTERVAL; IMPROVEMENTS; ACTIVATION; RESPONSES; mitochondrial biogenesis; mitochondrial respiration; p53; PGC-1 alpha; PHF20 (1)
EXPRESSION; INVASION; CELLS; PROGELATINASE; ACTIVATION; MIGRATION; MT1-MMP; MICE; (1)
EXPRESSION; LONGEVITY; DROSOPHILA; AGE; EVOLUTION; ALIGNMENT; ENVIRONMENT; HALLMARKS; PROTEINS; IMMUNITY; ageing; selection shadow; social insects; longevity; fecundity trade-off (1)
EXPRESSION; MICE; GLOMERULONEPHRITIS; NEPHRITIS; PHENOTYPE; (1)
EXPRESSION; MICROSCOPY; TUMORS; immunofluorescence; paraffin; formalin-fixed tissue; multicolor (1)
EXPRESSION; MIGRATION; AGONIST; ACID; (1)
EXPRESSION; MOUSE; TISSUE; FIBROBLASTS; NEURONS; CELLS; collagen XVI; DRG; axotomy (1)
EXPRESSION; ODONTOBLASTS; PROTEINS; BIOLOGY; GROWTH; ROLES; Dental stem cells; Odontogenic differentiation; Osteogenic differentiation; Dental neural crest-derived progenitor cells; SHED; Microarray analysis (1)
EXPRESSION; PEPTIDE; IDENTIFICATION; RECRUITMENT; METASTASIS; RESPONSES; MICE; QUANTIFICATION; IMMUNOTHERAPY; ENRICHMENT; (1)
EXPRESSION; pituitary; hypothalamus; adipocyte; hormone; receptor (1)
EXPRESSION; PRETERM; ASPIRIN; CEACAM1; MARKERS; FAMILY; CEACAM1; immune tolerance; preeclampsia (1)
EXPRESSION PROFILES; ADULT MICROGLIA; TISSUE; CELL; MONOCYTES; RESPONSES; IDENTITY; REVEALS; ORIGINS; (1)
EXPRESSION; PROLIFERATION; INFLAMMATION; CARCINOMA; chemerin; rhabdomyosarcoma; macrophage polarization (1)
expression quantitative trait loci; eQTL; colocalization; co-regulation; gene expression; gene regulation; haploinsufficient genes; crispra; gtex; regulatory relationships; regulatory gene clusters; co-regulated genes; genetic signals; (1)
Expression, Renin, Angiotensin, Maus, Nephron (1)
EXPRESSION; SARS-CoV-2; seroprevalence; population-based study; longitudinal; risk factors (1)
EXPRESSION SIGNATURE; PLUS RIBAVIRIN; PEGINTERFERON; STEATOSIS; THERAPY; USP18; HCV; genotype; HCV; IFN; interferon-stimulated genes; transcriptomics (1)
EXPRESSION; SIROLIMUS; GROWTH; CANCER; VOLUME; ADPKD; biomarker; progression; sFRP4 (1)
EXPRESSION; SUPERFAMILY; PCR; (1)
EXPRESSION; SURVIVAL; ANTIBODY; SAFETY; Programmed death-2 ligand; Papillary renal-cell carcinoma; Prognosis; Survival (1)
EXPRESSIVE SUPPRESSION; MENSTRUAL-CYCLE; FOOD; MODEL; QUESTIONNAIRE; IMPULSIVITY; ATTENTION; SMOKERS; TASKS; SCALE; Emotional eating; Emotional reactivity; Emotion regulation; Response inhibition; Event-related potentials (1)
; Exstrophy of the bladder; Epispadias; Down syndrome; Midline defect (1)
EXTENDED ADJUVANT THERAPY; RANDOMIZED-TRIAL (1)
EXTENDED HUCKEL CALCULATIONS; LYING ELECTRONIC STATES; SPIN-LATTICE-RELAXATION; TIME-RESOLVED SPECTRA; DIIMINE COMPLEXES; CRYSTAL-STRUCTURE; TEMPERATURE-DEPENDENCE; OPTICAL SPECTROSCOPY; RHENIUM(I) COMPLEXES; TRIPLET; (1)
EXTENDED PELVIC LYMPHADENECTOMY; RADICAL CYSTECTOMY; LYMPH-NODES; PROSTATE-CANCER; MINIMUM NUMBER; EAU GUIDELINES; DISSECTION; NOMOGRAMS; EPIDEMIOLOGY; VARIABILITY; Bladder cancer; Radical cystectomy; Lymph node metastasis; Clinical nodal staging score; Pathological nodal staging score (1)
extended pulmonary resection; locally advanced NSCLC; T4 non-small cell lung cancer; cardiopulmonary bypass (1)
EXTENDED-RIGHT HEPATECTOMIES; TUMOR-GROWTH; 2-STAGE HEPATECTOMY; HEPATIC RESECTION; EMBOLIZATION; SURVIVAL; RESECTABILITY; REMNANT; CANCER; METAANALYSIS; Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS); Colorectal liver metastases (CRLM); Apoptosis; Proliferation; Vascularization (1)
EXTENDED RISM EQUATION; INORGANIC-IONS; WATER; SPECTROSCOPY; COEFFICIENTS; SOLVATION; DYNAMICS; LIQUIDS; DENSITY; ACETYLCHOLINE; (1)
EXTENDED RISM EQUATION; ION HYDRATION; SOLVENT CONSTRAINTS; DYNAMICS; WATER; CONFORMATION; REORIENTATION; SPECTROSCOPY; ASSOCIATION; RELAXATION (1)
extended surfactant, salt effects, hydrotrope, triglycerides, nano-emulsions, liquid crystals, optical microscopy, NMR (1)
EXTENSIONS; ALGEBRAS; (1)
EXTENSIVE TRANSVERSE MYELITIS; COMMON INFECTIOUS AGENTS; NEUROMYELITIS-OPTICA; HUMAN CYTOMEGALOVIRUS; MOLECULAR MIMICRY; JAPANESE PATIENTS; IMMUNE-RESPONSE; IGG PREDICTS; ASSOCIATION; ENCEPHALITIS; Neuromyelitis optica; Multiple sclerosis; Infection; Herpes virus; Pathogenesis; Aquaporin-4 (1)
EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; ANTI-AQUAPORIN-4 ANTIBODY; CEREBROSPINAL-FLUID; NMO-IGG; AQUAPORIN-4 AUTOANTIBODIES; IMMUNE-RESPONSE; INTRACTABLE HICCUP; MYASTHENIA-GRAVIS; IMMUNOGLOBULIN-G; (1)
EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; NEUROLOGICAL DISEASES; IGG; DIAGNOSIS; CSF; IMMUNOGLOBULIN; PATHOGENESIS; MECHANISMS; RELEVANCE; Neuromyelitis optica (Devic disease); Longitudinally extensive transverse myelitis; Recurrent optic neuritis; Cerebrospinal fluid; Lumbar puncture; NMO-IgG; Antibody to aquaporin-4; Oligoclonal bands; IgG, IgM, IgA; Albumin Total protein; Lactate (1)
EXTENSIVE TRANSVERSE MYELITIS; OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; SPINAL-CORD; acute myelopathy; transverse myelitis; eculizumab; autoimmune myelitis; longitudinally extensive transverse myelitis; spinal cord hemorrhage; C5-inhibitor; interleukin-6 (1)
EXTERNAL-BEAM RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; OPEN-LABEL; CARCINOMA; OUTCOMES; TRIAL; Endometrial cancer; Radiotherapy; Chemotherapy; Adjuvant treatment (1)
EXTERNAL-BEAM RADIOTHERAPY; RADICAL PROSTATECTOMY; ONCOLOGIC OUTCOMES; FAILURE; COMPLICATIONS; BRACHYTHERAPY; CRYOABLATION; CRYOTHERAPY; ABLATION; MEN; high-intensity focused ultrasound; PSA; biochemical failure; follow-up; salvage therapy; #ProstateCancer (1)
EXTERNAL ELECTRIC-FIELD; TO-CYLINDER TRANSITION; BLOCK-COPOLYMER THEORY; POWER CONVERSION EFFICIENCY; THIN-FILMS; PHOTOVOLTAIC PERFORMANCE; DIBLOCK COPOLYMERS; SELF-ORGANIZATION; SURFACE-ENERGY; PHASE-BEHAVIOR; (1)
Externalizing spectrum, Taylor Aggression Paradigm, monetary mTAP, ScanSTRESS, Externalizing spectrum, fMRI, Anterior cingulate cortex, cortisol, dorsal striatum, (1)
EXTERNAL JUGULAR-VEIN; GENE-RELATED PEPTIDE; CEREBRAL VASOSPASM; CEREBROSPINAL-FLUID; IMMUNOREACTIVITY; INVOLVEMENT; ARTERIES; BRAIN; neuropeptide Y; neuropeptides; subarachnoid hemorrhage; intracerebral hemorrhage; cerebrospinal fluid (1)
EXTERNAL JUGULAR-VEIN; GENE-RELATED PEPTIDE; CEREBROSPINAL-FLUID; NERVE-FIBERS; VASOMOTOR RESPONSES; ISCHEMIC-STROKE; HUMAN-BRAIN; ARTERIES; IMMUNOCYTOCHEMISTRY; RADIOIMMUNOASSAY; Neuropeptide Y; NPY; Subarachnoid hemorrhage; Cerebral vasospasm; Biomarker; Neuropeptides (1)
EXTERNAL JUGULAR-VEIN; HEAD; COMPLICATIONS; OSTEORADIONECROSIS; SALVAGE; SURGERY; (1)
EXTERNALLY TRIGGERED MOVEMENTS; POSITRON-EMISSION-TOMOGRAPHY; SUPPLEMENTARY MOTOR AREA; CEREBRAL-BLOOD-FLOW; COGNITIVE PERFORMANCE; DRAWING MOVEMENTS; INTENTION TREMOR; BASAL GANGLIA; MICROGRAPHIA; CUES; handwriting; kinematics; Parkinson's disease (1)
EXTERNAL PLEXIFORM LAYER; LONG-LASTING DEPOLARIZATIONS; LATERAL INHIBITION; MITRAL CELLS; DENDRODENDRITIC SYNAPSES; PARVALBUMIN INTERNEURONS; GLUTAMATE RECEPTORS; MITRAL/TUFTED CELLS; GABAERGIC NEURONS; DENDRITIC SPINES; (1)
EXTERNAL QUANTUM EFFICIENCY; SPONTANEOUS EMISSION; GAAS; DEPENDENCE; ABSORPTION; electromagnetic scattering by rough surfaces; light-emitting diodes; Monte Carlo methods (1)
EXTERNAL TRANSCRIBED SPACER; LAST GLACIAL MAXIMUM; PHYLOGENETIC ANALYSIS; HYBRID SPECIATION; MILL. COMPOSITAE; 18S-26S RDNA; SAMPLE-SIZE; ASTERACEAE; CHARACTERS; DNA; GIS; Hybridisation; Iberian Peninsula; Niche modelling; nrDNA ETS; Polyploidy (1)
EXTERNAL TUFTED CELLS; ADULT-BORN NEURONS; GLOMERULAR LAYER; PERIGLOMERULAR CELLS; GRANULE CELLS; IN-VIVO; QUANTITATIVE-ANALYSIS; DOPAMINERGIC-NEURONS; DISTINCT MODES; GABA; juxtaglomerular cells; dopaminergic neurons; subcellular compartments; dendritic arborization analysis; calcium imaging; dendrites; two-photon imaging; morphological reconstruction (1)
EXTERNAL VALIDATION; PROSTATE-CANCER; RECURRENCE; SURVIVAL; IMPROVE; REGRESSION; NOMOGRAMS; MORTALITY; ACCURACY; Radical cystectomy; Outcome; Artificial neural network; Bladder cancer; Predictive accuracy (1)
EXTERNAL VALIDATION; SURGICAL-TREATMENT; 8TH EDITION; CANCER; perihilar cholangiocarcinoma; lymph nodes; resection margin; overall survival; recurrence-free survival (1)
Externes Ressourcenmanagement, intrinsische Motivation, Erwartungs-Wert-Modelle, Informationsquellen, Nützlichkeit von Informationsquellen, motivationale Studienorientierungen, Selbstwirksamkeitserwartung (1)
EXTRACAPSULAR CATARACT-EXTRACTION; POSTERIOR CAPSULE RUPTURE; LEARNING-CURVE; VITREOUS LOSS; VITRECTOMIZED EYES; OUTCOMES; EXPERIENCE; Cataract surgery; Phacoemsulsification; Vitreous loss; Posterior capsule tear; Learning curve (1)
EXTRACELLULAR ACIDIFICATION; PH; TDAG8; OGR1; GENE; G2A; MIGRATION; GPR4; PROLIFERATION; INFLAMMATION; (1)
extracellular DNA; periodontitis; polysaccharides; secretion; subgingival dental plaque; vesicles (1)
EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; LYMPHOCYTE MIGRATION; INTEGRIN RECEPTORS; ENDOTHELIAL-CELLS; HEART LAMININ; ADHESION; FIBRONECTIN; EXPRESSION; VARIANTS; laminin isoforms; leukemic cell; lymphocyte (1)
EXTRACELLULAR-MATRIX; CARCINOMA SYNDROME; EPITHELIAL-CELLS; P63; P53; PROTEIN; PROLIFERATION; MORPHOGENESIS; MUTATIONS; TOOTH; KCOT; Wnt-1; Wnt-10A; beta-catenin; E-cadherin; P63; CD1 (1)
EXTRACELLULAR-MATRIX COMPONENTS; TRABECULAR MESHWORK CELLS; ACTIN; LOCALIZATION; PANCORTINS; NEPHRIN; PROTEIN; TISSUE; A2-PANCORTINS; INTERACTS; dexamethasone; minimal change nephritis; olfactomedin domain proteins; puromycin (1)
EXTRACELLULAR-MATRIX; MEDIATED ACTIVATION; PROTEIN-KINASE; DEATH; IDENTIFICATION; DISRUPTION; PP125(FAK); MECHANISM; INTEGRINS; PP125FAK; (1)
EXTRACELLULAR-MATRIX MESOGLEA; HEAD REGENERATION; IV COLLAGEN; VULGARIS; FIBRONECTIN; EXPRESSION; DROSOPHILA; PROTEINS; CHAIN; METALLOPROTEINASE; hydra; morphogenesis; extracellular matrix; laminin; integrin (1)
EXTRACELLULAR-MATRIX PROTEINS; LEUCINE-RICH PROTEOGLYCANS; CUTIS-LAXA; OSTEOGENESIS IMPERFECTA; TISSUE LOCALIZATION; I COLLAGEN; MICE; GENE; DEFICIENCY; FIBRILLOGENESIS; Fibulin-4; Collagen cross-linking; Elastic fiber; Lysyl oxidase (1)
EXTRACELLULAR-MATRIX PROTEINS; LYSYL-OXIDASE; ELASTIC FIBER; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL CHARACTERIZATION; ARTERIAL TORTUOSITY; TISSUE LOCALIZATION; AORTIC-ANEURYSM; MARFAN-SYNDROME; CROSS-LINKING; Extracellular matrix protein; Fibulin-4; Mutations; Elastogenesis; Matrix assembly; Protein folding (1)
EXTRACELLULAR-MATRIX PROTEINS; MULTICELLULAR TUMOR SPHEROIDS; POLY(ADP-RIBOSE) POLYMERASE; MONOLAYER-CULTURES; PRESSURE-OVERLOAD; GENE-EXPRESSION; GROWTH; SPACE; SPACEFLIGHT; DEATH; extracellular matrix proteins; hormones; clinorotation; thyroid tumor; programmed cell death (1)
EXTRACELLULAR-MATRIX PROTEINS; RAT CARDIAC FIBROBLASTS; PRESSURE-OVERLOAD; GENE-EXPRESSION; TRANSGENIC RATS; BLOOD-PRESSURE; HEART-FAILURE; RECEPTOR BLOCKADE; MESSENGER-RNA; SYSTEM; extracellular matrix; hypertrophy; angiotensin; chondroitin sulfate; osteopontin (1)
EXTRACELLULAR-MATRIX; STEM-CELLS; COLLAGEN FIBRILLOGENESIS; CONNECTIVE-TISSUE; III COLLAGEN; DIFFERENTIATION; TENDINOPATHY; TENOMODULIN; EXPRESSION; SCLERAXIS; 3D multiplex models; composite living fibers; in vitro models; tendons; tissue engineering (1)
EXTRACELLULAR-MATRIX SUBSTRATA; STROMAL-VASCULAR CELLS; LONG-TERM CULTURE; IN-VITRO; ADIPOCYTE DIFFERENTIATION; BIOMATERIALS; BEHAVIOR; REPAIR; VIVO; METALLOPROTEINASES; Adipose tissue engineering; Biomimetic material; Cell adhesion; Degradation; Hydrogel; Mechanical properties (1)
EXTRACELLULAR-MATRIX; TENDON FIBROBLASTS; KNEE LIGAMENTS; GROWTH-FACTOR; HIGH GLUCOSE; TISSUE; CELLS; PROLIFERATION; EXPRESSION; MODEL; (1)
EXTRACELLULAR PH; GENE-EXPRESSION; SKIN; OXYGEN; REGENERATION; REPAIR; cutaneous; luminescence; ratiometric; RGB imaging; skin (1)
EXTRACELLULAR POLYMERIC SUBSTANCES; S-LAYER; CELL-ENVELOPE; THIOBACILLUS-FERROOXIDANS; 3-DIMENSIONAL STRUCTURE; IGNICOCCUS-HOSPITALIS; THERMOPROTEUS-TENAX; IRON COMPLEXATION; GLYCOPROTEIN; BACTERIA; Acidithiobacillus; Thiobacillus; Cell surface; S-layer; EPS; Pyrite; Electron microscopy; High-pressure freezing (1)
EXTRACELLULAR TLR4 DOMAIN; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; SOLUBLE FORMS; UNITED-STATES; SEVERE SEPSIS; MD-2; TOLL; RECEPTOR; LPS; (1)
EXTRACELLULAR TRAP FORMATION; COLONY-STIMULATING FACTOR; TUBULOVESICULAR EXTENSIONS CYTONEMES; INTERCELLULAR-ADHESION MOLECULE-1; SELECTIN GLYCOPROTEIN LIGAND-1; ACTIVATION PROTEIN-1 INTERLEUKIN-8; TRANSENDOTHELIAL CELL-MIGRATION; FORMYL PEPTIDE RECEPTORS; TUMOR-NECROSIS-FACTOR; LEUKOCYTE ADHESION; microtubule organization center; NEtosis; tumor association; neutrophil (PMN) function; neutrophil extravasation; extracellular matrix (ECM); chemotactic gradients; bidirectional (trans)migration (1)
EXTRACELLULAR TRAPS; IMMUNE FUNCTIONS; CD11B EXPRESSION; OXIDATIVE BURST; PHAGOCYTOSIS; BUPIVACAINE; CHEMOTAXIS; POLARITY; neutrophils; PMNs; isolation; local anesthetics; PMN functions; lidocaine; bupivacaine; levobupivacaine; ropivacaine (1)
EXTRACELLULAR VESICLES; CELL-SURFACE; exosomes; liver; kidney; brain; spleen; lung; lipopolysaccharide; inflammation; wheatgerm agglutinin; mannose-6 phosphate receptor (1)
Extracellular Vesicles (EVs), EV isolation, Plant pathogenic fungi, Plant pathogenic oomycetes, Plant-microbe interaction (1)
extracellular vesicles; exosomes; adipose-derived stem cells; tumor microenvironment; triple-negative breast cancer; T.A.E. technology (1)
extracellular vesicles; exosomes; musculoskeletal diseases; MSC; iMP; cell-free therapeutics (1)
EXTRACELLULAR VESICLES; INDUCED GENE; DSRNA; INTERFERENCE; HOST; RESISTANCE; DELIVERY; CARBON; WHEAT; NANOPARTICLES (1)
EXTRACELLULAR VESICLES; IN-VITRO; BIOGENESIS; INTESTINALIS; INFECTION; REVEALS; LAMBLIA; PROTEIN; ROLES; CARGO; Giardia lamblia; parasite to parasite communication; exosomal-like vesicles (ElVs); small RNAs (sRNA); msRNA; tsRNA; rsRNA; trophozoites; host-specificity; pathogenesis (1)
EXTRACELLULAR VESICLES; T-CELLS; ADENOSINE; CANCER; BIOLOGY; MICROVESICLES; SUPPRESSION; RESPONSES; CD73; exosomes; extracellular vesicles; TEX; HNSCC; head and neck cancer; purine metabolites; adenosine; purinergic signaling (1)
Extracorporale Photopherese (ECP), Sterilkontrollen, Cobe Spectra, Amicus, Uvar XTS, Spectra Optia, zentral-venöser Katheter, Photophereseprodukt, Blutprodukt, Kontamination (1)
EXTRACORPOREAL-CIRCULATION; FOLLOW-UP; SYSTEM; Extracorporeal circulation (ECC); Minimised extracorporeal circulation system (MECC); Coronary artery bypass grafting (CABG); EuroScore; High-risk patients (1)
extracorporeal circulation; minimal invasive extracorporeal circulation; cardiopulmonary bypass; modular systems; focused update (1)
; extracorporeal CO2 removal; lung protective ventilation; mechanical ventilation; experimental model (1)
EXTRACORPOREAL LIFE-SUPPORT; FLOW; ANTICOAGULATION; CONTRIBUTES; THROMBOSIS; SYSTEMS; BLOOD; ECMO; biocompatibility; cell adhesion; indirect immunofluorescence; clot formation (1)
Extracorporeal life support, OHCA, IHCA, Interleukins, Cytokins, Post-resuscitation syndrome (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE RESPIRATORY-FAILURE; DISTRESS-SYNDROME; COVID-19; SUPPORT; SURVIVAL; PATIENT; COVID-19; extracorporeal membrane oxygenation; ARDS; ECMO; prolonged; SARS-CoV-2 (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE RESPIRATORY-FAILURE; LIFE-SUPPORT; CARDIOGENIC-SHOCK; MORTALITY; (1)
extracorporeal membrane oxygenation; ARDS; ECMO; bleeding; thromboembolic; complication (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; COAGULATION MANAGEMENT; SUPPORT; ANTICOAGULATION; HEPARIN; THROMBOELASTOMETRY; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; COMPLICATIONS; ISCHEMIA; venoarterial extracorporeal membrane oxygenation; peripheral perfusion; limb perfusion; near infrared spectroscopy (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; INHALED NITRIC-OXIDE; SINGLE-LUNG TRANSPLANTATION; ARTERIAL-HYPERTENSION; RIGHT VENTRICLE; NONOBSTETRIC SURGERY; BRIDGE; LEVOSIMENDAN; PERICARDIUM; DOBUTAMINE; Pulmonary hypertension; Decompensation; Right heart failure; Intensive care; Perioperative management (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; LIFE-SUPPORT; COMPLICATIONS; CANNULATION; ISCHEMIA; METAANALYSIS; SURGERY; Perfusion control; Extracorporeal membrane oxygenation; Ischemia; Complications; Limb oxymetry (1)
extracorporeal membrane oxygenation, long-term outcome, low cardiac output, resuscitation, survival (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; INTENSIVE-CARE UNIT; CARDIAC-ARREST; TRANSPORT; RESUSCITATION; COMPLICATIONS; FAILURE; PATIENT; emergency medical service; cardiogenic shock; extracorporeal membrane oxygenation; cardiopulmonary bypass; Emergency-MECC (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; REFRACTORY CARDIOGENIC-SHOCK; ACUTE MYOCARDIAL-INFARCTION; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; ETHICAL DILEMMAS; HEART-FAILURE; PULMONARY; ARREST; Extracorporeal membrane oxygenation; Extracorporeal life support; Mechanical circulatory support; Cardiac failure; Cardiac arrest; Hospital organization; Critical care networks; Position article (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICALLY VENTILATED PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; NONINVASIVE VENTILATION; LUNG ASSIST; DIAPHRAGM LENGTH; WEANING FAILURE; DETERMINANTS; SUCCESS; Pulmonary ventilation; Ventilatory pump; Respiration, artificial; Ventilator weaning; Extracorporeal membrane oxygenation (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MORTALITY; FRAILTY; COVID-19; SARS-CoV-2; age; comorbidities; intensive care medicine; ventilation; ECMO; mortality (1)
; extracorporeal membrane oxygenation; multidetector computed tomography; volume rendering technique; thrombotic deposits (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NEAR-INFRARED SPECTROSCOPY; RESPIRATORY-DISTRESS-SYNDROME; HYPERCAPNIC ACIDOSIS; CARBON-DIOXIDE; LIFE-SUPPORT; LUNG INJURY; BLOOD-FLOW; VENTILATION; ADULTS; acute respiratory distress syndrome; acute lung injury; extracorporeal membrane oxygenation; near-infrared spectroscopy; brain injury (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NEUTROPHIL EXTRACELLULAR TRAPS; MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; LEUKOCYTE ADHESION; BRAIN-INJURY; INFLAMMATION; ENOXAPARIN; THROMBOSIS; APOPTOSIS; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NITRIC-OXIDE CONSUMPTION; ROTARY BLOOD PUMPS; FREE HEMOGLOBIN; IN-VITRO; CARDIAC-SURGERY; ADULTS; DAMAGE; PREDICTION; MORTALITY; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NITRIC-OXIDE; PEDIATRIC OXYGENATOR; AUTOMATIC-CONTROL; FIBER BUNDLE; BLOOD-FLOW; MODEL; HEPARIN; HEMOCOMPATIBILITY; BRIDGE; artificial lung; ECMO; lung assist; lung support; implantable artificial lung; biocompatibility; anticoagulation regimes; in silicoanalysis; in vitroverification; in vivovalidation; miniaturization; structural integration; hemocompatibility (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NONINVASIVE VENTILATION; INFLUENZA-VIRUS; MECHANICAL VENTILATION; DISTRESS-SYNDROME; GERMAN SOCIETY; PRESSURE VENTILATION; EXHALED BREATH; VIRAL LOAD; FAILURE; COVID-19; Respiratory support; Acute respiratory failure (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; CARDIAC-ARREST; LIFE-SUPPORT; REMOVAL; RESUSCITATION; EPIDEMIOLOGY; FAILURE; ADULTS; Critical illness; Heart failure; Ethics; Terminal care; Epidemiology (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; OUTCOMES; ARDS; ECMO; hyperfibrinolysis; outcome; SARS-CoV-2; thrombosis (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; PLATELET ACTIVATION; P-SELECTIN; THROMBOSIS; ADAMTS13; NEUTROPHILS; BLOOD; FLOW; COMPLICATIONS; INFLAMMATION; extracorporeal membrane oxygenation; liver dysfunction; shear stress; SOFA score; thrombogenesis; von Willebrand factor (1)
extracorporeal membrane oxygenation, pregnancy, peripartum, hemorrhage, influenza, pneumonia, acute respiratory distress syndrome, pulmonary embolism, amniotic fluid embolism, cardiomyopathy (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; BLOOD-STREAM INFECTIONS; CLINICAL-PRACTICE GUIDELINES; LIFE-SUPPORT; NOSOCOMIAL INFECTIONS; PREDICTING SURVIVAL; CARDIOGENIC-SHOCK; DISEASES SOCIETY; RISK-FACTORS; ECLS; ECMO; Infections; Complications; Nosocomial; ELSO registry (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; COAGULATION MANAGEMENT; CLINICAL-PRACTICE; HEPARIN; TRANSFUSION; ANTICOAGULATION; TIME; Extracorporeal membrane oxygenation; Hemorrhage; Blood transfusion; Blood coagulation (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; END-EXPIRATORY PRESSURE; ACUTE-RENAL-FAILURE; MECHANICAL VENTILATION; HYPOPROTEINEMIC PATIENTS; COMPLEMENT ACTIVATION; PEEP VENTILATION; Acute kidney injury; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Renal replacement therapy; Water-electrolyte balance (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; BRAIN-INJURY; LIFE; ADULTS; veno-venous extracorporeal membrane oxygenation; intracranial bleeding; intracranial hemorrhage; incidence; risk factors (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; LIFE-SUPPORT; BLOOD PUMPS; Oxygenator exchange; Pressure difference; Inflow cannula diameter; Technical-induced hemolysis; Technical complications; Extracorporeal membrane oxygenation; Flow dynamics (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RIGHT-VENTRICULAR FAILURE; ARTERIAL-HYPERTENSION; LUNG TRANSPLANTATION; BRIDGE; pulmonary hypertension; acute right heart failure (1)
EXTRACORPOREAL SEPTOPLASTY; LIP; NOSE; REPAIR; cleft; cleft nose rhinoplasty; secondary rhinoplasty; cartilage graft; rotational advancement; nasal asymmetry (1)
Extraction apparatus (distribution, Craig, for amines) Amines Bases (extn. of, app. for) (1)
extraction; green chemistry; curcuminoid; Iris germanica L.; isoflavone; ICAM-1; anti-inflammatory; isolation; SFME; antimicrobial; irisbutter (1)
Extraction · Green chemistry · High pressure liquid chromatography · Mass spectrometry · Material science (1)
EXTRACTION PROTOCOL; TRANSGENIC MICE; BLOOD-PRESSURE; TAIL BIOPSY; PCR; IDENTIFICATION; RESPONSES; CHELEX; TISSUE; MOUSE; 3Rs; alternatives; welfare; rodents; DNA isolation (1)
extraction, supercritical carbon dioxide, iris germanica, rosmarinus officinalis, rosemary, fragrances, antioxidants, micellar extraction, hydro distillation, microemulsion (1)
EXTRA DELOCALIZED ELECTRON; ELEMENTS; ION; BI; POLYPHOSPHIDES; CHEMISTRY; BISMUTH; COMPLEX; ANIONS; SALTS; ammoniates; bismuth; crystal structure; liquid ammonia (1)
EXTRAHEPATIC BILE-DUCT; GALLBLADDER-CANCER; TELOMERASE ACTIVITY; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; RAS MUTATIONS; NITRIC-OXIDE; P53; CARCINOGENESIS; INFECTION; Helicobacter pylori; bile; gallstones; biliary tract carcinoma; polymerase chain reaction (1)
Extrakorporale Membranoxygenierung, Respiratorische Insuffizienz, Blutungskomplikationen, Hämatothorax, Thoraxchirurgie (1)
Extrakorporaler Kreislauf , Enolase , Extrakorporale Zirkulation , Minimale extrakorporale Zirkulation , Neuronenspezifische Enolase , S-100ß , extracorporeal circulation , minimized extracorporeal circulation , Neuron-specific Enolase , S-100ß , cardiac surgery (1)
Extraktion; Löslichkeit; gamma-Irone; Iris germanica L.; Curcumin; Curcuma longa L.; Zimtaldehyd; Cinnamomum cassia (1)
EXTRAPLEURAL PNEUMONECTOMY; CISPLATIN CHEMOTHERAPY; PHASE-II; MESOTHELIOMA; PLEURECTOMY/DECORTICATION; RECOMMENDATIONS; CYTOPROTECTION; CHEMOPERFUSION; COMPLICATIONS; AMIFOSTINE; HITOC; hyperthermic intrathoracic chemotherapy; chemoperfusion; pleural malignancy; pleural mesothelioma; cytoreductive surgery (1)
EXTRAPLEURAL PNEUMONECTOMY; PHASE-II; MESOTHELIOMA; CISPLATIN; TRIAL; PLEURECTOMY/DECORTICATION; CYTOPROTECTION; FEASIBILITY; RESECTION; THYMOMA; Thymoma; Pleural mesothelioma; Cytoreductive surgery; Hyperthermic perfusion; Multimodality treatment (1)
extrazelluläre Matrix, Neutrophile, Chemotaxis, Inflammation, Gewebe (1)
Extrazelluläre Vesikel, Malignes Melanom, Immunzellen, Metastasierung, Onkologie (1)
Extreme environments; Microbiomes; Archaea; Bacteria; Propidium monoazide; Astrobiology; Space-analogue; Extremophiles; Extraterrestrial life; Metagenomics (1)
EXTREMELY PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; PERMISSIVE HYPERCAPNIA; POSITIVE-PRESSURE; CEREBRAL-PALSY; TRIAL SUPPORT; EARLY CPAP; SURFACTANT; RISK; HEMORRHAGE; (1)
EXTREMELY PRETERM INFANTS; SEVERE INTRAVENTRICULAR HEMORRHAGE; BRONCHOPULMONARY DYSPLASIA; HYPERCAPNIC ACIDOSIS; PRESSURE; FLUCTUATIONS; OXYGENATION; SURFACTANT; TARGETS; PHELBI; Neurodevelopmental outcome; Permissive hypercapnia; Bayley scales; Bronchopulmonary dysplasia; Intraventricular hemorrhage (1)
EXTREMELY RADIATION-RESISTANT; FATTY-ACID-COMPOSITION; GEN. NOV.; SP. NOV.; THERMOPHILIC BACTERIUM; THERMUS-AQUATICUS; CLASSIFICATION; ALGORITHM; DATABASE; ARCHAEA; microaerophilic; non-motile; Gram-negative; nitrate-reducing; moderate thermophilic; neutrophilic; chemolithoheterotrophic; hydrothermal vent; Thermaceae; GEBA (1)
EXTREME THERMOPHILE; ARABIDOPSIS-THALIANA; THERMUS-THERMOPHILUS; SPERMIDINE SYNTHASE; ARCHAEBACTERIUM; THERMOSPERMINE; TRANSFERASE; PYROCOCCUS; Long-chain polyamine; Archaea; Polyamine synthesis; Hyperthermus butylicus; Pyrobaculum aerophilum (1)
Extreme value theory; Index-linked hedging instruments; Copulas (1)
EXTREMITY LYMPHEDEMA; VIDEOANGIOGRAPHY; LYMPHOGRAPHY; (1)
Extrem thermophile Bakterien , Tryptophanstoffwechsel , Sulfolobus solfataricus , Enzymkinetik , Molekulare Evolution , Domäne <Biochemie> , Enzym , Anthranilat-Phosphoribosyltransferase , Domänenbewegung , Kleinwinkelstreuung , enzyme , Anthranilate-Phosphoribosyltransferase , enzyme kinetics , domain movement , small-angle-x-ray scattering (1)
EX-VIVO; ADOPTIVE TRANSFER; PANCREATIC-ISLETS; PERIPHERAL-BLOOD; TREG EXPANSION; HOST-DISEASE; TRANSPLANTATION; PREVENTION; TOLERANCE; IMMUNOTHERAPY; (1)
EX-VIVO EXPANSION; BLOOD STEM-CELLS; MEDIATED GENE-TRANSFER; MARROW STROMAL CELLS; BONE-MARROW; SCATTER FACTOR; C-KIT; REPOPULATING ACTIVITY; TYROSINE KINASE; CD34(+) CELLS; CD34; differentiation; hematopoietic progenitor cells; hepatocyte growth factor; thrombopoietin; lymphopoiesis (1)
EX-VIVO; RECEPTOR; INFLAMMATION; FIBROSIS; CMKLR1; GPR1; ACTIVATION; EXPRESSION; CHEMR23; MAST; Galectin-3; IL-6; Proliferation; Tango Assay; CMKLR1 (1)
Exziton, Dynamik, Heterostruktur, Van-der-Waals-Schichtstrukturen, 2D-Materialien, ultraschnelle Spektroskopie, Impulssynthese, Multi-THz (1)
Exziton, THz-Spektroskopie, Ultraschnelle Dynamik (1)
Exziton, THz-Spektroskopie, van-der-Waals-Heterostrukturen, Übergangsmetalldichalkogenide (1)
EYE-BLINK RATE; SEXUAL AROUSAL; EMOTIONAL AROUSAL; DECISION-MAKING; RISK-TAKING; SENSE; AGENCY; SELF; RESPONSES; AWARENESS; Sense of agency; Intentional binding; Action binding; General arousal; Sexual arousal (1)
EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; PROTEIN GENE; DEFECTIVE GLYCOSYLATION; FKRP GENE; DEFICIENCY; DISRUPTION; PHENOTYPE; FORM; POMT1 gene; LGMD2; WwS; hypoglycosylation of alpha-dystroglycan; A200P mutation (1)
Eyebrow, Temporal lift, Caucasia, Beauty standard, Eyebrow position, Eyebrow apex, Eyebrow elevation, Eyebrow angulation (1)
EYE CONTACT; VISUAL-ATTENTION; SEATING LOCATION; STUDENT SEX; GENDER; IMMEDIACY; BOYS; PARTICIPATION; COMMUNICATION; PERFORMANCE; Eye movement; eye tracking; attention; region of interest; individual differences; gaze (1)
EYE; DELIVERY; PENETRATION; DRUGS; VIVO; NANOSUSPENSION; FORMULATIONS; MICELLES; RABBITS; surfactant micelles; cyclosporin A; poor solubility; dry eye disease; bioavailability (1)
eye development, glaucoma, astrocytes, nanoparticles (1)
; Eye development; Trabecular meshwork; Glial lamina; Neural crest; Astrocyte (1)
eye movement, eye tracking, fixations, gaze, vergence, bias, calibration (1)
EYE-MOVEMENTS PLAY; VISUAL-IMAGERY; FUNCTIONAL-ROLE; MEMORY; PERCEPTION; LOOKING; (1)
eye movements, pursuit, saccades, covert attention, overt attention, dynamic causal modelling, DCM, fMRI, neurocomputation, human brain Augenfolgebewegungen, glatte, sakkaden, verdeckte Aufmerksamkeit, offene Aufmerksamkeit, dynamic causal modeling, DCM, fMRT, neurocomputationale Modelle, menschliches Gehirn (1)
EYE-MOVEMENTS; SIGHT; ABILITY; SKILLS; MODEL; Cognitive tests; eye tracking; incongruence; music reading; pupil size (1)
Eye tracker; Data quality; Head movements; Precision; Oculomotor drift; Corneal reflection; Pupil size artefact (1)
; Eye-tracker; Data quality; Resolution; Precision; Microsaccade; Corneal reflection; Saccade amplitude (1)
Eye Tracking, Data Preprocessing, Data Analysis, Machine Learning, Random Forest, Classification, Academic Cheating (1)
eye-tracking, gaze behaviour, imap, linear mixed models (1)
eye-tracking, information behavior, pictorial information, textual information, wikipedia article (1)
eye-tracking; information graphic; textual elements; pictorial elements (1)
eye tracking, mesh saliency, 3D object viewing (1)
Eyetracking, Preference Elicitation, Conversational Maxims,Information Search, Reading Behaviour (1)
Eye-Tracking, Software Engineering Education (1)
Eye tracking, Software engineering, Empirical, Systematic literature review (1)
EYEWITNESS-MEMORY; FALSE MEMORIES; RETRIEVAL; DISTINCTIVENESS; INFORMATION; MECHANISMS; RECALL; HAPPY; (1)
eywords: FiLBY, training, reading fluency, reading while listening, lesetraining (1)
EZB DBIS GOKB Alma FOLIO Fernleihe ZDB AG Systemlandschaft E-Ressourcen openCost (1)
EZB, Elektronische Zeitschriftenbibliothek, Entwicklungsstand, Neuerungen, Schnittstellen, Datenlieferdienste, Kooperation, Vernetzung, GOKB Task Force, openCost, Systemlandschaft E-Ressourcen, Universitätsbibliothek Regensburg, Anwenderfeedback, Bibliotheksservices (1)
EZB; Elektronische Zeitschriftenbibliothek; Schulung; Administrationsumgebung (1)
EZB; Elektronische Zeitschriftenbibliothek; Schulung; Administrationsumgebung; EZB-ZDB-Datendienst (1)
EZB GOKB Titellisten Kollektionen Zeitschriftenpaket Bibliotheken Datenaustausch (1)
EZB; Kostentransparenz; Open Access; Publikationskosten; openCost (1)
EZB, ZDB, AGV, Datenflüsse AG Systemlandschaft (1)
F-18-FDG PET/CT; FDG-PET/CT; NEOADJUVANT CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; RADICAL CYSTECTOMY; DIAGNOSTIC-ACCURACY; CLINICAL-VALUE; BLOOD-FLOW; CARCINOMA; RECURRENT; bladder cancer; computed tomography; fluorodeoxyglucose F18; positron emission tomography; urothelial (1)
F379; Alu; MIR repeat; Subtelomeric block; Retina; Tissue-specificity (1)
FAB-ARM EXCHANGE; EFFECTOR CELL DEGRANULATION; HUMAN B-CELLS; GRASS-POLLEN; SOMATIC HYPERMUTATION; DISTINCT REGULATION; GENE REARRANGEMENT; IMMUNOGLOBULIN G4; IGG(4) ANTIBODIES; BLOOD-LYMPHOCYTES; (1)
FABRY-PEROT INTERFERENCE; RESONATORS; SPIN; (1)
Facebook®, Gesundheitsförderung, Prävention, deutsche Krankenkassen, Gesundheitsförderung und soziale Medien (1)
; face distortion aftereffect; first-order relations; second-order relations; configurel processing; contrast polarity (1)
FACE; extra-intestinal manifestations; metastatic Crohn's disease; granulomatous skin changes; sarcoidal granulomas; tuberculoid granulomas; necrobiotic granulomas (1)
FACE-LIFT; RETAINING LIGAMENTS; ANATOMIC VARIATIONS; SURGICAL ANATOMY; PAROTID-GLAND; AXONAL LOAD; MUSCLE; PALSY; LOCALIZATION; REANIMATION; zygomaticus major; facial nerve; zygomatic nerve branches; buccal nerve branches; facial paralysis; facial muscles; mimetic muscles (1)
Face perception; Facial attributes; Inversion effect; Rotation (1)
Face perception; Inversion effect; Rotation; Discrimination; Association (1)
FACE-TO-FACE; MEDIATED SUPPORT GROUP; JOB-FINDING CLUB; SOCIAL SUPPORT; INFORMATION-SYSTEMS; SCIENCE RESEARCH; CAREER MATURITY; MENTAL-HEALTH; ONLINE; INTERNET; and phrases; societal benefits of ICT; mobile peer group; online peer group; youth unemployment; unemployment mitigation; field experiment (1)
Facettengelenkssyndrom, Bandscheibenvorfall, Rückenschmerzen (1)
Fachdidaktik; Bildung; Forschung und Lehre; Transformation; Digitalisierung; Digitale Medien; Lehrerbildung; Schule; Ethik; Kompetenz; Lehrer; Naturwissenschaftlicher Unterricht; Geografieunterricht; Fremdsprachenunterricht; Deutschunterricht; Musikunterricht; Sportunterricht; Technikunterricht; Physikunterricht; Pädagogikunterricht; Chemieunterricht; Lehr-Lern-System; Virtuelle Lehre; Medienkompetenz; Forschendes Lernen; Lehr-Lern-Prozess; Pandemie; Coronavirus; Virtuelle Realität; Recherche; Künstliche Intelligenz; Unterrichtsmedien; Tablet-PC; Feed-back; Heterogenität; Lesen; Lernumgebung; Primarbereich; Sekundarbereich; Lehramtsstudent; Online-Kurs; Außerschulischer Lernort; Kooperation; Aufsatzsammlung; Deutschland (1)
Fachdidaktik, Empirische Bildungsforschung, Pädagogik, Psychometrische Tests, Lehre (1)
Fachdidaktik; Physik; Chemie; Bildung; Naturwissenschaftliche Bildung; Naturwissenschaftlicher Unterricht; Mitgestaltung; Partizipation; Wissenschaftliche Bildung; Physikunterricht; Chemieunterricht; Lehr-Lern-Prozess; Didaktik; Lehramtsstudent; Vignette <Methode>; Pilotprojekt; Naturwissenschaften; Naturwissenschaftler; Naturwissenschaftliche Gesellschaft; Einstellung <Psy>; Wissenschaftliches Arbeiten; Naturwissenschaftliche Kompetenz; Experiment; Labor; Schüler; Schülerin; Unsicherheit; Schätzen <Math>; Schlussfolgerung; Digitale Medien; Inklusion; Lerngruppe; Medieneinsatz; Lernumgebung; Barrierefreiheit; Evaluation; Integrative Beschulung; Integrative Didaktik; Klassenraumgestaltung; Hochschullehre; Belastung; Studienanfänger; Praktikum; Seminar; Lehrerbildung; Fachwissen; Unterrichtsplanung; Reflexion <Phil>; Selbstreflexion; Unterrichtsqualität; Lernprozess; Naturwissenschaftlicher Beruf; Mathematik; Mathematikunterricht; Mathematisch-naturwissenschaftlicher Unterricht; Unterrichtsmedien (1)
Fachdidaktik; Physikunterricht; Chemieunterricht; Forschendes Lernen; Unterrichtsgestaltung; Lehrer; Lehrerfortbildung; Schüler; Lehrerausbildung; Unterrichtsplanung; Lehramtsstudent; Lehramtsstudiengang; Überzeugung; Einstellung <Psy>; Schulpraktikum; Experiment; Unterrichtsmethode; Sachunterricht; Fachwissen; Schulbuch; Selbstwirksamkeit; Selbstbestimmtes Lernen; Studienerfolg; Vorwissen; Entdeckendes Lernen; Laborarbeit; Textverständnis; Empirische Forschung; Tagungsbericht; Theorie-Praxis-Beziehung; Praxisbezug; Lehren; Fächerübergreifendes Lernziel; Sprachbewusstsein; Lehrerbildung; Selbst gesteuertes Lernen; Authentizität; Primarbereich; Computereinsatz; Unterrichtskonzeption; Geschlechtsspezifischer Unterschied; Praktikum; Kommunikationsverhalten; Unterrichtsqualität; Kompetenzentwicklung; Naturwissenschaftlich-technischer Unterricht; Videoanalyse; Inhaltsanalyse; Erhebungsinstrument; Leistungsmessung; Kompetenzmessung; Lehrbefähigung; Einflussfaktor; Hauptschule; Realschule; Berufsfachschule; Multimediales Lernen; Interaktives Lernen; Lehr-Lern-Prozess; Deutschland; Österreich; Schweiz; Finnland (1)
Fachdidaktik; Physikunterricht; Chemieunterricht; Inklusion; Forschendes Lernen; Unterrichtsgestaltung; Lehrer; Lehrerfortbildung; Schüler; Feed-back; Problemlösen; Lehrerausbildung; Unterrichtsplanung; Lehramtsstudent; Lehramtsstudiengang; Überzeugung; Einstellung <Psy>; Qualität; Schulpraktikum; Pädagogische Diagnostik; Kompetenz; Experiment; Unterrichtsmethode; Sachunterricht; Fachwissen; Messung; Curriculumentwicklung; Schulentwicklung; Sprachkompetenz; Medieneinsatz; Umweltbildung; Jahrgangsübergreifender Unterricht; Vorschulalter; Selbstkonzept; Grundschule; Sekundarbereich; Schulform; Schulbuch; Selbstwirksamkeit; Selbstbestimmtes Lernen; Unterrichtsinhalt; Unterrichtsbeispiel; Studienerfolg; Vorwissen; Entdeckendes Lernen; Smartphone; Motivation; Kompetenzentwicklung; Unterrichtszeit; Laborarbeit; Naturwissenschaftliche Bildung; Textverständnis; Empirische Forschung; Tagungsbericht (2)
FACIAL AFFECT RECOGNITION; EMOTIONAL FACES; VISUAL-SEARCH; ANGRY FACES; ATTENTION; ERP; THETA; EXPRESSIONS; POTENTIALS; DISORDER; Facial affect; Psychopathy; Female; Time-frequency; Event-related potentials (1)
FACIAL AFFECT RECOGNITION; EMOTION RECOGNITION; BEHAVIORAL TENDENCIES; EUTHYMIC PATIENTS; HEALTHY SIBLINGS; MIND DEFICITS; II DISORDER; SCHIZOPHRENIA; EXPRESSIONS; DEPRESSION; Empathy; Endophenotype; Relatives; Bipolar disorder (1)
FACIAL EXPRESSIONS; ACTION TENDENCIES; APPROACH BIAS; ALCOHOL; WOMEN; POWER; approach; avoidance; habit; motivation; speed advantage (1)
FACIAL EXPRESSIONS; BRAIN POTENTIALS; NEURAL MODELS; ADAPTATION; PERCEPTION; RECOGNITION; N170; AREAS; COMPONENT; FAMILIAR; Face perception; Adaptation; Event-related potential; N170 (1)
FACIAL EXPRESSIONS; HEART-RATE; PHOBIA; MECHANISMS; MOTIVATION; RESPONSES; EMOTION; HUMANS; BRAIN; OVERGENERALIZATION; Fear conditioning; Fear generalization; Social anxiety disorder; Patients; Heart rate; Skin conductance response (1)
FACIAL FRACTURES; CONSENSUS STATEMENT; SOCCER PLAYERS; CONCUSSION; SPORTS; MANAGEMENT; TRAUMA; Midfacial fracture; Concussion; Football; Soccer; Prevention; Return-to-play (1)
Facial nerve; zygomatic nerve branches; buccal nerve branches; facial paralysis; facial reanimation; facial anatomy; facial muscles; mimetic muscles; nerve transfer; cross-face-nerve grafts (CFNG); free muscle transplantation (1)
FACIAL PHENOTYPE; SPECTRUM; DIAGNOSIS; INDIVIDUALS; PREVALENCE; (1)
FACIAL RECONSTRUCTION; ENDOTHELIAL-CELLS; NORMAL-TISSUE; RADIATION; CYTOKINES; ADHESION; THERAPY; LARYNGECTOMY; MECHANISMS; MODEL; Wound healing; Radiation therapy; Fibroblasts; Endothelial cells; Stem cells (1)
Facial surgery Facial implants Alloplastic augmentation Facial measurements Anthropometric analysis (1)
FACIAL WOUNDS; IN-VIVO; GROWTH; MICE; IL-6; GENE; (1)
FACIAL WOUNDS; SCARS; GENE; IL-6; MICE; PATHOGENESIS; MANAGEMENT; PRIMATES; THERAPY; MODEL; Keloids; fibroblasts; botulinum toxin; cytokines (1)
FACILITATIVE GLUCOSE-TRANSPORTER; POSITRON-EMISSION-TOMOGRAPHY; BLOOD-BRAIN-BARRIER; GLUCOSE-TRANSPORTER-1 MESSENGER-RNA; YEAST SACCHAROMYCES-CEREVISIAE; HAPLOINSUFFICIENCY IN-VITRO; TUMOR-ASSOCIATED STROMA; KETOGENIC-DIET; CANCER-CELLS; DIFFERENTIAL EXPRESSION; anaerobic glycolysis; GLUT1; hepatocellular carcinoma (1)
FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; ENDOMETRIAL CANCER-RISK; ESTROGEN-RECEPTOR; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; DATABASE; DISEASE; DISCOVERY; INSULIN; GROWTH; (1)
FACTOR-ALPHA; RECOMBINANT HIRUDIN; SEPSIS; SHOCK; ANTIBODY; HEPARIN; COAGULATION; THERAPY; PROTEIN; RELEASE; (1)
FACTOR-ALPHA; SEPTIC-PERITONITIS; IRON SEQUESTRATION; INTERFERON-GAMMA; CHRONIC-DISEASE; MOUSE MODEL; HEPCIDIN; ANEMIA; FERROPORTIN; CELLS; hypoferraemia; blood; TNF; mouse; septic peritonitis (1)
FACTOR AP-2; RETINOIC ACID; MOUSE EMBRYOGENESIS; COLLAGEN GENE; IN-VIVO; BINDING; CLONING; FAMILY; CELLS; SOX9; integrin; cartilage; Chondrocytes; AP-2 epsilon; transcriptional regulator; Ets-1 (1)
FACTOR ARNO; BINDING; SEC7; GDP; P-31; PHOSPHOLIPIDS; ACTIVATION; DOMAINS; FAMILY; GTPASE; (1)
FACTOR-BETA; FACTOR-I; FACTOR KGF; REGENERATION; FIBROBLASTS; ACTIVATION; PROMOTER; CELLS; MODEL; RATS; gene transfer; KGF; wound healing; growth factors; gene therapy; skin (1)
FACTOR-BETA RECEPTOR; BREAST-CANCER CELLS; NF-KAPPA-B; LIGAND TRAIL; TUMORICIDAL ACTIVITY; EXPORT SIGNALS; APOPTOSIS; RESISTANCE; PROTEIN; ACTIVATION; TRAIL; nuclear TRAIL-R1; nuclear TRAIL-R2; trafficking; CRM-1 (1)
FACTOR-BETA-RECEPTOR; TYROSINE KINASE; SIGNAL-TRANSDUCTION; IN-VITRO; CELL-GROWTH; PDGF; DOMAIN; EXPRESSION; MECHANISM; FGF; (1)
FACTOR-BETA-RECEPTOR; TYROSINE KINASE; SIGNAL-TRANSDUCTION; MARINE ORIGIN; SELECTIVE-INHIBITION; POTENT INHIBITORS; CELL-GROWTH; PDGF; AUTOPHOSPHORYLATION; DERIVATIVES; beta-carbolines; PDGF receptor; tyrosine kinase; signal transduction (1)
FACTOR-BINDING PROTEIN-2; NUCLEAR-LOCALIZATION; TGF-BETA; EXPRESSION; GENE; PROGRESSION; MICRORNAS; REVEAL; DNA; POLYADENYLATION; YB-1; noncoding RNAs; miRNAs; prostate cancer (1)
FACTOR-BINDING PROTEIN-7; GROWTH-DIFFERENTIATION FACTOR-15; SENSITIVE TROPONIN-T; EJECTION FRACTION; TISSUE INHIBITOR; NT-PROBNP; ASSOCIATION; BIOMARKERS; PROGNOSIS; METALLOPROTEINASE-1; heart failure; hs-TnT; IGF-BP7; multimarker panel; NT-proBNP; prognostication (1)
FACTOR-BINDING SITES; SELECTIN LIGAND; MEMORY CD4(+); P-SELECTIN; DIFFERENTIAL REQUIREMENTS; LEUKOCYTE RECRUITMENT; EPIGENETIC REGULATION; FOXP3 EXPRESSION; CPG METHYLATION; DENDRITIC CELLS; (1)
FACTOR-C/EBP-ALPHA; TRANSCRIPTION FACTORS; DEVELOPMENTAL ENHANCERS; CHROMATIN INTERACTIONS; SELF-RENEWAL; HUMAN GENOME; EXPRESSION; LEUKEMIA; COMMITMENT; BINDING; (1)
FACTOR DELIVERY; INVITRO; COLLAGEN; RECEPTOR; INVIVO; cartilage; drug delivery; growth factors; IGF-I; insulin; tissue engineering (1)
FACTOR ENDOWMENTS; OIL; INSTITUTIONS; ABUNDANCE; BOOMS; CURSE; HISTORY; GAS; Natural resources; Income inequality; Synthetic control method; Developed countries (1)
FACTOR G-CSF; AMYOTROPHIC-LATERAL-SCLEROSIS; PROMOTES FUNCTIONAL RECOVERY; STEM-CELL MOBILIZATION; NERVOUS-SYSTEM INJURY; MARROW-DERIVED CELLS; CLINICAL-TRIALS; ICCP PANEL; NEUROPROTECTIVE THERAPY; SECONDARY INJURY; Traumatic SCI; SCI treatment; G-CSF; Neuroregeneration; Orphan diseases (1)
FACTOR HOMOLOGOUS FACTOR; LATE SODIUM CURRENT; HEART-FAILURE; KINASE-II; MASS-SPECTROMETRY; NA+ CHANNELS; QUANTITATIVE-ANALYSIS; MEMBRANE-PROTEINS; STATISTICAL-MODEL; CRYSTAL-STRUCTURE; (1)
FACTOR-H POLYMORPHISM; ADHESION MOLECULE; MACULAR DEGENERATION; FUNCTIONAL-CHARACTERIZATION; CONGENITAL RETINOSCHISIS; MURINE NA,K-ATPASE; MICE DEFICIENT; BETA-ISOFORMS; BIPOLAR CELLS; GENE DELIVERY; (1)
FACTOR-H POLYMORPHISM; GEOGRAPHIC ATROPHY; VISUAL IMPAIRMENT; CLINICAL-TRIAL; RISK-FACTORS; VITAMIN-E; AMD; PROGRESSION; CFH; SUSCEPTIBILITY; (1)
FACTOR-H POLYMORPHISM; HUMAN RPE CELLS; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; VITAMIN-C; ERYTHROPOIETIN; LIPOFUSCIN; VEGF; APOPTOSIS; DAMAGE; Retina; Pharmacology; Pathology (1)
FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ACTIVATED MICROGLIA; PHOTORECEPTOR DEGENERATION; COMPLEMENT ACTIVATION; APOPTOTIC CELLS; MOUSE RETINA; RCS RAT; DYSTROPHY; genetics; retina; microglia; complement system; retinal degeneration (1)
FACTOR-H POLYMORPHISM; RISK; VARIANT (1)
FACTOR HY402H POLYMORPHISM; C-REACTIVE PROTEIN; JAPANESE POPULATION; Y402H VARIANT; HEMICENTIN-1 GENES; CIGARETTE-SMOKING; CHROMOSOME 10Q26; NO ASSOCIATION; RISK-FACTORS; CFH GENE; Age-related macular degeneration (AMD); Complement factor H gene; meta-ananlysis (1)
FACTOR-I; CHONDROCYTE DIFFERENTIATION; ARTICULAR CHONDROCYTES; FACTOR 1-ALPHA; CARTILAGE; HIF-1-ALPHA; SOX9; AP-2-EPSILON; COLLAGEN; GENE; (1)
FACTOR-I; ISCHEMIA; STRESS; HIF-1; CARDIOPROTECTION; RESPONSES; (1)
Factorization, Renormalization Group, Higher-Order Perturbative Calculations, Scale and Conformal Symmetries, Specific QCD Phenomenology (1)
Factorization, Renormalization Group, Higher-Order Perturbative Calculations, Top Quark (1)
Factorization theorem, Gauge invariance, Drell-Yan process (1)
FACTORIZED S-MATRIX; PHASE-TRANSITIONS; ISOTOPIC SYMMETRY; 2 DIMENSIONS; MASS GAP; SYSTEMS; FERMIONS; NUMBER; O(N); QCD; (1)
FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; BINDING-PROTEINS; CELL-SURFACE; EXPRESSION; MOUSE; CANCER; DEATH; INFLAMMATION; RAGE; apoptosis; CD95; p53; p73 (1)
FACTOR-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; HEPATIC ISCHEMIA; RAT-LIVER; HEPATOCELLULAR-CARCINOMA; HUMULUS-LUPULUS; REACTIVE OXYGEN; KUPFFER CELLS; EXPRESSION; HOPS; Xanthohumol; Inflammation; ROS; NEkB; Liver; Warm ischemia-reperfusion injury (1)
FACTOR-KAPPA-B; RECEPTOR-ALPHA; INDUCED HYPERTENSION; HYPERTROPHIC GROWTH; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; CARDIAC FIBROSIS; AT(2) RECEPTORS; FATTY-ACIDS; EXPRESSION; peroxisome proliferator activated receptor; hypertension; cardiac remodeling; inflammation; angiotensin II (1)
FACTOR-KAPPA-B; SKIN FLAP CHAMBER; IN-VIVO; TISSUE-SECTIONS; CELL APOPTOSIS; CRYOSURGERY; INJURY; NECROSIS; HYPOXIA; MODEL; apoptosis; cryotherapy; leucocytes; microcirculation; tumour (1)
FACTOR KGF; SKIN; ANGIOGENESIS; REGENERATION; RATS; VIVO; (1)
FACTOR M-CSF; MOLECULAR-CLONING; HUMAN-MONOCYTES; CELLS; GENE; RNA; DIFFERENTIATION; PROTEIN; MUCOSA; CYTOTOXICITY; inflammatory bowel disease; Crohn's disease; ulcerative colitis; M-CSF; cytokine; macrophage (1)
FACTOR MIF; PROINFLAMMATORY FUNCTION; REGULATORY ROLE; ARTHRITIS; SEPSIS; GLUCOCORTICOIDS; TAUTOMERASE; BIOACTIVITY; ACTIVATION; CYTOKINE; (1)
FACTOR MODEL; MIDAS; INFORMATION; FORECAST; NUMBER; Bayesian VAR; dynamic and static principal components; european OECD countries; factor augmented VAR; nowcasting; real GDP growth; short-term forecasting (1)
FACTOR PATHWAY INHIBITOR-2; FECAL OCCULT BLOOD; CHROMATIN PATTERN; CELL FATE; GENE; HYPERMETHYLATION; MUTATIONS; CARCINOMA; POLYPS; MARKER; (1)
FACTOR PATHWAY INHIBITOR; ANTITHROMBOTIC ACTIVITY; UNFRACTIONATED HEPARIN; XA ACTIVITY; ANTICOAGULANT; PLASMA; BINDING; THROMBOCYTOPENIA; THROMBOSIS; MECHANISM; unfractionated heparin; medium-molecular-weight heparin; low-molecular-weight heparin; pharmacokinetics; pharmacodynamics (1)
FACTOR PEDF; INNER-EAR; CELLS; EXCITOTOXICITY; NEURONS; REPAIR; NOISE; VEGF; PEDF; organ of Corti; basilar membrane; cochlear ganglion neurons; glutamate; anti-angiogenic factors; organ development; rat (1)
FACTOR RAS-GRF; SECRETORY PATHWAY; GOLGI-APPARATUS; CELL POLARITY; LIVING CELLS; ACTIVATION; MEMBRANE; PROTEIN; GM130; POLARIZATION; (1)
FACTOR RECEPTOR-3 MUTATIONS; GROWTH-FACTOR RECEPTOR-1; CLINICAL PROSTATE; BLADDER-CANCER; TUMORS; EXPRESSION; ASSOCIATION; FREQUENCY; TARGET; Prostate cancer; FGFR3; Incidental prostate cancer (1)
FACTOR-RECEPTOR FAMILY; CD28 COSTIMULATION; APOPTOSIS; GROWTH; 4-1BB; MEMBER; DIFFERENTIATION; MACROPHAGES; EXPRESSION; DEATH; (1)
FACTOR-RECEPTOR FAMILY; DENDRITIC CELLS; 4-1BB LIGAND; LYMPHOCYTE-ACTIVATION; IN-VIVO; PROLIFERATION; SELECTINS; SURVIVAL; ADHESION; MEMBER; extravasation; vascular biology (1)
FACTOR-RECEPTOR FAMILY; HUMAN 4-1BB; GROWTH; MEMBER; ILA; PROLIFERATION; ILA/4-1BB; SURVIVAL; CD137; activation-induced cell death; apoptosis; lymphocyte (1)
FACTOR-RECEPTOR FAMILY; NECROSIS-FACTOR; HUMAN 4-1BB; ACTIVATION; MEMBER; CELLS; ILA; MACROPHAGES; PROLIFERATION; LYMPHOCYTES; CD137; blood vessel; tumor (1)
FACTOR SOX10; OLIG1 FUNCTION; RAT-BRAIN; GENE; PROTEINS; LINE; IDENTIFICATION; EXPRESSION; EXPANSION; REVEALS; (1)
FACTOR-VIII INHIBITORS; PATHOPHYSIOLOGY; DIAGNOSIS; UPDATE; (1)
FACTOR-V-LEIDEN; VENOUS THROMBOSIS; RISK FACTOR; 3'-UNTRANSLATED REGION; R506Q MUTATION; POSITION-20210; THROMBOPHILIA; RESISTANCE; RECIPIENTS; PREVALENCE; renal transplantation; G20210A prothrombin gene mutation; thrombophilia; graft survival (1)
Factor XIII, Fibrogammin, ECMO (1)
FACTOR-XIII GENE; FACTOR-VII GENE; FACTOR-V-LEIDEN; VENOUS THROMBOSIS; VAL34LEU POLYMORPHISM; MYOCARDIAL-INFARCTION; PRETERM INFANTS; INTRAVENTRICULAR HEMORRHAGE; INTRACRANIAL HEMORRHAGE; COMMON POLYMORPHISM; VLBW; outcome; hemostasis genes; polymorphism (1)
FACTOR-XIII GENE; MOLECULAR-WEIGHT HEPARIN; ANTITHROMBOTIC PROPHYLAXIS; PREGNANCY COMPLICATIONS; VENOUS THROMBOSIS; VAL34LEU POLYMORPHISM; FACTOR-VII; COMMON POLYMORPHISM; MEDICAL PROGRESS; WOMEN; preterm delivery; coagulation system; factorVII/factor XIII (1)
FACT, SSRP1, SPT16, ELF1, SPT6, Seed dormancy, AP-MS (1)
FACULTATIVE ANOXYGENIC PHOTOSYNTHESIS; OSCILLATORIA-LIMNETICA; RHODOBACTER-CAPSULATUS; ELECTRON-TRANSPORT; BACTERIUM; PURIFICATION; OXIDATION; PROTEINS; THYLAKOIDS; METABOLISM; (1)
FACULTATIVELY POLYGYNOUS ANT; KIN SELECTION; RATIOS; COLONIES; Stenamme debile; colony structure; sexual production; sex ratio; facultative polygyny (1)
F-AGGREGATE CENTERS; OPTICAL PROPERTIES; ABSORPTION; (1)
FAGUS-SYLVATICA L.; SHADE TOLERANCE; EUROPEAN BEECH; CLIMATE-CHANGE; PATTERNS; GROWTH; REGENERATION; TEMPERATE; MORTALITY; COMMUNITIES; dynamic model; Fagus sylvatica; monodominance; national forest inventory; natural regeneration; sapling competition; species interactions (1)
FAGUS-SYLVATICA L.; VEGETATION DYNAMICS; CO2 FERTILIZATION; LAND-USE; MODEL; GROWTH; PREDICTION; TEMPERATE; NITROGEN; BIOMASS (1)
FAILING HUMAN HEART; UBIQUITIN-PROTEASOME SYSTEM; ACTIVATED PROTEIN-KINASES; STEM-CELLS; MECHANICAL SUPPORT; DOWN-REGULATION; HYPERTROPHY; MYOCARDIUM; EXPRESSION; CYCLOOXYGENASE-2; Congestive heart failure; Left ventricular assist devices; Reverse cardiac remodeling; Cardiac transplantation; Cardiac hypertrophy (1)
FAILURE-FREE SURVIVAL; SYSTEMIC TREATMENT; RANDOMIZED-TRIAL; THERAPY; PREDNISONE; DIAGNOSIS; CYCLOSPORINE; THALIDOMIDE; MANAGEMENT; IBRUTINIB; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus Initial therapy; Treatment refractory (1)
FAILURE; STREPTOKINASE; DYSFUNCTION; GRAFT; (1)
FAILURE; SURVIVAL; ADULTS; SHOCK; ECMO; extracorporeal membrane oxygenation; long-term outcome; low cardiac output; resuscitation; survival (1)
Fake news detection, Social media networks, Graph machine learning (1)
fake news; fake news detection; BERT; transformer; pre-trained language model; binary classification (1)
FALICOV-KIMBALL MODEL; MEAN-FIELD THEORY; T-J MODEL; HUBBARD-MODEL; INFINITE DIMENSIONS; FERMIONS; LATTICE; SUPERCONDUCTORS (1)
Fallbeispiel, Lernschwierigkeiten, Einzelfallraster, protektive Faktoren, Risikofaktoren, Sonderpädagogik, Inklusion, problem-based learning (PBL), problemorientiertes Lernen (2)
Fallbeispiel, Verhaltensauffälligkeiten, Trauma, Lernschwierigkeiten, Einzelfallraster, protektive Faktoren, Risikofaktoren, Sonderpädagogik, Inklusion, problem-based learning (PBL), Lehrkraftpersönlichkeit (1)
FALSE ALARMS; ICU; FREQUENCY; intensive care unit; alarms (1)
FALSE ALARMS; NOISE; RELIABILITY; SLEEP; ICU; intensive care unit alarms; alarm algorithms; noise; cardiovascular monitoring; smart alarms; alarm database (1)
FALSE ALARMS; SLEEP; ICU; ICU alarms; Alarm reduction; Cardiovascular monitoring; Threshold alarms (1)
FALSE ALARMS; UNIT; ICU; RELIABILITY; NOISE; Monitoring alarrns; ICU; Noise level; Alarm algorithms; Collecting monitoring data (1)
FALSE DISCOVERY RATE; EEG; MEMORY; (1)
FALSE DISCOVERY RATE; GENOTYPING ERRORS; UNIFIED APPROACH; EMPIRICAL BAYES; TESTS; KORA; PROPORTION; GENETICS; GENES; false discovery rate; genome-wide association (GWA) studies; genotyping errors; multiple comparisons; multiple hypotheses testing; quality control; randomized p-values (1)
FALSE DISCOVERY RATES; N-TERMINAL ACETYLATION; S-LAYER GLYCOPROTEIN; HALOFERAX-VOLCANII; MASS-SPECTROMETRY; PEPTIDE IDENTIFICATION; MEMBRANE PROTEOME; STRESS RESPONSES; SIGNAL PEPTIDES; LONB PROTEASE; (1)
FALSE DISCOVERY RATE; SPINDLE CELL NEVUS; MALIGNANT-MELANOMAS; DNA-DAMAGE; PROTEIN; IDENTIFICATION; ACTIVATION; PATHWAYS; LESIONS; ATM; (1)
FALSE DISCOVERY RATE; STRESS REDUCTION; MINDFULNESS; MEDITATION; TRIALS; EEG; Sensorium; EEG; Neurofeedback; Mindfulness; Meditation (1)
false information; fake news; social media; gender; user type; trust in social media (1)
false information, rumours, perception of information, social media (1)
FALSE LUMEN; INTERNATIONAL REGISTRY; DESCENDING AORTA; ENTRY TEAR; FOLLOW-UP; THROMBOSIS; INSIGHTS; IRAD; FENESTRATION; LOCATION; Acute type B dissection; Uncomplicated; Stent graft; Thrombosis; Remodelling (1)
FALSE MEMORIES; ACCOUNT; LISTS; episodic memory; directed forgetting; intentional forgetting; encoding; inhibition (1)
FALSE MEMORIES; FREE-RECALL; STRATEGY DISRUPTION; TESTS; CUES; MECHANISMS; IMPAIRMENT; (1)
FAMILIAL ATRIAL-FIBRILLATION; LANGE-NIELSEN-SYNDROME; OF-FUNCTION MUTATION; I-KS CHANNELS; VENTRICULAR MYOCYTES; CARDIAC-ARRHYTHMIAS; PERIODIC PARALYSIS; ACID-SECRETION; CAUSE JERVELL; GENE; pH sensitivity; cardiac action potential; KvLQT1; IsK; Kv7.1 (1)
FAMILIAL COMBINED HYPERLIPIDEMIA; SOLUBLE ADENYLYL-CYCLASE; QUANTITATIVE TRAIT LOCUS; X-RAY-DIFFRACTION; TYROSINE PHOSPHORYLATION; CHOLESTEROL EFFLUX; HUMAN-SPERMATOZOA; MOUSE SPERM; MAMMALIAN SPERMATOZOA; CHROMOSOME 1Q21-Q23; (1)
FAMILIAL COMBINED HYPERLIPIDEMIA; TUMOR-NECROSIS-FACTOR; EARLY-ONSET OBESITY; ADIPOSE-TISSUE; PARTIAL LIPODYSTROPHY; STIMULATING PROTEIN; FRAMESHIFT MUTATION; FACTOR-ALPHA; GENE; EXPRESSION; apM-1; polymorphism; type 2 diabetes; obesity; adipocyte (1)
FAMILIAL DILATED CARDIOMYOPATHY; TITIN ISOFORM; MYOCARDIUM; EXPRESSION; MATURATION; STIFFNESS; HEART; GENE; FIBROBLASTS; DISRUPTION; RNA-binding motif protein 20 (RBM20); Induced pluripotent stem cells (iPSCs); Cardiomyocytes; Dilated cardiomyopathy (DCM); Alternative splicing; Titin (TTN) (1)